Citrus Sinensis ID: 010309

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510---
Protein Sequence
MNKDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEHENKCYYLHCHREYLITLGVVSGLILLTTFAIVIWLLAYRRSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPVTK
Secondary Structure (PSIPRED)
cccccccccccccccccccccEEEEEcccccHHHHHHHHHHccccccccccHHHHHHHHHHHccccccEEEccEEEcccccccEEEccccccccccccccccccccccccccccccccccEEEccccccccccccccccccccccccccccccccccccEEEEEEHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccHHHHHHHHccccccccccccccccccEEEEcccccEEEEEEcccccccHHHHHHHHHHHHHHccccccccEEEEEEEcccEEEEEEEcccccHHHHHcccccccccccHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccEEEcEEcccccccHHHHHccccccccccccHHHHHHHHHHHccccccccccccccHHHHHHHHHHHcccccccccccccccccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHcccccccccc
Secondary Structure Prediction (SSPRO)
cccccccccccccEEcccccccEEEEEccccccccccHccHccccHccccccHHHHHHHHHccccccccEEcccccccccccEcccccccccccccccccccccccccccccEccccccccccccccccccccccccccccccccccccccccccccccccEEEEHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccEEcHHHHHHHHccccHHccEccccccccEEEEEcccccEEEEEEEcccccccHHHHHHHHHHHHHHHHHHHHHEEEEEEccccEEEEEEEcccccHHHHHcccccccccccHHHHHHHHHHHHHHHHHHHHcccccEEEEcccHcHEEccccccccHccccHHEEcccccccEEEEEEEEEccHccHHHHHHccccHHHHHHHHHHHHHHHHccccccccccccccHHHHHHHHHHHHcccHHHHccHHHcccccccccHHHHHHHHHHHHHHHcccHcccccHHHHHHHHcccccccccc
Coil and Loop (DISEMBL)
mnkdwkapcppdwiineekskcfgyignfrswdesETYCKEIGGHLAALTSYEEEHSAQklcgknvngcwvggrsinttvglswkwsdnmsKWNESIHAVgsfnssctslpchvhaTVDLctlvsngsrslvtercntshpficmvehenkcyylHCHREYLITLGVVSGLILLTTFAIVIWLLAYRRSKrrrksrklsnpaasalvppswkvfttEELRSITKNFsegnrllgdsktggtysgilpdgsrVAVKRLKRSSFQRKKEFYSEIGRfarlhhpnlvavkgccydhgdryIVYEFVVngpldrwlhhiprggrsLDWAMRMKVATTLAQGIAFlhdkvkphvvhrdirasnvlldeefGAHLmgvglskfvpwevMQERTvmaggtygylapefvyrnelttksdvYSFGVLLLEIVsgrrpaqavdsVCWQSIFEWATPLVQSHRYLELLDPLIsslssdipeagVVQKVVDLVYACtqhvpsmrprmSHVVHQLqqlaqppvtk
Flexible Loop (DISEMBL)
mnkdwkapcppdwiineekSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEHENKCYYLHCHREYLITLGVVSGLILLTTFAIVIWLLAYrrskrrrksrklsnpaasalvppswkvftTEELRSITKnfsegnrllgdsktggtysgilpdgsrvavkrlkrssfqrkKEFYSEigrfarlhhpnLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQlqqlaqppvtk
Low Complexity Region (SEG)
MNKDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEHENKCYYLHCHREYLITLGVVSGLILLTTFAIVIWLLAYrrskrrrksrkLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYlelldplisslssdipeAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPVTK
Disordered region (IsUnstruct)
********CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEHENKCYYLHCHREYLITLGVVSGLILLTTFAIVIWLLAYR**********************SWKVFTTEELRSIT******************YSGIL*****VAV*******FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVP***********************
Disordered Region (DISOPRED)
******A*CPPDWIINEEKSKCFGYIGNFRSWDE*ETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVT*****************************ITLGVVSGLILLTTFAIVIWLL**************************WKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKR*K********EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQA*DSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA*P****
Disordered Region (DISEMBL)
MNKDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEHENKCYYLHCHREYLITLGVVSGLILLTTFAIVIWLLAYRR*****************LVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ*********
Disordered Region (DISPRO)
****WKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEHENKC****CHREYLITLGVVSGLILLTTFAIVIWLLAYRRSK******************PSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA******
Transmembrane Helix (TMHMM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MNKDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEHENKCYYLHCHREYLITLGVVSGLILLTTFAIVIWLLAYRRSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPVTK
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	513	2.2.26 [Sep-21-2011]
Q9C823	552	C-type lectin receptor-li	yes	no	0.964	0.896	0.699	0.0
Q9LSC2	361	PTI1-like tyrosine-protei	no	no	0.584	0.831	0.390	1e-54
Q9SX31	708	Proline-rich receptor-lik	no	no	0.664	0.481	0.338	3e-54
Q9FFW5	681	Proline-rich receptor-lik	no	no	0.654	0.493	0.333	5e-54
Q1PEM5	513	Proline-rich receptor-lik	no	no	0.666	0.666	0.351	8e-54
Q9LV48	652	Proline-rich receptor-lik	no	no	0.590	0.464	0.384	1e-53
Q9C660	762	Proline-rich receptor-lik	no	no	0.576	0.388	0.370	2e-53
C0LGG9	1035	Probable LRR receptor-lik	no	no	0.666	0.330	0.36	2e-53
Q9LS95	700	Putative proline-rich rec	no	no	0.551	0.404	0.405	1e-52
C0LGG8	1038	Probable LRR receptor-lik	no	no	0.573	0.283	0.387	4e-52

>sp|Q9C823|Y1523_ARATH C-type lectin receptor-like tyrosine-protein kinase At1g52310 OS=Arabidopsis thaliana GN=At1g52310 PE=2 SV=1

 Score =  703 bits (1814), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 353/505 (69%), Positives = 416/505 (82%), Gaps = 10/505 (1%)

Query: 9   CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 68
           CPPDWII   ++KC+ Y  N  SW++SE +C+  GGHLA+L S +E    QKLC  NV+ 
Sbjct: 50  CPPDWIIGPNQTKCYAYFKNSTSWEKSEMFCRTYGGHLASLASSKELSFVQKLCNGNVSS 109

Query: 69  CWVGGRSINT-TVGLSWKWSD-NMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN 126
           CW+GGRS+N+ T G  W WSD    +WN+S+       + C +         ++C  V+N
Sbjct: 110 CWIGGRSMNSSTSGFRWSWSDPKTPQWNQSMFPKVPIRTRCGNGNGSSSCRANICIAVTN 169

Query: 127 GSRSLVTERCNTSHPFICMVEHENKCYYLHCHREYLITLGVVSGLILLTTFAIVIWLLAY 186
           GS S+  ERCN SH F+C V+ + KC   +CH+ YL+ L VVSGLIL TTFAI++WLL Y
Sbjct: 170 GSSSIFGERCNASHAFVCAVDSDIKCR--NCHK-YLVILAVVSGLILFTTFAIILWLLVY 226

Query: 187 RRSKRRRKSRKLSNPAASALVPPS-WKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI 245
           +RSK+RRKSRK+SNPA+S+ V P  WK+FT+EELRS+TKNFSE NRL GD+KTGGTYSG 
Sbjct: 227 KRSKKRRKSRKVSNPASSSSVVPPSWKIFTSEELRSMTKNFSEANRLAGDAKTGGTYSGG 286

Query: 246 LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 305
           L DG++VAVKRLKRSSFQRKKEFYSEI R A+L+HPN+VA+KGCCYDHG+R+IVYEF+ +
Sbjct: 287 LSDGTKVAVKRLKRSSFQRKKEFYSEIRRAAKLYHPNVVAIKGCCYDHGERFIVYEFIAS 346

Query: 306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 365
           GPLDRWLHH+PRGGRSLDW MR+ +ATTLAQGIAFLHDKVKP VVHRDIRASNVLLDEEF
Sbjct: 347 GPLDRWLHHVPRGGRSLDWNMRLNIATTLAQGIAFLHDKVKPQVVHRDIRASNVLLDEEF 406

Query: 366 GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 425
           GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE+VYRNELTTKSDVYSFGVLLLEIVS
Sbjct: 407 GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEYVYRNELTTKSDVYSFGVLLLEIVS 466

Query: 426 GRRPAQAVD-SVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYA 484
           GRRP QAV+ SV WQSIFEWATPLVQ++R+LE+LDP+I   +  +PEA VVQKVVDLVY+
Sbjct: 467 GRRPTQAVNSSVGWQSIFEWATPLVQANRWLEILDPVI---TCGLPEACVVQKVVDLVYS 523

Query: 485 CTQHVPSMRPRMSHVVHQLQQLAQP 509
           CTQ+VPSMRPRMSHVVHQLQQL QP
Sbjct: 524 CTQNVPSMRPRMSHVVHQLQQLVQP 548

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 0EC: .EC: 1

>sp|Q9LSC2|Y3589_ARATH PTI1-like tyrosine-protein kinase At3g15890 OS=Arabidopsis thaliana GN=At3g15890 PE=1 SV=1

 Score =  214 bits (546), Expect = 1e-54,   Method: Compositional matrix adjust.
 Identities = 119/305 (39%), Positives = 176/305 (57%), Gaps = 5/305 (1%)

Query: 209 PSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEF 268
           PSW+VF+ +EL + T +F+  N+L G+ + G  Y G L DGS++AVKRLK  S + + +F
Sbjct: 22  PSWRVFSLKELHAATNSFNYDNKL-GEGRFGSVYWGQLWDGSQIAVKRLKEWSNREEIDF 80

Query: 269 YSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRM 328
             E+   AR+ H NL++V+G C +  +R +VYE++ N  L   LH        LDW  RM
Sbjct: 81  AVEVEILARIRHKNLLSVRGYCAEGQERLLVYEYMQNLSLVSHLHGQHSAECLLDWTKRM 140

Query: 329 KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 388
           K+A + AQ IA+LHD   PH+VH D+RASNVLLD EF A +   G  K +P +   +   
Sbjct: 141 KIAISSAQAIAYLHDHATPHIVHGDVRASNVLLDSEFEARVTDFGYGKLMPDDDTGDGAT 200

Query: 389 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPL 448
            A    GY++PE     + +  SDVYSFG+LL+ +VSG+RP + ++    + I EW  PL
Sbjct: 201 KAKSNNGYISPECDASGKESETSDVYSFGILLMVLVSGKRPLERLNPTTTRCITEWVLPL 260

Query: 449 VQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 508
           V    + E++D  +S        A  ++KVV +   C Q  P  RP MS VV  L   ++
Sbjct: 261 VYERNFGEIVDKRLSEEHV----AEKLKKVVLVGLMCAQTDPDKRPTMSEVVEMLVNESK 316

Query: 509 PPVTK 513
             +++
Sbjct: 317 EKISE 321

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 2

>sp|Q9SX31|PERK9_ARATH Proline-rich receptor-like protein kinase PERK9 OS=Arabidopsis thaliana GN=PERK9 PE=2 SV=1

 Score =  213 bits (542), Expect = 3e-54,   Method: Compositional matrix adjust.
 Identities = 132/390 (33%), Positives = 207/390 (53%), Gaps = 49/390 (12%)

Query: 162 LITLGVVSGLILLTTFAIVIWLLAYRRSKR-------------------------RRKS- 195
           ++ + V   L++ T F I +W L  +R KR                         R +S 
Sbjct: 281 VVGISVAVALVVFTLFGIFVWCL-RKREKRLSAVSGGDVTPSPMSSTARSDSAFFRMQSS 339

Query: 196 -------RKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPD 248
                  R  S  + S  +  S  +F+ EEL   T  FS+ N LLG+   G  Y GILPD
Sbjct: 340 APVGASKRSGSYQSQSGGLGNSKALFSYEELVKATNGFSQEN-LLGEGGFGCVYKGILPD 398

Query: 249 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 308
           G  VAVK+LK    Q  +EF +E+   +R+HH +LV++ G C     R ++Y++V N  L
Sbjct: 399 GRVVAVKQLKIGGGQGDREFKAEVETLSRIHHRHLVSIVGHCISGDRRLLIYDYVSNNDL 458

Query: 309 DRWLHHIPRGGRS-LDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA 367
              LH    G +S LDWA R+K+A   A+G+A+LH+   P ++HRDI++SN+LL++ F A
Sbjct: 459 YFHLH----GEKSVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLEDNFDA 514

Query: 368 HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGR 427
            +   GL++    +     T    GT+GY+APE+    +LT KSDV+SFGV+LLE+++GR
Sbjct: 515 RVSDFGLARLA-LDCNTHITTRVIGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGR 573

Query: 428 RPAQAVDSVCWQSIFEWATPL----VQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVY 483
           +P      +  +S+ EWA PL    +++  +  L DP    L  +  E+ +  ++++   
Sbjct: 574 KPVDTSQPLGDESLVEWARPLISHAIETEEFDSLADP---KLGGNYVESEMF-RMIEAAG 629

Query: 484 ACTQHVPSMRPRMSHVVHQLQQLAQPPVTK 513
           AC +H+ + RPRM  +V   + LA   +T 
Sbjct: 630 ACVRHLATKRPRMGQIVRAFESLAAEDLTN 659

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FFW5|PERK8_ARATH Proline-rich receptor-like protein kinase PERK8 OS=Arabidopsis thaliana GN=PERK8 PE=1 SV=1

 Score =  212 bits (540), Expect = 5e-54,   Method: Compositional matrix adjust.
 Identities = 131/393 (33%), Positives = 206/393 (52%), Gaps = 57/393 (14%)

Query: 162 LITLGVVSGLILLTTFAIVIWLLAYRRSKRRRKS-----------RKLSNPAASALV--- 207
           ++ +GV+ GL+ L+ F + +W       KR+RK               S+P  S +V   
Sbjct: 238 IVAIGVIVGLVFLSLFVMGVWFT----RKRKRKDPGTFVGYTMPPSAYSSPQGSDVVLFN 293

Query: 208 -----PPSWKV----------------------FTTEELRSITKNFSEGNRLLGDSKTGG 240
                PP  +                       F+ +EL  +T  FSE N LLG+   G 
Sbjct: 294 SRSSAPPKMRSHSGSDYMYASSDSGMVSNQRSWFSYDELSQVTSGFSEKN-LLGEGGFGC 352

Query: 241 TYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY 300
            Y G+L DG  VAVK+LK    Q ++EF +E+   +R+HH +LV + G C     R +VY
Sbjct: 353 VYKGVLSDGREVAVKQLKIGGSQGEREFKAEVEIISRVHHRHLVTLVGYCISEQHRLLVY 412

Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
           ++V N  L   LH    G   + W  R++VA   A+GIA+LH+   P ++HRDI++SN+L
Sbjct: 413 DYVPNNTLHYHLHA--PGRPVMTWETRVRVAAGAARGIAYLHEDCHPRIIHRDIKSSNIL 470

Query: 361 LDEEFGAHLMGVGLSKFV-PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVL 419
           LD  F A +   GL+K     ++    +    GT+GY+APE+    +L+ K+DVYS+GV+
Sbjct: 471 LDNSFEALVADFGLAKIAQELDLNTHVSTRVMGTFGYMAPEYATSGKLSEKADVYSYGVI 530

Query: 420 LLEIVSGRRPAQAVDSVCWQSIFEWATPL----VQSHRYLELLDPLISSLSSDIPEAGVV 475
           LLE+++GR+P      +  +S+ EWA PL    +++  + EL+DP +    + IP  G +
Sbjct: 531 LLELITGRKPVDTSQPLGDESLVEWARPLLGQAIENEEFDELVDPRLG--KNFIP--GEM 586

Query: 476 QKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 508
            ++V+   AC +H  + RP+MS VV  L  L +
Sbjct: 587 FRMVEAAAACVRHSAAKRPKMSQVVRALDTLEE 619

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q1PEM5|PERK3_ARATH Proline-rich receptor-like protein kinase PERK3 OS=Arabidopsis thaliana GN=PERK3 PE=2 SV=2

 Score =  211 bits (538), Expect = 8e-54,   Method: Compositional matrix adjust.
 Identities = 122/347 (35%), Positives = 193/347 (55%), Gaps = 5/347 (1%)

Query: 163 ITLGVVSGLILLTTFAIVIWLLAYRRSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSI 222
           ++ G V G+ +     ++  +    + KR R  + L  P    L       FT  EL   
Sbjct: 121 LSTGAVVGISIGGGVFVLTLIFFLCKKKRPRDDKALPAPIGLVL-GIHQSTFTYGELARA 179

Query: 223 TKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPN 282
           T  FSE N LLG+   G  Y GIL +G+ VAVK+LK  S Q +KEF +E+   +++HH N
Sbjct: 180 TNKFSEAN-LLGEGGFGFVYKGILNNGNEVAVKQLKVGSAQGEKEFQAEVNIISQIHHRN 238

Query: 283 LVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLH 342
           LV++ G C     R +VYEFV N  L+  LH   +G  +++W++R+K+A + ++G+++LH
Sbjct: 239 LVSLVGYCIAGAQRLLVYEFVPNNTLEFHLHG--KGRPTMEWSLRLKIAVSSSKGLSYLH 296

Query: 343 DKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFV 402
           +   P ++HRDI+A+N+L+D +F A +   GL+K +  +     +    GT+GYLAPE+ 
Sbjct: 297 ENCNPKIIHRDIKAANILIDFKFEAKVADFGLAK-IALDTNTHVSTRVMGTFGYLAPEYA 355

Query: 403 YRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI 462
              +LT KSDVYSFGV+LLE+++GRRP  A +     S+ +WA PL+         + L 
Sbjct: 356 ASGKLTEKSDVYSFGVVLLELITGRRPVDANNVYADDSLVDWARPLLVQALEESNFEGLA 415

Query: 463 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 509
               ++  +   + ++V    AC ++    RPRM  VV  L+    P
Sbjct: 416 DIKLNNEYDREEMARMVACAAACVRYTARRRPRMDQVVRVLEGNISP 462

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1

 Score =  211 bits (537), Expect = 1e-53,   Method: Compositional matrix adjust.
 Identities = 118/307 (38%), Positives = 178/307 (57%), Gaps = 4/307 (1%)

Query: 198 LSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRL 257
           L  P+   ++  S   FT EEL   T  FSE N LLG    G  + GILP G  VAVK+L
Sbjct: 252 LPPPSPGLVLGFSKSTFTYEELSRATNGFSEAN-LLGQGGFGYVHKGILPSGKEVAVKQL 310

Query: 258 KRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPR 317
           K  S Q ++EF +E+   +R+HH +LV++ G C     R +VYEFV N  L+  LH   +
Sbjct: 311 KAGSGQGEREFQAEVEIISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHG--K 368

Query: 318 GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF 377
           G  +++W+ R+K+A   A+G+++LH+   P ++HRDI+ASN+L+D +F A +   GL+K 
Sbjct: 369 GRPTMEWSTRLKIALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAK- 427

Query: 378 VPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVC 437
           +  +     +    GT+GYLAPE+    +LT KSDV+SFGV+LLE+++GRRP  A +   
Sbjct: 428 IASDTNTHVSTRVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYV 487

Query: 438 WQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMS 497
             S+ +WA PL+         + L  S   +  +   + ++V    AC +H    RPRMS
Sbjct: 488 DDSLVDWARPLLNRASEEGDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMS 547

Query: 498 HVVHQLQ 504
            +V  L+
Sbjct: 548 QIVRALE 554

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9C660|PEK10_ARATH Proline-rich receptor-like protein kinase PERK10 OS=Arabidopsis thaliana GN=PERK10 PE=1 SV=2

 Score =  210 bits (535), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 114/308 (37%), Positives = 178/308 (57%), Gaps = 12/308 (3%)

Query: 210 SWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFY 269
           S ++F+ EEL   T  FS+ N LLG+   G  Y G+LPD   VAVK+LK    Q  +EF 
Sbjct: 414 SRELFSYEELVIATNGFSDEN-LLGEGGFGRVYKGVLPDERVVAVKQLKIGGGQGDREFK 472

Query: 270 SEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMK 329
           +E+   +R+HH NL+++ G C     R ++Y++V N  L  + H    G   LDWA R+K
Sbjct: 473 AEVDTISRVHHRNLLSMVGYCISENRRLLIYDYVPNNNL--YFHLHAAGTPGLDWATRVK 530

Query: 330 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 389
           +A   A+G+A+LH+   P ++HRDI++SN+LL+  F A +   GL+K    +     T  
Sbjct: 531 IAAGAARGLAYLHEDCHPRIIHRDIKSSNILLENNFHALVSDFGLAKLA-LDCNTHITTR 589

Query: 390 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLV 449
             GT+GY+APE+    +LT KSDV+SFGV+LLE+++GR+P  A   +  +S+ EWA PL+
Sbjct: 590 VMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLL 649

Query: 450 ----QSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ 505
               ++  +  L DP +      +     + ++++   AC +H  + RPRMS +V     
Sbjct: 650 SNATETEEFTALADPKLGRNYVGV----EMFRMIEAAAACIRHSATKRPRMSQIVRAFDS 705

Query: 506 LAQPPVTK 513
           LA+  +T 
Sbjct: 706 LAEEDLTN 713

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGG9|Y5344_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53440 OS=Arabidopsis thaliana GN=At1g53440 PE=1 SV=2

 Score =  210 bits (534), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 126/350 (36%), Positives = 190/350 (54%), Gaps = 8/350 (2%)

Query: 166 GVVSGLILLTTFAIVIWLLAYRRSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKN 225
           GVV+G+++    A  + +L   R       +++        +      FT ++++  T N
Sbjct: 607 GVVAGIVIAACVAFGLLVLVILRLTGYLGGKEVDENEELRGLDLQTGSFTLKQIKRATNN 666

Query: 226 FSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVA 285
           F   N++ G+   G  Y G+L DG  +AVK+L   S Q  +EF +EIG  + L HPNLV 
Sbjct: 667 FDPENKI-GEGGFGPVYKGVLADGMTIAVKQLSSKSKQGNREFVTEIGMISALQHPNLVK 725

Query: 286 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 345
           + GCC +  +  +VYE++ N  L R L    +    LDW+ R KV   +A+G+A+LH++ 
Sbjct: 726 LYGCCIEGKELLLVYEYLENNSLARALFGTEKQRLHLDWSTRNKVCIGIAKGLAYLHEES 785

Query: 346 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN 405
           +  +VHRDI+A+NVLLD    A +   GL+K    E     T +A GT GY+APE+  R 
Sbjct: 786 RLKIVHRDIKATNVLLDLSLNAKISDFGLAKLDEEENTHISTRIA-GTIGYMAPEYAMRG 844

Query: 406 ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL 465
            LT K+DVYSFGV+ LEIVSG+          +  + +WA  L +    LEL+DP + + 
Sbjct: 845 YLTDKADVYSFGVVCLEIVSGKSNTNYRPKEEFIYLLDWAYVLQEQGSLLELVDPDLGT- 903

Query: 466 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ--LAQPPVTK 513
           S    EA    +++++   CT   P++RP MS VV  LQ     QPP+ K
Sbjct: 904 SFSKKEA---MRMLNIALLCTNPSPTLRPPMSSVVSMLQGKIKVQPPLVK 950

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LS95|PERK6_ARATH Putative proline-rich receptor-like protein kinase PERK6 OS=Arabidopsis thaliana GN=PERK6 PE=2 SV=2

 Score =  207 bits (528), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 120/296 (40%), Positives = 176/296 (59%), Gaps = 13/296 (4%)

Query: 213 VFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEI 272
            FT +EL + T+ FS+ +RLLG    G  + GILP+G  +AVK LK  S Q ++EF +E+
Sbjct: 324 TFTYDELAAATQGFSQ-SRLLGQGGFGYVHKGILPNGKEIAVKSLKAGSGQGEREFQAEV 382

Query: 273 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVAT 332
              +R+HH  LV++ G C   G R +VYEF+ N  L+  LH   + G+ LDW  R+K+A 
Sbjct: 383 DIISRVHHRFLVSLVGYCIAGGQRMLVYEFLPNDTLEFHLHG--KSGKVLDWPTRLKIAL 440

Query: 333 TLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG 392
             A+G+A+LH+   P ++HRDI+ASN+LLDE F A +   GL+K     V    T +  G
Sbjct: 441 GSAKGLAYLHEDCHPRIIHRDIKASNILLDESFEAKVADFGLAKLSQDNVTHVSTRIM-G 499

Query: 393 TYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPL---- 448
           T+GYLAPE+    +LT +SDV+SFGV+LLE+V+GRRP      +   S+ +WA P+    
Sbjct: 500 TFGYLAPEYASSGKLTDRSDVFSFGVMLLELVTGRRPVDLTGEM-EDSLVDWARPICLNA 558

Query: 449 VQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ 504
            Q   Y EL+DP + +      E   + ++V    A  +H    RP+MS +V  L+
Sbjct: 559 AQDGDYSELVDPRLENQY----EPHEMAQMVACAAAAVRHSARRRPKMSQIVRALE 610

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGG8|Y5343_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53430 OS=Arabidopsis thaliana GN=At1g53430 PE=1 SV=1

 Score =  206 bits (524), Expect = 4e-52,   Method: Compositional matrix adjust.
 Identities = 117/302 (38%), Positives = 173/302 (57%), Gaps = 8/302 (2%)

Query: 214 FTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIG 273
           FT ++++  T NF   N++ G+   G  Y G+L DG  +AVK+L   S Q  +EF +EIG
Sbjct: 657 FTLKQIKRATNNFDPENKI-GEGGFGPVYKGVLADGMTIAVKQLSSKSKQGNREFVTEIG 715

Query: 274 RFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATT 333
             + L HPNLV + GCC +  +  +VYE++ N  L R L    +    LDW+ R K+   
Sbjct: 716 MISALQHPNLVKLYGCCIEGKELLLVYEYLENNSLARALFGTEKQRLHLDWSTRNKICIG 775

Query: 334 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT 393
           +A+G+A+LH++ +  +VHRDI+A+NVLLD    A +   GL+K    E     T +A GT
Sbjct: 776 IAKGLAYLHEESRLKIVHRDIKATNVLLDLSLNAKISDFGLAKLNDDENTHISTRIA-GT 834

Query: 394 YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHR 453
            GY+APE+  R  LT K+DVYSFGV+ LEIVSG+          +  + +WA  L +   
Sbjct: 835 IGYMAPEYAMRGYLTDKADVYSFGVVCLEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGS 894

Query: 454 YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ--LAQPPV 511
            LEL+DP + + S    EA    +++++   CT   P++RP MS VV  L+     QPP+
Sbjct: 895 LLELVDPDLGT-SFSKKEA---MRMLNIALLCTNPSPTLRPPMSSVVSMLEGKIKVQPPL 950

Query: 512 TK 513
            K
Sbjct: 951 VK 952

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	513
225455058	542	PREDICTED: C-type lectin receptor-like t	0.978	0.926	0.828	0.0
255556651	552	kinase, putative [Ricinus communis] gi|2	0.992	0.922	0.802	0.0
224137796	516	predicted protein [Populus trichocarpa]	0.972	0.967	0.810	0.0
449503381	557	PREDICTED: C-type lectin receptor-like t	0.990	0.912	0.743	0.0
449454927	557	PREDICTED: C-type lectin receptor-like t	0.988	0.910	0.743	0.0
297745082	517	unnamed protein product [Vitis vinifera]	0.902	0.895	0.759	0.0
356532800	545	PREDICTED: C-type lectin receptor-like t	0.984	0.926	0.724	0.0
356558437	547	PREDICTED: C-type lectin receptor-like t	0.984	0.923	0.726	0.0
357134621	557	PREDICTED: C-type lectin receptor-like t	0.961	0.885	0.709	0.0
115434006	555	Os01g0104000 [Oryza sativa Japonica Grou	0.961	0.888	0.713	0.0

>gi|225455058|ref|XP_002263812.1| PREDICTED: C-type lectin receptor-like tyrosine-protein kinase At1g52310-like [Vitis vinifera]

 Score =  863 bits (2230), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 421/508 (82%), Positives = 455/508 (89%), Gaps = 6/508 (1%)

Query: 6   KAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN 65
           +A CPPDWI   +K+KCF YIGN +SWD SE YCK +GGHLAALTS++E  S Q LCG++
Sbjct: 41  EALCPPDWITGPDKNKCFRYIGNPQSWDVSEAYCKSLGGHLAALTSFQELSSVQNLCGES 100

Query: 66  VNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVS 125
            NGCWVGGR +N+T G  WKWSDN S WNESI        +CT+  CH+  +VD CTLV+
Sbjct: 101 NNGCWVGGRGVNSTFGAGWKWSDNTSHWNESIFP------NCTNSSCHIKNSVDSCTLVT 154

Query: 126 NGSRSLVTERCNTSHPFICMVEHENKCYYLHCHREYLITLGVVSGLILLTTFAIVIWLLA 185
           NGS  L+ ERCN SH  ICM++ ENKCY++HCH+EYLI L VVSGLIL TT A+VIWLLA
Sbjct: 155 NGSTFLIGERCNMSHASICMIDIENKCYHMHCHKEYLIILAVVSGLILSTTLAVVIWLLA 214

Query: 186 YRRSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI 245
           YRRSKRRR+SRKLSNPAASALVPPSWKVFT EELRSITKNFSEGNRLLGD+KTGGTYSG+
Sbjct: 215 YRRSKRRRRSRKLSNPAASALVPPSWKVFTNEELRSITKNFSEGNRLLGDAKTGGTYSGL 274

Query: 246 LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 305
           LPDGSRVAVKRLKRS+FQRKKEFYSEIGR ARLHHPNLVAVKGCCYDHGDRYIVYEF++N
Sbjct: 275 LPDGSRVAVKRLKRSTFQRKKEFYSEIGRVARLHHPNLVAVKGCCYDHGDRYIVYEFIIN 334

Query: 306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 365
           GPLDRWLHHIPRGGRSLDWAMRMK+ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF
Sbjct: 335 GPLDRWLHHIPRGGRSLDWAMRMKIATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 394

Query: 366 GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 425
           GAHLMGVGLSKFV WEVM + TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS
Sbjct: 395 GAHLMGVGLSKFVSWEVMHQGTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 454

Query: 426 GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYAC 485
           GRRPAQAVDSV WQSIFEWATPLVQSHRY ELLDPLISS S+DIPEAGV+QKVVDLVYAC
Sbjct: 455 GRRPAQAVDSVGWQSIFEWATPLVQSHRYPELLDPLISSSSADIPEAGVIQKVVDLVYAC 514

Query: 486 TQHVPSMRPRMSHVVHQLQQLAQPPVTK 513
           TQHVPSMRPRMSHVVHQLQQLAQPP+ K
Sbjct: 515 TQHVPSMRPRMSHVVHQLQQLAQPPIAK 542

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255556651|ref|XP_002519359.1| kinase, putative [Ricinus communis] gi|223541426|gb|EEF42976.1| kinase, putative [Ricinus communis]

 Score =  829 bits (2141), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 411/512 (80%), Positives = 443/512 (86%), Gaps = 3/512 (0%)

Query: 2   NKDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKL 61
           NK W   C   W I+  K KC  Y    +SWD+SE  C   GGHLAALTS +E   A++L
Sbjct: 44  NKGW---CHSGWDISPNKKKCLKYFEKSKSWDDSEALCASYGGHLAALTSSQELTFAKQL 100

Query: 62  CGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLC 121
           CG+ V+GCWVG R IN+TVG +WKW DN S WNESI +  SF+S CT+L CH +AT + C
Sbjct: 101 CGQIVDGCWVGERVINSTVGSNWKWFDNTSYWNESILSGASFDSKCTNLSCHNNATAEFC 160

Query: 122 TLVSNGSRSLVTERCNTSHPFICMVEHENKCYYLHCHREYLITLGVVSGLILLTTFAIVI 181
           TLV+N +  LV ERCN SH FICM++ ENKCY++HCHREYLI L VVSGLIL T  A+VI
Sbjct: 161 TLVNNRTTHLVDERCNKSHVFICMLDAENKCYHMHCHREYLIILAVVSGLILCTALAVVI 220

Query: 182 WLLAYRRSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGT 241
           WLLAYRRS++RRKSRKLSNPAASALVPPSWKVFT EELRSITKNFSEGNRL GD+KTGGT
Sbjct: 221 WLLAYRRSRKRRKSRKLSNPAASALVPPSWKVFTNEELRSITKNFSEGNRLPGDAKTGGT 280

Query: 242 YSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE 301
           YSG+LPDGSRVAVKRLKRSSFQRKKEFYSEIGR ARLHHPNLVA+KGCCYDHGDRYIVYE
Sbjct: 281 YSGLLPDGSRVAVKRLKRSSFQRKKEFYSEIGRVARLHHPNLVAIKGCCYDHGDRYIVYE 340

Query: 302 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL 361
           FVVNGPLDRWLHHI RGGRSLDW MRMK+ATTLAQGIAFLHDKVKPHVVHRDIRASNVLL
Sbjct: 341 FVVNGPLDRWLHHISRGGRSLDWTMRMKIATTLAQGIAFLHDKVKPHVVHRDIRASNVLL 400

Query: 362 DEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLL 421
           DEEFGAHLMGVGLSKFVPWEVM E TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLL
Sbjct: 401 DEEFGAHLMGVGLSKFVPWEVMHEGTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLL 460

Query: 422 EIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDL 481
           EIV+GRRPAQAVDSV WQSIFEWATPLVQ+HRY ELLDPLI S SS+IPE GV+QKVVDL
Sbjct: 461 EIVTGRRPAQAVDSVGWQSIFEWATPLVQAHRYPELLDPLIYSSSSEIPEPGVIQKVVDL 520

Query: 482 VYACTQHVPSMRPRMSHVVHQLQQLAQPPVTK 513
           VYACTQHVPSMRPRMSHVVHQLQQLAQ    K
Sbjct: 521 VYACTQHVPSMRPRMSHVVHQLQQLAQSSSLK 552

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224137796|ref|XP_002326442.1| predicted protein [Populus trichocarpa] gi|222833764|gb|EEE72241.1| predicted protein [Populus trichocarpa]

 Score =  823 bits (2126), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 406/501 (81%), Positives = 439/501 (87%), Gaps = 2/501 (0%)

Query: 9   CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 68
           CP  W I+  KSKCF  I  F+SW+ESE  C   GGH+A LTS EE   AQKLCG+  NG
Sbjct: 18  CPSGWAISPNKSKCFKLIRRFKSWNESENRCMHYGGHVAGLTSSEELSFAQKLCGQTANG 77

Query: 69  CWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS 128
           CW GGR +N+T+G  WKWSD+ S  N+SI     F  +CTSL C      DLCT+V NG+
Sbjct: 78  CWAGGRVMNSTIGFIWKWSDSTSHMNQSI-VPEPFPLNCTSLSCRNSIAADLCTVV-NGT 135

Query: 129 RSLVTERCNTSHPFICMVEHENKCYYLHCHREYLITLGVVSGLILLTTFAIVIWLLAYRR 188
             LV ERCN+SH FICM++ E KCY++HCHREYLI L VVSGLIL TT A+VIWLLAYRR
Sbjct: 136 ADLVAERCNSSHAFICMLDVEKKCYHMHCHREYLIILAVVSGLILCTTLAVVIWLLAYRR 195

Query: 189 SKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPD 248
           SK+RRKSRKLSNPAASALVPPSWKVFT EELRSITKNFSEGNRLLGD+KTGGTYSG LPD
Sbjct: 196 SKKRRKSRKLSNPAASALVPPSWKVFTNEELRSITKNFSEGNRLLGDAKTGGTYSGFLPD 255

Query: 249 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 308
           GSRVAVKRLKRSSFQRKKEFYSEIGR ARLHHPNLVA+KGCCYDHGDRYIVYEF++NGPL
Sbjct: 256 GSRVAVKRLKRSSFQRKKEFYSEIGRVARLHHPNLVAIKGCCYDHGDRYIVYEFILNGPL 315

Query: 309 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 368
           DRWLHH+PRGGRSLDWAMRMK+ATTLAQGIAFLHDKVKPHVVHRDIRAS+VLLDEEFGAH
Sbjct: 316 DRWLHHVPRGGRSLDWAMRMKIATTLAQGIAFLHDKVKPHVVHRDIRASSVLLDEEFGAH 375

Query: 369 LMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRR 428
           LMGVGLSKF+PWEVM ERT+MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRR
Sbjct: 376 LMGVGLSKFMPWEVMHERTMMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRR 435

Query: 429 PAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQH 488
           P QAVDSV WQSIFEWATPLVQ+HRY ELLDPLI+  SSD+PEAGV+QKVVDLVYACTQH
Sbjct: 436 PMQAVDSVGWQSIFEWATPLVQAHRYPELLDPLITPPSSDVPEAGVIQKVVDLVYACTQH 495

Query: 489 VPSMRPRMSHVVHQLQQLAQP 509
           VPSMRPRMSHVVHQLQQLAQP
Sbjct: 496 VPSMRPRMSHVVHQLQQLAQP 516

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449503381|ref|XP_004161974.1| PREDICTED: C-type lectin receptor-like tyrosine-protein kinase At1g52310-like [Cucumis sativus]

 Score =  790 bits (2039), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 380/511 (74%), Positives = 440/511 (86%), Gaps = 3/511 (0%)

Query: 6   KAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN 65
           K  CP  WII+  K+KCFG++ + +SW++SET C   GG+LAAL +Y+E   AQ LC   
Sbjct: 46  KGRCPHGWIISPSKTKCFGFMSSPKSWNDSETQCNSFGGNLAALVTYQEFSYAQNLCNGT 105

Query: 66  VNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVS 125
           + GCWVGGR+ N+     WKWSDN+SKWN+SI    +  S+C +  CH + +V+ CTL+ 
Sbjct: 106 LGGCWVGGRAFNSLNDFVWKWSDNVSKWNDSIFPSATLQSNCKNASCHRNDSVETCTLIF 165

Query: 126 NGSRS--LVTERCNTSHPFICMVEHENKCYYLHCHREYLITLGVVSGLILLTTFAIVIWL 183
            G  +  L  E+CN+SHPFICM+  +++C+ +HCH+EYL+ L VVSGLI  TT A+VIWL
Sbjct: 166 GGPATPFLRDEKCNSSHPFICMINLDDRCHRMHCHKEYLVILAVVSGLIFCTTLAVVIWL 225

Query: 184 LAYRRSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYS 243
           LA++RSK+RR+SRK SNPAASALVPP W+VFT EELRS+TKNFSEGNRLLGD+KTGGTYS
Sbjct: 226 LAHKRSKKRRRSRKPSNPAASALVPPLWRVFTKEELRSMTKNFSEGNRLLGDAKTGGTYS 285

Query: 244 GILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 303
           G+LPDGSRVA+KRLK+SSFQRKKEF+SEI R ARL HPNLVA+KGCCYDHGDRYIVYEF+
Sbjct: 286 GLLPDGSRVAIKRLKKSSFQRKKEFHSEIARVARLRHPNLVALKGCCYDHGDRYIVYEFI 345

Query: 304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 363
           VNGPLDRWLHH+PRGGRSLDW MRMK+ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE
Sbjct: 346 VNGPLDRWLHHVPRGGRSLDWTMRMKIATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 405

Query: 364 EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 423
           EFGAHLMGVGLSK V +EVM ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI
Sbjct: 406 EFGAHLMGVGLSKLVAYEVMHERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 465

Query: 424 VSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS-SDIPEAGVVQKVVDLV 482
           V+GRRPAQAVDSV WQSIFEWATPLVQ+HRYL+LLDP I++ S S+IPEAG+VQKVVDLV
Sbjct: 466 VTGRRPAQAVDSVGWQSIFEWATPLVQAHRYLDLLDPHITATSTSEIPEAGIVQKVVDLV 525

Query: 483 YACTQHVPSMRPRMSHVVHQLQQLAQPPVTK 513
           YACTQHVPSMRPRMSHVVHQLQQLA  P+T+
Sbjct: 526 YACTQHVPSMRPRMSHVVHQLQQLAPSPLTR 556

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449454927|ref|XP_004145205.1| PREDICTED: C-type lectin receptor-like tyrosine-protein kinase At1g52310-like [Cucumis sativus] gi|449473071|ref|XP_004153775.1| PREDICTED: C-type lectin receptor-like tyrosine-protein kinase At1g52310-like [Cucumis sativus]

 Score =  785 bits (2028), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 379/510 (74%), Positives = 438/510 (85%), Gaps = 3/510 (0%)

Query: 6   KAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN 65
           K  CP  WII+  K+KCFG++ + +SW++SET C   GG+LAAL +Y+E   AQ LC   
Sbjct: 46  KGRCPHGWIISPSKTKCFGFMSSPKSWNDSETQCNSFGGNLAALVTYQEFSYAQNLCNGT 105

Query: 66  VNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVS 125
           + GCWVGGR+ N+     WKWSDN+SKWN+SI    +  S+C +  C  + +V+ CTL+ 
Sbjct: 106 LGGCWVGGRAFNSLNDFVWKWSDNVSKWNDSIFPSATLQSNCKNASCLRNDSVETCTLIF 165

Query: 126 NGSRS--LVTERCNTSHPFICMVEHENKCYYLHCHREYLITLGVVSGLILLTTFAIVIWL 183
            G  +  L  E+CN+SHPFICM+  +++C+ +HCH+EYL+ L VVSGLI  TT A+VIWL
Sbjct: 166 GGPATPFLRDEKCNSSHPFICMINLDDRCHRMHCHKEYLVILAVVSGLIFCTTLAVVIWL 225

Query: 184 LAYRRSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYS 243
           LA++RSK+RR+SRK SNPAASALVPP W+VFT EELRS+TKNFSEGNRLLGD+KTGGTYS
Sbjct: 226 LAHKRSKKRRRSRKPSNPAASALVPPLWRVFTKEELRSMTKNFSEGNRLLGDAKTGGTYS 285

Query: 244 GILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 303
           G+LPDGSRVA+KRLK+SSFQRKKEF+SEI R ARL HPNLVA+KGCCYDHGDRYIVYEF+
Sbjct: 286 GLLPDGSRVAIKRLKKSSFQRKKEFHSEIARVARLRHPNLVALKGCCYDHGDRYIVYEFI 345

Query: 304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 363
           VNGPLDRWLHH+PRGGRSLDW MRMK+ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE
Sbjct: 346 VNGPLDRWLHHVPRGGRSLDWTMRMKIATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 405

Query: 364 EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 423
           EFGAHLMGVGLSK V +EVM ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI
Sbjct: 406 EFGAHLMGVGLSKLVAYEVMHERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 465

Query: 424 VSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS-SDIPEAGVVQKVVDLV 482
           V+GRRPAQAVDSV WQSIFEWATPLVQ+HRYL+LLDP I++ S S+IPEAG+VQKVVDLV
Sbjct: 466 VTGRRPAQAVDSVGWQSIFEWATPLVQAHRYLDLLDPHITATSTSEIPEAGIVQKVVDLV 525

Query: 483 YACTQHVPSMRPRMSHVVHQLQQLAQPPVT 512
           YACTQHVPSMRPRMSHVVHQLQQLA  P+T
Sbjct: 526 YACTQHVPSMRPRMSHVVHQLQQLAPSPLT 555

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297745082|emb|CBI38674.3| unnamed protein product [Vitis vinifera]

 Score =  774 bits (1998), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 386/508 (75%), Positives = 418/508 (82%), Gaps = 45/508 (8%)

Query: 6   KAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN 65
           +A CPPDWI   +K+KCF YIGN +SWD SE YCK +GGHLAALTS++E  S Q LCG++
Sbjct: 55  EALCPPDWITGPDKNKCFRYIGNPQSWDVSEAYCKSLGGHLAALTSFQELSSVQNLCGES 114

Query: 66  VNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVS 125
            NGCWVGGR +N+T G  WKWSDN S WNESI        +CT+  CH+  +VD CTLV+
Sbjct: 115 NNGCWVGGRGVNSTFGAGWKWSDNTSHWNESIFP------NCTNSSCHIKNSVDSCTLVT 168

Query: 126 NGSRSLVTERCNTSHPFICMVEHENKCYYLHCHREYLITLGVVSGLILLTTFAIVIWLLA 185
           NGS  L+ ERCN SH  ICM++ ENKCY++HCH+EYLI L VVSGLIL TT A+VIWLLA
Sbjct: 169 NGSTFLIGERCNMSHASICMIDIENKCYHMHCHKEYLIILAVVSGLILSTTLAVVIWLLA 228

Query: 186 YRRSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI 245
           YRRSKRRR+SRKLSNPAASALVPPSWKVFT EELRSITKNFSEGNRLLGD+KTGGTYSG+
Sbjct: 229 YRRSKRRRRSRKLSNPAASALVPPSWKVFTNEELRSITKNFSEGNRLLGDAKTGGTYSGL 288

Query: 246 LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 305
           LPDGSRVAVKRLKRS+FQRKKEFYSEIGR ARLHHPNLVAVKGCCYDHGDRYIVYEF++N
Sbjct: 289 LPDGSRVAVKRLKRSTFQRKKEFYSEIGRVARLHHPNLVAVKGCCYDHGDRYIVYEFIIN 348

Query: 306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 365
           GPLDRWLHHIPRGGRSLDWAMRMK+ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF
Sbjct: 349 GPLDRWLHHIPRGGRSLDWAMRMKIATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 408

Query: 366 GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 425
           GAHLMGVGLSKFV WEVM + TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS
Sbjct: 409 GAHLMGVGLSKFVSWEVMHQGTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 468

Query: 426 GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYAC 485
           GRRPAQAVDSV WQSIFEWATPL                                     
Sbjct: 469 GRRPAQAVDSVGWQSIFEWATPL------------------------------------- 491

Query: 486 TQHVPSMRPRMSHVVHQLQQLAQPPVTK 513
             HVPSMRPRMSHVVHQLQQLAQPP+ K
Sbjct: 492 --HVPSMRPRMSHVVHQLQQLAQPPIAK 517

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356532800|ref|XP_003534958.1| PREDICTED: C-type lectin receptor-like tyrosine-protein kinase At1g52310-like [Glycine max]

 Score =  746 bits (1927), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 371/512 (72%), Positives = 428/512 (83%), Gaps = 7/512 (1%)

Query: 1   MNKDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQK 60
           +N+D K PCP  W+++  K+KCF ++G  +SW++SET C + GGHL +LTS +E   AQ 
Sbjct: 37  LNRDPKVPCPIGWVMDPNKTKCFLHVGRPQSWNDSETCCSKYGGHLVSLTSLQELQFAQS 96

Query: 61  LCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSC--TSLPCHVHATV 118
           LCG+++N CW+GG+ +N+T G  W WS+N S WN SI ++ +    C  T   CH ++T 
Sbjct: 97  LCGESINSCWIGGQRLNSTAGYQWMWSNN-SPWNNSIFSMVNVPPHCNGTGPSCHRNSTD 155

Query: 119 DLCTLVSNGSRSLVTERCNTSHPFICMVEHENKCYYLHCHREYLITLGVVSGLILLTTFA 178
           +LCT+V+N S SL+TERC+  H  +C+++ + K   +H  REYLI L VVS LIL TT +
Sbjct: 156 NLCTVVTNNSNSLITERCDNPHASLCILDIDTKRNQMHRRREYLIILTVVSTLILSTTLS 215

Query: 179 IVIWLLAYRRSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKT 238
           +V+WLL Y+R K+RR+SRKLS P AS    PSWKVFT EELRSITKNFSEGNRL+GD+KT
Sbjct: 216 VVVWLLVYKRGKKRRRSRKLSIPGASL---PSWKVFTKEELRSITKNFSEGNRLVGDAKT 272

Query: 239 GGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYI 298
           GGTYSG+L DGS+VAVKRLKRSSFQRKKEFYSEI R ARL HPNLVAV GCCYDHGDRYI
Sbjct: 273 GGTYSGVLSDGSKVAVKRLKRSSFQRKKEFYSEISRVARLRHPNLVAVMGCCYDHGDRYI 332

Query: 299 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASN 358
           VYEFV NGPLD+WLHHIPRGGR+LDWAMRMK+ATTLAQGIAFLHDKVKP VVHRDIRASN
Sbjct: 333 VYEFVANGPLDKWLHHIPRGGRNLDWAMRMKIATTLAQGIAFLHDKVKPQVVHRDIRASN 392

Query: 359 VLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGV 418
           VLLDEEFGA LMGVGLSKFVP+EVM ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGV
Sbjct: 393 VLLDEEFGAQLMGVGLSKFVPYEVMHERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGV 452

Query: 419 LLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKV 478
           LLLEIVSGRRPAQAVDSV WQSIFEWATPLVQ+HRY ELLD  I+S SS IPEA  +QKV
Sbjct: 453 LLLEIVSGRRPAQAVDSVGWQSIFEWATPLVQAHRYHELLDLHITS-SSIIPEASTIQKV 511

Query: 479 VDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 510
           VDLVY+CTQHVPSMRPRMSHVVHQLQQ+AQPP
Sbjct: 512 VDLVYSCTQHVPSMRPRMSHVVHQLQQIAQPP 543

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356558437|ref|XP_003547513.1| PREDICTED: C-type lectin receptor-like tyrosine-protein kinase At1g52310-like [Glycine max]

 Score =  736 bits (1901), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 372/512 (72%), Positives = 421/512 (82%), Gaps = 7/512 (1%)

Query: 1   MNKDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQK 60
           +N+D K PCP  WI++  K+KCF ++G  +SW++SET C + GGHL +LTS  E   AQ 
Sbjct: 37  LNRDPKVPCPIGWIMDPNKTKCFLHVGRPQSWNDSETCCSKYGGHLVSLTSLPELQFAQG 96

Query: 61  LCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSC--TSLPCHVHATV 118
           LCG+++N CWVGG+ +N T G  W WSDN S WN SI ++      C  T   CH ++T 
Sbjct: 97  LCGESINSCWVGGQRVNATAGNQWMWSDN-SPWNNSIFSMVEVPPHCNGTGPSCHRNSTD 155

Query: 119 DLCTLVSNGSRSLVTERCNTSHPFICMVEHENKCYYLHCHREYLITLGVVSGLILLTTFA 178
           +LCT+V+N S SL TERCN  H  +C+++ + KC  +H  REY I L VVS LIL TT A
Sbjct: 156 NLCTVVTNNSNSLTTERCNNPHASLCILDIDTKCNQMHRRREYFIILTVVSALILSTTLA 215

Query: 179 IVIWLLAYRRSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKT 238
           +V+WLL Y+R K+RR+SRKLS P AS    PSWKVFT EELRSITKNFSEGNRL+GD+KT
Sbjct: 216 VVVWLLVYKRGKKRRRSRKLSIPGASL---PSWKVFTKEELRSITKNFSEGNRLVGDTKT 272

Query: 239 GGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYI 298
           GGTYSG++ DGS+VAVKRLKRS+FQRKKEFYSEIGR ARL HPNLVAV GCCYDHGDRYI
Sbjct: 273 GGTYSGVVSDGSKVAVKRLKRSNFQRKKEFYSEIGRVARLRHPNLVAVMGCCYDHGDRYI 332

Query: 299 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASN 358
           VYEFV NGPLD+WLHHIPRGGRSLDWAMRMK+ATTLAQGIAFLHDKVKP VVHRDIR SN
Sbjct: 333 VYEFVANGPLDKWLHHIPRGGRSLDWAMRMKIATTLAQGIAFLHDKVKPQVVHRDIRTSN 392

Query: 359 VLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGV 418
           VLLDEEFGA LMGVGLSKFVP+EVM ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGV
Sbjct: 393 VLLDEEFGARLMGVGLSKFVPYEVMHERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGV 452

Query: 419 LLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS-SLSSDIPEAGVVQK 477
           LLLEIVSGRRPAQAVDSV WQSIFEWATPLVQ+HRY ELLD  I+ S SS IPEA  +QK
Sbjct: 453 LLLEIVSGRRPAQAVDSVGWQSIFEWATPLVQAHRYHELLDLHITSSSSSIIPEASTIQK 512

Query: 478 VVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 509
           VVDLVY+CTQHVPSMRPRMSHV HQLQQ+ QP
Sbjct: 513 VVDLVYSCTQHVPSMRPRMSHVFHQLQQITQP 544

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357134621|ref|XP_003568915.1| PREDICTED: C-type lectin receptor-like tyrosine-protein kinase At1g52310-like [Brachypodium distachyon]

 Score =  727 bits (1877), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 356/502 (70%), Positives = 416/502 (82%), Gaps = 9/502 (1%)

Query: 9   CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 68
           CP  W I+ ++ KCF +I +  SWD SE  C+   GHLAAL+S ++ + A+ LCG + +G
Sbjct: 30  CPQGWQISPDRVKCFMHISSSLSWDGSEALCRNFSGHLAALSSVQDLNFAKSLCGASSSG 89

Query: 69  CWVGGR----SINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLV 124
           CWVGGR    S NTT  + WKWSD+ S WN+++      +++C S  C +  + D+CTLV
Sbjct: 90  CWVGGRRYNTSSNTTSVVGWKWSDDSSFWNQTVFPGEPSHANCNSTHCGLATSYDICTLV 149

Query: 125 SNGSRSLVTERCNTSHPFICMVEHENKCYYLHCHREYLITLGVVSGLILLTTFAIVIWLL 184
           +N   +L   +C  SH  ICM+ HE++CY+ HCH+EY I L VVSGLIL TT A+V+WLL
Sbjct: 150 TNKHAALTGRKCGESHGLICMINHEDRCYHDHCHKEYFIVLIVVSGLILSTTLAVVVWLL 209

Query: 185 AYRRSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSG 244
            YRRSK+RR+SR+ S  +A+ALVPP WKVFT EELRSITKNFSEGNRL G++KTGGTYSG
Sbjct: 210 VYRRSKKRRRSREASGTSATALVPPLWKVFTGEELRSITKNFSEGNRLPGNAKTGGTYSG 269

Query: 245 ILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 304
           I+PDGS+VA+KRLKRSS QRKK+FYSEI R A+L+HPNLVAVKGCCYDHGDR+IVYEFV 
Sbjct: 270 IMPDGSKVAIKRLKRSSLQRKKDFYSEISRVAKLYHPNLVAVKGCCYDHGDRFIVYEFVA 329

Query: 305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 364
           NGPLD WLHHIPRGGRSLDW  RM+VATTLAQGIAFLHDKVKP VVHRDIRASNVLLDEE
Sbjct: 330 NGPLDVWLHHIPRGGRSLDWVTRMRVATTLAQGIAFLHDKVKPQVVHRDIRASNVLLDEE 389

Query: 365 FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIV 424
           FG+HLMGVGLSKFVPWEVM ERTV A  TYGYLAPEF+YRNELTTKSDVYSFGVLLLEI+
Sbjct: 390 FGSHLMGVGLSKFVPWEVMHERTVKA-ATYGYLAPEFIYRNELTTKSDVYSFGVLLLEII 448

Query: 425 SGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYA 484
           SGRRPAQ+V+SV WQ+IFEWATPLVQSHRYLELLDPLI    +D+PE GV+QKVVDLVY+
Sbjct: 449 SGRRPAQSVESVGWQTIFEWATPLVQSHRYLELLDPLI----NDLPEVGVIQKVVDLVYS 504

Query: 485 CTQHVPSMRPRMSHVVHQLQQL 506
           CTQHVPS+RPRMSHVVHQLQQL
Sbjct: 505 CTQHVPSVRPRMSHVVHQLQQL 526

Source: Brachypodium distachyon

Species: Brachypodium distachyon

Genus: Brachypodium

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|115434006|ref|NP_001041761.1| Os01g0104000 [Oryza sativa Japonica Group] gi|52075662|dbj|BAD44832.1| putative protein kinase [Oryza sativa Japonica Group] gi|113531292|dbj|BAF03675.1| Os01g0104000 [Oryza sativa Japonica Group] gi|125568686|gb|EAZ10201.1| hypothetical protein OsJ_00032 [Oryza sativa Japonica Group]

 Score =  723 bits (1867), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 356/499 (71%), Positives = 408/499 (81%), Gaps = 6/499 (1%)

Query: 9   CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE-IGGHLAALTSYEEEHSAQKLCGKNVN 67
           CP  W I     KCF YI    SWD SE  C+     HLAAL+S ++ + A+ LCG + +
Sbjct: 32  CPDGWQITPALDKCFIYIPTPLSWDRSEALCRNNFTAHLAALSSLQDLNLAKSLCGPSPS 91

Query: 68  GCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG 127
           GCWVGG   NT    +WKWSD+ S WN++        ++C++  C +  T D CTLV+N 
Sbjct: 92  GCWVGGHRNNTASAFAWKWSDDSSSWNDTAFPADPLRANCSTTGCALATTNDACTLVTNT 151

Query: 128 SRSLVTERCNTSHPFICMVEHENKCYYLHCHREYLITLGVVSGLILLTTFAIVIWLLAYR 187
             +L  +RC+ SH  ICM+ HE++CY+ HCH+EY I L VVSG ILLTT A+V+WLL YR
Sbjct: 152 HAALTAKRCSDSHGLICMINHEDRCYHDHCHKEYFIVLVVVSGFILLTTLAVVVWLLVYR 211

Query: 188 RSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILP 247
           RSKRRR+SR+ S+ +A+ALVPP WKVFT+EELRSITKNFSEGNRL G++KTGGTYSGILP
Sbjct: 212 RSKRRRRSREGSSTSATALVPPLWKVFTSEELRSITKNFSEGNRLPGNAKTGGTYSGILP 271

Query: 248 DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 307
           DGSRVA+KRLKRSS QRKK+FYSEIGR A+L+HPNLVAVKGCCYDHGDR+IVYEFV NGP
Sbjct: 272 DGSRVAIKRLKRSSLQRKKDFYSEIGRVAKLYHPNLVAVKGCCYDHGDRFIVYEFVANGP 331

Query: 308 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA 367
           LD WLHH+PRGGR LDW MRM+VATTLAQGIAFLHDKVKP VVHRDIRASNVLLDEEFG+
Sbjct: 332 LDVWLHHVPRGGRCLDWPMRMRVATTLAQGIAFLHDKVKPQVVHRDIRASNVLLDEEFGS 391

Query: 368 HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGR 427
           HLMGVGLSKFVPWEVM ERTV A  TYGYLAPEF+YRNELTTKSDVYSFGVLLLEI+SGR
Sbjct: 392 HLMGVGLSKFVPWEVMHERTVKA-ATYGYLAPEFIYRNELTTKSDVYSFGVLLLEIISGR 450

Query: 428 RPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQ 487
           RP Q+V+SV WQ+IFEWATPLVQSHRYLELLDPLI  L    P+ GV+QKVVDLVYACTQ
Sbjct: 451 RPTQSVESVGWQTIFEWATPLVQSHRYLELLDPLIQEL----PDVGVIQKVVDLVYACTQ 506

Query: 488 HVPSMRPRMSHVVHQLQQL 506
           HVPS+RPRMSHVVHQLQQL
Sbjct: 507 HVPSVRPRMSHVVHQLQQL 525

Source: Oryza sativa Japonica Group

Species: Oryza sativa

Genus: Oryza

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	513
TAIR|locus:2018189	552	AT1G52310 [Arabidopsis thalian	0.964	0.896	0.669	1.4e-183
TAIR|locus:2026925	708	PERK9 "proline-rich extensin-l	0.571	0.413	0.374	2.6e-53
TAIR|locus:2159873	681	PERK8 "proline-rich extensin-l	0.573	0.431	0.37	1.4e-52
TAIR|locus:2028756	762	PERK10 "proline-rich extensin-	0.580	0.391	0.378	6.5e-51
TAIR|locus:2091722	652	PERK1 "proline-rich extensin-l	0.590	0.464	0.377	8.3e-51
UNIPROTKB|Q9ARH1	647	Q9ARH1 "Receptor protein kinas	0.590	0.468	0.374	1.1e-50
TAIR|locus:2093900	361	AT3G15890 [Arabidopsis thalian	0.565	0.803	0.396	4.6e-50
TAIR|locus:2093999	700	PERK6 "proline-rich extensin-l	0.557	0.408	0.388	7.4e-50
TAIR|locus:2026846	710	PERK13 "proline-rich extensin-	0.573	0.414	0.384	9.5e-50
TAIR|locus:2125692	731	PERK14 "proline-rich extensin-	0.586	0.411	0.375	3.4e-49

TAIR|locus:2018189 AT1G52310 [Arabidopsis thaliana (taxid:3702)]

 Score = 1781 (632.0 bits), Expect = 1.4e-183, P = 1.4e-183
 Identities = 338/505 (66%), Positives = 397/505 (78%)

Query:     9 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 68
             CPPDWII   ++KC+ Y  N  SW++SE +C+  GGHLA+L S +E    QKLC  NV+ 
Sbjct:    50 CPPDWIIGPNQTKCYAYFKNSTSWEKSEMFCRTYGGHLASLASSKELSFVQKLCNGNVSS 109

Query:    69 CWVGGRSINT-TVGLSWKWSDNMS-KWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN 126
             CW+GGRS+N+ T G  W WSD  + +WN+S+       + C +         ++C  V+N
Sbjct:   110 CWIGGRSMNSSTSGFRWSWSDPKTPQWNQSMFPKVPIRTRCGNGNGSSSCRANICIAVTN 169

Query:   127 GSRSLVTERCNTSHPFICMVEHENKCYYLHCHREYLITLGVVSGLILLTTFAIVIWLLAY 186
             GS S+  ERCN SH F+C V+ + KC   +CH+ YL+ L VVSGLIL TTFAI++WLL Y
Sbjct:   170 GSSSIFGERCNASHAFVCAVDSDIKCR--NCHK-YLVILAVVSGLILFTTFAIILWLLVY 226

Query:   187 XXXXXXXXXXXLSNPAASA-LVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI 245
                        +SNPA+S+ +VPPSWK+FT+EELRS+TKNFSE NRL GD+KTGGTYSG 
Sbjct:   227 KRSKKRRKSRKVSNPASSSSVVPPSWKIFTSEELRSMTKNFSEANRLAGDAKTGGTYSGG 286

Query:   246 LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 305
             L DG++VAVKRLKRSSFQRKKEFYSEI R A+L+HPN+VA+KGCCYDHG+R+IVYEF+ +
Sbjct:   287 LSDGTKVAVKRLKRSSFQRKKEFYSEIRRAAKLYHPNVVAIKGCCYDHGERFIVYEFIAS 346

Query:   306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 365
             GPLDRWLHH+PRGGRSLDW MR+ +ATTLAQGIAFLHDKVKP VVHRDIRASNVLLDEEF
Sbjct:   347 GPLDRWLHHVPRGGRSLDWNMRLNIATTLAQGIAFLHDKVKPQVVHRDIRASNVLLDEEF 406

Query:   366 GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 425
             GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE+VYRNELTTKSDVYSFGVLLLEIVS
Sbjct:   407 GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEYVYRNELTTKSDVYSFGVLLLEIVS 466

Query:   426 GRRPAQAVDS-VCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYA 484
             GRRP QAV+S V WQSIFEWATPLVQ++R+                 A VVQKVVDLVY+
Sbjct:   467 GRRPTQAVNSSVGWQSIFEWATPLVQANRWLEILDPVITCGLPE---ACVVQKVVDLVYS 523

Query:   485 CTQHVPSMRPRMSHVVHQLQQLAQP 509
             CTQ+VPSMRPRMSHVVHQLQQL QP
Sbjct:   524 CTQNVPSMRPRMSHVVHQLQQLVQP 548

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006346 "methylation-dependent chromatin silencing" evidence=RCA

GO:0007267 "cell-cell signaling" evidence=RCA

GO:0009616 "virus induced gene silencing" evidence=RCA

GO:0009855 "determination of bilateral symmetry" evidence=RCA

GO:0009887 "organ morphogenesis" evidence=RCA

GO:0010014 "meristem initiation" evidence=RCA

GO:0010048 "vernalization response" evidence=RCA

GO:0010050 "vegetative phase change" evidence=RCA

GO:0010051 "xylem and phloem pattern formation" evidence=RCA

GO:0010073 "meristem maintenance" evidence=RCA

GO:0010267 "production of ta-siRNAs involved in RNA interference" evidence=RCA

GO:0016246 "RNA interference" evidence=RCA

GO:0035196 "production of miRNAs involved in gene silencing by miRNA" evidence=RCA

GO:0048439 "flower morphogenesis" evidence=RCA

GO:0048519 "negative regulation of biological process" evidence=RCA

TAIR|locus:2026925 PERK9 "proline-rich extensin-like receptor kinase 9" [Arabidopsis thaliana (taxid:3702)]

 Score = 525 (189.9 bits), Expect = 2.6e-53, Sum P(2) = 2.6e-53
 Identities = 113/302 (37%), Positives = 173/302 (57%)

Query:   213 VFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEI 272
             +F+ EEL   T  FS+ N LLG+   G  Y GILPDG  VAVK+LK    Q  +EF +E+
Sbjct:   364 LFSYEELVKATNGFSQEN-LLGEGGFGCVYKGILPDGRVVAVKQLKIGGGQGDREFKAEV 422

Query:   273 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS-LDWAMRMKVA 331
                +R+HH +LV++ G C     R ++Y++V N  L   LH    G +S LDWA R+K+A
Sbjct:   423 ETLSRIHHRHLVSIVGHCISGDRRLLIYDYVSNNDLYFHLH----GEKSVLDWATRVKIA 478

Query:   332 TTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG 391
                A+G+A+LH+   P ++HRDI++SN+LL++ F A +   GL++    +     T    
Sbjct:   479 AGAARGLAYLHEDCHPRIIHRDIKSSNILLEDNFDARVSDFGLARLA-LDCNTHITTRVI 537

Query:   392 GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQS 451
             GT+GY+APE+    +LT KSDV+SFGV+LLE+++GR+P      +  +S+ EWA PL+ S
Sbjct:   538 GTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDTSQPLGDESLVEWARPLI-S 596

Query:   452 HRYXXXXXXXXXXXXXXXXXA-GVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 510
             H                       + ++++   AC +H+ + RPRM  +V   + LA   
Sbjct:   597 HAIETEEFDSLADPKLGGNYVESEMFRMIEAAGACVRHLATKRPRMGQIVRAFESLAAED 656

Query:   511 VT 512
             +T
Sbjct:   657 LT 658

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2159873 PERK8 "proline-rich extensin-like receptor kinase 8" [Arabidopsis thaliana (taxid:3702)]

 Score = 509 (184.2 bits), Expect = 1.4e-52, Sum P(2) = 1.4e-52
 Identities = 111/300 (37%), Positives = 168/300 (56%)

Query:   210 SWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFY 269
             SW  F+ +EL  +T  FSE N LLG+   G  Y G+L DG  VAVK+LK    Q ++EF 
Sbjct:   325 SW--FSYDELSQVTSGFSEKN-LLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGEREFK 381

Query:   270 SEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMK 329
             +E+   +R+HH +LV + G C     R +VY++V N  L   LH  P G   + W  R++
Sbjct:   382 AEVEIISRVHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLH-AP-GRPVMTWETRVR 439

Query:   330 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP-WEVMQERTV 388
             VA   A+GIA+LH+   P ++HRDI++SN+LLD  F A +   GL+K     ++    + 
Sbjct:   440 VAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVST 499

Query:   389 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPL 448
                GT+GY+APE+    +L+ K+DVYS+GV+LLE+++GR+P      +  +S+ EWA PL
Sbjct:   500 RVMGTFGYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDESLVEWARPL 559

Query:   449 VQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 508
             +                       G + ++V+   AC +H  + RP+MS VV  L  L +
Sbjct:   560 LGQAIENEEFDELVDPRLGKNFIPGEMFRMVEAAAACVRHSAAKRPKMSQVVRALDTLEE 619

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005199 "structural constituent of cell wall" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2028756 PERK10 "proline-rich extensin-like receptor kinase 10" [Arabidopsis thaliana (taxid:3702)]

 Score = 530 (191.6 bits), Expect = 6.5e-51, P = 6.5e-51
 Identities = 115/304 (37%), Positives = 173/304 (56%)

Query:   210 SWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFY 269
             S ++F+ EEL   T  FS+ N LLG+   G  Y G+LPD   VAVK+LK    Q  +EF 
Sbjct:   414 SRELFSYEELVIATNGFSDEN-LLGEGGFGRVYKGVLPDERVVAVKQLKIGGGQGDREFK 472

Query:   270 SEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMK 329
             +E+   +R+HH NL+++ G C     R ++Y++V N  L   LH    G   LDWA R+K
Sbjct:   473 AEVDTISRVHHRNLLSMVGYCISENRRLLIYDYVPNNNLYFHLH--AAGTPGLDWATRVK 530

Query:   330 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 389
             +A   A+G+A+LH+   P ++HRDI++SN+LL+  F A +   GL+K    +     T  
Sbjct:   531 IAAGAARGLAYLHEDCHPRIIHRDIKSSNILLENNFHALVSDFGLAKLA-LDCNTHITTR 589

Query:   390 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLV 449
               GT+GY+APE+    +LT KSDV+SFGV+LLE+++GR+P  A   +  +S+ EWA PL+
Sbjct:   590 VMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLL 649

Query:   450 QSHRYXXXXXXXXXXXXXXXXXAGVVQ-KVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 508
              S+                    GV   ++++   AC +H  + RPRMS +V     LA+
Sbjct:   650 -SNATETEEFTALADPKLGRNYVGVEMFRMIEAAAACIRHSATKRPRMSQIVRAFDSLAE 708

Query:   509 PPVT 512
               +T
Sbjct:   709 EDLT 712

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2091722 PERK1 "proline-rich extensin-like receptor kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 528 (190.9 bits), Expect = 8.3e-51, P = 8.3e-51
 Identities = 116/307 (37%), Positives = 172/307 (56%)

Query:   198 LSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRL 257
             L  P+   ++  S   FT EEL   T  FSE N LLG    G  + GILP G  VAVK+L
Sbjct:   252 LPPPSPGLVLGFSKSTFTYEELSRATNGFSEAN-LLGQGGFGYVHKGILPSGKEVAVKQL 310

Query:   258 KRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPR 317
             K  S Q ++EF +E+   +R+HH +LV++ G C     R +VYEFV N  L+  LH   +
Sbjct:   311 KAGSGQGEREFQAEVEIISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHG--K 368

Query:   318 GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF 377
             G  +++W+ R+K+A   A+G+++LH+   P ++HRDI+ASN+L+D +F A +   GL+K 
Sbjct:   369 GRPTMEWSTRLKIALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKI 428

Query:   378 VPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVC 437
                +     +    GT+GYLAPE+    +LT KSDV+SFGV+LLE+++GRRP  A +   
Sbjct:   429 AS-DTNTHVSTRVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYV 487

Query:   438 WQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMS 497
               S+ +WA PL+                         + ++V    AC +H    RPRMS
Sbjct:   488 DDSLVDWARPLLNRASEEGDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMS 547

Query:   498 HVVHQLQ 504
              +V  L+
Sbjct:   548 QIVRALE 554

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;ISS;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009611 "response to wounding" evidence=ISS

GO:0009620 "response to fungus" evidence=ISS

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

GO:0052541 "plant-type cell wall cellulose metabolic process" evidence=RCA

GO:0052546 "cell wall pectin metabolic process" evidence=RCA

UNIPROTKB|Q9ARH1 Q9ARH1 "Receptor protein kinase PERK1" [Brassica napus (taxid:3708)]

 Score = 527 (190.6 bits), Expect = 1.1e-50, P = 1.1e-50
 Identities = 115/307 (37%), Positives = 171/307 (55%)

Query:   198 LSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRL 257
             L  P+   ++  S   FT EEL   T  FSE N LLG    G  + G+LP G  VAVK+L
Sbjct:   247 LPPPSPGLVLGFSKSTFTYEELARATNGFSEAN-LLGQGGFGYVHKGVLPSGKEVAVKQL 305

Query:   258 KRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPR 317
             K  S Q ++EF +E+   +R+HH +LV++ G C     R +VYEFV N  L+  LH    
Sbjct:   306 KVGSGQGEREFQAEVEIISRVHHRHLVSLVGYCIAGAKRLLVYEFVPNNNLELHLHG--E 363

Query:   318 GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF 377
             G  +++W+ R+K+A   A+G+++LH+   P ++HRDI+ASN+L+D +F A +   GL+K 
Sbjct:   364 GRPTMEWSTRLKIALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKI 423

Query:   378 VPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVC 437
                +     +    GT+GYLAPE+    +LT KSDV+SFGV+LLE+++GRRP  A +   
Sbjct:   424 AS-DTNTHVSTRVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYV 482

Query:   438 WQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMS 497
               S+ +WA PL+                         + ++V    AC +H    RPRMS
Sbjct:   483 DDSLVDWARPLLNRASEQGDFEGLADAKMNNGYDREEMARMVACAAACVRHSARRRPRMS 542

Query:   498 HVVHQLQ 504
              +V  L+
Sbjct:   543 QIVRALE 549

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0005887 "integral to plasma membrane" evidence=IDA

TAIR|locus:2093900 AT3G15890 [Arabidopsis thaliana (taxid:3702)]

 Score = 521 (188.5 bits), Expect = 4.6e-50, P = 4.6e-50
 Identities = 117/295 (39%), Positives = 165/295 (55%)

Query:   209 PSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEF 268
             PSW+VF+ +EL + T +F+  N+L G+ + G  Y G L DGS++AVKRLK  S + + +F
Sbjct:    22 PSWRVFSLKELHAATNSFNYDNKL-GEGRFGSVYWGQLWDGSQIAVKRLKEWSNREEIDF 80

Query:   269 YSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRM 328
               E+   AR+ H NL++V+G C +  +R +VYE++ N  L   LH        LDW  RM
Sbjct:    81 AVEVEILARIRHKNLLSVRGYCAEGQERLLVYEYMQNLSLVSHLHGQHSAECLLDWTKRM 140

Query:   329 KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 388
             K+A + AQ IA+LHD   PH+VH D+RASNVLLD EF A +   G  K +P +   +   
Sbjct:   141 KIAISSAQAIAYLHDHATPHIVHGDVRASNVLLDSEFEARVTDFGYGKLMPDDDTGDGAT 200

Query:   389 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPL 448
              A    GY++PE     + +  SDVYSFG+LL+ +VSG+RP + ++    + I EW  PL
Sbjct:   201 KAKSNNGYISPECDASGKESETSDVYSFGILLMVLVSGKRPLERLNPTTTRCITEWVLPL 260

Query:   449 VQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQL 503
             V    Y                 A  ++KVV +   C Q  P  RP MS VV  L
Sbjct:   261 V----YERNFGEIVDKRLSEEHVAEKLKKVVLVGLMCAQTDPDKRPTMSEVVEML 311

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2093999 PERK6 "proline-rich extensin-like receptor kinase 6" [Arabidopsis thaliana (taxid:3702)]

 Score = 519 (187.8 bits), Expect = 7.4e-50, P = 7.4e-50
 Identities = 113/291 (38%), Positives = 167/291 (57%)

Query:   214 FTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIG 273
             FT +EL + T+ FS+ +RLLG    G  + GILP+G  +AVK LK  S Q ++EF +E+ 
Sbjct:   325 FTYDELAAATQGFSQ-SRLLGQGGFGYVHKGILPNGKEIAVKSLKAGSGQGEREFQAEVD 383

Query:   274 RFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATT 333
               +R+HH  LV++ G C   G R +VYEF+ N  L+  LH   + G+ LDW  R+K+A  
Sbjct:   384 IISRVHHRFLVSLVGYCIAGGQRMLVYEFLPNDTLEFHLHG--KSGKVLDWPTRLKIALG 441

Query:   334 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT 393
              A+G+A+LH+   P ++HRDI+ASN+LLDE F A +   GL+K     V    T + G T
Sbjct:   442 SAKGLAYLHEDCHPRIIHRDIKASNILLDESFEAKVADFGLAKLSQDNVTHVSTRIMG-T 500

Query:   394 YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHR 453
             +GYLAPE+    +LT +SDV+SFGV+LLE+V+GRRP      +   S+ +WA P+  +  
Sbjct:   501 FGYLAPEYASSGKLTDRSDVFSFGVMLLELVTGRRPVDLTGEM-EDSLVDWARPICLNAA 559

Query:   454 YXXXXXXXXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ 504
                                  + ++V    A  +H    RP+MS +V  L+
Sbjct:   560 QDGDYSELVDPRLENQYEPHEMAQMVACAAAAVRHSARRRPKMSQIVRALE 610

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2026846 PERK13 "proline-rich extensin-like receptor kinase 13" [Arabidopsis thaliana (taxid:3702)]

 Score = 518 (187.4 bits), Expect = 9.5e-50, P = 9.5e-50
 Identities = 116/302 (38%), Positives = 173/302 (57%)

Query:   204 SALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQ 263
             SA++      FT EEL  IT+ FS+ N +LG+   G  Y G L DG  VAVK+LK  S Q
Sbjct:   331 SAVMGSGQTHFTYEELTDITEGFSKHN-ILGEGGFGCVYKGKLNDGKLVAVKQLKVGSGQ 389

Query:   264 RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS-L 322
               +EF +E+   +R+HH +LV++ G C    +R ++YE+V N  L+   HH+   GR  L
Sbjct:   390 GDREFKAEVEIISRVHHRHLVSLVGYCIADSERLLIYEYVPNQTLE---HHLHGKGRPVL 446

Query:   323 DWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 382
             +WA R+++A   A+G+A+LH+   P ++HRDI+++N+LLD+EF A +   GL+K      
Sbjct:   447 EWARRVRIAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADFGLAKLNDSTQ 506

Query:   383 MQERT-VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSI 441
                 T VM  GT+GYLAPE+    +LT +SDV+SFGV+LLE+++GR+P      +  +S+
Sbjct:   507 THVSTRVM--GTFGYLAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQYQPLGEESL 564

Query:   442 FEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 501
              EWA PL+                         V ++++   AC +H    RPRM  VV 
Sbjct:   565 VEWARPLLHKAIETGDFSELVDRRLEKHYVENEVFRMIETAAACVRHSGPKRPRMVQVVR 624

Query:   502 QL 503
              L
Sbjct:   625 AL 626

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0016020 "membrane" evidence=ISS

GO:0048765 "root hair cell differentiation" evidence=RCA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2125692 PERK14 "proline-rich extensin-like receptor kinase 14" [Arabidopsis thaliana (taxid:3702)]

 Score = 513 (185.6 bits), Expect = 3.4e-49, P = 3.4e-49
 Identities = 116/309 (37%), Positives = 175/309 (56%)

Query:   199 SNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLK 258
             +N  A  +  PS  +F+ EEL   T  FSE N LLG+   G  + G+L +G+ VAVK+LK
Sbjct:   363 NNSVAKNISMPSG-MFSYEELSKATGGFSEEN-LLGEGGFGYVHKGVLKNGTEVAVKQLK 420

Query:   259 RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRG 318
               S+Q ++EF +E+   +R+HH +LV++ G C +   R +VYEFV    L+  LH     
Sbjct:   421 IGSYQGEREFQAEVDTISRVHHKHLVSLVGYCVNGDKRLLVYEFVPKDTLEFHLHE--NR 478

Query:   319 GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 378
             G  L+W MR+++A   A+G+A+LH+   P ++HRDI+A+N+LLD +F A +   GL+KF 
Sbjct:   479 GSVLEWEMRLRIAVGAAKGLAYLHEDCSPTIIHRDIKAANILLDSKFEAKVSDFGLAKFF 538

Query:   379 PWEVMQERTVMAG---GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS 435
               +     T ++    GT+GY+APE+    ++T KSDVYSFGV+LLE+++GR    A DS
Sbjct:   539 S-DTNSSFTHISTRVVGTFGYMAPEYASSGKVTDKSDVYSFGVVLLELITGRPSIFAKDS 597

Query:   436 VCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPR 495
                QS+ +WA PL+                         +  +     AC +    +RPR
Sbjct:   598 STNQSLVDWARPLLTKAISGESFDFLVDSRLEKNYDTTQMANMAACAAACIRQSAWLRPR 657

Query:   496 MSHVVHQLQ 504
             MS VV  L+
Sbjct:   658 MSQVVRALE 666

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9C823	Y1523_ARATH	2, ., 7, ., 1, 0, ., 1	0.6990	0.9649	0.8967	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: estExt_fgenesh4_pg.C_290027 hypothetical protein (517 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	513
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-37
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	4e-37
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-36
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	5e-36
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	7e-35
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	3e-34
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-33
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	9e-27
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-26
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	6e-26
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-25
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-24
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-24
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	4e-24
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	9e-24
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-23
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-22
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-22
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-21
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	6e-21
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-20
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	4e-20
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-19
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	3e-19
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	6e-19
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-18
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-18
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-18
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	4e-18
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-17
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	3e-17
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	5e-17
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-16
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-16
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-16
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-16
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-16
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-16
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-16
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-16
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	3e-16
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	3e-16
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	4e-16
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	4e-16
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	5e-16
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	7e-16
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	9e-16
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-15
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-15
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-15
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-15
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-15
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-15
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-15
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	3e-15
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-15
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	3e-15
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	3e-15
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	3e-15
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	4e-15
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	6e-15
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	6e-15
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	7e-15
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	7e-15
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-14
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-14
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-14
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-14
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	1e-14
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-14
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	4e-14
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	4e-14
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	5e-14
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	6e-14
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	6e-14
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	6e-14
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	7e-14
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	7e-14
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	8e-14
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	8e-14
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-13
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-13
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-13
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-13
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	3e-13
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	4e-13
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	5e-13
smart00034	124	smart00034, CLECT, C-type lectin (CTL) or carbohyd	5e-13
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	5e-13
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	6e-13
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	7e-13
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	7e-13
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	8e-13
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	9e-13
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	9e-13
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-12
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-12
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-12
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-12
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-12
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-12
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-12
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-12
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-12
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	3e-12
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	5e-12
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	5e-12
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	6e-12
cd00037	116	cd00037, CLECT, C-type lectin (CTL)/C-type lectin-	6e-12
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	9e-12
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	9e-12
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	9e-12
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	9e-12
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-11
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-11
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-11
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-11
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-11
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-11
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-11
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	3e-11
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-11
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	3e-11
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	4e-11
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	4e-11
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	5e-11
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	5e-11
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	6e-11
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	8e-11
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	9e-11
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-10
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-10
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-10
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-10
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-10
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	2e-10
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-10
cd03594	129	cd03594, CLECT_REG-1_like, C-type lectin-like doma	2e-10
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	2e-10
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-10
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-10
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	2e-10
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-10
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-10
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	3e-10
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	4e-10
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	5e-10
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	5e-10
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	6e-10
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	7e-10
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	7e-10
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	9e-10
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	9e-10
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-09
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-09
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-09
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-09
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-09
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-09
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	3e-09
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-09
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	3e-09
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	4e-09
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	4e-09
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	5e-09
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	6e-09
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	6e-09
cd03590	126	cd03590, CLECT_DC-SIGN_like, C-type lectin-like do	6e-09
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	6e-09
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	7e-09
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	7e-09
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	7e-09
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	8e-09
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	8e-09
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	9e-09
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	1e-08
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-08
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	1e-08
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	1e-08
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-08
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-08
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-08
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-08
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-08
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-08
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-08
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	3e-08
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	4e-08
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	4e-08
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	4e-08
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	5e-08
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	5e-08
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	6e-08
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	7e-08
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	7e-08
cd03593	116	cd03593, CLECT_NK_receptors_like, C-type lectin-li	8e-08
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-07
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-07
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-07
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-07
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-07
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-07
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-07
pfam00059	108	pfam00059, Lectin_C, Lectin C-type domain	2e-07
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-07
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-07
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-07
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	3e-07
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	4e-07
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	4e-07
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	4e-07
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	4e-07
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	4e-07
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	4e-07
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	4e-07
cd03603	118	cd03603, CLECT_VCBS, A bacterial subgroup of the C	5e-07
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	6e-07
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	6e-07
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	6e-07
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	8e-07
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-06
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-06
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-06
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-06
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-06
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-06
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	3e-06
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	3e-06
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	3e-06
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	3e-06
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	6e-06
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	7e-06
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	7e-06
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	7e-06
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	8e-06
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	8e-06
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	9e-06
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	9e-06
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	9e-06
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-05
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-05
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	2e-05
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-05
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-05
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-05
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	5e-05
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	5e-05
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	5e-05
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	8e-05
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	9e-05
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	9e-05
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-04
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-04
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-04
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-04
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-04
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	3e-04
cd03589	137	cd03589, CLECT_CEL-1_like, C-type lectin-like doma	3e-04
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	3e-04
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-04
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	3e-04
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	4e-04
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	5e-04
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	5e-04
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	5e-04
cd03588	124	cd03588, CLECT_CSPGs, C-type lectin-like domain (C	6e-04
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	6e-04
PHA02642	216	PHA02642, PHA02642, C-type lectin-like protein; Pr	7e-04
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	8e-04
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	0.001
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	0.001
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	0.001
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	0.002
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	0.002
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	0.002
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	0.002
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	0.003
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	0.004
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	0.004
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	0.004
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	0.004

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  138 bits (349), Expect = 2e-37
 Identities = 76/275 (27%), Positives = 121/275 (44%), Gaps = 36/275 (13%)

Query: 240 GTYSGILPDGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYI 298
           G   G     + VAVK LK   S + +K+F  E     +L HPN+V + G C +    Y+
Sbjct: 14  GKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYL 73

Query: 299 VYEFVVNGPLDRWL-----HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRD 353
           V E++  G L  +L             +L     +  A  +A+G+ +L  K     VHRD
Sbjct: 74  VLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRD 130

Query: 354 IRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY---GYLAPEFVYRNELTTK 410
           + A N L+ E+    +   GLS+ V  +   +      G      ++APE +     T+K
Sbjct: 131 LAARNCLVGEDLVVKISDFGLSRDVYDD---DYYRKKTGGKLPIRWMAPESLKDGIFTSK 187

Query: 411 SDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDI 469
           SDV+SFGVLL EI + G  P   +     + + E+   L + +R   L  P         
Sbjct: 188 SDVWSFGVLLWEIFTLGATPYPGLS---NEEVLEY---LRKGYR---LPKPEYCP----- 233

Query: 470 PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ 504
                  ++ +L+ +C Q  P  RP  S +V +L+
Sbjct: 234 ------DELYELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  137 bits (347), Expect = 4e-37
 Identities = 78/277 (28%), Positives = 122/277 (44%), Gaps = 49/277 (17%)

Query: 240 GTYSGILPDGS-RVAVKRLKRSSFQR-KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRY 297
           GT  G       +VAVK LK  + +  ++EF  E     +L HPN+V + G C      Y
Sbjct: 18  GTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRLLGVCTQGEPLY 77

Query: 298 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 357
           IV E++  G L  +L    + G  L     +++A  +A+G+ +L  K   + VHRD+ A 
Sbjct: 78  IVTEYMPGGDLLDFLR---KHGEKLTLKDLLQMALQIAKGMEYLESK---NFVHRDLAAR 131

Query: 358 NVLLDEE-------FGAHLMGVGLSKFVPWEVMQERTVMAGGTYG---YLAPEFVYRNEL 407
           N L+ E        F       GLS+ +  +   +     GG      ++APE +   + 
Sbjct: 132 NCLVTENLVVKISDF-------GLSRDIYED---DYYRKRGGGKLPIKWMAPESLKDGKF 181

Query: 408 TTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 466
           T+KSDV+SFGVLL EI + G +P   +     + + E    L   +R   L  P      
Sbjct: 182 TSKSDVWSFGVLLWEIFTLGEQPYPGMS---NEEVLEL---LEDGYR---LPRPENCP-- 230

Query: 467 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQL 503
                     ++ +L+  C  + P  RP  S +V  L
Sbjct: 231 ---------DELYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  134 bits (341), Expect = 3e-36
 Identities = 72/270 (26%), Positives = 112/270 (41%), Gaps = 35/270 (12%)

Query: 240 GTYSGILPDGS-RVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRY 297
           GT  G        VAVK LK   S Q+ +EF  E     +L HPN+V + G C +     
Sbjct: 18  GTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLM 77

Query: 298 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 357
           IV E++  G L  +L       + L  +  +  A  +A+G+ +L  K   + +HRD+ A 
Sbjct: 78  IVMEYMPGGDLLDYLR--KNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAAR 132

Query: 358 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT---YGYLAPEFVYRNELTTKSDVY 414
           N L+ E     +   GLS+ +      +      G      ++APE +   + T+KSDV+
Sbjct: 133 NCLVGENLVVKISDFGLSRDLY----DDDYYKVKGGKLPIRWMAPESLKEGKFTSKSDVW 188

Query: 415 SFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAG 473
           SFGVLL EI + G  P   +       + E+    ++    L                  
Sbjct: 189 SFGVLLWEIFTLGEEPYPGMS---NAEVLEY----LKKGYRLP-------------KPPN 228

Query: 474 VVQKVVDLVYACTQHVPSMRPRMSHVVHQL 503
              ++  L+  C    P  RP  S +V  L
Sbjct: 229 CPPELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  134 bits (339), Expect = 5e-36
 Identities = 73/270 (27%), Positives = 117/270 (43%), Gaps = 36/270 (13%)

Query: 240 GTYSGILPDGSR-VAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRY 297
           G   G        VAVK LK  +S Q+ +EF  E     +L HPN+V + G C +    Y
Sbjct: 18  GKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKLLGVCTEEEPLY 77

Query: 298 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 357
           IV E++  G L  +L    +    L  +  +  A  +A+G+ +L  K   + +HRD+ A 
Sbjct: 78  IVMEYMEGGDLLSYLR---KNRPKLSLSDLLSFALQIARGMEYLESK---NFIHRDLAAR 131

Query: 358 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT---YGYLAPEFVYRNELTTKSDVY 414
           N L+ E     +   GLS+ +      +      G      ++APE +   + T+KSDV+
Sbjct: 132 NCLVGENLVVKISDFGLSRDLY----DDDYYRKRGGKLPIRWMAPESLKEGKFTSKSDVW 187

Query: 415 SFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAG 473
           SFGVLL EI + G +P   +     + + E+    +++   L                  
Sbjct: 188 SFGVLLWEIFTLGEQPYPGMS---NEEVLEY----LKNGYRLP-------------QPPN 227

Query: 474 VVQKVVDLVYACTQHVPSMRPRMSHVVHQL 503
              ++ DL+  C    P  RP  S +V  L
Sbjct: 228 CPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  130 bits (330), Expect = 7e-35
 Identities = 63/248 (25%), Positives = 102/248 (41%), Gaps = 28/248 (11%)

Query: 248 DGSRVAVKRLKRSSFQRKKE-FYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 306
            G  VA+K +K+   ++ +E    EI    +L HPN+V +     D    Y+V E+   G
Sbjct: 23  TGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGG 82

Query: 307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 366
            L   L    RG  S D A        +   + +LH K    +VHRD++  N+LLDE+  
Sbjct: 83  DLFDLLKK--RGRLSEDEA--RFYLRQILSALEYLHSK---GIVHRDLKPENILLDEDGH 135

Query: 367 AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSG 426
             L   GL++ +         V   GT  Y+APE +         D++S GV+L E+++G
Sbjct: 136 VKLADFGLARQLDPGEKLTTFV---GTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTG 192

Query: 427 RRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACT 486
           + P    D +    +F+     +   +                PE  +  +  DL+    
Sbjct: 193 KPPFPGDDQL--LELFK----KIGKPKP-----------PFPPPEWDISPEAKDLIRKLL 235

Query: 487 QHVPSMRP 494
              P  R 
Sbjct: 236 VKDPEKRL 243

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  128 bits (323), Expect = 3e-34
 Identities = 53/179 (29%), Positives = 89/179 (49%), Gaps = 11/179 (6%)

Query: 248 DGSRVAVKRLKRSSFQRKKE-FYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 306
            G +VA+K +K+       E    EI    +L+HPN+V + G   D    Y+V E+   G
Sbjct: 17  TGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGG 76

Query: 307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 366
            L   L         L     +++   + +G+ +LH      ++HRD++  N+LLD + G
Sbjct: 77  SLKDLLKENEGK---LSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNG 130

Query: 367 -AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE-FVYRNELTTKSDVYSFGVLLLEI 423
              L   GLSK +  +    +T++  GT  Y+APE  + +   + KSD++S GV+L E+
Sbjct: 131 KVKLADFGLSKLLTSDKSLLKTIV--GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  127 bits (322), Expect = 1e-33
 Identities = 79/279 (28%), Positives = 114/279 (40%), Gaps = 35/279 (12%)

Query: 231 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKE--FYSEIGRFARLHHPNLVAVK 287
           R LG    G  Y       G  VAVK LK+ S + KK+     EI    RL HPN+V + 
Sbjct: 5   RKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLI 64

Query: 288 GCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKP 347
               D    Y+V E+   G L  +L      G  L      K+A  + +G+ +LH     
Sbjct: 65  DAFEDKDHLYLVMEYCEGGDLFDYL----SRGGPLSEDEAKKIALQILRGLEYLHSN--- 117

Query: 348 HVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFV-YRNE 406
            ++HRD++  N+LLDE     +   GL+K               GT  Y+APE +   N 
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKK--LLKSSSSLTTFVGTPWYMAPEVLLGGNG 175

Query: 407 LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS-- 464
              K DV+S GV+L E+++G+ P    + +             Q      +L P +    
Sbjct: 176 YGPKVDVWSLGVILYELLTGKPPFSGENILD------------QLQLIRRILGPPLEFDE 223

Query: 465 --LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 501
              SS   EA       DL+  C    PS RP    ++ 
Sbjct: 224 PKWSSGSEEA------KDLIKKCLNKDPSKRPTAEEILQ 256

Length = 260

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  108 bits (273), Expect = 9e-27
 Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 12/204 (5%)

Query: 231 RLLGDSKTGGTYSGILPD-GSRVAVK--RLKRSSFQRKKEFYSEIGRFARLHHPNLVAVK 287
            LLG    G  Y  +  D G  +AVK   L   S +  +    EI   + L HPN+V   
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 288 GCCYD--HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 345
           G   D       I  E+V  G L      + + G+ L   +  K    + +G+A+LH   
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLS---SLLKKFGK-LPEPVIRKYTRQILEGLAYLHSN- 120

Query: 346 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN 405
              +VHRDI+ +N+L+D +    L   G +K +      E T    GT  ++APE +   
Sbjct: 121 --GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGE 178

Query: 406 ELTTKSDVYSFGVLLLEIVSGRRP 429
           E    +D++S G  ++E+ +G+ P
Sbjct: 179 EYGRAADIWSLGCTVIEMATGKPP 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  107 bits (270), Expect = 1e-26
 Identities = 56/198 (28%), Positives = 93/198 (46%), Gaps = 10/198 (5%)

Query: 233 LGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 291
           +G    G  Y       G  VA+K +K  S ++K++  +EI    +  HPN+V   G   
Sbjct: 8   IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67

Query: 292 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 351
              + +IV EF   G L   L       ++L  +    V   L +G+ +LH      ++H
Sbjct: 68  KKDELWIVMEFCSGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSN---GIIH 121

Query: 352 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKS 411
           RDI+A+N+LL  +    L+  GLS  +     + R  M  GT  ++APE +       K+
Sbjct: 122 RDIKAANILLTSDGEVKLIDFGLSAQL--SDTKARNTMV-GTPYWMAPEVINGKPYDYKA 178

Query: 412 DVYSFGVLLLEIVSGRRP 429
           D++S G+  +E+  G+ P
Sbjct: 179 DIWSLGITAIELAEGKPP 196

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  106 bits (266), Expect = 6e-26
 Identities = 67/201 (33%), Positives = 97/201 (48%), Gaps = 17/201 (8%)

Query: 232 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 291
            +G  + G    G    G +VAVK LK  S    + F +E      L HPNLV + G   
Sbjct: 13  TIGKGEFGDVMLGDY-RGQKVAVKCLKDDS-TAAQAFLAEASVMTTLRHPNLVQLLGVVL 70

Query: 292 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 351
                YIV E++  G L  +L    RG   +  A ++  A  + +G+ +L +K   + VH
Sbjct: 71  QGNPLYIVTEYMAKGSLVDYLR--SRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVH 125

Query: 352 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTT 409
           RD+ A NVL+ E+  A +   GL+K       +       G     + APE +   + +T
Sbjct: 126 RDLAARNVLVSEDLVAKVSDFGLAK-------EASQGQDSGKLPVKWTAPEALREKKFST 178

Query: 410 KSDVYSFGVLLLEIVS-GRRP 429
           KSDV+SFG+LL EI S GR P
Sbjct: 179 KSDVWSFGILLWEIYSFGRVP 199

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  105 bits (264), Expect = 1e-25
 Identities = 82/278 (29%), Positives = 126/278 (45%), Gaps = 33/278 (11%)

Query: 233 LGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 291
           LG  + G  Y G+       VAVK LK  +    +EF  E      + HPNLV + G C 
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCT 72

Query: 292 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 351
                YI+ EF+  G L  +L    R  + ++  + + +AT ++  + +L  K   + +H
Sbjct: 73  REPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLEKK---NFIH 127

Query: 352 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTT 409
           RD+ A N L+ E     +   GLS+ +  +     T  AG  +   + APE +  N+ + 
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLAYNKFSI 184

Query: 410 KSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD 468
           KSDV++FGVLL EI + G  P   +D                S  Y ELL+        +
Sbjct: 185 KSDVWAFGVLLWEIATYGMSPYPGID---------------LSQVY-ELLE---KGYRME 225

Query: 469 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 506
            PE G   KV +L+ AC Q  PS RP  + +    + +
Sbjct: 226 RPE-GCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  102 bits (255), Expect = 2e-24
 Identities = 58/198 (29%), Positives = 103/198 (52%), Gaps = 13/198 (6%)

Query: 231 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 290
           R LG    G  + G+  +  RVA+K LK     ++++F  E+    RL H +L+++   C
Sbjct: 12  RKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVC 71

Query: 291 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 350
                 YI+ E +  G L  +L   P  G+ L  A  + +A  +A+G+A+L ++   + +
Sbjct: 72  SVGEPVYIITELMEKGSLLAFLRS-PE-GQVLPVASLIDMACQVAEGMAYLEEQ---NSI 126

Query: 351 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT---YGYLAPEFVYRNEL 407
           HRD+ A N+L+ E+    +   GL++     +++E   ++      Y + APE       
Sbjct: 127 HRDLAARNILVGEDLVCKVADFGLAR-----LIKEDVYLSSDKKIPYKWTAPEAASHGTF 181

Query: 408 TTKSDVYSFGVLLLEIVS 425
           +TKSDV+SFG+LL E+ +
Sbjct: 182 STKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  104 bits (258), Expect = 3e-24
 Identities = 77/280 (27%), Positives = 121/280 (43%), Gaps = 28/280 (10%)

Query: 231 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKE---FYSEIGRFARL-HHPNLVAV 286
           R LG+   G  Y     D   VA+K L +    + KE   F  EI   A L H PN+V +
Sbjct: 6   RKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKL 63

Query: 287 KGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVK 346
                D G  Y+V E+V  G L+  L  I R G   +      +   +   + +LH K  
Sbjct: 64  YDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEAL-FILAQILSALEYLHSK-- 120

Query: 347 PHVVHRDIRASNVLLDEE-FGAHLMGVGLSKFVPWEV----MQERTVMAGGTYGYLAPEF 401
             ++HRDI+  N+LLD +     L+  GL+K +P       +      + GT GY+APE 
Sbjct: 121 -GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEV 179

Query: 402 VYRNEL---TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL-EL 457
           +    L   ++ SD++S G+ L E+++G  P +   +    S         Q+ + + EL
Sbjct: 180 LLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATS---------QTLKIILEL 230

Query: 458 LDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMS 497
             P ++S  S      + +   DL+       P  R   S
Sbjct: 231 PTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSS 270

Length = 384

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  101 bits (253), Expect = 4e-24
 Identities = 65/202 (32%), Positives = 102/202 (50%), Gaps = 12/202 (5%)

Query: 231 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 290
           R LG  + G  + G+  + + VAVK LK  +    K+F +E     +L HP L+ +   C
Sbjct: 12  RKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVC 70

Query: 291 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 350
                 YIV E +  G L  +L      GR+L     + +A  +A G+A+L  +   + +
Sbjct: 71  TLEEPIYIVTELMKYGSLLEYLQG--GAGRALKLPQLIDMAAQVASGMAYLEAQ---NYI 125

Query: 351 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELT 408
           HRD+ A NVL+ E     +   GL++ +  ++ + R    G  +   + APE    N  +
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIKEDIYEARE---GAKFPIKWTAPEAALYNRFS 182

Query: 409 TKSDVYSFGVLLLEIVS-GRRP 429
            KSDV+SFG+LL EIV+ GR P
Sbjct: 183 IKSDVWSFGILLTEIVTYGRMP 204

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  100 bits (251), Expect = 9e-24
 Identities = 67/267 (25%), Positives = 123/267 (46%), Gaps = 23/267 (8%)

Query: 249 GSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVN 305
           G +VAVK L  S   Q + +F  EI     L H N+V  KG C   G R   ++ E++ +
Sbjct: 33  GEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPS 92

Query: 306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 365
           G L     ++ R    ++    +  ++ + +G+ +L  +     +HRD+ A N+L++ E 
Sbjct: 93  GSLR---DYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESED 146

Query: 366 GAHLMGVGLSKFVPWEVMQERTVMAGGTYG-----YLAPEFVYRNELTTKSDVYSFGVLL 420
              +   GL+K +P    +++        G     + APE +  ++ ++ SDV+SFGV L
Sbjct: 147 LVKISDFGLAKVLP----EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTL 202

Query: 421 LEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVD 480
            E+ +   P+Q+  +   + I      ++ + R LELL      L           +V D
Sbjct: 203 YELFTYGDPSQSPPAEFLRMIGIAQGQMIVT-RLLELLKE-GERLP---RPPSCPDEVYD 257

Query: 481 LVYACTQHVPSMRPRMSHVVHQLQQLA 507
           L+  C +  P  RP  + ++  + +L 
Sbjct: 258 LMKLCWEAEPQDRPSFADLILIVDRLR 284

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  104 bits (261), Expect = 1e-23
 Identities = 91/347 (26%), Positives = 162/347 (46%), Gaps = 38/347 (10%)

Query: 167 VVSGLILLTTFAIVIWLLAYRRSKRRRKSRKLSNPAASALVPPSWKV--FTTEELRSITK 224
           +   L      A+V +   + R +   + +++ N   +      W++  F ++  +SIT 
Sbjct: 632 ITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGT------WELQFFDSKVSKSITI 685

Query: 225 N-----FSEGNRLLGDSKTGGTYSG-ILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL 278
           N       E N ++   K G +Y G  + +G +  VK +   +        SEI    +L
Sbjct: 686 NDILSSLKEEN-VISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPS----SEIADMGKL 740

Query: 279 HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGI 338
            HPN+V + G C      Y+++E++    L   L       R+L W  R K+A  +A+ +
Sbjct: 741 QHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL-------RNLSWERRRKIAIGIAKAL 793

Query: 339 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLA 398
            FLH +  P VV  ++    +++D +   HL  + L    P  +  +          Y+A
Sbjct: 794 RFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSL----PGLLCTDTKCFISS--AYVA 846

Query: 399 PEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLEL- 457
           PE     ++T KSD+Y FG++L+E+++G+ PA A   V   SI EWA     S  +L++ 
Sbjct: 847 PETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV-HGSIVEWAR-YCYSDCHLDMW 904

Query: 458 LDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ 504
           +DP I    S + +  +V+ V++L   CT   P+ RP  + V+  L+
Sbjct: 905 IDPSIRGDVS-VNQNEIVE-VMNLALHCTATDPTARPCANDVLKTLE 949

Length = 968

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 96.9 bits (241), Expect = 2e-22
 Identities = 74/263 (28%), Positives = 123/263 (46%), Gaps = 19/263 (7%)

Query: 249 GSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVN 305
           G  VAVK LKR    Q    +  EI     L+H N+V  KGCC + G +   ++ E+V  
Sbjct: 33  GEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYV-- 90

Query: 306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 365
            PL     ++P+    L+ A  +  A  + +G+A+LH +   H +HRD+ A NVLLD + 
Sbjct: 91  -PLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDR 144

Query: 366 GAHLMGVGLSKFVPWEVMQERTVMAGGT-YGYLAPEFVYRNELTTKSDVYSFGVLLLEIV 424
              +   GL+K VP      R    G +   + A E +  N+ +  SDV+SFGV L E++
Sbjct: 145 LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELL 204

Query: 425 SGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS-SLSSDIPEAGVVQKVVDLVY 483
           +     Q+     ++ +       +   R +ELL+  +      + P     Q+V  L+ 
Sbjct: 205 THCDSKQSPPKK-FEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCP-----QEVYILMK 258

Query: 484 ACTQHVPSMRPRMSHVVHQLQQL 506
            C +     RP    ++  L+++
Sbjct: 259 NCWETEAKFRPTFRSLIPILKEM 281

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 95.5 bits (238), Expect = 3e-22
 Identities = 74/283 (26%), Positives = 117/283 (41%), Gaps = 48/283 (16%)

Query: 231 RLLGDSKTGGTYSGI-LPDGSRVAVK--RLKRSSFQRKKEFYSEIGRFARLHHPNLVAVK 287
             +G    G  Y+ + L  G  +AVK  R++ +  +  KE   E+     L HPNLV   
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 288 GCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKP 347
           G        YI  E+   G L+  L H    GR LD  +       L +G+A+LH     
Sbjct: 66  GVEVHREKVYIFMEYCSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSH--- 118

Query: 348 HVVHRDIRASNVLLDE-------EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 400
            +VHRDI+ +N+ LD        +FG  +  +  +     E +Q       GT  Y+APE
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVK-LKNNTTTMGEEVQSLA----GTPAYMAPE 173

Query: 401 FVYRNELTTK---SDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWA---TPLVQSHRY 454
            +   +       +D++S G ++LE+ +G+RP   +D+  +Q +F       P +     
Sbjct: 174 VITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-FQIMFHVGAGHKPPI----- 227

Query: 455 LELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMS 497
                P    LS +           D +  C +  P  RP  S
Sbjct: 228 -----PDSLQLSPE---------GKDFLDRCLESDPKKRPTAS 256

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 93.1 bits (232), Expect = 2e-21
 Identities = 60/211 (28%), Positives = 103/211 (48%), Gaps = 19/211 (9%)

Query: 225 NFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRK--KEFYSEIGRFARLHHP 281
           N+  G+ L+G    G  Y G+ L  G  VA+K++     + +  K    EI     L HP
Sbjct: 1   NYQLGD-LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHP 59

Query: 282 NLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ---GI 338
           N+V   G        YI+ E+  NG L + +        SL       VA  + Q   G+
Sbjct: 60  NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESL-------VAVYVYQVLQGL 112

Query: 339 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLA 398
           A+LH++    V+HRDI+A+N+L  ++    L   G++  +      + +V+  GT  ++A
Sbjct: 113 AYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVV--GTPYWMA 167

Query: 399 PEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           PE +  +  +T SD++S G  ++E+++G  P
Sbjct: 168 PEVIEMSGASTASDIWSLGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 92.0 bits (229), Expect = 6e-21
 Identities = 65/207 (31%), Positives = 99/207 (47%), Gaps = 20/207 (9%)

Query: 230 NRLLGDSKTG----GTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVA 285
            R LG  + G    GT++G       VAVK LK  +    + F  E     +L H  LV 
Sbjct: 11  ERKLGAGQFGEVWMGTWNGTTK----VAVKTLKPGTMS-PEAFLQEAQIMKKLRHDKLVQ 65

Query: 286 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 345
           +   C +    YIV E++  G L  +L      G+ L     + +A  +A+G+A+L  + 
Sbjct: 66  LYAVCSEEEPIYIVTEYMSKGSLLDFLKS--GEGKKLRLPQLVDMAAQIAEGMAYLESR- 122

Query: 346 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVY 403
             + +HRD+ A N+L+ E     +   GL++ +  +   E T   G  +   + APE   
Sbjct: 123 --NYIHRDLAARNILVGENLVCKIADFGLARLIEDD---EYTAREGAKFPIKWTAPEAAN 177

Query: 404 RNELTTKSDVYSFGVLLLEIVS-GRRP 429
               T KSDV+SFG+LL EIV+ GR P
Sbjct: 178 YGRFTIKSDVWSFGILLTEIVTYGRVP 204

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 89.9 bits (224), Expect = 3e-20
 Identities = 47/191 (24%), Positives = 86/191 (45%), Gaps = 15/191 (7%)

Query: 248 DGSRVAVKR--LKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 305
           DG    +K   L   S + +++  +E+    +L+HPN++       + G   IV E+   
Sbjct: 24  DGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADG 83

Query: 306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 365
           G L + +    + G+       +     L   + +LH +    ++HRDI+  N+ L    
Sbjct: 84  GDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNG 140

Query: 366 GAHLMGVGLSKFVPWEVMQERTVMAG---GTYGYLAPEFVYRNE-LTTKSDVYSFGVLLL 421
              L   G+SK     V+     +A    GT  YL+PE + +N+    KSD++S G +L 
Sbjct: 141 LVKLGDFGISK-----VLSSTVDLAKTVVGTPYYLSPE-LCQNKPYNYKSDIWSLGCVLY 194

Query: 422 EIVSGRRPAQA 432
           E+ + + P + 
Sbjct: 195 ELCTLKHPFEG 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 89.6 bits (222), Expect = 4e-20
 Identities = 67/256 (26%), Positives = 121/256 (47%), Gaps = 33/256 (12%)

Query: 252 VAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRW 311
           VA+K +K  S   + EF  E     +L H  LV + G C      YIV E++ NG L   
Sbjct: 31  VAIKMIKEGSMS-EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCL--- 86

Query: 312 LHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMG 371
           L+++   G+    +  +++   + +G+A+L  K     +HRD+ A N L+D++    +  
Sbjct: 87  LNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSD 143

Query: 372 VGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRR 428
            GLS++V   +  E T   G  +   +  PE +  ++ ++KSDV++FGVL+ E+ S G+ 
Sbjct: 144 FGLSRYV---LDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKM 200

Query: 429 PAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQH 488
           P +  ++       E    + Q  R   L  P ++S           +KV  ++Y+C   
Sbjct: 201 PYERFNNS------ETVEKVSQGLR---LYRPHLAS-----------EKVYAIMYSCWHE 240

Query: 489 VPSMRPRMSHVVHQLQ 504
               RP    ++  ++
Sbjct: 241 KAEERPTFQQLLSSIE 256

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 87.5 bits (217), Expect = 2e-19
 Identities = 61/262 (23%), Positives = 112/262 (42%), Gaps = 47/262 (17%)

Query: 252 VAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRW 311
           VA+K ++  +   + +F  E     +L HPNLV + G C      +IV E++ NG L  +
Sbjct: 31  VAIKMIREGAMS-EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNY 89

Query: 312 LHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMG 371
           L        +      + + + + + + +L        +HRD+ A N L+ E+    +  
Sbjct: 90  LRERKGKLGT---EWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSD 143

Query: 372 VGLSKFVPWEVMQERTVMAGGT---YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GR 427
            GL+++    V+ ++   + GT     +  PE    +  ++KSDV+SFGVL+ E+ S G+
Sbjct: 144 FGLARY----VLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGK 199

Query: 428 RP------AQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDL 481
            P      ++ V+SV                    L  P ++             +V  +
Sbjct: 200 MPYERFSNSEVVESV---------------SAGYRLYRPKLAP-----------TEVYTI 233

Query: 482 VYACTQHVPSMRPRMSHVVHQL 503
           +Y+C    P  RP    ++ QL
Sbjct: 234 MYSCWHEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 87.2 bits (216), Expect = 3e-19
 Identities = 64/200 (32%), Positives = 100/200 (50%), Gaps = 13/200 (6%)

Query: 233 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 292
           LG  + G  + G     ++VA+K LK+ S    + F +E     +L HP LV +      
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS-PEAFLAEANLMKQLQHPRLVRLYAVVTQ 72

Query: 293 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 352
               YI+ E++ NG L  +L      G  L     + +A  +A+G+AF+  K   + +HR
Sbjct: 73  E-PIYIITEYMENGSLVDFLK--TPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHR 126

Query: 353 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 410
           D+RA+N+L+ E     +   GL++ +      E T   G  +   + APE +     T K
Sbjct: 127 DLRAANILVSETLCCKIADFGLARLI---EDNEYTAREGAKFPIKWTAPEAINYGTFTIK 183

Query: 411 SDVYSFGVLLLEIVS-GRRP 429
           SDV+SFG+LL EIV+ GR P
Sbjct: 184 SDVWSFGILLTEIVTYGRIP 203

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 86.2 bits (213), Expect = 6e-19
 Identities = 72/258 (27%), Positives = 119/258 (46%), Gaps = 34/258 (13%)

Query: 249 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 308
           G +VAVK +K       + F  E     +LHH NLV + G    H   YIV E +  G L
Sbjct: 29  GQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVIL-HNGLYIVMELMSKGNL 85

Query: 309 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 368
             +L    RG   +     ++ +  +A+G+ +L  K    +VHRD+ A N+L+ E+  A 
Sbjct: 86  VNFLR--TRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAK 140

Query: 369 LMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GR 427
           +   GL++     V   +  +      + APE +   + ++KSDV+S+GVLL E+ S GR
Sbjct: 141 VSDFGLARVGSMGVDNSKLPVK-----WTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGR 195

Query: 428 RPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQ 487
            P   +      S+ E    + + +R    ++P         PE G    V  L+ +C +
Sbjct: 196 APYPKM------SLKEVKECVEKGYR----MEP---------PE-GCPADVYVLMTSCWE 235

Query: 488 HVPSMRPRMSHVVHQLQQ 505
             P  RP    +  +L++
Sbjct: 236 TEPKKRPSFHKLREKLEK 253

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 85.6 bits (212), Expect = 1e-18
 Identities = 74/291 (25%), Positives = 130/291 (44%), Gaps = 38/291 (13%)

Query: 231 RLLGDSKTGGTYSGIL--PDGS--RVAVKRLKRSSFQRK--KEFYSEIGRFARLHHPNLV 284
           ++LG+ + G    G L   DGS  +VAVK +K         +EF SE        HPN++
Sbjct: 5   KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64

Query: 285 AVKGCCYDHGDR------YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRM--KVATTLAQ 336
            + G C++           ++  F+ +G L  +L +   GG      ++   K    +A 
Sbjct: 65  KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124

Query: 337 GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGY 396
           G+ +L ++   + +HRD+ A N +L E+    +   GLSK +       +  +A     +
Sbjct: 125 GMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 181

Query: 397 LAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYL 455
           +A E +     T+KSDV++FGV + EI + G+ P                 P V++H   
Sbjct: 182 IAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP----------------YPGVENH--- 222

Query: 456 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 506
           E+ D L        PE   + ++ DL+Y+C +  P  RP  + +   L+ +
Sbjct: 223 EIYDYLRHGNRLKQPE-DCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 85.0 bits (210), Expect = 2e-18
 Identities = 74/275 (26%), Positives = 130/275 (47%), Gaps = 35/275 (12%)

Query: 233 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 292
           +G  + G  + G   +  +VA+K + R     +++F  E     +L HP LV + G C +
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70

Query: 293 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 352
                +V+EF+ +G L  +L    RG  S +  + M     + +G+A+L      +V+HR
Sbjct: 71  RSPICLVFEFMEHGCLSDYLRA-QRGKFSQETLLGM--CLDVCEGMAYLESS---NVIHR 124

Query: 353 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT---YGYLAPEFVYRNELTT 409
           D+ A N L+ E     +   G+++F    V+ ++   + GT     + +PE    ++ ++
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRF----VLDDQYTSSTGTKFPVKWSSPEVFSFSKYSS 180

Query: 410 KSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD 468
           KSDV+SFGVL+ E+ S G+ P +       +S  E    +    R   L  P ++S    
Sbjct: 181 KSDVWSFGVLMWEVFSEGKTPYEN------RSNSEVVETINAGFR---LYKPRLAS---- 227

Query: 469 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQL 503
                  Q V +L+  C +  P  RP  S ++HQL
Sbjct: 228 -------QSVYELMQHCWKERPEDRPSFSLLLHQL 255

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 84.5 bits (209), Expect = 3e-18
 Identities = 82/299 (27%), Positives = 127/299 (42%), Gaps = 56/299 (18%)

Query: 231 RLLGDSKTGGTYSG----ILPDGS---RVAVKRLKR-SSFQRKKEFYSEIGRFARLHHPN 282
             LG    G  Y G    IL  GS   RVAVK L++ ++ Q KKEF  E    +  +HPN
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 283 LVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS-------LDWAMRMKVATTLA 335
           +V + G C  +  +YI+ E +  G L   L ++ R  R        L     + +   +A
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDL---LSYL-RDARVERFGPPLLTLKELLDICLDVA 116

Query: 336 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV-----GLSKFV----PWEVMQER 386
           +G  +L      H +HRD+ A N L+ E+       V     GL++ +     +    E 
Sbjct: 117 KGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEG 173

Query: 387 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWA 445
            +       ++APE +   + TT+SDV+SFGVL+ EI++ G++P  A             
Sbjct: 174 LL----PVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPA------------- 216

Query: 446 TPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ 504
                     E+L  + +      PE     K+  L+  C    PS RP    +   LQ
Sbjct: 217 ------LNNQEVLQHVTAGGRLQKPE-NCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 83.9 bits (208), Expect = 4e-18
 Identities = 55/207 (26%), Positives = 101/207 (48%), Gaps = 14/207 (6%)

Query: 230 NRLLGDSKTGGTYSGILPDGSR----VAVKRLK-RSSFQRKKEFYSEIGRFARLHHPNLV 284
            +++G  + G    G L    +    VA+K LK  SS +++ +F +E     +  HPN++
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68

Query: 285 AVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 344
            ++G         I+ E++ NG LD++L      G+       + +   +A G+ +L + 
Sbjct: 69  RLEGVVTKSRPVMIITEYMENGSLDKFLRE--NDGK-FTVGQLVGMLRGIASGMKYLSEM 125

Query: 345 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT-YGYLAPEFVY 403
                VHRD+ A N+L++      +   GLS+ +  +     T   G     + APE + 
Sbjct: 126 N---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE-DSEATYTTKGGKIPIRWTAPEAIA 181

Query: 404 RNELTTKSDVYSFGVLLLEIVS-GRRP 429
             + T+ SDV+SFG+++ E++S G RP
Sbjct: 182 YRKFTSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 81.6 bits (202), Expect = 2e-17
 Identities = 60/219 (27%), Positives = 104/219 (47%), Gaps = 19/219 (8%)

Query: 238 TGGTYSGIL--PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG 294
             G  S +L  P G  +AVK ++       +K+   E+    + + P +V   G  Y++G
Sbjct: 13  NSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNG 72

Query: 295 DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDI 354
           D  I  E++  G LD+ L         +   +  K+A  + +G+ +LH+K    ++HRD+
Sbjct: 73  DISICMEYMDGGSLDKIL---KEVQGRIPERILGKIAVAVLKGLTYLHEKH--KIIHRDV 127

Query: 355 RASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG---GTYGYLAPEFVYRNELTTKS 411
           + SN+L++      L   G+S        Q    +A    GT  Y+APE +  N+ + KS
Sbjct: 128 KPSNILVNSRGQIKLCDFGVSG-------QLVNSLAKTFVGTSSYMAPERIQGNDYSVKS 180

Query: 412 DVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQ 450
           D++S G+ L+E+ +GR P    +      IFE    +V 
Sbjct: 181 DIWSLGLSLIELATGRFPYPPENDP-PDGIFELLQYIVN 218

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 82.4 bits (203), Expect = 3e-17
 Identities = 84/285 (29%), Positives = 133/285 (46%), Gaps = 51/285 (17%)

Query: 245 ILPDGSRV--AVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVY 300
           I  DG R+  A+KR+K  +S    ++F  E+    +L HHPN++ + G C   G  Y+  
Sbjct: 28  IKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI 87

Query: 301 EFVVNGPLDRWLHHIPRGGRSLD----WAMRMKVATTL------------AQGIAFLHDK 344
           E+  +G L  +L    R  R L+    +A+    A+TL            A+G+ +L  K
Sbjct: 88  EYAPHGNLLDFL----RKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK 143

Query: 345 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR 404
                +HRD+ A N+L+ E + A +   GLS+    EV  ++T M      ++A E +  
Sbjct: 144 ---QFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKT-MGRLPVRWMAIESLNY 197

Query: 405 NELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS 463
           +  TT SDV+S+GVLL EIVS G  P       C  +  E    L Q +R       L  
Sbjct: 198 SVYTTNSDVWSYGVLLWEIVSLGGTP------YCGMTCAELYEKLPQGYR-------LEK 244

Query: 464 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 508
            L+ D        +V DL+  C +  P  RP  + ++  L ++ +
Sbjct: 245 PLNCD-------DEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 282

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 81.0 bits (200), Expect = 5e-17
 Identities = 63/220 (28%), Positives = 107/220 (48%), Gaps = 29/220 (13%)

Query: 233 LGDSKTGGTYSGIL--PDGSR----VAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVA 285
           LG+   G  Y G L  P+       VA+K LK +   + ++EF  E    + L HPN+V 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 286 VKGCCYDHGDRYIVYEFVVNGPLDRWL-HHIP-----------RGGRSLDWAMRMKVATT 333
           + G C       +++E++ +G L  +L  + P               SLD +  + +A  
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 334 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV---PWEVMQERTVMA 390
           +A G+ +L      H VHRD+ A N L+ E     +   GLS+ +    +  +Q ++++ 
Sbjct: 133 IAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189

Query: 391 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRP 429
                ++ PE +   + TT+SD++SFGV+L EI S G +P
Sbjct: 190 ---VRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 80.6 bits (199), Expect = 1e-16
 Identities = 69/265 (26%), Positives = 115/265 (43%), Gaps = 37/265 (13%)

Query: 251 RVAVKRLKRSSFQRKKE-FYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 308
           +VAVK LK ++   ++E   SE+   + L +H N+V + G C   G   ++ E+   G L
Sbjct: 67  KVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDL 126

Query: 309 DRWLHHIPRGGRS-LDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA 367
             +L    R   S L     +  +  +A+G+AFL  K   + +HRD+ A NVLL      
Sbjct: 127 LNFLR---RKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIV 180

Query: 368 HLMGVGLSKFVPWEVMQERT-VMAGGTY---GYLAPEFVYRNELTTKSDVYSFGVLLLEI 423
            +   GL++    ++M +   V+ G       ++APE ++    T +SDV+S+G+LL EI
Sbjct: 181 KICDFGLAR----DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI 236

Query: 424 VS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLV 482
            S G  P   +               V S  Y      +        PE     ++ D++
Sbjct: 237 FSLGSNPYPGM--------------PVDSKFY----KLIKEGYRMAQPEHA-PAEIYDIM 277

Query: 483 YACTQHVPSMRPRMSHVVHQLQQLA 507
             C    P  RP    +V  + +  
Sbjct: 278 KTCWDADPLKRPTFKQIVQLIGKQL 302

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 79.7 bits (197), Expect = 1e-16
 Identities = 71/282 (25%), Positives = 122/282 (43%), Gaps = 47/282 (16%)

Query: 240 GTYSGILPD--GSRVAVKRL-KRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR 296
           G   G++     +RVA+K + + +S + + EF +E       +  ++V + G        
Sbjct: 25  GLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84

Query: 297 YIVYEFVVNGPLDRWL--------HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH 348
            +V E +  G L  +L        ++   G  +L   ++M  A  +A G+A+L  K    
Sbjct: 85  LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQM--AAEIADGMAYLAAK---K 139

Query: 349 VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL-----APEFVY 403
            VHRD+ A N ++ E+    +   G+++ +      E      G  G L     APE + 
Sbjct: 140 FVHRDLAARNCMVAEDLTVKIGDFGMTRDI-----YETDYYRKGGKGLLPVRWMAPESLK 194

Query: 404 RNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI 462
               TTKSDV+SFGV+L E+ +   +P Q + +       E     V    +L+L     
Sbjct: 195 DGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN-------EEVLKFVIDGGHLDL----- 242

Query: 463 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ 504
                  PE     K+++L+  C Q+ P MRP    +V  L+
Sbjct: 243 -------PE-NCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 79.8 bits (197), Expect = 1e-16
 Identities = 77/293 (26%), Positives = 122/293 (41%), Gaps = 47/293 (16%)

Query: 231 RLLGDSKTG----GTYSGILPDGSR--VAVKRLKRSSFQRKKE-FYSEIGRFARLHHPNL 283
           R LG    G    G Y G   D     VAVK L  S  ++ +  F  E    ++ +H N+
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 284 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHI-PRGGRSLDWAMR--MKVATTLAQGIAF 340
           V + G  ++   R+I+ E +  G L  +L    PR  R     M+  +  A  +A+G  +
Sbjct: 72  VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131

Query: 341 LHDKVKPHVVHRDIRASNVLLDEEFG----AHLMGVGLSKFVPWEVMQERTVMAGGT--- 393
           L +    H +HRDI A N LL  + G    A +   G+++    ++ +      GG    
Sbjct: 132 LEEN---HFIHRDIAARNCLLTCK-GPGRVAKIADFGMAR----DIYRASYYRKGGRAML 183

Query: 394 -YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQS 451
              ++ PE       T+K+DV+SFGVLL EI S G  P                      
Sbjct: 184 PIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP-------------------YPG 224

Query: 452 HRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ 504
               E+++ +      D P  G    V  ++  C QH P  RP  + ++ ++Q
Sbjct: 225 RTNQEVMEFVTGGGRLDPP-KGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 79.3 bits (195), Expect = 2e-16
 Identities = 59/202 (29%), Positives = 96/202 (47%), Gaps = 12/202 (5%)

Query: 231 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 290
           + LG  + G  + G   + ++VAVK LK  +    + F  E      L H  LV +    
Sbjct: 12  KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-VQAFLEEANLMKTLQHDKLVRLYAVV 70

Query: 291 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 350
                 YI+ E++  G L  +L      G  +     +  +  +A+G+A++  K   + +
Sbjct: 71  TKEEPIYIITEYMAKGSLLDFLK--SDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYI 125

Query: 351 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELT 408
           HRD+RA+NVL+ E     +   GL++ +      E T   G  +   + APE +     T
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIE---DNEYTAREGAKFPIKWTAPEAINFGSFT 182

Query: 409 TKSDVYSFGVLLLEIVS-GRRP 429
            KSDV+SFG+LL EIV+ G+ P
Sbjct: 183 IKSDVWSFGILLYEIVTYGKIP 204

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 79.8 bits (197), Expect = 2e-16
 Identities = 48/158 (30%), Positives = 75/158 (47%), Gaps = 19/158 (12%)

Query: 279 HHPNLVAVKGCCYDHGDR--YIVYEFVVNGPLDRWLHHI-PRGGRSLDWAMRMKVATTLA 335
             P +V   G   D       I  E+   G LD     +  RGGR  +  +  K+A ++ 
Sbjct: 57  KSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVL-GKIAESVL 115

Query: 336 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLS-KFVPWEVMQERTVMAG--- 391
           +G+++LH +    ++HRDI+ SN+LL  +    L   G+S + V          +AG   
Sbjct: 116 KGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELV--------NSLAGTFT 164

Query: 392 GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           GT  Y+APE +     +  SDV+S G+ LLE+   R P
Sbjct: 165 GTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFP 202

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 79.7 bits (196), Expect = 2e-16
 Identities = 82/295 (27%), Positives = 134/295 (45%), Gaps = 44/295 (14%)

Query: 232 LLGDSKTGGTYSGILP-DGSRV--AVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAV 286
           ++G+   G     ++  DG ++  A+K LK  +S    ++F  E+    +L HHPN++ +
Sbjct: 9   VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINL 68

Query: 287 KGCCYDHGDRYIVYEFVVNGPL------DRWLHHIPRGGR------SLDWAMRMKVATTL 334
            G C + G  YI  E+   G L       R L   P   +      +L     ++ A+ +
Sbjct: 69  LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDV 128

Query: 335 AQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY 394
           A G+ +L +K     +HRD+ A NVL+ E   + +   GLS+    EV  ++T M     
Sbjct: 129 ATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR--GEEVYVKKT-MGRLPV 182

Query: 395 GYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHR 453
            ++A E +  +  TTKSDV+SFGVLL EIVS G  P       C  +  E    L Q +R
Sbjct: 183 RWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTP------YCGMTCAELYEKLPQGYR 236

Query: 454 YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 508
                         + P      +V +L+  C +  P  RP  + +  QL ++ +
Sbjct: 237 M-------------EKPR-NCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 79.0 bits (194), Expect = 2e-16
 Identities = 76/295 (25%), Positives = 128/295 (43%), Gaps = 44/295 (14%)

Query: 232 LLGDSKTGGTYSGILP-DGSRV--AVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAV 286
           ++G+   G      +  DG R+  A+KR+K  +S    ++F  E+    +L HHPN++ +
Sbjct: 2   VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61

Query: 287 KGCCYDHGDRYIVYEFVVNGPL------DRWLHHIPRGGR------SLDWAMRMKVATTL 334
            G C   G  Y+  E+  +G L       R L   P          +L     +  A  +
Sbjct: 62  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121

Query: 335 AQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY 394
           A+G+ +L  K     +HRD+ A N+L+ E + A +   GLS+    + +  +  M     
Sbjct: 122 ARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPV 175

Query: 395 GYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHR 453
            ++A E +  +  TT SDV+S+GVLL EIVS G  P       C  +  E    L Q +R
Sbjct: 176 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP------YCGMTCAELYEKLPQGYR 229

Query: 454 YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 508
             +                    +V DL+  C +  P  RP  + ++  L ++ +
Sbjct: 230 LEK--------------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 270

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 78.5 bits (193), Expect = 2e-16
 Identities = 72/260 (27%), Positives = 116/260 (44%), Gaps = 34/260 (13%)

Query: 249 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY-DHGDRYIVYEFVVNGP 307
           G++VAVK +K  +    + F +E     +L H NLV + G    + G  YIV E++  G 
Sbjct: 29  GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 86

Query: 308 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA 367
           L  +L    RG   L     +K +  + + + +L      + VHRD+ A NVL+ E+  A
Sbjct: 87  LVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVA 141

Query: 368 HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-G 426
            +   GL+K       Q+   +      + APE +   + +TKSDV+SFG+LL EI S G
Sbjct: 142 KVSDFGLTKEA--SSTQDTGKLP---VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFG 196

Query: 427 RRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACT 486
           R P   +             PL       +++  +      D P+ G    V D++  C 
Sbjct: 197 RVPYPRI-------------PLK------DVVPRVEKGYKMDAPD-GCPPVVYDVMKQCW 236

Query: 487 QHVPSMRPRMSHVVHQLQQL 506
               + RP    +  QL+ +
Sbjct: 237 HLDAATRPSFLQLREQLEHI 256

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 78.4 bits (193), Expect = 3e-16
 Identities = 64/256 (25%), Positives = 121/256 (47%), Gaps = 33/256 (12%)

Query: 251 RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 310
           +VA+K +   +   +++F  E     +L HP LV + G C      YIV EF+ NG L  
Sbjct: 30  KVAIKAINEGAMS-EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLN 88

Query: 311 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLM 370
           +L    +G  S D  M + +   + +G+ +L    +   +HRD+ A N L+       + 
Sbjct: 89  YLRQ-RQGKLSKD--MLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVS 142

Query: 371 GVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GR 427
             G++++V   +  E T  +G  +   +  PE    ++ ++KSDV+SFGVL+ E+ + G+
Sbjct: 143 DFGMTRYV---LDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGK 199

Query: 428 RPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQ 487
            P +       +S +E    + +  R   L  P ++S++           V +++Y+C  
Sbjct: 200 MPFEK------KSNYEVVEMISRGFR---LYRPKLASMT-----------VYEVMYSCWH 239

Query: 488 HVPSMRPRMSHVVHQL 503
             P  RP  + ++  +
Sbjct: 240 EKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 78.8 bits (195), Expect = 3e-16
 Identities = 52/211 (24%), Positives = 93/211 (44%), Gaps = 36/211 (17%)

Query: 233 LGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 291
           +G+  +G  Y       G  VA+K+++    Q K+   +EI       HPN+V       
Sbjct: 27  IGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKHPNIVDYYDSYL 85

Query: 292 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMK------VATTLAQGIAFLHDKV 345
              + ++V E++  G L   +             +RM       V   + QG+ +LH + 
Sbjct: 86  VGDELWVVMEYMDGGSLTDIITQNF---------VRMNEPQIAYVCREVLQGLEYLHSQ- 135

Query: 346 KPHVVHRDIRASNVLLDEE-------FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLA 398
             +V+HRDI++ N+LL ++       FG       L+K        +R  + G  Y ++A
Sbjct: 136 --NVIHRDIKSDNILLSKDGSVKLADFG---FAAQLTKEK-----SKRNSVVGTPY-WMA 184

Query: 399 PEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           PE + R +   K D++S G++ +E+  G  P
Sbjct: 185 PEVIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 78.7 bits (194), Expect = 4e-16
 Identities = 68/263 (25%), Positives = 126/263 (47%), Gaps = 17/263 (6%)

Query: 249 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVNG 306
           G  VAVK+L+ S+ +  ++F  EI     L H N+V  KG CY  G R   +V E++  G
Sbjct: 33  GEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYG 92

Query: 307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 366
            L  +L    +    LD    +  A+ + +G+ +L  K     VHRD+   N+L++ E  
Sbjct: 93  SLRDYLQ---KHRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENR 146

Query: 367 AHLMGVGLSKFVPWEVMQERTVMAGGT--YGYLAPEFVYRNELTTKSDVYSFGVLLLEIV 424
             +   GL+K +P +    +    G +  + Y APE +  ++ +  SDV+SFGV+L E+ 
Sbjct: 147 VKIGDFGLTKVLPQDKEYYKVREPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELF 205

Query: 425 SGRRPAQAVDSVCWQSI-FEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVY 483
           +    + +  +   + +  +    ++  H    L++ L ++     P  G   ++  ++ 
Sbjct: 206 TYSDKSCSPPAEFMRMMGNDKQGQMIVYH----LIELLKNNGRLPAPP-GCPAEIYAIMK 260

Query: 484 ACTQHVPSMRPRMSHVVHQLQQL 506
            C  + PS RP  S +  Q++ +
Sbjct: 261 ECWNNDPSQRPSFSELALQVEAI 283

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 77.5 bits (191), Expect = 4e-16
 Identities = 59/205 (28%), Positives = 93/205 (45%), Gaps = 14/205 (6%)

Query: 233 LGDSKTGGTYSGILPDGSRV-AVKRLKRSSFQR--KKEFYSEIGRFARLHHPNLVAVKGC 289
           +G    G  +  +     RV A+K++  S   R  ++E   E    A+L    ++     
Sbjct: 8   IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67

Query: 290 CYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSL--DWAMRMKVATTLAQGIAFLHDKVKP 347
             D G   IV E+  NG L + L    + GR L  D   R  +   L  G+A LH K   
Sbjct: 68  FLDKGKLNIVMEYAENGDLHKLLKM--QRGRPLPEDQVWRFFIQILL--GLAHLHSK--- 120

Query: 348 HVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL 407
            ++HRDI++ N+ LD      +  +G++K +        T++  GT  YL+PE       
Sbjct: 121 KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV--GTPYYLSPELCEDKPY 178

Query: 408 TTKSDVYSFGVLLLEIVSGRRPAQA 432
             KSDV++ GV+L E  +G+ P  A
Sbjct: 179 NEKSDVWALGVVLYECCTGKHPFDA 203

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 77.7 bits (191), Expect = 5e-16
 Identities = 77/286 (26%), Positives = 128/286 (44%), Gaps = 39/286 (13%)

Query: 231 RLLGDSKTGGTYSGILPDGSR----VAVKRLKRSSFQRKK-EFYSEIGRFARLHHPNLVA 285
           +++G  + G  + GIL    R    VA+K LK    ++++ +F SE     +  H N++ 
Sbjct: 11  KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIR 70

Query: 286 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 345
           ++G         I+ E++ NG LD++L        S      ++    +A G+ +L D  
Sbjct: 71  LEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIAAGMKYLSDM- 126

Query: 346 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG---TYGYLAPEFV 402
             + VHRD+ A N+L++      +   GLS+ +  E   E T    G      + APE +
Sbjct: 127 --NYVHRDLAARNILVNSNLECKVSDFGLSRVL--EDDPEGTYTTSGGKIPIRWTAPEAI 182

Query: 403 YRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQ-SIFEWATPLVQSHRYLELLDP 460
              + T+ SDV+SFG+++ E++S G RP        W  S  E    +    R   L  P
Sbjct: 183 AYRKFTSASDVWSFGIVMWEVMSFGERPY-------WDMSNHEVMKAINDGFR---LPAP 232

Query: 461 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 506
           +      D P A     V  L+  C Q   + RPR   +V+ L +L
Sbjct: 233 M------DCPSA-----VYQLMLQCWQQDRARRPRFVDIVNLLDKL 267

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 77.4 bits (191), Expect = 7e-16
 Identities = 69/215 (32%), Positives = 99/215 (46%), Gaps = 37/215 (17%)

Query: 233 LGDSKTGGTYSGI--LPDGSR--VAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVK 287
           LG    G    G+  +  G    VAVK LK+      KKEF  E    A+L HP +V + 
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 288 GCCYDHGDRYI-VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVK 346
           G C   G+  + V E    GPL ++L    +  R +  +   ++A  +A G+A+L  K  
Sbjct: 63  GVC--KGEPLMLVMELAPLGPLLKYL----KKRREIPVSDLKELAHQVAMGMAYLESK-- 114

Query: 347 PHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY-----------G 395
            H VHRD+ A NVLL     A +   G+S          R + AG  Y            
Sbjct: 115 -HFVHRDLAARNVLLVNRHQAKISDFGMS----------RALGAGSDYYRATTAGRWPLK 163

Query: 396 YLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRP 429
           + APE +   + ++KSDV+S+GV L E  S G +P
Sbjct: 164 WYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKP 198

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 77.0 bits (190), Expect = 9e-16
 Identities = 50/196 (25%), Positives = 90/196 (45%), Gaps = 13/196 (6%)

Query: 277 RLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ 336
            L+HP LV +     D  + Y+V + ++ G L R+  H+ +  +  +  ++  +   +  
Sbjct: 56  ELNHPFLVNLWYSFQDEENMYLVVDLLLGGDL-RY--HLSQKVKFSEEQVKFWICE-IVL 111

Query: 337 GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGY 396
            + +LH K    ++HRDI+  N+LLDE+   H+    ++  V  + +   T    GT GY
Sbjct: 112 ALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS---GTPGY 165

Query: 397 LAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVC---WQSIFEWATPLVQSHR 453
           +APE + R   +   D +S GV   E + G+RP +          ++  E A  L  +  
Sbjct: 166 MAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATW 225

Query: 454 YLELLDPLISSLSSDI 469
             E +D +   L  D 
Sbjct: 226 STEAIDAINKLLERDP 241

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 76.4 bits (189), Expect = 1e-15
 Identities = 53/186 (28%), Positives = 88/186 (47%), Gaps = 12/186 (6%)

Query: 253 AVKRL-KRSSFQRKKEFYSEIGRF--ARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 309
           A+K L K+   +RK+  ++   R   +R++HP +V +          Y+V E+   G L 
Sbjct: 22  AMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL- 80

Query: 310 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHL 369
               H+ + GR  +   R   A  +   + +LH      +++RD++  N+LLD +    L
Sbjct: 81  --FSHLSKEGRFSEERARFYAAE-IVLALEYLHSL---GIIYRDLKPENILLDADGHIKL 134

Query: 370 MGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
              GL+K +  E  +  T    GT  YLAPE +         D +S GVLL E+++G+ P
Sbjct: 135 TDFGLAKELSSEGSRTNTFC--GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP 192

Query: 430 AQAVDS 435
             A D 
Sbjct: 193 FYAEDR 198

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 76.8 bits (189), Expect = 1e-15
 Identities = 65/239 (27%), Positives = 114/239 (47%), Gaps = 28/239 (11%)

Query: 232 LLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSF-----QRKKEFYS----EIGRFARLHHP 281
           L+G    G  Y G+    G  +AVK+++  S       RK+        EI     L H 
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 282 NLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 341
           N+V   G   D     I  E+V  G +   L++      +L   +R  V   L +G+ +L
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETL---VRNFVRQIL-KGLNYL 122

Query: 342 HDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM-----QERTVMAGGTYGY 396
           H++    ++HRDI+ +N+L+D + G  +   G+SK +    +       R  + G  + +
Sbjct: 123 HNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVF-W 178

Query: 397 LAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIF---EWATPLVQSH 452
           +APE V +   T K+D++S G L++E+++G+ P      +  Q+IF   E A+P + S+
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL--QAIFKIGENASPEIPSN 235

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 76.3 bits (188), Expect = 1e-15
 Identities = 55/208 (26%), Positives = 89/208 (42%), Gaps = 29/208 (13%)

Query: 231 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-HPNLVAVKGC 289
             +G    G  Y G+L   + VAVK  + +     K  + +     + + HPN+V + G 
Sbjct: 1   EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60

Query: 290 CYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHV 349
           C      YIV E V  G L   L  + +    L     ++++   A G+ +L  K   + 
Sbjct: 61  CVQKQPIYIVMELVPGGSL---LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK---NC 114

Query: 350 VHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG-----------YLA 398
           +HRD+ A N L+ E     +   G+S+       +E     GG Y            + A
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSR-------EE----EGGIYTVSDGLKQIPIKWTA 163

Query: 399 PEFVYRNELTTKSDVYSFGVLLLEIVSG 426
           PE +     T++SDV+S+G+LL E  S 
Sbjct: 164 PEALNYGRYTSESDVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 77.0 bits (189), Expect = 1e-15
 Identities = 78/295 (26%), Positives = 132/295 (44%), Gaps = 49/295 (16%)

Query: 233 LGDSKTGGTYSG--ILP---DGSRVAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAV 286
           LG+   G  Y G   LP       VA+K LK  ++ Q+  EF  E    A LHHPN+V +
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 287 KGCCYDHGDRYIVYEFVVNGPLDRWL----HHIPRG---------GRSLDWAMRMKVATT 333
            G         +++E++  G L  +L     H   G           SLD    + +A  
Sbjct: 73  LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132

Query: 334 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV---PWEVMQERTVMA 390
           +A G+ +L        VH+D+ A N+L+ E+    +  +GLS+ +    +  +Q ++++ 
Sbjct: 133 IAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189

Query: 391 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLV 449
                ++ PE +   + ++ SD++SFGV+L EI S G +P     +   Q + E    +V
Sbjct: 190 ---IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN---QEVIE----MV 239

Query: 450 QSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ 504
           +  + L          S D P      ++  L+  C Q  PS RPR   +  +L+
Sbjct: 240 RKRQLL--------PCSEDCPP-----RMYSLMTECWQEGPSRRPRFKDIHTRLR 281

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 75.4 bits (185), Expect = 2e-15
 Identities = 63/205 (30%), Positives = 90/205 (43%), Gaps = 28/205 (13%)

Query: 232 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKK-EFYSEIGRFARLHHPNLVAVKGCC 290
           LLG    G  + G L D + VAVK  K    Q  K +F SE     +  HPN+V + G C
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 291 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 350
                 YIV E V  G    +L  + +    L     +K A   A G+A+L  K   + +
Sbjct: 62  TQRQPIYIVMELVPGGD---FLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK---NCI 115

Query: 351 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG----------YLAPE 400
           HRD+ A N L+ E     +   G+S+       QE      G Y           + APE
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR-------QED----DGIYSSSGLKQIPIKWTAPE 164

Query: 401 FVYRNELTTKSDVYSFGVLLLEIVS 425
            +     +++SDV+S+G+LL E  S
Sbjct: 165 ALNYGRYSSESDVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 76.3 bits (187), Expect = 2e-15
 Identities = 70/271 (25%), Positives = 119/271 (43%), Gaps = 41/271 (15%)

Query: 252 VAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRW 311
           VAVK LK +S   +K+F+ E      L H ++V   G C +     +V+E++ +G L+++
Sbjct: 38  VAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKF 97

Query: 312 LH-HIPRG--------GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 362
           L  H P             L  +  + +A  +A G+ +L  +   H VHRD+   N L+ 
Sbjct: 98  LRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVG 154

Query: 363 EEFGAHLMGVGLSKFVPWEVMQERTVMAGG----TYGYLAPEFVYRNELTTKSDVYSFGV 418
           E     +   G+S+    +V        GG       ++ PE +   + TT+SDV+S GV
Sbjct: 155 ENLLVKIGDFGMSR----DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGV 210

Query: 419 LLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQK 477
           +L EI + G++P        W  +              E+++ +        P     ++
Sbjct: 211 VLWEIFTYGKQP--------WYQLSN-----------NEVIECITQGRVLQRPRT-CPKE 250

Query: 478 VVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 508
           V DL+  C Q  P MR  +  +   LQ LA+
Sbjct: 251 VYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 75.7 bits (186), Expect = 2e-15
 Identities = 69/277 (24%), Positives = 119/277 (42%), Gaps = 43/277 (15%)

Query: 232 LLGDSKTGGTYSGILPDGSRVAVKRL------KRSSFQRKKEFYSEIGRFARLHHPNLVA 285
           +LG    G  Y G+   G  +AVK++        ++ +  ++   E+     L H N+V 
Sbjct: 7   VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66

Query: 286 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 345
             G C D     I  EFV  G +   L+   R G   +     K    +  G+A+LH+  
Sbjct: 67  YLGTCLDDNTISIFMEFVPGGSISSILN---RFGPLPEPVFC-KYTKQILDGVAYLHNN- 121

Query: 346 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW--------EVMQERTVMAGGTYGYL 397
              VVHRDI+ +NV+L       L+  G ++ + W         +++    M G  Y ++
Sbjct: 122 --CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKS---MHGTPY-WM 175

Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLEL 457
           APE +  +    KSD++S G  + E+ +G+ P  ++D +   ++F      + +HR   L
Sbjct: 176 APEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL--AAMF-----YIGAHR--GL 226

Query: 458 LDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP 494
           +  L  S S+           +D V +C       RP
Sbjct: 227 MPRLPDSFSAA---------AIDFVTSCLTRDQHERP 254

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 75.8 bits (186), Expect = 3e-15
 Identities = 59/219 (26%), Positives = 103/219 (47%), Gaps = 29/219 (13%)

Query: 233 LGDSKTGGTY----SGILPDGSR--VAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAV 286
           LG+   G  +      +LP+  +  VAVK LK +S   +++F  E      L H ++V  
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 287 KGCCYDHGDRYIVYEFVVNGPLDRWLH------HIPRGGR-----SLDWAMRMKVATTLA 335
            G C +     +V+E++ +G L+R+L        I  GG       L     + +A+ +A
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 336 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG--- 392
            G+ +L      H VHRD+   N L+ +     +   G+S+    ++        GG   
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR----DIYSTDYYRVGGRTM 185

Query: 393 -TYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRP 429
               ++ PE +   + TT+SD++SFGV+L EI + G++P
Sbjct: 186 LPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 75.6 bits (186), Expect = 3e-15
 Identities = 54/181 (29%), Positives = 85/181 (46%), Gaps = 12/181 (6%)

Query: 252 VAVKRL-KRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 310
           V VK L K      + EF  E+  F +L H N+V + G C +    Y++ E+   G L +
Sbjct: 38  VLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQ 97

Query: 311 WL-----HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 365
           +L              L    ++ + T +A G+  L        VHRD+ A N L+  + 
Sbjct: 98  FLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQR 154

Query: 366 GAHLMGVGLSKFV-PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIV 424
              +  + LSK V   E  + R  +      +LAPE V  ++ +TKSDV+SFGVL+ E+ 
Sbjct: 155 EVKVSLLSLSKDVYNSEYYKLRNALI--PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVF 212

Query: 425 S 425
           +
Sbjct: 213 T 213

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 75.4 bits (185), Expect = 3e-15
 Identities = 60/201 (29%), Positives = 99/201 (49%), Gaps = 15/201 (7%)

Query: 233 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 292
           LG+ + G  + G     ++VAVK LK  +    + F  E     +L H  LV +     +
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS-PESFLEEAQIMKKLRHDKLVQLYAVVSE 72

Query: 293 HGDRYIVYEFVVNGPLDRWLHHIPRG-GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 351
               YIV E++  G L   L  +  G GR+L     + +A  +A G+A++    + + +H
Sbjct: 73  E-PIYIVTEYMSKGSL---LDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIH 125

Query: 352 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTT 409
           RD+R++N+L+ +     +   GL++ +      E T   G  +   + APE       T 
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARLIE---DNEYTARQGAKFPIKWTAPEAALYGRFTI 182

Query: 410 KSDVYSFGVLLLEIVS-GRRP 429
           KSDV+SFG+LL E+V+ GR P
Sbjct: 183 KSDVWSFGILLTELVTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 75.9 bits (187), Expect = 3e-15
 Identities = 55/190 (28%), Positives = 89/190 (46%), Gaps = 17/190 (8%)

Query: 250 SRVAVKRLKRSSFQRK-KEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGP 307
           S VAVK LK  + ++   +  SE+     +  H N++ + G C   G  Y+V E+  +G 
Sbjct: 43  STVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGN 102

Query: 308 LDRWLH-HIPRG-----------GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIR 355
           L  +L    P G             +L     +  A  +A+G+ FL  K     +HRD+ 
Sbjct: 103 LRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLA 159

Query: 356 ASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYS 415
           A NVL+ E+    +   GL++ +       +T        ++APE ++    T +SDV+S
Sbjct: 160 ARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 219

Query: 416 FGVLLLEIVS 425
           FGVLL EI +
Sbjct: 220 FGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 75.2 bits (185), Expect = 3e-15
 Identities = 74/273 (27%), Positives = 122/273 (44%), Gaps = 40/273 (14%)

Query: 231 RLLGDSKTGGTYSGI-LPDGSRVAVKRLK-----RSSFQRKKEFYSEIGRFARLHHPNLV 284
            LLG    G  Y G+ L DG   AVK +      ++  +  K+   EI   ++L HPN+V
Sbjct: 6   ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65

Query: 285 AVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 344
              G   +  + YI  E V  G L + L    + G   +  +R+     L  G+ +LHD+
Sbjct: 66  QYLGTEREEDNLYIFLELVPGGSLAKLLK---KYGSFPEPVIRLYTRQILL-GLEYLHDR 121

Query: 345 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV--MAGGTYGYLAPEFV 402
              + VHRDI+ +N+L+D      L   G++K    +V++        G  Y ++APE +
Sbjct: 122 ---NTVHRDIKGANILVDTNGVVKLADFGMAK----QVVEFSFAKSFKGSPY-WMAPEVI 173

Query: 403 YR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL 461
            +       +D++S G  +LE+ +G+ P   ++ V   ++F+              L P+
Sbjct: 174 AQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV--AAVFKIGRSKE--------LPPI 223

Query: 462 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP 494
              LS    EA       D +  C Q  PS+RP
Sbjct: 224 PDHLS---DEAK------DFILKCLQRDPSLRP 247

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 75.5 bits (186), Expect = 4e-15
 Identities = 69/294 (23%), Positives = 130/294 (44%), Gaps = 48/294 (16%)

Query: 231 RLLGDSKTGGTYSGI-LPDGSR----VAVKRLKRSSFQR-KKEFYSEIGRFARLHHPNLV 284
           ++LG    G  Y G+ +P+G +    VA+K L+  +  +  KE   E    A + HP++V
Sbjct: 13  KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72

Query: 285 AVKGCCYDHGDRY-IVYEFVVNGPLDRWLH-HIPRGGRS--LDWAMRMKVATTLAQGIAF 340
            + G C     +  ++ + +  G L  ++  H    G    L+W         +A+G+++
Sbjct: 73  RLLGICL--SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWC------VQIAKGMSY 124

Query: 341 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG---TYGYL 397
           L +K    +VHRD+ A NVL+       +   GL+K +    + E+   A G      ++
Sbjct: 125 LEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLD---VDEKEYHAEGGKVPIKWM 178

Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLE 456
           A E +     T KSDV+S+GV + E+++ G +P + + +V    + E    L Q      
Sbjct: 179 ALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQ------ 232

Query: 457 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 510
              P I ++            V  ++  C       RP    ++++  ++A+ P
Sbjct: 233 ---PPICTID-----------VYMVLVKCWMIDAESRPTFKELINEFSKMARDP 272

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 75.0 bits (184), Expect = 6e-15
 Identities = 56/199 (28%), Positives = 94/199 (47%), Gaps = 24/199 (12%)

Query: 248 DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 307
           D   VAVK LK  +   +K+F  E      L H ++V   G C D     +V+E++ +G 
Sbjct: 34  DKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGD 93

Query: 308 LDRWLH-HIP-----------RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIR 355
           L+++L  H P           +    L  +  + +A+ +A G+ +L  +   H VHRD+ 
Sbjct: 94  LNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLA 150

Query: 356 ASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG----TYGYLAPEFVYRNELTTKS 411
             N L+       +   G+S+    +V        GG       ++ PE +   + TT+S
Sbjct: 151 TRNCLVGANLLVKIGDFGMSR----DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTES 206

Query: 412 DVYSFGVLLLEIVS-GRRP 429
           DV+SFGV+L EI + G++P
Sbjct: 207 DVWSFGVILWEIFTYGKQP 225

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 74.3 bits (182), Expect = 6e-15
 Identities = 60/201 (29%), Positives = 96/201 (47%), Gaps = 15/201 (7%)

Query: 233 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 292
           LG    G  + G     ++VA+K LK  +    + F  E     +L H  LV +     +
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM-PEAFLQEAQIMKKLRHDKLVPLYAVVSE 72

Query: 293 HGDRYIVYEFVVNGPLDRWLHHIPRG-GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 351
               YIV EF+  G L   L  +  G G+ L     + +A  +A G+A++    + + +H
Sbjct: 73  E-PIYIVTEFMGKGSL---LDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIH 125

Query: 352 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTT 409
           RD+RA+N+L+ +     +   GL++ +      E T   G  +   + APE       T 
Sbjct: 126 RDLRAANILVGDNLVCKIADFGLARLIE---DNEYTARQGAKFPIKWTAPEAALYGRFTI 182

Query: 410 KSDVYSFGVLLLEIVS-GRRP 429
           KSDV+SFG+LL E+V+ GR P
Sbjct: 183 KSDVWSFGILLTELVTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 74.6 bits (184), Expect = 7e-15
 Identities = 65/274 (23%), Positives = 111/274 (40%), Gaps = 43/274 (15%)

Query: 247 PDGSRVAVKRLKRSSFQRKKEFYSEIGRFAR-LH---HPNLVAVKGCCYDHGDRYIVYEF 302
           P G   A+K++        +EF  ++ R  + L     P +V   G  Y  G+  IV E+
Sbjct: 24  PTGKIYALKKIH---VDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80

Query: 303 VVNGPLDRWL---HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNV 359
           +  G L   L     IP         +   +A  + +G+ +LH K   H++HRDI+ SN+
Sbjct: 81  MDGGSLADLLKKVGKIPE-------PVLAYIARQILKGLDYLHTKR--HIIHRDIKPSNL 131

Query: 360 LLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVL 419
           L++ +    +   G+SK +  E   ++     GT  Y++PE +     +  +D++S G+ 
Sbjct: 132 LINSKGEVKIADFGISKVL--ENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLT 189

Query: 420 LLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVV 479
           LLE   G+ P        +                 EL+  +       +P      +  
Sbjct: 190 LLECALGKFPFLPPGQPSF----------------FELMQAICDGPPPSLPAEEFSPEFR 233

Query: 480 DLVYACTQHVPSMRPRMSHVVHQLQQLAQPPVTK 513
           D + AC Q  P  RP       +L Q   P + K
Sbjct: 234 DFISACLQKDPKKRPS----AAELLQH--PFIKK 261

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 74.9 bits (184), Expect = 7e-15
 Identities = 61/221 (27%), Positives = 100/221 (45%), Gaps = 20/221 (9%)

Query: 217 EELRSIT------KNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFY 269
           E+LR+I       K ++   ++ G   +G  Y+ I +  G  VA+K++      +K+   
Sbjct: 6   EKLRTIVSVGDPKKKYTRFEKI-GQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELII 64

Query: 270 SEIGRFARLHHPNLVAVKGCCYDHGDR-YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRM 328
           +EI       HPN+V      Y  GD  ++V E++  G L   +         +D     
Sbjct: 65  NEILVMRENKHPNIVNYLDS-YLVGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIA 118

Query: 329 KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 388
            V     Q + FLH      V+HRDI++ N+LL  +    L   G    +  E   +R+ 
Sbjct: 119 AVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-QSKRST 174

Query: 389 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           M G  Y ++APE V R     K D++S G++ +E+V G  P
Sbjct: 175 MVGTPY-WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 74.0 bits (182), Expect = 1e-14
 Identities = 66/261 (25%), Positives = 110/261 (42%), Gaps = 33/261 (12%)

Query: 246 LPDGSRVAVKRLKRSSFQRKK---EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 302
           L DG  VA+K+++       K   +   EI    +L HPN++       ++ +  IV E 
Sbjct: 24  LLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLEL 83

Query: 303 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 362
              G L R + H  +  R +      K    L   +  +H K    ++HRDI+ +NV + 
Sbjct: 84  ADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFIT 140

Query: 363 EEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLE 422
                 L  +GL +F   +     +++  GT  Y++PE ++ N    KSD++S G LL E
Sbjct: 141 ATGVVKLGDLGLGRFFSSKTTAAHSLV--GTPYYMSPERIHENGYNFKSDIWSLGCLLYE 198

Query: 423 IVSGRRP----AQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKV 478
           + + + P       + S+C + I +   P + +  Y E L                    
Sbjct: 199 MAALQSPFYGDKMNLYSLC-KKIEKCDYPPLPADHYSEELR------------------- 238

Query: 479 VDLVYACTQHVPSMRPRMSHV 499
            DLV  C    P  RP +S+V
Sbjct: 239 -DLVSRCINPDPEKRPDISYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 74.0 bits (182), Expect = 1e-14
 Identities = 60/221 (27%), Positives = 104/221 (47%), Gaps = 29/221 (13%)

Query: 231 RLLGDSKTGGTYSG----ILPDGSR--VAVKRLKRSSFQR-KKEFYSEIGRFARLHHPNL 283
           R LG+   G  + G    + P+  +  VAVK LK ++    +K+F  E        H N+
Sbjct: 11  RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI 70

Query: 284 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLH-HIPRGGRS---------LDWAMRMKVATT 333
           V   G C +     +V+E++ +G L+++L  H P              L  +  +++A  
Sbjct: 71  VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130

Query: 334 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT 393
           +A G+ +L  +   H VHRD+   N L+  +    +   G+S+    +V        GG 
Sbjct: 131 IASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSR----DVYTTDYYRVGGH 183

Query: 394 ----YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRP 429
                 ++ PE +   + TT+SDV+SFGV+L EI + G++P
Sbjct: 184 TMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 74.1 bits (182), Expect = 1e-14
 Identities = 60/258 (23%), Positives = 108/258 (41%), Gaps = 30/258 (11%)

Query: 249 GSRVAVKRLKRSSFQRKKEFYSEIGRFAR---------LHH---PNLVAVKGCCYDHGDR 296
           GS   VK +   +   KK  +       R         +H    P +V+  G   +  + 
Sbjct: 19  GSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNI 78

Query: 297 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRA 356
            +  EF+  G LDR    I + G  +   +  K+A  + +G+ +L++     ++HRDI+ 
Sbjct: 79  CMCMEFMDCGSLDR----IYKKGGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKP 132

Query: 357 SNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSF 416
           SN+L++      L   G+S     E++        GT  Y++PE +   + T KSDV+S 
Sbjct: 133 SNILVNSRGQIKLCDFGVSG----ELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSL 188

Query: 417 GVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQ 476
           G+ ++E+  G+ P        +                L+LL  ++      +P +   +
Sbjct: 189 GISIIELALGKFP--------FAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPE 240

Query: 477 KVVDLVYACTQHVPSMRP 494
            + D V AC    P+ RP
Sbjct: 241 DLRDFVDACLLKDPTERP 258

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 73.8 bits (181), Expect = 1e-14
 Identities = 56/182 (30%), Positives = 91/182 (50%), Gaps = 12/182 (6%)

Query: 249 GSRVAVKRLK-RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYI--VYEFVVN 305
           G +VAVK LK  S      +   EI     L+H N+V  KG C + G   I  + EF+ +
Sbjct: 33  GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 92

Query: 306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 365
           G L  +L   PR    ++   ++K A  + +G+ +L  +     VHRD+ A NVL++ E 
Sbjct: 93  GSLKEYL---PRNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEH 146

Query: 366 GAHLMGVGLSKFVPW--EVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 423
              +   GL+K +    E    +  +    + Y APE + +++    SDV+SFGV L E+
Sbjct: 147 QVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APECLIQSKFYIASDVWSFGVTLYEL 205

Query: 424 VS 425
           ++
Sbjct: 206 LT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 73.7 bits (181), Expect = 1e-14
 Identities = 56/213 (26%), Positives = 92/213 (43%), Gaps = 44/213 (20%)

Query: 244 GILP--DGSRVAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY 300
           G+LP    + VAVK LK  +S   + +F  E    A   HPN+V + G C       +++
Sbjct: 28  GLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLF 87

Query: 301 EFVVNGPLD--------RWLHHIPRGGRS----------LDWAMRMKVATTLAQGIAFLH 342
           E++  G L+        R    +     S          L    ++ +A  +A G+A+L 
Sbjct: 88  EYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS 147

Query: 343 DKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG------- 395
           ++     VHRD+   N L+ E     +   GLS          R + +   Y        
Sbjct: 148 ER---KFVHRDLATRNCLVGENMVVKIADFGLS----------RNIYSADYYKASENDAI 194

Query: 396 ---YLAPEFVYRNELTTKSDVYSFGVLLLEIVS 425
              ++ PE ++ N  TT+SDV+++GV+L EI S
Sbjct: 195 PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 74.0 bits (181), Expect = 2e-14
 Identities = 61/221 (27%), Positives = 102/221 (46%), Gaps = 20/221 (9%)

Query: 217 EELRSIT------KNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFY 269
           E+LR+I       K ++   ++ G   +G  ++ I +  G  VA+K++      +K+   
Sbjct: 6   EKLRTIVSIGDPKKKYTRYEKI-GQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELII 64

Query: 270 SEIGRFARLHHPNLVAVKGCCYDHGDR-YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRM 328
           +EI     L +PN+V      +  GD  ++V E++  G L   +         +D A   
Sbjct: 65  NEILVMKELKNPNIVNFLDS-FLVGDELFVVMEYLAGGSLTDVVTET-----CMDEAQIA 118

Query: 329 KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 388
            V     Q + FLH      V+HRDI++ NVLL  +    L   G    +  E   +R+ 
Sbjct: 119 AVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE-QSKRST 174

Query: 389 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           M G  Y ++APE V R     K D++S G++ +E+V G  P
Sbjct: 175 MVGTPY-WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 72.5 bits (178), Expect = 4e-14
 Identities = 54/188 (28%), Positives = 97/188 (51%), Gaps = 24/188 (12%)

Query: 249 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR-YIVYEFVVNGP 307
           G +VAVK++     QR++  ++E+       HPN+V +    Y  GD  ++V EF+  G 
Sbjct: 44  GRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSS-YLVGDELWVVMEFLEGGA 102

Query: 308 LDRWLHHIPRGGRSLDWAMRM---KVATT---LAQGIAFLHDKVKPHVVHRDIRASNVLL 361
           L   + H            RM   ++AT    + + ++FLH +    V+HRDI++ ++LL
Sbjct: 103 LTDIVTH-----------TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILL 148

Query: 362 DEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLL 421
             +    L   G    V  EV + ++++  GT  ++APE + R    T+ D++S G++++
Sbjct: 149 TSDGRVKLSDFGFCAQVSKEVPRRKSLV--GTPYWMAPEVISRLPYGTEVDIWSLGIMVI 206

Query: 422 EIVSGRRP 429
           E+V G  P
Sbjct: 207 EMVDGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 72.7 bits (178), Expect = 4e-14
 Identities = 67/283 (23%), Positives = 123/283 (43%), Gaps = 45/283 (15%)

Query: 246 LPDGSRVAVKRLKRSSFQRK-KEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 304
               + VAVK LK ++   + ++  SE     +++HP+++ + G C   G   ++ E+  
Sbjct: 27  RAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAK 86

Query: 305 NGPLDRWLH--------HIPRGG------------RSLDWAMRMKVATTLAQGIAFLHDK 344
            G L  +L         ++   G            R+L     +  A  +++G+ +L + 
Sbjct: 87  YGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM 146

Query: 345 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR 404
               +VHRD+ A NVL+ E     +   GLS+ V  E    +         ++A E ++ 
Sbjct: 147 ---KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD 203

Query: 405 NELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS 463
           +  TT+SDV+SFGVLL EIV+ G  P                 P +   R   LL    +
Sbjct: 204 HIYTTQSDVWSFGVLLWEIVTLGGNP----------------YPGIAPERLFNLLK---T 244

Query: 464 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 506
               + PE    +++ +L+  C +  P  RP  + +  +L+++
Sbjct: 245 GYRMERPE-NCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 72.4 bits (178), Expect = 5e-14
 Identities = 53/197 (26%), Positives = 93/197 (47%), Gaps = 32/197 (16%)

Query: 252 VAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 310
           VAVK L+   S   +++F  E+   +RL  PN+  + G C       ++ E++ NG L++
Sbjct: 49  VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108

Query: 311 WLH-HIPR------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 363
           +L  H+          +SL ++  + +AT +A G+ +L      + VHRD+   N L+ +
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLVGK 165

Query: 364 EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG----------YLAPEFVYRNELTTKSDV 413
            +   +   G+S          R + +   Y           ++A E V   + TTKSDV
Sbjct: 166 NYTIKIADFGMS----------RNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDV 215

Query: 414 YSFGVLLLEIVS-GRRP 429
           ++FGV L EI++  R  
Sbjct: 216 WAFGVTLWEILTLCREQ 232

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 72.1 bits (177), Expect = 6e-14
 Identities = 67/254 (26%), Positives = 119/254 (46%), Gaps = 30/254 (11%)

Query: 247 PDGSRVAVKRLKRS-SFQRKKEFYSEIGRFAR-LHHPNLVAVKGCCYDHGDRYIVYEFVV 304
           P G+ +AVKR++ + + Q +K    ++    R +  P  V   G  +  GD +I  E V+
Sbjct: 24  PTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME-VM 82

Query: 305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 364
           +  LD++   +   G ++   +  K+A ++ + + +LH K+   V+HRD++ SNVL++  
Sbjct: 83  DTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRN 140

Query: 365 FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFV----YRNELTTKSDVYSFGVLL 420
               L   G+S ++   V   +T+ A G   Y+APE +     +     KSDV+S G+ +
Sbjct: 141 GQVKLCDFGISGYLVDSVA--KTIDA-GCKPYMAPERINPELNQKGYDVKSDVWSLGITM 197

Query: 421 LEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVD 480
           +E+ +GR P              W TP  Q  + +E  +P     S  +P      +  D
Sbjct: 198 IELATGRFPYD-----------SWKTPFQQLKQVVE--EP-----SPQLPAEKFSPEFQD 239

Query: 481 LVYACTQHVPSMRP 494
            V  C +     RP
Sbjct: 240 FVNKCLKKNYKERP 253

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 72.0 bits (176), Expect = 6e-14
 Identities = 62/263 (23%), Positives = 123/263 (46%), Gaps = 29/263 (11%)

Query: 249 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 308
           G +VAVK++     QR++  ++E+      HH N+V +        + ++V EF+  G L
Sbjct: 47  GKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106

Query: 309 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 368
              + H       ++      V  ++ + +++LH++    V+HRDI++ ++LL  +    
Sbjct: 107 TDIVTHT-----RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIK 158

Query: 369 LMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRR 428
           L   G    V  EV + ++++  GT  ++APE + R    T+ D++S G++++E++ G  
Sbjct: 159 LSDFGFCAQVSKEVPKRKSLV--GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEP 216

Query: 429 PAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQH 488
           P              +  P +Q+ R +   D L   +      + V++  +DL+      
Sbjct: 217 PY-------------FNEPPLQAMRRIR--DNLPPRVKDSHKVSSVLRGFLDLMLV---R 258

Query: 489 VPSMRPRMSHVV-HQLQQLAQPP 510
            PS R     ++ H   +LA PP
Sbjct: 259 EPSQRATAQELLQHPFLKLAGPP 281

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 71.8 bits (176), Expect = 6e-14
 Identities = 64/276 (23%), Positives = 115/276 (41%), Gaps = 35/276 (12%)

Query: 232 LLGDSKTGGTYSGI-LPDGSRVAVKR--LKRSSFQRKKE--------FYSEIGRFARLHH 280
           L+G    G  Y  + +  G  +AVK+  L  +   R             SEI     L H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 281 PNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAF 340
            N+V   G         I  E+V  G +   L      GR  +  +       + +G+A+
Sbjct: 68  LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLR---TYGR-FEEQLVRFFTEQVLEGLAY 123

Query: 341 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 400
           LH K    ++HRD++A N+L+D +    +   G+SK        ++ +   G+  ++APE
Sbjct: 124 LHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180

Query: 401 FV--YRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELL 458
            +  Y    + K D++S G ++LE+ +GRRP    +++   ++F+      +        
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI--AAMFKLGN---KRSA----- 230

Query: 459 DPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP 494
            P+   +S ++         +D + AC    P  RP
Sbjct: 231 PPIPPDVSMNLSPVA-----LDFLNACFTINPDNRP 261

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 71.8 bits (177), Expect = 7e-14
 Identities = 50/200 (25%), Positives = 87/200 (43%), Gaps = 29/200 (14%)

Query: 252 VAVKRLKRSSFQR-KKEFYSEIGR--FARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGP 307
            A+K L +    + KK  Y +I +    RL  HP ++ +     D  + Y V E+  NG 
Sbjct: 29  YAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGE 88

Query: 308 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE--- 364
           L   L +I + G SLD       A  +   + +LH K    ++HRD++  N+LLD++   
Sbjct: 89  L---LQYIRKYG-SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHI 141

Query: 365 ----FGA-----------HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTT 409
               FG               G   +     E  + R     GT  Y++PE +       
Sbjct: 142 KITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGK 201

Query: 410 KSDVYSFGVLLLEIVSGRRP 429
            SD+++ G ++ ++++G+ P
Sbjct: 202 SSDLWALGCIIYQMLTGKPP 221

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 71.9 bits (176), Expect = 7e-14
 Identities = 76/297 (25%), Positives = 124/297 (41%), Gaps = 45/297 (15%)

Query: 231 RLLGDSKTGGTYSGILPD------GSRVAVKRLKRSSFQRKK-EFYSEIGRFARLHHPNL 283
           R LG    G  Y G   D       +RVAVK +  S+  R++ EF +E          ++
Sbjct: 12  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 71

Query: 284 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHI------PRGGRSLDWAMRMKVATTLAQG 337
           V + G         +V E + +G L  +L  +        G         +++A  +A G
Sbjct: 72  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131

Query: 338 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT---- 393
           +A+L+ K     VHRD+ A N ++  +F   +   G+++    ++ +      GG     
Sbjct: 132 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKGLLP 184

Query: 394 YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSH 452
             ++APE +     TT SD++SFGV+L EI S   +P Q + +       E     V   
Sbjct: 185 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-------EQVLKFVMDG 237

Query: 453 RYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 509
            YL            D P+    ++V DL+  C Q  P MRP    +V+ L+    P
Sbjct: 238 GYL------------DQPD-NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHP 281

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 71.2 bits (174), Expect = 8e-14
 Identities = 60/200 (30%), Positives = 94/200 (47%), Gaps = 13/200 (6%)

Query: 233 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 292
           LG    G  + G     +RVA+K LK  +    + F  E     +L H  LV +     +
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVSE 72

Query: 293 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 352
               YIV E++  G L  +L      G+ L     + +A  +A G+A++    + + VHR
Sbjct: 73  E-PIYIVTEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 126

Query: 353 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 410
           D+RA+N+L+ E     +   GL++ +      E T   G  +   + APE       T K
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIE---DNEYTARQGAKFPIKWTAPEAALYGRFTIK 183

Query: 411 SDVYSFGVLLLEIVS-GRRP 429
           SDV+SFG+LL E+ + GR P
Sbjct: 184 SDVWSFGILLTELTTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 71.4 bits (176), Expect = 8e-14
 Identities = 51/183 (27%), Positives = 85/183 (46%), Gaps = 19/183 (10%)

Query: 252 VAVKRLKRSSFQRKKE---FYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 308
            A+K L ++   + K+     +E      + HP LV + G   D  + Y+V E+V  G L
Sbjct: 29  YALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGEL 88

Query: 309 DRWLHHIPRGGR-SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA 367
                H+ + GR     A        LA  + +LH      +V+RD++  N+LLD +   
Sbjct: 89  ---FSHLRKSGRFPEPVARFYAAQVVLA--LEYLHSL---DIVYRDLKPENLLLDSDGYI 140

Query: 368 HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKS-DVYSFGVLLLEIVSG 426
            +   G +K V       RT    GT  YLAPE +  ++   K+ D ++ G+L+ E+++G
Sbjct: 141 KITDFGFAKRVK-----GRTYTLCGTPEYLAPE-IILSKGYGKAVDWWALGILIYEMLAG 194

Query: 427 RRP 429
             P
Sbjct: 195 YPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 71.2 bits (174), Expect = 1e-13
 Identities = 61/249 (24%), Positives = 111/249 (44%), Gaps = 16/249 (6%)

Query: 248 DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 304
           DG  VA+K+++       + + +   EI    +L+HPN++       +  +  IV E   
Sbjct: 26  DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELAD 85

Query: 305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 364
            G L R + H  +  R +      K    L   +  +H +    V+HRDI+ +NV +   
Sbjct: 86  AGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITAT 142

Query: 365 FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIV 424
               L  +GL +F   +     +++  GT  Y++PE ++ N    KSD++S G LL E+ 
Sbjct: 143 GVVKLGDLGLGRFFSSKTTAAHSLV--GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA 200

Query: 425 SGRRP----AQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVD 480
           + + P       + S+C + I +   P + S  Y E L  L++   +  PE    +  + 
Sbjct: 201 ALQSPFYGDKMNLYSLC-KKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEK---RPDIT 256

Query: 481 LVYACTQHV 489
            VY   + +
Sbjct: 257 YVYDVAKRM 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 71.3 bits (174), Expect = 1e-13
 Identities = 58/220 (26%), Positives = 98/220 (44%), Gaps = 18/220 (8%)

Query: 217 EELRSIT------KNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFY 269
           E+LRSI       K ++   ++ G   +G  Y+ I +  G  VA+K++      +K+   
Sbjct: 6   EKLRSIVSVGDPKKKYTRFEKI-GQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELII 64

Query: 270 SEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMK 329
           +EI       +PN+V          + ++V E++  G L   +         +D      
Sbjct: 65  NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAA 119

Query: 330 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 389
           V     Q + FLH      V+HRDI++ N+LL  +    L   G    +  E   +R+ M
Sbjct: 120 VCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-QSKRSTM 175

Query: 390 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
            G  Y ++APE V R     K D++S G++ +E+V G  P
Sbjct: 176 VGTPY-WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 70.9 bits (174), Expect = 2e-13
 Identities = 48/156 (30%), Positives = 74/156 (47%), Gaps = 11/156 (7%)

Query: 280 HPNLVAVKGCCYDHGDR-YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGI 338
           HP L  +   C+   DR + V E+V  G L   + HI R GR  D       A  +  G+
Sbjct: 55  HPFLTQLH-SCFQTKDRLFFVMEYVNGGDL---MFHIQRSGR-FDEPRARFYAAEIVLGL 109

Query: 339 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLA 398
            FLH++    +++RD++  NVLLD E    +   G+ K      +   T    GT  Y+A
Sbjct: 110 QFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC--GTPDYIA 164

Query: 399 PEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVD 434
           PE +         D ++ GVLL E+++G+ P +  D
Sbjct: 165 PEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD 200

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 70.1 bits (171), Expect = 2e-13
 Identities = 63/268 (23%), Positives = 114/268 (42%), Gaps = 33/268 (12%)

Query: 246 LPDGSRVAVKRLK---RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 302
           L D   VA+K+++       + +++   EI    +L+HPN++       +  +  IV E 
Sbjct: 24  LLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLEL 83

Query: 303 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 362
              G L + + +  +  R +      K    L   +  +H +    V+HRDI+ +NV + 
Sbjct: 84  ADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFIT 140

Query: 363 EEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLE 422
                 L  +GL +F   +     +++  GT  Y++PE ++ N    KSD++S G LL E
Sbjct: 141 ATGVVKLGDLGLGRFFSSKTTAAHSLV--GTPYYMSPERIHENGYNFKSDIWSLGCLLYE 198

Query: 423 IVSGRRP----AQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKV 478
           + + + P       + S+C Q I +   P            PL        P     +K+
Sbjct: 199 MAALQSPFYGDKMNLFSLC-QKIEQCDYP------------PL--------PTEHYSEKL 237

Query: 479 VDLVYACTQHVPSMRPRMSHVVHQLQQL 506
            +LV  C    P  RP + +V    +Q+
Sbjct: 238 RELVSMCIYPDPDQRPDIGYVHQIAKQM 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 69.3 bits (169), Expect = 3e-13
 Identities = 58/203 (28%), Positives = 94/203 (46%), Gaps = 13/203 (6%)

Query: 230 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGC 289
            + LG  + G  +       ++VAVK +K  S    + F +E      L H  LV +   
Sbjct: 11  EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAV 69

Query: 290 CYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHV 349
                  YI+ EF+  G L  +L      G        +  +  +A+G+AF+  +   + 
Sbjct: 70  VTKE-PIYIITEFMAKGSLLDFLK--SDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NY 123

Query: 350 VHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNEL 407
           +HRD+RA+N+L+       +   GL++ +      E T   G  +   + APE +     
Sbjct: 124 IHRDLRAANILVSASLVCKIADFGLARVIE---DNEYTAREGAKFPIKWTAPEAINFGSF 180

Query: 408 TTKSDVYSFGVLLLEIVS-GRRP 429
           T KSDV+SFG+LL+EIV+ GR P
Sbjct: 181 TIKSDVWSFGILLMEIVTYGRIP 203

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 69.0 bits (169), Expect = 4e-13
 Identities = 60/258 (23%), Positives = 110/258 (42%), Gaps = 29/258 (11%)

Query: 248 DGSRVAVKR--LKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 305
           D S V  K   L R S + +++  +EI   + L HPN++A      D     I  E+   
Sbjct: 24  DDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANG 83

Query: 306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 365
           G L   +    + G+  +  M +     +   ++++H   K  ++HRDI+  N+ L +  
Sbjct: 84  GTLYDKIVR--QKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAG 138

Query: 366 GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 425
              L   G+SK +  E     TV+  GT  Y++PE     +   KSD+++ G +L E+++
Sbjct: 139 LIKLGDFGISKILGSEYSMAETVV--GTPYYMSPELCQGVKYNFKSDIWALGCVLYELLT 196

Query: 426 GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYAC 485
            +R             F+   P       L L+  ++    + +       +++ LV++ 
Sbjct: 197 LKR------------TFDATNP-------LNLVVKIVQGNYTPVVS-VYSSELISLVHSL 236

Query: 486 TQHVPSMRPRMSHVVHQL 503
            Q  P  RP    V+ Q 
Sbjct: 237 LQQDPEKRPTADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 68.6 bits (168), Expect = 5e-13
 Identities = 50/200 (25%), Positives = 97/200 (48%), Gaps = 14/200 (7%)

Query: 240 GTYSGI-----LPDGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYD 292
           G+Y  +     L D    A+K +   S   + +++  +EI   A ++HPN+++ K    D
Sbjct: 11  GSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD 70

Query: 293 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 352
                IV E+   G L + +    +  + +      ++   L +G+  LH++    ++HR
Sbjct: 71  GNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHR 127

Query: 353 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSD 412
           D++++N+LL       +  +G+SK +  +    +T +  GT  Y+APE       + KSD
Sbjct: 128 DLKSANILLVANDLVKIGDLGISKVL--KKNMAKTQI--GTPHYMAPEVWKGRPYSYKSD 183

Query: 413 VYSFGVLLLEIVSGRRPAQA 432
           ++S G LL E+ +   P +A
Sbjct: 184 IWSLGCLLYEMATFAPPFEA 203

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|214480 smart00034, CLECT, C-type lectin (CTL) or carbohydrate-recognition domain (CRD)

 Score = 65.3 bits (159), Expect = 5e-13
 Identities = 32/138 (23%), Positives = 60/138 (43%), Gaps = 17/138 (12%)

Query: 9   CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 68
           CP  WI    K  C+ +    ++W++++ +C+ +GGHLA++ S  E      L   + + 
Sbjct: 1   CPSGWISYGGK--CYKFSTEKKTWEDAQAFCQSLGGHLASIHSEAENDFVASLLKNSGSS 58

Query: 69  --CWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN 126
              W+G    ++    SW+WSD  S          S+++     P   + +   C ++S 
Sbjct: 59  DYYWIGLSDPDSNG--SWQWSDG-SGPV-------SYSNWAPGEP---NNSSGDCVVLST 105

Query: 127 GSRSLVTERCNTSHPFIC 144
                    C +  PF+C
Sbjct: 106 SGGKWNDVSCTSKLPFVC 123

Many of these domains function as calcium-dependent carbohydrate binding modules. Length = 124

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 68.7 bits (168), Expect = 5e-13
 Identities = 79/289 (27%), Positives = 129/289 (44%), Gaps = 43/289 (14%)

Query: 231 RLLGDSKTGGTYSGIL--PDGSRV--AVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVA 285
           R++G    G  Y G L   DG ++  AVK L R +  +  ++F  E        HPN+++
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 286 VKGCCY-DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 344
           + G C    G   +V  ++ +G L    + I     +      +     +A+G+ +L  K
Sbjct: 61  LLGICLPSEGSPLVVLPYMKHGDL---RNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK 117

Query: 345 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV---PWEVMQERTVMAGGTYGYLAPEF 401
                VHRD+ A N +LDE F   +   GL++ +    +  +   T  A     ++A E 
Sbjct: 118 ---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHT-GAKLPVKWMALES 173

Query: 402 VYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLE---L 457
           +   + TTKSDV+SFGVLL E+++ G  P   VDS      F+    L+Q  R L+    
Sbjct: 174 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS------FDITVYLLQGRRLLQPEYC 227

Query: 458 LDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 506
            DPL                   ++ +C    P MRP  S +V +++Q+
Sbjct: 228 PDPLYE-----------------VMLSCWHPKPEMRPTFSELVSRIEQI 259

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 69.3 bits (169), Expect = 6e-13
 Identities = 51/199 (25%), Positives = 97/199 (48%), Gaps = 13/199 (6%)

Query: 233 LGDSKTGGT-YSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 291
           +G+  TG    + +   G  VAVK++     QR++  ++E+       H N+V +    Y
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS-Y 86

Query: 292 DHGDR-YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 350
             GD  ++V EF+  G L   + H       ++      V   + + ++ LH +    V+
Sbjct: 87  LVGDELWVVMEFLEGGALTDIVTHT-----RMNEEQIAAVCLAVLKALSVLHAQ---GVI 138

Query: 351 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 410
           HRDI++ ++LL  +    L   G    V  EV + ++++  GT  ++APE + R     +
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV--GTPYWMAPELISRLPYGPE 196

Query: 411 SDVYSFGVLLLEIVSGRRP 429
            D++S G++++E+V G  P
Sbjct: 197 VDIWSLGIMVIEMVDGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 68.6 bits (168), Expect = 7e-13
 Identities = 62/211 (29%), Positives = 97/211 (45%), Gaps = 14/211 (6%)

Query: 230 NRLLGDSKTGGTYSGI--LPDGSR--VAVKRLKRSSFQRKKE-FYSEIGRFARLHHPNLV 284
            R +G+ + G  Y G+   P+  +  VAVK  K  +    +E F  E     +  HP++V
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70

Query: 285 AVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 344
            + G   ++   +IV E    G L  +L        SLD A  +  +  L+  +A+L  K
Sbjct: 71  KLIGVITEN-PVWIVMELAPLGELRSYLQ---VNKYSLDLASLILYSYQLSTALAYLESK 126

Query: 345 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR 404
                VHRDI A NVL+       L   GLS+++  E   + +        ++APE +  
Sbjct: 127 ---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKL-PIKWMAPESINF 182

Query: 405 NELTTKSDVYSFGVLLLEIVS-GRRPAQAVD 434
              T+ SDV+ FGV + EI+  G +P Q V 
Sbjct: 183 RRFTSASDVWMFGVCMWEILMLGVKPFQGVK 213

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 69.0 bits (168), Expect = 7e-13
 Identities = 55/220 (25%), Positives = 98/220 (44%), Gaps = 18/220 (8%)

Query: 217 EELRSIT------KNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFY 269
           E+LRSI       K ++   ++ G   +G  Y+ + +  G  VA++++      +K+   
Sbjct: 7   EKLRSIVSVGDPKKKYTRFEKI-GQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII 65

Query: 270 SEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMK 329
           +EI       +PN+V          + ++V E++  G L   +         +D      
Sbjct: 66  NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAA 120

Query: 330 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 389
           V     Q + FLH      V+HRDI++ N+LL  +    L   G    +  E   +R+ M
Sbjct: 121 VCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-QSKRSTM 176

Query: 390 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
            G  Y ++APE V R     K D++S G++ +E++ G  P
Sbjct: 177 VGTPY-WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 68.2 bits (167), Expect = 8e-13
 Identities = 57/203 (28%), Positives = 98/203 (48%), Gaps = 11/203 (5%)

Query: 233 LGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRK-KEFYSEIGRFARLHHPNLVAVKGCC 290
           +G   T   Y+ I LP+  +VA+KR+     Q    E   E+   ++ +HPN+V      
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68

Query: 291 YDHGDRYIVYEFVVNGP-LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHV 349
               + ++V  ++  G  LD      PRGG  LD A+   V   + +G+ +LH   +   
Sbjct: 69  VVGDELWLVMPYLSGGSLLDIMKSSYPRGG--LDEAIIATVLKEVLKGLEYLHSNGQ--- 123

Query: 350 VHRDIRASNVLLDEEFGAHL--MGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY-RNE 406
           +HRDI+A N+LL E+    +   GV  S     +  ++      GT  ++APE +   + 
Sbjct: 124 IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHG 183

Query: 407 LTTKSDVYSFGVLLLEIVSGRRP 429
              K+D++SFG+  +E+ +G  P
Sbjct: 184 YDFKADIWSFGITAIELATGAAP 206

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 68.9 bits (168), Expect = 9e-13
 Identities = 54/178 (30%), Positives = 87/178 (48%), Gaps = 13/178 (7%)

Query: 290 CYDHGDR-YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH 348
           C+   DR Y V E+V  G L   ++ I + GR       +  A  +A G+ FLH K    
Sbjct: 69  CFQTMDRLYFVMEYVNGGDL---MYQIQQVGR-FKEPHAVFYAAEIAIGLFFLHSK---G 121

Query: 349 VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELT 408
           +++RD++  NV+LD E    +   G+ K   W+ +  +T    GT  Y+APE +      
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFC--GTPDYIAPEIIAYQPYG 179

Query: 409 TKSDVYSFGVLLLEIVSGRRPAQAVDS-VCWQSIFEW--ATPLVQSHRYLELLDPLIS 463
              D ++FGVLL E+++G+ P +  D    +QSI E   A P   S   + +   L++
Sbjct: 180 KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMT 237

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 68.2 bits (167), Expect = 9e-13
 Identities = 51/186 (27%), Positives = 85/186 (45%), Gaps = 13/186 (6%)

Query: 249 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 308
           G   A K ++  S +  ++F  EI   +   HPN+V +    +     +I+ EF   G L
Sbjct: 30  GLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGAL 89

Query: 309 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 368
           D  +  + RG   L       V   + + + FLH      V+HRD++A N+LL  +    
Sbjct: 90  DSIMLELERG---LTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVK 143

Query: 369 LMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFV----YR-NELTTKSDVYSFGVLLLEI 423
           L   G+S       +Q+R    G  Y ++APE V    ++ N    K+D++S G+ L+E+
Sbjct: 144 LADFGVSAKNKST-LQKRDTFIGTPY-WMAPEVVACETFKDNPYDYKADIWSLGITLIEL 201

Query: 424 VSGRRP 429
                P
Sbjct: 202 AQMEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 67.7 bits (166), Expect = 1e-12
 Identities = 51/199 (25%), Positives = 87/199 (43%), Gaps = 22/199 (11%)

Query: 247 PDGSRVAVKRLKRSSFQRKKEFY--SEIGRFARLHHPNLVAVKGCCYDHG-DR-----YI 298
            DG  +  K +   +   K++    SE+     L HPN+V      YD   DR     YI
Sbjct: 23  SDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRY----YDRIIDRSNQTLYI 78

Query: 299 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH--VVHRDIRA 356
           V E+   G L + +    +  + ++     ++ T L   +   H++  P   V+HRD++ 
Sbjct: 79  VMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKP 138

Query: 357 SNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG---GTYGYLAPEFVYRNELTTKSDV 413
           +N+ LD      L   GL+K     ++   +  A    GT  Y++PE +       KSD+
Sbjct: 139 ANIFLDANNNVKLGDFGLAK-----ILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDI 193

Query: 414 YSFGVLLLEIVSGRRPAQA 432
           +S G L+ E+ +   P  A
Sbjct: 194 WSLGCLIYELCALSPPFTA 212

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 67.6 bits (165), Expect = 1e-12
 Identities = 60/211 (28%), Positives = 103/211 (48%), Gaps = 23/211 (10%)

Query: 232 LLGDSKTGGTYSGIL-PDGSR---VAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAV 286
           ++G  + G    G L   G R   VA+K LK   + +++++F SE     +  HPN++ +
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 287 KGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA----FLH 342
           +G         I+ EF+ NG LD +L       R  D    +     + +GIA    +L 
Sbjct: 71  EGVVTKSRPVMIITEFMENGALDSFL-------RQNDGQFTVIQLVGMLRGIAAGMKYLS 123

Query: 343 DKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER-TVMAGGTYG--YLAP 399
           +    + VHRD+ A N+L++      +   GLS+F+  +      T   GG     + AP
Sbjct: 124 EM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180

Query: 400 EFVYRNELTTKSDVYSFGVLLLEIVS-GRRP 429
           E +   + T+ SDV+S+G+++ E++S G RP
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMSYGERP 211

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 67.7 bits (166), Expect = 1e-12
 Identities = 51/186 (27%), Positives = 85/186 (45%), Gaps = 18/186 (9%)

Query: 248 DGSRVAVKRLKRSSFQR--KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 305
            G  VA+K++K         K    EI     L+HPN++ +       GD Y+V+EF   
Sbjct: 23  TGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF--- 79

Query: 306 GPLDRWLHHIPRG-GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 364
             +D  L+ + +   R L  ++       L QG+AF H      ++HRD++  N+L++ E
Sbjct: 80  --MDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTE 134

Query: 365 FGAHLMGVGLSKFV--PWEVMQERTVMAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLL 421
               L   GL++    P        V    T  Y APE +  ++  +T  D++S G +  
Sbjct: 135 GVLKLADFGLARSFGSPVRPYTHYVV----TRWYRAPELLLGDKGYSTPVDIWSVGCIFA 190

Query: 422 EIVSGR 427
           E++S R
Sbjct: 191 ELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 67.4 bits (164), Expect = 2e-12
 Identities = 61/219 (27%), Positives = 100/219 (45%), Gaps = 17/219 (7%)

Query: 231 RLLGDSKTGGTYSGILPDGS---RVAVKRLKRSSFQRKK--EFYSEIGRFARLHHPNLVA 285
           + LG+ + G    G L       +VAVK +K +   R +  +F SE        HPN++ 
Sbjct: 5   KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64

Query: 286 VKGCCYDHGDR------YIVYEFVVNGPLDRWLHHIPRGGRS--LDWAMRMKVATTLAQG 337
           + G C    +        ++  F+ +G L  +L +   G     L   M +K  T +A G
Sbjct: 65  LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124

Query: 338 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 397
           + +L  K     +HRD+ A N +L+E     +   GLSK +       +  +A     ++
Sbjct: 125 MEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWI 181

Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDS 435
           A E +     TTKSDV+SFGV + EI + G+ P   V++
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN 220

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 67.3 bits (165), Expect = 2e-12
 Identities = 55/204 (26%), Positives = 93/204 (45%), Gaps = 21/204 (10%)

Query: 232 LLGDSKTGGTYSGI-LPDGSRVAVK--RLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKG 288
            LG+   G  Y  I    G  VA+K   ++    +  KE    I    +   P +V   G
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKE----ISILKQCDSPYIVKYYG 65

Query: 289 CCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ---GIAFLHDKV 345
             + + D +IV E+   G +      +    ++L      ++A  L Q   G+ +LH   
Sbjct: 66  SYFKNTDLWIVMEYCGAGSV---SDIMKITNKTLTEE---EIAAILYQTLKGLEYLHSN- 118

Query: 346 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN 405
               +HRDI+A N+LL+EE  A L   G+S  +   + +  TV+  GT  ++APE +   
Sbjct: 119 --KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI--GTPFWMAPEVIQEI 174

Query: 406 ELTTKSDVYSFGVLLLEIVSGRRP 429
               K+D++S G+  +E+  G+ P
Sbjct: 175 GYNNKADIWSLGITAIEMAEGKPP 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 66.8 bits (163), Expect = 2e-12
 Identities = 59/211 (27%), Positives = 103/211 (48%), Gaps = 23/211 (10%)

Query: 231 RLLGDSKTGGTYSGILP-DGSR---VAVKRLKRSSFQR-KKEFYSEIGRFARLHHPNLVA 285
           +++G  + G   SG L   G R   VA+K LK    ++ +++F SE     +  HPN++ 
Sbjct: 10  KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIH 69

Query: 286 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 345
           ++G         IV E++ NG LD +L    +          + +   +A G+ +L D  
Sbjct: 70  LEGVVTKSKPVMIVTEYMENGSLDAFLR---KHDGQFTVIQLVGMLRGIASGMKYLSDM- 125

Query: 346 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG------YLAP 399
               VHRD+ A N+L++      +   GLS+     V+++    A  T G      + AP
Sbjct: 126 --GYVHRDLAARNILVNSNLVCKVSDFGLSR-----VLEDDPEAAYTTRGGKIPIRWTAP 178

Query: 400 EFVYRNELTTKSDVYSFGVLLLEIVS-GRRP 429
           E +   + T+ SDV+S+G+++ E++S G RP
Sbjct: 179 EAIAYRKFTSASDVWSYGIVMWEVMSYGERP 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 67.5 bits (165), Expect = 2e-12
 Identities = 57/234 (24%), Positives = 98/234 (41%), Gaps = 33/234 (14%)

Query: 281 PNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAF 340
           P +V   G  Y  G+  I  E +  G LD+ L    R    +   +  K++  + +G+ +
Sbjct: 59  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR----IPENILGKISIAVLRGLTY 114

Query: 341 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG---GTYGYL 397
           L +K K  ++HRD++ SN+L++      L   G+S        Q    MA    GT  Y+
Sbjct: 115 LREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSG-------QLIDSMANSFVGTRSYM 165

Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIF-------EWATPLV- 449
           +PE +     T +SD++S G+ L+E+  GR P    D+   +++F       E       
Sbjct: 166 SPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRP 225

Query: 450 ---------QSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP 494
                    +     ELLD +++     +P      +  D V  C +  P  R 
Sbjct: 226 VSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERA 279

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 66.9 bits (163), Expect = 2e-12
 Identities = 74/291 (25%), Positives = 124/291 (42%), Gaps = 38/291 (13%)

Query: 231 RLLGDSKTGGTYSGILP--DGS--RVAVKRLKRSSFQRK--KEFYSEIGRFARLHHPNLV 284
           R+LG  + G      L   DGS  +VAVK LK   F     +EF  E        HPN++
Sbjct: 5   RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVI 64

Query: 285 AVKGCCYDHGDR------YIVYEFVVNGPLDRWL--HHIPRGGRSLDWAMRMKVATTLAQ 336
            + G       +       ++  F+ +G L  +L    I     +L     ++    +A 
Sbjct: 65  KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124

Query: 337 GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGY 396
           G+ +L  K   + +HRD+ A N +L+E     +   GLSK +       +   +     +
Sbjct: 125 GMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKW 181

Query: 397 LAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYL 455
           LA E +  N  TT SDV++FGV + EI++ G+ P   V++     I+ +   L++ +R  
Sbjct: 182 LALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEIYNY---LIKGNRLK 235

Query: 456 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 506
           +  D L              + V +L+  C    P  RP   H+  QL+ +
Sbjct: 236 QPPDCL--------------EDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 66.6 bits (162), Expect = 2e-12
 Identities = 57/195 (29%), Positives = 86/195 (44%), Gaps = 8/195 (4%)

Query: 233 LGDSKTGGTYSGIL-PDGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCC 290
           +G    G  +SG L  D + VAVK  + +     K +F  E     +  HPN+V + G C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 291 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 350
                 YIV E V  G    +L      G  L     +++    A G+ +L  K   H +
Sbjct: 63  TQKQPIYIVMELVQGGDFLTFLRT---EGPRLKVKELIQMVENAAAGMEYLESK---HCI 116

Query: 351 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 410
           HRD+ A N L+ E+    +   G+S+     V      M      + APE +     +++
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSE 176

Query: 411 SDVYSFGVLLLEIVS 425
           SDV+SFG+LL E  S
Sbjct: 177 SDVWSFGILLWEAFS 191

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 67.0 bits (163), Expect = 3e-12
 Identities = 68/274 (24%), Positives = 117/274 (42%), Gaps = 42/274 (15%)

Query: 250 SRVAVKRLKRSSFQRK-KEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGP 307
           ++VAVK LK  + ++   +  SE+     +  H N++ + G C   G  Y++ E+   G 
Sbjct: 51  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 110

Query: 308 LDRWLH--------------HIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRD 353
           L  +L                +P     L +   +  A  +A+G+ +L  K     +HRD
Sbjct: 111 LREYLRARRPPGMEYCYNPTQVPE--EQLSFKDLVSCAYQVARGMEYLASK---KCIHRD 165

Query: 354 IRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDV 413
           + A NVL+ E+    +   GL++ +      ++T        ++APE ++    T +SDV
Sbjct: 166 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDV 225

Query: 414 YSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEA 472
           +SFGVLL EI + G  P   V       + E    L + HR              D P +
Sbjct: 226 WSFGVLLWEIFTLGGSPYPGV------PVEELFKLLKEGHRM-------------DKP-S 265

Query: 473 GVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 506
               ++  ++  C   VPS RP    +V  L ++
Sbjct: 266 NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 66.5 bits (162), Expect = 5e-12
 Identities = 51/193 (26%), Positives = 94/193 (48%), Gaps = 25/193 (12%)

Query: 252 VAVKRLK-RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 310
           VAVK L+  ++   + +F  E+   +RL  PN++ + G C D     ++ E++ NG L++
Sbjct: 49  VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108

Query: 311 WL--HHIPRG-------------GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIR 355
           +L  HH+                  ++ ++  + VA  +A G+ +L      + VHRD+ 
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHRDLA 165

Query: 356 ASNVLLDEEFGAHLMGVGLSKFV---PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSD 412
             N L+ E     +   G+S+ +    +  +Q R V+      ++A E +   + TT SD
Sbjct: 166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLP---IRWMAWECILMGKFTTASD 222

Query: 413 VYSFGVLLLEIVS 425
           V++FGV L EI+ 
Sbjct: 223 VWAFGVTLWEILM 235

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 66.4 bits (162), Expect = 5e-12
 Identities = 57/208 (27%), Positives = 97/208 (46%), Gaps = 46/208 (22%)

Query: 247 PD-GSRVAVKRLKRSSFQRKKEFYSEIGR--FARLHHPNLVAVKGCCYDHGDRYIVYEFV 303
           PD G   A+K LK+++ + +    +++ R   A ++HP +V +       G  Y++ +F+
Sbjct: 21  PDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80

Query: 304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH--------------- 348
                        RGG          + T L++ + F  + VK +               
Sbjct: 81  -------------RGG---------DLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG 118

Query: 349 VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM--QERTVMAGGTYGYLAPEFVYRNE 406
           +++RD++  N+LLDEE    L   GLSK    E +  +++     GT  Y+APE V R  
Sbjct: 119 IIYRDLKPENILLDEEGHIKLTDFGLSK----ESIDHEKKAYSFCGTVEYMAPEVVNRRG 174

Query: 407 LTTKSDVYSFGVLLLEIVSGRRPAQAVD 434
            T  +D +SFGVL+ E+++G  P Q  D
Sbjct: 175 HTQSADWWSFGVLMFEMLTGSLPFQGKD 202

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 65.6 bits (160), Expect = 6e-12
 Identities = 54/200 (27%), Positives = 88/200 (44%), Gaps = 22/200 (11%)

Query: 249 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLH----HPNLVAVKGCCYDHGDR-YIVYEFV 303
           G   A+K LK+S    K +  +     A +      P  VA     +   D  Y+V E++
Sbjct: 21  GDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPY-VAKLYYSFQSKDYLYLVMEYL 79

Query: 304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 363
             G     +  +  GG   DWA   +    +  G+  LH +    ++HRDI+  N+L+D+
Sbjct: 80  NGGDCASLIKTL--GGLPEDWAK--QYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQ 132

Query: 364 EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 423
                L   GLS+     +  ++ V   GT  YLAPE +        SD +S G ++ E 
Sbjct: 133 TGHLKLTDFGLSRNG---LENKKFV---GTPDYLAPETILGVGDDKMSDWWSLGCVIFEF 186

Query: 424 VSGRRP--AQAVDSVCWQSI 441
           + G  P  A+  D+V + +I
Sbjct: 187 LFGYPPFHAETPDAV-FDNI 205

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|153057 cd00037, CLECT, C-type lectin (CTL)/C-type lectin-like (CTLD) domain

 Score = 62.3 bits (151), Expect = 6e-12
 Identities = 32/130 (24%), Positives = 56/130 (43%), Gaps = 22/130 (16%)

Query: 21  KCFGYIGNFRSWDESETYCKEIGGHLAALTSYEE-EHSAQKLCGKNVNGCWVGGRSINTT 79
            C+ +     +W+E++ YC+ +GGHLA++ S EE +  A  L   + +  W+G   +++ 
Sbjct: 1   SCYKFSTEKLTWEEAQEYCRSLGGHLASIHSEEENDFLASLLKKSSSSDVWIGLNDLSS- 59

Query: 80  VGLSWKWSD-----NMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTE 134
              +WKWSD     + + W       G  +  C               L S+        
Sbjct: 60  -EGTWKWSDGSPLVDYTNWAPGEPNPGG-SEDCV-------------VLSSSSDGKWNDV 104

Query: 135 RCNTSHPFIC 144
            C++  PFIC
Sbjct: 105 SCSSKLPFIC 114

CLECT: C-type lectin (CTL)/C-type lectin-like (CTLD) domain; protein domains homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. This group is chiefly comprised of eukaryotic CTLDs, but contains some, as yet functionally uncharacterized, bacterial CTLDs. Many CTLDs are calcium-dependent carbohydrate binding modules; other CTLDs bind protein ligands, lipids, and inorganic surfaces, including CaCO3 and ice. Animal C-type lectins are involved in such functions as extracellular matrix organization, endocytosis, complement activation, pathogen recognition, and cell-cell interactions. For example: mannose-binding lectin and lung surfactant proteins A and D bind carbohydrates on surfaces (e.g. pathogens, allergens, necrotic, and apoptotic cells) and mediate functions associated with killing and phagocytosis; P (platlet)-, E (endothelial)-, and L (leukocyte)- selectins (sels) mediate the initial attachment, tethering, and rolling of lymphocytes on inflamed vascular walls enabling subsequent lymphocyte adhesion and transmigration. CTLDs may bind a variety of carbohydrate ligands including mannose, N-acetylglucosamine, galactose, N-acetylgalactosamine, and fucose. Several CTLDs bind to protein ligands, and only some of these binding interactions are Ca2+-dependent; including the CTLDs of Coagulation Factors IX/X (IX/X) and Von Willebrand Factor (VWF) binding proteins, and natural killer cell receptors. C-type lectins, such as lithostathine, and some type II antifreeze glycoproteins function in a Ca2+-independent manner to bind inorganic surfaces. Many proteins in this group contain a single CTLD; these CTLDs associate with each other through several different surfaces to form dimers, trimers, or tetramers, from which ligand-binding sites project in different orientations. Various vertebrate type 1 transmembrane proteins including macrophage mannose receptor, endo180, phospholipase A2 receptor, and dendritic and epithelial cell receptor (DEC205) have extracellular domains containing 8 or more CTLDs; these CTLDs remain in the parent model. In some members (IX/X and VWF binding proteins), a loop extends to the adjoining domain to form a loop-swapped dimer. A similar conformation is seen in the macrophage mannose receptor CRD4's putative non-sugar bound form of the domain in the acid environment of the endosome. Lineage specific expansions of CTLDs have occurred in several animal lineages including Drosophila melanogaster and Caenorhabditis elegans; these CTLDs also remain in the parent model. Length = 116

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 65.5 bits (160), Expect = 9e-12
 Identities = 72/269 (26%), Positives = 120/269 (44%), Gaps = 28/269 (10%)

Query: 249 GSRVAVKRLKRSSFQR--KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 306
           G  VA+K+   S   +  KK    EI    +L H NLV +          Y+V+EFV + 
Sbjct: 26  GQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHT 85

Query: 307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 366
            LD  L   P G   LD +   K    + +GI F H     +++HRDI+  N+L+ +   
Sbjct: 86  VLDD-LEKYPNG---LDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGV 138

Query: 367 AHLMGVGLSKFV--PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKS-DVYSFGVLLLEI 423
             L   G ++ +  P EV  +       T  Y APE +  +    ++ D+++ G L+ E+
Sbjct: 139 VKLCDFGFARTLAAPGEVYTDYV----ATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEM 194

Query: 424 VSGRRPAQAVDSVCWQ--SIFEWATPLVQSHRYLELLDPLISSLS-SDIPEAGVVQK--- 477
           ++G  P    DS   Q   I +    L+  H+ +   +PL + +   ++ E   ++K   
Sbjct: 195 LTG-EPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFP 253

Query: 478 -----VVDLVYACTQHVPSMRPRMSHVVH 501
                V+DL   C +  P  RP  S ++H
Sbjct: 254 KLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 65.4 bits (159), Expect = 9e-12
 Identities = 44/181 (24%), Positives = 89/181 (49%), Gaps = 10/181 (5%)

Query: 249 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 308
           G +VAVK +     QR++  ++E+       H N+V +        + +++ EF+  G L
Sbjct: 46  GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105

Query: 309 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 368
              +         L+      V  ++ Q + +LH +    V+HRDI++ ++LL  +    
Sbjct: 106 TDIVSQT-----RLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVK 157

Query: 369 LMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRR 428
           L   G    +  +V + ++++  GT  ++APE + R    T+ D++S G++++E+V G  
Sbjct: 158 LSDFGFCAQISKDVPKRKSLV--GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEP 215

Query: 429 P 429
           P
Sbjct: 216 P 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 66.0 bits (161), Expect = 9e-12
 Identities = 57/186 (30%), Positives = 84/186 (45%), Gaps = 19/186 (10%)

Query: 249 GSRVAVKRLKRSSFQRKKE---FYSEIGRFARLHHPNLVAVKGCCYDHGDR-YIVYEFVV 304
           G   A+K LK+    + K+      E      L HP +V +  C +   +R Y + EFVV
Sbjct: 43  GEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMM-CSFQDENRVYFLLEFVV 101

Query: 305 NGPLDRWLHHIPRGGR-SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 363
            G L     H+ + GR   D A        LA    +LH K    +++RD++  N+LLD 
Sbjct: 102 GGEL---FTHLRKAGRFPNDVAKFYHAELVLA--FEYLHSK---DIIYRDLKPENLLLDN 153

Query: 364 EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 423
           +    +   G +K VP     +RT    GT  YLAPE +         D ++ GVLL E 
Sbjct: 154 KGHVKVTDFGFAKKVP-----DRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEF 208

Query: 424 VSGRRP 429
           ++G  P
Sbjct: 209 IAGYPP 214

Length = 329

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 65.8 bits (160), Expect = 9e-12
 Identities = 49/171 (28%), Positives = 81/171 (47%), Gaps = 11/171 (6%)

Query: 275 FARLHHPNLVAVKGCCYDHGDR-YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATT 333
            A    P  +     C+   DR Y V E+V  G L   ++HI + G+       +  A  
Sbjct: 54  LALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDL---MYHIQQVGK-FKEPQAVFYAAE 109

Query: 334 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT 393
           ++ G+ FLH +    +++RD++  NV+LD E    +   G+ K    + +  RT    GT
Sbjct: 110 ISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFC--GT 164

Query: 394 YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS-VCWQSIFE 443
             Y+APE +         D +++GVLL E+++G+ P    D    +QSI E
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME 215

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 64.9 bits (158), Expect = 1e-11
 Identities = 61/261 (23%), Positives = 118/261 (45%), Gaps = 44/261 (16%)

Query: 249 GSRVAVKRLK--RSSFQRKKEFYS----EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 302
           G+ +AVK++   R++   ++E       EI   ARL+HP+++ + G   +     +  E+
Sbjct: 25  GTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEW 84

Query: 303 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 362
           +  G +   L        +   A+ +     L +G+++LH+     ++HRD++ +N+L+D
Sbjct: 85  MAGGSVSHLLSKYG----AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLID 137

Query: 363 EEFGAHLMGVGLSKFVPWEVMQERTVMAG-------GTYGYLAPEFVYRNELTTKS-DVY 414
              G  L    ++ F     +  +   AG       GT  ++APE V R E   +S DV+
Sbjct: 138 ST-GQRLR---IADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE-VLRGEQYGRSCDVW 192

Query: 415 SFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS-DIPEAG 473
           S G +++E+ + + P              W      +H  L L+  + S+ ++  IPE  
Sbjct: 193 SVGCVIIEMATAKPP--------------WNAEKHSNH--LALIFKIASATTAPSIPEH- 235

Query: 474 VVQKVVDLVYACTQHVPSMRP 494
           +   + D+   C +  P  RP
Sbjct: 236 LSPGLRDVTLRCLELQPEDRP 256

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 64.9 bits (158), Expect = 2e-11
 Identities = 51/156 (32%), Positives = 73/156 (46%), Gaps = 15/156 (9%)

Query: 280 HPNLVAVKGCCYDHGDR-YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGI 338
           HP L  +  CC+   DR + V EFV  G L   + HI +  R  D A     A  +   +
Sbjct: 55  HPFLTQLY-CCFQTPDRLFFVMEFVNGGDL---MFHIQKS-RRFDEARARFYAAEITSAL 109

Query: 339 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGY 396
            FLHDK    +++RD++  NVLLD E    L   G+ K    E +      +   GT  Y
Sbjct: 110 MFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK----EGIFNGKTTSTFCGTPDY 162

Query: 397 LAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQA 432
           +APE +         D ++ GVLL E++ G  P +A
Sbjct: 163 IAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEA 198

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 64.7 bits (157), Expect = 2e-11
 Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 16/204 (7%)

Query: 233 LGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 291
           LGD   G  Y     + G+  A K ++  S +  +++  EI   A  +HP +V + G  Y
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 292 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 351
             G  +I+ EF   G +D  +  + RG   L       +   + + + +LH      ++H
Sbjct: 80  WDGKLWIMIEFCPGGAVDAIMLELDRG---LTEPQIQVICRQMLEALQYLHSM---KIIH 133

Query: 352 RDIRASNVLLDEEFGAHLMGVGLS-KFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTT- 409
           RD++A NVLL  +    L   G+S K V  + +Q R    G  Y ++APE V    +   
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSAKNV--KTLQRRDSFIGTPY-WMAPEVVMCETMKDT 190

Query: 410 ----KSDVYSFGVLLLEIVSGRRP 429
               K+D++S G+ L+E+     P
Sbjct: 191 PYDYKADIWSLGITLIEMAQIEPP 214

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 64.2 bits (157), Expect = 2e-11
 Identities = 45/195 (23%), Positives = 79/195 (40%), Gaps = 26/195 (13%)

Query: 249 GSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAVKGCCYDHGDR-YIVYEFVV 304
           G   A+K +K++   RK    +  +E    ++   P +V +    +      Y+V E++ 
Sbjct: 18  GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY-YSFQGKKNLYLVMEYLP 76

Query: 305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 364
            G L   L ++     SLD  +       +   + +LH      ++HRD++  N+L+D  
Sbjct: 77  GGDLASLLENV----GSLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSN 129

Query: 365 FGAHLMGVGLSKFVPWEVMQERTVMAG----------GTYGYLAPEFVYRNELTTKSDVY 414
               L   GLSK      +  R +             GT  Y+APE +     +   D +
Sbjct: 130 GHLKLTDFGLSKVG----LVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWW 185

Query: 415 SFGVLLLEIVSGRRP 429
           S G +L E + G  P
Sbjct: 186 SLGCILYEFLVGIPP 200

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 64.8 bits (158), Expect = 2e-11
 Identities = 50/157 (31%), Positives = 77/157 (49%), Gaps = 11/157 (7%)

Query: 289 CCYDHGDR-YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKP 347
            C+   DR Y V E+V  G L   ++HI + G+       +  A  +A G+ FLH K   
Sbjct: 68  SCFQTMDRLYFVMEYVNGGDL---MYHIQQVGK-FKEPHAVFYAAEIAIGLFFLHSK--- 120

Query: 348 HVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL 407
            +++RD++  NV+LD E    +   G+ K   +     RT    GT  Y+APE +     
Sbjct: 121 GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFC--GTPDYIAPEIIAYQPY 178

Query: 408 TTKSDVYSFGVLLLEIVSGRRPAQAVDS-VCWQSIFE 443
               D ++FGVLL E+++G+ P    D    +QSI E
Sbjct: 179 GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIME 215

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 64.7 bits (157), Expect = 2e-11
 Identities = 72/275 (26%), Positives = 117/275 (42%), Gaps = 48/275 (17%)

Query: 252 VAVKRLKRSSFQR-------KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 304
           VAVK LK  + ++       + E    IG+     H N++ + G C   G  Y++ E+  
Sbjct: 50  VAVKMLKDDATEKDLSDLVSEMEMMKMIGK-----HKNIINLLGACTQDGPLYVIVEYAS 104

Query: 305 NGPLDRWLH-HIPRG-------GRSLDWAMRMK--VATT--LAQGIAFLHDKVKPHVVHR 352
            G L  +L    P G        R  D  M  K  V+ T  +A+G+ +L  +     +HR
Sbjct: 105 KGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHR 161

Query: 353 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSD 412
           D+ A NVL+ E     +   GL++ V      ++T        ++APE ++    T +SD
Sbjct: 162 DLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSD 221

Query: 413 VYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPE 471
           V+SFGVL+ EI + G  P   +       + E    L + HR              D P 
Sbjct: 222 VWSFGVLMWEIFTLGGSPYPGI------PVEELFKLLKEGHRM-------------DKP- 261

Query: 472 AGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 506
           A    ++  ++  C   +PS RP    +V  L ++
Sbjct: 262 ANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRI 296

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 64.7 bits (157), Expect = 2e-11
 Identities = 52/208 (25%), Positives = 99/208 (47%), Gaps = 15/208 (7%)

Query: 239 GGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHH----PNLVAVKGCCYDHG 294
           GG  + +    S + + R K    + K    ++I R  ++ H    P +V   G  Y  G
Sbjct: 18  GGVVTKVQHKPSGLIMAR-KLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG 76

Query: 295 DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDI 354
           +  I  E +  G LD+ L    +  + +   +  KV+  + +G+A+L +K    ++HRD+
Sbjct: 77  EISICMEHMDGGSLDQVL----KEAKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDV 130

Query: 355 RASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVY 414
           + SN+L++      L   G+S     +++        GT  Y++PE +     + +SD++
Sbjct: 131 KPSNILVNSRGEIKLCDFGVSG----QLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIW 186

Query: 415 SFGVLLLEIVSGRRPAQAVDSVCWQSIF 442
           S G+ L+E+  GR P    D+   ++IF
Sbjct: 187 SMGLSLVELAIGRYPIPPPDAKELEAIF 214

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 64.2 bits (156), Expect = 3e-11
 Identities = 50/190 (26%), Positives = 93/190 (48%), Gaps = 26/190 (13%)

Query: 252 VAVKRLKRSSFQR-KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 310
           VAVK L+    +  + +F  EI   +RL +PN++ + G C       ++ E++ NG L++
Sbjct: 47  VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQ 106

Query: 311 WL------------HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASN 358
           +L            ++IP    S+  A  + +A  +A G+ +L      + VHRD+   N
Sbjct: 107 FLSQREIESTFTHANNIP----SVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRN 159

Query: 359 VLLDEEFGAHLMGVGLSKFV---PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYS 415
            L+   +   +   G+S+ +    +  +Q R V+      ++A E +   + TT SDV++
Sbjct: 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLP---IRWMAWESILLGKFTTASDVWA 216

Query: 416 FGVLLLEIVS 425
           FGV L E+ +
Sbjct: 217 FGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 63.5 bits (155), Expect = 3e-11
 Identities = 48/211 (22%), Positives = 91/211 (43%), Gaps = 19/211 (9%)

Query: 232 LLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGC 289
           ++G+   G  Y       G  VA+K +       ++E   E     +  +HPN+    G 
Sbjct: 13  VIGEGTYGKVYKARHKKTGQLVAIKIMD-IIEDEEEEIKEEYNILRKYSNHPNIATFYGA 71

Query: 290 CY------DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 343
                   +    ++V E    G +   +  + + G+ L       +     +G+A+LH+
Sbjct: 72  FIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE 131

Query: 344 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 403
                V+HRDI+  N+LL +     L+  G+S  +   + +  T +  GT  ++APE + 
Sbjct: 132 N---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI--GTPYWMAPEVIA 186

Query: 404 RNE-----LTTKSDVYSFGVLLLEIVSGRRP 429
            +E        +SDV+S G+  +E+  G+ P
Sbjct: 187 CDEQPDASYDARSDVWSLGITAIELADGKPP 217

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 63.3 bits (154), Expect = 3e-11
 Identities = 48/185 (25%), Positives = 92/185 (49%), Gaps = 19/185 (10%)

Query: 248 DGSRVAVKRLKRSSFQRKK--EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 305
           DG +  +K +  S    K+  E   E+   + + HPN+V  +    ++G+ YIV ++   
Sbjct: 24  DGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEG 83

Query: 306 GPLDRWLHHIPRG-----GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
           G L + ++   RG      + LDW +++ +A      +  +HD+    ++HRDI++ N+ 
Sbjct: 84  GDLYKKINA-QRGVLFPEDQILDWFVQICLA------LKHVHDR---KILHRDIKSQNIF 133

Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLL 420
           L ++    L   G+++ +   V   RT +  GT  YL+PE         KSD+++ G +L
Sbjct: 134 LTKDGTIKLGDFGIARVLNSTVELARTCI--GTPYYLSPEICENRPYNNKSDIWALGCVL 191

Query: 421 LEIVS 425
            E+ +
Sbjct: 192 YEMCT 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 63.9 bits (155), Expect = 4e-11
 Identities = 55/231 (23%), Positives = 101/231 (43%), Gaps = 28/231 (12%)

Query: 252 VAVKRLKRSSFQ---RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 308
           VA+K++  S  Q   + ++   E+    +L HPN +  +GC       ++V E+ +    
Sbjct: 43  VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSAS 102

Query: 309 DRW-LHHIPRGGRSLDWAMRMKVATTL---AQGIAFLHDKVKPHVVHRDIRASNVLLDEE 364
           D   +H  P           +++A       QG+A+LH     +++HRD++A N+LL E 
Sbjct: 103 DLLEVHKKP--------LQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEP 151

Query: 365 FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY---RNELTTKSDVYSFGVLLL 421
                  V L  F    +M       G  Y ++APE +      +   K DV+S G+  +
Sbjct: 152 -----GLVKLGDFGSASIMAPANXFVGTPY-WMAPEVILAMDEGQYDGKVDVWSLGITCI 205

Query: 422 EIVSGRRPAQAVDSV-CWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPE 471
           E+   + P   ++++     I +  +P +QS  + E     + S    IP+
Sbjct: 206 ELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQ 256

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 63.1 bits (153), Expect = 4e-11
 Identities = 66/262 (25%), Positives = 114/262 (43%), Gaps = 38/262 (14%)

Query: 248 DGSRVAVKRL--KRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY-DHGDRYIVYEFVV 304
           DG +  +K+L  + +S + +K    E    ++L HPN+VA +     + G  YIV  F  
Sbjct: 24  DGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCE 83

Query: 305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 364
            G L   L    + G+ L     ++    +A  + +LH+K   H++HRD++  NV L   
Sbjct: 84  GGDLYHKLKE--QKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRT 138

Query: 365 FGAHLMGVGLSKFVPWEVMQERTVMAG---GTYGYLAPEFVYRNELTTKSDVYSFGVLLL 421
               +  +G+++     V++ +  MA    GT  Y++PE         KSDV++ G  + 
Sbjct: 139 NIIKVGDLGIAR-----VLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVY 193

Query: 422 EIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLE-LLDPLISSLSSDIPEAGVVQKVVD 480
           E+ + +    A D             LV  +R +E  L P+    S   PE G      +
Sbjct: 194 EMATLKHAFNAKD----------MNSLV--YRIIEGKLPPMPKDYS---PELG------E 232

Query: 481 LVYACTQHVPSMRPRMSHVVHQ 502
           L+       P  RP +  ++ Q
Sbjct: 233 LIATMLSKRPEKRPSVKSILRQ 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 62.9 bits (153), Expect = 5e-11
 Identities = 62/226 (27%), Positives = 91/226 (40%), Gaps = 39/226 (17%)

Query: 233 LGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRK---------KEFYSEIGRFARLHHPN 282
           LG       Y G+L        V   +  S   K           F+      ++L H +
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 283 LVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLH 342
           LV + G C    +  +V E+V  GPLD +LH       SL W  ++ VA  LA  + +L 
Sbjct: 63  LVKLYGVCVRDENI-MVEEYVKFGPLDVFLHREK-NNVSLHW--KLDVAKQLASALHYLE 118

Query: 343 DKVKPHVVHRDIRASNVLL---DEEFGAHLM------GVGLSKFVPWEVMQERTVMAGGT 393
           DK    +VH ++   N+L+       G          G+ ++  +  E   ER       
Sbjct: 119 DK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPIT-VLSREERVERI------ 168

Query: 394 YGYLAPEFVYRN---ELTTKSDVYSFGVLLLEIVS-GRRPAQAVDS 435
             ++APE   RN    LT  +D +SFG  LLEI S G  P   + S
Sbjct: 169 -PWIAPEC-IRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS 212

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 63.1 bits (153), Expect = 5e-11
 Identities = 67/294 (22%), Positives = 127/294 (43%), Gaps = 47/294 (15%)

Query: 231 RLLGDSKTGGTYSGIL-------PDGSRVAVKRLKRSSFQRKK-EFYSEIGRFARLHHPN 282
           R LG    G  Y GI        P+ +RVA+K +  ++  R++ EF +E       +  +
Sbjct: 12  RELGQGSFGMVYEGIAKGVVKDEPE-TRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 70

Query: 283 LVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHI-----PRGGRSLDWAMRM-KVATTLAQ 336
           +V + G         ++ E +  G L  +L  +         ++     +M ++A  +A 
Sbjct: 71  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130

Query: 337 GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT--- 393
           G+A+L+       VHRD+ A N ++ E+F   +   G+++    ++ +      GG    
Sbjct: 131 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLL 183

Query: 394 -YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQS 451
              +++PE +     TT SDV+SFGV+L EI +   +P Q + +       E     V  
Sbjct: 184 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN-------EQVLRFVME 236

Query: 452 HRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ 505
              L+  D        + P+      + +L+  C Q+ P MRP    ++  +++
Sbjct: 237 GGLLDKPD--------NCPDM-----LFELMRMCWQYNPKMRPSFLEIISSIKE 277

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 63.5 bits (154), Expect = 6e-11
 Identities = 68/292 (23%), Positives = 125/292 (42%), Gaps = 44/292 (15%)

Query: 231 RLLGDSKTGGTYSGI-LPDGSR----VAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLV 284
           ++LG    G  Y G+ +P+G +    VA+K L+  +S +  KE   E    A + +P++ 
Sbjct: 13  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72

Query: 285 AVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS--LDWAMRMKVATTLAQGIAFLH 342
            + G C     + I         LD    H    G    L+W ++      +A+G+ +L 
Sbjct: 73  RLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLE 126

Query: 343 DKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG---TYGYLAP 399
           ++    +VHRD+ A NVL+       +   GL+K +  +   E+   A G      ++A 
Sbjct: 127 ER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD---EKEYHAEGGKVPIKWMAL 180

Query: 400 EFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELL 458
           E +     T +SDV+S+GV + E+++ G +P   + +    SI E    L Q        
Sbjct: 181 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ-------- 232

Query: 459 DPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 510
            P I ++            V  ++  C       RP+   ++ +  ++A+ P
Sbjct: 233 -PPICTI-----------DVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 62.7 bits (152), Expect = 8e-11
 Identities = 58/206 (28%), Positives = 92/206 (44%), Gaps = 22/206 (10%)

Query: 240 GTYSGIL-----PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCY-- 291
           GTY  +       DGS  AVK L   S    +E  +E      L +HPN+V   G  Y  
Sbjct: 33  GTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91

Query: 292 DH---GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH 348
           D    G  ++V E    G +   +  +   G+ LD AM   +      G+  LH+     
Sbjct: 92  DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---R 148

Query: 349 VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFV-----Y 403
           ++HRD++ +N+LL  E G  L+  G+S  +    ++  T +  GT  ++APE +     Y
Sbjct: 149 IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV--GTPFWMAPEVIACEQQY 206

Query: 404 RNELTTKSDVYSFGVLLLEIVSGRRP 429
                 + DV+S G+  +E+  G  P
Sbjct: 207 DYSYDARCDVWSLGITAIELGDGDPP 232

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 62.8 bits (152), Expect = 9e-11
 Identities = 55/234 (23%), Positives = 103/234 (44%), Gaps = 34/234 (14%)

Query: 252 VAVKRLKRS---SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 308
           VA+K++  S   S ++ ++   E+    R+ HPN +  KGC       ++V E+ +    
Sbjct: 53  VAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSAS 112

Query: 309 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE----- 363
           D    H     + L       +     QG+A+LH     +++HRDI+A N+LL E     
Sbjct: 113 DLLEVH----KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVK 165

Query: 364 --EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY---RNELTTKSDVYSFGV 418
             +FG+  +    + FV             GT  ++APE +      +   K DV+S G+
Sbjct: 166 LADFGSASIASPANSFV-------------GTPYWMAPEVILAMDEGQYDGKVDVWSLGI 212

Query: 419 LLLEIVSGRRPAQAVDSV-CWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPE 471
             +E+   + P   ++++     I +  +P +QS+ + +     + S    IP+
Sbjct: 213 TCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQ 266

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 62.1 bits (151), Expect = 1e-10
 Identities = 57/214 (26%), Positives = 94/214 (43%), Gaps = 19/214 (8%)

Query: 225 NFSEGNRLLGDSKTGGTYSGILPD-GSRVAVKRLK--RSSFQRKKEFYS---EIGRFARL 278
           N+  G +LLG    G  Y     D G  +AVK++     S + KKE  +   EI     L
Sbjct: 3   NWRRG-KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61

Query: 279 HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGI 338
            H  +V   GC  D     I  E++  G +      +   G +L   +  K    + +G+
Sbjct: 62  QHERIVQYYGCLRDDETLSIFMEYMPGGSVK---DQLKAYG-ALTETVTRKYTRQILEGV 117

Query: 339 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE---RTVMAGGTYG 395
            +LH      +VHRDI+ +N+L D      L   G SK +          ++V   GT  
Sbjct: 118 EYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVT--GTPY 172

Query: 396 YLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           +++PE +       K+DV+S G  ++E+++ + P
Sbjct: 173 WMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 62.7 bits (152), Expect = 1e-10
 Identities = 70/277 (25%), Positives = 114/277 (41%), Gaps = 52/277 (18%)

Query: 252 VAVKRLKR-------SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 304
           VAVK LK        S    + E    IG+     H N++ + G C   G  Y++ E+  
Sbjct: 47  VAVKMLKDDATDKDLSDLVSEMEMMKMIGK-----HKNIINLLGACTQDGPLYVLVEYAS 101

Query: 305 NGPLDRWLHHIPRGGRSLDWAMR--------------MKVATTLAQGIAFLHDKVKPHVV 350
            G L  +L    R    +D++                +  A  +A+G+ +L  +     +
Sbjct: 102 KGNLREYLR--ARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCI 156

Query: 351 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 410
           HRD+ A NVL+ E+    +   GL++ V      ++T        ++APE ++    T +
Sbjct: 157 HRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ 216

Query: 411 SDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDI 469
           SDV+SFGVLL EI + G  P   +       + E    L + HR              D 
Sbjct: 217 SDVWSFGVLLWEIFTLGGSPYPGI------PVEELFKLLKEGHRM-------------DK 257

Query: 470 PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 506
           P A    ++  ++  C   VPS RP    +V  L ++
Sbjct: 258 P-ANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRV 293

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 62.3 bits (152), Expect = 1e-10
 Identities = 66/262 (25%), Positives = 104/262 (39%), Gaps = 32/262 (12%)

Query: 252 VAVKRLK--RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 309
           VA+K+ K        KK    E+    +L H N+V +K      G  Y+V+E+V    L+
Sbjct: 29  VAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLE 88

Query: 310 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHL 369
             L   P G   L           L Q IA+ H     +++HRDI+  N+L+ E     L
Sbjct: 89  L-LEASPGG---LPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKL 141

Query: 370 MGVGLSKFVPWEVMQERTVMAGGTY----GYLAPEFVYRNELTTKS-DVYSFGVLLLEIV 424
              G ++      ++ R       Y     Y APE +  +    K  DV++ G ++ E++
Sbjct: 142 CDFGFARA-----LRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELL 196

Query: 425 SGRRPAQAVDSVCWQ--SIFEWATPLVQSHRYLELLDPLISSLS----SDI------PEA 472
            G  P    DS   Q   I +   PL  SH+ L   +P  + ++    S           
Sbjct: 197 DG-EPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPG 255

Query: 473 GVVQKVVDLVYACTQHVPSMRP 494
            V    +D + AC +  P  R 
Sbjct: 256 KVSSPALDFLKACLRMDPKERL 277

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 62.0 bits (151), Expect = 1e-10
 Identities = 58/228 (25%), Positives = 99/228 (43%), Gaps = 29/228 (12%)

Query: 240 GTYSGILPDGSR-VAVKRLK-RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC-YDHGDR 296
           G      P     V VK +K  +S  +      E      L H N++ +   C  D    
Sbjct: 25  GILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84

Query: 297 YIVYEFVVNGPLDRWLH---HIPR-GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 352
           +++Y ++  G L  +L           ++L     + +A  +A G+++LH +    V+H+
Sbjct: 85  FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHK 141

Query: 353 DIRASNVLLDEEFGAHLMGVGLSK-FVPWEVM-----QERTVMAGGTYGYLAPEFVYRNE 406
           DI A N ++DEE    +    LS+   P +       + R V       ++A E +   E
Sbjct: 142 DIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK------WMALESLVNKE 195

Query: 407 LTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHR 453
            ++ SDV+SFGVLL E+++ G+ P   +D       FE A  L   +R
Sbjct: 196 YSSASDVWSFGVLLWELMTLGQTPYVEID------PFEMAAYLKDGYR 237

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 56/236 (23%), Positives = 102/236 (43%), Gaps = 26/236 (11%)

Query: 271 EIGRFARLHHPNLVAVKGCCYDHGDRY--IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRM 328
           EI     L H  +V   GC  D  ++   I  E++  G +   L    +   +L  ++  
Sbjct: 54  EIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL----KAYGALTESVTR 109

Query: 329 KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 388
           K    + +G+++LH  +   +VHRDI+ +N+L D      L   G SK +    M    +
Sbjct: 110 KYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGI 166

Query: 389 MA-GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATP 447
            +  GT  +++PE +       K+DV+S G  ++E+++ + P    +++   +IF+ AT 
Sbjct: 167 RSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA--AIFKIAT- 223

Query: 448 LVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQL 503
                       P    L S I E    +  +  ++   +H PS    + H   QL
Sbjct: 224 -----------QPTNPQLPSHISEHA--RDFLGCIFVEARHRPSAEELLRHPFAQL 266

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 61.7 bits (150), Expect = 2e-10
 Identities = 61/275 (22%), Positives = 111/275 (40%), Gaps = 44/275 (16%)

Query: 242 YSGILPDGSRVAVKRLKRSSFQRKK---EFYSEIGRFARLHHPNLVAVKGCCYDHGDRY- 297
           Y GI  +   V ++  K+     K       +EI    R+   N++ + G   D  D   
Sbjct: 37  YKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95

Query: 298 ---IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV-KPHVVHRD 353
              ++ E+   G L   L       + L +  ++ +A    +G+  L+    KP+   ++
Sbjct: 96  RLSLILEYCTRGYLREVL----DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPY---KN 148

Query: 354 IRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDV 413
           + + + L+ E +   ++  GL K +     +    M   +Y  L   F   +E T K D+
Sbjct: 149 LTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIF---SEYTIKDDI 205

Query: 414 YSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS---SLSSDIP 470
           YS GV+L EI +G+ P            FE  T         E+ D +I+   SL   + 
Sbjct: 206 YSLGVVLWEIFTGKIP------------FENLT-------TKEIYDLIINKNNSLKLPLD 246

Query: 471 EAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ 505
               ++ +V+   ACT H    RP +  +++ L  
Sbjct: 247 CPLEIKCIVE---ACTSHDSIKRPNIKEILYNLSL 278

Length = 283

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 62.0 bits (150), Expect = 2e-10
 Identities = 55/213 (25%), Positives = 105/213 (49%), Gaps = 20/213 (9%)

Query: 231 RLLGDSKTGGTYSGI-LPDGSRV----AVKRLKRSSFQRKK-EFYSEIGRFARLHHPNLV 284
           ++LG    G  Y GI +P+G  V    A+K L  ++  +   EF  E    A + HP+LV
Sbjct: 13  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72

Query: 285 AVKGCCYDHGDRYIVYEFVVNGPLDRWLH-HIPRGGRSL--DWAMRMKVATTLAQGIAFL 341
            + G C     + +V + + +G L  ++H H    G  L  +W ++      +A+G+ +L
Sbjct: 73  RLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYL 125

Query: 342 HDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEF 401
            ++    +VHRD+ A NVL+       +   GL++ +  +  +           ++A E 
Sbjct: 126 EER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 182

Query: 402 VYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAV 433
           ++  + T +SDV+S+GV + E+++ G +P   +
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI 215

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|153064 cd03594, CLECT_REG-1_like, C-type lectin-like domain (CTLD) of the type found in Human REG-1 (lithostathine), REG-4, and avian eggshell-specific proteins: ansocalcin, structhiocalcin-1(SCA-1), and -2(SCA-2)

 Score = 58.5 bits (142), Expect = 2e-10
 Identities = 35/146 (23%), Positives = 51/146 (34%), Gaps = 29/146 (19%)

Query: 9   CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEE-----EH-SAQK 60
           CP  W+    K  C+GY     SW ++E +C++   G HLA++ S  E        S+ +
Sbjct: 1   CPKGWL--PYKGNCYGYFRQPLSWSDAELFCQKYGPGAHLASIHSPAEAAAIASLISSYQ 58

Query: 61  LCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNS--SCTSLPCHVHATV 118
              + V   W+G           W+WSD       S      +     C  L        
Sbjct: 59  KAYQPV---WIGLHDPQQ--SRGWEWSDGSKLDYRSWDRNPPYARGGYCAELSR------ 107

Query: 119 DLCTLVSNGSRSLVTERCNTSHPFIC 144
                 S G        C   +PFIC
Sbjct: 108 ------STGFLKWNDANCEERNPFIC 127

CLECT_REG-1_like: C-type lectin-like domain (CTLD) of the type found in Human REG-1 (lithostathine), REG-4, and avian eggshell-specific proteins: ansocalcin, structhiocalcin-1(SCA-1), and -2(SCA-2). CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. REG-1 is a proliferating factor which participates in various kinds of tissue regeneration including pancreatic beta-cell regeneration, regeneration of intestinal mucosa, regeneration of motor neurons, and perhaps in tissue regeneration of damaged heart. REG-1 may play a role on the pathophysiology of Alzheimer's disease and in the development of gastric cancers. Its expression is correlated with reduced survival from early-stage colorectal cancer. REG-1 also binds and aggregates several bacterial strains from the intestinal flora and it has been suggested that it is involved in the control of the intestinal bacterial ecosystem. Rat lithostathine has calcium carbonate crystal inhibitor activity in vitro. REG-IV is unregulated in pancreatic, gastric, hepatocellular, and prostrate adenocarcinomas. REG-IV activates the EGF receptor/Akt/AP-1 signaling pathway in colorectal carcinoma. Ansocalcin, SCA-1 and -2 are found at high concentration in the calcified egg shell layer of goose and ostrich, respectively and tend to form aggregates. Ansocalcin nucleates calcite crystal aggregates in vitro. Length = 129

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 61.0 bits (148), Expect = 2e-10
 Identities = 57/195 (29%), Positives = 90/195 (46%), Gaps = 24/195 (12%)

Query: 252 VAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRW 311
           V +K L +S     + F+      ++L H +LV   G C    +  +V E+V  G LD +
Sbjct: 30  VLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTY 89

Query: 312 LHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH--- 368
           L    +    ++ + +++VA  LA  + FL DK    + H ++ A NVLL  E       
Sbjct: 90  LK---KNKNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGN 143

Query: 369 -----LMGVGLSKFV-PWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLL 421
                L   G+S  V P E++ ER         ++ PE +     L+  +D +SFG  L 
Sbjct: 144 PPFIKLSDPGISITVLPKEILLERI-------PWVPPECIENPQNLSLAADKWSFGTTLW 196

Query: 422 EIVSG-RRPAQAVDS 435
           EI SG  +P  A+DS
Sbjct: 197 EIFSGGDKPLSALDS 211

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 61.0 bits (148), Expect = 2e-10
 Identities = 59/264 (22%), Positives = 108/264 (40%), Gaps = 29/264 (10%)

Query: 233 LGDSKTGGTYSGILPDGSRV-AVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCC 290
           LG    G  Y        R+ AVK +    + + +K+  SE+    +   P ++   G  
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68

Query: 291 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 350
           +      I  EF+  G LD +        R +   +  ++A  + +G+ +L       ++
Sbjct: 69  FVENRISICTEFMDGGSLDVY--------RKIPEHVLGRIAVAVVKGLTYLWSL---KIL 117

Query: 351 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 410
           HRD++ SN+L++      L   G+S     +++        GT  Y+APE +   +    
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGVST----QLVNSIAKTYVGTNAYMAPERISGEQYGIH 173

Query: 411 SDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIP 470
           SDV+S G+  +E+  GR P        +  I +    L+     L+LL  ++      +P
Sbjct: 174 SDVWSLGISFMELALGRFP--------YPQIQKNQGSLMP----LQLLQCIVDEDPPVLP 221

Query: 471 EAGVVQKVVDLVYACTQHVPSMRP 494
                +K V  +  C +  P  RP
Sbjct: 222 VGQFSEKFVHFITQCMRKQPKERP 245

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 61.9 bits (150), Expect = 2e-10
 Identities = 52/197 (26%), Positives = 91/197 (46%), Gaps = 18/197 (9%)

Query: 252 VAVKRLKRSSFQRKKEF---YSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 308
           VA+KR ++S   ++K+    +SE      ++HP  V + G   D    Y+V EFV+ G  
Sbjct: 59  VAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEF 118

Query: 309 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKP-HVVHRDIRASNVLLDEEFGA 367
             +L    R            V    A  I  + + ++  ++V+RD++  N+LLD++   
Sbjct: 119 FTFLRRNKR--------FPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFI 170

Query: 368 HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGR 427
            +   G +K     V+  RT    GT  Y+APE +        +D ++ G+ + EI+ G 
Sbjct: 171 KMTDFGFAK-----VVDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGC 225

Query: 428 RPAQAVDS-VCWQSIFE 443
            P  A +  + +Q I E
Sbjct: 226 PPFYANEPLLIYQKILE 242

Length = 340

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 61.1 bits (148), Expect = 2e-10
 Identities = 57/206 (27%), Positives = 89/206 (43%), Gaps = 47/206 (22%)

Query: 251 RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 310
           RV +K L  S       F+      +++ H +L  V G C    +  +V EFV +GPLD 
Sbjct: 46  RVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDV 105

Query: 311 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD----EEFG 366
            L    +G   + W  ++ VA  LA  +++L DK   ++VH ++ A N+LL      E  
Sbjct: 106 CLRK-EKGRVPVAW--KITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAEGT 159

Query: 367 AHLM-----GVGLSKF--------VPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSD 412
           +  +     GV  +          +PW                +APE V   N L+T +D
Sbjct: 160 SPFIKLSDPGVSFTALSREERVERIPW----------------IAPECVPGGNSLSTAAD 203

Query: 413 VYSFGVLLLEI-------VSGRRPAQ 431
            +SFG  LLEI       +  R P++
Sbjct: 204 KWSFGTTLLEICFDGEVPLKERTPSE 229

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 62.9 bits (153), Expect = 2e-10
 Identities = 57/229 (24%), Positives = 106/229 (46%), Gaps = 28/229 (12%)

Query: 249 GSRVAVKRLKRSSFQRKKE---FYSEIGRFARLHHPNLVAV--KGCCYDHGDRYIVYEFV 303
           G  VA+K L+  + + + +   F  E    ARL+HPN+VA+   G     G  + V+E+V
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPP-GLLFAVFEYV 61

Query: 304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL-- 361
                 R L  +     +L      ++   +   +A  H++    +VHRD++  N+++  
Sbjct: 62  PG----RTLREVLAADGALPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQ 114

Query: 362 -DEEFGAHLMGVGLSKFVP--WEVMQERTVMAG---GTYGYLAPEFVYRNE-LTTKSDVY 414
                 A ++  G+   +P   +             GT  Y APE + R E +T  SD+Y
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQL-RGEPVTPNSDLY 173

Query: 415 SFGVLLLEIVSGRRPAQ--AVDSVCWQ--SIFEWATP-LVQSHRYLELL 458
           ++G++ LE ++G+R  Q  +V  + +Q  S  + + P  +  H   ++L
Sbjct: 174 AWGLIFLECLTGQRVVQGASVAEILYQQLSPVDVSLPPWIAGHPLGQVL 222

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 61.5 bits (149), Expect = 2e-10
 Identities = 65/277 (23%), Positives = 115/277 (41%), Gaps = 48/277 (17%)

Query: 250 SRVAVKRLKRSSFQR-------KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 302
             VAVK LK ++  +       + E    IG+     H N++ + G C   G  Y++ E+
Sbjct: 45  VTVAVKMLKDNATDKDLADLISEMELMKLIGK-----HKNIINLLGVCTQEGPLYVIVEY 99

Query: 303 VVNGPLDRWLH--------HIPRGGRSLDWAMRMK----VATTLAQGIAFLHDKVKPHVV 350
              G L  +L         +     +  +  +  K     A  +A+G+ +L  +     +
Sbjct: 100 AAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCI 156

Query: 351 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 410
           HRD+ A NVL+ E+    +   GL++ V      ++T        ++APE ++    T +
Sbjct: 157 HRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQ 216

Query: 411 SDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDI 469
           SDV+SFG+L+ EI + G  P   +       + E    L + HR              D 
Sbjct: 217 SDVWSFGILMWEIFTLGGSPYPGI------PVEELFKLLREGHRM-------------DK 257

Query: 470 PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 506
           P +    ++  L+  C   VP+ RP    +V  L ++
Sbjct: 258 P-SNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV 293

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 61.1 bits (148), Expect = 3e-10
 Identities = 54/186 (29%), Positives = 88/186 (47%), Gaps = 13/186 (6%)

Query: 248 DGSRV-AVKRLKRSSFQRKKEF---YSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 303
           D  R+ A+K ++++    + E     +E    A+++ P +V +K         Y+V  F+
Sbjct: 16  DTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFI 75

Query: 304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 363
             G L    HH+ R GR      R   A  L   +  LH   K +V++RD++  N+LLD 
Sbjct: 76  NGGEL---FHHLQREGRFDLSRARFYTAELLC-ALENLH---KFNVIYRDLKPENILLDY 128

Query: 364 EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 423
           +    L   GL K    +   ++T    GT  YLAPE +  +  T   D ++ GVLL E+
Sbjct: 129 QGHIALCDFGLCKLNMKD--DDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEM 186

Query: 424 VSGRRP 429
           ++G  P
Sbjct: 187 LTGLPP 192

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 60.4 bits (146), Expect = 4e-10
 Identities = 72/302 (23%), Positives = 124/302 (41%), Gaps = 63/302 (20%)

Query: 233 LGDSKTGGTYSGIL------PDGSRVAVKRLK-RSSFQRKKEFYSEIGRFARLHHPNLVA 285
           LG+ + G  Y G L           VA+K LK ++    ++EF  E    +RL HPN+V 
Sbjct: 13  LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72

Query: 286 VKGCCYDHGDRYIVYEFVVNGPLDRWL----HHIPRGGRSLDWAMR--------MKVATT 333
           + G         +++ +  +  L  +L     H   G    D  ++        + + T 
Sbjct: 73  LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132

Query: 334 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT 393
           +A G+ FL      HVVH+D+   NVL+ ++    +  +GL           R V A   
Sbjct: 133 IAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLF----------REVYAADY 179

Query: 394 YG----------YLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIF 442
           Y           +++PE +   + +  SD++S+GV+L E+ S G +P     +   Q + 
Sbjct: 180 YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---QDVI 236

Query: 443 EWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 502
           E    ++++ + L   D        D P       V  L+  C    PS RPR   +  +
Sbjct: 237 E----MIRNRQVLPCPD--------DCPAW-----VYTLMLECWNEFPSRRPRFKDIHSR 279

Query: 503 LQ 504
           L+
Sbjct: 280 LR 281

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 59.8 bits (145), Expect = 5e-10
 Identities = 55/217 (25%), Positives = 92/217 (42%), Gaps = 24/217 (11%)

Query: 225 NFSEGNR--LLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHP 281
            + E     +LG    G  Y+   L    R+A+K +     +  +  + EI   + L H 
Sbjct: 6   EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHR 65

Query: 282 NLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVAT------TLA 335
           N+V   G   ++G   I  E V  G L   L       RS    ++    T       + 
Sbjct: 66  NIVQYLGSDSENGFFKIFMEQVPGGSLSALL-------RSKWGPLKDNEQTIIFYTKQIL 118

Query: 336 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA-HLMGVGLSKFVPWEVMQERTVMAGGTY 394
           +G+ +LHD     +VHRDI+  NVL++   G   +   G SK +    +   T    GT 
Sbjct: 119 EGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG--INPCTETFTGTL 173

Query: 395 GYLAPEFVYRNE--LTTKSDVYSFGVLLLEIVSGRRP 429
            Y+APE + +        +D++S G  ++E+ +G+ P
Sbjct: 174 QYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 59.6 bits (144), Expect = 5e-10
 Identities = 44/159 (27%), Positives = 73/159 (45%), Gaps = 9/159 (5%)

Query: 275 FARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIP-RGGRSLDWAMRMKVATT 333
            A++ HPN+VA K      G  YIV E+   G L   +  I  + G+       ++    
Sbjct: 52  LAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDL---MQKIKLQRGKLFPEDTILQWFVQ 108

Query: 334 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT 393
           +  G+  +H+K    V+HRDI++ N+ L +     L   G ++ +        T +  GT
Sbjct: 109 MCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV--GT 163

Query: 394 YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQA 432
             Y+ PE         KSD++S G +L E+ + + P QA
Sbjct: 164 PYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQA 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 60.3 bits (146), Expect = 6e-10
 Identities = 60/196 (30%), Positives = 87/196 (44%), Gaps = 17/196 (8%)

Query: 248 DGSRV-AVKRLKRSSFQRKKEFYSEIG------RFARLHHPNLVAVKGCCYDHGDRYIVY 300
           D  R+ A+K L +     KKE    IG      R      P +V +K       D Y+V 
Sbjct: 16  DTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVT 75

Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
           +++  G L  W  H+ + GR  +   +  +A  L   +  LH   K  +V+RD++  N+L
Sbjct: 76  DYMSGGEL-FW--HLQKEGRFSEDRAKFYIAE-LVLALEHLH---KYDIVYRDLKPENIL 128

Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKS-DVYSFGVL 419
           LD      L   GLSK        + T    GT  YLAPE +   +  TK  D +S GVL
Sbjct: 129 LDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVL 186

Query: 420 LLEIVSGRRPAQAVDS 435
           + E+  G  P  A D+
Sbjct: 187 VFEMCCGWSPFYAEDT 202

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 59.6 bits (144), Expect = 7e-10
 Identities = 66/293 (22%), Positives = 121/293 (41%), Gaps = 46/293 (15%)

Query: 231 RLLGDSKTGGTYSGI-LPDGSR----VAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLV 284
           ++LG    G  Y GI +PDG      VA+K L+  +S +  KE   E    A +  P + 
Sbjct: 13  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72

Query: 285 AVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS--LDWAMRMKVATTLAQGIAFLH 342
            + G C     + +         LD    +  R G    L+W ++      +A+G+++L 
Sbjct: 73  RLLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKGMSYLE 126

Query: 343 DKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG---TYGYLAP 399
           +     +VHRD+ A NVL+       +   GL++ +    + E    A G      ++A 
Sbjct: 127 EV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLD---IDETEYHADGGKVPIKWMAL 180

Query: 400 EFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELL 458
           E +     T +SDV+S+GV + E+++ G +P                   + +    +LL
Sbjct: 181 ESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG----------------IPAREIPDLL 224

Query: 459 DPLISSLSSDIPEAGVVQKVVDLVYA-CTQHVPSMRPRMSHVVHQLQQLAQPP 510
           +         +P+  +    V ++   C       RPR   +V +  ++A+ P
Sbjct: 225 EK-----GERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 60.0 bits (145), Expect = 7e-10
 Identities = 44/162 (27%), Positives = 81/162 (50%), Gaps = 10/162 (6%)

Query: 281 PNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAF 340
           P +V   G  Y  G+  I  E +  G LD+ L    + GR +   +  KV+  + +G+ +
Sbjct: 63  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGR-IPEQILGKVSIAVIKGLTY 118

Query: 341 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 400
           L +K K  ++HRD++ SN+L++      L   G+S     +++        GT  Y++PE
Sbjct: 119 LREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSG----QLIDSMANSFVGTRSYMSPE 172

Query: 401 FVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIF 442
            +     + +SD++S G+ L+E+  GR P    D+   + +F
Sbjct: 173 RLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMF 214

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 60.1 bits (145), Expect = 9e-10
 Identities = 45/159 (28%), Positives = 77/159 (48%), Gaps = 13/159 (8%)

Query: 279 HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGI 338
           +HP LV +  C       + V E+V  G L   + H+ R  +  +   R   A  ++  +
Sbjct: 54  NHPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAE-ISLAL 109

Query: 339 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ--ERTVMAGGTYGY 396
            +LH++    +++RD++  NVLLD E    L   G+ K    E ++  + T    GT  Y
Sbjct: 110 NYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK----EGLRPGDTTSTFCGTPNY 162

Query: 397 LAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS 435
           +APE +   +     D ++ GVL+ E+++GR P   V S
Sbjct: 163 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGS 201

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 58.9 bits (143), Expect = 9e-10
 Identities = 53/190 (27%), Positives = 78/190 (41%), Gaps = 27/190 (14%)

Query: 252 VAVKRLKRSSFQR-KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL-- 308
           VAVK LK         +F  E      L H NL+ + G    H    +V E    G L  
Sbjct: 26  VAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLM-MVTELAPLGSLLD 84

Query: 309 ---DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 365
                 L H        D+A++      +A G+ +L  K     +HRD+ A N+LL  + 
Sbjct: 85  RLRKDALGHFLIS-TLCDYAVQ------IANGMRYLESK---RFIHRDLAARNILLASDD 134

Query: 366 GAHLMGVGLSKFVPWE----VMQE-RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLL 420
              +   GL + +P      VM+E   V     + + APE +     +  SDV+ FGV L
Sbjct: 135 KVKIGDFGLMRALPQNEDHYVMEEHLKV----PFAWCAPESLRTRTFSHASDVWMFGVTL 190

Query: 421 LEIVS-GRRP 429
            E+ + G  P
Sbjct: 191 WEMFTYGEEP 200

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 59.8 bits (145), Expect = 1e-09
 Identities = 87/345 (25%), Positives = 140/345 (40%), Gaps = 75/345 (21%)

Query: 201 PAASALVPPSWKVFTTEELRSITKNFSEGNRL--LGDSKTGGTYSGIL--PDGSRVAVKR 256
           P  S+    S     +    S  K+ SE  R+  +G S  GGT   ++  P G   A+K 
Sbjct: 48  PPPSSSSSSSSSSSASGSAPSAAKSLSELERVNRIG-SGAGGTVYKVIHRPTGRLYALKV 106

Query: 257 L---KRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH-GDRYIVYEFVVNGPLDRWL 312
           +      + +R  +   EI     ++HPN+V      +DH G+  ++ EF+  G L+   
Sbjct: 107 IYGNHEDTVRR--QICREIEILRDVNHPNVVKCHDM-FDHNGEIQVLLEFMDGGSLEG-- 161

Query: 313 HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV 372
            HI       D      VA  +  GIA+LH   + H+VHRDI+ SN+L++      +   
Sbjct: 162 THIADEQFLAD------VARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADF 212

Query: 373 GLSKFVPWEVMQ--ERTVMAGGTYGYLAPEFVYRNELTT------KSDVYSFGVLLLEIV 424
           G+S+ +  + M     +V   GT  Y++PE +   +L          D++S GV +LE  
Sbjct: 213 GVSRILA-QTMDPCNSSV---GTIAYMSPERI-NTDLNHGAYDGYAGDIWSLGVSILEFY 267

Query: 425 SGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS-SDIPEA--GVVQKVVDL 481
            GR P      V  Q   +WA+              L+ ++  S  PEA     ++    
Sbjct: 268 LGRFPF----GVGRQG--DWAS--------------LMCAICMSQPPEAPATASREFRHF 307

Query: 482 VYACTQHVPSMRPRMSHVVH----------------QLQQLAQPP 510
           +  C Q  P+ R     ++                  L QL  PP
Sbjct: 308 ISCCLQREPAKRWSAMQLLQHPFILRAQPGQGQGGPNLHQLLPPP 352

Length = 353

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 59.1 bits (143), Expect = 1e-09
 Identities = 28/102 (27%), Positives = 50/102 (49%), Gaps = 6/102 (5%)

Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 390
           A  +  G+  LH +    +V+RD++  NVLLD+     +  +GL+  +      ++    
Sbjct: 101 AAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELK---GGKKIKGR 154

Query: 391 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQA 432
            GT GY+APE +         D ++ G  L E+++GR P + 
Sbjct: 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQ 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 59.0 bits (143), Expect = 1e-09
 Identities = 46/160 (28%), Positives = 75/160 (46%), Gaps = 13/160 (8%)

Query: 271 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 330
           EI     L+HPN+V +    +     Y+V+EF+ +  L +++   P  G  L   +    
Sbjct: 49  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPL--PLIKSY 105

Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 388
              L QG+AF H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 106 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 162

Query: 389 MAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEIVSGR 427
               T  Y APE +   +  +T  D++S G +  E+V+ R
Sbjct: 163 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 59.0 bits (143), Expect = 1e-09
 Identities = 40/153 (26%), Positives = 72/153 (47%), Gaps = 12/153 (7%)

Query: 277 RLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ 336
            + HP ++ +    +D    Y++ E+V  G L  +L    R       +  +  A+ +  
Sbjct: 57  EVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYL----RNSGRFSNSTGLFYASEIVC 112

Query: 337 GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGY 396
            + +LH K    +V+RD++  N+LLD+E    L   G +K +     ++RT    GT  Y
Sbjct: 113 ALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKL-----RDRTWTLCGTPEY 164

Query: 397 LAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           LAPE +         D ++ G+L+ E++ G  P
Sbjct: 165 LAPEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 58.7 bits (142), Expect = 2e-09
 Identities = 49/156 (31%), Positives = 74/156 (47%), Gaps = 15/156 (9%)

Query: 280 HPNLVAVKGCCYDHGDR-YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGI 338
           HP L A+  CC+   DR + V E+V  G L   +  I R  R  D       A  +   +
Sbjct: 55  HPFLTALH-CCFQTKDRLFFVMEYVNGGDL---MFQIQRS-RKFDEPRSRFYAAEVTLAL 109

Query: 339 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE--RTVMAGGTYGY 396
            FLH   +  V++RD++  N+LLD E    L   G+ K    E +     T    GT  Y
Sbjct: 110 MFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCK----EGILNGVTTTTFCGTPDY 162

Query: 397 LAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQA 432
           +APE +   E     D ++ GVL+ E+++G+ P +A
Sbjct: 163 IAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEA 198

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 58.2 bits (141), Expect = 2e-09
 Identities = 53/184 (28%), Positives = 88/184 (47%), Gaps = 18/184 (9%)

Query: 271 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 330
           EI     L HPN+V ++         Y+++EF ++  L ++L  +P  G+ +D A  +K 
Sbjct: 49  EISLLKELQHPNIVCLQDVLMQESRLYLIFEF-LSMDLKKYLDSLP-KGQYMD-AELVKS 105

Query: 331 AT-TLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERT 387
               + QGI F H +    V+HRD++  N+L+D +    L   GL++   +P  V     
Sbjct: 106 YLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEV 162

Query: 388 VMAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ--SIFE- 443
           V    T  Y APE +  +   +T  D++S G +  E+ + ++P    DS   Q   IF  
Sbjct: 163 V----TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT-KKPLFHGDSEIDQLFRIFRI 217

Query: 444 WATP 447
             TP
Sbjct: 218 LGTP 221

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 58.1 bits (140), Expect = 3e-09
 Identities = 43/140 (30%), Positives = 66/140 (47%), Gaps = 13/140 (9%)

Query: 297 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRA 356
           + V E++  G L   + HI    +  D       A  +  G+ FLH K    +V+RD++ 
Sbjct: 72  FFVMEYLNGGDL---MFHIQSCHK-FDLPRATFYAAEIICGLQFLHSK---GIVYRDLKL 124

Query: 357 SNVLLDEEFGAHLMGVGLSKFVPWEVM--QERTVMAGGTYGYLAPEFVYRNELTTKSDVY 414
            N+LLD +    +   G+ K    E M    +T    GT  Y+APE +   +  T  D +
Sbjct: 125 DNILLDTDGHIKIADFGMCK----ENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWW 180

Query: 415 SFGVLLLEIVSGRRPAQAVD 434
           SFGVLL E++ G+ P    D
Sbjct: 181 SFGVLLYEMLIGQSPFHGHD 200

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 57.3 bits (138), Expect = 3e-09
 Identities = 46/192 (23%), Positives = 87/192 (45%), Gaps = 24/192 (12%)

Query: 248 DGSRVAVKR--LKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 305
           D     +K   L +   + K+    E+   A++ HPN+V       ++G  +IV E+   
Sbjct: 24  DSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDG 83

Query: 306 GPLDRWLHHIPRG-----GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
           G L + ++   RG      + L W ++      ++ G+  +HD+    ++HRDI++ N+ 
Sbjct: 84  GDLMKRINR-QRGVLFSEDQILSWFVQ------ISLGLKHIHDR---KILHRDIKSQNIF 133

Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMA---GGTYGYLAPEFVYRNELTTKSDVYSFG 417
           L +    + M   L  F     + +   +A    GT  YL+PE         K+D++S G
Sbjct: 134 LSK----NGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLG 189

Query: 418 VLLLEIVSGRRP 429
            +L E+ + + P
Sbjct: 190 CVLYELCTLKHP 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 57.4 bits (139), Expect = 3e-09
 Identities = 50/212 (23%), Positives = 92/212 (43%), Gaps = 22/212 (10%)

Query: 232 LLGDSKTGGTYSGI-LPDGSRVAVKRLKR-------SSFQRKKEFYSEIGRFARLHHPNL 283
           L+G    G  Y G  +P G  VA+K +         S  QR+    S++ +      PN+
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQP---PNI 64

Query: 284 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 343
               G        +I+ E+   G +   +   P   + +   +R      +   + ++H 
Sbjct: 65  TKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIR-----EVLVALKYIH- 118

Query: 344 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 403
             K  V+HRDI+A+N+L+       L   G++  +  +   +R+   G  Y ++APE + 
Sbjct: 119 --KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLN-QNSSKRSTFVGTPY-WMAPEVIT 174

Query: 404 R-NELTTKSDVYSFGVLLLEIVSGRRPAQAVD 434
                 TK+D++S G+ + E+ +G  P   VD
Sbjct: 175 EGKYYDTKADIWSLGITIYEMATGNPPYSDVD 206

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 57.6 bits (139), Expect = 4e-09
 Identities = 47/185 (25%), Positives = 93/185 (50%), Gaps = 17/185 (9%)

Query: 252 VAVKRLKRSSFQR-KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 310
           VAVK L+  + +  + +F  EI   +RL  PN++ +   C       ++ E++ NG L++
Sbjct: 49  VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108

Query: 311 WL--HHIPRGG-----RSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 363
           +L  H            ++ ++  + +AT +A G+ +L      + VHRD+   N L+ +
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLVGK 165

Query: 364 EFGAHLMGVGLSKFV---PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLL 420
            +   +   G+S+ +    +  +Q R V+      +++ E +   + TT SDV++FGV L
Sbjct: 166 NYTIKIADFGMSRNLYSGDYYRIQGRAVLP---IRWMSWESILLGKFTTASDVWAFGVTL 222

Query: 421 LEIVS 425
            EI++
Sbjct: 223 WEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 57.2 bits (138), Expect = 4e-09
 Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 15/206 (7%)

Query: 231 RLLGDSKTGGTYSGILPDGSR----VAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVA 285
           R+LG  + G    G L   S+    VA+  L+   S ++++ F +E     +  H N+V 
Sbjct: 11  RILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVR 70

Query: 286 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 345
           ++G         IV E++ NG LD +L    +    L     M +   LA G+ +L +  
Sbjct: 71  LEGVITRGNTMMIVTEYMSNGALDSFLR---KHEGQLVAGQLMGMLPGLASGMKYLSEM- 126

Query: 346 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG-YLAPEFVYR 404
               VH+ + A  VL++ +    + G    +    E +   T M+G +   + APE +  
Sbjct: 127 --GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIY--TTMSGKSPVLWAAPEAIQY 182

Query: 405 NELTTKSDVYSFGVLLLEIVS-GRRP 429
           +  ++ SDV+SFG+++ E++S G RP
Sbjct: 183 HHFSSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 57.3 bits (138), Expect = 5e-09
 Identities = 54/227 (23%), Positives = 95/227 (41%), Gaps = 20/227 (8%)

Query: 252 VAVKRLKRSSFQ---RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 308
           VAVK++  S  Q   + ++   E+    +L HPN +  KGC       ++V E+ +    
Sbjct: 49  VAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSAS 108

Query: 309 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 368
           D    H     + L       +     QG+A+LH       +HRDI+A N+LL E     
Sbjct: 109 DLLEVH----KKPLQEVEIAAITHGALQGLAYLHSHNM---IHRDIKAGNILLTEP---- 157

Query: 369 LMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY---RNELTTKSDVYSFGVLLLEIVS 425
              V L+ F             G  Y ++APE +      +   K DV+S G+  +E+  
Sbjct: 158 -GQVKLADFGSASKSSPANSFVGTPY-WMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 215

Query: 426 GRRPAQAVDSV-CWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPE 471
            + P   ++++     I +  +P +QS+ + +     +      IP+
Sbjct: 216 RKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQ 262

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 57.0 bits (137), Expect = 6e-09
 Identities = 36/120 (30%), Positives = 65/120 (54%), Gaps = 13/120 (10%)

Query: 318 GGRSLDWAM-----RMKVATTLAQ---GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHL 369
           GG +LD          ++AT L +   G+ +LH + K   +HRDI+A+NVLL E+    L
Sbjct: 86  GGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKL 142

Query: 370 MGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
              G++  +    ++  T +  GT  ++APE + ++   +K+D++S G+  +E+  G  P
Sbjct: 143 ADFGVAGQLTDTQIKRNTFV--GTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 56.8 bits (138), Expect = 6e-09
 Identities = 51/212 (24%), Positives = 88/212 (41%), Gaps = 46/212 (21%)

Query: 240 GTYSGI-----LPDGSRVAVKRLKRSSFQRKKEFYS-----EIGRFARLHHPNLVAVKGC 289
           GTY  +        G  VA+K+++    + +KE +      EI    +L HPN+V +K  
Sbjct: 10  GTYGQVYKARNKKTGELVALKKIR---MENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66

Query: 290 CYDH--GDRYIVYEFV---VNGPLDRWLHHIPRGG-RSLDWAMRMKVATTLAQGIAFLHD 343
                 G  Y+V+E++   + G LD           +     M+      L +G+ +LH 
Sbjct: 67  VTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCY---MKQ-----LLEGLQYLHS 118

Query: 344 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF---VPWEVMQERTVMAGGTYGYLAPE 400
                ++HRDI+ SN+L++ +    L   GL++            R +    T  Y  PE
Sbjct: 119 N---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI----TLWYRPPE 171

Query: 401 -----FVYRNELTTKSDVYSFGVLLLEIVSGR 427
                  Y      + D++S G +L E+  G+
Sbjct: 172 LLLGATRY----GPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|153060 cd03590, CLECT_DC-SIGN_like, C-type lectin-like domain (CTLD) of the type found in human dendritic cell (DC)-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN) and the related receptor, DC-SIGN receptor (DC-SIGNR)

 Score = 53.8 bits (130), Expect = 6e-09
 Identities = 26/82 (31%), Positives = 41/82 (50%), Gaps = 7/82 (8%)

Query: 9  CPPDWIINEEKSKCFGYIGNFR-SWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 67
          CP +W     +S C+ +    + SW+ES  +C+++G HL  + S EE+    K+   N +
Sbjct: 1  CPTNWK--SFQSSCY-FFSTEKKSWEESRQFCEDMGAHLVIINSQEEQEFISKILSGNRS 57

Query: 68 GCWVGGRSINTTVGLSWKWSDN 89
            W+G     T  G  WKW D 
Sbjct: 58 -YWIGLSDEETE-G-EWKWVDG 76

CLECT_DC-SIGN_like: C-type lectin-like domain (CTLD) of the type found in human dendritic cell (DC)-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN) and the related receptor, DC-SIGN receptor (DC-SIGNR). This group also contains proteins similar to hepatic asialoglycoprotein receptor (ASGP-R) and langerin in human. These proteins are type II membrane proteins with a CTLD ectodomain. CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. DC-SIGN is thought to mediate the initial contact between dendritic cells and resting T cells, and may also mediate the rolling of DCs on epithelium. DC-SIGN and DC-SIGNR bind to oligosaccharides present on human tissues, as well as, on pathogens including parasites, bacteria, and viruses. DC-SIGN and DC-SIGNR bind to HIV enhancing viral infection of T cells. DC-SIGN and DC-SIGNR are homotetrameric, and contain four CTLDs stabilized by a coiled coil of alpha helices. The hepatic ASGP-R is an endocytic recycling receptor which binds and internalizes desialylated glycoproteins having a terminal galactose or N-acetylgalactosamine residues on their N-linked carbohydrate chains, via the clathrin-coated pit mediated endocytic pathway, and delivers them to lysosomes for degradation. It has been proposed that glycoproteins bearing terminal Sia (sialic acid) alpha2, 6GalNAc and Sia alpha2, 6Gal are endogenous ligands for ASGP-R and that ASGP-R participates in regulating the relative concentration of serum glycoproteins bearing alpha 2,6-linked Sia. The human ASGP-R is a hetero-oligomer composed of two subunits, both of which are found within this group. Langerin is expressed in a subset of dendritic leukocytes, the Langerhans cells (LC). Langerin induces the formation of Birbeck Granules (BGs) and associates with these BGs following internalization. Langerin binds, in a calcium-dependent manner, to glyco-conjugates containing mannose and related sugars mediating their uptake and degradation. Langerin molecules oligomerize as trimers with three CTLDs held together by a coiled-coil of alpha helices. Length = 126

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 57.1 bits (138), Expect = 6e-09
 Identities = 44/152 (28%), Positives = 74/152 (48%), Gaps = 13/152 (8%)

Query: 280 HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA 339
           HP LV +  C       + V EFV  G L   + H+ R  +  +   R   +  ++  + 
Sbjct: 55  HPFLVGLHSCFQTESRLFFVIEFVSGGDL---MFHMQRQRKLPEEHARF-YSAEISLALN 110

Query: 340 FLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ--ERTVMAGGTYGYL 397
           FLH++    +++RD++  NVLLD E    L   G+ K    E ++  + T    GT  Y+
Sbjct: 111 FLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCK----EGIRPGDTTSTFCGTPNYI 163

Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           APE +   +     D ++ GVL+ E+++GR P
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGRSP 195

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 57.0 bits (137), Expect = 7e-09
 Identities = 44/152 (28%), Positives = 72/152 (47%), Gaps = 13/152 (8%)

Query: 280 HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA 339
           +P LV +  C       ++V E+V  G L   + H+ R  R L        A  +   + 
Sbjct: 55  NPFLVGLHSCFQTTSRLFLVIEYVNGGDL---MFHMQRQ-RKLPEEHARFYAAEICIALN 110

Query: 340 FLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ--ERTVMAGGTYGYL 397
           FLH++    +++RD++  NVLLD +    L   G+ K    E +   + T    GT  Y+
Sbjct: 111 FLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCK----EGLGPGDTTSTFCGTPNYI 163

Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           APE +   E     D ++ GVL+ E+++GR P
Sbjct: 164 APEILRGEEYGFSVDWWALGVLMFEMMAGRSP 195

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 57.3 bits (138), Expect = 7e-09
 Identities = 53/183 (28%), Positives = 81/183 (44%), Gaps = 41/183 (22%)

Query: 334 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT-VMAGG 392
           +A+G+ FL  K   + VHRD+ A NVLL +     +   GL++    ++M +   V  G 
Sbjct: 246 VARGMEFLASK---NCVHRDLAARNVLLAQGKIVKICDFGLAR----DIMHDSNYVSKGS 298

Query: 393 TY---GYLAPEFVYRNELTTKSDVYSFGVLLLEIVS---GRRPAQAVDSVCWQSI---FE 443
           T+    ++APE ++ N  TT SDV+S+G+LL EI S      P   VDS  +  I   + 
Sbjct: 299 TFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYR 358

Query: 444 WATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQL 503
            A P    H                       Q+V D++  C    P  RP   H+   +
Sbjct: 359 MAKP---DH---------------------ATQEVYDIMVKCWNSEPEKRPSFLHLSDIV 394

Query: 504 QQL 506
           + L
Sbjct: 395 ESL 397

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 56.1 bits (135), Expect = 7e-09
 Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 20/186 (10%)

Query: 252 VAVKRLKRSSFQR--KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 309
           VAVK LK  +     K E   E     +L +P +V + G C +     +V E    GPL+
Sbjct: 25  VAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGIC-EAESWMLVMELAELGPLN 83

Query: 310 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHL 369
           ++L       + +      ++   ++ G+ +L +    + VHRD+ A NVLL  +  A +
Sbjct: 84  KFLQK----NKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKI 136

Query: 370 MGVGLSKFVPWEVMQERTVMAGGTYG-----YLAPEFVYRNELTTKSDVYSFGVLLLEIV 424
              GLSK     +  +       T+G     + APE +   + ++KSDV+SFGVL+ E  
Sbjct: 137 SDFGLSK----ALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAF 192

Query: 425 S-GRRP 429
           S G++P
Sbjct: 193 SYGQKP 198

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 56.6 bits (136), Expect = 8e-09
 Identities = 52/203 (25%), Positives = 85/203 (41%), Gaps = 14/203 (6%)

Query: 233 LGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 291
           LGD   G  Y     + G   A K +   S +  +++  EI   A   HPN+V +    Y
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 292 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 351
              + +I+ EF   G +D  +  +    R L       V     + + +LH+     ++H
Sbjct: 73  YENNLWILIEFCAGGAVDAVMLELE---RPLTEPQIRVVCKQTLEALNYLHEN---KIIH 126

Query: 352 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY-----RNE 406
           RD++A N+L   +    L   G+S       +Q R    G  Y ++APE V         
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSA-KNTRTIQRRDSFIGTPY-WMAPEVVMCETSKDRP 184

Query: 407 LTTKSDVYSFGVLLLEIVSGRRP 429
              K+DV+S G+ L+E+     P
Sbjct: 185 YDYKADVWSLGITLIEMAQIEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 57.3 bits (138), Expect = 8e-09
 Identities = 51/187 (27%), Positives = 81/187 (43%), Gaps = 50/187 (26%)

Query: 307 PLDRWLHHIPRGGR---------SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 357
           P D++L   P   R         +L +   +  +  +A G+ FL  K   + VHRD+ A 
Sbjct: 212 PYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAAR 268

Query: 358 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT----YGYLAPEFVYRNELTTKSDV 413
           NVL+ E     +   GL++    ++M++   ++ G+      ++APE ++ N  TT SDV
Sbjct: 269 NVLICEGKLVKICDFGLAR----DIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDV 324

Query: 414 YSFGVLLLEIVS---------------------GRR---PAQAVDSV------CWQSIFE 443
           +SFG+LL EI +                     G R   PA A D +      CW+  FE
Sbjct: 325 WSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFE 384

Query: 444 WATPLVQ 450
                 Q
Sbjct: 385 IRPDFSQ 391

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 57.6 bits (139), Expect = 9e-09
 Identities = 45/147 (30%), Positives = 68/147 (46%), Gaps = 20/147 (13%)

Query: 348 HVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL 407
           H++HRDI+++N+LL       L   G SK     V  +      GT  Y+APE   R   
Sbjct: 163 HMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPY 222

Query: 408 TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS 467
           + K+D++S GVLL E+++ +RP    D    + +         + RY    DPL  S+S 
Sbjct: 223 SKKADMFSLGVLLYELLTLKRP---FDGENMEEVMHKTL----AGRY----DPLPPSIS- 270

Query: 468 DIPEAGVVQKVVDLVYACTQHVPSMRP 494
             PE      + ++V A     P  RP
Sbjct: 271 --PE------MQEIVTALLSSDPKRRP 289

Length = 496

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 55.7 bits (134), Expect = 1e-08
 Identities = 60/213 (28%), Positives = 91/213 (42%), Gaps = 35/213 (16%)

Query: 233 LGDSKTGGTYSGILPDGS-------------RVAVKRLKRSSFQRKKEFYSEIGRFARLH 279
           LG       Y+GIL                 +V +K L  S       F+       ++ 
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62

Query: 280 HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA 339
           H ++V + G C    +  +V EFV  GPLD ++H   R    L    + KVA  LA  ++
Sbjct: 63  HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMH---RKSDVLTTPWKFKVAKQLASALS 119

Query: 340 FLHDKVKPHVVHRDIRASNVLL-----DEEFGAHLMGVGLSK-FVPWEVM--QERTVMAG 391
           +L DK    +VH ++   N+LL     D E G     + LS   +P  V+  QE      
Sbjct: 120 YLEDK---DLVHGNVCTKNILLAREGIDGECGPF---IKLSDPGIPITVLSRQECV---- 169

Query: 392 GTYGYLAPEFVYRNE-LTTKSDVYSFGVLLLEI 423
               ++APE V  ++ L+  +D +SFG  L EI
Sbjct: 170 ERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 57.5 bits (139), Expect = 1e-08
 Identities = 56/227 (24%), Positives = 90/227 (39%), Gaps = 32/227 (14%)

Query: 231 RLLGDSKTGGTYSGILPDGSR-VAVKRLKR--SSFQR-KKEFYSEIGRFARLHHPNLVAV 286
           RL+G    G  Y    P  SR VA+K+++   S     KK F  E    A L HP +V V
Sbjct: 8   RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67

Query: 287 KGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSL--DWAMRMKVAT------TLAQGI 338
              C D    Y    ++    L   L  +     SL  + A +  V         +   I
Sbjct: 68  YSICSDGDPVYYTMPYIEGYTLKSLLKSV-WQKESLSKELAEKTSVGAFLSIFHKICATI 126

Query: 339 AFLHDKVKPHVVHRDIRASNVLLDE-------EFGAHLMGVG-------LSKFVPWEVMQ 384
            ++H K    V+HRD++  N+LL         ++GA +           +          
Sbjct: 127 EYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYS 183

Query: 385 ERTVMAG--GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
             T+     GT  Y+APE +     +  +D+Y+ GV+L ++++   P
Sbjct: 184 SMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230

Length = 932

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 56.2 bits (135), Expect = 1e-08
 Identities = 39/136 (28%), Positives = 66/136 (48%), Gaps = 12/136 (8%)

Query: 298 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 357
           +V   +  G L   ++H+   G   +    +  A  +  G+  LH   +  +V+RD++  
Sbjct: 77  LVLTLMNGGDLKFHIYHMGEAG--FEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPE 131

Query: 358 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVYS 415
           N+LLD+     +  +GL+  VP     E   + G  GT GY+APE V     T   D ++
Sbjct: 132 NILLDDHGHIRISDLGLAVHVP-----EGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWA 186

Query: 416 FGVLLLEIVSGRRPAQ 431
            G LL E+++G+ P Q
Sbjct: 187 LGCLLYEMIAGQSPFQ 202

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 56.0 bits (135), Expect = 1e-08
 Identities = 51/221 (23%), Positives = 93/221 (42%), Gaps = 35/221 (15%)

Query: 229 GNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVK 287
           GN   G    G  + G+    +RV VK L+ S+    +  F  E+  +  L+HPN++   
Sbjct: 4   GNGWFGKVLLGEAHRGM--SKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61

Query: 288 GCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRM--------KVATTLAQGIA 339
           G C +     +V EF   G L  +L       RS    +          ++A  +A G+ 
Sbjct: 62  GQCIESIPYLLVLEFCPLGDLKNYL-------RSNRGMVAQMAQKDVLQRMACEVASGLL 114

Query: 340 FLHDKVKPHVVHRDIRASNVLLDEEFGAHL--MGVGLSKFVP-WEVMQERTVMAGGTYGY 396
           +LH   +   +H D+   N  L  +    +   G+ L ++   + + ++   +      +
Sbjct: 115 WLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVP---LRW 168

Query: 397 LAPEFV-------YRNELTTKSDVYSFGVLLLEIVS-GRRP 429
           LAPE V          + T KS+++S GV + E+ +   +P
Sbjct: 169 LAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQP 209

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 56.2 bits (136), Expect = 1e-08
 Identities = 56/228 (24%), Positives = 92/228 (40%), Gaps = 26/228 (11%)

Query: 219 LRSITKNFSEG-NRLLGDSKTGGTYSGILPDGSRVAVKR--LKRSSFQRKKEFYSEIGRF 275
           L  I K F +     L   K   T          VAVK+  L   S +  K    EI   
Sbjct: 3   LTLIGKCFEDLMIVHLAKHKPTNTL---------VAVKKINLDSCSKEDLKLLQQEIITS 53

Query: 276 ARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWL-HHIPRGGRSLDWAMRMKVATTL 334
            +L HPN++          + Y+V   +  G  +  L  H P G   L  A  +K    +
Sbjct: 54  RQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILK---DV 110

Query: 335 AQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY 394
              + ++H K     +HR ++AS++LL  +    L G+  S  +     ++R V      
Sbjct: 111 LNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKS 167

Query: 395 G-----YLAPEFVYRNEL--TTKSDVYSFGVLLLEIVSGRRPAQAVDS 435
                 +L+PE + +N      KSD+YS G+   E+ +G  P + + +
Sbjct: 168 SVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPA 215

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 56.1 bits (135), Expect = 1e-08
 Identities = 58/206 (28%), Positives = 90/206 (43%), Gaps = 22/206 (10%)

Query: 240 GTYSGIL-----PDGSRVAVKRLKRSSFQRKKEFYSEIGR----FARLHHPNLVAVKGCC 290
           G++  +L      DGS  AVK L++ +  +KKE    +         L HP LV +    
Sbjct: 6   GSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSF 65

Query: 291 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 350
                 Y V ++V  G L     H+ R    L+   R   A  +A  I +LH     +++
Sbjct: 66  QTAEKLYFVLDYVNGGEL---FFHLQRERCFLEPRARF-YAAEVASAIGYLHSL---NII 118

Query: 351 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ--ERTVMAGGTYGYLAPEFVYRNELT 408
           +RD++  N+LLD +    L   GL K    E ++  E T    GT  YLAPE + +    
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCK----EGVEPEETTSTFCGTPEYLAPEVLRKEPYD 174

Query: 409 TKSDVYSFGVLLLEIVSGRRPAQAVD 434
              D +  G +L E++ G  P  + D
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPPFYSRD 200

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 56.0 bits (135), Expect = 2e-08
 Identities = 41/134 (30%), Positives = 65/134 (48%), Gaps = 11/134 (8%)

Query: 297 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRA 356
           + V E++  G L   + HI   GR  +   R   A  +  G+ FLH K    +++RD++ 
Sbjct: 72  FFVMEYLNGGDL---MFHIQSSGRFDEARARFYAAEIIC-GLQFLHKK---GIIYRDLKL 124

Query: 357 SNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA-GGTYGYLAPEFVYRNELTTKSDVYS 415
            NVLLD++    +   G+ K     +  E       GT  Y+APE +   +     D +S
Sbjct: 125 DNVLLDKDGHIKIADFGMCKE---NMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWS 181

Query: 416 FGVLLLEIVSGRRP 429
           FGVLL E++ G+ P
Sbjct: 182 FGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 55.8 bits (135), Expect = 2e-08
 Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 21/160 (13%)

Query: 339 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLA 398
           A  + K +  ++HRD++ SN+LLD      L   G+S  +   + + R     G   Y+A
Sbjct: 119 ALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDA---GCRPYMA 175

Query: 399 PEFV---YRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL 455
           PE +    R+    +SDV+S G+ L E+ +G+ P        W S+F+  T +V+     
Sbjct: 176 PERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPK-----WNSVFDQLTQVVKG---- 226

Query: 456 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPR 495
              DP I  LS+   E       V+ +  C     S RP+
Sbjct: 227 ---DPPI--LSNS-EEREFSPSFVNFINLCLIKDESKRPK 260

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 55.3 bits (133), Expect = 2e-08
 Identities = 44/175 (25%), Positives = 80/175 (45%), Gaps = 10/175 (5%)

Query: 255 KRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHH 314
           KRLK+ S ++      EI    +++ P +V +           +V   +  G L   +++
Sbjct: 29  KRLKKKSGEKMALLEKEI--LEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYN 86

Query: 315 IPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGL 374
           +  G R L+    +  +  +  GI  LH      +V+RD++  NVLLD++    L  +GL
Sbjct: 87  V--GERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGL 141

Query: 375 SKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           +  +      +      GT GY+APE +     +   D ++ G  + E+V+GR P
Sbjct: 142 AVELK---DGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 56.0 bits (135), Expect = 2e-08
 Identities = 39/123 (31%), Positives = 66/123 (53%), Gaps = 14/123 (11%)

Query: 320 RSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP 379
             LD    ++ ++ +AQG+ FL  K   + +HRD+ A NVLL +   A +   GL++   
Sbjct: 207 WPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLAR--- 260

Query: 380 WEVMQERTVMAGGT----YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRR--PAQA 432
            ++M +   +  G       ++APE ++    T +SDV+S+G+LL EI S G+   P   
Sbjct: 261 -DIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGIL 319

Query: 433 VDS 435
           V+S
Sbjct: 320 VNS 322

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 55.2 bits (133), Expect = 2e-08
 Identities = 30/97 (30%), Positives = 52/97 (53%), Gaps = 5/97 (5%)

Query: 336 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG 395
            G+  LH +    +++RD++  NVLLD +    +  +GL+  V  +  Q +T    GT G
Sbjct: 108 SGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLA--VELKDGQSKTKGYAGTPG 162

Query: 396 YLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQA 432
           ++APE +   E     D ++ GV L E+++ R P +A
Sbjct: 163 FMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRA 199

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 54.9 bits (132), Expect = 3e-08
 Identities = 43/138 (31%), Positives = 64/138 (46%), Gaps = 9/138 (6%)

Query: 297 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRA 356
           + V EF+  G L   + HI   GR  D       A  +  G+ FLH K    +++RD++ 
Sbjct: 72  FFVMEFLNGGDL---MFHIQDKGR-FDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKL 124

Query: 357 SNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSF 416
            NV+LD +    +   G+ K         R     GT  Y+APE +   + T   D +SF
Sbjct: 125 DNVMLDRDGHIKIADFGMCK--ENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSF 182

Query: 417 GVLLLEIVSGRRPAQAVD 434
           GVLL E++ G+ P    D
Sbjct: 183 GVLLYEMLIGQSPFHGDD 200

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 54.2 bits (130), Expect = 4e-08
 Identities = 57/236 (24%), Positives = 102/236 (43%), Gaps = 28/236 (11%)

Query: 212 KVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSR----VAVKRLK-RSSFQRK 265
           ++    ELR +        +LLG    G  + GI +P+G      VA+K ++ RS  Q  
Sbjct: 2   RILKETELRKL--------KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTF 53

Query: 266 KEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWA 325
           +E    +     L H  +V + G C       +V +     PL   L H+ +   SLD  
Sbjct: 54  QEITDHMLAMGSLDHAYIVRLLGIC-PGASLQLVTQLS---PLGSLLDHVRQHRDSLDPQ 109

Query: 326 MRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 385
             +     +A+G+ +L +     +VHR++ A N+LL  +    +   G++  +  +  + 
Sbjct: 110 RLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKY 166

Query: 386 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-------GRRPAQAVD 434
                     ++A E +     T +SDV+S+GV + E++S       G RP +  D
Sbjct: 167 FYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPD 222

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 54.2 bits (130), Expect = 4e-08
 Identities = 55/187 (29%), Positives = 90/187 (48%), Gaps = 22/187 (11%)

Query: 252 VAVKRLKRSSFQRKKEFYSEIGRFARLHH----PNLVAVKGCCYDHGDRYIVYEFVVNGP 307
           VA+K LK    + +K    E+ R A + H    P +V + G C +     +V E    GP
Sbjct: 25  VAIKVLKN---ENEKSVRDEMMREAEIMHQLDNPYIVRMIGVC-EAEALMLVMEMASGGP 80

Query: 308 LDRWLHHIPRGGRSLDWAMRMKVATTLAQ---GIAFLHDKVKPHVVHRDIRASNVLLDEE 364
           L+++L      G+  D      V   + Q   G+ +L  K   + VHRD+ A NVLL  +
Sbjct: 81  LNKFL-----SGKK-DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQ 131

Query: 365 FGAHLMGVGLSKFVPWEVMQERTVMAGG-TYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 423
             A +   GLSK +  +    +   AG     + APE +   + +++SDV+S+G+ + E 
Sbjct: 132 HYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEA 191

Query: 424 VS-GRRP 429
            S G++P
Sbjct: 192 FSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 53.9 bits (129), Expect = 4e-08
 Identities = 57/225 (25%), Positives = 102/225 (45%), Gaps = 18/225 (8%)

Query: 231 RLLGDSKTGGTYSGILPD-GSRVAVKRL--KRSSFQRKKEFYS---EIGRFARLHHPNLV 284
           +LLG    G  Y     D G  +AVK++     S +  KE  +   EI     L H  +V
Sbjct: 8   KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67

Query: 285 AVKGCCYDHGDR--YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLH 342
              GC  D  ++   I  E++  G +   L    +   +L   +  +    + QG+++LH
Sbjct: 68  QYYGCLRDPEEKKLSIFVEYMPGGSIKDQL----KAYGALTENVTRRYTRQILQGVSYLH 123

Query: 343 DKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA-GGTYGYLAPEF 401
             +   +VHRDI+ +N+L D      L   G SK +    M    + +  GT  +++PE 
Sbjct: 124 SNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEV 180

Query: 402 VYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWAT 446
           +       K+DV+S    ++E+++ + P    +++   +IF+ AT
Sbjct: 181 ISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA--AIFKIAT 223

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 54.3 bits (131), Expect = 5e-08
 Identities = 53/185 (28%), Positives = 76/185 (41%), Gaps = 20/185 (10%)

Query: 253 AVKRLKRSSFQRKKE---FYSEIGRF---ARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 306
           A+K LK+     + E      E   F       HP LV +  C         V E+   G
Sbjct: 28  AIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGG 87

Query: 307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 366
            L   + HI     S   A+       L  G+ +LH+     +V+RD++  N+LLD E  
Sbjct: 88  DL---MMHIHTDVFSEPRAVFYAACVVL--GLQYLHEN---KIVYRDLKLDNLLLDTEGF 139

Query: 367 AHLMGVGLSKFVPWEVM--QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIV 424
             +   GL K    E M   +RT    GT  +LAPE +     T   D +  GVL+ E++
Sbjct: 140 VKIADFGLCK----EGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEML 195

Query: 425 SGRRP 429
            G  P
Sbjct: 196 VGESP 200

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 54.2 bits (130), Expect = 5e-08
 Identities = 52/211 (24%), Positives = 92/211 (43%), Gaps = 19/211 (9%)

Query: 231 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVA---- 285
            ++G+   G  Y G      ++A  ++   +   ++E   EI    +  HH N+      
Sbjct: 22  EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGA 81

Query: 286 -VKGCCYDHGDR-YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 343
            +K     H D+ ++V EF   G +   + +        DW     +   + +G+A LH 
Sbjct: 82  FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGLAHLHA 139

Query: 344 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 403
                V+HRDI+  NVLL E     L+  G+S  +   V +  T +  GT  ++APE + 
Sbjct: 140 H---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI--GTPYWMAPEVIA 194

Query: 404 RNE-----LTTKSDVYSFGVLLLEIVSGRRP 429
            +E        +SD++S G+  +E+  G  P
Sbjct: 195 CDENPDATYDYRSDIWSLGITAIEMAEGAPP 225

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 53.9 bits (129), Expect = 6e-08
 Identities = 52/232 (22%), Positives = 94/232 (40%), Gaps = 36/232 (15%)

Query: 266 KEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWA 325
           ++   EI   ++   P +    G        +I+ E++  G     L   P     LD  
Sbjct: 47  EDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-----LDET 101

Query: 326 MRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLS-KFVPWEVMQ 384
               +   + +G+ +LH + K   +HRDI+A+NVLL E     L   G++ +    ++ +
Sbjct: 102 QIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 158

Query: 385 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEW 444
              V   GT  ++APE + ++   +K+D++S G+  +E+  G  P               
Sbjct: 159 NTFV---GTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPP--------------- 200

Query: 445 ATPLVQSHRYLELLDPLISSLSSDIP--EAGVVQKVVDLVYACTQHVPSMRP 494
                  H  L  +  L     ++ P  E    + + + V AC    PS RP
Sbjct: 201 -------HSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRP 245

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 53.3 bits (128), Expect = 7e-08
 Identities = 50/205 (24%), Positives = 87/205 (42%), Gaps = 17/205 (8%)

Query: 229 GNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFAR-LHHPNLVAVK 287
           GN   G       Y+      +RV VK LK ++  +++  + + G   R L HPN++   
Sbjct: 4   GNGWFGKVLLSEIYTD--TGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61

Query: 288 GCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKP 347
           G C +     +V+E+   G L  +L       R+    +  ++A  +A G+  +H   K 
Sbjct: 62  GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KH 118

Query: 348 HVVHRDIRASNVLLDEEFGAHL--MGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFV--- 402
           + +H D+   N  L  +    +   G+G S++    +  E          +LAPE V   
Sbjct: 119 NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCV--PLRWLAPELVGEF 176

Query: 403 ----YRNELTTKSDVYSFGVLLLEI 423
                  E T  S+V++ GV L E+
Sbjct: 177 HGGLITAEQTKPSNVWALGVTLWEL 201

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 53.5 bits (128), Expect = 7e-08
 Identities = 32/103 (31%), Positives = 58/103 (56%), Gaps = 8/103 (7%)

Query: 330 VATTLAQ---GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 386
           +AT L +   G+ +LH + K   +HRDI+A+NVLL E+    L   G++  +    ++  
Sbjct: 103 IATILREILKGLDYLHSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN 159

Query: 387 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           T +  GT  ++APE + ++    K+D++S G+  +E+  G  P
Sbjct: 160 TFV--GTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|153063 cd03593, CLECT_NK_receptors_like, C-type lectin-like domain (CTLD) of the type found in natural killer cell receptors (NKRs)

 Score = 50.4 bits (121), Expect = 8e-08
 Identities = 34/137 (24%), Positives = 51/137 (37%), Gaps = 22/137 (16%)

Query: 9   CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 68
           CP DWI    K  C+ +    ++W+ES+  C      L  +   EE    Q   G   + 
Sbjct: 1   CPKDWICYGNK--CYYFSMEKKTWNESKEACSSKNSSLLKIDDEEELEFLQSQIGS--SS 56

Query: 69  CWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS 128
            W+G     +     WKW D  S  N   +  GS  S               C  +S+  
Sbjct: 57  YWIGLSREKS--EKPWKWIDG-SPLNNLFNIRGSTKS-------------GNCAYLSST- 99

Query: 129 RSLVTERCNTSHPFICM 145
             + +E C+T   +IC 
Sbjct: 100 -GIYSEDCSTKKRWICE 115

CLECT_NK_receptors_like: C-type lectin-like domain (CTLD) of the type found in natural killer cell receptors (NKRs), including proteins similar to oxidized low density lipoprotein (OxLDL) receptor (LOX-1), CD94, CD69, NKG2-A and -D, osteoclast inhibitory lectin (OCIL), dendritic cell-associated C-type lectin-1 (dectin-1), human myeloid inhibitory C-type lectin-like receptor (MICL), mast cell-associated functional antigen (MAFA), killer cell lectin-like receptors: subfamily F, member 1 (KLRF1) and subfamily B, member 1 (KLRB1), and lys49 receptors. CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. NKRs are variously associated with activation or inhibition of natural killer (NK) cells. Activating NKRs stimulate cytolysis by NK cells of virally infected or transformed cells; inhibitory NKRs block cytolysis upon recognition of markers of healthy self cells. Most Lys49 receptors are inhibitory; some are stimulatory. OCIL inhibits NK cell function via binding to the receptor NKRP1D. Murine OCIL in addition to inhibiting NK cell function inhibits osteoclast differentiation. MAFA clusters with the type I Fc epsilon receptor (FcepsilonRI) and inhibits the mast cells secretory response to FcepsilonRI stimulus. CD72 is a negative regulator of B cell receptor signaling. NKG2D is an activating receptor for stress-induced antigens; human NKG2D ligands include the stress induced MHC-I homologs, MICA, MICB, and ULBP family of glycoproteins Several NKRs have a carbohydrate-binding capacity which is not mediated through calcium ions (e.g. OCIL binds a range of high molecular weight sulfated glycosaminoglycans including dextran sulfate, fucoidan, and gamma-carrageenan sugars). Dectin-1 binds fungal beta-glucans and in involved in the innate immune responses to fungal pathogens. MAFA binds saccharides having terminal alpha-D mannose residues in a calcium-dependent manner. LOX-1 is the major receptor for OxLDL in endothelial cells and thought to play a role in the pathology of atherosclerosis. Some NKRs exist as homodimers (e.g.Lys49, NKG2D, CD69, LOX-1) and some as heterodimers (e.g. CD94/NKG2A). Dectin-1 can function as a monomer in vitro. Length = 116

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 52.6 bits (127), Expect = 1e-07
 Identities = 47/194 (24%), Positives = 86/194 (44%), Gaps = 19/194 (9%)

Query: 247 PDGSRVAVKRLKRSS-FQRKKE--FYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 303
                 A+K +K+    +  ++   +SE       +HP +V +     D    Y++ E+ 
Sbjct: 16  SKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYC 75

Query: 304 VNGPLDRWLHHIPRGGRSLDWAMRMKVAT-TLAQGIAFLHDKVKPHVVHRDIRASNVLLD 362
           + G L   L      G   ++  R  +A   LA    +LH++    +++RD++  N+LLD
Sbjct: 76  LGGELWTILRDR---GLFDEYTARFYIACVVLA--FEYLHNR---GIIYRDLKPENLLLD 127

Query: 363 EEFGAHLMGVGLSKFVPWEVMQ--ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLL 420
                 L+  G +K      ++  ++T    GT  Y+APE +         D +S G+LL
Sbjct: 128 SNGYVKLVDFGFAK-----KLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILL 182

Query: 421 LEIVSGRRPAQAVD 434
            E+++GR P    D
Sbjct: 183 YELLTGRPPFGEDD 196

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 52.9 bits (127), Expect = 1e-07
 Identities = 39/136 (28%), Positives = 66/136 (48%), Gaps = 12/136 (8%)

Query: 297 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRA 356
           +++ ++V  G L     H+ +     +  +R+ +A  +   +  LH   +  +++RDI+ 
Sbjct: 81  HLILDYVNGGEL---FTHLYQREHFTESEVRVYIAE-IVLALDHLH---QLGIIYRDIKL 133

Query: 357 SNVLLDEEFGAHLMGVGLSK-FVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKS--DV 413
            N+LLD E    L   GLSK F+  E  +ER     GT  Y+APE +           D 
Sbjct: 134 ENILLDSEGHVVLTDFGLSKEFLAEE--EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDW 191

Query: 414 YSFGVLLLEIVSGRRP 429
           +S GVL  E+++G  P
Sbjct: 192 WSLGVLTFELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 52.5 bits (126), Expect = 2e-07
 Identities = 61/275 (22%), Positives = 112/275 (40%), Gaps = 53/275 (19%)

Query: 252 VAVKRLK---RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 308
           VA+K++    + S ++ ++   E+    +L HPN +  KGC       ++V E+ +    
Sbjct: 43  VAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSAS 102

Query: 309 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE----- 363
           D    H  +  + ++ A    +     QG+A+LH   +   +HRDI+A N+LL E     
Sbjct: 103 DILEVH-KKPLQEVEIA---AICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVK 155

Query: 364 --EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY---RNELTTKSDVYSFGV 418
             +FG+  +    + FV             GT  ++APE +      +   K DV+S G+
Sbjct: 156 LADFGSASLVSPANSFV-------------GTPYWMAPEVILAMDEGQYDGKVDVWSLGI 202

Query: 419 LLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKV 478
             +E+   R+P                 PL  +   +  L  +  + S  +         
Sbjct: 203 TCIELAE-RKP-----------------PLF-NMNAMSALYHIAQNDSPTLSSNDWSDYF 243

Query: 479 VDLVYACTQHVPSMRPRMSHVV-HQLQQLAQPPVT 512
            + V +C Q +P  RP    ++ H+     +PP  
Sbjct: 244 RNFVDSCLQKIPQDRPSSEELLKHRFVLRERPPTV 278

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 52.7 bits (126), Expect = 2e-07
 Identities = 52/178 (29%), Positives = 80/178 (44%), Gaps = 27/178 (15%)

Query: 334 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT 393
           +A+G+ FL  +     +HRD+ A N+LL E     +   GL++ +  +    R   A   
Sbjct: 188 VAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244

Query: 394 YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS---GRRPAQAVDSVCWQSIFEWATPLVQ 450
             ++APE ++    T +SDV+SFGVLL EI S      P   +D        E+   L +
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-------EFCRRLKE 297

Query: 451 SHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 508
             R   +  P  ++     PE  + Q ++D    C    PS RP  S +V  L  L Q
Sbjct: 298 GTR---MRAPDYTT-----PE--MYQTMLD----CWHGEPSQRPTFSELVEHLGNLLQ 341

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 52.6 bits (126), Expect = 2e-07
 Identities = 33/83 (39%), Positives = 48/83 (57%), Gaps = 4/83 (4%)

Query: 349 VVHRDIRASNVLLDEEFGAHLMGVGLSK-FVPWEVMQERTVMAGGTYGYLAPEFVYRNEL 407
           +V+RDI+  N+LLD E    L   GLSK F+  E  +ERT    GT  Y+APE +     
Sbjct: 126 IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE--KERTYSFCGTIEYMAPEIIRGKGG 183

Query: 408 TTKS-DVYSFGVLLLEIVSGRRP 429
             K+ D +S G+L+ E+++G  P
Sbjct: 184 HGKAVDWWSLGILIFELLTGASP 206

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 32/118 (27%), Positives = 65/118 (55%), Gaps = 9/118 (7%)

Query: 313 HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV 372
           +H+ + G   +  MR   AT +  G+  +H++    VV+RD++ +N+LLDE     +  +
Sbjct: 86  YHLSQHGVFSEKEMRF-YATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDL 141

Query: 373 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRP 429
           GL+     +  +++   + GT+GY+APE + +     + +D +S G +L +++ G  P
Sbjct: 142 GLA----CDFSKKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 52.7 bits (126), Expect = 2e-07
 Identities = 33/92 (35%), Positives = 51/92 (55%), Gaps = 3/92 (3%)

Query: 334 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT 393
           +A+G+ FL  +     +HRD+ A N+LL E     +   GL++ +  +    R   A   
Sbjct: 183 VARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239

Query: 394 YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 425
             ++APE ++    TT+SDV+SFGVLL EI S
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|215684 pfam00059, Lectin_C, Lectin C-type domain

 Score = 48.9 bits (117), Expect = 2e-07
 Identities = 30/116 (25%), Positives = 53/116 (45%), Gaps = 11/116 (9%)

Query: 30  RSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDN 89
           ++W E+E  C+++GGHL ++ S EE+     L   +    W+G   INT    +W W+D 
Sbjct: 3   KTWAEAEAACQKLGGHLVSIQSAEEQDFLTSLVKASNTYAWIGLTDINT--EGTWVWTDG 60

Query: 90  MSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICM 145
            S  N +  A G  N+   +  C V        + ++ +     E C +   ++C 
Sbjct: 61  -SPVNYTNWAPGEPNNKGGNEDC-VE-------IYTDTNGKWNDEPCGSKRLYVCE 107

This family includes both long and short form C-type. Length = 108

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 51.6 bits (123), Expect = 3e-07
 Identities = 51/210 (24%), Positives = 90/210 (42%), Gaps = 19/210 (9%)

Query: 232 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCC 290
           L+G+   G  Y G      ++A  ++   +   ++E   EI    +  HH N+    G  
Sbjct: 13  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72

Query: 291 YDHG------DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 344
                       ++V EF   G +   + +    G +L       +   + +G++ LH  
Sbjct: 73  IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLH-- 128

Query: 345 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR 404
            +  V+HRDI+  NVLL E     L+  G+S  +   V +  T +  GT  ++APE +  
Sbjct: 129 -QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI--GTPYWMAPEVIAC 185

Query: 405 NE-----LTTKSDVYSFGVLLLEIVSGRRP 429
           +E        KSD++S G+  +E+  G  P
Sbjct: 186 DENPDATYDFKSDLWSLGITAIEMAEGAPP 215

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 51.5 bits (123), Expect = 3e-07
 Identities = 28/90 (31%), Positives = 49/90 (54%), Gaps = 5/90 (5%)

Query: 341 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP-WEVMQERTVMAGGTYGYLAP 399
           L D  +  +V+RD++  N+LLD+     +  +GL+  +P  E ++ R     GT GY+AP
Sbjct: 115 LEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV----GTVGYMAP 170

Query: 400 EFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           E +   + T   D +  G L+ E++ G+ P
Sbjct: 171 EVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 51.5 bits (123), Expect = 3e-07
 Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 24/210 (11%)

Query: 233 LGDSKTGGTYSGI-LPDGSR-VAVKRLKRSSFQRKKEFYSEIGRFARL------HHPNLV 284
           +G+   G  +    L +G R VA+KR++  + +      S I   A L       HPN+V
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPL-STIREVAVLRHLETFEHPNVV 67

Query: 285 AV-KGCCYDHGDR----YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA 339
            +   C     DR     +V+E V +  L  +L  +P  G   +    M     L +G+ 
Sbjct: 68  RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMF--QLLRGLD 124

Query: 340 FLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAP 399
           FLH      VVHRD++  N+L+       L   GL++   +++     V+   T  Y AP
Sbjct: 125 FLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV---TLWYRAP 178

Query: 400 EFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           E + ++   T  D++S G +  E+   R+P
Sbjct: 179 EVLLQSSYATPVDLWSVGCIFAEMFR-RKP 207

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 51.9 bits (124), Expect = 3e-07
 Identities = 61/235 (25%), Positives = 99/235 (42%), Gaps = 20/235 (8%)

Query: 249 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLH---HPNLVAVKGCCYDHGDRYIVYEFVVN 305
           G   A+K LK+     K E    +     L    HP L A+K     H     V E+   
Sbjct: 20  GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANG 79

Query: 306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 365
           G L     H+ R  R             +   + +LH   + +VV+RD++  N++LD++ 
Sbjct: 80  GEL---FFHLSRE-RVFSEDRARFYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDG 133

Query: 366 GAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 423
              +   GL K    E +++   M    GT  YLAPE +  N+     D +  GV++ E+
Sbjct: 134 HIKITDFGLCK----EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEM 189

Query: 424 VSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKV 478
           + GR P    D    + +FE    L++  R+   L P   SL S + +    Q++
Sbjct: 190 MCGRLPFYNQDH---EKLFELI--LMEEIRFPRTLSPEAKSLLSGLLKKDPKQRL 239

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 51.3 bits (123), Expect = 4e-07
 Identities = 50/228 (21%), Positives = 93/228 (40%), Gaps = 34/228 (14%)

Query: 277 RLHHPNLVAVKGCCYDHGDR-YIVYEFVVNGPLDRWLHHIPRGGRSLD----WAMRMKVA 331
           +L HPN+V      +   DR YIV + +   PL    + +    +       W + +++ 
Sbjct: 65  QLRHPNIVRYYKT-FLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMV 123

Query: 332 TTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG 391
             L     +LH + +  +VHRD+  +N++L E+    +   GL+K    +  + +     
Sbjct: 124 LALR----YLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTSVV 174

Query: 392 GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQS 451
           GT  Y  PE V       K+DV++FG +L ++ +                     P   S
Sbjct: 175 GTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT-------------------LQPPFYS 215

Query: 452 HRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHV 499
              L L   ++ ++   +PE    + V D++ +C       RP +  V
Sbjct: 216 TNMLSLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQV 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 51.5 bits (123), Expect = 4e-07
 Identities = 46/187 (24%), Positives = 81/187 (43%), Gaps = 11/187 (5%)

Query: 249 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPN--LVAVKGCCYDHGDRYIVYEFVVNG 306
           G   A KRL++   +++K     +     L   N   V      Y+  D   +   ++NG
Sbjct: 25  GKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNG 84

Query: 307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 366
             D   H    G    +    +  A  +  G+  LH   + + V+RD++  N+LLD+   
Sbjct: 85  G-DLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGH 140

Query: 367 AHLMGVGLSKFVP-WEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 425
             +  +GL+  +P  E ++ R     GT GY+APE +     T   D +  G L+ E++ 
Sbjct: 141 IRISDLGLAVKIPEGESIRGRV----GTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIE 196

Query: 426 GRRPAQA 432
           G+ P + 
Sbjct: 197 GQSPFRG 203

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 51.2 bits (123), Expect = 4e-07
 Identities = 53/168 (31%), Positives = 81/168 (48%), Gaps = 14/168 (8%)

Query: 271 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 330
           EI     L+HPN+V +    +     Y+V+EF ++  L +++   P  G  LD  +    
Sbjct: 48  EISLLKELNHPNIVRLLDVVHSENKLYLVFEF-LDLDLKKYMDSSPLTG--LDPPLIKSY 104

Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK-F-VPWEVMQERTV 388
              L QGIA+ H      V+HRD++  N+L+D E    L   GL++ F VP        V
Sbjct: 105 LYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV 161

Query: 389 MAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEIVSGRRPAQAVDS 435
               T  Y APE +  +   +T  D++S G +  E+V+ RRP    DS
Sbjct: 162 ----TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVN-RRPLFPGDS 204

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 51.2 bits (122), Expect = 4e-07
 Identities = 57/225 (25%), Positives = 103/225 (45%), Gaps = 18/225 (8%)

Query: 231 RLLGDSKTGGTYSGILPD-GSRVAVKRLK--RSSFQRKKEFYS---EIGRFARLHHPNLV 284
           +LLG    G  Y     D G  +AVK+++    S +  KE  +   EI     L H  +V
Sbjct: 8   KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67

Query: 285 AVKGCCYDHGDRY--IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLH 342
              GC  D  +R   I  E +  G +   L    +   +L   +  K    + +G+++LH
Sbjct: 68  QYYGCLRDPMERTLSIFMEHMPGGSIKDQL----KSYGALTENVTRKYTRQILEGVSYLH 123

Query: 343 DKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA-GGTYGYLAPEF 401
             +   +VHRDI+ +N+L D      L   G SK +    +    + +  GT  +++PE 
Sbjct: 124 SNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEV 180

Query: 402 VYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWAT 446
           +       K+D++S G  ++E+++ + P    +++   +IF+ AT
Sbjct: 181 ISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA--AIFKIAT 223

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 51.6 bits (124), Expect = 4e-07
 Identities = 56/192 (29%), Positives = 90/192 (46%), Gaps = 25/192 (13%)

Query: 249 GSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAVKGCCYDHG-----DRYIVY 300
             +VA+K++  ++F  +   K    EI     L H N++A+K            D YIVY
Sbjct: 30  NEKVAIKKIA-NAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVY 88

Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
           E      +D  LH I R  ++L           L +G+ ++H     +V+HRD++ SN+L
Sbjct: 89  EL-----MDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLL 140

Query: 361 LDEEFGAHLMGVGLSKF--VPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFG 417
           L+      +   GL++      + M E  V    T  Y APE +   +E TT  DV+S G
Sbjct: 141 LNANCDLKICDFGLARTTSEKGDFMTEYVV----TRWYRAPELLLNCSEYTTAIDVWSVG 196

Query: 418 VLLLEIVSGRRP 429
            +  E++ GR+P
Sbjct: 197 CIFAELL-GRKP 207

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 51.0 bits (122), Expect = 4e-07
 Identities = 42/167 (25%), Positives = 75/167 (44%), Gaps = 15/167 (8%)

Query: 270 SEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMK 329
           +E      L HPN++       +     IV E+   G L  ++    R    LD    + 
Sbjct: 48  NECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQK--RCNSLLDEDTILH 105

Query: 330 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER--- 386
               +   +  +H K+   ++HRD++  N+LLD+    H M V +  F   +++  +   
Sbjct: 106 FFVQILLALHHVHTKL---ILHRDLKTQNILLDK----HKMVVKIGDFGISKILSSKSKA 158

Query: 387 -TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQA 432
            TV+  GT  Y++PE         KSD+++ G +L E+ S +R  +A
Sbjct: 159 YTVV--GTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEA 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 51.4 bits (123), Expect = 4e-07
 Identities = 33/92 (35%), Positives = 51/92 (55%), Gaps = 3/92 (3%)

Query: 334 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT 393
           +A+G+ FL  +     +HRD+ A N+LL E     +   GL++ +  +    R   A   
Sbjct: 182 VARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238

Query: 394 YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 425
             ++APE ++    TT+SDV+SFGVLL EI S
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|153073 cd03603, CLECT_VCBS, A bacterial subgroup of the C-type lectin-like (CTLD) domain; a subgroup of bacterial protein domains homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins

 Score = 48.2 bits (115), Expect = 5e-07
 Identities = 21/70 (30%), Positives = 31/70 (44%), Gaps = 7/70 (10%)

Query: 31 SWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDN- 89
          +W+ ++T  + +GGHL  + S EE        G      W+G  S   T G +WKWSD  
Sbjct: 11 TWEAAQTLAESLGGHLVTINSAEENDWLLSNFGGYGAS-WIGA-SDAATEG-TWKWSDGE 67

Query: 90 ---MSKWNES 96
              + W   
Sbjct: 68 ESTYTNWGSG 77

CLECT_VCBS: A bacterial subgroup of the C-type lectin-like (CTLD) domain; a subgroup of bacterial protein domains homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. Many CTLDs are calcium-dependent carbohydrate binding modules; other CTLDs bind protein ligands, lipids, and inorganic surfaces including CaCO3 and ice. Bacterial CTLDs within this group are functionally uncharacterized. Animal C-type lectins are involved in such functions as extracellular matrix organization, endocytosis, complement activation, pathogen recognition, and cell-cell interactions. CTLDs may bind a variety of carbohydrate ligands including mannose, N-acetylglucosamine, galactose, N-acetylgalactosamine, and fucose. CTLDs associate with each other through several different surfaces to form dimers, trimers, or tetramers from which ligand-binding sites project in different orientations. In some CTLDs a loop extends to the adjoining domain to form a loop-swapped dimer. Length = 118

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 51.2 bits (122), Expect = 6e-07
 Identities = 50/183 (27%), Positives = 83/183 (45%), Gaps = 17/183 (9%)

Query: 253 AVKRLKRSSFQRKKE---FYSEIGRFAR-LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 308
           AVK L++ +  +KKE     SE     + + HP LV +          Y V +++  G L
Sbjct: 24  AVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGEL 83

Query: 309 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 368
               +H+ R    L+   R   A  +A  + +LH     ++V+RD++  N+LLD +    
Sbjct: 84  ---FYHLQRERCFLEPRARF-YAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIV 136

Query: 369 LMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSG 426
           L   GL K    E ++     +   GT  YLAPE +++       D +  G +L E++ G
Sbjct: 137 LTDFGLCK----ENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192

Query: 427 RRP 429
             P
Sbjct: 193 LPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 50.9 bits (122), Expect = 6e-07
 Identities = 51/188 (27%), Positives = 83/188 (44%), Gaps = 17/188 (9%)

Query: 248 DGSRVAVKRLKRSSFQRKKE---FYSEIGRFAR-LHHPNLVAVKGCCYDHGDRYIVYEFV 303
           DG   AVK L++ +  +KKE     +E     + + HP LV +          Y V ++V
Sbjct: 19  DGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYV 78

Query: 304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 363
             G L     H+ R     +   R   A  +A  + +LH     ++++RD++  N+LLD 
Sbjct: 79  NGGEL---FFHLQRERSFPEPRARF-YAAEIASALGYLHSL---NIIYRDLKPENILLDS 131

Query: 364 EFGAHLMGVGLSKFVPWEVMQ--ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLL 421
           +    L   GL K    E ++  + T    GT  YLAPE + +       D +  G +L 
Sbjct: 132 QGHVVLTDFGLCK----EGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLY 187

Query: 422 EIVSGRRP 429
           E++ G  P
Sbjct: 188 EMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 51.2 bits (123), Expect = 6e-07
 Identities = 68/262 (25%), Positives = 110/262 (41%), Gaps = 49/262 (18%)

Query: 249 GSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYI-VYEFVVN 305
           G +VA+K++  +       K    E+       H N++A++      G  +  VY  VV 
Sbjct: 30  GKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY--VVM 87

Query: 306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE-- 363
             ++  LHHI    + L           L +G+ ++H     +V+HRD++ SN+L++E  
Sbjct: 88  DLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDC 144

Query: 364 -----EFGAHLMGVGLSKFVPWEV---MQERTVMAGGTYGYLAPEFVYR-NELTTKSDVY 414
                +FG   M  GLS   P E    M E       T  Y APE +    E TT  D++
Sbjct: 145 ELRIGDFG---MARGLSSS-PTEHKYFMTEYV----ATRWYRAPELLLSLPEYTTAIDMW 196

Query: 415 SFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGV 474
           S G +  E++ GRR            +F     + Q       L  ++S L S  P   V
Sbjct: 197 SVGCIFAEML-GRRQ-----------LFPGKNYVHQ-------LKLILSVLGS--PSEEV 235

Query: 475 VQKV-VDLVYACTQHVPSMRPR 495
           + ++  D V    Q++P  +P 
Sbjct: 236 LNRIGSDRVRKYIQNLPRKQPV 257

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 50.0 bits (120), Expect = 8e-07
 Identities = 57/205 (27%), Positives = 93/205 (45%), Gaps = 28/205 (13%)

Query: 239 GGTYSGI-----LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH 293
            GTY  +     +  G  VA+K +K       +    EI       HPN+VA  G  Y  
Sbjct: 13  SGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS-YLR 71

Query: 294 GDR-YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVA----TTLAQGIAFLHDKVKPH 348
            D+ +IV E+   G L   ++ + RG  S       ++A     TL +G+A+LH+     
Sbjct: 72  RDKLWIVMEYCGGGSLQD-IYQVTRGPLSEL-----QIAYVCRETL-KGLAYLHET---G 121

Query: 349 VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELT 408
            +HRDI+ +N+LL E+    L   G+S  +    + +R    G  Y ++APE V   E  
Sbjct: 122 KIHRDIKGANILLTEDGDVKLADFGVSAQLT-ATIAKRKSFIGTPY-WMAPE-VAAVERK 178

Query: 409 ----TKSDVYSFGVLLLEIVSGRRP 429
                K D+++ G+  +E+   + P
Sbjct: 179 GGYDGKCDIWALGITAIELAELQPP 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 49.9 bits (119), Expect = 1e-06
 Identities = 37/163 (22%), Positives = 74/163 (45%), Gaps = 12/163 (7%)

Query: 313 HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV 372
           +H+ + G   +  MR   A  +  G+  +H++    VV+RD++ +N+LLDE     +  +
Sbjct: 86  YHLSQHGVFSEAEMRF-YAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDL 141

Query: 373 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQ 431
           GL+     +  +++   + GT+GY+APE + +     + +D +S G +L +++ G  P +
Sbjct: 142 GLA----CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR 197

Query: 432 ---AVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPE 471
                D      +       +      EL   L   L  D+  
Sbjct: 198 QHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNR 240

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 49.9 bits (119), Expect = 2e-06
 Identities = 44/169 (26%), Positives = 80/169 (47%), Gaps = 14/169 (8%)

Query: 321 SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 380
           +LD    +  +  +A+G++FL  K   + +HRD+ A N+LL       +   GL++    
Sbjct: 210 ALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLAR---- 262

Query: 381 EVMQERTVMAGGT----YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS---GRRPAQAV 433
           ++  +   +  G       ++APE ++    T +SDV+S+G+LL EI S      P   V
Sbjct: 263 DIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV 322

Query: 434 DSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLV 482
           DS  ++ I E    L       E+ D + S   +D  +    +++V L+
Sbjct: 323 DSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLI 371

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 49.5 bits (118), Expect = 2e-06
 Identities = 53/222 (23%), Positives = 93/222 (41%), Gaps = 34/222 (15%)

Query: 281 PNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAF 340
           P +V   G  +  G  Y+  E++  G LD+            +  +R ++   + +G+ F
Sbjct: 59  PYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLR-RITYAVVKGLKF 117

Query: 341 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 400
           L ++   +++HRD++ +NVL++      L   G+S  +   + +       G   Y+APE
Sbjct: 118 LKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI----GCQSYMAPE 171

Query: 401 FVY------RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRY 454
            +           T +SDV+S G+ +LE+  GR P        + +IF   + +V     
Sbjct: 172 RIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP---YPPETYANIFAQLSAIVDG--- 225

Query: 455 LELLDP--LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP 494
               DP  L S  S D           D V  C   +P+ RP
Sbjct: 226 ----DPPTLPSGYSDD---------AQDFVAKCLNKIPNRRP 254

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 49.4 bits (118), Expect = 2e-06
 Identities = 44/167 (26%), Positives = 80/167 (47%), Gaps = 26/167 (15%)

Query: 271 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLH-HIPRGGRSLDWAMRMK 329
           EI     L H N+V +    +      +V+E++ +  L +++  H  RG   LD      
Sbjct: 48  EISLMKELKHENIVRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGA--LDPNTVKS 104

Query: 330 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE-------EFG-AHLMGVGLSKFVPWE 381
               L +GIAF H+     V+HRD++  N+L+++       +FG A   G+ ++ F   E
Sbjct: 105 FTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSN-E 160

Query: 382 VMQERTVMAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEIVSGR 427
           V+         T  Y AP+ +  +   +T  D++S G ++ E+++GR
Sbjct: 161 VV---------TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 49.4 bits (119), Expect = 2e-06
 Identities = 38/168 (22%), Positives = 73/168 (43%), Gaps = 42/168 (25%)

Query: 277 RLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLA- 335
            L HPN+V +    +     Y+V+E+  +  L ++L   P         +   +  ++  
Sbjct: 54  ELKHPNIVKLLDVIHTERKLYLVFEYC-DMDLKKYLDKRPGP-------LSPNLIKSIMY 105

Query: 336 ---QGIAFLHDKVKPHVVHRDIRASNVLLDEE-------FG-AHLMGVGLSKFVPWEVMQ 384
              +G+A+ H      ++HRD++  N+L++ +       FG A   G+ L  +   EV+ 
Sbjct: 106 QLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTH-EVV- 160

Query: 385 ERTVMAGGTYGYLAPE-----FVYRNELTTKSDVYSFGVLLLEIVSGR 427
                   T  Y APE       Y    +T  D++S G +  E+++G+
Sbjct: 161 --------TLWYRAPEILLGSKHY----STAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 49.6 bits (118), Expect = 2e-06
 Identities = 53/188 (28%), Positives = 82/188 (43%), Gaps = 18/188 (9%)

Query: 280 HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA 339
           HP L A+K     H     V E+   G L     H+ R     +   R   A  +   + 
Sbjct: 54  HPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAE-IVSALE 109

Query: 340 FLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYL 397
           +LH +    VV+RDI+  N++LD++    +   GL K    E + +   M    GT  YL
Sbjct: 110 YLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK----EGISDGATMKTFCGTPEYL 162

Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLEL 457
           APE +  N+     D +  GV++ E++ GR P    D    + +FE    L++  R+   
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---ERLFELI--LMEEIRFPRT 217

Query: 458 LDPLISSL 465
           L P   SL
Sbjct: 218 LSPEAKSL 225

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 48.9 bits (117), Expect = 3e-06
 Identities = 29/90 (32%), Positives = 47/90 (52%), Gaps = 7/90 (7%)

Query: 344 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 403
           K K  V+HRD++ SN+LLD      L   G+S  +     + R+    G   Y+APE + 
Sbjct: 131 KEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS---AGCAAYMAPERID 187

Query: 404 RNELTTK----SDVYSFGVLLLEIVSGRRP 429
             +   K    +DV+S G+ L+E+ +G+ P
Sbjct: 188 PPDPNPKYDIRADVWSLGISLVELATGQFP 217

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 48.8 bits (117), Expect = 3e-06
 Identities = 42/161 (26%), Positives = 67/161 (41%), Gaps = 36/161 (22%)

Query: 297 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVA-TTLAQGIAFLHDKVKPHVVHRDIR 355
           Y+V E++  G L   L  I +     + A R  +A   LA  +  +H   K   +HRDI+
Sbjct: 77  YLVMEYMPGGDLMNLL--IRKDVFPEETA-RFYIAELVLA--LDSVH---KLGFIHRDIK 128

Query: 356 ASNVLLDEE-------FG-----------------AHLMGVGLSKFVPWEVMQERTVMAG 391
             N+L+D +       FG                 +H +    +  V     ++R V A 
Sbjct: 129 PDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRAN 188

Query: 392 ---GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
              GT  Y+APE +       + D +S GV+L E++ G  P
Sbjct: 189 STVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 48.7 bits (116), Expect = 3e-06
 Identities = 31/103 (30%), Positives = 53/103 (51%), Gaps = 8/103 (7%)

Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP-WEVMQERTVM 389
           A  +  G+  LH   +  +V+RD++  N+LLD+     +  +GL+  +P  E ++ R   
Sbjct: 108 AAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRV-- 162

Query: 390 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQA 432
             GT GY+APE V     T   D +  G L+ E++ G+ P + 
Sbjct: 163 --GTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQ 203

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 49.3 bits (117), Expect = 3e-06
 Identities = 52/218 (23%), Positives = 100/218 (45%), Gaps = 23/218 (10%)

Query: 220 RSITKNFSEGNRLLGDSKTGGTYSGILPDGS-RVAVKRLKRSSFQRKKEFYSEIGRFARL 278
           RS  K++  GN ++G+   G  Y  I  D S +VA+K++ +    + +E          L
Sbjct: 62  RSPNKSYKLGN-IIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLI----MKNL 116

Query: 279 HHPNLVAVKGCCYDHGDRY--------IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 330
           +H N++ +K   Y    +         +V EF+    + +++ H  R   +L   +    
Sbjct: 117 NHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLY 175

Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD-EEFGAHLMGVGLSKFVPWEVMQERTVM 389
           +  L + +A++H K    + HRD++  N+L+D       L   G +K +   +  +R+V 
Sbjct: 176 SYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL---LAGQRSVS 229

Query: 390 AGGTYGYLAPEFVY-RNELTTKSDVYSFGVLLLEIVSG 426
              +  Y APE +      TT  D++S G ++ E++ G
Sbjct: 230 YICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 47.8 bits (114), Expect = 6e-06
 Identities = 67/266 (25%), Positives = 111/266 (41%), Gaps = 66/266 (24%)

Query: 257 LKRSSFQRKKEFY-----SEIGRFARLHHPNLVAVKGCCYDHGDR----------YIVYE 301
           LK+     +KE +      EI    +L+H N+V +K    D  D           Y+V+E
Sbjct: 37  LKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFE 96

Query: 302 FV---VNGPLDRWLHHIPRGG-RSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 357
           ++   + G L+  L H      +S      MK    L +G+ + H K   + +HRDI+ S
Sbjct: 97  YMDHDLMGLLESGLVHFSEDHIKSF-----MK---QLLEGLNYCHKK---NFLHRDIKCS 145

Query: 358 NVLLDEEFGAHLMGVGLSKFVPWEVMQER----TVMAGGTYGYLAPEFVYRNELTTKS-D 412
           N+LL+ +    L   GL++   +   + R     V+   T  Y  PE +   E    + D
Sbjct: 146 NILLNNKGQIKLADFGLARL--YNSEESRPYTNKVI---TLWYRPPELLLGEERYGPAID 200

Query: 413 VYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEA 472
           V+S G +L E+ + +                   P+ Q+++ L  L+ LIS L    P  
Sbjct: 201 VWSCGCILGELFTKK-------------------PIFQANQELAQLE-LISRLCGS-PCP 239

Query: 473 GVVQKVVDLVYACTQHVPSMRPRMSH 498
            V   V+ L Y  T     M+P+  +
Sbjct: 240 AVWPDVIKLPYFNT-----MKPKKQY 260

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 47.7 bits (113), Expect = 7e-06
 Identities = 53/186 (28%), Positives = 78/186 (41%), Gaps = 13/186 (6%)

Query: 248 DGSRVAVKRL-KRSSFQRKKEFYSEIGR---FARLHHPNLVAVKGCCYDHGDRYIVYEFV 303
           DG   AVK L K+    RK++ +    R      + HP LV +          Y V +FV
Sbjct: 19  DGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFV 78

Query: 304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 363
             G L     H+ R  RS         A  +A  + +LH     ++V+RD++  N+LLD 
Sbjct: 79  NGGEL---FFHLQRE-RSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDS 131

Query: 364 EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 423
           +    L   GL K        + T    GT  YLAPE + +       D +  G +L E+
Sbjct: 132 QGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEM 189

Query: 424 VSGRRP 429
           + G  P
Sbjct: 190 LYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 47.6 bits (114), Expect = 7e-06
 Identities = 53/197 (26%), Positives = 88/197 (44%), Gaps = 46/197 (23%)

Query: 252 VAVKRLKRSSFQRKKEFYS-----EIGRFARLHHPNLVAVK----GCCYDHGDRYIVYEF 302
           VA+K+LK    +++KE +      EI    +L HPN+V VK    G   +    Y+V E+
Sbjct: 33  VALKKLK---MEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGS--NLDKIYMVMEY 87

Query: 303 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ---GIAFLHDKVKPHVVHRDIRASNV 359
           V +  L   +  + +           +V   + Q   G+A LHD     ++HRD++ SN+
Sbjct: 88  VEH-DLKSLMETMKQPFLQ------SEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNL 137

Query: 360 LLDE-------EFG-AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY-RNELTTK 410
           LL+        +FG A   G  L  +    V          T  Y APE +    E +T 
Sbjct: 138 LLNNRGILKICDFGLAREYGSPLKPYTQLVV----------TLWYRAPELLLGAKEYSTA 187

Query: 411 SDVYSFGVLLLEIVSGR 427
            D++S G +  E+++ +
Sbjct: 188 IDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 48.2 bits (114), Expect = 7e-06
 Identities = 47/190 (24%), Positives = 88/190 (46%), Gaps = 27/190 (14%)

Query: 247 PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIV------- 299
           P   R+  KR+K  S +   +  +EI    RL+H N++ ++       + Y++       
Sbjct: 190 PKCERLIAKRVKAGS-RAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFD 248

Query: 300 -YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASN 358
            Y F+ +   D W        R L    R  +   L   + ++HDK    ++HRDI+  N
Sbjct: 249 LYSFMYDEAFD-W------KDRPLLKQTR-AIMKQLLCAVEYIHDKK---LIHRDIKLEN 297

Query: 359 VLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLA---PEFVYRNELTTKSDVYS 415
           + L+ + G  ++G      +P+E  +ER     G  G +A   PE +  +     +D++S
Sbjct: 298 IFLNCD-GKIVLG-DFGTAMPFE--KEREAFDYGWVGTVATNSPEILAGDGYCEITDIWS 353

Query: 416 FGVLLLEIVS 425
            G++LL+++S
Sbjct: 354 CGLILLDMLS 363

Length = 501

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 47.2 bits (113), Expect = 8e-06
 Identities = 30/94 (31%), Positives = 53/94 (56%), Gaps = 5/94 (5%)

Query: 336 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG 395
            G+ +LH++ K   +HRDI+A+N+LL EE    L   G+S  +    M +R    G  + 
Sbjct: 109 LGLEYLHEEGK---IHRDIKAANILLSEEGDVKLADFGVSGQLT-STMSKRNTFVGTPF- 163

Query: 396 YLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           ++APE + ++    K+D++S G+  +E+  G  P
Sbjct: 164 WMAPEVIKQSGYDEKADIWSLGITAIELAKGEPP 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 47.3 bits (112), Expect = 8e-06
 Identities = 31/84 (36%), Positives = 44/84 (52%), Gaps = 5/84 (5%)

Query: 349 VVHRDIRASNVLLDEEFGAHLMGVGLSK-FVPWEVMQERTVMAGGTYGYLAPEFVYRNEL 407
           +++RDI+  N+LLD      L   GLSK F   EV  ER     GT  Y+AP+ V   + 
Sbjct: 126 IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV--ERAYSFCGTIEYMAPDIVRGGDG 183

Query: 408 --TTKSDVYSFGVLLLEIVSGRRP 429
                 D +S GVL+ E+++G  P
Sbjct: 184 GHDKAVDWWSMGVLMYELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 47.0 bits (111), Expect = 9e-06
 Identities = 51/201 (25%), Positives = 86/201 (42%), Gaps = 23/201 (11%)

Query: 240 GTYSGI-----LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG 294
           GTY  +     +  G   A+K +K    +       EI       H N+VA  G      
Sbjct: 20  GTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRD 79

Query: 295 DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDI 354
             +I  EF   G L   ++H+         A    V+    QG+ +LH K K   +HRDI
Sbjct: 80  KLWICMEFCGGGSLQD-IYHVTGPLSESQIAY---VSRETLQGLYYLHSKGK---MHRDI 132

Query: 355 RASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEF--VYR----NELT 408
           + +N+LL +     L   G+S  +   + + ++ +  GT  ++APE   V R    N+L 
Sbjct: 133 KGANILLTDNGHVKLADFGVSAQITATIAKRKSFI--GTPYWMAPEVAAVERKGGYNQLC 190

Query: 409 TKSDVYSFGVLLLEIVSGRRP 429
              D+++ G+  +E+   + P
Sbjct: 191 ---DIWAVGITAIELAELQPP 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 47.6 bits (113), Expect = 9e-06
 Identities = 24/106 (22%), Positives = 57/106 (53%), Gaps = 6/106 (5%)

Query: 320 RSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP 379
           R L     + +   + +G+ +LH +    ++HRD++  N+ +++     +  +G ++F  
Sbjct: 152 RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQF-- 206

Query: 380 WEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 425
             V+    +   GT    APE + R++  +K+D++S G++L E+++
Sbjct: 207 -PVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251

Length = 357

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 47.3 bits (112), Expect = 9e-06
 Identities = 41/163 (25%), Positives = 68/163 (41%), Gaps = 19/163 (11%)

Query: 274 RFARLHHPNLVAVKGCCYD-HGDRYIVYEFV---VNGPLDRWLHHIPRGGRSLDWAMRMK 329
           R     HPN+V +   C     DR      V   V+  L  +L  +P  G   +      
Sbjct: 55  RLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAE-----T 109

Query: 330 VATTLAQ---GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 386
           +   + Q   G+ FLH      +VHRD++  N+L+       L   GL++    ++    
Sbjct: 110 IKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTP 166

Query: 387 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
            V+   T  Y APE + ++   T  D++S G +  E+   R+P
Sbjct: 167 VVV---TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKP 205

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 47.4 bits (112), Expect = 1e-05
 Identities = 55/210 (26%), Positives = 88/210 (41%), Gaps = 27/210 (12%)

Query: 231 RLLGDSKTGGTYSGIL-----PDGSRVAVKRLKRSSFQRKKEF---YSEIGRFARLHHPN 282
           +LLG     GT+  ++       G   A+K LK+     K E     +E        HP 
Sbjct: 1   KLLGK----GTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPF 56

Query: 283 LVAVKGCCYDHGDRY-IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 341
           L ++K   +   DR   V E+V  G L     H+ R  R             +   + +L
Sbjct: 57  LTSLK-YSFQTKDRLCFVMEYVNGGEL---FFHLSRE-RVFSEDRTRFYGAEIVSALDYL 111

Query: 342 HDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAP 399
           H      +V+RD++  N++LD++    +   GL K    E + +   M    GT  YLAP
Sbjct: 112 HSG---KIVYRDLKLENLMLDKDGHIKITDFGLCK----EGITDAATMKTFCGTPEYLAP 164

Query: 400 EFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           E +  N+     D +  GV++ E++ GR P
Sbjct: 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 46.5 bits (111), Expect = 2e-05
 Identities = 23/96 (23%), Positives = 46/96 (47%), Gaps = 11/96 (11%)

Query: 271 EIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVNGPLDRWL---HHIPRGGRSLDWA 325
           EI     L H N+V++     +H D+  Y+++++  +   D W     H      S+  +
Sbjct: 52  EIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEH---DLWQIIKFHRQAKRVSIPPS 108

Query: 326 MRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL 361
           M   +   +  G+ +LH      V+HRD++ +N+L+
Sbjct: 109 MVKSLLWQILNGVHYLHSN---WVLHRDLKPANILV 141

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 46.1 bits (109), Expect = 2e-05
 Identities = 60/215 (27%), Positives = 93/215 (43%), Gaps = 23/215 (10%)

Query: 229 GNRLLGDSKTGGTYSGILPDGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVK 287
           GN   G    G   SG  P  ++V VK L+ S S Q + +F  E   +  L H NL+   
Sbjct: 4   GNGWFGKVILGEVNSGYTP--AQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61

Query: 288 GCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSL--DWAMRMKVATTLAQGIAFLHDKV 345
           G C +     +V EF   G L  +L    R    +  D     ++A  +A G+  LH   
Sbjct: 62  GQCTEVTPYLLVMEFCPLGDLKGYLRSC-RKAELMTPDPTTLQRMACEIALGLLHLH--- 117

Query: 346 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY---GYLAPEF- 401
           K + +H D+   N LL  +    +   GLS     +  ++  V     +    ++APE  
Sbjct: 118 KNNFIHSDLALRNCLLTADLTVKIGDYGLSHN---KYKEDYYVTPDQLWVPLRWIAPELV 174

Query: 402 --VYRNEL----TTKSDVYSFGVLLLEIVS-GRRP 429
             V+ N L    T +S+V+S GV + E+   G +P
Sbjct: 175 DEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQP 209

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 46.6 bits (110), Expect = 2e-05
 Identities = 56/234 (23%), Positives = 102/234 (43%), Gaps = 28/234 (11%)

Query: 249 GSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAV------KGCCYDHGDRYIV 299
           G  VAVK+L R  FQ +   K  Y E+     ++H N++++      +    +  D Y+V
Sbjct: 46  GINVAVKKLSRP-FQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLV 104

Query: 300 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNV 359
            E +++  L + +H        LD      +   +  GI  LH      ++HRD++ SN+
Sbjct: 105 ME-LMDANLCQVIH------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNI 154

Query: 360 LLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVL 419
           ++  +    ++  GL++      M    V+   T  Y APE +         D++S G +
Sbjct: 155 VVKSDCTLKILDFGLARTACTNFMMTPYVV---TRYYRAPEVILGMGYKENVDIWSVGCI 211

Query: 420 LLEIVSGRRPAQAVDSV-CWQSIFE-WATPLVQSHRYLELLDPLISSLSSDIPE 471
           + E+V G    Q  D +  W  + E   TP   S  ++  L P + +   + P+
Sbjct: 212 MGELVKGSVIFQGTDHIDQWNKVIEQLGTP---SAEFMNRLQPTVRNYVENRPQ 262

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 22/206 (10%)

Query: 240 GTYSGILP-----DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-HPNLVAVKGCCYD- 292
           GTY  +       +GS+ AVK L        +E  +E      L  HPN+V   G  Y  
Sbjct: 29  GTYGKVFKVLNKKNGSKAAVKILD-PIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87

Query: 293 ---HGDR-YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH 348
              +GD+ ++V E    G +   +    + G  ++  +   +      G+  LH      
Sbjct: 88  DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---K 144

Query: 349 VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY-RNEL 407
            +HRD++ +N+LL  E G  L+  G+S  +    ++  T +  GT  ++APE +    +L
Sbjct: 145 TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV--GTPFWMAPEVIACEQQL 202

Query: 408 TT----KSDVYSFGVLLLEIVSGRRP 429
            +    + DV+S G+  +E+  G  P
Sbjct: 203 DSTYDARCDVWSLGITAIELGDGDPP 228

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 46.5 bits (110), Expect = 2e-05
 Identities = 36/128 (28%), Positives = 60/128 (46%), Gaps = 8/128 (6%)

Query: 349 VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELT 408
           ++HRD++++N+ L       L   G SK     V  +      GT  YLAPE   R   +
Sbjct: 190 MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYS 249

Query: 409 TKSDVYSFGVLLLEIVSGRRPAQA------VDSVCWQSIFEWATPLVQSHRYLELLDPLI 462
            K+D++S GV+L E+++  RP +       +  V +     +  P+    +   LLDPL+
Sbjct: 250 KKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMK--ALLDPLL 307

Query: 463 SSLSSDIP 470
           S   +  P
Sbjct: 308 SKNPALRP 315

Length = 478

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 45.2 bits (107), Expect = 5e-05
 Identities = 55/206 (26%), Positives = 84/206 (40%), Gaps = 25/206 (12%)

Query: 229 GNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEF---YSEIGRFARLHHPNLVA 285
           G  +L   K  G Y          A+K LK+     K E     +E        HP L A
Sbjct: 9   GKVILVREKATGKY---------YAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTA 59

Query: 286 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 345
           +K     H     V E+   G L     H+ R     +   R   A  ++  + +LH   
Sbjct: 60  LKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVS-ALGYLHSC- 114

Query: 346 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVY 403
              VV+RD++  N++LD++    +   GL K    E + +   M    GT  YLAPE + 
Sbjct: 115 --DVVYRDLKLENLMLDKDGHIKITDFGLCK----EGISDGATMKTFCGTPEYLAPEVLE 168

Query: 404 RNELTTKSDVYSFGVLLLEIVSGRRP 429
            N+     D +  GV++ E++ GR P
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 45.0 bits (106), Expect = 5e-05
 Identities = 46/178 (25%), Positives = 76/178 (42%), Gaps = 10/178 (5%)

Query: 252 VAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 309
           VA+K+ K S  + + K+    E+     L   N+V +K      G  Y+V+E+V    L+
Sbjct: 29  VAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLE 88

Query: 310 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHL 369
             L  +P G          KV + + Q I  +H   K  +VHRDI+  N+L+       L
Sbjct: 89  -LLEEMPNG------VPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKL 141

Query: 370 MGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGR 427
              G ++ +  E           T  Y +PE +         D++S G +L E+  G+
Sbjct: 142 CDFGFARNLS-EGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 44.9 bits (107), Expect = 5e-05
 Identities = 47/201 (23%), Positives = 83/201 (41%), Gaps = 42/201 (20%)

Query: 248 DGSRVAVKRLKRSSFQRKKE-----FYSEIGRFARLHHPN---LVAVKGCCYDHGDR-YI 298
            G  VA+K++K    +  K+        EI     L HPN   L+ V    + H     +
Sbjct: 24  TGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDV----FGHKSNINL 79

Query: 299 VYEFVVNGPLDRWLHHIPRGGRSLDWA-------MRMKVATTLAQGIAFLHDKVKPHVVH 351
           V+EF     ++  L  + +  +S+          M M       +G+ +LH      ++H
Sbjct: 80  VFEF-----METDLEKVIKD-KSIVLTPADIKSYMLM-----TLRGLEYLHSN---WILH 125

Query: 352 RDIRASNVLLDEEFGAHLMGVGLSKFV--PWEVMQERTVMAGGTYGYLAPEFVY-RNELT 408
           RD++ +N+L+  +    L   GL++    P   M  + V    T  Y APE ++      
Sbjct: 126 RDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV----TRWYRAPELLFGARHYG 181

Query: 409 TKSDVYSFGVLLLEIVSGRRP 429
              D++S G +  E++  R P
Sbjct: 182 VGVDMWSVGCIFAELLL-RVP 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 44.6 bits (105), Expect = 8e-05
 Identities = 52/231 (22%), Positives = 98/231 (42%), Gaps = 28/231 (12%)

Query: 252 VAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAV------KGCCYDHGDRYIVYEF 302
           VA+K+L R  FQ +   K  Y E+     ++H N++ +      +    +  D YIV E 
Sbjct: 52  VAIKKLSRP-FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110

Query: 303 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 362
                +D  L  + +    LD      +   +  GI  LH      ++HRD++ SN+++ 
Sbjct: 111 -----MDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVK 160

Query: 363 EEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLE 422
            +    ++  GL++      M    V+   T  Y APE +         D++S G ++ E
Sbjct: 161 SDCTLKILDFGLARTAGTSFMMTPYVV---TRYYRAPEVILGMGYKENVDIWSVGCIMGE 217

Query: 423 IVSGRRPAQAVDSV-CWQSIFE-WATPLVQSHRYLELLDPLISSLSSDIPE 471
           ++ G       D +  W  + E   TP  +   +++ L P + +   + P+
Sbjct: 218 MIKGGVLFPGTDHIDQWNKVIEQLGTPCPE---FMKKLQPTVRTYVENRPK 265

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 44.4 bits (106), Expect = 9e-05
 Identities = 50/200 (25%), Positives = 82/200 (41%), Gaps = 38/200 (19%)

Query: 249 GSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAVK-----GCCYDHGDRYIVY 300
           G +VA+K++    F      K    EI     L H N++ +          D  D YIV 
Sbjct: 25  GRKVAIKKISNV-FDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVT 83

Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ---GIAFLHDKVKPHVVHRDIRAS 357
           E      ++  LH + +  + L       +   L Q   G+ +LH     +V+HRD++ S
Sbjct: 84  EL-----METDLHKVIKSPQPLTDD---HIQYFLYQILRGLKYLH---SANVIHRDLKPS 132

Query: 358 NVLLDEE-------FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 410
           N+L++         FG  L             + E  V    T  Y APE +  +   TK
Sbjct: 133 NILVNSNCDLKICDFG--LARGVDPDEDEKGFLTEYVV----TRWYRAPELLLSSSRYTK 186

Query: 411 S-DVYSFGVLLLEIVSGRRP 429
           + D++S G +  E++  R+P
Sbjct: 187 AIDIWSVGCIFAELL-TRKP 205

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 44.0 bits (104), Expect = 9e-05
 Identities = 42/164 (25%), Positives = 75/164 (45%), Gaps = 20/164 (12%)

Query: 271 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 330
           EI     + H N+V ++   +     Y+V+E++ +  L + +   P   ++     R+ +
Sbjct: 51  EISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNP----RL-I 104

Query: 331 ATTLAQ---GIAFLHDKVKPHVVHRDIRASNVLLDEEFGA-HLMGVGLSKF--VPWEVMQ 384
            T L Q   GIA+ H      V+HRD++  N+L+D    A  L   GL++   +P     
Sbjct: 105 KTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT 161

Query: 385 ERTVMAGGTYGYLAPEFVY-RNELTTKSDVYSFGVLLLEIVSGR 427
              V    T  Y APE +      +T  D++S G +  E+V+ +
Sbjct: 162 HEVV----TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 44.0 bits (104), Expect = 1e-04
 Identities = 51/214 (23%), Positives = 92/214 (42%), Gaps = 49/214 (22%)

Query: 240 GTYSGILP-----DGSRVAVKRLK--------RSSFQRKKEFYSEIGRFARLHHPNLVAV 286
           GTY  +           VA+KR++         SS  R      EI     L H N+V +
Sbjct: 11  GTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR------EICLLKELKHKNIVRL 64

Query: 287 KGCCYD--HGDR--YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATT----LAQGI 338
               YD  H D+   +V+E+  +  L ++         S +  +  ++  +    L +G+
Sbjct: 65  ----YDVLHSDKKLTLVFEYC-DQDLKKYFD-------SCNGDIDPEIVKSFMFQLLKGL 112

Query: 339 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTVMAGGTYGY 396
           AF H     +V+HRD++  N+L+++     L   GL++   +P        V    T  Y
Sbjct: 113 AFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV----TLWY 165

Query: 397 LAPEFVYRNEL-TTKSDVYSFGVLLLEIVSGRRP 429
             P+ ++  +L +T  D++S G +  E+ +  RP
Sbjct: 166 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 43.4 bits (102), Expect = 1e-04
 Identities = 35/149 (23%), Positives = 66/149 (44%), Gaps = 6/149 (4%)

Query: 275 FARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTL 334
            ++L HP +V       +     I+ E+     LD  L  +   G++L      +    L
Sbjct: 56  LSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQL 115

Query: 335 AQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY 394
             G+ ++H +    ++HRD++A N+ L       +   G+S+ +        T    GT 
Sbjct: 116 LLGVHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTFT--GTP 169

Query: 395 GYLAPEFVYRNELTTKSDVYSFGVLLLEI 423
            Y++PE +      +KSD++S G +L E+
Sbjct: 170 YYMSPEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 43.5 bits (102), Expect = 1e-04
 Identities = 51/198 (25%), Positives = 84/198 (42%), Gaps = 17/198 (8%)

Query: 240 GTYSGI-----LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG 294
           GTY  +     L  G   AVK +K            EI       H N+VA  G      
Sbjct: 20  GTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSRE 79

Query: 295 DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDI 354
             +I  E+   G L   ++H+      L  A    V     QG+A+LH K K   +HRDI
Sbjct: 80  KLWICMEYCGGGSLQD-IYHVTGPLSELQIAY---VCRETLQGLAYLHSKGK---MHRDI 132

Query: 355 RASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEF--VYRN-ELTTKS 411
           + +N+LL +     L   G++  +   + + ++ +  GT  ++APE   V +N       
Sbjct: 133 KGANILLTDNGDVKLADFGVAAKITATIAKRKSFI--GTPYWMAPEVAAVEKNGGYNQLC 190

Query: 412 DVYSFGVLLLEIVSGRRP 429
           D+++ G+  +E+   + P
Sbjct: 191 DIWAVGITAIELAELQPP 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 43.6 bits (103), Expect = 2e-04
 Identities = 55/219 (25%), Positives = 90/219 (41%), Gaps = 35/219 (15%)

Query: 231 RLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGC 289
           R LG    G  +S +  D   RVAVK++  +  Q  K    EI    RL H N+V V   
Sbjct: 11  RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEV 70

Query: 290 CYDHGDR--------------YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLA 335
               G                YIV E+ +   L   L      G   +   R+     L 
Sbjct: 71  LGPSGSDLTEDVGSLTELNSVYIVQEY-METDLANVLEQ----GPLSEEHARL-FMYQLL 124

Query: 336 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMG-VGLSKFVPWEV-----MQERTVM 389
           +G+ ++H     +V+HRD++ +NV ++ E     +G  GL++ V         + E  V 
Sbjct: 125 RGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV- 180

Query: 390 AGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR 427
              T  Y +P  +   N  T   D+++ G +  E+++G+
Sbjct: 181 ---TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 43.0 bits (102), Expect = 2e-04
 Identities = 46/162 (28%), Positives = 76/162 (46%), Gaps = 23/162 (14%)

Query: 277 RLHHPNLVAVKGCCYD-HGDR----YIVYEFVVNGPLDRWLHHIPRGGRSLD---WAMRM 328
              HPN+V +   C+    DR     +V+E V +  L  +L   P+ G   +     MR 
Sbjct: 57  SFEHPNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDLMRQ 115

Query: 329 KVATTLAQGIAFLHDKVKPH-VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 387
                L +G+ FLH     H +VHRD++  N+L+  +    +   GL++   +E M   +
Sbjct: 116 -----LLRGVDFLHS----HRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE-MALTS 165

Query: 388 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           V+   T  Y APE + ++   T  D++S G +  E+   RRP
Sbjct: 166 VVV--TLWYRAPEVLLQSSYATPVDMWSVGCIFAELFR-RRP 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 43.1 bits (101), Expect = 3e-04
 Identities = 24/100 (24%), Positives = 49/100 (49%), Gaps = 4/100 (4%)

Query: 328 MKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 387
           + +  ++ + I +LH+     ++HRDI+A N+ ++      L   G + F P ++   + 
Sbjct: 185 LAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACF-PVDINANKY 240

Query: 388 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGR 427
               GT    APE + R+      D++S G++L E+ +  
Sbjct: 241 YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|153059 cd03589, CLECT_CEL-1_like, C-type lectin-like domain (CTLD) of the type found in CEL-1 from Cucumaria echinata and Echinoidin from Anthocidaris crassispina

 Score = 40.8 bits (96), Expect = 3e-04
 Identities = 28/152 (18%), Positives = 48/152 (31%), Gaps = 33/152 (21%)

Query: 9   CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIG-----GHLAALTSYEEEHSAQKLCG 63
           CP  W        C+ + G+  +W+E+E  C+         HL ++ S EE      L  
Sbjct: 1   CPTFW--TAFGGYCYRFFGDRLTWEEAELRCRSFSIPGLIAHLVSIHSQEENDFVYDL-- 56

Query: 64  KNVNGCWVGGRSINTTVGL-------SWKWSD----NMSKWNESIHAVGSFNSSCTSLPC 112
                           +GL        ++W+D    + +KW          N  C  +  
Sbjct: 57  --FESSRGPDTPYGLWIGLHDRTSEGPFEWTDGSPVDFTKWAGGQPDNYGGNEDCVQMWR 114

Query: 113 HVHATVDLCTLVSNGSRSLVTERCNTSHPFIC 144
                        +  +S     C+   P+IC
Sbjct: 115 R-----------GDAGQSWNDMPCDAVFPYIC 135

CLECT_CEL-1_like: C-type lectin-like domain (CTLD) of the type found in CEL-1 from Cucumaria echinata and Echinoidin from Anthocidaris crassispina. CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. The CEL-1 CTLD binds three calcium ions and has a high specificity for N-acteylgalactosamine (GalNAc). CEL-1 exhibits strong cytotoxicity which is inhibited by GalNAc. This protein may play a role as a toxin defending against predation. Echinoidin is found in the coelomic fluid of the sea urchin and is specific for GalBeta1-3GalNAc. Echinoidin has a cell adhesive activity towards human cancer cells which is not mediated through the CTLD. Both CEL-1 and Echinoidin are multimeric proteins comprised of multiple dimers linked by disulfide bonds. Length = 137

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 43.0 bits (101), Expect = 3e-04
 Identities = 44/197 (22%), Positives = 88/197 (44%), Gaps = 41/197 (20%)

Query: 249 GSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 305
           G++VA+K+L R  FQ +   K  Y E+     + H N++             ++  F  +
Sbjct: 40  GAKVAIKKLYRP-FQSELFAKRAYRELRLLKHMKHENVIG------------LLDVFTPD 86

Query: 306 GPLDRWLHH---IPRGGRSLDWAMRMK---------VATTLAQGIAFLHDKVKPHVVHRD 353
             LDR+      +P  G  L   M+ +         +   + +G+ ++H      ++HRD
Sbjct: 87  LSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRD 143

Query: 354 IRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG--TYGYLAPEFVYR-NELTTK 410
           ++  N+ ++E+    ++  GL++       Q  + M G   T  Y APE +      T  
Sbjct: 144 LKPGNLAVNEDCELKILDFGLAR-------QTDSEMTGYVVTRWYRAPEVILNWMHYTQT 196

Query: 411 SDVYSFGVLLLEIVSGR 427
            D++S G ++ E+++G+
Sbjct: 197 VDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 42.7 bits (101), Expect = 3e-04
 Identities = 46/196 (23%), Positives = 81/196 (41%), Gaps = 39/196 (19%)

Query: 249 GSRVAVKR--LKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR-YIVYEFVVN 305
           G  VA+K+  L+R       +   EI       HP +V +    + HG    +V E++ +
Sbjct: 25  GETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV-FPHGSGFVLVMEYMPS 83

Query: 306 GPLDRWLHHIPRG-----GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
             L   L    R       +S    MRM     L +G+A++H      ++HRD++ +N+L
Sbjct: 84  D-LSEVLRDEERPLPEAQVKSY---MRM-----LLKGVAYMHAN---GIMHRDLKPANLL 131

Query: 361 LDE-------EFG-AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY-RNELTTKS 411
           +         +FG A L      +    +V          T  Y APE +Y   +     
Sbjct: 132 ISADGVLKIADFGLARLFSEEEPRLYSHQV---------ATRWYRAPELLYGARKYDPGV 182

Query: 412 DVYSFGVLLLEIVSGR 427
           D+++ G +  E+++G 
Sbjct: 183 DLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 42.1 bits (100), Expect = 3e-04
 Identities = 46/195 (23%), Positives = 89/195 (45%), Gaps = 38/195 (19%)

Query: 249 GSRVAVKRLKRSSFQRKKEFYS--------EIGRFARL-HHPNLVAVKGCCYDHGDRYIV 299
           G  VA+K++K       K+FYS        E+    +L  HPN+V +K    ++ + Y V
Sbjct: 24  GELVAIKKMK-------KKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFV 76

Query: 300 YEFVVNGPLDRWLHHI--PRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 357
           +E+     ++  L+ +   R G+    ++   +   + QG+A +H   K    HRD++  
Sbjct: 77  FEY-----MEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPE 128

Query: 358 NVLLDEEFGAHLMGVGLSKFVPWEVMQERT----VMAGGTYGYLAPEFVYRNEL-TTKSD 412
           N+L+       +   GL++    E+         V    T  Y APE + R+   ++  D
Sbjct: 129 NLLVSGPEVVKIADFGLAR----EIRSRPPYTDYV---STRWYRAPEILLRSTSYSSPVD 181

Query: 413 VYSFGVLLLEIVSGR 427
           +++ G ++ E+ + R
Sbjct: 182 IWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 42.0 bits (99), Expect = 4e-04
 Identities = 57/226 (25%), Positives = 104/226 (46%), Gaps = 37/226 (16%)

Query: 218 ELRSITKNFSEGNRLLGDSKTGGTYSGI------LPDGSRVAVKRLKRSSFQRKKEFYS- 270
             RS+T  F + NR+ G+    GTY GI         G  VA+K+++      +++    
Sbjct: 2   RCRSVT-EFEKLNRI-GE----GTY-GIVYRARDTTSGEIVALKKVR---MDNERDGIPI 51

Query: 271 ----EIGRFARLHHPNLVAVKGCCY-DHGDR-YIVYEFVVNGPLDRWLHHIPRGGRSLDW 324
               EI     L HPN+V +K      H D  ++V E+     L   L ++P        
Sbjct: 52  SSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYC-EQDLASLLDNMPT---PFSE 107

Query: 325 AMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEV 382
           +    +   L +G+ +LH+     ++HRD++ SN+LL ++    +   GL++   +P + 
Sbjct: 108 SQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP 164

Query: 383 MQERTVMAGGTYGYLAPEFVYRNELTTKS-DVYSFGVLLLEIVSGR 427
           M  + V    T  Y APE +      T + D+++ G +L E+++ +
Sbjct: 165 MTPKVV----TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 42.1 bits (99), Expect = 5e-04
 Identities = 45/156 (28%), Positives = 73/156 (46%), Gaps = 15/156 (9%)

Query: 280 HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSL-DWAMRMKVATTLAQGI 338
           HP +V +       G  Y++ E++  G L     H+ R G  + D A       +LA  +
Sbjct: 59  HPFIVDLIYAFQTGGKLYLILEYLSGGEL---FMHLEREGIFMEDTACFYLSEISLA--L 113

Query: 339 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGY 396
             LH   +  +++RD++  N+LLD +    L   GL K    E + E TV     GT  Y
Sbjct: 114 EHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCK----ESIHEGTVTHTFCGTIEY 166

Query: 397 LAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQA 432
           +APE + R+      D +S G L+ ++++G  P  A
Sbjct: 167 MAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTA 202

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 41.9 bits (99), Expect = 5e-04
 Identities = 44/191 (23%), Positives = 85/191 (44%), Gaps = 29/191 (15%)

Query: 249 GSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIV 299
           G +VA+K+L R  FQ     K  Y E+     + H N++ +           D  D Y+V
Sbjct: 40  GRKVAIKKLSRP-FQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLV 98

Query: 300 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNV 359
              +        L++I +  +  D  ++  V   L +G+ ++H      ++HRD++ SN+
Sbjct: 99  THLM-----GADLNNIVKCQKLSDDHIQFLVYQIL-RGLKYIH---SAGIIHRDLKPSNI 149

Query: 360 LLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVY-RNELTTKSDVYSF 416
            ++E+    ++  GL++            M G   T  Y APE +          D++S 
Sbjct: 150 AVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 202

Query: 417 GVLLLEIVSGR 427
           G ++ E+++G+
Sbjct: 203 GCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 41.9 bits (98), Expect = 5e-04
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)

Query: 249 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAV------KGCCYDHGDRYIVY 300
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 42  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 101

Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
                  +   L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 102 HL-----MGADLNNIVKCQKLTDDHVQFLIYQIL-RGLKYIHSA---DIIHRDLKPSNLA 152

Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 417
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 153 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 205

Query: 418 VLLLEIVSGR 427
            ++ E+++GR
Sbjct: 206 CIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|153058 cd03588, CLECT_CSPGs, C-type lectin-like domain (CTLD) of the type found in chondroitin sulfate proteoglycan core proteins

 Score = 39.5 bits (92), Expect = 6e-04
 Identities = 20/81 (24%), Positives = 41/81 (50%), Gaps = 9/81 (11%)

Query: 9  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 68
          C   W  ++ +  C+ +  +  +W+++E  C+E  GHL+++ + EE    Q+    N   
Sbjct: 1  CEEGW--DKFQGHCYRHFPDRETWEDAERRCREQQGHLSSIVTPEE----QEFVNNNAQD 54

Query: 69 C-WVGGRSINTTVGLSWKWSD 88
            W+G    + T+   ++WSD
Sbjct: 55 YQWIGLN--DRTIEGDFRWSD 73

CLECT_CSPGs: C-type lectin-like domain (CTLD) of the type found in chondroitin sulfate proteoglycan core proteins (CSPGs) in human and chicken aggrecan, frog brevican, and zebra fish dermacan. CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. In cartilage, aggrecan forms cartilage link protein stabilized aggregates with hyaluronan (HA). These aggregates contribute to the tissue's load bearing properties. Aggregates having other CSPGs substituting for aggrecan may contribute to the structural integrity of many different tissues. Xenopus brevican is expressed in the notochord and the brain during early embryogenesis. Zebra fish dermacan is expressed in dermal bones and may play a role in dermal bone development. CSPGs do contain LINK domain(s) which bind HA. These LINK domains are considered by one classification system to be a variety of CTLD, but are omitted from this hierarchical classification based on insignificant sequence similarity. Length = 124

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 41.0 bits (96), Expect = 6e-04
 Identities = 51/202 (25%), Positives = 83/202 (41%), Gaps = 39/202 (19%)

Query: 232 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHH-PNLVAVKGCC 290
           L+ D++T  T+           +K L++SS       YS        H  PN+V +    
Sbjct: 11  LVMDTRTQQTF----------ILKGLRKSSE------YSRERLTIIPHCVPNMVCLHKYI 54

Query: 291 YDHGDRYIVYEFVVNGPLDRWLH-----HIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 345
                 ++V +    G L  W H     +IP       WA  M VA      +  LH + 
Sbjct: 55  VSEDSVFLVLQHAEGGKL--WSHISKFLNIPEE-CVKRWAAEMVVA------LDALHRE- 104

Query: 346 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN 405
              +V RD+  +N+LLD+    H   + L+ F  W  +++          Y APE    +
Sbjct: 105 --GIVCRDLNPNNILLDDR--GH---IQLTYFSRWSEVEDSCDGEAVENMYCAPEVGGIS 157

Query: 406 ELTTKSDVYSFGVLLLEIVSGR 427
           E T   D +S G +L E+++G+
Sbjct: 158 EETEACDWWSLGAILFELLTGK 179

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|165024 PHA02642, PHA02642, C-type lectin-like protein; Provisional

 Score = 40.9 bits (95), Expect = 7e-04
 Identities = 26/94 (27%), Positives = 44/94 (46%), Gaps = 7/94 (7%)

Query: 9   CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 68
           CP  WI      KCF +  + ++W    T+C  +G  L  + + EE +  ++   K+ + 
Sbjct: 88  CPKGWI--GFGYKCFYFSEDSKNWTFGNTFCTSLGATLVKVETEEELNFLKRY--KDSSD 143

Query: 69  CWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGS 102
            W+G      +    WKW+DN S +N S    G+
Sbjct: 144 HWIGLN--RESSNHPWKWADN-SNYNASFVITGT 174

Length = 216

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 41.1 bits (96), Expect = 8e-04
 Identities = 39/161 (24%), Positives = 73/161 (45%), Gaps = 16/161 (9%)

Query: 271 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 330
           E+     L H N+V +    +      +V+E+     LD+ L        ++     +K+
Sbjct: 54  EVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY-----LDKDLKQYMDDCGNIMSMHNVKI 108

Query: 331 -ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGL--SKFVPWEVMQERT 387
               + +G+A+ H   +  V+HRD++  N+L++E     L   GL  +K VP +      
Sbjct: 109 FLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEV 165

Query: 388 VMAGGTYGYLAPEFVY-RNELTTKSDVYSFGVLLLEIVSGR 427
           V    T  Y  P+ +   +E +T+ D++  G +  E+ SGR
Sbjct: 166 V----TLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 40.9 bits (96), Expect = 0.001
 Identities = 55/203 (27%), Positives = 91/203 (44%), Gaps = 39/203 (19%)

Query: 251 RVAVKRLKRSSF----QRKKEFYS-EIGRFARLHHPNLVAVKGCCYDHGDRYI--VYEFV 303
           R A+K++ + +     Q ++ F   +I  FA   +P +V++  C ++   R++  V E+V
Sbjct: 28  RFAMKKINKQNLILRNQIQQVFVERDILTFA--ENPFVVSMF-CSFE-TKRHLCMVMEYV 83

Query: 304 VNGPLDRWLHHIPRGGRSLDWAMRMKVA-TTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 362
             G     L +I  G   +D A RM  A T LA  + +LH+     +VHRD++  N+L+ 
Sbjct: 84  EGGDCATLLKNI--GALPVDMA-RMYFAETVLA--LEYLHNY---GIVHRDLKPDNLLIT 135

Query: 363 EEFGAHLMGVGLSKFVPWEVMQERTVMAG----------------GTYGYLAPEFVYRNE 406
                 L   GLSK     +M   T +                  GT  Y+APE + R  
Sbjct: 136 SMGHIKLTDFGLSKI---GLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQG 192

Query: 407 LTTKSDVYSFGVLLLEIVSGRRP 429
                D ++ G++L E + G  P
Sbjct: 193 YGKPVDWWAMGIILYEFLVGCVP 215

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 40.8 bits (95), Expect = 0.001
 Identities = 34/114 (29%), Positives = 54/114 (47%), Gaps = 26/114 (22%)

Query: 334 LAQGIAFLHDKVKPHVVHRDIRASNVLLD-------EEFGAHLMGVGLSKFVPWEVMQER 386
           +A+ +  +H   + H VHRDI+  NVLLD        +FG+ L           ++ Q+ 
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCL-----------KMNQDG 156

Query: 387 TV---MAGGTYGYLAPEFVYRNE-----LTTKSDVYSFGVLLLEIVSGRRPAQA 432
           TV   +A GT  Y++PE +   E        + D +S GV + E++ G  P  A
Sbjct: 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 210

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 40/171 (23%), Positives = 79/171 (46%), Gaps = 23/171 (13%)

Query: 271 EIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVNGPLDRW----LHHIPRGGRSLDW 324
           EI     L HPN++A++     H DR  ++++++  +   D W     H   +  +    
Sbjct: 48  EIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH---DLWHIIKFHRASKANKKPMQ 104

Query: 325 AMRMKVATTLAQ---GIAFLHDKVKPHVVHRDIRASNVLL----DEEFGAHLMGVGLSKF 377
             R  V + L Q   GI +LH      V+HRD++ +N+L+     E     +  +G ++ 
Sbjct: 105 LPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161

Query: 378 V--PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKS-DVYSFGVLLLEIVS 425
              P + + +   +   T+ Y APE +      TK+ D+++ G +  E+++
Sbjct: 162 FNSPLKPLADLDPVV-VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 40.0 bits (93), Expect = 0.002
 Identities = 37/161 (22%), Positives = 72/161 (44%), Gaps = 16/161 (9%)

Query: 271 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWL-HHIPRGGRSLDWAMRMK 329
           E+     L H N+V +    +      +V+E+     LD+ L  ++   G S++      
Sbjct: 54  EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY-----LDKDLKQYLDDCGNSINMHNVKL 108

Query: 330 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGL--SKFVPWEVMQERT 387
               L +G+ + H   +  V+HRD++  N+L++E     L   GL  +K +P +      
Sbjct: 109 FLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEV 165

Query: 388 VMAGGTYGYLAPEFVY-RNELTTKSDVYSFGVLLLEIVSGR 427
           V    T  Y  P+ +    + +T+ D++  G +  E+ +GR
Sbjct: 166 V----TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 40.1 bits (94), Expect = 0.002
 Identities = 51/196 (26%), Positives = 86/196 (43%), Gaps = 27/196 (13%)

Query: 248 DGSRVAVKRLKRSSFQRK---KEFYSEIG--RFARLHHPNLVAVKGCCYDHGDRYIVYEF 302
           +   VA+K++    F +K   K    E+   R  R  H N+     C YD     IV+  
Sbjct: 26  EEETVAIKKITNV-FSKKILAKRALRELKLLRHFR-GHKNIT----CLYDMD---IVFPG 76

Query: 303 VVNG------PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRA 356
             N        ++  LH I R G+ L  A        +  G+ ++H     +V+HRD++ 
Sbjct: 77  NFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKP 133

Query: 357 SNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKS-DV 413
            N+L++ +    +   GL++       +    M     T  Y APE +   +  TK+ DV
Sbjct: 134 GNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDV 193

Query: 414 YSFGVLLLEIVSGRRP 429
           +S G +L E++ GR+P
Sbjct: 194 WSVGCILAELL-GRKP 208

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 40.2 bits (94), Expect = 0.002
 Identities = 45/185 (24%), Positives = 81/185 (43%), Gaps = 22/185 (11%)

Query: 249 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD-HGDRYIVYEFVVN 305
           G  VA+K++ +  S+    K  Y E+     L H N++++         D Y V E    
Sbjct: 35  GQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTEL--- 91

Query: 306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 365
             L   LH +      L+          + +G+ ++H      VVHRD++ SN+L++E  
Sbjct: 92  --LGTDLHRLLTSRP-LEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENC 145

Query: 366 GAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFGVLLLE 422
              +   GL++      +Q+   M G   T  Y APE +    +   + D++S G +  E
Sbjct: 146 DLKICDFGLAR------IQDPQ-MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAE 198

Query: 423 IVSGR 427
           ++ G+
Sbjct: 199 MLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 40.5 bits (94), Expect = 0.002
 Identities = 46/192 (23%), Positives = 80/192 (41%), Gaps = 28/192 (14%)

Query: 263 QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVNGPLDRWLHHIPRGGR 320
           + K +   E+     L H N+V       +  ++  YI+ EF   G L R +    +   
Sbjct: 54  REKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFG 113

Query: 321 SLDWAMRMKVATTLAQGIAFLHD-KVKPH---VVHRDIRASNVLLD---EEFG------- 366
            ++    + +   L   +A+ H+ K  P+   V+HRD++  N+ L       G       
Sbjct: 114 KIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQAN 173

Query: 367 -------AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELT--TKSDVYSFG 417
                  A +   GLSK +  E M    V   GT  Y +PE +     +   KSD+++ G
Sbjct: 174 NLNGRPIAKIGDFGLSKNIGIESMAHSCV---GTPYYWSPELLLHETKSYDDKSDMWALG 230

Query: 418 VLLLEIVSGRRP 429
            ++ E+ SG+ P
Sbjct: 231 CIIYELCSGKTP 242

Length = 1021

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 39.3 bits (92), Expect = 0.003
 Identities = 45/182 (24%), Positives = 78/182 (42%), Gaps = 14/182 (7%)

Query: 249 GSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 306
           G  VA+K+   S      KK    EI    +L HPNLV +          ++V+E+  + 
Sbjct: 26  GQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHT 85

Query: 307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 366
            L+    + PRG   +   +  K+     Q + F H   K + +HRD++  N+L+ ++  
Sbjct: 86  VLNELEKN-PRG---VPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQ 138

Query: 367 AHLMGVGLSKFV-PWEVMQERTVMAGGTYGYLAPEF-VYRNELTTKSDVYSFGVLLLEIV 424
             L   G ++ +          V    T  Y APE  V   +     DV++ G +  E++
Sbjct: 139 IKLCDFGFARILTGPGDDYTDYV---ATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELL 195

Query: 425 SG 426
           +G
Sbjct: 196 TG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 39.3 bits (91), Expect = 0.004
 Identities = 39/171 (22%), Positives = 79/171 (46%), Gaps = 23/171 (13%)

Query: 271 EIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVNGPLDRW----LHHIPRGGRSLDW 324
           EI     L HPN+++++     H DR  ++++++  +   D W     H   +  +    
Sbjct: 48  EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH---DLWHIIKFHRASKANKKPVQ 104

Query: 325 AMRMKVATTLAQ---GIAFLHDKVKPHVVHRDIRASNVLL----DEEFGAHLMGVGLSKF 377
             R  V + L Q   GI +LH      V+HRD++ +N+L+     E     +  +G ++ 
Sbjct: 105 LPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161

Query: 378 V--PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKS-DVYSFGVLLLEIVS 425
              P + + +   +   T+ Y APE +      TK+ D+++ G +  E+++
Sbjct: 162 FNSPLKPLADLDPVV-VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 38.8 bits (90), Expect = 0.004
 Identities = 39/161 (24%), Positives = 72/161 (44%), Gaps = 16/161 (9%)

Query: 271 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 330
           E+     L H N+V +    +      +V+E+     LD  L        +L     +K+
Sbjct: 53  EVSLLKNLKHANIVTLHDIIHTERCLTLVFEY-----LDSDLKQYLDNCGNLMSMHNVKI 107

Query: 331 AT-TLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGL--SKFVPWEVMQERT 387
               L +G+++ H +    ++HRD++  N+L++E+    L   GL  +K VP +      
Sbjct: 108 FMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEV 164

Query: 388 VMAGGTYGYLAPEFVY-RNELTTKSDVYSFGVLLLEIVSGR 427
           V    T  Y  P+ +    E +T  D++  G +L E+ +GR
Sbjct: 165 V----TLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 39.3 bits (91), Expect = 0.004
 Identities = 51/231 (22%), Positives = 99/231 (42%), Gaps = 28/231 (12%)

Query: 252 VAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAV------KGCCYDHGDRYIVYEF 302
           VA+K+L R  FQ +   K  Y E+     ++H N++++      +    +  D Y+V E 
Sbjct: 45  VAIKKLSRP-FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMEL 103

Query: 303 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 362
                +D  L  + +    LD      +   +  GI  LH      ++HRD++ SN+++ 
Sbjct: 104 -----MDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVK 153

Query: 363 EEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLE 422
            +    ++  GL++      M    V+   T  Y APE +         D++S G ++ E
Sbjct: 154 SDCTLKILDFGLARTAGTSFMMTPYVV---TRYYRAPEVILGMGYKENVDIWSVGCIMGE 210

Query: 423 IVSGRRPAQAVDSV-CWQSIFE-WATPLVQSHRYLELLDPLISSLSSDIPE 471
           +V  +      D +  W  + E   TP  +   +++ L P + +   + P+
Sbjct: 211 MVRHKILFPGRDYIDQWNKVIEQLGTPCPE---FMKKLQPTVRNYVENRPK 258

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 39.0 bits (91), Expect = 0.004
 Identities = 54/240 (22%), Positives = 91/240 (37%), Gaps = 47/240 (19%)

Query: 253 AVKRLKRSSF--QRKKEFYSEIGR-FARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 309
           A+K +K+S    Q    F+ E     +  + P +  ++    D  + Y+V E+   G L 
Sbjct: 30  AMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDL- 88

Query: 310 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE------ 363
             L  + R     D  M       LA+ +  +H   +   VHRDI+  NVL+D       
Sbjct: 89  --LSLLNRYEDQFDEDM---AQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKL 143

Query: 364 -EFGA-----------HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKS 411
            +FG+             + VG   ++  EV+        GTYG              + 
Sbjct: 144 ADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYG-------------VEC 190

Query: 412 DVYSFGVLLLEIVSGRRPAQAVDSV-------CWQSIFEWATPLVQSHRYLELLDPLISS 464
           D +S GV+  E++ GR P     S         +Q   ++      S  +L+L+  L+  
Sbjct: 191 DWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLCG 250

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	513
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.97
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.97
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.97
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.97
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.96
KOG1152	772	consensus Signal transduction serine/threonine kin	99.96
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.96
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.96
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.96
cd03599	153	CLECT_DGCR2_like C-type lectin-like domain (CTLD)	99.96
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.95
cd03588	124	CLECT_CSPGs C-type lectin-like domain (CTLD) of th	99.95
PLN00181	793	protein SPA1-RELATED; Provisional	99.94
cd03597	129	CLECT_attractin_like C-type lectin-like domain (CT	99.94
cd03589	137	CLECT_CEL-1_like C-type lectin-like domain (CTLD)	99.94
cd03596	129	CLECT_tetranectin_like C-type lectin-like domain (	99.94
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.94
cd03590	126	CLECT_DC-SIGN_like C-type lectin-like domain (CTLD	99.93
PHA02642	216	C-type lectin-like protein; Provisional	99.93
cd03594	129	CLECT_REG-1_like C-type lectin-like domain (CTLD)	99.93
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.93
cd03593	116	CLECT_NK_receptors_like C-type lectin-like domain	99.93
cd03598	117	CLECT_EMBP_like C-type lectin-like domain (CTLD) o	99.91
PHA02953	170	IEV and EEV membrane glycoprotein; Provisional	99.91
cd03591	114	CLECT_collectin_like C-type lectin-like domain (CT	99.91
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.91
PRK09188	365	serine/threonine protein kinase; Provisional	99.91
cd03603	118	CLECT_VCBS A bacterial subgroup of the C-type lect	99.9
cd03601	119	CLECT_TC14_like C-type lectin-like domain (CTLD) o	99.9
PHA03097	157	C-type lectin-like protein; Provisional	99.9
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.9
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.9
cd03592	115	CLECT_selectins_like C-type lectin-like domain (CT	99.9
TIGR00864	2740	PCC polycystin cation channel protein. Note: this	99.89
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.89
smart00034	126	CLECT C-type lectin (CTL) or carbohydrate-recognit	99.88
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.88
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.88
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.88
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.88
cd03602	108	CLECT_1 C-type lectin (CTL)/C-type lectin-like (CT	99.87
cd03595	149	CLECT_chondrolectin_like C-type lectin-like domain	99.87
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.86
cd03600	141	CLECT_thrombomodulin_like C-type lectin-like domai	99.86
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.85
PHA02867	167	C-type lectin protein; Provisional	99.85
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.84
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.84
PRK12274	218	serine/threonine protein kinase; Provisional	99.84
PRK10345	210	hypothetical protein; Provisional	99.83
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.81
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.81
smart00090	237	RIO RIO-like kinase.	99.78
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.78
PRK14879	211	serine/threonine protein kinase; Provisional	99.77
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.75
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.73
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.73
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.72
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.68
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.68
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.65
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.64
cd00037	116	CLECT C-type lectin (CTL)/C-type lectin-like (CTLD	99.64
PHA02911	213	C-type lectin-like protein; Provisional	99.6
PF00059	105	Lectin_C: Lectin C-type domain; InterPro: IPR00130	99.57
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.56
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.53
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.48
KOG1243	690	consensus Protein kinase [General function predict	99.45
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.42
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.38
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.36
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.24
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.23
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.23
KOG3087	229	consensus Serine/threonine protein kinase [General	99.21
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.13
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.11
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.07
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.06
COG4248	637	Uncharacterized protein with protein kinase and he	98.98
PF05473	200	Herpes_UL45: UL45 protein; InterPro: IPR008646 Thi	98.92
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.83
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.81
PRK09902	216	hypothetical protein; Provisional	98.77
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.76
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.7
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.54
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.43
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.42
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.33
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.29
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.28
PF01636	239	APH: Phosphotransferase enzyme family This family	98.28
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.2
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.11
PLN02876	822	acyl-CoA dehydrogenase	98.1
PRK10593	297	hypothetical protein; Provisional	98.1
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.07
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.98
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.95
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.81
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.8
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.8
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.75
PRK05231	319	homoserine kinase; Provisional	97.68

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-54  Score=427.06  Aligned_cols=291  Identities=43%  Similarity=0.748  Sum_probs=252.3

Q ss_pred             CccccCHHHHHHHhhCcccCCceecccCceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeE
Q 010309          210 SWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGC  289 (513)
Q Consensus       210 ~~~~~~~~~l~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~  289 (513)
                      ..+.|+++|+..+|++|...+ +||+|+||.||+|.+++|+.||||++.........+|.+|+.++.+++|||+|+|+|+
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~-~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy  139 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESN-LIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY  139 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhc-ceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence            577899999999999999876 4599999999999999999999998877643315569999999999999999999999


Q ss_pred             EeeCCc-eEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeE
Q 010309          290 CYDHGD-RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH  368 (513)
Q Consensus       290 ~~~~~~-~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~k  368 (513)
                      |.+.+. .+||+|||++|+|.++|......  .++|..+++|+.++|+||+|||+.+.+.||||||||+|||||+++++|
T Consensus       140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK  217 (361)
T KOG1187|consen  140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK  217 (361)
T ss_pred             EecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence            999994 99999999999999999863322  899999999999999999999999888999999999999999999999


Q ss_pred             EecccccccCCc-cccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhH
Q 010309          369 LMGVGLSKFVPW-EVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATP  447 (513)
Q Consensus       369 l~Dfg~~~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  447 (513)
                      |+|||+|+.... ........  .||.+|+|||++..+..+.|+|||||||+|+||+||+.|.+.........+.+|+.+
T Consensus       218 lsDFGLa~~~~~~~~~~~~~~--~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~  295 (361)
T KOG1187|consen  218 LSDFGLAKLGPEGDTSVSTTV--MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKP  295 (361)
T ss_pred             ccCccCcccCCccccceeeec--CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHH
Confidence            999999976654 22111110  499999999999999999999999999999999999998876554445568999999


Q ss_pred             HhhcccccccccccccCCCCCCCc-HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcC
Q 010309          448 LVQSHRYLELLDPLISSLSSDIPE-AGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  508 (513)
Q Consensus       448 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  508 (513)
                      .....++.+++|+.+..   .... ......+..+..+|++.+|.+||+|.+|++.|+.+..
T Consensus       296 ~~~~~~~~eiiD~~l~~---~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  296 LLEEGKLREIVDPRLKE---GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS  354 (361)
T ss_pred             HHHCcchhheeCCCccC---CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence            99999999999998853   2222 2567779999999999999999999999999976553

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-50  Score=375.64  Aligned_cols=246  Identities=25%  Similarity=0.438  Sum_probs=207.5

Q ss_pred             ceecccCceEEEEEEeC-CCCEEEEEEeccc-chhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCc-eEEEEeeccCCC
Q 010309          231 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD-RYIVYEFVVNGP  307 (513)
Q Consensus       231 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-~~lv~e~~~~gs  307 (513)
                      ..||+|..|+||++.++ +++.+|+|++... .....+++.+|+++++..+||+||++||.|...+. ..|+||||++|+
T Consensus        85 ~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGS  164 (364)
T KOG0581|consen   85 GVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGS  164 (364)
T ss_pred             hhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCC
Confidence            35799999999999975 6889999999544 34556889999999999999999999999999995 999999999999


Q ss_pred             HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccc
Q 010309          308 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD-KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  386 (513)
Q Consensus       308 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  386 (513)
                      |++++..    .+.+++...-+|+.+|++||.|||+ .   +||||||||+|||++..|.+||+|||.+..+....    
T Consensus       165 Ld~~~k~----~g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS~----  233 (364)
T KOG0581|consen  165 LDDILKR----VGRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNSI----  233 (364)
T ss_pred             HHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhhhh----
Confidence            9999964    3669999999999999999999996 6   99999999999999999999999999999876552    


Q ss_pred             eeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCC
Q 010309          387 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  466 (513)
Q Consensus       387 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  466 (513)
                      .....||..|||||.+.+..|+.++||||||++++|+.+|+.||....+. ...             ..+++..+..+.+
T Consensus       234 a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~-~~~-------------~~~Ll~~Iv~~pp  299 (364)
T KOG0581|consen  234 ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP-YLD-------------IFELLCAIVDEPP  299 (364)
T ss_pred             cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCC-CCC-------------HHHHHHHHhcCCC
Confidence            22334999999999999999999999999999999999999999764111 111             1122233333333


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          467 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       467 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      +..|...+++++.+|+..||++||.+|||+.|+++
T Consensus       300 P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  300 PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            44444458899999999999999999999999986

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.9e-49  Score=392.24  Aligned_cols=247  Identities=23%  Similarity=0.379  Sum_probs=212.3

Q ss_pred             CcccCCceecccCceEEEEEEe-CCCCEEEEEEecccc---hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEE
Q 010309          225 NFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY  300 (513)
Q Consensus       225 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  300 (513)
                      ..++..++||+|+|+.+|.++. ..|+.||+|++.+..   ....+.+.+|+++.++|+|||||+++++|++.++.|||+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            4567788999999999999997 789999999998752   344678999999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCc
Q 010309          301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW  380 (513)
Q Consensus       301 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~  380 (513)
                      |+|+.++|..+++    .++.+++.+++.+++||+.||.|||+.   +|+|||||..|+||+++.++||+|||+|..+..
T Consensus        98 ELC~~~sL~el~K----rrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~  170 (592)
T KOG0575|consen   98 ELCHRGSLMELLK----RRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY  170 (592)
T ss_pred             EecCCccHHHHHH----hcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence            9999999999985    357899999999999999999999999   999999999999999999999999999998865


Q ss_pred             cccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccc
Q 010309          381 EVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP  460 (513)
Q Consensus       381 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  460 (513)
                      +..  .....+|||.|+|||++....++..+||||+||++|.||+|++||+..+-.+   ...   . +...        
T Consensus       171 ~~E--rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke---ty~---~-Ik~~--------  233 (592)
T KOG0575|consen  171 DGE--RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE---TYN---K-IKLN--------  233 (592)
T ss_pred             ccc--ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH---HHH---H-HHhc--------
Confidence            432  3344569999999999999999999999999999999999999998653211   111   0 0000        


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          461 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       461 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                            .-..+...+.+..+||.++|+.||.+|||+++|+.
T Consensus       234 ------~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  234 ------EYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             ------CcccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                  11223356778999999999999999999999986

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=6e-49  Score=386.60  Aligned_cols=251  Identities=30%  Similarity=0.518  Sum_probs=206.8

Q ss_pred             eecccCceEEEEEEeCCCCEEEEEEecccchhc--HHHHHHHHHHHhhcCCCcEeeeeeEEeeCC-ceEEEEeeccCCCH
Q 010309          232 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQR--KKEFYSEIGRFARLHHPNLVAVKGCCYDHG-DRYIVYEFVVNGPL  308 (513)
Q Consensus       232 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-~~~lv~e~~~~gsL  308 (513)
                      .||.|+||+||+|.+.....||||++.......  .++|.+|+.+|.+++|||||+++|++.+.. ..+|||||+++|+|
T Consensus        48 ~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL  127 (362)
T KOG0192|consen   48 VLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSL  127 (362)
T ss_pred             hcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcH
Confidence            379999999999999444449999998654332  568999999999999999999999999988 79999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-ceEcCCCCCceEecCCC-CeEEecccccccCCccccccc
Q 010309          309 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH-VVHRDIRASNVLLDEEF-GAHLMGVGLSKFVPWEVMQER  386 (513)
Q Consensus       309 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~-ivH~Dikp~NIll~~~~-~~kl~Dfg~~~~~~~~~~~~~  386 (513)
                      .++++..  ....+++..++.++.|||.||.|||++   + ||||||||+|||++.++ ++||+|||+++......  ..
T Consensus       128 ~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~~  200 (362)
T KOG0192|consen  128 SVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--TS  200 (362)
T ss_pred             HHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc--cc
Confidence            9999763  357899999999999999999999999   7 99999999999999997 99999999998765432  11


Q ss_pred             eeecCcccccccccccc--cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccC
Q 010309          387 TVMAGGTYGYLAPEFVY--RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS  464 (513)
Q Consensus       387 ~~~~~gt~~y~aPE~~~--~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  464 (513)
                      .....||+.|||||++.  ...|+.|+||||||++||||+||+.||......      ..+........     .     
T Consensus       201 ~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~------~~~~~v~~~~~-----R-----  264 (362)
T KOG0192|consen  201 MTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV------QVASAVVVGGL-----R-----  264 (362)
T ss_pred             ccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhcCC-----C-----
Confidence            11234999999999999  568999999999999999999999999886542      11111111111     1     


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcC
Q 010309          465 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  508 (513)
Q Consensus       465 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  508 (513)
                        +.. +..+++.+..||.+||+.||..||++.+++..|+.+..
T Consensus       265 --p~~-p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~  305 (362)
T KOG0192|consen  265 --PPI-PKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS  305 (362)
T ss_pred             --CCC-CccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence              111 22266779999999999999999999999999986643

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-49  Score=375.51  Aligned_cols=254  Identities=23%  Similarity=0.331  Sum_probs=207.6

Q ss_pred             HhhCcccCCceecccCceEEEEEEe-CCCCEEEEEEecccchh-------cHHHHHHHHHHHhhcCCCcEeeeeeEEeeC
Q 010309          222 ITKNFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQ-------RKKEFYSEIGRFARLHHPNLVAVKGCCYDH  293 (513)
Q Consensus       222 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  293 (513)
                      ..++++...+.||+|+||.|-+|.. ++|+.||||++++....       ....+.+|+++|++|+|||||++++++...
T Consensus       169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~  248 (475)
T KOG0615|consen  169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP  248 (475)
T ss_pred             hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence            3677888888999999999999985 46999999999865322       223467999999999999999999999999


Q ss_pred             CceEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCC---CCeEEe
Q 010309          294 GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE---FGAHLM  370 (513)
Q Consensus       294 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~---~~~kl~  370 (513)
                      +..||||||++||+|.+++-.    .+.+.+..-..+++|++.|+.|||++   ||+||||||+|||+..+   ..+||+
T Consensus       249 ds~YmVlE~v~GGeLfd~vv~----nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKIt  321 (475)
T KOG0615|consen  249 DSSYMVLEYVEGGELFDKVVA----NKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKIT  321 (475)
T ss_pred             CceEEEEEEecCccHHHHHHh----ccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEec
Confidence            999999999999999999854    45688888899999999999999999   99999999999999766   779999


Q ss_pred             cccccccCCccccccceeecCcccccccccccccCCC---CchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhH
Q 010309          371 GVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL---TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATP  447 (513)
Q Consensus       371 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  447 (513)
                      |||+|+....   .......+||+.|.|||++.+..+   ..+.|+||+||+||-+++|.+||+......  .+.+    
T Consensus       322 DFGlAK~~g~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl~e----  392 (475)
T KOG0615|consen  322 DFGLAKVSGE---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SLKE----  392 (475)
T ss_pred             ccchhhcccc---ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cHHH----
Confidence            9999998752   233445679999999999987543   348899999999999999999998754431  1111    


Q ss_pred             HhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          448 LVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       448 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      .+..+++..          .......++++..+||.+||..||++|||++|+|+
T Consensus       393 QI~~G~y~f----------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  393 QILKGRYAF----------GPLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             HHhcCcccc----------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence            111111110          11224578899999999999999999999999986

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-49  Score=386.51  Aligned_cols=251  Identities=28%  Similarity=0.464  Sum_probs=214.1

Q ss_pred             eecccCceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCCHHHH
Q 010309          232 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRW  311 (513)
Q Consensus       232 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~  311 (513)
                      -||+|.||.||.|.++....||+|.++... ...+.|.+|+++|++|+|+|||+++++|..++.+|||||||+.|+|.++
T Consensus       213 ~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~y  291 (468)
T KOG0197|consen  213 ELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDY  291 (468)
T ss_pred             HhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHH
Confidence            479999999999999777799999998763 4557888999999999999999999999999999999999999999999


Q ss_pred             hccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccceeecC
Q 010309          312 LHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG  391 (513)
Q Consensus       312 l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  391 (513)
                      |+.  ..+..+...+.+.++.|||+||+||+++   ++|||||.++||||+++..+||+|||+|+....+....... ..
T Consensus       292 Lr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~-~k  365 (468)
T KOG0197|consen  292 LRT--REGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEG-GK  365 (468)
T ss_pred             hhh--cCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCceeecCC-CC
Confidence            986  4567799999999999999999999999   99999999999999999999999999999655444333222 22


Q ss_pred             cccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCCCCC
Q 010309          392 GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIP  470 (513)
Q Consensus       392 gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  470 (513)
                      -+..|.|||.+..+.++.|||||||||+||||+| |+.||...+..+....++      ..              ..-..
T Consensus       366 fPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le------~G--------------yRlp~  425 (468)
T KOG0197|consen  366 FPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLE------RG--------------YRLPR  425 (468)
T ss_pred             CCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHh------cc--------------CcCCC
Confidence            5678999999999999999999999999999999 999988776532211111      11              12223


Q ss_pred             cHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcCC
Q 010309          471 EAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP  509 (513)
Q Consensus       471 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  509 (513)
                      +..+++++.++|..||+.+|++|||++.+...|+.+...
T Consensus       426 P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~  464 (468)
T KOG0197|consen  426 PEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS  464 (468)
T ss_pred             CCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence            445788999999999999999999999999999887654

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.2e-50  Score=359.15  Aligned_cols=252  Identities=24%  Similarity=0.371  Sum_probs=210.2

Q ss_pred             eecccCceEEEEEE-eCCCCEEEEEEeccc--chhcHHHHHHHHHHHhhcCCCcEeeeee-EEeeCCc-eEEEEeeccCC
Q 010309          232 LLGDSKTGGTYSGI-LPDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKG-CCYDHGD-RYIVYEFVVNG  306 (513)
Q Consensus       232 ~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~-~~~~~~~-~~lv~e~~~~g  306 (513)
                      .||.|+||+||++. ..+|..||.|.++..  +....+++..|+.+|++|+|||||++++ .+.+++. .+||||+|.+|
T Consensus        26 ~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~G  105 (375)
T KOG0591|consen   26 KIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAG  105 (375)
T ss_pred             HHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhccc
Confidence            56999999999998 468999999999855  3445678999999999999999999999 4555555 89999999999


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CceEcCCCCCceEecCCCCeEEecccccccCCcccccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKP-HVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  385 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~-~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  385 (513)
                      +|...++...+.++.+++..+++++.|++.||.++|+.... -|+||||||.||+|+.+|.+||+|||+++.+.......
T Consensus       106 DLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~tfA  185 (375)
T KOG0591|consen  106 DLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKTTFA  185 (375)
T ss_pred             CHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcchhHHH
Confidence            99999998888889999999999999999999999994211 38999999999999999999999999999987654333


Q ss_pred             ceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCC
Q 010309          386 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  465 (513)
Q Consensus       386 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  465 (513)
                      .  ...|||.||+||.+.+.+|+.||||||+||++|||..-.+||.+.+-      .+....             +-++.
T Consensus       186 ~--S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~------~~L~~K-------------I~qgd  244 (375)
T KOG0591|consen  186 H--SLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL------LSLCKK-------------IEQGD  244 (375)
T ss_pred             H--hhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccH------HHHHHH-------------HHcCC
Confidence            2  23399999999999999999999999999999999999999987531      111111             11111


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 010309          466 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ  504 (513)
Q Consensus       466 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  504 (513)
                      .+..|...++.++..||..|+..||+.||+...++..+.
T Consensus       245 ~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~  283 (375)
T KOG0591|consen  245 YPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ  283 (375)
T ss_pred             CCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence            233455778999999999999999999999666665554

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-48  Score=366.07  Aligned_cols=201  Identities=26%  Similarity=0.472  Sum_probs=178.3

Q ss_pred             CcccCCceecccCceEEEEEEeC-CCCEEEEEEeccc--chhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEe
Q 010309          225 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE  301 (513)
Q Consensus       225 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  301 (513)
                      +|....+ ||.|+||+||+|+++ ++..||||.+.+.  ..+..+.+..|+.+|+.++|||||.+++++..++..|||||
T Consensus        11 ~y~~~~~-iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME   89 (429)
T KOG0595|consen   11 DYELSRE-IGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME   89 (429)
T ss_pred             cceehhh-ccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence            4444444 699999999999975 5899999999877  44456778999999999999999999999999999999999


Q ss_pred             eccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCC------CCeEEeccccc
Q 010309          302 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE------FGAHLMGVGLS  375 (513)
Q Consensus       302 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~------~~~kl~Dfg~~  375 (513)
                      ||.||+|.+||+.    .+.+++..++.++.|||.||++||++   +||||||||+||||+..      -.+||+|||+|
T Consensus        90 yC~gGDLs~yi~~----~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA  162 (429)
T KOG0595|consen   90 YCNGGDLSDYIRR----RGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA  162 (429)
T ss_pred             eCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence            9999999999975    35799999999999999999999999   99999999999999764      45899999999


Q ss_pred             ccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcc
Q 010309          376 KFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSV  436 (513)
Q Consensus       376 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~  436 (513)
                      +.+.......   ..+|++.|||||++....|+.|+|+||+|+|||++++|+.||...+..
T Consensus       163 R~L~~~~~a~---tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~  220 (429)
T KOG0595|consen  163 RFLQPGSMAE---TLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPK  220 (429)
T ss_pred             hhCCchhHHH---HhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHH
Confidence            9987554433   345999999999999999999999999999999999999999876654

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.3e-47  Score=393.40  Aligned_cols=257  Identities=27%  Similarity=0.407  Sum_probs=214.0

Q ss_pred             CceecccCceEEEEEEeC------CCCEEEEEEecccchh-cHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEee
Q 010309          230 NRLLGDSKTGGTYSGILP------DGSRVAVKRLKRSSFQ-RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF  302 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  302 (513)
                      .+-||+|+||+||+|...      +...||||.++..... ..++|++|+++|..|+|||||+|+|+|.+++..++|+||
T Consensus       491 ~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEY  570 (774)
T KOG1026|consen  491 KEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEY  570 (774)
T ss_pred             hhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEe
Confidence            345799999999999953      3567999999987555 678999999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhccCCC------C----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecc
Q 010309          303 VVNGPLDRWLHHIPR------G----GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV  372 (513)
Q Consensus       303 ~~~gsL~~~l~~~~~------~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df  372 (513)
                      |..|||.+||.....      .    ..+++..+.+.|+.|||.||.||-++   .+|||||..+|+||.++..|||+||
T Consensus       571 m~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~VKIsDf  647 (774)
T KOG1026|consen  571 MDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVVKISDF  647 (774)
T ss_pred             cccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEEEeccc
Confidence            999999999964321      1    23488999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhc
Q 010309          373 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQS  451 (513)
Q Consensus       373 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  451 (513)
                      |+++..-..+........--.++|||||.++.+++|.+||||||||+|||++| |+.||.+....+.       ...+..
T Consensus       648 GLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV-------Ie~i~~  720 (774)
T KOG1026|consen  648 GLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV-------IECIRA  720 (774)
T ss_pred             ccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH-------HHHHHc
Confidence            99997655443332211114689999999999999999999999999999999 9999988765321       112222


Q ss_pred             ccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcCC
Q 010309          452 HRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP  509 (513)
Q Consensus       452 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  509 (513)
                      +++             -..+.+++.+++.||..||+.+|++||++.||-..|+...+.
T Consensus       721 g~l-------------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  721 GQL-------------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             CCc-------------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence            221             122445778899999999999999999999999999876543

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-46  Score=349.98  Aligned_cols=238  Identities=22%  Similarity=0.313  Sum_probs=199.5

Q ss_pred             cCCceecccCceEEEEEEeC-CCCEEEEEEecccch---hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeec
Q 010309          228 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  303 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  303 (513)
                      +.-++||+|+||.||.++.. +++.+|+|++++...   ...+....|..+|.+++||.||++...|++.+.+|||+||+
T Consensus        28 ~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~  107 (357)
T KOG0598|consen   28 EILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYL  107 (357)
T ss_pred             eeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEecc
Confidence            34567899999999999965 589999999987633   34567889999999999999999999999999999999999


Q ss_pred             cCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccc
Q 010309          304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM  383 (513)
Q Consensus       304 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~  383 (513)
                      .||.|..+|++    .+.+++..+.-++..|+.||.|||++   +||||||||+|||||.+|+++|+|||+++..-....
T Consensus       108 ~GGeLf~hL~~----eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~  180 (357)
T KOG0598|consen  108 NGGELFYHLQR----EGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD  180 (357)
T ss_pred             CCccHHHHHHh----cCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcccCCC
Confidence            99999999964    46799999999999999999999999   999999999999999999999999999986543322


Q ss_pred             ccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccccccccccc
Q 010309          384 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS  463 (513)
Q Consensus       384 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  463 (513)
                        .+...+||+.|||||++.+..|+..+|-||||+++|||++|.+||...+.....      ..... .+          
T Consensus       181 --~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~------~~I~~-~k----------  241 (357)
T KOG0598|consen  181 --ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMY------DKILK-GK----------  241 (357)
T ss_pred             --ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHH------HHHhc-Cc----------
Confidence              223356999999999999999999999999999999999999999876542111      11111 00          


Q ss_pred             CCCCCCCcHHHHHHHHHHHHHhcCCCCCCCC
Q 010309          464 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRP  494 (513)
Q Consensus       464 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP  494 (513)
                         ...++.-.+.+.++++.++|+.||++|.
T Consensus       242 ---~~~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  242 ---LPLPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             ---CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence               0112223566799999999999999996

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-47  Score=380.70  Aligned_cols=259  Identities=25%  Similarity=0.401  Sum_probs=219.6

Q ss_pred             ccCCceecccCceEEEEEEeCC----CCEEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEe
Q 010309          227 SEGNRLLGDSKTGGTYSGILPD----GSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE  301 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  301 (513)
                      ....++||.|.||.|++|+++-    ...||||.++... .+.+.+|+.|+.||.+++||||++|.|+.......+||+|
T Consensus       631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE  710 (996)
T KOG0196|consen  631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE  710 (996)
T ss_pred             eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence            3456889999999999999753    4579999998763 4456789999999999999999999999999999999999


Q ss_pred             eccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcc
Q 010309          302 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE  381 (513)
Q Consensus       302 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~  381 (513)
                      ||++|+|+.||+..   ...++..+...++++|+.||.||-++   ++|||||.++|||++.+..+|++|||+++.+..+
T Consensus       711 yMENGsLDsFLR~~---DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd  784 (996)
T KOG0196|consen  711 YMENGSLDSFLRQN---DGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  784 (996)
T ss_pred             hhhCCcHHHHHhhc---CCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecccC
Confidence            99999999999853   35699999999999999999999999   9999999999999999999999999999987655


Q ss_pred             ccccce-eecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhccccccccc
Q 010309          382 VMQERT-VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD  459 (513)
Q Consensus       382 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  459 (513)
                      .....+ ....-+.+|.|||.+...+++.+|||||||+++||.++ |..||.+++..+..+.++                
T Consensus       785 ~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe----------------  848 (996)
T KOG0196|consen  785 PEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE----------------  848 (996)
T ss_pred             CCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHH----------------
Confidence            422211 11113579999999999999999999999999999887 999998876532211111                


Q ss_pred             ccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcCCCC
Q 010309          460 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPV  511 (513)
Q Consensus       460 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~  511 (513)
                          ......++.+++..|.+||..||++|-.+||++.+|+..|+++...|.
T Consensus       849 ----~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~  896 (996)
T KOG0196|consen  849 ----QGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPN  896 (996)
T ss_pred             ----hccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCch
Confidence                111445677889999999999999999999999999999999877764

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-45  Score=355.94  Aligned_cols=244  Identities=22%  Similarity=0.324  Sum_probs=203.8

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccc---hhcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCCceEEEEeecc
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVV  304 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~  304 (513)
                      .++||+|+|++|++|+.. .++.||||++.+.-   ....+.+..|-.+|.+| .||.|++|+-.|.+...+|+|+||++
T Consensus        78 g~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~  157 (604)
T KOG0592|consen   78 GKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAP  157 (604)
T ss_pred             hheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecC
Confidence            457899999999999954 69999999997752   23345677888999999 89999999999999999999999999


Q ss_pred             CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccc
Q 010309          305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  384 (513)
Q Consensus       305 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  384 (513)
                      +|+|.++|.+    -+.+++...+.++.+|+.||+|||++   |||||||||+|||||.++++||+|||.|+.+......
T Consensus       158 nGdll~~i~K----~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~  230 (604)
T KOG0592|consen  158 NGDLLDLIKK----YGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKS  230 (604)
T ss_pred             CCcHHHHHHH----hCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCChhhcc
Confidence            9999999975    36799999999999999999999999   9999999999999999999999999999988644222


Q ss_pred             -----------cceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccc
Q 010309          385 -----------ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHR  453 (513)
Q Consensus       385 -----------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  453 (513)
                                 .......||..|.+||++.....++.+|||+||||||.|+.|.+||.+.++-.   ++..+..      
T Consensus       231 ~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl---iFqkI~~------  301 (604)
T KOG0592|consen  231 QENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL---IFQKIQA------  301 (604)
T ss_pred             ccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH---HHHHHHH------
Confidence                       11123459999999999999999999999999999999999999998766421   1111100      


Q ss_pred             ccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          454 YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       454 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                            -      .-..+.++++.+.+||.+.|..||.+|+|+++|.+
T Consensus       302 ------l------~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~  337 (604)
T KOG0592|consen  302 ------L------DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA  337 (604)
T ss_pred             ------h------cccCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence                  0      11122345577999999999999999999988865

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-45  Score=348.94  Aligned_cols=249  Identities=24%  Similarity=0.433  Sum_probs=198.5

Q ss_pred             CCceecccCceEEEEEEeCC-CCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCC--ceEEEEeeccC
Q 010309          229 GNRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG--DRYIVYEFVVN  305 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--~~~lv~e~~~~  305 (513)
                      ..+.||+|+||.||++...+ |...|||.+........+.+.+|+.+|.+|+|||||+++|......  .++++|||+++
T Consensus        21 ~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~  100 (313)
T KOG0198|consen   21 KGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPG  100 (313)
T ss_pred             hhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCC
Confidence            35578999999999999754 8999999997664333677999999999999999999999855544  58999999999


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecC-CCCeEEecccccccCCcc-cc
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE-EFGAHLMGVGLSKFVPWE-VM  383 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~-~~~~kl~Dfg~~~~~~~~-~~  383 (513)
                      |+|.+++...  ++ .+++..++.+.+||++||.|||++   +|+|+||||+|||++. ++.+||+|||++...... ..
T Consensus       101 GsL~~~~~~~--g~-~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~  174 (313)
T KOG0198|consen  101 GSLSDLIKRY--GG-KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTK  174 (313)
T ss_pred             CcHHHHHHHc--CC-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccccccc
Confidence            9999999752  22 699999999999999999999999   9999999999999999 799999999999877641 11


Q ss_pred             ccceeecCcccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCC-CccccchhHHhhhHHhhccccccccccc
Q 010309          384 QERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAV-DSVCWQSIFEWATPLVQSHRYLELLDPL  461 (513)
Q Consensus       384 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  461 (513)
                      ........||+.|||||++..+ ....++|||||||++.||+||++||... ..      .+.........        .
T Consensus       175 ~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~------~~~~~~ig~~~--------~  240 (313)
T KOG0198|consen  175 SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEE------AEALLLIGRED--------S  240 (313)
T ss_pred             ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcch------HHHHHHHhccC--------C
Confidence            1222234499999999999864 3345999999999999999999998763 11      01111100000        0


Q ss_pred             ccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010309          462 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  502 (513)
Q Consensus       462 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  502 (513)
                      .    +. .+...+++..+|+.+|+..||++||||+++|+.
T Consensus       241 ~----P~-ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~h  276 (313)
T KOG0198|consen  241 L----PE-IPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEH  276 (313)
T ss_pred             C----CC-CCcccCHHHHHHHHHHhhcCcccCcCHHHHhhC
Confidence            0    11 123367789999999999999999999999974

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.8e-45  Score=332.77  Aligned_cols=261  Identities=19%  Similarity=0.240  Sum_probs=199.6

Q ss_pred             eecccCceEEEEEEeC-CCCEEEEEEecccc--hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCCH
Q 010309          232 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  308 (513)
Q Consensus       232 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL  308 (513)
                      .+|+|+||.||+.+.+ +|+.||||++....  ..-.+-.++|+++|++|+|||+|.++++|......+||+|||+..-|
T Consensus         9 kvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhTvL   88 (396)
T KOG0593|consen    9 KVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHTVL   88 (396)
T ss_pred             ccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchHHH
Confidence            4599999999999976 49999999997653  23346678999999999999999999999999999999999977555


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccccee
Q 010309          309 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  388 (513)
Q Consensus       309 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  388 (513)
                      .+ |...   ...++...+.+++.|++.|+.|+|++   ++|||||||+||||+.++.+||+|||+|+.+.......+  
T Consensus        89 ~e-Le~~---p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YT--  159 (396)
T KOG0593|consen   89 HE-LERY---PNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYT--  159 (396)
T ss_pred             HH-HHhc---cCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCCcchhh--
Confidence            44 4432   35699999999999999999999999   999999999999999999999999999998874322222  


Q ss_pred             ecCccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHh--------hhHHhh-cccccccc
Q 010309          389 MAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEW--------ATPLVQ-SHRYLELL  458 (513)
Q Consensus       389 ~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~--------~~~~~~-~~~~~~~~  458 (513)
                      ....|..|.|||++.+ .+|+...||||+||++.||++|.+.|.+.++.+....+..        ...+.. ...+..+.
T Consensus       160 DYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~  239 (396)
T KOG0593|consen  160 DYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVR  239 (396)
T ss_pred             hhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeee
Confidence            1227999999999988 6899999999999999999999999988766432221111        111111 11111111


Q ss_pred             cccccCCCC-CCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          459 DPLISSLSS-DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       459 ~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      -|......+ ...-...+.-+.+|++.||+.||.+|++.++++.
T Consensus       240 lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  240 LPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             cCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            111100000 0001235567899999999999999999999875

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-44  Score=348.89  Aligned_cols=262  Identities=21%  Similarity=0.272  Sum_probs=203.7

Q ss_pred             ceecccCceEEEEEEe-CCCCEEEEEEecccc--hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeC--CceEEEEeeccC
Q 010309          231 RLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDRYIVYEFVVN  305 (513)
Q Consensus       231 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lv~e~~~~  305 (513)
                      +.||+|.||.||+|+. .+|+.||+|++....  ........+|+.+|++|+||||++|.+...+.  ..+|||+|||++
T Consensus       123 ~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh  202 (560)
T KOG0600|consen  123 EKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH  202 (560)
T ss_pred             HHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccc
Confidence            3569999999999995 579999999998764  33346678999999999999999999998877  689999999965


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccc
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  385 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  385 (513)
                       +|..++..   ..-.+++.++..++.||+.||+|+|++   +|+|||||.+|||||.+|.+||+|||+|+++.......
T Consensus       203 -DL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~  275 (560)
T KOG0600|consen  203 -DLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAP  275 (560)
T ss_pred             -hhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccCCCCcc
Confidence             89888863   346799999999999999999999999   99999999999999999999999999999876654333


Q ss_pred             ceeecCcccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccc-------cc
Q 010309          386 RTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL-------EL  457 (513)
Q Consensus       386 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~  457 (513)
                      .+ ...-|..|.|||++.+. .|+.+.|+||.||||.||++|++.|.+.++.+....+-....-.....+.       ..
T Consensus       276 ~T-~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~  354 (560)
T KOG0600|consen  276 YT-SRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATI  354 (560)
T ss_pred             cc-cceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccc
Confidence            22 22379999999999875 79999999999999999999999999987654332221111100111111       11


Q ss_pred             ccccccCCCC--CCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          458 LDPLISSLSS--DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       458 ~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      +.+... ...  ...-...+....+|+..+|..||.+|.|+.++|+
T Consensus       355 ~kp~~~-y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  355 FKPQQP-YKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             cCCCCc-ccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            111000 000  0001234567899999999999999999999985

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-44  Score=349.57  Aligned_cols=265  Identities=24%  Similarity=0.344  Sum_probs=214.0

Q ss_pred             CcccCCceecccCceEEEEEEeCCCCEEEEEEecccchhc-HHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeec
Q 010309          225 NFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQR-KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  303 (513)
Q Consensus       225 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  303 (513)
                      .-....+.||+|.||+|.+.....+.+||||.++...... ..+|.+|+++|.+|+||||+.++|+|..++.+++++|||
T Consensus       538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm  617 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM  617 (807)
T ss_pred             hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence            3333445679999999999999778999999999875444 489999999999999999999999999999999999999


Q ss_pred             cCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccc
Q 010309          304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM  383 (513)
Q Consensus       304 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~  383 (513)
                      ++|+|.+|+......  .+.-.....|+.||++||+||.+.   ++|||||.++|+|++.++++||+|||+++.+-....
T Consensus       618 EnGDLnqFl~aheap--t~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y  692 (807)
T KOG1094|consen  618 ENGDLNQFLSAHELP--TAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY  692 (807)
T ss_pred             hcCcHHHHHHhccCc--ccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCc
Confidence            999999999764222  245566678999999999999999   999999999999999999999999999997765554


Q ss_pred             ccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc--CCCCCCCCCccccchhHHhhhHHhhccccccccccc
Q 010309          384 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS--GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL  461 (513)
Q Consensus       384 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  461 (513)
                      ........-+++|||||.+..++++.+||||+||+++||+++  ...||+...++   +.++....+.........    
T Consensus       693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e---~vven~~~~~~~~~~~~~----  765 (807)
T KOG1094|consen  693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE---QVVENAGEFFRDQGRQVV----  765 (807)
T ss_pred             eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH---HHHHhhhhhcCCCCccee----
Confidence            444433336789999999999999999999999999999886  77898776543   223322222221111111    


Q ss_pred             ccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCc
Q 010309          462 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  507 (513)
Q Consensus       462 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  507 (513)
                            ...+.-++..+.++|.+||..|-++||++++|...|++.+
T Consensus       766 ------l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~  805 (807)
T KOG1094|consen  766 ------LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA  805 (807)
T ss_pred             ------ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence                  1112346778999999999999999999999999887654

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-44  Score=355.62  Aligned_cols=246  Identities=23%  Similarity=0.395  Sum_probs=209.6

Q ss_pred             cCCceecccCceEEEEEEe-CCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          228 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      ...+.||+|+.|.||.|.. .+++.||||++.......++-+.+|+.+|+..+|+|||.+++.+...+++++|||||+||
T Consensus       276 ~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~gg  355 (550)
T KOG0578|consen  276 TDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGG  355 (550)
T ss_pred             cchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCC
Confidence            3345579999999999984 468899999999887777888999999999999999999999999999999999999999


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  386 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  386 (513)
                      +|.+.+..     ..+++.++..|+++++.||+|||.+   +|+|||||.+|||++.++.+||+|||++..+........
T Consensus       356 sLTDvVt~-----~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~  427 (550)
T KOG0578|consen  356 SLTDVVTK-----TRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRS  427 (550)
T ss_pred             chhhhhhc-----ccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccCccc
Confidence            99999865     4599999999999999999999999   999999999999999999999999999998876554222


Q ss_pred             eeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCC
Q 010309          387 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  466 (513)
Q Consensus       387 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  466 (513)
                        ...||+.|||||++....|+++.||||||++++||+-|.+||-..++.  +.+..     +...     -.+      
T Consensus       428 --TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl--rAlyL-----Ia~n-----g~P------  487 (550)
T KOG0578|consen  428 --TMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPL--RALYL-----IATN-----GTP------  487 (550)
T ss_pred             --cccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChH--HHHHH-----Hhhc-----CCC------
Confidence              233999999999999999999999999999999999999999864432  11111     1100     011      


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          467 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       467 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      ....+...++.+.+|+.+||+.||.+||++.|+|+
T Consensus       488 ~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  488 KLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             CcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence            12223457788999999999999999999999997

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-44  Score=384.89  Aligned_cols=262  Identities=31%  Similarity=0.437  Sum_probs=215.4

Q ss_pred             CcccCCceecccCceEEEEEEeCC--CC----EEEEEEeccc-chhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceE
Q 010309          225 NFSEGNRLLGDSKTGGTYSGILPD--GS----RVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRY  297 (513)
Q Consensus       225 ~~~~~~~~lg~G~~g~Vy~~~~~~--~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  297 (513)
                      .--...+.||+|+||.||.|...+  |.    .||||.+++. +.+...+|.+|..+|+.++|||||+++|++.+....+
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~  771 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL  771 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence            334456789999999999999643  43    4999999876 4566789999999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccc
Q 010309          298 IVYEFVVNGPLDRWLHHIPR---GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGL  374 (513)
Q Consensus       298 lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~  374 (513)
                      |++|||++|+|..||++.+.   ....++..+.+.++.|||+|+.||+++   ++|||||.++|+||+....|||+|||+
T Consensus       772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGl  848 (1025)
T KOG1095|consen  772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGL  848 (1025)
T ss_pred             EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccch
Confidence            99999999999999986421   245689999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhccc
Q 010309          375 SKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHR  453 (513)
Q Consensus       375 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  453 (513)
                      |+.+.............-...|||||.+..+.++.|+|||||||+|||++| |..||...+..+...      .....+ 
T Consensus       849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~------~~~~gg-  921 (1025)
T KOG1095|consen  849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLL------DVLEGG-  921 (1025)
T ss_pred             hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHH------HHHhCC-
Confidence            995543333222221224578999999999999999999999999999999 999998766532111      111111 


Q ss_pred             ccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcCC
Q 010309          454 YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP  509 (513)
Q Consensus       454 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  509 (513)
                                   .-.++..+++.+.++|.+||+.+|++||++..|++++..+...
T Consensus       922 -------------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~  964 (1025)
T KOG1095|consen  922 -------------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA  964 (1025)
T ss_pred             -------------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence                         2233456788899999999999999999999999998877554

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-43  Score=337.91  Aligned_cols=259  Identities=20%  Similarity=0.308  Sum_probs=207.5

Q ss_pred             ccCCceecccCceEEEEEE-eCCCCEEEEEEecccch-hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeecc
Q 010309          227 SEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV  304 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  304 (513)
                      ++....||.|..++||+|+ .+.++.||||++..+.- ...+.+.+|+..|+.++||||++++..|..+..+++||.||.
T Consensus        28 YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa  107 (516)
T KOG0582|consen   28 YELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMA  107 (516)
T ss_pred             eeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhc
Confidence            4556678999999999999 46789999999976533 335889999999999999999999999999999999999999


Q ss_pred             CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccc
Q 010309          305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  384 (513)
Q Consensus       305 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  384 (513)
                      +|++.+++.....  ..+++..+..|++++++||.|||.+   |.||||||+.||||+.+|.|||+|||.+..+......
T Consensus       108 ~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R  182 (516)
T KOG0582|consen  108 GGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDR  182 (516)
T ss_pred             CCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccCce
Confidence            9999999976433  4599999999999999999999999   9999999999999999999999999998776554322


Q ss_pred             cce--eecCccccccccccccc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccc
Q 010309          385 ERT--VMAGGTYGYLAPEFVYR--NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP  460 (513)
Q Consensus       385 ~~~--~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  460 (513)
                      ...  ....||+.|||||+++.  ..|+.|+||||||++..||.+|..||....+..  -+.....     +......  
T Consensus       183 ~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk--vLl~tLq-----n~pp~~~--  253 (516)
T KOG0582|consen  183 QVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK--VLLLTLQ-----NDPPTLL--  253 (516)
T ss_pred             eeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH--HHHHHhc-----CCCCCcc--
Confidence            211  23349999999999764  468999999999999999999999998876531  1111000     0000000  


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          461 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       461 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                        ...........++..+..++..||+.||++|||++++++
T Consensus       254 --t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  254 --TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             --cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence              001112223345668999999999999999999999986

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-44  Score=352.97  Aligned_cols=248  Identities=24%  Similarity=0.323  Sum_probs=203.8

Q ss_pred             hCcccCCceecccCceEEEEEEeC-CCCEEEEEEeccc----ch-hcHHHHHHHHHHHhhcC-CCcEeeeeeEEeeCCce
Q 010309          224 KNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS----SF-QRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDR  296 (513)
Q Consensus       224 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~  296 (513)
                      .+.+...+.||+|+||.|+.|... ++..||+|++.+.    .. ...+.+.+|+.+++.++ ||||+++++++......
T Consensus        16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~   95 (370)
T KOG0583|consen   16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKI   95 (370)
T ss_pred             cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeE
Confidence            445566778899999999999854 6899999987664    22 23456778999999998 99999999999999999


Q ss_pred             EEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCC-CCeEEeccccc
Q 010309          297 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE-FGAHLMGVGLS  375 (513)
Q Consensus       297 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~-~~~kl~Dfg~~  375 (513)
                      |+||||+.+|+|.+++.+    ...+.+..+..+++|+++|++|+|+.   +|+||||||+|||++.+ +++||+|||++
T Consensus        96 ~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s  168 (370)
T KOG0583|consen   96 YIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLS  168 (370)
T ss_pred             EEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence            999999999999999964    46789999999999999999999999   99999999999999999 99999999999


Q ss_pred             ccCCccccccceeecCcccccccccccccCC-CC-chhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccc
Q 010309          376 KFVPWEVMQERTVMAGGTYGYLAPEFVYRNE-LT-TKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHR  453 (513)
Q Consensus       376 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  453 (513)
                      ....  .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||...+..   .+...    +..+ 
T Consensus       169 ~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~---~l~~k----i~~~-  238 (370)
T KOG0583|consen  169 AISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP---NLYRK----IRKG-  238 (370)
T ss_pred             cccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH---HHHHH----HhcC-
Confidence            9874  1122333456999999999999877 75 7899999999999999999999874322   11111    0000 


Q ss_pred             ccccccccccCCCCCCCcHHH-HHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          454 YLELLDPLISSLSSDIPEAGV-VQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       454 ~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                                   .-..+... +.++.+|+.+||..||.+|+|+.+|++
T Consensus       239 -------------~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~  274 (370)
T KOG0583|consen  239 -------------EFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE  274 (370)
T ss_pred             -------------CccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence                         00111122 678999999999999999999999993

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-45  Score=349.30  Aligned_cols=261  Identities=21%  Similarity=0.303  Sum_probs=201.4

Q ss_pred             eecccCceEEEEEEe-CCCCEEEEEEecccchhcH-HHHHHHHHHHhhcC-CCcEeeeeeEEeeCC-ceEEEEeeccCCC
Q 010309          232 LLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRK-KEFYSEIGRFARLH-HPNLVAVKGCCYDHG-DRYIVYEFVVNGP  307 (513)
Q Consensus       232 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~-~~~lv~e~~~~gs  307 (513)
                      .||.|.||.||+|+. ..|..||||++++.-..-. -.=.+|++.|++|+ ||||+++.+++.+.+ .+|+||||| ..+
T Consensus        17 klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~M-d~N   95 (538)
T KOG0661|consen   17 KLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFM-DCN   95 (538)
T ss_pred             HhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhh-hhh
Confidence            459999999999995 4689999999987633222 22368999999998 999999999999988 899999999 559


Q ss_pred             HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccce
Q 010309          308 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  387 (513)
Q Consensus       308 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  387 (513)
                      |.++++++   ++.+++..++.|+.||++||+|+|.+   |+.||||||+|||+..+..+||+|||+|+...........
T Consensus        96 LYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpPYTeY  169 (538)
T KOG0661|consen   96 LYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVRSKPPYTEY  169 (538)
T ss_pred             HHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccccCCCcchh
Confidence            99999863   57899999999999999999999999   9999999999999998889999999999988765544333


Q ss_pred             eecCccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccc-hhHHhhh-HH-------hhccccccc
Q 010309          388 VMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ-SIFEWAT-PL-------VQSHRYLEL  457 (513)
Q Consensus       388 ~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~-~~~~~~~-~~-------~~~~~~~~~  457 (513)
                      .   .|..|+|||++.. +.|+.+.|+||+|||++|+.+-++.|.+.++.+.. .+.+... +.       ....+...+
T Consensus       170 V---STRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf  246 (538)
T KOG0661|consen  170 V---STRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNF  246 (538)
T ss_pred             h---hcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhcc
Confidence            2   7899999998875 67899999999999999999999999887654211 1111000 00       000000111


Q ss_pred             ccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010309          458 LDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  502 (513)
Q Consensus       458 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  502 (513)
                      .-+...+..-...-...+.++.++|.+|+..||.+||||+++++.
T Consensus       247 ~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  247 RFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             CCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            111111111111112367789999999999999999999999873

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=8.2e-44  Score=355.68  Aligned_cols=260  Identities=27%  Similarity=0.369  Sum_probs=201.7

Q ss_pred             ccCCceecccCceEEEEEEe------CCCCEEEEEEecccc-hhcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCC-ceE
Q 010309          227 SEGNRLLGDSKTGGTYSGIL------PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHG-DRY  297 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~-~~~  297 (513)
                      +...+.||+|+||.||+|..      .+++.||||+++... ......+.+|+.++..+ +||||+++++++...+ ..+
T Consensus         9 ~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~   88 (338)
T cd05102           9 LRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLM   88 (338)
T ss_pred             ceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceE
Confidence            34456789999999999974      235689999997543 23346789999999999 8999999999887654 578


Q ss_pred             EEEeeccCCCHHHHhccCCCC----------------------------------------------------------C
Q 010309          298 IVYEFVVNGPLDRWLHHIPRG----------------------------------------------------------G  319 (513)
Q Consensus       298 lv~e~~~~gsL~~~l~~~~~~----------------------------------------------------------~  319 (513)
                      +||||+++|+|.+++......                                                          .
T Consensus        89 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (338)
T cd05102          89 VIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWK  168 (338)
T ss_pred             EEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccccc
Confidence            999999999999998642110                                                          1


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccceeecCcccccccc
Q 010309          320 RSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAP  399 (513)
Q Consensus       320 ~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aP  399 (513)
                      ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++...............+++.|+||
T Consensus       169 ~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP  245 (338)
T cd05102         169 SPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAP  245 (338)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCc
Confidence            3478889999999999999999999   9999999999999999999999999999865432221112222356789999


Q ss_pred             cccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCCCCCcHHHHHHH
Q 010309          400 EFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKV  478 (513)
Q Consensus       400 E~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  478 (513)
                      |++.+..++.++||||||+++|||++ |..||.......  ...    .......             ....+...++.+
T Consensus       246 E~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--~~~----~~~~~~~-------------~~~~~~~~~~~l  306 (338)
T cd05102         246 ESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--EFC----QRLKDGT-------------RMRAPENATPEI  306 (338)
T ss_pred             HHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--HHH----HHHhcCC-------------CCCCCCCCCHHH
Confidence            99998999999999999999999997 999997643211  000    0011000             000112345679


Q ss_pred             HHHHHHhcCCCCCCCCCHHHHHHHHhcCcC
Q 010309          479 VDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  508 (513)
Q Consensus       479 ~~li~~cl~~dP~~RPs~~evl~~L~~~~~  508 (513)
                      .+|+.+||+.||++|||+.+|++.|+++..
T Consensus       307 ~~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         307 YRIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-44  Score=352.94  Aligned_cols=263  Identities=23%  Similarity=0.381  Sum_probs=208.5

Q ss_pred             HHhhCcccCCceecccCceEEEEEEeCCCCEEEEEEecccc--hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEE
Q 010309          221 SITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYI  298 (513)
Q Consensus       221 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l  298 (513)
                      .+.-++......||+|.||+||+|.+.  ..||||++.-..  ....+.|.+|+..+++-+|.||+-+.|++..+.. .|
T Consensus       388 eIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AI  464 (678)
T KOG0193|consen  388 EIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AI  464 (678)
T ss_pred             ccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-ee
Confidence            344444455667899999999999983  369999997653  3456789999999999999999999999988877 99


Q ss_pred             EEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccC
Q 010309          299 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV  378 (513)
Q Consensus       299 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~  378 (513)
                      |+.+|+|.+|..+|+.   .+..++..+.+.|++||++||.|||.+   +|||||||..|||+.++++|||+|||++...
T Consensus       465 iTqwCeGsSLY~hlHv---~etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk  538 (678)
T KOG0193|consen  465 ITQWCEGSSLYTHLHV---QETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVK  538 (678)
T ss_pred             eehhccCchhhhhccc---hhhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceeee
Confidence            9999999999999985   336799999999999999999999999   9999999999999999999999999999754


Q ss_pred             CccccccceeecCccccccccccccc---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccc
Q 010309          379 PWEVMQERTVMAGGTYGYLAPEFVYR---NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL  455 (513)
Q Consensus       379 ~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  455 (513)
                      ..-..........|...|||||++..   .+|++.+||||||+++|||+||..||.......  -++...     .+   
T Consensus       539 ~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dq--IifmVG-----rG---  608 (678)
T KOG0193|consen  539 TRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQ--IIFMVG-----RG---  608 (678)
T ss_pred             eeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhh--eEEEec-----cc---
Confidence            33222222223347889999999974   478999999999999999999999998432211  110000     00   


Q ss_pred             ccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcC
Q 010309          456 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  508 (513)
Q Consensus       456 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  508 (513)
                       .+.+.     .......++.++.+|+..||..+|++||.+.+|+..|+.+..
T Consensus       609 -~l~pd-----~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  609 -YLMPD-----LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             -ccCcc-----chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence             00011     111233566789999999999999999999999998887765

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=5.5e-43  Score=340.53  Aligned_cols=246  Identities=20%  Similarity=0.344  Sum_probs=199.4

Q ss_pred             ceecccCceEEEEEEeCCCCEEEEEEecccchhc---HHHHHHHHHHHhhcCCCcEeeeeeEEee----CCceEEEEeec
Q 010309          231 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQR---KKEFYSEIGRFARLHHPNLVAVKGCCYD----HGDRYIVYEFV  303 (513)
Q Consensus       231 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~~lv~e~~  303 (513)
                      ..||+|++|.||+|.. +|+.||||+++......   .+.+.+|+.+|.+++||||+++++++.+    ....++||||+
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            4679999999999998 78999999997653333   4677899999999999999999999877    34679999999


Q ss_pred             cCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccc
Q 010309          304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM  383 (513)
Q Consensus       304 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~  383 (513)
                      ++|+|.+++..    ...+++.....++.|++.||.|||+..  +++||||||+|||++.++.+||+|||+++.......
T Consensus       105 ~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~~  178 (283)
T PHA02988        105 TRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPF  178 (283)
T ss_pred             CCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhccccc
Confidence            99999999964    346889999999999999999999732  788999999999999999999999999986543221


Q ss_pred             ccceeecCccccccccccccc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccccccccc
Q 010309          384 QERTVMAGGTYGYLAPEFVYR--NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL  461 (513)
Q Consensus       384 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  461 (513)
                           ...++..|+|||++.+  ..++.++|||||||++|||++|+.||...+...   +..   .......     .  
T Consensus       179 -----~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~---~~~---~i~~~~~-----~--  240 (283)
T PHA02988        179 -----KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE---IYD---LIINKNN-----S--  240 (283)
T ss_pred             -----cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH---HHH---HHHhcCC-----C--
Confidence                 1237889999999976  678999999999999999999999998654321   111   1110000     0  


Q ss_pred             ccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCc
Q 010309          462 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  507 (513)
Q Consensus       462 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  507 (513)
                           . ..+...++.+.+|+.+||+.||++|||+++|++.|+.+.
T Consensus       241 -----~-~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        241 -----L-KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             -----C-CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence                 0 011234667999999999999999999999999998764

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=8e-44  Score=346.82  Aligned_cols=238  Identities=26%  Similarity=0.456  Sum_probs=202.0

Q ss_pred             eecccCceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCCHHHH
Q 010309          232 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRW  311 (513)
Q Consensus       232 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~  311 (513)
                      -||+|+.|.||+|++ .++.||||+++.-       -..+++.|++|+||||+.+.|+|....-++||||||..|-|.+.
T Consensus       131 WlGSGaQGAVF~Grl-~netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~V  202 (904)
T KOG4721|consen  131 WLGSGAQGAVFLGRL-HNETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEV  202 (904)
T ss_pred             hhccCcccceeeeec-cCceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHH
Confidence            579999999999999 6889999988533       23578899999999999999999999999999999999999999


Q ss_pred             hccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccceeecC
Q 010309          312 LHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG  391 (513)
Q Consensus       312 l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  391 (513)
                      |+.    +..+.......+..+||.||.|||.+   .|||||||.-||||+.+..+||+|||.++.....   ......+
T Consensus       203 Lka----~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSFa  272 (904)
T KOG4721|consen  203 LKA----GRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSFA  272 (904)
T ss_pred             Hhc----cCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhhh
Confidence            953    57789999999999999999999999   9999999999999999999999999999876543   2334456


Q ss_pred             cccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCCCCCc
Q 010309          392 GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPE  471 (513)
Q Consensus       392 gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  471 (513)
                      ||..|||||++...+.+.|.|||||||||||||||..||.+.+...+    -|           .+-...+    ....+
T Consensus       273 GTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI----Iw-----------GVGsNsL----~LpvP  333 (904)
T KOG4721|consen  273 GTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI----IW-----------GVGSNSL----HLPVP  333 (904)
T ss_pred             hhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee----EE-----------eccCCcc----cccCc
Confidence            99999999999999999999999999999999999999987664310    00           0001111    22234


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q 010309          472 AGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  506 (513)
Q Consensus       472 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  506 (513)
                      ..+++.+.-|+++||+..|..||++.+|+.-|+-.
T Consensus       334 stcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa  368 (904)
T KOG4721|consen  334 STCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA  368 (904)
T ss_pred             ccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence            45677899999999999999999999999988743

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=6.8e-43  Score=312.16  Aligned_cols=264  Identities=19%  Similarity=0.247  Sum_probs=204.2

Q ss_pred             CceecccCceEEEEEEe-CCCCEEEEEEecccchhc--HHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          230 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQR--KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      .+.||+|.||.||+|+. .+|+.||||+++.....+  .....+|++.|+.++|+||+.++++|...+...||+||++ .
T Consensus         7 ~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~-t   85 (318)
T KOG0659|consen    7 LEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMP-T   85 (318)
T ss_pred             hhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEecc-c
Confidence            34679999999999995 469999999998764332  3567899999999999999999999999999999999994 5


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  386 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  386 (513)
                      +|...+++   ....++..++..++.++++||+|||++   .|+||||||.|+|++++|.+||+|||+++.+........
T Consensus        86 dLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~  159 (318)
T KOG0659|consen   86 DLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQT  159 (318)
T ss_pred             cHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCCcccc
Confidence            99999974   446799999999999999999999999   999999999999999999999999999998876544333


Q ss_pred             eeecCcccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccc------cccc
Q 010309          387 TVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL------ELLD  459 (513)
Q Consensus       387 ~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~  459 (513)
                      ..  .-|..|.|||++.+. .|+...|+||.|||+.||+-|.+-|.+.++.+....+-.+........+.      +...
T Consensus       160 ~~--V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~  237 (318)
T KOG0659|consen  160 HQ--VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVK  237 (318)
T ss_pred             cc--eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHH
Confidence            22  278899999999874 68999999999999999999998888776543222211111000111111      0000


Q ss_pred             cc-ccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010309          460 PL-ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  502 (513)
Q Consensus       460 ~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  502 (513)
                      -. .........-...+.++.+|+.+|+..||.+|+|+.|+++.
T Consensus       238 ~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  238 IQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             HhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            00 00000000112345667999999999999999999999863

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-43  Score=319.19  Aligned_cols=230  Identities=24%  Similarity=0.334  Sum_probs=197.9

Q ss_pred             ceecccCceEEEEEEeC-CCCEEEEEEecccchhc---HHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          231 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQR---KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       231 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      +.||.|+||.|.+++.+ +|..+|+|++++.....   .+...+|..+|+.+.||+++++++.+.+.+..||||||++||
T Consensus        50 ~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GG  129 (355)
T KOG0616|consen   50 KTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGG  129 (355)
T ss_pred             eeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCCc
Confidence            46799999999999965 58899999998764433   455678999999999999999999999999999999999999


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  386 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  386 (513)
                      .|..+|++    .+++++..++.++.||+.||+|||+.   +|++|||||+|||||.+|.+||+|||+|+....     .
T Consensus       130 ElFS~Lrk----~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~-----r  197 (355)
T KOG0616|consen  130 ELFSYLRK----SGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG-----R  197 (355)
T ss_pred             cHHHHHHh----cCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecC-----c
Confidence            99999964    46799999999999999999999999   999999999999999999999999999997653     2


Q ss_pred             eeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCC
Q 010309          387 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  466 (513)
Q Consensus       387 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  466 (513)
                      +...+|||.|+|||++...+++.++|-|||||++|||+.|.+||....+.   .+.+                .++.+  
T Consensus       198 T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~---~iY~----------------KI~~~--  256 (355)
T KOG0616|consen  198 TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI---QIYE----------------KILEG--  256 (355)
T ss_pred             EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH---HHHH----------------HHHhC--
Confidence            45567999999999999999999999999999999999999999876542   1111                11111  


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCC
Q 010309          467 SDIPEAGVVQKVVDLVYACTQHVPSMR  493 (513)
Q Consensus       467 ~~~~~~~~~~~l~~li~~cl~~dP~~R  493 (513)
                      .-..+...+.++.+|+.++|+.|-.+|
T Consensus       257 ~v~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  257 KVKFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             cccCCcccCHHHHHHHHHHHhhhhHhh
Confidence            112344567789999999999999999

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=2.1e-43  Score=344.06  Aligned_cols=241  Identities=22%  Similarity=0.343  Sum_probs=204.1

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccc--hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      .+.||+|+||.||+|+.+ +.+.||+|.+.+..  .++.+.+.+|+++++.++||||+.++++|+...+.++|+||+.| 
T Consensus         7 ~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-   85 (808)
T KOG0597|consen    7 YEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-   85 (808)
T ss_pred             HHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-
Confidence            346799999999999965 58899999998753  33457799999999999999999999999999999999999966 


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  386 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  386 (513)
                      +|..+|..    ...++++.+..|+.|++.||.|||+.   +|+|||+||.|||++.++++|++|||+++.+.....  .
T Consensus        86 ~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~--v  156 (808)
T KOG0597|consen   86 DLFTILEQ----DGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTS--V  156 (808)
T ss_pred             hHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccCce--e
Confidence            99999964    46799999999999999999999999   999999999999999999999999999998765332  2


Q ss_pred             eeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCC
Q 010309          387 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  466 (513)
Q Consensus       387 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  466 (513)
                      .....|||-|||||++.+.+|+..+|+||+|||+||+++|++||....-      ......             ++..  
T Consensus       157 ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si------~~Lv~~-------------I~~d--  215 (808)
T KOG0597|consen  157 LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSI------TQLVKS-------------ILKD--  215 (808)
T ss_pred             eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHH------HHHHHH-------------HhcC--
Confidence            2334499999999999999999999999999999999999999975321      111111             1111  


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          467 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       467 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      +-.++...+..+..|+...|.+||..|.|..+++.
T Consensus       216 ~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  216 PVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             CCCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence            22234467788999999999999999999998874

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-43  Score=348.92  Aligned_cols=253  Identities=29%  Similarity=0.404  Sum_probs=206.3

Q ss_pred             ceecccCceEEEEEEeCC--C---CEEEEEEeccc---chhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEee
Q 010309          231 RLLGDSKTGGTYSGILPD--G---SRVAVKRLKRS---SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF  302 (513)
Q Consensus       231 ~~lg~G~~g~Vy~~~~~~--~---~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  302 (513)
                      +.||+|+||.||+|.+..  +   ..||||..+..   ......++.+|+++|++++|||||++||++....+++||||+
T Consensus       163 kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl  242 (474)
T KOG0194|consen  163 KKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMEL  242 (474)
T ss_pred             ceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEe
Confidence            678999999999999643  2   23899999853   345568899999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccc
Q 010309          303 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV  382 (513)
Q Consensus       303 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~  382 (513)
                      |.||+|.++|....   ..++..+...++.+.|.||+|||++   +++||||.++|+|++.++.+||+|||+++......
T Consensus       243 ~~gGsL~~~L~k~~---~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~  316 (474)
T KOG0194|consen  243 CNGGSLDDYLKKNK---KSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYV  316 (474)
T ss_pred             cCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccCCccee
Confidence            99999999997532   3699999999999999999999999   99999999999999999999999999998764222


Q ss_pred             cccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhccccccccccc
Q 010309          383 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL  461 (513)
Q Consensus       383 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  461 (513)
                      ....  ...-+..|+|||.+..+.++.++|||||||++||+++ |..||.+......   ..++   ...+         
T Consensus       317 ~~~~--~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v---~~kI---~~~~---------  379 (474)
T KOG0194|consen  317 MKKF--LKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEV---KAKI---VKNG---------  379 (474)
T ss_pred             eccc--cccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHH---HHHH---HhcC---------
Confidence            1111  1125689999999999999999999999999999999 8889987654311   1111   0100         


Q ss_pred             ccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcCCC
Q 010309          462 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP  510 (513)
Q Consensus       462 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  510 (513)
                          ..-..+...+..+..++.+|+..||++||+|.++.+.|+.+....
T Consensus       380 ----~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~  424 (474)
T KOG0194|consen  380 ----YRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKK  424 (474)
T ss_pred             ----ccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcc
Confidence                011122245667889999999999999999999999998776653

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=8.8e-42  Score=335.89  Aligned_cols=262  Identities=23%  Similarity=0.328  Sum_probs=200.1

Q ss_pred             cCCceecccCceEEEEEEeCC-----------------CCEEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeE
Q 010309          228 EGNRLLGDSKTGGTYSGILPD-----------------GSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGC  289 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~  289 (513)
                      ...+.||+|+||.||++.+.+                 +..||+|++.... .....++.+|+.++.+++||||++++++
T Consensus         8 ~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~   87 (304)
T cd05096           8 LFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGV   87 (304)
T ss_pred             eeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEEE
Confidence            345568999999999998532                 3479999997653 2345679999999999999999999999


Q ss_pred             EeeCCceEEEEeeccCCCHHHHhccCCC---------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCC
Q 010309          290 CYDHGDRYIVYEFVVNGPLDRWLHHIPR---------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDI  354 (513)
Q Consensus       290 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Di  354 (513)
                      +.+.+..++||||+++++|.+++.....               ....+++..+..++.||+.||.|||+.   +|+||||
T Consensus        88 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH~dl  164 (304)
T cd05096          88 CVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHRDL  164 (304)
T ss_pred             EecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---CccccCc
Confidence            9999999999999999999999864221               113478889999999999999999999   9999999


Q ss_pred             CCCceEecCCCCeEEecccccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc--CCCCCCC
Q 010309          355 RASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS--GRRPAQA  432 (513)
Q Consensus       355 kp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt--g~~p~~~  432 (513)
                      ||+|||++.++.+||+|||++................++..|+|||++.+..++.++||||||+++|||++  +..||..
T Consensus       165 kp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~  244 (304)
T cd05096         165 ATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGE  244 (304)
T ss_pred             chhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCc
Confidence            99999999999999999999986543322111122225788999999988899999999999999999987  5677765


Q ss_pred             CCccccchhHHhhhHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 010309          433 VDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ  505 (513)
Q Consensus       433 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  505 (513)
                      .+..   ............... ..    .    .. .+..++..+.+|+.+||+.||++|||+++|.+.|++
T Consensus       245 ~~~~---~~~~~~~~~~~~~~~-~~----~----~~-~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         245 LTDE---QVIENAGEFFRDQGR-QV----Y----LF-RPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CCHH---HHHHHHHHHhhhccc-cc----c----cc-CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            4432   111111111110000 00    0    00 011244679999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-43  Score=336.12  Aligned_cols=242  Identities=23%  Similarity=0.381  Sum_probs=204.8

Q ss_pred             ceecccCceEEEEEEeC-CCCEEEEEEecccch-hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCCH
Q 010309          231 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  308 (513)
Q Consensus       231 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL  308 (513)
                      .+||+|.||.||+|... .++.||+|++.-+.. ...+++++|+.+|.+++++||.++|+.+..+..++++|||+.||++
T Consensus        19 ~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv   98 (467)
T KOG0201|consen   19 ELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSV   98 (467)
T ss_pred             hhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcch
Confidence            46799999999999964 588999999986643 3457899999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccccee
Q 010309          309 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  388 (513)
Q Consensus       309 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  388 (513)
                      .+.|+.    +..+.+..+.-|+++++.||.|||.+   +.+|||||+.|||+..+|.+||+|||.+-.+.......  .
T Consensus        99 ~~lL~~----~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr--~  169 (467)
T KOG0201|consen   99 LDLLKS----GNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR--K  169 (467)
T ss_pred             hhhhcc----CCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhcc--c
Confidence            999853    34458888888999999999999999   99999999999999999999999999998876554433  2


Q ss_pred             ecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCCC
Q 010309          389 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD  468 (513)
Q Consensus       389 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  468 (513)
                      ...||+.|||||++....|+.|+||||||++++||++|.+|+....+....                -++...   .++.
T Consensus       170 tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl----------------flIpk~---~PP~  230 (467)
T KOG0201|consen  170 TFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL----------------FLIPKS---APPR  230 (467)
T ss_pred             cccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEE----------------EeccCC---CCCc
Confidence            344999999999999889999999999999999999999999877653211                111111   1111


Q ss_pred             CCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          469 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       469 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      . ...+++.+.+|+..||+.||+.||+|.++++
T Consensus       231 L-~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  231 L-DGDFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             c-ccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            1 2256778999999999999999999999986

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.8e-43  Score=346.59  Aligned_cols=243  Identities=21%  Similarity=0.299  Sum_probs=206.1

Q ss_pred             cCCceecccCceEEEEEEe-CCCCEEEEEEecccc---hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeec
Q 010309          228 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  303 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  303 (513)
                      ..++-||.|+.|.|-+|++ .+|+.+|||++.+..   ......+.+|+-+|+.+.||||+++|+++++..++|+|+||+
T Consensus        15 kLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv   94 (786)
T KOG0588|consen   15 KLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYV   94 (786)
T ss_pred             eccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEec
Confidence            4566789999999999996 479999999998762   223466889999999999999999999999999999999999


Q ss_pred             cCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccc
Q 010309          304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM  383 (513)
Q Consensus       304 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~  383 (513)
                      ++|-|.+++..    .+++++.++.++++||+.|+.|+|..   +|+||||||+|+|||..+++||+|||+|..-.....
T Consensus        95 ~gGELFdylv~----kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gkl  167 (786)
T KOG0588|consen   95 PGGELFDYLVR----KGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKL  167 (786)
T ss_pred             CCchhHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCCcc
Confidence            99999999954    47799999999999999999999999   999999999999999999999999999987554433


Q ss_pred             ccceeecCcccccccccccccCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccc
Q 010309          384 QERTVMAGGTYGYLAPEFVYRNELT-TKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI  462 (513)
Q Consensus       384 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  462 (513)
                      .   ...||.+.|.|||++++.+|. .++||||.|||||.||||+.||++.+   ...+...+.    .+          
T Consensus       168 L---eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN---ir~LLlKV~----~G----------  227 (786)
T KOG0588|consen  168 L---ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN---IRVLLLKVQ----RG----------  227 (786)
T ss_pred             c---cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc---HHHHHHHHH----cC----------
Confidence            2   234699999999999999985 68999999999999999999998543   222222111    11          


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          463 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       463 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                          ....+..++.++.+|+.+||..||++|.|++||++
T Consensus       228 ----~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~k  262 (786)
T KOG0588|consen  228 ----VFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILK  262 (786)
T ss_pred             ----cccCCCcCCHHHHHHHHHHhccCccccccHHHHhh
Confidence                11223567778999999999999999999999987

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=3.6e-42  Score=335.52  Aligned_cols=245  Identities=21%  Similarity=0.275  Sum_probs=200.5

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccchhc---HHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccC
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQR---KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  305 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  305 (513)
                      -+.||+|+||.||+++-+ +|..+|+|++++.....   .+.++.|-.+|....+|.||+|+..|.+.+.+||||||++|
T Consensus       146 Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPG  225 (550)
T KOG0605|consen  146 LKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPG  225 (550)
T ss_pred             heeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCC
Confidence            456799999999999954 59999999999875433   45678899999999999999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccc---
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV---  382 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~---  382 (513)
                      |++..+|..    ...|++..++.++.+++.|+.-||..   |+|||||||+|+|||..|++||+|||++..+....   
T Consensus       226 GD~mTLL~~----~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~  298 (550)
T KOG0605|consen  226 GDMMTLLMR----KDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIE  298 (550)
T ss_pred             ccHHHHHHh----cCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhhhhhhh
Confidence            999999964    46799999999999999999999999   99999999999999999999999999995432100   


Q ss_pred             ----------------cccc--------------------------eeecCcccccccccccccCCCCchhhHHHHHHHH
Q 010309          383 ----------------MQER--------------------------TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLL  420 (513)
Q Consensus       383 ----------------~~~~--------------------------~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil  420 (513)
                                      ....                          .....|||.|+|||++.+..|+..+|.||||||+
T Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~Im  378 (550)
T KOG0605|consen  299 SYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIM  378 (550)
T ss_pred             hhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHH
Confidence                            0000                          0011289999999999999999999999999999


Q ss_pred             HHHHcCCCCCCCCCcc-ccchhHHhhhHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCC---H
Q 010309          421 LEIVSGRRPAQAVDSV-CWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPR---M  496 (513)
Q Consensus       421 ~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~  496 (513)
                      ||||.|.+||...++. .+.++..|...+                  ..+.....++++.+||.+||. ||++|..   +
T Consensus       379 yEmLvGyPPF~s~tp~~T~rkI~nwr~~l------------------~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~  439 (550)
T KOG0605|consen  379 YEMLVGYPPFCSETPQETYRKIVNWRETL------------------KFPEEVDLSDEAKDLITRLLC-DPENRLGSKGA  439 (550)
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHHhhhc------------------cCCCcCcccHHHHHHHHHHhc-CHHHhcCcccH
Confidence            9999999999887664 233444443321                  111222345789999999999 9999975   5


Q ss_pred             HHHH
Q 010309          497 SHVV  500 (513)
Q Consensus       497 ~evl  500 (513)
                      +||.
T Consensus       440 ~EIK  443 (550)
T KOG0605|consen  440 EEIK  443 (550)
T ss_pred             HHHh
Confidence            5554

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=9.5e-41  Score=377.74  Aligned_cols=264  Identities=27%  Similarity=0.483  Sum_probs=207.1

Q ss_pred             hCcccCCceecccCceEEEEEEe-CCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEee
Q 010309          224 KNFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF  302 (513)
Q Consensus       224 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  302 (513)
                      ..+.+ ..+||+|+||.||+|.. .++..||||++......    ...|++++++++||||+++++++.+.+..++||||
T Consensus       690 ~~~~~-~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey  764 (968)
T PLN00113        690 SSLKE-ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY  764 (968)
T ss_pred             hhCCc-ccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence            34444 45779999999999997 47899999998754321    23468889999999999999999999999999999


Q ss_pred             ccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccc
Q 010309          303 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV  382 (513)
Q Consensus       303 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~  382 (513)
                      +++|+|.++++       .+++..+..++.|++.||+|||..+.++|+||||||+||+++.++.+++. |+.........
T Consensus       765 ~~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~~  836 (968)
T PLN00113        765 IEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDT  836 (968)
T ss_pred             CCCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccCC
Confidence            99999999994       38899999999999999999996655699999999999999999888775 66554332111


Q ss_pred             cccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccc
Q 010309          383 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI  462 (513)
Q Consensus       383 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  462 (513)
                            ...+|+.|+|||++.+..++.++|||||||++|||+||+.||..... ......+|.............+++.+
T Consensus       837 ------~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  909 (968)
T PLN00113        837 ------KCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSI  909 (968)
T ss_pred             ------CccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCccc
Confidence                  11378999999999999999999999999999999999999854322 22344555544433333344455544


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcCC
Q 010309          463 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP  509 (513)
Q Consensus       463 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  509 (513)
                      ...  .........++.+++.+||+.||++||||+||++.|+++...
T Consensus       910 ~~~--~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~  954 (968)
T PLN00113        910 RGD--VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS  954 (968)
T ss_pred             cCC--CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence            321  122345566789999999999999999999999999988653

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=9.5e-42  Score=332.43  Aligned_cols=247  Identities=19%  Similarity=0.273  Sum_probs=198.0

Q ss_pred             CceecccCceEEEEEEe-CCCCEEEEEEecccch---hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccC
Q 010309          230 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  305 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  305 (513)
                      .+.||+|+||.||++.. .+|+.||||.+.....   .....+.+|+.++.+++|+||+++++++.+.+..++||||+++
T Consensus         5 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~   84 (285)
T cd05631           5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNG   84 (285)
T ss_pred             EEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCC
Confidence            45789999999999986 4699999999875432   2234678899999999999999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccc
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  385 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  385 (513)
                      |+|.+++...  ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.++|+|||++......... 
T Consensus        85 g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-  158 (285)
T cd05631          85 GDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETV-  158 (285)
T ss_pred             CcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCee-
Confidence            9999887542  234689999999999999999999999   9999999999999999999999999999865432211 


Q ss_pred             ceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCC
Q 010309          386 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  465 (513)
Q Consensus       386 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  465 (513)
                        ....||..|+|||++.+..++.++|||||||++|||++|+.||...........   ......        ..     
T Consensus       159 --~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~---~~~~~~--------~~-----  220 (285)
T cd05631         159 --RGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREE---VDRRVK--------ED-----  220 (285)
T ss_pred             --cCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHH---HHHHhh--------cc-----
Confidence              122389999999999999999999999999999999999999986543211110   000000        00     


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 010309          466 SSDIPEAGVVQKVVDLVYACTQHVPSMRPR-----MSHVVH  501 (513)
Q Consensus       466 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  501 (513)
                       ........+.++.+|+.+||+.||.+||+     ++++++
T Consensus       221 -~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         221 -QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             -cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence             01112234567999999999999999997     788876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=4e-42  Score=341.08  Aligned_cols=240  Identities=23%  Similarity=0.263  Sum_probs=196.0

Q ss_pred             eecccCceEEEEEEeC-CCCEEEEEEecccc---hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCC
Q 010309          232 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  307 (513)
Q Consensus       232 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs  307 (513)
                      +||+|+||.||++... +|+.||||+++...   ......+.+|+.++++++||||+++++++...+..++||||+++++
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~   81 (323)
T cd05571           2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGE   81 (323)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCc
Confidence            5899999999999864 68999999997642   2233567889999999999999999999999999999999999999


Q ss_pred             HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccce
Q 010309          308 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  387 (513)
Q Consensus       308 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  387 (513)
                      |.+++..    ...+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++........  .
T Consensus        82 L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~--~  152 (323)
T cd05571          82 LFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT--M  152 (323)
T ss_pred             HHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCc--c
Confidence            9998864    35689999999999999999999999   9999999999999999999999999998754222111  1


Q ss_pred             eecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCC
Q 010309          388 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS  467 (513)
Q Consensus       388 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  467 (513)
                      ....||+.|+|||++.+..++.++|||||||++|||++|..||...+...   ....    .....              
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~---~~~~----~~~~~--------------  211 (323)
T cd05571         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFEL----ILMEE--------------  211 (323)
T ss_pred             cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH---HHHH----HHcCC--------------
Confidence            12338999999999999999999999999999999999999997644321   1110    00000              


Q ss_pred             CCCcHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 010309          468 DIPEAGVVQKVVDLVYACTQHVPSMRP-----RMSHVVH  501 (513)
Q Consensus       468 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  501 (513)
                      ...+...++++.+|+.+||+.||++||     ++.++++
T Consensus       212 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         212 IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            001123456799999999999999999     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=6.6e-42  Score=346.07  Aligned_cols=257  Identities=25%  Similarity=0.372  Sum_probs=200.6

Q ss_pred             cCCceecccCceEEEEEEe------CCCCEEEEEEecccc-hhcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCCceEEE
Q 010309          228 EGNRLLGDSKTGGTYSGIL------PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIV  299 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv  299 (513)
                      ...+.||+|+||.||+|..      .++..||||+++... ....+.+.+|+.++..+ +||||+++++++.+.+..++|
T Consensus        38 ~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv  117 (375)
T cd05104          38 SFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVI  117 (375)
T ss_pred             ehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceee
Confidence            3356789999999999973      246689999997543 23456788999999999 899999999999999999999


Q ss_pred             EeeccCCCHHHHhccCCC--------------------------------------------------------------
Q 010309          300 YEFVVNGPLDRWLHHIPR--------------------------------------------------------------  317 (513)
Q Consensus       300 ~e~~~~gsL~~~l~~~~~--------------------------------------------------------------  317 (513)
                      |||+++|+|.+++.....                                                              
T Consensus       118 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (375)
T cd05104         118 TEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQ  197 (375)
T ss_pred             ehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceeccc
Confidence            999999999999864211                                                              


Q ss_pred             ---------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccccee
Q 010309          318 ---------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  388 (513)
Q Consensus       318 ---------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  388 (513)
                               ....+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++.............
T Consensus       198 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~  274 (375)
T cd05104         198 DVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKG  274 (375)
T ss_pred             ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccccccC
Confidence                     112578889999999999999999999   99999999999999999999999999998664332211111


Q ss_pred             ecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCC
Q 010309          389 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS  467 (513)
Q Consensus       389 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  467 (513)
                      ...++..|+|||++.+..++.++||||||+++|||++ |..||......  .....    ......     ..       
T Consensus       275 ~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~--~~~~~----~~~~~~-----~~-------  336 (375)
T cd05104         275 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD--SKFYK----MIKEGY-----RM-------  336 (375)
T ss_pred             CCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch--HHHHH----HHHhCc-----cC-------
Confidence            1225668999999999999999999999999999998 88898754321  01111    111110     00       


Q ss_pred             CCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q 010309          468 DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  506 (513)
Q Consensus       468 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  506 (513)
                      . .+...+.++.+|+.+||+.||++|||+.+|++.|++.
T Consensus       337 ~-~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         337 L-SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             C-CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            0 0112245799999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-42  Score=330.52  Aligned_cols=249  Identities=21%  Similarity=0.320  Sum_probs=192.6

Q ss_pred             cCCceecccCceEEEEEEeC-CCCEEEEEEecccch--------------hcHHHHHHHHHHHhhcCCCcEeeeeeEEee
Q 010309          228 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF--------------QRKKEFYSEIGRFARLHHPNLVAVKGCCYD  292 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  292 (513)
                      +..+-||+|.||.|-+|+.. +++.||||++.+...              ...+...+|+.+|++++|||||+|+++..+
T Consensus       100 ~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDD  179 (576)
T KOG0585|consen  100 ELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDD  179 (576)
T ss_pred             ehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecC
Confidence            33445699999999999964 699999999975421              123578999999999999999999999876


Q ss_pred             C--CceEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEe
Q 010309          293 H--GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLM  370 (513)
Q Consensus       293 ~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~  370 (513)
                      .  +.+|||+|||..|.+...=    .....+++.++++++++++.||.|||.+   +||||||||+|+||+++|++||+
T Consensus       180 P~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~VKIs  252 (576)
T KOG0585|consen  180 PESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGTVKIS  252 (576)
T ss_pred             cccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCcEEee
Confidence            5  6789999999988774422    2223399999999999999999999999   99999999999999999999999


Q ss_pred             cccccccCCccc---cccceeecCcccccccccccccCC----CCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHH
Q 010309          371 GVGLSKFVPWEV---MQERTVMAGGTYGYLAPEFVYRNE----LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFE  443 (513)
Q Consensus       371 Dfg~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~  443 (513)
                      |||.+.......   .........|||.|+|||...++.    .+.+.||||+||+||-|+.|+.||.+....   .+++
T Consensus       253 DFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~---~l~~  329 (576)
T KOG0585|consen  253 DFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL---ELFD  329 (576)
T ss_pred             ccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH---HHHH
Confidence            999998763221   111111234999999999998743    256889999999999999999999865431   1111


Q ss_pred             hhhHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010309          444 WATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  502 (513)
Q Consensus       444 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  502 (513)
                                  .++...+    ......++.+.+.+||++||.+||+.|.+..+|...
T Consensus       330 ------------KIvn~pL----~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H  372 (576)
T KOG0585|consen  330 ------------KIVNDPL----EFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLH  372 (576)
T ss_pred             ------------HHhcCcc----cCCCcccccHHHHHHHHHHhhcChhheeehhhheec
Confidence                        1111111    111122466789999999999999999999988653

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-42  Score=349.21  Aligned_cols=256  Identities=24%  Similarity=0.378  Sum_probs=216.1

Q ss_pred             cCCceecccCceEEEEEEe-CCC----CEEEEEEeccc-chhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEe
Q 010309          228 EGNRLLGDSKTGGTYSGIL-PDG----SRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE  301 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~-~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  301 (513)
                      ...++||+|+||+||+|.+ ++|    -+||||++... ..+...++++|+-+|.+|+|||+++++++|.... ..||++
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq  777 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ  777 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence            3456889999999999995 444    47999998765 4455688999999999999999999999998776 789999


Q ss_pred             eccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcc
Q 010309          302 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE  381 (513)
Q Consensus       302 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~  381 (513)
                      |++.|+|.++++.   .+..+..+..+.|..|||+||.|||.+   .+|||||.++|||+.+...+||.|||+++.+..+
T Consensus       778 ~mP~G~LlDyvr~---hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d  851 (1177)
T KOG1025|consen  778 LMPLGCLLDYVRE---HRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD  851 (1177)
T ss_pred             hcccchHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence            9999999999985   346688999999999999999999999   9999999999999999999999999999998876


Q ss_pred             ccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccccc
Q 010309          382 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP  460 (513)
Q Consensus       382 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  460 (513)
                      ..........-.+.|||-|.+....++.++|||||||++||++| |..|+++....++.++++....             
T Consensus       852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR-------------  918 (1177)
T KOG1025|consen  852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER-------------  918 (1177)
T ss_pred             cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc-------------
Confidence            65554444445788999999999999999999999999999999 9999998776544444332211             


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcCCC
Q 010309          461 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP  510 (513)
Q Consensus       461 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  510 (513)
                       +      ..+.-++.++..++.+||..|+..||+++++...+.+++..|
T Consensus       919 -L------sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardp  961 (1177)
T KOG1025|consen  919 -L------SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDP  961 (1177)
T ss_pred             -C------CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence             1      112346667999999999999999999999999998887655

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-41  Score=326.39  Aligned_cols=262  Identities=25%  Similarity=0.378  Sum_probs=199.5

Q ss_pred             ceecccCceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhh--cCCCcEeeeeeEEeeCC----ceEEEEeecc
Q 010309          231 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFAR--LHHPNLVAVKGCCYDHG----DRYIVYEFVV  304 (513)
Q Consensus       231 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~l~~~~~~~~----~~~lv~e~~~  304 (513)
                      .++|+|.||.||+|.+ +++.||||++...   ..+.|++|-.|.+.  ++|+||+++++.-....    .++||+||.+
T Consensus       216 eli~~Grfg~V~KaqL-~~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~  291 (534)
T KOG3653|consen  216 ELIGRGRFGCVWKAQL-DNRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHP  291 (534)
T ss_pred             HHhhcCccceeehhhc-cCceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeecc
Confidence            3689999999999999 6699999999643   56678888777665  48999999999876555    7899999999


Q ss_pred             CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC------CCCCceEcCCCCCceEecCCCCeEEecccccccC
Q 010309          305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK------VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV  378 (513)
Q Consensus       305 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~------~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~  378 (513)
                      .|+|.++|..     ..++|....+|+..+++||+|||+.      .+|+|+|||||.+||||.+|+++.|+|||+|..+
T Consensus       292 kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~  366 (534)
T KOG3653|consen  292 KGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRL  366 (534)
T ss_pred             CCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEe
Confidence            9999999975     5699999999999999999999965      3678999999999999999999999999999988


Q ss_pred             CccccccceeecCcccccccccccccCC-C-----CchhhHHHHHHHHHHHHcCCCCCCCCCccccchh----------H
Q 010309          379 PWEVMQERTVMAGGTYGYLAPEFVYRNE-L-----TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSI----------F  442 (513)
Q Consensus       379 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~-----~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~----------~  442 (513)
                      .............||.+|||||++.+.- +     -.+.||||+|.|||||++...-+......+.+--          +
T Consensus       367 ~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~  446 (534)
T KOG3653|consen  367 EPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTL  446 (534)
T ss_pred             cCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCH
Confidence            7665444444455999999999997631 1     2468999999999999996654432111111111          1


Q ss_pred             HhhhHHhhccc-ccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcCC
Q 010309          443 EWATPLVQSHR-YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP  509 (513)
Q Consensus       443 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  509 (513)
                      +..+.++...+ ...+.+...        .......+.+.+..||+.||+.|.|+.=+.+++.++...
T Consensus       447 e~mq~~VV~kK~RP~~p~~W~--------~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~  506 (534)
T KOG3653|consen  447 EEMQELVVRKKQRPKIPDAWR--------KHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML  506 (534)
T ss_pred             HHHHHHHHhhccCCCChhhhh--------cCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence            11111111111 111111111        123456789999999999999999999999888776554

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.7e-41  Score=337.82  Aligned_cols=262  Identities=23%  Similarity=0.379  Sum_probs=201.5

Q ss_pred             CCceecccCceEEEEEEeC-CCCEEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          229 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      ..+.||+|+||.||++... ++..||+|.+.... ....+.+.+|++++++++||||+++++++...+..++||||++++
T Consensus         9 ~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   88 (331)
T cd06649           9 RISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG   88 (331)
T ss_pred             EEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCC
Confidence            3456799999999999975 58899999997642 233467899999999999999999999999999999999999999


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  386 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  386 (513)
                      +|.+++..    ...+++..+..++.|++.||.|||+..  +|+||||||+|||++.++.+||+|||++........   
T Consensus        89 ~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---  159 (331)
T cd06649          89 SLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---  159 (331)
T ss_pred             cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccccc---
Confidence            99999964    345899999999999999999999852  699999999999999999999999999876543221   


Q ss_pred             eeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhc-c-c-----------
Q 010309          387 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQS-H-R-----------  453 (513)
Q Consensus       387 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~-~-----------  453 (513)
                       ....|++.|+|||++.+..++.++|||||||++|||++|+.||...+..........  +.... . .           
T Consensus       160 -~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  236 (331)
T cd06649         160 -NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGR--PVVDGEEGEPHSISPRPRPP  236 (331)
T ss_pred             -ccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcc--cccccccCCccccCcccccc
Confidence             122389999999999988999999999999999999999999976543221111100  00000 0 0           


Q ss_pred             ----------------ccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010309          454 ----------------YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  502 (513)
Q Consensus       454 ----------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  502 (513)
                                      ..+..+..........+....++++.+||.+||+.||++|||+++|++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         237 GRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             cccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                            0000000011111111222356789999999999999999999999873

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.6e-41  Score=327.38  Aligned_cols=252  Identities=24%  Similarity=0.372  Sum_probs=201.3

Q ss_pred             cCCceecccCceEEEEEEeC----CCCEEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEee
Q 010309          228 EGNRLLGDSKTGGTYSGILP----DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF  302 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  302 (513)
                      ...++||+|+||.||+|.+.    .+..||+|.++... ......+.+|+.++.+++||||+++++++...+..++||||
T Consensus         8 ~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   87 (266)
T cd05064           8 KIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEY   87 (266)
T ss_pred             EEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEe
Confidence            34567899999999999853    36689999998653 23346789999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccc
Q 010309          303 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV  382 (513)
Q Consensus       303 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~  382 (513)
                      +++|+|.+++...   ...+++..++.++.|++.||+|||+.   +++||||||+|||++.++.++++|||.+.......
T Consensus        88 ~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~  161 (266)
T cd05064          88 MSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA  161 (266)
T ss_pred             CCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence            9999999998642   24689999999999999999999999   99999999999999999999999999876543222


Q ss_pred             cccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhccccccccccc
Q 010309          383 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL  461 (513)
Q Consensus       383 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  461 (513)
                      .. ......++..|+|||.+.+..++.++||||||+++||+++ |..||.......   ...   . .....        
T Consensus       162 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~---~~~---~-~~~~~--------  225 (266)
T cd05064         162 IY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD---VIK---A-VEDGF--------  225 (266)
T ss_pred             hh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHH---H-HHCCC--------
Confidence            11 1111225678999999999999999999999999999875 999997654321   111   0 11000        


Q ss_pred             ccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q 010309          462 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  506 (513)
Q Consensus       462 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  506 (513)
                           ....+..++..+.+++.+||+.+|.+||++++|++.|+++
T Consensus       226 -----~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         226 -----RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             -----CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence                 0011223456799999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.1e-41  Score=344.20  Aligned_cols=258  Identities=26%  Similarity=0.393  Sum_probs=200.9

Q ss_pred             cCCceecccCceEEEEEEeC------CCCEEEEEEecccc-hhcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCCceEEE
Q 010309          228 EGNRLLGDSKTGGTYSGILP------DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIV  299 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv  299 (513)
                      +..+.||+|+||.||+|...      ++..||||.++... ......+.+|+.+++.+ +||||+++++.+...+..++|
T Consensus        41 ~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv  120 (374)
T cd05106          41 QFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVI  120 (374)
T ss_pred             eehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEe
Confidence            34567899999999998842      34589999997643 23346788999999999 899999999999999999999


Q ss_pred             EeeccCCCHHHHhccCCC--------------------------------------------------------------
Q 010309          300 YEFVVNGPLDRWLHHIPR--------------------------------------------------------------  317 (513)
Q Consensus       300 ~e~~~~gsL~~~l~~~~~--------------------------------------------------------------  317 (513)
                      |||+++|+|.+++.....                                                              
T Consensus       121 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  200 (374)
T cd05106         121 TEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDE  200 (374)
T ss_pred             HhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccccch
Confidence            999999999999854210                                                              


Q ss_pred             ----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccceeecCcc
Q 010309          318 ----GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT  393 (513)
Q Consensus       318 ----~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt  393 (513)
                          ....+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++................++
T Consensus       201 ~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~  277 (374)
T cd05106         201 EDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP  277 (374)
T ss_pred             hccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCc
Confidence                113478889999999999999999999   9999999999999999999999999999765433221111112256


Q ss_pred             cccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCCCCCcH
Q 010309          394 YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEA  472 (513)
Q Consensus       394 ~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  472 (513)
                      ..|+|||++.+..++.++||||||+++|||++ |+.||.......  ....    .....     ...        ..+.
T Consensus       278 ~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~~~~----~~~~~-----~~~--------~~~~  338 (374)
T cd05106         278 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--KFYK----MVKRG-----YQM--------SRPD  338 (374)
T ss_pred             cceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--HHHH----HHHcc-----cCc--------cCCC
Confidence            68999999988899999999999999999997 999997643211  1100    00000     000        0011


Q ss_pred             HHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCc
Q 010309          473 GVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  507 (513)
Q Consensus       473 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  507 (513)
                      ..++++.+++.+||+.||++|||+.+|++.|+++.
T Consensus       339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            13467999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8e-42  Score=337.30  Aligned_cols=239  Identities=22%  Similarity=0.263  Sum_probs=193.4

Q ss_pred             ecccCceEEEEEEeC-CCCEEEEEEecccc---hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCCH
Q 010309          233 LGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  308 (513)
Q Consensus       233 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL  308 (513)
                      ||+|+||.||++... +++.||+|+++...   ......+.+|+.++.+++||||+++++++.+.+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999975 58899999997542   23345678899999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccccee
Q 010309          309 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  388 (513)
Q Consensus       309 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  388 (513)
                      .+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++........  ..
T Consensus        81 ~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~--~~  151 (312)
T cd05585          81 FHHLQR----EGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK--TN  151 (312)
T ss_pred             HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCc--cc
Confidence            999864    34689999999999999999999999   9999999999999999999999999999864322211  12


Q ss_pred             ecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCCC
Q 010309          389 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD  468 (513)
Q Consensus       389 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  468 (513)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||...+...   .   ......         .      ..
T Consensus       152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~---~---~~~~~~---------~------~~  210 (312)
T cd05585         152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE---M---YRKILQ---------E------PL  210 (312)
T ss_pred             cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH---H---HHHHHc---------C------CC
Confidence            2348999999999999999999999999999999999999997643211   1   111100         0      00


Q ss_pred             CCcHHHHHHHHHHHHHhcCCCCCCCCC---HHHHHH
Q 010309          469 IPEAGVVQKVVDLVYACTQHVPSMRPR---MSHVVH  501 (513)
Q Consensus       469 ~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~  501 (513)
                      ..+...++++.+++.+||+.||++||+   +.+++.
T Consensus       211 ~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~  246 (312)
T cd05585         211 RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN  246 (312)
T ss_pred             CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence            111234567999999999999999986   455543

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.6e-41  Score=351.91  Aligned_cols=252  Identities=20%  Similarity=0.230  Sum_probs=203.7

Q ss_pred             ccCCceecccCceEEEEEEeC-C-CCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeecc
Q 010309          227 SEGNRLLGDSKTGGTYSGILP-D-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV  304 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  304 (513)
                      +...++||+|++|.||+|... + +..||+|.+..........+.+|+.+|+.++||||+++++++...+..||||||++
T Consensus        69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~  148 (478)
T PTZ00267         69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS  148 (478)
T ss_pred             EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence            445667899999999999854 3 67899998766555555678889999999999999999999999999999999999


Q ss_pred             CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccc
Q 010309          305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  384 (513)
Q Consensus       305 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  384 (513)
                      +|+|.+++.........+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++.........
T Consensus       149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~  225 (478)
T PTZ00267        149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL  225 (478)
T ss_pred             CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence            9999998865434445789999999999999999999999   9999999999999999999999999999876543222


Q ss_pred             cceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccC
Q 010309          385 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS  464 (513)
Q Consensus       385 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  464 (513)
                      .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+...   +   ...... ..        .  
T Consensus       226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~---~---~~~~~~-~~--------~--  288 (478)
T PTZ00267        226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE---I---MQQVLY-GK--------Y--  288 (478)
T ss_pred             ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH---H---HHHHHh-CC--------C--
Confidence            22223348999999999999999999999999999999999999997643211   1   111000 00        0  


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          465 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       465 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                         ...+...+.++.++|.+||+.||++||++++++.
T Consensus       289 ---~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        289 ---DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             ---CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence               0111234567999999999999999999999874

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.4e-42  Score=321.55  Aligned_cols=241  Identities=22%  Similarity=0.345  Sum_probs=203.4

Q ss_pred             CceecccCceEEEEEEe-CCCCEEEEEEecccchhcHH---HHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccC
Q 010309          230 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKK---EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  305 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~---~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  305 (513)
                      .+.||+|.||.|-+|.. ..|+.||||.+++....+.+   .+.+|++||..|+||||+.++.+|++.+...|||||..+
T Consensus        58 ~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~  137 (668)
T KOG0611|consen   58 TETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASG  137 (668)
T ss_pred             HHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCC
Confidence            34579999999999985 67999999999887555544   568999999999999999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccc
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  385 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  385 (513)
                      |.|.+|+..    .+.+++.+++.+++||.+|+.|+|.+   +++|||||.+|||+|.++++||+|||++..+.....  
T Consensus       138 GeLYDYiSe----r~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kf--  208 (668)
T KOG0611|consen  138 GELYDYISE----RGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKF--  208 (668)
T ss_pred             ccHHHHHHH----hccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhccccH--
Confidence            999999965    46799999999999999999999999   999999999999999999999999999988765443  


Q ss_pred             ceeecCcccccccccccccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccC
Q 010309          386 RTVMAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS  464 (513)
Q Consensus       386 ~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  464 (513)
                       ....+|++-|.+||++.+.+| .+..|-|||||+||.|+.|..||++.+..   .++    ..+..+.+.+        
T Consensus       209 -LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk---~lv----rQIs~GaYrE--------  272 (668)
T KOG0611|consen  209 -LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK---RLV----RQISRGAYRE--------  272 (668)
T ss_pred             -HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH---HHH----HHhhcccccC--------
Confidence             234569999999999999988 47899999999999999999999987642   111    1112222111        


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010309          465 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  502 (513)
Q Consensus       465 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  502 (513)
                             ...+....-||++||..||++|.|+++|..-
T Consensus       273 -------P~~PSdA~gLIRwmLmVNP~RRATieDiAsH  303 (668)
T KOG0611|consen  273 -------PETPSDASGLIRWMLMVNPERRATIEDIASH  303 (668)
T ss_pred             -------CCCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence                   1122347789999999999999999999763

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=5.7e-42  Score=329.18  Aligned_cols=248  Identities=30%  Similarity=0.505  Sum_probs=193.4

Q ss_pred             ceecccCceEEEEEEeC-----CCCEEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeecc
Q 010309          231 RLLGDSKTGGTYSGILP-----DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV  304 (513)
Q Consensus       231 ~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  304 (513)
                      +.||.|.||.||+|.+.     .+..|+||.++... ....+.+.+|++.+++++||||++++|++...+..++|+||++
T Consensus         5 ~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~   84 (259)
T PF07714_consen    5 KQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCP   84 (259)
T ss_dssp             EEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--T
T ss_pred             eEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccccc
Confidence            46899999999999976     26789999996543 3346889999999999999999999999998888999999999


Q ss_pred             CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccc
Q 010309          305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  384 (513)
Q Consensus       305 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  384 (513)
                      +|+|.++|...  ....+++..+..|+.||+.||.|||+.   +++|+||+++|||++.++.+||+|||++.........
T Consensus        85 ~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   85 GGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             TEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             ccccccccccc--ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence            99999999863  245699999999999999999999999   9999999999999999999999999999876322211


Q ss_pred             cceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhccccccccccccc
Q 010309          385 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS  463 (513)
Q Consensus       385 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  463 (513)
                      ...........|+|||.+....++.++||||||+++|||++ |+.||...+...   +.   ... .....         
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~---~~---~~~-~~~~~---------  223 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE---II---EKL-KQGQR---------  223 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH---HH---HHH-HTTEE---------
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccc---cc---ccc-ccccc---------
Confidence            11111226778999999998889999999999999999999 789987654321   11   111 11100         


Q ss_pred             CCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 010309          464 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQL  503 (513)
Q Consensus       464 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  503 (513)
                          ...+..++..+.++|.+||+.||++|||+++|++.|
T Consensus       224 ----~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  224 ----LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             ----TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ----ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence                001122455699999999999999999999999987

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3e-42  Score=303.77  Aligned_cols=244  Identities=26%  Similarity=0.337  Sum_probs=205.8

Q ss_pred             cCCceecccCceEEEEEEeC-CCCEEEEEEecccch---hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeec
Q 010309          228 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  303 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  303 (513)
                      +..+.||+|.||.||.|+.+ ++-.||+|++.+...   ....++.+|+++-+.|+||||+++|++|.+....||++||.
T Consensus        25 eigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya  104 (281)
T KOG0580|consen   25 EIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYA  104 (281)
T ss_pred             cccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEec
Confidence            45678899999999999964 578999999977632   34578999999999999999999999999999999999999


Q ss_pred             cCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccc
Q 010309          304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM  383 (513)
Q Consensus       304 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~  383 (513)
                      .+|+|...|..  .....+++.....++.|+|.||.|+|..   +|+||||||+|+|++.++.+||+|||-+...+.   
T Consensus       105 ~~gel~k~L~~--~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~---  176 (281)
T KOG0580|consen  105 PRGELYKDLQE--GRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS---  176 (281)
T ss_pred             CCchHHHHHHh--cccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecCC---
Confidence            99999999975  3456799999999999999999999999   999999999999999999999999999986542   


Q ss_pred             ccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccccccccccc
Q 010309          384 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS  463 (513)
Q Consensus       384 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  463 (513)
                       ......+||..|.|||...+..++...|+|++|++.||++.|.+||......+   ......       ..++      
T Consensus       177 -~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e---tYkrI~-------k~~~------  239 (281)
T KOG0580|consen  177 -NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE---TYKRIR-------KVDL------  239 (281)
T ss_pred             -CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH---HHHHHH-------Hccc------
Confidence             22334569999999999999999999999999999999999999998654221   111100       0111      


Q ss_pred             CCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          464 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       464 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                           ..+..++..+.++|.+|+..+|.+|.+..|+++
T Consensus       240 -----~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~  272 (281)
T KOG0580|consen  240 -----KFPSTISGGAADLISRLLVKNPIERLALTEVMD  272 (281)
T ss_pred             -----cCCcccChhHHHHHHHHhccCccccccHHHHhh
Confidence                 112446678999999999999999999999986

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.8e-41  Score=336.37  Aligned_cols=241  Identities=23%  Similarity=0.276  Sum_probs=195.5

Q ss_pred             ceecccCceEEEEEEeC-CCCEEEEEEecccc---hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          231 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       231 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      ++||+|+||.||++... +|..||+|+++...   ......+.+|+.+++.++||||+++++.+...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            36899999999999964 68999999997642   223456778999999999999999999999999999999999999


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  386 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  386 (513)
                      +|..++..    ...+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++.........  
T Consensus        81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~--  151 (323)
T cd05595          81 ELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--  151 (323)
T ss_pred             cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCc--
Confidence            99988854    34689999999999999999999999   9999999999999999999999999998753222111  


Q ss_pred             eeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCC
Q 010309          387 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  466 (513)
Q Consensus       387 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  466 (513)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+...   ...   .... ..             
T Consensus       152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~---~~~---~~~~-~~-------------  211 (323)
T cd05595         152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---LFE---LILM-EE-------------  211 (323)
T ss_pred             cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH---HHH---HHhc-CC-------------
Confidence            112348999999999998999999999999999999999999997654321   100   0000 00             


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 010309          467 SDIPEAGVVQKVVDLVYACTQHVPSMRP-----RMSHVVH  501 (513)
Q Consensus       467 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  501 (513)
                       ...+...++++.+++.+||+.||.+||     ++.++++
T Consensus       212 -~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         212 -IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             -CCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence             001123456799999999999999998     7888775

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-41  Score=332.46  Aligned_cols=239  Identities=19%  Similarity=0.236  Sum_probs=196.4

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccch---hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccC
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  305 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  305 (513)
                      .+.||+|+||.||++... +++.||+|++.....   ...+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus         6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   85 (291)
T cd05612           6 IKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPG   85 (291)
T ss_pred             eeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCC
Confidence            456799999999999975 589999999975422   2345688999999999999999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccc
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  385 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  385 (513)
                      |+|.+++..    ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++.......   
T Consensus        86 ~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~---  155 (291)
T cd05612          86 GELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT---  155 (291)
T ss_pred             CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCCc---
Confidence            999999864    34689999999999999999999999   99999999999999999999999999998654321   


Q ss_pred             ceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCC
Q 010309          386 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  465 (513)
Q Consensus       386 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  465 (513)
                        ....|++.|+|||++.+..++.++|||||||++|+|++|+.||...+....   .   ..... ..            
T Consensus       156 --~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~---~---~~i~~-~~------------  214 (291)
T cd05612         156 --WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGI---Y---EKILA-GK------------  214 (291)
T ss_pred             --ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---H---HHHHh-CC------------
Confidence              122389999999999988899999999999999999999999976543211   1   11000 00            


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 010309          466 SSDIPEAGVVQKVVDLVYACTQHVPSMRPR-----MSHVVH  501 (513)
Q Consensus       466 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  501 (513)
                        ...+...+..+.+||.+||+.||.+||+     ++++++
T Consensus       215 --~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  253 (291)
T cd05612         215 --LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN  253 (291)
T ss_pred             --cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence              0011123557899999999999999995     888775

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=3.8e-41  Score=328.68  Aligned_cols=263  Identities=17%  Similarity=0.208  Sum_probs=195.2

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccch-hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCC
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  307 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs  307 (513)
                      .+.||.|+||.||+|... +++.||+|+++.... .....+.+|+.++++++||||+++++++.+.+..++||||++ ++
T Consensus        10 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~   88 (288)
T cd07871          10 LDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD-SD   88 (288)
T ss_pred             eeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC-cC
Confidence            456799999999999965 588999999975432 234567899999999999999999999999999999999996 48


Q ss_pred             HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccce
Q 010309          308 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  387 (513)
Q Consensus       308 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  387 (513)
                      |.+++...   ...+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++..........  
T Consensus        89 l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~--  160 (288)
T cd07871          89 LKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTY--  160 (288)
T ss_pred             HHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCccc--
Confidence            99888642   34578999999999999999999999   99999999999999999999999999997653322111  


Q ss_pred             eecCccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhH-----Hhh----ccccccc
Q 010309          388 VMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATP-----LVQ----SHRYLEL  457 (513)
Q Consensus       388 ~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~-----~~~----~~~~~~~  457 (513)
                      ....+++.|+|||++.+ ..++.++|||||||++|||+||++||...+..+..........     .+.    ...+...
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (288)
T cd07871         161 SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSY  240 (288)
T ss_pred             cCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhcc
Confidence            11237899999998875 5689999999999999999999999976543221111100000     000    0000001


Q ss_pred             ccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          458 LDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       458 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      ..+..............+.++.+|+.+||+.||.+|||++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         241 LFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             ccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            10100000000001123567899999999999999999999984

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.9e-41  Score=336.84  Aligned_cols=240  Identities=22%  Similarity=0.259  Sum_probs=195.8

Q ss_pred             eecccCceEEEEEEeC-CCCEEEEEEecccc---hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCC
Q 010309          232 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  307 (513)
Q Consensus       232 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs  307 (513)
                      +||+|+||.||++... +|+.||||++.+..   ......+.+|+.+++.++||||+++++++...+..++||||+++|+
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~   81 (328)
T cd05593           2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGE   81 (328)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCC
Confidence            5899999999999964 58999999997642   2334577889999999999999999999999999999999999999


Q ss_pred             HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccce
Q 010309          308 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  387 (513)
Q Consensus       308 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  387 (513)
                      |..++..    ...+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.......  ..
T Consensus        82 L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~  152 (328)
T cd05593          82 LFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA--TM  152 (328)
T ss_pred             HHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCccc--cc
Confidence            9988854    34689999999999999999999999   999999999999999999999999999875432211  11


Q ss_pred             eecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCC
Q 010309          388 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS  467 (513)
Q Consensus       388 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  467 (513)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||...+...   ...   . ....              .
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~---~~~---~-~~~~--------------~  211 (328)
T cd05593         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFE---L-ILME--------------D  211 (328)
T ss_pred             ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH---HHH---H-hccC--------------C
Confidence            22348999999999998899999999999999999999999997644321   110   0 0000              0


Q ss_pred             CCCcHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 010309          468 DIPEAGVVQKVVDLVYACTQHVPSMRP-----RMSHVVH  501 (513)
Q Consensus       468 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  501 (513)
                      ...+...+.++.+|+.+||+.||++||     ++.++++
T Consensus       212 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  250 (328)
T cd05593         212 IKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR  250 (328)
T ss_pred             ccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence            011123456799999999999999997     8888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-41  Score=340.19  Aligned_cols=236  Identities=24%  Similarity=0.342  Sum_probs=200.1

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccch---hcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCCceEEEEeecc
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVV  304 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~  304 (513)
                      -++||+|+||.|+++..+ +++.+|||++++...   .+.+..+.|.+++... +||.++.++..|.+.++.|.||||+.
T Consensus       373 l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~  452 (694)
T KOG0694|consen  373 LAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVA  452 (694)
T ss_pred             EEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecC
Confidence            467899999999999975 588999999998743   4456778898888887 59999999999999999999999999


Q ss_pred             CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccc
Q 010309          305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  384 (513)
Q Consensus       305 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  384 (513)
                      ||++..+.+     ...+++..+.-++..|+.||+|||++   +||+||||.+|||||.+|++||+|||+++..-..  .
T Consensus       453 Ggdm~~~~~-----~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~--g  522 (694)
T KOG0694|consen  453 GGDLMHHIH-----TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ--G  522 (694)
T ss_pred             CCcEEEEEe-----cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccCCC--C
Confidence            999544433     36799999999999999999999999   9999999999999999999999999999865322  2


Q ss_pred             cceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccC
Q 010309          385 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS  464 (513)
Q Consensus       385 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  464 (513)
                      ..+...+|||.|||||++.+..|+.+.|-|||||+||||+.|..||.+.++++                   +++.++..
T Consensus       523 ~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee-------------------~FdsI~~d  583 (694)
T KOG0694|consen  523 DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE-------------------VFDSIVND  583 (694)
T ss_pred             CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH-------------------HHHHHhcC
Confidence            34556779999999999999999999999999999999999999999877642                   22222211


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCH
Q 010309          465 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRM  496 (513)
Q Consensus       465 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  496 (513)
                        .-..+..++.+...+++++|..+|++|..+
T Consensus       584 --~~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  584 --EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             --CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence              222345677889999999999999999865

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=4.8e-41  Score=323.08  Aligned_cols=251  Identities=25%  Similarity=0.403  Sum_probs=203.1

Q ss_pred             CCceecccCceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCCH
Q 010309          229 GNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  308 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL  308 (513)
                      ..+.||+|++|.||+|...++..||+|.+.... ...+.+.+|+.+++.++||||+++++.+.+.+..++||||+++++|
T Consensus        10 ~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   88 (261)
T cd05072          10 LVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSL   88 (261)
T ss_pred             EeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcH
Confidence            345679999999999998888999999987543 3457889999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccccee
Q 010309          309 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  388 (513)
Q Consensus       309 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  388 (513)
                      .+++...  ....+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++........... .
T Consensus        89 ~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~-~  162 (261)
T cd05072          89 LDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAR-E  162 (261)
T ss_pred             HHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCceecc-C
Confidence            9999652  235688899999999999999999999   999999999999999999999999999987643322111 1


Q ss_pred             ecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCC
Q 010309          389 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS  467 (513)
Q Consensus       389 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  467 (513)
                      ...++..|+|||++....++.++||||||+++|+|+| |..||.......   ....    ....     ..        
T Consensus       163 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~----~~~~-----~~--------  222 (261)
T cd05072         163 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---VMSA----LQRG-----YR--------  222 (261)
T ss_pred             CCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---HHHH----HHcC-----CC--------
Confidence            1225678999999988889999999999999999998 999987543321   1111    0100     00        


Q ss_pred             CCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q 010309          468 DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  506 (513)
Q Consensus       468 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  506 (513)
                      .......+.++.+++.+||+.+|++||+++++++.|+++
T Consensus       223 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         223 MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence            001112445789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1e-41  Score=301.74  Aligned_cols=267  Identities=22%  Similarity=0.323  Sum_probs=213.7

Q ss_pred             HhhCcccCCceecccCceEEEEEE-eCCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCC-----c
Q 010309          222 ITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG-----D  295 (513)
Q Consensus       222 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-----~  295 (513)
                      +.++.+...+.||+|||+-||++. ..++..+|+|++...+.++.+..++|++..++++||||++++++...+.     .
T Consensus        18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~   97 (302)
T KOG2345|consen   18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE   97 (302)
T ss_pred             EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence            344455566788999999999998 5678999999999887788889999999999999999999998876543     4


Q ss_pred             eEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEeccccc
Q 010309          296 RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLS  375 (513)
Q Consensus       296 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~  375 (513)
                      .||+++|...|+|.+.+......+..+++.+++.|+.+|++||.+||+. .++++||||||.|||+++++.++|.|||.+
T Consensus        98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~  176 (302)
T KOG2345|consen   98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSA  176 (302)
T ss_pred             EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCc
Confidence            7999999999999999988777777899999999999999999999998 345999999999999999999999999999


Q ss_pred             ccCCccccccc-------eeecCcccccccccccc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhh
Q 010309          376 KFVPWEVMQER-------TVMAGGTYGYLAPEFVY---RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWA  445 (513)
Q Consensus       376 ~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~  445 (513)
                      ...........       ......|..|.|||++.   +...+.++|||||||+||+|+.|..||+..-.          
T Consensus       177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~----------  246 (302)
T KOG2345|consen  177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ----------  246 (302)
T ss_pred             cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh----------
Confidence            87653321111       11112688999999885   34568899999999999999999999974321          


Q ss_pred             hHHhhcccc-cccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCc
Q 010309          446 TPLVQSHRY-LELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  507 (513)
Q Consensus       446 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  507 (513)
                          +.+.+ ..+..+.+    .......+++.+.++|+.||+.||.+||++.+++..++.+.
T Consensus       247 ----~GgSlaLAv~n~q~----s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  247 ----QGGSLALAVQNAQI----SIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             ----cCCeEEEeeecccc----ccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence                11111 11112122    11112237788999999999999999999999999988653

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=6.2e-41  Score=325.71  Aligned_cols=252  Identities=25%  Similarity=0.406  Sum_probs=202.2

Q ss_pred             ceecccCceEEEEEEeCC------CCEEEEEEecccchh-cHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeec
Q 010309          231 RLLGDSKTGGTYSGILPD------GSRVAVKRLKRSSFQ-RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  303 (513)
Q Consensus       231 ~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  303 (513)
                      +.||+|+||.||+|...+      +..||||.++..... ..+.+.+|+++++.++||||+++++++......++||||+
T Consensus        11 ~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   90 (280)
T cd05049          11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYM   90 (280)
T ss_pred             hhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEecC
Confidence            467999999999998633      478999999765433 4578999999999999999999999999999999999999


Q ss_pred             cCCCHHHHhccCC----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEeccc
Q 010309          304 VNGPLDRWLHHIP----------RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVG  373 (513)
Q Consensus       304 ~~gsL~~~l~~~~----------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg  373 (513)
                      ++++|.+++....          .....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||
T Consensus        91 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~kl~d~g  167 (280)
T cd05049          91 EHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFG  167 (280)
T ss_pred             CCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeEEECCcc
Confidence            9999999996531          2234588999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcc
Q 010309          374 LSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSH  452 (513)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  452 (513)
                      ++................+++.|+|||++.+..++.++||||||+++|||++ |..||...+...   ....    ....
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~---~~~~----~~~~  240 (280)
T cd05049         168 MSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE---VIEC----ITQG  240 (280)
T ss_pred             cceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHH----HHcC
Confidence            9976533221111111225778999999999999999999999999999998 999987654321   1111    0100


Q ss_pred             cccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 010309          453 RYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ  505 (513)
Q Consensus       453 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  505 (513)
                      .             ...++...+..+.+++.+||+.||++||++.||++.|++
T Consensus       241 ~-------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         241 R-------------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             C-------------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence            0             011112345679999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-42  Score=319.96  Aligned_cols=264  Identities=20%  Similarity=0.286  Sum_probs=202.3

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEec--ccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEee-----CCceEEEEe
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLK--RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD-----HGDRYIVYE  301 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-----~~~~~lv~e  301 (513)
                      .+.||+|+||.|..+... +|+.||||.+.  .......++..+|+++|+.++|+||+.+++++..     -+..|+|+|
T Consensus        27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e  106 (359)
T KOG0660|consen   27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE  106 (359)
T ss_pred             cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence            345799999999999964 68999999997  3444556788999999999999999999999865     356799999


Q ss_pred             eccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcc
Q 010309          302 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE  381 (513)
Q Consensus       302 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~  381 (513)
                      +| +.+|...++.    +..++...+..++.|++.||.|+|+.   +|+||||||.|+|++.+..+||+|||+|+.....
T Consensus       107 lM-etDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~  178 (359)
T KOG0660|consen  107 LM-ETDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARYLDKF  178 (359)
T ss_pred             HH-hhHHHHHHHc----CccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceeecccc
Confidence            99 7799999964    45599999999999999999999999   9999999999999999999999999999988643


Q ss_pred             ccccceeecCccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccc--
Q 010309          382 VMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELL--  458 (513)
Q Consensus       382 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  458 (513)
                      ......+....|..|.|||++.. ..|+.+.||||.|||+.||++|++.|.+.+.....+++....+......+..+-  
T Consensus       179 ~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~  258 (359)
T KOG0660|consen  179 FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSE  258 (359)
T ss_pred             CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccH
Confidence            11222122237899999998865 579999999999999999999999999877654333332211111111110000  


Q ss_pred             --cccccCCCCC--CC----cHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          459 --DPLISSLSSD--IP----EAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       459 --~~~~~~~~~~--~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                        .+.+++++..  .+    -.+..+...+|+.+||..||.+|+|++|+|+
T Consensus       259 ~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  259 KARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             HHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence              0011111110  00    0145567999999999999999999999986

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.5e-42  Score=323.00  Aligned_cols=260  Identities=23%  Similarity=0.309  Sum_probs=200.7

Q ss_pred             CCceecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCc-----eEEEEee
Q 010309          229 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD-----RYIVYEF  302 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-----~~lv~e~  302 (513)
                      ..+++|.|+||.||+|... +++.||||++-.+..    .-.+|+.+|+.+.|||||+++-+|.....     ..+||||
T Consensus        28 ~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVley  103 (364)
T KOG0658|consen   28 AVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEY  103 (364)
T ss_pred             eeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHh
Confidence            3568899999999999964 479999999865422    23479999999999999999988875432     3589999


Q ss_pred             ccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCC-CCeEEecccccccCCcc
Q 010309          303 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE-FGAHLMGVGLSKFVPWE  381 (513)
Q Consensus       303 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~-~~~kl~Dfg~~~~~~~~  381 (513)
                      |+. +|.++++.....+..++...+.-+..||.+||+|||+.   +|+||||||.|+|+|.+ +.+||+|||.|+.+...
T Consensus       104 mP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~  179 (364)
T KOG0658|consen  104 MPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKG  179 (364)
T ss_pred             chH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceeeccC
Confidence            965 89999987656677899999999999999999999998   99999999999999987 78999999999998766


Q ss_pred             ccccceeecCcccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHh--h-------c
Q 010309          382 VMQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLV--Q-------S  451 (513)
Q Consensus       382 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~--~-------~  451 (513)
                      .......   .|..|+|||.+.+. .|+.+.||||.|||+.||+-|++.|.+.+...  ++.+..+-+-  .       .
T Consensus       180 epniSYi---cSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~d--QL~eIik~lG~Pt~e~I~~mn  254 (364)
T KOG0658|consen  180 EPNISYI---CSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVD--QLVEIIKVLGTPTREDIKSMN  254 (364)
T ss_pred             CCceeEE---EeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHH--HHHHHHHHhCCCCHHHHhhcC
Confidence            6554333   68899999999874 79999999999999999999999999866542  2222211110  0       0


Q ss_pred             ccccccccccccCCC-CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          452 HRYLELLDPLISSLS-SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       452 ~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      ....+...+.+.... ........++++.+|+.++|+.+|.+|.++.|++.
T Consensus       255 ~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  255 PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             cccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence            111111222221111 11123345678999999999999999999999985

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=9.1e-41  Score=319.44  Aligned_cols=248  Identities=28%  Similarity=0.389  Sum_probs=197.8

Q ss_pred             eecccCceEEEEEEeC-CCCEEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCCHH
Q 010309          232 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD  309 (513)
Q Consensus       232 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~  309 (513)
                      .||+|+||.||+|... +++.||+|.+.... ......+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   81 (252)
T cd05084           2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL   81 (252)
T ss_pred             ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHH
Confidence            4799999999999974 68999999886542 234567899999999999999999999999999999999999999999


Q ss_pred             HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccceee
Q 010309          310 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM  389 (513)
Q Consensus       310 ~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  389 (513)
                      +++..   ....+++..++.++.|++.||.|||+.   +++|+||||+|||++.++.+||+|||++..............
T Consensus        82 ~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  155 (252)
T cd05084          82 TFLRT---EGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM  155 (252)
T ss_pred             HHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence            99863   234589999999999999999999999   999999999999999999999999999876543211111111


Q ss_pred             cCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCCC
Q 010309          390 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD  468 (513)
Q Consensus       390 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  468 (513)
                      ...+..|+|||.+.+..++.++||||||+++|||++ |..||........       .......     .        ..
T Consensus       156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~-------~~~~~~~-----~--------~~  215 (252)
T cd05084         156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT-------REAIEQG-----V--------RL  215 (252)
T ss_pred             CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHH-------HHHHHcC-----C--------CC
Confidence            113467999999988889999999999999999998 8888865433210       0000000     0        00


Q ss_pred             CCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 010309          469 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ  505 (513)
Q Consensus       469 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  505 (513)
                      ..+...+..+.+++.+||+.+|++|||+.+|++.|+.
T Consensus       216 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~  252 (252)
T cd05084         216 PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS  252 (252)
T ss_pred             CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence            1112345679999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-41  Score=347.90  Aligned_cols=257  Identities=21%  Similarity=0.296  Sum_probs=209.4

Q ss_pred             cCCceecccCceEEEEEEeCCC-CEEEEEEecccchhcHHHHHHHHHHHhhcC-CCcEeeeeeEE-ee------CCceEE
Q 010309          228 EGNRLLGDSKTGGTYSGILPDG-SRVAVKRLKRSSFQRKKEFYSEIGRFARLH-HPNLVAVKGCC-YD------HGDRYI  298 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~-~~------~~~~~l  298 (513)
                      ...++|.+|||+.||+|....+ ..||+|++-..+....+.+.+|+.+|++|. |+|||.+++.. ..      .-+.+|
T Consensus        40 ~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Evll  119 (738)
T KOG1989|consen   40 TVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLL  119 (738)
T ss_pred             EEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEe
Confidence            3457899999999999998766 999999998777778889999999999996 99999999932 21      124689


Q ss_pred             EEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccC
Q 010309          299 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV  378 (513)
Q Consensus       299 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~  378 (513)
                      +||||.+|.|-+++..+..  ..|++.++++|+.|+++|+++||.. +++|||||||.|||||+.+++.||||||.+...
T Consensus       120 LmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~  196 (738)
T KOG1989|consen  120 LMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATTK  196 (738)
T ss_pred             ehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccccc
Confidence            9999999999999986433  4499999999999999999999986 778999999999999999999999999998754


Q ss_pred             Ccccccc-------ceeecCcccccccccccc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHH
Q 010309          379 PWEVMQE-------RTVMAGGTYGYLAPEFVY---RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPL  448 (513)
Q Consensus       379 ~~~~~~~-------~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  448 (513)
                      .......       ......-|+.|+|||++.   +.+.++|+|||+|||+||.|+....||+.....            
T Consensus       197 ~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l------------  264 (738)
T KOG1989|consen  197 ILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL------------  264 (738)
T ss_pred             cCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce------------
Confidence            3221100       111122689999999874   568899999999999999999999999865321            


Q ss_pred             hhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcCCC
Q 010309          449 VQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP  510 (513)
Q Consensus       449 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  510 (513)
                             .++....    ...+...++..+.+||+.||+.||.+||++-+|+..+.+++..+
T Consensus       265 -------aIlng~Y----~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~  315 (738)
T KOG1989|consen  265 -------AILNGNY----SFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP  315 (738)
T ss_pred             -------eEEeccc----cCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence                   1222111    22333578899999999999999999999999999998887654

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=4.6e-41  Score=327.92  Aligned_cols=265  Identities=18%  Similarity=0.209  Sum_probs=197.6

Q ss_pred             CCceecccCceEEEEEEeC-CCCEEEEEEecccc--hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccC
Q 010309          229 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  305 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  305 (513)
                      ..+.||+|+||.||+++.. +++.||||++....  ....+.+.+|+.+++.++||||+++++++...+..++||||+++
T Consensus         5 ~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   84 (287)
T cd07848           5 VLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEK   84 (287)
T ss_pred             EEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCC
Confidence            3456799999999999975 58899999997542  22346788999999999999999999999999999999999998


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccc
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  385 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  385 (513)
                      ++|..+...    ...+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++..........
T Consensus        85 ~~l~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  157 (287)
T cd07848          85 NMLELLEEM----PNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN  157 (287)
T ss_pred             CHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccccccc
Confidence            877655432    34689999999999999999999999   99999999999999999999999999998764322211


Q ss_pred             ceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHh-hhH--------Hhhcccccc
Q 010309          386 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEW-ATP--------LVQSHRYLE  456 (513)
Q Consensus       386 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~-~~~--------~~~~~~~~~  456 (513)
                      . ....|++.|+|||++.+..++.++|||||||++|||++|++||...+.......... ..+        .........
T Consensus       158 ~-~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (287)
T cd07848         158 Y-TEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG  236 (287)
T ss_pred             c-cccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcc
Confidence            1 122388999999999988899999999999999999999999986543211100000 000        000000000


Q ss_pred             cccccccCCC--CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          457 LLDPLISSLS--SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       457 ~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      ...+......  ........+..+.+|+.+||+.||++|||++++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         237 LRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             cccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0000000000  00001124567999999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=7e-41  Score=326.88  Aligned_cols=258  Identities=28%  Similarity=0.414  Sum_probs=205.1

Q ss_pred             CCceecccCceEEEEEEeC------CCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEee
Q 010309          229 GNRLLGDSKTGGTYSGILP------DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF  302 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  302 (513)
                      ..+.||+|+||.||++...      ++..+|+|.+........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus         9 ~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   88 (288)
T cd05093           9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEY   88 (288)
T ss_pred             eccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEc
Confidence            3456799999999999842      3457999999876555667899999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhccCC---------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEeccc
Q 010309          303 VVNGPLDRWLHHIP---------RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVG  373 (513)
Q Consensus       303 ~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg  373 (513)
                      +++++|.+++....         .....+++..++.++.|++.||+|||+.   +++||||||+|||+++++.++|+|||
T Consensus        89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg  165 (288)
T cd05093          89 MKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFG  165 (288)
T ss_pred             CCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEeccCC
Confidence            99999999986432         1123589999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcc
Q 010309          374 LSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSH  452 (513)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  452 (513)
                      ++................++..|+|||++.+..++.++||||||+++|+|++ |..||.......   ...    .....
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~---~~~----~i~~~  238 (288)
T cd05093         166 MSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VIE----CITQG  238 (288)
T ss_pred             ccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH----HHHcC
Confidence            9986543322111112225778999999988889999999999999999998 899987554321   111    01111


Q ss_pred             cccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcCC
Q 010309          453 RYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP  509 (513)
Q Consensus       453 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  509 (513)
                      ...            . .+...+.++.+|+.+||+.||.+|||+.++++.|+++...
T Consensus       239 ~~~------------~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         239 RVL------------Q-RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             CcC------------C-CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence            000            0 0112345699999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1e-40  Score=324.72  Aligned_cols=254  Identities=28%  Similarity=0.467  Sum_probs=202.1

Q ss_pred             CceecccCceEEEEEEeCC------CCEEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEee
Q 010309          230 NRLLGDSKTGGTYSGILPD------GSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF  302 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  302 (513)
                      .+.||+|+||.||+|....      ...||+|.+.... ......+.+|+.++.+++||||+++++++...+..+++|||
T Consensus        10 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~   89 (283)
T cd05048          10 LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEY   89 (283)
T ss_pred             hhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEec
Confidence            3457999999999998643      2579999997543 23346789999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEe
Q 010309          303 VVNGPLDRWLHHIPR------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLM  370 (513)
Q Consensus       303 ~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~  370 (513)
                      +++++|.+++.....            ....+++..++.++.|++.||.|||+.   +++|+||||+||++++++.++|+
T Consensus        90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~L~  166 (283)
T cd05048          90 LAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKIS  166 (283)
T ss_pred             CCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCCcEEEC
Confidence            999999999965321            114588999999999999999999999   99999999999999999999999


Q ss_pred             cccccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHh
Q 010309          371 GVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLV  449 (513)
Q Consensus       371 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  449 (513)
                      |||++................+++.|+|||.+.+..++.++|||||||++|||++ |..||.+....+   ...    .+
T Consensus       167 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~---~~~----~i  239 (283)
T cd05048         167 DFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE---VIE----MI  239 (283)
T ss_pred             CCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH----HH
Confidence            9999986543322111222236788999999988899999999999999999998 999997654321   111    11


Q ss_pred             hcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q 010309          450 QSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  506 (513)
Q Consensus       450 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  506 (513)
                      ....        .    . ..+..++.++.+|+.+||+.||.+||++.+|++.|+.+
T Consensus       240 ~~~~--------~----~-~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05048         240 RSRQ--------L----L-PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW  283 (283)
T ss_pred             HcCC--------c----C-CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence            1110        0    0 11234567899999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.5e-40  Score=320.61  Aligned_cols=257  Identities=23%  Similarity=0.346  Sum_probs=206.6

Q ss_pred             CCceecccCceEEEEEEeC-CCCEEEEEEeccc---chhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeecc
Q 010309          229 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS---SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV  304 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  304 (513)
                      ..+.||+|+||.||+|... +++.||||.+...   .......+.+|+.+++.++||||+++++++.+.+..++|+||++
T Consensus         6 i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~   85 (267)
T cd08228           6 IEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELAD   85 (267)
T ss_pred             eeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecC
Confidence            3456799999999999964 6899999988643   22334578899999999999999999999999999999999999


Q ss_pred             CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccc
Q 010309          305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  384 (513)
Q Consensus       305 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  384 (513)
                      +++|.+++.........+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++.........
T Consensus        86 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~  162 (267)
T cd08228          86 AGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA  162 (267)
T ss_pred             CCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccchhHH
Confidence            9999998865444445689999999999999999999999   9999999999999999999999999998876543221


Q ss_pred             cceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccC
Q 010309          385 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS  464 (513)
Q Consensus       385 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  464 (513)
                      .  ....+++.|+|||.+.+..++.++|+||||+++|||++|..||......    ........ ...            
T Consensus       163 ~--~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~----~~~~~~~~-~~~------------  223 (267)
T cd08228         163 A--HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LFSLCQKI-EQC------------  223 (267)
T ss_pred             H--hcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc----HHHHHHHH-hcC------------
Confidence            1  1123788999999998888899999999999999999999998654321    01111110 000            


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCc
Q 010309          465 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  507 (513)
Q Consensus       465 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  507 (513)
                      .....+....+..+.+++.+||+.+|++||++.+|++.|+++.
T Consensus       224 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         224 DYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             CCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence            0011222345677999999999999999999999999998864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2.5e-41  Score=336.23  Aligned_cols=240  Identities=25%  Similarity=0.325  Sum_probs=196.2

Q ss_pred             CCceecccCceEEEEEEeC-CCCEEEEEEecccch---hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeecc
Q 010309          229 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV  304 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  304 (513)
                      ..+.||+|+||.||++... +++.||||++.....   ...+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus        22 ~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~  101 (329)
T PTZ00263         22 MGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVV  101 (329)
T ss_pred             EEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCC
Confidence            3457899999999999975 589999999975422   234568899999999999999999999999999999999999


Q ss_pred             CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccc
Q 010309          305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  384 (513)
Q Consensus       305 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  384 (513)
                      +|+|.+++..    ...+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++........ 
T Consensus       102 ~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-  173 (329)
T PTZ00263        102 GGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF-  173 (329)
T ss_pred             CChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCCcc-
Confidence            9999999864    34688999999999999999999999   999999999999999999999999999986643221 


Q ss_pred             cceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccC
Q 010309          385 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS  464 (513)
Q Consensus       385 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  464 (513)
                          ...||+.|+|||++.+..++.++|||||||++|||++|..||...+...   ..   .... ...        .  
T Consensus       174 ----~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---~~---~~i~-~~~--------~--  232 (329)
T PTZ00263        174 ----TLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR---IY---EKIL-AGR--------L--  232 (329)
T ss_pred             ----eecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH---HH---HHHh-cCC--------c--
Confidence                2348999999999999889999999999999999999999997644311   10   1100 000        0  


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 010309          465 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPR-----MSHVVH  501 (513)
Q Consensus       465 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  501 (513)
                          ..+...+..+.+|+.+||+.||.+||+     ++++++
T Consensus       233 ----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        233 ----KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             ----CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence                001123456899999999999999997     577763

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.5e-40  Score=318.68  Aligned_cols=247  Identities=25%  Similarity=0.425  Sum_probs=199.0

Q ss_pred             CceecccCceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCCHH
Q 010309          230 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD  309 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~  309 (513)
                      .+.||+|+||.||++...++..+|+|.+.... ....++.+|+.++++++||||+++++++.+.+..++||||+++|+|.
T Consensus         9 ~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~   87 (256)
T cd05114           9 MKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLL   87 (256)
T ss_pred             eeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHH
Confidence            34679999999999999888899999987543 34567899999999999999999999999999999999999999999


Q ss_pred             HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccceee
Q 010309          310 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM  389 (513)
Q Consensus       310 ~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  389 (513)
                      +++...   ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||.+........... ..
T Consensus        88 ~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~-~~  160 (256)
T cd05114          88 NYLRQR---QGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS-SG  160 (256)
T ss_pred             HHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceecc-CC
Confidence            998642   23588999999999999999999999   999999999999999999999999999886543222111 11


Q ss_pred             cCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCCC
Q 010309          390 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD  468 (513)
Q Consensus       390 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  468 (513)
                      ..++..|+|||++.+..++.++||||||+++|||++ |+.||...+...   ...   .......   ...         
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~---~~~---~i~~~~~---~~~---------  222 (256)
T cd05114         161 AKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE---VVE---MISRGFR---LYR---------  222 (256)
T ss_pred             CCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHH---HHHCCCC---CCC---------
Confidence            125668999999988889999999999999999999 899987654321   111   1111000   000         


Q ss_pred             CCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 010309          469 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ  504 (513)
Q Consensus       469 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  504 (513)
                        +...+..+.+++.+||+.+|++||+++++++.|.
T Consensus       223 --~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         223 --PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             --CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence              1112456899999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-40  Score=320.16  Aligned_cols=251  Identities=29%  Similarity=0.471  Sum_probs=203.2

Q ss_pred             CCceecccCceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCCH
Q 010309          229 GNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  308 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL  308 (513)
                      ..+.||+|++|.||+|...+++.||+|.++... ...+++.+|+.++++++||||+++++++...+..++||||+++++|
T Consensus        10 ~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   88 (261)
T cd05068          10 LLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSL   88 (261)
T ss_pred             eEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcH
Confidence            346789999999999998778899999997653 3456789999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccccee
Q 010309          309 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  388 (513)
Q Consensus       309 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  388 (513)
                      .+++....  ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++........... .
T Consensus        89 ~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~-~  162 (261)
T cd05068          89 LEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAR-E  162 (261)
T ss_pred             HHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCccccc-C
Confidence            99996522  35689999999999999999999999   999999999999999999999999999987653221111 1


Q ss_pred             ecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCC
Q 010309          389 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS  467 (513)
Q Consensus       389 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  467 (513)
                      ....+..|+|||++.+..++.++||||||+++|||+| |+.||.......   ...    ......             .
T Consensus       163 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~----~~~~~~-------------~  222 (261)
T cd05068         163 GAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE---VLQ----QVDQGY-------------R  222 (261)
T ss_pred             CCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHH----HHHcCC-------------C
Confidence            1113457999999988889999999999999999999 999987644221   111    010000             0


Q ss_pred             CCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q 010309          468 DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  506 (513)
Q Consensus       468 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  506 (513)
                      ...+...+..+.+++.+||+.+|++||++.+|++.|+.+
T Consensus       223 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         223 MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence            001122456799999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=8.1e-41  Score=339.34  Aligned_cols=260  Identities=28%  Similarity=0.401  Sum_probs=202.6

Q ss_pred             ccCCceecccCceEEEEEEeC------CCCEEEEEEecccc-hhcHHHHHHHHHHHhhcC-CCcEeeeeeEEeeCCceEE
Q 010309          227 SEGNRLLGDSKTGGTYSGILP------DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYI  298 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~l  298 (513)
                      ....++||+|+||.||+|...      .+..||||+++... ....+.+.+|+.+|+++. ||||+++++++.+.+..+|
T Consensus        39 ~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~l  118 (400)
T cd05105          39 LVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYI  118 (400)
T ss_pred             eehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEE
Confidence            344567899999999999852      13479999997543 233467899999999995 9999999999999999999


Q ss_pred             EEeeccCCCHHHHhccCCC-------------------------------------------------------------
Q 010309          299 VYEFVVNGPLDRWLHHIPR-------------------------------------------------------------  317 (513)
Q Consensus       299 v~e~~~~gsL~~~l~~~~~-------------------------------------------------------------  317 (513)
                      ||||+++|+|.++|.....                                                             
T Consensus       119 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  198 (400)
T cd05105         119 ITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEAS  198 (400)
T ss_pred             EEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhh
Confidence            9999999999998864210                                                             


Q ss_pred             -------------------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCC
Q 010309          318 -------------------------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG  366 (513)
Q Consensus       318 -------------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~  366 (513)
                                                     ....+++..+..++.|++.||+|||+.   +|+|+||||+|||++.++.
T Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~~~~  275 (400)
T cd05105         199 KYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQGKI  275 (400)
T ss_pred             hhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeCCCE
Confidence                                           113478888999999999999999999   9999999999999999999


Q ss_pred             eEEecccccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhh
Q 010309          367 AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWA  445 (513)
Q Consensus       367 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~  445 (513)
                      +||+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |..||.......  ...   
T Consensus       276 ~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~--~~~---  350 (400)
T cd05105         276 VKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS--TFY---  350 (400)
T ss_pred             EEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH--HHH---
Confidence            99999999986543222111122236778999999998899999999999999999997 999987543210  000   


Q ss_pred             hHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcC
Q 010309          446 TPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  508 (513)
Q Consensus       446 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  508 (513)
                       ......     ..        ...+...+..+.+++.+||+.||++||++.+|.+.|+++.+
T Consensus       351 -~~~~~~-----~~--------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         351 -NKIKSG-----YR--------MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             -HHHhcC-----CC--------CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence             000000     00        00112345679999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.4e-40  Score=325.25  Aligned_cols=258  Identities=26%  Similarity=0.416  Sum_probs=206.9

Q ss_pred             CceecccCceEEEEEEeC------CCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeec
Q 010309          230 NRLLGDSKTGGTYSGILP------DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  303 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  303 (513)
                      .+.||+|+||.||++...      ++..+++|.+........+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus        10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   89 (291)
T cd05094          10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYM   89 (291)
T ss_pred             eeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecC
Confidence            457899999999999842      35579999998776666678999999999999999999999999999999999999


Q ss_pred             cCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEec
Q 010309          304 VNGPLDRWLHHIPR------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMG  371 (513)
Q Consensus       304 ~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~D  371 (513)
                      ++++|.+++.....            ....+++..++.++.||+.||+|||++   +|+||||||+|||++.++.++|+|
T Consensus        90 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~d  166 (291)
T cd05094          90 KHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGD  166 (291)
T ss_pred             CCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEECC
Confidence            99999999964321            124589999999999999999999999   999999999999999999999999


Q ss_pred             ccccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhh
Q 010309          372 VGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQ  450 (513)
Q Consensus       372 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  450 (513)
                      ||++................++..|+|||.+.+..++.++||||||+++|||+| |..||...+...   ..+    ...
T Consensus       167 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~----~~~  239 (291)
T cd05094         167 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE---VIE----CIT  239 (291)
T ss_pred             CCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH----HHh
Confidence            999976543322111112226788999999998899999999999999999999 999987654321   111    011


Q ss_pred             cccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcCCC
Q 010309          451 SHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP  510 (513)
Q Consensus       451 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  510 (513)
                      .....             ......+..+.+++.+||+.||++|||+++|++.|+++..+.
T Consensus       240 ~~~~~-------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~  286 (291)
T cd05094         240 QGRVL-------------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKAT  286 (291)
T ss_pred             CCCCC-------------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhc
Confidence            11100             011123457999999999999999999999999999886553

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-41  Score=335.26  Aligned_cols=248  Identities=21%  Similarity=0.237  Sum_probs=199.8

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccch---hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccC
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  305 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  305 (513)
                      .+.||+|+||.||+|+.. +++.||||+++....   .....+.+|+.++..++||||+++++++.+.+..++||||+++
T Consensus         6 ~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g   85 (333)
T cd05600           6 LTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPG   85 (333)
T ss_pred             EEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCC
Confidence            456799999999999975 589999999976422   2345688999999999999999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccc
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  385 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  385 (513)
                      ++|.+++..    ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++......    
T Consensus        86 ~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~----  154 (333)
T cd05600          86 GDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTY----  154 (333)
T ss_pred             CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCcccccc----
Confidence            999999954    34689999999999999999999999   9999999999999999999999999999865431    


Q ss_pred             ceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCC
Q 010309          386 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  465 (513)
Q Consensus       386 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  465 (513)
                       .....||+.|+|||++.+..++.++|||||||++|||++|..||...+....   ....   ...   ...+....   
T Consensus       155 -~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~---~~~i---~~~---~~~~~~~~---  221 (333)
T cd05600         155 -ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET---WENL---KYW---KETLQRPV---  221 (333)
T ss_pred             -cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH---HHHH---Hhc---cccccCCC---
Confidence             1122389999999999999999999999999999999999999976543211   1100   000   00000000   


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010309          466 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  502 (513)
Q Consensus       466 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  502 (513)
                       ...+....++++.+++.+||..+|.+||+++++++.
T Consensus       222 -~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         222 -YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             -CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence             011112356789999999999999999999999863

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=8.7e-41  Score=332.75  Aligned_cols=264  Identities=22%  Similarity=0.344  Sum_probs=198.9

Q ss_pred             cCCceecccCceEEEEEEeC-CCCEEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccC
Q 010309          228 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  305 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  305 (513)
                      +..+.||+|+||.||++... ++..+|+|.+.... ......+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus         8 ~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   87 (333)
T cd06650           8 EKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDG   87 (333)
T ss_pred             heeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCC
Confidence            34456799999999999975 58899999887642 23346789999999999999999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccc
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  385 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  385 (513)
                      ++|.+++..    ...+++..+..++.|++.||.|||+..  +|+|+||||+|||++.++.+||+|||++........  
T Consensus        88 ~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~--  159 (333)
T cd06650          88 GSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--  159 (333)
T ss_pred             CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhcc--
Confidence            999999964    345889999999999999999999741  799999999999999999999999999876533211  


Q ss_pred             ceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHh-hcc------------
Q 010309          386 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLV-QSH------------  452 (513)
Q Consensus       386 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~-~~~------------  452 (513)
                        ....++..|+|||++.+..++.++|||||||++|||++|+.||................... ...            
T Consensus       160 --~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (333)
T cd06650         160 --NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRP  237 (333)
T ss_pred             --ccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccch
Confidence              12238899999999998889999999999999999999999997644321111100000000 000            


Q ss_pred             ------------cccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          453 ------------RYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       453 ------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                                  ......+..........+....+.++.+|+.+||+.||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~  298 (333)
T cd06650         238 LSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV  298 (333)
T ss_pred             hhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence                        0000000001111111111124567899999999999999999999975

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=9.1e-41  Score=324.67  Aligned_cols=247  Identities=20%  Similarity=0.260  Sum_probs=197.1

Q ss_pred             ecccCceEEEEEEeC-CCCEEEEEEecccchh---cHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCCH
Q 010309          233 LGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQ---RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  308 (513)
Q Consensus       233 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL  308 (513)
                      ||+|+||+||++... +++.||+|.+......   ..+.+..|+.+++.++||||+++.+++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999864 6889999999754322   235677899999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccccee
Q 010309          309 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  388 (513)
Q Consensus       309 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  388 (513)
                      ..++.........+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.++|+|||++.........  ..
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--cc
Confidence            988865434456799999999999999999999999   9999999999999999999999999999765433221  11


Q ss_pred             ecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCCC
Q 010309          389 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD  468 (513)
Q Consensus       389 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  468 (513)
                      ...||+.|+|||++.+..++.++||||||+++|||++|+.||.........  .....         .....      ..
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~--~~~~~---------~~~~~------~~  218 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KELKQ---------RILND------SV  218 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH--HHHHH---------hhccc------CC
Confidence            223899999999999999999999999999999999999999764321100  00000         00000      00


Q ss_pred             CCcHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 010309          469 IPEAGVVQKVVDLVYACTQHVPSMRP-----RMSHVVH  501 (513)
Q Consensus       469 ~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  501 (513)
                      ..+...++.+.+++.+||+.||++||     +++++++
T Consensus       219 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         219 TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            11223566799999999999999999     7777875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.5e-40  Score=320.15  Aligned_cols=250  Identities=29%  Similarity=0.482  Sum_probs=202.1

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCCH
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  308 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL  308 (513)
                      .+.||+|++|.||+|... .++.||+|.+.... .....+.+|+.+++.++||||+++++++...+..++||||+++++|
T Consensus        11 ~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   89 (263)
T cd05052          11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL   89 (263)
T ss_pred             eeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcH
Confidence            346799999999999965 48899999987543 3456789999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccccee
Q 010309          309 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  388 (513)
Q Consensus       309 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  388 (513)
                      .+++...  ....+++..++.++.|++.||+|||+.   +++||||||+||++++++.+||+|||++............ 
T Consensus        90 ~~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~-  163 (263)
T cd05052          90 LDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA-  163 (263)
T ss_pred             HHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceeeccC-
Confidence            9998642  234689999999999999999999999   9999999999999999999999999999876543221111 


Q ss_pred             ecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCC
Q 010309          389 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS  467 (513)
Q Consensus       389 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  467 (513)
                      ....+..|+|||.+.+..++.++||||||+++|||++ |..||...+...   ....    ....     ..       .
T Consensus       164 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~~~~----~~~~-----~~-------~  224 (263)
T cd05052         164 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYEL----LEKG-----YR-------M  224 (263)
T ss_pred             CCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH----HHCC-----CC-------C
Confidence            1114568999999988899999999999999999998 999987643321   1110    0000     00       0


Q ss_pred             CCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q 010309          468 DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  506 (513)
Q Consensus       468 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  506 (513)
                       ..+...+.++.+++.+||+.||++|||+.++++.|+++
T Consensus       225 -~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         225 -ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             -CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence             11123456799999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-41  Score=332.92  Aligned_cols=247  Identities=21%  Similarity=0.299  Sum_probs=208.1

Q ss_pred             CCceecccCceEEEEEEeC-CCCEEEEEEecccc--hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCc-eEEEEeecc
Q 010309          229 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD-RYIVYEFVV  304 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-~~lv~e~~~  304 (513)
                      ..+.+|+|+||.+++.+.+ ++..||+|.+.-..  ...++...+|+.++++++|||||.+.+.+.+++. .+|||+|++
T Consensus         8 ~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~e   87 (426)
T KOG0589|consen    8 VLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCE   87 (426)
T ss_pred             hhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecC
Confidence            3456799999999999864 57899999997553  2334578999999999999999999999999998 899999999


Q ss_pred             CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccc
Q 010309          305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  384 (513)
Q Consensus       305 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  384 (513)
                      ||+|.+.|...  .+..++++.+..++.|++.|+.|||++   .|+|||||+.|||++.+..+||+|||+|+.+......
T Consensus        88 Gg~l~~~i~~~--k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~  162 (426)
T KOG0589|consen   88 GGDLAQLIKEQ--KGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSL  162 (426)
T ss_pred             CCCHHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCchhh
Confidence            99999999763  357799999999999999999999999   9999999999999999999999999999998766522


Q ss_pred             cceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccC
Q 010309          385 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS  464 (513)
Q Consensus       385 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  464 (513)
                      ..  ...||+.||.||++.+.+|..|+|||||||++|||++-+++|...+..   .++..                ....
T Consensus       163 a~--tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~---~Li~k----------------i~~~  221 (426)
T KOG0589|consen  163 AS--TVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS---ELILK----------------INRG  221 (426)
T ss_pred             hh--eecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH---HHHHH----------------Hhhc
Confidence            22  233999999999999999999999999999999999999999876532   11111                1111


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010309          465 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  502 (513)
Q Consensus       465 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  502 (513)
                      . ....+...+.++..+|..||+.+|..||++.++|..
T Consensus       222 ~-~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  222 L-YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             c-CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            1 122344677889999999999999999999999975

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.2e-40  Score=320.30  Aligned_cols=250  Identities=27%  Similarity=0.481  Sum_probs=206.3

Q ss_pred             CceecccCceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCCHH
Q 010309          230 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD  309 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~  309 (513)
                      .+.||.|++|.||+|...++..+|+|.+..........+.+|+.+++.++||||+++++++.+.+..++||||+++++|.
T Consensus        11 ~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   90 (261)
T cd05148          11 ERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLL   90 (261)
T ss_pred             hhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHH
Confidence            44679999999999998889999999998776656778999999999999999999999999999999999999999999


Q ss_pred             HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccceee
Q 010309          310 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM  389 (513)
Q Consensus       310 ~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  389 (513)
                      +++...  ....+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||.+...........  .
T Consensus        91 ~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~--~  163 (261)
T cd05148          91 AFLRSP--EGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSS--D  163 (261)
T ss_pred             HHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCcccccc--C
Confidence            999752  335689999999999999999999999   999999999999999999999999999987643322111  2


Q ss_pred             cCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCCC
Q 010309          390 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD  468 (513)
Q Consensus       390 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  468 (513)
                      ..++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..   .......   ...              ..
T Consensus       164 ~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~---~~~~~~~---~~~--------------~~  223 (261)
T cd05148         164 KKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH---EVYDQIT---AGY--------------RM  223 (261)
T ss_pred             CCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH---HHHHHHH---hCC--------------cC
Confidence            225678999999988889999999999999999998 89999765421   1111110   000              00


Q ss_pred             CCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q 010309          469 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  506 (513)
Q Consensus       469 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  506 (513)
                      ..+...++.+.+++.+||+.||++|||+.++++.|+.+
T Consensus       224 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         224 PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence            01123456799999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=8.8e-41  Score=330.59  Aligned_cols=256  Identities=21%  Similarity=0.372  Sum_probs=201.2

Q ss_pred             cCCceecccCceEEEEEEeC-CCC----EEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEe
Q 010309          228 EGNRLLGDSKTGGTYSGILP-DGS----RVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE  301 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  301 (513)
                      ...+.||+|+||.||+|.+. ++.    .||+|.++... ....+++.+|+.+++.++||||+++++++... ..++|+|
T Consensus        10 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e   88 (316)
T cd05108          10 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQ   88 (316)
T ss_pred             eeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cceeeee
Confidence            33457799999999999853 333    48999997543 34456788999999999999999999998765 5679999


Q ss_pred             eccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcc
Q 010309          302 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE  381 (513)
Q Consensus       302 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~  381 (513)
                      |+++|+|.+++...   ...+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        89 ~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~  162 (316)
T cd05108          89 LMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD  162 (316)
T ss_pred             cCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccccCC
Confidence            99999999998742   34588999999999999999999999   9999999999999999999999999999876543


Q ss_pred             ccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccccc
Q 010309          382 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP  460 (513)
Q Consensus       382 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  460 (513)
                      ..........++..|+|||++.+..++.++||||||+++|||++ |..||.+.........       .....       
T Consensus       163 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~-------~~~~~-------  228 (316)
T cd05108         163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-------LEKGE-------  228 (316)
T ss_pred             CcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-------HhCCC-------
Confidence            32221112224678999999999999999999999999999998 9999876543211111       11000       


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcCCC
Q 010309          461 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP  510 (513)
Q Consensus       461 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  510 (513)
                      ..      ..+..++.++.+++.+||+.||++||++.+++..|..+...+
T Consensus       229 ~~------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~  272 (316)
T cd05108         229 RL------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  272 (316)
T ss_pred             CC------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence            00      001123456899999999999999999999999998776554

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=4.7e-40  Score=317.10  Aligned_cols=256  Identities=24%  Similarity=0.385  Sum_probs=207.6

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEeccc---chhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccC
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS---SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  305 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  305 (513)
                      .+.||+|++|.||+|... +|+.||+|.++..   .....+.+.+|++++++++|+||+++++.+...+..++||||+++
T Consensus         7 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   86 (267)
T cd08224           7 EKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADA   86 (267)
T ss_pred             eeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCC
Confidence            456799999999999976 7999999998643   223356789999999999999999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccc
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  385 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  385 (513)
                      ++|.+++.........+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++..........
T Consensus        87 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~  163 (267)
T cd08224          87 GDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA  163 (267)
T ss_pred             CCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccCCCccc
Confidence            999999876444456689999999999999999999999   99999999999999999999999999987654332111


Q ss_pred             ceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCC
Q 010309          386 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  465 (513)
Q Consensus       386 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  465 (513)
                        ....++..|+|||.+.+..++.++||||||+++|+|++|+.||......    ..+......             ...
T Consensus       164 --~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~-------------~~~  224 (267)
T cd08224         164 --HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKIE-------------KCD  224 (267)
T ss_pred             --ceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----HHHHHhhhh-------------cCC
Confidence              1223788999999998888999999999999999999999998654321    111111000             000


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCc
Q 010309          466 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  507 (513)
Q Consensus       466 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  507 (513)
                      ....+....+..+.++|.+||+.+|++|||+.+|++.|+++.
T Consensus       225 ~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         225 YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence            111222345668999999999999999999999999998874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2e-40  Score=321.69  Aligned_cols=247  Identities=20%  Similarity=0.282  Sum_probs=194.9

Q ss_pred             ecccCceEEEEEEeC-CCCEEEEEEecccch---hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCCH
Q 010309          233 LGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  308 (513)
Q Consensus       233 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL  308 (513)
                      ||+|+||.||++... +|+.||+|.+.....   .....+..|++++++++||||+++++++.+....++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999864 589999999975322   2234566799999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccccee
Q 010309          309 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  388 (513)
Q Consensus       309 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  388 (513)
                      .+++..  .....+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++|+|||++.........   .
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~---~  152 (277)
T cd05607          81 KYHIYN--VGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI---T  152 (277)
T ss_pred             HHHHHh--ccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCcee---e
Confidence            988854  2334588999999999999999999999   9999999999999999999999999998766432211   1


Q ss_pred             ecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCCC
Q 010309          389 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD  468 (513)
Q Consensus       389 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  468 (513)
                      ...|+..|+|||++.+..++.++|||||||++|||++|+.||........  .........         ....     .
T Consensus       153 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~~~~~~---------~~~~-----~  216 (277)
T cd05607         153 QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEELKRRTL---------EDEV-----K  216 (277)
T ss_pred             ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHHHHHhh---------cccc-----c
Confidence            22388999999999988899999999999999999999999975432110  000000000         0000     0


Q ss_pred             CCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 010309          469 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQL  503 (513)
Q Consensus       469 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  503 (513)
                      ......++++.+|+.+||+.||++||++.|+++.+
T Consensus       217 ~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         217 FEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             cccccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence            11123456799999999999999999997766433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=3.2e-41  Score=335.00  Aligned_cols=241  Identities=22%  Similarity=0.255  Sum_probs=194.8

Q ss_pred             ceecccCceEEEEEEeC-CCCEEEEEEecccc---hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          231 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       231 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      ++||+|+||.||++... +|+.||+|+++...   ......+.+|++++..++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            36899999999999864 68999999997642   223456778999999999999999999999999999999999999


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD-KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  385 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  385 (513)
                      +|..++..    ...+++..+..++.||+.||+|||+ .   +|+||||||+|||++.++.+||+|||++......... 
T Consensus        81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~-  152 (325)
T cd05594          81 ELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT-  152 (325)
T ss_pred             cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc-
Confidence            99988854    3468999999999999999999997 7   9999999999999999999999999998754322111 


Q ss_pred             ceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCC
Q 010309          386 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  465 (513)
Q Consensus       386 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  465 (513)
                       .....||+.|+|||++.+..++.++|||||||++|||++|..||...+.......       .....            
T Consensus       153 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~-------i~~~~------------  212 (325)
T cd05594         153 -MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL-------ILMEE------------  212 (325)
T ss_pred             -cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHH-------HhcCC------------
Confidence             1123389999999999988999999999999999999999999976543211110       00000            


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 010309          466 SSDIPEAGVVQKVVDLVYACTQHVPSMRP-----RMSHVVH  501 (513)
Q Consensus       466 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  501 (513)
                        ...+...++++.+|+.+||+.||++|+     ++.++++
T Consensus       213 --~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  251 (325)
T cd05594         213 --IRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ  251 (325)
T ss_pred             --CCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence              001122456789999999999999996     8999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=8e-41  Score=331.75  Aligned_cols=241  Identities=22%  Similarity=0.290  Sum_probs=194.1

Q ss_pred             ceecccCceEEEEEEe----CCCCEEEEEEecccc----hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEee
Q 010309          231 RLLGDSKTGGTYSGIL----PDGSRVAVKRLKRSS----FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF  302 (513)
Q Consensus       231 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  302 (513)
                      +.||+|+||.||++..    .+++.||||+++...    ......+.+|+.+|+.++||||+++++++..++..|+||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            3679999999999985    357899999997542    12335678899999999999999999999999999999999


Q ss_pred             ccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccc
Q 010309          303 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV  382 (513)
Q Consensus       303 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~  382 (513)
                      +++++|.+++..    ...+.+..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus        82 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  154 (323)
T cd05584          82 LSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG  154 (323)
T ss_pred             CCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence            999999999854    34688889999999999999999999   99999999999999999999999999987543222


Q ss_pred             cccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccc
Q 010309          383 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI  462 (513)
Q Consensus       383 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  462 (513)
                      ..  .....||+.|+|||++.+..++.++||||||+++|||++|+.||...+...   .   ......         ...
T Consensus       155 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~---~---~~~~~~---------~~~  217 (323)
T cd05584         155 TV--THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK---T---IDKILK---------GKL  217 (323)
T ss_pred             Cc--ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH---H---HHHHHc---------CCC
Confidence            11  112348999999999998889999999999999999999999997654321   0   111100         000


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 010309          463 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP-----RMSHVVH  501 (513)
Q Consensus       463 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  501 (513)
                            ..+...++.+.++|.+||+.||++||     +++++++
T Consensus       218 ------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         218 ------NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             ------CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence                  00112356789999999999999999     7888765

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=7.7e-41  Score=307.77  Aligned_cols=265  Identities=20%  Similarity=0.243  Sum_probs=199.7

Q ss_pred             ccCCceecccCceEEEEEEeC-CCCEEEEEEecccchhc--HHHHHHHHHHHhhcCCCcEeeeeeEEeeC--CceEEEEe
Q 010309          227 SEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQR--KKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDRYIVYE  301 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lv~e  301 (513)
                      ...+++ ++|.||.||+|+++ +++.||+|+++......  .-.-++|+.+|.+++|||||.+-.+....  +..|||||
T Consensus        79 e~lnrI-~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe  157 (419)
T KOG0663|consen   79 EKLNRI-EEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVME  157 (419)
T ss_pred             HHHhhc-ccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHH
Confidence            334444 99999999999975 58999999998653221  23458999999999999999998887643  57899999


Q ss_pred             eccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcc
Q 010309          302 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE  381 (513)
Q Consensus       302 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~  381 (513)
                      ||++ +|..++....   .++...++.-+..|+++||+|||.+   .|+||||||+|+|++..|.+||+|||+|+.+...
T Consensus       158 ~~Eh-DLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp  230 (419)
T KOG0663|consen  158 YVEH-DLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSP  230 (419)
T ss_pred             HHHh-hHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence            9965 9999998643   6799999999999999999999999   9999999999999999999999999999988765


Q ss_pred             ccccceeecCcccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccc-----c
Q 010309          382 VMQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRY-----L  455 (513)
Q Consensus       382 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----~  455 (513)
                      .......  .-|..|.|||++.+. .|+++.|+||+|||+.||+++++.|.+..+......+-.......+.-+     .
T Consensus       231 ~k~~T~l--VVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~l  308 (419)
T KOG0663|consen  231 LKPYTPL--VVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSEL  308 (419)
T ss_pred             cccCcce--EEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcccc
Confidence            3322222  268999999999875 6899999999999999999999999887654322211100000000000     0


Q ss_pred             cccc------ccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          456 ELLD------PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       456 ~~~~------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      ....      .....+.........++.-.+|+..+|..||.+|.|++|.|+
T Consensus       309 p~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  309 PAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             chhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence            0000      000001111112225577889999999999999999999885

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.1e-40  Score=332.28  Aligned_cols=260  Identities=26%  Similarity=0.367  Sum_probs=201.4

Q ss_pred             cCCceecccCceEEEEEEeC------CCCEEEEEEecccc-hhcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeC-CceEE
Q 010309          228 EGNRLLGDSKTGGTYSGILP------DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDH-GDRYI  298 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~-~~~~l  298 (513)
                      +..++||+|+||.||+|...      +++.||+|+++... ....+.+.+|+.++.++ +||||+++++++... ...++
T Consensus        10 ~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~   89 (337)
T cd05054          10 KLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMV   89 (337)
T ss_pred             hhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEE
Confidence            34567899999999999742      35789999997543 22345678899999999 899999999988654 56789


Q ss_pred             EEeeccCCCHHHHhccCCCC---------------------------------------------------------CCC
Q 010309          299 VYEFVVNGPLDRWLHHIPRG---------------------------------------------------------GRS  321 (513)
Q Consensus       299 v~e~~~~gsL~~~l~~~~~~---------------------------------------------------------~~~  321 (513)
                      +|||+++++|.+++......                                                         ...
T Consensus        90 v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (337)
T cd05054          90 IVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEP  169 (337)
T ss_pred             EEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcC
Confidence            99999999999998542110                                                         136


Q ss_pred             CCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccceeecCcccccccccc
Q 010309          322 LDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEF  401 (513)
Q Consensus       322 l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~  401 (513)
                      +++..+..++.||+.||+|||+.   +|+||||||+|||++.++.++|+|||++..+.............++..|+|||+
T Consensus       170 l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~  246 (337)
T cd05054         170 LTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPES  246 (337)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHH
Confidence            88999999999999999999999   999999999999999999999999999987643322222222235678999999


Q ss_pred             cccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCCCCCcHHHHHHHHH
Q 010309          402 VYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVD  480 (513)
Q Consensus       402 ~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  480 (513)
                      +.+..++.++|||||||++|||++ |..||......+  .+.    .......     .       . ..+...++++.+
T Consensus       247 ~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~--~~~----~~~~~~~-----~-------~-~~~~~~~~~~~~  307 (337)
T cd05054         247 IFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--EFC----RRLKEGT-----R-------M-RAPEYATPEIYS  307 (337)
T ss_pred             hcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH--HHH----HHHhccC-----C-------C-CCCccCCHHHHH
Confidence            999999999999999999999998 999987533211  010    0011000     0       0 011234567999


Q ss_pred             HHHHhcCCCCCCCCCHHHHHHHHhcCcCC
Q 010309          481 LVYACTQHVPSMRPRMSHVVHQLQQLAQP  509 (513)
Q Consensus       481 li~~cl~~dP~~RPs~~evl~~L~~~~~~  509 (513)
                      ++.+||+.+|++||++.+|++.|+++.+.
T Consensus       308 l~~~cl~~~p~~RPs~~ell~~l~~~~~~  336 (337)
T cd05054         308 IMLDCWHNNPEDRPTFSELVEILGDLLQE  336 (337)
T ss_pred             HHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            99999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.7e-40  Score=346.06  Aligned_cols=251  Identities=23%  Similarity=0.285  Sum_probs=200.4

Q ss_pred             cCCceecccCceEEEEEEe-CCCCEEEEEEecccc--hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCC--------ce
Q 010309          228 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG--------DR  296 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--------~~  296 (513)
                      ...++||+|+||.||++.. .+|+.||||++....  ......+.+|+.++..++|+||+++.+.+...+        ..
T Consensus        35 ~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i  114 (496)
T PTZ00283         35 WISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMI  114 (496)
T ss_pred             EEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEE
Confidence            3456789999999999985 469999999997542  334467889999999999999999988775432        25


Q ss_pred             EEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccc
Q 010309          297 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK  376 (513)
Q Consensus       297 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~  376 (513)
                      ++||||+++|+|.+++.........+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus       115 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~DFGls~  191 (496)
T PTZ00283        115 ALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGDFGFSK  191 (496)
T ss_pred             EEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEecccCe
Confidence            899999999999999976544556799999999999999999999999   99999999999999999999999999998


Q ss_pred             cCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccc
Q 010309          377 FVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLE  456 (513)
Q Consensus       377 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  456 (513)
                      ...............||+.|+|||++.+..++.++|||||||++|||++|+.||...+...   .   ...... ..   
T Consensus       192 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~---~---~~~~~~-~~---  261 (496)
T PTZ00283        192 MYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE---V---MHKTLA-GR---  261 (496)
T ss_pred             eccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH---H---HHHHhc-CC---
Confidence            7643322222223448999999999999999999999999999999999999997643211   1   111000 00   


Q ss_pred             cccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          457 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       457 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                       ..         ..+...++++.+++.+||+.||.+||++.++++
T Consensus       262 -~~---------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~  296 (496)
T PTZ00283        262 -YD---------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN  296 (496)
T ss_pred             -CC---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence             00         111234567999999999999999999999986

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.3e-40  Score=313.08  Aligned_cols=247  Identities=22%  Similarity=0.271  Sum_probs=201.6

Q ss_pred             ceecccCceEEEEEEeCC-CCEEEEEEecccchhc---HHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          231 RLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQR---KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       231 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      +.||.|.-|+||++...+ +..+|+|++.+.....   ..+.+.|.+||+.++||.++.||..++.+...++|||||+||
T Consensus        83 k~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGG  162 (459)
T KOG0610|consen   83 KRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGG  162 (459)
T ss_pred             HHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCc
Confidence            367999999999999864 6899999998875443   356778999999999999999999999999999999999999


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcc-----
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE-----  381 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~-----  381 (513)
                      +|..+++.  +.++.+++..++.++..|+.||+|||-.   |||.|||||+||||.++|++.|+||.++......     
T Consensus       163 dL~~Lrqk--Qp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~  237 (459)
T KOG0610|consen  163 DLHSLRQK--QPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVK  237 (459)
T ss_pred             cHHHHHhh--CCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeec
Confidence            99998876  5567899999999999999999999999   9999999999999999999999999998643210     


Q ss_pred             ---------------------------c-c---------------------ccceeecCcccccccccccccCCCCchhh
Q 010309          382 ---------------------------V-M---------------------QERTVMAGGTYGYLAPEFVYRNELTTKSD  412 (513)
Q Consensus       382 ---------------------------~-~---------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sD  412 (513)
                                                 . .                     ........||-.|.|||++.+...+.+.|
T Consensus       238 s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVD  317 (459)
T KOG0610|consen  238 SSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVD  317 (459)
T ss_pred             cCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhh
Confidence                                       0 0                     00011223889999999999999999999


Q ss_pred             HHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCC
Q 010309          413 VYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSM  492 (513)
Q Consensus       413 vwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~  492 (513)
                      -|+|||+||||+.|..||.+.+..+               .+.+++...+    ........+..+.+||+++|.+||++
T Consensus       318 WWtfGIflYEmLyG~TPFKG~~~~~---------------Tl~NIv~~~l----~Fp~~~~vs~~akDLIr~LLvKdP~k  378 (459)
T KOG0610|consen  318 WWTFGIFLYEMLYGTTPFKGSNNKE---------------TLRNIVGQPL----KFPEEPEVSSAAKDLIRKLLVKDPSK  378 (459)
T ss_pred             HHHHHHHHHHHHhCCCCcCCCCchh---------------hHHHHhcCCC----cCCCCCcchhHHHHHHHHHhccChhh
Confidence            9999999999999999999876531               1111221111    11112256678999999999999999


Q ss_pred             CCC----HHHHHH
Q 010309          493 RPR----MSHVVH  501 (513)
Q Consensus       493 RPs----~~evl~  501 (513)
                      |..    +.||-+
T Consensus       379 Rlg~~rGA~eIK~  391 (459)
T KOG0610|consen  379 RLGSKRGAAEIKR  391 (459)
T ss_pred             hhccccchHHhhc
Confidence            987    777654

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=7.5e-41  Score=333.64  Aligned_cols=239  Identities=22%  Similarity=0.308  Sum_probs=195.2

Q ss_pred             CceecccCceEEEEEEeCC--CCEEEEEEecccc---hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeecc
Q 010309          230 NRLLGDSKTGGTYSGILPD--GSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV  304 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  304 (513)
                      .+.||+|+||.||+|...+  +..||+|++....   ....+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus        35 ~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~  114 (340)
T PTZ00426         35 IRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVI  114 (340)
T ss_pred             EEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCC
Confidence            4567999999999998643  3689999996542   2234568899999999999999999999999999999999999


Q ss_pred             CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccc
Q 010309          305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  384 (513)
Q Consensus       305 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  384 (513)
                      +|+|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++.......  
T Consensus       115 ~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~~--  185 (340)
T PTZ00426        115 GGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRT--  185 (340)
T ss_pred             CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCCCc--
Confidence            9999999964    34689999999999999999999999   99999999999999999999999999998654321  


Q ss_pred             cceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccC
Q 010309          385 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS  464 (513)
Q Consensus       385 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  464 (513)
                         ....||+.|+|||++.+..++.++|||||||++|||++|..||...+....      ......         ...  
T Consensus       186 ---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~------~~~i~~---------~~~--  245 (340)
T PTZ00426        186 ---YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI------YQKILE---------GII--  245 (340)
T ss_pred             ---ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHH------HHHHhc---------CCC--
Confidence               123489999999999988899999999999999999999999986543210      000000         000  


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 010309          465 LSSDIPEAGVVQKVVDLVYACTQHVPSMRP-----RMSHVVH  501 (513)
Q Consensus       465 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  501 (513)
                          ..+...++.+.++|.+||+.||++|+     +++++++
T Consensus       246 ----~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~  283 (340)
T PTZ00426        246 ----YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE  283 (340)
T ss_pred             ----CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence                01122345689999999999999995     8888875

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.7e-40  Score=308.40  Aligned_cols=267  Identities=21%  Similarity=0.305  Sum_probs=200.8

Q ss_pred             ecccCceEEEEEEe-CCCCEEEEEEecccchh--cHHHHHHHHHHHhhcCCCc-EeeeeeEEeeCC------ceEEEEee
Q 010309          233 LGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQ--RKKEFYSEIGRFARLHHPN-LVAVKGCCYDHG------DRYIVYEF  302 (513)
Q Consensus       233 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~------~~~lv~e~  302 (513)
                      ||+|+||+||+|+. .+|+.||+|.++-....  ......+|+.+|+.|+|+| |+.+++++...+      ..++|+||
T Consensus        19 lGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~   98 (323)
T KOG0594|consen   19 LGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEF   98 (323)
T ss_pred             hCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEe
Confidence            69999999999996 46899999999765332  3456789999999999999 999999999887      78999999


Q ss_pred             ccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccc
Q 010309          303 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV  382 (513)
Q Consensus       303 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~  382 (513)
                      + .-+|..++.........++...+..++.||+.||+|||++   +|+||||||+||||+++|.+||+|||+|+......
T Consensus        99 ~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~  174 (323)
T KOG0594|consen   99 L-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGLARAFSIPM  174 (323)
T ss_pred             e-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccchHHHhcCCc
Confidence            9 5699999987554335678899999999999999999999   99999999999999999999999999999765332


Q ss_pred             cccceeecCcccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCccccch-hHHhhhHHhhccccccccc-
Q 010309          383 MQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS-IFEWATPLVQSHRYLELLD-  459 (513)
Q Consensus       383 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~-  459 (513)
                      ...  ....+|..|.|||++.+. .|+...||||+|||+.||+++++.|.+..+..... +++.. .......+..... 
T Consensus       175 ~~y--t~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~l-GtP~e~~Wp~v~~~  251 (323)
T KOG0594|consen  175 RTY--TPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLL-GTPNEKDWPGVSSL  251 (323)
T ss_pred             ccc--cccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHc-CCCCccCCCCcccc
Confidence            221  122278899999999986 78999999999999999999999998876532111 11110 0001111111000 


Q ss_pred             cccc-CCCCCCCc-------HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--HhcC
Q 010309          460 PLIS-SLSSDIPE-------AGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ--LQQL  506 (513)
Q Consensus       460 ~~~~-~~~~~~~~-------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~  506 (513)
                      +... .......+       ....+...+++.+||+.+|.+|.|++.+++.  +..+
T Consensus       252 ~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~  308 (323)
T KOG0594|consen  252 PDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL  308 (323)
T ss_pred             ccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence            0000 00000000       0112478899999999999999999999975  4444

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=2.7e-40  Score=320.89  Aligned_cols=254  Identities=23%  Similarity=0.396  Sum_probs=198.6

Q ss_pred             CCceecccCceEEEEEEeC------CCCEEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEe
Q 010309          229 GNRLLGDSKTGGTYSGILP------DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE  301 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  301 (513)
                      ..+.||+|++|.||+|...      .+..||||++.... .....++.+|+.+++.++||||+++++++.+....++|||
T Consensus        10 ~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e   89 (277)
T cd05062          10 MSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIME   89 (277)
T ss_pred             eeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEe
Confidence            3456799999999999853      25679999986542 2344678899999999999999999999999999999999


Q ss_pred             eccCCCHHHHhccCCCC------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEeccccc
Q 010309          302 FVVNGPLDRWLHHIPRG------GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLS  375 (513)
Q Consensus       302 ~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~  375 (513)
                      |+++++|.+++......      ...+++..+..++.|++.||.|||+.   +++|+||||+||++++++.++|+|||++
T Consensus        90 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l~dfg~~  166 (277)
T cd05062          90 LMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT  166 (277)
T ss_pred             cCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEECCCCCc
Confidence            99999999998653211      23467888999999999999999999   9999999999999999999999999998


Q ss_pred             ccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccc
Q 010309          376 KFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRY  454 (513)
Q Consensus       376 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  454 (513)
                      ................+++.|+|||++.+..++.++||||||+++|||++ |..||.......   ...    .......
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~---~~~----~~~~~~~  239 (277)
T cd05062         167 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ---VLR----FVMEGGL  239 (277)
T ss_pred             cccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH----HHHcCCc
Confidence            76543222111111225778999999998889999999999999999999 788887654321   111    0111100


Q ss_pred             cccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 010309          455 LELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ  505 (513)
Q Consensus       455 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  505 (513)
                      .             ..+...+..+.+++.+||+.||++|||+.|+++.|++
T Consensus       240 ~-------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         240 L-------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             C-------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            0             0011234579999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1e-40  Score=330.40  Aligned_cols=235  Identities=28%  Similarity=0.366  Sum_probs=190.4

Q ss_pred             eecccCceEEEEEEeC-CCCEEEEEEecccc---hhcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          232 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       232 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      +||+|+||.||+|... +++.||||++.+..   ....+.+..|..++..+ +||||+++++++...+..++||||+++|
T Consensus         2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g   81 (320)
T cd05590           2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGG   81 (320)
T ss_pred             eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCc
Confidence            5799999999999975 58899999997542   22345677888888876 7999999999999999999999999999


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  386 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  386 (513)
                      +|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++.........  
T Consensus        82 ~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~--  152 (320)
T cd05590          82 DLMFHIQK----SRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--  152 (320)
T ss_pred             hHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCc--
Confidence            99998854    34689999999999999999999999   9999999999999999999999999998754322111  


Q ss_pred             eeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCC
Q 010309          387 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  466 (513)
Q Consensus       387 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  466 (513)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+...   +..   ... ...             
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~---~~~---~i~-~~~-------------  212 (320)
T cd05590         153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD---LFE---AIL-NDE-------------  212 (320)
T ss_pred             ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH---HHH---HHh-cCC-------------
Confidence            112348999999999998899999999999999999999999997654321   111   000 000             


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCH
Q 010309          467 SDIPEAGVVQKVVDLVYACTQHVPSMRPRM  496 (513)
Q Consensus       467 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  496 (513)
                       ...+...+.++.+++.+||+.||++||++
T Consensus       213 -~~~~~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         213 -VVYPTWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             -CCCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence             00111245678999999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=3.8e-40  Score=317.83  Aligned_cols=252  Identities=25%  Similarity=0.403  Sum_probs=201.8

Q ss_pred             CCceecccCceEEEEEEeCC----CCEEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeec
Q 010309          229 GNRLLGDSKTGGTYSGILPD----GSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  303 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  303 (513)
                      ..+.||+|+||.||+|.+..    ...||||.++... ......+.+|+.++++++||||+++++.+...+..++||||+
T Consensus         8 ~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   87 (266)
T cd05033           8 IEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYM   87 (266)
T ss_pred             eeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcC
Confidence            34577999999999999743    4589999987543 233567889999999999999999999999999999999999


Q ss_pred             cCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccc
Q 010309          304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM  383 (513)
Q Consensus       304 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~  383 (513)
                      ++++|.+++...   ...+++..++.++.|++.||+|||+.   +|+|+||||+|||++.++.++|+|||++........
T Consensus        88 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~  161 (266)
T cd05033          88 ENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA  161 (266)
T ss_pred             CCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccccccc
Confidence            999999998642   24689999999999999999999999   999999999999999999999999999987752221


Q ss_pred             ccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccccccc
Q 010309          384 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI  462 (513)
Q Consensus       384 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  462 (513)
                      ........++..|+|||.+.+..++.++||||||+++|+|++ |..||.......   ....    .....         
T Consensus       162 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~---~~~~----~~~~~---------  225 (266)
T cd05033         162 TYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD---VIKA----VEDGY---------  225 (266)
T ss_pred             ceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH---HHHH----HHcCC---------
Confidence            111112225678999999998899999999999999999998 999986543221   1110    00000         


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q 010309          463 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  506 (513)
Q Consensus       463 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  506 (513)
                          ....+...++.+.+++.+||+.+|++||++++|++.|+++
T Consensus       226 ----~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         226 ----RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             ----CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                0001123456799999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=4e-40  Score=315.83  Aligned_cols=246  Identities=27%  Similarity=0.447  Sum_probs=198.5

Q ss_pred             ceecccCceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCCHHH
Q 010309          231 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR  310 (513)
Q Consensus       231 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~  310 (513)
                      +.||+|++|.||+|...++..||||.+.... ...+.+.+|+.++++++||||+++++++.+.+..++||||+.+++|.+
T Consensus        10 ~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~   88 (256)
T cd05113          10 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLN   88 (256)
T ss_pred             eEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHH
Confidence            4579999999999998777789999987543 345678999999999999999999999999999999999999999999


Q ss_pred             HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccceeec
Q 010309          311 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA  390 (513)
Q Consensus       311 ~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  390 (513)
                      ++...   ...+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||.++.......... ...
T Consensus        89 ~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~-~~~  161 (256)
T cd05113          89 YLREH---GKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS-VGS  161 (256)
T ss_pred             HHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCceeec-CCC
Confidence            98642   23689999999999999999999999   999999999999999999999999999886543322111 111


Q ss_pred             CcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCCCC
Q 010309          391 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDI  469 (513)
Q Consensus       391 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  469 (513)
                      .++..|+|||++.+..++.++||||||+++|+|++ |..||.......   ...   .......      .        .
T Consensus       162 ~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~---~~~~~~~------~--------~  221 (256)
T cd05113         162 KFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE---TVE---KVSQGLR------L--------Y  221 (256)
T ss_pred             ccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHH---HHhcCCC------C--------C
Confidence            25678999999988889999999999999999999 999987544321   111   1000000      0        0


Q ss_pred             CcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 010309          470 PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ  504 (513)
Q Consensus       470 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  504 (513)
                      .+...+..+.+++.+||+.||.+||++.+|++.|+
T Consensus       222 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         222 RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            01123467999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=8e-41  Score=331.54  Aligned_cols=240  Identities=25%  Similarity=0.333  Sum_probs=193.3

Q ss_pred             eecccCceEEEEEEeC-CCCEEEEEEecccc---hhcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          232 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       232 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      +||+|+||.||+|... +++.||||++++..   ....+.+..|.+++..+ +||||+++++++.+.+..++||||++++
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   81 (321)
T cd05591           2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG   81 (321)
T ss_pred             ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCC
Confidence            5799999999999975 47899999997642   22345577888888876 8999999999999999999999999999


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  386 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  386 (513)
                      +|..++..    ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++.........  
T Consensus        82 ~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~--  152 (321)
T cd05591          82 DLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--  152 (321)
T ss_pred             cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCcc--
Confidence            99988854    34689999999999999999999999   9999999999999999999999999998754322211  


Q ss_pred             eeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCC
Q 010309          387 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  466 (513)
Q Consensus       387 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  466 (513)
                      .....||+.|+|||++.+..++.++||||||+++|||++|+.||...+...   ...   .... .   +          
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~---~~~---~i~~-~---~----------  212 (321)
T cd05591         153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD---LFE---SILH-D---D----------  212 (321)
T ss_pred             ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH---HHH---HHHc-C---C----------
Confidence            112338999999999998899999999999999999999999998654321   111   1000 0   0          


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCC-------CHHHHHH
Q 010309          467 SDIPEAGVVQKVVDLVYACTQHVPSMRP-------RMSHVVH  501 (513)
Q Consensus       467 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-------s~~evl~  501 (513)
                       ...+...+.++.+++.+||+.||++||       +++++++
T Consensus       213 -~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         213 -VLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             -CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence             001112356789999999999999999       7777764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=2.2e-40  Score=329.39  Aligned_cols=248  Identities=23%  Similarity=0.294  Sum_probs=194.1

Q ss_pred             ceecccCceEEEEEEeC-CCCEEEEEEecccch---hcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCCceEEEEeeccC
Q 010309          231 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVN  305 (513)
Q Consensus       231 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~  305 (513)
                      ++||+|+||.||++... +++.||||++++...   ...+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            36899999999999975 588999999986422   2345678899999998 799999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccc
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  385 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  385 (513)
                      |+|.+++..    ...+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++........  
T Consensus        81 g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~--  151 (329)
T cd05588          81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--  151 (329)
T ss_pred             CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCCC--
Confidence            999988853    35699999999999999999999999   999999999999999999999999999875322111  


Q ss_pred             ceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccc--cchhHHhhhHHhhccccccccccccc
Q 010309          386 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVC--WQSIFEWATPLVQSHRYLELLDPLIS  463 (513)
Q Consensus       386 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  463 (513)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......  .....++........        .. 
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--------~~-  222 (329)
T cd05588         152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK--------QI-  222 (329)
T ss_pred             ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC--------CC-
Confidence            1122348999999999999999999999999999999999999996432211  011111111111100        00 


Q ss_pred             CCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCC------HHHHHH
Q 010309          464 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPR------MSHVVH  501 (513)
Q Consensus       464 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs------~~evl~  501 (513)
                          . .+...+.++.+++.+||+.||.+||+      ++++++
T Consensus       223 ----~-~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         223 ----R-IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             ----C-CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence                0 11224567899999999999999997      566653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=4e-40  Score=321.84  Aligned_cols=262  Identities=21%  Similarity=0.281  Sum_probs=190.8

Q ss_pred             CceecccCceEEEEEEeC--CCCEEEEEEecccch--hcHHHHHHHHHHHhhc---CCCcEeeeeeEEee-----CCceE
Q 010309          230 NRLLGDSKTGGTYSGILP--DGSRVAVKRLKRSSF--QRKKEFYSEIGRFARL---HHPNLVAVKGCCYD-----HGDRY  297 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~-----~~~~~  297 (513)
                      .+.||+|+||.||+|...  +++.||||+++....  .....+.+|+.+++.+   +||||+++++++..     ....+
T Consensus         6 ~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~   85 (290)
T cd07862           6 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT   85 (290)
T ss_pred             eeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEE
Confidence            456799999999999863  468899999875422  2234566777777665   69999999999852     45689


Q ss_pred             EEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEeccccccc
Q 010309          298 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF  377 (513)
Q Consensus       298 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~  377 (513)
                      +||||++ ++|.+++...  ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++..
T Consensus        86 lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~  159 (290)
T cd07862          86 LVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARI  159 (290)
T ss_pred             EEEccCC-CCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccceEe
Confidence            9999995 6899988652  234589999999999999999999999   999999999999999999999999999986


Q ss_pred             CCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccc-hhHHhhhHHhhcccccc
Q 010309          378 VPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ-SIFEWATPLVQSHRYLE  456 (513)
Q Consensus       378 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~  456 (513)
                      ......   .....||+.|+|||++.+..++.++|||||||++|||++|++||.+....... .+.+.... ........
T Consensus       160 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~-~~~~~~~~  235 (290)
T cd07862         160 YSFQMA---LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL-PGEEDWPR  235 (290)
T ss_pred             ccCCcc---cccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCC-CChhhchh
Confidence            543321   11223899999999998888999999999999999999999999876542211 11110000 00000000


Q ss_pred             ---cccccccCCCCCC---CcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          457 ---LLDPLISSLSSDI---PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       457 ---~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                         .............   .....++.+.+|+.+||+.||++|||+.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         236 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             hhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence               0000000000000   00124567889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=3.9e-40  Score=321.94  Aligned_cols=257  Identities=25%  Similarity=0.414  Sum_probs=203.5

Q ss_pred             CceecccCceEEEEEEeC------CCCEEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEee
Q 010309          230 NRLLGDSKTGGTYSGILP------DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF  302 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  302 (513)
                      .+.||+|+||.||+|...      ....+|+|.+.... ......+.+|+.+++.++||||+++++.+...+..++|+||
T Consensus         5 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (290)
T cd05045           5 GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEY   84 (290)
T ss_pred             cccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEe
Confidence            456799999999999853      23579999887553 23346789999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhccCCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEec
Q 010309          303 VVNGPLDRWLHHIPR--------------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD  362 (513)
Q Consensus       303 ~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~  362 (513)
                      +.+++|.+++.....                    ....+++..++.++.|++.||.|||+.   +++||||||+|||++
T Consensus        85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~nill~  161 (290)
T cd05045          85 AKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVA  161 (290)
T ss_pred             cCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---CeehhhhhhheEEEc
Confidence            999999999864221                    124588999999999999999999999   999999999999999


Q ss_pred             CCCCeEEecccccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchh
Q 010309          363 EEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSI  441 (513)
Q Consensus       363 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~  441 (513)
                      +++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.......   +
T Consensus       162 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~  238 (290)
T cd05045         162 EGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER---L  238 (290)
T ss_pred             CCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH---H
Confidence            999999999999986543322111222235678999999988889999999999999999998 999987654321   1


Q ss_pred             HHhhhHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcCC
Q 010309          442 FEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP  509 (513)
Q Consensus       442 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  509 (513)
                      ....    ...         .    ....+...+.++.+++.+||+.+|++||++.++++.|+++..+
T Consensus       239 ~~~~----~~~---------~----~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~  289 (290)
T cd05045         239 FNLL----KTG---------Y----RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK  289 (290)
T ss_pred             HHHH----hCC---------C----CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence            1111    000         0    0001123456799999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=5e-40  Score=319.98  Aligned_cols=253  Identities=27%  Similarity=0.435  Sum_probs=199.7

Q ss_pred             CceecccCceEEEEEEe-----CCCCEEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeec
Q 010309          230 NRLLGDSKTGGTYSGIL-----PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  303 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  303 (513)
                      .+.||+|+||.||+|..     .++..||+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||+
T Consensus        10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   89 (283)
T cd05090          10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYL   89 (283)
T ss_pred             eeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcC
Confidence            35679999999999984     246789999997543 233467889999999999999999999999999999999999


Q ss_pred             cCCCHHHHhccCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEe
Q 010309          304 VNGPLDRWLHHIPR-------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLM  370 (513)
Q Consensus       304 ~~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~  370 (513)
                      ++++|.+++.....             ....+++..++.++.|++.||+|||++   +++|+||||+|||++.++.+||+
T Consensus        90 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~~~kl~  166 (283)
T cd05090          90 NQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLHVKIS  166 (283)
T ss_pred             CCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCCcEEec
Confidence            99999999853211             123578899999999999999999999   99999999999999999999999


Q ss_pred             cccccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHh
Q 010309          371 GVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLV  449 (513)
Q Consensus       371 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  449 (513)
                      |||++................++..|+|||++.+..++.++||||||+++|||++ |..||.......   ..+    ..
T Consensus       167 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~---~~~----~~  239 (283)
T cd05090         167 DLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE---VIE----MV  239 (283)
T ss_pred             cccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHH----HH
Confidence            9999986543322211222225678999999988889999999999999999999 999987643211   111    11


Q ss_pred             hcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 010309          450 QSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ  505 (513)
Q Consensus       450 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  505 (513)
                      .....       +      ..+..+++.+.+++.+||+.||++||++.+|++.|..
T Consensus       240 ~~~~~-------~------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         240 RKRQL-------L------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HcCCc-------C------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            11000       0      0112245679999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=4.3e-40  Score=317.50  Aligned_cols=256  Identities=23%  Similarity=0.361  Sum_probs=206.5

Q ss_pred             CceecccCceEEEEEEe-CCCCEEEEEEecccc---hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccC
Q 010309          230 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  305 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  305 (513)
                      .+.||+|++|.||++.. .+++.+|||.+....   .....++.+|+.+++.++||||+++++++.+++..+++|||+++
T Consensus         7 ~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~   86 (267)
T cd08229           7 EKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADA   86 (267)
T ss_pred             hhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCC
Confidence            45679999999999995 478999999886532   23346788999999999999999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccc
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  385 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  385 (513)
                      ++|.+++.........+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++..........
T Consensus        87 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~  163 (267)
T cd08229          87 GDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA  163 (267)
T ss_pred             CCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhccccCCccc
Confidence            999999875444456789999999999999999999999   99999999999999999999999999987664332211


Q ss_pred             ceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCC
Q 010309          386 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  465 (513)
Q Consensus       386 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  465 (513)
                        ....++..|+|||.+.+..++.++||||||+++|+|++|..||.......    .......      ....       
T Consensus       164 --~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~------~~~~-------  224 (267)
T cd08229         164 --HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----YSLCKKI------EQCD-------  224 (267)
T ss_pred             --ccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH----HHHhhhh------hcCC-------
Confidence              12237889999999988889999999999999999999999986543210    0100000      0000       


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCc
Q 010309          466 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  507 (513)
Q Consensus       466 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  507 (513)
                      ....+....++.+.+++.+||+.||++|||+.+|++.++++.
T Consensus       225 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         225 YPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             CCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence            011222346678999999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-41  Score=332.83  Aligned_cols=252  Identities=29%  Similarity=0.456  Sum_probs=212.4

Q ss_pred             ceecccCceEEEEEEeCC-CCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCCHH
Q 010309          231 RLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD  309 (513)
Q Consensus       231 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~  309 (513)
                      ..||-|.||.||.|+++. .-.||||.++.+. ...++|+.|+.+|+.++|||+|+|+|+|..+..+|||+|||..|+|.
T Consensus       273 hKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLL  351 (1157)
T KOG4278|consen  273 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLL  351 (1157)
T ss_pred             eccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHH
Confidence            346999999999999865 6789999998764 56789999999999999999999999999999999999999999999


Q ss_pred             HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccceee
Q 010309          310 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM  389 (513)
Q Consensus       310 ~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  389 (513)
                      +||+...  +..++.-..+.++.||++||.||..+   ++|||||.++|+|+.++..+|++|||+++++..+....... 
T Consensus       352 dYLRecn--r~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAG-  425 (1157)
T KOG4278|consen  352 DYLRECN--RSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAG-  425 (1157)
T ss_pred             HHHHHhc--hhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcCCceecccC-
Confidence            9998743  45677888899999999999999999   99999999999999999999999999999987654433222 


Q ss_pred             cCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCCC
Q 010309          390 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD  468 (513)
Q Consensus       390 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  468 (513)
                      ..-.+.|.|||.+....++.|+|||+|||+|||+.| |..||.+.+-.   +.    ..+.+.+-             .-
T Consensus       426 AKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS---qV----Y~LLEkgy-------------RM  485 (1157)
T KOG4278|consen  426 AKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QV----YGLLEKGY-------------RM  485 (1157)
T ss_pred             ccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH---HH----HHHHhccc-------------cc
Confidence            224678999999999999999999999999999998 99999876532   11    11111111             11


Q ss_pred             CCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcCC
Q 010309          469 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP  509 (513)
Q Consensus       469 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  509 (513)
                      ..+.++++.+.+||+.||+.+|.+||++.|+-+.++.+...
T Consensus       486 ~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~  526 (1157)
T KOG4278|consen  486 DGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS  526 (1157)
T ss_pred             cCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence            12346788899999999999999999999999999877543

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.2e-40  Score=327.49  Aligned_cols=239  Identities=23%  Similarity=0.294  Sum_probs=190.2

Q ss_pred             eecccCceEEEEEEeC-CCCEEEEEEecccc---hhcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          232 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       232 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      .||+|+||.||+|... +++.||||+++...   ....+.+..|..++..+ +||||+++++++...+..++||||+++|
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg   81 (316)
T cd05592           2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGG   81 (316)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence            5799999999999975 58899999997642   12334556677777654 8999999999999999999999999999


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  386 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  386 (513)
                      +|..++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++........  .
T Consensus        82 ~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~--~  152 (316)
T cd05592          82 DLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG--K  152 (316)
T ss_pred             cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC--c
Confidence            99998864    34689999999999999999999999   999999999999999999999999999975432221  1


Q ss_pred             eeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCC
Q 010309          387 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  466 (513)
Q Consensus       387 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  466 (513)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+...   +..   .... .      .       
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~---~~~---~i~~-~------~-------  212 (316)
T cd05592         153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE---LFD---SILN-D------R-------  212 (316)
T ss_pred             cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH---HHH---HHHc-C------C-------
Confidence            122348999999999998899999999999999999999999998654321   111   0000 0      0       


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHH-HHH
Q 010309          467 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMS-HVV  500 (513)
Q Consensus       467 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl  500 (513)
                      . ..+...+.++.+++.+||+.||++||++. +++
T Consensus       213 ~-~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         213 P-HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             C-CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            0 01122456789999999999999999875 454

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=3.8e-40  Score=324.12  Aligned_cols=261  Identities=18%  Similarity=0.258  Sum_probs=193.1

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccch-hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCC
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  307 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs  307 (513)
                      .+.||+|+||.||+|... +++.||||++..... .....+.+|+.+++.++||||+++++++.+.+..++||||++ ++
T Consensus        10 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~   88 (303)
T cd07869          10 LEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TD   88 (303)
T ss_pred             eeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cC
Confidence            456799999999999975 689999999975432 223567889999999999999999999999999999999995 68


Q ss_pred             HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccce
Q 010309          308 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  387 (513)
Q Consensus       308 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  387 (513)
                      |.+++..   ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++.........  .
T Consensus        89 l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~  160 (303)
T cd07869          89 LCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHT--Y  160 (303)
T ss_pred             HHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCCcc--C
Confidence            8877753   234588999999999999999999999   9999999999999999999999999998754322111  1


Q ss_pred             eecCccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcc---cccc-----cc
Q 010309          388 VMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSH---RYLE-----LL  458 (513)
Q Consensus       388 ~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~-----~~  458 (513)
                      ....+++.|+|||++.+ ..++.++|||||||++|||++|..||.+....  ..............   ....     ..
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (303)
T cd07869         161 SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI--QDQLERIFLVLGTPNEDTWPGVHSLPHF  238 (303)
T ss_pred             CCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHHhCCCChhhccchhhcccc
Confidence            12237899999999865 45788999999999999999999999865432  11111110000000   0000     00


Q ss_pred             cc-cccCCCCCC-----CcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          459 DP-LISSLSSDI-----PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       459 ~~-~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      .+ .........     .....+..+.+|+.+||+.||++|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         239 KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             ccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            00 000000000     00012356889999999999999999999986

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.9e-40  Score=320.73  Aligned_cols=270  Identities=28%  Similarity=0.392  Sum_probs=203.0

Q ss_pred             CcccCCceecccCceEEEEEEe-----CCCCEEEEEEecccch-hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeC--Cce
Q 010309          225 NFSEGNRLLGDSKTGGTYSGIL-----PDGSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDR  296 (513)
Q Consensus       225 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~  296 (513)
                      +++...+.||+|+||.||++..     .++..||+|.++.... .....+.+|++++++++||||+++++++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (283)
T cd05080           4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL   83 (283)
T ss_pred             hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence            4445566789999999988653     3578999999976532 3456788999999999999999999987754  357


Q ss_pred             EEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccc
Q 010309          297 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK  376 (513)
Q Consensus       297 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~  376 (513)
                      ++||||+++++|.+++..     ..+++.++..++.|++.||.|||+.   +++||||||+|||++.++.++|+|||++.
T Consensus        84 ~lv~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~  155 (283)
T cd05080          84 QLIMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAK  155 (283)
T ss_pred             EEEecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeeccccc
Confidence            899999999999999864     3599999999999999999999999   99999999999999999999999999998


Q ss_pred             cCCccccccc-eeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccc
Q 010309          377 FVPWEVMQER-TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL  455 (513)
Q Consensus       377 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  455 (513)
                      .......... .....++..|+|||.+.+..++.++||||||+++|||+||..|+...... ..................
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~  234 (283)
T cd05080         156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK-FEEMIGPKQGQMTVVRLI  234 (283)
T ss_pred             ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch-hhhhhcccccccchhhhh
Confidence            7653322111 11122566799999998888999999999999999999999998654321 111111000000000111


Q ss_pred             ccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCc
Q 010309          456 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  507 (513)
Q Consensus       456 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  507 (513)
                      +.++...    ....+...+.++.+++.+||+.||++|||+++|++.|+++.
T Consensus       235 ~~~~~~~----~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         235 ELLERGM----RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hhhhcCC----CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            1111111    00112234567999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=3.6e-40  Score=331.18  Aligned_cols=242  Identities=24%  Similarity=0.376  Sum_probs=190.1

Q ss_pred             ceecccCceEEEEEEeC-CCCEEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCCH
Q 010309          231 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  308 (513)
Q Consensus       231 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL  308 (513)
                      +.||+|+||.||+|... +++.||||++.... ......+.+|+++++.++|+||+++++++...+..++||||+++++|
T Consensus        80 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  159 (353)
T PLN00034         80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSL  159 (353)
T ss_pred             hhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCcc
Confidence            45799999999999965 68999999996543 23346789999999999999999999999999999999999999998


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccccee
Q 010309          309 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  388 (513)
Q Consensus       309 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  388 (513)
                      .+.        ...++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++.........  ..
T Consensus       160 ~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~--~~  226 (353)
T PLN00034        160 EGT--------HIADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP--CN  226 (353)
T ss_pred             ccc--------ccCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccccccc--cc
Confidence            643        2356778889999999999999999   9999999999999999999999999999866432211  11


Q ss_pred             ecCccccccccccccc-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccccccccccc
Q 010309          389 MAGGTYGYLAPEFVYR-----NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS  463 (513)
Q Consensus       389 ~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  463 (513)
                      ...||..|+|||++..     ...+.++|||||||++|||++|+.||.......+..+....   .. ..          
T Consensus       227 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~---~~-~~----------  292 (353)
T PLN00034        227 SSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAI---CM-SQ----------  292 (353)
T ss_pred             ccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHH---hc-cC----------
Confidence            2238999999998743     23356899999999999999999999743332221111100   00 00          


Q ss_pred             CCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010309          464 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  502 (513)
Q Consensus       464 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  502 (513)
                         ........+.++.+||.+||+.||++|||+.||++.
T Consensus       293 ---~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        293 ---PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             ---CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               001112345679999999999999999999999973

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=3.1e-40  Score=326.39  Aligned_cols=239  Identities=23%  Similarity=0.327  Sum_probs=191.1

Q ss_pred             eecccCceEEEEEEeC-CCCEEEEEEecccc---hhcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          232 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       232 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      .||+|+||.||+|... +++.||||+++...   ......+..|..++..+ +||||+++++++.+.+..++||||+++|
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g   81 (316)
T cd05619           2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGG   81 (316)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCC
Confidence            5799999999999975 47899999997642   12334566777888764 9999999999999999999999999999


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  386 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  386 (513)
                      +|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++........  .
T Consensus        82 ~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~  152 (316)
T cd05619          82 DLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--K  152 (316)
T ss_pred             cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--c
Confidence            99999864    34688999999999999999999999   999999999999999999999999999875322211  1


Q ss_pred             eeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCC
Q 010309          387 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  466 (513)
Q Consensus       387 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  466 (513)
                      .....||+.|+|||++.+..++.++|||||||++|||++|..||...+...   +....    ...      .+.     
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~~~~i----~~~------~~~-----  214 (316)
T cd05619         153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE---LFQSI----RMD------NPC-----  214 (316)
T ss_pred             eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH---HHHHH----HhC------CCC-----
Confidence            112338999999999998899999999999999999999999997654321   11110    000      000     


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHH-HHH
Q 010309          467 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMS-HVV  500 (513)
Q Consensus       467 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl  500 (513)
                         .+...+.++.+++.+||+.||++||++. +++
T Consensus       215 ---~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         215 ---YPRWLTREAKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             ---CCccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence               1112455789999999999999999997 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.9e-40  Score=315.23  Aligned_cols=247  Identities=24%  Similarity=0.401  Sum_probs=198.5

Q ss_pred             CceecccCceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCCHH
Q 010309          230 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD  309 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~  309 (513)
                      .+.||+|++|.||++..+++..+|+|.+.... .....+.+|+.+++.++||||+++++++...+..++||||+++++|.
T Consensus         9 ~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   87 (256)
T cd05059           9 LKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLL   87 (256)
T ss_pred             hhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHH
Confidence            44679999999999998777899999986543 34467889999999999999999999999999999999999999999


Q ss_pred             HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccceee
Q 010309          310 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM  389 (513)
Q Consensus       310 ~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  389 (513)
                      +++...   ...+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++.......... ..
T Consensus        88 ~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~-~~  160 (256)
T cd05059          88 NYLRER---KGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS-QG  160 (256)
T ss_pred             HHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccccccc-CC
Confidence            998642   23689999999999999999999999   999999999999999999999999999876543221111 11


Q ss_pred             cCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCCC
Q 010309          390 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD  468 (513)
Q Consensus       390 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  468 (513)
                      ..++..|+|||.+.+..++.++||||||+++|||++ |..||...+...   ...   ....      ....        
T Consensus       161 ~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~---~~~~------~~~~--------  220 (256)
T cd05059         161 TKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---VVE---SVSA------GYRL--------  220 (256)
T ss_pred             CCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---HHH---HHHc------CCcC--------
Confidence            114457999999998899999999999999999999 899987644321   110   1000      0000        


Q ss_pred             CCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 010309          469 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ  504 (513)
Q Consensus       469 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  504 (513)
                      ..+...+.++.+++.+||+.+|++|||+.++++.|.
T Consensus       221 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~  256 (256)
T cd05059         221 YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT  256 (256)
T ss_pred             CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence            011124567999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=6.9e-40  Score=316.95  Aligned_cols=254  Identities=26%  Similarity=0.425  Sum_probs=197.5

Q ss_pred             CceecccCceEEEEEEeCC-CC--EEEEEEeccc--chhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeC------CceEE
Q 010309          230 NRLLGDSKTGGTYSGILPD-GS--RVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH------GDRYI  298 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~~~~l  298 (513)
                      .+.||+|+||.||+|...+ +.  .||+|.++..  .....+.+.+|+.+++.++||||+++++++...      ...++
T Consensus         4 ~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~   83 (272)
T cd05075           4 GKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVV   83 (272)
T ss_pred             ccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEE
Confidence            4568999999999999754 33  6999998754  233456788999999999999999999987532      24689


Q ss_pred             EEeeccCCCHHHHhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccc
Q 010309          299 VYEFVVNGPLDRWLHHIP--RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK  376 (513)
Q Consensus       299 v~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~  376 (513)
                      +|||+++|+|.+++....  .....+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++.
T Consensus        84 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  160 (272)
T cd05075          84 ILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSK  160 (272)
T ss_pred             EEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCccc
Confidence            999999999999874321  2234589999999999999999999999   99999999999999999999999999998


Q ss_pred             cCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhccccc
Q 010309          377 FVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYL  455 (513)
Q Consensus       377 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  455 (513)
                      ...............+++.|+|||.+.+..++.++||||||+++|||++ |..||.......   ....    ...... 
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~~----~~~~~~-  232 (272)
T cd05075         161 KIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE---IYDY----LRQGNR-  232 (272)
T ss_pred             ccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH----HHcCCC-
Confidence            7643322111122236778999999998889999999999999999999 889987643321   1110    111000 


Q ss_pred             ccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q 010309          456 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  506 (513)
Q Consensus       456 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  506 (513)
                            .      ..+...+..+.+++.+||+.||++|||+.+|++.|+++
T Consensus       233 ------~------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         233 ------L------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             ------C------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                  0      01112445689999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2.5e-40  Score=327.49  Aligned_cols=240  Identities=23%  Similarity=0.313  Sum_probs=194.1

Q ss_pred             eecccCceEEEEEEeC-CCCEEEEEEecccc---hhcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          232 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       232 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      +||+|+||.||++... +++.||||++++..   ......+.+|..++..+ +||||+++++++.+.+..++||||+++|
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (318)
T cd05570           2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGG   81 (318)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence            5799999999999975 47899999998642   22345677888999888 7999999999999999999999999999


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  386 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  386 (513)
                      +|..++..    ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++.........  
T Consensus        82 ~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--  152 (318)
T cd05570          82 DLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--  152 (318)
T ss_pred             CHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCc--
Confidence            99988854    24699999999999999999999999   9999999999999999999999999998753222111  


Q ss_pred             eeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCC
Q 010309          387 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  466 (513)
Q Consensus       387 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  466 (513)
                      .....|++.|+|||++.+..++.++|||||||++|+|++|+.||...+...   ...   .... ..             
T Consensus       153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~---~~~---~i~~-~~-------------  212 (318)
T cd05570         153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE---LFQ---SILE-DE-------------  212 (318)
T ss_pred             ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH---HHH---HHHc-CC-------------
Confidence            112238999999999999999999999999999999999999997654321   111   0000 00             


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHH
Q 010309          467 SDIPEAGVVQKVVDLVYACTQHVPSMRPRM-----SHVVH  501 (513)
Q Consensus       467 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~  501 (513)
                       ...+...+..+.+||.+||+.||++||++     .++++
T Consensus       213 -~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         213 -VRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             -CCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence             00112245678999999999999999999     77765

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=7.3e-40  Score=312.73  Aligned_cols=246  Identities=28%  Similarity=0.391  Sum_probs=198.6

Q ss_pred             eecccCceEEEEEEeCCCCEEEEEEecccch-hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCCHHH
Q 010309          232 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR  310 (513)
Q Consensus       232 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~  310 (513)
                      +||+|+||.||+|...+++.||+|.+..... .....+.+|+.+++.++||||+++++++...+..++||||+++++|.+
T Consensus         2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   81 (250)
T cd05085           2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS   81 (250)
T ss_pred             ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHH
Confidence            5799999999999988899999999876532 234568899999999999999999999999999999999999999999


Q ss_pred             HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccceeec
Q 010309          311 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA  390 (513)
Q Consensus       311 ~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  390 (513)
                      ++...   ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++........... ...
T Consensus        82 ~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~-~~~  154 (250)
T cd05085          82 FLRKK---KDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSS-GLK  154 (250)
T ss_pred             HHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccC-CCC
Confidence            98642   24588999999999999999999999   999999999999999999999999999875433221111 111


Q ss_pred             CcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCCCC
Q 010309          391 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDI  469 (513)
Q Consensus       391 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  469 (513)
                      .++..|+|||++.+..++.++||||||+++|++++ |..||.......   ..    ......     ..       . .
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~---~~----~~~~~~-----~~-------~-~  214 (250)
T cd05085         155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ---AR----EQVEKG-----YR-------M-S  214 (250)
T ss_pred             CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH---HH----HHHHcC-----CC-------C-C
Confidence            24677999999988889999999999999999998 999997653321   10    001000     00       0 0


Q ss_pred             CcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 010309          470 PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ  504 (513)
Q Consensus       470 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  504 (513)
                      .+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus       215 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         215 CPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            01124567999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=3.3e-40  Score=328.06  Aligned_cols=243  Identities=22%  Similarity=0.285  Sum_probs=190.5

Q ss_pred             ceecccCceEEEEEEeC-CCCEEEEEEecccc---hhcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCCceEEEEeeccC
Q 010309          231 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVN  305 (513)
Q Consensus       231 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~  305 (513)
                      ++||+|+||.||++... +++.||+|++++..   ......+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            36899999999999965 58899999998642   22345677888888877 899999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccc
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  385 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  385 (513)
                      |+|..++..    ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++........ 
T Consensus        81 ~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~-  152 (329)
T cd05618          81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT-  152 (329)
T ss_pred             CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCc-
Confidence            999988853    35689999999999999999999999   9999999999999999999999999998754222111 


Q ss_pred             ceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccc--cchhHHhhhHHhhccccccccccccc
Q 010309          386 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVC--WQSIFEWATPLVQSHRYLELLDPLIS  463 (513)
Q Consensus       386 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  463 (513)
                       .....||+.|+|||++.+..++.++||||||+++|||++|+.||.......  ......+.........          
T Consensus       153 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~----------  221 (329)
T cd05618         153 -TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----------  221 (329)
T ss_pred             -cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC----------
Confidence             112348999999999999999999999999999999999999996422111  0111111111111100          


Q ss_pred             CCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCH
Q 010309          464 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRM  496 (513)
Q Consensus       464 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  496 (513)
                         . ..+...+..+.+++.+||+.||++||++
T Consensus       222 ---~-~~p~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         222 ---I-RIPRSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             ---C-CCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence               0 0112345678999999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2.4e-40  Score=327.29  Aligned_cols=239  Identities=25%  Similarity=0.314  Sum_probs=191.3

Q ss_pred             eecccCceEEEEEEeC-CCCEEEEEEecccc---hhcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          232 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       232 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      +||+|+||.||+|... +|+.||+|.++...   ......+..|..++..+ +||||+++++++.+.+..++||||+++|
T Consensus         2 ~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g   81 (316)
T cd05620           2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGG   81 (316)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCC
Confidence            5899999999999975 58899999997642   12345567788888765 8999999999999999999999999999


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  386 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  386 (513)
                      +|..++..    ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.++|+|||++........  .
T Consensus        82 ~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~  152 (316)
T cd05620          82 DLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN--R  152 (316)
T ss_pred             cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC--c
Confidence            99998854    34689999999999999999999999   999999999999999999999999999874322111  1


Q ss_pred             eeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCC
Q 010309          387 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  466 (513)
Q Consensus       387 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  466 (513)
                      .....||+.|+|||++.+..++.++|||||||++|||++|..||...+...   +.+...    ..      .+      
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~---~~~~~~----~~------~~------  213 (316)
T cd05620         153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE---LFESIR----VD------TP------  213 (316)
T ss_pred             eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---HHHHHH----hC------CC------
Confidence            122348999999999999999999999999999999999999997654321   111100    00      00      


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHH-HHH
Q 010309          467 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMS-HVV  500 (513)
Q Consensus       467 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl  500 (513)
                       . .+...+.++.+++.+||+.||++||++. +++
T Consensus       214 -~-~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         214 -H-YPRWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             -C-CCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence             0 0112455789999999999999999984 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=3.5e-40  Score=327.39  Aligned_cols=241  Identities=24%  Similarity=0.301  Sum_probs=190.9

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccc---hhcHHHHHHHHHHH---hhcCCCcEeeeeeEEeeCCceEEEEee
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRF---ARLHHPNLVAVKGCCYDHGDRYIVYEF  302 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~nIv~l~~~~~~~~~~~lv~e~  302 (513)
                      .+.||+|+||.||+|... +++.||||++++..   ....+.+.+|..++   +.++||||+++++++.+.+..|+||||
T Consensus         4 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~   83 (324)
T cd05589           4 LAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEY   83 (324)
T ss_pred             EEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcC
Confidence            356899999999999864 58999999997542   22234566676555   566899999999999999999999999


Q ss_pred             ccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccc
Q 010309          303 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV  382 (513)
Q Consensus       303 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~  382 (513)
                      +++++|..++..     ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++.......
T Consensus        84 ~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05589          84 AAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG  155 (324)
T ss_pred             CCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence            999999988753     4699999999999999999999999   99999999999999999999999999987533221


Q ss_pred             cccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccc
Q 010309          383 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI  462 (513)
Q Consensus       383 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  462 (513)
                      .  ......|++.|+|||++.+..++.++|||||||++|||++|+.||...+....   .   ..... ..         
T Consensus       156 ~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~---~---~~i~~-~~---------  217 (324)
T cd05589         156 D--RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV---F---DSIVN-DE---------  217 (324)
T ss_pred             C--cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHH---H---HHHHh-CC---------
Confidence            1  11223489999999999998999999999999999999999999976543211   1   00000 00         


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 010309          463 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP-----RMSHVVH  501 (513)
Q Consensus       463 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  501 (513)
                           ...+...+..+.++|.+||+.||.+||     ++.++++
T Consensus       218 -----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         218 -----VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             -----CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence                 001122456789999999999999999     5666655

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=6.1e-40  Score=318.70  Aligned_cols=254  Identities=22%  Similarity=0.314  Sum_probs=198.1

Q ss_pred             CceecccCceEEEEEEeC-CCC----EEEEEEecccch-hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeec
Q 010309          230 NRLLGDSKTGGTYSGILP-DGS----RVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  303 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  303 (513)
                      .+.||+|+||.||+|.+. +++    +|++|.+..... ....++..|+..+++++||||+++++++. ....++++||+
T Consensus        12 ~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i~e~~   90 (279)
T cd05111          12 LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLVTQLS   90 (279)
T ss_pred             ccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEEEEeC
Confidence            346799999999999963 344    578888764422 23356788888999999999999999875 45678999999


Q ss_pred             cCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccc
Q 010309          304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM  383 (513)
Q Consensus       304 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~  383 (513)
                      ++|+|.+++...   ...+++..+..++.||+.||+|||+.   +++|+||||+|||++.++.+||+|||+++.......
T Consensus        91 ~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~  164 (279)
T cd05111          91 PLGSLLDHVRQH---RDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDK  164 (279)
T ss_pred             CCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccCCCc
Confidence            999999999642   34689999999999999999999999   999999999999999999999999999986543322


Q ss_pred             ccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccccccc
Q 010309          384 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI  462 (513)
Q Consensus       384 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  462 (513)
                      ........++..|+|||.+.+..++.++||||||+++|||++ |..||.+........+       .......  .    
T Consensus       165 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~-------~~~~~~~--~----  231 (279)
T cd05111         165 KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDL-------LEKGERL--A----  231 (279)
T ss_pred             ccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-------HHCCCcC--C----
Confidence            211222336778999999998899999999999999999998 9999976543211111       1111000  0    


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcCCC
Q 010309          463 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP  510 (513)
Q Consensus       463 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  510 (513)
                             .+..++..+.+++.+||..||++|||+.|+++.|..+...|
T Consensus       232 -------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~  272 (279)
T cd05111         232 -------QPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP  272 (279)
T ss_pred             -------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence                   01112346789999999999999999999999998876655

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-40  Score=319.40  Aligned_cols=247  Identities=19%  Similarity=0.256  Sum_probs=197.8

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccchh---cHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccC
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQ---RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  305 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  305 (513)
                      .++||+|+||.||++... +++.||||++......   ....+.+|+.+++.++||||+++++.+..++..++||||+++
T Consensus         5 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   84 (285)
T cd05605           5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG   84 (285)
T ss_pred             EEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCC
Confidence            457899999999999964 6899999999754322   234577899999999999999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccc
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  385 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  385 (513)
                      |+|.+++..  .....+++..+..++.|++.||.|||+.   +++||||||+||++++++.++|+|||++......... 
T Consensus        85 ~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~-  158 (285)
T cd05605          85 GDLKFHIYN--MGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETI-  158 (285)
T ss_pred             CcHHHHHHh--cCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcc-
Confidence            999988864  2235689999999999999999999999   9999999999999999999999999999865432211 


Q ss_pred             ceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCC
Q 010309          386 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  465 (513)
Q Consensus       386 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  465 (513)
                        ....|++.|+|||++.+..++.++||||||+++|||++|..||.+........   .......         ..    
T Consensus       159 --~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~---~~~~~~~---------~~----  220 (285)
T cd05605         159 --RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKRE---EVERRVK---------ED----  220 (285)
T ss_pred             --ccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHH---HHHHHhh---------hc----
Confidence              12238899999999998889999999999999999999999998654321100   0000000         00    


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 010309          466 SSDIPEAGVVQKVVDLVYACTQHVPSMRP-----RMSHVVH  501 (513)
Q Consensus       466 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  501 (513)
                       ....+...+..+.+|+.+||+.||++||     +++++++
T Consensus       221 -~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         221 -QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             -ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence             0111223566789999999999999999     8888865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=9e-40  Score=316.17  Aligned_cols=254  Identities=25%  Similarity=0.455  Sum_probs=200.0

Q ss_pred             CceecccCceEEEEEEeCC----CCEEEEEEecccc--hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCc------eE
Q 010309          230 NRLLGDSKTGGTYSGILPD----GSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD------RY  297 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~------~~  297 (513)
                      .++||+|+||.||+|....    +..||||.++...  ......+.+|+..++.++||||+++++++.....      .+
T Consensus         4 ~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   83 (273)
T cd05035           4 GKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPM   83 (273)
T ss_pred             ccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccE
Confidence            4568999999999998642    3689999997542  2334678999999999999999999998876554      79


Q ss_pred             EEEeeccCCCHHHHhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEeccccc
Q 010309          298 IVYEFVVNGPLDRWLHHIP--RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLS  375 (513)
Q Consensus       298 lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~  375 (513)
                      +||||+++++|..++....  .....+++..+..++.|++.||.|||+.   +++||||||+||++++++.+||+|||++
T Consensus        84 ~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~  160 (273)
T cd05035          84 VILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLS  160 (273)
T ss_pred             EEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCccce
Confidence            9999999999999985432  2234689999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccc
Q 010309          376 KFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRY  454 (513)
Q Consensus       376 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  454 (513)
                      +...............++..|+|||.+.+..++.++||||||+++|||++ |..||.......   ..+..   .. ...
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---~~~~~---~~-~~~  233 (273)
T cd05035         161 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---IYDYL---RH-GNR  233 (273)
T ss_pred             eeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH---Hc-CCC
Confidence            86644322211222225678999999988889999999999999999999 889986544321   11111   10 000


Q ss_pred             cccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q 010309          455 LELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  506 (513)
Q Consensus       455 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  506 (513)
                                  .. .+...+.++.+++.+||+.||++|||+.++++.|+++
T Consensus       234 ------------~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         234 ------------LK-QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             ------------CC-CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                        00 1123456799999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=6.2e-41  Score=331.94  Aligned_cols=238  Identities=26%  Similarity=0.324  Sum_probs=192.6

Q ss_pred             ceecccCceEEEEEEe----CCCCEEEEEEecccch--hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeecc
Q 010309          231 RLLGDSKTGGTYSGIL----PDGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV  304 (513)
Q Consensus       231 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  304 (513)
                      +.||+|+||.||++..    .+|+.||+|++.....  .....+.+|++++++++||||+++++++.+.+..|+||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            3579999999999875    3588999999976432  234567789999999999999999999999999999999999


Q ss_pred             CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccc
Q 010309          305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  384 (513)
Q Consensus       305 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  384 (513)
                      +|+|.+++..    ...+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++........ 
T Consensus        82 ~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-  153 (318)
T cd05582          82 GGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-  153 (318)
T ss_pred             CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-
Confidence            9999999854    34689999999999999999999999   999999999999999999999999999876543211 


Q ss_pred             cceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccC
Q 010309          385 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS  464 (513)
Q Consensus       385 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  464 (513)
                       ......|++.|+|||++.+..++.++||||||+++|||++|+.||...+...   ..   ..... ..        .  
T Consensus       154 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~---~~i~~-~~--------~--  215 (318)
T cd05582         154 -KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE---TM---TMILK-AK--------L--  215 (318)
T ss_pred             -ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH---HH---HHHHc-CC--------C--
Confidence             1122348999999999988888999999999999999999999997654321   11   00000 00        0  


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHH
Q 010309          465 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSH  498 (513)
Q Consensus       465 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  498 (513)
                          ..+...++.+.+|+.+||+.||++||++.+
T Consensus       216 ----~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         216 ----GMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             ----CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence                011224567899999999999999999555

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-40  Score=327.90  Aligned_cols=253  Identities=28%  Similarity=0.442  Sum_probs=211.0

Q ss_pred             cCCceecccCceEEEEEEeCC---CC--EEEEEEeccc-chhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEe
Q 010309          228 EGNRLLGDSKTGGTYSGILPD---GS--RVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE  301 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~~---~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  301 (513)
                      ..+++||.|.||.||+|+..+   |.  .||||+-+.+ ...+.+.|+.|+.+|++++||||++++|+|.+. ..+||||
T Consensus       392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~WivmE  470 (974)
T KOG4257|consen  392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVME  470 (974)
T ss_pred             cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEEe
Confidence            446789999999999999643   33  5999999874 445578899999999999999999999998764 7799999


Q ss_pred             eccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcc
Q 010309          302 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE  381 (513)
Q Consensus       302 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~  381 (513)
                      .++-|.|..||+.   ....++......++.||+.||+|||+.   ++|||||..+|||+.+..-+||+|||+++.+..+
T Consensus       471 L~~~GELr~yLq~---nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~  544 (974)
T KOG4257|consen  471 LAPLGELREYLQQ---NKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYLEDD  544 (974)
T ss_pred             cccchhHHHHHHh---ccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence            9999999999974   346799999999999999999999999   9999999999999999999999999999998876


Q ss_pred             ccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccccc
Q 010309          382 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP  460 (513)
Q Consensus       382 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  460 (513)
                      ....... ..-++.|||||.+...+++.+||||-|||.+||+++ |..||++....+                   ++-.
T Consensus       545 ~yYkaS~-~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD-------------------VI~~  604 (974)
T KOG4257|consen  545 AYYKASR-GKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD-------------------VIGH  604 (974)
T ss_pred             chhhccc-cccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc-------------------eEEE
Confidence            6544442 225788999999999999999999999999999998 999998765421                   1111


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcC
Q 010309          461 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  508 (513)
Q Consensus       461 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  508 (513)
                       +........+..+++.+..|+.+||..||.+||.+.++...|..+.+
T Consensus       605 -iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  605 -IENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             -ecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence             11111223345678889999999999999999999999998876543

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=7.9e-40  Score=314.49  Aligned_cols=251  Identities=28%  Similarity=0.448  Sum_probs=201.3

Q ss_pred             cCCceecccCceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCC
Q 010309          228 EGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  307 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs  307 (513)
                      ...+.||+|+||.||+|..++++.||+|.+.... .....+.+|+.++++++||||+++++++ ..+..++||||+++++
T Consensus         9 ~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~~~~~~   86 (260)
T cd05067           9 KLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEYMENGS   86 (260)
T ss_pred             eeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEcCCCCC
Confidence            3345789999999999998889999999997654 3456789999999999999999999986 4567899999999999


Q ss_pred             HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccce
Q 010309          308 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  387 (513)
Q Consensus       308 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  387 (513)
                      |.+++...  ....+++.++..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++........... 
T Consensus        87 L~~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~-  160 (260)
T cd05067          87 LVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAR-  160 (260)
T ss_pred             HHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCcccc-
Confidence            99998652  335689999999999999999999999   999999999999999999999999999976653222111 


Q ss_pred             eecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCC
Q 010309          388 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  466 (513)
Q Consensus       388 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  466 (513)
                      ....++..|+|||++....++.++||||||+++|||++ |+.||...+....   ..   .. ...     ..       
T Consensus       161 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~---~~-~~~-----~~-------  221 (260)
T cd05067         161 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV---IQ---NL-ERG-----YR-------  221 (260)
T ss_pred             cCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH---HH---HH-HcC-----CC-------
Confidence            11225678999999988889999999999999999999 9999976543211   11   00 000     00       


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q 010309          467 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  506 (513)
Q Consensus       467 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  506 (513)
                       ...+...+.++.+++.+||+.+|++||+++++++.|+.+
T Consensus       222 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  260 (260)
T cd05067         222 -MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF  260 (260)
T ss_pred             -CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence             001112345799999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.4e-40  Score=329.59  Aligned_cols=263  Identities=19%  Similarity=0.267  Sum_probs=192.4

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEeccc--chhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCC-----ceEEEEe
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG-----DRYIVYE  301 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-----~~~lv~e  301 (513)
                      .+.||+|+||.||+|... +|+.||||++...  .......+.+|+.++++++||||+++++++...+     ..|+|||
T Consensus         5 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e   84 (338)
T cd07859           5 QEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFE   84 (338)
T ss_pred             EEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEe
Confidence            457899999999999964 6899999998743  2233456889999999999999999999886432     4799999


Q ss_pred             eccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcc
Q 010309          302 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE  381 (513)
Q Consensus       302 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~  381 (513)
                      |+ +++|.+++..    ...+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        85 ~~-~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  156 (338)
T cd07859          85 LM-ESDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFND  156 (338)
T ss_pred             cC-CCCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence            99 4689888853    34689999999999999999999999   9999999999999999999999999999865322


Q ss_pred             ccc-cceeecCccccccccccccc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhh--------hHHhh
Q 010309          382 VMQ-ERTVMAGGTYGYLAPEFVYR--NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWA--------TPLVQ  450 (513)
Q Consensus       382 ~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~  450 (513)
                      ... .......||+.|+|||++.+  ..++.++|||||||++|||+||++||...+...........        ...+.
T Consensus       157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~  236 (338)
T cd07859         157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVR  236 (338)
T ss_pred             cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence            211 11112338999999999865  67899999999999999999999999765432111100000        00000


Q ss_pred             cccccccccccccCCCCCCC---cHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          451 SHRYLELLDPLISSLSSDIP---EAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       451 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      .......+....... ....   ....++.+.+++.+||+.||++|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         237 NEKARRYLSSMRKKQ-PVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             hhhHHHHHHhhcccC-CCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            000000000000000 0000   0123456889999999999999999999986

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=6.5e-40  Score=325.74  Aligned_cols=242  Identities=21%  Similarity=0.259  Sum_probs=191.6

Q ss_pred             eecccCceEEEEEEeC-CCCEEEEEEecccch---hcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          232 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       232 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      +||+|+||.||++... +++.||+|++++...   ...+.+.+|..++.++ +||||+++++++.+.+..++||||+++|
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (327)
T cd05617           2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGG   81 (327)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCC
Confidence            5899999999999965 578999999986532   2345678899999888 6999999999999999999999999999


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  386 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  386 (513)
                      +|..++..    ...+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++........  .
T Consensus        82 ~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~  152 (327)
T cd05617          82 DLMFHMQR----QRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--T  152 (327)
T ss_pred             cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC--c
Confidence            99988853    34699999999999999999999999   999999999999999999999999999875322111  1


Q ss_pred             eeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCC
Q 010309          387 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  466 (513)
Q Consensus       387 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  466 (513)
                      .....||+.|+|||++.+..++.++|||||||++|||++|..||............+.........              
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--------------  218 (327)
T cd05617         153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK--------------  218 (327)
T ss_pred             eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC--------------
Confidence            122348999999999999999999999999999999999999997543321111111111111100              


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCH
Q 010309          467 SDIPEAGVVQKVVDLVYACTQHVPSMRPRM  496 (513)
Q Consensus       467 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  496 (513)
                      ....+...+..+.+++.+||+.||++||++
T Consensus       219 ~~~~p~~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         219 PIRIPRFLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             CCCCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence            001112345678999999999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.2e-39  Score=313.21  Aligned_cols=248  Identities=26%  Similarity=0.427  Sum_probs=199.1

Q ss_pred             CceecccCceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCCHH
Q 010309          230 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD  309 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~  309 (513)
                      .+.||+|++|.||+|...++..||+|.+..... ..+.+.+|+.++++++||||+++++++. .+..+++|||+++++|.
T Consensus        11 ~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~   88 (260)
T cd05070          11 IKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGSLL   88 (260)
T ss_pred             hheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCCcHH
Confidence            446799999999999988888999999976533 4567899999999999999999999875 45689999999999999


Q ss_pred             HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccceee
Q 010309          310 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM  389 (513)
Q Consensus       310 ~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  389 (513)
                      +++...  ....+++..++.++.|++.||+|||+.   +++|+||||+||++++++.++|+|||++............ .
T Consensus        89 ~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~-~  162 (260)
T cd05070          89 DFLKDG--EGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQ-G  162 (260)
T ss_pred             HHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCccccccc-C
Confidence            998642  234589999999999999999999999   9999999999999999999999999999865433221111 1


Q ss_pred             cCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCCC
Q 010309          390 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD  468 (513)
Q Consensus       390 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  468 (513)
                      ..++..|+|||.+.+..++.++||||||+++|+|++ |..||...+...   ....   .....              ..
T Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~---~~~~~--------------~~  222 (260)
T cd05070         163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE---VLEQ---VERGY--------------RM  222 (260)
T ss_pred             CCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---HHHH---HHcCC--------------CC
Confidence            114567999999988889999999999999999999 899987643221   1111   00000              00


Q ss_pred             CCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 010309          469 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ  505 (513)
Q Consensus       469 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  505 (513)
                      ..+...+..+.+|+.+||+.+|++|||+.++++.|++
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         223 PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            0112345679999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=7.4e-40  Score=321.74  Aligned_cols=255  Identities=25%  Similarity=0.360  Sum_probs=201.2

Q ss_pred             cCCceecccCceEEEEEEeC------CCCEEEEEEecccc-hhcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCCceEEE
Q 010309          228 EGNRLLGDSKTGGTYSGILP------DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIV  299 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv  299 (513)
                      ...+.||+|+||.||++...      .+..||||.++... ....+.+.+|+.+++++ +||||+++++++...+..++|
T Consensus        38 ~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv  117 (302)
T cd05055          38 SFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVI  117 (302)
T ss_pred             EEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEE
Confidence            34567799999999999741      35589999987653 23346789999999999 799999999999999999999


Q ss_pred             EeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCC
Q 010309          300 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP  379 (513)
Q Consensus       300 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~  379 (513)
                      |||+++|+|.+++...  ....+++.++..++.|++.||+|||++   +++|+||||+|||++.++.++|+|||++....
T Consensus       118 ~e~~~~~~L~~~i~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~  192 (302)
T cd05055         118 TEYCCYGDLLNFLRRK--RESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDIM  192 (302)
T ss_pred             EEcCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCccccccc
Confidence            9999999999999642  223489999999999999999999999   99999999999999999999999999998654


Q ss_pred             ccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccc
Q 010309          380 WEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELL  458 (513)
Q Consensus       380 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  458 (513)
                      ............++..|+|||.+.+..++.++||||||+++|||++ |..||.......  ...    .......     
T Consensus       193 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~--~~~----~~~~~~~-----  261 (302)
T cd05055         193 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS--KFY----KLIKEGY-----  261 (302)
T ss_pred             CCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH--HHH----HHHHcCC-----
Confidence            3321111111225678999999998889999999999999999998 999987644311  000    0111000     


Q ss_pred             cccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q 010309          459 DPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  506 (513)
Q Consensus       459 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  506 (513)
                      .       . ..+...++++.+++.+||+.+|++|||+.+|++.|+++
T Consensus       262 ~-------~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         262 R-------M-AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             c-------C-CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            0       0 01112345799999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.9e-40  Score=331.44  Aligned_cols=265  Identities=16%  Similarity=0.180  Sum_probs=195.2

Q ss_pred             ccCCceecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccC
Q 010309          227 SEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  305 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  305 (513)
                      +...+.||+|+||.||++... +++.||+|...      ...+.+|+.++++++||||+++++++......++|+|++ .
T Consensus        94 y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~-~  166 (391)
T PHA03212         94 FSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY-K  166 (391)
T ss_pred             cEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC-C
Confidence            444567899999999999964 58899999753      234678999999999999999999999999999999999 4


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccc
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  385 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  385 (513)
                      ++|..++..    ...+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++......... 
T Consensus       167 ~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~-  238 (391)
T PHA03212        167 TDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN-  238 (391)
T ss_pred             CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccccc-
Confidence            788888854    34689999999999999999999999   9999999999999999999999999999754322111 


Q ss_pred             ceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccc-----chhHHhhhHHh---hc------
Q 010309          386 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW-----QSIFEWATPLV---QS------  451 (513)
Q Consensus       386 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~-----~~~~~~~~~~~---~~------  451 (513)
                      ......||+.|+|||++.+..++.++|||||||++|||++|..||...+....     ..+........   ..      
T Consensus       239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~  318 (391)
T PHA03212        239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ  318 (391)
T ss_pred             ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence            11123489999999999999999999999999999999999988754322110     00000000000   00      


Q ss_pred             ccccccc---cccccCCCCCC----CcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcC
Q 010309          452 HRYLELL---DPLISSLSSDI----PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH--QLQQL  506 (513)
Q Consensus       452 ~~~~~~~---~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~  506 (513)
                      .......   ...........    .....+.++.+||.+||+.||++|||++|+++  .+..+
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~  382 (391)
T PHA03212        319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI  382 (391)
T ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence            0000000   00000000000    01234668999999999999999999999985  44444

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-40  Score=324.28  Aligned_cols=249  Identities=24%  Similarity=0.326  Sum_probs=209.0

Q ss_pred             CcccCCceecccCceEEEEEEeCC-CCEEEEEEecccchh---cHHHHHHHHHHHhhcC-CCcEeeeeeEEeeCCceEEE
Q 010309          225 NFSEGNRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQ---RKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIV  299 (513)
Q Consensus       225 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv  299 (513)
                      .+++..+.||+|.||.||+++.+. |+.+|+|.+.+....   ....+.+|+.+|+++. |||||.+++++++....++|
T Consensus        35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv  114 (382)
T KOG0032|consen   35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV  114 (382)
T ss_pred             ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence            445556788999999999999765 999999999876443   3468999999999998 99999999999999999999


Q ss_pred             EeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCC----CCeEEeccccc
Q 010309          300 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE----FGAHLMGVGLS  375 (513)
Q Consensus       300 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~----~~~kl~Dfg~~  375 (513)
                      ||++.||.|.+.+...     .+++..+..++.|++.++.|||+.   +|+||||||+|+|+...    +.+|++|||++
T Consensus       115 mEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla  186 (382)
T KOG0032|consen  115 MELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLA  186 (382)
T ss_pred             EEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence            9999999999999753     399999999999999999999999   99999999999999543    47999999999


Q ss_pred             ccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccc
Q 010309          376 KFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL  455 (513)
Q Consensus       376 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  455 (513)
                      .....   .......+||+.|+|||++....|+..+||||+|+++|.|++|.+||.+.+......       .+....+ 
T Consensus       187 ~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-------~i~~~~~-  255 (382)
T KOG0032|consen  187 KFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-------AILRGDF-  255 (382)
T ss_pred             eEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------HHHcCCC-
Confidence            98765   223334459999999999999999999999999999999999999998876432111       1111111 


Q ss_pred             ccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          456 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       456 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                               .....+...++..+.++|..||..||.+|+|+.++|+
T Consensus       256 ---------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  256 ---------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             ---------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence                     0123334557888999999999999999999999997

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=5.4e-40  Score=321.37  Aligned_cols=256  Identities=27%  Similarity=0.437  Sum_probs=202.6

Q ss_pred             CCceecccCceEEEEEEeC------CCCEEEEEEecccc-hhcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCCceEEEE
Q 010309          229 GNRLLGDSKTGGTYSGILP------DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVY  300 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~  300 (513)
                      ..+.||+|++|.||++...      ....+|+|.+.... ......+.+|+.++.++ +||||+++++++...+..+++|
T Consensus        16 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~   95 (293)
T cd05053          16 LGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVV   95 (293)
T ss_pred             EeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEE
Confidence            3457899999999999863      23689999987642 23345688999999999 8999999999999999999999


Q ss_pred             eeccCCCHHHHhccCC------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeE
Q 010309          301 EFVVNGPLDRWLHHIP------------RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH  368 (513)
Q Consensus       301 e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~k  368 (513)
                      ||+++|+|.+++....            .....+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+|
T Consensus        96 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~~~~~k  172 (293)
T cd05053          96 EYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMK  172 (293)
T ss_pred             EeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcCCCeEE
Confidence            9999999999986421            2345689999999999999999999999   999999999999999999999


Q ss_pred             EecccccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhH
Q 010309          369 LMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATP  447 (513)
Q Consensus       369 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~  447 (513)
                      |+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.......   ...    
T Consensus       173 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~----  245 (293)
T cd05053         173 IADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE---LFK----  245 (293)
T ss_pred             eCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH---HHH----
Confidence            999999987654322221222225678999999988889999999999999999998 999987543221   111    


Q ss_pred             HhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCc
Q 010309          448 LVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  507 (513)
Q Consensus       448 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  507 (513)
                      .......            .. .+...+..+.+|+.+||+.||++|||+.++++.|+.+.
T Consensus       246 ~~~~~~~------------~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         246 LLKEGYR------------ME-KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             HHHcCCc------------CC-CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence            0100000            00 11123557999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-39  Score=312.82  Aligned_cols=250  Identities=30%  Similarity=0.456  Sum_probs=204.1

Q ss_pred             eecccCceEEEEEEeCC----CCEEEEEEecccchhc-HHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          232 LLGDSKTGGTYSGILPD----GSRVAVKRLKRSSFQR-KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       232 ~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      .||+|+||.||++....    +..||+|.+....... .+.+.+|+..+..++|+||+++++++.+....++||||++++
T Consensus         2 ~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (262)
T cd00192           2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGG   81 (262)
T ss_pred             ccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCC
Confidence            57999999999999754    8899999998764333 678899999999999999999999999999999999999999


Q ss_pred             CHHHHhccCCCC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcc
Q 010309          307 PLDRWLHHIPRG-----GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE  381 (513)
Q Consensus       307 sL~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~  381 (513)
                      +|.+++......     ...+++..+..++.|++.||+|||++   +++|+||||+||+++.++.++|+|||.+......
T Consensus        82 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  158 (262)
T cd00192          82 DLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD  158 (262)
T ss_pred             cHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEcccccccccccc
Confidence            999999764221     36799999999999999999999999   9999999999999999999999999999877644


Q ss_pred             ccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccccc
Q 010309          382 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP  460 (513)
Q Consensus       382 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  460 (513)
                      ..........++..|+|||.+....++.++||||||+++|||++ |..||...+...   +....   .. ..       
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~---~~-~~-------  224 (262)
T cd00192         159 DYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE---VLEYL---RK-GY-------  224 (262)
T ss_pred             cccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH---Hc-CC-------
Confidence            32111222337889999999988889999999999999999999 699997754321   11111   00 00       


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 010309          461 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ  504 (513)
Q Consensus       461 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  504 (513)
                            ....+...+.++.+++.+||+.||++|||+.++++.|+
T Consensus       225 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         225 ------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             ------CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                  00111233567999999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.2e-39  Score=312.75  Aligned_cols=247  Identities=26%  Similarity=0.380  Sum_probs=196.6

Q ss_pred             eecccCceEEEEEEe---CCCCEEEEEEecccc--hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          232 LLGDSKTGGTYSGIL---PDGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       232 ~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      .||+|+||.||+|.+   .++..||+|+++...  ....+.+.+|+.+++.+.||||+++++++. .+..++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            369999999999975   357899999987543  223567899999999999999999999875 45678999999999


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  386 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  386 (513)
                      +|.+++..    ...+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++...........
T Consensus        81 ~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~  153 (257)
T cd05116          81 PLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK  153 (257)
T ss_pred             cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence            99999854    24689999999999999999999999   999999999999999999999999999987654322111


Q ss_pred             -eeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccccccccC
Q 010309          387 -TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS  464 (513)
Q Consensus       387 -~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  464 (513)
                       .....++..|+|||.+....++.++||||||+++|||++ |..||...........       ......          
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~-------i~~~~~----------  216 (257)
T cd05116         154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQM-------IESGER----------  216 (257)
T ss_pred             ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-------HHCCCC----------
Confidence             111124578999999988888999999999999999998 9999976543211111       111100          


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q 010309          465 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  506 (513)
Q Consensus       465 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  506 (513)
                        .. .+...++++.++|.+||+.||++||++++|.+.|++.
T Consensus       217 --~~-~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         217 --ME-CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             --CC-CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence              00 1123456799999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=9.6e-40  Score=317.29  Aligned_cols=257  Identities=22%  Similarity=0.366  Sum_probs=202.0

Q ss_pred             cCCceecccCceEEEEEEeC-CCC----EEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEe
Q 010309          228 EGNRLLGDSKTGGTYSGILP-DGS----RVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE  301 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  301 (513)
                      +..+.||+|+||.||+|.+. ++.    +||+|+++... ......+.+|+.+++.++||||+++++++.. ...++++|
T Consensus        10 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~~~   88 (279)
T cd05109          10 KKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLVTQ   88 (279)
T ss_pred             eeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEEEE
Confidence            33457899999999999853 444    58999997543 3345678899999999999999999999875 45789999


Q ss_pred             eccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcc
Q 010309          302 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE  381 (513)
Q Consensus       302 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~  381 (513)
                      |+++|+|.+++...   ...+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++.....
T Consensus        89 ~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~  162 (279)
T cd05109          89 LMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDID  162 (279)
T ss_pred             cCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeecccc
Confidence            99999999998642   34689999999999999999999999   9999999999999999999999999999876533


Q ss_pred             ccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccccc
Q 010309          382 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP  460 (513)
Q Consensus       382 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  460 (513)
                      ..........+++.|+|||.+.+..++.++||||||+++|||++ |..||.......   +..    ......       
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~----~~~~~~-------  228 (279)
T cd05109         163 ETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IPD----LLEKGE-------  228 (279)
T ss_pred             cceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH----HHHCCC-------
Confidence            22211111124678999999988899999999999999999998 899987543211   111    111100       


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcCCCC
Q 010309          461 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPV  511 (513)
Q Consensus       461 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~  511 (513)
                            ....+...+..+.+++.+||+.||++||++.++++.|+.+...|.
T Consensus       229 ------~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~~  273 (279)
T cd05109         229 ------RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDPS  273 (279)
T ss_pred             ------cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCCc
Confidence                  001112345678999999999999999999999999998877663

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.4e-39  Score=312.31  Aligned_cols=247  Identities=23%  Similarity=0.357  Sum_probs=196.1

Q ss_pred             ecccCceEEEEEEeC---CCCEEEEEEecccch-hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCCH
Q 010309          233 LGDSKTGGTYSGILP---DGSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  308 (513)
Q Consensus       233 lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL  308 (513)
                      ||+|+||.||+|.+.   .+..||+|++..... ...+.+.+|+.++++++||||+++++++. .+..++||||+++++|
T Consensus         3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L   81 (257)
T cd05115           3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPL   81 (257)
T ss_pred             cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCH
Confidence            699999999999863   355799999976532 23467899999999999999999999875 4578999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccc-e
Q 010309          309 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER-T  387 (513)
Q Consensus       309 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~-~  387 (513)
                      .+++..   ....+++..++.++.|++.||+|||++   +++|+||||+|||++.++.+||+|||++........... .
T Consensus        82 ~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  155 (257)
T cd05115          82 NKFLSG---KKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR  155 (257)
T ss_pred             HHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence            999863   234689999999999999999999999   999999999999999999999999999986543322111 1


Q ss_pred             eecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCC
Q 010309          388 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  466 (513)
Q Consensus       388 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  466 (513)
                      ....++..|+|||++....++.++||||||+++|||++ |..||.........       .......             
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-------~~~~~~~-------------  215 (257)
T cd05115         156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVM-------SFIEQGK-------------  215 (257)
T ss_pred             CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHH-------HHHHCCC-------------
Confidence            11123578999999988889999999999999999996 99999765432111       1111110             


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q 010309          467 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  506 (513)
Q Consensus       467 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  506 (513)
                      ....+...++++.+++.+||+.||++||++.+|.+.|+.+
T Consensus       216 ~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         216 RLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            0011123456799999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=9.6e-40  Score=317.95  Aligned_cols=252  Identities=25%  Similarity=0.387  Sum_probs=199.1

Q ss_pred             ceecccCceEEEEEEeC------CCCEEEEEEecccchh-cHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeec
Q 010309          231 RLLGDSKTGGTYSGILP------DGSRVAVKRLKRSSFQ-RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  303 (513)
Q Consensus       231 ~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  303 (513)
                      +.||+|+||.||+|...      ++..||||+++..... ....+.+|+.++..++||||+++++++...+..++++||+
T Consensus        11 ~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~   90 (283)
T cd05091          11 EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYC   90 (283)
T ss_pred             HHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcC
Confidence            35699999999999863      2578999999755322 2466889999999999999999999999999999999999


Q ss_pred             cCCCHHHHhccCC------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEec
Q 010309          304 VNGPLDRWLHHIP------------RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMG  371 (513)
Q Consensus       304 ~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~D  371 (513)
                      .+++|.+++....            .....+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.+||+|
T Consensus        91 ~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~kl~D  167 (283)
T cd05091          91 SHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISD  167 (283)
T ss_pred             CCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCceEecc
Confidence            9999999985311            1123588889999999999999999999   999999999999999999999999


Q ss_pred             ccccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhh
Q 010309          372 VGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQ  450 (513)
Q Consensus       372 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  450 (513)
                      ||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..||.+.....   ..+.    ..
T Consensus       168 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~~~----i~  240 (283)
T cd05091         168 LGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---VIEM----IR  240 (283)
T ss_pred             cccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH----HH
Confidence            999886543322221222225778999999988889999999999999999998 888887643321   1111    11


Q ss_pred             cccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 010309          451 SHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ  505 (513)
Q Consensus       451 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  505 (513)
                      ...        .     ...+.+++..+.+|+.+||+.+|.+||++.+|+..|+.
T Consensus       241 ~~~--------~-----~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         241 NRQ--------V-----LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             cCC--------c-----CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            100        0     01122355679999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.1e-39  Score=317.65  Aligned_cols=267  Identities=25%  Similarity=0.378  Sum_probs=198.9

Q ss_pred             CceecccCceEEEEEEeC-----CCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeC--CceEEEEee
Q 010309          230 NRLLGDSKTGGTYSGILP-----DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDRYIVYEF  302 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lv~e~  302 (513)
                      .+.||+|+||.||++...     ++..||+|.+........+.+.+|++++++++||||+++++++...  ...++||||
T Consensus         9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~   88 (284)
T cd05081           9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEY   88 (284)
T ss_pred             eeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEe
Confidence            356899999999999742     5889999999876655667899999999999999999999987543  467899999


Q ss_pred             ccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccc
Q 010309          303 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV  382 (513)
Q Consensus       303 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~  382 (513)
                      +++++|.+++...   ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++.......
T Consensus        89 ~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  162 (284)
T cd05081          89 LPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK  162 (284)
T ss_pred             cCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccccccCCC
Confidence            9999999998642   24589999999999999999999999   99999999999999999999999999998765332


Q ss_pred             cccc-eeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccccccccc
Q 010309          383 MQER-TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL  461 (513)
Q Consensus       383 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  461 (513)
                      .... .....++..|+|||++.+..++.++||||||+++|||++|..|+.........................+.+.  
T Consensus       163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  240 (284)
T cd05081         163 EYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK--  240 (284)
T ss_pred             cceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHh--
Confidence            2111 1111134569999999888899999999999999999998877543321100000000000000000000000  


Q ss_pred             ccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q 010309          462 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  506 (513)
Q Consensus       462 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  506 (513)
                        .......+...+.++.+|+.+||+.+|++|||+.+|++.|+.+
T Consensus       241 --~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         241 --NNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             --cCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence              0001111223456799999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=9.6e-40  Score=317.50  Aligned_cols=253  Identities=24%  Similarity=0.363  Sum_probs=200.8

Q ss_pred             CceecccCceEEEEEEeC------CCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeec
Q 010309          230 NRLLGDSKTGGTYSGILP------DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  303 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  303 (513)
                      .+.||+|+||.||++...      ++..+|+|.+..........+.+|+++++.++||||+++++++...+..++||||+
T Consensus        10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   89 (280)
T cd05092          10 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYM   89 (280)
T ss_pred             ccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecC
Confidence            446799999999999742      36689999998776666778999999999999999999999999999999999999


Q ss_pred             cCCCHHHHhccCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecc
Q 010309          304 VNGPLDRWLHHIPR-----------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV  372 (513)
Q Consensus       304 ~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df  372 (513)
                      ++++|.+++.....           ....+++..++.++.|++.||+|||+.   +++|+||||+|||+++++.+||+||
T Consensus        90 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~kL~df  166 (280)
T cd05092          90 RHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVVKIGDF  166 (280)
T ss_pred             CCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCEEECCC
Confidence            99999999865321           113588999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhc
Q 010309          373 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQS  451 (513)
Q Consensus       373 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  451 (513)
                      |++................+++.|+|||.+.+..++.++|||||||++|||++ |.+||........   .   ... ..
T Consensus       167 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~---~~~-~~  239 (280)
T cd05092         167 GMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA---I---ECI-TQ  239 (280)
T ss_pred             CceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH---H---HHH-Hc
Confidence            99875543221111111225678999999998899999999999999999998 9999865433211   0   000 00


Q ss_pred             ccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 010309          452 HRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ  505 (513)
Q Consensus       452 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  505 (513)
                      ..             ....+..+++.+.+++.+||+.||++||++.+|++.|+.
T Consensus       240 ~~-------------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         240 GR-------------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             Cc-------------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence            00             000112345679999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=2.1e-40  Score=328.83  Aligned_cols=236  Identities=23%  Similarity=0.312  Sum_probs=188.1

Q ss_pred             eecccCceEEEEEEeC-CCCEEEEEEecccch---hcHHHHHHHHH-HHhhcCCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          232 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIG-RFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       232 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      +||+|+||.||+|... +|+.||||++.....   .....+..|.. +++.++||||+++++.+.+.+..++||||+++|
T Consensus         2 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g   81 (323)
T cd05575           2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGG   81 (323)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCC
Confidence            6899999999999975 689999999975422   22344555554 567889999999999999999999999999999


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  386 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  386 (513)
                      +|..++..    ...+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++........  .
T Consensus        82 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~  152 (323)
T cd05575          82 ELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--T  152 (323)
T ss_pred             CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC--c
Confidence            99998854    35689999999999999999999999   999999999999999999999999999875422211  1


Q ss_pred             eeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCC
Q 010309          387 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  466 (513)
Q Consensus       387 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  466 (513)
                      .....||+.|+|||++.+..++.++|||||||++|||++|..||...+...   +.   .....         ...    
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~---~~---~~i~~---------~~~----  213 (323)
T cd05575         153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE---MY---DNILN---------KPL----  213 (323)
T ss_pred             cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH---HH---HHHHc---------CCC----
Confidence            122348999999999999999999999999999999999999997654321   11   11100         000    


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 010309          467 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMS  497 (513)
Q Consensus       467 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  497 (513)
                      .  .....+..+.+++.+||+.||.+||++.
T Consensus       214 ~--~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         214 R--LKPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             C--CCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            0  0112356799999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.6e-39  Score=312.83  Aligned_cols=251  Identities=26%  Similarity=0.396  Sum_probs=199.7

Q ss_pred             cCCceecccCceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCC
Q 010309          228 EGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  307 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs  307 (513)
                      ...+.||+|++|.||+|...++..||+|.++... ...+.+.+|+.+++.++||||+++++.+. .+..++||||+++++
T Consensus         9 ~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~   86 (262)
T cd05071           9 RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGS   86 (262)
T ss_pred             eEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCCCc
Confidence            3445679999999999998777789999997643 24567899999999999999999999874 456799999999999


Q ss_pred             HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccce
Q 010309          308 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  387 (513)
Q Consensus       308 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  387 (513)
                      |.+++...  ....+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||.+........... 
T Consensus        87 L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~-  160 (262)
T cd05071          87 LLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR-  160 (262)
T ss_pred             HHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccccccc-
Confidence            99999642  234578999999999999999999999   999999999999999999999999999976643322111 


Q ss_pred             eecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCC
Q 010309          388 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  466 (513)
Q Consensus       388 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  466 (513)
                      ....++..|+|||+..+..++.++||||||+++|||+| |..||.......   ...   .... .     .        
T Consensus       161 ~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~---~~~---~~~~-~-----~--------  220 (262)
T cd05071         161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VLD---QVER-G-----Y--------  220 (262)
T ss_pred             cCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH---HHH---HHhc-C-----C--------
Confidence            11225678999999988889999999999999999999 888887554321   100   0000 0     0        


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q 010309          467 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  506 (513)
Q Consensus       467 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  506 (513)
                      ........+..+.+++.+|++.||++||++.++++.|+..
T Consensus       221 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         221 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence            0011123556799999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-42  Score=304.31  Aligned_cols=246  Identities=21%  Similarity=0.286  Sum_probs=198.9

Q ss_pred             CCceecccCceEEEEEEe-CCCCEEEEEEeccc--chhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccC
Q 010309          229 GNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  305 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  305 (513)
                      ..+.||+|.|+.||+... ++|+.+|+|++...  +....+++.+|++|.+.|+||||+++.+.+.+....|||+|+|.|
T Consensus        15 l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G   94 (355)
T KOG0033|consen   15 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTG   94 (355)
T ss_pred             HHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccc
Confidence            345679999999999875 56999999988643  334568899999999999999999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCC---CCeEEecccccccCCccc
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE---FGAHLMGVGLSKFVPWEV  382 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~---~~~kl~Dfg~~~~~~~~~  382 (513)
                      ++|..-|-.    +...++..+-..++||+.||.|.|.+   +|||||+||+|+++.+.   --+||+|||++..+....
T Consensus        95 ~dl~~eIV~----R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~  167 (355)
T KOG0033|consen   95 GELFEDIVA----REFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGE  167 (355)
T ss_pred             hHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEeCCcc
Confidence            999765533    25578889999999999999999999   99999999999999543   348999999999876332


Q ss_pred             cccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccc
Q 010309          383 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI  462 (513)
Q Consensus       383 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  462 (513)
                      ...   ...|||.|||||++...+|+..+|||+.|||||-|+.|.+||.+.+...   +++...    .+.+ +.     
T Consensus       168 ~~~---G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r---lye~I~----~g~y-d~-----  231 (355)
T KOG0033|consen  168 AWH---GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---LYEQIK----AGAY-DY-----  231 (355)
T ss_pred             ccc---cccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH---HHHHHh----cccc-CC-----
Confidence            222   2339999999999999999999999999999999999999998855431   111111    0100 00     


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          463 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       463 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                          +......++++..+|+++||..||.+|.|+.|.|+
T Consensus       232 ----~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  232 ----PSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             ----CCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence                11122356778999999999999999999999875

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=5.4e-40  Score=333.20  Aligned_cols=249  Identities=20%  Similarity=0.247  Sum_probs=193.7

Q ss_pred             CCceecccCceEEEEEEeC-CCCEEEEEEecccch---hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeecc
Q 010309          229 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV  304 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  304 (513)
                      ..+.||+|+||.||+|... +++.||||++.....   .....+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus         5 ~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~   84 (381)
T cd05626           5 KIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIP   84 (381)
T ss_pred             EEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCC
Confidence            3456899999999999864 588999999976432   234568899999999999999999999999999999999999


Q ss_pred             CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccc
Q 010309          305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  384 (513)
Q Consensus       305 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  384 (513)
                      +|+|.+++..    ...+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++.........
T Consensus        85 gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~  157 (381)
T cd05626          85 GGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS  157 (381)
T ss_pred             CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence            9999999864    34688999999999999999999999   9999999999999999999999999997643210000


Q ss_pred             ---------------------------------------------cceeecCcccccccccccccCCCCchhhHHHHHHH
Q 010309          385 ---------------------------------------------ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVL  419 (513)
Q Consensus       385 ---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvi  419 (513)
                                                                   .......||+.|+|||++.+..++.++|||||||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i  237 (381)
T cd05626         158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI  237 (381)
T ss_pred             ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence                                                         00012348999999999998889999999999999


Q ss_pred             HHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHh--cCCCCCCCCCHH
Q 010309          420 LLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYAC--TQHVPSMRPRMS  497 (513)
Q Consensus       420 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c--l~~dP~~RPs~~  497 (513)
                      +|||+||..||...+.....      ........       .+    ........++++.+||.+|  +..+|..||+++
T Consensus       238 l~elltG~~Pf~~~~~~~~~------~~i~~~~~-------~~----~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~  300 (381)
T cd05626         238 LFEMLVGQPPFLAPTPTETQ------LKVINWEN-------TL----HIPPQVKLSPEAVDLITKLCCSAEERLGRNGAD  300 (381)
T ss_pred             HHHHHhCCCCCcCCCHHHHH------HHHHcccc-------cc----CCCCCCCCCHHHHHHHHHHccCcccccCCCCHH
Confidence            99999999999765432100      00000000       00    0011123456788999884  455666799999


Q ss_pred             HHHH
Q 010309          498 HVVH  501 (513)
Q Consensus       498 evl~  501 (513)
                      ++++
T Consensus       301 ~~l~  304 (381)
T cd05626         301 DIKA  304 (381)
T ss_pred             HHhc
Confidence            9986

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-39  Score=309.98  Aligned_cols=248  Identities=26%  Similarity=0.398  Sum_probs=200.3

Q ss_pred             eecccCceEEEEEEeCCCCEEEEEEecccchh-cHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCCHHH
Q 010309          232 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQ-RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR  310 (513)
Q Consensus       232 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~  310 (513)
                      +||+|++|.||++...+++.||+|.+...... ....+.+|+.++++++||||+++++++.+....++||||+++++|.+
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~   81 (251)
T cd05041           2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLT   81 (251)
T ss_pred             ccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHH
Confidence            57999999999999877999999998765433 45678999999999999999999999999999999999999999999


Q ss_pred             HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccceeec
Q 010309          311 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA  390 (513)
Q Consensus       311 ~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  390 (513)
                      ++...   ...+++..+..++.+++.||+|||++   +++||||||+||+++.++.++|+|||.+...............
T Consensus        82 ~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (251)
T cd05041          82 FLRKK---KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK  155 (251)
T ss_pred             HHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence            98642   24588999999999999999999999   9999999999999999999999999999865422211111112


Q ss_pred             CcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCCCC
Q 010309          391 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDI  469 (513)
Q Consensus       391 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  469 (513)
                      ..+..|+|||.+.+..++.++||||||+++|||+| |..||...........       ....     .        ...
T Consensus       156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~-------~~~~-----~--------~~~  215 (251)
T cd05041         156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRER-------IESG-----Y--------RMP  215 (251)
T ss_pred             cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHH-------HhcC-----C--------CCC
Confidence            24567999999988889999999999999999999 8888866543211110       0000     0        001


Q ss_pred             CcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 010309          470 PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ  505 (513)
Q Consensus       470 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  505 (513)
                      .+...+..+.+++.+||+.+|++|||+.||++.|+.
T Consensus       216 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~  251 (251)
T cd05041         216 APQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI  251 (251)
T ss_pred             CCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence            112345679999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-39  Score=310.56  Aligned_cols=246  Identities=30%  Similarity=0.456  Sum_probs=201.9

Q ss_pred             CCceecccCceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCCH
Q 010309          229 GNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  308 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL  308 (513)
                      ..+.||.|++|.||+|.. .|+.||||.+..... ..+.+.+|+.+++.++|+||+++++++.+.+..++||||+++++|
T Consensus        10 ~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L   87 (256)
T cd05039          10 LGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSL   87 (256)
T ss_pred             ceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcH
Confidence            345789999999999987 589999999987643 567899999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccccee
Q 010309          309 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  388 (513)
Q Consensus       309 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  388 (513)
                      .+++...  ....+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||.+........     
T Consensus        88 ~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-----  157 (256)
T cd05039          88 VDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-----  157 (256)
T ss_pred             HHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc-----
Confidence            9999652  223689999999999999999999999   999999999999999999999999999987633221     


Q ss_pred             ecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCC
Q 010309          389 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS  467 (513)
Q Consensus       389 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  467 (513)
                      ....+..|+|||.+....++.++||||||+++|||++ |..||.......   +...    .....     .       .
T Consensus       158 ~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~----~~~~~-----~-------~  218 (256)
T cd05039         158 SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPH----VEKGY-----R-------M  218 (256)
T ss_pred             cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHH----HhcCC-----C-------C
Confidence            1125667999999988889999999999999999997 999986543221   1110    00000     0       0


Q ss_pred             CCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q 010309          468 DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  506 (513)
Q Consensus       468 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  506 (513)
                      . .+...++.+.+++.+||+.+|++|||++++++.|+++
T Consensus       219 ~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         219 E-APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             C-CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence            0 1122456799999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.1e-39  Score=317.08  Aligned_cols=257  Identities=25%  Similarity=0.384  Sum_probs=203.8

Q ss_pred             CCceecccCceEEEEEEeCC-----CCEEEEEEeccc-chhcHHHHHHHHHHHhhcCCCcEeeeeeEEee-CCceEEEEe
Q 010309          229 GNRLLGDSKTGGTYSGILPD-----GSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD-HGDRYIVYE  301 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~lv~e  301 (513)
                      ..++||+|+||.||+|...+     +..|++|++... .....+.+.+|+.++++++||||+++++++.. +...++++|
T Consensus        10 ~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~   89 (280)
T cd05043          10 LSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYP   89 (280)
T ss_pred             EeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEE
Confidence            45678999999999999765     788999998754 23345678899999999999999999998776 467899999


Q ss_pred             eccCCCHHHHhccCCCC----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEeccccccc
Q 010309          302 FVVNGPLDRWLHHIPRG----GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF  377 (513)
Q Consensus       302 ~~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~  377 (513)
                      |+++++|.+++......    ...+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||+++.
T Consensus        90 ~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~g~~~~  166 (280)
T cd05043          90 YMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRD  166 (280)
T ss_pred             cCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCCCCccc
Confidence            99999999998653322    15689999999999999999999999   999999999999999999999999999986


Q ss_pred             CCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccc
Q 010309          378 VPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLE  456 (513)
Q Consensus       378 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  456 (513)
                      +.............++..|+|||++.+..++.++||||||+++||+++ |+.||...+...   +...   ......   
T Consensus       167 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~---~~~~~~---  237 (280)
T cd05043         167 LFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAAY---LKDGYR---  237 (280)
T ss_pred             ccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHHH---HHcCCC---
Confidence            543322211111225678999999988889999999999999999999 999997654321   1111   000000   


Q ss_pred             cccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcC
Q 010309          457 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  508 (513)
Q Consensus       457 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  508 (513)
                           .     . ....+++++.+++.+||+.||++|||+.++++.|+.+..
T Consensus       238 -----~-----~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         238 -----L-----A-QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             -----C-----C-CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                 0     0 011234678999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.1e-40  Score=316.99  Aligned_cols=253  Identities=25%  Similarity=0.400  Sum_probs=200.6

Q ss_pred             CceecccCceEEEEEEeCC------CCEEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEee
Q 010309          230 NRLLGDSKTGGTYSGILPD------GSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF  302 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  302 (513)
                      .+.||+|+||.||+|....      +..||+|.+.... ......+.+|+.+++.++||||+++++++......++||||
T Consensus        11 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   90 (277)
T cd05032          11 IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMEL   90 (277)
T ss_pred             EeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEec
Confidence            4567999999999998642      4689999987553 23446788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhccCCC------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccc
Q 010309          303 VVNGPLDRWLHHIPR------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK  376 (513)
Q Consensus       303 ~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~  376 (513)
                      +++++|.+++.....      ....+++..++.++.|++.||.|||+.   +++|+||||+|||++.++.+||+|||+++
T Consensus        91 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~dfg~~~  167 (277)
T cd05032          91 MAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTR  167 (277)
T ss_pred             CCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEECCcccch
Confidence            999999999965322      123478899999999999999999999   99999999999999999999999999987


Q ss_pred             cCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhccccc
Q 010309          377 FVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYL  455 (513)
Q Consensus       377 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  455 (513)
                      ...............++..|+|||.+.+..++.++||||||+++|||+| |..||...+...   .....    ..... 
T Consensus       168 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~~~----~~~~~-  239 (277)
T cd05032         168 DIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE---VLKFV----IDGGH-  239 (277)
T ss_pred             hhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH---HHHHH----hcCCC-
Confidence            6543322111122236788999999988889999999999999999998 999987644321   11111    00000 


Q ss_pred             ccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 010309          456 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ  505 (513)
Q Consensus       456 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  505 (513)
                                 .. .+...+.++.+++.+||+.+|++|||+.++++.|++
T Consensus       240 -----------~~-~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         240 -----------LD-LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             -----------CC-CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence                       00 011235679999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-39  Score=311.38  Aligned_cols=251  Identities=28%  Similarity=0.456  Sum_probs=202.9

Q ss_pred             cCCceecccCceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCC
Q 010309          228 EGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  307 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs  307 (513)
                      ...+.||+|++|.||+|..++++.||||.+.... ...+++.+|+.++++++||||+++++++......++||||+++++
T Consensus         9 ~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~   87 (261)
T cd05034           9 KLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGS   87 (261)
T ss_pred             eeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCC
Confidence            3345789999999999998888899999997653 345779999999999999999999999999899999999999999


Q ss_pred             HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccce
Q 010309          308 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  387 (513)
Q Consensus       308 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  387 (513)
                      |.+++...  ....+++..+..++.|++.||.|||++   +++|+||||+||++++++.++|+|||.+............
T Consensus        88 L~~~i~~~--~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~  162 (261)
T cd05034          88 LLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTARE  162 (261)
T ss_pred             HHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhhhhhh
Confidence            99999652  235689999999999999999999999   9999999999999999999999999999876532211111


Q ss_pred             eecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCC
Q 010309          388 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  466 (513)
Q Consensus       388 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  466 (513)
                       ....+..|+|||.+.+..++.++||||||+++|+|++ |+.||......   ......   ...      ..       
T Consensus       163 -~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~~~---~~~------~~-------  222 (261)
T cd05034         163 -GAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR---EVLEQV---ERG------YR-------  222 (261)
T ss_pred             -ccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH---HcC------CC-------
Confidence             1114568999999998889999999999999999999 99999754321   111110   000      00       


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 010309          467 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ  505 (513)
Q Consensus       467 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  505 (513)
                       ...+...+.++.+++.+||+.+|++||+++++++.|+.
T Consensus       223 -~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         223 -MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             -CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence             00111235679999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.4e-39  Score=311.53  Aligned_cols=239  Identities=26%  Similarity=0.390  Sum_probs=189.5

Q ss_pred             eecccCceEEEEEEeCC-------------CCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEE
Q 010309          232 LLGDSKTGGTYSGILPD-------------GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYI  298 (513)
Q Consensus       232 ~lg~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l  298 (513)
                      .||+|+||.||+|....             ...||+|.+..........+.+|+.++..++||||+++++++......++
T Consensus         2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l   81 (262)
T cd05077           2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM   81 (262)
T ss_pred             ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence            47999999999998532             23699999876654555678899999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCC-------eEEec
Q 010309          299 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG-------AHLMG  371 (513)
Q Consensus       299 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~-------~kl~D  371 (513)
                      ||||+++++|..++..   ....+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.       ++++|
T Consensus        82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d  155 (262)
T cd05077          82 VEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSD  155 (262)
T ss_pred             EEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence            9999999999998863   234589999999999999999999999   9999999999999987654       89999


Q ss_pred             ccccccCCccccccceeecCcccccccccccc-cCCCCchhhHHHHHHHHHHHH-cCCCCCCCCCccccchhHHhhhHHh
Q 010309          372 VGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY-RNELTTKSDVYSFGVLLLEIV-SGRRPAQAVDSVCWQSIFEWATPLV  449 (513)
Q Consensus       372 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvil~ell-tg~~p~~~~~~~~~~~~~~~~~~~~  449 (513)
                      ||++.......      ...++..|+|||++. +..++.++||||||+++|||+ +|..|+......+..       ...
T Consensus       156 ~g~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-------~~~  222 (262)
T cd05077         156 PGIPITVLSRQ------ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-------RFY  222 (262)
T ss_pred             CCCCccccCcc------cccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-------HHH
Confidence            99987553221      122778899999886 466889999999999999998 588887654321100       000


Q ss_pred             hcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 010309          450 QSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ  504 (513)
Q Consensus       450 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  504 (513)
                      .. .        .    ..  ....++++.+||.+||+.||.+||++.+|++.|+
T Consensus       223 ~~-~--------~----~~--~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         223 EG-Q--------C----ML--VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             hc-C--------c----cC--CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            00 0        0    00  0112356899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2.3e-39  Score=311.28  Aligned_cols=249  Identities=27%  Similarity=0.413  Sum_probs=198.8

Q ss_pred             CCceecccCceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCCH
Q 010309          229 GNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  308 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL  308 (513)
                      ....||+|++|.||++....+..+|+|.+.... ...+.+.+|+.++++++||||+++++++. .+..++||||+++++|
T Consensus        10 ~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L   87 (260)
T cd05069          10 LDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSL   87 (260)
T ss_pred             eeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCH
Confidence            345679999999999998777789999987543 34567889999999999999999999875 4568999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccccee
Q 010309          309 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  388 (513)
Q Consensus       309 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  388 (513)
                      .+++...  ....+++..+..++.|++.||.|||+.   +++|+||||+||++++++.++|+|||++........... .
T Consensus        88 ~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~-~  161 (260)
T cd05069          88 LDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTAR-Q  161 (260)
T ss_pred             HHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCccccc-C
Confidence            9999652  234588999999999999999999999   999999999999999999999999999976543221111 1


Q ss_pred             ecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCC
Q 010309          389 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS  467 (513)
Q Consensus       389 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  467 (513)
                      ...++..|+|||...+..++.++||||||+++|||+| |..||.......   .....   ...      ..       .
T Consensus       162 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~---~~~------~~-------~  222 (260)
T cd05069         162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---VLEQV---ERG------YR-------M  222 (260)
T ss_pred             CCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH---HcC------CC-------C
Confidence            1125678999999988889999999999999999999 899987644321   11100   000      00       0


Q ss_pred             CCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 010309          468 DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ  505 (513)
Q Consensus       468 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  505 (513)
                       ..+...+..+.+++.+||+.||++||++++|++.|++
T Consensus       223 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         223 -PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             -CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence             0112345679999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.5e-39  Score=315.69  Aligned_cols=254  Identities=28%  Similarity=0.413  Sum_probs=198.8

Q ss_pred             CCceecccCceEEEEEEeCC------CCEEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEe
Q 010309          229 GNRLLGDSKTGGTYSGILPD------GSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE  301 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  301 (513)
                      ..+.||+|++|.||+|...+      +..||+|.+.... ......+.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus        10 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   89 (277)
T cd05036          10 LLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLE   89 (277)
T ss_pred             eeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEe
Confidence            34578999999999999753      5689999887543 2334678999999999999999999999999999999999


Q ss_pred             eccCCCHHHHhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCC---CeEEeccccc
Q 010309          302 FVVNGPLDRWLHHIPR---GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF---GAHLMGVGLS  375 (513)
Q Consensus       302 ~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~---~~kl~Dfg~~  375 (513)
                      |+++++|.+++.....   ....+++..++.++.||+.||+|||+.   +++|+||||+||+++.++   .+||+|||++
T Consensus        90 ~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~  166 (277)
T cd05036          90 LMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMA  166 (277)
T ss_pred             cCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEeccCccc
Confidence            9999999999865321   123589999999999999999999999   999999999999998754   5899999999


Q ss_pred             ccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccc
Q 010309          376 KFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRY  454 (513)
Q Consensus       376 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  454 (513)
                      +................+..|+|||++.+..++.++|||||||++|||++ |..||...+...   ...    ...... 
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~---~~~----~~~~~~-  238 (277)
T cd05036         167 RDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE---VME----FVTGGG-  238 (277)
T ss_pred             cccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH----HHHcCC-
Confidence            87633221111111113568999999998899999999999999999997 999997654321   111    111000 


Q ss_pred             cccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 010309          455 LELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ  505 (513)
Q Consensus       455 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  505 (513)
                                  ....+...+..+.+++.+||+.+|++|||+.+|++.|++
T Consensus       239 ------------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~  277 (277)
T cd05036         239 ------------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY  277 (277)
T ss_pred             ------------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence                        001112345679999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=8.3e-40  Score=325.94  Aligned_cols=247  Identities=22%  Similarity=0.260  Sum_probs=193.7

Q ss_pred             CceecccCceEEEEEEe----CCCCEEEEEEecccc----hhcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCCceEEEE
Q 010309          230 NRLLGDSKTGGTYSGIL----PDGSRVAVKRLKRSS----FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVY  300 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~  300 (513)
                      .+.||+|+||.||++..    .+++.||+|++.+..    ....+.+.+|+.++..+ +||||+++++++...+..++||
T Consensus         5 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (332)
T cd05614           5 LKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLIL   84 (332)
T ss_pred             EEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEE
Confidence            45689999999999885    358899999997542    12345678899999999 5999999999999999999999


Q ss_pred             eeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCc
Q 010309          301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW  380 (513)
Q Consensus       301 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~  380 (513)
                      ||+++|+|.+++..    ...+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++.....
T Consensus        85 e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~  157 (332)
T cd05614          85 DYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS  157 (332)
T ss_pred             eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence            99999999999854    34689999999999999999999999   999999999999999999999999999986533


Q ss_pred             cccccceeecCcccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccccccc
Q 010309          381 EVMQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD  459 (513)
Q Consensus       381 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  459 (513)
                      ..... .....||+.|+|||++.+. .++.++|||||||++|||+||..||...........+  ......       .+
T Consensus       158 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~--~~~~~~-------~~  227 (332)
T cd05614         158 EEKER-TYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV--SRRILK-------CD  227 (332)
T ss_pred             cCCCc-cccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHH--HHHHhc-------CC
Confidence            22211 1123489999999998765 4788999999999999999999999754322111110  000000       00


Q ss_pred             ccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 010309          460 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP-----RMSHVVH  501 (513)
Q Consensus       460 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  501 (513)
                      +        ..+...+..+.+++.+||+.||++||     +++++++
T Consensus       228 ~--------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         228 P--------PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             C--------CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence            0        01122456789999999999999999     6777764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=8.3e-40  Score=324.68  Aligned_cols=237  Identities=24%  Similarity=0.305  Sum_probs=189.8

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccc---hhcHHHHHHHHHHHhhcCC-CcEeeeeeEEeeCCceEEEEeecc
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHH-PNLVAVKGCCYDHGDRYIVYEFVV  304 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~lv~e~~~  304 (513)
                      .+.||+|+||.||+|... +++.||||++.+..   ....+.+..|..++..+.| ++|+++++++.+.+..|+||||++
T Consensus         5 ~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~   84 (324)
T cd05587           5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN   84 (324)
T ss_pred             EEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCC
Confidence            456899999999999975 47899999997642   2334567889999999966 568889999999999999999999


Q ss_pred             CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccc
Q 010309          305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  384 (513)
Q Consensus       305 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  384 (513)
                      +|+|.+++..    ...+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++........ 
T Consensus        85 ~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~-  156 (324)
T cd05587          85 GGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK-  156 (324)
T ss_pred             CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC-
Confidence            9999998854    34589999999999999999999999   999999999999999999999999999875322211 


Q ss_pred             cceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccC
Q 010309          385 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS  464 (513)
Q Consensus       385 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  464 (513)
                       ......||+.|+|||++.+..++.++|||||||++|||+||+.||...+...   ...   ... ...           
T Consensus       157 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~~~---~i~-~~~-----------  217 (324)
T cd05587         157 -TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---LFQ---SIM-EHN-----------  217 (324)
T ss_pred             -ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---HHH---HHH-cCC-----------
Confidence             1222348999999999999999999999999999999999999997654321   111   000 000           


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCH
Q 010309          465 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRM  496 (513)
Q Consensus       465 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  496 (513)
                         ...+...+.++.+++.+||+.||.+||+.
T Consensus       218 ---~~~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         218 ---VSYPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             ---CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence               00112245678999999999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=7e-40  Score=337.38  Aligned_cols=261  Identities=19%  Similarity=0.288  Sum_probs=190.5

Q ss_pred             ccCCceecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeC--------CceE
Q 010309          227 SEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--------GDRY  297 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--------~~~~  297 (513)
                      +...+.||+|+||.||+|... +++.||||++....    ....+|+.+|+.++||||+++++++...        ...+
T Consensus        68 y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~  143 (440)
T PTZ00036         68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLN  143 (440)
T ss_pred             EEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEE
Confidence            344567899999999999974 58899999886432    2345799999999999999999887532        1357


Q ss_pred             EEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCC-CeEEecccccc
Q 010309          298 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF-GAHLMGVGLSK  376 (513)
Q Consensus       298 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~-~~kl~Dfg~~~  376 (513)
                      +||||++ ++|.+++.........+++..++.++.||+.||+|||+.   +|+||||||+|||++.++ .+||+|||+++
T Consensus       144 lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGla~  219 (440)
T PTZ00036        144 VVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSAK  219 (440)
T ss_pred             EEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccccch
Confidence            8999996 478777765444556799999999999999999999999   999999999999998665 69999999998


Q ss_pred             cCCccccccceeecCcccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhc----
Q 010309          377 FVPWEVMQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQS----  451 (513)
Q Consensus       377 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----  451 (513)
                      .........   ...+|+.|+|||++.+. .++.++|||||||++|||++|.+||.+.....  .+..... ....    
T Consensus       220 ~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~--~~~~i~~-~~~~p~~~  293 (440)
T PTZ00036        220 NLLAGQRSV---SYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD--QLVRIIQ-VLGTPTED  293 (440)
T ss_pred             hccCCCCcc---cCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHH-HhCCCCHH
Confidence            664322211   22378999999998764 68999999999999999999999998754321  1111100 0000    


Q ss_pred             ------ccccccccccccC-CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          452 ------HRYLELLDPLISS-LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       452 ------~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                            ..+.++.-+.... ......+...++++.+||.+||+.||.+|||+.|+++
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence                  0000000000000 0000011124567999999999999999999999984

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-40  Score=316.96  Aligned_cols=257  Identities=21%  Similarity=0.303  Sum_probs=212.1

Q ss_pred             cccCCceecccCceEEEEEEe-CCCCEEEEEEecccchhc--HHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEee
Q 010309          226 FSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQR--KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF  302 (513)
Q Consensus       226 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  302 (513)
                      .+...+-||+|.|+.|-+|++ =+|.+||||++.+.....  ...+.+|++.|+.++|||||++|++......+|||+|+
T Consensus        19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL   98 (864)
T KOG4717|consen   19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL   98 (864)
T ss_pred             eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence            445566789999999999984 379999999998875433  46789999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEec-CCCCeEEecccccccCCcc
Q 010309          303 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD-EEFGAHLMGVGLSKFVPWE  381 (513)
Q Consensus       303 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~-~~~~~kl~Dfg~~~~~~~~  381 (513)
                      -++|+|.+||-+.   ...+.+..+.+++.||+.|+.|+|..   .+|||||||+||.+- .-|-+||.|||++..+...
T Consensus        99 GD~GDl~DyImKH---e~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG  172 (864)
T KOG4717|consen   99 GDGGDLFDYIMKH---EEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG  172 (864)
T ss_pred             cCCchHHHHHHhh---hccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence            9999999999753   35699999999999999999999999   999999999998774 5677999999999877654


Q ss_pred             ccccceeecCcccccccccccccCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccc
Q 010309          382 VMQERTVMAGGTYGYLAPEFVYRNELT-TKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP  460 (513)
Q Consensus       382 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  460 (513)
                      ..   ....+|+..|.|||++.+..|+ ++.||||||||||.|++|++||+..++.+...               -++|-
T Consensus       173 ~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLT---------------mImDC  234 (864)
T KOG4717|consen  173 KK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLT---------------MIMDC  234 (864)
T ss_pred             ch---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhh---------------hhhcc
Confidence            32   3345699999999999999886 68899999999999999999998766542111               11111


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcCcCCCCC
Q 010309          461 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH--QLQQLAQPPVT  512 (513)
Q Consensus       461 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~~~~~t  512 (513)
                            .-..+...+.++++||..||..||.+|.+.+||..  .|+..-+++.|
T Consensus       235 ------KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~sT  282 (864)
T KOG4717|consen  235 ------KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGLST  282 (864)
T ss_pred             ------cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCccc
Confidence                  11234568889999999999999999999999986  35555444443

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=7.8e-40  Score=329.97  Aligned_cols=248  Identities=19%  Similarity=0.228  Sum_probs=192.7

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccch---hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccC
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  305 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  305 (513)
                      .+.||+|+||+||++... +++.||||++.+...   .....+.+|+.++..++||||+++++.+.+....++||||+++
T Consensus         6 ~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~g   85 (363)
T cd05628           6 LKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPG   85 (363)
T ss_pred             eEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCC
Confidence            457899999999999865 588999999976422   2335678899999999999999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccc-
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ-  384 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~-  384 (513)
                      |+|.+++..    ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++........ 
T Consensus        86 g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~  158 (363)
T cd05628          86 GDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE  158 (363)
T ss_pred             CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence            999999864    35689999999999999999999999   9999999999999999999999999998754321100 


Q ss_pred             --------------------------------cceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 010309          385 --------------------------------ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQA  432 (513)
Q Consensus       385 --------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~  432 (513)
                                                      .......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~  238 (363)
T cd05628         159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS  238 (363)
T ss_pred             ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence                                            001123489999999999999999999999999999999999999976


Q ss_pred             CCccccchhHHhhhHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCC---CCCCHHHHHHH
Q 010309          433 VDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPS---MRPRMSHVVHQ  502 (513)
Q Consensus       433 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~---~RPs~~evl~~  502 (513)
                      .+...   ..   .......  ...         ...+....++++.++|.+++. +|.   .||+++||++.
T Consensus       239 ~~~~~---~~---~~i~~~~--~~~---------~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         239 ETPQE---TY---KKVMNWK--ETL---------IFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             CCHHH---HH---HHHHcCc--Ccc---------cCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCC
Confidence            54321   10   1110000  000         000111245578888888664 444   56899999873

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.9e-39  Score=314.28  Aligned_cols=239  Identities=27%  Similarity=0.390  Sum_probs=188.7

Q ss_pred             eecccCceEEEEEEeCC-------------------------CCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeee
Q 010309          232 LLGDSKTGGTYSGILPD-------------------------GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAV  286 (513)
Q Consensus       232 ~lg~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l  286 (513)
                      .||+|+||.||+|....                         ...||+|++..........+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            47999999999997421                         23599999976544445678899999999999999999


Q ss_pred             eeEEeeCCceEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCC-
Q 010309          287 KGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF-  365 (513)
Q Consensus       287 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~-  365 (513)
                      ++++.+.+..++||||+++|+|..++..   ....+++..+..++.|++.||+|||+.   +|+||||||+|||++..+ 
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~  155 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGL  155 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCc
Confidence            9999999999999999999999998863   235689999999999999999999999   999999999999997643 


Q ss_pred             ------CeEEecccccccCCccccccceeecCccccccccccccc-CCCCchhhHHHHHHHHHHHH-cCCCCCCCCCccc
Q 010309          366 ------GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIV-SGRRPAQAVDSVC  437 (513)
Q Consensus       366 ------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~ell-tg~~p~~~~~~~~  437 (513)
                            .+|++|||++........      ..++..|+|||.+.+ ..++.++||||||+++|||+ +|..||.......
T Consensus       156 ~~~~~~~~kl~d~g~~~~~~~~~~------~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~  229 (274)
T cd05076         156 AEGTSPFIKLSDPGVSFTALSREE------RVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE  229 (274)
T ss_pred             ccCccceeeecCCccccccccccc------cccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence                  379999998864422111      126788999998875 56789999999999999995 7999987654321


Q ss_pred             cchhHHhhhHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 010309          438 WQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ  504 (513)
Q Consensus       438 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  504 (513)
                      ....       ....       ...        +....+.+.++|.+||+.+|++|||+.+|++.|+
T Consensus       230 ~~~~-------~~~~-------~~~--------~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         230 KERF-------YEKK-------HRL--------PEPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             HHHH-------HHhc-------cCC--------CCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            1110       0000       000        0112346899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.5e-39  Score=319.93  Aligned_cols=258  Identities=24%  Similarity=0.394  Sum_probs=203.3

Q ss_pred             CCceecccCceEEEEEEeC--------CCCEEEEEEecccc-hhcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCCceEE
Q 010309          229 GNRLLGDSKTGGTYSGILP--------DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYI  298 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~l  298 (513)
                      ..+.||+|+||.||++...        ++..||+|.+.... ......+.+|+.+++.+ +||||+++++++...+..++
T Consensus        19 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l   98 (304)
T cd05101          19 LGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV   98 (304)
T ss_pred             ecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCceEE
Confidence            4467899999999999741        24579999987542 33456789999999999 89999999999999999999


Q ss_pred             EEeeccCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCC
Q 010309          299 VYEFVVNGPLDRWLHHIPR------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG  366 (513)
Q Consensus       299 v~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~  366 (513)
                      ||||+++++|.+++.....            ....+++..+..++.||+.||.|||++   +++||||||+||+++.++.
T Consensus        99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nili~~~~~  175 (304)
T cd05101          99 IVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNV  175 (304)
T ss_pred             EEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEEEcCCCc
Confidence            9999999999999975321            123578889999999999999999999   9999999999999999999


Q ss_pred             eEEecccccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhh
Q 010309          367 AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWA  445 (513)
Q Consensus       367 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~  445 (513)
                      +||+|||+++...............+++.|+|||++.+..++.++||||||+++|+|++ |..||...+...   +..  
T Consensus       176 ~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~--  250 (304)
T cd05101         176 MKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---LFK--  250 (304)
T ss_pred             EEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH---HHH--
Confidence            99999999987644322222222235678999999988889999999999999999998 788886543221   111  


Q ss_pred             hHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcCC
Q 010309          446 TPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP  509 (513)
Q Consensus       446 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  509 (513)
                       .. ....             ....+..++..+.+++.+||+.+|++|||+.+|++.|+++...
T Consensus       251 -~~-~~~~-------------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~  299 (304)
T cd05101         251 -LL-KEGH-------------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL  299 (304)
T ss_pred             -HH-HcCC-------------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence             11 1000             0001123456799999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.2e-39  Score=330.54  Aligned_cols=257  Identities=27%  Similarity=0.378  Sum_probs=200.3

Q ss_pred             CCceecccCceEEEEEEeC------CCCEEEEEEecccch-hcHHHHHHHHHHHhhcC-CCcEeeeeeEEeeCCceEEEE
Q 010309          229 GNRLLGDSKTGGTYSGILP------DGSRVAVKRLKRSSF-QRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVY  300 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~  300 (513)
                      ..+.||+|+||.||+|.+.      .+..||||+++.... ...+.+.+|+.+|.++. ||||+++++++...+..++||
T Consensus        41 ~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~  120 (401)
T cd05107          41 LGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIIT  120 (401)
T ss_pred             hhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEE
Confidence            3567899999999999853      346899999976532 22457889999999997 999999999999999999999


Q ss_pred             eeccCCCHHHHhccCCC---------------------------------------------------------------
Q 010309          301 EFVVNGPLDRWLHHIPR---------------------------------------------------------------  317 (513)
Q Consensus       301 e~~~~gsL~~~l~~~~~---------------------------------------------------------------  317 (513)
                      ||+++|+|.++++....                                                               
T Consensus       121 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  200 (401)
T cd05107         121 EYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVK  200 (401)
T ss_pred             eccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhh
Confidence            99999999999964311                                                               


Q ss_pred             -------------------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCC
Q 010309          318 -------------------------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG  366 (513)
Q Consensus       318 -------------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~  366 (513)
                                                     ....+++..++.++.|++.||+|||+.   +++||||||+|||++.++.
T Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiLl~~~~~  277 (401)
T cd05107         201 YADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLICEGKL  277 (401)
T ss_pred             hhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEEEeCCCE
Confidence                                           112467788899999999999999999   9999999999999999999


Q ss_pred             eEEecccccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhh
Q 010309          367 AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWA  445 (513)
Q Consensus       367 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~  445 (513)
                      +||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||......+      ..
T Consensus       278 ~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~------~~  351 (401)
T cd05107         278 VKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE------QF  351 (401)
T ss_pred             EEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH------HH
Confidence            99999999986532221111111226788999999988889999999999999999998 888986543211      00


Q ss_pred             hHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCc
Q 010309          446 TPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  507 (513)
Q Consensus       446 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  507 (513)
                      ........     .       .. .+...+.++.+|+.+||+.+|.+||++++|++.|+++.
T Consensus       352 ~~~~~~~~-----~-------~~-~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         352 YNAIKRGY-----R-------MA-KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             HHHHHcCC-----C-------CC-CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            01111000     0       00 11124567999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.7e-39  Score=311.56  Aligned_cols=248  Identities=24%  Similarity=0.346  Sum_probs=199.4

Q ss_pred             eecccCceEEEEEEeCC--C--CEEEEEEecccch-hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          232 LLGDSKTGGTYSGILPD--G--SRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       232 ~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      .||+|++|.||+|.+.+  +  ..||||.+..... ...+.+.+|+.++++++||||+++++.+.. ...++||||++++
T Consensus         2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~   80 (257)
T cd05040           2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLG   80 (257)
T ss_pred             cCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCC
Confidence            57999999999999643  3  3699999987755 556789999999999999999999999988 8899999999999


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccc-c
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ-E  385 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~-~  385 (513)
                      +|.+++.....  ..+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++......... .
T Consensus        81 ~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          81 SLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             cHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEecccccccccccccccee
Confidence            99999975322  4689999999999999999999999   9999999999999999999999999999876542211 1


Q ss_pred             ceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccccccccC
Q 010309          386 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS  464 (513)
Q Consensus       386 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  464 (513)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |..||...+...   ...   ......       ...  
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~---~~~~~~-------~~~--  220 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ---ILK---KIDKEG-------ERL--  220 (257)
T ss_pred             cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHH---HHHhcC-------CcC--
Confidence            1112236788999999988899999999999999999999 999986543321   111   000000       000  


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 010309          465 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ  504 (513)
Q Consensus       465 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  504 (513)
                          ..+...+..+.+++.+||+.+|++|||+.+|++.|.
T Consensus       221 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         221 ----ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             ----CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence                001123567999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.8e-39  Score=319.82  Aligned_cols=259  Identities=26%  Similarity=0.419  Sum_probs=202.2

Q ss_pred             cCCceecccCceEEEEEEeC--------CCCEEEEEEecccc-hhcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCCceE
Q 010309          228 EGNRLLGDSKTGGTYSGILP--------DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRY  297 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~  297 (513)
                      ...+.||+|+||.||++...        +...+|+|.++... ......+.+|+.+++.+ +||||+++++++...+..+
T Consensus        21 ~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  100 (307)
T cd05098          21 VLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLY  100 (307)
T ss_pred             EEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence            44556799999999999852        23579999997642 23446788899999999 7999999999999999999


Q ss_pred             EEEeeccCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCC
Q 010309          298 IVYEFVVNGPLDRWLHHIPR------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF  365 (513)
Q Consensus       298 lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~  365 (513)
                      +||||+++|+|.+++.....            ....+++.+++.++.|++.||+|||+.   +++||||||+||+++.++
T Consensus       101 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~~~~  177 (307)
T cd05098         101 VIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDN  177 (307)
T ss_pred             EEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEEcCCC
Confidence            99999999999999975321            123588999999999999999999999   999999999999999999


Q ss_pred             CeEEecccccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHh
Q 010309          366 GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEW  444 (513)
Q Consensus       366 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~  444 (513)
                      .+||+|||.+................+++.|+|||++.+..++.++||||||+++|||++ |..||......   .+.. 
T Consensus       178 ~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~---~~~~-  253 (307)
T cd05098         178 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---ELFK-  253 (307)
T ss_pred             cEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH---HHHH-
Confidence            999999999876543221111111124568999999988889999999999999999998 88888654321   1111 


Q ss_pred             hhHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcCC
Q 010309          445 ATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP  509 (513)
Q Consensus       445 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  509 (513)
                         .......            .. .+...+.++.+|+.+||+.+|++|||+.+|++.|+++...
T Consensus       254 ---~~~~~~~------------~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~  302 (307)
T cd05098         254 ---LLKEGHR------------MD-KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL  302 (307)
T ss_pred             ---HHHcCCC------------CC-CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence               0111000            00 1123456799999999999999999999999999887543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=5.1e-40  Score=331.65  Aligned_cols=246  Identities=19%  Similarity=0.232  Sum_probs=195.0

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccc---hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccC
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  305 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  305 (513)
                      .+.||+|+||.||++... +++.||+|++.+..   ......+.+|+.+++.++||||+++++++.+.+..++||||+++
T Consensus        48 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~g  127 (370)
T cd05596          48 IKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPG  127 (370)
T ss_pred             EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCC
Confidence            456799999999999975 58899999997532   22335578899999999999999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccc
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  385 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  385 (513)
                      |+|.+++..     ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++..........
T Consensus       128 g~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~  199 (370)
T cd05596         128 GDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVR  199 (370)
T ss_pred             CcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCccc
Confidence            999999864     3588899999999999999999999   99999999999999999999999999998654322111


Q ss_pred             ceeecCcccccccccccccC----CCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccccccccc
Q 010309          386 RTVMAGGTYGYLAPEFVYRN----ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL  461 (513)
Q Consensus       386 ~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  461 (513)
                       .....||+.|+|||++.+.    .++.++|||||||++|||++|+.||...+...   ..   ........  .     
T Consensus       200 -~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~---~~---~~i~~~~~--~-----  265 (370)
T cd05596         200 -CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG---TY---SKIMDHKN--S-----  265 (370)
T ss_pred             -CCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH---HH---HHHHcCCC--c-----
Confidence             1123489999999998653    47889999999999999999999998654321   10   11110000  0     


Q ss_pred             ccCCCCCCCcHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHH
Q 010309          462 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSM--RPRMSHVVH  501 (513)
Q Consensus       462 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~  501 (513)
                      +    ........+.++.+||.+||+.+|.+  |||++++++
T Consensus       266 ~----~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~  303 (370)
T cd05596         266 L----TFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKS  303 (370)
T ss_pred             C----CCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence            0    00111134667999999999999988  999999975

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-39  Score=312.50  Aligned_cols=250  Identities=28%  Similarity=0.485  Sum_probs=196.6

Q ss_pred             eecccCceEEEEEEeCC-CC--EEEEEEecccc-hhcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          232 LLGDSKTGGTYSGILPD-GS--RVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       232 ~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      +||+|+||.||+|...+ +.  .+|+|.++... ....+.+.+|+.++.++ +||||+++++++...+..++||||++++
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~   81 (270)
T cd05047           2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG   81 (270)
T ss_pred             cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence            57999999999999754 43  57899887532 33456788999999999 8999999999999999999999999999


Q ss_pred             CHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccc
Q 010309          307 PLDRWLHHIPR------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGL  374 (513)
Q Consensus       307 sL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~  374 (513)
                      +|.+++.....            ....+++..+..++.|++.||+|||+.   +++|+||||+|||++.++.+||+|||+
T Consensus        82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfgl  158 (270)
T cd05047          82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGL  158 (270)
T ss_pred             cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCCC
Confidence            99999864321            123588999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhccc
Q 010309          375 SKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHR  453 (513)
Q Consensus       375 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  453 (513)
                      +.......   .......+..|+|||++....++.++||||||+++|||++ |..||...+...   ...   .......
T Consensus       159 ~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~~~---~~~~~~~  229 (270)
T cd05047         159 SRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYE---KLPQGYR  229 (270)
T ss_pred             ccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH---HHH---HHhCCCC
Confidence            86432111   1111224567999999988889999999999999999997 999996543211   111   0000000


Q ss_pred             ccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCc
Q 010309          454 YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  507 (513)
Q Consensus       454 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  507 (513)
                                   .. .+...+.++.+++.+||+.||.+|||+.++++.|+++.
T Consensus       230 -------------~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         230 -------------LE-KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             -------------CC-CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence                         00 01123457899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-40  Score=332.42  Aligned_cols=248  Identities=21%  Similarity=0.259  Sum_probs=199.1

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccch---hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccC
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  305 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  305 (513)
                      .+.||+|+||.||+|... +|+.||||+++....   .....+.+|+.++..++||||+++++++.+.+..++||||+++
T Consensus         6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   85 (350)
T cd05573           6 IKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPG   85 (350)
T ss_pred             EEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCC
Confidence            457899999999999975 689999999976422   3346788999999999999999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccc---
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV---  382 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~---  382 (513)
                      ++|.+++...    ..+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++.......   
T Consensus        86 ~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~  158 (350)
T cd05573          86 GDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE  158 (350)
T ss_pred             CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence            9999999642    5689999999999999999999999   99999999999999999999999999998664432   


Q ss_pred             ------------------------cccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccc
Q 010309          383 ------------------------MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW  438 (513)
Q Consensus       383 ------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~  438 (513)
                                              .........||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~  238 (350)
T cd05573         159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQET  238 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHH
Confidence                                    00111123389999999999999999999999999999999999999986543210


Q ss_pred             chhHHhhhHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCC-HHHHHHH
Q 010309          439 QSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPR-MSHVVHQ  502 (513)
Q Consensus       439 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~  502 (513)
                            ........   .    .+    ........++++.+||.+||. ||.+||+ ++++++.
T Consensus       239 ------~~~i~~~~---~----~~----~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         239 ------YNKIINWK---E----SL----RFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             ------HHHHhccC---C----cc----cCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence                  00110000   0    00    000011146679999999997 9999999 9999863

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=2.3e-39  Score=312.46  Aligned_cols=251  Identities=22%  Similarity=0.290  Sum_probs=197.6

Q ss_pred             cCCceecccCceEEEEEEe-CCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          228 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      +..+.||+|+||.||+|+. .+++.||+|++..........+.+|+.++++++||||+++++++...+..++||||++++
T Consensus        12 ~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~   91 (267)
T cd06646          12 ELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGG   91 (267)
T ss_pred             chhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCC
Confidence            3445679999999999996 468899999997654445567889999999999999999999999999999999999999


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  386 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  386 (513)
                      +|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||++.........  
T Consensus        92 ~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~--  162 (267)
T cd06646          92 SLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK--  162 (267)
T ss_pred             cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecccccc--
Confidence            99998853    34689999999999999999999999   9999999999999999999999999999865432211  


Q ss_pred             eeecCcccccccccccc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccccccccccc
Q 010309          387 TVMAGGTYGYLAPEFVY---RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS  463 (513)
Q Consensus       387 ~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  463 (513)
                      .....++..|+|||.+.   ...++.++||||||+++|||++|..||........  ..     .....   ....+.. 
T Consensus       163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~--~~-----~~~~~---~~~~~~~-  231 (267)
T cd06646         163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--LF-----LMSKS---NFQPPKL-  231 (267)
T ss_pred             cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh--he-----eeecC---CCCCCCC-
Confidence            11223788999999884   34578899999999999999999999864432100  00     00000   0000000 


Q ss_pred             CCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 010309          464 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQL  503 (513)
Q Consensus       464 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  503 (513)
                           ......+..+.+++.+||+.+|++|||+++|++.|
T Consensus       232 -----~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         232 -----KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             -----ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence                 01123456799999999999999999999998753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=5.3e-40  Score=326.22  Aligned_cols=240  Identities=21%  Similarity=0.275  Sum_probs=189.3

Q ss_pred             eecccCceEEEEEEeC-CCCEEEEEEecccch---hcHHHHHHHH-HHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          232 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEI-GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       232 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~-~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      .||+|+||.||++... +++.||+|++.....   .....+..|. .+++.++||||+++++++...+..++||||++++
T Consensus         2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~   81 (325)
T cd05602           2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG   81 (325)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCC
Confidence            5799999999999975 578899999975422   2223444444 4567889999999999999999999999999999


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  386 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  386 (513)
                      +|.+++..    ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++........  .
T Consensus        82 ~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--~  152 (325)
T cd05602          82 ELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--T  152 (325)
T ss_pred             cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--C
Confidence            99999864    34588889999999999999999999   999999999999999999999999999875432211  1


Q ss_pred             eeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCC
Q 010309          387 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  466 (513)
Q Consensus       387 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  466 (513)
                      .....||+.|+|||++.+..++.++|||||||++|||++|.+||...+...   ...   ....         ...    
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~---~i~~---------~~~----  213 (325)
T cd05602         153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE---MYD---NILN---------KPL----  213 (325)
T ss_pred             cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH---HHH---HHHh---------CCc----
Confidence            122348999999999999999999999999999999999999997654321   111   1100         000    


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          467 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       467 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                        ......+..+.+++.+||+.||.+||++.+.+.
T Consensus       214 --~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~  246 (325)
T cd05602         214 --QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFM  246 (325)
T ss_pred             --CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence              011134567899999999999999999875443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=3e-39  Score=309.45  Aligned_cols=246  Identities=24%  Similarity=0.346  Sum_probs=200.4

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEeccc--chhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      .+.||+|++|.||++... +++.|++|.+...  .......+.+|+++++.++||||+++++++.+.+..++||||++++
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (256)
T cd08529           5 LNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENG   84 (256)
T ss_pred             eEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCC
Confidence            346799999999999975 5899999998653  2344577899999999999999999999999999999999999999


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  386 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  386 (513)
                      +|.+++...  ....+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.......... 
T Consensus        85 ~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~-  158 (256)
T cd08529          85 DLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFA-  158 (256)
T ss_pred             cHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccchh-
Confidence            999999752  235689999999999999999999999   99999999999999999999999999988665432211 


Q ss_pred             eeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCC
Q 010309          387 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  466 (513)
Q Consensus       387 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  466 (513)
                       ....+++.|+|||++.+..++.++||||||+++|+|++|+.||...+...   ..   ... ..        ...    
T Consensus       159 -~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~---~~~-~~--------~~~----  218 (256)
T cd08529         159 -NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA---LI---LKI-IR--------GVF----  218 (256)
T ss_pred             -hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---HH---HHH-Hc--------CCC----
Confidence             12237889999999998889999999999999999999999997654211   00   000 00        000    


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010309          467 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  502 (513)
Q Consensus       467 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  502 (513)
                      .. .....+..+.+++.+||+.+|++||++.++++.
T Consensus       219 ~~-~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         219 PP-VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             CC-CccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            11 111355679999999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.1e-39  Score=323.65  Aligned_cols=237  Identities=24%  Similarity=0.338  Sum_probs=190.0

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccch---hcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCCceEEEEeecc
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVV  304 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~  304 (513)
                      .+.||+|+||.||+|... +++.||||++.+...   ...+.+..|..++..+ +|++|+++++++.+.+..++||||++
T Consensus         5 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~   84 (323)
T cd05616           5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVN   84 (323)
T ss_pred             EEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCC
Confidence            456899999999999975 478999999976422   2234567788888777 68999999999999999999999999


Q ss_pred             CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccc
Q 010309          305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  384 (513)
Q Consensus       305 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  384 (513)
                      +|+|.+++..    ...+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++.........
T Consensus        85 ~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~  157 (323)
T cd05616          85 GGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT  157 (323)
T ss_pred             CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCc
Confidence            9999998854    24589999999999999999999999   9999999999999999999999999998754322211


Q ss_pred             cceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccC
Q 010309          385 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS  464 (513)
Q Consensus       385 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  464 (513)
                        .....||+.|+|||++.+..++.++|||||||++|||+||+.||...+...   +..   .... ..           
T Consensus       158 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~---~~~---~i~~-~~-----------  217 (323)
T cd05616         158 --TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LFQ---SIME-HN-----------  217 (323)
T ss_pred             --cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH---HHH---HHHh-CC-----------
Confidence              122348999999999999999999999999999999999999997654321   111   0000 00           


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCH
Q 010309          465 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRM  496 (513)
Q Consensus       465 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  496 (513)
                         ...+...+.++.+++.+||+.||++|++.
T Consensus       218 ---~~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         218 ---VAYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             ---CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence               01112345678999999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-39  Score=317.47  Aligned_cols=262  Identities=22%  Similarity=0.321  Sum_probs=198.5

Q ss_pred             cCCceecccCceEEEEEEeCC---------------CCEEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEe
Q 010309          228 EGNRLLGDSKTGGTYSGILPD---------------GSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCY  291 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  291 (513)
                      +..+.||+|+||.||++....               ...||+|.++... ......+.+|++++++++||||+++++++.
T Consensus         8 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~   87 (295)
T cd05097           8 RLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCV   87 (295)
T ss_pred             eehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEc
Confidence            344568999999999987532               2358999997652 233467899999999999999999999999


Q ss_pred             eCCceEEEEeeccCCCHHHHhccCCC--------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecC
Q 010309          292 DHGDRYIVYEFVVNGPLDRWLHHIPR--------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE  363 (513)
Q Consensus       292 ~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~  363 (513)
                      ..+..++||||+++++|.+++.....        ....+++..++.++.|++.||+|||+.   +++|+||||+||+++.
T Consensus        88 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nill~~  164 (295)
T cd05097          88 SDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCLVGN  164 (295)
T ss_pred             CCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEEEcC
Confidence            99999999999999999999854211        112478899999999999999999999   9999999999999999


Q ss_pred             CCCeEEecccccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc--CCCCCCCCCccccchh
Q 010309          364 EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS--GRRPAQAVDSVCWQSI  441 (513)
Q Consensus       364 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt--g~~p~~~~~~~~~~~~  441 (513)
                      ++.+||+|||++................++..|+|||++.+..++.++||||||+++|+|++  |..||.......   .
T Consensus       165 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~---~  241 (295)
T cd05097         165 HYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ---V  241 (295)
T ss_pred             CCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH---H
Confidence            99999999999976543322111112225678999999988889999999999999999998  667776544321   1


Q ss_pred             HHhhhHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 010309          442 FEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ  505 (513)
Q Consensus       442 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  505 (513)
                      ............     ....    .. .+...++.+.+|+.+||+.||++|||+++|++.|++
T Consensus       242 ~~~~~~~~~~~~-----~~~~----~~-~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         242 IENTGEFFRNQG-----RQIY----LS-QTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             HHHHHHhhhhcc-----cccc----CC-CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence            111111110000     0000    00 011234579999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=3.2e-40  Score=327.78  Aligned_cols=240  Identities=23%  Similarity=0.291  Sum_probs=189.7

Q ss_pred             eecccCceEEEEEEeC-CCCEEEEEEecccc---hhcHHHHHHHHH-HHhhcCCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          232 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIG-RFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       232 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      +||+|+||.||++... +|+.||+|++.+..   ......+..|.. +++.++||||+++++.+...+..++||||+++|
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~   81 (325)
T cd05604           2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGG   81 (325)
T ss_pred             ceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCC
Confidence            5799999999999964 68999999997542   122344555654 467789999999999999999999999999999


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  386 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  386 (513)
                      +|..++..    ...+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++........  .
T Consensus        82 ~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~  152 (325)
T cd05604          82 ELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--T  152 (325)
T ss_pred             CHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--C
Confidence            99988853    35689999999999999999999999   999999999999999999999999999875432211  1


Q ss_pred             eeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCC
Q 010309          387 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  466 (513)
Q Consensus       387 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  466 (513)
                      .....||+.|+|||++.+..++.++|||||||++|||++|..||...+...   +.   .....         ..+    
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~~---~~~~~---------~~~----  213 (325)
T cd05604         153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE---MY---DNILH---------KPL----  213 (325)
T ss_pred             cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH---HH---HHHHc---------CCc----
Confidence            122348999999999999999999999999999999999999997654321   11   11110         000    


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          467 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       467 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      .  .....+..+.+++.+||+.||.+||++.+.++
T Consensus       214 ~--~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~  246 (325)
T cd05604         214 V--LRPGASLTAWSILEELLEKDRQRRLGAKEDFL  246 (325)
T ss_pred             c--CCCCCCHHHHHHHHHHhccCHHhcCCCCCCHH
Confidence            0  01123456889999999999999998864333

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.4e-39  Score=309.51  Aligned_cols=248  Identities=29%  Similarity=0.424  Sum_probs=197.6

Q ss_pred             eecccCceEEEEEEeCC----CCEEEEEEecccch-hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          232 LLGDSKTGGTYSGILPD----GSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       232 ~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      .||+|+||.||+|....    +..||+|.+..... ...+.+.+|+.+++.+.||||+++++++. .+..++||||++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~   80 (257)
T cd05060           2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPLG   80 (257)
T ss_pred             ccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCCC
Confidence            57999999999998532    36899999986643 34567899999999999999999999875 55789999999999


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  386 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  386 (513)
                      +|.+++..    ...+++..+..++.|++.||+|||+.   +++|+||||+|||++.++.+||+|||++...........
T Consensus        81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~  153 (257)
T cd05060          81 PLLKYLKK----RREIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR  153 (257)
T ss_pred             cHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence            99999964    23689999999999999999999999   999999999999999999999999999986643322111


Q ss_pred             -eeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccccccccC
Q 010309          387 -TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS  464 (513)
Q Consensus       387 -~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  464 (513)
                       .....++..|+|||.+.+..++.++||||||+++|||++ |..||...+...   +....    ....           
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~---~~~~~----~~~~-----------  215 (257)
T cd05060         154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE---VIAML----ESGE-----------  215 (257)
T ss_pred             cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHH----HcCC-----------
Confidence             111113567999999988899999999999999999998 999997654321   11111    1110           


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCc
Q 010309          465 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  507 (513)
Q Consensus       465 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  507 (513)
                        ....+...+..+.++|.+||+.+|++||++.+|++.|+++.
T Consensus       216 --~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         216 --RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             --cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence              00111224467999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=5.9e-39  Score=314.47  Aligned_cols=260  Identities=23%  Similarity=0.346  Sum_probs=200.8

Q ss_pred             CceecccCceEEEEEEeCC-----------------CCEEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEe
Q 010309          230 NRLLGDSKTGGTYSGILPD-----------------GSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCY  291 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  291 (513)
                      .+.||+|+||.||++...+                 +..||+|.+.... ....+.+.+|+.++++++||||+++++++.
T Consensus        10 ~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   89 (296)
T cd05051          10 VEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCT   89 (296)
T ss_pred             cccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence            4567999999999988642                 2468999987653 234567899999999999999999999999


Q ss_pred             eCCceEEEEeeccCCCHHHHhccCCC-------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCC
Q 010309          292 DHGDRYIVYEFVVNGPLDRWLHHIPR-------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE  364 (513)
Q Consensus       292 ~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~  364 (513)
                      .++..++||||+++++|.+++.....       ....+++..++.++.|++.||+|||+.   +++|+||||+||+++.+
T Consensus        90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~Nili~~~  166 (296)
T cd05051          90 VDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLVGKN  166 (296)
T ss_pred             cCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---CccccccchhceeecCC
Confidence            99999999999999999999865321       123689999999999999999999999   99999999999999999


Q ss_pred             CCeEEecccccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc--CCCCCCCCCccccchhH
Q 010309          365 FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS--GRRPAQAVDSVCWQSIF  442 (513)
Q Consensus       365 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt--g~~p~~~~~~~~~~~~~  442 (513)
                      +.++|+|||++................+++.|+|||++.+..++.++||||||+++|||++  +..||......   ...
T Consensus       167 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~---~~~  243 (296)
T cd05051         167 YTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ---QVI  243 (296)
T ss_pred             CceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH---HHH
Confidence            9999999999986543322222222336778999999988889999999999999999998  67787654321   111


Q ss_pred             HhhhHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 010309          443 EWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ  505 (513)
Q Consensus       443 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  505 (513)
                      ..............          ....+...+.++.+++.+||+.||++|||+.+|++.|++
T Consensus       244 ~~~~~~~~~~~~~~----------~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         244 ENAGHFFRDDGRQI----------YLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             HHHHhccccccccc----------cCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence            11111100000000          000112244679999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-39  Score=329.23  Aligned_cols=247  Identities=19%  Similarity=0.224  Sum_probs=195.7

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccc---hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccC
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  305 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  305 (513)
                      .++||+|+||.||++... +|+.||||++....   ......+.+|+.++..++||||+++++++.+.+..++||||+++
T Consensus         6 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~   85 (364)
T cd05599           6 IKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPG   85 (364)
T ss_pred             EEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCC
Confidence            457899999999999975 58999999997542   22345678899999999999999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccc
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  385 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  385 (513)
                      |+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.++|+|||++..+.......
T Consensus        86 g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~  158 (364)
T cd05599          86 GDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE  158 (364)
T ss_pred             cHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence            999999864    34689999999999999999999999   99999999999999999999999999987543211000


Q ss_pred             ------------------------------------ceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCC
Q 010309          386 ------------------------------------RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP  429 (513)
Q Consensus       386 ------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p  429 (513)
                                                          ......||+.|+|||++.+..++.++|||||||++|||++|..|
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~P  238 (364)
T cd05599         159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP  238 (364)
T ss_pred             ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCC
Confidence                                                00112489999999999999999999999999999999999999


Q ss_pred             CCCCCccccchhHHhhhHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCC---HHHHHH
Q 010309          430 AQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPR---MSHVVH  501 (513)
Q Consensus       430 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~  501 (513)
                      |...+...   .   ........       ..+    ........++++.+||.+|+. +|.+|++   ++++++
T Consensus       239 f~~~~~~~---~---~~~i~~~~-------~~~----~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         239 FCSDNPQE---T---YRKIINWK-------ETL----QFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             CCCCCHHH---H---HHHHHcCC-------Ccc----CCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            97654321   0   01111000       000    000111245678999999996 9999998   888876

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=7.7e-40  Score=324.56  Aligned_cols=236  Identities=24%  Similarity=0.314  Sum_probs=187.2

Q ss_pred             eecccCceEEEEEEeC-CCCEEEEEEecccch---hcHHHHHHHHH-HHhhcCCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          232 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIG-RFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       232 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      +||+|+||.||+|+.. +++.||+|++.+...   .....+..|.. +++.++||||+++++++.+.+..++||||++++
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~   81 (321)
T cd05603           2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGG   81 (321)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence            5899999999999975 588999999975422   22344555554 678889999999999999999999999999999


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  386 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  386 (513)
                      +|...+..    ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++........  .
T Consensus        82 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~  152 (321)
T cd05603          82 ELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--T  152 (321)
T ss_pred             CHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC--c
Confidence            99888853    35688999999999999999999999   999999999999999999999999999875322211  1


Q ss_pred             eeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCC
Q 010309          387 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  466 (513)
Q Consensus       387 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  466 (513)
                      .....||+.|+|||++.+..++.++|||||||++|||++|..||...+..   .+.+   ....         ...    
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~---~i~~---------~~~----  213 (321)
T cd05603         153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS---QMYD---NILH---------KPL----  213 (321)
T ss_pred             cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH---HHHH---HHhc---------CCC----
Confidence            12234899999999999888999999999999999999999999765421   1111   1000         000    


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 010309          467 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMS  497 (513)
Q Consensus       467 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  497 (513)
                        ..+...+..+.+++.+||+.||.+||++.
T Consensus       214 --~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         214 --QLPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             --CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence              01112345789999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=3.9e-39  Score=308.93  Aligned_cols=244  Identities=29%  Similarity=0.434  Sum_probs=196.3

Q ss_pred             CceecccCceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEe-eCCceEEEEeeccCCCH
Q 010309          230 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY-DHGDRYIVYEFVVNGPL  308 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~-~~~~~~lv~e~~~~gsL  308 (513)
                      .+.||+|++|.||++.. .|..||+|.++...  ..+.+.+|+.++++++|+||+++++++. ..+..++||||+++++|
T Consensus        11 ~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L   87 (256)
T cd05082          11 LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL   87 (256)
T ss_pred             eeeecccCCCeEEEEEE-cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcH
Confidence            45789999999999987 58889999986542  3567899999999999999999999764 45678999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccccee
Q 010309          309 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  388 (513)
Q Consensus       309 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  388 (513)
                      .+++...  ....+++..++.++.|++.||+|||++   +++||||||+||+++.++.+||+|||++........     
T Consensus        88 ~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~-----  157 (256)
T cd05082          88 VDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-----  157 (256)
T ss_pred             HHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccCC-----
Confidence            9998652  234588999999999999999999999   999999999999999999999999999876533221     


Q ss_pred             ecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCC
Q 010309          389 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS  467 (513)
Q Consensus       389 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  467 (513)
                      ...++..|+|||++.+..++.++||||||+++|||++ |+.||......   .....    .....     .       .
T Consensus       158 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~---~~~~~----~~~~~-----~-------~  218 (256)
T cd05082         158 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPR----VEKGY-----K-------M  218 (256)
T ss_pred             CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH----HhcCC-----C-------C
Confidence            1125668999999988889999999999999999998 99998654321   11111    11000     0       0


Q ss_pred             CCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q 010309          468 DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  506 (513)
Q Consensus       468 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  506 (513)
                       ......++.+.+++.+||+.+|++|||+.++++.|+++
T Consensus       219 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         219 -DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             -CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence             01123456799999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=2.8e-39  Score=317.02  Aligned_cols=253  Identities=29%  Similarity=0.475  Sum_probs=198.3

Q ss_pred             CceecccCceEEEEEEeCC-C--CEEEEEEeccc-chhcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCCceEEEEeecc
Q 010309          230 NRLLGDSKTGGTYSGILPD-G--SRVAVKRLKRS-SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVV  304 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~~-~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~  304 (513)
                      .++||+|+||.||+|...+ +  ..+++|.++.. .....+.+.+|+.++.++ +||||+++++++...+..++||||++
T Consensus         7 ~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~   86 (297)
T cd05089           7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAP   86 (297)
T ss_pred             eeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecC
Confidence            4578999999999998754 3  35789988743 233456789999999999 79999999999999999999999999


Q ss_pred             CCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecc
Q 010309          305 NGPLDRWLHHIPR------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV  372 (513)
Q Consensus       305 ~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df  372 (513)
                      +++|.+++.....            ....+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+||
T Consensus        87 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~df  163 (297)
T cd05089          87 YGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADF  163 (297)
T ss_pred             CCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeEEECCc
Confidence            9999999964221            113588999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhc
Q 010309          373 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQS  451 (513)
Q Consensus       373 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  451 (513)
                      |++........   ......+..|+|||++.+..++.++|||||||++|||++ |..||.......   ...   .... 
T Consensus       164 g~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~---~~~---~~~~-  233 (297)
T cd05089         164 GLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE---LYE---KLPQ-  233 (297)
T ss_pred             CCCccccceec---cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH---HHhc-
Confidence            99874322111   111113567999999988889999999999999999998 999997654321   111   0000 


Q ss_pred             ccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcC
Q 010309          452 HRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  508 (513)
Q Consensus       452 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  508 (513)
                      .     ..       .. .+..++..+.+|+.+||+.+|.+||+++++++.|+.+..
T Consensus       234 ~-----~~-------~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~  277 (297)
T cd05089         234 G-----YR-------ME-KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE  277 (297)
T ss_pred             C-----CC-------CC-CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            0     00       00 112245679999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=3.8e-39  Score=311.37  Aligned_cols=254  Identities=24%  Similarity=0.343  Sum_probs=192.7

Q ss_pred             eecccCceEEEEEEeCC---CCEEEEEEecccch-hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCC
Q 010309          232 LLGDSKTGGTYSGILPD---GSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  307 (513)
Q Consensus       232 ~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs  307 (513)
                      .||+|+||.||+|...+   +..+|+|.++.... .....+.+|+.++++++||||+++++.+.+....++||||+++|+
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD   81 (269)
T ss_pred             cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence            47999999999998643   45799999876532 334578899999999999999999999999999999999999999


Q ss_pred             HHHHhccCCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccc
Q 010309          308 LDRWLHHIPR-GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  386 (513)
Q Consensus       308 L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  386 (513)
                      |.+++..... ....+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++...........
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~  158 (269)
T cd05087          82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT  158 (269)
T ss_pred             HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence            9999965322 223567778889999999999999999   999999999999999999999999999975443322111


Q ss_pred             eeecCcccccccccccccC-------CCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccc
Q 010309          387 TVMAGGTYGYLAPEFVYRN-------ELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELL  458 (513)
Q Consensus       387 ~~~~~gt~~y~aPE~~~~~-------~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  458 (513)
                      .....++..|+|||++.+.       .++.++||||||+++|||++ |..||........   ...   ... .......
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~---~~~---~~~-~~~~~~~  231 (269)
T cd05087         159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV---LTY---TVR-EQQLKLP  231 (269)
T ss_pred             CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH---HHH---Hhh-cccCCCC
Confidence            1122367889999998642       35789999999999999996 9999976443211   000   000 0001111


Q ss_pred             cccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 010309          459 DPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ  504 (513)
Q Consensus       459 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  504 (513)
                      .+.+        ....++.+.+++.+|+ .+|++|||+++|+..|+
T Consensus       232 ~~~~--------~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         232 KPRL--------KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCcc--------CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            1111        1123456889999999 68999999999999885

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=4.9e-39  Score=313.85  Aligned_cols=257  Identities=27%  Similarity=0.431  Sum_probs=200.1

Q ss_pred             CceecccCceEEEEEEeC------CCCEEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEee
Q 010309          230 NRLLGDSKTGGTYSGILP------DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF  302 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  302 (513)
                      .+.||+|+||.||+|...      .+..||+|.+.... ......+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus        11 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   90 (288)
T cd05061          11 LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMEL   90 (288)
T ss_pred             eeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeC
Confidence            456799999999999753      24589999987543 23345678899999999999999999999999999999999


Q ss_pred             ccCCCHHHHhccCCC------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccc
Q 010309          303 VVNGPLDRWLHHIPR------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK  376 (513)
Q Consensus       303 ~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~  376 (513)
                      +++|+|.+++.....      ....++...+..++.|++.||.|||++   +|+||||||+||+++.++.++|+|||+++
T Consensus        91 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L~Dfg~~~  167 (288)
T cd05061          91 MAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR  167 (288)
T ss_pred             CCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEECcCCccc
Confidence            999999999965321      123456788899999999999999999   99999999999999999999999999988


Q ss_pred             cCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhccccc
Q 010309          377 FVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYL  455 (513)
Q Consensus       377 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  455 (513)
                      ...............++..|+|||.+.+..++.++||||||+++|||++ |..||...+...   ...   .... ....
T Consensus       168 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~---~~~---~~~~-~~~~  240 (288)
T cd05061         168 DIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ---VLK---FVMD-GGYL  240 (288)
T ss_pred             cccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH---HHHc-CCCC
Confidence            6543222111111225678999999988889999999999999999998 788887644321   111   0000 0000


Q ss_pred             ccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcCC
Q 010309          456 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP  509 (513)
Q Consensus       456 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  509 (513)
                                  . .+...++.+.+++.+||+.||++|||+.++++.|++...+
T Consensus       241 ------------~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~  281 (288)
T cd05061         241 ------------D-QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHP  281 (288)
T ss_pred             ------------C-CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCC
Confidence                        0 0112346799999999999999999999999999876544

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=4.5e-39  Score=310.65  Aligned_cols=251  Identities=25%  Similarity=0.437  Sum_probs=200.0

Q ss_pred             CceecccCceEEEEEEeCC-C---CEEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeecc
Q 010309          230 NRLLGDSKTGGTYSGILPD-G---SRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV  304 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  304 (513)
                      .+.||+|++|.||+|.... +   ..+|+|.++... ....+.+.+|+.++++++||||+++.+++...+..++||||++
T Consensus        10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   89 (268)
T cd05063          10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYME   89 (268)
T ss_pred             eeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCC
Confidence            4578999999999999753 3   379999987652 3345678999999999999999999999999999999999999


Q ss_pred             CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccc
Q 010309          305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  384 (513)
Q Consensus       305 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  384 (513)
                      +++|.+++..   ....+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++.........
T Consensus        90 ~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~  163 (268)
T cd05063          90 NGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEG  163 (268)
T ss_pred             CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceeccccccc
Confidence            9999999864   235689999999999999999999999   9999999999999999999999999999866433221


Q ss_pred             cce-eecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccccccc
Q 010309          385 ERT-VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI  462 (513)
Q Consensus       385 ~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  462 (513)
                      ... .....+..|+|||++.+..++.++||||||+++|||++ |..||...+...   ...   . .....         
T Consensus       164 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~---~~~---~-i~~~~---------  227 (268)
T cd05063         164 TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE---VMK---A-INDGF---------  227 (268)
T ss_pred             ceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH---HHH---H-HhcCC---------
Confidence            111 11113457999999988889999999999999999998 999996544321   111   1 00000         


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q 010309          463 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  506 (513)
Q Consensus       463 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  506 (513)
                          ........+..+.+++.+||+.+|++||++.+|++.|+++
T Consensus       228 ----~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         228 ----RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             ----CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                0001112456789999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=4.1e-39  Score=309.54  Aligned_cols=252  Identities=25%  Similarity=0.403  Sum_probs=201.6

Q ss_pred             ccCCceecccCceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          227 SEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      ....+.||+|+||.||++...++..+|+|.+.... ...+.+.+|+.++++++|+||+++.+.+.+ ...+++|||++++
T Consensus         8 ~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~   85 (260)
T cd05073           8 LKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKG   85 (260)
T ss_pred             eeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCC
Confidence            34456789999999999998788889999987643 345678999999999999999999999887 7789999999999


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  386 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  386 (513)
                      +|.+++...  ....+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||.+...........
T Consensus        86 ~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~  160 (260)
T cd05073          86 SLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAR  160 (260)
T ss_pred             cHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCcccc
Confidence            999999652  235688899999999999999999999   999999999999999999999999999976543221111


Q ss_pred             eeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccccccccCC
Q 010309          387 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  465 (513)
Q Consensus       387 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  465 (513)
                       ....++..|+|||++....++.++|+||||+++|+++| |..||...+....   ...    .....            
T Consensus       161 -~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~---~~~----~~~~~------------  220 (260)
T cd05073         161 -EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV---IRA----LERGY------------  220 (260)
T ss_pred             -cCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHH---HHH----HhCCC------------
Confidence             11125677999999988889999999999999999999 9999976543211   110    00000            


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q 010309          466 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  506 (513)
Q Consensus       466 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  506 (513)
                       ........+.++.+++.+||+.+|++||++.++++.|+.+
T Consensus       221 -~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~  260 (260)
T cd05073         221 -RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF  260 (260)
T ss_pred             -CCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence             0001123445799999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=8.5e-40  Score=325.57  Aligned_cols=247  Identities=23%  Similarity=0.274  Sum_probs=196.8

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccch---hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccC
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  305 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  305 (513)
                      .+.||+|+||.||++... +|+.||||+++....   ...+.+.+|+.+++.++||||+++++++.+.+..++||||+++
T Consensus         6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   85 (330)
T cd05601           6 KSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPG   85 (330)
T ss_pred             EEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCC
Confidence            456799999999999965 689999999986532   2345688899999999999999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccc
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  385 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  385 (513)
                      |+|.+++...   ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++......... 
T Consensus        86 ~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-  158 (330)
T cd05601          86 GDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV-  158 (330)
T ss_pred             CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCCce-
Confidence            9999999642   24699999999999999999999999   9999999999999999999999999999876543222 


Q ss_pred             ceeecCcccccccccccc------cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccccccc
Q 010309          386 RTVMAGGTYGYLAPEFVY------RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD  459 (513)
Q Consensus       386 ~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  459 (513)
                      ......||+.|+|||++.      ...++.++|||||||++|||++|..||.......      ............    
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~------~~~~i~~~~~~~----  228 (330)
T cd05601         159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK------TYNNIMNFQRFL----  228 (330)
T ss_pred             eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH------HHHHHHcCCCcc----
Confidence            112234899999999986      4567889999999999999999999997654321      011111100000    


Q ss_pred             ccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          460 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       460 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                             ........+..+.+|+.+||+ +|.+|||++++++
T Consensus       229 -------~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         229 -------KFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             -------CCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence                   000111245678999999998 9999999999885

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=5.9e-39  Score=314.54  Aligned_cols=262  Identities=21%  Similarity=0.322  Sum_probs=199.5

Q ss_pred             cCCceecccCceEEEEEEeC-----------------CCCEEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeE
Q 010309          228 EGNRLLGDSKTGGTYSGILP-----------------DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGC  289 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~  289 (513)
                      +..+.||+|+||.||++...                 ++..||+|++.... ......+.+|+.+++.++||||++++++
T Consensus         8 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~   87 (296)
T cd05095           8 TFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAV   87 (296)
T ss_pred             eeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence            33456899999999998532                 24469999997543 3345688999999999999999999999


Q ss_pred             EeeCCceEEEEeeccCCCHHHHhccCCCC-------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEec
Q 010309          290 CYDHGDRYIVYEFVVNGPLDRWLHHIPRG-------GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD  362 (513)
Q Consensus       290 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~  362 (513)
                      +...+..++||||+++++|.+++......       ...+++..+..++.|++.||+|||+.   +++|+||||+|||++
T Consensus        88 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Nili~  164 (296)
T cd05095          88 CITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLVG  164 (296)
T ss_pred             EecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheEEEc
Confidence            99999999999999999999998653211       13478889999999999999999999   999999999999999


Q ss_pred             CCCCeEEecccccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc--CCCCCCCCCccccch
Q 010309          363 EEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS--GRRPAQAVDSVCWQS  440 (513)
Q Consensus       363 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt--g~~p~~~~~~~~~~~  440 (513)
                      .++.++|+|||++................++..|+|||...++.++.++||||||+++|||++  |..||...+...   
T Consensus       165 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~---  241 (296)
T cd05095         165 KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ---  241 (296)
T ss_pred             CCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH---
Confidence            999999999999986543322111111224678999999888889999999999999999998  778886544321   


Q ss_pred             hHHhhhHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 010309          441 IFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ  505 (513)
Q Consensus       441 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  505 (513)
                      .............. ....         ..+..++..+.+|+.+||+.||.+||++.+|++.|++
T Consensus       242 ~~~~~~~~~~~~~~-~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         242 VIENTGEFFRDQGR-QVYL---------PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             HHHHHHHHHhhccc-cccC---------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            11111111100000 0000         0111244679999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=5.3e-39  Score=314.82  Aligned_cols=244  Identities=21%  Similarity=0.355  Sum_probs=199.0

Q ss_pred             CceecccCceEEEEEEe-CCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCCH
Q 010309          230 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  308 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL  308 (513)
                      .+.||+|++|.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++.+......++||||+++++|
T Consensus        25 ~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L  104 (296)
T cd06654          25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL  104 (296)
T ss_pred             EEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCH
Confidence            34579999999999996 46899999999876555667889999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccccee
Q 010309          309 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  388 (513)
Q Consensus       309 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  388 (513)
                      .+++..     ..+++.++..++.|++.||+|||+.   +|+|+||||+|||++.++.++|+|||++..........  .
T Consensus       105 ~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~--~  174 (296)
T cd06654         105 TDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--S  174 (296)
T ss_pred             HHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccccccc--C
Confidence            999853     3578999999999999999999999   99999999999999999999999999987654322111  1


Q ss_pred             ecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCCC
Q 010309          389 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD  468 (513)
Q Consensus       389 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  468 (513)
                      ...+++.|+|||.+.+..++.++|||||||++|+|++|+.||.......  .....    ....      .+      ..
T Consensus       175 ~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~--~~~~~----~~~~------~~------~~  236 (296)
T cd06654         175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--ALYLI----ATNG------TP------EL  236 (296)
T ss_pred             cccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH--hHHHH----hcCC------CC------CC
Confidence            1237889999999988888999999999999999999999997544311  11000    0000      00      00


Q ss_pred             CCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          469 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       469 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      ..+...+..+.+++.+||..||++||++.+|++
T Consensus       237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence            112235567999999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=3.8e-39  Score=319.08  Aligned_cols=199  Identities=18%  Similarity=0.327  Sum_probs=160.6

Q ss_pred             CceecccCceEEEEEEeC---CCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEee--CCceEEEEeecc
Q 010309          230 NRLLGDSKTGGTYSGILP---DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD--HGDRYIVYEFVV  304 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lv~e~~~  304 (513)
                      .+.||+|+||.||+|...   +++.||+|.+....  ....+.+|+.++++++||||+++++++..  ....++||||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            456799999999999864   46789999997543  23457889999999999999999999864  455789999985


Q ss_pred             CCCHHHHhccCC-----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEe----cCCCCeEEeccccc
Q 010309          305 NGPLDRWLHHIP-----RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL----DEEFGAHLMGVGLS  375 (513)
Q Consensus       305 ~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll----~~~~~~kl~Dfg~~  375 (513)
                       ++|.+++....     .....+++..+..++.||+.||+|||++   +|+||||||+|||+    +.++.+||+|||++
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence             58888775321     1123589999999999999999999999   99999999999999    45678999999999


Q ss_pred             ccCCccccc-cceeecCcccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 010309          376 KFVPWEVMQ-ERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVD  434 (513)
Q Consensus       376 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~  434 (513)
                      +........ .......+|+.|+|||++.+. .++.++|||||||++|||++|++||....
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            876433211 111223379999999998764 58899999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=3.7e-39  Score=317.75  Aligned_cols=262  Identities=22%  Similarity=0.361  Sum_probs=199.6

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCC
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  307 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs  307 (513)
                      .+.||+|+||.||++... ++..+|+|.+.... .....++.+|++++.+++||||+++++++.+++..++||||+++++
T Consensus         6 ~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~   85 (308)
T cd06615           6 LGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS   85 (308)
T ss_pred             EeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCc
Confidence            446799999999999964 58889999987542 2334668899999999999999999999999999999999999999


Q ss_pred             HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccc
Q 010309          308 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD-KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  386 (513)
Q Consensus       308 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  386 (513)
                      |.+++..    ...+++..+..++.|++.||.|||+ .   +++|+||||+|||++.++.+||+|||++........   
T Consensus        86 L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~---  155 (308)
T cd06615          86 LDQVLKK----AGRIPENILGKISIAVLRGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---  155 (308)
T ss_pred             HHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhC---CEEECCCChHHEEEecCCcEEEccCCCccccccccc---
Confidence            9999964    2568999999999999999999997 5   899999999999999999999999999876533221   


Q ss_pred             eeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcc--------------
Q 010309          387 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSH--------------  452 (513)
Q Consensus       387 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--------------  452 (513)
                       ....++..|+|||++.+..++.++||||||+++|+|++|+.||...+..................              
T Consensus       156 -~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (308)
T cd06615         156 -NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSP  234 (308)
T ss_pred             -ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCcc
Confidence             12237889999999988889999999999999999999999987544322111111000000000              


Q ss_pred             ---cccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010309          453 ---RYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  502 (513)
Q Consensus       453 ---~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  502 (513)
                         ...+..+..........+....+.++.+|+.+||+.||++|||+.+|++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         235 RPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             chhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               00000000111111122222356679999999999999999999999875

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=4.1e-39  Score=311.10  Aligned_cols=252  Identities=25%  Similarity=0.437  Sum_probs=200.1

Q ss_pred             CCceecccCceEEEEEEeCC-C---CEEEEEEeccc-chhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeec
Q 010309          229 GNRLLGDSKTGGTYSGILPD-G---SRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  303 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  303 (513)
                      ..+.||+|+||.||+|.... +   ..||||.+... .......+..|+.+++.++||||+++++++.+++..++||||+
T Consensus         8 ~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~   87 (269)
T cd05065           8 IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFM   87 (269)
T ss_pred             EEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecC
Confidence            45678999999999999643 3   36999999764 3334568999999999999999999999999999999999999


Q ss_pred             cCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccc
Q 010309          304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM  383 (513)
Q Consensus       304 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~  383 (513)
                      ++++|.+++...   ...+++.+++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++........
T Consensus        88 ~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~  161 (269)
T cd05065          88 ENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS  161 (269)
T ss_pred             CCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence            999999998642   34689999999999999999999999   999999999999999999999999999876543221


Q ss_pred             cccee-ecC--cccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhccccccccc
Q 010309          384 QERTV-MAG--GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD  459 (513)
Q Consensus       384 ~~~~~-~~~--gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  459 (513)
                      ..... ...  .+..|+|||.+.+..++.++||||||+++|||++ |..||...+...   .....    ...     . 
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~---~~~~i----~~~-----~-  228 (269)
T cd05065         162 DPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---VINAI----EQD-----Y-  228 (269)
T ss_pred             ccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH---HHHHH----HcC-----C-
Confidence            11111 111  2457999999998899999999999999999887 999987654321   11111    000     0 


Q ss_pred             ccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q 010309          460 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  506 (513)
Q Consensus       460 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  506 (513)
                             ....+.+++..+.+++.+||+.+|++||++++|+..|+++
T Consensus       229 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         229 -------RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             -------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                   0011123456789999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=3.3e-39  Score=318.37  Aligned_cols=264  Identities=17%  Similarity=0.223  Sum_probs=194.9

Q ss_pred             CCceecccCceEEEEEEeC-CCCEEEEEEecccch-hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          229 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      ..+.||+|+||.||+|+.. +++.||+|.++.... .....+.+|+.++++++||||+++++++..++..++||||+++ 
T Consensus        10 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-   88 (309)
T cd07872          10 KLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-   88 (309)
T ss_pred             EEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-
Confidence            3456799999999999975 588999999975432 2335678899999999999999999999999999999999964 


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  386 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  386 (513)
                      +|.+++..   ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++.......... 
T Consensus        89 ~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-  161 (309)
T cd07872          89 DLKQYMDD---CGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTY-  161 (309)
T ss_pred             CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCcccc-
Confidence            88887754   234588999999999999999999999   99999999999999999999999999997643322111 


Q ss_pred             eeecCccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhh--------HHhhc-ccccc
Q 010309          387 TVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWAT--------PLVQS-HRYLE  456 (513)
Q Consensus       387 ~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~~-~~~~~  456 (513)
                       ....+++.|+|||++.+ ..++.++||||||+++|+|+||++||...+............        +.... .....
T Consensus       162 -~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
T cd07872         162 -SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKN  240 (309)
T ss_pred             -ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhh
Confidence             11237889999998865 467899999999999999999999997655432111111000        00000 00000


Q ss_pred             cccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          457 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       457 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      .-.+..............++++.+|+.+||+.||.+|||++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         241 YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            000000000000001124567899999999999999999999987

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=3.2e-39  Score=311.75  Aligned_cols=251  Identities=29%  Similarity=0.454  Sum_probs=198.6

Q ss_pred             eecccCceEEEEEEeCC-------CCEEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeec
Q 010309          232 LLGDSKTGGTYSGILPD-------GSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  303 (513)
Q Consensus       232 ~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  303 (513)
                      +||+|+||.||+|...+       +..||||.+.... ......+.+|+.+++.++||||+++++++...+..++||||+
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM   81 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence            57999999999998643       2579999886543 234567899999999999999999999999999999999999


Q ss_pred             cCCCHHHHhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCC-----CeEEeccccc
Q 010309          304 VNGPLDRWLHHIPR---GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF-----GAHLMGVGLS  375 (513)
Q Consensus       304 ~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~-----~~kl~Dfg~~  375 (513)
                      ++++|.+++.....   ....+++..++.++.|++.||.|||+.   +++|+||||+||+++.++     .++|+|||++
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~  158 (269)
T cd05044          82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA  158 (269)
T ss_pred             CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence            99999999965321   224578899999999999999999999   999999999999999877     8999999999


Q ss_pred             ccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccc
Q 010309          376 KFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRY  454 (513)
Q Consensus       376 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  454 (513)
                      ................++..|+|||++.+..++.++||||||+++|||+| |..||...+...   .....    .... 
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~---~~~~~----~~~~-  230 (269)
T cd05044         159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE---VLQHV----TAGG-  230 (269)
T ss_pred             cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH---HHHHH----hcCC-
Confidence            76543322111112225678999999998999999999999999999998 999987543221   11100    0000 


Q ss_pred             cccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 010309          455 LELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ  505 (513)
Q Consensus       455 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  505 (513)
                                  ....+...+..+.+++.+||+.+|++||++++|++.|++
T Consensus       231 ------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         231 ------------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             ------------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence                        001122346679999999999999999999999999864

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=4.6e-39  Score=314.00  Aligned_cols=252  Identities=26%  Similarity=0.431  Sum_probs=198.4

Q ss_pred             ceecccCceEEEEEEeC------CCCEEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeec
Q 010309          231 RLLGDSKTGGTYSGILP------DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  303 (513)
Q Consensus       231 ~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  303 (513)
                      +.||+|+||.||++...      ++..||+|++.... ......+.+|+.++++++||||+++++++.+++..++||||+
T Consensus        11 ~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   90 (288)
T cd05050          11 RDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYM   90 (288)
T ss_pred             ccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEecC
Confidence            45699999999999863      46789999987653 233567889999999999999999999999999999999999


Q ss_pred             cCCCHHHHhccCC------------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCC
Q 010309          304 VNGPLDRWLHHIP------------------RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF  365 (513)
Q Consensus       304 ~~gsL~~~l~~~~------------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~  365 (513)
                      ++++|.+++....                  .....+++..++.++.|++.||+|||+.   +++||||||+||+++.++
T Consensus        91 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~nil~~~~~  167 (288)
T cd05050          91 AYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENM  167 (288)
T ss_pred             CCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhheEecCCC
Confidence            9999999996421                  1123578899999999999999999999   999999999999999999


Q ss_pred             CeEEecccccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHh
Q 010309          366 GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEW  444 (513)
Q Consensus       366 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~  444 (513)
                      .++|+|||++.................+..|+|||.+.+..++.++|||||||++|||++ |..||.+....+   ..  
T Consensus       168 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~---~~--  242 (288)
T cd05050         168 VVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE---VI--  242 (288)
T ss_pred             ceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HH--
Confidence            999999999876533221111111124667999999988899999999999999999998 888886543321   11  


Q ss_pred             hhHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 010309          445 ATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ  505 (513)
Q Consensus       445 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  505 (513)
                       . ........             ..+...+.++.+|+.+||+.||++|||+.||++.|++
T Consensus       243 -~-~~~~~~~~-------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         243 -Y-YVRDGNVL-------------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             -H-HHhcCCCC-------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence             0 01111000             0011245679999999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=2.6e-39  Score=318.12  Aligned_cols=255  Identities=28%  Similarity=0.471  Sum_probs=198.4

Q ss_pred             CCceecccCceEEEEEEeC-CCC--EEEEEEecccc-hhcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCCceEEEEeec
Q 010309          229 GNRLLGDSKTGGTYSGILP-DGS--RVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFV  303 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~  303 (513)
                      ..+.||+|+||.||+|.+. ++.  .+|+|.++... ......+.+|+.++.++ +||||+++++++...+..++||||+
T Consensus        11 ~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~   90 (303)
T cd05088          11 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA   90 (303)
T ss_pred             eeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeC
Confidence            3457899999999999964 454  46888776432 23456788999999999 8999999999999999999999999


Q ss_pred             cCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEec
Q 010309          304 VNGPLDRWLHHIPR------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMG  371 (513)
Q Consensus       304 ~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~D  371 (513)
                      ++++|.+++.....            ....+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|
T Consensus        91 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~kl~d  167 (303)
T cd05088          91 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIAD  167 (303)
T ss_pred             CCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcEEeCc
Confidence            99999999964321            123588999999999999999999999   999999999999999999999999


Q ss_pred             ccccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhh
Q 010309          372 VGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQ  450 (513)
Q Consensus       372 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  450 (513)
                      ||++.......   .......+..|+|||++.+..++.++||||||+++|||+| |..||...+...   ...   ....
T Consensus       168 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~---~~~~  238 (303)
T cd05088         168 FGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYE---KLPQ  238 (303)
T ss_pred             cccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH---HHH---HHhc
Confidence            99986432111   1111124667999999988889999999999999999998 999987544321   111   0000


Q ss_pred             cccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcCC
Q 010309          451 SHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP  509 (513)
Q Consensus       451 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  509 (513)
                       .     ..       .. .+...+..+.+|+.+||+.+|++||+++++++.|+++.+.
T Consensus       239 -~-----~~-------~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~  283 (303)
T cd05088         239 -G-----YR-------LE-KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  283 (303)
T ss_pred             -C-----Cc-------CC-CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence             0     00       00 0112345789999999999999999999999998876443

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.2e-39  Score=330.92  Aligned_cols=248  Identities=20%  Similarity=0.250  Sum_probs=193.2

Q ss_pred             CCceecccCceEEEEEEeC-CCCEEEEEEecccch---hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeecc
Q 010309          229 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV  304 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  304 (513)
                      ..+.||+|+||.||+|+.. +++.||+|++.+...   .....+.+|+.++++++||||+++++.+.+.+..++||||++
T Consensus         5 ~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~   84 (382)
T cd05625           5 KIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIP   84 (382)
T ss_pred             EEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCC
Confidence            3457899999999999964 588999999976432   234578899999999999999999999999999999999999


Q ss_pred             CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccc-
Q 010309          305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM-  383 (513)
Q Consensus       305 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~-  383 (513)
                      +|+|.+++..    ...+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++........ 
T Consensus        85 gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~  157 (382)
T cd05625          85 GGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  157 (382)
T ss_pred             CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence            9999999864    24688999999999999999999999   999999999999999999999999999753211000 


Q ss_pred             --------------------------------------------ccceeecCcccccccccccccCCCCchhhHHHHHHH
Q 010309          384 --------------------------------------------QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVL  419 (513)
Q Consensus       384 --------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvi  419 (513)
                                                                  ........||+.|+|||++.+..++.++|||||||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi  237 (382)
T cd05625         158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI  237 (382)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence                                                        000011248999999999999999999999999999


Q ss_pred             HHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCC---H
Q 010309          420 LLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPR---M  496 (513)
Q Consensus       420 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~  496 (513)
                      +|||++|++||...+....      .......       ....    ........++++.++|.+|+ .+|.+|++   +
T Consensus       238 l~elltG~~Pf~~~~~~~~------~~~i~~~-------~~~~----~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~  299 (382)
T cd05625         238 LYEMLVGQPPFLAQTPLET------QMKVINW-------QTSL----HIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGA  299 (382)
T ss_pred             HHHHHhCCCCCCCCCHHHH------HHHHHcc-------CCCc----CCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCH
Confidence            9999999999986543210      0000000       0000    01111234567889998876 59999997   7


Q ss_pred             HHHHH
Q 010309          497 SHVVH  501 (513)
Q Consensus       497 ~evl~  501 (513)
                      +++++
T Consensus       300 ~ei~~  304 (382)
T cd05625         300 DEIKA  304 (382)
T ss_pred             HHHhc
Confidence            77764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.2e-38  Score=309.68  Aligned_cols=245  Identities=22%  Similarity=0.370  Sum_probs=194.4

Q ss_pred             CceecccCceEEEEEEe-CCCCEEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCC
Q 010309          230 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  307 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs  307 (513)
                      .++||+|++|.||+|.. .+++.||+|.+.... ......+.+|+.++++++||||+++++.+...+..++||||+++++
T Consensus         6 ~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   85 (279)
T cd06619           6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGS   85 (279)
T ss_pred             eeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCC
Confidence            45789999999999986 468899999987542 3334678899999999999999999999999999999999999999


Q ss_pred             HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccce
Q 010309          308 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  387 (513)
Q Consensus       308 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  387 (513)
                      |..+.        .+++..+..++.|++.||+|||+.   +|+|+||||+|||++.++.++|+|||++........    
T Consensus        86 l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~----  150 (279)
T cd06619          86 LDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIA----  150 (279)
T ss_pred             hHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccccc----
Confidence            96542        378888999999999999999999   999999999999999999999999999976543211    


Q ss_pred             eecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccch-hHHhhhHHhhcccccccccccccCCC
Q 010309          388 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS-IFEWATPLVQSHRYLELLDPLISSLS  466 (513)
Q Consensus       388 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  466 (513)
                      ....++..|+|||++.+..++.++||||||+++|+|++|+.||.......... .........         +..    .
T Consensus       151 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~---------~~~----~  217 (279)
T cd06619         151 KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIV---------DED----P  217 (279)
T ss_pred             cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHh---------ccC----C
Confidence            12238899999999998889999999999999999999999997533211000 000000000         000    0


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010309          467 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  502 (513)
Q Consensus       467 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  502 (513)
                      ...+....++++.+++.+||+.||++||+++++++.
T Consensus       218 ~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         218 PVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             CCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            111122345678999999999999999999999863

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=5.1e-39  Score=313.14  Aligned_cols=248  Identities=21%  Similarity=0.282  Sum_probs=197.0

Q ss_pred             CCceecccCceEEEEEEeC-CCCEEEEEEecccchh---cHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeecc
Q 010309          229 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQ---RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV  304 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  304 (513)
                      ..++||+|+||.||++... +++.||||.+......   ....+.+|+.++++++|+||+++++.+.+.+..++||||++
T Consensus         4 ~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   83 (285)
T cd05630           4 QYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMN   83 (285)
T ss_pred             eeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecC
Confidence            3457899999999999965 5889999998754322   23457789999999999999999999999999999999999


Q ss_pred             CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccc
Q 010309          305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  384 (513)
Q Consensus       305 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  384 (513)
                      +++|.+++...  ....+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||++.........
T Consensus        84 g~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  158 (285)
T cd05630          84 GGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI  158 (285)
T ss_pred             CCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccc
Confidence            99999988642  234589999999999999999999999   9999999999999999999999999998765432211


Q ss_pred             cceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccC
Q 010309          385 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS  464 (513)
Q Consensus       385 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  464 (513)
                         ....|+..|+|||++.+..++.++||||||+++|+|++|..||...........   ......         ...  
T Consensus       159 ---~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~---~~~~~~---------~~~--  221 (285)
T cd05630         159 ---KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE---VERLVK---------EVQ--  221 (285)
T ss_pred             ---cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHH---HHhhhh---------hhh--
Confidence               112389999999999988999999999999999999999999976432110000   000000         000  


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 010309          465 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPR-----MSHVVH  501 (513)
Q Consensus       465 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  501 (513)
                        . ......++++.+|+.+||+.||++|||     ++|+++
T Consensus       222 --~-~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         222 --E-EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             --h-hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence              0 011224456899999999999999999     888886

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-38  Score=304.20  Aligned_cols=263  Identities=22%  Similarity=0.369  Sum_probs=198.8

Q ss_pred             cCCceecccCceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhc--CCCcEeeeeeEEeeCC----ceEEEEe
Q 010309          228 EGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL--HHPNLVAVKGCCYDHG----DRYIVYE  301 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~nIv~l~~~~~~~~----~~~lv~e  301 (513)
                      ...+.||+|.||+||+|.+ .|+.||||++...   ++..+.+|.++.+..  +|+||+.+++.-..++    .++||++
T Consensus       214 ~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTd  289 (513)
T KOG2052|consen  214 VLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTD  289 (513)
T ss_pred             EEEEEecCccccceeeccc-cCCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeee
Confidence            3456789999999999999 7999999999654   456788888888764  9999999998755443    4699999


Q ss_pred             eccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCceEcCCCCCceEecCCCCeEEecccccc
Q 010309          302 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK-----VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK  376 (513)
Q Consensus       302 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-----~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~  376 (513)
                      |.+.|||.+||..     ..++....++++..+|.||+|||..     .+|.|.|||||+.|||+.+++.+.|+|+|+|.
T Consensus       290 YHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv  364 (513)
T KOG2052|consen  290 YHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  364 (513)
T ss_pred             cccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeE
Confidence            9999999999974     5699999999999999999999943     47899999999999999999999999999998


Q ss_pred             cCCcccc--ccceeecCcccccccccccccCC----C--CchhhHHHHHHHHHHHHcC----------CCCCCCCCcccc
Q 010309          377 FVPWEVM--QERTVMAGGTYGYLAPEFVYRNE----L--TTKSDVYSFGVLLLEIVSG----------RRPAQAVDSVCW  438 (513)
Q Consensus       377 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~----~--~~~sDvwSlGvil~elltg----------~~p~~~~~~~~~  438 (513)
                      .......  ........||.+|||||++...-    +  -..+||||||.|+||+.-.          .+||.+..+.+ 
T Consensus       365 ~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~D-  443 (513)
T KOG2052|consen  365 RHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSD-  443 (513)
T ss_pred             EecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCC-
Confidence            7654421  22223344999999999996531    1  2368999999999999852          45665543221 


Q ss_pred             chhHHhhhHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcC
Q 010309          439 QSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  508 (513)
Q Consensus       439 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  508 (513)
                       ..++.....+-..+    +.|   ..+...........+.++|+.||..+|..|.|+-.|-+.|.++.+
T Consensus       444 -Ps~eeMrkVVCv~~----~RP---~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  444 -PSFEEMRKVVCVQK----LRP---NIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             -CCHHHHhcceeecc----cCC---CCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence             00111111111111    111   111222234567788999999999999999999999999988764

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=6.7e-39  Score=324.35  Aligned_cols=258  Identities=21%  Similarity=0.306  Sum_probs=193.9

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEeccc--chhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCC-----ceEEEEe
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG-----DRYIVYE  301 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-----~~~lv~e  301 (513)
                      .+.||+|+||.||++... +|+.||||++...  .....+.+.+|+.+++.++||||+++++++...+     ..|+|||
T Consensus         5 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e   84 (372)
T cd07853           5 DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTE   84 (372)
T ss_pred             cceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEee
Confidence            456799999999999964 6899999998653  2234467889999999999999999999998776     7899999


Q ss_pred             eccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcc
Q 010309          302 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE  381 (513)
Q Consensus       302 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~  381 (513)
                      |+. ++|.+++..    ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++......
T Consensus        85 ~~~-~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~  156 (372)
T cd07853          85 LMQ-SDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD  156 (372)
T ss_pred             ccc-cCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence            995 678887743    35689999999999999999999999   9999999999999999999999999999865432


Q ss_pred             ccccceeecCcccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccc------
Q 010309          382 VMQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRY------  454 (513)
Q Consensus       382 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------  454 (513)
                      ..... ....+++.|+|||++.+. .++.++|||||||++|||++|+.||...+.......+   .........      
T Consensus       157 ~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i---~~~~g~~~~~~~~~~  232 (372)
T cd07853         157 ESKHM-TQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLI---TDLLGTPSLEAMRSA  232 (372)
T ss_pred             ccccC-CCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHH---HHHcCCCCHHHHHHh
Confidence            21111 112378899999998774 4789999999999999999999999876543211111   000000000      


Q ss_pred             ----cc-ccc-----ccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          455 ----LE-LLD-----PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       455 ----~~-~~~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                          .. +..     +.....  .......++++.+||.+||+.||++|||+.|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  287 (372)
T cd07853         233 CEGARAHILRGPHKPPSLPVL--YTLSSQATHEAVHLLCRMLVFDPDKRISAADALA  287 (372)
T ss_pred             hHHHHHHHHhCCCCCCchHHh--cccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence                00 000     000000  0001123567899999999999999999999986

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-39  Score=330.10  Aligned_cols=248  Identities=19%  Similarity=0.212  Sum_probs=192.9

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccc---hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccC
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  305 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  305 (513)
                      .+.||+|+||.||++... +++.||||++.+..   ....+.+.+|+++++.++||||+++++++.+.+..|+||||+++
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~g   85 (377)
T cd05629           6 VKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPG   85 (377)
T ss_pred             eEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCC
Confidence            456799999999999864 68999999986542   22345678899999999999999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccc-
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ-  384 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~-  384 (513)
                      |+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++........ 
T Consensus        86 g~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  158 (377)
T cd05629          86 GDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA  158 (377)
T ss_pred             CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence            999999864    35689999999999999999999999   9999999999999999999999999998633210000 


Q ss_pred             -----------c---------------------------------ceeecCcccccccccccccCCCCchhhHHHHHHHH
Q 010309          385 -----------E---------------------------------RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLL  420 (513)
Q Consensus       385 -----------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil  420 (513)
                                 .                                 ......||+.|+|||++.+..++.++|||||||++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil  238 (377)
T cd05629         159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM  238 (377)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhh
Confidence                       0                                 00012489999999999988999999999999999


Q ss_pred             HHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCC---CCHH
Q 010309          421 LEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMR---PRMS  497 (513)
Q Consensus       421 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~  497 (513)
                      |||++|..||...+...   ..   ........  .     +    ........+.++.+||.+||. +|.+|   +++.
T Consensus       239 ~elltG~~Pf~~~~~~~---~~---~~i~~~~~--~-----~----~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~  300 (377)
T cd05629         239 FECLIGWPPFCSENSHE---TY---RKIINWRE--T-----L----YFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAH  300 (377)
T ss_pred             hhhhcCCCCCCCCCHHH---HH---HHHHccCC--c-----c----CCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence            99999999997654321   10   01000000  0     0    000011245678999999997 77765   5999


Q ss_pred             HHHHH
Q 010309          498 HVVHQ  502 (513)
Q Consensus       498 evl~~  502 (513)
                      ++++.
T Consensus       301 ~~l~h  305 (377)
T cd05629         301 EIKSH  305 (377)
T ss_pred             HHhcC
Confidence            98863

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.6e-39  Score=308.03  Aligned_cols=248  Identities=21%  Similarity=0.312  Sum_probs=197.6

Q ss_pred             CCceecccCceEEEEEEeC-CCCEEEEEEecccch-----hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEee
Q 010309          229 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF-----QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF  302 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  302 (513)
                      ..+.||+|++|.||++... ++++||+|.+.....     ...+.+.+|+.++++++||||+++++++.+.+..++|+||
T Consensus         6 ~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   85 (263)
T cd06625           6 RGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEY   85 (263)
T ss_pred             ccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEE
Confidence            3567899999999999864 589999999875421     1235688899999999999999999999999999999999


Q ss_pred             ccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccc
Q 010309          303 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV  382 (513)
Q Consensus       303 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~  382 (513)
                      +++++|.+++..    ...+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        86 ~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~  158 (263)
T cd06625          86 MPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC  158 (263)
T ss_pred             CCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence            999999998864    24588999999999999999999999   99999999999999999999999999987654321


Q ss_pred             cccc-eeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccccccccc
Q 010309          383 MQER-TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL  461 (513)
Q Consensus       383 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  461 (513)
                      .... .....++..|+|||++.+..++.++||||||+++|||++|+.||...+...  .    .........        
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~----~~~~~~~~~--------  224 (263)
T cd06625         159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA--A----IFKIATQPT--------  224 (263)
T ss_pred             cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH--H----HHHHhccCC--------
Confidence            1111 012237789999999998889999999999999999999999987543210  0    000000000        


Q ss_pred             ccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010309          462 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  502 (513)
Q Consensus       462 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  502 (513)
                           ....+...+..+.+++.+||+.+|.+|||+.++++.
T Consensus       225 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         225 -----NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             -----CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence                 001112345678999999999999999999999863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=2e-39  Score=327.00  Aligned_cols=248  Identities=19%  Similarity=0.223  Sum_probs=194.0

Q ss_pred             CCceecccCceEEEEEEeC-CCCEEEEEEecccc---hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeecc
Q 010309          229 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV  304 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  304 (513)
                      ..+.||+|+||.||++... +++.||+|++.+..   ......+.+|+.+++.++||||+++++++.+++..++||||++
T Consensus        47 ~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~  126 (370)
T cd05621          47 VVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMP  126 (370)
T ss_pred             EEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCC
Confidence            3457899999999999975 58899999997532   2234567889999999999999999999999999999999999


Q ss_pred             CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccc
Q 010309          305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  384 (513)
Q Consensus       305 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  384 (513)
                      +|+|.+++..     ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++.........
T Consensus       127 gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~  198 (370)
T cd05621         127 GGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV  198 (370)
T ss_pred             CCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecccCCce
Confidence            9999999864     3588999999999999999999999   9999999999999999999999999999876432211


Q ss_pred             cceeecCcccccccccccccC----CCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccc
Q 010309          385 ERTVMAGGTYGYLAPEFVYRN----ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP  460 (513)
Q Consensus       385 ~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  460 (513)
                       ......||+.|+|||++.+.    .++.++|||||||++|||++|+.||...+...   .   ..........      
T Consensus       199 -~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~---~---~~~i~~~~~~------  265 (370)
T cd05621         199 -RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG---T---YSKIMDHKNS------  265 (370)
T ss_pred             -ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH---H---HHHHHhCCcc------
Confidence             11223489999999998754    37889999999999999999999997654311   0   1111110000      


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHH
Q 010309          461 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSM--RPRMSHVVHQ  502 (513)
Q Consensus       461 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~  502 (513)
                       +    ........+..+.+++.+||..+|.+  ||++.++++.
T Consensus       266 -~----~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         266 -L----NFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             -c----CCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence             0    00111234567899999999865543  8899999874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=5.9e-39  Score=312.26  Aligned_cols=246  Identities=22%  Similarity=0.351  Sum_probs=196.6

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCCH
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  308 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL  308 (513)
                      .+.||+|+||.||+|... ++..+++|.+........+.+.+|+.+++.++||||+++++++...+..++||||+++++|
T Consensus        10 ~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l   89 (282)
T cd06643          10 IGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAV   89 (282)
T ss_pred             HhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcH
Confidence            445799999999999975 4778999999776656667889999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccccee
Q 010309          309 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  388 (513)
Q Consensus       309 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  388 (513)
                      ..++..   ....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.........  ..
T Consensus        90 ~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~--~~  161 (282)
T cd06643          90 DAVMLE---LERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR--RD  161 (282)
T ss_pred             HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccccc--cc
Confidence            988753   235689999999999999999999999   9999999999999999999999999998765332211  11


Q ss_pred             ecCcccccccccccc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccccccccccc
Q 010309          389 MAGGTYGYLAPEFVY-----RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS  463 (513)
Q Consensus       389 ~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  463 (513)
                      ...++..|+|||++.     +..++.++|||||||++|||++|.+||...+...  ..    .......      .+.. 
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--~~----~~~~~~~------~~~~-  228 (282)
T cd06643         162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR--VL----LKIAKSE------PPTL-  228 (282)
T ss_pred             cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH--HH----HHHhhcC------CCCC-
Confidence            223888999999984     3457789999999999999999999987643211  10    0000000      0000 


Q ss_pred             CCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          464 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       464 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                           ..+...+.++.++|.+||+.||.+||++.++++
T Consensus       229 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         229 -----AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             -----CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                 011234567999999999999999999999985

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=5.2e-39  Score=313.01  Aligned_cols=263  Identities=24%  Similarity=0.355  Sum_probs=200.7

Q ss_pred             CcccCCceecccCceEEEEEEe-----CCCCEEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeC--Cce
Q 010309          225 NFSEGNRLLGDSKTGGTYSGIL-----PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDR  296 (513)
Q Consensus       225 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~  296 (513)
                      .++...+.||+|+||.||++..     .++..||+|.++... ......+.+|+.+++.++||||+++++++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            3445556789999999999984     357899999997553 33346789999999999999999999998875  567


Q ss_pred             EEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccc
Q 010309          297 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK  376 (513)
Q Consensus       297 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~  376 (513)
                      ++||||+++++|.+++...   ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+|||++.
T Consensus        84 ~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~  157 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK  157 (284)
T ss_pred             EEEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccc
Confidence            9999999999999998642   23589999999999999999999999   99999999999999999999999999998


Q ss_pred             cCCccccc-cceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccc--------chhHHhhhH
Q 010309          377 FVPWEVMQ-ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW--------QSIFEWATP  447 (513)
Q Consensus       377 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~--------~~~~~~~~~  447 (513)
                      ........ .......++..|+|||++.+..++.++||||||+++|||+|+..|.........        .........
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05079         158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR  237 (284)
T ss_pred             ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence            76433211 111122367789999999888899999999999999999998776533211000        000000000


Q ss_pred             HhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q 010309          448 LVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  506 (513)
Q Consensus       448 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  506 (513)
                      ......             ....+..++..+.+|+.+||+.||++|||+.++++.|+.+
T Consensus       238 ~~~~~~-------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         238 VLEEGK-------------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHHcCc-------------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            000000             0011123566899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=7.2e-39  Score=316.62  Aligned_cols=257  Identities=25%  Similarity=0.405  Sum_probs=200.8

Q ss_pred             CCceecccCceEEEEEEeC--------CCCEEEEEEecccc-hhcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCCceEE
Q 010309          229 GNRLLGDSKTGGTYSGILP--------DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYI  298 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~l  298 (513)
                      ..+.||+|+||.||++...        ....||+|.++... ......+.+|+.+++++ +||||+++++++...+..++
T Consensus        16 ~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l   95 (314)
T cd05099          16 LGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYV   95 (314)
T ss_pred             eeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEE
Confidence            3456799999999999742        24579999987542 23356788999999999 69999999999999999999


Q ss_pred             EEeeccCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCC
Q 010309          299 VYEFVVNGPLDRWLHHIPR------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG  366 (513)
Q Consensus       299 v~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~  366 (513)
                      ||||+++|+|.+++.....            ....+++..+..++.|++.||.|||++   +++||||||+|||++.++.
T Consensus        96 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~~~~~  172 (314)
T cd05099          96 IVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNV  172 (314)
T ss_pred             EEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEEcCCCc
Confidence            9999999999999965321            124588999999999999999999999   9999999999999999999


Q ss_pred             eEEecccccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhh
Q 010309          367 AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWA  445 (513)
Q Consensus       367 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~  445 (513)
                      +||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.......   .... 
T Consensus       173 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~~~~-  248 (314)
T cd05099         173 MKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE---LFKL-  248 (314)
T ss_pred             EEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH---HHHH-
Confidence            99999999986643222111111224567999999988889999999999999999999 888986544321   1111 


Q ss_pred             hHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcC
Q 010309          446 TPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  508 (513)
Q Consensus       446 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  508 (513)
                         ......            .. .+..++.++.+++.+||+.||++|||+.++++.|+++..
T Consensus       249 ---~~~~~~------------~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~  295 (314)
T cd05099         249 ---LREGHR------------MD-KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA  295 (314)
T ss_pred             ---HHcCCC------------CC-CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence               111000            00 012234578899999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=7.9e-39  Score=322.30  Aligned_cols=265  Identities=22%  Similarity=0.308  Sum_probs=194.1

Q ss_pred             HhhCcccCCceecccCceEEEEEEeC-CCCEEEEEEeccc--chhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCC----
Q 010309          222 ITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG----  294 (513)
Q Consensus       222 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----  294 (513)
                      +.++|.. .+.||+|+||.||++... +|..||||++...  .......+.+|+.+++.++||||+++++++...+    
T Consensus        19 ~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   97 (359)
T cd07876          19 VLKRYQQ-LKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE   97 (359)
T ss_pred             hhhceEE-EEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence            3445544 467899999999999864 5899999999754  2234567889999999999999999999986543    


Q ss_pred             --ceEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecc
Q 010309          295 --DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV  372 (513)
Q Consensus       295 --~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df  372 (513)
                        ..++||||+++ +|...+.      ..+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+||
T Consensus        98 ~~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Df  167 (359)
T cd07876          98 FQDVYLVMELMDA-NLCQVIH------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF  167 (359)
T ss_pred             cceeEEEEeCCCc-CHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecC
Confidence              46999999965 6666653      3488899999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccc-chhHH--------
Q 010309          373 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW-QSIFE--------  443 (513)
Q Consensus       373 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~-~~~~~--------  443 (513)
                      |++.........   ....+|+.|+|||++.+..++.++||||||+++|+|++|+.||...+.... .....        
T Consensus       168 g~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  244 (359)
T cd07876         168 GLARTACTNFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAE  244 (359)
T ss_pred             CCccccccCccC---CCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHH
Confidence            999765332211   112388999999999999999999999999999999999999986543210 00000        


Q ss_pred             ---h----hhHHhhcc-c-----ccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          444 ---W----ATPLVQSH-R-----YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       444 ---~----~~~~~~~~-~-----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                         .    ........ .     ..+........ .........++.+.+|+.+||+.||++|||+.|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  314 (359)
T cd07876         245 FMNRLQPTVRNYVENRPQYPGISFEELFPDWIFP-SESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR  314 (359)
T ss_pred             HHHHHHHHHHHHHhhCCCCCCcchhhhccccccc-cccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence               0    00000000 0     00000000000 000011123467899999999999999999999997

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=7.9e-39  Score=312.26  Aligned_cols=262  Identities=19%  Similarity=0.263  Sum_probs=189.9

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccch--hcHHHHHHHHHHHhhc---CCCcEeeeeeEEeeC-----CceEE
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF--QRKKEFYSEIGRFARL---HHPNLVAVKGCCYDH-----GDRYI  298 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~~-----~~~~l  298 (513)
                      .+.||+|+||.||+|... +++.||+|.++....  .....+.+|+.+++.+   +||||+++++++...     ...++
T Consensus         5 ~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~l   84 (288)
T cd07863           5 VAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTL   84 (288)
T ss_pred             eeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEE
Confidence            356799999999999975 588999999875422  1234556777776665   799999999988653     44799


Q ss_pred             EEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccC
Q 010309          299 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV  378 (513)
Q Consensus       299 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~  378 (513)
                      ||||+. ++|.+++...  ....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++...
T Consensus        85 v~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~~~  158 (288)
T cd07863          85 VFEHVD-QDLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY  158 (288)
T ss_pred             EEcccc-cCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCccccc
Confidence            999996 5898888652  234589999999999999999999999   9999999999999999999999999999866


Q ss_pred             CccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccc-hhHHhhhHHhhccccccc
Q 010309          379 PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ-SIFEWATPLVQSHRYLEL  457 (513)
Q Consensus       379 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  457 (513)
                      .......   ...+|..|+|||++.+..++.++|||||||++|+|++|++||......... .+...... .........
T Consensus       159 ~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~-~~~~~~~~~  234 (288)
T cd07863         159 SCQMALT---PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL-PPEDDWPRD  234 (288)
T ss_pred             cCcccCC---CccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCC-CChhhCccc
Confidence            4322211   123788999999999889999999999999999999999999765432111 11110000 000000000


Q ss_pred             c---cccccCCCCC---CCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          458 L---DPLISSLSSD---IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       458 ~---~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      .   ..........   ......++.+.+++.+||+.||++|||+.+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            0   0000000000   001134567899999999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=6.5e-39  Score=309.73  Aligned_cols=254  Identities=22%  Similarity=0.333  Sum_probs=190.4

Q ss_pred             eecccCceEEEEEEeCC---CCEEEEEEecccch-hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCC
Q 010309          232 LLGDSKTGGTYSGILPD---GSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  307 (513)
Q Consensus       232 ~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs  307 (513)
                      .||+|+||.||+|...+   ...+|+|.+..... .....+.+|+.+++.++||||+++++.+...+..++||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            36999999999997543   45788998765432 334578899999999999999999999999999999999999999


Q ss_pred             HHHHhccCCCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccc
Q 010309          308 LDRWLHHIPRG-GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  386 (513)
Q Consensus       308 L~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  386 (513)
                      |.+++...... ....++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++...........
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            99999753321 23356788899999999999999999   999999999999999999999999999875433221111


Q ss_pred             eeecCccccccccccccc-------CCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccc
Q 010309          387 TVMAGGTYGYLAPEFVYR-------NELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELL  458 (513)
Q Consensus       387 ~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  458 (513)
                      .....+++.|+|||++..       ..++.++||||||+++|||++ |..||.......   .   ........ .....
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~---~~~~~~~~-~~~~~  231 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ---V---LKQVVREQ-DIKLP  231 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH---H---HHHHhhcc-CccCC
Confidence            122225678999998743       356789999999999999999 788886543221   0   00111110 01111


Q ss_pred             cccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 010309          459 DPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ  504 (513)
Q Consensus       459 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  504 (513)
                      .+        ......+..+.+++..|+ .||++|||+++|++.|.
T Consensus       232 ~~--------~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         232 KP--------QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CC--------cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            11        112234566788999998 59999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2e-39  Score=311.41  Aligned_cols=239  Identities=27%  Similarity=0.414  Sum_probs=189.9

Q ss_pred             eecccCceEEEEEEeCC--------CCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeec
Q 010309          232 LLGDSKTGGTYSGILPD--------GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  303 (513)
Q Consensus       232 ~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  303 (513)
                      .||+|+||.||+|....        ..+||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus         2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~   81 (258)
T cd05078           2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYV   81 (258)
T ss_pred             CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecC
Confidence            47999999999998632        3358999887655455678899999999999999999999999999999999999


Q ss_pred             cCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCC--------eEEeccccc
Q 010309          304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG--------AHLMGVGLS  375 (513)
Q Consensus       304 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~--------~kl~Dfg~~  375 (513)
                      ++|+|.+++...   ...+++..++.++.||+.||+|||+.   +|+||||||+||+++.++.        ++++|||++
T Consensus        82 ~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          82 KFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             CCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccccc
Confidence            999999999642   24689999999999999999999999   9999999999999987765        599999998


Q ss_pred             ccCCccccccceeecCccccccccccccc-CCCCchhhHHHHHHHHHHHHcCC-CCCCCCCccccchhHHhhhHHhhccc
Q 010309          376 KFVPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR-RPAQAVDSVCWQSIFEWATPLVQSHR  453 (513)
Q Consensus       376 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~  453 (513)
                      .......      ...++..|+|||++.+ ..++.++||||||+++|||++|. .|+...+......       .... .
T Consensus       156 ~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-------~~~~-~  221 (258)
T cd05078         156 ITVLPKE------ILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-------FYED-R  221 (258)
T ss_pred             cccCCch------hccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-------HHHc-c
Confidence            7553221      1227888999999976 45789999999999999999985 5555433211000       0000 0


Q ss_pred             ccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 010309          454 YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ  504 (513)
Q Consensus       454 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  504 (513)
                                   .. .+.....++.+++.+||+.||++|||++++++.|+
T Consensus       222 -------------~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         222 -------------HQ-LPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             -------------cc-CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                         00 01122356899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.2e-38  Score=312.33  Aligned_cols=244  Identities=22%  Similarity=0.348  Sum_probs=199.4

Q ss_pred             CceecccCceEEEEEEe-CCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCCH
Q 010309          230 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  308 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL  308 (513)
                      .+.||+|++|.||++.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||+++++|
T Consensus        24 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L  103 (297)
T cd06656          24 FEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL  103 (297)
T ss_pred             eeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCH
Confidence            34679999999999996 46999999999876555567788999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccccee
Q 010309          309 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  388 (513)
Q Consensus       309 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  388 (513)
                      .+++..     ..+++.++..++.|++.||.|||+.   +++||||||+|||++.++.++|+|||++..........  .
T Consensus       104 ~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~--~  173 (297)
T cd06656         104 TDVVTE-----TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--S  173 (297)
T ss_pred             HHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCccCc--C
Confidence            999853     4588999999999999999999999   99999999999999999999999999987654332211  1


Q ss_pred             ecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCCC
Q 010309          389 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD  468 (513)
Q Consensus       389 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  468 (513)
                      ...+++.|+|||.+.+..++.++||||||+++|+|++|..||...+....  ..             ...   .......
T Consensus       174 ~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~--~~-------------~~~---~~~~~~~  235 (297)
T cd06656         174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LY-------------LIA---TNGTPEL  235 (297)
T ss_pred             cccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh--ee-------------eec---cCCCCCC
Confidence            22378899999999988899999999999999999999999976443210  00             000   0000011


Q ss_pred             CCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          469 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       469 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      ..+...+..+.+++.+||+.||++||++++|++
T Consensus       236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         236 QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            112335567899999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=8.5e-39  Score=307.57  Aligned_cols=250  Identities=27%  Similarity=0.437  Sum_probs=192.8

Q ss_pred             eecccCceEEEEEEeC----CCCEEEEEEeccc-chhcHHHHHHHHHHHhhcCCCcEeeeeeEEe-eCCceEEEEeeccC
Q 010309          232 LLGDSKTGGTYSGILP----DGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCY-DHGDRYIVYEFVVN  305 (513)
Q Consensus       232 ~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~-~~~~~~lv~e~~~~  305 (513)
                      +||+|+||.||+|...    ++..||+|.+... .....+.+.+|+.+++.++||||+++++++. .++..++||||+.+
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~   81 (262)
T cd05058           2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKH   81 (262)
T ss_pred             cccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCC
Confidence            5799999999999853    2457999998643 2344567889999999999999999999876 45567999999999


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccc
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  385 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  385 (513)
                      ++|.+++...   ...+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++.........
T Consensus        82 ~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~  155 (262)
T cd05058          82 GDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS  155 (262)
T ss_pred             CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence            9999999642   23467788899999999999999999   99999999999999999999999999997654321111


Q ss_pred             --ceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcC-CCCCCCCCccccchhHHhhhHHhhcccccccccccc
Q 010309          386 --RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSG-RRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI  462 (513)
Q Consensus       386 --~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  462 (513)
                        ......++..|+|||.+.+..++.++||||||+++|||++| .+||...+..      +.........          
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~------~~~~~~~~~~----------  219 (262)
T cd05058         156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF------DITVYLLQGR----------  219 (262)
T ss_pred             ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHHHhcCC----------
Confidence              11112256789999999888899999999999999999995 5566543321      1111111000          


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCc
Q 010309          463 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  507 (513)
Q Consensus       463 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  507 (513)
                          ....+...+..+.+++.+||+.+|++||++.+|++.|+++.
T Consensus       220 ----~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         220 ----RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             ----CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence                00001123457999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.2e-39  Score=291.98  Aligned_cols=245  Identities=20%  Similarity=0.336  Sum_probs=199.4

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccch----hc----HHHHHHHHHHHhhc-CCCcEeeeeeEEeeCCceEEE
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF----QR----KKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIV  299 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~----~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv  299 (513)
                      .++||.|..+.|-+...+ +|..+|+|++.....    ..    .+.-.+|+.+|+++ -||+|+++.++++.+...++|
T Consensus        22 keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlV  101 (411)
T KOG0599|consen   22 KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLV  101 (411)
T ss_pred             HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhh
Confidence            457799999999888754 688999999863211    11    24457899999998 699999999999999999999


Q ss_pred             EeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCC
Q 010309          300 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP  379 (513)
Q Consensus       300 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~  379 (513)
                      +|.|+.|.|.++|..    .-.+++...+.|++|+..|+.|||..   +||||||||+|||+|++.++||+|||++..+.
T Consensus       102 Fdl~prGELFDyLts----~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGFa~~l~  174 (411)
T KOG0599|consen  102 FDLMPRGELFDYLTS----KVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGFACQLE  174 (411)
T ss_pred             hhhcccchHHHHhhh----heeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccceeeccC
Confidence            999999999999964    46799999999999999999999999   99999999999999999999999999999886


Q ss_pred             ccccccceeecCccccccccccccc------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccc
Q 010309          380 WEVMQERTVMAGGTYGYLAPEFVYR------NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHR  453 (513)
Q Consensus       380 ~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  453 (513)
                      ....   ....+|||+|.|||.+.-      ..|+...|+||.|||+|.|+.|.+||......     .  ...++.+++
T Consensus       175 ~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQm-----l--MLR~ImeGk  244 (411)
T KOG0599|consen  175 PGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQM-----L--MLRMIMEGK  244 (411)
T ss_pred             Cchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHH-----H--HHHHHHhcc
Confidence            5433   233569999999998852      36888999999999999999999999653221     1  111222222


Q ss_pred             ccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          454 YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       454 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      +.-          ......+++..+.+||.+||+.||.+|.|++|+|.
T Consensus       245 yqF----------~speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  245 YQF----------RSPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             ccc----------CCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence            210          22234567888999999999999999999999986

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.1e-38  Score=305.74  Aligned_cols=247  Identities=26%  Similarity=0.449  Sum_probs=198.2

Q ss_pred             CceecccCceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCCHH
Q 010309          230 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD  309 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~  309 (513)
                      .+.||+|++|.||++.+.++..+|+|.+.... .....+.+|++++++++||||+++++++......++||||+++++|.
T Consensus         9 ~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~   87 (256)
T cd05112           9 VQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLS   87 (256)
T ss_pred             EeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHH
Confidence            35679999999999998778899999987543 34567899999999999999999999999999999999999999999


Q ss_pred             HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccceee
Q 010309          310 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM  389 (513)
Q Consensus       310 ~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  389 (513)
                      +++...   ...+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||.+........... ..
T Consensus        88 ~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~-~~  160 (256)
T cd05112          88 DYLRAQ---RGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS-TG  160 (256)
T ss_pred             HHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCccccc-CC
Confidence            998642   24588999999999999999999999   999999999999999999999999999876543221111 11


Q ss_pred             cCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCCC
Q 010309          390 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD  468 (513)
Q Consensus       390 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  468 (513)
                      ..++..|+|||.+.+..++.++||||||+++|||++ |..||.......   ...   ......   ....         
T Consensus       161 ~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~~---~~~~~~---~~~~---------  222 (256)
T cd05112         161 TKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE---VVE---TINAGF---RLYK---------  222 (256)
T ss_pred             CccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH---HHH---HHhCCC---CCCC---------
Confidence            124678999999988889999999999999999998 999987544221   111   100000   0000         


Q ss_pred             CCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 010309          469 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ  504 (513)
Q Consensus       469 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  504 (513)
                        +...+..+.+|+.+||+.+|++|||+.++++.|.
T Consensus       223 --~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         223 --PRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             --CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence              1113467999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=6.7e-39  Score=307.06  Aligned_cols=246  Identities=22%  Similarity=0.317  Sum_probs=198.9

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEeccc-chhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCC
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  307 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs  307 (513)
                      .+.||+|+||.||++... +++.||+|.++.. .....+.+.+|+.+++.++||||+++++.+.+.+..++||||+++++
T Consensus         5 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   84 (255)
T cd08219           5 LRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGD   84 (255)
T ss_pred             EEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCc
Confidence            457899999999999965 5889999998643 23345678899999999999999999999999999999999999999


Q ss_pred             HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccce
Q 010309          308 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  387 (513)
Q Consensus       308 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  387 (513)
                      |.+++..  .....+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||.+..........  
T Consensus        85 l~~~~~~--~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~--  157 (255)
T cd08219          85 LMQKIKL--QRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYA--  157 (255)
T ss_pred             HHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccccc--
Confidence            9998864  2234588999999999999999999999   99999999999999999999999999997664332211  


Q ss_pred             eecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCC
Q 010309          388 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS  467 (513)
Q Consensus       388 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  467 (513)
                      ....+++.|+|||++.+..++.++|+||||+++|+|++|..||...+...   .   .... .....             
T Consensus       158 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~---~---~~~~-~~~~~-------------  217 (255)
T cd08219         158 CTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN---L---ILKV-CQGSY-------------  217 (255)
T ss_pred             ccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH---H---HHHH-hcCCC-------------
Confidence            11237889999999988889999999999999999999999997543211   1   1110 00000             


Q ss_pred             CCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010309          468 DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  502 (513)
Q Consensus       468 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  502 (513)
                      ...+...+..+.+++.+||+.||++||++.+|+..
T Consensus       218 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         218 KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            00112345578999999999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.2e-39  Score=330.25  Aligned_cols=248  Identities=20%  Similarity=0.235  Sum_probs=193.7

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccch---hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccC
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  305 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  305 (513)
                      .+.||+|+||.||++... +++.||||++.+...   .....+.+|+.+|+.++||||+++++.+.+.+..++||||+++
T Consensus         6 ~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~   85 (376)
T cd05598           6 IKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPG   85 (376)
T ss_pred             EEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCC
Confidence            456799999999999964 589999999975422   2345688999999999999999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccc--
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM--  383 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~--  383 (513)
                      |+|.+++..    ...+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++..+.....  
T Consensus        86 g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~  158 (376)
T cd05598          86 GDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK  158 (376)
T ss_pred             CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence            999999964    34688999999999999999999999   999999999999999999999999999753210000  


Q ss_pred             ---------------------------------------ccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHH
Q 010309          384 ---------------------------------------QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIV  424 (513)
Q Consensus       384 ---------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ell  424 (513)
                                                             ........||+.|+|||++.+..++.++|||||||++|||+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell  238 (376)
T cd05598         159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML  238 (376)
T ss_pred             ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehh
Confidence                                                   00001224899999999999999999999999999999999


Q ss_pred             cCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCC---CHHHHHH
Q 010309          425 SGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP---RMSHVVH  501 (513)
Q Consensus       425 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~evl~  501 (513)
                      +|+.||..........      ......       ...    ........++++.++|.+|+ .+|.+|+   ++.++++
T Consensus       239 ~G~~Pf~~~~~~~~~~------~i~~~~-------~~~----~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~  300 (376)
T cd05598         239 VGQPPFLADTPAETQL------KVINWE-------TTL----HIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKA  300 (376)
T ss_pred             hCCCCCCCCCHHHHHH------HHhccC-------ccc----cCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence            9999998655321110      000000       000    00111224566888999876 5999999   8888885


Q ss_pred             H
Q 010309          502 Q  502 (513)
Q Consensus       502 ~  502 (513)
                      .
T Consensus       301 h  301 (376)
T cd05598         301 H  301 (376)
T ss_pred             C
Confidence            3

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=4.3e-39  Score=319.30  Aligned_cols=237  Identities=23%  Similarity=0.306  Sum_probs=189.8

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccc---hhcHHHHHHHHHHHhhcC-CCcEeeeeeEEeeCCceEEEEeecc
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVYEFVV  304 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~  304 (513)
                      .++||+|+||.||++... +|+.||+|++.+..   ....+.+..|..++..+. |++|+++++++.+.+..|+||||++
T Consensus         5 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~   84 (323)
T cd05615           5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVN   84 (323)
T ss_pred             EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCC
Confidence            357899999999999965 58999999997642   223356778888888885 5788889999999999999999999


Q ss_pred             CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccc
Q 010309          305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  384 (513)
Q Consensus       305 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  384 (513)
                      +|+|.+++..    ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++.........
T Consensus        85 ~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~  157 (323)
T cd05615          85 GGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT  157 (323)
T ss_pred             CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCCcc
Confidence            9999998854    34689999999999999999999999   9999999999999999999999999998754322211


Q ss_pred             cceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccC
Q 010309          385 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS  464 (513)
Q Consensus       385 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  464 (513)
                        .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+...   ...   .... ..           
T Consensus       158 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~~~---~i~~-~~-----------  217 (323)
T cd05615         158 --TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE---LFQ---SIME-HN-----------  217 (323)
T ss_pred             --ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH---HHH---HHHh-CC-----------
Confidence              122338999999999998899999999999999999999999997654321   111   1000 00           


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCH
Q 010309          465 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRM  496 (513)
Q Consensus       465 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  496 (513)
                         ...+...+.++.+++.+||+.||.+|++.
T Consensus       218 ---~~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         218 ---VSYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             ---CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence               00112245678999999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.9e-39  Score=325.68  Aligned_cols=261  Identities=18%  Similarity=0.214  Sum_probs=196.1

Q ss_pred             ccCCceecccCceEEEEEEeC---CCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeec
Q 010309          227 SEGNRLLGDSKTGGTYSGILP---DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  303 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  303 (513)
                      +...+.||+|+||.||++...   .+..||+|.+...     ....+|+.+|++++||||+++++++......++|||++
T Consensus        94 y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~  168 (392)
T PHA03207         94 YNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKY  168 (392)
T ss_pred             eEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhc
Confidence            344567799999999999753   3678999988643     23568999999999999999999999999999999999


Q ss_pred             cCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccc
Q 010309          304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM  383 (513)
Q Consensus       304 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~  383 (513)
                      . ++|.+++..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.++|+|||++........
T Consensus       169 ~-~~l~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~  240 (392)
T PHA03207        169 K-CDLFTYVDR----SGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD  240 (392)
T ss_pred             C-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence            5 688888842    35689999999999999999999999   999999999999999999999999999976654332


Q ss_pred             ccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccc----------
Q 010309          384 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHR----------  453 (513)
Q Consensus       384 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----------  453 (513)
                      ........||+.|+|||++.+..++.++|||||||++|||++|+.||.+.....................          
T Consensus       241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~  320 (392)
T PHA03207        241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTN  320 (392)
T ss_pred             cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchh
Confidence            2222233489999999999999999999999999999999999999976543221111111111000000          


Q ss_pred             -------ccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          454 -------YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       454 -------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                             +.....+.. ...........+.++.++|.+||..||++|||+.|++.
T Consensus       321 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~  374 (392)
T PHA03207        321 LCKHFKQYAIVLRPPY-TIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS  374 (392)
T ss_pred             HHHHHHhhcccccCCc-cccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence                   000000000 00000001123457889999999999999999999986

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-41  Score=304.16  Aligned_cols=241  Identities=23%  Similarity=0.373  Sum_probs=204.4

Q ss_pred             ecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCCHHHH
Q 010309          233 LGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRW  311 (513)
Q Consensus       233 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~  311 (513)
                      ||+|+||.||+|.++ .|..||||.+.-.  .+.+++.+|+.+++++..|++|++||.+.....+++|||||..|+..+.
T Consensus        41 LGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI  118 (502)
T KOG0574|consen   41 LGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDI  118 (502)
T ss_pred             hcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHH
Confidence            599999999999975 5999999999765  4678899999999999999999999999999999999999999999999


Q ss_pred             hccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccceeecC
Q 010309          312 LHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG  391 (513)
Q Consensus       312 l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  391 (513)
                      ++.   .++++++.++..+++..++||+|||..   .-+|||||+.|||++.+|.+||+|||.+-.+........  ...
T Consensus       119 ~R~---R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRN--TVI  190 (502)
T KOG0574|consen  119 MRA---RRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRN--TVI  190 (502)
T ss_pred             HHH---hcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhC--ccc
Confidence            974   347899999999999999999999999   899999999999999999999999999987765433222  233


Q ss_pred             cccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCCCCCc
Q 010309          392 GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPE  471 (513)
Q Consensus       392 gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  471 (513)
                      ||+.|||||++..-.|+.++||||||++..||..|++||.+..+..  .++               +-+. ...+....+
T Consensus       191 GTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR--AIF---------------MIPT-~PPPTF~KP  252 (502)
T KOG0574|consen  191 GTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR--AIF---------------MIPT-KPPPTFKKP  252 (502)
T ss_pred             cCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc--eeE---------------eccC-CCCCCCCCh
Confidence            9999999999999999999999999999999999999998765431  000               0000 000111224


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          472 AGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       472 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      ...+.++.+++++||-.+|++|-|+.++++
T Consensus       253 E~WS~~F~DFi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  253 EEWSSEFNDFIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             HhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence            567888999999999999999999999886

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.2e-38  Score=307.59  Aligned_cols=251  Identities=25%  Similarity=0.401  Sum_probs=199.7

Q ss_pred             CceecccCceEEEEEEeC----CCCEEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeecc
Q 010309          230 NRLLGDSKTGGTYSGILP----DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV  304 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  304 (513)
                      .+.||+|+||.||+|...    .+..+|+|.++... ....+.+.+|+.++++++||||+++++++..++..++||||++
T Consensus         9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   88 (267)
T cd05066           9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYME   88 (267)
T ss_pred             eeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCC
Confidence            457899999999999863    23479999987543 2335678999999999999999999999999999999999999


Q ss_pred             CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccc
Q 010309          305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  384 (513)
Q Consensus       305 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  384 (513)
                      +++|.+++...   ...+++.++..++.|++.||+|||+.   +++|+||||+|||++.++.++|+|||++.........
T Consensus        89 ~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~  162 (267)
T cd05066          89 NGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA  162 (267)
T ss_pred             CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccccccce
Confidence            99999999642   24589999999999999999999999   9999999999999999999999999999876543221


Q ss_pred             cce-eecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccccccc
Q 010309          385 ERT-VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI  462 (513)
Q Consensus       385 ~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  462 (513)
                      ... ....++..|+|||.+.+..++.++||||||+++||+++ |..||.......   .....   .. .     ..   
T Consensus       163 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~~~~---~~-~-----~~---  227 (267)
T cd05066         163 AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VIKAI---EE-G-----YR---  227 (267)
T ss_pred             eeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HHHHH---hC-C-----Cc---
Confidence            111 11113568999999998889999999999999999887 999987654321   11100   00 0     00   


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q 010309          463 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  506 (513)
Q Consensus       463 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  506 (513)
                           .......++.+.+++.+||+.+|.+||++.++++.|+++
T Consensus       228 -----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         228 -----LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             -----CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence                 001122456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=5e-39  Score=321.54  Aligned_cols=260  Identities=27%  Similarity=0.366  Sum_probs=198.7

Q ss_pred             ccCCceecccCceEEEEEEe------CCCCEEEEEEecccc-hhcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeC-CceE
Q 010309          227 SEGNRLLGDSKTGGTYSGIL------PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDH-GDRY  297 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~-~~~~  297 (513)
                      +...+.||+|+||.||+|..      .+++.||||+++... ......+.+|+.++.++ +||||+++++++... ...+
T Consensus         9 ~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~   88 (343)
T cd05103           9 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM   88 (343)
T ss_pred             hcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceE
Confidence            34456789999999999973      347899999997643 23346788999999999 789999999988654 4678


Q ss_pred             EEEeeccCCCHHHHhccCCC------------------------------------------------------------
Q 010309          298 IVYEFVVNGPLDRWLHHIPR------------------------------------------------------------  317 (513)
Q Consensus       298 lv~e~~~~gsL~~~l~~~~~------------------------------------------------------------  317 (513)
                      +||||+++|+|.+++.....                                                            
T Consensus        89 lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (343)
T cd05103          89 VIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQ  168 (343)
T ss_pred             EEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhh
Confidence            99999999999999864211                                                            


Q ss_pred             ---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccceeecCccc
Q 010309          318 ---GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY  394 (513)
Q Consensus       318 ---~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~  394 (513)
                         ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++................++.
T Consensus       169 ~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~  245 (343)
T cd05103         169 EDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL  245 (343)
T ss_pred             hhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCc
Confidence               012467888899999999999999999   99999999999999999999999999998653322111111222567


Q ss_pred             ccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCCCCCcHH
Q 010309          395 GYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAG  473 (513)
Q Consensus       395 ~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  473 (513)
                      .|+|||.+.+..++.++||||||+++|+|++ |..||.......  ...   .. ......            ... +..
T Consensus       246 ~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~---~~-~~~~~~------------~~~-~~~  306 (343)
T cd05103         246 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFC---RR-LKEGTR------------MRA-PDY  306 (343)
T ss_pred             ceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH--HHH---HH-HhccCC------------CCC-CCC
Confidence            8999999988889999999999999999997 999986543210  010   00 110000            000 111


Q ss_pred             HHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcC
Q 010309          474 VVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  508 (513)
Q Consensus       474 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  508 (513)
                      .++++.+++.+||+.||++|||+.+|++.|+.+.+
T Consensus       307 ~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         307 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            34568999999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=7.3e-39  Score=342.95  Aligned_cols=258  Identities=22%  Similarity=0.298  Sum_probs=200.1

Q ss_pred             CCceecccCceEEEEEEeC-CCCEEEEEEecccch---hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeecc
Q 010309          229 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV  304 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  304 (513)
                      ..+.||+|+||.||+|... +|+.||||++.....   ...+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus         6 Ii~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~e   85 (932)
T PRK13184          6 IIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIE   85 (932)
T ss_pred             EEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCC
Confidence            3457799999999999975 589999999975422   234678999999999999999999999999999999999999


Q ss_pred             CCCHHHHhccCCC-------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEeccccccc
Q 010309          305 NGPLDRWLHHIPR-------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF  377 (513)
Q Consensus       305 ~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~  377 (513)
                      +++|.+++.....       ....+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.++|+|||++..
T Consensus        86 GGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFGLAk~  162 (932)
T PRK13184         86 GYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIF  162 (932)
T ss_pred             CCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecCccee
Confidence            9999999864211       123456778899999999999999999   999999999999999999999999999986


Q ss_pred             CCccccc----------------cceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchh
Q 010309          378 VPWEVMQ----------------ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSI  441 (513)
Q Consensus       378 ~~~~~~~----------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~  441 (513)
                      .......                .......||+.|+|||++.+..++.++|||||||++|||+||..||...+.....  
T Consensus       163 i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~--  240 (932)
T PRK13184        163 KKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKIS--  240 (932)
T ss_pred             cccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhh--
Confidence            6211100                0011124899999999999999999999999999999999999999764321100  


Q ss_pred             HHhhhHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHhcCc
Q 010309          442 FEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP-RMSHVVHQLQQLA  507 (513)
Q Consensus       442 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~  507 (513)
                              ...   ....+.     ...+....++.+.+++.+||+.||++|| +++++++.|+...
T Consensus       241 --------~~~---~i~~P~-----~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~l  291 (932)
T PRK13184        241 --------YRD---VILSPI-----EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHL  291 (932)
T ss_pred             --------hhh---hccChh-----hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence                    000   000000     0011124556789999999999999995 6777877776653

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1e-38  Score=311.11  Aligned_cols=247  Identities=20%  Similarity=0.271  Sum_probs=195.8

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccchh---cHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccC
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQ---RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  305 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  305 (513)
                      .++||+|+||+||++... +++.||+|.+......   ....+.+|+.+++.++|+||+++.+.+..++..++||||+++
T Consensus         5 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   84 (285)
T cd05632           5 YRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNG   84 (285)
T ss_pred             EEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccC
Confidence            356899999999999874 6889999999754322   234578899999999999999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccc
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  385 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  385 (513)
                      ++|.+++...  ....+++..+..++.|++.||.|||+.   +|+||||||+||++++++.++|+|||++......... 
T Consensus        85 ~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~-  158 (285)
T cd05632          85 GDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESI-  158 (285)
T ss_pred             ccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcc-
Confidence            9999888642  234699999999999999999999999   9999999999999999999999999998765432211 


Q ss_pred             ceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCC
Q 010309          386 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  465 (513)
Q Consensus       386 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  465 (513)
                        ....|+..|+|||++.+..++.++|+||||+++|||++|..||...........   ......     ...       
T Consensus       159 --~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~---~~~~~~-----~~~-------  221 (285)
T cd05632         159 --RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREE---VDRRVL-----ETE-------  221 (285)
T ss_pred             --cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHhhh-----ccc-------
Confidence              122389999999999888899999999999999999999999976543211000   000000     000       


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 010309          466 SSDIPEAGVVQKVVDLVYACTQHVPSMRPR-----MSHVVH  501 (513)
Q Consensus       466 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  501 (513)
                        .......+..+.+|+.+||+.||++||+     +.++++
T Consensus       222 --~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         222 --EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             --cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence              0011234556899999999999999999     667665

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.5e-38  Score=311.46  Aligned_cols=244  Identities=23%  Similarity=0.373  Sum_probs=199.6

Q ss_pred             CceecccCceEEEEEEe-CCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCCH
Q 010309          230 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  308 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL  308 (513)
                      .+.||.|++|.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++|+||+++++|
T Consensus        24 ~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  103 (296)
T cd06655          24 YEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSL  103 (296)
T ss_pred             EEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcH
Confidence            34679999999999986 46899999999766555567889999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccccee
Q 010309          309 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  388 (513)
Q Consensus       309 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  388 (513)
                      .+++..     ..+++.++..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++..........  .
T Consensus       104 ~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~--~  173 (296)
T cd06655         104 TDVVTE-----TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR--S  173 (296)
T ss_pred             HHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccccC--C
Confidence            998853     3589999999999999999999999   99999999999999999999999999987654332211  1


Q ss_pred             ecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCCC
Q 010309          389 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD  468 (513)
Q Consensus       389 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  468 (513)
                      ...++..|+|||.+.+..++.++|||||||++|+|++|+.||...+....  ..    .... ..     .+      ..
T Consensus       174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~--~~----~~~~-~~-----~~------~~  235 (296)
T cd06655         174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LY----LIAT-NG-----TP------EL  235 (296)
T ss_pred             CcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HH----HHHh-cC-----Cc------cc
Confidence            22378899999999888899999999999999999999999976543210  00    0000 00     00      00


Q ss_pred             CCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          469 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       469 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      ..+...++.+.++|.+||..||++||++.+|++
T Consensus       236 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         236 QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            112234567899999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-40  Score=324.70  Aligned_cols=246  Identities=23%  Similarity=0.347  Sum_probs=202.6

Q ss_pred             CceecccCceEEEEEEeCC-CCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCCH
Q 010309          230 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  308 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL  308 (513)
                      ..+||+|.||+||.|++.+ ...+|||-+........+.+..|+.+.++|+|.|||+++|.+.+++.+-|.||.++||+|
T Consensus       580 rvVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL  659 (1226)
T KOG4279|consen  580 RVVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL  659 (1226)
T ss_pred             eEEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence            3478999999999999754 567999999888777778899999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEec-CCCCeEEecccccccCCcccccc
Q 010309          309 DRWLHHIPRGGRSL--DWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD-EEFGAHLMGVGLSKFVPWEVMQE  385 (513)
Q Consensus       309 ~~~l~~~~~~~~~l--~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~-~~~~~kl~Dfg~~~~~~~~~~~~  385 (513)
                      .++|+..-   +++  ++..+-.+.+||++||.|||++   .|||||||-+|||++ -.|.+||+|||.++.+..-..-.
T Consensus       660 SsLLrskW---GPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~T  733 (1226)
T KOG4279|consen  660 SSLLRSKW---GPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCT  733 (1226)
T ss_pred             HHHHHhcc---CCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCccc
Confidence            99997532   445  7888889999999999999999   999999999999995 56789999999999876433222


Q ss_pred             ceeecCcccccccccccccC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccccccccccc
Q 010309          386 RTVMAGGTYGYLAPEFVYRN--ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS  463 (513)
Q Consensus       386 ~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  463 (513)
                      .  ...||..|||||++..+  .|+.++|||||||++.||.||++||-...... ..++.                --.-
T Consensus       734 E--TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq-AAMFk----------------VGmy  794 (1226)
T KOG4279|consen  734 E--TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ-AAMFK----------------VGMY  794 (1226)
T ss_pred             c--ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh-Hhhhh----------------hcce
Confidence            2  23399999999999875  58899999999999999999999997543320 00000                0000


Q ss_pred             CCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          464 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       464 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      .. -...+...+.+...+|.+|+.+||.+||++.++|+
T Consensus       795 Kv-HP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  795 KV-HPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             ec-CCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            00 11224578889999999999999999999999986

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=9.6e-39  Score=308.43  Aligned_cols=254  Identities=22%  Similarity=0.353  Sum_probs=190.4

Q ss_pred             eecccCceEEEEEEeCCC---CEEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCC
Q 010309          232 LLGDSKTGGTYSGILPDG---SRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  307 (513)
Q Consensus       232 ~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs  307 (513)
                      .||+|+||.||+|...++   ..+++|.+.... ....+.+.+|+.+++.++||||+++++.+.+....++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            479999999999985443   356677776543 3345789999999999999999999999999999999999999999


Q ss_pred             HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccce
Q 010309          308 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  387 (513)
Q Consensus       308 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  387 (513)
                      |.+++.........+++..+..++.||+.||+|||+.   +++||||||+|||++.++.++|+|||++............
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            9999975433334577788899999999999999999   9999999999999999999999999998643222111111


Q ss_pred             eecCccccccccccccc-------CCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhccccccccc
Q 010309          388 VMAGGTYGYLAPEFVYR-------NELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD  459 (513)
Q Consensus       388 ~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  459 (513)
                      ....++..|+|||++..       ..++.++||||||+++|||++ |..||...+..   ...   ..... .......+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---~~~---~~~~~-~~~~~~~~  231 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR---EVL---NHVIK-DQQVKLFK  231 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH---HHH---HHHHh-hcccccCC
Confidence            12337889999998753       245789999999999999997 56787654321   111   11111 11111222


Q ss_pred             ccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 010309          460 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ  504 (513)
Q Consensus       460 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  504 (513)
                      +.+        ....++.+.+++..|| .+|++||++++|++.|.
T Consensus       232 ~~~--------~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         232 PQL--------ELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             Ccc--------CCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            221        1124457888999999 67999999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=8.4e-39  Score=309.13  Aligned_cols=252  Identities=28%  Similarity=0.393  Sum_probs=199.9

Q ss_pred             CCceecccCceEEEEEEeCC----CCEEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeec
Q 010309          229 GNRLLGDSKTGGTYSGILPD----GSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  303 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  303 (513)
                      ..+.||+|++|.||+|...+    ...||||...... ....+.+.+|+.++++++||||+++++++.+ +..++||||+
T Consensus        10 ~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~   88 (270)
T cd05056          10 LGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELA   88 (270)
T ss_pred             eeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcC
Confidence            34678999999999998643    3479999987654 3455689999999999999999999998875 5678999999


Q ss_pred             cCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccc
Q 010309          304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM  383 (513)
Q Consensus       304 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~  383 (513)
                      ++++|.+++...   ...+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++........
T Consensus        89 ~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  162 (270)
T cd05056          89 PLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY  162 (270)
T ss_pred             CCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeecccccc
Confidence            999999999642   24589999999999999999999999   999999999999999999999999999986644322


Q ss_pred             ccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccccccc
Q 010309          384 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI  462 (513)
Q Consensus       384 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  462 (513)
                      .... ...++..|+|||.+....++.++||||||+++|||++ |..||...+....   ..   .......         
T Consensus       163 ~~~~-~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~---~~---~~~~~~~---------  226 (270)
T cd05056         163 YKAS-KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV---IG---RIENGER---------  226 (270)
T ss_pred             eecC-CCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH---HH---HHHcCCc---------
Confidence            1111 1124568999999988889999999999999999996 9999976543211   00   0000000         


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcC
Q 010309          463 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  508 (513)
Q Consensus       463 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  508 (513)
                          . ..+...+..+.+++.+|+..+|++|||+.++++.|+++..
T Consensus       227 ----~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~  267 (270)
T cd05056         227 ----L-PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ  267 (270)
T ss_pred             ----C-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                0 0112345679999999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=9.5e-39  Score=308.99  Aligned_cols=244  Identities=23%  Similarity=0.381  Sum_probs=192.3

Q ss_pred             ceecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeC------CceEEEEee
Q 010309          231 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDH------GDRYIVYEF  302 (513)
Q Consensus       231 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~------~~~~lv~e~  302 (513)
                      +.||+|+||.||+|... +++.||+|++.... .....+.+|+.++.++ +||||+++++++...      ...++||||
T Consensus        12 ~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~   90 (272)
T cd06637          12 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEF   90 (272)
T ss_pred             HheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEc
Confidence            45799999999999964 58899999987553 3456788999999998 799999999998753      357999999


Q ss_pred             ccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccc
Q 010309          303 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV  382 (513)
Q Consensus       303 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~  382 (513)
                      +++++|.+++...  ....+++..+..++.|++.||+|||+.   +|+|+||||+||+++.++.++|+|||++.......
T Consensus        91 ~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~  165 (272)
T cd06637          91 CGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV  165 (272)
T ss_pred             CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCceeccccc
Confidence            9999999998752  234689999999999999999999999   99999999999999999999999999998654322


Q ss_pred             cccceeecCcccccccccccc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccccc
Q 010309          383 MQERTVMAGGTYGYLAPEFVY-----RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLEL  457 (513)
Q Consensus       383 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  457 (513)
                      ..  .....|++.|+|||++.     +..++.++|||||||++|||++|..||.........     . . ....     
T Consensus       166 ~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~-----~-~-~~~~-----  231 (272)
T cd06637         166 GR--RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL-----F-L-IPRN-----  231 (272)
T ss_pred             cc--CCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH-----H-H-HhcC-----
Confidence            11  12233888999999986     335788999999999999999999999654321100     0 0 0000     


Q ss_pred             ccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          458 LDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       458 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      ..       ........+..+.+|+.+||+.||.+|||+.++++
T Consensus       232 ~~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         232 PA-------PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             CC-------CCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            00       11111234567999999999999999999999975

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.5e-38  Score=305.16  Aligned_cols=237  Identities=27%  Similarity=0.441  Sum_probs=189.9

Q ss_pred             eecccCceEEEEEEeCCCC-----------EEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEE
Q 010309          232 LLGDSKTGGTYSGILPDGS-----------RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY  300 (513)
Q Consensus       232 ~lg~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  300 (513)
                      .||+|+||.||+|...+..           .|++|.+...... ...+.+|+.++++++||||+++++++.. ...++||
T Consensus         2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~   79 (259)
T cd05037           2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE   79 (259)
T ss_pred             cccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence            5799999999999975432           5888887655433 6788999999999999999999999988 7889999


Q ss_pred             eeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCC-------CeEEeccc
Q 010309          301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF-------GAHLMGVG  373 (513)
Q Consensus       301 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~-------~~kl~Dfg  373 (513)
                      ||+++|+|.+++...   ...+++..++.++.||+.||+|||+.   +|+||||||+|||++.++       .+||+|||
T Consensus        80 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          80 EYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             EcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCC
Confidence            999999999999752   22689999999999999999999999   999999999999999887       79999999


Q ss_pred             ccccCCccccccceeecCcccccccccccccC--CCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhh
Q 010309          374 LSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN--ELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQ  450 (513)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  450 (513)
                      ++.......      ...++..|+|||++...  .++.++||||||+++|||++ |..|+...+........       .
T Consensus       154 ~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~-------~  220 (259)
T cd05037         154 IPITVLSRE------ERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFY-------Q  220 (259)
T ss_pred             ccccccccc------ccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHH-------h
Confidence            998654311      12266789999999876  78999999999999999999 57777655322111110       0


Q ss_pred             cccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 010309          451 SHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ  504 (513)
Q Consensus       451 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  504 (513)
                      ..       ...    . .+   ....+.+++.+||..+|.+|||+.+|++.|+
T Consensus       221 ~~-------~~~----~-~~---~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         221 DQ-------HRL----P-MP---DCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             cC-------CCC----C-CC---CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            00       000    0 00   1157899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-39  Score=298.18  Aligned_cols=263  Identities=21%  Similarity=0.347  Sum_probs=208.5

Q ss_pred             HHHHHHHhhCcccCCceecccCceEEEEEE-eCCCCEEEEEEecccchhcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeC
Q 010309          216 TEELRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDH  293 (513)
Q Consensus       216 ~~~l~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~  293 (513)
                      ++++-.++.      ++||+|+++.|-.++ +.+|..+|||++.+.....+..+.+|++++.+. .|+||++++++|+++
T Consensus        75 F~d~YkLt~------e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd  148 (463)
T KOG0607|consen   75 FEDMYKLTS------ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD  148 (463)
T ss_pred             HHHHHHhHH------HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence            566666663      468999999999887 568999999999988777889999999999999 599999999999999


Q ss_pred             CceEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCC---eEEe
Q 010309          294 GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG---AHLM  370 (513)
Q Consensus       294 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~---~kl~  370 (513)
                      ..+|||||.|.||+|..+|.+    .+.+++.++..+.++|+.||.|||.+   ||.||||||+|||......   +||+
T Consensus       149 ~~FYLVfEKm~GGplLshI~~----~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiC  221 (463)
T KOG0607|consen  149 TRFYLVFEKMRGGPLLSHIQK----RKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKIC  221 (463)
T ss_pred             ceEEEEEecccCchHHHHHHH----hhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeee
Confidence            999999999999999999864    46799999999999999999999999   9999999999999976544   7999


Q ss_pred             cccccccCCcc-----ccccceeecCcccccccccccc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccc--c
Q 010309          371 GVGLSKFVPWE-----VMQERTVMAGGTYGYLAPEFVY-----RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVC--W  438 (513)
Q Consensus       371 Dfg~~~~~~~~-----~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~--~  438 (513)
                      ||.+..-....     ........++|+..|||||+..     ...|+.++|.||||||||-|++|.+||.+.-..+  |
T Consensus       222 DfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGW  301 (463)
T KOG0607|consen  222 DFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGW  301 (463)
T ss_pred             ccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCc
Confidence            99987644221     1222334456889999999864     2357899999999999999999999998764321  1


Q ss_pred             c---hhHHhhh---HHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          439 Q---SIFEWAT---PLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       439 ~---~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      .   .-.....   .-++++.+ ++         ++.....++.+..++|..+|..||..|.++.++++
T Consensus       302 drGe~Cr~CQ~~LFesIQEGkY-eF---------PdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  302 DRGEVCRVCQNKLFESIQEGKY-EF---------PDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             cCCCccHHHHHHHHHHHhccCC-cC---------ChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            0   0000000   01111111 00         22234568899999999999999999999999886

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-38  Score=310.04  Aligned_cols=254  Identities=22%  Similarity=0.387  Sum_probs=201.4

Q ss_pred             CceecccCceEEEEEEeCC-CC----EEEEEEecccch-hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeec
Q 010309          230 NRLLGDSKTGGTYSGILPD-GS----RVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  303 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~~-~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  303 (513)
                      .+.||+|+||.||+|...+ |.    .||+|.+..... .....+.+|+.++++++||||+++++++.. ...++||||+
T Consensus        12 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~   90 (279)
T cd05057          12 IKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLM   90 (279)
T ss_pred             cceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecC
Confidence            4578999999999998643 33    699998876543 345678899999999999999999999887 7889999999


Q ss_pred             cCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccc
Q 010309          304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM  383 (513)
Q Consensus       304 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~  383 (513)
                      ++|+|.+++..   ....+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||+++.......
T Consensus        91 ~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~  164 (279)
T cd05057          91 PLGCLLDYVRN---HKDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEK  164 (279)
T ss_pred             CCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccccCccc
Confidence            99999999864   234589999999999999999999998   999999999999999999999999999987653322


Q ss_pred             ccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccccccc
Q 010309          384 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI  462 (513)
Q Consensus       384 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  462 (513)
                      ........++..|+|||.+....++.++||||||+++||+++ |+.||..........       ......         
T Consensus       165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~-------~~~~~~---------  228 (279)
T cd05057         165 EYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPD-------LLEKGE---------  228 (279)
T ss_pred             ceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHH-------HHhCCC---------
Confidence            111111114568999999988889999999999999999999 999997654321111       111000         


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcCCC
Q 010309          463 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP  510 (513)
Q Consensus       463 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  510 (513)
                          ....+...+..+.+++.+||..||++||++.++++.|+++...|
T Consensus       229 ----~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05057         229 ----RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDP  272 (279)
T ss_pred             ----CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCC
Confidence                00011123456889999999999999999999999999876554

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.3e-38  Score=307.27  Aligned_cols=246  Identities=21%  Similarity=0.304  Sum_probs=195.2

Q ss_pred             ceecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCCHH
Q 010309          231 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD  309 (513)
Q Consensus       231 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~  309 (513)
                      +.||+|+||.||+|... +++.||+|.++.........+.+|+.+++.++||||+++++.+...+..++||||+++++|.
T Consensus        15 ~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~   94 (267)
T cd06645          15 QRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQ   94 (267)
T ss_pred             HHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHH
Confidence            45799999999999864 58899999997665445567889999999999999999999999999999999999999999


Q ss_pred             HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccceee
Q 010309          310 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM  389 (513)
Q Consensus       310 ~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  389 (513)
                      +++..    ...+++.+++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.........  ...
T Consensus        95 ~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~--~~~  165 (267)
T cd06645          95 DIYHV----TGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAK--RKS  165 (267)
T ss_pred             HHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcccc--ccc
Confidence            99854    34689999999999999999999999   9999999999999999999999999998765432111  112


Q ss_pred             cCcccccccccccc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCC
Q 010309          390 AGGTYGYLAPEFVY---RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  466 (513)
Q Consensus       390 ~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  466 (513)
                      ..|+..|+|||++.   ...++.++|||||||++|+|++|..||.......  ....     ....   ....+...   
T Consensus       166 ~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~--~~~~-----~~~~---~~~~~~~~---  232 (267)
T cd06645         166 FIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR--ALFL-----MTKS---NFQPPKLK---  232 (267)
T ss_pred             ccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh--hHHh-----hhcc---CCCCCccc---
Confidence            23889999999874   4567889999999999999999999986543211  0000     0000   00001000   


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          467 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       467 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                         .....+..+.+++.+||+.+|++||++++|++
T Consensus       233 ---~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         233 ---DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             ---ccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence               01123456899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.8e-38  Score=315.60  Aligned_cols=264  Identities=18%  Similarity=0.250  Sum_probs=193.4

Q ss_pred             ceeccc--CceEEEEEEe-CCCCEEEEEEecccc--hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccC
Q 010309          231 RLLGDS--KTGGTYSGIL-PDGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  305 (513)
Q Consensus       231 ~~lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  305 (513)
                      .+||+|  +|++||++.. .+|+.||||++....  ......+.+|+.+++.++||||+++++++..++..++||||+++
T Consensus         4 ~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~   83 (327)
T cd08227           4 TVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAY   83 (327)
T ss_pred             hhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCC
Confidence            467999  7899999986 468999999997642  22345678899999999999999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccc-
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ-  384 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~-  384 (513)
                      |+|.+++....  ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.++++||+........... 
T Consensus        84 ~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          84 GSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             CcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence            99999986422  24589999999999999999999999   9999999999999999999999999865433211100 


Q ss_pred             ----cceeecCccccccccccccc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhh----c---
Q 010309          385 ----ERTVMAGGTYGYLAPEFVYR--NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQ----S---  451 (513)
Q Consensus       385 ----~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~----~---  451 (513)
                          .......++..|+|||++.+  ..++.++|||||||++|||++|+.||........  ..........    .   
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~  236 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGTVPCLLDTTTI  236 (327)
T ss_pred             cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--HHHHhcCCccccccccch
Confidence                00111226778999999976  4588999999999999999999999975432210  0000000000    0   


Q ss_pred             --cc-------------ccc--c---ccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          452 --HR-------------YLE--L---LDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       452 --~~-------------~~~--~---~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                        ..             ..+  .   ..+..............++.+.+|+.+||+.||++|||+++|++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence              00             000  0   00000000001112245678999999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2.7e-38  Score=302.86  Aligned_cols=244  Identities=24%  Similarity=0.381  Sum_probs=199.2

Q ss_pred             CceecccCceEEEEEEeCC-CCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCCH
Q 010309          230 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  308 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL  308 (513)
                      .+.||+|++|.||+|...+ ++.||+|.+.....  .+++.+|++++++++||||+++++.+.+....++++||+++++|
T Consensus         8 ~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L   85 (256)
T cd06612           8 LEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSV   85 (256)
T ss_pred             hhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcH
Confidence            4457999999999999765 88999999976532  67899999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccccee
Q 010309          309 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  388 (513)
Q Consensus       309 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  388 (513)
                      .+++..   ....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.........  ..
T Consensus        86 ~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~--~~  157 (256)
T cd06612          86 SDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK--RN  157 (256)
T ss_pred             HHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCccc--cc
Confidence            999863   235689999999999999999999999   9999999999999999999999999999876543211  11


Q ss_pred             ecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCCC
Q 010309          389 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD  468 (513)
Q Consensus       389 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  468 (513)
                      ...++..|+|||++.+..++.++||||||+++|+|++|+.||........  ...     ..     ....+      ..
T Consensus       158 ~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~--~~~-----~~-----~~~~~------~~  219 (256)
T cd06612         158 TVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA--IFM-----IP-----NKPPP------TL  219 (256)
T ss_pred             cccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh--hhh-----hc-----cCCCC------CC
Confidence            22278899999999888899999999999999999999999976433210  000     00     00000      01


Q ss_pred             CCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          469 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       469 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      ..+...+..+.+++.+||+.||++|||+.+|++
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         220 SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            112235567999999999999999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=3.1e-38  Score=308.77  Aligned_cols=246  Identities=23%  Similarity=0.348  Sum_probs=196.5

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCCH
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  308 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL  308 (513)
                      .+.||+|+||.||+|... ++..||+|.+........+.+.+|+.+++.++||||+++++.+..++..++||||+++++|
T Consensus        17 ~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l   96 (292)
T cd06644          17 IGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAV   96 (292)
T ss_pred             hheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcH
Confidence            445799999999999975 4899999999877666677889999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccccee
Q 010309          309 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  388 (513)
Q Consensus       309 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  388 (513)
                      ..++..   ....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++..........  .
T Consensus        97 ~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~--~  168 (292)
T cd06644          97 DAIMLE---LDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRR--D  168 (292)
T ss_pred             HHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccccccc--c
Confidence            888753   234689999999999999999999999   99999999999999999999999999987543221111  1


Q ss_pred             ecCcccccccccccc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccccccccccc
Q 010309          389 MAGGTYGYLAPEFVY-----RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS  463 (513)
Q Consensus       389 ~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  463 (513)
                      ...+++.|+|||++.     ...++.++||||||+++|||++|..||...+...      ........      ..+   
T Consensus       169 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~------~~~---  233 (292)
T cd06644         169 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR------VLLKIAKS------EPP---  233 (292)
T ss_pred             eecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH------HHHHHhcC------CCc---
Confidence            223788999999985     3446789999999999999999999987543210      00000000      000   


Q ss_pred             CCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          464 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       464 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                         ....+...+.++.+++.+||+.||++||+++++++
T Consensus       234 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         234 ---TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             ---cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence               00112234567899999999999999999999986

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.9e-38  Score=306.34  Aligned_cols=245  Identities=22%  Similarity=0.312  Sum_probs=194.5

Q ss_pred             ceecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCCHH
Q 010309          231 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD  309 (513)
Q Consensus       231 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~  309 (513)
                      .+||+|+||.||+|... ++..||+|.+........+.+.+|+.+++.++|+||+++++++..++..++|+||+++++|.
T Consensus        14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~   93 (268)
T cd06624          14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLS   93 (268)
T ss_pred             EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHH
Confidence            46799999999999964 57889999998776666778999999999999999999999999999999999999999999


Q ss_pred             HHhccCCCCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecC-CCCeEEecccccccCCccccccc
Q 010309          310 RWLHHIPRGGRSL--DWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE-EFGAHLMGVGLSKFVPWEVMQER  386 (513)
Q Consensus       310 ~~l~~~~~~~~~l--~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~-~~~~kl~Dfg~~~~~~~~~~~~~  386 (513)
                      +++...   ...+  ++..+..++.|++.||+|||+.   +|+||||||+||+++. ++.++|+|||.+.........  
T Consensus        94 ~~l~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~--  165 (268)
T cd06624          94 ALLRSK---WGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC--  165 (268)
T ss_pred             HHHHHh---cccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCc--
Confidence            998642   1234  7888999999999999999999   9999999999999976 678999999998765432211  


Q ss_pred             eeecCcccccccccccccCC--CCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccC
Q 010309          387 TVMAGGTYGYLAPEFVYRNE--LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS  464 (513)
Q Consensus       387 ~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  464 (513)
                      .....+++.|+|||++....  ++.++||||||+++|+|++|..||........   ..+....          ....  
T Consensus       166 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~~~~~----------~~~~--  230 (268)
T cd06624         166 TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMFKVGM----------FKIH--  230 (268)
T ss_pred             cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHhhhhh----------hccC--
Confidence            11123788999999986643  78899999999999999999999865432110   0000000          0000  


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          465 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       465 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                        .. .+...++++.+++.+||+.+|++|||+.++++
T Consensus       231 --~~-~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         231 --PE-IPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             --CC-CCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence              11 12235567999999999999999999999985

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=2e-38  Score=307.25  Aligned_cols=253  Identities=26%  Similarity=0.383  Sum_probs=198.4

Q ss_pred             CceecccCceEEEEEEeC------CCCEEEEEEecccchh-cHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEee
Q 010309          230 NRLLGDSKTGGTYSGILP------DGSRVAVKRLKRSSFQ-RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF  302 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  302 (513)
                      .+.||+|+||.||+|+.+      +.+.|++|.+...... ..+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus        10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   89 (275)
T cd05046          10 ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEY   89 (275)
T ss_pred             eeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEe
Confidence            346799999999999964      2467999998765433 356799999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhccCCCC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEeccccccc
Q 010309          303 VVNGPLDRWLHHIPRG-----GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF  377 (513)
Q Consensus       303 ~~~gsL~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~  377 (513)
                      +++++|.+++......     ...+++..+..++.|++.||+|||+.   +|+|+||||+||+++.++.++|+|||++..
T Consensus        90 ~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~~~~~~  166 (275)
T cd05046          90 TDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKD  166 (275)
T ss_pred             cCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEcccccccc
Confidence            9999999999753311     12689999999999999999999999   999999999999999999999999999875


Q ss_pred             CCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccc
Q 010309          378 VPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLE  456 (513)
Q Consensus       378 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  456 (513)
                      ........ .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.......   ....    ....... 
T Consensus       167 ~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~~~~----~~~~~~~-  237 (275)
T cd05046         167 VYNSEYYK-LRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---VLNR----LQAGKLE-  237 (275)
T ss_pred             cCcccccc-cCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---HHHH----HHcCCcC-
Confidence            43222111 111125678999999988888999999999999999999 888886543221   1110    0000000 


Q ss_pred             cccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 010309          457 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ  505 (513)
Q Consensus       457 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  505 (513)
                                 .......+..+.+++.+||+.+|++|||+.++++.|.+
T Consensus       238 -----------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~  275 (275)
T cd05046         238 -----------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE  275 (275)
T ss_pred             -----------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence                       00011244579999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.4e-38  Score=317.31  Aligned_cols=257  Identities=26%  Similarity=0.399  Sum_probs=201.3

Q ss_pred             cCCceecccCceEEEEEEeC--------CCCEEEEEEecccc-hhcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCCceE
Q 010309          228 EGNRLLGDSKTGGTYSGILP--------DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRY  297 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~  297 (513)
                      ...+.||+|+||.||++...        .+..||+|.++... ....+.+.+|+.+++++ +||||+++++++...+..+
T Consensus        15 ~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~   94 (334)
T cd05100          15 TLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLY   94 (334)
T ss_pred             eecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceE
Confidence            44567899999999999742        12369999887542 23456789999999999 8999999999999999999


Q ss_pred             EEEeeccCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCC
Q 010309          298 IVYEFVVNGPLDRWLHHIPR------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF  365 (513)
Q Consensus       298 lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~  365 (513)
                      ++|||+++|+|.+++.....            ....+++..++.++.|++.||+|||+.   +++||||||+|||++.++
T Consensus        95 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill~~~~  171 (334)
T cd05100          95 VLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDN  171 (334)
T ss_pred             EEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCC
Confidence            99999999999999865321            224588899999999999999999999   999999999999999999


Q ss_pred             CeEEecccccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHh
Q 010309          366 GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEW  444 (513)
Q Consensus       366 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~  444 (513)
                      .+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||...+....   .  
T Consensus       172 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~--  246 (334)
T cd05100         172 VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL---F--  246 (334)
T ss_pred             cEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH---H--
Confidence            999999999986543221111111224567999999998899999999999999999998 8888876443211   1  


Q ss_pred             hhHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCc
Q 010309          445 ATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  507 (513)
Q Consensus       445 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  507 (513)
                       .. ......            .. .+...+.++.+++.+||+.+|++|||+.++++.|+++.
T Consensus       247 -~~-~~~~~~------------~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~  294 (334)
T cd05100         247 -KL-LKEGHR------------MD-KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL  294 (334)
T ss_pred             -HH-HHcCCC------------CC-CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence             11 110000            00 11123457999999999999999999999999998776

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-39  Score=323.50  Aligned_cols=240  Identities=23%  Similarity=0.284  Sum_probs=187.1

Q ss_pred             ecccCceEEEEEEeC-CCCEEEEEEecccchh---cHHHHHHHHHHHhhc---CCCcEeeeeeEEeeCCceEEEEeeccC
Q 010309          233 LGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQ---RKKEFYSEIGRFARL---HHPNLVAVKGCCYDHGDRYIVYEFVVN  305 (513)
Q Consensus       233 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~~~~~~lv~e~~~~  305 (513)
                      ||+|+||.||+|... +++.||||++.+....   ....+..|..++..+   +||||+++++++.+.+..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999975 5899999999754222   223455666676655   699999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccc
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  385 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  385 (513)
                      |+|..++..    ...+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.++|+|||++......... 
T Consensus        81 g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~-  152 (330)
T cd05586          81 GELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT-  152 (330)
T ss_pred             ChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCC-
Confidence            999988854    35689999999999999999999999   9999999999999999999999999998754322211 


Q ss_pred             ceeecCcccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccC
Q 010309          386 RTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS  464 (513)
Q Consensus       386 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  464 (513)
                       .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+...   ..   .. .....           
T Consensus       153 -~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~---~~---~~-i~~~~-----------  213 (330)
T cd05586         153 -TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ---MY---RN-IAFGK-----------  213 (330)
T ss_pred             -ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH---HH---HH-HHcCC-----------
Confidence             1223489999999998764 47899999999999999999999997644321   11   00 00000           


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCC----CHHHHHH
Q 010309          465 LSSDIPEAGVVQKVVDLVYACTQHVPSMRP----RMSHVVH  501 (513)
Q Consensus       465 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP----s~~evl~  501 (513)
                        ...+....++++.+++.+||+.||.+||    ++.++++
T Consensus       214 --~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         214 --VRFPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             --CCCCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence              0111122456789999999999999998    4566554

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.7e-38  Score=341.46  Aligned_cols=256  Identities=20%  Similarity=0.316  Sum_probs=196.3

Q ss_pred             CCceecccCceEEEEEEeC-CCCEEEEEEecccc--hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeC--CceEEEEeec
Q 010309          229 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDRYIVYEFV  303 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lv~e~~  303 (513)
                      ..+.||+|+||.||++... .+..||+|.+....  ......+..|+.+|++|+||||+++++++...  ..+||||||+
T Consensus        17 Il~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~   96 (1021)
T PTZ00266         17 VIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFC   96 (1021)
T ss_pred             EEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCC
Confidence            3456799999999999975 47789999987542  23356789999999999999999999988654  4689999999


Q ss_pred             cCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC----CCceEcCCCCCceEecCC---------------
Q 010309          304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVK----PHVVHRDIRASNVLLDEE---------------  364 (513)
Q Consensus       304 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~----~~ivH~Dikp~NIll~~~---------------  364 (513)
                      ++++|.++|.........+++..++.|+.||+.||+|||+...    .+||||||||+||||+.+               
T Consensus        97 ~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~n  176 (1021)
T PTZ00266         97 DAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLN  176 (1021)
T ss_pred             CCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccC
Confidence            9999999997543334579999999999999999999998510    259999999999999642               


Q ss_pred             --CCeEEecccccccCCccccccceeecCccccccccccccc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccch
Q 010309          365 --FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR--NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS  440 (513)
Q Consensus       365 --~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~  440 (513)
                        ..+||+|||++.........   ....||+.|+|||++.+  ..++.++||||||||||||+||..||...+..  ..
T Consensus       177 g~~iVKLsDFGlAr~l~~~s~~---~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~--~q  251 (1021)
T PTZ00266        177 GRPIAKIGDFGLSKNIGIESMA---HSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNF--SQ  251 (1021)
T ss_pred             CCCceEEccCCccccccccccc---cccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcH--HH
Confidence              34899999999866433221   12238999999999864  45789999999999999999999999754321  11


Q ss_pred             hHHhhhHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHH--HHHhcCc
Q 010309          441 IFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVV--HQLQQLA  507 (513)
Q Consensus       441 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl--~~L~~~~  507 (513)
                      +..    .....              ...+....+.++.+||..||+.+|.+||++.++|  ..+..+.
T Consensus       252 li~----~lk~~--------------p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~  302 (1021)
T PTZ00266        252 LIS----ELKRG--------------PDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG  302 (1021)
T ss_pred             HHH----HHhcC--------------CCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence            111    00000              0111122456799999999999999999999999  4555443

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.3e-38  Score=310.37  Aligned_cols=262  Identities=21%  Similarity=0.364  Sum_probs=200.0

Q ss_pred             HHHHHHHhhCcccCCceecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhc-CCCcEeeeeeEEe--
Q 010309          216 TEELRSITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCY--  291 (513)
Q Consensus       216 ~~~l~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~--  291 (513)
                      .+.+..+.++|... +.||+|+||.||++... +++.+|+|++.... .....+.+|+.+++.+ +||||+++++++.  
T Consensus        10 ~~~~~~~~~~~~~~-~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   87 (286)
T cd06638          10 FDSFPDPSDTWEII-ETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKK   87 (286)
T ss_pred             eecCCCcccceeee-eeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence            34455566666554 46799999999999864 58899999886532 2345688899999999 6999999999874  


Q ss_pred             ---eCCceEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeE
Q 010309          292 ---DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH  368 (513)
Q Consensus       292 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~k  368 (513)
                         .++..++||||+++++|.+++.........+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++
T Consensus        88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~k  164 (286)
T cd06638          88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVK  164 (286)
T ss_pred             ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEE
Confidence               34568999999999999998864333445689999999999999999999999   999999999999999999999


Q ss_pred             EecccccccCCccccccceeecCccccccccccccc-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHH
Q 010309          369 LMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR-----NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFE  443 (513)
Q Consensus       369 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~  443 (513)
                      |+|||++.........  .....|++.|+|||++..     ..++.++|||||||++|||++|+.||.......  .+..
T Consensus       165 l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~--~~~~  240 (286)
T cd06638         165 LVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR--ALFK  240 (286)
T ss_pred             EccCCceeecccCCCc--cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH--HHhh
Confidence            9999998765432211  112238899999998853     447889999999999999999999987643211  0000


Q ss_pred             hhhHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010309          444 WATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  502 (513)
Q Consensus       444 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  502 (513)
                          . .     ....+..      ..+...+..+.+++.+||+.||++|||+.||++.
T Consensus       241 ----~-~-----~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         241 ----I-P-----RNPPPTL------HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             ----c-c-----ccCCCcc------cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence                0 0     0000000      0011234569999999999999999999999874

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=8.7e-39  Score=306.87  Aligned_cols=250  Identities=29%  Similarity=0.427  Sum_probs=196.4

Q ss_pred             CCceecccCceEEEEEEeCC-CCEEEEEEecccchhcHH--HHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccC
Q 010309          229 GNRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKK--EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  305 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  305 (513)
                      ..+.||+|+||+||++.... ++.||+|++.........  ...+|+.++++++||||+++++++.+....++|||++++
T Consensus         3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~   82 (260)
T PF00069_consen    3 LVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPG   82 (260)
T ss_dssp             EEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETT
T ss_pred             EeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccccc
Confidence            34678999999999999765 568999999877543332  345699999999999999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccc
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  385 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  385 (513)
                      ++|.+++..    ...+++..+..++.|++.||.+||+.   +++|+||||+||+++.++.++|+|||.+.......  .
T Consensus        83 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~--~  153 (260)
T PF00069_consen   83 GSLQDYLQK----NKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSENN--E  153 (260)
T ss_dssp             EBHHHHHHH----HSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTSTT--S
T ss_pred             ccccccccc----cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc--c
Confidence            999999972    35689999999999999999999999   99999999999999999999999999997641111  1


Q ss_pred             ceeecCcccccccccccc-cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccC
Q 010309          386 RTVMAGGTYGYLAPEFVY-RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS  464 (513)
Q Consensus       386 ~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  464 (513)
                      ......++..|+|||++. +...+.++||||||+++|+|++|..||..................       ......   
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~-------~~~~~~---  223 (260)
T PF00069_consen  154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKR-------PLPSSS---  223 (260)
T ss_dssp             EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHT-------HHHHHT---
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccc-------cccccc---
Confidence            122233889999999998 788899999999999999999999999865211111111100000       000000   


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          465 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       465 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                        .  ........+.+++.+||+.||++||++.++++
T Consensus       224 --~--~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  224 --Q--QSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             --T--SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             --c--ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              0  00011267999999999999999999999985

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-38  Score=302.90  Aligned_cols=249  Identities=22%  Similarity=0.325  Sum_probs=200.9

Q ss_pred             CCceecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCC
Q 010309          229 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  307 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs  307 (513)
                      ..+.||+|++|.||++... +++.+|+|.+........+.+.+|+.++++++||||+++++++.+.+..+++|||+++++
T Consensus         7 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~   86 (262)
T cd06613           7 LIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGS   86 (262)
T ss_pred             EEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCc
Confidence            3456799999999999974 578999999987655566889999999999999999999999999999999999999999


Q ss_pred             HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccce
Q 010309          308 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  387 (513)
Q Consensus       308 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  387 (513)
                      |.+++...   ...+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++.........  .
T Consensus        87 l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~--~  158 (262)
T cd06613          87 LQDIYQVT---RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK--R  158 (262)
T ss_pred             HHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhhhc--c
Confidence            99988642   25689999999999999999999999   9999999999999999999999999998865432211  1


Q ss_pred             eecCcccccccccccccC---CCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccC
Q 010309          388 VMAGGTYGYLAPEFVYRN---ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS  464 (513)
Q Consensus       388 ~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  464 (513)
                      ....++..|+|||.+.+.   .++.++||||||+++|||+||+.||...+...  ....     ....   .....    
T Consensus       159 ~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~--~~~~-----~~~~---~~~~~----  224 (262)
T cd06613         159 KSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR--ALFL-----ISKS---NFPPP----  224 (262)
T ss_pred             ccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHH-----HHhc---cCCCc----
Confidence            122378889999998776   78899999999999999999999997654321  0000     0000   00000    


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          465 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       465 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                        ........+.++.+++.+||+.+|.+|||+++|+.
T Consensus       225 --~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         225 --KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             --cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence              01112345678999999999999999999999974

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.8e-38  Score=311.96  Aligned_cols=264  Identities=17%  Similarity=0.220  Sum_probs=194.9

Q ss_pred             CCceecccCceEEEEEEeC-CCCEEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          229 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      ..+.||+|+||.||+|... +++.||+|.++... ......+.+|+.+++.++||||+++++++...+..++||||++ +
T Consensus        10 ~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~   88 (301)
T cd07873          10 KLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-K   88 (301)
T ss_pred             EeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-c
Confidence            3456799999999999875 58899999987543 2234567889999999999999999999999999999999996 5


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  386 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  386 (513)
                      +|.+++..   ....+++..+..++.|++.||+|||+.   +++|+||||+|||++.++.++|+|||++.......... 
T Consensus        89 ~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~-  161 (301)
T cd07873          89 DLKQYLDD---CGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY-  161 (301)
T ss_pred             CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcc-
Confidence            89888864   234688999999999999999999999   99999999999999999999999999997643322111 


Q ss_pred             eeecCcccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccccccc------
Q 010309          387 TVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD------  459 (513)
Q Consensus       387 ~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------  459 (513)
                       ....+++.|+|||++.+. .++.++||||||+++|||+||++||...+.......................+.      
T Consensus       162 -~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (301)
T cd07873         162 -SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKS  240 (301)
T ss_pred             -cccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccc
Confidence             112268899999988654 578899999999999999999999976543211111000000000000000000      


Q ss_pred             ccccCCCCC---CCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          460 PLISSLSSD---IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       460 ~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      .........   ......++.+.+||.+||+.||.+|||++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         241 YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            000000000   001124567899999999999999999999997

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=6e-39  Score=323.83  Aligned_cols=252  Identities=19%  Similarity=0.225  Sum_probs=194.6

Q ss_pred             hCcccCCceecccCceEEEEEEeC-CCCEEEEEEecccc---hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEE
Q 010309          224 KNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIV  299 (513)
Q Consensus       224 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv  299 (513)
                      ++|.. .+.||+|+||.||++... +++.||+|++.+..   ......+.+|..+++.++||||+++++.+.+++..++|
T Consensus        43 ~~y~i-~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv  121 (371)
T cd05622          43 EDYEV-VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV  121 (371)
T ss_pred             hhcEE-EEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            44444 457799999999999975 58899999986532   22345678899999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCC
Q 010309          300 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP  379 (513)
Q Consensus       300 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~  379 (513)
                      |||+++|+|.+++..     ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++....
T Consensus       122 ~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~  193 (371)
T cd05622         122 MEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN  193 (371)
T ss_pred             EcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeEcC
Confidence            999999999999864     3488899999999999999999999   99999999999999999999999999998764


Q ss_pred             ccccccceeecCcccccccccccccC----CCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccc
Q 010309          380 WEVMQERTVMAGGTYGYLAPEFVYRN----ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL  455 (513)
Q Consensus       380 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  455 (513)
                      ...... .....||+.|+|||++.+.    .++.++|||||||++|||++|..||...+...   .   .......... 
T Consensus       194 ~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~---~---~~~i~~~~~~-  265 (371)
T cd05622         194 KEGMVR-CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG---T---YSKIMNHKNS-  265 (371)
T ss_pred             cCCccc-ccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH---H---HHHHHcCCCc-
Confidence            332211 1123489999999998754    37889999999999999999999997654311   0   1111110000 


Q ss_pred             ccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHH
Q 010309          456 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSM--RPRMSHVVHQ  502 (513)
Q Consensus       456 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~  502 (513)
                            +    ........+..+.++|.+||..+|.+  ||+++++++.
T Consensus       266 ------~----~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         266 ------L----TFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             ------c----cCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence                  0    00111235667899999999844433  7899988873

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.6e-38  Score=307.73  Aligned_cols=267  Identities=24%  Similarity=0.372  Sum_probs=201.5

Q ss_pred             CceecccCceEEEEEEeC-----CCCEEEEEEecccchh-cHHHHHHHHHHHhhcCCCcEeeeeeEEee--CCceEEEEe
Q 010309          230 NRLLGDSKTGGTYSGILP-----DGSRVAVKRLKRSSFQ-RKKEFYSEIGRFARLHHPNLVAVKGCCYD--HGDRYIVYE  301 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lv~e  301 (513)
                      .+.||+|+||.||++...     ++..||||++...... ..+.+.+|+++++.++||||+++++++..  ....++|||
T Consensus         9 ~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   88 (284)
T cd05038           9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIME   88 (284)
T ss_pred             heeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEe
Confidence            356799999999999853     3689999999866443 46789999999999999999999999887  557899999


Q ss_pred             eccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcc
Q 010309          302 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE  381 (513)
Q Consensus       302 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~  381 (513)
                      |+++++|.+++...   ...+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||.+......
T Consensus        89 ~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  162 (284)
T cd05038          89 YLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPED  162 (284)
T ss_pred             cCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccccccccC
Confidence            99999999999642   23589999999999999999999999   9999999999999999999999999999876532


Q ss_pred             cccc-ceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccc
Q 010309          382 VMQE-RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP  460 (513)
Q Consensus       382 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  460 (513)
                      .... ......++..|+|||.+.+..++.++||||||+++|||+||..|+......... ...............+.+..
T Consensus       163 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  241 (284)
T cd05038         163 KDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR-MIGIAQGQMIVTRLLELLKE  241 (284)
T ss_pred             CcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc-ccccccccccHHHHHHHHHc
Confidence            2111 111112456799999998888999999999999999999999998653321100 00000000000000000000


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCc
Q 010309          461 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  507 (513)
Q Consensus       461 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  507 (513)
                      ..    ....+..++.++.+++.+||+.+|++|||+.||+++|+++.
T Consensus       242 ~~----~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~  284 (284)
T cd05038         242 GE----RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR  284 (284)
T ss_pred             CC----cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence            00    01111234467999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=5.2e-38  Score=304.81  Aligned_cols=243  Identities=20%  Similarity=0.342  Sum_probs=198.9

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCC
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  307 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs  307 (513)
                      .+.||.|+||.||+|... ++..||||.+.... ......+.+|+.++++++||||+++++++.+++..++||||+++++
T Consensus         9 ~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   88 (277)
T cd06640           9 LERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGS   88 (277)
T ss_pred             hhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCc
Confidence            345799999999999975 58899999987543 3445678899999999999999999999999999999999999999


Q ss_pred             HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccce
Q 010309          308 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  387 (513)
Q Consensus       308 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  387 (513)
                      |.+++..     ..+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++.........  .
T Consensus        89 L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~--~  158 (277)
T cd06640          89 ALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK--R  158 (277)
T ss_pred             HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCccc--c
Confidence            9999853     4588999999999999999999999   9999999999999999999999999999766433211  1


Q ss_pred             eecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCC
Q 010309          388 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS  467 (513)
Q Consensus       388 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  467 (513)
                      ....++..|+|||++.+..++.++|+||||+++|||+||..||...........       ..         .    ...
T Consensus       159 ~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~-------~~---------~----~~~  218 (277)
T cd06640         159 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFL-------IP---------K----NNP  218 (277)
T ss_pred             ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhh-------hh---------c----CCC
Confidence            122378889999999888899999999999999999999999876543210000       00         0    001


Q ss_pred             CCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010309          468 DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  502 (513)
Q Consensus       468 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  502 (513)
                      .......+..+.+++.+||+.+|++||+++++++.
T Consensus       219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         219 PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            11223467789999999999999999999999764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-38  Score=306.40  Aligned_cols=242  Identities=21%  Similarity=0.344  Sum_probs=198.0

Q ss_pred             ceecccCceEEEEEEeC-CCCEEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCCH
Q 010309          231 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  308 (513)
Q Consensus       231 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL  308 (513)
                      +.||.|++|.||+|... +++.||+|.+.... ......+.+|+.+++.++||||+++++++.++...++|+||+++++|
T Consensus         7 ~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   86 (274)
T cd06609           7 ECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSC   86 (274)
T ss_pred             hhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcH
Confidence            45799999999999975 58899999997653 33446788999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccccee
Q 010309          309 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  388 (513)
Q Consensus       309 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  388 (513)
                      .+++..     ..+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++..........  .
T Consensus        87 ~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~--~  156 (274)
T cd06609          87 LDLLKP-----GKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKR--N  156 (274)
T ss_pred             HHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccccccc--c
Confidence            999864     2689999999999999999999999   99999999999999999999999999998775432211  1


Q ss_pred             ecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCCC
Q 010309          389 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD  468 (513)
Q Consensus       389 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  468 (513)
                      ...+++.|+|||++.+..++.++||||||+++|+|+||..||...+....   .   . ....     ...       ..
T Consensus       157 ~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~---~---~-~~~~-----~~~-------~~  217 (274)
T cd06609         157 TFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV---L---F-LIPK-----NNP-------PS  217 (274)
T ss_pred             cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH---H---H-Hhhh-----cCC-------CC
Confidence            22378889999999988899999999999999999999999976442110   0   0 0000     000       11


Q ss_pred             CCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          469 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       469 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      .....++..+.+++.+||..+|++|||++++++
T Consensus       218 ~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         218 LEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             CcccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            111125567999999999999999999999976

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=6.8e-39  Score=320.92  Aligned_cols=199  Identities=24%  Similarity=0.301  Sum_probs=170.9

Q ss_pred             ccCCceecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhcC-C-----CcEeeeeeEEeeCCceEEE
Q 010309          227 SEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-H-----PNLVAVKGCCYDHGDRYIV  299 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~nIv~l~~~~~~~~~~~lv  299 (513)
                      ++..++||+|.||.|.++.+. +++.||||+++... .-..+...|+.+|..|+ |     -|+|+++++|...++.|||
T Consensus       188 Y~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV  266 (586)
T KOG0667|consen  188 YEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV  266 (586)
T ss_pred             EEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence            344678999999999999964 59999999998653 33456678999999996 4     4899999999999999999


Q ss_pred             EeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCC--CeEEeccccccc
Q 010309          300 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF--GAHLMGVGLSKF  377 (513)
Q Consensus       300 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~--~~kl~Dfg~~~~  377 (513)
                      +|.+ ..+|.++|+..  .-..++...++.|+.||+.||.+||+.   +|||+||||+||||....  .+||+|||.|..
T Consensus       267 fELL-~~NLYellK~n--~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~  340 (586)
T KOG0667|consen  267 FELL-STNLYELLKNN--KFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCF  340 (586)
T ss_pred             ehhh-hhhHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccccc
Confidence            9999 66999999863  345699999999999999999999999   999999999999996543  699999999997


Q ss_pred             CCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccc
Q 010309          378 VPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVC  437 (513)
Q Consensus       378 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~  437 (513)
                      ......     ...-+..|+|||++.+.+|+.+.||||||||+.||++|.+.|.+.++.+
T Consensus       341 ~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~D  395 (586)
T KOG0667|consen  341 ESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYD  395 (586)
T ss_pred             cCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHH
Confidence            754433     1226778999999999999999999999999999999999998876543

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4e-38  Score=323.33  Aligned_cols=260  Identities=20%  Similarity=0.176  Sum_probs=190.9

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCCH
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  308 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL  308 (513)
                      .+.||+|+||.||++... .++.||||....      ..+.+|+.+|++++||||+++++++...+..++|||++ .++|
T Consensus       174 ~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~-~~~L  246 (461)
T PHA03211        174 HRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY-RSDL  246 (461)
T ss_pred             EEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc-CCCH
Confidence            456899999999999975 478999996432      23568999999999999999999999999999999999 5788


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccccee
Q 010309          309 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  388 (513)
Q Consensus       309 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  388 (513)
                      .+++...   ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++............
T Consensus       247 ~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~  320 (461)
T PHA03211        247 YTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHY  320 (461)
T ss_pred             HHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccccccccc
Confidence            8888542   24699999999999999999999999   99999999999999999999999999998654332221122


Q ss_pred             ecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccc-----chhHHhhhHHhh-ccccccccc---
Q 010309          389 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW-----QSIFEWATPLVQ-SHRYLELLD---  459 (513)
Q Consensus       389 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~-----~~~~~~~~~~~~-~~~~~~~~~---  459 (513)
                      ...||+.|+|||++.+..++.++|||||||+||||++|..|+........     ..+......... ...+.....   
T Consensus       321 ~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l  400 (461)
T PHA03211        321 GIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRL  400 (461)
T ss_pred             ccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHH
Confidence            23489999999999999999999999999999999998876543321110     111111110000 000000000   


Q ss_pred             -----cc----ccCCCCCCC---cHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010309          460 -----PL----ISSLSSDIP---EAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  502 (513)
Q Consensus       460 -----~~----~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  502 (513)
                           ..    .........   ....+..+.+||.+||+.||.+|||+.|+|+.
T Consensus       401 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        401 VSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             HHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence                 00    000000000   01234578899999999999999999999863

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=5.5e-38  Score=310.73  Aligned_cols=199  Identities=19%  Similarity=0.326  Sum_probs=160.0

Q ss_pred             CceecccCceEEEEEEeC---CCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEee--CCceEEEEeecc
Q 010309          230 NRLLGDSKTGGTYSGILP---DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD--HGDRYIVYEFVV  304 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lv~e~~~  304 (513)
                      ...||+|+||.||+|...   ++..||+|.+....  ....+.+|+.++++++||||+++++++..  +...++||||+.
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            346799999999999964   35789999987543  23467889999999999999999999854  456799999985


Q ss_pred             CCCHHHHhccCC-----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEe----cCCCCeEEeccccc
Q 010309          305 NGPLDRWLHHIP-----RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL----DEEFGAHLMGVGLS  375 (513)
Q Consensus       305 ~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll----~~~~~~kl~Dfg~~  375 (513)
                       ++|.+++....     .....+++..+..++.||+.||.|||+.   +|+||||||+|||+    +.++.+||+|||++
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence             57877764221     1223588999999999999999999999   99999999999999    55678999999999


Q ss_pred             ccCCcccccc-ceeecCcccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 010309          376 KFVPWEVMQE-RTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVD  434 (513)
Q Consensus       376 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~  434 (513)
                      +......... ......+|+.|+|||++.+. .++.++|||||||++|||+||++||....
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~  220 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence            8764332111 11122378999999998764 57899999999999999999999997543

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=2.5e-38  Score=305.55  Aligned_cols=250  Identities=22%  Similarity=0.366  Sum_probs=198.4

Q ss_pred             CceecccCceEEEEEEeCC--CCEEEEEEecccc----------hhcHHHHHHHHHHHhh-cCCCcEeeeeeEEeeCCce
Q 010309          230 NRLLGDSKTGGTYSGILPD--GSRVAVKRLKRSS----------FQRKKEFYSEIGRFAR-LHHPNLVAVKGCCYDHGDR  296 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~-l~h~nIv~l~~~~~~~~~~  296 (513)
                      .+.||+|+||.||+|....  ++.+|+|.+....          .....++.+|+.++.+ ++||||+++++++.+.+..
T Consensus         5 ~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~   84 (269)
T cd08528           5 LEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRL   84 (269)
T ss_pred             hhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeE
Confidence            3467999999999999765  6889999886321          1223557788888875 6999999999999999999


Q ss_pred             EEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCceEcCCCCCceEecCCCCeEEeccccc
Q 010309          297 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD-KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLS  375 (513)
Q Consensus       297 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~  375 (513)
                      ++||||+++++|.+++.........+++..++.++.|++.||.|||+ .   +++|+||+|+||+++.++.++|+|||.+
T Consensus        85 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~  161 (269)
T cd08528          85 YIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITDFGLA  161 (269)
T ss_pred             EEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEecccce
Confidence            99999999999999886543445679999999999999999999996 5   8999999999999999999999999999


Q ss_pred             ccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccc
Q 010309          376 KFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL  455 (513)
Q Consensus       376 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  455 (513)
                      .......   ......++..|+|||.+.+..++.++||||||+++|+|++|+.||...+...      ....... ..  
T Consensus       162 ~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~------~~~~~~~-~~--  229 (269)
T cd08528         162 KQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS------LATKIVE-AV--  229 (269)
T ss_pred             eeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH------HHHHHhh-cc--
Confidence            8765432   1122337889999999998889999999999999999999999986543211      0111000 00  


Q ss_pred             ccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 010309          456 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ  504 (513)
Q Consensus       456 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  504 (513)
                            .    ........++.+.+++.+||+.||++||++.|+.++|+
T Consensus       230 ------~----~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         230 ------Y----EPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             ------C----CcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence                  0    00111124567999999999999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.5e-38  Score=308.57  Aligned_cols=241  Identities=22%  Similarity=0.364  Sum_probs=196.4

Q ss_pred             ceecccCceEEEEEEeC-CCCEEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCCH
Q 010309          231 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  308 (513)
Q Consensus       231 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL  308 (513)
                      +.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.++++++||||+++++.+...+..++||||+++++|
T Consensus        10 ~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   89 (277)
T cd06642          10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSA   89 (277)
T ss_pred             HHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcH
Confidence            35799999999999864 57899999987543 23446789999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccccee
Q 010309          309 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  388 (513)
Q Consensus       309 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  388 (513)
                      .+++..     ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++..........  .
T Consensus        90 ~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~--~  159 (277)
T cd06642          90 LDLLKP-----GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR--N  159 (277)
T ss_pred             HHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcchhh--h
Confidence            998853     4588999999999999999999999   99999999999999999999999999998665332211  1


Q ss_pred             ecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCCC
Q 010309          389 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD  468 (513)
Q Consensus       389 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  468 (513)
                      ...++..|+|||++.+..++.++||||||+++|||++|..|+..........       ...     ....+        
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~-------~~~-----~~~~~--------  219 (277)
T cd06642         160 TFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF-------LIP-----KNSPP--------  219 (277)
T ss_pred             cccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh-------hhh-----cCCCC--------
Confidence            1237889999999998889999999999999999999999987543321000       000     00000        


Q ss_pred             CCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          469 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       469 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      ......+..+.+++.+||+.+|++||++.++++
T Consensus       220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06642         220 TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK  252 (277)
T ss_pred             CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            111234567999999999999999999999997

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=2.6e-38  Score=308.03  Aligned_cols=261  Identities=22%  Similarity=0.334  Sum_probs=194.3

Q ss_pred             ceecccCceEEEEEEeC-CCCEEEEEEecccch--hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCC
Q 010309          231 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  307 (513)
Q Consensus       231 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs  307 (513)
                      +.||+|++|.||+|... ++..||||.++....  .....+.+|+.++++++||||+++++++.+++..++||||++ ++
T Consensus         6 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~   84 (285)
T cd07861           6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MD   84 (285)
T ss_pred             eEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CC
Confidence            46799999999999975 689999999865422  234678899999999999999999999999999999999996 68


Q ss_pred             HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccce
Q 010309          308 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  387 (513)
Q Consensus       308 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  387 (513)
                      |.+++..... ...+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++.........  .
T Consensus        85 l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~--~  158 (285)
T cd07861          85 LKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRV--Y  158 (285)
T ss_pred             HHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCccc--c
Confidence            9888865332 35689999999999999999999999   9999999999999999999999999998765432111  1


Q ss_pred             eecCcccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHH-------hhc----cccc
Q 010309          388 VMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPL-------VQS----HRYL  455 (513)
Q Consensus       388 ~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~-------~~~----~~~~  455 (513)
                      ....+++.|+|||++.+. .++.++||||||+++|+|+||++||.......  .........       +..    ....
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (285)
T cd07861         159 THEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID--QLFRIFRILGTPTEDVWPGVTSLPDYK  236 (285)
T ss_pred             cCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhcchhhHHHH
Confidence            112268899999988654 57889999999999999999999997654321  000000000       000    0000


Q ss_pred             ccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          456 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       456 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      .......... ........++++.++|.+||+.||++|||+.+|++
T Consensus       237 ~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         237 NTFPKWKKGS-LRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             hhccccCcch-hHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            0000000000 00001124567899999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=3.4e-38  Score=303.93  Aligned_cols=247  Identities=26%  Similarity=0.439  Sum_probs=196.9

Q ss_pred             CceecccCceEEEEEEeCCCCEEEEEEecccch------hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeec
Q 010309          230 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSF------QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  303 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  303 (513)
                      .+.||+|+||.||+|...+++.+|||.+.....      .....+.+|+.++++++|+||+++++++.+.+..++|+||+
T Consensus         5 ~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   84 (265)
T cd06631           5 GEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFV   84 (265)
T ss_pred             cceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecC
Confidence            456899999999999988899999999864321      12356889999999999999999999999999999999999


Q ss_pred             cCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccc
Q 010309          304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM  383 (513)
Q Consensus       304 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~  383 (513)
                      ++++|.+++..    ...+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++........
T Consensus        85 ~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  157 (265)
T cd06631          85 PGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL  157 (265)
T ss_pred             CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence            99999999964    24588999999999999999999999   999999999999999999999999999876532111


Q ss_pred             ----ccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccccccc
Q 010309          384 ----QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD  459 (513)
Q Consensus       384 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  459 (513)
                          ........++..|+|||++.+..++.++||||||+++|+|++|..||...+...  ...    .....   ... .
T Consensus       158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~--~~~----~~~~~---~~~-~  227 (265)
T cd06631         158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA--AMF----YIGAH---RGL-M  227 (265)
T ss_pred             cccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH--HHH----Hhhhc---cCC-C
Confidence                111112237889999999998889999999999999999999999997543211  000    00000   000 0


Q ss_pred             ccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          460 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       460 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      +        ..+...+.++.++|.+||+.+|++||++.++++
T Consensus       228 ~--------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         228 P--------RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             C--------CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            0        011234567899999999999999999999885

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=3.2e-38  Score=302.21  Aligned_cols=243  Identities=29%  Similarity=0.459  Sum_probs=195.6

Q ss_pred             CCceecccCceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCCH
Q 010309          229 GNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  308 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL  308 (513)
                      ..+.||+|+||.||++.. +++.||+|.++...  ..+.+.+|+.+++.++||||+++++++... ..++||||+++++|
T Consensus        10 ~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L   85 (254)
T cd05083          10 LGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNL   85 (254)
T ss_pred             eeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCH
Confidence            346789999999999985 78889999986542  346788999999999999999999998654 57999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccccee
Q 010309          309 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  388 (513)
Q Consensus       309 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  388 (513)
                      .+++...  ....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++........     
T Consensus        86 ~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~-----  155 (254)
T cd05083          86 VNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD-----  155 (254)
T ss_pred             HHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccCC-----
Confidence            9999752  234689999999999999999999999   999999999999999999999999999875432211     


Q ss_pred             ecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCC
Q 010309          389 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS  467 (513)
Q Consensus       389 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  467 (513)
                      ....+..|+|||.+.+..++.++|+||||+++|||++ |+.||...+.....   .    ......             .
T Consensus       156 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~---~----~~~~~~-------------~  215 (254)
T cd05083         156 NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVK---E----CVEKGY-------------R  215 (254)
T ss_pred             CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHH---H----HHhCCC-------------C
Confidence            1124567999999988889999999999999999998 99998765432111   0    111000             0


Q ss_pred             CCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 010309          468 DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ  505 (513)
Q Consensus       468 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  505 (513)
                      ..+....+..+.+++.+||+.+|++||++++|++.|++
T Consensus       216 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         216 MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            01112345678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=5.7e-39  Score=323.39  Aligned_cols=247  Identities=19%  Similarity=0.220  Sum_probs=192.9

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccc---hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccC
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  305 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  305 (513)
                      .+.||+|+||.||++... +++.||||+++...   ......+.+|+.++..++||||+++++.+.+.+..++||||+++
T Consensus         6 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~g   85 (360)
T cd05627           6 LKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPG   85 (360)
T ss_pred             EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCC
Confidence            457899999999999975 58999999997542   22345678899999999999999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccc-
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ-  384 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~-  384 (513)
                      |+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.++|+|||++......... 
T Consensus        86 g~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~  158 (360)
T cd05627          86 GDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE  158 (360)
T ss_pred             ccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence            999999864    35689999999999999999999999   9999999999999999999999999998754321100 


Q ss_pred             --------------------------------cceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 010309          385 --------------------------------ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQA  432 (513)
Q Consensus       385 --------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~  432 (513)
                                                      .......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~  238 (360)
T cd05627         159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS  238 (360)
T ss_pred             cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCC
Confidence                                            001123489999999999999999999999999999999999999976


Q ss_pred             CCccccchhHHhhhHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCC---HHHHHH
Q 010309          433 VDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPR---MSHVVH  501 (513)
Q Consensus       433 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~  501 (513)
                      .+....      ........       ..+    ...+....++++.+||.+++. ||.+|++   ++++++
T Consensus       239 ~~~~~~------~~~i~~~~-------~~~----~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~  292 (360)
T cd05627         239 ETPQET------YRKVMNWK-------ETL----VFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKS  292 (360)
T ss_pred             CCHHHH------HHHHHcCC-------Cce----ecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhc
Confidence            543211      00000000       000    000111245678899999774 9999985   555554

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.3e-38  Score=313.21  Aligned_cols=255  Identities=23%  Similarity=0.402  Sum_probs=198.3

Q ss_pred             CCceecccCceEEEEEEeC-CCC----EEEEEEecccch-hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEee
Q 010309          229 GNRLLGDSKTGGTYSGILP-DGS----RVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF  302 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  302 (513)
                      ..+.||+|+||.||+|... +|.    .||+|.+..... .....+.+|+.+++.++||||+++++++... ..++++||
T Consensus        11 ~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~   89 (303)
T cd05110          11 RVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQL   89 (303)
T ss_pred             eccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeehh
Confidence            3456899999999999863 343    579998875532 2234688999999999999999999998754 56799999


Q ss_pred             ccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccc
Q 010309          303 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV  382 (513)
Q Consensus       303 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~  382 (513)
                      +++|+|.+++...   ...+++..+..++.|++.||+|||+.   +|+|+||||+||+++.++.+||+|||+++......
T Consensus        90 ~~~g~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~  163 (303)
T cd05110          90 MPHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE  163 (303)
T ss_pred             cCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccccCcc
Confidence            9999999998642   24588999999999999999999999   99999999999999999999999999998765332


Q ss_pred             cccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhccccccccccc
Q 010309          383 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL  461 (513)
Q Consensus       383 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  461 (513)
                      .........++..|+|||.+.+..++.++||||||+++|||++ |..||.......   ...    .......       
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~---~~~----~~~~~~~-------  229 (303)
T cd05110         164 KEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE---IPD----LLEKGER-------  229 (303)
T ss_pred             cccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH----HHHCCCC-------
Confidence            2211112225678999999988889999999999999999997 899987643221   111    1111100       


Q ss_pred             ccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcCCC
Q 010309          462 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP  510 (513)
Q Consensus       462 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  510 (513)
                      .      ..+...+..+.+++.+||..+|++||+++++++.|+.+...+
T Consensus       230 ~------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~  272 (303)
T cd05110         230 L------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP  272 (303)
T ss_pred             C------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence            0      001123456899999999999999999999999998876543

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.2e-38  Score=313.96  Aligned_cols=188  Identities=19%  Similarity=0.325  Sum_probs=159.3

Q ss_pred             ccCCceecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccC
Q 010309          227 SEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  305 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  305 (513)
                      +...+.||+|+||.||+|... +++.||+|+....      ....|+.++++++||||+++++++...+..++|||++ .
T Consensus        68 y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~-~  140 (357)
T PHA03209         68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-S  140 (357)
T ss_pred             cEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc-C
Confidence            344567799999999999975 4778999976433      2356899999999999999999999999999999999 5


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccc
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  385 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  385 (513)
                      ++|.+++..   ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++......... 
T Consensus       141 ~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~-  213 (357)
T PHA03209        141 SDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAF-  213 (357)
T ss_pred             CcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccCccc-
Confidence            688888853   235689999999999999999999999   9999999999999999999999999999754322111 


Q ss_pred             ceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCC
Q 010309          386 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPA  430 (513)
Q Consensus       386 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~  430 (513)
                        ....||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus       214 --~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        214 --LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             --ccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence              1223899999999999999999999999999999999865554

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=4.7e-38  Score=303.26  Aligned_cols=245  Identities=24%  Similarity=0.447  Sum_probs=196.5

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccchh---------cHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEE
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQ---------RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIV  299 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv  299 (513)
                      ..+||+|++|.||+|... +++.||+|.+......         ..+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus         5 ~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (267)
T cd06628           5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIF   84 (267)
T ss_pred             cceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEE
Confidence            357899999999999864 5889999988654222         125678899999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCC
Q 010309          300 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP  379 (513)
Q Consensus       300 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~  379 (513)
                      |||+++++|.+++..    ...+++..+..++.|++.||+|||+.   +++||||+|+||++++++.++|+|||.++...
T Consensus        85 ~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~  157 (267)
T cd06628          85 LEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLE  157 (267)
T ss_pred             EEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence            999999999999964    24688999999999999999999999   99999999999999999999999999998765


Q ss_pred             cccccc----ceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccc
Q 010309          380 WEVMQE----RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL  455 (513)
Q Consensus       380 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  455 (513)
                      ......    ......++..|+|||.+.+..++.++||||||+++|+|++|..||...+..  ....    ...      
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~----~~~------  225 (267)
T cd06628         158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL--QAIF----KIG------  225 (267)
T ss_pred             cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH--HHHH----HHh------
Confidence            321111    111223788999999998888999999999999999999999999764321  0100    000      


Q ss_pred             ccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          456 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       456 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      ....+       . .+...+..+.++|.+||+.||.+||++.+|++
T Consensus       226 ~~~~~-------~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         226 ENASP-------E-IPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             ccCCC-------c-CCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence            00001       1 11234567999999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-38  Score=316.37  Aligned_cols=250  Identities=21%  Similarity=0.235  Sum_probs=192.2

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccc---hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccC
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  305 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  305 (513)
                      .+.||+|+||.||++... +++.||||++.+..   ....+.+.+|..++..++|+||+++++++.+.+..++||||+++
T Consensus         6 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g   85 (331)
T cd05597           6 LKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVG   85 (331)
T ss_pred             EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCC
Confidence            456899999999999965 58999999997532   22345688899999999999999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccc
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  385 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  385 (513)
                      |+|.+++..   ....+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++..........
T Consensus        86 ~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  159 (331)
T cd05597          86 GDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ  159 (331)
T ss_pred             CcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCcc
Confidence            999999964   234689999999999999999999999   99999999999999999999999999987654332211


Q ss_pred             ceeecCccccccccccccc-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccc
Q 010309          386 RTVMAGGTYGYLAPEFVYR-----NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP  460 (513)
Q Consensus       386 ~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  460 (513)
                      . ....||+.|+|||++..     ..++.++|||||||++|||++|+.||......      +.............    
T Consensus       160 ~-~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~------~~~~~i~~~~~~~~----  228 (331)
T cd05597         160 S-NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHKEHFQ----  228 (331)
T ss_pred             c-cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH------HHHHHHHcCCCccc----
Confidence            1 12238999999999863     45788999999999999999999999764321      11111111000000    


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhcCCCCC--CCCCHHHHHHH
Q 010309          461 LISSLSSDIPEAGVVQKVVDLVYACTQHVPS--MRPRMSHVVHQ  502 (513)
Q Consensus       461 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~--~RPs~~evl~~  502 (513)
                       +   ...  ....++.+.+++.+||..+++  .||+++++++.
T Consensus       229 -~---~~~--~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         229 -F---PPD--VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             -C---CCc--cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence             0   000  112456789999998865443  37899888864

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=3.1e-38  Score=318.56  Aligned_cols=265  Identities=20%  Similarity=0.277  Sum_probs=194.2

Q ss_pred             HhhCcccCCceecccCceEEEEEEeC-CCCEEEEEEecccc--hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeC-----
Q 010309          222 ITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH-----  293 (513)
Q Consensus       222 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----  293 (513)
                      +.++|.. .+.||+|+||.||++... .++.||||++....  ......+.+|+.+++.++||||+++++++...     
T Consensus        22 ~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~  100 (364)
T cd07875          22 VLKRYQN-LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE  100 (364)
T ss_pred             hhcceeE-EEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence            3445544 456799999999999964 58899999997542  23346788999999999999999999987643     


Q ss_pred             -CceEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecc
Q 010309          294 -GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV  372 (513)
Q Consensus       294 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df  372 (513)
                       ...|+||||+++ +|.+.+.      ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+||
T Consensus       101 ~~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df  170 (364)
T cd07875         101 FQDVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF  170 (364)
T ss_pred             cCeEEEEEeCCCC-CHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeC
Confidence             356999999964 7777764      3478899999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccch-hHHh-------
Q 010309          373 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS-IFEW-------  444 (513)
Q Consensus       373 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~-~~~~-------  444 (513)
                      |+++........   ....+|+.|+|||++.+..++.++|||||||++|||++|+.||...+...... ....       
T Consensus       171 G~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  247 (364)
T cd07875         171 GLARTAGTSFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPE  247 (364)
T ss_pred             CCccccCCCCcc---cCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence            999865433211   12238899999999999999999999999999999999999997654321110 0000       


Q ss_pred             ----hhH----Hhhc-ccc-----cccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          445 ----ATP----LVQS-HRY-----LELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       445 ----~~~----~~~~-~~~-----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                          ...    .... ...     ........... ...........+.+||.+||+.||.+|||+.++++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~  317 (364)
T cd07875         248 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPA-DSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  317 (364)
T ss_pred             HHHhhhHHHHHHHhhCCCcCCCChHhhCccccccc-cccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                000    0000 000     00000000000 00001113457899999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=3e-38  Score=317.60  Aligned_cols=267  Identities=20%  Similarity=0.273  Sum_probs=194.6

Q ss_pred             HhhCcccCCceecccCceEEEEEEeC-CCCEEEEEEecccc--hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeC-----
Q 010309          222 ITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH-----  293 (513)
Q Consensus       222 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----  293 (513)
                      +.++|.. .+.||+|+||.||++... .++.||||++....  ......+.+|+.+++.++||||+++++++...     
T Consensus        15 ~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          15 VLKRYQN-LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhceeE-EEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            4445544 456799999999999864 58899999997542  23346778899999999999999999988654     


Q ss_pred             -CceEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecc
Q 010309          294 -GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV  372 (513)
Q Consensus       294 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df  372 (513)
                       ...++||||+++ +|.+.+.      ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Df  163 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF  163 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeC
Confidence             346999999965 6766664      3488899999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccc-chhHHh-------
Q 010309          373 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW-QSIFEW-------  444 (513)
Q Consensus       373 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~-~~~~~~-------  444 (513)
                      |+++........   ....+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.... ......       
T Consensus       164 g~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  240 (355)
T cd07874         164 GLARTAGTSFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE  240 (355)
T ss_pred             cccccCCCcccc---CCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            999865433211   122388999999999988999999999999999999999999976542210 000000       


Q ss_pred             --------hhHHhhc-ccccccccccc--cCCC--CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010309          445 --------ATPLVQS-HRYLELLDPLI--SSLS--SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  502 (513)
Q Consensus       445 --------~~~~~~~-~~~~~~~~~~~--~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  502 (513)
                              ....... ........+..  ....  ........+.++.+||.+||+.||++|||+.|+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                    0000000 00000000000  0000  000111234578999999999999999999999973

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-38  Score=305.66  Aligned_cols=246  Identities=24%  Similarity=0.371  Sum_probs=197.6

Q ss_pred             ceecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCCHH
Q 010309          231 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD  309 (513)
Q Consensus       231 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~  309 (513)
                      +.||.|++|.||++... ++..||+|++........+.+.+|+.++++++||||+++++.+...+..++||||+++++|.
T Consensus        11 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   90 (280)
T cd06611          11 GELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALD   90 (280)
T ss_pred             HHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHH
Confidence            34699999999999974 58999999998766566678999999999999999999999999999999999999999999


Q ss_pred             HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccceee
Q 010309          310 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM  389 (513)
Q Consensus       310 ~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  389 (513)
                      +++...   ...+++..+..++.|++.||.|||+.   +|+|+||||+||+++.++.++|+|||++..........  ..
T Consensus        91 ~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~--~~  162 (280)
T cd06611          91 SIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR--DT  162 (280)
T ss_pred             HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccccccc--ce
Confidence            998642   34699999999999999999999999   99999999999999999999999999987654322211  12


Q ss_pred             cCcccccccccccc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccC
Q 010309          390 AGGTYGYLAPEFVY-----RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS  464 (513)
Q Consensus       390 ~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  464 (513)
                      ..+++.|+|||++.     ...++.++||||||+++|||++|+.||...+...  ..    ... ...     ..+.+  
T Consensus       163 ~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~--~~----~~~-~~~-----~~~~~--  228 (280)
T cd06611         163 FIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR--VL----LKI-LKS-----EPPTL--  228 (280)
T ss_pred             eecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH--HH----HHH-hcC-----CCCCc--
Confidence            23788999999875     3456789999999999999999999997654321  00    000 000     00000  


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010309          465 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  502 (513)
Q Consensus       465 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  502 (513)
                          ..+...+.++.+++.+||+.+|.+||++.++++.
T Consensus       229 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         229 ----DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             ----CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence                1112345678999999999999999999999863

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.8e-38  Score=310.32  Aligned_cols=243  Identities=23%  Similarity=0.371  Sum_probs=197.7

Q ss_pred             eecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCCHHH
Q 010309          232 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR  310 (513)
Q Consensus       232 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~  310 (513)
                      .||+|+||.||++... ++..||||.+........+.+.+|+.+++.++||||+++++.+...+..++||||+++++|.+
T Consensus        29 ~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~  108 (292)
T cd06658          29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTD  108 (292)
T ss_pred             cccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHH
Confidence            4799999999999864 588999999976655556778999999999999999999999999999999999999999999


Q ss_pred             HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccceeec
Q 010309          311 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA  390 (513)
Q Consensus       311 ~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  390 (513)
                      ++..     ..+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.++|+|||++..........  ...
T Consensus       109 ~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~--~~~  178 (292)
T cd06658         109 IVTH-----TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR--KSL  178 (292)
T ss_pred             HHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccC--cee
Confidence            8853     3588999999999999999999999   99999999999999999999999999987654322211  112


Q ss_pred             CcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCCCCC
Q 010309          391 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIP  470 (513)
Q Consensus       391 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  470 (513)
                      .++..|+|||.+.+..++.++||||||+++|||++|+.||...+...   .....         ...+.+..    .  .
T Consensus       179 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~---~~~~~---------~~~~~~~~----~--~  240 (292)
T cd06658         179 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ---AMRRI---------RDNLPPRV----K--D  240 (292)
T ss_pred             ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHH---------HhcCCCcc----c--c
Confidence            37889999999988889999999999999999999999997543311   00000         00111111    0  0


Q ss_pred             cHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010309          471 EAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  502 (513)
Q Consensus       471 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  502 (513)
                      ....+..+.+++.+||..||++|||++++++.
T Consensus       241 ~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         241 SHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            11245578899999999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-39  Score=318.28  Aligned_cols=238  Identities=24%  Similarity=0.391  Sum_probs=198.3

Q ss_pred             ecccCceEEEEEEe-CCCCEEEEEEecccc---hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCCH
Q 010309          233 LGDSKTGGTYSGIL-PDGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  308 (513)
Q Consensus       233 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL  308 (513)
                      ||.|+||.||-|+. .+.+.||||.+.-..   ...-.++.+|+..|++++|||++.+-|++..+...+|||||| -|+-
T Consensus        34 IGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC-lGSA  112 (948)
T KOG0577|consen   34 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC-LGSA  112 (948)
T ss_pred             hcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH-hccH
Confidence            59999999999996 468899999997543   334478999999999999999999999999999999999999 5677


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccccee
Q 010309          309 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  388 (513)
Q Consensus       309 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  388 (513)
                      .+++.-.   .+++.+..+..|..+.+.||+|||+.   +.||||||+.|||+++.|.|||+|||.+....+..      
T Consensus       113 sDlleVh---kKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn------  180 (948)
T KOG0577|consen  113 SDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN------  180 (948)
T ss_pred             HHHHHHH---hccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCchh------
Confidence            7777532   36799999999999999999999999   99999999999999999999999999998765432      


Q ss_pred             ecCcccccccccccc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCC
Q 010309          389 MAGGTYGYLAPEFVY---RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  465 (513)
Q Consensus       389 ~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  465 (513)
                      ...|||.|||||++.   .+.|+-++||||||++..||.-.++|+..++..      .......+.             .
T Consensus       181 sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM------SALYHIAQN-------------e  241 (948)
T KOG0577|consen  181 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQN-------------E  241 (948)
T ss_pred             cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH------HHHHHHHhc-------------C
Confidence            234999999999986   478999999999999999999999998776432      111111111             1


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010309          466 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  502 (513)
Q Consensus       466 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  502 (513)
                      ++.....+.+..+.+|+..||+.-|.+|||.++++.-
T Consensus       242 sPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  242 SPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             CCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence            1223345678889999999999999999999999864

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.6e-38  Score=307.11  Aligned_cols=250  Identities=23%  Similarity=0.346  Sum_probs=199.1

Q ss_pred             ceecccCceEEEEEEeC-CCCEEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCCH
Q 010309          231 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  308 (513)
Q Consensus       231 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL  308 (513)
                      +.||+|++|+||++... +|+.||+|++.... ....+.+.+|+++++.++||||+++++.+...+..++||||+++++|
T Consensus        11 ~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   90 (284)
T cd06620          11 SDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSL   90 (284)
T ss_pred             HHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCH
Confidence            46799999999999964 58899999886542 33457889999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccccee
Q 010309          309 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  388 (513)
Q Consensus       309 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  388 (513)
                      .+++..    ...+++..+..++.+++.||.|||+..  +++|+||||+||+++.++.++|+|||++........    .
T Consensus        91 ~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~----~  160 (284)
T cd06620          91 DRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA----D  160 (284)
T ss_pred             HHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhcc----C
Confidence            998854    346899999999999999999999732  899999999999999999999999999875432211    1


Q ss_pred             ecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccc-----chhHHhhhHHhhccccccccccccc
Q 010309          389 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW-----QSIFEWATPLVQSHRYLELLDPLIS  463 (513)
Q Consensus       389 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~  463 (513)
                      ...++..|+|||++.+..++.++|||||||++|+|+||..||........     ..+.+......             .
T Consensus       161 ~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------------~  227 (284)
T cd06620         161 TFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV-------------Q  227 (284)
T ss_pred             ccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHh-------------h
Confidence            22388999999999888899999999999999999999999986543210     11111111111             0


Q ss_pred             CCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 010309          464 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQL  503 (513)
Q Consensus       464 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  503 (513)
                      ......+....+..+.+|+.+||+.||++|||+.|+++..
T Consensus       228 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         228 EPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             ccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence            0011122223566799999999999999999999999753

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2.6e-38  Score=310.04  Aligned_cols=242  Identities=21%  Similarity=0.351  Sum_probs=197.3

Q ss_pred             eecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCCHHH
Q 010309          232 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR  310 (513)
Q Consensus       232 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~  310 (513)
                      .||+|+||.||++... +++.||+|.+........+.+.+|+.++..++||||+++++++..++..++||||+++++|..
T Consensus        28 ~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~  107 (297)
T cd06659          28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTD  107 (297)
T ss_pred             hcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHH
Confidence            4699999999999864 689999999976555556778899999999999999999999999999999999999999999


Q ss_pred             HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccceeec
Q 010309          311 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA  390 (513)
Q Consensus       311 ~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  390 (513)
                      ++..     ..+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++..........  ...
T Consensus       108 ~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~--~~~  177 (297)
T cd06659         108 IVSQ-----TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR--KSL  177 (297)
T ss_pred             HHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccccc--cce
Confidence            8753     4589999999999999999999999   99999999999999999999999999987554332211  123


Q ss_pred             CcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCCCCC
Q 010309          391 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIP  470 (513)
Q Consensus       391 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  470 (513)
                      .++..|+|||++.+..++.++||||||+++|||++|+.||...+....  +    .. ....     .....      ..
T Consensus       178 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~----~~-~~~~-----~~~~~------~~  239 (297)
T cd06659         178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA--M----KR-LRDS-----PPPKL------KN  239 (297)
T ss_pred             ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--H----HH-Hhcc-----CCCCc------cc
Confidence            388999999999888899999999999999999999999975443211  0    00 0000     00000      00


Q ss_pred             cHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          471 EAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       471 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      ....+..+.+++.+||+.+|++||+++++++
T Consensus       240 ~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~  270 (297)
T cd06659         240 AHKISPVLRDFLERMLTREPQERATAQELLD  270 (297)
T ss_pred             cCCCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence            1123456899999999999999999999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=6.8e-38  Score=303.17  Aligned_cols=254  Identities=26%  Similarity=0.406  Sum_probs=196.9

Q ss_pred             CceecccCceEEEEEEeC----CCCEEEEEEecccc--hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCC------ceE
Q 010309          230 NRLLGDSKTGGTYSGILP----DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG------DRY  297 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------~~~  297 (513)
                      .++||+|+||.||+|...    +++.||||++....  ....+++.+|+.+++.++||||+++++++....      ..+
T Consensus         4 ~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   83 (273)
T cd05074           4 GRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPM   83 (273)
T ss_pred             hhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceE
Confidence            456899999999999853    36889999997542  234567889999999999999999999886542      237


Q ss_pred             EEEeeccCCCHHHHhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEeccccc
Q 010309          298 IVYEFVVNGPLDRWLHHIP--RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLS  375 (513)
Q Consensus       298 lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~  375 (513)
                      +++||+.+|+|.+++....  .....+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++
T Consensus        84 ~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg~~  160 (273)
T cd05074          84 VILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLS  160 (273)
T ss_pred             EEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECccccc
Confidence            8999999999998875321  1223578999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccc
Q 010309          376 KFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRY  454 (513)
Q Consensus       376 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  454 (513)
                      +...............+++.|++||.+....++.++||||||+++|||++ |.+||...+...   ....    ......
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~---~~~~----~~~~~~  233 (273)
T cd05074         161 KKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE---IYNY----LIKGNR  233 (273)
T ss_pred             ccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH---HHHH----HHcCCc
Confidence            86643322111112225678999999988889999999999999999999 888887544321   1111    000000


Q ss_pred             cccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q 010309          455 LELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  506 (513)
Q Consensus       455 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  506 (513)
                             .      ......+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus       234 -------~------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         234 -------L------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             -------C------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                   0      00112345799999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=4.7e-38  Score=307.34  Aligned_cols=262  Identities=25%  Similarity=0.401  Sum_probs=201.0

Q ss_pred             CHHHHHHHhhCcccCCceecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhc-CCCcEeeeeeEEee
Q 010309          215 TTEELRSITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYD  292 (513)
Q Consensus       215 ~~~~l~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~  292 (513)
                      ..+++..++++|.... .||+|+||.||++... +++.+|+|++.... .....+.+|+.+++++ +||||+++++++..
T Consensus        13 ~~~~~~~~~~~y~~~~-~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          13 GLESLGDPTDTWEIIE-TIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hcccCCCCCCCeEEEE-EeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            3345555566665544 5699999999999974 68899999986542 2345678899999999 89999999999875


Q ss_pred             C-----CceEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCe
Q 010309          293 H-----GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA  367 (513)
Q Consensus       293 ~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~  367 (513)
                      .     +..++||||+++++|.+++.........+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~  167 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGV  167 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCE
Confidence            4     357999999999999998865433446789999999999999999999999   99999999999999999999


Q ss_pred             EEecccccccCCccccccceeecCcccccccccccccC-----CCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhH
Q 010309          368 HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN-----ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIF  442 (513)
Q Consensus       368 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~  442 (513)
                      ||+|||++..........  ....++..|+|||++...     .++.++|||||||++|||++|++||...+..  ..+.
T Consensus       168 kl~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~--~~~~  243 (291)
T cd06639         168 KLVDFGVSAQLTSTRLRR--NTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV--KTLF  243 (291)
T ss_pred             EEeecccchhcccccccc--cCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH--HHHH
Confidence            999999988654322211  112378899999988643     3678999999999999999999999765431  1111


Q ss_pred             HhhhHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          443 EWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       443 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      ..    .. ..     .+.+      ..+......+.++|.+||+.+|++||++.++++
T Consensus       244 ~~----~~-~~-----~~~~------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         244 KI----PR-NP-----PPTL------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             HH----hc-CC-----CCCC------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            00    00 00     0000      011223456999999999999999999999985

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.8e-39  Score=322.16  Aligned_cols=249  Identities=20%  Similarity=0.341  Sum_probs=197.8

Q ss_pred             hCcccCCceecccCceEEEEEEeC-CCCEEEEEEeccc----chhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCc--e
Q 010309          224 KNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS----SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD--R  296 (513)
Q Consensus       224 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~--~  296 (513)
                      ..|.....+||+|+|-+||+|.+. +|..||--.++..    +....+.|..|+.+|+.|+||||+++|.++.+...  .
T Consensus        39 gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~i  118 (632)
T KOG0584|consen   39 GRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTI  118 (632)
T ss_pred             CceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCcee
Confidence            445555668999999999999974 4777875555432    23445789999999999999999999999988765  7


Q ss_pred             EEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCC-CCeEEeccccc
Q 010309          297 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE-FGAHLMGVGLS  375 (513)
Q Consensus       297 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~-~~~kl~Dfg~~  375 (513)
                      .+|+|.+..|+|..|+++.    +.++...+..|++||++||.|||++ .|+|+|||||.+||||+.+ |.|||+|+|+|
T Consensus       119 n~iTEL~TSGtLr~Y~kk~----~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLA  193 (632)
T KOG0584|consen  119 NFITELFTSGTLREYRKKH----RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLA  193 (632)
T ss_pred             eeeeecccCCcHHHHHHHh----ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHH
Confidence            8899999999999999753    5688899999999999999999997 7889999999999999765 77999999999


Q ss_pred             ccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccc
Q 010309          376 KFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL  455 (513)
Q Consensus       376 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  455 (513)
                      ..........    ..|||.|||||++. ..|+...||||||+.++||+|+..||..-...  .+    +...+..+.. 
T Consensus       194 tl~r~s~aks----vIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~--AQ----IYKKV~SGiK-  261 (632)
T KOG0584|consen  194 TLLRKSHAKS----VIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNP--AQ----IYKKVTSGIK-  261 (632)
T ss_pred             HHhhccccce----eccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCH--HH----HHHHHHcCCC-
Confidence            9875443222    33999999999886 78999999999999999999999999754332  11    1111111111 


Q ss_pred             ccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          456 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       456 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                                 +.....--.+++++||.+||.. .++|||+.|+|+
T Consensus       262 -----------P~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  262 -----------PAALSKVKDPEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             -----------HHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence                       1111111245799999999999 999999999986

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.6e-38  Score=316.61  Aligned_cols=264  Identities=19%  Similarity=0.282  Sum_probs=192.4

Q ss_pred             HhhCcccCCceecccCceEEEEEEeC-CCCEEEEEEecccc--hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeC-----
Q 010309          222 ITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH-----  293 (513)
Q Consensus       222 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----  293 (513)
                      +.++|.. .+.||+|+||.||+|... +++.||||++....  ......+.+|+.++++++||||+++++++...     
T Consensus        13 ~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          13 VPERYQN-LTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhh-heecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            4444444 456799999999999864 68899999997542  22345678899999999999999999987643     


Q ss_pred             -CceEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecc
Q 010309          294 -GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV  372 (513)
Q Consensus       294 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df  372 (513)
                       ...++++|++ +++|.+++..     ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Df  162 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDF  162 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCC
Confidence             3468999988 7899888753     4599999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCccccccceeecCccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccc-hhHHhhh----
Q 010309          373 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ-SIFEWAT----  446 (513)
Q Consensus       373 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~-~~~~~~~----  446 (513)
                      |++.......     ....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..... .+.....    
T Consensus       163 g~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  237 (343)
T cd07878         163 GLARQADDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSP  237 (343)
T ss_pred             ccceecCCCc-----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            9998654321     11238899999999876 56889999999999999999999999764422100 0000000    


Q ss_pred             ---HHhhcccccccccccccCCCCCC---CcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          447 ---PLVQSHRYLELLDPLISSLSSDI---PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       447 ---~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                         ...........+. .+.......   .....++.+.+|+.+||+.||.+|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         238 EVLKKISSEHARKYIQ-SLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             HHHHhcchhhHHHHhh-ccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence               0000000000000 000000000   00112345789999999999999999999995

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=8.6e-38  Score=299.48  Aligned_cols=248  Identities=29%  Similarity=0.467  Sum_probs=199.0

Q ss_pred             CceecccCceEEEEEEeCC-----CCEEEEEEecccchh-cHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeec
Q 010309          230 NRLLGDSKTGGTYSGILPD-----GSRVAVKRLKRSSFQ-RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  303 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  303 (513)
                      .+.||.|+||.||++...+     +..||+|.+...... ..+.+.+|+..+..++|+||+++++++.+.+..+++|||+
T Consensus         4 ~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~   83 (258)
T smart00219        4 GKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYM   83 (258)
T ss_pred             cceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEecc
Confidence            3467999999999999754     488999999766433 5678999999999999999999999999999999999999


Q ss_pred             cCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccc
Q 010309          304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM  383 (513)
Q Consensus       304 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~  383 (513)
                      ++++|.+++....  ...+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++........
T Consensus        84 ~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  158 (258)
T smart00219       84 EGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY  158 (258)
T ss_pred             CCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence            9999999986421  12289999999999999999999999   999999999999999999999999999987654422


Q ss_pred             ccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccccccc
Q 010309          384 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI  462 (513)
Q Consensus       384 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  462 (513)
                      .... ...+++.|+|||.+.+..++.++||||||+++|+|++ |.+||...+..   .....    ......        
T Consensus       159 ~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~---~~~~~----~~~~~~--------  222 (258)
T smart00219      159 YKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE---EVLEY----LKKGYR--------  222 (258)
T ss_pred             cccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH----HhcCCC--------
Confidence            2111 1226789999999988889999999999999999998 78888654321   11111    010000        


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 010309          463 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQL  503 (513)
Q Consensus       463 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  503 (513)
                          .. .....+.++.+++.+||+.||++|||+.++++.|
T Consensus       223 ----~~-~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      223 ----LP-KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             ----CC-CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                00 1112456799999999999999999999999865

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=9.4e-38  Score=299.22  Aligned_cols=247  Identities=23%  Similarity=0.311  Sum_probs=199.9

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccc--hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      .++||.|+||.||.+... +++.+++|.+....  ......+.+|+.++++++|+||+++++++.+.+..++||||++++
T Consensus         5 ~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~   84 (256)
T cd08221           5 IRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGG   84 (256)
T ss_pred             eeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCC
Confidence            457899999999998854 58899999986542  344567889999999999999999999999999999999999999


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  386 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  386 (513)
                      +|.+++....  ...+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||++.........  
T Consensus        85 ~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~--  157 (256)
T cd08221          85 TLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM--  157 (256)
T ss_pred             cHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccccc--
Confidence            9999997532  35689999999999999999999999   9999999999999999999999999999866443311  


Q ss_pred             eeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCC
Q 010309          387 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  466 (513)
Q Consensus       387 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  466 (513)
                      .....+++.|+|||.+.+..++.++||||||+++|||++|..||...+...      ...... ...        .    
T Consensus       158 ~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~------~~~~~~-~~~--------~----  218 (256)
T cd08221         158 AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN------LVVKIV-QGN--------Y----  218 (256)
T ss_pred             ccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHH-cCC--------C----
Confidence            112237899999999988888999999999999999999999987543211      111110 000        0    


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 010309          467 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQL  503 (513)
Q Consensus       467 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  503 (513)
                      . ......+.++.+++.+||+.+|.+||++.++++.+
T Consensus       219 ~-~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         219 T-PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             C-CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence            0 01123456799999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.2e-37  Score=298.57  Aligned_cols=246  Identities=22%  Similarity=0.329  Sum_probs=196.2

Q ss_pred             CCceecccCceEEEEEEeC-CCCEEEEEEecccc--hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeC-CceEEEEeecc
Q 010309          229 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH-GDRYIVYEFVV  304 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-~~~~lv~e~~~  304 (513)
                      ..+.||+|++|.||++... +++.||+|.+....  ....+.+.+|+.++++++|||++++++.+... ...++||||++
T Consensus         4 ~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~   83 (257)
T cd08223           4 FVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCE   83 (257)
T ss_pred             EEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccC
Confidence            3457899999999999965 47899999997542  23446788999999999999999999987644 45789999999


Q ss_pred             CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccc
Q 010309          305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  384 (513)
Q Consensus       305 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  384 (513)
                      +++|.+++...  ....+++.++..++.|++.||++||+.   +++|+||||+||+++.++.++|+|||++.........
T Consensus        84 ~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~  158 (257)
T cd08223          84 GGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDM  158 (257)
T ss_pred             CCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccCCc
Confidence            99999998652  235689999999999999999999999   9999999999999999999999999999766432211


Q ss_pred             cceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccC
Q 010309          385 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS  464 (513)
Q Consensus       385 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  464 (513)
                        .....+++.|+|||++.+..++.++||||||+++|+|++|+.||...+..      ........ ..        +  
T Consensus       159 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~------~~~~~~~~-~~--------~--  219 (257)
T cd08223         159 --ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN------SLVYRIIE-GK--------L--  219 (257)
T ss_pred             --cccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------HHHHHHHh-cC--------C--
Confidence              11223788999999999888999999999999999999999998754321      11111111 00        0  


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          465 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       465 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                        . ..+...++.+.+++.+||+.||++||++.++++
T Consensus       220 --~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         220 --P-PMPKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             --C-CCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence              0 112235567999999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=7.6e-38  Score=304.41  Aligned_cols=256  Identities=23%  Similarity=0.386  Sum_probs=196.2

Q ss_pred             HHHHHhhCcccCCceecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhc-CCCcEeeeeeEEee---
Q 010309          218 ELRSITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYD---  292 (513)
Q Consensus       218 ~l~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~---  292 (513)
                      ++....+.|.. .+.||.|+||.||+|... +++.||+|++.... .....+..|+.++.++ +||||+++++++..   
T Consensus        10 ~~~~~~~~~~~-~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~   87 (282)
T cd06636          10 ALRDPAGIFEL-VEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSP   87 (282)
T ss_pred             hhcChhhhhhh-heeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccc
Confidence            33333444443 456799999999999974 58899999986543 3345688899999998 79999999999853   


Q ss_pred             ---CCceEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEE
Q 010309          293 ---HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHL  369 (513)
Q Consensus       293 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl  369 (513)
                         .+..+++|||+++|+|.+++....  ...+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|
T Consensus        88 ~~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l  162 (282)
T cd06636          88 PGHDDQLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKL  162 (282)
T ss_pred             cCCCCEEEEEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEE
Confidence               456799999999999999986522  34588889999999999999999999   9999999999999999999999


Q ss_pred             ecccccccCCccccccceeecCcccccccccccc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHh
Q 010309          370 MGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY-----RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEW  444 (513)
Q Consensus       370 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~  444 (513)
                      +|||++.........  .....+++.|+|||.+.     ...++.++||||||+++|||++|..||.......  .... 
T Consensus       163 ~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~--~~~~-  237 (282)
T cd06636         163 VDFGVSAQLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR--ALFL-  237 (282)
T ss_pred             eeCcchhhhhccccC--CCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh--hhhh-
Confidence            999998765322111  11223888999999886     3457889999999999999999999996543210  0000 


Q ss_pred             hhHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          445 ATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       445 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                                  .....    ........++..+.+||.+||+.||.+||++.||++
T Consensus       238 ------------~~~~~----~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         238 ------------IPRNP----PPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             ------------HhhCC----CCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence                        00000    011112235667999999999999999999999974

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=4.9e-38  Score=302.72  Aligned_cols=247  Identities=26%  Similarity=0.444  Sum_probs=199.8

Q ss_pred             ceecccCceEEEEEEeC-CCCEEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCCH
Q 010309          231 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  308 (513)
Q Consensus       231 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL  308 (513)
                      +.||+|++|.||++... +++.||+|.+.... ......+.+|++++++++||||+++++.+...+..++|+||+++++|
T Consensus         7 ~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   86 (265)
T cd06605           7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSL   86 (265)
T ss_pred             HHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcH
Confidence            45799999999999975 58999999987653 23456789999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccce
Q 010309          309 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD-KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  387 (513)
Q Consensus       309 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  387 (513)
                      .+++....   ..+++..+..++.|++.||+|||+ .   +++|+||||+||+++.++.++|+|||.+..........  
T Consensus        87 ~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~--  158 (265)
T cd06605          87 DKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT--  158 (265)
T ss_pred             HHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhhc--
Confidence            99996522   568999999999999999999999 8   99999999999999999999999999987654322111  


Q ss_pred             eecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCC
Q 010309          388 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS  467 (513)
Q Consensus       388 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  467 (513)
                        ..++..|+|||.+.+..++.++||||||+++|+|++|..||...+... ....+.......             ....
T Consensus       159 --~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~-------------~~~~  222 (265)
T cd06605         159 --FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQYIVN-------------EPPP  222 (265)
T ss_pred             --ccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHHHhc-------------CCCC
Confidence              337889999999998899999999999999999999999997653210 111111111111             1111


Q ss_pred             CCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          468 DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       468 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      ..+....+.++.++|.+||..||++|||+.+++.
T Consensus       223 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         223 RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            1222225677999999999999999999999985

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=9.2e-38  Score=302.16  Aligned_cols=250  Identities=24%  Similarity=0.396  Sum_probs=194.8

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccchh----------cHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEE
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQ----------RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYI  298 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l  298 (513)
                      .+.||.|++|.||+|... +|+.||+|.++.....          ..+.+.+|+.+++.++||||+++++++...+..++
T Consensus         6 ~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   85 (272)
T cd06629           6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSI   85 (272)
T ss_pred             cceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEE
Confidence            457899999999999864 6899999988642110          12457889999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccC
Q 010309          299 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV  378 (513)
Q Consensus       299 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~  378 (513)
                      ||||+++++|.+++...    ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++...
T Consensus        86 v~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~  158 (272)
T cd06629          86 FLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKS  158 (272)
T ss_pred             EEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccccccc
Confidence            99999999999998642    4689999999999999999999999   9999999999999999999999999999865


Q ss_pred             CccccccceeecCcccccccccccccCC--CCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccc
Q 010309          379 PWEVMQERTVMAGGTYGYLAPEFVYRNE--LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLE  456 (513)
Q Consensus       379 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  456 (513)
                      .............++..|+|||.+....  ++.++|+||||+++|+|++|..||...+..  ....+    ......   
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~----~~~~~~---  229 (272)
T cd06629         159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI--AAMFK----LGNKRS---  229 (272)
T ss_pred             cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH--HHHHH----hhcccc---
Confidence            4322111122233788999999987654  789999999999999999999998643321  01110    000000   


Q ss_pred             cccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          457 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       457 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                        ....    .......++..+.+++.+||+.+|++|||+++|++
T Consensus       230 --~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         230 --APPI----PPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             --CCcC----CccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence              0000    01111234567999999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-39  Score=318.17  Aligned_cols=248  Identities=24%  Similarity=0.350  Sum_probs=204.6

Q ss_pred             CceecccCceEEEEEEeCC--CC--EEEEEEecccchh-cHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeecc
Q 010309          230 NRLLGDSKTGGTYSGILPD--GS--RVAVKRLKRSSFQ-RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV  304 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~~--~~--~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  304 (513)
                      .++||+|.||.|++|.|..  |+  .||||.++..... ...+|++|+.+|.+|+|||+++|||+..+ ....||||+++
T Consensus       115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELap  193 (1039)
T KOG0199|consen  115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAP  193 (1039)
T ss_pred             HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcc
Confidence            4578999999999999853  43  6999999877554 56899999999999999999999999887 67889999999


Q ss_pred             CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccc
Q 010309          305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  384 (513)
Q Consensus       305 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  384 (513)
                      .|+|.+.|++  .....|.......++.|||.||.||.++   ++|||||..+|+||-..-.+||+|||+.+.+......
T Consensus       194 lGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~  268 (1039)
T KOG0199|consen  194 LGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM  268 (1039)
T ss_pred             cchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence            9999999986  3446688889999999999999999999   9999999999999999889999999999988654332


Q ss_pred             cce-eecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccccccc
Q 010309          385 ERT-VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI  462 (513)
Q Consensus       385 ~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  462 (513)
                      ... ....-...|.|||.+....++.+||||+|||+||||+| |..||-+.....+.+.                +|.  
T Consensus       269 Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~----------------iD~--  330 (1039)
T KOG0199|consen  269 YVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKN----------------IDA--  330 (1039)
T ss_pred             eEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHh----------------ccc--
Confidence            211 11124678999999999999999999999999999999 8889887654321111                110  


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 010309          463 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQL  503 (513)
Q Consensus       463 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  503 (513)
                        ......+..++++++++++.||..+|++|||+..|.+.+
T Consensus       331 --~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  331 --GERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             --cccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence              001223456889999999999999999999999998433

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.4e-37  Score=302.98  Aligned_cols=263  Identities=19%  Similarity=0.261  Sum_probs=195.8

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccc--hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      .+.||+|++|.||+|... +|+.||+|++....  ....+.+.+|+.++++++||||+++++++......++||||++++
T Consensus         6 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~   85 (286)
T cd07847           6 LSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHT   85 (286)
T ss_pred             eeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCcc
Confidence            456799999999999976 58999999986542  223456789999999999999999999999999999999999999


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  386 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  386 (513)
                      +|..++..    ...+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++.......... 
T Consensus        86 ~l~~~~~~----~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~-  157 (286)
T cd07847          86 VLNELEKN----PRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY-  157 (286)
T ss_pred             HHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCcccc-
Confidence            88887643    34589999999999999999999999   99999999999999999999999999998765432111 


Q ss_pred             eeecCccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHH-hhhHH-------hhccccc-c
Q 010309          387 TVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFE-WATPL-------VQSHRYL-E  456 (513)
Q Consensus       387 ~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~-~~~~~-------~~~~~~~-~  456 (513)
                       ....++..|+|||.+.+ ..++.++||||||+++|+|++|..||.+....+...... .....       ....... .
T Consensus       158 -~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T cd07847         158 -TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKG  236 (286)
T ss_pred             -cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccc
Confidence             11226788999999876 457889999999999999999999998654321110000 00000       0000000 0


Q ss_pred             cccccccCCCC-CCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          457 LLDPLISSLSS-DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       457 ~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      ...+....... .......+..+.+|+.+||+.||++||++.|++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         237 LSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             ccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            00000000000 0000123567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1e-37  Score=299.05  Aligned_cols=243  Identities=26%  Similarity=0.447  Sum_probs=196.6

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccc-----hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeec
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-----FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  303 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  303 (513)
                      .+.||+|++|.||+|... +++.|++|.+....     ....+.+.+|+.+++.++||||+++++++.+....++|+||+
T Consensus         5 ~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   84 (258)
T cd06632           5 GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELV   84 (258)
T ss_pred             cceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEec
Confidence            457899999999999976 78999999986543     123467889999999999999999999999999999999999


Q ss_pred             cCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccc
Q 010309          304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM  383 (513)
Q Consensus       304 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~  383 (513)
                      ++++|.+++..    ...+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.+||+|||++........
T Consensus        85 ~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~  157 (258)
T cd06632          85 PGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF  157 (258)
T ss_pred             CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecccccc
Confidence            99999999864    24588999999999999999999999   999999999999999999999999999886543321


Q ss_pred             ccceeecCcccccccccccccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccc
Q 010309          384 QERTVMAGGTYGYLAPEFVYRNE-LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI  462 (513)
Q Consensus       384 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  462 (513)
                         .....++..|+|||.+.... ++.++|+||||+++|+|++|..||......  ...    ........        .
T Consensus       158 ---~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~--~~~----~~~~~~~~--------~  220 (258)
T cd06632         158 ---AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV--AAV----FKIGRSKE--------L  220 (258)
T ss_pred             ---ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH--HHH----HHHHhccc--------C
Confidence               11223788999999987766 899999999999999999999999764421  001    00000000        0


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          463 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       463 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                          . ..+...++.+.+++.+||+.+|++||++.+++.
T Consensus       221 ----~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         221 ----P-PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             ----C-CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence                0 011224567899999999999999999999985

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=3.8e-38  Score=313.82  Aligned_cols=250  Identities=19%  Similarity=0.229  Sum_probs=192.0

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccc---hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccC
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  305 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  305 (513)
                      .+.||+|+||.||++..+ +++.||+|++.+..   ......+.+|+.++..++|+||+++++.+.+.+..++||||+++
T Consensus         6 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~   85 (332)
T cd05623           6 LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVG   85 (332)
T ss_pred             EEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCC
Confidence            456799999999999975 47889999996532   12234578899999999999999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccc
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  385 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  385 (513)
                      |+|.+++...   ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++......... 
T Consensus        86 g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~-  158 (332)
T cd05623          86 GDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV-  158 (332)
T ss_pred             CcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCCcc-
Confidence            9999999642   34689999999999999999999999   9999999999999999999999999998765332211 


Q ss_pred             ceeecCcccccccccccc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccc
Q 010309          386 RTVMAGGTYGYLAPEFVY-----RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP  460 (513)
Q Consensus       386 ~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  460 (513)
                      ......||+.|+|||++.     ...++.++|||||||++|||++|+.||...+...      ..........  ..   
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~------~~~~i~~~~~--~~---  227 (332)
T cd05623         159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIMNHKE--RF---  227 (332)
T ss_pred             eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH------HHHHHhCCCc--cc---
Confidence            111234899999999986     3467889999999999999999999997654321      1111111000  00   


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHH
Q 010309          461 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSM--RPRMSHVVHQ  502 (513)
Q Consensus       461 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~  502 (513)
                      ..    + ......+.++.+|+.+|+..+|.+  |++++++++.
T Consensus       228 ~~----p-~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         228 QF----P-AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             cC----C-CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            00    0 001234667899999998665444  6889988764

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-39  Score=318.57  Aligned_cols=243  Identities=23%  Similarity=0.366  Sum_probs=201.5

Q ss_pred             ecccCceEEEEEEeCC-CCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCCHHHH
Q 010309          233 LGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRW  311 (513)
Q Consensus       233 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~  311 (513)
                      ||.|+||.||+|..++ +-..|.|++...+....++++-|++||..+.||+||+|++.|+..+.++|+.|||.||..+.+
T Consensus        40 LGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDai  119 (1187)
T KOG0579|consen   40 LGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAI  119 (1187)
T ss_pred             hcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHH
Confidence            5999999999999765 445678888877777889999999999999999999999999999999999999999999988


Q ss_pred             hccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccceeecC
Q 010309          312 LHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG  391 (513)
Q Consensus       312 l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  391 (513)
                      +..   -++.+.+.++.-+++|++.||.|||++   +|||||||+.|||++-+|.++|+|||.+......  ........
T Consensus       120 mlE---L~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t--~qkRDsFI  191 (1187)
T KOG0579|consen  120 MLE---LGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST--RQKRDSFI  191 (1187)
T ss_pred             HHH---hccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhH--Hhhhcccc
Confidence            864   347799999999999999999999999   9999999999999999999999999998765432  22233445


Q ss_pred             cccccccccccc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCC
Q 010309          392 GTYGYLAPEFVY-----RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  466 (513)
Q Consensus       392 gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  466 (513)
                      |||.|||||+..     ..+|+.++||||||++|.||..+.+|....++..  -+...+     .           +..+
T Consensus       192 GTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR--VllKia-----K-----------SePP  253 (1187)
T KOG0579|consen  192 GTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--VLLKIA-----K-----------SEPP  253 (1187)
T ss_pred             CCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH--HHHHHh-----h-----------cCCC
Confidence            999999999875     4689999999999999999999999976554321  111000     0           0001


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          467 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       467 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      ....+...+..+.+++.+||..||..||++.++++
T Consensus       254 TLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  254 TLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             cccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence            11224456778999999999999999999999986

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.8e-37  Score=299.21  Aligned_cols=245  Identities=22%  Similarity=0.366  Sum_probs=190.6

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccc-----hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeC--CceEEEEe
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-----FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDRYIVYE  301 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lv~e  301 (513)
                      .++||+|+||.||+|... ++..||+|.+....     ......+.+|+.+++.++||||+++++++.+.  ...++++|
T Consensus         7 ~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e   86 (266)
T cd06651           7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFME   86 (266)
T ss_pred             cceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEe
Confidence            457799999999999874 58999999986432     12335688899999999999999999988753  56789999


Q ss_pred             eccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcc
Q 010309          302 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE  381 (513)
Q Consensus       302 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~  381 (513)
                      |+++++|.+++..    ...+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++......
T Consensus        87 ~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~  159 (266)
T cd06651          87 YMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI  159 (266)
T ss_pred             CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCccccccc
Confidence            9999999999864    24588999999999999999999999   9999999999999999999999999998765432


Q ss_pred             ccc-cceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccc
Q 010309          382 VMQ-ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP  460 (513)
Q Consensus       382 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  460 (513)
                      ... .......++..|+|||++.+..++.++||||||+++|||++|+.||...+...  ..    .....     ....+
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~--~~----~~~~~-----~~~~~  228 (266)
T cd06651         160 CMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA--AI----FKIAT-----QPTNP  228 (266)
T ss_pred             cccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH--HH----HHHhc-----CCCCC
Confidence            111 11112237889999999988889999999999999999999999997543210  00    00000     00001


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          461 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       461 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                              ..+...++.+.+++ +||..+|++||+++||++
T Consensus       229 --------~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         229 --------QLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             --------CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence                    11223455677787 688899999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.3e-37  Score=303.53  Aligned_cols=248  Identities=22%  Similarity=0.399  Sum_probs=195.5

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEeccc-chhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCC
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  307 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs  307 (513)
                      .+.||+|+||.||++... ++..||+|.+... .......+.+|+.++++++||||+++++.+...+..++||||+++++
T Consensus         6 ~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~   85 (286)
T cd06622           6 LDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGS   85 (286)
T ss_pred             hhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCC
Confidence            346799999999999975 6899999998754 22334678899999999999999999999999999999999999999


Q ss_pred             HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccce
Q 010309          308 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  387 (513)
Q Consensus       308 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  387 (513)
                      |..++... .....+++..+..++.|++.||.|||+..  +++|+||||+||+++.++.++|+|||++.........   
T Consensus        86 l~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~---  159 (286)
T cd06622          86 LDKLYAGG-VATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAK---  159 (286)
T ss_pred             HHHHHHhc-cccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCccc---
Confidence            99988642 12346899999999999999999999632  8999999999999999999999999998765332211   


Q ss_pred             eecCcccccccccccccCC------CCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccccccccc
Q 010309          388 VMAGGTYGYLAPEFVYRNE------LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL  461 (513)
Q Consensus       388 ~~~~gt~~y~aPE~~~~~~------~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  461 (513)
                       ...+++.|+|||.+.+..      ++.++|||||||++|+|++|..||.......   .......         .....
T Consensus       160 -~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~---------~~~~~  226 (286)
T cd06622         160 -TNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN---IFAQLSA---------IVDGD  226 (286)
T ss_pred             -cCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh---HHHHHHH---------HhhcC
Confidence             123788999999986543      4789999999999999999999996543211   1110000         00000


Q ss_pred             ccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          462 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       462 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      .    ... +..++.++.++|.+||+.+|++||+++++++
T Consensus       227 ~----~~~-~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         227 P----PTL-PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             C----CCC-CcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence            0    111 2236678999999999999999999999987

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=9.9e-38  Score=303.66  Aligned_cols=247  Identities=25%  Similarity=0.439  Sum_probs=191.4

Q ss_pred             ceecccCceEEEEEEeC-CCCEEEEEEecccch-hcHHHHHHHHHH-HhhcCCCcEeeeeeEEeeCCceEEEEeeccCCC
Q 010309          231 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF-QRKKEFYSEIGR-FARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  307 (513)
Q Consensus       231 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs  307 (513)
                      +.||+|+||.||++... +|+.||||+++.... .....+..|+.+ ++.++||||+++++++..++..++||||++ ++
T Consensus         7 ~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~   85 (283)
T cd06617           7 EELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-TS   85 (283)
T ss_pred             EEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-cc
Confidence            45799999999999975 599999999976532 234456667665 566689999999999999999999999995 68


Q ss_pred             HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccce
Q 010309          308 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  387 (513)
Q Consensus       308 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  387 (513)
                      |.+++.........+++..++.++.|++.||+|||++.  +++||||||+||+++.++.+||+|||++.........   
T Consensus        86 l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~---  160 (283)
T cd06617          86 LDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK---  160 (283)
T ss_pred             HHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeeccccccccccccc---
Confidence            98888654444467999999999999999999999753  8999999999999999999999999999865432211   


Q ss_pred             eecCccccccccccccc----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccccccccccc
Q 010309          388 VMAGGTYGYLAPEFVYR----NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS  463 (513)
Q Consensus       388 ~~~~gt~~y~aPE~~~~----~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  463 (513)
                      ....++..|+|||.+.+    ..++.++|+||||+++|+|++|+.||...... ...+    .....         .   
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~----~~~~~---------~---  223 (283)
T cd06617         161 TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-FQQL----KQVVE---------E---  223 (283)
T ss_pred             ccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-HHHH----HHHHh---------c---
Confidence            11237889999998865    45688999999999999999999998653221 0111    11000         0   


Q ss_pred             CCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          464 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       464 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                       .....+...+++++.++|.+||..+|++||+++++++
T Consensus       224 -~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         224 -PSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             -CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             0011122235677999999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-38  Score=310.53  Aligned_cols=259  Identities=20%  Similarity=0.283  Sum_probs=204.6

Q ss_pred             HHHHHhhCcccCCceecccCceEEEEEEeCCCCEEEEEEeccc--chhcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCC
Q 010309          218 ELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHG  294 (513)
Q Consensus       218 ~l~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~  294 (513)
                      ++..+.+..++.-+.||+||.+.||++...+.+.||+|.+...  +.+....|.+|+..|.+| .|.+||+|++|-..++
T Consensus       354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~  433 (677)
T KOG0596|consen  354 EIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDG  433 (677)
T ss_pred             eeEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCc
Confidence            4445555566666788999999999999988899999987543  445567899999999999 5999999999999999


Q ss_pred             ceEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccc
Q 010309          295 DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGL  374 (513)
Q Consensus       295 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~  374 (513)
                      .+|||||+= ..+|..+|.+.   ...++.-.++.+..|++.|+.++|.+   ||||.||||.|+|+-.. .+||+|||+
T Consensus       434 ~lYmvmE~G-d~DL~kiL~k~---~~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVkG-~LKLIDFGI  505 (677)
T KOG0596|consen  434 YLYMVMECG-DIDLNKILKKK---KSIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVKG-RLKLIDFGI  505 (677)
T ss_pred             eEEEEeecc-cccHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEee-eEEeeeech
Confidence            999999986 67999999752   23344347888999999999999999   99999999999999664 799999999


Q ss_pred             cccCCccccccceeecCcccccccccccccC-----------CCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHH
Q 010309          375 SKFVPWEVMQERTVMAGGTYGYLAPEFVYRN-----------ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFE  443 (513)
Q Consensus       375 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~  443 (513)
                      |..+..+.........+||+.||+||.+...           ..+.+|||||||||||+|+.|+.||.....     .. 
T Consensus       506 A~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-----~~-  579 (677)
T KOG0596|consen  506 ANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-----QI-  579 (677)
T ss_pred             hcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-----HH-
Confidence            9998877766666666799999999998642           256789999999999999999999975321     11 


Q ss_pred             hhhHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          444 WATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       444 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                              .++..+.++...-..+..++   ..++.++++.||..||.+|||+.+||+
T Consensus       580 --------aKl~aI~~P~~~Iefp~~~~---~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  580 --------AKLHAITDPNHEIEFPDIPE---NDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             --------HHHHhhcCCCccccccCCCC---chHHHHHHHHHHhcCcccCCCcHHHhc
Confidence                    11223333322111122222   123999999999999999999999986

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.2e-37  Score=298.39  Aligned_cols=245  Identities=20%  Similarity=0.344  Sum_probs=197.7

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEeccc--chhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      .+.||+|+||.||++... +|+.||+|.+...  .....+++.+|+.++++++||||+++++++...+..++||||++++
T Consensus         5 ~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (256)
T cd08218           5 VKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGG   84 (256)
T ss_pred             EEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCC
Confidence            356799999999999864 6889999998653  2234467899999999999999999999999999999999999999


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  386 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  386 (513)
                      +|.+++..  .....+++.+++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++...........
T Consensus        85 ~l~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~  159 (256)
T cd08218          85 DLYKKINA--QRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELAR  159 (256)
T ss_pred             cHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhh
Confidence            99998864  2234578999999999999999999999   999999999999999999999999999986644322111


Q ss_pred             eeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCC
Q 010309          387 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  466 (513)
Q Consensus       387 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  466 (513)
                        ...+++.|+|||++.+...+.++|+||||+++++|++|+.||...+..      +....... .        ..    
T Consensus       160 --~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~~~~~-~--------~~----  218 (256)
T cd08218         160 --TCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK------NLVLKIIR-G--------SY----  218 (256)
T ss_pred             --hccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH------HHHHHHhc-C--------CC----
Confidence              122788899999998888999999999999999999999998754321      11111100 0        00    


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          467 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       467 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      . ..+...+.++.++|.+||+.+|++||++.+|++
T Consensus       219 ~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         219 P-PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             C-CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            0 011234567999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.2e-37  Score=324.08  Aligned_cols=263  Identities=16%  Similarity=0.207  Sum_probs=187.0

Q ss_pred             hCcccCCceecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhcC------CCcEeeeeeEEeeC-Cc
Q 010309          224 KNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH------HPNLVAVKGCCYDH-GD  295 (513)
Q Consensus       224 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~nIv~l~~~~~~~-~~  295 (513)
                      ++|. ..+.||+|+||.||+|... .++.||||+++... .....+..|+.++..++      |.+|+++++++... .+
T Consensus       129 ~~y~-i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~  206 (467)
T PTZ00284        129 QRFK-ILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGH  206 (467)
T ss_pred             CcEE-EEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCce
Confidence            3443 4457799999999999964 57899999996532 22344566777776664      45689999988765 56


Q ss_pred             eEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCceEcCCCCCceEecCCC---------
Q 010309          296 RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD-KVKPHVVHRDIRASNVLLDEEF---------  365 (513)
Q Consensus       296 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dikp~NIll~~~~---------  365 (513)
                      .++|||++ +++|.+++..    ...+++..+..|+.||+.||+|||+ .   +|+||||||+|||++.++         
T Consensus       207 ~~iv~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~~~~~~~  278 (467)
T PTZ00284        207 MCIVMPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVVDPVTNR  278 (467)
T ss_pred             EEEEEecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCccccccccc
Confidence            78999988 7788888854    2469999999999999999999997 6   999999999999998765         


Q ss_pred             -------CeEEecccccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccc
Q 010309          366 -------GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW  438 (513)
Q Consensus       366 -------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~  438 (513)
                             .+||+|||.+......     .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+....
T Consensus       279 ~~~~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~  353 (467)
T PTZ00284        279 ALPPDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEH  353 (467)
T ss_pred             ccCCCCceEEECCCCccccCccc-----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence                   4999999987643221     1123489999999999999999999999999999999999999987654322


Q ss_pred             chhHHhhhH----Hhhc----cccccccc------cccc-----CCCCC--CCcHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 010309          439 QSIFEWATP----LVQS----HRYLELLD------PLIS-----SLSSD--IPEAGVVQKVVDLVYACTQHVPSMRPRMS  497 (513)
Q Consensus       439 ~~~~~~~~~----~~~~----~~~~~~~~------~~~~-----~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~  497 (513)
                      ...+.....    .+..    ....++.+      +...     .....  .......+.+.+||.+||+.||.+|||++
T Consensus       354 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~  433 (467)
T PTZ00284        354 LHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNAR  433 (467)
T ss_pred             HHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHH
Confidence            221111100    0000    00000000      0000     00000  00011245688999999999999999999


Q ss_pred             HHHH
Q 010309          498 HVVH  501 (513)
Q Consensus       498 evl~  501 (513)
                      |+++
T Consensus       434 e~L~  437 (467)
T PTZ00284        434 QMTT  437 (467)
T ss_pred             HHhc
Confidence            9987

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=4.1e-38  Score=313.38  Aligned_cols=249  Identities=20%  Similarity=0.223  Sum_probs=191.9

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccc---hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccC
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  305 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  305 (513)
                      .+.||+|+||.||+++.. +++.||+|++.+..   ......+.+|..++..++|+||+++++++.+.+..|+||||+++
T Consensus         6 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~g   85 (331)
T cd05624           6 IKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVG   85 (331)
T ss_pred             EEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCC
Confidence            456799999999999975 58899999997532   22334578899999999999999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccc
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  385 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  385 (513)
                      |+|.+++...   ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++..........
T Consensus        86 g~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  159 (331)
T cd05624          86 GDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ  159 (331)
T ss_pred             CcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCCcee
Confidence            9999999642   24689999999999999999999999   99999999999999999999999999997654332211


Q ss_pred             ceeecCccccccccccccc-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccc
Q 010309          386 RTVMAGGTYGYLAPEFVYR-----NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP  460 (513)
Q Consensus       386 ~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  460 (513)
                       .....||+.|+|||++.+     +.++.++||||||+++|||++|+.||...+...      .............    
T Consensus       160 -~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~------~~~~i~~~~~~~~----  228 (331)
T cd05624         160 -SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIMNHEERFQ----  228 (331)
T ss_pred             -eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH------HHHHHHcCCCccc----
Confidence             112348999999999875     467889999999999999999999997644211      1111111000000    


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHH
Q 010309          461 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSM--RPRMSHVVH  501 (513)
Q Consensus       461 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~  501 (513)
                       .   ...  ....++++.+++.+||..++++  |++++++++
T Consensus       229 -~---p~~--~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~  265 (331)
T cd05624         229 -F---PSH--ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK  265 (331)
T ss_pred             -C---CCc--cccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence             0   000  1124567999999999876554  467888764

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.7e-37  Score=298.61  Aligned_cols=246  Identities=21%  Similarity=0.320  Sum_probs=198.0

Q ss_pred             ceecccCceEEEEEEeC-CCCEEEEEEecccc--hhcHHHHHHHHHHHhhcCCCcEeeeeeEEee--CCceEEEEeeccC
Q 010309          231 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYD--HGDRYIVYEFVVN  305 (513)
Q Consensus       231 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lv~e~~~~  305 (513)
                      +.||.|++|.||++... ++..||+|.+....  ....+.+.+|+.++++++||||+++++++..  ....+++|||+++
T Consensus         6 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~   85 (265)
T cd08217           6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEG   85 (265)
T ss_pred             eeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccC
Confidence            45799999999999864 68899999987542  2335678899999999999999999998764  3457999999999


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHh-----cCCCCCceEcCCCCCceEecCCCCeEEecccccccCCc
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLH-----DKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW  380 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH-----~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~  380 (513)
                      ++|.+++.........+++..++.++.|++.||+|||     +.   +++|+||+|+||+++.++.+||+|||++.....
T Consensus        86 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~  162 (265)
T cd08217          86 GDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLAKILGH  162 (265)
T ss_pred             CCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEecccccccccC
Confidence            9999999764444567999999999999999999999     77   999999999999999999999999999987654


Q ss_pred             cccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccc
Q 010309          381 EVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP  460 (513)
Q Consensus       381 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  460 (513)
                      .....  ....+++.|+|||.+.+..++.++||||||+++|+|++|..||...+..   .+..    ......       
T Consensus       163 ~~~~~--~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~----~~~~~~-------  226 (265)
T cd08217         163 DSSFA--KTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL---QLAS----KIKEGK-------  226 (265)
T ss_pred             Ccccc--cccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH---HHHH----HHhcCC-------
Confidence            33211  1123789999999999888999999999999999999999999765421   1111    011000       


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          461 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       461 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                            ....+...+..+.+++.+||+.+|++||++.+|++
T Consensus       227 ------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~  261 (265)
T cd08217         227 ------FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ  261 (265)
T ss_pred             ------CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence                  00112235567999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.3e-37  Score=299.94  Aligned_cols=255  Identities=23%  Similarity=0.343  Sum_probs=197.7

Q ss_pred             ceecccCceEEEEEEeC-CCCEEEEEEecccch-hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeC--CceEEEEeeccCC
Q 010309          231 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDRYIVYEFVVNG  306 (513)
Q Consensus       231 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lv~e~~~~g  306 (513)
                      +.||.|++|.||++... +++.+|+|.+..... .....+.+|++++++++||||+++++++.+.  +..++||||++++
T Consensus         7 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~   86 (287)
T cd06621           7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGG   86 (287)
T ss_pred             EEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCC
Confidence            45699999999999974 588999999975432 3456789999999999999999999998654  4679999999999


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  386 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  386 (513)
                      +|.+++.........+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++.........  
T Consensus        87 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~--  161 (287)
T cd06621          87 SLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAG--  161 (287)
T ss_pred             CHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccccccc--
Confidence            99998765434456689999999999999999999999   9999999999999999999999999998765432211  


Q ss_pred             eeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCC
Q 010309          387 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  466 (513)
Q Consensus       387 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  466 (513)
                        ...++..|+|||.+.+..++.++||||||+++|+|++|..||....... ....+....... ..     .+.+..  
T Consensus       162 --~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~-~~-----~~~~~~--  230 (287)
T cd06621         162 --TFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP-LGPIELLSYIVN-MP-----NPELKD--  230 (287)
T ss_pred             --cccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCC-CChHHHHHHHhc-CC-----chhhcc--
Confidence              1237788999999988899999999999999999999999997653210 011111111000 00     000100  


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          467 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       467 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      ........++.+.+++.+||+.+|++|||+.||++
T Consensus       231 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         231 EPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             CCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            00001234677999999999999999999999987

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-37  Score=299.82  Aligned_cols=243  Identities=21%  Similarity=0.370  Sum_probs=195.3

Q ss_pred             CceecccCceEEEEEEe-CCCCEEEEEEecccc-hhcHHHHHHHHHHHhhcC---CCcEeeeeeEEeeCCceEEEEeecc
Q 010309          230 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLH---HPNLVAVKGCCYDHGDRYIVYEFVV  304 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~lv~e~~~  304 (513)
                      .+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.++++++   ||||+++++++......++||||++
T Consensus         6 ~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06917           6 LELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAE   85 (277)
T ss_pred             hhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCC
Confidence            34679999999999996 468999999987542 334567889999999996   9999999999999999999999999


Q ss_pred             CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccc
Q 010309          305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  384 (513)
Q Consensus       305 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  384 (513)
                      +++|.+++..     ..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.........
T Consensus        86 ~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~  157 (277)
T cd06917          86 GGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK  157 (277)
T ss_pred             CCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccc
Confidence            9999999853     3689999999999999999999999   9999999999999999999999999999876543321


Q ss_pred             cceeecCcccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccccccccccc
Q 010309          385 ERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS  463 (513)
Q Consensus       385 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  463 (513)
                      .  ....|+..|+|||.+.++ .++.++||||||+++|+|++|..||..........       ..     .....    
T Consensus       158 ~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~-------~~-----~~~~~----  219 (277)
T cd06917         158 R--STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM-------LI-----PKSKP----  219 (277)
T ss_pred             c--ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh-------cc-----ccCCC----
Confidence            1  122388899999988654 46889999999999999999999997643321000       00     00000    


Q ss_pred             CCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          464 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       464 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                         ........+.++.+++.+||+.||++||++.++++
T Consensus       220 ---~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         220 ---PRLEDNGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             ---CCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence               11111124567999999999999999999999986

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=8.6e-38  Score=304.33  Aligned_cols=261  Identities=19%  Similarity=0.227  Sum_probs=192.3

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccch--hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      .+.||+|++|.||+|... +|+.||+|+++....  .....+.+|+.++++++||||+++++++.+.+..++|+||++ +
T Consensus         5 ~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~   83 (284)
T cd07839           5 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD-Q   83 (284)
T ss_pred             EEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC-C
Confidence            356799999999999975 689999999975422  223567889999999999999999999999999999999996 5


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  386 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  386 (513)
                      +|.+++..   ....+++..++.++.||+.||.|||+.   +++|+||||+||+++.++.++|+|||++.......... 
T Consensus        84 ~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~-  156 (284)
T cd07839          84 DLKKYFDS---CNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCY-  156 (284)
T ss_pred             CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCc-
Confidence            78887753   234689999999999999999999999   99999999999999999999999999998654322111 


Q ss_pred             eeecCcccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcc------ccccccc
Q 010309          387 TVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSH------RYLELLD  459 (513)
Q Consensus       387 ~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~  459 (513)
                       ....+++.|+|||++.+. .++.++||||||+++|+|+||..|+....+..  .............      ......+
T Consensus       157 -~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07839         157 -SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEESWPGVSKLPD  233 (284)
T ss_pred             -CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH--HHHHHHHHHhCCCChHHhHHhhhccc
Confidence             112368899999998764 46899999999999999999998865433211  1100000000000      0000000


Q ss_pred             c-cccCCCC----CCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          460 P-LISSLSS----DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       460 ~-~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      . .......    .......++++.+++.+||+.||.+|||++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         234 YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             ccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            0 0000000    0011234567899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-37  Score=307.51  Aligned_cols=248  Identities=24%  Similarity=0.300  Sum_probs=197.5

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccchh---cHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccC
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQ---RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  305 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  305 (513)
                      .+.||+|++|.||++... +++.||+|.+......   ..+.+.+|++++..++||||+++++.+.+.+..++||||+.+
T Consensus         6 ~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   85 (316)
T cd05574           6 IKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPG   85 (316)
T ss_pred             eeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCC
Confidence            356799999999999975 4899999999765332   346788999999999999999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccc
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  385 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  385 (513)
                      ++|.+++..  .....+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++..........
T Consensus        86 ~~L~~~~~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~  160 (316)
T cd05574          86 GELFRLLQR--QPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV  160 (316)
T ss_pred             CCHHHHHHh--CCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence            999999864  2235689999999999999999999999   99999999999999999999999999987653221100


Q ss_pred             ---------------------------ceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccc
Q 010309          386 ---------------------------RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW  438 (513)
Q Consensus       386 ---------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~  438 (513)
                                                 ......|+..|+|||++.+..++.++||||||+++|+|++|..||...+... 
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~-  239 (316)
T cd05574         161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE-  239 (316)
T ss_pred             ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHH-
Confidence                                       0001237888999999998889999999999999999999999997654321 


Q ss_pred             chhHHhhhHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCC----HHHHHH
Q 010309          439 QSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPR----MSHVVH  501 (513)
Q Consensus       439 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~evl~  501 (513)
                       .+    ..         ......    ........++.+.+++.+||+.||++|||    ++++++
T Consensus       240 -~~----~~---------~~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         240 -TF----SN---------ILKKEV----TFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             -HH----HH---------HhcCCc----cCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence             00    00         000000    00011125678999999999999999999    777776

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-37  Score=300.65  Aligned_cols=250  Identities=22%  Similarity=0.380  Sum_probs=196.4

Q ss_pred             cCCceecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCCc------eEEE
Q 010309          228 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGD------RYIV  299 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~------~~lv  299 (513)
                      +..+.||+|++|.||+|... +++.+++|++..... ..+.+.+|+.+++++ .||||+++++++.....      .++|
T Consensus         9 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv   87 (275)
T cd06608           9 ELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLV   87 (275)
T ss_pred             eheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEE
Confidence            33467799999999999975 578999999876543 446789999999999 79999999999976554      7999


Q ss_pred             EeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCC
Q 010309          300 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP  379 (513)
Q Consensus       300 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~  379 (513)
                      |||+++++|.+++.........+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++....
T Consensus        88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~  164 (275)
T cd06608          88 MELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLD  164 (275)
T ss_pred             EEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCccceecc
Confidence            999999999999875433346789999999999999999999999   99999999999999999999999999987654


Q ss_pred             ccccccceeecCccccccccccccc-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccc
Q 010309          380 WEVMQERTVMAGGTYGYLAPEFVYR-----NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRY  454 (513)
Q Consensus       380 ~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  454 (513)
                      .....  .....++..|+|||++..     ..++.++||||||+++|+|++|..||......  .....    ..     
T Consensus       165 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~----~~-----  231 (275)
T cd06608         165 STLGR--RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM--RALFK----IP-----  231 (275)
T ss_pred             cchhh--hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH--HHHHH----hh-----
Confidence            32211  112237889999998754     34678899999999999999999999754321  01100    00     


Q ss_pred             cccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          455 LELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       455 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                       ....+      ........++.+.+|+.+||..||++|||+.++++
T Consensus       232 -~~~~~------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         232 -RNPPP------TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             -ccCCC------CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence             00000      11112235678999999999999999999999985

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=3.6e-37  Score=296.30  Aligned_cols=247  Identities=23%  Similarity=0.420  Sum_probs=202.1

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccch-hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCC
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  307 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs  307 (513)
                      .+.||+|++|.||++... +++.||||++..... .....+.+|+..+.+++||||+++++++...+..++||||+++++
T Consensus         6 ~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~   85 (264)
T cd06623           6 VKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGS   85 (264)
T ss_pred             eeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCc
Confidence            457899999999999976 499999999977643 346789999999999999999999999999999999999999999


Q ss_pred             HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccc
Q 010309          308 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD-KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  386 (513)
Q Consensus       308 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  386 (513)
                      |.+++...    ..+++..+..++.|++.||+|||+ .   +++|+||+|+||+++.++.++|+|||.+...........
T Consensus        86 L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~  158 (264)
T cd06623          86 LADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN  158 (264)
T ss_pred             HHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCCccc
Confidence            99999642    568999999999999999999999 8   999999999999999999999999999987654332211


Q ss_pred             eeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCC
Q 010309          387 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  466 (513)
Q Consensus       387 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  466 (513)
                        ...++..|+|||.+.+..++.++||||||+++|+|+||..||................            ....    
T Consensus       159 --~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~------------~~~~----  220 (264)
T cd06623         159 --TFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC------------DGPP----  220 (264)
T ss_pred             --ceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh------------cCCC----
Confidence              1227889999999988889999999999999999999999997664311111111111            0000    


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          467 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       467 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      ...+....+..+.+++.+||+.+|++||++.++++
T Consensus       221 ~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~  255 (264)
T cd06623         221 PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ  255 (264)
T ss_pred             CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence            11111115567999999999999999999999987

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=2.2e-37  Score=301.68  Aligned_cols=244  Identities=23%  Similarity=0.362  Sum_probs=198.2

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCCH
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  308 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL  308 (513)
                      .+.||+|++|.||++... +++.||+|++........+.+.+|+.+++.++||||+++++++...+..++|+||+++++|
T Consensus        24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L  103 (285)
T cd06648          24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL  103 (285)
T ss_pred             ceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCH
Confidence            347899999999999964 6889999998765555566788999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccccee
Q 010309          309 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  388 (513)
Q Consensus       309 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  388 (513)
                      .+++..     ..+++..+..++.|++.||+|||+.   +++||||+|+||+++.++.++|+|||.+..........  .
T Consensus       104 ~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~--~  173 (285)
T cd06648         104 TDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRR--K  173 (285)
T ss_pred             HHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCccc--c
Confidence            999864     4588999999999999999999999   99999999999999999999999999887554322111  1


Q ss_pred             ecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCCC
Q 010309          389 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD  468 (513)
Q Consensus       389 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  468 (513)
                      ...+++.|+|||.+.+..++.++||||||+++|||++|..||...+....      ......      ...+..    . 
T Consensus       174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~------~~~~~~------~~~~~~----~-  236 (285)
T cd06648         174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA------MKRIRD------NLPPKL----K-  236 (285)
T ss_pred             cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH------HHHHHh------cCCCCC----c-
Confidence            22378899999999888899999999999999999999999876432110      110000      000000    0 


Q ss_pred             CCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          469 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       469 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                       .....+..+.+++.+||+.+|++||++.++++
T Consensus       237 -~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         237 -NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             -ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence             01124567999999999999999999999996

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=3.3e-37  Score=297.13  Aligned_cols=253  Identities=22%  Similarity=0.334  Sum_probs=200.4

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCC
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  307 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs  307 (513)
                      .+.||.|++|.||+|... ++..+|+|++.... ....+.+.+|+.+++.++|+||+++++.+...+..++|||++++++
T Consensus         6 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~   85 (267)
T cd06610           6 IEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGS   85 (267)
T ss_pred             eeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCc
Confidence            456799999999999964 58899999997543 2345788999999999999999999999999999999999999999


Q ss_pred             HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccc--
Q 010309          308 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE--  385 (513)
Q Consensus       308 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~--  385 (513)
                      |.+++..... ...+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++..........  
T Consensus        86 l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~  161 (267)
T cd06610          86 LLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRK  161 (267)
T ss_pred             HHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccccc
Confidence            9999965221 24689999999999999999999999   99999999999999999999999999987665432221  


Q ss_pred             ceeecCcccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccC
Q 010309          386 RTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS  464 (513)
Q Consensus       386 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  464 (513)
                      ......++..|+|||++... .++.++|+||||+++|+|++|+.||...+...  ......    ..      ..+..  
T Consensus       162 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~~~~~~----~~------~~~~~--  227 (267)
T cd06610         162 VRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--VLMLTL----QN------DPPSL--  227 (267)
T ss_pred             ccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--hHHHHh----cC------CCCCc--
Confidence            11222378899999998876 78899999999999999999999997654321  111100    00      00001  


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          465 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       465 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                       .........++.+.+++.+||+.||++||++.+|++
T Consensus       228 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         228 -ETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             -CCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence             011112345678999999999999999999999985

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=3.4e-37  Score=301.60  Aligned_cols=245  Identities=22%  Similarity=0.348  Sum_probs=198.8

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCCH
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  308 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL  308 (513)
                      .+.||+|+||.||++... ++..||+|.+........+.+.+|+.+++.++||||+++++.+...+..++|+||+++++|
T Consensus        24 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L  103 (293)
T cd06647          24 FEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSL  103 (293)
T ss_pred             eeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcH
Confidence            356799999999999864 6889999998765555567789999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccccee
Q 010309          309 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  388 (513)
Q Consensus       309 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  388 (513)
                      .+++..     ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++..........  .
T Consensus       104 ~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~--~  173 (293)
T cd06647         104 TDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--S  173 (293)
T ss_pred             HHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccccc--c
Confidence            999864     3578899999999999999999999   99999999999999999999999999987654332211  1


Q ss_pred             ecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCCC
Q 010309          389 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD  468 (513)
Q Consensus       389 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  468 (513)
                      ...+++.|+|||.+....++.++||||||+++|++++|+.||...+.......      ...        .    .....
T Consensus       174 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~------~~~--------~----~~~~~  235 (293)
T cd06647         174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IAT--------N----GTPEL  235 (293)
T ss_pred             cccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee------hhc--------C----CCCCC
Confidence            12378899999999888889999999999999999999999976443210000      000        0    00011


Q ss_pred             CCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010309          469 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  502 (513)
Q Consensus       469 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  502 (513)
                      ......+..+.+++.+||+.+|++||++.+++..
T Consensus       236 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         236 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1122345679999999999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.9e-37  Score=297.89  Aligned_cols=249  Identities=19%  Similarity=0.335  Sum_probs=197.3

Q ss_pred             CceecccCceEEEEEEe-CCCCEEEEEEecccch------hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEee
Q 010309          230 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSF------QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF  302 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  302 (513)
                      .++||+|++|.||++.. .+++.||+|++.....      ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         5 ~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~   84 (268)
T cd06630           5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEW   84 (268)
T ss_pred             cceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEec
Confidence            35679999999999985 5689999999975421      1246788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCC-CeEEecccccccCCcc
Q 010309          303 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF-GAHLMGVGLSKFVPWE  381 (513)
Q Consensus       303 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~-~~kl~Dfg~~~~~~~~  381 (513)
                      +++++|.+++..    ...+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++ .++|+|||.+......
T Consensus        85 ~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~  157 (268)
T cd06630          85 MAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK  157 (268)
T ss_pred             cCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence            999999999864    24688999999999999999999999   999999999999998776 5999999999876543


Q ss_pred             cccc--ceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccccccc
Q 010309          382 VMQE--RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD  459 (513)
Q Consensus       382 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  459 (513)
                      ....  ......++..|+|||.+.+..++.++||||||+++|+|++|..||..........   .......         
T Consensus       158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~---~~~~~~~---------  225 (268)
T cd06630         158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLA---LIFKIAS---------  225 (268)
T ss_pred             cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHH---HHHHHhc---------
Confidence            2111  1111237889999999988888999999999999999999999996543211111   0000000         


Q ss_pred             ccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          460 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       460 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                          .......+...++++.+++.+||+.+|++||++.++++
T Consensus       226 ----~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         226 ----ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             ----cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence                00011122345678999999999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.7e-37  Score=297.24  Aligned_cols=244  Identities=20%  Similarity=0.300  Sum_probs=196.7

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccc--hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      .+.||+|++|.||++... +++.+|||.+....  ......+.+|+.+++.++||||+++++.+...+..++||||++++
T Consensus         5 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (256)
T cd08220           5 IRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGG   84 (256)
T ss_pred             EEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCC
Confidence            456899999999999864 68899999987543  234567889999999999999999999999999999999999999


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCC-CeEEecccccccCCcccccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF-GAHLMGVGLSKFVPWEVMQE  385 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~-~~kl~Dfg~~~~~~~~~~~~  385 (513)
                      +|.+++...  ....+++..+..++.|++.||+|||++   +++|+||+|+||+++.++ .+||+|||.+..........
T Consensus        85 ~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~  159 (256)
T cd08220          85 TLAEYIQKR--CNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAY  159 (256)
T ss_pred             CHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcccc
Confidence            999999652  234589999999999999999999999   999999999999998654 57999999998765432211


Q ss_pred             ceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCC
Q 010309          386 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  465 (513)
Q Consensus       386 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  465 (513)
                         ...++..|+|||.+.+..++.++||||||+++|+|++|..||...+...   ...   ....         ...   
T Consensus       160 ---~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~---~~~---~~~~---------~~~---  218 (256)
T cd08220         160 ---TVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA---LVL---KIMS---------GTF---  218 (256)
T ss_pred             ---ccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH---HHH---HHHh---------cCC---
Confidence               1237889999999988888999999999999999999999997654321   110   0000         000   


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          466 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       466 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                       . ..+...+..+.+++.+||+.+|++|||+.++++
T Consensus       219 -~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         219 -A-PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             -C-CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence             0 011224567999999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-37  Score=302.37  Aligned_cols=262  Identities=19%  Similarity=0.267  Sum_probs=192.1

Q ss_pred             CCceecccCceEEEEEEeC-CCCEEEEEEecccch-hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          229 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      ..+.||+|++|.||+|... +++.||||.+..... .....+.+|+.++++++||||+++++++.+.+..++||||+. +
T Consensus         9 ~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~   87 (291)
T cd07844           9 KLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD-T   87 (291)
T ss_pred             EEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCC-C
Confidence            3457799999999999975 689999999875432 223457789999999999999999999999999999999997 4


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  386 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  386 (513)
                      +|.+++...   ...+++..+..++.|++.||.|||+.   +|+|+||||+||+++.++.+||+|||+++......... 
T Consensus        88 ~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~-  160 (291)
T cd07844          88 DLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTY-  160 (291)
T ss_pred             CHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCCccc-
Confidence            999988642   24689999999999999999999999   99999999999999999999999999987543221111 


Q ss_pred             eeecCccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhc---cc---------
Q 010309          387 TVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQS---HR---------  453 (513)
Q Consensus       387 ~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~---------  453 (513)
                       ....++..|+|||++.+ ..++.++||||||+++|+|++|+.||.......  ............   ..         
T Consensus       161 -~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (291)
T cd07844         161 -SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE--DQLHKIFRVLGTPTEETWPGVSSNPE  237 (291)
T ss_pred             -cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHhcCCCChhhhhhhhhccc
Confidence             11126788999999875 457899999999999999999999997554210  000000000000   00         


Q ss_pred             ccccccccc--cCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          454 YLELLDPLI--SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       454 ~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      .........  ...............+.+++.+||+.+|++|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence            000000000  000000001111257889999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=3.3e-37  Score=297.10  Aligned_cols=245  Identities=22%  Similarity=0.348  Sum_probs=191.8

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccc-----hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeC--CceEEEEe
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-----FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDRYIVYE  301 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lv~e  301 (513)
                      .++||+|+||.||+|... ++..||||.+....     ....+.+.+|+.++++++||||+++++++.+.  ...++|||
T Consensus         7 ~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e   86 (265)
T cd06652           7 GKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFME   86 (265)
T ss_pred             eeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEE
Confidence            457899999999999974 58999999886421     12245788899999999999999999988764  45789999


Q ss_pred             eccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcc
Q 010309          302 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE  381 (513)
Q Consensus       302 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~  381 (513)
                      |+++++|.+++..    ...+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++......
T Consensus        87 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~  159 (265)
T cd06652          87 HMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTI  159 (265)
T ss_pred             ecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccccccc
Confidence            9999999999864    23578899999999999999999999   9999999999999999999999999999865432


Q ss_pred             ccc-cceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccc
Q 010309          382 VMQ-ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP  460 (513)
Q Consensus       382 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  460 (513)
                      ... .......++..|+|||++.+..++.++||||||+++|||++|+.||...+...  ..    .....        .+
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--~~----~~~~~--------~~  225 (265)
T cd06652         160 CLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA--AI----FKIAT--------QP  225 (265)
T ss_pred             cccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH--HH----HHHhc--------CC
Confidence            111 11112237889999999988889999999999999999999999997543210  00    00000        00


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          461 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       461 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      .     ....+...+..+.+++.+|+. +|++||++++|++
T Consensus       226 ~-----~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         226 T-----NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             C-----CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence            0     111123456678899999995 9999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2.5e-37  Score=303.23  Aligned_cols=264  Identities=18%  Similarity=0.216  Sum_probs=196.0

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccchh-----cHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeec
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQ-----RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  303 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  303 (513)
                      .+.||+|++|.||+|... +++.||||.+......     ....+..|+++++.++|+||+++++++.+.+..++||||+
T Consensus         5 ~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   84 (298)
T cd07841           5 GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM   84 (298)
T ss_pred             eeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc
Confidence            346799999999999975 5899999999765432     2355778999999999999999999999999999999999


Q ss_pred             cCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccc
Q 010309          304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM  383 (513)
Q Consensus       304 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~  383 (513)
                       +++|.+++...   ...+++..+..++.||++||+|||++   +++|+||+|+||+++.++.++|+|||++........
T Consensus        85 -~~~L~~~i~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~  157 (298)
T cd07841          85 -ETDLEKVIKDK---SIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR  157 (298)
T ss_pred             -CCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence             99999999642   13699999999999999999999999   999999999999999999999999999987654321


Q ss_pred             ccceeecCccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccc-hhHHhhhHH-----hhcccccc
Q 010309          384 QERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ-SIFEWATPL-----VQSHRYLE  456 (513)
Q Consensus       384 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~-~~~~~~~~~-----~~~~~~~~  456 (513)
                      ..  ....+++.|+|||.+.+ ..++.++||||||+++|||++|.+||......... .........     ........
T Consensus       158 ~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (298)
T cd07841         158 KM--THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPD  235 (298)
T ss_pred             cc--cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccc
Confidence            11  11126778999998865 45789999999999999999998887654432110 110000000     00000000


Q ss_pred             cccccc-cCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010309          457 LLDPLI-SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  502 (513)
Q Consensus       457 ~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  502 (513)
                      ...... ............+.++.++|.+||+.||++|||+.|+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             cccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            000000 0000000112345789999999999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2e-37  Score=301.95  Aligned_cols=261  Identities=18%  Similarity=0.241  Sum_probs=196.7

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccc--hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      .+.||+|++|.||+|... +|+.||+|++....  ......+.+|+.++++++||||+++++++...+..++||||+ ++
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~   83 (286)
T cd07832           5 LGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PS   83 (286)
T ss_pred             EeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CC
Confidence            356799999999999974 68999999997653  233467899999999999999999999999999999999999 99


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  386 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  386 (513)
                      +|.+++...   ...+++.+++.++.||+.||+|||+.   +++|+||||+||+++.++.++|+|||++.......... 
T Consensus        84 ~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~-  156 (286)
T cd07832          84 DLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL-  156 (286)
T ss_pred             CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCc-
Confidence            999998642   25699999999999999999999999   99999999999999999999999999998765432111 


Q ss_pred             eeecCcccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhc------------cc
Q 010309          387 TVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQS------------HR  453 (513)
Q Consensus       387 ~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------------~~  453 (513)
                      .....++..|+|||.+.+. .++.++||||||+++|||++|.+||........   ..........            ..
T Consensus       157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07832         157 YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ---LAIVFRTLGTPNEETWPGLTSLPD  233 (286)
T ss_pred             cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHH---HHHHHHHcCCCChHHHhhccCcch
Confidence            1122378899999998654 468999999999999999999888865443211   1111000000            00


Q ss_pred             ccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          454 YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       454 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      ......+..............+..+.+++.+||+.||++|||++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            000000000000000000123478999999999999999999999985

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=4.3e-37  Score=298.39  Aligned_cols=242  Identities=21%  Similarity=0.366  Sum_probs=196.6

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCC
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  307 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs  307 (513)
                      .+.||+|+||.||+|... ++..||||.+.... ......+.+|+.++.+++||||+++++.+..++..++||||+++++
T Consensus         9 ~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   88 (277)
T cd06641           9 LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS   88 (277)
T ss_pred             heeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCc
Confidence            446799999999999864 68899999986543 2334678899999999999999999999999999999999999999


Q ss_pred             HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccce
Q 010309          308 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  387 (513)
Q Consensus       308 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  387 (513)
                      |.+++..     ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++..........  
T Consensus        89 l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~--  158 (277)
T cd06641          89 ALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--  158 (277)
T ss_pred             HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchhhh--
Confidence            9999853     4589999999999999999999999   99999999999999999999999999987654332111  


Q ss_pred             eecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCC
Q 010309          388 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS  467 (513)
Q Consensus       388 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  467 (513)
                      ....++..|+|||.+.+...+.++|+||||+++|+|++|..||.......   .   ... .....             .
T Consensus       159 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---~---~~~-~~~~~-------------~  218 (277)
T cd06641         159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK---V---LFL-IPKNN-------------P  218 (277)
T ss_pred             ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH---H---HHH-HhcCC-------------C
Confidence            11237888999999988888999999999999999999999987543211   0   000 00000             0


Q ss_pred             CCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          468 DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       468 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      .......+.++.+++.+||+.+|.+||++.++++
T Consensus       219 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  252 (277)
T cd06641         219 PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK  252 (277)
T ss_pred             CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            0111234567899999999999999999999998

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2.1e-37  Score=304.87  Aligned_cols=251  Identities=20%  Similarity=0.283  Sum_probs=196.4

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccch---hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccC
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  305 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  305 (513)
                      .+.||+|+||.||++... .++.||+|.+.....   ...+.+.+|+.+++.++||||+++++.+..++..++||||+++
T Consensus         6 ~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g   85 (305)
T cd05609           6 IKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEG   85 (305)
T ss_pred             eeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCC
Confidence            356799999999999975 478999999876532   2345788999999999999999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccc--
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM--  383 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~--  383 (513)
                      ++|.+++..    ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||+++.......  
T Consensus        86 ~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~  158 (305)
T cd05609          86 GDCATLLKN----IGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN  158 (305)
T ss_pred             CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence            999999954    24689999999999999999999999   999999999999999999999999999874211100  


Q ss_pred             -----------ccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcc
Q 010309          384 -----------QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSH  452 (513)
Q Consensus       384 -----------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  452 (513)
                                 ........++..|+|||.+.+..++.++||||||+++|||++|..||.+.....   +..   .... .
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~---~~~---~~~~-~  231 (305)
T cd05609         159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE---LFG---QVIS-D  231 (305)
T ss_pred             ccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH---HHHh-c
Confidence                       000011236788999999988889999999999999999999999997543221   111   0000 0


Q ss_pred             cccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 010309          453 RYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ  505 (513)
Q Consensus       453 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  505 (513)
                         ....+       . .....+.++.++|.+||+.||++||++.++++.|+.
T Consensus       232 ---~~~~~-------~-~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         232 ---DIEWP-------E-GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             ---ccCCC-------C-ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence               00000       0 011345678999999999999999997777766654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=2.8e-37  Score=297.06  Aligned_cols=242  Identities=21%  Similarity=0.281  Sum_probs=195.5

Q ss_pred             ecccCceEEEEEEeC-CCCEEEEEEecccch---hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCCH
Q 010309          233 LGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  308 (513)
Q Consensus       233 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL  308 (513)
                      ||.|++|.||+++.. +++.||+|++.....   ...+.+.+|+.+++.++||||+++++.+.+++..++|+||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            599999999999975 489999999975432   2346789999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccccee
Q 010309          309 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  388 (513)
Q Consensus       309 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  388 (513)
                      .+++..    ...+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++........   ..
T Consensus        81 ~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~---~~  150 (262)
T cd05572          81 WTILRD----RGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK---TW  150 (262)
T ss_pred             HHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccc---cc
Confidence            999964    24589999999999999999999999   999999999999999999999999999987654321   11


Q ss_pred             ecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCCC
Q 010309          389 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD  468 (513)
Q Consensus       389 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  468 (513)
                      ...++..|+|||.+.+..++.++|+||||+++|+|++|..||.......    ............             ..
T Consensus       151 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~-------------~~  213 (262)
T cd05572         151 TFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP----MEIYNDILKGNG-------------KL  213 (262)
T ss_pred             cccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH----HHHHHHHhccCC-------------CC
Confidence            2237889999999988889999999999999999999999997655311    010110000000             00


Q ss_pred             CCcHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 010309          469 IPEAGVVQKVVDLVYACTQHVPSMRPR-----MSHVVH  501 (513)
Q Consensus       469 ~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  501 (513)
                      ..+...++++.++|.+||+.+|++||+     +.|+++
T Consensus       214 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         214 EFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             CCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            111122567999999999999999999     777765

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=2e-38  Score=284.19  Aligned_cols=244  Identities=23%  Similarity=0.399  Sum_probs=195.6

Q ss_pred             eecccCceEEEEEEeC-CCCEEEEEEecccch-hcHHHHHHHHHHHhhcC-CCcEeeeeeEEeeCCceEEEEeeccCCCH
Q 010309          232 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF-QRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVYEFVVNGPL  308 (513)
Q Consensus       232 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~~gsL  308 (513)
                      .||.|..|.|++.+.. .|...|||.+.+... ...++++..+.++.+.+ .|.||+.+|+|..+...++.||.| ..-+
T Consensus        99 dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM-s~C~  177 (391)
T KOG0983|consen   99 DLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM-STCA  177 (391)
T ss_pred             hhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-HHHH
Confidence            4699999999999965 589999999987643 34467788888777664 899999999999999999999998 4456


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccccee
Q 010309          309 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  388 (513)
Q Consensus       309 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  388 (513)
                      +.++..   ...++++..+-++...+++||.||-+++  +|+|||+||+|||+|..|++||+|||++-.+.....+....
T Consensus       178 ekLlkr---ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAhtrsA  252 (391)
T KOG0983|consen  178 EKLLKR---IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHTRSA  252 (391)
T ss_pred             HHHHHH---hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccccccccc
Confidence            666653   3467999999999999999999999876  99999999999999999999999999998876554443332


Q ss_pred             ecCccccccccccccc---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCC
Q 010309          389 MAGGTYGYLAPEFVYR---NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  465 (513)
Q Consensus       389 ~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  465 (513)
                         |.+.|||||.+.-   ..|+.++||||||++|+||.||..||.+.+.+     ++......+      -..+.+   
T Consensus       253 ---GC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td-----Fe~ltkvln------~ePP~L---  315 (391)
T KOG0983|consen  253 ---GCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD-----FEVLTKVLN------EEPPLL---  315 (391)
T ss_pred             ---CCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc-----HHHHHHHHh------cCCCCC---
Confidence               8899999999864   46888999999999999999999999875432     111111111      011222   


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          466 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       466 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                         ....++++.+.+++..||..|+.+||...++++
T Consensus       316 ---~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  316 ---PGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             ---CcccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence               112337889999999999999999999999886

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=6.3e-37  Score=301.80  Aligned_cols=241  Identities=24%  Similarity=0.391  Sum_probs=192.6

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccch---hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccC
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  305 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  305 (513)
                      .+.||+|++|.||+|... +++.||+|.+.....   ...+.+.+|+.+++.++||||+++.+++.+.+..++||||+. 
T Consensus        20 ~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-   98 (307)
T cd06607          20 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-   98 (307)
T ss_pred             heeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-
Confidence            346799999999999975 589999999864422   234578899999999999999999999999999999999996 


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccc
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  385 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  385 (513)
                      |+|.+++...   ...+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.......   
T Consensus        99 g~l~~~~~~~---~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~---  169 (307)
T cd06607          99 GSASDILEVH---KKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN---  169 (307)
T ss_pred             CCHHHHHHHc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCCC---
Confidence            5777776532   24689999999999999999999999   99999999999999999999999999987654321   


Q ss_pred             ceeecCcccccccccccc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccc
Q 010309          386 RTVMAGGTYGYLAPEFVY---RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI  462 (513)
Q Consensus       386 ~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  462 (513)
                         ...++..|+|||++.   ...++.++||||||+++|||+||..||...+....      ...... .          
T Consensus       170 ---~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~------~~~~~~-~----------  229 (307)
T cd06607         170 ---SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQ-N----------  229 (307)
T ss_pred             ---CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH------HHHHhc-C----------
Confidence               123788999999874   35678899999999999999999999876543210      000000 0          


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010309          463 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  502 (513)
Q Consensus       463 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  502 (513)
                        ..........+..+.+++.+||+.||++||++.+|+..
T Consensus       230 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         230 --DSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             --CCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence              00111223456789999999999999999999999873

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=4.3e-37  Score=298.68  Aligned_cols=241  Identities=20%  Similarity=0.248  Sum_probs=187.0

Q ss_pred             eecccCceEEEEEEeC-CCCEEEEEEecccchh---cHHHHHHHHHHHh---hcCCCcEeeeeeEEeeCCceEEEEeecc
Q 010309          232 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQ---RKKEFYSEIGRFA---RLHHPNLVAVKGCCYDHGDRYIVYEFVV  304 (513)
Q Consensus       232 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~---~l~h~nIv~l~~~~~~~~~~~lv~e~~~  304 (513)
                      +||+|+||.||++... +++.||+|.+.+....   ....+.+|..++.   ..+||||+.+++.+...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            3799999999999974 5899999998754221   1233444444333   3479999999999999999999999999


Q ss_pred             CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccc
Q 010309          305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  384 (513)
Q Consensus       305 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  384 (513)
                      +++|.+++..    ...+++..+..++.|++.||+|||+.   +|+|+||||+|||++.++.++|+|||++........ 
T Consensus        81 ~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~-  152 (279)
T cd05633          81 GGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-  152 (279)
T ss_pred             CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc-
Confidence            9999998854    34699999999999999999999999   999999999999999999999999999875533221 


Q ss_pred             cceeecCccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccccccccccc
Q 010309          385 ERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS  463 (513)
Q Consensus       385 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  463 (513)
                         ....|+..|+|||.+.. ..++.++||||||+++|+|++|..||.............    ...      ..     
T Consensus       153 ---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~----~~~------~~-----  214 (279)
T cd05633         153 ---HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR----MTL------TV-----  214 (279)
T ss_pred             ---cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHH----Hhh------cC-----
Confidence               12238999999998864 567899999999999999999999997654321111100    000      00     


Q ss_pred             CCCCCCCcHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 010309          464 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRP-----RMSHVVH  501 (513)
Q Consensus       464 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  501 (513)
                         ....+...+.++.++|.+||+.||++||     |++++++
T Consensus       215 ---~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~  254 (279)
T cd05633         215 ---NVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE  254 (279)
T ss_pred             ---CcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence               0011223566799999999999999999     5998887

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=4.3e-37  Score=298.41  Aligned_cols=244  Identities=21%  Similarity=0.279  Sum_probs=193.0

Q ss_pred             ecccCceEEEEEEeC-CCCEEEEEEecccch---hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCCH
Q 010309          233 LGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  308 (513)
Q Consensus       233 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL  308 (513)
                      ||+|+||+||++... +|+.||+|.+.....   .....+.+|+.++++++||||+++++.+...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            599999999999864 589999999975422   2344567899999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccccee
Q 010309          309 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  388 (513)
Q Consensus       309 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  388 (513)
                      .+++...  ....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||.+.........   .
T Consensus        81 ~~~l~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~---~  152 (277)
T cd05577          81 KYHIYNV--GEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKI---K  152 (277)
T ss_pred             HHHHHHc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCCcc---c
Confidence            9998652  224689999999999999999999999   9999999999999999999999999998765432111   1


Q ss_pred             ecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCCC
Q 010309          389 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD  468 (513)
Q Consensus       389 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  468 (513)
                      ...++..|+|||++.+..++.++||||||+++|+|++|+.||............      .. .    .. ..     ..
T Consensus       153 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~------~~-~----~~-~~-----~~  215 (277)
T cd05577         153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEEL------KR-R----TL-EM-----AV  215 (277)
T ss_pred             cccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHH------Hh-c----cc-cc-----cc
Confidence            123778999999998888999999999999999999999999765431100000      00 0    00 00     00


Q ss_pred             CCcHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 010309          469 IPEAGVVQKVVDLVYACTQHVPSMRP-----RMSHVVH  501 (513)
Q Consensus       469 ~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  501 (513)
                      ..+...++.+.++|.+||+.||++||     ++.++++
T Consensus       216 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         216 EYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             cCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            11122466799999999999999999     6666764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-38  Score=302.49  Aligned_cols=255  Identities=22%  Similarity=0.288  Sum_probs=211.2

Q ss_pred             HHHHHhhCcccCCceecccCceEEEEEEeC-CCCEEEEEEecccch---hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeC
Q 010309          218 ELRSITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDH  293 (513)
Q Consensus       218 ~l~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  293 (513)
                      |++.++.+.....++||+|+||.||..... +|+.+|.|.+.+...   ......++|-.+|.+++.+.||.+-..+++.
T Consensus       178 E~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTk  257 (591)
T KOG0986|consen  178 ELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETK  257 (591)
T ss_pred             HhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCC
Confidence            556677777788899999999999998854 699999999876533   2345678899999999999999999999999


Q ss_pred             CceEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEeccc
Q 010309          294 GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVG  373 (513)
Q Consensus       294 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg  373 (513)
                      +.+++|+..|.||+|.-+|.+.  ++..++++.++.++.+|+.||.+||+.   +||.|||||+|||+|+.|+++|+|+|
T Consensus       258 d~LClVLtlMNGGDLkfHiyn~--g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLG  332 (591)
T KOG0986|consen  258 DALCLVLTLMNGGDLKFHIYNH--GNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLG  332 (591)
T ss_pred             CceEEEEEeecCCceeEEeecc--CCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccc
Confidence            9999999999999999998763  346799999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccc
Q 010309          374 LSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHR  453 (513)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  453 (513)
                      +|..+.........   .||.+|||||++.++.|+...|-|||||+||||+.|..||....+..        ..      
T Consensus       333 LAvei~~g~~~~~r---vGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv--------k~------  395 (591)
T KOG0986|consen  333 LAVEIPEGKPIRGR---VGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV--------KR------  395 (591)
T ss_pred             eEEecCCCCccccc---cCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh--------hH------
Confidence            99988765544333   39999999999999999999999999999999999999997543210        00      


Q ss_pred             ccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 010309          454 YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMS  497 (513)
Q Consensus       454 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  497 (513)
                        +-++.+.... ....+..+++++.+|....|..||++|....
T Consensus       396 --eEvdrr~~~~-~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  396 --EEVDRRTLED-PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             --HHHHHHHhcc-hhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence              0111111111 2223356888999999999999999996443

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=2e-37  Score=302.05  Aligned_cols=263  Identities=24%  Similarity=0.294  Sum_probs=194.9

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccchh--cHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQ--RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      .+.||+|++|.||+|... +++.||+|++......  ..+.+.+|+++++.++||||+++++++..++..++||||++++
T Consensus         6 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   85 (286)
T cd07846           6 LGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHT   85 (286)
T ss_pred             eeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCcc
Confidence            456799999999999975 5899999998654322  3457889999999999999999999999999999999999999


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  386 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  386 (513)
                      +|..+...    ...+++..++.++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++.......... 
T Consensus        86 ~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~-  157 (286)
T cd07846          86 VLDDLEKY----PNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY-  157 (286)
T ss_pred             HHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcccc-
Confidence            99887643    23589999999999999999999999   99999999999999999999999999988654332211 


Q ss_pred             eeecCcccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCcccc-chhHHhhhHHhhccc----ccccccc
Q 010309          387 TVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW-QSIFEWATPLVQSHR----YLELLDP  460 (513)
Q Consensus       387 ~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~----~~~~~~~  460 (513)
                       ....++..|+|||++.+. .++.++||||||+++|||++|++||......+. ..+............    .......
T Consensus       158 -~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T cd07846         158 -TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG  236 (286)
T ss_pred             -CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhc
Confidence             112278899999998753 468899999999999999999999875443210 000000000000000    0000000


Q ss_pred             cc-cCCCCC----CCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          461 LI-SSLSSD----IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       461 ~~-~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      .. ......    ......+..+.+|+.+||+.+|++||++.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         237 MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             cccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            00 000000    001134677999999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=5.9e-37  Score=298.80  Aligned_cols=245  Identities=22%  Similarity=0.358  Sum_probs=199.2

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCCH
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  308 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL  308 (513)
                      ...||+|++|.||+|... ++..||+|++..... ..+.+.+|+++++.++|+||+++++.+...+..++|+||+++++|
T Consensus        24 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L  102 (286)
T cd06614          24 LEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSL  102 (286)
T ss_pred             hHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcH
Confidence            356799999999999986 689999999976543 567788999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccccee
Q 010309          309 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  388 (513)
Q Consensus       309 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  388 (513)
                      .+++....   ..+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++..........  .
T Consensus       103 ~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~--~  174 (286)
T cd06614         103 TDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKR--N  174 (286)
T ss_pred             HHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhh--c
Confidence            99997522   3799999999999999999999999   99999999999999999999999999987654332111  1


Q ss_pred             ecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCCC
Q 010309          389 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD  468 (513)
Q Consensus       389 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  468 (513)
                      ...++..|+|||.+.+..++.++||||||+++|+|++|..||...+....  .    ..... ..        .   ...
T Consensus       175 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~--~----~~~~~-~~--------~---~~~  236 (286)
T cd06614         175 SVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA--L----FLITT-KG--------I---PPL  236 (286)
T ss_pred             cccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH--H----HHHHh-cC--------C---CCC
Confidence            12277899999999888899999999999999999999999875443210  0    00000 00        0   011


Q ss_pred             CCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          469 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       469 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      .....++..+.++|.+||+.+|.+||++.++++
T Consensus       237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         237 KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             cchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            111224567999999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-37  Score=309.01  Aligned_cols=246  Identities=21%  Similarity=0.327  Sum_probs=203.9

Q ss_pred             CcccCCceecccCceEEEEEEeC-CCCEEEEEEecccchhc--HHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEe
Q 010309          225 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQR--KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE  301 (513)
Q Consensus       225 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  301 (513)
                      +++...+.||+|.|+.|.+|+.. ++..||||.+.+.....  .+.+.+|+++|..|+|||||+++.+......+|+|||
T Consensus        56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~e  135 (596)
T KOG0586|consen   56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVME  135 (596)
T ss_pred             cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEE
Confidence            34555667899999999999964 59999999998874433  3558999999999999999999999999999999999


Q ss_pred             eccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcc
Q 010309          302 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE  381 (513)
Q Consensus       302 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~  381 (513)
                      |+.+|.+.+++.+    ...+.+..+..++.|+.+|++|||++   +|+|||||++||||+.+.++||+|||++..+...
T Consensus       136 ya~~ge~~~yl~~----~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~  208 (596)
T KOG0586|consen  136 YASGGELFDYLVK----HGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDYG  208 (596)
T ss_pred             eccCchhHHHHHh----cccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeeccc
Confidence            9999999999975    34566688999999999999999999   9999999999999999999999999999988754


Q ss_pred             ccccceeecCcccccccccccccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccc
Q 010309          382 VMQERTVMAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP  460 (513)
Q Consensus       382 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  460 (513)
                      ...   ...+|++.|.|||++.+..| ++.+|+||+|++||-|+.|..||++..-.+..                   ..
T Consensus       209 ~~l---qt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr-------------------~r  266 (596)
T KOG0586|consen  209 LML---QTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR-------------------PR  266 (596)
T ss_pred             ccc---cccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc-------------------ch
Confidence            433   34559999999999998876 57999999999999999999999875432111                   11


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          461 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       461 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      .+.+...  -+.-.+.++.++|+++|-.+|.+|++++++.+
T Consensus       267 vl~gk~r--Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  267 VLRGKYR--IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             heeeeec--ccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence            1111001  11224556889999999999999999999876

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=7.1e-37  Score=294.39  Aligned_cols=248  Identities=27%  Similarity=0.426  Sum_probs=198.1

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccchh--cHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQ--RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      .+.||+|++|.||+|... +++.||+|.++.....  ..+.+.+|+.+++.++|+||+++++.+...+..++|+||++++
T Consensus         5 ~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (264)
T cd06626           5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGG   84 (264)
T ss_pred             eeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCC
Confidence            456799999999999964 6899999999766443  5678899999999999999999999999999999999999999


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  386 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  386 (513)
                      +|.+++..    ...+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||++...........
T Consensus        85 ~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~  157 (264)
T cd06626          85 TLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG  157 (264)
T ss_pred             cHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence            99999864    24578899999999999999999999   999999999999999999999999999987654322211


Q ss_pred             e--eecCcccccccccccccCC---CCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccccccccc
Q 010309          387 T--VMAGGTYGYLAPEFVYRNE---LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL  461 (513)
Q Consensus       387 ~--~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  461 (513)
                      .  ....++..|+|||++.+..   .+.++||||||+++|+|++|..||...+.. ....    ..... .     ..+.
T Consensus       158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-~~~~----~~~~~-~-----~~~~  226 (264)
T cd06626         158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-FQIM----FHVGA-G-----HKPP  226 (264)
T ss_pred             ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-HHHH----HHHhc-C-----CCCC
Confidence            1  1123788999999998766   789999999999999999999999754321 0000    00000 0     0000


Q ss_pred             ccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          462 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       462 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      +      ......++.+.+++.+||+.+|++|||+.+++.
T Consensus       227 ~------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         227 I------PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             C------CcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0      111123567889999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.2e-36  Score=301.10  Aligned_cols=246  Identities=23%  Similarity=0.400  Sum_probs=194.2

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccch---hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccC
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  305 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  305 (513)
                      .+.||+|+||.||++... ++..||+|.+.....   .....+.+|+.++++++|||++++++++.+++..++||||+. 
T Consensus        30 ~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-  108 (317)
T cd06635          30 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-  108 (317)
T ss_pred             hheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCC-
Confidence            345799999999999964 688999999875422   234578899999999999999999999999999999999996 


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccc
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  385 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  385 (513)
                      |+|.+++..   ....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.......   
T Consensus       109 g~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~~---  179 (317)
T cd06635         109 GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPAN---  179 (317)
T ss_pred             CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCcc---
Confidence            578777653   235689999999999999999999999   99999999999999999999999999987543221   


Q ss_pred             ceeecCcccccccccccc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccc
Q 010309          386 RTVMAGGTYGYLAPEFVY---RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI  462 (513)
Q Consensus       386 ~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  462 (513)
                         ...+++.|+|||++.   .+.++.++||||||+++|||++|..||...+...  ..    .......         .
T Consensus       180 ---~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--~~----~~~~~~~---------~  241 (317)
T cd06635         180 ---SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--AL----YHIAQNE---------S  241 (317)
T ss_pred             ---cccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH--HH----HHHHhcc---------C
Confidence               123788999999874   4568899999999999999999999987643211  00    0000000         0


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCc
Q 010309          463 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  507 (513)
Q Consensus       463 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  507 (513)
                          ........++.+.+++.+||+.+|.+||++.++++.+-.+.
T Consensus       242 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  282 (317)
T cd06635         242 ----PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR  282 (317)
T ss_pred             ----CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence                11112234567999999999999999999999998654333

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=7e-37  Score=299.36  Aligned_cols=262  Identities=22%  Similarity=0.271  Sum_probs=193.3

Q ss_pred             ceecccCceEEEEEEeC-CCCEEEEEEecccchh--cHHHHHHHHHHHhhcCCCcEeeeeeEEeeC--CceEEEEeeccC
Q 010309          231 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQ--RKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDRYIVYEFVVN  305 (513)
Q Consensus       231 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lv~e~~~~  305 (513)
                      +.||+|++|.||+|... +++.+|+|.++.....  ....+.+|+.++++++||||+++++++...  +..++||||++ 
T Consensus        11 ~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~-   89 (293)
T cd07843          11 NRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE-   89 (293)
T ss_pred             hhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcC-
Confidence            45799999999999975 5889999999754322  234567899999999999999999998877  88999999996 


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccc
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  385 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  385 (513)
                      ++|.+++...   ...+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++..........
T Consensus        90 ~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~  163 (293)
T cd07843          90 HDLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY  163 (293)
T ss_pred             cCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccCCcccc
Confidence            5999888642   23689999999999999999999999   99999999999999999999999999998765432111


Q ss_pred             ceeecCcccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCccccch-hHHhh-------hHHhhccc-c-
Q 010309          386 RTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS-IFEWA-------TPLVQSHR-Y-  454 (513)
Q Consensus       386 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~-~~~~~-------~~~~~~~~-~-  454 (513)
                        ....+++.|+|||.+.+. .++.++||||||+++|+|++|.+||.......... +....       .+...... . 
T Consensus       164 --~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (293)
T cd07843         164 --TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAK  241 (293)
T ss_pred             --ccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhc
Confidence              112267889999998764 46889999999999999999999997654321110 00000       00000000 0 


Q ss_pred             -cccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          455 -LELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       455 -~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                       ...............+....++.+.++|.+||+.||++|||+.|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         242 KKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             ccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence             00000000000011111113667899999999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2e-37  Score=297.35  Aligned_cols=243  Identities=21%  Similarity=0.311  Sum_probs=197.8

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccch---hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccC
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  305 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  305 (513)
                      .+.||.|+||.||++... +++.||+|.+.+...   ...+.+.+|++++++++||||+++++.+.+++..++|+||+.+
T Consensus         5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   84 (258)
T cd05578           5 LRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLG   84 (258)
T ss_pred             EEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCC
Confidence            457899999999999975 589999999976432   3457889999999999999999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccc
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  385 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  385 (513)
                      ++|.+++..    ...+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||.+......... 
T Consensus        85 ~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-  156 (258)
T cd05578          85 GDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT-  156 (258)
T ss_pred             CCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCccc-
Confidence            999999964    24689999999999999999999999   9999999999999999999999999999876543211 


Q ss_pred             ceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCC
Q 010309          386 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  465 (513)
Q Consensus       386 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  465 (513)
                        ....++..|+|||.+.+..++.++|+||||+++|+|++|..||...+......+.    .....        .     
T Consensus       157 --~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~----~~~~~--------~-----  217 (258)
T cd05578         157 --TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR----AKQET--------A-----  217 (258)
T ss_pred             --cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHH----HHhcc--------c-----
Confidence              1223788999999998888999999999999999999999999866532111111    00000        0     


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCCCH--HHHH
Q 010309          466 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRM--SHVV  500 (513)
Q Consensus       466 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~--~evl  500 (513)
                       ....+...+..+.++|.+||+.||.+||++  +|++
T Consensus       218 -~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         218 -DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             -cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence             111122345779999999999999999999  5554

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-38  Score=285.79  Aligned_cols=255  Identities=20%  Similarity=0.271  Sum_probs=203.7

Q ss_pred             HHhhCcccCCceecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeC----C
Q 010309          221 SITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDH----G  294 (513)
Q Consensus       221 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~----~  294 (513)
                      .++.+|....++||-|-.|.|-....+ +++++|+|++...     ...++|+++.-.. .|||||.+++++++.    .
T Consensus        58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk  132 (400)
T KOG0604|consen   58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRK  132 (400)
T ss_pred             cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence            467778888889999999999988864 6899999998543     4456788766555 699999999998753    4


Q ss_pred             ceEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecC---CCCeEEec
Q 010309          295 DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE---EFGAHLMG  371 (513)
Q Consensus       295 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~---~~~~kl~D  371 (513)
                      .+.+|||.|+||.|...+++  ++...+++.++-.|.+||..|+.|||+.   +|.||||||+|+|.+.   |-.+||+|
T Consensus       133 cLLiVmE~meGGeLfsriq~--~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtD  207 (400)
T KOG0604|consen  133 CLLIVMECMEGGELFSRIQD--RGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTD  207 (400)
T ss_pred             eeEeeeecccchHHHHHHHH--cccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecc
Confidence            56899999999999999976  4557799999999999999999999999   9999999999999964   44589999


Q ss_pred             ccccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhc
Q 010309          372 VGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQS  451 (513)
Q Consensus       372 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  451 (513)
                      ||+|+.....   ......+-|+.|.|||++...+|+...|+||+||++|-|++|.+||.......+.   .-.+..+..
T Consensus       208 fGFAK~t~~~---~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ais---pgMk~rI~~  281 (400)
T KOG0604|consen  208 FGFAKETQEP---GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---PGMKRRIRT  281 (400)
T ss_pred             cccccccCCC---ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCC---hhHHhHhhc
Confidence            9999876532   2334456899999999999999999999999999999999999999765432111   001111111


Q ss_pred             ccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          452 HRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       452 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      +.+          ..+.......++...++|+.+|..+|.+|.|++++++
T Consensus       282 gqy----------~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  282 GQY----------EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             cCc----------cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence            110          0123334578899999999999999999999999986

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=6.3e-37  Score=299.27  Aligned_cols=239  Identities=23%  Similarity=0.324  Sum_probs=195.4

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccc---hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccC
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  305 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  305 (513)
                      .+.||+|++|.||++... +++.||+|++....   ....+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus         6 ~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~   85 (290)
T cd05580           6 IKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPG   85 (290)
T ss_pred             EEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCC
Confidence            457899999999999975 58999999997542   23346788999999999999999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccc
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  385 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  385 (513)
                      ++|.+++..    ...+++..+..++.|++.||.|||+.   +++|+||+|+|||++.++.+||+|||++......    
T Consensus        86 ~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~----  154 (290)
T cd05580          86 GELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----  154 (290)
T ss_pred             CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC----
Confidence            999999864    25689999999999999999999999   9999999999999999999999999999876443    


Q ss_pred             ceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCC
Q 010309          386 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  465 (513)
Q Consensus       386 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  465 (513)
                       .....+++.|+|||.+.+...+.++||||||+++|+|++|..||...+..   ....   ... ...      .     
T Consensus       155 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~---~~~-~~~------~-----  215 (290)
T cd05580         155 -TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI---QIYE---KIL-EGK------V-----  215 (290)
T ss_pred             -CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---HHHH---HHh-cCC------c-----
Confidence             11223889999999998888899999999999999999999999765421   0000   000 000      0     


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 010309          466 SSDIPEAGVVQKVVDLVYACTQHVPSMRP-----RMSHVVH  501 (513)
Q Consensus       466 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  501 (513)
                         ..+...+..+.+++.+||+.||.+||     +++++++
T Consensus       216 ---~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         216 ---RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             ---cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence               01112356789999999999999999     7777763

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-37  Score=298.58  Aligned_cols=265  Identities=23%  Similarity=0.282  Sum_probs=196.8

Q ss_pred             CCceecccCceEEEEEEeC-CCCEEEEEEecccc--hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccC
Q 010309          229 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  305 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  305 (513)
                      ..+.||+|++|.||+|... +++.||||.++...  ....+.+.+|++++++++|+||+++++++...+..++||||+++
T Consensus         5 ~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~   84 (288)
T cd07833           5 VLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVER   84 (288)
T ss_pred             EEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCC
Confidence            3456799999999999975 58899999987542  23346789999999999999999999999999999999999988


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccc
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  385 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  385 (513)
                      +.|..++..    ...+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||++..........
T Consensus        85 ~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~  157 (288)
T cd07833          85 TLLELLEAS----PGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASP  157 (288)
T ss_pred             CHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccc
Confidence            777665532    34589999999999999999999999   99999999999999999999999999998765443211


Q ss_pred             ceeecCcccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCccccc-hhHHhhhHHhhccccccccccccc
Q 010309          386 RTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ-SIFEWATPLVQSHRYLELLDPLIS  463 (513)
Q Consensus       386 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  463 (513)
                      . ....++..|+|||++.+. .++.++||||||+++|+|++|.+||......... ...................++...
T Consensus       158 ~-~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07833         158 L-TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFA  236 (288)
T ss_pred             c-cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccc
Confidence            1 112378889999999887 7899999999999999999999999764332100 000000000000000000000000


Q ss_pred             C-----CC-----CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          464 S-----LS-----SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       464 ~-----~~-----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      .     ..     ....+..++.++.+||.+||+.+|++|||++++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             ccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            0     00     00011123678999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=7.6e-37  Score=298.85  Aligned_cols=243  Identities=22%  Similarity=0.353  Sum_probs=197.2

Q ss_pred             ceecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCCHH
Q 010309          231 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD  309 (513)
Q Consensus       231 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~  309 (513)
                      ..||+|++|.||++... +++.||||.+..........+.+|+.+++.++|+||+++++.+...+..++||||+++++|.
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  105 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT  105 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence            35799999999999874 68999999987655555677899999999999999999999999999999999999999999


Q ss_pred             HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccceee
Q 010309          310 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM  389 (513)
Q Consensus       310 ~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  389 (513)
                      +++..     ..+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++.........  ...
T Consensus       106 ~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~--~~~  175 (292)
T cd06657         106 DIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKS  175 (292)
T ss_pred             HHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccccc--ccc
Confidence            98753     3588999999999999999999999   9999999999999999999999999998765432211  112


Q ss_pred             cCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCCCC
Q 010309          390 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDI  469 (513)
Q Consensus       390 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  469 (513)
                      ..+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.......       ..     ......+.      
T Consensus       176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~-------~~-----~~~~~~~~------  237 (292)
T cd06657         176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM-------IR-----DNLPPKLK------  237 (292)
T ss_pred             cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------HH-----hhCCcccC------
Confidence            2378899999999888889999999999999999999999876433211100       00     00011110      


Q ss_pred             CcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          470 PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       470 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      .....+..+.+++.+||+.||.+||++.++++
T Consensus       238 ~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         238 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             CcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            01123456889999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=4.7e-37  Score=299.11  Aligned_cols=257  Identities=21%  Similarity=0.291  Sum_probs=193.4

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccch--hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      .+.||.|++|.||+|+.. +|+.||||.+.....  .....+.+|++++++++||||+++++++.+.+..++||||+. +
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~   83 (284)
T cd07860           5 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-Q   83 (284)
T ss_pred             eeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-c
Confidence            346799999999999975 689999999875432  233578899999999999999999999999999999999995 6


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  386 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  386 (513)
                      +|.+++...  ....+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.+||+|||++.......... 
T Consensus        84 ~l~~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~-  157 (284)
T cd07860          84 DLKKFMDAS--PLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-  157 (284)
T ss_pred             CHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcccc-
Confidence            898888652  235689999999999999999999999   99999999999999999999999999987654322111 


Q ss_pred             eeecCcccccccccccccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhc--------------
Q 010309          387 TVMAGGTYGYLAPEFVYRNE-LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQS--------------  451 (513)
Q Consensus       387 ~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--------------  451 (513)
                       ....+++.|+|||++.+.. ++.++||||||+++|||+||+.||...+...  ............              
T Consensus       158 -~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07860         158 -THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTLGTPDEVVWPGVTSLPDY  234 (284)
T ss_pred             -ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhhhhHHHHH
Confidence             1122678899999887644 5889999999999999999999997644321  111100000000              


Q ss_pred             -ccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          452 -HRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       452 -~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                       ..+..........     .....++++.++|.+||+.||++|||++++++
T Consensus       235 ~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         235 KPSFPKWARQDFSK-----VVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HhhcccccccCHHH-----HcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence             0000000000000     00123467889999999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.4e-36  Score=296.83  Aligned_cols=262  Identities=18%  Similarity=0.218  Sum_probs=190.5

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccch-hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCC
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  307 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs  307 (513)
                      .+.||+|+||.||+|... +|+.||+|++..... .....+.+|+.+++.++|+||+++++++..++..++||||+. ++
T Consensus        10 ~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~   88 (291)
T cd07870          10 LEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TD   88 (291)
T ss_pred             EEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CC
Confidence            456799999999999864 689999999975432 223467889999999999999999999999999999999995 67


Q ss_pred             HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccce
Q 010309          308 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  387 (513)
Q Consensus       308 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  387 (513)
                      |.+++..   ....+++..+..++.|++.||.|||+.   +|+|+||||+|||++.++.++|+|||+++.........  
T Consensus        89 l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~--  160 (291)
T cd07870          89 LAQYMIQ---HPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTY--  160 (291)
T ss_pred             HHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCC--
Confidence            7776643   124578888999999999999999999   99999999999999999999999999987643322111  


Q ss_pred             eecCcccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhh-----------HHhhccccc
Q 010309          388 VMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWAT-----------PLVQSHRYL  455 (513)
Q Consensus       388 ~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~-----------~~~~~~~~~  455 (513)
                      ....+++.|+|||++.+. .++.++||||||+++|||++|..||...+... ..+.....           .........
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (291)
T cd07870         161 SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF-EQLEKIWTVLGVPTEDTWPGVSKLPNYK  239 (291)
T ss_pred             CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH-HHHHHHHHHcCCCChhhhhhhhhccccc
Confidence            112268899999998754 57889999999999999999999997654321 11100000           000000000


Q ss_pred             ccccccc-cC-CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          456 ELLDPLI-SS-LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       456 ~~~~~~~-~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      ....... .. ..........+..+.+++.+|+..||++|||+.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         240 PEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             chhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence            0000000 00 0000000012457889999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=9.8e-37  Score=306.34  Aligned_cols=266  Identities=20%  Similarity=0.304  Sum_probs=196.2

Q ss_pred             HhhCcccCCceecccCceEEEEEEeC-CCCEEEEEEeccc--chhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeC-----
Q 010309          222 ITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH-----  293 (513)
Q Consensus       222 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----  293 (513)
                      +.+.|.. .+.||+|+||.||+|... +|+.||||.+...  .......+.+|+.++++++||||+++++++...     
T Consensus        14 ~~~~y~~-~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   92 (353)
T cd07850          14 VLKRYQN-LKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE   92 (353)
T ss_pred             hhcceEE-EEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence            4455554 456799999999999964 6899999998653  223345678899999999999999999988644     


Q ss_pred             -CceEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecc
Q 010309          294 -GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV  372 (513)
Q Consensus       294 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df  372 (513)
                       ...++||||+. ++|.+.+..      .++...+..++.|++.||+|||+.   +++||||||+||+++.++.+||+||
T Consensus        93 ~~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Df  162 (353)
T cd07850          93 FQDVYLVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF  162 (353)
T ss_pred             cCcEEEEEeccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccC
Confidence             35699999995 588887742      288999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccc-chhHH--------
Q 010309          373 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW-QSIFE--------  443 (513)
Q Consensus       373 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~-~~~~~--------  443 (513)
                      |++.........   ....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.... ..+..        
T Consensus       163 g~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  239 (353)
T cd07850         163 GLARTAGTSFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDE  239 (353)
T ss_pred             ccceeCCCCCCC---CCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence            999866433221   112378899999999999999999999999999999999999976543110 00000        


Q ss_pred             ---hhh----HHhhcc------cccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          444 ---WAT----PLVQSH------RYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       444 ---~~~----~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                         ...    ......      .+.+..................+..+.++|.+||+.||++|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         240 FMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             HHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence               000    000000      0001111111000011112234667899999999999999999999985

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-36  Score=298.87  Aligned_cols=267  Identities=18%  Similarity=0.256  Sum_probs=193.4

Q ss_pred             ceecccCceEEEEEEeC---CCCEEEEEEecccc---hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeC--CceEEEEee
Q 010309          231 RLLGDSKTGGTYSGILP---DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDRYIVYEF  302 (513)
Q Consensus       231 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lv~e~  302 (513)
                      +.||+|++|.||+|...   +++.||+|.+....   ......+.+|+.++.+++||||+++++++.+.  +..++||||
T Consensus         6 ~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~   85 (316)
T cd07842           6 GCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDY   85 (316)
T ss_pred             EEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeC
Confidence            45799999999999975   47899999998742   23346778899999999999999999999988  789999999


Q ss_pred             ccCCCHHHHhccCCCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecC----CCCeEEeccccccc
Q 010309          303 VVNGPLDRWLHHIPRG-GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE----EFGAHLMGVGLSKF  377 (513)
Q Consensus       303 ~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~----~~~~kl~Dfg~~~~  377 (513)
                      +++ +|.+++...... ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.    ++.+||+|||++..
T Consensus        86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~  161 (316)
T cd07842          86 AEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARL  161 (316)
T ss_pred             CCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCCccccc
Confidence            964 677766543322 23789999999999999999999999   9999999999999999    89999999999987


Q ss_pred             CCccccc-cceeecCcccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCccccch------hHHhhhHHh
Q 010309          378 VPWEVMQ-ERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS------IFEWATPLV  449 (513)
Q Consensus       378 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~------~~~~~~~~~  449 (513)
                      ....... .......+++.|+|||++.+. .++.++||||||+++|+|++|.+||..........      .........
T Consensus       162 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  241 (316)
T cd07842         162 FNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVL  241 (316)
T ss_pred             cCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHh
Confidence            6433221 111122378889999988764 57899999999999999999999997654432000      000000000


Q ss_pred             h------------cccccccccccccCCCC-CCC----cH--HHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          450 Q------------SHRYLELLDPLISSLSS-DIP----EA--GVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       450 ~------------~~~~~~~~~~~~~~~~~-~~~----~~--~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      .            ........+........ ...    ..  ..+.++.+++.+||+.||++|||+.|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         242 GTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             CCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            0            00000000000000000 000    00  23457899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.7e-36  Score=289.10  Aligned_cols=245  Identities=24%  Similarity=0.390  Sum_probs=200.3

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCCH
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  308 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL  308 (513)
                      .+.||+|++|.||++... +++.+++|++..........+.+|+.++++++||||+++++++...+..++++||+++++|
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L   84 (253)
T cd05122           5 LEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSL   84 (253)
T ss_pred             eeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcH
Confidence            346799999999999975 6899999999876555667899999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccccee
Q 010309          309 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  388 (513)
Q Consensus       309 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  388 (513)
                      .+++...   ...+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||.+........   ..
T Consensus        85 ~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~  155 (253)
T cd05122          85 KDLLKST---NQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---RN  155 (253)
T ss_pred             HHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc---cc
Confidence            9998652   25689999999999999999999998   999999999999999999999999999987654332   11


Q ss_pred             ecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCCC
Q 010309          389 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD  468 (513)
Q Consensus       389 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  468 (513)
                      ...++..|+|||.+.+..++.++||||||+++|+|++|..||...+......      .. ......           ..
T Consensus       156 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~------~~-~~~~~~-----------~~  217 (253)
T cd05122         156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF------KI-ATNGPP-----------GL  217 (253)
T ss_pred             ceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHH------HH-HhcCCC-----------Cc
Confidence            2237889999999988888999999999999999999999987653211000      00 000000           00


Q ss_pred             CCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          469 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       469 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      ......+..+.+++.+||+.||++|||+.++++
T Consensus       218 ~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         218 RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             CcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            011112567999999999999999999999985

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=6.1e-37  Score=299.01  Aligned_cols=249  Identities=23%  Similarity=0.403  Sum_probs=190.4

Q ss_pred             eecccCceEEEEEEeC-CCCEEEEEEecccc-hhcHHHHHHHHHHHhhcC-CCcEeeeeeEEeeCCceEEEEeeccCCCH
Q 010309          232 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVYEFVVNGPL  308 (513)
Q Consensus       232 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~~gsL  308 (513)
                      .||+|+||.||++... +++.||+|.+.... ......+.+|+.++.++. ||||+++++++..++..+++|||+. ++|
T Consensus        11 ~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~-~~l   89 (288)
T cd06616          11 EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD-ISL   89 (288)
T ss_pred             HhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc-CCH
Confidence            5799999999999964 58999999997543 234567889999999996 9999999999999999999999985 466


Q ss_pred             HHHhccC-CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccce
Q 010309          309 DRWLHHI-PRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  387 (513)
Q Consensus       309 ~~~l~~~-~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  387 (513)
                      .++.... ......+++..+..++.|++.||+|||+..  +++||||||+||+++.++.++|+|||++..........  
T Consensus        90 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~--  165 (288)
T cd06616          90 DKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKT--  165 (288)
T ss_pred             HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccCCccc--
Confidence            5543211 122356999999999999999999999632  89999999999999999999999999987654322111  


Q ss_pred             eecCcccccccccccccC---CCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccC
Q 010309          388 VMAGGTYGYLAPEFVYRN---ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS  464 (513)
Q Consensus       388 ~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  464 (513)
                       ...+++.|+|||++.+.   .++.++||||||+++|||++|+.||.....     ..+.......      ...+.+  
T Consensus       166 -~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~------~~~~~~--  231 (288)
T cd06616         166 -RDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQVVK------GDPPIL--  231 (288)
T ss_pred             -cccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhhcC------CCCCcC--
Confidence             12378899999998766   688999999999999999999999875431     1111111000      000111  


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          465 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       465 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                        .......++.++.+|+.+||+.||++|||+++|++
T Consensus       232 --~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~  266 (288)
T cd06616         232 --SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE  266 (288)
T ss_pred             --CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              01111235678999999999999999999999986

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.2e-36  Score=297.87  Aligned_cols=264  Identities=19%  Similarity=0.239  Sum_probs=191.9

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccch--hcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCCc-----eEEEE
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF--QRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGD-----RYIVY  300 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~-----~~lv~  300 (513)
                      .+.||+|+||.||+|... +++.||||.++....  .....+.+|+.+++.+ +||||+++++++...+.     .|+||
T Consensus         6 ~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~   85 (295)
T cd07837           6 LEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVF   85 (295)
T ss_pred             eeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEe
Confidence            456799999999999975 689999999865422  2335788899999999 46999999999887666     79999


Q ss_pred             eeccCCCHHHHhccCCCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecC-CCCeEEecccccccC
Q 010309          301 EFVVNGPLDRWLHHIPRG-GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE-EFGAHLMGVGLSKFV  378 (513)
Q Consensus       301 e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~-~~~~kl~Dfg~~~~~  378 (513)
                      ||+++ +|.+++...... ...+++..++.++.||+.||.|||+.   +++||||||+||+++. ++.+||+|||++...
T Consensus        86 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~  161 (295)
T cd07837          86 EYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF  161 (295)
T ss_pred             eccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecccceec
Confidence            99975 898888653322 35689999999999999999999999   9999999999999998 889999999998765


Q ss_pred             CccccccceeecCccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhh--ccccc
Q 010309          379 PWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQ--SHRYL  455 (513)
Q Consensus       379 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~  455 (513)
                      .......  ....+++.|+|||++.+ ..++.++||||||+++|+|++|..||...+...  ...........  .....
T Consensus       162 ~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~  237 (295)
T cd07837         162 SIPVKSY--THEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ--QLLHIFKLLGTPTEQVWP  237 (295)
T ss_pred             CCCcccc--CCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHHHHhCCCChhhCc
Confidence            3321111  11126788999998865 457899999999999999999999997654321  11100000000  00000


Q ss_pred             cc---cc----ccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          456 EL---LD----PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       456 ~~---~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      ..   ..    +..............++++.++|.+||+.||.+||++.+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         238 GVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             chhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            00   00    000000000001135677999999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=3.4e-37  Score=296.49  Aligned_cols=246  Identities=20%  Similarity=0.317  Sum_probs=196.0

Q ss_pred             ecccCceEEEEEEeCC-CCEEEEEEecccch---hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCCH
Q 010309          233 LGDSKTGGTYSGILPD-GSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  308 (513)
Q Consensus       233 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL  308 (513)
                      ||.|++|.||++.... |+.||+|.+.....   ...+.+.+|+.++++++||||+++++.+...+..++||||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            5899999999999864 99999999976543   3456788999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccc----
Q 010309          309 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ----  384 (513)
Q Consensus       309 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~----  384 (513)
                      .+++...    ..+++..+..++.||+.||+|||+.   +++|+||+|+||+++.++.++|+|||++.........    
T Consensus        81 ~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  153 (265)
T cd05579          81 ASLLENV----GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND  153 (265)
T ss_pred             HHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence            9999642    3689999999999999999999999   9999999999999999999999999998765432110    


Q ss_pred             --cceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccc
Q 010309          385 --ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI  462 (513)
Q Consensus       385 --~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  462 (513)
                        .......++..|+|||.......+.++||||||+++|+|++|..||.......   ...   .... ...        
T Consensus       154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---~~~---~~~~-~~~--------  218 (265)
T cd05579         154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE---IFQ---NILN-GKI--------  218 (265)
T ss_pred             ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH---HHH---HHhc-CCc--------
Confidence              01122237788999999988888999999999999999999999997554221   110   0000 000        


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 010309          463 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ  504 (513)
Q Consensus       463 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  504 (513)
                          ........+..+.+++.+||+.+|.+|||+.++.+.|+
T Consensus       219 ----~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         219 ----EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             ----CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence                00000113567999999999999999999966665554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-36  Score=292.32  Aligned_cols=243  Identities=21%  Similarity=0.254  Sum_probs=188.7

Q ss_pred             eecccCceEEEEEEeC-CCCEEEEEEecccchh---cHHHHHHHHHHH-hhcCCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          232 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQ---RKKEFYSEIGRF-ARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       232 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l-~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      .||+|++|.||+|... +|+.||||++.+....   ....+..|..++ ...+||||+++++++...+..++|+||++++
T Consensus         3 ~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   82 (260)
T cd05611           3 PISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGG   82 (260)
T ss_pred             cCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCC
Confidence            4799999999999874 5899999999764322   223344555444 4458999999999999999999999999999


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  386 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  386 (513)
                      +|.+++..    ...+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++......     
T Consensus        83 ~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-----  150 (260)
T cd05611          83 DCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN-----  150 (260)
T ss_pred             CHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceecccc-----
Confidence            99999864    24689999999999999999999999   9999999999999999999999999998764321     


Q ss_pred             eeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCC
Q 010309          387 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  466 (513)
Q Consensus       387 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  466 (513)
                       ....++..|+|||.+.+..++.++||||||+++|+|++|..||...+...   ...   .. .....    .  .    
T Consensus       151 -~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~---~~-~~~~~----~--~----  212 (260)
T cd05611         151 -KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA---VFD---NI-LSRRI----N--W----  212 (260)
T ss_pred             -ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH---HHH---HH-Hhccc----C--C----
Confidence             11237889999999988888999999999999999999999997644321   111   00 00000    0  0    


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 010309          467 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ  504 (513)
Q Consensus       467 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  504 (513)
                      .......+++.+.+++.+||+.||++||++.++.+.|.
T Consensus       213 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~  250 (260)
T cd05611         213 PEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS  250 (260)
T ss_pred             CCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence            00011134567999999999999999998766655443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=3.2e-36  Score=288.39  Aligned_cols=247  Identities=25%  Similarity=0.374  Sum_probs=200.8

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccch--hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeC--CceEEEEeecc
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDRYIVYEFVV  304 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lv~e~~~  304 (513)
                      .+.||+|++|.||+|... +++.|++|++.....  ...+.+.+|+.++++++||||+++++.+...  +..++|+||++
T Consensus         5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~   84 (260)
T cd06606           5 GELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVS   84 (260)
T ss_pred             eeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecC
Confidence            457899999999999976 689999999976543  4467889999999999999999999999988  88999999999


Q ss_pred             CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccc
Q 010309          305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  384 (513)
Q Consensus       305 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  384 (513)
                      +++|.+++...    ..+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||.+.........
T Consensus        85 ~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  157 (260)
T cd06606          85 GGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG  157 (260)
T ss_pred             CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence            99999999652    3789999999999999999999999   9999999999999999999999999999877654321


Q ss_pred             cceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccC
Q 010309          385 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS  464 (513)
Q Consensus       385 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  464 (513)
                      .......++..|+|||.+.....+.++||||||+++|+|++|..||...+..     ..........        ..   
T Consensus       158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~--------~~---  221 (260)
T cd06606         158 EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP-----MAALYKIGSS--------GE---  221 (260)
T ss_pred             ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-----HHHHHhcccc--------CC---
Confidence            1112233788999999998888999999999999999999999999765411     0001000000        00   


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          465 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       465 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                        ....+...+..+.+++.+|++.||++||++.++++
T Consensus       222 --~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         222 --PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             --CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence              01111233667999999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=4.7e-36  Score=289.45  Aligned_cols=249  Identities=20%  Similarity=0.239  Sum_probs=190.3

Q ss_pred             HHHHHhhCcccCCce-ecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCC
Q 010309          218 ELRSITKNFSEGNRL-LGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHG  294 (513)
Q Consensus       218 ~l~~~~~~~~~~~~~-lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~  294 (513)
                      +.....+++.....+ ||+|+||.||++..+ ++..+|+|.+........     |+.....+ +||||+++++.+...+
T Consensus         8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~   82 (267)
T PHA03390          8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLK   82 (267)
T ss_pred             HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCC
Confidence            334444454444433 699999999999964 688999999875432211     22222222 7999999999999999


Q ss_pred             ceEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCC-CeEEeccc
Q 010309          295 DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF-GAHLMGVG  373 (513)
Q Consensus       295 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~-~~kl~Dfg  373 (513)
                      ..++||||+++++|.+++..    ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++ .++|+|||
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg  155 (267)
T PHA03390         83 GHVLIMDYIKDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYG  155 (267)
T ss_pred             eeEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCc
Confidence            99999999999999999964    23799999999999999999999999   999999999999999998 99999999


Q ss_pred             ccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccc
Q 010309          374 LSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHR  453 (513)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  453 (513)
                      ++.......      ...++..|+|||++.+..++.++||||||+++|||++|..||........ ....+...      
T Consensus       156 ~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~------  222 (267)
T PHA03390        156 LCKIIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL-DLESLLKR------  222 (267)
T ss_pred             cceecCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchh-hHHHHHHh------
Confidence            987654322      12378899999999988899999999999999999999999975433210 00010000      


Q ss_pred             ccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCC-HHHHHH
Q 010309          454 YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPR-MSHVVH  501 (513)
Q Consensus       454 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~  501 (513)
                          ...      ........++.+.++|.+||+.+|.+||+ ++++++
T Consensus       223 ----~~~------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        223 ----QQK------KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             ----hcc------cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence                000      00111245677999999999999999996 588874

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=2.4e-36  Score=294.02  Aligned_cols=264  Identities=21%  Similarity=0.265  Sum_probs=195.0

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccch-hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCC
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  307 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs  307 (513)
                      .+.||.|++|.||+|+.. +|..||||.++.... .....+.+|+.++++++||||+++++++.+.+..++||||+++ +
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~   83 (284)
T cd07836           5 LEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-D   83 (284)
T ss_pred             eeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-c
Confidence            346799999999999975 588999999976532 2346678899999999999999999999999999999999975 8


Q ss_pred             HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccce
Q 010309          308 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  387 (513)
Q Consensus       308 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  387 (513)
                      |.+++..... ...+++..+..++.|++.||+|||+.   +++|+||||+||++++++.++|+|||++..........  
T Consensus        84 l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~--  157 (284)
T cd07836          84 LKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTF--  157 (284)
T ss_pred             HHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcccc--
Confidence            8888864322 34689999999999999999999999   99999999999999999999999999997654321111  


Q ss_pred             eecCcccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCccccch-hHHhhh--------HHhhccccccc
Q 010309          388 VMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS-IFEWAT--------PLVQSHRYLEL  457 (513)
Q Consensus       388 ~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~-~~~~~~--------~~~~~~~~~~~  457 (513)
                      ....++..|+|||++.+. .++.++||||||+++|+|++|+.||...+...... ......        .......+...
T Consensus       158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd07836         158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPT  237 (284)
T ss_pred             ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhccc
Confidence            112267889999988664 56889999999999999999999997655321111 110000        00000000000


Q ss_pred             ccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          458 LDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       458 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      ...... ..........+..+.+++.+||+.||.+||++.++++
T Consensus       238 ~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         238 FPRYPP-QDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             ccCCCh-HHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            000000 0000001124567899999999999999999999984

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-36  Score=293.21  Aligned_cols=264  Identities=19%  Similarity=0.242  Sum_probs=195.0

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccc--hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeC--CceEEEEeecc
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDRYIVYEFVV  304 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lv~e~~~  304 (513)
                      .+.||+|++|.||+|... +++.+|+|++....  ......+.+|+.+++.++|||++++++++...  +..++||||++
T Consensus         4 ~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~   83 (287)
T cd07840           4 IAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD   83 (287)
T ss_pred             eEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecccc
Confidence            346799999999999975 48899999998663  23346788999999999999999999999988  88999999996


Q ss_pred             CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccc
Q 010309          305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  384 (513)
Q Consensus       305 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  384 (513)
                       ++|.+++...   ...+++..++.++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++.........
T Consensus        84 -~~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~  156 (287)
T cd07840          84 -HDLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA  156 (287)
T ss_pred             -ccHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence             4898888642   24689999999999999999999999   9999999999999999999999999999876544321


Q ss_pred             cceeecCccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccccccc----
Q 010309          385 ERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD----  459 (513)
Q Consensus       385 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  459 (513)
                      .. ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+........................+    
T Consensus       157 ~~-~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07840         157 DY-TNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWF  235 (287)
T ss_pred             cc-cccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhh
Confidence            11 11226788999998765 4578999999999999999999999976553211110000000000000000000    


Q ss_pred             ----cc--ccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          460 ----PL--ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       460 ----~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                          +.  ............++..+.+++.+||+.+|++||+++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             hhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                00  0000000000112667999999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1e-36  Score=291.98  Aligned_cols=245  Identities=20%  Similarity=0.375  Sum_probs=195.9

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccc--hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      .+.||+|++|.||++... +|..||+|.+....  ....+.+.+|+.+++.++|+||+++++.+...+..++|+||++++
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (257)
T cd08225           5 IKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGG   84 (257)
T ss_pred             EEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCC
Confidence            356799999999999975 58899999986542  234467889999999999999999999999999999999999999


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCC-eEEecccccccCCcccccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG-AHLMGVGLSKFVPWEVMQE  385 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~-~kl~Dfg~~~~~~~~~~~~  385 (513)
                      +|.+++...  ....+++..+..++.|++.||.|||+.   +++|+||||+||++++++. +||+|||.+......... 
T Consensus        85 ~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~-  158 (257)
T cd08225          85 DLMKRINRQ--RGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMEL-  158 (257)
T ss_pred             cHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCccc-
Confidence            999998652  234579999999999999999999999   9999999999999998854 699999999876433211 


Q ss_pred             ceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCC
Q 010309          386 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  465 (513)
Q Consensus       386 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  465 (513)
                       .....|++.|+|||++.+..++.++|+||||+++|||++|..||...+..      ........     ....+    .
T Consensus       159 -~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~-----~~~~~----~  222 (257)
T cd08225         159 -AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH------QLVLKICQ-----GYFAP----I  222 (257)
T ss_pred             -ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHhc-----ccCCC----C
Confidence             11223888999999998888999999999999999999999998754321      11111110     00000    0


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          466 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       466 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                           ....+..+.+++.+||+.+|++|||+.+|++
T Consensus       223 -----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         223 -----SPNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             -----CCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence                 1123457999999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=2.2e-36  Score=289.53  Aligned_cols=247  Identities=22%  Similarity=0.372  Sum_probs=201.7

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccch--hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      .+.||.|++|.||++... ++..||+|++.....  .....+.+|+++++.++|||++++++.+...+..++|+|+++++
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~   84 (258)
T cd08215           5 IKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGG   84 (258)
T ss_pred             EeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCC
Confidence            356799999999999975 589999999976533  45567899999999999999999999999999999999999999


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  386 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  386 (513)
                      +|.+++.........+++..+..++.+++.||.|||+.   +++|+||+|+||+++.++.++|+|||.+.........  
T Consensus        85 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--  159 (258)
T cd08215          85 DLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL--  159 (258)
T ss_pred             cHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCcce--
Confidence            99999976443346799999999999999999999999   9999999999999999999999999999876543311  


Q ss_pred             eeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCC
Q 010309          387 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  466 (513)
Q Consensus       387 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  466 (513)
                      .....+++.|+|||.+.+..++.++|+||||+++++|++|..||...+..   ..   ...... .        ..    
T Consensus       160 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~---~~---~~~~~~-~--------~~----  220 (258)
T cd08215         160 AKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL---EL---ALKILK-G--------QY----  220 (258)
T ss_pred             ecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH---HH---HHHHhc-C--------CC----
Confidence            11223788999999998888999999999999999999999998654421   11   111100 0        01    


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          467 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       467 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      .. .+...+..+.+++.+||+.+|++|||+.++++
T Consensus       221 ~~-~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         221 PP-IPSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             CC-CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            00 11134567999999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-36  Score=295.07  Aligned_cols=262  Identities=22%  Similarity=0.292  Sum_probs=194.3

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccch--hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      .+.||.|++|.||+|... +|..||+|++.....  .....+.+|+.+++.++||||+++++++.+.+..+++|||++ +
T Consensus         4 ~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~   82 (283)
T cd07835           4 VEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-L   82 (283)
T ss_pred             heEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-c
Confidence            346799999999999964 699999999875432  223568899999999999999999999999999999999994 6


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  386 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  386 (513)
                      +|.+++....  ...+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++.......... 
T Consensus        83 ~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~-  156 (283)
T cd07835          83 DLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY-  156 (283)
T ss_pred             CHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcccc-
Confidence            8999886522  24689999999999999999999999   99999999999999999999999999997654322111 


Q ss_pred             eeecCcccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhc--------cccccc
Q 010309          387 TVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQS--------HRYLEL  457 (513)
Q Consensus       387 ~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~  457 (513)
                       ....++..|+|||++.+. .++.++||||||+++|+|++|++||...+...  .+..........        ....+.
T Consensus       157 -~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd07835         157 -THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID--QLFRIFRTLGTPDEDVWPGVTSLPDY  233 (283)
T ss_pred             -CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCChHHhhhhhhchhh
Confidence             111267889999988664 56889999999999999999999997654321  111100000000        000000


Q ss_pred             ccccccC--CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          458 LDPLISS--LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       458 ~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      .......  ..........+..+.+++.+||+.||++|||++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            0000000  0000001224467899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-37  Score=309.67  Aligned_cols=272  Identities=23%  Similarity=0.335  Sum_probs=200.1

Q ss_pred             cCCceecccCceEEEEEEe-CCCCEEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCC------ceEEE
Q 010309          228 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG------DRYIV  299 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------~~~lv  299 (513)
                      +..+.||+|+||.||+|+. ..|+.||||.++... ....+...+|+++|++|+|||||++.++-++..      ...+|
T Consensus        16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlv   95 (732)
T KOG4250|consen   16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLV   95 (732)
T ss_pred             eehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEE
Confidence            3455789999999999995 569999999998754 344577889999999999999999999865543      45899


Q ss_pred             EeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEec--CCC--CeEEeccccc
Q 010309          300 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD--EEF--GAHLMGVGLS  375 (513)
Q Consensus       300 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~--~~~--~~kl~Dfg~~  375 (513)
                      ||||.+|||+..|.+ +.+...|++.+.+.++.++..||.|||++   +|+||||||.||++-  .+|  ..||+|||.|
T Consensus        96 mEyC~gGsL~~~L~~-PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   96 MEYCSGGSLRKVLNS-PENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             EeecCCCcHHHHhcC-cccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            999999999999976 45567899999999999999999999999   999999999999993  333  3699999999


Q ss_pred             ccCCccccccceeecCccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccc
Q 010309          376 KFVPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRY  454 (513)
Q Consensus       376 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  454 (513)
                      +.++....   .....||..|.+||++.. ..|+..+|.|||||++|+.+||..||..........-+.|....-.....
T Consensus       172 rel~d~s~---~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v  248 (732)
T KOG4250|consen  172 RELDDNSL---FTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGV  248 (732)
T ss_pred             ccCCCCCe---eeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCce
Confidence            98876542   223349999999999984 78899999999999999999999999765433110001111100000000


Q ss_pred             -----cccccccccC--CC-CCCCcHHHHHHHHHHHHHhcCCCCCCCC--CHHHHHHHHhcC
Q 010309          455 -----LELLDPLISS--LS-SDIPEAGVVQKVVDLVYACTQHVPSMRP--RMSHVVHQLQQL  506 (513)
Q Consensus       455 -----~~~~~~~~~~--~~-~~~~~~~~~~~l~~li~~cl~~dP~~RP--s~~evl~~L~~~  506 (513)
                           .+.-.+....  ++ +..........+-..+..+|..+|++|-  ...+....+..+
T Consensus       249 ~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dI  310 (732)
T KOG4250|consen  249 AIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDI  310 (732)
T ss_pred             eEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHH
Confidence                 0000010000  00 1111234555677888899999999998  555555554433

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2.7e-36  Score=301.09  Aligned_cols=271  Identities=16%  Similarity=0.232  Sum_probs=197.7

Q ss_pred             HhhCcccCCceecccCceEEEEEEeC-CCCEEEEEEecccchhc--------------HHHHHHHHHHHhhcCCCcEeee
Q 010309          222 ITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQR--------------KKEFYSEIGRFARLHHPNLVAV  286 (513)
Q Consensus       222 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~nIv~l  286 (513)
                      +.+.|....++||+|+||.||+|... +++.||||.+.......              ...+.+|+++++.++||||+++
T Consensus         6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~   85 (335)
T PTZ00024          6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL   85 (335)
T ss_pred             cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence            34456666678899999999999965 68999999986543221              1257789999999999999999


Q ss_pred             eeEEeeCCceEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCC
Q 010309          287 KGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG  366 (513)
Q Consensus       287 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~  366 (513)
                      ++++...+..++||||+. ++|.+++..    ...+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.
T Consensus        86 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~  157 (335)
T PTZ00024         86 VDVYVEGDFINLVMDIMA-SDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGI  157 (335)
T ss_pred             eEEEecCCcEEEEEeccc-cCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCC
Confidence            999999999999999996 689998853    34589999999999999999999999   9999999999999999999


Q ss_pred             eEEecccccccCCcccc------------ccceeecCcccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 010309          367 AHLMGVGLSKFVPWEVM------------QERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAV  433 (513)
Q Consensus       367 ~kl~Dfg~~~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~  433 (513)
                      ++|+|||++........            ........++..|+|||.+.+. .++.++||||||+++|||++|.+||...
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~  237 (335)
T PTZ00024        158 CKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE  237 (335)
T ss_pred             EEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            99999999976541110            0111112267789999998764 4689999999999999999999999766


Q ss_pred             Cccccch-hHHhhhHHhhcccccccc-----cccccCCCCC--CCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          434 DSVCWQS-IFEWATPLVQSHRYLELL-----DPLISSLSSD--IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       434 ~~~~~~~-~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      +...... +....... ....+....     .+........  ......+.++.+++.+||+.+|++|||+++++.
T Consensus       238 ~~~~~~~~i~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        238 NEIDQLGRIFELLGTP-NEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             CHHHHHHHHHHHhCCC-chhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            5421110 00000000 000000000     0000000000  000123567899999999999999999999986

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2.8e-36  Score=293.27  Aligned_cols=257  Identities=18%  Similarity=0.187  Sum_probs=189.6

Q ss_pred             ceecccCceEEEEEEeC-CCCEEEEEEecccc-hhcHHHHHHHHHHHhhcC-CCcEeeeeeEEeeC--CceEEEEeeccC
Q 010309          231 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDH--GDRYIVYEFVVN  305 (513)
Q Consensus       231 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~--~~~~lv~e~~~~  305 (513)
                      +.||+|+||.||+|... +++.||+|+++... ........+|+.++.++. ||||+++++++.+.  +..++||||++ 
T Consensus         5 ~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~-   83 (282)
T cd07831           5 GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD-   83 (282)
T ss_pred             eeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC-
Confidence            45799999999999964 68999999987642 222334567888899885 99999999999987  88999999996 


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccc
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  385 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  385 (513)
                      ++|.+++...   ...+++..+..++.|++.||.|||+.   +++||||+|+||+++. +.+||+|||++..........
T Consensus        84 ~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~  156 (282)
T cd07831          84 MNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYT  156 (282)
T ss_pred             ccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCCCcC
Confidence            5888777542   24689999999999999999999999   9999999999999999 999999999998764332211


Q ss_pred             ceeecCccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhh-----------ccc
Q 010309          386 RTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQ-----------SHR  453 (513)
Q Consensus       386 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-----------~~~  453 (513)
                      .   ..++..|+|||++.. ..++.++|||||||++|||++|..||...+..+.   .........           ...
T Consensus       157 ~---~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
T cd07831         157 E---YISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ---IAKIHDVLGTPDAEVLKKFRKSR  230 (282)
T ss_pred             C---CCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH---HHHHHHHcCCCCHHHHHhhcccc
Confidence            1   227889999997654 5578899999999999999999999976543211   111110000           000


Q ss_pred             ccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          454 YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       454 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      ......+..............+..+.++|.+||+.+|++||+++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            000000000000000001235678999999999999999999999985

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=2.1e-36  Score=298.42  Aligned_cols=263  Identities=17%  Similarity=0.239  Sum_probs=191.4

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccchh--cHHHHHHHHHHHhhcCCCcEeeeeeEEeeC--CceEEEEeecc
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQ--RKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDRYIVYEFVV  304 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lv~e~~~  304 (513)
                      .+.||+|+||.||+|... +|+.||+|+++.....  ....+.+|+.++++++|+||+++++++...  +..++||||+.
T Consensus        12 ~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~   91 (309)
T cd07845          12 LNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE   91 (309)
T ss_pred             eeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCC
Confidence            446799999999999975 5899999998754322  233567899999999999999999998765  46799999996


Q ss_pred             CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccc
Q 010309          305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  384 (513)
Q Consensus       305 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  384 (513)
                       ++|.+++...   ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++.........
T Consensus        92 -~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~  164 (309)
T cd07845          92 -QDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP  164 (309)
T ss_pred             -CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCCccCC
Confidence             5888888642   25689999999999999999999999   9999999999999999999999999999876533211


Q ss_pred             cceeecCccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccccc-----c
Q 010309          385 ERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLEL-----L  458 (513)
Q Consensus       385 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~  458 (513)
                      .  ....++..|+|||.+.+ ..++.++||||||+++|||++|.+||...+.......................     .
T Consensus       165 ~--~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (309)
T cd07845         165 M--TPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLV  242 (309)
T ss_pred             C--CcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccccc
Confidence            1  11125778999999865 45789999999999999999999999765543211111000000000000000     0


Q ss_pred             cc-cccCCC-CC--CCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          459 DP-LISSLS-SD--IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       459 ~~-~~~~~~-~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      .. .+.... ..  ......++.+.++|.+||+.||++|||++++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         243 GKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             ccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            00 000000 00  000123667899999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=2.8e-36  Score=298.11  Aligned_cols=260  Identities=19%  Similarity=0.227  Sum_probs=191.4

Q ss_pred             cccCceEEEEEEeCCCCEEEEEEeccc--chhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCCHHHH
Q 010309          234 GDSKTGGTYSGILPDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRW  311 (513)
Q Consensus       234 g~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~  311 (513)
                      |.|+++.||++.. +++.||||++...  .....+.+.+|+.+++.++||||+++++++.+.+..+++|||+++++|.++
T Consensus        11 ~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~   89 (314)
T cd08216          11 EDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDL   89 (314)
T ss_pred             cCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHH
Confidence            4445555555544 6999999999764  334457899999999999999999999999999999999999999999999


Q ss_pred             hccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccc-----ccc
Q 010309          312 LHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM-----QER  386 (513)
Q Consensus       312 l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~-----~~~  386 (513)
                      +...  ....+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||.+........     ...
T Consensus        90 l~~~--~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~  164 (314)
T cd08216          90 LKTH--FPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDF  164 (314)
T ss_pred             HHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccccccc
Confidence            9753  234588999999999999999999999   999999999999999999999999998875532211     111


Q ss_pred             eeecCccccccccccccc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHH----hhccc-------
Q 010309          387 TVMAGGTYGYLAPEFVYR--NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPL----VQSHR-------  453 (513)
Q Consensus       387 ~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~----~~~~~-------  453 (513)
                      .....++..|+|||++..  ..++.++||||||+++|||++|..||.......  ...+.....    .....       
T Consensus       165 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  242 (314)
T cd08216         165 PKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTYPLYEDS  242 (314)
T ss_pred             cccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCchhhhcCC
Confidence            112226778999999876  357889999999999999999999998654321  111110000    00000       


Q ss_pred             ccc----cccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          454 YLE----LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       454 ~~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      ...    ...+..............+.++.+|+.+||+.||++|||++++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         243 MSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             cCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence            000    000111001111223356678999999999999999999999987

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=3.6e-36  Score=292.07  Aligned_cols=241  Identities=19%  Similarity=0.260  Sum_probs=187.3

Q ss_pred             eecccCceEEEEEEeC-CCCEEEEEEecccchh---cHHHHHHHH---HHHhhcCCCcEeeeeeEEeeCCceEEEEeecc
Q 010309          232 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQ---RKKEFYSEI---GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV  304 (513)
Q Consensus       232 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~---~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  304 (513)
                      +||+|+||.||++... +++.||+|.+.+....   ....+..|.   ..+....||||+++++++.+.+..++||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            3799999999999864 5889999998764322   122233443   34444589999999999999999999999999


Q ss_pred             CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccc
Q 010309          305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  384 (513)
Q Consensus       305 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  384 (513)
                      +++|.+++..    ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++.........
T Consensus        81 g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~~  153 (278)
T cd05606          81 GGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH  153 (278)
T ss_pred             CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccCCc
Confidence            9999998853    34699999999999999999999999   9999999999999999999999999998765432211


Q ss_pred             cceeecCcccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccccccccccc
Q 010309          385 ERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS  463 (513)
Q Consensus       385 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  463 (513)
                          ...|+..|+|||++.++ .++.++||||||+++|||++|+.||............    ....      ...    
T Consensus       154 ----~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~----~~~~------~~~----  215 (278)
T cd05606         154 ----ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----RMTL------TMA----  215 (278)
T ss_pred             ----CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH----HHhh------ccC----
Confidence                22389999999998754 6889999999999999999999999765332111100    0000      000    


Q ss_pred             CCCCCCCcHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 010309          464 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRP-----RMSHVVH  501 (513)
Q Consensus       464 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  501 (513)
                         .. .+...+.++.+++.+||..+|.+||     ++.++++
T Consensus       216 ---~~-~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         216 ---VE-LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             ---CC-CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence               01 1112356799999999999999999     9999985

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=3.7e-36  Score=299.05  Aligned_cols=262  Identities=18%  Similarity=0.262  Sum_probs=191.4

Q ss_pred             eccc--CceEEEEEEeC-CCCEEEEEEecccc--hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCC
Q 010309          233 LGDS--KTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  307 (513)
Q Consensus       233 lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs  307 (513)
                      ||+|  +||+||++... +|+.||+|++....  ....+.+.+|+.+++.++||||+++++++..++..++||||+.+++
T Consensus         6 ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~   85 (328)
T cd08226           6 IGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGS   85 (328)
T ss_pred             hCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCC
Confidence            4666  99999999974 69999999987542  2234678899999999999999999999999999999999999999


Q ss_pred             HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccc-
Q 010309          308 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER-  386 (513)
Q Consensus       308 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~-  386 (513)
                      |.+++....  ...+++..+..++.|++.||+|||+.   +++||||||+|||++.++.++++||+.+........... 
T Consensus        86 l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (328)
T cd08226          86 ANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV  160 (328)
T ss_pred             HHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence            999987532  24589999999999999999999999   999999999999999999999999986543321111000 


Q ss_pred             ----eeecCcccccccccccccC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhH-------------
Q 010309          387 ----TVMAGGTYGYLAPEFVYRN--ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATP-------------  447 (513)
Q Consensus       387 ----~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~-------------  447 (513)
                          .....++..|+|||++.+.  .++.++||||||+++|||++|..||.......  ........             
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  238 (328)
T cd08226         161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ--MLLQKLKGPPYSPLDITTFPC  238 (328)
T ss_pred             cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH--HHHHHhcCCCCCCccccccch
Confidence                0011245679999998764  47899999999999999999999997654321  00000000             


Q ss_pred             ---Hhhc--ccc----c-cccc-----ccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          448 ---LVQS--HRY----L-ELLD-----PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       448 ---~~~~--~~~----~-~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                         ....  ...    . ....     ..............++..+.+|+.+||+.||++|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence               0000  000    0 0000     000000011112346778999999999999999999999985

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.8e-36  Score=290.07  Aligned_cols=245  Identities=23%  Similarity=0.331  Sum_probs=200.6

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccc--hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      .+.||+|++|.||++... +++.+|+|.+....  ......+.+|+.+++.++||||+++++++.+....++||||++++
T Consensus         5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~   84 (256)
T cd08530           5 LKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFG   84 (256)
T ss_pred             eeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCC
Confidence            346799999999999864 68899999987542  233467788999999999999999999999999999999999999


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  386 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  386 (513)
                      +|.+++.........+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.+||+|||++.........  
T Consensus        85 ~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~--  159 (256)
T cd08530          85 DLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK--  159 (256)
T ss_pred             CHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccCCcc--
Confidence            99999876444446789999999999999999999999   9999999999999999999999999999876544111  


Q ss_pred             eeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCC
Q 010309          387 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  466 (513)
Q Consensus       387 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  466 (513)
                        ...++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+......       ......        .    
T Consensus       160 --~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~-------~~~~~~--------~----  218 (256)
T cd08530         160 --TQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRY-------KVQRGK--------Y----  218 (256)
T ss_pred             --cccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-------HHhcCC--------C----
Confidence              1237889999999998889999999999999999999999997654321100       000000        0    


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          467 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       467 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      .. .....+.++.+++.+||+.+|++||++.++++
T Consensus       219 ~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         219 PP-IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             CC-CchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            11 11245677999999999999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.8e-37  Score=319.03  Aligned_cols=274  Identities=16%  Similarity=0.182  Sum_probs=185.2

Q ss_pred             HhhCcccCCceecccCceEEEEEEeCC--CCEEEEEEe--------------cc---cchhcHHHHHHHHHHHhhcCCCc
Q 010309          222 ITKNFSEGNRLLGDSKTGGTYSGILPD--GSRVAVKRL--------------KR---SSFQRKKEFYSEIGRFARLHHPN  282 (513)
Q Consensus       222 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~--------------~~---~~~~~~~~~~~E~~~l~~l~h~n  282 (513)
                      ...+|.. .+.||+|+||.||++....  +..+++|.+              .+   ........+.+|+.+|++++|||
T Consensus       146 ~~~~Y~i-i~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        146 FLAHFRV-IDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhccEE-EeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence            3444544 3466999999999987532  222222211              11   11123456889999999999999


Q ss_pred             EeeeeeEEeeCCceEEEEeeccCCCHHHHhccCC-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEe
Q 010309          283 LVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIP-RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL  361 (513)
Q Consensus       283 Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll  361 (513)
                      |+++++++...+..|+|+|++ +++|.+++.... ..........+..++.||+.||.|||++   +|+||||||+|||+
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl  300 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFL  300 (501)
T ss_pred             cCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence            999999999999999999999 457777764321 1122344667888999999999999999   99999999999999


Q ss_pred             cCCCCeEEecccccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCC-CCCCCccccch
Q 010309          362 DEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP-AQAVDSVCWQS  440 (513)
Q Consensus       362 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p-~~~~~~~~~~~  440 (513)
                      +.++.+||+|||++..+........ ....||..|+|||++.+..++.++|||||||++|||++|..+ +.........+
T Consensus       301 ~~~~~vkL~DFGla~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~  379 (501)
T PHA03210        301 NCDGKIVLGDFGTAMPFEKEREAFD-YGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ  379 (501)
T ss_pred             CCCCCEEEEeCCCceecCccccccc-ccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence            9999999999999987653322111 123389999999999999999999999999999999998754 43322221112


Q ss_pred             hHHhhhHHhh-cccc-------cccccc-ccc----CCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          441 IFEWATPLVQ-SHRY-------LELLDP-LIS----SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       441 ~~~~~~~~~~-~~~~-------~~~~~~-~~~----~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      +......... ...+       .+.+.. ...    ...........+..+.++|.+||+.||++|||+.|+++
T Consensus       380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence            2111110000 0000       000000 000    00000001123456788999999999999999999986

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=3.3e-36  Score=296.92  Aligned_cols=265  Identities=18%  Similarity=0.226  Sum_probs=189.4

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccch--hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCc--------eEE
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD--------RYI  298 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~--------~~l  298 (513)
                      .+.||+|++|.||+|... +++.||||.+.....  .....+.+|+.++++++||||+++++++...+.        .++
T Consensus        17 ~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~l   96 (310)
T cd07865          17 LAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYL   96 (310)
T ss_pred             EEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEE
Confidence            456799999999999975 589999999865422  223456789999999999999999999876543        499


Q ss_pred             EEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccC
Q 010309          299 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV  378 (513)
Q Consensus       299 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~  378 (513)
                      ||||+. ++|.+++..   ....+++..++.++.|++.||+|||++   +++|+||||+||+++.++.+||+|||++...
T Consensus        97 v~e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  169 (310)
T cd07865          97 VFEFCE-HDLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAF  169 (310)
T ss_pred             EEcCCC-cCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCCcccc
Confidence            999995 588887753   224689999999999999999999999   9999999999999999999999999999866


Q ss_pred             Ccccccc--ceeecCcccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccc
Q 010309          379 PWEVMQE--RTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL  455 (513)
Q Consensus       379 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  455 (513)
                      .......  ......++..|+|||.+.+. .++.++||||||+++|||++|..||...+.....................
T Consensus       170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (310)
T cd07865         170 SLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWP  249 (310)
T ss_pred             cCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence            4332211  11112367889999988664 46889999999999999999999997654321111111110000000000


Q ss_pred             -----cccc------ccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          456 -----ELLD------PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       456 -----~~~~------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                           ...+      ...............+..+.+||.+||+.||.+|||++++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         250 GVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             cccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence                 0000      000000000000012346789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=4.4e-36  Score=293.86  Aligned_cols=264  Identities=19%  Similarity=0.244  Sum_probs=190.4

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccch--hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      .+.||+|++|.||+|... +|+.||+|.+.....  .....+.+|++++++++||||+++++++.+.+..++||||++ +
T Consensus         7 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~   85 (294)
T PLN00009          7 VEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-L   85 (294)
T ss_pred             EEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-c
Confidence            346799999999999975 689999999865432  234578899999999999999999999999999999999995 5


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecC-CCCeEEecccccccCCcccccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE-EFGAHLMGVGLSKFVPWEVMQE  385 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~-~~~~kl~Dfg~~~~~~~~~~~~  385 (513)
                      +|.+++..  .....+++..+..++.||+.||+|||++   +++|+||+|+||+++. ++.+||+|||++..........
T Consensus        86 ~l~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~  160 (294)
T PLN00009         86 DLKKHMDS--SPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF  160 (294)
T ss_pred             cHHHHHHh--CCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCCcccc
Confidence            88887754  2233468888999999999999999999   9999999999999985 4568999999997653321111


Q ss_pred             ceeecCcccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCcccc-chhHHhhh-H---Hhhc-ccccccc
Q 010309          386 RTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW-QSIFEWAT-P---LVQS-HRYLELL  458 (513)
Q Consensus       386 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~-~~~~~~~~-~---~~~~-~~~~~~~  458 (513)
                        ....+++.|+|||++.+. .++.++||||||+++|+|+||.+||...+.... ........ +   .+.. ....+..
T Consensus       161 --~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (294)
T PLN00009        161 --THEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYK  238 (294)
T ss_pred             --ccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhh
Confidence              112267899999988664 578999999999999999999999976543210 00000000 0   0000 0000000


Q ss_pred             c--ccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          459 D--PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       459 ~--~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      .  +..............++++.+++.+||+.+|++||++.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        239 SAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             hhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0  000000000001124567899999999999999999999986

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1e-35  Score=290.01  Aligned_cols=262  Identities=21%  Similarity=0.301  Sum_probs=192.5

Q ss_pred             CceecccCceEEEEEEeCC-CCEEEEEEecccch--hcHHHHHHHHHHHhhc---CCCcEeeeeeEEeeCCc-----eEE
Q 010309          230 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSF--QRKKEFYSEIGRFARL---HHPNLVAVKGCCYDHGD-----RYI  298 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~~~~-----~~l  298 (513)
                      .+.||+|++|.||+|.... ++.||+|.++....  .....+.+|+.++.++   +||||+++++++...+.     .++
T Consensus         4 ~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l   83 (287)
T cd07838           4 LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTL   83 (287)
T ss_pred             EEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEE
Confidence            3467999999999999864 89999999975422  1234566787777665   69999999999998776     899


Q ss_pred             EEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccC
Q 010309          299 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV  378 (513)
Q Consensus       299 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~  378 (513)
                      +|||+. ++|.+++....  ...+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++...
T Consensus        84 ~~e~~~-~~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~~  157 (287)
T cd07838          84 VFEHVD-QDLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIY  157 (287)
T ss_pred             Eehhcc-cCHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcceec
Confidence            999996 58988886522  23589999999999999999999999   9999999999999999999999999999876


Q ss_pred             CccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccc-hhHHhhhHHhhccccccc
Q 010309          379 PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ-SIFEWATPLVQSHRYLEL  457 (513)
Q Consensus       379 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  457 (513)
                      ........   ..++..|+|||++.+..++.++||||||+++|||++|.+||......+.. ...+..... ........
T Consensus       158 ~~~~~~~~---~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  233 (287)
T cd07838         158 SFEMALTS---VVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLP-SEEEWPRN  233 (287)
T ss_pred             cCCccccc---ccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCC-ChHhcCCC
Confidence            44322111   12678899999999888999999999999999999999998765432111 111000000 00000000


Q ss_pred             c---cccccCCCC---CCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          458 L---DPLISSLSS---DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       458 ~---~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      .   .........   .......++.+.+++.+||+.||++||++++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         234 VSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             cccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            0   000000000   0011235677899999999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-36  Score=292.29  Aligned_cols=259  Identities=22%  Similarity=0.285  Sum_probs=196.5

Q ss_pred             ceecccCceEEEEEEeC-CCCEEEEEEecccchh--cHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCC
Q 010309          231 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQ--RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  307 (513)
Q Consensus       231 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs  307 (513)
                      +.||+|++|.||++... +++.+++|.+......  ....+.+|+.++++++||||+++++++..++..++|+||+++ +
T Consensus         5 ~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~   83 (283)
T cd05118           5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-D   83 (283)
T ss_pred             eeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-C
Confidence            46799999999999975 6889999998765332  356788999999999999999999999999999999999965 8


Q ss_pred             HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccce
Q 010309          308 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  387 (513)
Q Consensus       308 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  387 (513)
                      |.+++...   ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||.+.........  .
T Consensus        84 l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~--~  155 (283)
T cd05118          84 LYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP--Y  155 (283)
T ss_pred             HHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccc--c
Confidence            88887642   25789999999999999999999999   9999999999999999999999999999876543311  1


Q ss_pred             eecCcccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhc---cccccccc----
Q 010309          388 VMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQS---HRYLELLD----  459 (513)
Q Consensus       388 ~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~----  459 (513)
                      ....++..|+|||.+.+. .++.++||||||+++|+|+||+.||...+.......   .......   ........    
T Consensus       156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd05118         156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFK---IFRTLGTPDPEVWPKFTSLARN  232 (283)
T ss_pred             cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHcCCCchHhcccchhhhhh
Confidence            112277889999998876 788999999999999999999999976543211100   0000000   00000000    


Q ss_pred             -----ccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          460 -----PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       460 -----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                           +..............+.++.++|.+||+.||.+||++++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence                 000000000011245778999999999999999999999985

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=4.7e-36  Score=293.62  Aligned_cols=261  Identities=14%  Similarity=0.193  Sum_probs=184.6

Q ss_pred             HhhCcccCCceecccCceEEEEEEeCC----CCEEEEEEecccchhc--H---------HHHHHHHHHHhhcCCCcEeee
Q 010309          222 ITKNFSEGNRLLGDSKTGGTYSGILPD----GSRVAVKRLKRSSFQR--K---------KEFYSEIGRFARLHHPNLVAV  286 (513)
Q Consensus       222 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~--~---------~~~~~E~~~l~~l~h~nIv~l  286 (513)
                      +..+.+...++||+|+||.||+|...+    +..+|+|+........  .         .....+...+..+.|+||+++
T Consensus         9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~   88 (294)
T PHA02882          9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY   88 (294)
T ss_pred             cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence            333445566788999999999999654    4566777543322111  0         112233445667789999999


Q ss_pred             eeEEeeCC----ceEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEec
Q 010309          287 KGCCYDHG----DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD  362 (513)
Q Consensus       287 ~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~  362 (513)
                      ++++....    ..++++|++. .++.+.+..    ....++..+..++.|++.||+|||+.   +|+||||||+|||++
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~  160 (294)
T PHA02882         89 YGCGSFKRCRMYYRFILLEKLV-ENTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVD  160 (294)
T ss_pred             EEeeeEecCCceEEEEEEehhc-cCHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEc
Confidence            99766543    3378888873 467666643    13357888999999999999999999   999999999999999


Q ss_pred             CCCCeEEecccccccCCcccc-----ccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccc
Q 010309          363 EEFGAHLMGVGLSKFVPWEVM-----QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVC  437 (513)
Q Consensus       363 ~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~  437 (513)
                      .++.++|+|||+++.......     ........||+.|+|||++.+..++.++|||||||++|||++|..||.......
T Consensus       161 ~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~  240 (294)
T PHA02882        161 GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG  240 (294)
T ss_pred             CCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch
Confidence            999999999999986542211     111122348999999999999999999999999999999999999998763221


Q ss_pred             cchhHHhhh-HHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 010309          438 WQSIFEWAT-PLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ  504 (513)
Q Consensus       438 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  504 (513)
                        ....... ....     .+.....       .....+..+.+++..|++.+|++||+++++++.|+
T Consensus       241 --~~~~~~~~~~~~-----~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        241 --NLIHAAKCDFIK-----RLHEGKI-------KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             --HHHHHhHHHHHH-----Hhhhhhh-------ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence              1110000 0000     0000000       01123467999999999999999999999998764

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=8.2e-36  Score=294.57  Aligned_cols=239  Identities=23%  Similarity=0.391  Sum_probs=189.5

Q ss_pred             ceecccCceEEEEEEeC-CCCEEEEEEecccch---hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          231 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       231 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      +.||+|++|.||+|+.. +++.||+|.+.....   .....+.+|+.+++.++|||++++++++.+.+..++||||+. +
T Consensus        27 ~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~  105 (313)
T cd06633          27 HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-G  105 (313)
T ss_pred             eeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-C
Confidence            44799999999999964 588999999875422   233568889999999999999999999999999999999995 5


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  386 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  386 (513)
                      +|.+++..   ....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||++.......    
T Consensus       106 ~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~~----  175 (313)
T cd06633         106 SASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPAN----  175 (313)
T ss_pred             CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCCCC----
Confidence            77777753   235689999999999999999999999   99999999999999999999999999986532211    


Q ss_pred             eeecCcccccccccccc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccccccccccc
Q 010309          387 TVMAGGTYGYLAPEFVY---RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS  463 (513)
Q Consensus       387 ~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  463 (513)
                        ...++..|+|||++.   ...++.++||||||+++|+|++|..||...+....      ....... ..         
T Consensus       176 --~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~------~~~~~~~-~~---------  237 (313)
T cd06633         176 --SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQN-DS---------  237 (313)
T ss_pred             --CccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHHhc-CC---------
Confidence              123788999999984   35678899999999999999999999876543210      0000000 00         


Q ss_pred             CCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          464 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       464 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                         ........+..+.+|+.+||+.+|.+||++.+++.
T Consensus       238 ---~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~  272 (313)
T cd06633         238 ---PTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLR  272 (313)
T ss_pred             ---CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence               11111223456899999999999999999999985

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=2e-36  Score=302.05  Aligned_cols=266  Identities=21%  Similarity=0.293  Sum_probs=192.8

Q ss_pred             hCcccCCceecccCceEEEEEEeC-CCCEEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeC-----Cce
Q 010309          224 KNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH-----GDR  296 (513)
Q Consensus       224 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~  296 (513)
                      ++|. ..+.||+|++|.||+|... +|+.||||++.... ......+.+|+.++++++||||+++++++...     ...
T Consensus         5 ~~y~-i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           5 PRYQ-NLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             cceE-EEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            3443 3457799999999999864 68999999996432 22345678899999999999999999987654     357


Q ss_pred             EEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccc
Q 010309          297 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK  376 (513)
Q Consensus       297 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~  376 (513)
                      ++|+||+. ++|.+++..     ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++.
T Consensus        84 ~lv~e~~~-~~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~  154 (336)
T cd07849          84 YIVQELME-TDLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLAR  154 (336)
T ss_pred             EEEehhcc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECccccee
Confidence            99999995 588887753     4699999999999999999999999   99999999999999999999999999997


Q ss_pred             cCCccccccc-eeecCccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhc---
Q 010309          377 FVPWEVMQER-TVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQS---  451 (513)
Q Consensus       377 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---  451 (513)
                      .......... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+....   ..........   
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~---~~~~~~~~~~~~~  231 (336)
T cd07849         155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ---LNLILGVLGTPSQ  231 (336)
T ss_pred             eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCCH
Confidence            6543221111 112237889999998754 4688999999999999999999999976432110   0000000000   


Q ss_pred             cccccccccc----ccCCC--CCCC----cHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010309          452 HRYLELLDPL----ISSLS--SDIP----EAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  502 (513)
Q Consensus       452 ~~~~~~~~~~----~~~~~--~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  502 (513)
                      .....+....    +....  ...+    ....+.++.+++.+||+.||++|||+.++++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         232 EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            0000000000    00000  0000    01235679999999999999999999999974

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-38  Score=333.89  Aligned_cols=254  Identities=28%  Similarity=0.455  Sum_probs=201.4

Q ss_pred             HhhCcccCCceecccCceEEEEEEe-CCCCEEEEEEecccc--hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEE
Q 010309          222 ITKNFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYI  298 (513)
Q Consensus       222 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l  298 (513)
                      ++-+..... .||.|.||.||.|.. .+|...|+|-++...  ......+.+|..+|..|+|||+|+++|+-.+.+..+|
T Consensus      1233 V~~rWqrg~-~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1233 VTFRWQRGN-FIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred             ceeeecccc-ccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence            343444444 459999999999995 468999999886543  2334678899999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccC
Q 010309          299 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV  378 (513)
Q Consensus       299 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~  378 (513)
                      .||||++|+|.+.+..    ++..++.....+..|++.|++|||++   |||||||||.||+|+.+|.+|++|||.|...
T Consensus      1312 FMEyC~~GsLa~ll~~----gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEH----GRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKI 1384 (1509)
T ss_pred             HHHHhccCcHHHHHHh----cchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEe
Confidence            9999999999999964    35577777788899999999999999   9999999999999999999999999999887


Q ss_pred             Ccccc--ccceeecCcccccccccccccC---CCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccc
Q 010309          379 PWEVM--QERTVMAGGTYGYLAPEFVYRN---ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHR  453 (513)
Q Consensus       379 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  453 (513)
                      .....  ........||+.|||||++.+.   ....+.||||+|||+.||+||+.||...+.. |+-++.     +..+.
T Consensus      1385 ~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-~aIMy~-----V~~gh 1458 (1509)
T KOG4645|consen 1385 KNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-WAIMYH-----VAAGH 1458 (1509)
T ss_pred             cCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-hHHHhH-----HhccC
Confidence            65421  1111122399999999999764   3567899999999999999999999876642 111111     11111


Q ss_pred             ccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010309          454 YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  502 (513)
Q Consensus       454 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  502 (513)
                                  .+..|. ..+.+-.++|.+||+.||++|.++.|+++.
T Consensus      1459 ------------~Pq~P~-~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1459 ------------KPQIPE-RLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             ------------CCCCch-hhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence                        122233 378889999999999999999999988863

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=6.7e-36  Score=294.55  Aligned_cols=244  Identities=24%  Similarity=0.390  Sum_probs=192.4

Q ss_pred             ceecccCceEEEEEEeC-CCCEEEEEEeccc---chhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          231 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRS---SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       231 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      +.||+|++|.||+|... ++..||+|.+...   ......++.+|+.+++.++|+|++++++++...+..++||||+. |
T Consensus        21 ~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~   99 (308)
T cd06634          21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-G   99 (308)
T ss_pred             HheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-C
Confidence            35699999999999964 5789999998643   22234568889999999999999999999999999999999996 6


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  386 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  386 (513)
                      +|.+++..   ....+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||++.......    
T Consensus       100 ~l~~~~~~---~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~----  169 (308)
T cd06634         100 SASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN----  169 (308)
T ss_pred             CHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCcc----
Confidence            88777653   234589999999999999999999999   99999999999999999999999999987654321    


Q ss_pred             eeecCcccccccccccc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccccccccccc
Q 010309          387 TVMAGGTYGYLAPEFVY---RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS  463 (513)
Q Consensus       387 ~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  463 (513)
                        ...+++.|+|||.+.   ...++.++||||||+++|+|++|..||...+....      ...... ..          
T Consensus       170 --~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~~-~~----------  230 (308)
T cd06634         170 --XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQ-NE----------  230 (308)
T ss_pred             --cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH------HHHHhh-cC----------
Confidence              123788999999874   35678899999999999999999999865432110      000000 00          


Q ss_pred             CCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q 010309          464 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  506 (513)
Q Consensus       464 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  506 (513)
                        .........+..+.+||.+||+.+|++||+++++++..--.
T Consensus       231 --~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~  271 (308)
T cd06634         231 --SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL  271 (308)
T ss_pred             --CCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccc
Confidence              01111223556789999999999999999999999764433

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.6e-36  Score=286.80  Aligned_cols=246  Identities=23%  Similarity=0.357  Sum_probs=192.8

Q ss_pred             CCceecccCceEEEEEEeC-CCCEEEEEEeccc-----chhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeC--CceEEEE
Q 010309          229 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS-----SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDRYIVY  300 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lv~  300 (513)
                      ..++||+|++|.||+|... ++..||+|.+...     .......+.+|+.++++++||||+++++++.+.  +..++|+
T Consensus         6 ~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~   85 (264)
T cd06653           6 LGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFV   85 (264)
T ss_pred             eeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEE
Confidence            3557899999999999964 5899999988532     123345788999999999999999999998764  4578999


Q ss_pred             eeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCc
Q 010309          301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW  380 (513)
Q Consensus       301 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~  380 (513)
                      ||+++++|.+++..    ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||+++....
T Consensus        86 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  158 (264)
T cd06653          86 EYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQT  158 (264)
T ss_pred             EeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence            99999999999864    24588999999999999999999999   999999999999999999999999999986543


Q ss_pred             cccc-cceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccccccc
Q 010309          381 EVMQ-ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD  459 (513)
Q Consensus       381 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  459 (513)
                      .... .......++..|+|||++.+..++.++|+||||+++|+|++|+.||......  ....    .....        
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~----~~~~~--------  224 (264)
T cd06653         159 ICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM--AAIF----KIATQ--------  224 (264)
T ss_pred             ccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH--HHHH----HHHcC--------
Confidence            2111 1111223788999999998888899999999999999999999999754321  0110    00000        


Q ss_pred             ccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          460 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       460 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      +     .....+...++.+.+++.+||+ +|..||++.+++.
T Consensus       225 ~-----~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         225 P-----TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             C-----CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence            0     0111223456779999999999 5799999998875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=7.3e-36  Score=290.54  Aligned_cols=263  Identities=20%  Similarity=0.320  Sum_probs=193.0

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccch-hcHHHHHHHHHHHhhcC-CCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF-QRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      .+.||+|++|.||+|... +++.||||++..... .......+|+..+++++ ||||+++++++.+++..++||||+ ++
T Consensus         4 ~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~   82 (283)
T cd07830           4 IKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EG   82 (283)
T ss_pred             heeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CC
Confidence            346799999999999975 478999999875432 22334567999999998 999999999999999999999999 88


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  386 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  386 (513)
                      +|.+++...  ....+++..+..++.|++.+|.|||++   +++|+||+|+||+++.++.++|+|||++...........
T Consensus        83 ~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~  157 (283)
T cd07830          83 NLYQLMKDR--KGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTD  157 (283)
T ss_pred             CHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCC
Confidence            999888642  234689999999999999999999999   999999999999999999999999999986643322111


Q ss_pred             eeecCccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccc-hhHHhhhHH-----hhccccccccc
Q 010309          387 TVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ-SIFEWATPL-----VQSHRYLELLD  459 (513)
Q Consensus       387 ~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~-~~~~~~~~~-----~~~~~~~~~~~  459 (513)
                         ..++..|+|||++.. ..++.++|+||||++++||++|++||......... .........     ...........
T Consensus       158 ---~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07830         158 ---YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG  234 (283)
T ss_pred             ---CCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence               227888999998854 45789999999999999999999999765432110 000000000     00000000000


Q ss_pred             ccccCCCCCC---CcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          460 PLISSLSSDI---PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       460 ~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      ..........   .....+..+.+++.+||+.||++|||++|++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            0000000000   00012467999999999999999999999975

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-35  Score=284.03  Aligned_cols=243  Identities=26%  Similarity=0.447  Sum_probs=198.9

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccch--hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      .+.||+|++|.||++... +++.|++|.+.....  ...+.+.+|++++++++|||++++++++.+.+..++||||++++
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~   84 (254)
T cd06627           5 GDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENG   84 (254)
T ss_pred             eeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCC
Confidence            457899999999999865 578999999987643  34578899999999999999999999999999999999999999


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  386 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  386 (513)
                      +|.+++..    ...+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||.+.........  
T Consensus        85 ~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~--  155 (254)
T cd06627          85 SLRQIIKK----FGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--  155 (254)
T ss_pred             cHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCccc--
Confidence            99999864    25689999999999999999999999   9999999999999999999999999999876543321  


Q ss_pred             eeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCC
Q 010309          387 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  466 (513)
Q Consensus       387 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  466 (513)
                      .....++..|+|||.+.+..++.++||||||+++|+|++|..||...+..  .....    ... ..             
T Consensus       156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~--~~~~~----~~~-~~-------------  215 (254)
T cd06627         156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM--AALFR----IVQ-DD-------------  215 (254)
T ss_pred             ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH--HHHHH----Hhc-cC-------------
Confidence            11223788999999998878899999999999999999999998754321  00000    000 00             


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          467 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       467 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      ....+...++.+.+++.+||+.+|++|||+.+++.
T Consensus       216 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         216 HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             CCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            00111234567999999999999999999999984

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=4.7e-36  Score=293.96  Aligned_cols=246  Identities=23%  Similarity=0.419  Sum_probs=189.0

Q ss_pred             CceecccCceEEEEEEeCC-CCEEEEEEecccch-hcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          230 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSF-QRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      .+.||+|++|.||+|...+ ++.||||.++.... .....+..|+.++.++ .||||+++++++.+....++||||+ ++
T Consensus        20 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~   98 (296)
T cd06618          20 LGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELM-ST   98 (296)
T ss_pred             eeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeecc-Cc
Confidence            4567999999999999865 89999999976432 2345567777777776 4999999999999999999999998 45


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD-KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  385 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  385 (513)
                      +|.+++...   ...+++..+..++.|++.||+|||+ .   +|+||||+|+||+++.++.+||+|||++..........
T Consensus        99 ~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~~  172 (296)
T cd06618          99 CLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKT  172 (296)
T ss_pred             CHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECccccchhccCCCccc
Confidence            777776542   2468999999999999999999997 5   89999999999999999999999999987654322211


Q ss_pred             ceeecCcccccccccccccCC----CCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccccccccc
Q 010309          386 RTVMAGGTYGYLAPEFVYRNE----LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL  461 (513)
Q Consensus       386 ~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  461 (513)
                         ...++..|+|||.+.+..    ++.++||||||+++|+|++|+.||......     .+.........      .+.
T Consensus       173 ---~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~~------~~~  238 (296)
T cd06618         173 ---RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FEVLTKILQEE------PPS  238 (296)
T ss_pred             ---CCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HHHHHHHhcCC------CCC
Confidence               122778899999987553    788999999999999999999998653221     11111111100      000


Q ss_pred             ccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010309          462 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  502 (513)
Q Consensus       462 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  502 (513)
                      .      .....++.++.+|+.+||+.||++||+++++++.
T Consensus       239 ~------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         239 L------PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             C------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            0      0011245679999999999999999999999864

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.4e-35  Score=291.44  Aligned_cols=268  Identities=21%  Similarity=0.244  Sum_probs=192.2

Q ss_pred             CcccCCceecccCceEEEEEEeC-CCCEEEEEEecccch--hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCC-------
Q 010309          225 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG-------  294 (513)
Q Consensus       225 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-------  294 (513)
                      +|.. .+.||+|++|.||+|... +|+.||||+++....  .....+.+|+.+++.++||||+++++++.+..       
T Consensus         8 ~~~~-~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~   86 (302)
T cd07864           8 KFDI-IGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKK   86 (302)
T ss_pred             hhhe-eeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccc
Confidence            3433 346799999999999975 588999999975432  23356788999999999999999999987655       


Q ss_pred             ---ceEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEec
Q 010309          295 ---DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMG  371 (513)
Q Consensus       295 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~D  371 (513)
                         ..++|+||+++ +|..++..   ....+++..++.++.|++.||+|||+.   +|+|+||||+||++++++.+||+|
T Consensus        87 ~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~d  159 (302)
T cd07864          87 DKGAFYLVFEYMDH-DLMGLLES---GLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLAD  159 (302)
T ss_pred             cCCcEEEEEcccCc-cHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeCc
Confidence               78999999975 77777653   234689999999999999999999999   999999999999999999999999


Q ss_pred             ccccccCCccccccceeecCccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhh
Q 010309          372 VGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQ  450 (513)
Q Consensus       372 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  450 (513)
                      ||++........... ....++..|+|||.+.+ ..++.++||||||+++|||++|++||....................
T Consensus       160 fg~~~~~~~~~~~~~-~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~  238 (302)
T cd07864         160 FGLARLYNSEESRPY-TNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC  238 (302)
T ss_pred             ccccccccCCccccc-ccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            999987654322111 11125778999998865 3568899999999999999999999975443211110000000000


Q ss_pred             cccccccc--------cccccCCC-CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          451 SHRYLELL--------DPLISSLS-SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       451 ~~~~~~~~--------~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      ...+..+.        +....... ........+..+.+++.+||+.||++||++.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         239 PAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             hhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            00000000        00000000 00000123567999999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=3.8e-36  Score=300.17  Aligned_cols=264  Identities=21%  Similarity=0.262  Sum_probs=191.6

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEeccc--chhcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeC--CceEEEEeec
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDH--GDRYIVYEFV  303 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~--~~~~lv~e~~  303 (513)
                      .+.||+|+||.||+|... +++.||||++...  .......+.+|+.+++++ +||||+++++++...  ...++||||+
T Consensus        12 ~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~   91 (337)
T cd07852          12 LQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYM   91 (337)
T ss_pred             hHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEeccc
Confidence            346799999999999975 5889999988643  223345677899999999 999999999998654  3579999999


Q ss_pred             cCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccc
Q 010309          304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM  383 (513)
Q Consensus       304 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~  383 (513)
                      + ++|.+++..     ..+++..+..++.|++.||+|||+.   +|+|+||||+||+++.++.+||+|||++........
T Consensus        92 ~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~  162 (337)
T cd07852          92 E-TDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE  162 (337)
T ss_pred             c-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhccccccc
Confidence            6 599988853     2688899999999999999999999   999999999999999999999999999986643321


Q ss_pred             c---cceeecCccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhH--------Hhhc
Q 010309          384 Q---ERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATP--------LVQS  451 (513)
Q Consensus       384 ~---~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~--------~~~~  451 (513)
                      .   .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.................        ....
T Consensus       163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (337)
T cd07852         163 NPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKS  242 (337)
T ss_pred             cccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHh
Confidence            1   11112237889999998765 4578899999999999999999999976543211100000000        0000


Q ss_pred             ccccccccccccCCC--CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010309          452 HRYLELLDPLISSLS--SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  502 (513)
Q Consensus       452 ~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  502 (513)
                      ......++.......  ........+.++.++|.+||+.||++|||+.++++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         243 PFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             hhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            000001100000000  000011145679999999999999999999999974

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.8e-36  Score=300.15  Aligned_cols=263  Identities=21%  Similarity=0.267  Sum_probs=192.4

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEeccc--chhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeC-----CceEEEEe
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH-----GDRYIVYE  301 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~~lv~e  301 (513)
                      .+.||+|+||.||++... +++.||||.+...  .......+.+|+.+++.++||||+++++++...     ...++|+|
T Consensus        10 ~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e   89 (337)
T cd07858          10 IKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYE   89 (337)
T ss_pred             EEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEe
Confidence            457799999999999964 6899999998753  223345678899999999999999999987654     34799999


Q ss_pred             eccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcc
Q 010309          302 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE  381 (513)
Q Consensus       302 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~  381 (513)
                      |+. ++|.+++..    ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++......
T Consensus        90 ~~~-~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~  161 (337)
T cd07858          90 LMD-TDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK  161 (337)
T ss_pred             CCC-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence            995 689888853    35699999999999999999999999   9999999999999999999999999999866433


Q ss_pred             ccccceeecCccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHH-hhh-------HHhhcc
Q 010309          382 VMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFE-WAT-------PLVQSH  452 (513)
Q Consensus       382 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~-~~~-------~~~~~~  452 (513)
                      ...  .....++..|+|||.+.. ..++.++||||||+++|+|++|++||...+......... ...       ......
T Consensus       162 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (337)
T cd07858         162 GDF--MTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNE  239 (337)
T ss_pred             ccc--ccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCch
Confidence            211  112237889999998865 468899999999999999999999997653211110000 000       000000


Q ss_pred             cccccccccccCCCC--CCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010309          453 RYLELLDPLISSLSS--DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  502 (513)
Q Consensus       453 ~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  502 (513)
                      .....+.........  .......++++.++|.+||+.||++|||++++++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         240 KARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             hhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence            000000000000000  00012356779999999999999999999999874

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-36  Score=283.76  Aligned_cols=256  Identities=23%  Similarity=0.337  Sum_probs=208.1

Q ss_pred             cCCceecccCceEEEEEEeC------CCCEEEEEEeccc-chhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeC-CceEEE
Q 010309          228 EGNRLLGDSKTGGTYSGILP------DGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH-GDRYIV  299 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-~~~~lv  299 (513)
                      ...-++-+|.||.||+|.+.      +.+.|-+|.++.. +.-....+..|.-.+..+.|||+.++.+++.+. ...+++
T Consensus       287 ~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~  366 (563)
T KOG1024|consen  287 RLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVL  366 (563)
T ss_pred             echhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEE
Confidence            34456799999999999754      3456778888654 333456788999999999999999999998764 567899


Q ss_pred             EeeccCCCHHHHhccC----CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEeccccc
Q 010309          300 YEFVVNGPLDRWLHHI----PRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLS  375 (513)
Q Consensus       300 ~e~~~~gsL~~~l~~~----~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~  375 (513)
                      +.++.-|+|..||...    +...+.++..+...++.|++.|++|||++   ++||.||.++|.+||+..++||+|=.++
T Consensus       367 y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqVkltDsaLS  443 (563)
T KOG1024|consen  367 YPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQVKLTDSALS  443 (563)
T ss_pred             EeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeEEeccchhc
Confidence            9999999999999732    23446688889999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccc
Q 010309          376 KFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRY  454 (513)
Q Consensus       376 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  454 (513)
                      +.+-....+........+..||+||.+....|+.++|||||||+||||+| |+.|+...++.+.......      ..  
T Consensus       444 RDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkd------Gy--  515 (563)
T KOG1024|consen  444 RDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKD------GY--  515 (563)
T ss_pred             cccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhc------cc--
Confidence            98766554443333336788999999999999999999999999999999 9999988776543322211      11  


Q ss_pred             cccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q 010309          455 LELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  506 (513)
Q Consensus       455 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  506 (513)
                                  ....+.++++++..++.-||..+|++||++++++.-|.+.
T Consensus       516 ------------RlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF  555 (563)
T KOG1024|consen  516 ------------RLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF  555 (563)
T ss_pred             ------------eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence                        1112345778899999999999999999999999988764

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=3.8e-36  Score=299.81  Aligned_cols=262  Identities=20%  Similarity=0.312  Sum_probs=192.9

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccc--hhcHHHHHHHHHHHhhcCCCcEeeeeeEEee----CCceEEEEee
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYD----HGDRYIVYEF  302 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~~lv~e~  302 (513)
                      .+.||+|++|.||+|... +|+.||+|++....  ....+.+.+|+.++++++||||+++++++..    ....++||||
T Consensus        10 ~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~   89 (334)
T cd07855          10 IENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDL   89 (334)
T ss_pred             eeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEeh
Confidence            456799999999999964 59999999997542  2334677889999999999999999998763    3467999999


Q ss_pred             ccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccc
Q 010309          303 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV  382 (513)
Q Consensus       303 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~  382 (513)
                      +. ++|.+++..    ...+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||++.......
T Consensus        90 ~~-~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  161 (334)
T cd07855          90 ME-SDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP  161 (334)
T ss_pred             hh-hhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceeecccC
Confidence            95 689888853    34589999999999999999999999   99999999999999999999999999997654322


Q ss_pred             cccc--eeecCccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhH-----Hh---hc
Q 010309          383 MQER--TVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATP-----LV---QS  451 (513)
Q Consensus       383 ~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~-----~~---~~  451 (513)
                      ....  .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+.............     ..   ..
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~  241 (334)
T cd07855         162 TEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGS  241 (334)
T ss_pred             cCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhch
Confidence            1111  111237889999998865 4578999999999999999999999976543211110000000     00   00


Q ss_pred             ccccccccccccCCCCCCC----cHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          452 HRYLELLDPLISSLSSDIP----EAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       452 ~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      ....+..+. ... ....+    ....++++.++|.+||+.+|++|||+++++.
T Consensus       242 ~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         242 DRVRKYIQN-LPR-KQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             hhHHHHHhh-ccc-CCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            000000000 000 00000    1224678999999999999999999999887

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-37  Score=296.41  Aligned_cols=244  Identities=22%  Similarity=0.367  Sum_probs=201.6

Q ss_pred             CceecccCceEEEEEEe-CCCCEEEEEEecccch--hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          230 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      .++||+|.||+||-|+. ++|+.||||++.+...  +...++++|+.||++++||.||.+.-.|+..+..++|||.+ +|
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence            45789999999999996 4799999999987533  44578999999999999999999999999999999999999 45


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCC---CCeEEecccccccCCcccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE---FGAHLMGVGLSKFVPWEVM  383 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~---~~~kl~Dfg~~~~~~~~~~  383 (513)
                      +..+.|..  .....+++..-..++.||+.||.|||.+   +|+|+||||+|||+.+.   -++||+|||+++.......
T Consensus       648 DMLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF  722 (888)
T KOG4236|consen  648 DMLEMILS--SEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF  722 (888)
T ss_pred             hHHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhhh
Confidence            65555543  3456799999999999999999999999   99999999999999654   4599999999999876554


Q ss_pred             ccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccccccccccc
Q 010309          384 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS  463 (513)
Q Consensus       384 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  463 (513)
                      ...   ..||+.|.|||++.+..|...-|+||.|||+|--++|..||....+.     .+    .++..   .+      
T Consensus       723 Rrs---VVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdI-----nd----QIQNA---aF------  781 (888)
T KOG4236|consen  723 RRS---VVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDI-----ND----QIQNA---AF------  781 (888)
T ss_pred             hhh---hcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccch-----hH----Hhhcc---cc------
Confidence            433   33999999999999999999999999999999999999999764331     11    11111   11      


Q ss_pred             CCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          464 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       464 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                       ..+..|..+++++.++||..+|+..-.+|-|.+.-+.
T Consensus       782 -MyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls  818 (888)
T KOG4236|consen  782 -MYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS  818 (888)
T ss_pred             -ccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence             1244566788899999999999999999999887653

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.4e-35  Score=289.35  Aligned_cols=252  Identities=21%  Similarity=0.230  Sum_probs=196.1

Q ss_pred             CceecccCceEEEEEEe----CCCCEEEEEEecccch----hcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCCceEEEE
Q 010309          230 NRLLGDSKTGGTYSGIL----PDGSRVAVKRLKRSSF----QRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVY  300 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~  300 (513)
                      .+.||+|++|.||++..    .+++.||||++++...    ...+.+.+|+.++.++ +||||+++++.+......++||
T Consensus         5 ~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   84 (288)
T cd05583           5 LRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLIL   84 (288)
T ss_pred             EEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEE
Confidence            45689999999999984    3578999999975422    2335678999999999 6999999999999999999999


Q ss_pred             eeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCc
Q 010309          301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW  380 (513)
Q Consensus       301 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~  380 (513)
                      ||+++++|.+++..    ...+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        85 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  157 (288)
T cd05583          85 DYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA  157 (288)
T ss_pred             ecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence            99999999998853    24688999999999999999999999   999999999999999999999999999876543


Q ss_pred             cccccceeecCcccccccccccccCC--CCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccc
Q 010309          381 EVMQERTVMAGGTYGYLAPEFVYRNE--LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELL  458 (513)
Q Consensus       381 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  458 (513)
                      ..... .....++..|+|||.+.+..  .+.++||||||+++|||++|..||.......  ...+.......        
T Consensus       158 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~--------  226 (288)
T cd05583         158 EEEER-AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQSEISRRILK--------  226 (288)
T ss_pred             ccccc-cccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hHHHHHHHHHc--------
Confidence            32211 11223788999999987654  7889999999999999999999986432211  00111111000        


Q ss_pred             cccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q 010309          459 DPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  506 (513)
Q Consensus       459 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  506 (513)
                       .      ....+...+..+.+++.+||+.||++|||+.++.+.|+..
T Consensus       227 -~------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~  267 (288)
T cd05583         227 -S------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP  267 (288)
T ss_pred             -c------CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence             0      0001122445789999999999999999998888777643

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=2.2e-35  Score=288.33  Aligned_cols=247  Identities=20%  Similarity=0.255  Sum_probs=192.1

Q ss_pred             CceecccCceEEEEEEe----CCCCEEEEEEecccch----hcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCCceEEEE
Q 010309          230 NRLLGDSKTGGTYSGIL----PDGSRVAVKRLKRSSF----QRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVY  300 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~  300 (513)
                      .+.||+|+||.||++..    .+|..||+|++.....    ...+.+.+|+.++.++ +|+||+++++.+..+...++||
T Consensus         5 ~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (290)
T cd05613           5 LKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLIL   84 (290)
T ss_pred             eeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEE
Confidence            45679999999999986    3689999999975422    2346678899999999 6999999999999999999999


Q ss_pred             eeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCc
Q 010309          301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW  380 (513)
Q Consensus       301 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~  380 (513)
                      ||+++++|.+++..    ...+++..+..++.|++.||.|||+.   +++||||+|+|||++.++.+||+|||++.....
T Consensus        85 e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  157 (290)
T cd05613          85 DYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE  157 (290)
T ss_pred             ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence            99999999999864    34688999999999999999999999   999999999999999999999999999986543


Q ss_pred             cccccceeecCcccccccccccccC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccc
Q 010309          381 EVMQERTVMAGGTYGYLAPEFVYRN--ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELL  458 (513)
Q Consensus       381 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  458 (513)
                      ..... .....++..|+|||.+...  .++.++||||||+++|+|++|..||.......  ............       
T Consensus       158 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~-------  227 (290)
T cd05613         158 DEVER-AYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN--SQAEISRRILKS-------  227 (290)
T ss_pred             ccccc-cccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc--cHHHHHHHhhcc-------
Confidence            32211 1122378899999998753  46789999999999999999999986432210  111111110000       


Q ss_pred             cccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 010309          459 DPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP-----RMSHVVH  501 (513)
Q Consensus       459 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  501 (513)
                              ....+...++.+.+++.+||+.||++||     ++++++.
T Consensus       228 --------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         228 --------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             --------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence                    0001122456789999999999999997     6777765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.5e-35  Score=296.60  Aligned_cols=272  Identities=19%  Similarity=0.300  Sum_probs=197.7

Q ss_pred             cCHHHHHHHhhCcccCCceecccCceEEEEEEe-CCCCEEEEEEecccc--hhcHHHHHHHHHHHhhcCCCcEeeeeeEE
Q 010309          214 FTTEELRSITKNFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCC  290 (513)
Q Consensus       214 ~~~~~l~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  290 (513)
                      ....++..+.++|... +.||+|+||.||++.. .+++.||+|++....  ....+.+.+|+.++.+++||||+++++++
T Consensus         7 ~~~~~~~~~~~~y~~~-~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~   85 (345)
T cd07877           7 ELNKTIWEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVF   85 (345)
T ss_pred             hHHHHHhhccCceEEE-EEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeee
Confidence            3455667777777654 5679999999999985 468999999997542  22346688899999999999999999988


Q ss_pred             eeC------CceEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCC
Q 010309          291 YDH------GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE  364 (513)
Q Consensus       291 ~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~  364 (513)
                      ...      ...+++++++ +++|.+++..     ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.+
T Consensus        86 ~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~  156 (345)
T cd07877          86 TPARSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNED  156 (345)
T ss_pred             eecccccccccEEEEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCC
Confidence            643      3468888887 7899888753     3589999999999999999999999   99999999999999999


Q ss_pred             CCeEEecccccccCCccccccceeecCccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccch-hH
Q 010309          365 FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS-IF  442 (513)
Q Consensus       365 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~-~~  442 (513)
                      +.+||+|||++.......     ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+...... ..
T Consensus       157 ~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~  231 (345)
T cd07877         157 CELKILDFGLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL  231 (345)
T ss_pred             CCEEEecccccccccccc-----cccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            999999999987653221     11237889999998866 467889999999999999999999996544321100 00


Q ss_pred             Hhh-------hHHhhccc---ccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          443 EWA-------TPLVQSHR---YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       443 ~~~-------~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      ...       ........   ....+...... .........++++.++|.+||+.||.+||++.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  299 (345)
T cd07877         232 RLVGTPGAELLKKISSESARNYIQSLTQMPKM-NFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  299 (345)
T ss_pred             HHhCCCCHHHHhhcccHhHHHHHHHhcccCCc-chhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence            000       00000000   00000000000 000000123557899999999999999999999886

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.3e-35  Score=296.85  Aligned_cols=266  Identities=17%  Similarity=0.274  Sum_probs=191.4

Q ss_pred             hCcccCCceecccCceEEEEEEeC-CCCEEEEEEecccc--hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCC------
Q 010309          224 KNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG------  294 (513)
Q Consensus       224 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------  294 (513)
                      .+|.. ...||+|++|.||+|... +|+.||||++....  ......+.+|+.+++.++||||+++++++....      
T Consensus        15 ~~y~~-~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          15 ERYTS-LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             cceEE-EEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            45543 467799999999999964 68999999987542  222456889999999999999999999987543      


Q ss_pred             ceEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccc
Q 010309          295 DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGL  374 (513)
Q Consensus       295 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~  374 (513)
                      ..++|+||+. .+|..++.      ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+
T Consensus        94 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~  163 (342)
T cd07879          94 DFYLVMPYMQ-TDLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGL  163 (342)
T ss_pred             eEEEEecccc-cCHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCC
Confidence            4599999995 47776652      3589999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCccccccceeecCccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhh-------
Q 010309          375 SKFVPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWAT-------  446 (513)
Q Consensus       375 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~-------  446 (513)
                      +........     ...++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+............       
T Consensus       164 ~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (342)
T cd07879         164 ARHADAEMT-----GYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEF  238 (342)
T ss_pred             CcCCCCCCC-----CceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            876532211     1226788999999876 468899999999999999999999998654211000000000       


Q ss_pred             -HHhhcccccccccccccCCCCCCC---cHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--HhcC
Q 010309          447 -PLVQSHRYLELLDPLISSLSSDIP---EAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ--LQQL  506 (513)
Q Consensus       447 -~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~  506 (513)
                       .............. .........   ....+..+.+||.+||+.||++||++++++..  ++..
T Consensus       239 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~  303 (342)
T cd07879         239 VQKLEDKAAKSYIKS-LPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF  303 (342)
T ss_pred             HHHhcccchHHHHhh-cCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence             00000000000000 000000000   01234568899999999999999999999853  5444

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.4e-36  Score=297.27  Aligned_cols=273  Identities=21%  Similarity=0.266  Sum_probs=201.3

Q ss_pred             CCceecccCceEEEEEEeC-CCCEEEEEEecccc--hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCC-----ceEEEE
Q 010309          229 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG-----DRYIVY  300 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-----~~~lv~  300 (513)
                      ..+.||.|++|.||+|... +++.||||.+....  ....+.+.+|+.+++.++||||+++++++...+     ..|+||
T Consensus         4 i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~   83 (330)
T cd07834           4 LLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVT   83 (330)
T ss_pred             eeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEe
Confidence            3457899999999999975 48999999997653  334567899999999999999999999988775     789999


Q ss_pred             eeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCc
Q 010309          301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW  380 (513)
Q Consensus       301 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~  380 (513)
                      ||++ ++|.+++..    ...+++..++.++.|++.||+|||+.   +|+|+||||+|||++.++.++|+|||++.....
T Consensus        84 e~~~-~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~  155 (330)
T cd07834          84 ELME-TDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDP  155 (330)
T ss_pred             cchh-hhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence            9996 589888853    24799999999999999999999999   999999999999999999999999999987654


Q ss_pred             cccc-cceeecCcccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHH--------hh
Q 010309          381 EVMQ-ERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPL--------VQ  450 (513)
Q Consensus       381 ~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~--------~~  450 (513)
                      .... .......++..|+|||.+.+. .++.++||||||+++|+|++|.+||...+..............        ..
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  235 (330)
T cd07834         156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFIT  235 (330)
T ss_pred             cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcc
Confidence            3210 011112278889999999887 7899999999999999999999999776532111100000000        00


Q ss_pred             cccccccccccccC--CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--HhcCcCC
Q 010309          451 SHRYLELLDPLISS--LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ--LQQLAQP  509 (513)
Q Consensus       451 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~~~  509 (513)
                      .....+.+......  ..........+..+.+++.+||+.+|.+||++++++..  ++++..+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~  298 (330)
T cd07834         236 SEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP  298 (330)
T ss_pred             ccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence            00000000000000  00000011245679999999999999999999999983  5554443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.2e-35  Score=288.20  Aligned_cols=244  Identities=20%  Similarity=0.329  Sum_probs=196.9

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccc---hhcHHHHHHHHHHHhhcC-CCcEeeeeeEEeeCCceEEEEeecc
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVYEFVV  304 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~  304 (513)
                      .+.||+|++|.||++... +++.||+|++....   ....+.+.+|+.++.+++ ||||+++++++...+..++|||+++
T Consensus         6 ~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~   85 (280)
T cd05581           6 GKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAP   85 (280)
T ss_pred             eeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCC
Confidence            456799999999999975 69999999997632   233467889999999998 9999999999999999999999999


Q ss_pred             CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccc
Q 010309          305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  384 (513)
Q Consensus       305 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  384 (513)
                      +++|.+++..    ...+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.........
T Consensus        86 ~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~  158 (280)
T cd05581          86 NGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP  158 (280)
T ss_pred             CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence            9999999964    24699999999999999999999999   9999999999999999999999999999876543221


Q ss_pred             ------------------cceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhh
Q 010309          385 ------------------ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWAT  446 (513)
Q Consensus       385 ------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~  446 (513)
                                        .......++..|+|||.+....++.++||||||++++++++|..||......   ....   
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~---  232 (280)
T cd05581         159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY---LTFQ---  232 (280)
T ss_pred             ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH---HHHH---
Confidence                              1111223678999999998888999999999999999999999999865421   0000   


Q ss_pred             HHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCH----HHHHH
Q 010309          447 PLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRM----SHVVH  501 (513)
Q Consensus       447 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~evl~  501 (513)
                      ....         .      ....+...++.+.+++.+||+.+|++||++    +++++
T Consensus       233 ~~~~---------~------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         233 KILK---------L------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             HHHh---------c------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            0000         0      001112335679999999999999999999    77664

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=8.2e-36  Score=298.25  Aligned_cols=269  Identities=21%  Similarity=0.294  Sum_probs=192.5

Q ss_pred             CCceecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeC--------------
Q 010309          229 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--------------  293 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--------------  293 (513)
                      ..+.||.|+||.||+|... +|+.||+|.+........+.+.+|+.++++++||||+++++++...              
T Consensus         9 ~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~   88 (342)
T cd07854           9 DLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTEL   88 (342)
T ss_pred             EEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccccccc
Confidence            3456799999999999974 5899999999776555667889999999999999999999876554              


Q ss_pred             CceEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecC-CCCeEEecc
Q 010309          294 GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE-EFGAHLMGV  372 (513)
Q Consensus       294 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~-~~~~kl~Df  372 (513)
                      ...++||||++ ++|.+++..     ..+++..++.++.||+.||.|||+.   +++||||||+||+++. ++.++|+||
T Consensus        89 ~~~~lv~e~~~-~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl~df  159 (342)
T cd07854          89 NSVYIVQEYME-TDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDF  159 (342)
T ss_pred             ceEEEEeeccc-ccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEECCc
Confidence            35789999996 589888753     3589999999999999999999999   9999999999999974 556899999


Q ss_pred             cccccCCcccccc-ceeecCccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhh
Q 010309          373 GLSKFVPWEVMQE-RTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQ  450 (513)
Q Consensus       373 g~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  450 (513)
                      |.+.......... ......++..|+|||.+.. ..++.++|||||||++|+|++|+.||................+...
T Consensus       160 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  239 (342)
T cd07854         160 GLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVR  239 (342)
T ss_pred             ccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            9997653321111 1111236888999998754 4578899999999999999999999976543211110000000000


Q ss_pred             c---cccccccccccc--CCCCCCC----cHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcC
Q 010309          451 S---HRYLELLDPLIS--SLSSDIP----EAGVVQKVVDLVYACTQHVPSMRPRMSHVVH--QLQQL  506 (513)
Q Consensus       451 ~---~~~~~~~~~~~~--~~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~  506 (513)
                      .   ............  ......+    ....+.++.+|+.+||+.||.+|||+++++.  .++..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~  306 (342)
T cd07854         240 EEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY  306 (342)
T ss_pred             hHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence            0   000000000000  0000000    0124567899999999999999999999984  44433

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-35  Score=315.27  Aligned_cols=255  Identities=27%  Similarity=0.424  Sum_probs=204.3

Q ss_pred             CceecccCceEEEEEEeC----C----CCEEEEEEecccc-hhcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCCceEEE
Q 010309          230 NRLLGDSKTGGTYSGILP----D----GSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIV  299 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~----~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv  299 (513)
                      .+.||+|.||.|++|...    .    ...||||.++... ..+.+.+..|+++|..+ .||||+.++|+|...+..++|
T Consensus       301 ~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v  380 (609)
T KOG0200|consen  301 GKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVI  380 (609)
T ss_pred             cceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEE
Confidence            447899999999999843    1    4579999998653 34567899999999999 799999999999999999999


Q ss_pred             EeeccCCCHHHHhccCC---CC-------C--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCe
Q 010309          300 YEFVVNGPLDRWLHHIP---RG-------G--RSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA  367 (513)
Q Consensus       300 ~e~~~~gsL~~~l~~~~---~~-------~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~  367 (513)
                      +||+..|+|.++|+..+   ..       .  ..++..+.+.++.|||.|++||++.   ++|||||.++|||++.+..+
T Consensus       381 ~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi~~~~~~  457 (609)
T KOG0200|consen  381 VEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLITKNKVI  457 (609)
T ss_pred             EEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEecCCCEE
Confidence            99999999999998654   00       0  2388999999999999999999999   99999999999999999999


Q ss_pred             EEecccccccCCccccccceeec-CcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhh
Q 010309          368 HLMGVGLSKFVPWEVMQERTVMA-GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWA  445 (513)
Q Consensus       368 kl~Dfg~~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~  445 (513)
                      ||+|||+++.............. .-...|||||.+....++.+||||||||+||||+| |..||.+....  ..+.+  
T Consensus       458 kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~--~~l~~--  533 (609)
T KOG0200|consen  458 KIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT--EELLE--  533 (609)
T ss_pred             EEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH--HHHHH--
Confidence            99999999965544333211111 02456999999999999999999999999999999 88998763311  11111  


Q ss_pred             hHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q 010309          446 TPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  506 (513)
Q Consensus       446 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  506 (513)
                        ....+.             ....+..+.+++.++|+.||+.+|++||++.++.+.|+.+
T Consensus       534 --~l~~G~-------------r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  534 --FLKEGN-------------RMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             --HHhcCC-------------CCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence              111111             1122344577899999999999999999999999999874

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.9e-35  Score=293.75  Aligned_cols=265  Identities=22%  Similarity=0.323  Sum_probs=194.7

Q ss_pred             HHhhCcccCCceecccCceEEEEEEeC-CCCEEEEEEecccc--hhcHHHHHHHHHHHhhcCCCcEeeeeeEEee-CCce
Q 010309          221 SITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYD-HGDR  296 (513)
Q Consensus       221 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~  296 (513)
                      .++++|.. .+.||.|+||.||++... +++.||||++.+..  ....+.+.+|+.+++.++||||+++++++.. ....
T Consensus         7 ~~~~~y~~-~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   85 (328)
T cd07856           7 EITNRYVD-LQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI   85 (328)
T ss_pred             ccccceEE-EEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence            34555544 467799999999999865 68999999886532  2234678899999999999999999999876 5678


Q ss_pred             EEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccc
Q 010309          297 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK  376 (513)
Q Consensus       297 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~  376 (513)
                      ++|+||+ +++|.+++..     ..+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||.+.
T Consensus        86 ~lv~e~~-~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~  156 (328)
T cd07856          86 YFVTELL-GTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLAR  156 (328)
T ss_pred             EEEeehh-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccccc
Confidence            9999998 6689888853     4578888999999999999999999   99999999999999999999999999987


Q ss_pred             cCCccccccceeecCccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccch-hHHhhh-------H
Q 010309          377 FVPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS-IFEWAT-------P  447 (513)
Q Consensus       377 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~-~~~~~~-------~  447 (513)
                      .......     ...++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.......... +.+...       .
T Consensus       157 ~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  231 (328)
T cd07856         157 IQDPQMT-----GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVIN  231 (328)
T ss_pred             ccCCCcC-----CCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            5432211     1226788999998766 568999999999999999999999997654311000 000000       0


Q ss_pred             HhhcccccccccccccCCCCCCCc----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010309          448 LVQSHRYLELLDPLISSLSSDIPE----AGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  502 (513)
Q Consensus       448 ~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  502 (513)
                      ........+.+.....  ....+.    ...++.+.++|.+||+.+|++|||+++++..
T Consensus       232 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         232 TICSENTLRFVQSLPK--REPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             hccchhhHHHHhhccc--cCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0000000000000000  000010    1235679999999999999999999999864

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.4e-35  Score=284.89  Aligned_cols=246  Identities=19%  Similarity=0.291  Sum_probs=192.4

Q ss_pred             CceecccCceEEEEEEeCC-CCEEEEEEecccc-----hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeec
Q 010309          230 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSS-----FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  303 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  303 (513)
                      .+.||+|+||.||++.... +..+++|+++...     ......+..|+.+++.++||||+++++++.+....++||||+
T Consensus         5 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (260)
T cd08222           5 QQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYC   84 (260)
T ss_pred             eeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeC
Confidence            4568999999999998643 4556666665321     123345778999999999999999999999999999999999


Q ss_pred             cCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccc
Q 010309          304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM  383 (513)
Q Consensus       304 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~  383 (513)
                      ++++|.+++.........+++..++.++.|++.||.|||+.   +++|+||+|+||+++. +.++|+|||++........
T Consensus        85 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~  160 (260)
T cd08222          85 EGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCD  160 (260)
T ss_pred             CCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecCCCcc
Confidence            99999998865444456799999999999999999999999   9999999999999986 4699999999876543221


Q ss_pred             ccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccccccccccc
Q 010309          384 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS  463 (513)
Q Consensus       384 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  463 (513)
                      .  .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||......      ........         ..  
T Consensus       161 ~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~------~~~~~~~~---------~~--  221 (260)
T cd08222         161 L--ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL------SVVLRIVE---------GP--  221 (260)
T ss_pred             c--ccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHHc---------CC--
Confidence            1  11223788999999998888899999999999999999999998643321      11111000         00  


Q ss_pred             CCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          464 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       464 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                         ....+...+.++.++|.+||+.||++||++.++++
T Consensus       222 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         222 ---TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             ---CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence               00112345678999999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-35  Score=286.58  Aligned_cols=261  Identities=21%  Similarity=0.305  Sum_probs=195.7

Q ss_pred             ceecccCceEEEEEEeC-CCCEEEEEEecccc--hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCC
Q 010309          231 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  307 (513)
Q Consensus       231 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs  307 (513)
                      +.||+|++|.||+|+.. +++.||+|.+....  ....+.+.+|+.++++++||||+++++++.+.+..++||||++ ++
T Consensus         5 ~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~   83 (282)
T cd07829           5 EKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-MD   83 (282)
T ss_pred             hcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-cC
Confidence            46799999999999975 49999999998653  2334677889999999999999999999999999999999997 59


Q ss_pred             HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccce
Q 010309          308 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  387 (513)
Q Consensus       308 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  387 (513)
                      |.+++....   ..+++..+..++.|++.||+|||+.   +|+|+||+|+||+++.++.++|+|||.+..........  
T Consensus        84 l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~--  155 (282)
T cd07829          84 LKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY--  155 (282)
T ss_pred             HHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcccc--
Confidence            999997521   4699999999999999999999999   99999999999999999999999999998764432211  


Q ss_pred             eecCcccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCccccc-hhHHhh-------hHHhhccc-cccc
Q 010309          388 VMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ-SIFEWA-------TPLVQSHR-YLEL  457 (513)
Q Consensus       388 ~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~-~~~~~~-------~~~~~~~~-~~~~  457 (513)
                      ....++..|+|||.+.+. .++.++||||||+++|||++|.+||......... .+....       ........ ....
T Consensus       156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (282)
T cd07829         156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPT  235 (282)
T ss_pred             CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccc
Confidence            111256789999998776 7899999999999999999999999765432110 000000       00000000 0000


Q ss_pred             ccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          458 LDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       458 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      ........ ........+..+.+++.+||+.||++||++++++.
T Consensus       236 ~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         236 FPKFPPKD-LEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             ccccCccc-hHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            00000000 00001123567999999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-35  Score=281.46  Aligned_cols=236  Identities=25%  Similarity=0.323  Sum_probs=192.1

Q ss_pred             ecccCceEEEEEEeC-CCCEEEEEEecccchh---cHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCCH
Q 010309          233 LGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQ---RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  308 (513)
Q Consensus       233 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL  308 (513)
                      ||.|++|.||++... +++.+|+|++......   ....+..|+.++++++||||+++++.+..++..++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            599999999999975 4899999999765332   345788999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccccee
Q 010309          309 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  388 (513)
Q Consensus       309 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  388 (513)
                      .+++..    ...+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||.+........  ...
T Consensus        81 ~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~  151 (250)
T cd05123          81 FSHLSK----EGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTN  151 (250)
T ss_pred             HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCC--ccc
Confidence            999964    23689999999999999999999998   999999999999999999999999999987644321  112


Q ss_pred             ecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCCC
Q 010309          389 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD  468 (513)
Q Consensus       389 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  468 (513)
                      ...++..|+|||...+...+.++|+||||+++|+|++|..||...+..   ....   ....         .      ..
T Consensus       152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~~~---~~~~---------~------~~  210 (250)
T cd05123         152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK---EIYE---KILK---------D------PL  210 (250)
T ss_pred             CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHH---HHhc---------C------CC
Confidence            223788999999998888899999999999999999999999755431   1111   0000         0      00


Q ss_pred             CCcHHHHHHHHHHHHHhcCCCCCCCCCHHH
Q 010309          469 IPEAGVVQKVVDLVYACTQHVPSMRPRMSH  498 (513)
Q Consensus       469 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  498 (513)
                      ..+...+..+.+++.+||..||++||++.+
T Consensus       211 ~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         211 RFPEFLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence            111122567899999999999999999944

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1e-37  Score=278.73  Aligned_cols=262  Identities=23%  Similarity=0.413  Sum_probs=202.3

Q ss_pred             cccCHHHHHHHhhCcccCCceecccCceEEEEEEeC-CCCEEEEEEecccch-hcHHHHHHHHHHHhhc-CCCcEeeeee
Q 010309          212 KVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF-QRKKEFYSEIGRFARL-HHPNLVAVKG  288 (513)
Q Consensus       212 ~~~~~~~l~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~  288 (513)
                      ..|+.+.|+.+.        .||.|+||+|++-.++ .|+..|||+++.... .+.++++.|.+...+- +.||||++||
T Consensus        59 ~~F~~~~Lqdlg--------~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyG  130 (361)
T KOG1006|consen   59 HTFTSDNLQDLG--------EIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYG  130 (361)
T ss_pred             cccccchHHHHH--------HhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhh
Confidence            345555555432        4699999999998864 699999999987644 5567888898876655 7899999999


Q ss_pred             EEeeCCceEEEEeeccCCCHHHHhccC-CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCe
Q 010309          289 CCYDHGDRYIVYEFVVNGPLDRWLHHI-PRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA  367 (513)
Q Consensus       289 ~~~~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~  367 (513)
                      .+..++..+|.||+| ..||+.+.... ......+++..+-+|..-.+.||.||-...  .|||||+||+|||++..|.+
T Consensus       131 a~F~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~v  207 (361)
T KOG1006|consen  131 ALFSEGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDV  207 (361)
T ss_pred             hhhcCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCE
Confidence            999999999999999 55776554211 123456899999999999999999998764  89999999999999999999


Q ss_pred             EEecccccccCCccccccceeecCccccccccccccc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhh
Q 010309          368 HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR--NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWA  445 (513)
Q Consensus       368 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~  445 (513)
                      ||+|||++-.+..+....   ...|...|||||.+..  ..|+.+|||||||++|||+.||..||...+     ++++..
T Consensus       208 KLCDFGIcGqLv~SiAkT---~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~-----svfeql  279 (361)
T KOG1006|consen  208 KLCDFGICGQLVDSIAKT---VDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD-----SVFEQL  279 (361)
T ss_pred             eeecccchHhHHHHHHhh---hccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH-----HHHHHH
Confidence            999999998765443222   2238889999999864  358899999999999999999999998654     344444


Q ss_pred             hHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          446 TPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       446 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      ........      |.+   .........+..+.++|..||.+|-++||+..++++
T Consensus       280 ~~Vv~gdp------p~l---~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  280 CQVVIGDP------PIL---LFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             HHHHcCCC------Cee---cCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence            43333211      111   111222346778999999999999999999999875

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.4e-35  Score=294.94  Aligned_cols=265  Identities=18%  Similarity=0.288  Sum_probs=193.3

Q ss_pred             HHhhCcccCCceecccCceEEEEEEeC-CCCEEEEEEecccc--hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCC---
Q 010309          221 SITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG---  294 (513)
Q Consensus       221 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~---  294 (513)
                      ++.++|.. .+.||+|++|.||++... ++..||||++....  ......+.+|+.+++.++||||+++++++....   
T Consensus        12 ~~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07880          12 EVPDRYRD-LKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD   90 (343)
T ss_pred             ccccceEE-EEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence            34445544 456799999999999854 68999999986532  223456889999999999999999999987654   


Q ss_pred             ---ceEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEec
Q 010309          295 ---DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMG  371 (513)
Q Consensus       295 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~D  371 (513)
                         ..++||||+ +++|.+++..     ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.++|+|
T Consensus        91 ~~~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~d  161 (343)
T cd07880          91 RFHDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILD  161 (343)
T ss_pred             ccceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEee
Confidence               358999999 7799888753     4689999999999999999999999   999999999999999999999999


Q ss_pred             ccccccCCccccccceeecCccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccc-chhHHhh----
Q 010309          372 VGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW-QSIFEWA----  445 (513)
Q Consensus       372 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~-~~~~~~~----  445 (513)
                      ||++........     ...+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.... .......    
T Consensus       162 fg~~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  236 (343)
T cd07880         162 FGLARQTDSEMT-----GYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPS  236 (343)
T ss_pred             cccccccccCcc-----ccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            999986543211     1237889999999876 4578999999999999999999999976543210 0000000    


Q ss_pred             ---hHHhhcccccccccccccCCCCC---CCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          446 ---TPLVQSHRYLELLDPLISSLSSD---IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       446 ---~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                         ............... +......   ......+..+.++|.+||+.||++|||+.+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         237 KEFVQKLQSEDAKNYVKK-LPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             HHHHHhhcchhHHHHHHh-ccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence               000000000000000 0000000   001123456899999999999999999999983

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.4e-35  Score=312.55  Aligned_cols=254  Identities=24%  Similarity=0.324  Sum_probs=185.2

Q ss_pred             HHhhCcccCCceecccCceEEEEEEeC-CCCEEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeC-----
Q 010309          221 SITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH-----  293 (513)
Q Consensus       221 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----  293 (513)
                      +...+|.+. ++||+||||.||+++.+ ||+.||||++.... ......+.+|+..|++|+|||||+++..+.+.     
T Consensus       476 RY~~DFEEL-~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~  554 (1351)
T KOG1035|consen  476 RYLNDFEEL-ELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT  554 (1351)
T ss_pred             hHhhhhHHH-HHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence            455566554 47799999999999965 89999999997653 23346788999999999999999986543110     


Q ss_pred             --------------------------------------------------------------------------------
Q 010309          294 --------------------------------------------------------------------------------  293 (513)
Q Consensus       294 --------------------------------------------------------------------------------  293 (513)
                                                                                                      
T Consensus       555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS  634 (1351)
T KOG1035|consen  555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS  634 (1351)
T ss_pred             cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ----------------------------------CceEEEEeeccCCCHHHHhccCCCCCCCC-CHHHHHHHHHHHHHHH
Q 010309          294 ----------------------------------GDRYIVYEFVVNGPLDRWLHHIPRGGRSL-DWAMRMKVATTLAQGI  338 (513)
Q Consensus       294 ----------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l-~~~~~~~i~~qi~~~L  338 (513)
                                                        ..+||-||||+..+|.+++....    .. .....++++++|+.||
T Consensus       635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~----~~~~~d~~wrLFreIlEGL  710 (1351)
T KOG1035|consen  635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNH----FNSQRDEAWRLFREILEGL  710 (1351)
T ss_pred             ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcc----cchhhHHHHHHHHHHHHHH
Confidence                                              01267889998888888876421    11 4567889999999999


Q ss_pred             HHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCC----c------------cccccceeecCccccccccccc
Q 010309          339 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP----W------------EVMQERTVMAGGTYGYLAPEFV  402 (513)
Q Consensus       339 ~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~----~------------~~~~~~~~~~~gt~~y~aPE~~  402 (513)
                      +|+|++   |||||||||.|||+|++..|||+|||++....    .            .......+...||.-|+|||++
T Consensus       711 aYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll  787 (1351)
T KOG1035|consen  711 AYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELL  787 (1351)
T ss_pred             HHHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHh
Confidence            999999   99999999999999999999999999998721    0            0111122233499999999999


Q ss_pred             ccC---CCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCCCCCcHHHHHHHH
Q 010309          403 YRN---ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVV  479 (513)
Q Consensus       403 ~~~---~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  479 (513)
                      .+.   .|+.|+|+||||||++||+.   ||...-        +.+..+.      ++-+..+... .+ ...+..+.-.
T Consensus       788 ~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM--------ERa~iL~------~LR~g~iP~~-~~-f~~~~~~~e~  848 (1351)
T KOG1035|consen  788 SDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSM--------ERASILT------NLRKGSIPEP-AD-FFDPEHPEEA  848 (1351)
T ss_pred             cccccccccchhhhHHHHHHHHHHhc---cCCchH--------HHHHHHH------hcccCCCCCC-cc-cccccchHHH
Confidence            764   49999999999999999996   565421        1111111      1111111110 01 1122334567


Q ss_pred             HHHHHhcCCCCCCCCCHHHHHH
Q 010309          480 DLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       480 ~li~~cl~~dP~~RPs~~evl~  501 (513)
                      .+|.+|++.||++||||.|+|.
T Consensus       849 slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  849 SLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             HHHHHHhcCCCccCCCHHHHhh
Confidence            8999999999999999999985

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=6.2e-35  Score=287.94  Aligned_cols=269  Identities=19%  Similarity=0.223  Sum_probs=190.0

Q ss_pred             CcccCCceecccCceEEEEEEeC-CCCEEEEEEecccchh--cHHHHHHHHHHHhhcCCCcEeeeeeEEeeCC-------
Q 010309          225 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQ--RKKEFYSEIGRFARLHHPNLVAVKGCCYDHG-------  294 (513)
Q Consensus       225 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-------  294 (513)
                      +|.. .+.||+|++|.||+|... +++.||||++......  ....+.+|+++++.++||||+++++++.+..       
T Consensus         9 ~y~~-~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   87 (311)
T cd07866           9 DYEI-LGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKR   87 (311)
T ss_pred             cEEE-EEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccC
Confidence            4443 446799999999999965 5899999998654322  2346788999999999999999999876543       


Q ss_pred             -ceEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEeccc
Q 010309          295 -DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVG  373 (513)
Q Consensus       295 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg  373 (513)
                       ..++|+||+.+ +|...+..   ....+++..+..++.|+++||+|||+.   +++|+||||+||++++++.++|+|||
T Consensus        88 ~~~~lv~~~~~~-~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg  160 (311)
T cd07866          88 GSVYMVTPYMDH-DLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFG  160 (311)
T ss_pred             ceEEEEEecCCc-CHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCc
Confidence             35999999954 67776653   235699999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCccccccc---------eeecCcccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHH
Q 010309          374 LSKFVPWEVMQER---------TVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFE  443 (513)
Q Consensus       374 ~~~~~~~~~~~~~---------~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~  443 (513)
                      ++...........         .....+++.|+|||.+.+. .++.++||||||+++|||++|++||.+.+.........
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~  240 (311)
T cd07866         161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF  240 (311)
T ss_pred             cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            9986543221111         0111267889999987654 57899999999999999999999997655432111100


Q ss_pred             hhhHH-----hh-ccccccccc-ccccCCCCCC--CcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          444 WATPL-----VQ-SHRYLELLD-PLISSLSSDI--PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       444 ~~~~~-----~~-~~~~~~~~~-~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      .....     .. ........+ ..........  ......+.+.+++.+||+.||.+|||+.+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            00000     00 000000000 0000000000  00112357899999999999999999999874

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=8.1e-35  Score=289.98  Aligned_cols=263  Identities=18%  Similarity=0.224  Sum_probs=188.2

Q ss_pred             CceecccCceEEEEEEeC-C--CCEEEEEEecccc--hhcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeC----CceEEE
Q 010309          230 NRLLGDSKTGGTYSGILP-D--GSRVAVKRLKRSS--FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDH----GDRYIV  299 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~----~~~~lv  299 (513)
                      .+.||+|+||.||++... .  +..||+|.+....  ....+.+.+|+.+++++ +||||+++++.....    ...+++
T Consensus         5 ~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~   84 (332)
T cd07857           5 IKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLY   84 (332)
T ss_pred             EEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEE
Confidence            456899999999999964 3  7799999987532  22346778899999999 599999999875432    456889


Q ss_pred             EeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCC
Q 010309          300 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP  379 (513)
Q Consensus       300 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~  379 (513)
                      +|++. ++|.+++..    ...+++..++.++.||+.||.|||+.   +++||||||+|||++.++.+||+|||++....
T Consensus        85 ~e~~~-~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~  156 (332)
T cd07857          85 EELME-ADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFS  156 (332)
T ss_pred             Eeccc-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence            99985 689888853    35689999999999999999999999   99999999999999999999999999998654


Q ss_pred             cccccc--ceeecCccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccch-hHHhhh-------HH
Q 010309          380 WEVMQE--RTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS-IFEWAT-------PL  448 (513)
Q Consensus       380 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~-~~~~~~-------~~  448 (513)
                      ......  ......|+..|+|||++.+ ..++.++||||||+++|+|++|.+||...+...... ......       ..
T Consensus       157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (332)
T cd07857         157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR  236 (332)
T ss_pred             cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            322111  1112237889999998765 468899999999999999999999997654321100 000000       00


Q ss_pred             hhcccccccccccccCCCCC---CCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          449 VQSHRYLELLDPLISSLSSD---IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       449 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      ............ .......   ......+..+.+++.+||+.||++|||+.+++.
T Consensus       237 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         237 IGSPKAQNYIRS-LPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             hhhhhHHHHHHh-ccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            000000000000 0000000   000112457999999999999999999999875

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-36  Score=274.96  Aligned_cols=235  Identities=23%  Similarity=0.279  Sum_probs=196.3

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccchhcHH---HHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccC
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKK---EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  305 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~---~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  305 (513)
                      -++||+|.||.|.+.+-+ .++.+|+|++++.....++   .-..|-++|+..+||.+..+-..|...+.+++||||+.|
T Consensus       173 LKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanG  252 (516)
T KOG0690|consen  173 LKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANG  252 (516)
T ss_pred             HHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccC
Confidence            467899999999999854 6999999999987544433   346788999999999999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccc
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  385 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  385 (513)
                      |.|.-+|.+    .+.+++...+.+...|++||.|||++   +||.||||.+|.|+|.+|++||+|||+++.--..  ..
T Consensus       253 GeLf~HLsr----er~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~--g~  323 (516)
T KOG0690|consen  253 GELFFHLSR----ERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY--GD  323 (516)
T ss_pred             ceEeeehhh----hhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcccc--cc
Confidence            999888854    46799999999999999999999999   9999999999999999999999999999854322  23


Q ss_pred             ceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCC
Q 010309          386 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  465 (513)
Q Consensus       386 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  465 (513)
                      .....+|||.|.|||++....|..+.|-|.+||++|||++|+.||...+..   .+++...  ..               
T Consensus       324 t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~---kLFeLIl--~e---------------  383 (516)
T KOG0690|consen  324 TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE---KLFELIL--ME---------------  383 (516)
T ss_pred             eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh---HHHHHHH--hh---------------
Confidence            344567999999999999999999999999999999999999999876643   2222111  00               


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCC
Q 010309          466 SSDIPEAGVVQKVVDLVYACTQHVPSMRP  494 (513)
Q Consensus       466 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP  494 (513)
                       ....+...+++...|+..+|..||.+|.
T Consensus       384 -d~kFPr~ls~eAktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  384 -DLKFPRTLSPEAKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             -hccCCccCCHHHHHHHHHHhhcChHhhc
Confidence             1122345667899999999999999994

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=7.3e-36  Score=272.30  Aligned_cols=202  Identities=19%  Similarity=0.316  Sum_probs=165.5

Q ss_pred             cCCceecccCceEEEEEEeCC-----CCEEEEEEecccch--hcHHHHHHHHHHHhhcCCCcEeeeeeEEee-CCceEEE
Q 010309          228 EGNRLLGDSKTGGTYSGILPD-----GSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYD-HGDRYIV  299 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~lv  299 (513)
                      +..+.||+|.||.||+|+..+     ...+|||.++....  .-.....+|+.+++.++||||+.+..++.+ +...+++
T Consensus        27 e~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~  106 (438)
T KOG0666|consen   27 EGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLL  106 (438)
T ss_pred             hccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEE
Confidence            445567999999999997432     33799999976522  123557799999999999999999999988 7788999


Q ss_pred             EeeccCCCHHHHhccCC-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCC----CCeEEecccc
Q 010309          300 YEFVVNGPLDRWLHHIP-RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE----FGAHLMGVGL  374 (513)
Q Consensus       300 ~e~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~----~~~kl~Dfg~  374 (513)
                      +||.+. +|...|+..+ ...+.++...+..|+.||+.|+.|||++   =|+||||||.|||+..+    |.|||+|||+
T Consensus       107 fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaDlGl  182 (438)
T KOG0666|consen  107 FDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIADLGL  182 (438)
T ss_pred             ehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeecccH
Confidence            999966 8888886433 2346799999999999999999999999   89999999999999877    8999999999


Q ss_pred             cccCCcccccc-ceeecCcccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 010309          375 SKFVPWEVMQE-RTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAV  433 (513)
Q Consensus       375 ~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~  433 (513)
                      ++.+......- ......-|..|.|||++.+. .||++.||||.|||+.||+|-.+.|.+.
T Consensus       183 aR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~  243 (438)
T KOG0666|consen  183 ARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR  243 (438)
T ss_pred             HHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence            99876543221 11122268999999999885 5899999999999999999999888764

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=8.4e-35  Score=275.59  Aligned_cols=220  Identities=19%  Similarity=0.171  Sum_probs=176.7

Q ss_pred             cCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCCHHHHhcc
Q 010309          236 SKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHH  314 (513)
Q Consensus       236 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~  314 (513)
                      |.+|.||++... +++.||+|++....     .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            889999999974 68899999997653     233455555566799999999999999999999999999999999864


Q ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccceeecCccc
Q 010309          315 IPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY  394 (513)
Q Consensus       315 ~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~  394 (513)
                          ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++++|||.+........     ...++.
T Consensus        79 ----~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~-----~~~~~~  146 (237)
T cd05576          79 ----FLNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCD-----GEAVEN  146 (237)
T ss_pred             ----hcCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccccc-----cCCcCc
Confidence                23589999999999999999999999   999999999999999999999999998866543211     122567


Q ss_pred             ccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCCCCCcHHH
Q 010309          395 GYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGV  474 (513)
Q Consensus       395 ~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  474 (513)
                      .|+|||.+.+..++.++||||+|+++|||++|..|+......            ..     ....       .. .+...
T Consensus       147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------------~~-----~~~~-------~~-~~~~~  201 (237)
T cd05576         147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG------------IN-----THTT-------LN-IPEWV  201 (237)
T ss_pred             cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh------------cc-----cccc-------cC-CcccC
Confidence            799999998888899999999999999999999886532110            00     0000       00 11224


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCHH
Q 010309          475 VQKVVDLVYACTQHVPSMRPRMS  497 (513)
Q Consensus       475 ~~~l~~li~~cl~~dP~~RPs~~  497 (513)
                      ++.+.+++.+||+.||++||++.
T Consensus       202 ~~~~~~li~~~l~~dp~~R~~~~  224 (237)
T cd05576         202 SEEARSLLQQLLQFNPTERLGAG  224 (237)
T ss_pred             CHHHHHHHHHHccCCHHHhcCCC
Confidence            56799999999999999999973

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.6e-35  Score=294.80  Aligned_cols=265  Identities=19%  Similarity=0.317  Sum_probs=193.9

Q ss_pred             HhhCcccCCceecccCceEEEEEEeC-CCCEEEEEEeccc--chhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCc---
Q 010309          222 ITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD---  295 (513)
Q Consensus       222 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~---  295 (513)
                      +.++|.. .+.||+|++|.||+|... +++.||||++...  .....+.+.+|+.++++++||||+++++++...+.   
T Consensus        13 ~~~~y~~-~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          13 VPDRYQN-LSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             ccCceEE-EEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence            3445543 456799999999999975 5889999998753  22234567889999999999999999998876654   


Q ss_pred             ---eEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecc
Q 010309          296 ---RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV  372 (513)
Q Consensus       296 ---~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df  372 (513)
                         .++|+||+ +++|.+++..     ..+++..+..++.|++.||+|||+.   +|+|+||||+||+++.++.++|+||
T Consensus        92 ~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~df  162 (343)
T cd07851          92 FQDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDF  162 (343)
T ss_pred             cccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEccc
Confidence               89999999 6799998863     4689999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCccccccceeecCccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccc-hhHHhhh----
Q 010309          373 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ-SIFEWAT----  446 (513)
Q Consensus       373 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~-~~~~~~~----  446 (513)
                      |++.......     ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......... .+.+...    
T Consensus       163 g~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  237 (343)
T cd07851         163 GLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDE  237 (343)
T ss_pred             cccccccccc-----cCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCH
Confidence            9998654321     11237888999998865 36788999999999999999999999764432110 0000000    


Q ss_pred             HHh---hcccccccccccccCCCCCC--CcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          447 PLV---QSHRYLELLDPLISSLSSDI--PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       447 ~~~---~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      ...   ........+...........  .....++++.+++.+||+.||++|||+.+|++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         238 ELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             HHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence            000   00000000000000000000  00123668999999999999999999999976

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-35  Score=245.36  Aligned_cols=261  Identities=19%  Similarity=0.225  Sum_probs=194.0

Q ss_pred             eecccCceEEEEEEeC-CCCEEEEEEecccch--hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCCH
Q 010309          232 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  308 (513)
Q Consensus       232 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL  308 (513)
                      .||+|.||+||+|+.. +++.||+|.++..+.  .......+|+-+|+.++|.|||+++++...+...-+|+||| ..+|
T Consensus         9 kigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c-dqdl   87 (292)
T KOG0662|consen    9 KIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC-DQDL   87 (292)
T ss_pred             hhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh-hHHH
Confidence            3599999999999964 588999999976532  23467889999999999999999999999999999999999 5588


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccccee
Q 010309          309 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  388 (513)
Q Consensus       309 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  388 (513)
                      ..+...   -++.++.+.++.++.|++.||.|.|++   ++.||||||.|.||+.+|.+||+|||+++.+.....-... 
T Consensus        88 kkyfds---lng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvrcysa-  160 (292)
T KOG0662|consen   88 KKYFDS---LNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSA-  160 (292)
T ss_pred             HHHHHh---cCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceEeeec-
Confidence            888864   346799999999999999999999999   9999999999999999999999999999987644321111 


Q ss_pred             ecCcccccccccccccC-CCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccc---ccccccc
Q 010309          389 MAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLE---LLDPLIS  463 (513)
Q Consensus       389 ~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~  463 (513)
                       ..-|..|.+|.++.+. -|+...|+||.|||+.|+.. |++.|.+.+-......+-+......+..+..   +.+....
T Consensus       161 -evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~y  239 (292)
T KOG0662|consen  161 -EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPY  239 (292)
T ss_pred             -eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCccc
Confidence             1268899999999875 47899999999999999987 6666766554322211111111111111111   1111110


Q ss_pred             CCCC-CCCcHH----HHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          464 SLSS-DIPEAG----VVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       464 ~~~~-~~~~~~----~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      ...+ .....+    ....=++++.+.|.-+|..|.++++.++
T Consensus       240 p~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  240 PIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             CCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            0000 000111    2233478999999999999999999875

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-36  Score=269.07  Aligned_cols=263  Identities=19%  Similarity=0.262  Sum_probs=193.1

Q ss_pred             eecccCceEEEEEEeC-CCCEEEEEEecccch--hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeC--------CceEEEE
Q 010309          232 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--------GDRYIVY  300 (513)
Q Consensus       232 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--------~~~~lv~  300 (513)
                      .||+|.||.||+|+.+ +|+.||+|++-.+..  .-.....+|+++|..|.|+|++.++++|...        ..+|+||
T Consensus        24 kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf  103 (376)
T KOG0669|consen   24 KIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVF  103 (376)
T ss_pred             hcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeH
Confidence            5699999999999965 478899987643321  2235678999999999999999999988642        3479999


Q ss_pred             eeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCc
Q 010309          301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW  380 (513)
Q Consensus       301 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~  380 (513)
                      .+|+. +|..+|.+   ....++..++.+++.++..||.|+|+.   .|+|||+||.|+||+.++.+||+|||+++.+..
T Consensus       104 ~~ceh-DLaGlLsn---~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGlar~fs~  176 (376)
T KOG0669|consen  104 DFCEH-DLAGLLSN---RKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLARAFST  176 (376)
T ss_pred             HHhhh-hHHHHhcC---ccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccccceec
Confidence            99965 89998864   235689999999999999999999999   999999999999999999999999999987654


Q ss_pred             ccccc--ceeecCcccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccc--
Q 010309          381 EVMQE--RTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL--  455 (513)
Q Consensus       381 ~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--  455 (513)
                      .....  ......-|..|.+||.+.+. .|+++.|||..|||+.||+|+.+.+++.++.....++.....-....-+.  
T Consensus       177 ~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~  256 (376)
T KOG0669|consen  177 SKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNV  256 (376)
T ss_pred             ccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCc
Confidence            33221  11122258999999999874 68999999999999999999999998876543222222111110000000  


Q ss_pred             ---ccc-----ccc----ccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          456 ---ELL-----DPL----ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       456 ---~~~-----~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                         .+.     .|.    .+.+.....+..-.++..+|+.++|..||.+||++++++.
T Consensus       257 d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln  314 (376)
T KOG0669|consen  257 DNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN  314 (376)
T ss_pred             ccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence               000     000    0000011111122347889999999999999999999986

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-35  Score=276.64  Aligned_cols=262  Identities=19%  Similarity=0.240  Sum_probs=197.4

Q ss_pred             cCCceecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhcC-C-C----cEeeeeeEEeeCCceEEEE
Q 010309          228 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-H-P----NLVAVKGCCYDHGDRYIVY  300 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-~----nIv~l~~~~~~~~~~~lv~  300 (513)
                      ....++|+|.||.|-...+. .+..||||+++... .-.+..+-|+++|+++. + |    -+|.+.++|.-.++.+||+
T Consensus        92 ~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivf  170 (415)
T KOG0671|consen   92 EIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVF  170 (415)
T ss_pred             ehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEE
Confidence            33456799999999998864 37899999997653 34556678999999993 2 2    3788999999999999999


Q ss_pred             eeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecC-----------------
Q 010309          301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE-----------------  363 (513)
Q Consensus       301 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~-----------------  363 (513)
                      |.+ |-|+.++|..  .+-.+++...++.|+.|++.+++|||+.   +++|-||||+|||+.+                 
T Consensus       171 ell-G~S~~dFlk~--N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r  244 (415)
T KOG0671|consen  171 ELL-GLSTFDFLKE--NNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKKVCFIR  244 (415)
T ss_pred             ecc-ChhHHHHhcc--CCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCccceec
Confidence            998 7799999975  4456799999999999999999999999   9999999999999832                 


Q ss_pred             ---CCCeEEecccccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccch
Q 010309          364 ---EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS  440 (513)
Q Consensus       364 ---~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~  440 (513)
                         +..++|+|||.|.......     .....|..|.|||++.+-.++.++||||+||||+||.||...|+..+..+...
T Consensus       245 ~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLa  319 (415)
T KOG0671|consen  245 PLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLA  319 (415)
T ss_pred             cCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHH
Confidence               3458999999998654332     12237899999999999999999999999999999999999999887654333


Q ss_pred             hHHhhhHHhhcccccc----------ccc---ccccC----CC--------CCCCcHHHHHHHHHHHHHhcCCCCCCCCC
Q 010309          441 IFEWATPLVQSHRYLE----------LLD---PLISS----LS--------SDIPEAGVVQKVVDLVYACTQHVPSMRPR  495 (513)
Q Consensus       441 ~~~~~~~~~~~~~~~~----------~~~---~~~~~----~~--------~~~~~~~~~~~l~~li~~cl~~dP~~RPs  495 (513)
                      +.+.+........+..          -++   ....+    ..        .-........+|.+|+++||..||.+|+|
T Consensus       320 MMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiT  399 (415)
T KOG0671|consen  320 MMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRIT  399 (415)
T ss_pred             HHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccccc
Confidence            3332211110000000          000   00000    00        00112234567999999999999999999


Q ss_pred             HHHHHH
Q 010309          496 MSHVVH  501 (513)
Q Consensus       496 ~~evl~  501 (513)
                      +.|++.
T Consensus       400 l~EAL~  405 (415)
T KOG0671|consen  400 LREALS  405 (415)
T ss_pred             HHHHhc
Confidence            999985

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-35  Score=276.37  Aligned_cols=234  Identities=24%  Similarity=0.307  Sum_probs=193.6

Q ss_pred             ceecccCceEEEEEEeC-CCCEEEEEEecccchh---cHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCCceEEEEeeccC
Q 010309          231 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQ---RKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVN  305 (513)
Q Consensus       231 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~  305 (513)
                      .+||+|+||.|.+|..+ +.+.+|||+++++-..   +.+--+.|-++|... +-|.++++..++..-+.+|.||||+.|
T Consensus       355 ~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnG  434 (683)
T KOG0696|consen  355 MVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNG  434 (683)
T ss_pred             EEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEecC
Confidence            47899999999999865 4678999999886332   223345677787777 578999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccc
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  385 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  385 (513)
                      |+|-..+++    -..+.+..+..++..||-||-|||++   +|+.||||.+|||+|.+|++||+|||+++..-..  ..
T Consensus       435 GDLMyhiQQ----~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~--~~  505 (683)
T KOG0696|consen  435 GDLMYHIQQ----VGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD--GV  505 (683)
T ss_pred             chhhhHHHH----hcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccccccC--Cc
Confidence            999888864    35688889999999999999999999   9999999999999999999999999999854333  23


Q ss_pred             ceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCC
Q 010309          386 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  465 (513)
Q Consensus       386 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  465 (513)
                      .+...+||+.|+|||++...+|+.++|-|||||+||||+.|.+||++.++.+.-+.+               .+.     
T Consensus       506 TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI---------------~eh-----  565 (683)
T KOG0696|consen  506 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAI---------------MEH-----  565 (683)
T ss_pred             ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH---------------HHc-----
Confidence            344567999999999999999999999999999999999999999998765321111               111     


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCC
Q 010309          466 SSDIPEAGVVQKVVDLVYACTQHVPSMRP  494 (513)
Q Consensus       466 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP  494 (513)
                       .-..+...+.+...+....|...|.+|.
T Consensus       566 -nvsyPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  566 -NVSYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             -cCcCcccccHHHHHHHHHHhhcCCcccc
Confidence             2233456777899999999999999994

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-34  Score=289.55  Aligned_cols=231  Identities=25%  Similarity=0.294  Sum_probs=187.6

Q ss_pred             eecccCceEEEEEEe-CCCCEEEEEEecccchhcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCCceEEEEeeccCCCHH
Q 010309          232 LLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD  309 (513)
Q Consensus       232 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~  309 (513)
                      -+|.|+|+.|-.+.. .+++..++|++.+.    ..+..+|+.++... +||||+++.+++.+..+.|+|||.+.++-|.
T Consensus       329 ~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell  404 (612)
T KOG0603|consen  329 ELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELL  404 (612)
T ss_pred             ccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHH
Confidence            369999999998885 46889999999765    22345677666665 7999999999999999999999999999887


Q ss_pred             HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEe-cCCCCeEEecccccccCCcccccccee
Q 010309          310 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL-DEEFGAHLMGVGLSKFVPWEVMQERTV  388 (513)
Q Consensus       310 ~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll-~~~~~~kl~Dfg~~~~~~~~~~~~~~~  388 (513)
                      +.+..     .+.....+..|+.+|+.|+.|||++   |+|||||||+|||+ ++.++++|+|||.++.....     ..
T Consensus       405 ~ri~~-----~~~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-----~~  471 (612)
T KOG0603|consen  405 RRIRS-----KPEFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-----CD  471 (612)
T ss_pred             HHHHh-----cchhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh-----hc
Confidence            76643     2223377888999999999999999   99999999999999 58899999999999877654     22


Q ss_pred             ecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCCC
Q 010309          389 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD  468 (513)
Q Consensus       389 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  468 (513)
                      ..+-|..|.|||++....|++++|+||||++||+|++|+.||......  ..+.    ..+.                ..
T Consensus       472 tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~----~~i~----------------~~  529 (612)
T KOG0603|consen  472 TPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIH----TRIQ----------------MP  529 (612)
T ss_pred             ccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHH----Hhhc----------------CC
Confidence            334688999999999999999999999999999999999999865442  0110    0000                11


Q ss_pred             CCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          469 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       469 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      .....+++..++|+.+||+.||.+||++.++..
T Consensus       530 ~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  530 KFSECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             ccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence            112457788999999999999999999999875

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1.4e-33  Score=303.93  Aligned_cols=140  Identities=24%  Similarity=0.372  Sum_probs=125.6

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccch---hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccC
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  305 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  305 (513)
                      .+.||+|+||.||+|... +++.||||+++....   .....+..|+.++..++||||+++++++...+..||||||+.+
T Consensus         9 ~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g   88 (669)
T cd05610           9 VKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIG   88 (669)
T ss_pred             EEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCC
Confidence            456799999999999975 589999999976432   2246788999999999999999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccc
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK  376 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~  376 (513)
                      ++|.+++..    ...+++..++.++.||+.||+|||..   +|+||||||+|||++.++.+||+|||+++
T Consensus        89 ~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          89 GDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999864    24588999999999999999999999   99999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-35  Score=286.38  Aligned_cols=235  Identities=21%  Similarity=0.280  Sum_probs=199.0

Q ss_pred             eecccCceEEEEEEeCCCC-EEEEEEecccc---hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCC
Q 010309          232 LLGDSKTGGTYSGILPDGS-RVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  307 (513)
Q Consensus       232 ~lg~G~~g~Vy~~~~~~~~-~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs  307 (513)
                      -||-|+||.|=++..+... .+|+|.+++..   ....+.+..|-.+|...+.|.||++|..|.+....|++||-|-||.
T Consensus       427 TLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGE  506 (732)
T KOG0614|consen  427 TLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGE  506 (732)
T ss_pred             hcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCch
Confidence            3699999999999875433 48999998753   3445668889999999999999999999999999999999999999


Q ss_pred             HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccce
Q 010309          308 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  387 (513)
Q Consensus       308 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  387 (513)
                      |...|++    +..++......++..+++|++|||++   +||.|||||+|.+++.+|-+||.|||+|+.+...   ..+
T Consensus       507 lWTiLrd----Rg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g---~KT  576 (732)
T KOG0614|consen  507 LWTILRD----RGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG---RKT  576 (732)
T ss_pred             hhhhhhh----cCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccC---Cce
Confidence            9999964    56799999999999999999999999   9999999999999999999999999999987654   345


Q ss_pred             eecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCC
Q 010309          388 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS  467 (513)
Q Consensus       388 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  467 (513)
                      ...+||+.|.|||++.+...+.++|.||||+++|||++|.+||++.++...-+++                   ++++..
T Consensus       577 wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~I-------------------LkGid~  637 (732)
T KOG0614|consen  577 WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLI-------------------LKGIDK  637 (732)
T ss_pred             eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH-------------------Hhhhhh
Confidence            5677999999999999999999999999999999999999999988764222211                   111112


Q ss_pred             CCCcHHHHHHHHHHHHHhcCCCCCCCCC
Q 010309          468 DIPEAGVVQKVVDLVYACTQHVPSMRPR  495 (513)
Q Consensus       468 ~~~~~~~~~~l~~li~~cl~~dP~~RPs  495 (513)
                      -..+..+.....+||+++...+|.+|..
T Consensus       638 i~~Pr~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  638 IEFPRRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             hhcccccchhHHHHHHHHHhcCcHhhhc
Confidence            2234456667899999999999999975

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-34  Score=302.40  Aligned_cols=252  Identities=21%  Similarity=0.222  Sum_probs=201.5

Q ss_pred             hhCcccCCceecccCceEEEEEEeC-CCCEEEEEEecccc---hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEE
Q 010309          223 TKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYI  298 (513)
Q Consensus       223 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l  298 (513)
                      ..+|.. -++||+|+||.|..++.+ +++.||+|++.+..   .....-|..|-.+|..-+.+-|+.+.-.|.+..++|+
T Consensus        74 ~~Dfei-lKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYl  152 (1317)
T KOG0612|consen   74 AEDFEI-LKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYL  152 (1317)
T ss_pred             HHhhHH-HHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEE
Confidence            334433 467899999999999975 58899999998742   2344668889999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccC
Q 010309          299 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV  378 (513)
Q Consensus       299 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~  378 (513)
                      |||||+||+|-.++.+.    ..+++..++.++..|+.||+-||+.   |+|||||||+|||||..|++||+|||.+-.+
T Consensus       153 VMdY~pGGDlltLlSk~----~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsClkm  225 (1317)
T KOG0612|consen  153 VMDYMPGGDLLTLLSKF----DRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCLKM  225 (1317)
T ss_pred             EEecccCchHHHHHhhc----CCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHHhc
Confidence            99999999999999752    2699999999999999999999999   9999999999999999999999999999888


Q ss_pred             CccccccceeecCccccccccccccc-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccc
Q 010309          379 PWEVMQERTVMAGGTYGYLAPEFVYR-----NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHR  453 (513)
Q Consensus       379 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  453 (513)
                      ..+...... ...|||.|++||++..     +.|+..+|-||+||++|||+.|..||...+-      ++-........ 
T Consensus       226 ~~dG~V~s~-~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl------veTY~KIm~hk-  297 (1317)
T KOG0612|consen  226 DADGTVRSS-VAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSL------VETYGKIMNHK-  297 (1317)
T ss_pred             CCCCcEEec-cccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHH------HHHHHHHhchh-
Confidence            755443332 3449999999999862     5789999999999999999999999975432      22111111110 


Q ss_pred             ccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCC---HHHHHH
Q 010309          454 YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPR---MSHVVH  501 (513)
Q Consensus       454 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~  501 (513)
                            ..+    ..+....++++..+||.+.+. +|+.|..   ++++..
T Consensus       298 ------~~l----~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~  337 (1317)
T KOG0612|consen  298 ------ESL----SFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN  337 (1317)
T ss_pred             ------hhc----CCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence                  011    111234478899999999885 7888987   777653

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=3.7e-33  Score=264.17  Aligned_cols=238  Identities=25%  Similarity=0.378  Sum_probs=192.4

Q ss_pred             CceEEEEEEeC-CCCEEEEEEecccchhc-HHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCCHHHHhcc
Q 010309          237 KTGGTYSGILP-DGSRVAVKRLKRSSFQR-KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHH  314 (513)
Q Consensus       237 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~  314 (513)
                      +||.||+|... +|+.+|+|++....... .+.+.+|++.+++++|+||+++++.+......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999986 48999999998765444 67899999999999999999999999999999999999999999999864


Q ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccceeecCccc
Q 010309          315 IPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY  394 (513)
Q Consensus       315 ~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~  394 (513)
                      .    ..+++..+..++.+++.+|.|||+.   +++|+||+|+||+++.++.++|+|||.+........   .....++.
T Consensus        81 ~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~  150 (244)
T smart00220       81 R----GRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGL---LTTFVGTP  150 (244)
T ss_pred             c----cCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeeccccc---cccccCCc
Confidence            2    2389999999999999999999999   999999999999999999999999999987654321   11223788


Q ss_pred             ccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCCCCCcHHH
Q 010309          395 GYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGV  474 (513)
Q Consensus       395 ~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  474 (513)
                      .|+|||.+....++.++||||||+++++|++|..||......  ....+..    ......           ........
T Consensus       151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--~~~~~~~----~~~~~~-----------~~~~~~~~  213 (244)
T smart00220      151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL--LELFKKI----GKPKPP-----------FPPPEWKI  213 (244)
T ss_pred             CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHH----hccCCC-----------CccccccC
Confidence            999999998888899999999999999999999998763221  1111110    000000           00000014


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          475 VQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       475 ~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      +.++.+++.+||..+|++||++.++++
T Consensus       214 ~~~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      214 SPEAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             CHHHHHHHHHHccCCchhccCHHHHhh
Confidence            467999999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-34  Score=272.02  Aligned_cols=251  Identities=22%  Similarity=0.316  Sum_probs=194.3

Q ss_pred             ceecccCceEEEEEEe-CCCCEEEEEEecccc-------hhcHHHHHHHHHHHhhcCCCcEeeeeeEEee-CCceEEEEe
Q 010309          231 RLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS-------FQRKKEFYSEIGRFARLHHPNLVAVKGCCYD-HGDRYIVYE  301 (513)
Q Consensus       231 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~lv~e  301 (513)
                      .+||+|+|+.||+|.+ ...+.||||+-....       ..-.+...+|..|.+.|.||.||++|+++.- .+.++-|+|
T Consensus       469 hLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLE  548 (775)
T KOG1151|consen  469 HLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLE  548 (775)
T ss_pred             HHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeee
Confidence            4689999999999995 457889999865321       1112456789999999999999999999874 467789999


Q ss_pred             eccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecC---CCCeEEecccccccC
Q 010309          302 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE---EFGAHLMGVGLSKFV  378 (513)
Q Consensus       302 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~---~~~~kl~Dfg~~~~~  378 (513)
                      ||+|.+|+-+|..    .+.+++.+++.|+.||+.||.||.+. +++|||-||||.|||+-+   -|.+||.|||+++.+
T Consensus       549 YceGNDLDFYLKQ----hklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIM  623 (775)
T KOG1151|consen  549 YCEGNDLDFYLKQ----HKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIM  623 (775)
T ss_pred             ecCCCchhHHHHh----hhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchhhhc
Confidence            9999999999954    56799999999999999999999986 789999999999999954   467999999999998


Q ss_pred             Ccccccc-----ceeecCcccccccccccccC----CCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHh
Q 010309          379 PWEVMQE-----RTVMAGGTYGYLAPEFVYRN----ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLV  449 (513)
Q Consensus       379 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  449 (513)
                      ..+....     .+....||..|++||.+.-+    ..+.|.||||+|||+|..+.|+.||......  +.       ..
T Consensus       624 dddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ--Qd-------IL  694 (775)
T KOG1151|consen  624 DDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ--QD-------IL  694 (775)
T ss_pred             cCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH--HH-------HH
Confidence            7654332     12234499999999988643    4688999999999999999999999764321  11       11


Q ss_pred             hcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          450 QSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       450 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      +...+.....-      ...+....+.+..++|++||+..-++|....++..
T Consensus       695 qeNTIlkAtEV------qFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  695 QENTILKATEV------QFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             hhhchhcceec------cCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence            22222111111      11122345678999999999999999988877653

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-33  Score=285.71  Aligned_cols=247  Identities=23%  Similarity=0.360  Sum_probs=202.6

Q ss_pred             cCCceecccCceEEEEEEe-CCCCEEEEEEecccchhcHHHHHHHHHHHhhc-CCCcEeeeeeEEee-----CCceEEEE
Q 010309          228 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYD-----HGDRYIVY  300 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~-----~~~~~lv~  300 (513)
                      +....||.|.+|.||+++. ++++.+|||++.... ...+++..|.++|+.+ .|||++.++|++..     ++.++|||
T Consensus        22 ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVM  100 (953)
T KOG0587|consen   22 EIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVM  100 (953)
T ss_pred             EEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEe
Confidence            4455789999999999994 579999999987653 4456788899999988 79999999999874     56789999


Q ss_pred             eeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCc
Q 010309          301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW  380 (513)
Q Consensus       301 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~  380 (513)
                      |||.+||..+++++..  +..+.|..+..|++.++.||.+||.+   .++|||||-.|||++.++.|||.|||.+..++.
T Consensus       101 EfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGvSaQlds  175 (953)
T KOG0587|consen  101 EFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDS  175 (953)
T ss_pred             eccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeeeeeeeec
Confidence            9999999999998754  67899999999999999999999999   999999999999999999999999999987765


Q ss_pred             cccccceeecCcccccccccccccC-----CCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccc
Q 010309          381 EVMQERTVMAGGTYGYLAPEFVYRN-----ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL  455 (513)
Q Consensus       381 ~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  455 (513)
                      .....  ....||+.|||||++.-.     .|+..+|+||||++..||.-|.+|+.++.+..  .+              
T Consensus       176 T~grR--nT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr--aL--------------  237 (953)
T KOG0587|consen  176 TVGRR--NTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR--AL--------------  237 (953)
T ss_pred             ccccc--cCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh--hh--------------
Confidence            43332  233499999999999643     46778999999999999999999998766531  11              


Q ss_pred             ccccccccCCC-CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          456 ELLDPLISSLS-SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       456 ~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                         -++...-+ ....+..-++++.++|..||..|-.+||++.++++
T Consensus       238 ---F~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  238 ---FLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             ---ccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence               01110001 11124567889999999999999999999999885

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=3e-34  Score=292.45  Aligned_cols=250  Identities=24%  Similarity=0.330  Sum_probs=189.9

Q ss_pred             hCcccCCceecccCceE-EEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCCceEEEEe
Q 010309          224 KNFSEGNRLLGDSKTGG-TYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYE  301 (513)
Q Consensus       224 ~~~~~~~~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e  301 (513)
                      +.+....+++|.|+.|+ ||+|.. +|+.||||++-..   ...-..+|+..|+.- +|||||++++.-.++...||..|
T Consensus       508 k~~~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalE  583 (903)
T KOG1027|consen  508 KLFFSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALE  583 (903)
T ss_pred             eeeeccHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEeh
Confidence            44555567889999875 799999 8999999998544   234568999999988 79999999999889999999999


Q ss_pred             eccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecC---C--CCeEEecccccc
Q 010309          302 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE---E--FGAHLMGVGLSK  376 (513)
Q Consensus       302 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~---~--~~~kl~Dfg~~~  376 (513)
                      .| ..+|.+++...............+.++.|+++||++||+.   +||||||||.||||+.   +  ..++|+|||+++
T Consensus       584 LC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK  659 (903)
T KOG1027|consen  584 LC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSK  659 (903)
T ss_pred             Hh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEeccccccc
Confidence            99 5699999976311111111144577899999999999998   9999999999999976   3  468999999999


Q ss_pred             cCCccccccc-eeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcC-CCCCCCCCccccchhHHhhhHHhhcccc
Q 010309          377 FVPWEVMQER-TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSG-RRPAQAVDSVCWQSIFEWATPLVQSHRY  454 (513)
Q Consensus       377 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~  454 (513)
                      .+......-. .....||-+|+|||++....-+.++||||+||++|+.++| .+||.+.-..        .........-
T Consensus       660 kl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R--------~~NIl~~~~~  731 (903)
T KOG1027|consen  660 KLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER--------QANILTGNYT  731 (903)
T ss_pred             ccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh--------hhhhhcCccc
Confidence            9876543222 2234499999999999998888899999999999999995 9999764321        0000000000


Q ss_pred             cccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          455 LELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       455 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      ..          .-.+..+.  +..+||.+|++++|..||++.+|+.
T Consensus       732 L~----------~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  732 LV----------HLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             ee----------eeccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence            00          00111112  7899999999999999999999974

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-33  Score=243.51  Aligned_cols=198  Identities=25%  Similarity=0.444  Sum_probs=168.7

Q ss_pred             eecccCceEEEEEEe-CCCCEEEEEEeccc-chhcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCCceEEEEeeccCCCH
Q 010309          232 LLGDSKTGGTYSGIL-PDGSRVAVKRLKRS-SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  308 (513)
Q Consensus       232 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL  308 (513)
                      -||+|++|.|-+-++ .+|+..|+|.+... ..+..+++.+|+.+..+. ..|.+|.++|........++.||.| ..||
T Consensus        53 elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M-~tSl  131 (282)
T KOG0984|consen   53 ELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM-DTSL  131 (282)
T ss_pred             hhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh-hhhH
Confidence            469999999987775 47999999999765 334567788899887766 7999999999999999999999999 5688


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccccee
Q 010309          309 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  388 (513)
Q Consensus       309 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  388 (513)
                      +.+-.+.-+.+..+++..+-+|+..++.||.|||++.  .++|||+||+|||++.+|++|++|||++-.+..+.....  
T Consensus       132 dkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAkt~--  207 (282)
T KOG0984|consen  132 DKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAKTM--  207 (282)
T ss_pred             HHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhhhHHHH--
Confidence            8877665566788999999999999999999999985  999999999999999999999999999987765433221  


Q ss_pred             ecCccccccccccccc----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCc
Q 010309          389 MAGGTYGYLAPEFVYR----NELTTKSDVYSFGVLLLEIVSGRRPAQAVDS  435 (513)
Q Consensus       389 ~~~gt~~y~aPE~~~~----~~~~~~sDvwSlGvil~elltg~~p~~~~~~  435 (513)
                       ..|...|||||.+..    ..|+.+|||||||+++.||.+++.||.....
T Consensus       208 -daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t  257 (282)
T KOG0984|consen  208 -DAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT  257 (282)
T ss_pred             -hcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence             227889999998853    3689999999999999999999999986543

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=4.2e-32  Score=278.57  Aligned_cols=263  Identities=17%  Similarity=0.168  Sum_probs=177.1

Q ss_pred             hCcccCCceecccCceEEEEEEe-----------------CCCCEEEEEEecccchhcHHH--------------HHHHH
Q 010309          224 KNFSEGNRLLGDSKTGGTYSGIL-----------------PDGSRVAVKRLKRSSFQRKKE--------------FYSEI  272 (513)
Q Consensus       224 ~~~~~~~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~E~  272 (513)
                      ++|.. .++||+|+||.||+|..                 .+++.||||++........++              ...|+
T Consensus       145 d~F~i-~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        145 DDFQL-RDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             cCceE-eeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            34444 45679999999999964                 235689999987543322223              33466


Q ss_pred             HHHhhcCCCcE-----eeeeeEEee--------CCceEEEEeeccCCCHHHHhccCCC--------------------CC
Q 010309          273 GRFARLHHPNL-----VAVKGCCYD--------HGDRYIVYEFVVNGPLDRWLHHIPR--------------------GG  319 (513)
Q Consensus       273 ~~l~~l~h~nI-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~  319 (513)
                      .++.+++|.++     +++++++..        .+..+|||||+++++|.++++....                    ..
T Consensus       224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~  303 (507)
T PLN03224        224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ  303 (507)
T ss_pred             HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence            77777766554     667777653        3567999999999999999864211                    01


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccceeecCcccccccc
Q 010309          320 RSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAP  399 (513)
Q Consensus       320 ~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aP  399 (513)
                      ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++.......... .....+++.|+||
T Consensus       304 ~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~g~~tp~Y~aP  379 (507)
T PLN03224        304 DKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN-PLYGMLDPRYSPP  379 (507)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccC-ccccCCCcceeCh
Confidence            2356778899999999999999999   99999999999999999999999999997654322111 1112257899999


Q ss_pred             cccccCCC----------------------CchhhHHHHHHHHHHHHcCCC-CCCCCCccccchhHH--hhhHHhhcccc
Q 010309          400 EFVYRNEL----------------------TTKSDVYSFGVLLLEIVSGRR-PAQAVDSVCWQSIFE--WATPLVQSHRY  454 (513)
Q Consensus       400 E~~~~~~~----------------------~~~sDvwSlGvil~elltg~~-p~~~~~~~~~~~~~~--~~~~~~~~~~~  454 (513)
                      |.+.....                      ..+.||||+||++|+|++|.. |+....... ..+..  .....+.    
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~-~~~~~~~~~~~~~r----  454 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFN-TELRQYDNDLNRWR----  454 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhh-hHHhhccchHHHHH----
Confidence            98754321                      124699999999999999875 665322110 00000  0000000    


Q ss_pred             cccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCC---CCCCCHHHHHH
Q 010309          455 LELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVP---SMRPRMSHVVH  501 (513)
Q Consensus       455 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~RPs~~evl~  501 (513)
                       .......    ........++...+|+.+||..+|   .+|+|++|+|+
T Consensus       455 -~~~~~~~----~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        455 -MYKGQKY----DFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             -hhcccCC----CcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence             0000000    001112345678999999999876   68999999985

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=3.8e-32  Score=285.80  Aligned_cols=262  Identities=14%  Similarity=0.134  Sum_probs=161.6

Q ss_pred             cCCceecccCceEEEEEEeC-C----CCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeE------EeeCCce
Q 010309          228 EGNRLLGDSKTGGTYSGILP-D----GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDR  296 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~------~~~~~~~  296 (513)
                      +..+.||+|+||.||+|.+. +    +..||||++.....  .+....|  .+....+.+++.++..      .......
T Consensus       135 ~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  210 (566)
T PLN03225        135 VLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEY  210 (566)
T ss_pred             EEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccccCCce
Confidence            44567899999999999975 4    68999999865421  1111111  1122222222222211      2456678


Q ss_pred             EEEEeeccCCCHHHHhccCCCC----------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceE
Q 010309          297 YIVYEFVVNGPLDRWLHHIPRG----------------GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL  360 (513)
Q Consensus       297 ~lv~e~~~~gsL~~~l~~~~~~----------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIl  360 (513)
                      ++|+||+.+++|.+++......                ........+..++.||+.||.|||+.   +|+||||||+|||
T Consensus       211 ~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP~NIL  287 (566)
T PLN03225        211 WLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQNII  287 (566)
T ss_pred             EEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCHHHEE
Confidence            9999999999999988642100                01112345668999999999999999   9999999999999


Q ss_pred             ecC-CCCeEEecccccccCCccccccceeecCcccccccccccccC----------------------CCCchhhHHHHH
Q 010309          361 LDE-EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN----------------------ELTTKSDVYSFG  417 (513)
Q Consensus       361 l~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~sDvwSlG  417 (513)
                      ++. ++.+||+|||+++.+........ ....+++.|+|||.+...                      .++.++||||||
T Consensus       288 l~~~~~~~KL~DFGlA~~l~~~~~~~~-~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlG  366 (566)
T PLN03225        288 FSEGSGSFKIIDLGAAADLRVGINYIP-KEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG  366 (566)
T ss_pred             EeCCCCcEEEEeCCCccccccccccCC-cccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHH
Confidence            986 57899999999986543322111 122388999999966422                      234467999999


Q ss_pred             HHHHHHHcCCCCCCCCCccccchhHHhhhHH-hhcccccccccccccC-CCCCC-CcHHHHHHHHHHHHHhcCCCCCCCC
Q 010309          418 VLLLEIVSGRRPAQAVDSVCWQSIFEWATPL-VQSHRYLELLDPLISS-LSSDI-PEAGVVQKVVDLVYACTQHVPSMRP  494 (513)
Q Consensus       418 vil~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~l~~li~~cl~~dP~~RP  494 (513)
                      |+||||+++..|+....    ..+....... .....+...+.+.... ..... ..........+||.+||+.||++||
T Consensus       367 viL~el~~~~~~~~~~~----~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~  442 (566)
T PLN03225        367 LIFLQMAFPNLRSDSNL----IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRI  442 (566)
T ss_pred             HHHHHHHhCcCCCchHH----HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCC
Confidence            99999999776643211    0110000000 0000000000100000 00000 0000122456899999999999999


Q ss_pred             CHHHHHH
Q 010309          495 RMSHVVH  501 (513)
Q Consensus       495 s~~evl~  501 (513)
                      |+.++++
T Consensus       443 ta~e~L~  449 (566)
T PLN03225        443 SAKAALA  449 (566)
T ss_pred             CHHHHhC
Confidence            9999987

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=4.1e-32  Score=268.14  Aligned_cols=242  Identities=21%  Similarity=0.247  Sum_probs=188.9

Q ss_pred             ccCCceecccCceEEEEEEe-CCCCEEEEEEecccchhc---HHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEee
Q 010309          227 SEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQR---KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF  302 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  302 (513)
                      ....+-||-|+||+|.++.. ++...+|.|.+++.+.-.   ...+..|-.||..-..+-||+||-.|.+.+.+|+||+|
T Consensus       631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY  710 (1034)
T KOG0608|consen  631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY  710 (1034)
T ss_pred             eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence            34455689999999999984 457789999998764333   34467789999999999999999999999999999999


Q ss_pred             ccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccc
Q 010309          303 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV  382 (513)
Q Consensus       303 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~  382 (513)
                      ++||++-.+|-+    ...+++..++.++..+..|+++.|..   |+|||||||+|||||.+|++||.|||++.-+....
T Consensus       711 IPGGDmMSLLIr----mgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH  783 (1034)
T KOG0608|consen  711 IPGGDMMSLLIR----MGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  783 (1034)
T ss_pred             cCCccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceecc
Confidence            999999998854    35689999999999999999999999   99999999999999999999999999986442110


Q ss_pred             c--------cc--------------------------------ceeecCcccccccccccccCCCCchhhHHHHHHHHHH
Q 010309          383 M--------QE--------------------------------RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLE  422 (513)
Q Consensus       383 ~--------~~--------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~e  422 (513)
                      .        +.                                ......||+.|+|||++....++..+|-||.||||||
T Consensus       784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e  863 (1034)
T KOG0608|consen  784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE  863 (1034)
T ss_pred             ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence            0        00                                0001128999999999999999999999999999999


Q ss_pred             HHcCCCCCCCCCccccc-hhHHhhhHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCC
Q 010309          423 IVSGRRPAQAVDSVCWQ-SIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP  494 (513)
Q Consensus       423 lltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP  494 (513)
                      |+.|++||-...+.+.+ .++.|...          +        ...+....+.++.++|.++. -+++.|.
T Consensus       864 m~~g~~pf~~~tp~~tq~kv~nw~~~----------l--------~~~~~~~ls~e~~~li~kLc-~sad~RL  917 (1034)
T KOG0608|consen  864 MLVGQPPFLADTPGETQYKVINWRNF----------L--------HIPYQGNLSKEALDLIQKLC-CSADSRL  917 (1034)
T ss_pred             HhhCCCCccCCCCCcceeeeeehhhc----------c--------ccccccccCHHHHHHHHHHh-cChhhhh
Confidence            99999999876654322 22222211          1        12223345667778877654 3566664

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.6e-33  Score=249.71  Aligned_cols=265  Identities=19%  Similarity=0.255  Sum_probs=194.1

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEeccc--chhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCC-----ceEEEEe
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG-----DRYIVYE  301 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-----~~~lv~e  301 (513)
                      .+-||-|+||.||...++ +|+.||+|++...  +....+.+.+|+++|..++|.|++..+++..-..     +.|+++|
T Consensus        58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE  137 (449)
T KOG0664|consen   58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE  137 (449)
T ss_pred             CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence            456899999999999974 6999999998653  3344578999999999999999999999876543     4578899


Q ss_pred             eccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcc
Q 010309          302 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE  381 (513)
Q Consensus       302 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~  381 (513)
                      .| ..+|..++-    ....++...+.-++.||+.||.|||+.   +|.||||||.|.|++++..+||+|||+++.....
T Consensus       138 Lm-QSDLHKIIV----SPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d  209 (449)
T KOG0664|consen  138 LM-QSDLHKIIV----SPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQR  209 (449)
T ss_pred             HH-Hhhhhheec----cCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchh
Confidence            88 557877774    346688888999999999999999999   9999999999999999999999999999976544


Q ss_pred             ccccceeecCcccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhH--Hh------hcc
Q 010309          382 VMQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATP--LV------QSH  452 (513)
Q Consensus       382 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~--~~------~~~  452 (513)
                      .....+ ...-|..|.|||++++. .|+.+.||||.|||+.||+..+..|+...+....+++.....  ..      -++
T Consensus       210 ~~~hMT-qEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG  288 (449)
T KOG0664|consen  210 DRLNMT-HEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG  288 (449)
T ss_pred             hhhhhH-HHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence            322211 12257899999999975 689999999999999999999999987665433222211100  00      000


Q ss_pred             ccccccc-----ccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 010309          453 RYLELLD-----PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQL  503 (513)
Q Consensus       453 ~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  503 (513)
                      ....++.     +.+.-+.....+..-..+...+..+++..||.+|.+.++.+..+
T Consensus       289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence            0001111     11111111111112233567888999999999999998887643

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.9e-31  Score=245.57  Aligned_cols=242  Identities=23%  Similarity=0.293  Sum_probs=190.4

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccchh---cHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCCceEEEEeecc
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQ---RKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVV  304 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~  304 (513)
                      -++||+|+|+.|..+++. +.+.+|+|++++.-..   +.+-.+.|-.+..+. +||.+|.+..+|..+..+++|.||++
T Consensus       255 l~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~  334 (593)
T KOG0695|consen  255 LRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVN  334 (593)
T ss_pred             eeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEec
Confidence            357899999999999964 5789999999876333   334456777777766 79999999999999999999999999


Q ss_pred             CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccc
Q 010309          305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  384 (513)
Q Consensus       305 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  384 (513)
                      ||+|--++++    .+.++++.++.+...|..||.|||+.   ||+.||||.+|||+|..|++||+|+|+.+.--..  .
T Consensus       335 ggdlmfhmqr----qrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l~~--g  405 (593)
T KOG0695|consen  335 GGDLMFHMQR----QRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP--G  405 (593)
T ss_pred             Ccceeeehhh----hhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCCCC--C
Confidence            9999766643    46799999999999999999999999   9999999999999999999999999999854332  2


Q ss_pred             cceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcc-ccchhHHhhhHHhhccccccccccccc
Q 010309          385 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSV-CWQSIFEWATPLVQSHRYLELLDPLIS  463 (513)
Q Consensus       385 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  463 (513)
                      ..+...+|||.|+|||++.+..|....|-|+|||+++||+.|+.||+-.... ..++.-++.-..+        +...+ 
T Consensus       406 d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvi--------lekqi-  476 (593)
T KOG0695|consen  406 DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVI--------LEKQI-  476 (593)
T ss_pred             cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHH--------hhhcc-
Confidence            3344567999999999999999999999999999999999999999743211 1111112211111        11111 


Q ss_pred             CCCCCCCcHHHHHHHHHHHHHhcCCCCCCCC
Q 010309          464 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRP  494 (513)
Q Consensus       464 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP  494 (513)
                           ..+...+.....+++.-|++||.+|.
T Consensus       477 -----riprslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  477 -----RIPRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             -----cccceeehhhHHHHHHhhcCCcHHhc
Confidence                 11223444577888999999999995

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.7e-30  Score=250.37  Aligned_cols=129  Identities=19%  Similarity=0.261  Sum_probs=108.5

Q ss_pred             ccCCceecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhcC-----C---CcEeeeeeEEee----C
Q 010309          227 SEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-----H---PNLVAVKGCCYD----H  293 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~nIv~l~~~~~~----~  293 (513)
                      +...+.||-|.|++||++.+. +.+.||+|+.+.. ..-.+..+.|+++|++++     |   .+||+|++.|..    +
T Consensus        80 Y~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG  158 (590)
T KOG1290|consen   80 YHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNG  158 (590)
T ss_pred             EEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCC
Confidence            344456799999999999964 5788999999765 244567789999999983     3   469999999975    4


Q ss_pred             CceEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEe
Q 010309          294 GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL  361 (513)
Q Consensus       294 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll  361 (513)
                      .+.+||+|++ |.+|..+|..  ..-+.++...+.+|++||+.||.|||..|  +|||-||||+|||+
T Consensus       159 ~HVCMVfEvL-GdnLLklI~~--s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl  221 (590)
T KOG1290|consen  159 QHVCMVFEVL-GDNLLKLIKY--SNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL  221 (590)
T ss_pred             cEEEEEehhh-hhHHHHHHHH--hCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence            5789999999 7788888875  33467999999999999999999999998  99999999999998

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=2.8e-31  Score=232.62  Aligned_cols=253  Identities=19%  Similarity=0.284  Sum_probs=191.6

Q ss_pred             eecccCceEEEEEE-eCCCCEEEEEEecccchhcHHHHHHHHHHHhhcC-CCcEeeeeeEEeeC--CceEEEEeeccCCC
Q 010309          232 LLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDH--GDRYIVYEFVVNGP  307 (513)
Q Consensus       232 ~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~--~~~~lv~e~~~~gs  307 (513)
                      .+|+|.+++||.|. ..++++++||++++.   ..+.+.+|+++|+.|. ||||++++++..++  ....|++||+.+.+
T Consensus        45 k~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~D  121 (338)
T KOG0668|consen   45 KVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTD  121 (338)
T ss_pred             HHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhcccc
Confidence            45999999999998 457899999999764   4567899999999996 99999999998875  45689999999998


Q ss_pred             HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCC-CCeEEecccccccCCccccccc
Q 010309          308 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE-FGAHLMGVGLSKFVPWEVMQER  386 (513)
Q Consensus       308 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~-~~~kl~Dfg~~~~~~~~~~~~~  386 (513)
                      +..+.       ..++...++.++.+++.||.|+|++   ||.|||+||.|++||.. -.++|+|.|+|.+.........
T Consensus       122 fk~ly-------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYnV  191 (338)
T KOG0668|consen  122 FKQLY-------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV  191 (338)
T ss_pred             HHHHh-------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCCCceeee
Confidence            88766       3488889999999999999999999   99999999999999865 4599999999988765443322


Q ss_pred             eeecCccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhc------cccccccc
Q 010309          387 TVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQS------HRYLELLD  459 (513)
Q Consensus       387 ~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~  459 (513)
                      .   ..+..|.-||++.. ..|+.+-|+|||||+|..|+..+.||....+. ..+++..+.-+-..      .++.-.++
T Consensus       192 R---VASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN-~DQLVkIakVLGt~el~~Yl~KY~i~Ld  267 (338)
T KOG0668|consen  192 R---VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN-YDQLVKIAKVLGTDELYAYLNKYQIDLD  267 (338)
T ss_pred             e---eehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCC-HHHHHHHHHHhChHHHHHHHHHHccCCC
Confidence            2   26678899999875 45788999999999999999999998654432 22333222211100      00111122


Q ss_pred             ccccC------------CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          460 PLISS------------LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       460 ~~~~~------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      +....            ........-.++++.+|+.+.|..|-++|||+.|.+.
T Consensus       268 p~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  268 PQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             hhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence            22111            0011111223578999999999999999999999874

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.97  E-value=1e-31  Score=260.19  Aligned_cols=272  Identities=17%  Similarity=0.175  Sum_probs=204.0

Q ss_pred             HHHhhCcccCCceecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhcC------CCcEeeeeeEEee
Q 010309          220 RSITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH------HPNLVAVKGCCYD  292 (513)
Q Consensus       220 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~nIv~l~~~~~~  292 (513)
                      .++..+.++.....|+|-|++|.+|... .|..||||+|..... -.+.=+.|+++|++|+      --|+++|+..|..
T Consensus       427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h  505 (752)
T KOG0670|consen  427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH  505 (752)
T ss_pred             hhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence            3444455555556799999999999965 488999999986532 2344568999999995      3579999999999


Q ss_pred             CCceEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCC-CCeEEec
Q 010309          293 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE-FGAHLMG  371 (513)
Q Consensus       293 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~-~~~kl~D  371 (513)
                      .+++|||+|-+ ..+|.++|....+ +..|....+..++.|+..||..|-..   +|+|.||||+|||+++. ..+||||
T Consensus       506 knHLClVFE~L-slNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLCD  580 (752)
T KOG0670|consen  506 KNHLCLVFEPL-SLNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLCD  580 (752)
T ss_pred             cceeEEEehhh-hchHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeecc
Confidence            99999999998 6799999987543 35688899999999999999999988   99999999999999875 4589999


Q ss_pred             ccccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhH----
Q 010309          372 VGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATP----  447 (513)
Q Consensus       372 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~----  447 (513)
                      ||.|............    -+..|.|||++.+.+|+...|+||+||+||||.||+..|.+.+......++.....    
T Consensus       581 fGSA~~~~eneitPYL----VSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~  656 (752)
T KOG0670|consen  581 FGSASFASENEITPYL----VSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPN  656 (752)
T ss_pred             CccccccccccccHHH----HHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcH
Confidence            9999887655433322    35679999999999999999999999999999999999988765543333221111    


Q ss_pred             -Hhhcccc---------------------------cccccc------cccC-CCCCCCcHHHHHHHHHHHHHhcCCCCCC
Q 010309          448 -LVQSHRY---------------------------LELLDP------LISS-LSSDIPEAGVVQKVVDLVYACTQHVPSM  492 (513)
Q Consensus       448 -~~~~~~~---------------------------~~~~~~------~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~  492 (513)
                       ++..+.+                           ...+.|      .+.. .............+.+|+.+||..||++
T Consensus       657 KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~K  736 (752)
T KOG0670|consen  657 KMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEK  736 (752)
T ss_pred             HHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhh
Confidence             1100000                           001111      0000 0001112346678999999999999999


Q ss_pred             CCCHHHHHH
Q 010309          493 RPRMSHVVH  501 (513)
Q Consensus       493 RPs~~evl~  501 (513)
                      |.|..++|.
T Consensus       737 Rit~nqAL~  745 (752)
T KOG0670|consen  737 RITVNQALK  745 (752)
T ss_pred             cCCHHHHhc
Confidence            999999875

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=1.7e-29  Score=233.27  Aligned_cols=211  Identities=29%  Similarity=0.498  Sum_probs=182.9

Q ss_pred             ecccCceEEEEEEeCC-CCEEEEEEecccchh-cHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCCHHH
Q 010309          233 LGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQ-RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR  310 (513)
Q Consensus       233 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~  310 (513)
                      ||+|.+|.||++...+ ++.+++|++...... ..+.+.+|+..++.+.|++|+++++++......++++|++.+++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            5899999999999854 899999999866432 34679999999999999999999999999999999999999999999


Q ss_pred             HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecC-CCCeEEecccccccCCccccccceee
Q 010309          311 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE-EFGAHLMGVGLSKFVPWEVMQERTVM  389 (513)
Q Consensus       311 ~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~  389 (513)
                      ++....   ..++...+..++.+++.+|++||+.   +++|+||+|.||+++. ++.++|+|||.+........  ....
T Consensus        81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~  152 (215)
T cd00180          81 LLKENE---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKT  152 (215)
T ss_pred             HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhc
Confidence            986421   4689999999999999999999999   9999999999999999 89999999999987654321  1111


Q ss_pred             cCcccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCCC
Q 010309          390 AGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD  468 (513)
Q Consensus       390 ~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  468 (513)
                      ..+...|++||.+... ..+.++|+|++|+++++|                                             
T Consensus       153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------  187 (215)
T cd00180         153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------  187 (215)
T ss_pred             ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------
Confidence            2277889999999877 788999999999999998                                             


Q ss_pred             CCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 010309          469 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQL  503 (513)
Q Consensus       469 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  503 (513)
                             ..+.+++.+|++.||++||++.++++.|
T Consensus       188 -------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 -------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             -------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                   2488999999999999999999998643

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.96  E-value=2.8e-30  Score=237.17  Aligned_cols=255  Identities=20%  Similarity=0.296  Sum_probs=185.7

Q ss_pred             eecccCceEEEEEEeC-CCCEEEEEEeccc--chhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeC------CceEEEEee
Q 010309          232 LLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH------GDRYIVYEF  302 (513)
Q Consensus       232 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~~~~lv~e~  302 (513)
                      .+|.|.- .|-.+.+. .+++||+|.+...  .....+...+|+.++..++|+||++++.++.-.      .+.|+|||+
T Consensus        24 p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~  102 (369)
T KOG0665|consen   24 PIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMEL  102 (369)
T ss_pred             ccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHh
Confidence            3577776 55555532 5899999988654  223346788999999999999999999998644      356999999


Q ss_pred             ccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccc
Q 010309          303 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV  382 (513)
Q Consensus       303 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~  382 (513)
                      | ..+|...+.      -.++-..+..|+.|++.|+.|||+.   +|+||||||+||++..+..+||.|||+++......
T Consensus       103 m-~~nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~~  172 (369)
T KOG0665|consen  103 M-DANLCQVIL------MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTDF  172 (369)
T ss_pred             h-hhHHHHHHH------HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcccCccc
Confidence            9 668988885      3477889999999999999999999   99999999999999999999999999998765441


Q ss_pred             cccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccc-cchhHH---------------hhh
Q 010309          383 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVC-WQSIFE---------------WAT  446 (513)
Q Consensus       383 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~-~~~~~~---------------~~~  446 (513)
                      .   ......|..|.|||++.+..+.+.+||||+||++.||++|...|.+.+... |.++.+               .+.
T Consensus       173 ~---mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r  249 (369)
T KOG0665|consen  173 M---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVR  249 (369)
T ss_pred             c---cCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHH
Confidence            1   111227889999999999889999999999999999999999987654321 111111               011


Q ss_pred             HHh------hcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          447 PLV------QSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       447 ~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      ...      ....+.+.+...+-....+ .+.--...+.+++.+||-.||++|.|++++|+
T Consensus       250 ~yv~~~~~y~~~~f~~~fpD~~f~~~~e-~~~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  250 NYVENRPQYQAISFSELFPDSLFPVVLE-GSKLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             HHhhcChHhhccchhhhCCccccccccc-CCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence            110      0011111111111000000 01123346889999999999999999999986

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.96  E-value=1.4e-30  Score=255.22  Aligned_cols=190  Identities=24%  Similarity=0.336  Sum_probs=162.9

Q ss_pred             ceecccCceEEEEEEeCC-CCEEEEEEecccchh--------cHHHHHHHHHHHhhcC---CCcEeeeeeEEeeCCceEE
Q 010309          231 RLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQ--------RKKEFYSEIGRFARLH---HPNLVAVKGCCYDHGDRYI  298 (513)
Q Consensus       231 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~l  298 (513)
                      +.+|+|+||.|+++.++. ...|+||.+.++..-        ..-.+-.|+.||..|+   |+||++++++|++++.+||
T Consensus       567 q~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl  646 (772)
T KOG1152|consen  567 QPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYYL  646 (772)
T ss_pred             eeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeEE
Confidence            456999999999999764 668999999765321        1123556999999997   9999999999999999999


Q ss_pred             EEeec-cCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEeccccccc
Q 010309          299 VYEFV-VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF  377 (513)
Q Consensus       299 v~e~~-~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~  377 (513)
                      +||-- ++.+|.++|..    ...+++.++..|++||+.|+++||++   +|||||||-+||.++.+|-+||+|||.+..
T Consensus       647 ~te~hg~gIDLFd~IE~----kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfgsaa~  719 (772)
T KOG1152|consen  647 ETEVHGEGIDLFDFIEF----KPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFGSAAY  719 (772)
T ss_pred             EecCCCCCcchhhhhhc----cCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeeccchhh
Confidence            99975 46689999964    45699999999999999999999999   999999999999999999999999999987


Q ss_pred             CCccccccceeecCcccccccccccccCCC-CchhhHHHHHHHHHHHHcCCCCCC
Q 010309          378 VPWEVMQERTVMAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEIVSGRRPAQ  431 (513)
Q Consensus       378 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvil~elltg~~p~~  431 (513)
                      .......    ...||..|.|||++.+.+| ...-|||++|++||.++....||.
T Consensus       720 ~ksgpfd----~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  720 TKSGPFD----VFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             hcCCCcc----eeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            6554333    2339999999999999887 467899999999999999998875

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.96  E-value=2.2e-30  Score=257.85  Aligned_cols=246  Identities=22%  Similarity=0.320  Sum_probs=198.8

Q ss_pred             ceecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCCHH
Q 010309          231 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD  309 (513)
Q Consensus       231 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~  309 (513)
                      ..+|+|.+|.||++++. .++..|+|+++.....+..-+++|+-+++..+||||+.++|.+...+..++.||||.+|+|.
T Consensus        21 qrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQ  100 (829)
T KOG0576|consen   21 QRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQ  100 (829)
T ss_pred             eeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCccc
Confidence            35699999999999964 68999999999877677788899999999999999999999999999999999999999998


Q ss_pred             HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccceee
Q 010309          310 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM  389 (513)
Q Consensus       310 ~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  389 (513)
                      +.-+    ...++++.++..+.+..+.||+|||++   +-+|||||-.|||+++.+.+|++|||.+-.+......  ...
T Consensus       101 diy~----~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitati~K--rks  171 (829)
T KOG0576|consen  101 DIYH----VTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAK--RKS  171 (829)
T ss_pred             ceee----ecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhhhhh--hhc
Confidence            8664    357899999999999999999999999   9999999999999999999999999998766543222  223


Q ss_pred             cCcccccccccccc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCC
Q 010309          390 AGGTYGYLAPEFVY---RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  466 (513)
Q Consensus       390 ~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  466 (513)
                      ..||+.|||||+..   .+.|...+|||++|+...|+---.+|.....+.  +.++-..+.         ..++.     
T Consensus       172 fiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm--r~l~LmTkS---------~~qpp-----  235 (829)
T KOG0576|consen  172 FIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM--RALFLMTKS---------GFQPP-----  235 (829)
T ss_pred             ccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH--HHHHHhhcc---------CCCCC-----
Confidence            44999999999874   467899999999999999998888886544332  111111111         11110     


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          467 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       467 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      .......-.+.+.+|++.+|..+|.+||+++.+|.
T Consensus       236 ~lkDk~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  236 TLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             cccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            01112234567899999999999999999998765

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.96  E-value=6.6e-28  Score=225.75  Aligned_cols=196  Identities=29%  Similarity=0.449  Sum_probs=168.9

Q ss_pred             CceecccCceEEEEEEeCC-CCEEEEEEecccchh-cHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCC
Q 010309          230 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQ-RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  307 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs  307 (513)
                      .+.||+|++|.||++...+ ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++.+......++++|++++++
T Consensus         4 ~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~   83 (225)
T smart00221        4 GKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGD   83 (225)
T ss_pred             eeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCC
Confidence            3467999999999999865 899999999876544 56789999999999999999999999999999999999999999


Q ss_pred             HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccce
Q 010309          308 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  387 (513)
Q Consensus       308 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  387 (513)
                      |.+++....   ..+++..+..++.+++.+|.+||+.   +++|+||+|+||+++.++.++|+|||.+......... ..
T Consensus        84 L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-~~  156 (225)
T smart00221       84 LFDYLRKKG---GKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-LL  156 (225)
T ss_pred             HHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-cc
Confidence            999986422   1188999999999999999999999   9999999999999999999999999999876543210 11


Q ss_pred             eecCccccccccccc-ccCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 010309          388 VMAGGTYGYLAPEFV-YRNELTTKSDVYSFGVLLLEIVSGRRPAQA  432 (513)
Q Consensus       388 ~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlGvil~elltg~~p~~~  432 (513)
                      ....++..|++||.+ ....++.++|||+||+++++|++|+.||..
T Consensus       157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            112267889999998 666778899999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=3.4e-29  Score=224.81  Aligned_cols=248  Identities=21%  Similarity=0.299  Sum_probs=183.4

Q ss_pred             cCCceecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhc-CCCcEeeeeeE-EeeCCceEEEEeecc
Q 010309          228 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGC-CYDHGDRYIVYEFVV  304 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~-~~~~~~~~lv~e~~~  304 (513)
                      ..++.||+|.||.+-++.++ ..+.+|+|.+.+. ....++|.+|...--.| .|.||+.-|++ |+..+.+++++||++
T Consensus        27 ~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP  105 (378)
T KOG1345|consen   27 TINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAP  105 (378)
T ss_pred             hHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCc
Confidence            34567899999999999975 5788999999776 35678899999776666 58999998776 566677889999999


Q ss_pred             CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEe-cC-CCCeEEecccccccCCccc
Q 010309          305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL-DE-EFGAHLMGVGLSKFVPWEV  382 (513)
Q Consensus       305 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll-~~-~~~~kl~Dfg~~~~~~~~~  382 (513)
                      .|+|.+-+..     ..+.+.....++.|+++||.|+|++   ++||||||.+|||| +. ..++||+|||.++......
T Consensus       106 ~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV  177 (378)
T KOG1345|consen  106 RGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV  177 (378)
T ss_pred             cchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccCcee
Confidence            9999887753     4588889999999999999999999   99999999999999 33 3479999999998664332


Q ss_pred             cccceeecCcccccccccccccC-----CCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccccc
Q 010309          383 MQERTVMAGGTYGYLAPEFVYRN-----ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLEL  457 (513)
Q Consensus       383 ~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  457 (513)
                      ...     .-+..|.|||.....     ...+.+|||.||+++|..+||++|++..... .....+|..  +.....   
T Consensus       178 ~~~-----~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~-d~~Y~~~~~--w~~rk~---  246 (378)
T KOG1345|consen  178 KYL-----EYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIM-DKPYWEWEQ--WLKRKN---  246 (378)
T ss_pred             hhh-----hhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhcc-CchHHHHHH--HhcccC---
Confidence            211     145679999977532     3467899999999999999999999843221 122222211  111111   


Q ss_pred             ccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010309          458 LDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  502 (513)
Q Consensus       458 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  502 (513)
                        +.+    +.. -..+++.+.++.++-|.++|++|-...++.+.
T Consensus       247 --~~~----P~~-F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~  284 (378)
T KOG1345|consen  247 --PAL----PKK-FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKM  284 (378)
T ss_pred             --ccC----chh-hcccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence              111    000 11245678899999999999999555554443

>cd03599 CLECT_DGCR2_like C-type lectin-like domain (CTLD) of the type found in DGCR2, an integral membrane protein deleted in DiGeorge Syndrome (DGS)

Probab=99.96  E-value=1.5e-28  Score=211.09  Aligned_cols=124  Identities=19%  Similarity=0.321  Sum_probs=102.7

Q ss_pred             CCCCCcccCCCC--eeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCC---------CCCeEEeee---
Q 010309            9 CPPDWIINEEKS--KCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN---------VNGCWVGGR---   74 (513)
Q Consensus         9 Cp~~w~~~~~~~--~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~---------~~~~WiGl~---   74 (513)
                      ||+||.  .|++  +||+++.+.+||.+|+.+|+++||+||+|+|.+|++||.+++.+.         ...+||||+   
T Consensus         1 CP~gw~--~~~~~~~CYk~~~~~~tw~dA~~~C~~~Gg~Lasi~s~~e~~fl~~l~~~~~~~~~~~~~~~~~WIGL~~~~   78 (153)
T cd03599           1 CPSGWH--HYEGTASCYKVYLSGENYWDAVQTCQKVNGSLATFTTDQELQFILAQEWDFDERVFGRKDQCKFWVGYQYVI   78 (153)
T ss_pred             CCCchh--ccCCCCeEEEEeCCcCCHHHHHHHHHHcCCEEcCCCCHHHHHHHHHHHHhhcccccccccCCCEEEeecccc
Confidence            999999  7988  899999999999999999999999999999999999999998421         146999995   


Q ss_pred             -ecCCCCCCceEEc-CCCCCccCCcc----cCCCCCCCCCCCCCCCCcCCCceeEeec---------CCCcccccccCCC
Q 010309           75 -SINTTVGLSWKWS-DNMSKWNESIH----AVGSFNSSCTSLPCHVHATVDLCTLVSN---------GSRSLVTERCNTS  139 (513)
Q Consensus        75 -~~~~~~~~~w~W~-dg~~~~~~~~~----~~~~~~~~~~~~~c~~~~~~~~C~~~~~---------~~~~w~d~~C~~~  139 (513)
                       +.+...+|.|+|+ ||+++.|.+|.    +++|           ++ ++|+|+.+..         ....|+|..|...
T Consensus        79 ~~~~~~~eg~w~WsddGs~~~y~~w~~~w~~geP-----------n~-~~e~C~~~~~~~~~~~~~~~~~~W~d~~C~~~  146 (153)
T cd03599          79 TNRNHSLEGRWEVAYKGSMEVFLPPEPIFATGMS-----------TN-DNVFCAQLQCFQIPSLRERGLHSWHAENCYEK  146 (153)
T ss_pred             cccCcccCCeEEEecCCccceecCccccCCCCCC-----------CC-CCCCCeEEEeeccccccccccCeeeCccCCCC
Confidence             2255678999999 59998877664    4444           22 5678888852         3357999999999


Q ss_pred             CCccccc
Q 010309          140 HPFICMV  146 (513)
Q Consensus       140 ~~~iC~~  146 (513)
                      .+||||+
T Consensus       147 ~~fiCq~  153 (153)
T cd03599         147 SSFLCKR  153 (153)
T ss_pred             CcceeCC
Confidence            9999984

CLECT_DGCR2_like: C-type lectin-like domain (CTLD) of the type found in DGCR2, an integral membrane protein deleted in DiGeorge Syndrome (DGS). CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. DGS is also known velo-cardio-facial syndrome (VCFS). DGS is a genetic abnormality that results in malformations of the heart, face, and limbs and is associated with schizophrenia and depressive disorders. DGCR2 is a candidate for involvement in the pathogenesis of DGS since the DGCR2 gene lies within the minimal DGS critical region (MDGRC) of 22q11, which when deleted gives rise to DGS, and the DGCR2 gene is in close proximity to the balanced translocation breakpoint in a DGS patient having a balanced translocation.

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.95  E-value=1e-28  Score=235.17  Aligned_cols=267  Identities=25%  Similarity=0.330  Sum_probs=193.1

Q ss_pred             HHhhCcccCCceecccCceEEEEEEeC----CCCEEEEEEecccchhcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCCc
Q 010309          221 SITKNFSEGNRLLGDSKTGGTYSGILP----DGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGD  295 (513)
Q Consensus       221 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~  295 (513)
                      .+.+.|...+ .||+|.|++||++.+.    ..+.||+|.+...+  ....+.+|++.|..+ -+.||+++.+++...+.
T Consensus        33 ~~~~~~~~v~-kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~  109 (418)
T KOG1167|consen   33 FISNAYKVVN-KIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ  109 (418)
T ss_pred             hhhhhhhhhc-cccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence            3444444444 5599999999999953    46789999997663  456689999999999 59999999999999999


Q ss_pred             eEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCC-CCeEEecccc
Q 010309          296 RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE-FGAHLMGVGL  374 (513)
Q Consensus       296 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~-~~~kl~Dfg~  374 (513)
                      ..+|+||+++.+..++...       ++...+..+++.++.||.++|.+   |||||||||.|+|.+.. +.-.|.|||+
T Consensus       110 v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgL  179 (418)
T KOG1167|consen  110 VAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGL  179 (418)
T ss_pred             eEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechh
Confidence            9999999999999998853       77899999999999999999999   99999999999999865 4578999999


Q ss_pred             cccCCccc------------------------------------------cccceeecCcccccccccccccC-CCCchh
Q 010309          375 SKFVPWEV------------------------------------------MQERTVMAGGTYGYLAPEFVYRN-ELTTKS  411 (513)
Q Consensus       375 ~~~~~~~~------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~s  411 (513)
                      +.......                                          .........||++|.|||++..- .-++++
T Consensus       180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai  259 (418)
T KOG1167|consen  180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI  259 (418)
T ss_pred             HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence            97211000                                          00000112289999999999764 468899


Q ss_pred             hHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhh---------------H--Hhhccc---ccc------ccc-ccccC
Q 010309          412 DVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWAT---------------P--LVQSHR---YLE------LLD-PLISS  464 (513)
Q Consensus       412 DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~---------------~--~~~~~~---~~~------~~~-~~~~~  464 (513)
                      ||||.|||++-+++++.||....... ..+.+.+.               .  +++...   ..+      -++ ..+..
T Consensus       260 Diws~GVI~Lslls~~~PFf~a~dd~-~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~  338 (418)
T KOG1167|consen  260 DIWSAGVILLSLLSRRYPFFKAKDDA-DALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYK  338 (418)
T ss_pred             ceeeccceeehhhccccccccCcccc-chHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccc
Confidence            99999999999999999986543321 11111000               0  000000   000      000 00000


Q ss_pred             -----CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          465 -----LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       465 -----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                           ..........+..+.+|+.+|+..||.+|.|+++.|+
T Consensus       339 ~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk  380 (418)
T KOG1167|consen  339 SRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK  380 (418)
T ss_pred             ccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence                 0011111223457899999999999999999999885

>cd03588 CLECT_CSPGs C-type lectin-like domain (CTLD) of the type found in chondroitin sulfate proteoglycan core proteins

Probab=99.95  E-value=1.5e-27  Score=201.54  Aligned_cols=122  Identities=23%  Similarity=0.471  Sum_probs=106.5

Q ss_pred             CCCCCcccCCCCeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEcC
Q 010309            9 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSD   88 (513)
Q Consensus         9 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~d   88 (513)
                      ||+||+  .|+++||+|+.+.++|.+|++.|+.+||+||+|+|.+|++||.++..   ..+||||+  +...++.|+|+|
T Consensus         1 Cp~gw~--~~~~~Cy~~~~~~~sw~~A~~~C~~~gg~La~i~s~~e~~fl~~~~~---~~~WIGl~--~~~~~~~~~W~d   73 (124)
T cd03588           1 CEEGWD--KFQGHCYRHFPDRETWEDAERRCREQQGHLSSIVTPEEQEFVNNNAQ---DYQWIGLN--DRTIEGDFRWSD   73 (124)
T ss_pred             CCccce--ecCCEEEEEECCccCHHHHHHHHHhcCCEEeccCCHHHHHHHHHhcc---CcEEecce--ecCCCCceEeCC
Confidence            999999  89999999999999999999999999999999999999999998764   46899999  666779999999


Q ss_pred             CCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEee-cCCCcccccccCCCCCccccc
Q 010309           89 NMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVS-NGSRSLVTERCNTSHPFICMV  146 (513)
Q Consensus        89 g~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~-~~~~~w~d~~C~~~~~~iC~~  146 (513)
                      |+++.|.+|.+++|.+.         ..+.++|+.+. ...+.|++..|....+|||+.
T Consensus        74 g~~~~~~~W~~~~p~~~---------~~~~~~Cv~~~~~~~~~W~d~~C~~~~~fICe~  123 (124)
T cd03588          74 GHPLQFENWRPNQPDNF---------FATGEDCVVMIWHEEGEWNDVPCNYHLPFTCKK  123 (124)
T ss_pred             CCcccccCcCCCCCCCC---------CCCCCCeEEEecCCCCeEcCCCCCCCCeeeeeC
Confidence            99999999999988321         12345788874 345679999999999999985

CLECT_CSPGs: C-type lectin-like domain (CTLD) of the type found in chondroitin sulfate proteoglycan core proteins (CSPGs) in human and chicken aggrecan, frog brevican, and zebra fish dermacan. CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. In cartilage, aggrecan forms cartilage link protein stabilized aggregates with hyaluronan (HA). These aggregates contribute to the tissue's load bearing properties. Aggregates having other CSPGs substituting for aggrecan may contribute to the structural integrity of many different tissues. Xenopus brevican is expressed in the notochord and the brain during early embryogenesis. Zebra fish dermacan is expressed in dermal bones and may play a role in dermal bone development. CSPGs do contain LINK domain(s) which bind HA. These LINK domains are considered by one classif

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.94  E-value=5.9e-28  Score=266.57  Aligned_cols=196  Identities=21%  Similarity=0.262  Sum_probs=139.6

Q ss_pred             hcCC-CcEeeeeeEE-------eeCCceEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 010309          277 RLHH-PNLVAVKGCC-------YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH  348 (513)
Q Consensus       277 ~l~h-~nIv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~  348 (513)
                      .++| +||+++++++       .....+++++|++ +++|.++|..   ....+++.+++.++.||+.||+|||++   +
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---g  100 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHSQ---G  100 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence            3455 5788888877       2334567888987 6799999963   235699999999999999999999999   9


Q ss_pred             ceEcCCCCCceEecC-------------------CCCeEEecccccccCCcccc--------------ccceeecCcccc
Q 010309          349 VVHRDIRASNVLLDE-------------------EFGAHLMGVGLSKFVPWEVM--------------QERTVMAGGTYG  395 (513)
Q Consensus       349 ivH~Dikp~NIll~~-------------------~~~~kl~Dfg~~~~~~~~~~--------------~~~~~~~~gt~~  395 (513)
                      |+||||||+||||+.                   ++.+|++|||+++.......              ........||+.
T Consensus       101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  180 (793)
T PLN00181        101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW  180 (793)
T ss_pred             eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence            999999999999954                   44566677777654221000              000011237888


Q ss_pred             cccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCCCCCcHHHH
Q 010309          396 YLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVV  475 (513)
Q Consensus       396 y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  475 (513)
                      |+|||++.+..++.++|||||||+||||++|.+|+.....     ...   ....     ..+.+..         ....
T Consensus       181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-----~~~---~~~~-----~~~~~~~---------~~~~  238 (793)
T PLN00181        181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR-----TMS---SLRH-----RVLPPQI---------LLNW  238 (793)
T ss_pred             eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH-----HHH---HHHH-----hhcChhh---------hhcC
Confidence            9999999999999999999999999999999888643211     000   0000     0000000         0112


Q ss_pred             HHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          476 QKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       476 ~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      ....+++.+||++||.+||++.||++
T Consensus       239 ~~~~~~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        239 PKEASFCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HHHHHHHHHhCCCChhhCcChHHHhh
Confidence            34678899999999999999999985

>cd03597 CLECT_attractin_like C-type lectin-like domain (CTLD) of the type found in human and mouse attractin (AtrN) and attractin-like protein (ALP)

Probab=99.94  E-value=4.6e-27  Score=199.25  Aligned_cols=120  Identities=20%  Similarity=0.356  Sum_probs=102.4

Q ss_pred             CCCCCcccCCCCeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCC-----CCCeEEeeeecCCCCCCc
Q 010309            9 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN-----VNGCWVGGRSINTTVGLS   83 (513)
Q Consensus         9 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~-----~~~~WiGl~~~~~~~~~~   83 (513)
                      ||+||.  .++++||+++...++|.+|+.+|+++||+||+|++.+|++||.+++.+.     ...+||||+  |.. +|.
T Consensus         1 Cp~gw~--~~~~~Cy~~~~~~~tw~~A~~~C~~~g~~La~i~~~~E~~fi~~~~~~~~~~~~~~~~WIGl~--d~~-~g~   75 (129)
T cd03597           1 CGEGWH--LVGNSCLKINTARESYDNAKLYCRNLNAVLASLTTQKKVEFVLKELQKHQMTKQKLTPWVGLR--KIN-VSY   75 (129)
T ss_pred             CCCcCE--EcCCEEEEEEcCCCCHHHHHHHHHHcCCEEcCCCCHHHHHHHHHHHHhhcccCCCCceEEeee--cCC-CCc
Confidence            999999  7999999999999999999999999999999999999999999877542     246999999  554 588


Q ss_pred             eEEcCCCCC--ccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecC-CCcccccccCCC-CCccccc
Q 010309           84 WKWSDNMSK--WNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG-SRSLVTERCNTS-HPFICMV  146 (513)
Q Consensus        84 w~W~dg~~~--~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~-~~~w~d~~C~~~-~~~iC~~  146 (513)
                      |.|+||+++  .|++|.+++|++             .++|+.+... ..+|+|..|... ..|||++
T Consensus        76 w~W~Dgs~~~~~~~~W~~geP~~-------------~~~C~~~~~~~~~~w~d~~C~~~~~~~iCe~  129 (129)
T cd03597          76 WCWEDMSPFTNTTLQWLPGEPSD-------------AGFCGYLEEPAVSGLKANPCTNPVNGSVCER  129 (129)
T ss_pred             eEECCCCCCCCccccCCCCCCCC-------------cccEEEEcccccCccccCCcCCCCcceeecC
Confidence            999999987  467899999832             1478887533 446999999998 6999974

CLECT_attractin_like: C-type lectin-like domain (CTLD) of the type found in human and mouse attractin (AtrN) and attractin-like protein (ALP). CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. Mouse AtrN (the product of the mahogany gene) has been shown to bind Agouti protein and to function in agouti-induced pigmentation and obesity. Mutations in AtrN have also been shown to cause spongiform encephalopathy and hypomyelination in rats and hamsters. The cytoplasmic region of mouse ALP has been shown to binds to melanocortin receptor (MCR4). Signaling through MCR4 plays a role in appetite suppression. Attractin may have therapeutic potential in the treatment of obesity. Human attractin (hAtrN) has been shown to be expressed on activated T cells and released extracellularly. The

>cd03589 CLECT_CEL-1_like C-type lectin-like domain (CTLD) of the type found in CEL-1 from Cucumaria echinata and Echinoidin from Anthocidaris crassispina

Probab=99.94  E-value=8.9e-27  Score=200.87  Aligned_cols=124  Identities=23%  Similarity=0.468  Sum_probs=107.6

Q ss_pred             CCCCCcccCCCCeeEEEECCCCChHHHHHHHhhc-----CCEEeeeCCHHHHHHHHHHhCCC-----CCCeEEeeeecCC
Q 010309            9 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI-----GGHLAALTSYEEEHSAQKLCGKN-----VNGCWVGGRSINT   78 (513)
Q Consensus         9 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~-----~~~L~~i~~~~e~~f~~~~~~~~-----~~~~WiGl~~~~~   78 (513)
                      ||+||+  .|+++||+++...++|.+|+..|+.+     ||+||+|+|.+|++||.+++...     ...+||||+  +.
T Consensus         1 Cp~gw~--~~~~~Cy~~~~~~~~w~~A~~~C~~~~~~g~~~~La~i~s~~e~~~l~~~~~~~~~~~~~~~~WiGl~--~~   76 (137)
T cd03589           1 CPTFWT--AFGGYCYRFFGDRLTWEEAELRCRSFSIPGLIAHLVSIHSQEENDFVYDLFESSRGPDTPYGLWIGLH--DR   76 (137)
T ss_pred             CCcchh--hhCCEEEEEeCCCcCHHHHHHHHHhhcCCCCCceEcccCCHHHHHHHHHHHhhccccCCCCcEEEeee--cC
Confidence            999999  89999999999999999999999987     69999999999999999988632     457999999  66


Q ss_pred             CCCCceEEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecC---CCcccccccCCCCCccccc
Q 010309           79 TVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG---SRSLVTERCNTSHPFICMV  146 (513)
Q Consensus        79 ~~~~~w~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~---~~~w~d~~C~~~~~~iC~~  146 (513)
                      ..++.|+|+||+++.|++|.+++|.+.          .+.++|+.+...   .+.|++.+|....+|||+.
T Consensus        77 ~~~~~~~W~dG~~~~~~~W~~~~P~~~----------~~~~~C~~~~~~~~~~~~W~d~~C~~~~~fIC~~  137 (137)
T cd03589          77 TSEGPFEWTDGSPVDFTKWAGGQPDNY----------GGNEDCVQMWRRGDAGQSWNDMPCDAVFPYICKM  137 (137)
T ss_pred             CccCceEeCCcCcCCcCCcCCCCCCCC----------CCCCCceeeecCCCCCCeecCCCCCCCcceeeeC
Confidence            678999999999999999999998321          245688888654   3469999999999999983

CLECT_CEL-1_like: C-type lectin-like domain (CTLD) of the type found in CEL-1 from Cucumaria echinata and Echinoidin from Anthocidaris crassispina. CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. The CEL-1 CTLD binds three calcium ions and has a high specificity for N-acteylgalactosamine (GalNAc). CEL-1 exhibits strong cytotoxicity which is inhibited by GalNAc. This protein may play a role as a toxin defending against predation. Echinoidin is found in the coelomic fluid of the sea urchin and is specific for GalBeta1-3GalNAc. Echinoidin has a cell adhesive activity towards human cancer cells which is not mediated through the CTLD. Both CEL-1 and Echinoidin are multimeric proteins comprised of multiple dimers linked by disulfide bonds.

>cd03596 CLECT_tetranectin_like C-type lectin-like domain (CTLD) of the type found in the tetranectin (TN), cartilage derived C-type lectin (CLECSF1), and stem cell growth factor (SCGF)

Probab=99.94  E-value=1e-26  Score=197.88  Aligned_cols=122  Identities=16%  Similarity=0.286  Sum_probs=105.9

Q ss_pred             CCCCCcccCCCCeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCC---CCCeEEeeeecCCCCCCceE
Q 010309            9 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN---VNGCWVGGRSINTTVGLSWK   85 (513)
Q Consensus         9 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~---~~~~WiGl~~~~~~~~~~w~   85 (513)
                      ||.||.   .+++||+++.++++|.+|+..|++.||+||+|+|.+|++||.+++...   ...+||||+  |...++.|+
T Consensus         1 c~~g~~---~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~WiGl~--~~~~~~~w~   75 (129)
T cd03596           1 CLKGTK---IHKKCYLVSEETKHYHEASEDCIARGGTLATPRDSDENDALRDYVKASVPGNWEVWLGIN--DMVAEGKWV   75 (129)
T ss_pred             CCCCcE---ECCEEEEEecccCCHHHHHHHHHhcCCeEecCCCHHHHHHHHHHHHhccCCCCcEEEecc--ccCccCeEE
Confidence            999997   789999999999999999999999999999999999999999877532   347999999  777789999


Q ss_pred             EcCCCCCccCCccc---CCCCCCCCCCCCCCCCcCCCceeEeecC-CCcccccccCCCCCccccc
Q 010309           86 WSDNMSKWNESIHA---VGSFNSSCTSLPCHVHATVDLCTLVSNG-SRSLVTERCNTSHPFICMV  146 (513)
Q Consensus        86 W~dg~~~~~~~~~~---~~~~~~~~~~~~c~~~~~~~~C~~~~~~-~~~w~d~~C~~~~~~iC~~  146 (513)
                      |+||+++.|++|.+   ++|+           +.+.++|+.+... .+.|++..|....+|||+.
T Consensus        76 w~dG~~~~~~~W~~~~~~~p~-----------~~~~~~Cv~l~~~~~~~W~d~~C~~~~~fICe~  129 (129)
T cd03596          76 DVNGSPISYFNWEREITAQPD-----------GGKRENCVALSSSAQGKWFDEDCRREKPYVCEF  129 (129)
T ss_pred             eCCCCCccccccCCCCCCCCC-----------CCCCCCCEEEccCCCCcCcCccCCCCCceeccC
Confidence            99999999999997   5551           2345689898654 5679999999999999974

CLECT_tetranectin_like: C-type lectin-like domain (CTLD) of the type found in the tetranectin (TN), cartilage derived C-type lectin (CLECSF1), and stem cell growth factor (SCGF). CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. TN binds to plasminogen and stimulates activation of plasminogen, playing a key role in the regulation of proteolytic processes. The TN CTLD binds two calcium ions. Its calcium free form binds to various kringle-like protein ligands. Two residues involved in the coordination of calcium are critical for the binding of TN to the fourth kringle (K4) domain of plasminogen (Plg K4). TN binds the kringle 1-4 form of angiostatin (AST K1-4). AST K1-4 is a fragment of Plg, commonly found in cancer tissues. TN inhibits the bin

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.94  E-value=1.3e-26  Score=208.93  Aligned_cols=167  Identities=23%  Similarity=0.274  Sum_probs=126.1

Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccc
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  385 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  385 (513)
                      |+|.+++...   +..+++.+++.++.|++.||+|||+.   +      ||+|||++.++.+|+  ||++.......   
T Consensus         1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---   63 (176)
T smart00750        1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ---   63 (176)
T ss_pred             CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc---
Confidence            6899999642   35699999999999999999999998   6      999999999999999  99987654321   


Q ss_pred             ceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCC
Q 010309          386 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  465 (513)
Q Consensus       386 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  465 (513)
                          ..||+.|+|||++.+..++.++|||||||++|||+||+.||......  ............     .. .+.    
T Consensus        64 ----~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~--~~~~~~~~~~~~-----~~-~~~----  127 (176)
T smart00750       64 ----SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL--SAILEILLNGMP-----AD-DPR----  127 (176)
T ss_pred             ----CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh--cHHHHHHHHHhc-----cC-Ccc----
Confidence                13889999999999999999999999999999999999999654321  111111100000     00 000    


Q ss_pred             CCCCCcHHHHH--HHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q 010309          466 SSDIPEAGVVQ--KVVDLVYACTQHVPSMRPRMSHVVHQLQQL  506 (513)
Q Consensus       466 ~~~~~~~~~~~--~l~~li~~cl~~dP~~RPs~~evl~~L~~~  506 (513)
                       ..........  ++.+++.+||+.||.+||++.++++.+..+
T Consensus       128 -~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      128 -DRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             -ccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence             0011223333  699999999999999999999999987654

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>cd03590 CLECT_DC-SIGN_like C-type lectin-like domain (CTLD) of the type found in human dendritic cell (DC)-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN) and the related receptor, DC-SIGN receptor (DC-SIGNR)

Probab=99.93  E-value=7.3e-26  Score=192.19  Aligned_cols=124  Identities=25%  Similarity=0.516  Sum_probs=108.5

Q ss_pred             CCCCCcccCCCCeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEcC
Q 010309            9 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSD   88 (513)
Q Consensus         9 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~d   88 (513)
                      ||.||.  .|+++||+++...++|.+|+..|+.+||+||+|+|.+|++||.+++. ....+||||+  +...++.|+|+|
T Consensus         1 Cp~~w~--~~~~~Cy~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~-~~~~~WiGl~--~~~~~~~~~W~d   75 (126)
T cd03590           1 CPTNWK--SFQSSCYFFSTEKKSWEESRQFCEDMGAHLVIINSQEEQEFISKILS-GNRSYWIGLS--DEETEGEWKWVD   75 (126)
T ss_pred             CCCCce--EeCCEEEEEeCCCcCHHHHHHHHHhCCCEEEeeCCHHHHHHHHHHhC-CCCCEEEeee--cCCCcCCeEecC
Confidence            999999  79999999999999999999999999999999999999999999985 3468999999  655679999999


Q ss_pred             CCCC--ccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCccccc
Q 010309           89 NMSK--WNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMV  146 (513)
Q Consensus        89 g~~~--~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~  146 (513)
                      |+++  .|.+|.+++|.+...         +.++|+.+....+.|.+..|....+|||+.
T Consensus        76 g~~~~~~~~~W~~~~p~~~~~---------~~~~C~~~~~~~~~w~~~~C~~~~~fiCek  126 (126)
T cd03590          76 GTPLNSSKTFWHPGEPNNWGG---------GGEDCAELVYDSGGWNDVPCNLEYRWICEK  126 (126)
T ss_pred             CCCCCCccCCcCCCcCCCCCC---------CCCCCEEEECCCCcEeCcCCCCCEeeeeeC
Confidence            9998  899999988833211         356788886655689999999999999983

CLECT_DC-SIGN_like: C-type lectin-like domain (CTLD) of the type found in human dendritic cell (DC)-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN) and the related receptor, DC-SIGN receptor (DC-SIGNR). This group also contains proteins similar to hepatic asialoglycoprotein receptor (ASGP-R) and langerin in human. These proteins are type II membrane proteins with a CTLD ectodomain. CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. DC-SIGN is thought to mediate the initial contact between dendritic cells and resting T cells, and may also mediate the rolling of DCs on epithelium. DC-SIGN and DC-SIGNR bind to oligosaccharides present on human tissues, as well as, on path

>PHA02642 C-type lectin-like protein; Provisional

Probab=99.93  E-value=9.4e-26  Score=200.76  Aligned_cols=123  Identities=21%  Similarity=0.480  Sum_probs=104.3

Q ss_pred             CCCcCCCCCCCcccCCCCeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCC
Q 010309            3 KDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGL   82 (513)
Q Consensus         3 ~~~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~   82 (513)
                      ...+.+||.||.  .|+++||+|+.+.++|.+|+..|+++||+||+|++++|++||.++..  ...+||||+  +...++
T Consensus        82 ~~k~~~CP~gW~--~~~~kCYyfs~~~ksW~eA~~~C~s~ga~La~I~seeE~~FL~~~~~--~~~yWIGLs--d~~~e~  155 (216)
T PHA02642         82 TIKYVTCPKGWI--GFGYKCFYFSEDSKNWTFGNTFCTSLGATLVKVETEEELNFLKRYKD--SSDHWIGLN--RESSNH  155 (216)
T ss_pred             CcccCCCCCcCE--EECCEEEEEeCcccCHHHHHHHHhhCCCeEeeECCHHHHHHHHHhhc--CCeEEEEeE--eCCCCC
Confidence            345789999999  89999999999999999999999999999999999999999998865  457999999  555679


Q ss_pred             ceEEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCccccccccC
Q 010309           83 SWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEHEN  150 (513)
Q Consensus        83 ~w~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~~~~~  150 (513)
                      .|+|+||+++.+..|..+                 .++|+.+..  .++.+..|.....|||+.....
T Consensus       156 ~W~WvDGS~~n~~~~i~G-----------------~g~CAyLs~--~~i~s~~C~~~~~wIC~K~l~~  204 (216)
T PHA02642        156 PWKWADNSNYNASFVITG-----------------TGECAYLND--IRISSSRVYANRKWICSKTYTN  204 (216)
T ss_pred             ceEECCCCccCcceeccC-----------------CCceEEEeC--CceEccCcCCCceEEeeeeccc
Confidence            999999998776665322                 235766644  4799999999999999986544

>cd03594 CLECT_REG-1_like C-type lectin-like domain (CTLD) of the type found in Human REG-1 (lithostathine), REG-4, and avian eggshell-specific proteins: ansocalcin, structhiocalcin-1(SCA-1), and -2(SCA-2)

Probab=99.93  E-value=1e-25  Score=192.05  Aligned_cols=122  Identities=27%  Similarity=0.625  Sum_probs=105.2

Q ss_pred             CCCCCcccCCCCeeEEEECCCCChHHHHHHHhhc--CCEEeeeCCHHHHHHHHHHhCCC---CCCeEEeeeecCCCCCCc
Q 010309            9 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKN---VNGCWVGGRSINTTVGLS   83 (513)
Q Consensus         9 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~--~~~L~~i~~~~e~~f~~~~~~~~---~~~~WiGl~~~~~~~~~~   83 (513)
                      ||+||.  .|+++||+++.+.++|.+|+..|+.+  ||+||+|+|.+|++||.+++...   ...+||||+  +...++.
T Consensus         1 Cp~gw~--~~~~~Cy~~~~~~~tw~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~WiGl~--~~~~~~~   76 (129)
T cd03594           1 CPKGWL--PYKGNCYGYFRQPLSWSDAELFCQKYGPGAHLASIHSPAEAAAIASLISSYQKAYQPVWIGLH--DPQQSRG   76 (129)
T ss_pred             CCCCCE--ecCCEeeeEeccCcCHHHHHHHHHhcCCCceEcccCCHHHHHHHHHHHHhhccCCccEEEeec--cCCCCCc
Confidence            999999  89999999999999999999999998  59999999999999999988542   347999999  6666689


Q ss_pred             eEEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCC--CcccccccCCCCCccccc
Q 010309           84 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMV  146 (513)
Q Consensus        84 w~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~--~~w~d~~C~~~~~~iC~~  146 (513)
                      |+|+||+++.|.+|.+++|.            .+.++|+.+...+  ..|++..|....+|||+.
T Consensus        77 ~~W~dg~~~~~~~W~~~~p~------------~~~~~Cv~~~~~~~~~~W~~~~C~~~~~fICe~  129 (129)
T cd03594          77 WEWSDGSKLDYRSWDRNPPY------------ARGGYCAELSRSTGFLKWNDANCEERNPFICKY  129 (129)
T ss_pred             eEeCCCCcceecccCCCCCC------------CCCCCceEEEecCCCCeEECCCCCCCceeeeeC
Confidence            99999999999999988871            1245788886543  269999999999999974

CLECT_REG-1_like: C-type lectin-like domain (CTLD) of the type found in Human REG-1 (lithostathine), REG-4, and avian eggshell-specific proteins: ansocalcin, structhiocalcin-1(SCA-1), and -2(SCA-2). CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. REG-1 is a proliferating factor which participates in various kinds of tissue regeneration including pancreatic beta-cell regeneration, regeneration of intestinal mucosa, regeneration of motor neurons, and perhaps in tissue regeneration of damaged heart. REG-1 may play a role on the pathophysiology of Alzheimer's disease and in the development of gastric cancers. Its expression is correlated with reduced survival from early-stage colorectal cancer. REG-1 also binds and aggregates

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.93  E-value=2e-26  Score=207.06  Aligned_cols=243  Identities=23%  Similarity=0.432  Sum_probs=189.5

Q ss_pred             ecccCceEEEEEEeCCCCEEEEEEecccc--hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCCHHH
Q 010309          233 LGDSKTGGTYSGILPDGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR  310 (513)
Q Consensus       233 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~  310 (513)
                      |.+...|+.|+|++ .|..+++|++.-..  .....+|..|.-.|+.+.||||+.+++.|..+.+..++..||+.|+|..
T Consensus       198 l~e~hsgelwrgrw-qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslyn  276 (448)
T KOG0195|consen  198 LAESHSGELWRGRW-QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYN  276 (448)
T ss_pred             hccCCCcccccccc-cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHH
Confidence            57888999999999 56677888876442  2334679999999999999999999999999999999999999999999


Q ss_pred             HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEe--cccccccCCcccccccee
Q 010309          311 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLM--GVGLSKFVPWEVMQERTV  388 (513)
Q Consensus       311 ~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~--Dfg~~~~~~~~~~~~~~~  388 (513)
                      .|+.  ..+..++..++.+++.+++.|++|||+. .+-|.---|....|++|++.+++|+  |--++.         ...
T Consensus       277 vlhe--~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsf---------qe~  344 (448)
T KOG0195|consen  277 VLHE--QTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSF---------QEV  344 (448)
T ss_pred             HHhc--CccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeee---------ecc
Confidence            9986  4455678889999999999999999997 3334445689999999999988774  222211         011


Q ss_pred             ecCcccccccccccccCCCC---chhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCC
Q 010309          389 MAGGTYGYLAPEFVYRNELT---TKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  465 (513)
Q Consensus       389 ~~~gt~~y~aPE~~~~~~~~---~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  465 (513)
                      ...-.+.||+||.+...+-+   .++|+|||+++||||.|...||.+..+.+..-                  .-.+.++
T Consensus       345 gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm------------------kialegl  406 (448)
T KOG0195|consen  345 GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM------------------KIALEGL  406 (448)
T ss_pred             ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh------------------hhhhccc
Confidence            11156889999999876543   57899999999999999999998876542111                  0112222


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCc
Q 010309          466 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  507 (513)
Q Consensus       466 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  507 (513)
                      +..+| .+.+..+.+|+.-|++.||.+||.++.|+-.|+++.
T Consensus       407 rv~ip-pgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  407 RVHIP-PGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             cccCC-CCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            23333 357778999999999999999999999999998764

>cd03593 CLECT_NK_receptors_like C-type lectin-like domain (CTLD) of the type found in natural killer cell receptors (NKRs)

Probab=99.93  E-value=1.9e-25  Score=186.71  Aligned_cols=116  Identities=25%  Similarity=0.551  Sum_probs=100.9

Q ss_pred             CCCCCcccCCCCeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEcC
Q 010309            9 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSD   88 (513)
Q Consensus         9 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~d   88 (513)
                      ||+||+  .|+++||+++.+.++|.+|+..|+.+||+||+|+|.+|++||.+++.  ...+||||+  +...++.|.|+|
T Consensus         1 Cp~gw~--~~~~~Cy~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~--~~~~WiGl~--~~~~~~~~~W~d   74 (116)
T cd03593           1 CPKDWI--CYGNKCYYFSMEKKTWNESKEACSSKNSSLLKIDDEEELEFLQSQIG--SSSYWIGLS--REKSEKPWKWID   74 (116)
T ss_pred             CCCcCE--EeCCEEEEEEcCCCCHHHHHHHHHhCCCcEEEECCHHHHHHHHHhcC--CCceEEEEe--ecCCCCCeEccC
Confidence            999999  89999999999999999999999999999999999999999999874  567999999  555679999999


Q ss_pred             CCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCccccc
Q 010309           89 NMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMV  146 (513)
Q Consensus        89 g~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~  146 (513)
                      |+++.  +|..++|++            ..++|+.+...  .|.+..|....+|||+.
T Consensus        75 g~~~~--~~~~~~~~~------------~~~~C~~~~~~--~w~~~~C~~~~~~IC~k  116 (116)
T cd03593          75 GSPLN--NLFNIRGST------------KSGNCAYLSST--GIYSEDCSTKKRWICEK  116 (116)
T ss_pred             CCccc--ccccccCCC------------CCCCceEEcCC--cEEcccCCcCceeeeeC
Confidence            99876  676666521            34578887554  79999999999999974

CLECT_NK_receptors_like: C-type lectin-like domain (CTLD) of the type found in natural killer cell receptors (NKRs), including proteins similar to oxidized low density lipoprotein (OxLDL) receptor (LOX-1), CD94, CD69, NKG2-A and -D, osteoclast inhibitory lectin (OCIL), dendritic cell-associated C-type lectin-1 (dectin-1), human myeloid inhibitory C-type lectin-like receptor (MICL), mast cell-associated functional antigen (MAFA), killer cell lectin-like receptors: subfamily F, member 1 (KLRF1) and subfamily B, member 1 (KLRB1), and lys49 receptors. CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. NKRs are variously associated with activation or inhibition of natural killer (NK) cells. Activating NKRs stimulate cytolysis by NK cells of virally infected or transformed cells; inhibitory NKRs block cytolysis up

>cd03598 CLECT_EMBP_like C-type lectin-like domain (CTLD) of the type found in the human proteins, eosinophil major basic protein (EMBP) and prepro major basic protein homolog (MBPH)

Probab=99.91  E-value=2.4e-24  Score=179.90  Aligned_cols=115  Identities=18%  Similarity=0.395  Sum_probs=99.1

Q ss_pred             CeeEEEECCCCChHHHHHHHhhc-CCEEeeeCCHHHHHHHHHHhCCC-CCCeEEeeeecCCCCCCceEEcCCCCCccCCc
Q 010309           20 SKCFGYIGNFRSWDESETYCKEI-GGHLAALTSYEEEHSAQKLCGKN-VNGCWVGGRSINTTVGLSWKWSDNMSKWNESI   97 (513)
Q Consensus        20 ~~Cy~~~~~~~~w~~a~~~C~~~-~~~L~~i~~~~e~~f~~~~~~~~-~~~~WiGl~~~~~~~~~~w~W~dg~~~~~~~~   97 (513)
                      ++||+|+...++|.+|+..|+.+ ||+||+|+|++|++||.+++... ...+||||++.+...++.|.|+||+++.|.+|
T Consensus         1 ~~Cy~~~~~~~t~~~A~~~C~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~WiGl~~~~~~~~~~~~W~dg~~~~y~~W   80 (117)
T cd03598           1 GRCYRFVKSPRTFRDAQVICRRCYRGNLASIHSFAFNYRVQRLVSTLNQAQVWIGGIITGKGRCRRFSWVDGSVWNYAYW   80 (117)
T ss_pred             CceEEEecCCCCHHHHHHHhhcCCCceEeeecChhHhHHHHHHHhCCCCCCEEEeeEcCCCCcCCeeEeCCCCccCcCCC
Confidence            47999999999999999999995 99999999999999999998543 45799999944225679999999999999999


Q ss_pred             ccCCCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCccccc
Q 010309           98 HAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMV  146 (513)
Q Consensus        98 ~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~  146 (513)
                      .+++|.+            +.++|+.+....+.|++..|....+|||++
T Consensus        81 ~~g~p~~------------~~~~Cv~~~~~~g~W~~~~C~~~~~fiC~~  117 (117)
T cd03598          81 APGQPGN------------RRGHCVELCTRGGHWRRAHCKLRRPFICSY  117 (117)
T ss_pred             CCCCCCC------------CCCCcEEEeCCCCeECCCcCCCCceeeecC
Confidence            9998832            345788887656789999999999999974

CLECT_EMBP_like: C-type lectin-like domain (CTLD) of the type found in the human proteins, eosinophil major basic protein (EMBP) and prepro major basic protein homolog (MBPH). CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. Eosinophils and basophils carry out various functions in allergic, parasitic, and inflammatory diseases. EMBP is stored in eosinophil crystalloid granules and is released upon degranulation. EMBP is also expressed in basophils. The proform of EMBP is expressed in placental X cells and breast tissue and increases significantly during human pregnancy. EMBP has cytotoxic properties and damages bacteria and mammalian cells, in vitro, as well as, helminth parasites. EMBP deposition has been observed in the inflamed tissue of all

>PHA02953 IEV and EEV membrane glycoprotein; Provisional

Probab=99.91  E-value=1.1e-24  Score=190.15  Aligned_cols=117  Identities=15%  Similarity=0.238  Sum_probs=95.5

Q ss_pred             cCCCCCCCcccCCCCeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceE
Q 010309            6 KAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWK   85 (513)
Q Consensus         6 ~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~   85 (513)
                      ..+||+||.  .|+++||+++.+.++|.+|+.+|+.+||+|++++  +|+.|+..+..  ...+||||+  |  .+|.|.
T Consensus        44 ~~~CP~GW~--~~~~~CYk~f~~~~tW~~A~~~C~~~Gg~L~~~~--~e~~fv~~~~~--~~~~WIGL~--d--~eg~W~  113 (170)
T PHA02953         44 PSACAKGWI--PYDNYCYLDTNIQLSTYGAVYLCNKYRARLPKPN--FRHLKVLSLTY--GKDFWVSLK--K--KNNRWL  113 (170)
T ss_pred             cCcCcccCh--hhCCEEEEEECCcCCHHHHHHHHHhcCCCCCCCc--HHHHHHHHhcc--CCCEEEeEE--C--CCCceE
Confidence            368999999  8999999999999999999999999999998877  67888887754  446999999  6  578999


Q ss_pred             EcCCC-CCccCC------cccCCCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCcccccc
Q 010309           86 WSDNM-SKWNES------IHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE  147 (513)
Q Consensus        86 W~dg~-~~~~~~------~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~~  147 (513)
                      |.||+ .+.|++      |. ++|            +.+.|+|+.+..  +.|+|..|....+|||+.+
T Consensus       114 w~Dggs~~~y~~~~~~~~w~-~~~------------~~~~e~C~~~~~--~~W~d~~C~~~~~fICqk~  167 (170)
T PHA02953        114 DINTNKTVDMNKNTELKKIK-SKT------------KNDNEACYIYKS--GELKETVCNSVNYIICVKR  167 (170)
T ss_pred             eCCCCeeecccccccccccc-CCC------------CCCCCCceEEeC--CeEEeccCCCCcEEEEEEe
Confidence            99975 455554      33 222            225578987754  4799999999999999864

>cd03591 CLECT_collectin_like C-type lectin-like domain (CTLD) of the type found in human collectins including lung surfactant proteins A and D, mannose- or mannan binding lectin (MBL), and CL-L1 (collectin liver 1)

Probab=99.91  E-value=3.3e-24  Score=178.22  Aligned_cols=114  Identities=18%  Similarity=0.247  Sum_probs=100.1

Q ss_pred             CeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEcCCCCCccCCccc
Q 010309           20 SKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHA   99 (513)
Q Consensus        20 ~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~dg~~~~~~~~~~   99 (513)
                      .+||+++.++++|.+|+.+|+.+||+||+|+|.+|+.||.+++......+||||+  +...++.|+|+||+++.|++|.+
T Consensus         1 ~k~y~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~WiGl~--~~~~~~~~~w~dg~~~~y~~W~~   78 (114)
T cd03591           1 EKIFVTNGEEKNFDDAQKLCSEAGGTLAMPRNAAENAAIASYVKKGNTYAFIGIT--DLETEGQFVYLDGGPLTYTNWKP   78 (114)
T ss_pred             CcEEEeCCceeCHHHHHHHHhhcCCEEecCCCHHHHHHHHHHHhcCCccEEEecc--cCCcCCcEEeCCCCCcccCCcCC
Confidence            3799999999999999999999999999999999999999999754567999999  66678999999999999999999


Q ss_pred             CCCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCccccc
Q 010309          100 VGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMV  146 (513)
Q Consensus       100 ~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~  146 (513)
                      ++|.+          .++.++|+.+. .++.|++.+|....+|||+.
T Consensus        79 ~ep~~----------~~~~~~Cv~~~-~~~~W~~~~C~~~~~fICe~  114 (114)
T cd03591          79 GEPNN----------AGGGEDCVEMY-TSGKWNDVACNLTRLFVCEF  114 (114)
T ss_pred             CCCCC----------CCCCCCeEEEC-CCCcCcCccCCCCeeEEeeC
Confidence            98832          12356899987 45689999999999999974

CLECT_collectin_like: C-type lectin-like domain (CTLD) of the type found in human collectins including lung surfactant proteins A and D, mannose- or mannan binding lectin (MBL), and CL-L1 (collectin liver 1). CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. The CTLDs of these collectins bind carbohydrates on surfaces (e.g. pathogens, allergens, necrotic, or apoptotic cells) and mediate functions associated with killing and phagocytosis. MBPs recognize high mannose oligosaccharides in a calcium dependent manner, bind to a broad range of pathogens, and trigger cell killing by activating the complement pathway. MBP also acts directly as an opsonin. SP-A and SP-D in addition to functioning as host defense components, a

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=2.5e-23  Score=205.59  Aligned_cols=260  Identities=17%  Similarity=0.174  Sum_probs=192.8

Q ss_pred             ccCCceecccCceEEEEEEeCCC--CEEEEEEecccchhcHHHHHHHHHHHhhcCC----CcEeeeeeEE-eeCCceEEE
Q 010309          227 SEGNRLLGDSKTGGTYSGILPDG--SRVAVKRLKRSSFQRKKEFYSEIGRFARLHH----PNLVAVKGCC-YDHGDRYIV  299 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~nIv~l~~~~-~~~~~~~lv  299 (513)
                      +...+.||+|+||.||++.....  ..+|+|............+..|..++..+..    +++..+++.. ......++|
T Consensus        20 ~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iV   99 (322)
T KOG1164|consen   20 YKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIV   99 (322)
T ss_pred             eEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEE
Confidence            34456789999999999997553  4799998876533333367888888888863    6889999888 477788999


Q ss_pred             EeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCC-----CCeEEecccc
Q 010309          300 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE-----FGAHLMGVGL  374 (513)
Q Consensus       300 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~-----~~~kl~Dfg~  374 (513)
                      |+.+ |.+|.++.....  .+.++..+++.|+.|++.+|.+||+.   |++||||||+|+++...     ..+.|.|||+
T Consensus       100 M~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl  173 (322)
T KOG1164|consen  100 MSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL  173 (322)
T ss_pred             Eecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence            9998 889999876533  57799999999999999999999999   99999999999999765     3589999999


Q ss_pred             cccCC--ccccc------cceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhh
Q 010309          375 SKFVP--WEVMQ------ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWAT  446 (513)
Q Consensus       375 ~~~~~--~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~  446 (513)
                      ++...  .....      .......||..|+++.+..+...+.+.|+||++.++.|++.|..|+...........+....
T Consensus       174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~  253 (322)
T KOG1164|consen  174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP  253 (322)
T ss_pred             CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence            99322  22110      10122349999999999999999999999999999999999999987654321111110000


Q ss_pred             HHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcC
Q 010309          447 PLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  508 (513)
Q Consensus       447 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  508 (513)
                      .       ......         .....+.++.++...+-+.+..++|....+...|+....
T Consensus       254 ~-------~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~  299 (322)
T KOG1164|consen  254 R-------KLLTDR---------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFD  299 (322)
T ss_pred             h-------hhcccc---------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHH
Confidence            0       000000         011123456667777777899999999999988765543

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.91  E-value=7e-24  Score=209.05  Aligned_cols=164  Identities=15%  Similarity=0.130  Sum_probs=124.3

Q ss_pred             HhhCcccCCceecccCceEEEEEEeC--CCCEEEEEEeccc-----chhcHHHHHHHHHHHhhcCCCcEee-eeeEEeeC
Q 010309          222 ITKNFSEGNRLLGDSKTGGTYSGILP--DGSRVAVKRLKRS-----SFQRKKEFYSEIGRFARLHHPNLVA-VKGCCYDH  293 (513)
Q Consensus       222 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~nIv~-l~~~~~~~  293 (513)
                      +..+|. ..+.||+|+||.||+|...  +++.||||++...     .....+.+.+|+++|++++|+||++ +++    .
T Consensus        16 ~~~~Y~-~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----~   90 (365)
T PRK09188         16 LSARFV-ETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----T   90 (365)
T ss_pred             ccCCce-EccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----c
Confidence            334444 4567799999999999864  5778899987533     1123466899999999999999985 443    2


Q ss_pred             CceEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCC-CCCceEecCCCCeEEecc
Q 010309          294 GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDI-RASNVLLDEEFGAHLMGV  372 (513)
Q Consensus       294 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Di-kp~NIll~~~~~~kl~Df  372 (513)
                      +..+|||||++|++|.. +.   .    ..   ...++.|++.||.|||+.   +|+|||| ||+|||++.++.+||+||
T Consensus        91 ~~~~LVmE~~~G~~L~~-~~---~----~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDF  156 (365)
T PRK09188         91 GKDGLVRGWTEGVPLHL-AR---P----HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDF  156 (365)
T ss_pred             CCcEEEEEccCCCCHHH-hC---c----cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEEC
Confidence            56899999999999963 21   0    11   146789999999999999   9999999 999999999999999999


Q ss_pred             cccccCCccccccc------eeecCccccccccccccc
Q 010309          373 GLSKFVPWEVMQER------TVMAGGTYGYLAPEFVYR  404 (513)
Q Consensus       373 g~~~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~  404 (513)
                      |+++..........      .....+++.|+|||.+..
T Consensus       157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             ccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            99997654321111      012237888999998864

>cd03603 CLECT_VCBS A bacterial subgroup of the C-type lectin-like (CTLD) domain; a subgroup of bacterial protein domains homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins

Probab=99.90  E-value=1.4e-23  Score=175.22  Aligned_cols=113  Identities=17%  Similarity=0.330  Sum_probs=97.9

Q ss_pred             eeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEcCCCCCccCCcccC
Q 010309           21 KCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAV  100 (513)
Q Consensus        21 ~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~dg~~~~~~~~~~~  100 (513)
                      +||+|+.++++|.+|+..|+++||+||+|+|++|++||.+++. ....+||||+  +...++.|+|+||+++.|.+|.++
T Consensus         1 ~~Y~~~~~~~sw~~A~~~C~~~g~~La~I~s~~E~~fv~~~~~-~~~~~WiG~~--~~~~~~~w~W~dg~~~~~~~W~~~   77 (118)
T cd03603           1 HFYKFVDGGMTWEAAQTLAESLGGHLVTINSAEENDWLLSNFG-GYGASWIGAS--DAATEGTWKWSDGEESTYTNWGSG   77 (118)
T ss_pred             CeEEEeCCCcCHHHHHHHHHHcCCEEcccCCHHHHHHHHHHhc-cCCCEEEeee--cCCCCCceEeCCCCcCCCCCcCCC
Confidence            6999999999999999999999999999999999999999986 3457999999  655679999999999999999999


Q ss_pred             CCCCCCCCCCCCCCCcCCCceeEeec---CCCcccccccC-CCCCcccc
Q 010309          101 GSFNSSCTSLPCHVHATVDLCTLVSN---GSRSLVTERCN-TSHPFICM  145 (513)
Q Consensus       101 ~~~~~~~~~~~c~~~~~~~~C~~~~~---~~~~w~d~~C~-~~~~~iC~  145 (513)
                      +|.+         +..+.|+|+.+..   ..+.|+|..|. ....|||+
T Consensus        78 eP~~---------~~~~~~~Cv~~~~~~~~~~~W~d~~C~~~~~~~iCe  117 (118)
T cd03603          78 EPHN---------NGGGNEDYAAINHFPGISGKWNDLANSYNTLGYVIE  117 (118)
T ss_pred             CCCC---------CCCCCcCeEEeecCCCCCCcCccCCCCccccceEEe
Confidence            8821         1234578988854   45689999999 99999996

CLECT_VCBS: A bacterial subgroup of the C-type lectin-like (CTLD) domain; a subgroup of bacterial protein domains homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. Many CTLDs are calcium-dependent carbohydrate binding modules; other CTLDs bind protein ligands, lipids, and inorganic surfaces including CaCO3 and ice. Bacterial CTLDs within this group are functionally uncharacterized. Animal C-type lectins are involved in such functions as extracellular matrix organization, endocytosis, complement activation, pathogen recognition, and cell-cell interactions. CTLDs may bind a variety of carbohydrate ligands including mannose, N-acetylglucosamine, galactose, N-acetylgalactosamine, and fucose. CTLDs associate with each other through several different surface

>cd03601 CLECT_TC14_like C-type lectin-like domain (CTLD) of the type found in lectins TC14, TC14-2, TC14-3, and TC14-4 from the budding tunicate Polyandrocarpa misakiensis and PfG6 from the Acorn worm

Probab=99.90  E-value=1.3e-23  Score=175.76  Aligned_cols=112  Identities=19%  Similarity=0.311  Sum_probs=91.1

Q ss_pred             EEEECCCCChHHHHHHHhhcCCEEeeeCCHHH--HHHHHHHhCCCCCCeEEeeeecCC-CCCCceEEcCCCCC--ccCCc
Q 010309           23 FGYIGNFRSWDESETYCKEIGGHLAALTSYEE--EHSAQKLCGKNVNGCWVGGRSINT-TVGLSWKWSDNMSK--WNESI   97 (513)
Q Consensus        23 y~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e--~~f~~~~~~~~~~~~WiGl~~~~~-~~~~~w~W~dg~~~--~~~~~   97 (513)
                      |+|+.++++|.+|+.+|+.+||+||+|+|.+|  .++|..........+||||+  |. ..+|.|+|+||+++  .|++|
T Consensus         3 ~~~~~~~~~w~~A~~~C~~~G~~La~i~s~~e~~~~~i~~~~~~~~~~~WIGl~--d~~~~~g~~~W~dG~~~~~~y~~W   80 (119)
T cd03601           3 ILCSDETMNYAKAGAFCRSRGMRLASLAMRDSEMRDAILAFTLVKGHGYWVGAD--NLQDGEYDFLWNDGVSLPTDSDLW   80 (119)
T ss_pred             EEEcCCcCCHHHHHHHHHhcCCEEeeecCHHHHHHHHHHhccccCCccEEEEec--cCCCCCCCeEeCCCCCcCCCCCcc
Confidence            89999999999999999999999999999887  33333321111346999999  76 67899999999997  68999


Q ss_pred             ccCCCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCccccc
Q 010309           98 HAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMV  146 (513)
Q Consensus        98 ~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~  146 (513)
                      .+++|++          .++.|+|+.+....+.|+|..|....+|||+.
T Consensus        81 ~~geP~~----------~~~~e~Cv~~~~~~~~W~d~~C~~~~~fICek  119 (119)
T cd03601          81 APNEPSN----------PQSRQLCVQLWSKYNLLDDEYCGRAKRVICEK  119 (119)
T ss_pred             CCCcCcC----------cCCCcCCeEEeCCCCCEeCccCCCCceeeecC
Confidence            9999832          12457899887656789999999999999974

CLECT_TC14_like: C-type lectin-like domain (CTLD) of the type found in lectins TC14, TC14-2, TC14-3, and TC14-4 from the budding tunicate Polyandrocarpa misakiensis and PfG6 from the Acorn worm. CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. TC14 is homodimeric. The CTLD of TC14 binds D-galactose and D-fucose. TC14 is expressed constitutively by multipotent epithelial and mesenchymal cells and plays in role during budding, in inducing the aggregation of undifferentiated mesenchymal cells to give rise to epithelial forming tissue. TC14-2 and TC14-3 shows calcium-dependent galactose binding activity. TC14-3 is a cytostatic factor which blocks cell growth and dedifferentiation of the atrial epithelium during asexual reproducti

>PHA03097 C-type lectin-like protein; Provisional

Probab=99.90  E-value=2.2e-23  Score=180.65  Aligned_cols=115  Identities=16%  Similarity=0.394  Sum_probs=95.4

Q ss_pred             CcCCCCCCCcccCCCCeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCce
Q 010309            5 WKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSW   84 (513)
Q Consensus         5 ~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w   84 (513)
                      ....||.||.  .|+++||+|+.+.++|.+|+..|+++||+||+|++++|++||.+++.  ...|||||+  |..  .  
T Consensus        42 ~~~~CP~gW~--~~~~~CY~~s~~~~sW~~A~~~C~~~g~~La~I~~~~E~~fi~~~~~--~~~~WIGL~--d~~--~--  111 (157)
T PHA03097         42 SGLNCRSGWV--GYNNKCYTFSENITNKHLAIERCADMDGILTLIDDQKEVLFVSRYKG--GQDLWIGIE--KKK--G--  111 (157)
T ss_pred             cCCCCCCCce--eeCCEEEEEecCCCcHHHHHHHHHhCCCEEeeeCCHHHHHHHHHhcC--CCCEEEeee--cCC--C--
Confidence            3457999999  89999999999999999999999999999999999999999999876  457999999  543  2  


Q ss_pred             EEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCccccccc
Q 010309           85 KWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEH  148 (513)
Q Consensus        85 ~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~~~  148 (513)
                       |+||++..+ +|+.               +.++|+|+.+...  .|+|..|.....|||+.+.
T Consensus       112 -W~dgs~~~~-~~~~---------------~~~~e~Cv~i~~~--~w~d~~C~~~~~~ICek~~  156 (157)
T PHA03097        112 -DDDDREVLD-KVVK---------------PPKSGKCAYLKDK--TIISSNCNATKGWICFDRL  156 (157)
T ss_pred             -ccCCCcccc-cccC---------------CCCCCCEEEEECC--cEEeCCCCCCeeEEEeecC
Confidence             999987543 3321               1235679887554  5999999999999999864

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.90  E-value=6.4e-22  Score=195.60  Aligned_cols=258  Identities=27%  Similarity=0.387  Sum_probs=193.6

Q ss_pred             CceecccCceEEEEEEeCCCCEEEEEEecccchh---cHHHHHHHHHHHhhcCCC-cEeeeeeEEeeCCceEEEEeeccC
Q 010309          230 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQ---RKKEFYSEIGRFARLHHP-NLVAVKGCCYDHGDRYIVYEFVVN  305 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-nIv~l~~~~~~~~~~~lv~e~~~~  305 (513)
                      .+.||.|+||.||++...  ..+++|.+......   ....+.+|+.++..+.|+ +|+++++.+......+++++++.+
T Consensus         5 ~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~   82 (384)
T COG0515           5 LRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDG   82 (384)
T ss_pred             EEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCC
Confidence            346799999999999986  88999999766433   367899999999999988 799999999777778999999999


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCC-CeEEecccccccCCccccc
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF-GAHLMGVGLSKFVPWEVMQ  384 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~-~~kl~Dfg~~~~~~~~~~~  384 (513)
                      ++|.+++...... ..+.......++.|++.++.|+|+.   +++||||||+||+++..+ .++++|||.+.........
T Consensus        83 ~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~  158 (384)
T COG0515          83 GSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST  158 (384)
T ss_pred             CcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence            9999777542211 3689999999999999999999999   999999999999999988 6999999999865443322


Q ss_pred             c----ceeecCccccccccccccc---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcc-ccchhHHhhhHHhhcccccc
Q 010309          385 E----RTVMAGGTYGYLAPEFVYR---NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSV-CWQSIFEWATPLVQSHRYLE  456 (513)
Q Consensus       385 ~----~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvil~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~  456 (513)
                      .    ......++..|+|||.+.+   ..++...|+||+|++++++++|..||...... ...........    .... 
T Consensus       159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~----~~~~-  233 (384)
T COG0515         159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILE----LPTP-  233 (384)
T ss_pred             ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHh----cCCc-
Confidence            1    1223348999999999987   57889999999999999999999997655431 00011111100    0000 


Q ss_pred             cccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010309          457 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  502 (513)
Q Consensus       457 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  502 (513)
                      ......   ..... ......+.+++..++..+|..|.+..+....
T Consensus       234 ~~~~~~---~~~~~-~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         234 SLASPL---SPSNP-ELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             cccccc---Ccccc-chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            000000   00000 2233568899999999999999998877653

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.90  E-value=2.4e-24  Score=226.05  Aligned_cols=256  Identities=18%  Similarity=0.207  Sum_probs=187.7

Q ss_pred             cccCCceecccCceEEEEEEeC-CCCEEEEEEec----cc-chh-cHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEE
Q 010309          226 FSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLK----RS-SFQ-RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYI  298 (513)
Q Consensus       226 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~----~~-~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l  298 (513)
                      +.....++|.|++|.|+..... .....+.|...    .. ... ....+..|+-+-..|+|||++..+..+.+....+-
T Consensus       319 y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~  398 (601)
T KOG0590|consen  319 YGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQ  398 (601)
T ss_pred             cCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchh
Confidence            4445678899999988777643 33334444332    11 111 11226678888888999999998888877777767


Q ss_pred             EEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccC
Q 010309          299 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV  378 (513)
Q Consensus       299 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~  378 (513)
                      +||||++ +|..++..    ...+...++..++.|++.|++|||+.   ||.||||||+|++++.++.+||+|||.+..+
T Consensus       399 ~mE~~~~-Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf  470 (601)
T KOG0590|consen  399 SMEYCPY-DLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVF  470 (601)
T ss_pred             hhhcccH-HHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceee
Confidence            7999999 99999864    24688889999999999999999999   9999999999999999999999999999876


Q ss_pred             Cccccc--cceeecCcccccccccccccCCCCc-hhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccc
Q 010309          379 PWEVMQ--ERTVMAGGTYGYLAPEFVYRNELTT-KSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL  455 (513)
Q Consensus       379 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  455 (513)
                      ......  .......|+..|+|||++.+..|.+ ..||||.|+++..|++|+.||........+. .    .........
T Consensus       471 ~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-~----~~~~~~~~~  545 (601)
T KOG0590|consen  471 RYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-K----TNNYSDQRN  545 (601)
T ss_pred             ccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-h----hhccccccc
Confidence            544332  2233344889999999999998876 5799999999999999999997654332111 0    000000000


Q ss_pred             ccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          456 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       456 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      ..       ..........+.+.+.+|.+||+.||.+|.|+++|++
T Consensus       546 ~~-------~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  546 IF-------EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             cc-------cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            00       0011122345667899999999999999999999986

>cd03592 CLECT_selectins_like C-type lectin-like domain (CTLD) of the type found in the type 1 transmembrane proteins: P(platlet)-, E(endothelial)-, and L(leukocyte)- selectins (sels)

Probab=99.90  E-value=2.8e-23  Score=173.04  Aligned_cols=111  Identities=19%  Similarity=0.307  Sum_probs=96.1

Q ss_pred             EEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCC-CCCeEEeeeecCCCCCCceEEcCCCCCccCCcccCC
Q 010309           23 FGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN-VNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVG  101 (513)
Q Consensus        23 y~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~-~~~~WiGl~~~~~~~~~~w~W~dg~~~~~~~~~~~~  101 (513)
                      |+|+.++++|.+|+.+|+.+||+||+|+|++|++||.+++... ...|||||+  +...++.|.|+||+++.|.+|.+++
T Consensus         3 Y~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~i~~~~~~~~~~~~WiG~~--~~~~~~~W~~~dg~~~~y~~W~~ge   80 (115)
T cd03592           3 YHYSTEKMTFNEAVKYCKSRGTDLVAIQNAEENALLNGFALKYNLGYYWIDGN--DINNEGTWVDTDKKELEYKNWAPGE   80 (115)
T ss_pred             EEEcCCccCHHHHHHHHHHcCCeEeecCCHHHHHHHHHHHHhcCCCCEEEeCc--cCCccCeEEeCCCCcccccccCCCC
Confidence            8999999999999999999999999999999999999986543 347999999  6666789999999999999999998


Q ss_pred             CCCCCCCCCCCCCCcCCCceeEeecC-CCcccccccCCCCCccccc
Q 010309          102 SFNSSCTSLPCHVHATVDLCTLVSNG-SRSLVTERCNTSHPFICMV  146 (513)
Q Consensus       102 ~~~~~~~~~~c~~~~~~~~C~~~~~~-~~~w~d~~C~~~~~~iC~~  146 (513)
                      |.+           .+.++|+.+... .+.|++.+|....+|||++
T Consensus        81 P~~-----------~~~~~Cv~~~~~~~g~W~d~~C~~~~~fICe~  115 (115)
T cd03592          81 PNN-----------GRNENCLEIYIKDNGKWNDEPCSKKKSAICYT  115 (115)
T ss_pred             CCC-----------CCCCCceEEccCCCCCCcCcCCCCCccceeCC
Confidence            832           224678888653 5689999999999999984

CLECT_selectins_like: C-type lectin-like domain (CTLD) of the type found in the type 1 transmembrane proteins: P(platlet)-, E(endothelial)-, and L(leukocyte)- selectins (sels). CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. P- E- and L-sels are cell adhesion receptors that mediate the initial attachment, tethering, and rolling of lymphocytes on inflamed vascular walls enabling subsequent lymphocyte adhesion and transmigration. L- sel is expressed constitutively on most leukocytes. P-sel is stored in the Weibel-Palade bodies of endothelial cells and in the alpha granules of platlets. E- sels are present on endothelial cells. Following platelet and/or endothelial cell activation P- sel is rapidly translocated to the cell surface and E-sel exp

>TIGR00864 PCC polycystin cation channel protein

Probab=99.89  E-value=3.5e-23  Score=235.76  Aligned_cols=135  Identities=19%  Similarity=0.321  Sum_probs=113.3

Q ss_pred             CCCcCCCCCCCcccCCCCeeEEEECCCCChHHHHHHHhhc-CCEEeeeCCHHHHHHHHHHhCCC-CCCeEEeeeecCCCC
Q 010309            3 KDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI-GGHLAALTSYEEEHSAQKLCGKN-VNGCWVGGRSINTTV   80 (513)
Q Consensus         3 ~~~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~-~~~L~~i~~~~e~~f~~~~~~~~-~~~~WiGl~~~~~~~   80 (513)
                      +.+...||+||...+++++||+++.+.++|.+|+..|+++ |||||+|+|.+|++||.+++... ...+||||+  |...
T Consensus       312 ~~~~~~CP~GW~~f~~~g~CYk~~~e~~TW~dAe~~C~s~GGAhLAsI~S~eEn~FL~~lv~~s~~~~vWIGLs--D~~~  389 (2740)
T TIGR00864       312 KASHPHCPKDGEIFEENGHCFQIVPEEAAWLDAQEQCLARAGAALAIVDNDALQNFLARKVTHSLDRGVWIGFS--DVNG  389 (2740)
T ss_pred             cccCCCCCCCCeecCCCCEEEEEeCCccCHHHHHHHhhccCCeEEecCCCHHHHHHHHHHhhccCCccEEEeee--CCCC
Confidence            3455789999974356899999999999999999999999 69999999999999999988643 346999999  7666


Q ss_pred             CCc--eEEcCCCCC-ccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCccccccccCc
Q 010309           81 GLS--WKWSDNMSK-WNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEHENK  151 (513)
Q Consensus        81 ~~~--w~W~dg~~~-~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~~~~~~  151 (513)
                      +|.  |+|+||+++ .|.+|.+++|+           |.+.|+|+.+... +.|+|..|....+|||+.++...
T Consensus       390 EG~g~WvWsDGS~l~~YtnW~pGEPN-----------n~~~EdCV~l~~~-g~WND~~Cs~~~~FICE~~~~~~  451 (2740)
T TIGR00864       390 AEKGPAHQGEAFEAEECEEGLAGEPH-----------PARAEHCVRLDPR-GQCNSDLCNAPHAYVCELNPGGP  451 (2740)
T ss_pred             CCceeeEECCCCcccCccCcCCCCCC-----------CCCCCCCEEEcCC-CCEEccCCCCCeeEEeEECCCCc
Confidence            665  999999997 69999999983           2344789887543 56999999999999999866554

Note: this model has been restricted to the amino half because for technical reasons.

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.89  E-value=1.9e-22  Score=186.53  Aligned_cols=255  Identities=16%  Similarity=0.211  Sum_probs=191.7

Q ss_pred             CCceecccCceEEEEEE-eCCCCEEEEEEecccchhcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          229 GNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      ..+.||+|.||.++.|+ +-++++||||.-...+  +.-++..|.+..+.| ..++|...|-+-.++.+..||+|++ |.
T Consensus        32 VGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GP  108 (449)
T KOG1165|consen   32 VGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GP  108 (449)
T ss_pred             eccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-Cc
Confidence            35566999999999999 3579999999765543  445788899888888 5789999999888998999999999 88


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCC-----CeEEecccccccCCcc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF-----GAHLMGVGLSKFVPWE  381 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~-----~~kl~Dfg~~~~~~~~  381 (513)
                      ||++++.-   .++.++..++..++.|++.-++|+|++   .+|.|||||+|+||...+     .+.++|||+++.....
T Consensus       109 SLEDLFD~---CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp  182 (449)
T KOG1165|consen  109 SLEDLFDL---CGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDP  182 (449)
T ss_pred             CHHHHHHH---hcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhcCc
Confidence            99998863   357799999999999999999999999   999999999999996433     4899999999977554


Q ss_pred             ccccc-----eeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccc
Q 010309          382 VMQER-----TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLE  456 (513)
Q Consensus       382 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  456 (513)
                      .+...     .....||.+||+--...+..-+.+-|+=|||-++.+.|-|..||++..........+.+...-....   
T Consensus       183 ~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~---  259 (449)
T KOG1165|consen  183 KTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTP---  259 (449)
T ss_pred             cccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCC---
Confidence            33221     1223499999999998899999999999999999999999999998765433222221111000000   


Q ss_pred             cccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 010309          457 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ  505 (513)
Q Consensus       457 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  505 (513)
                                ......+++.++..-+.-.-..+-.+-|..+-+...+..
T Consensus       260 ----------i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~d  298 (449)
T KOG1165|consen  260 ----------IEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDD  298 (449)
T ss_pred             ----------HHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence                      011112345566666666666677777777665554443

>smart00034 CLECT C-type lectin (CTL) or carbohydrate-recognition domain (CRD)

Probab=99.88  E-value=1.8e-22  Score=171.04  Aligned_cols=121  Identities=23%  Similarity=0.586  Sum_probs=104.4

Q ss_pred             CCCCCcccCCCCeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCC---CCCeEEeeeecCCCCCCceE
Q 010309            9 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN---VNGCWVGGRSINTTVGLSWK   85 (513)
Q Consensus         9 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~---~~~~WiGl~~~~~~~~~~w~   85 (513)
                      ||+||.  .++++||+++....+|.+|+..|+.+||+||+|++.+|++||.+++...   ...+||||+  +....+.|+
T Consensus         1 Cp~~w~--~~~~~Cy~~~~~~~~~~~A~~~C~~~~~~La~i~~~~e~~~i~~~~~~~~~~~~~~WiG~~--~~~~~~~~~   76 (126)
T smart00034        1 CPSGWI--SYGGKCYKFSTEKKTWADAQAFCQSLGAHLASIHSEAENDFVASLLKNSGSNSDYYWIGLS--DPDSNGSWQ   76 (126)
T ss_pred             CCcchh--hhCCEEEEEECCccCHHHHHHHHHhcCCEEcccCCHHHHHHHHHHHHhhcCCCCCEEEecC--ccCcCCCeE
Confidence            999999  7999999999999999999999999999999999999999999998753   568999999  445578999


Q ss_pred             EcCCCC-CccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCC-CcccccccCCCCCcccc
Q 010309           86 WSDNMS-KWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS-RSLVTERCNTSHPFICM  145 (513)
Q Consensus        86 W~dg~~-~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~-~~w~d~~C~~~~~~iC~  145 (513)
                      |+||++ ..|.+|.++ +           +....++|+.+.... +.|.+.+|....+|||+
T Consensus        77 W~dg~~~~~~~~w~~~-~-----------~~~~~~~C~~~~~~~~~~w~~~~C~~~~~~ICe  126 (126)
T smart00034       77 WSDGSGPVNYSNWAPG-E-----------PNGGSGDCVVLSTSGGGKWNDVSCTSKLPFVCE  126 (126)
T ss_pred             ECCCCCCCCccccCCC-C-----------CCCCCCCCEEEecCCCCcccCCCCCCCcccccC
Confidence            999998 678898877 3           122445788886654 57999999999999996

Many of these domains function as calcium-dependent carbohydrate binding modules.

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.88  E-value=2.3e-22  Score=178.10  Aligned_cols=200  Identities=20%  Similarity=0.282  Sum_probs=163.3

Q ss_pred             cCCceecccCceEEEEEE-eCCCCEEEEEEecccchhcHHHHHHHHHHHhhcCC-CcEeeeeeEEeeCCceEEEEeeccC
Q 010309          228 EGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHH-PNLVAVKGCCYDHGDRYIVYEFVVN  305 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~lv~e~~~~  305 (513)
                      ...+.||+|+||.+|.|. ..+|..||||+-...  ....++.-|.++...|++ ..|..+..+..+.....+||+.+ |
T Consensus        18 ~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-G   94 (341)
T KOG1163|consen   18 KLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-G   94 (341)
T ss_pred             EEEEeecCCchhheeeeeeccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-C
Confidence            344567999999999999 467999999987544  234567889999999975 67888888888889999999999 8


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCC---CCeEEecccccccCCccc
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE---FGAHLMGVGLSKFVPWEV  382 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~---~~~kl~Dfg~~~~~~~~~  382 (513)
                      .+|.+++.-.   .+.++..+++-++-|++.-++|+|.+   +++||||||+|.|+.-+   ..+.|+|||+|+...+..
T Consensus        95 PsLEdLfnfC---~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~  168 (341)
T KOG1163|consen   95 PSLEDLFNFC---SRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIR  168 (341)
T ss_pred             ccHHHHHHHH---hhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhcccc
Confidence            8999988643   36699999999999999999999999   99999999999999643   458999999998765432


Q ss_pred             cccc-----eeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcc
Q 010309          383 MQER-----TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSV  436 (513)
Q Consensus       383 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~  436 (513)
                      ....     .....||.+|.+--...+-.-+..-|+=|+|.+|.++.-|..||++....
T Consensus       169 t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~  227 (341)
T KOG1163|consen  169 TRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA  227 (341)
T ss_pred             ccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchh
Confidence            2111     11223899999888777777788899999999999999999999987654

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.88  E-value=2.3e-22  Score=182.50  Aligned_cols=138  Identities=17%  Similarity=0.156  Sum_probs=107.9

Q ss_pred             ceecccCceEEEEEEeCCCCEEEEEEecccchh--c-------H-----------------HHHHHHHHHHhhcCCCcEe
Q 010309          231 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQ--R-------K-----------------KEFYSEIGRFARLHHPNLV  284 (513)
Q Consensus       231 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~E~~~l~~l~h~nIv  284 (513)
                      ..||+|++|.||+|...+|++||||+++.....  .       .                 ....+|+..+.++.++++.
T Consensus         3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~   82 (190)
T cd05147           3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP   82 (190)
T ss_pred             CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence            468999999999999888999999999754211  1       0                 1224599999999877764


Q ss_pred             eeeeEEeeCCceEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCceEcCCCCCceEecC
Q 010309          285 AVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL-HDKVKPHVVHRDIRASNVLLDE  363 (513)
Q Consensus       285 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~L-H~~~~~~ivH~Dikp~NIll~~  363 (513)
                      ....+.  ....+|||||+++++|...+..    ...++...+..++.|++.+|.+| |+.   +|+||||||+|||++.
T Consensus        83 ~p~~~~--~~~~~iVmE~i~g~~l~~~~~~----~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~~  153 (190)
T cd05147          83 CPEPIL--LKSHVLVMEFIGDDGWAAPRLK----DAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYHD  153 (190)
T ss_pred             CCcEEE--ecCCEEEEEEeCCCCCcchhhh----cCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEEC
Confidence            433322  2234899999998877654321    24688999999999999999999 688   9999999999999984


Q ss_pred             CCCeEEecccccccC
Q 010309          364 EFGAHLMGVGLSKFV  378 (513)
Q Consensus       364 ~~~~kl~Dfg~~~~~  378 (513)
                       +.++|+|||++...
T Consensus       154 -~~v~LiDFG~a~~~  167 (190)
T cd05147         154 -GKLYIIDVSQSVEH  167 (190)
T ss_pred             -CcEEEEEccccccC
Confidence             68999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.88  E-value=2.6e-23  Score=218.14  Aligned_cols=249  Identities=21%  Similarity=0.233  Sum_probs=179.6

Q ss_pred             CceecccCceEEEEEEeCCCCEEEEEEecccc-hhcHHHH---HHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccC
Q 010309          230 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSS-FQRKKEF---YSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  305 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~---~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  305 (513)
                      .+.||++.|=.|.++++++|. |+||++-+.. .-....+   ..|++ ...++|||.+++.-+.......|||-+|.. 
T Consensus        28 ~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqyvk-  104 (1431)
T KOG1240|consen   28 VENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQYVK-  104 (1431)
T ss_pred             ecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHHHh-
Confidence            345799999999999998887 9999986553 2233334   34444 555699999999888778888899999994 


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccC--Ccccc
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV--PWEVM  383 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~--~~~~~  383 (513)
                      .+|.+.|..    +.-+...+.+-|+.|++.||.-+|..   ||+|||||.+||||++-+-+.|+||..-+..  +.+..
T Consensus       105 hnLyDRlST----RPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP  177 (1431)
T KOG1240|consen  105 HNLYDRLST----RPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP  177 (1431)
T ss_pred             hhhhhhhcc----chHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence            489888853    34577778888999999999999999   9999999999999999988999999876532  22222


Q ss_pred             cccee---ecCccccccccccccc----------CC-CCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHH
Q 010309          384 QERTV---MAGGTYGYLAPEFVYR----------NE-LTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPL  448 (513)
Q Consensus       384 ~~~~~---~~~gt~~y~aPE~~~~----------~~-~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  448 (513)
                      .....   ....-..|+|||.+..          .+ .+++.||||+||++.||++ |++||.-      .++..+...-
T Consensus       178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L------SQL~aYr~~~  251 (1431)
T KOG1240|consen  178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL------SQLLAYRSGN  251 (1431)
T ss_pred             ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH------HHHHhHhccC
Confidence            22111   1113357999998753          12 5788999999999999998 6888753      2222221110


Q ss_pred             hhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcC
Q 010309          449 VQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  508 (513)
Q Consensus       449 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  508 (513)
                        .    ......+    ..+.    ...+++++..|++.||++|.++++.|+.-..+.-
T Consensus       252 --~----~~~e~~L----e~Ie----d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~F  297 (1431)
T KOG1240|consen  252 --A----DDPEQLL----EKIE----DVSLRNLILSMIQRDPSKRLSAEDYLQKYRGLVF  297 (1431)
T ss_pred             --c----cCHHHHH----HhCc----CccHHHHHHHHHccCchhccCHHHHHHhhhcccc
Confidence              0    0011111    0111    1248899999999999999999999998665543

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.88  E-value=2.1e-22  Score=184.69  Aligned_cols=175  Identities=10%  Similarity=0.109  Sum_probs=135.2

Q ss_pred             HHHHhhCcccCCceecccCceEEEEEEeCCCCEEEEEEecccchhcHH---------HHHHHHHHHhhcCCCcEeeeeeE
Q 010309          219 LRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKK---------EFYSEIGRFARLHHPNLVAVKGC  289 (513)
Q Consensus       219 l~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~---------~~~~E~~~l~~l~h~nIv~l~~~  289 (513)
                      +..+..+-+...++||.|+||.||+... ++..+|||++.........         .+.+|+..+.+++||+|..+.++
T Consensus        25 ~~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~  103 (232)
T PRK10359         25 FDDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDF  103 (232)
T ss_pred             HHHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEe
Confidence            4455666667778999999999999766 6779999999765332222         26889999999999999999888


Q ss_pred             EeeC--------CceEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEe
Q 010309          290 CYDH--------GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL  361 (513)
Q Consensus       290 ~~~~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll  361 (513)
                      +...        +..+|||||++|.+|.++..        +++    ....+++.+|..+|+.   |++||||||+||++
T Consensus       104 ~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili  168 (232)
T PRK10359        104 YLLAERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIV  168 (232)
T ss_pred             eeecccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEE
Confidence            6643        35789999999999988642        222    2456999999999999   99999999999999


Q ss_pred             cCCCCeEEecccccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHH
Q 010309          362 DEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIV  424 (513)
Q Consensus       362 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ell  424 (513)
                      +.++ ++|+|||............              .++....+..++|+||||+++..+.
T Consensus       169 ~~~g-i~liDfg~~~~~~e~~a~d--------------~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        169 SKNG-LRIIDLSGKRCTAQRKAKD--------------RIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             eCCC-EEEEECCCcccccchhhHH--------------HHHHHhHhcccccccceeEeehHHH
Confidence            9988 9999999887553221111              1334455667899999999887654

>cd03602 CLECT_1 C-type lectin (CTL)/C-type lectin-like (CTLD) domain subgroup 1; a subgroup of protein domains homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins

Probab=99.87  E-value=3.3e-22  Score=164.57  Aligned_cols=108  Identities=22%  Similarity=0.480  Sum_probs=93.7

Q ss_pred             eeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEcCCCCCccCCcccC
Q 010309           21 KCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAV  100 (513)
Q Consensus        21 ~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~dg~~~~~~~~~~~  100 (513)
                      .||+++.++++|.+|+.+|+.+||+||+|+|.+|++||.+++......+||||+  +.  ++.|.|+||++..|.+|.++
T Consensus         1 ~~y~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~WiGl~--~~--~~~~~W~dg~~~~~~~w~~~   76 (108)
T cd03602           1 RTFYLVNESKTWSEAQQYCRENYTDLATVQNQEDNALLSNLSRVSNSAAWIGLY--RD--VDSWRWSDGSESSFRNWNTF   76 (108)
T ss_pred             CceEEeccccCHHHHHHHHHHHCCccCeecCHHHHHHHHHHHhccCCcEEEEEE--CC--CCceEEcCCCCCccCccCCC
Confidence            489999999999999999999999999999999999999998533568999999  43  68999999999999999887


Q ss_pred             CCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCccccc
Q 010309          101 GSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMV  146 (513)
Q Consensus       101 ~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~  146 (513)
                      +|.             ..++|+.+... +.|++..|....+|||+.
T Consensus        77 ~~~-------------~~~~C~~~~~~-~~w~~~~C~~~~~fIC~~  108 (108)
T cd03602          77 QPF-------------GQGDCATMYSS-GRWYAALCSALKPFICYD  108 (108)
T ss_pred             CCC-------------CCCCeeEECcC-CeECcccCCCCcCEeccC
Confidence            641             23578888654 689999999999999973

CLECT_1: C-type lectin (CTL)/C-type lectin-like (CTLD) domain subgroup 1; a subgroup of protein domains homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. Many CTLDs are calcium-dependent carbohydrate binding modules; other CTLDs bind protein ligands, lipids, and inorganic surfaces including CaCO3 and ice. Animal C-type lectins are involved in such functions as extracellular matrix organization, endocytosis, complement activation, pathogen recognition, and cell-cell interactions. CTLDs may bind a variety of carbohydrate ligands including mannose, N-acetylglucosamine, galactose, N-acetylgalactosamine, and fucose. CTLDs associate with each other through several different surfaces to form dimers, trimers, or tetramers from which ligand-binding sites project in differe

>cd03595 CLECT_chondrolectin_like C-type lectin-like domain (CTLD) of the type found in the human type-1A transmembrane proteins chondrolectin (CHODL) and layilin

Probab=99.87  E-value=5.9e-22  Score=172.41  Aligned_cols=116  Identities=17%  Similarity=0.348  Sum_probs=95.3

Q ss_pred             CCCCeeEEEE-----CCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCC---CCCeEEeeeecCCCC--------
Q 010309           17 EEKSKCFGYI-----GNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN---VNGCWVGGRSINTTV--------   80 (513)
Q Consensus        17 ~~~~~Cy~~~-----~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~---~~~~WiGl~~~~~~~--------   80 (513)
                      .|+++||+++     ..+++|.+|+..|+.+||+||+|+|++|++||.+++...   ...+||||+  +...        
T Consensus         7 ~~~~~Cy~~~~~~~~~~~~tw~~A~~~C~~~g~~LasI~s~~E~~~i~~~i~~~~~~~~~~WIGl~--~~~~~~~~~~~~   84 (149)
T cd03595           7 GTEKPCYKIAYFQDSRRRLNFEEARQACREDGGELLSIESENEQKLIERFIQTLRASDGDFWIGLR--RSSQYNVTSSAC   84 (149)
T ss_pred             CCCCccEEEEEEeccccccCHHHHHHHHHHcCCEECccCCHHHHHHHHHHHHhhcCCCCcEEEEeE--CCCCcccccccc
Confidence            3569999864     789999999999999999999999999999999887532   457999999  4433        


Q ss_pred             CCceEEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecC-----------CCcccccccCCCCCccccc
Q 010309           81 GLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG-----------SRSLVTERCNTSHPFICMV  146 (513)
Q Consensus        81 ~~~w~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~-----------~~~w~d~~C~~~~~~iC~~  146 (513)
                      ++.|.|+||+++.|.+|.+++|.+            +.++|+.+...           ...|+|..|....+|||+.
T Consensus        85 ~~~~~W~dG~~~~y~~W~~~eP~~------------~~~~Cv~l~~~~~~~~~~~~~~~~~W~d~~C~~~~~fICe~  149 (149)
T cd03595          85 SSLYYWLDGSISTFRNWYVDEPSC------------GSEVCVVMYHQPSAPAGQGGPYLFQWNDDNCNMKNNFICKY  149 (149)
T ss_pred             CCccEEcCCCccCccCCCCCCCCC------------cccCCEEEEecCCCCcCcCcccCCCccCCCCCCCcccccCC
Confidence            256999999999999999998832            34578877532           2369999999999999974

CLECT_chondrolectin_like: C-type lectin-like domain (CTLD) of the type found in the human type-1A transmembrane proteins chondrolectin (CHODL) and layilin. CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. CHODL is predominantly expressed in muscle cells and is associated with T-cell maturation. Various alternatively spliced isoforms have been of CHODL have been identified. The transmembrane form of CHODL is localized in the ER-Golgi apparatus. Layilin is widely expressed in different cell types. The extracellular CTLD of layilin binds hyaluronan (HA), a major constituent of the extracellular matrix (ECM). The cytoplasmic tail of layilin binds various members of the band 4.1/ERM superfamily (talin, radixin, and merlin). The ERM proteins are cytoskeleton-membrane l

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.86  E-value=4.8e-21  Score=174.49  Aligned_cols=139  Identities=17%  Similarity=0.169  Sum_probs=110.5

Q ss_pred             ceecccCceEEEEEEeCCCCEEEEEEecccchh--c------------------------HHHHHHHHHHHhhcCCCcEe
Q 010309          231 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQ--R------------------------KKEFYSEIGRFARLHHPNLV  284 (513)
Q Consensus       231 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~h~nIv  284 (513)
                      +.||+|++|.||+|...+|+.||||+++.....  .                        ...+..|...+.++.|++|.
T Consensus         3 ~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   82 (190)
T cd05145           3 GCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVP   82 (190)
T ss_pred             ceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence            468999999999999878999999999764211  0                        12235789999999999875


Q ss_pred             eeeeEEeeCCceEEEEeeccCCCHHHH-hccCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCceEcCCCCCceEec
Q 010309          285 AVKGCCYDHGDRYIVYEFVVNGPLDRW-LHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD-KVKPHVVHRDIRASNVLLD  362 (513)
Q Consensus       285 ~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dikp~NIll~  362 (513)
                      ....+...  ..+|||||++++++... +.     ...++......++.|++.+|.+||+ .   ||+||||||+|||++
T Consensus        83 ~p~~~~~~--~~~lVmE~~~g~~~~~~~l~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~  152 (190)
T cd05145          83 VPEPILLK--KNVLVMEFIGDDGSPAPRLK-----DVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH  152 (190)
T ss_pred             CceEEEec--CCEEEEEEecCCCchhhhhh-----hccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE
Confidence            44443332  34899999988865433 32     2457788999999999999999999 8   999999999999999


Q ss_pred             CCCCeEEecccccccCCc
Q 010309          363 EEFGAHLMGVGLSKFVPW  380 (513)
Q Consensus       363 ~~~~~kl~Dfg~~~~~~~  380 (513)
                       ++.++|+|||++.....
T Consensus       153 -~~~~~liDFG~a~~~~~  169 (190)
T cd05145         153 -DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             -CCCEEEEEcccceecCC
Confidence             78999999999986643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>cd03600 CLECT_thrombomodulin_like C-type lectin-like domain (CTLD) of the type found in human thrombomodulin(TM), Endosialin, C14orf27, and C1qR

Probab=99.86  E-value=3.9e-21  Score=166.07  Aligned_cols=118  Identities=18%  Similarity=0.303  Sum_probs=94.5

Q ss_pred             CCCeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCC-------CCCeEEeeeecCC------CCCCce
Q 010309           18 EKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN-------VNGCWVGGRSINT------TVGLSW   84 (513)
Q Consensus        18 ~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~-------~~~~WiGl~~~~~------~~~~~w   84 (513)
                      .+++||+++...++|.+|+.+|+.+||+||+|+|.+|++||..++...       ...+||||++...      ..++.|
T Consensus         2 ~~~~Cy~~~~~~~sw~~A~~~C~~~gg~La~i~s~~E~~~v~~~l~~~~~~~~~~~~~~WIGl~~~~~~~~~~~~~~~~f   81 (141)
T cd03600           2 VSDACYTLHPQKLTFLEAQRSCIELGGNLATVRSGEEADVVSLLLAAGPGRHGRGSLRLWIGLQREPRQCSDPSLPLRGF   81 (141)
T ss_pred             CCCceEEEeCCccCHHHHHHHHHhhCCEeeecCCHHHHHHHHHHHhhccccccCCCccEEEeEecCcccCccccccCCcc
Confidence            367899999999999999999999999999999999999999988643       3479999994211      234789


Q ss_pred             EEcCCCC-CccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCC-----CcccccccCCC-CCccccc
Q 010309           85 KWSDNMS-KWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS-----RSLVTERCNTS-HPFICMV  146 (513)
Q Consensus        85 ~W~dg~~-~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~-----~~w~d~~C~~~-~~~iC~~  146 (513)
                      .|+||++ ..|++|.++ |+ +.+         +.++|+.+....     ..|+|.+|... ..|||+.
T Consensus        82 ~W~d~~~~~~y~~W~~~-p~-n~~---------~~~~Cv~l~~~~~~~~~~~W~d~~C~~~~~~fIC~~  139 (141)
T cd03600          82 SWVTGDQDTDFSNWLQE-PA-GTC---------TSPRCVALSAAGSTPDNLKWKDGPCSARADGYLCKF  139 (141)
T ss_pred             EECCCCCCCCccccccC-CC-CCC---------CCCccEEEEccCCCCCCCccccCCcCCCCCCeEEee
Confidence            9999865 578899887 52 222         346788886543     46999999998 4799986

CLECT_thrombomodulin_like: C-type lectin-like domain (CTLD) of the type found in human thrombomodulin(TM), Endosialin, C14orf27, and C1qR. CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. In these thrombomodulin-like proteins the residues involved in coordinating Ca2+ in the classical MBP-A CTLD are not conserved. TM exerts anti-fibrinolytic and anti-inflammatory activity. TM also regulates blood coagulation in the anticoagulant protein C pathway. In this pathway, the procoagulant properties of thrombin (T) are lost when it binds TM. TM also plays a key role in tumor biology. It is expressed on endothelial cells and on several type of tumor cell including squamous cell carcinoma. Loss of TM expression correlates with advanced stage and poor prognosis. Loss of function of TM func

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.85  E-value=5.1e-21  Score=180.81  Aligned_cols=231  Identities=18%  Similarity=0.183  Sum_probs=148.0

Q ss_pred             CCceecccCceEEEEEEeCC-CCEEEEEEecccc---hhcHHHHHHHHHHHhhcCC----------CcEeeeeeEEee--
Q 010309          229 GNRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHH----------PNLVAVKGCCYD--  292 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h----------~nIv~l~~~~~~--  292 (513)
                      ...+||.|+++.||.+++.+ |+++|||++....   ....+++.+|.-....+.+          -.++..++...-  
T Consensus        16 ~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~   95 (288)
T PF14531_consen   16 RGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPG   95 (288)
T ss_dssp             EEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETT
T ss_pred             EccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcC
Confidence            35678999999999999864 8999999985432   2234666666655544322          122222222211  


Q ss_pred             -------C---C-----ceEEEEeeccCCCHHHHhcc---CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCC
Q 010309          293 -------H---G-----DRYIVYEFVVNGPLDRWLHH---IPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDI  354 (513)
Q Consensus       293 -------~---~-----~~~lv~e~~~~gsL~~~l~~---~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Di  354 (513)
                             .   +     ..+++|+-+ .+||.+++..   .......+....++.+..|+++.+++||+.   |++|+||
T Consensus        96 ~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgdi  171 (288)
T PF14531_consen   96 KPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGDI  171 (288)
T ss_dssp             S-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST-
T ss_pred             CCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEeccc
Confidence                   1   1     236788877 6688887542   222223344555677789999999999999   9999999


Q ss_pred             CCCceEecCCCCeEEecccccccCCccccccceeecCcccccccccccccC--------CCCchhhHHHHHHHHHHHHcC
Q 010309          355 RASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN--------ELTTKSDVYSFGVLLLEIVSG  426 (513)
Q Consensus       355 kp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~sDvwSlGvil~elltg  426 (513)
                      +|+|+|++.+|.+.|+||+...........     ...+..|.|||.....        .++.+.|.|+||+++|.|++|
T Consensus       172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~  246 (288)
T PF14531_consen  172 KPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG  246 (288)
T ss_dssp             SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred             ceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence            999999999999999999887765433221     1255779999977432        468899999999999999999


Q ss_pred             CCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCC
Q 010309          427 RRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMR  493 (513)
Q Consensus       427 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R  493 (513)
                      ..||...........                   ..    ... . +.++.+..||..+|+.||.+|
T Consensus       247 ~lPf~~~~~~~~~~~-------------------~f----~~C-~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  247 RLPFGLSSPEADPEW-------------------DF----SRC-R-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             S-STCCCGGGSTSGG-------------------GG----TTS-S----HHHHHHHHHHT-SSGGGS
T ss_pred             cCCCCCCCccccccc-------------------cc----hhc-C-CcCHHHHHHHHHHccCCcccC
Confidence            999986543211100                   11    111 2 677889999999999999988

>PHA02867 C-type lectin protein; Provisional

Probab=99.85  E-value=2.9e-21  Score=165.93  Aligned_cols=114  Identities=18%  Similarity=0.403  Sum_probs=91.9

Q ss_pred             CCcCCCCCCCcccCCCCeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCc
Q 010309            4 DWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLS   83 (513)
Q Consensus         4 ~~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~   83 (513)
                      ..+++||.||.  .|+++||+|+.+.++|.+|+..|..+||+||+|++++|++||.++..   ..|||||+  +..   .
T Consensus        44 ~~~~~CP~gWi--~~~~~CY~fs~~~~tW~~A~~~C~~~ga~La~I~s~eE~~Fl~~~~~---~~~WIGLs--~~~---~  113 (167)
T PHA02867         44 YFSKVCPDEWI--GYNSKCYYFTINETNWNDSKKLCDVMDSSLIRFDNIETLNFVSRYGK---GSYWIDIN--QNR---K  113 (167)
T ss_pred             CcCCCCCCCCE--EECCEEEEEeccccCHHHHHHHHhhCCCEECCcCCHHHHHHHHHcCC---CCEEEEEE--eCC---C
Confidence            45789999999  89999999999999999999999999999999999999999998754   47999999  432   3


Q ss_pred             eEEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCcccccccc
Q 010309           84 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEHE  149 (513)
Q Consensus        84 w~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~~~~  149 (513)
                      |.|.+++..     . +.              .+.++|+.+..+  ...+.+|.....+||+.+..
T Consensus       114 ~~~~~~s~~-----~-~~--------------~~~~~Ca~i~~~--~i~s~~C~~~~~wIC~K~~~  157 (167)
T PHA02867        114 IPGINFSLY-----Y-EQ--------------GVNDICLLFDTS--NIIEMSCIFHERTICVKEDR  157 (167)
T ss_pred             CCCccCcee-----e-ec--------------CCCCcEEEEeCC--eEEeecccCCcEEEEEccCc
Confidence            455554332     1 11              133467777554  79999999999999998754

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.84  E-value=7e-21  Score=191.04  Aligned_cols=217  Identities=23%  Similarity=0.382  Sum_probs=164.0

Q ss_pred             HhhcCCCcEeeeeeEEeeCCceEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCc-eEcC
Q 010309          275 FARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHV-VHRD  353 (513)
Q Consensus       275 l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i-vH~D  353 (513)
                      |+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+..   ....+++.....++++++.||+|||+.   +| .|+.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~   74 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGA   74 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcC---cceeeee
Confidence            4578999999999999999999999999999999999975   346689999999999999999999987   55 9999


Q ss_pred             CCCCceEecCCCCeEEecccccccCCccccccceeecCcccccccccccccC-------CCCchhhHHHHHHHHHHHHcC
Q 010309          354 IRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN-------ELTTKSDVYSFGVLLLEIVSG  426 (513)
Q Consensus       354 ikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~sDvwSlGvil~elltg  426 (513)
                      +++.|.++|....+||+|||+.................-..-|.|||.+...       ..+.+.||||||++++|+++.
T Consensus        75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r  154 (484)
T KOG1023|consen   75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR  154 (484)
T ss_pred             eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence            9999999999999999999999877531111111111134569999998763       146779999999999999999


Q ss_pred             CCCCCCCCcccc-chhHHhhhHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 010309          427 RRPAQAVDSVCW-QSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ  505 (513)
Q Consensus       427 ~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  505 (513)
                      ..||........ ..++....   .  .....+.|.+..      .....+++..++..||..+|.+||++++|-..++.
T Consensus       155 ~~~~~~~~~~~~~~eii~~~~---~--~~~~~~rP~i~~------~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~  223 (484)
T KOG1023|consen  155 SGPFDLRNLVEDPDEIILRVK---K--GGSNPFRPSIEL------LNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLT  223 (484)
T ss_pred             cCccccccccCChHHHHHHHH---h--cCCCCcCcchhh------hhhcchHHHHHHHHhcccChhhCccHHHHHhhhhh
Confidence            999976433211 11111111   1  111222222211      11344579999999999999999999999998876


Q ss_pred             CcC
Q 010309          506 LAQ  508 (513)
Q Consensus       506 ~~~  508 (513)
                      +..
T Consensus       224 ~~~  226 (484)
T KOG1023|consen  224 INK  226 (484)
T ss_pred             hcc
Confidence            654

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.84  E-value=2.6e-22  Score=201.08  Aligned_cols=230  Identities=26%  Similarity=0.278  Sum_probs=183.5

Q ss_pred             ecccCceEEEEEE----eCCCCEEEEEEecccchhc--HHHHHHHHHHHhhcC-CCcEeeeeeEEeeCCceEEEEeeccC
Q 010309          233 LGDSKTGGTYSGI----LPDGSRVAVKRLKRSSFQR--KKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVYEFVVN  305 (513)
Q Consensus       233 lg~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~~  305 (513)
                      +|+|+||.|++..    .+.|..+|+|++++.....  ......|-.++...+ ||.++++...+..+...++++++..+
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg   81 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG   81 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence            6999999999866    3357889999987653222  124456777888886 99999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccc
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  385 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  385 (513)
                      |.|...+.+    ...+.+.....+...++.+++++|..   +|+|||+|++||+++.+|++++.|||+++..-..... 
T Consensus        82 g~lft~l~~----~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~-  153 (612)
T KOG0603|consen   82 GDLFTRLSK----EVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA-  153 (612)
T ss_pred             chhhhcccc----CCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc-
Confidence            999887743    35577788888899999999999999   9999999999999999999999999999876443322 


Q ss_pred             ceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCC
Q 010309          386 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  465 (513)
Q Consensus       386 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  465 (513)
                           +||..|||||++.  .....+|-||||++++||+||..||....          ...         ++..     
T Consensus       154 -----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~~----------~~~---------Il~~-----  202 (612)
T KOG0603|consen  154 -----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGDT----------MKR---------ILKA-----  202 (612)
T ss_pred             -----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchHH----------HHH---------Hhhh-----
Confidence                 5899999999997  56788999999999999999999998610          000         0000     


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCCCH--HHHHHH
Q 010309          466 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRM--SHVVHQ  502 (513)
Q Consensus       466 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~--~evl~~  502 (513)
                       ....+...+..+.+++..++..+|..|.-.  ..+.+.
T Consensus       203 -~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~ei  240 (612)
T KOG0603|consen  203 -ELEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEI  240 (612)
T ss_pred             -ccCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHH
Confidence             122355677889999999999999999754  344443

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.84  E-value=3.8e-20  Score=166.13  Aligned_cols=186  Identities=12%  Similarity=0.005  Sum_probs=139.1

Q ss_pred             CceecccCceEEEEEEeCCCCEEEEEEecccchhc----HHHHHHHHHHHhhcC-CCcEeeeeeEEeeCCceEEEEeecc
Q 010309          230 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQR----KKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVYEFVV  304 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~  304 (513)
                      ...|++|+||+||.+.. .+.+++.+.+.....-.    ...+.+|+++|++|. |++|++++++    +..+++|||+.
T Consensus         7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~   81 (218)
T PRK12274          7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA   81 (218)
T ss_pred             ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence            34689999999997776 78889988887653311    235789999999995 5889999886    45699999999


Q ss_pred             CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCC-CCCceEecCCCCeEEecccccccCCcccc
Q 010309          305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDI-RASNVLLDEEFGAHLMGVGLSKFVPWEVM  383 (513)
Q Consensus       305 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Di-kp~NIll~~~~~~kl~Dfg~~~~~~~~~~  383 (513)
                      |.+|...+..           ....++.|++.+|.++|+.   ||+|||| ||+|||++.++.++|+|||++........
T Consensus        82 G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~  147 (218)
T PRK12274         82 GAAMYQRPPR-----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR  147 (218)
T ss_pred             CccHHhhhhh-----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence            9998654311           1135788999999999999   9999999 79999999999999999999986543321


Q ss_pred             c----c-------ceeecCcccccccccccccC-CCC-chhhHHHHHHHHHHHHcCCCCCCCCC
Q 010309          384 Q----E-------RTVMAGGTYGYLAPEFVYRN-ELT-TKSDVYSFGVLLLEIVSGRRPAQAVD  434 (513)
Q Consensus       384 ~----~-------~~~~~~gt~~y~aPE~~~~~-~~~-~~sDvwSlGvil~elltg~~p~~~~~  434 (513)
                      .    .       .......++.|++|+...-. ..+ ...+-++.|.-+|.++|+..+.....
T Consensus       148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence            0    0       00011156677777744322 233 56789999999999999998875543

>PRK10345 hypothetical protein; Provisional

Probab=99.83  E-value=5.5e-20  Score=168.37  Aligned_cols=134  Identities=17%  Similarity=0.240  Sum_probs=106.0

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhc-----CCCcEeeeeeEEeeCC---ceE-EE
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-----HHPNLVAVKGCCYDHG---DRY-IV  299 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~nIv~l~~~~~~~~---~~~-lv  299 (513)
                      .++||+|++|.||.  ++ ++.. +||++........+.+.+|+.+++.+     .||||++++|+++++.   ..+ +|
T Consensus         7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I   83 (210)
T PRK10345          7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI   83 (210)
T ss_pred             cceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence            45789999999996  43 4444 79998765445567899999999999     5799999999998874   323 78


Q ss_pred             Eee--ccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHH-HHHhcCCCCCceEcCCCCCceEecC----CCCeEEecc
Q 010309          300 YEF--VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGI-AFLHDKVKPHVVHRDIRASNVLLDE----EFGAHLMGV  372 (513)
Q Consensus       300 ~e~--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L-~~LH~~~~~~ivH~Dikp~NIll~~----~~~~kl~Df  372 (513)
                      +||  +.+++|.+++.+     ..+++.  ..++.|++.++ +|||++   +|+||||||+|||++.    +..++|+||
T Consensus        84 ~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg  153 (210)
T PRK10345         84 ADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDN  153 (210)
T ss_pred             ecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence            999  557999999964     235555  35678888787 999999   9999999999999974    347999995


Q ss_pred             cccc
Q 010309          373 GLSK  376 (513)
Q Consensus       373 g~~~  376 (513)
                      +.+.
T Consensus       154 ~G~~  157 (210)
T PRK10345        154 IGES  157 (210)
T ss_pred             CCCc
Confidence            5443

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.81  E-value=1.1e-19  Score=172.13  Aligned_cols=197  Identities=23%  Similarity=0.328  Sum_probs=141.0

Q ss_pred             CCCcEeeeeeEEeeC---------------------------CceEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHH
Q 010309          279 HHPNLVAVKGCCYDH---------------------------GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVA  331 (513)
Q Consensus       279 ~h~nIv~l~~~~~~~---------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~  331 (513)
                      +|||||++.+.|.+.                           ...|+||..++ .+|.+++-.     ...+.....-++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~-----~~~s~r~~~~~l  347 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT-----RHRSYRTGRVIL  347 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc-----CCCchHHHHHHH
Confidence            599999999887642                           23489999884 589999964     446677788899


Q ss_pred             HHHHHHHHHHhcCCCCCceEcCCCCCceEe--cCCC--CeEEecccccccCCcc----ccccceeecCcccccccccccc
Q 010309          332 TTLAQGIAFLHDKVKPHVVHRDIRASNVLL--DEEF--GAHLMGVGLSKFVPWE----VMQERTVMAGGTYGYLAPEFVY  403 (513)
Q Consensus       332 ~qi~~~L~~LH~~~~~~ivH~Dikp~NIll--~~~~--~~kl~Dfg~~~~~~~~----~~~~~~~~~~gt~~y~aPE~~~  403 (513)
                      .|+++|+.|||.+   ||.|||+|++|||+  |+|.  .+.|+|||++-.-+..    ..........|...-||||+..
T Consensus       348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t  424 (598)
T KOG4158|consen  348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT  424 (598)
T ss_pred             HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence            9999999999999   99999999999999  3443  3689999987543321    1112222344788899999986


Q ss_pred             cCC--C----CchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCCCCCcHHHHHH
Q 010309          404 RNE--L----TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQK  477 (513)
Q Consensus       404 ~~~--~----~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  477 (513)
                      ..+  .    -.|+|.|+.|.+.||+++...||...-+..           .+...+.+   ..+..+     +..+++.
T Consensus       425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~-----------L~~r~Yqe---~qLPal-----p~~vpp~  485 (598)
T KOG4158|consen  425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML-----------LDTRTYQE---SQLPAL-----PSRVPPV  485 (598)
T ss_pred             cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe-----------echhhhhh---hhCCCC-----cccCChH
Confidence            532  1    248999999999999999999997632211           00011111   111111     2234566


Q ss_pred             HHHHHHHhcCCCCCCCCCHHHHHHHH
Q 010309          478 VVDLVYACTQHVPSMRPRMSHVVHQL  503 (513)
Q Consensus       478 l~~li~~cl~~dP~~RPs~~evl~~L  503 (513)
                      +.+++...|+.||++|++..-....|
T Consensus       486 ~rqlV~~lL~r~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  486 ARQLVFDLLKRDPSKRVSPNIAANVL  511 (598)
T ss_pred             HHHHHHHHhcCCccccCCccHHHhHH
Confidence            99999999999999999977665554

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.81  E-value=1.9e-19  Score=192.90  Aligned_cols=192  Identities=19%  Similarity=0.210  Sum_probs=151.7

Q ss_pred             cCCceecccCceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhcC---CCcEeeeeeEEeeCCceEEEEeecc
Q 010309          228 EGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH---HPNLVAVKGCCYDHGDRYIVYEFVV  304 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~lv~e~~~  304 (513)
                      ...+.||+|+||.||+|...+|+.||+|+=+....-+   |.--.+++.+|+   -+.|..+...+.-.+.-+||+||.+
T Consensus       701 ~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~  777 (974)
T KOG1166|consen  701 CISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSP  777 (974)
T ss_pred             EEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeeccc
Confidence            3356789999999999998889999999887653221   111222333333   2445556666666778899999999


Q ss_pred             CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecC-------CCCeEEeccccccc
Q 010309          305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE-------EFGAHLMGVGLSKF  377 (513)
Q Consensus       305 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~-------~~~~kl~Dfg~~~~  377 (513)
                      .|+|.+++.    ..+.+++...+.++.|++..+++||..   +|||+||||+|.||..       ...++|+|||.+-.
T Consensus       778 ~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siD  850 (974)
T KOG1166|consen  778 YGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSID  850 (974)
T ss_pred             cccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEeccccee
Confidence            999999996    457799999999999999999999999   9999999999999932       34589999999976


Q ss_pred             CCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCC
Q 010309          378 VPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP  429 (513)
Q Consensus       378 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p  429 (513)
                      +..-.....-....+|-.+--+|+..+.+++.+.|.|.|+.+++-||.|+.-
T Consensus       851 m~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  851 MKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             eeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence            6433333222333478889999999999999999999999999999999754

>smart00090 RIO RIO-like kinase

Probab=99.78  E-value=2e-18  Score=162.05  Aligned_cols=141  Identities=16%  Similarity=0.150  Sum_probs=109.8

Q ss_pred             cccCCceecccCceEEEEEE--eCCCCEEEEEEecccchh------------------------cHHHHHHHHHHHhhcC
Q 010309          226 FSEGNRLLGDSKTGGTYSGI--LPDGSRVAVKRLKRSSFQ------------------------RKKEFYSEIGRFARLH  279 (513)
Q Consensus       226 ~~~~~~~lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~  279 (513)
                      .+...+.||+|++|.||+|.  ..+|+.||||+++.....                        ....+..|+.++.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            35556788999999999998  568999999998754210                        0123568999999997


Q ss_pred             CC--cEeeeeeEEeeCCceEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-ceEcCCCC
Q 010309          280 HP--NLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH-VVHRDIRA  356 (513)
Q Consensus       280 h~--nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~-ivH~Dikp  356 (513)
                      +.  .++++++.    ...++||||+++.+|...+..    ...+.......++.|++.+|.+||+.   + ++||||||
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp  177 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSE  177 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCCh
Confidence            53  34444442    235899999999888665422    23456667789999999999999999   9 99999999


Q ss_pred             CceEecCCCCeEEecccccccC
Q 010309          357 SNVLLDEEFGAHLMGVGLSKFV  378 (513)
Q Consensus       357 ~NIll~~~~~~kl~Dfg~~~~~  378 (513)
                      +||+++ ++.++|+|||.+...
T Consensus       178 ~NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      178 YNILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             hhEEEE-CCCEEEEEChhhhcc
Confidence            999999 788999999998754

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.78  E-value=2.3e-18  Score=158.38  Aligned_cols=131  Identities=20%  Similarity=0.299  Sum_probs=107.6

Q ss_pred             eecccCceEEEEEEeCCCCEEEEEEecccch--------hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeec
Q 010309          232 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSF--------QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  303 (513)
Q Consensus       232 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  303 (513)
                      +||+|++|.||+|.. +|..|++|+......        .....+.+|++++..+.|+++.....+....+..++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            379999999999996 678999998654321        11256778999999999887665555556677789999999


Q ss_pred             cCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccC
Q 010309          304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV  378 (513)
Q Consensus       304 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~  378 (513)
                      +|++|.+++...    . .      .++.+++.+|.+||+.   +++|+|++|+||+++ ++.++++|||++...
T Consensus        80 ~g~~l~~~~~~~----~-~------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        80 EGKPLKDVIEEG----N-D------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             CCccHHHHHhhc----H-H------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            999999887531    1 0      7899999999999999   999999999999999 789999999998764

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.77  E-value=3e-18  Score=159.12  Aligned_cols=133  Identities=19%  Similarity=0.309  Sum_probs=113.3

Q ss_pred             eecccCceEEEEEEeCCCCEEEEEEecccchh--------cHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeec
Q 010309          232 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQ--------RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  303 (513)
Q Consensus       232 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  303 (513)
                      .||+|++|.||+|.. +|..|+||+.......        ....+.+|+.++..+.|++|.....++...+..++||||+
T Consensus         3 ~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   81 (211)
T PRK14879          3 LIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI   81 (211)
T ss_pred             ccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence            579999999999988 7888999987643211        1245788999999999999887777777778889999999


Q ss_pred             cCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEeccccccc
Q 010309          304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF  377 (513)
Q Consensus       304 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~  377 (513)
                      +|++|.+++...       .. .+..++.+++.+|.+||+.   +++|+|++|+|||++ ++.++|+|||.+..
T Consensus        82 ~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         82 EGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             CCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            999999988531       12 7889999999999999999   999999999999999 77899999999875

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.75  E-value=1.6e-17  Score=152.54  Aligned_cols=137  Identities=16%  Similarity=0.149  Sum_probs=107.8

Q ss_pred             ccCCceecccCceEEEEEEeCCCCEEEEEEecccchh----------------------cHHHHHHHHHHHhhcCCCc--
Q 010309          227 SEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQ----------------------RKKEFYSEIGRFARLHHPN--  282 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~~l~h~n--  282 (513)
                      +...+.||+|+||.||++..++|+.||||++......                      ....+..|+.++..+.|++  
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   96 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP   96 (198)
T ss_pred             hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence            4445678999999999999888999999987643210                      1123677889999998774  


Q ss_pred             EeeeeeEEeeCCceEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEec
Q 010309          283 LVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD  362 (513)
Q Consensus       283 Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~  362 (513)
                      +++.++    ....++||||+++++|......          .....++.+++.++.++|+.   +++|+||||+||+++
T Consensus        97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill~  159 (198)
T cd05144          97 VPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILVD  159 (198)
T ss_pred             CCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEEc
Confidence            444443    3456899999999998765420          23567889999999999999   999999999999999


Q ss_pred             CCCCeEEecccccccCCc
Q 010309          363 EEFGAHLMGVGLSKFVPW  380 (513)
Q Consensus       363 ~~~~~kl~Dfg~~~~~~~  380 (513)
                      .++.++|+|||.+.....
T Consensus       160 ~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         160 DDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             CCCcEEEEECCccccCCC
Confidence            999999999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.73  E-value=1.3e-18  Score=171.42  Aligned_cols=174  Identities=18%  Similarity=0.322  Sum_probs=127.6

Q ss_pred             ceEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccc
Q 010309          295 DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGL  374 (513)
Q Consensus       295 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~  374 (513)
                      ..||.|++|...+|.++|.... .....++...+.++.|++.|+.|   +   +.+|+|+||.||++..+..+||.|||+
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~-~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl  402 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRR-TGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL  402 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCC-cccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence            4689999999999999997533 34557788899999999999999   6   999999999999999999999999999


Q ss_pred             cccCCccc----cccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHh
Q 010309          375 SKFVPWEV----MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLV  449 (513)
Q Consensus       375 ~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  449 (513)
                      ........    .........||..||+||.+.+..|+.++||||||+||+||++ -..++...                
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~----------------  466 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI----------------  466 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH----------------
Confidence            98765544    1111222239999999999999999999999999999999998 22222110                


Q ss_pred             hcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHH
Q 010309          450 QSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSH  498 (513)
Q Consensus       450 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  498 (513)
                        ....++-+..+..    .. ..-.+.-..|+.+++...|.+||++.+
T Consensus       467 --~t~~d~r~g~ip~----~~-~~d~p~e~~ll~~lls~~p~~RP~~~~  508 (516)
T KOG1033|consen  467 --ATLTDIRDGIIPP----EF-LQDYPEEYTLLQQLLSPSPEERPSAIE  508 (516)
T ss_pred             --HhhhhhhcCCCCh----HH-hhcCcHHHHHHHHhcCCCcccCchHHH
Confidence              0011111111110    00 011123468999999999999994443

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.73  E-value=3.2e-17  Score=173.02  Aligned_cols=133  Identities=18%  Similarity=0.246  Sum_probs=108.7

Q ss_pred             CCceecccCceEEEEEEeCCCCEEEEEEe-ccc-ch------hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEE
Q 010309          229 GNRLLGDSKTGGTYSGILPDGSRVAVKRL-KRS-SF------QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY  300 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~-~~~-~~------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  300 (513)
                      ..++||+|+||.||+|.+... .+++|+. .+. ..      ...+.+.+|++++..++|++|+....+.......++||
T Consensus       337 ~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~  415 (535)
T PRK09605        337 PDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVM  415 (535)
T ss_pred             ccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEE
Confidence            356789999999999987544 4444433 221 11      12356889999999999999988887777777889999


Q ss_pred             eeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccC
Q 010309          301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV  378 (513)
Q Consensus       301 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~  378 (513)
                      ||+++++|.+++.            ....++.+++.+|.+||+.   +++||||||+|||+ .++.++|+|||+++..
T Consensus       416 E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        416 EYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             EecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            9999999998874            3467899999999999999   99999999999999 5678999999999753

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.72  E-value=3.4e-18  Score=179.91  Aligned_cols=204  Identities=21%  Similarity=0.299  Sum_probs=140.7

Q ss_pred             CCceecccCceEEEEEEeCC-CCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCC
Q 010309          229 GNRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  307 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs  307 (513)
                      ..+++..|++|.||..+++. .+++|+| +.+...     +.+-  ++.....|.+|                     |+
T Consensus        87 ~IklisngAygavylvrh~~trqrfa~k-iNkq~l-----ilRn--ilt~a~npfvv---------------------gD  137 (1205)
T KOG0606|consen   87 TIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL-----ILRN--ILTFAGNPFVV---------------------GD  137 (1205)
T ss_pred             eeEeeccCCCCceeeeeccccccchhhc-ccccch-----hhhc--cccccCCccee---------------------ch
Confidence            35688999999999998754 6788884 332211     1111  22333344433                     45


Q ss_pred             HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcc------
Q 010309          308 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE------  381 (513)
Q Consensus       308 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~------  381 (513)
                      -...++.    -+.++..        ++.+++|||+.   +|+|||+||+|.+|+.-|++|+.|||+++..-..      
T Consensus       138 c~tllk~----~g~lPvd--------mvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~  202 (1205)
T KOG0606|consen  138 CATLLKN----IGPLPVD--------MVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLK  202 (1205)
T ss_pred             hhhhccc----CCCCcch--------hhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccchhh
Confidence            5554532    2334432        27899999999   9999999999999999999999999999753211      


Q ss_pred             ------cccc-ceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccc
Q 010309          382 ------VMQE-RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRY  454 (513)
Q Consensus       382 ------~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  454 (513)
                            ..++ .....+||+.|+|||++....|...+|-|++|+|+||.+.|..||.+..+++....+   ..  ....+
T Consensus       203 eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~v---is--d~i~w  277 (1205)
T KOG0606|consen  203 EGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV---IS--DDIEW  277 (1205)
T ss_pred             hcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhh---hh--hhccc
Confidence                  1111 112335999999999999999999999999999999999999999988765321111   00  00000


Q ss_pred             cccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCC
Q 010309          455 LELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP  494 (513)
Q Consensus       455 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP  494 (513)
                                  .+. ....++++.+++.++|+.+|..|-
T Consensus       278 ------------pE~-dea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  278 ------------PEE-DEALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             ------------ccc-CcCCCHHHHHHHHHHHHhChHhhc
Confidence                        000 123456799999999999999995

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.68  E-value=3.6e-16  Score=147.14  Aligned_cols=137  Identities=21%  Similarity=0.217  Sum_probs=107.2

Q ss_pred             CCceec-ccCceEEEEEEeCCCCEEEEEEecccc-------------hhcHHHHHHHHHHHhhcCCCcE--eeeeeEEee
Q 010309          229 GNRLLG-DSKTGGTYSGILPDGSRVAVKRLKRSS-------------FQRKKEFYSEIGRFARLHHPNL--VAVKGCCYD  292 (513)
Q Consensus       229 ~~~~lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~nI--v~l~~~~~~  292 (513)
                      ...+|| .|+.|+||.+.. ++..+|||.+....             ......+.+|+.++..|.|++|  +..+++...
T Consensus        35 ~~~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~  113 (239)
T PRK01723         35 QARVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV  113 (239)
T ss_pred             cCceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence            345778 899999999988 57889999885421             1223567889999999988775  667766443


Q ss_pred             CCc----eEEEEeeccC-CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCe
Q 010309          293 HGD----RYIVYEFVVN-GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA  367 (513)
Q Consensus       293 ~~~----~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~  367 (513)
                      ...    .++|||++++ .+|.+++..     ..++..    .+.+++.+|.+||+.   ||+|+||||+|||++.++.+
T Consensus       114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v  181 (239)
T PRK01723        114 RHGLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKF  181 (239)
T ss_pred             ecCcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCE
Confidence            322    2599999997 699988853     234543    357899999999999   99999999999999998899


Q ss_pred             EEecccccccC
Q 010309          368 HLMGVGLSKFV  378 (513)
Q Consensus       368 kl~Dfg~~~~~  378 (513)
                      +|+|||.+...
T Consensus       182 ~LIDfg~~~~~  192 (239)
T PRK01723        182 WLIDFDRGELR  192 (239)
T ss_pred             EEEECCCcccC
Confidence            99999998753

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.68  E-value=2.8e-16  Score=142.90  Aligned_cols=135  Identities=19%  Similarity=0.213  Sum_probs=97.9

Q ss_pred             ceecccCceEEEEEEeCCCCEEEEEEecccchh--cHHH----------------------HHHHHHHHhhcCCC--cEe
Q 010309          231 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQ--RKKE----------------------FYSEIGRFARLHHP--NLV  284 (513)
Q Consensus       231 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~h~--nIv  284 (513)
                      +.||+|+||.||+|...+|+.||||++......  ....                      ...|...+..+.+.  .+.
T Consensus         3 ~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~   82 (187)
T cd05119           3 GPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVP   82 (187)
T ss_pred             cccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCC
Confidence            467999999999999888999999998754211  1111                      13566666666433  244


Q ss_pred             eeeeEEeeCCceEEEEeeccCCCHHH-HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCceEcCCCCCceEec
Q 010309          285 AVKGCCYDHGDRYIVYEFVVNGPLDR-WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD-KVKPHVVHRDIRASNVLLD  362 (513)
Q Consensus       285 ~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dikp~NIll~  362 (513)
                      +.++.    ...++||||++++++.. .+..     .... ..+..++.+++.++.++|. .   +|+|+||||+||+++
T Consensus        83 ~~~~~----~~~~lv~e~~~g~~~~~~~l~~-----~~~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~  149 (187)
T cd05119          83 KPIDL----NRHVLVMEFIGGDGIPAPRLKD-----VRLL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD  149 (187)
T ss_pred             ceEec----CCCEEEEEEeCCCCccChhhhh-----hhhc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE
Confidence            44443    34689999999854421 1111     0011 5678899999999999999 7   999999999999999


Q ss_pred             CCCCeEEecccccccCC
Q 010309          363 EEFGAHLMGVGLSKFVP  379 (513)
Q Consensus       363 ~~~~~kl~Dfg~~~~~~  379 (513)
                       ++.++|+|||.+....
T Consensus       150 -~~~~~liDfg~a~~~~  165 (187)
T cd05119         150 -DGKVYIIDVPQAVEID  165 (187)
T ss_pred             -CCcEEEEECccccccc
Confidence             8899999999997554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.65  E-value=1.1e-15  Score=133.36  Aligned_cols=134  Identities=18%  Similarity=0.152  Sum_probs=113.2

Q ss_pred             ceecccCceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhcCC--CcEeeeeeEEeeCCceEEEEeeccCCCH
Q 010309          231 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHH--PNLVAVKGCCYDHGDRYIVYEFVVNGPL  308 (513)
Q Consensus       231 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~~~~lv~e~~~~gsL  308 (513)
                      +.||+|.++.||++... +..+++|.......  ...+.+|+.++..++|  .++++++++....+..+++|||++++.+
T Consensus         4 ~~i~~g~~~~v~~~~~~-~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~   80 (155)
T cd05120           4 KLLKGGLTNRVYLLGTK-DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL   80 (155)
T ss_pred             eecccccccceEEEEec-CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence            45799999999999984 48899999876533  5678899999999976  5899999988888889999999988776


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccC
Q 010309          309 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV  378 (513)
Q Consensus       309 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~  378 (513)
                      ..+           +......++.+++.+|++||.....+++|+|++|+||+++..+.+++.|||.+...
T Consensus        81 ~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~  139 (155)
T cd05120          81 DEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG  139 (155)
T ss_pred             ccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence            432           55667788999999999999864447999999999999999889999999998753

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.64  E-value=2.1e-17  Score=173.88  Aligned_cols=249  Identities=20%  Similarity=0.233  Sum_probs=186.8

Q ss_pred             ceecccCceEEEEEEeCC--CCEEEEEEecccc--hhcHHHHHHHHHHHhhcC-CCcEeeeeeEEeeCCceEEEEeeccC
Q 010309          231 RLLGDSKTGGTYSGILPD--GSRVAVKRLKRSS--FQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVYEFVVN  305 (513)
Q Consensus       231 ~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~~  305 (513)
                      +-||+|+++.|-......  ...+|+|.+....  .........|..+-..+. |+|++.+++...+.+..+++++|..+
T Consensus        26 ~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g  105 (601)
T KOG0590|consen   26 RSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDG  105 (601)
T ss_pred             ccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCcccc
Confidence            347999999998877533  4567777665442  222344555777777776 99999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHh-cCCCCCceEcCCCCCceEecCCC-CeEEecccccccCCc-cc
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLH-DKVKPHVVHRDIRASNVLLDEEF-GAHLMGVGLSKFVPW-EV  382 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH-~~~~~~ivH~Dikp~NIll~~~~-~~kl~Dfg~~~~~~~-~~  382 (513)
                      +++.+.+..  ......+...+-.++.|+..++.|+| ..   ++.|+||||+|.+++..+ ..+++|||+|..+.. ..
T Consensus       106 ~~~f~~i~~--~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g  180 (601)
T KOG0590|consen  106 GSLFSKISH--PDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNG  180 (601)
T ss_pred             ccccccccc--CCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhccccccCC
Confidence            999887731  12224666677789999999999999 77   999999999999999999 999999999998776 44


Q ss_pred             cccceeecCc-ccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccc
Q 010309          383 MQERTVMAGG-TYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP  460 (513)
Q Consensus       383 ~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  460 (513)
                      ........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+.......              ..+......
T Consensus       181 ~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~--------------~~~~~~~~~  246 (601)
T KOG0590|consen  181 AERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD--------------GRYSSWKSN  246 (601)
T ss_pred             cceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc--------------ccceeeccc
Confidence            4444444557 9999999999874 45678999999999999999999987654432              011111111


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 010309          461 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVV  500 (513)
Q Consensus       461 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  500 (513)
                      .  ......+.........+++.+++..+|..|.+.+++.
T Consensus       247 ~--~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~  284 (601)
T KOG0590|consen  247 K--GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK  284 (601)
T ss_pred             c--cccccCccccCChhhhhcccccccCCchhcccccccc
Confidence            0  0001222334556688999999999999999988875

>cd00037 CLECT C-type lectin (CTL)/C-type lectin-like (CTLD) domain

Probab=99.64  E-value=1.5e-15  Score=125.96  Aligned_cols=113  Identities=26%  Similarity=0.550  Sum_probs=93.2

Q ss_pred             eeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCC-CCCCeEEeeeecCCCCCCceEEcCCCC-CccCCcc
Q 010309           21 KCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGK-NVNGCWVGGRSINTTVGLSWKWSDNMS-KWNESIH   98 (513)
Q Consensus        21 ~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~-~~~~~WiGl~~~~~~~~~~w~W~dg~~-~~~~~~~   98 (513)
                      .||+++....+|.+|+..|+.+||+|++|++.+|++||.+++.. ....+|||+++  ....+.|.|+||++ ..+.+|.
T Consensus         1 ~Cy~~~~~~~~~~~A~~~C~~~~~~L~~~~~~~e~~~i~~~~~~~~~~~~wvg~~~--~~~~~~~~~~~~~~~~~~~~w~   78 (116)
T cd00037           1 SCYKFSTEKLTWEEAQEYCRSLGGHLASIHSEEENDFLASLLKKSSSSDVWIGLND--LSSEGTWKWSDGSPLVDYTNWA   78 (116)
T ss_pred             CCEEEcCCccCHHHHHHHHHHcCCEEcccCCHHHHHHHHHHHhCCCCCCEEEcccc--cCcCCCeEecCCCccccccCCC
Confidence            49999999999999999999999999999999999999999852 25579999994  33468999999988 6778888


Q ss_pred             cCCCCCCCCCCCCCCCCcCCCceeEeecC-CCcccccccCCCCCccccc
Q 010309           99 AVGSFNSSCTSLPCHVHATVDLCTLVSNG-SRSLVTERCNTSHPFICMV  146 (513)
Q Consensus        99 ~~~~~~~~~~~~~c~~~~~~~~C~~~~~~-~~~w~d~~C~~~~~~iC~~  146 (513)
                      +++|.           ....++|+.+... ...|.+.+|....+++|+.
T Consensus        79 ~~~~~-----------~~~~~~C~~~~~~~~~~~~~~~C~~~~~~iC~~  116 (116)
T cd00037          79 PGEPN-----------PGGSEDCVVLSSSSDGKWNDVSCSSKLPFICEK  116 (116)
T ss_pred             CCCcC-----------CCCCCCeeEEccCCCCCccCCCCCCCceeeecC
Confidence            87761           2233467777554 3579999999999999974

CLECT: C-type lectin (CTL)/C-type lectin-like (CTLD) domain; protein domains homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. This group is chiefly comprised of eukaryotic CTLDs, but contains some, as yet functionally uncharacterized, bacterial CTLDs. Many CTLDs are calcium-dependent carbohydrate binding modules; other CTLDs bind protein ligands, lipids, and inorganic surfaces, including CaCO3 and ice. Animal C-type lectins are involved in such functions as extracellular matrix organization, endocytosis, complement activation, pathogen recognition, and cell-cell interactions. For example: mannose-binding lectin and lung surfactant proteins A and D bind carbohydrates on surfaces (e.g. pathogens, allergens, necrotic, and apoptotic cells) and mediate functions associated with killing and phagocytosis; P (platlet)-, E (endothelial)-, and L (leukocyte)- selectins (sels) mediate the initia

>PHA02911 C-type lectin-like protein; Provisional

Probab=99.60  E-value=3.3e-15  Score=128.32  Aligned_cols=107  Identities=22%  Similarity=0.563  Sum_probs=79.3

Q ss_pred             CcCCCCCCCcccCCCCeeEEEECCCCCh--HHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCC
Q 010309            5 WKAPCPPDWIINEEKSKCFGYIGNFRSW--DESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGL   82 (513)
Q Consensus         5 ~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w--~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~   82 (513)
                      .-.+||.+|.  .|+++||+|+...++|  ..|+++|..+||+|+. ++.+|++||++        +|.|+.       +
T Consensus        99 ~~~pC~~nW~--~H~nkCYlFS~~s~sWsW~~Srr~C~~kGATLLk-~sdEELeFIqn--------~wkGks-------~  160 (213)
T PHA02911         99 SEPICSRDWI--NHMGICLLSLGEEVGFRMEIAKRFCEKKDADLIG-KIDEEKKALEN--------IWTGND-------H  160 (213)
T ss_pred             CCCCCchhhH--hhCCEEEEEeccccccchhHHHHHHHhcCCEecc-CcHHHHHHHHH--------HHhccc-------c
Confidence            3468999999  8999999999995555  8899999999999999 88899999985        466663       5


Q ss_pred             ceEEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecC----CCcccccccCCCCCccccccc
Q 010309           83 SWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG----SRSLVTERCNTSHPFICMVEH  148 (513)
Q Consensus        83 ~w~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~----~~~w~d~~C~~~~~~iC~~~~  148 (513)
                      .|.|+||.. .      +-..+.            .-+|+.+...    .+...+.+|.....|||+...
T Consensus       161 ~~fWID~r~-n------gSt~n~------------s~sCA~Is~~~~~~~~~V~sesCs~~~~wICqK~~  211 (213)
T PHA02911        161 SRFWIDNRA-A------ASTFDP------------VNECAIGTQNHIPEVPEVLKSPCDERHSFICIKKD  211 (213)
T ss_pred             ceEEecCcc-c------cceecC------------CCCeEEEEcccccCCCceEccccCCCceEEEEecc
Confidence            677777621 0      000000            1136666542    246888999999999999864

>PF00059 Lectin_C: Lectin C-type domain; InterPro: IPR001304 Lectins occur in plants, animals, bacteria and viruses

Probab=99.57  E-value=2.3e-15  Score=122.83  Aligned_cols=100  Identities=25%  Similarity=0.528  Sum_probs=79.0

Q ss_pred             CCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEcCCCCCcc----CCcccCCCC
Q 010309           28 NFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWN----ESIHAVGSF  103 (513)
Q Consensus        28 ~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~dg~~~~~----~~~~~~~~~  103 (513)
                      ++++|.+|+..|+.+||+||+|++.+|++||.+++. ....+|||+.   ....+.|.|+||++..+    .+|   .  
T Consensus         1 e~~~~~~A~~~C~~~~~~L~~i~~~~e~~~i~~~~~-~~~~~Wig~~---~~~~~~~~w~~~~~~~~~~~~~~w---~--   71 (105)
T PF00059_consen    1 EPMTWEEAQQYCQSMGAHLASINSEEENDFIQSQLK-SNESYWIGLD---SDNNGTWKWIDGSPNSPENFYTNW---N--   71 (105)
T ss_dssp             EEEEHHHHHHHHHHTTSEEB-GSSHHHHHHHHHHHH-SSSEEEEEEE---SSSTSEEEETTSSBSSSTTBSGCB---S--
T ss_pred             CCCCHHHHHHHHhcCCCEEeEeCCHHHhhhhhhccc-ccceeeeeee---ccccceeccccCCCcccccccccc---c--
Confidence            367999999999999999999999999999999985 3568999992   22458999999987653    344   1  


Q ss_pred             CCCCCCCCCCCCcCCCceeEe-ecCCCcccccccCCCCCccccc
Q 010309          104 NSSCTSLPCHVHATVDLCTLV-SNGSRSLVTERCNTSHPFICMV  146 (513)
Q Consensus       104 ~~~~~~~~c~~~~~~~~C~~~-~~~~~~w~d~~C~~~~~~iC~~  146 (513)
                                .....++|+.+ ....+.|.+.+|....+|||+.
T Consensus        72 ----------~~~~~~~C~~~~~~~~~~w~~~~C~~~~~fiCek  105 (105)
T PF00059_consen   72 ----------PPNDSENCAYIYYSSSGKWNDVPCSEKYPFICEK  105 (105)
T ss_dssp             ----------SGGSSEEEEEEGCSTTTEEEEEETTSEEEEEEEE
T ss_pred             ----------cCCCCCCeEEEEEcCCCeEEeeCCCCCeeEEeeC
Confidence                      12344578888 4455679999999999999974

Initially described for their carbohydrate-binding activity [], they are now recognised as a more diverse group of proteins, some of which are involved in protein-protein, protein-lipid or protein-nucleic acid interactions []. There are at least twelve structural families of lectins: C-type lectins, which are Ca+-dependent. S-type (galectins), a widespread family of glycan-binding proteins []. I-type, which have an immunoglobulin-like fold and can recognise sialic acids, other sugars and glycosaminoglycans []. P-type, which bind phosphomannosyl receptors []. Pentraxins []. (Trout) egg lectins. Calreticulin and calnexin, which act as molecular chaperones of the endoplasmic reticulum []. ERGIC-53 and VIP-36 []. Discoidins []. Eel aggutinins (fucolectins) []. Annexin lectins []. Fibrinogen-type lectins, which includes ficolins, tachylectins 5A and 5B, and Limax flavus (Spotted garden slug) agglutinin (these proteins have clear distinctions from one another, but they share a homologous fibrinogen-like domain used for carbohydrate binding). Also unclassified orphan lectins, including amphoterin, Cel-II, complement factor H, thrombospondin, sailic acid-binding lectins, adherence lectin, and cytokins (such as tumour necrosis factor and several interleukins). C-type lectins can be further divided into seven subgroups based on additional non-lectin domains and gene structure: (I) hyalectans, (II) asialoglycoprotein receptors, (III) collectins, (IV) selectins, (V) NK group transmembrane receptors, (VI) macrophage mannose receptors, and (VII) simple (single domain) lectins []. Therefore, lectins are a diverse group of proteins, both in terms of structure and activity. Carbohydrate binding ability may have evolved independently and sporadically in numerous unrelated families, where each evolved a structure that was conserved to fulfil some other activity and function. In general, animal lectins act as recognition molecules within the immune system, their functions involving defence against pathogens, cell trafficking, immune regulation and the prevention of autoimmunity [].; GO: 0005488 binding; PDB: 1T8D_A 2H2T_B 1T8C_A 2H2R_A 1TN3_A 1RJH_A 1HTN_A 3G8K_B 2E3X_B 1UMR_D ....

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.56  E-value=4e-15  Score=138.20  Aligned_cols=206  Identities=19%  Similarity=0.286  Sum_probs=145.4

Q ss_pred             HHHHhhcCCCcEeeeeeEEeeC-----CceEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 010309          272 IGRFARLHHPNLVAVKGCCYDH-----GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVK  346 (513)
Q Consensus       272 ~~~l~~l~h~nIv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~  346 (513)
                      +.-|-++.|.|||++..++.+.     ....++.|||..|+|..+|++..+....+......+++.||++||.|||+. .
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~  196 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-D  196 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-C
Confidence            4456667899999999887654     345889999999999999998877788899999999999999999999995 7


Q ss_pred             CCceEcCCCCCceEecCCCCeEEecccccccCCcc--ccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHH
Q 010309          347 PHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE--VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIV  424 (513)
Q Consensus       347 ~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ell  424 (513)
                      |.|+|+++..+-|++..++-+|+.--.-......-  ..........+-++|.|||.-.....+.++|||+||+..+||.
T Consensus       197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema  276 (458)
T KOG1266|consen  197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA  276 (458)
T ss_pred             CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence            88999999999999998887877432211111100  0011111222678899999877777888999999999999999


Q ss_pred             cCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          425 SGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       425 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      .+..--......           ...+    +.+...+.++...        .-+.++.+|++..|+.||+|.+++-
T Consensus       277 ilEiq~tnseS~-----------~~~e----e~ia~~i~~len~--------lqr~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  277 ILEIQSTNSESK-----------VEVE----ENIANVIIGLENG--------LQRGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             HheeccCCCcce-----------eehh----hhhhhheeeccCc--------cccCcCcccccCCCCCCcchhhhhc
Confidence            876542221110           0000    0011111111111        1246788999999999999998864

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.53  E-value=6.2e-14  Score=143.28  Aligned_cols=140  Identities=19%  Similarity=0.200  Sum_probs=100.3

Q ss_pred             ceecccCceEEEEEEeCCCCEEEEEEecccchhc----------------------------------------HHHHHH
Q 010309          231 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQR----------------------------------------KKEFYS  270 (513)
Q Consensus       231 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~~~  270 (513)
                      +.||.|++|.||+|++++|+.||||+.+......                                        +-++.+
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            4689999999999999999999999986542110                                        012455


Q ss_pred             HHHHHhhcC-----CCcEeeeeeEE-eeCCceEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHH-HHHHHhc
Q 010309          271 EIGRFARLH-----HPNLVAVKGCC-YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ-GIAFLHD  343 (513)
Q Consensus       271 E~~~l~~l~-----h~nIv~l~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~-~L~~LH~  343 (513)
                      |+..+.++.     +++| .+-.++ ...+..+|||||++|++|.++.....   ...   ....++.+++. .+..+|.
T Consensus       203 Ea~n~~~~~~~~~~~~~v-~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~---~~~---~~~~ia~~~~~~~l~ql~~  275 (437)
T TIGR01982       203 EAANASELGENFKNDPGV-YVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE---AGL---DRKALAENLARSFLNQVLR  275 (437)
T ss_pred             HHHHHHHHHHhcCCCCCE-EeCCEehhhcCCceEEEEeECCcccccHHHHHh---cCC---CHHHHHHHHHHHHHHHHHh
Confidence            666665552     3433 322232 22455799999999999988764311   112   23456666665 4788898


Q ss_pred             CCCCCceEcCCCCCceEecCCCCeEEecccccccCCc
Q 010309          344 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW  380 (513)
Q Consensus       344 ~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~  380 (513)
                      .   |++|+|++|.||+++.++.++++|||++..++.
T Consensus       276 ~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       276 D---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             C---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            8   999999999999999999999999999987754

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.48  E-value=3.4e-14  Score=143.17  Aligned_cols=242  Identities=18%  Similarity=0.213  Sum_probs=178.2

Q ss_pred             eecc--cCceEEEEEEe---CCCCEEEEEEecc--cchhcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCCceEEEEeec
Q 010309          232 LLGD--SKTGGTYSGIL---PDGSRVAVKRLKR--SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFV  303 (513)
Q Consensus       232 ~lg~--G~~g~Vy~~~~---~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~  303 (513)
                      -+|.  |.+|.||.+..   .++..+|+|.-+.  ........=.+|+....++ .|+|.++.+..+...+..++-+|++
T Consensus       121 ~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~  200 (524)
T KOG0601|consen  121 RTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQTELC  200 (524)
T ss_pred             ccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcceeeeccc
Confidence            4688  99999999986   3588899998433  2223334445677766777 5999999999999999999999999


Q ss_pred             cCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHH----HHHHHhcCCCCCceEcCCCCCceEecCC-CCeEEecccccccC
Q 010309          304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ----GIAFLHDKVKPHVVHRDIRASNVLLDEE-FGAHLMGVGLSKFV  378 (513)
Q Consensus       304 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~----~L~~LH~~~~~~ivH~Dikp~NIll~~~-~~~kl~Dfg~~~~~  378 (513)
                       +.+|..+.+.   ....++...++.++.+...    ||.++|+.   +++|-|+||.||++..+ ...+++|||+...+
T Consensus       201 -~~sl~~~~~~---~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i  273 (524)
T KOG0601|consen  201 -GESLQSYCHT---PCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDFGLVSKI  273 (524)
T ss_pred             -cchhHHhhhc---ccccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCcceeEEc
Confidence             5788887764   2344778888888888888    99999999   99999999999999999 88999999999887


Q ss_pred             Cccccccce---eecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccc
Q 010309          379 PWEVMQERT---VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL  455 (513)
Q Consensus       379 ~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  455 (513)
                      .........   ....|...|++||+. .+-++..+|||++|.++.+..++..+....-...|.++..+.          
T Consensus       274 ~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~----------  342 (524)
T KOG0601|consen  274 SDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY----------  342 (524)
T ss_pred             cCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc----------
Confidence            655422211   111367789999977 456788999999999999999988776543222122111100          


Q ss_pred             ccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          456 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       456 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                            +    ........+.++...+..|++.+|-.|++.+.+..
T Consensus       343 ------i----p~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  343 ------I----PLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             ------C----chhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence                  0    11111122344666899999999999999877653

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.45  E-value=1.5e-12  Score=132.61  Aligned_cols=167  Identities=23%  Similarity=0.264  Sum_probs=128.9

Q ss_pred             eCCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCCHHHHhccCCCCCCCCCHH
Q 010309          246 LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWA  325 (513)
Q Consensus       246 ~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~  325 (513)
                      ..++.+|.|...+...........+.++.|+.++||||+++++.++..+..|||+|.+.  .|..++..       +...
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-------l~~~  104 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-------LGKE  104 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-------hHHH
Confidence            34688999998877655344567788999999999999999999999999999999984  46777754       4466


Q ss_pred             HHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccceeecCcccccccccccccC
Q 010309          326 MRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN  405 (513)
Q Consensus       326 ~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  405 (513)
                      .....+.||+.||.|||+.+  +++|++|.-+.|+++..|..||++|.++.........  ......-..|..|+.+...
T Consensus       105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~--~~~~~~~~s~~~P~~~~~s  180 (690)
T KOG1243|consen  105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAP--AKSLYLIESFDDPEEIDPS  180 (690)
T ss_pred             HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcc--cccchhhhcccChhhcCcc
Confidence            67778999999999999765  9999999999999999999999999988654322210  0000022346666654322


Q ss_pred             CCCchhhHHHHHHHHHHHHcCC
Q 010309          406 ELTTKSDVYSFGVLLLEIVSGR  427 (513)
Q Consensus       406 ~~~~~sDvwSlGvil~elltg~  427 (513)
                      .  ...|.|-||++++|++.|.
T Consensus       181 ~--~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  181 E--WSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             c--cchhhhhHHHHHHHHhCcc
Confidence            2  4569999999999999993

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.42  E-value=2.3e-13  Score=140.63  Aligned_cols=148  Identities=16%  Similarity=0.164  Sum_probs=96.9

Q ss_pred             HhhCcccCCceecccCceEEEEEEeCC-CCEEEEEEecccchhc----------------------------------H-
Q 010309          222 ITKNFSEGNRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQR----------------------------------K-  265 (513)
Q Consensus       222 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~----------------------------------~-  265 (513)
                      +...|..  +-||+|++|.||+|++++ |+.||||++++.-...                                  . 
T Consensus       118 ~F~~fd~--~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~  195 (537)
T PRK04750        118 WFDDFDI--KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEK  195 (537)
T ss_pred             HHHhcCh--hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHH
Confidence            3344554  467999999999999987 9999999997541100                                  0 


Q ss_pred             -----HHHHHHHHHHhhcC----CCcEeeeeeEEee-CCceEEEEeeccCCCHHHHh--ccCCCCCCCCCHHHHHHHHHH
Q 010309          266 -----KEFYSEIGRFARLH----HPNLVAVKGCCYD-HGDRYIVYEFVVNGPLDRWL--HHIPRGGRSLDWAMRMKVATT  333 (513)
Q Consensus       266 -----~~~~~E~~~l~~l~----h~nIv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l--~~~~~~~~~l~~~~~~~i~~q  333 (513)
                           -++.+|+..+.+++    +.+.+.+-.++.+ ....+|||||++|+.+.++-  .........+....+..++.|
T Consensus       196 ~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q  275 (537)
T PRK04750        196 TLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ  275 (537)
T ss_pred             HHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence                 12344555555442    3333333333332 45678999999999998743  211000112333334444444


Q ss_pred             HHHHHHHHhcCCCCCceEcCCCCCceEecCCC----CeEEecccccccCCcc
Q 010309          334 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF----GAHLMGVGLSKFVPWE  381 (513)
Q Consensus       334 i~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~----~~kl~Dfg~~~~~~~~  381 (513)
                      +.       ..   |++|+|+||.||+++.++    .+++.|||+...++..
T Consensus       276 if-------~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~  317 (537)
T PRK04750        276 VF-------RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE  317 (537)
T ss_pred             HH-------hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence            43       45   999999999999999888    8999999999877543

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.38  E-value=1.7e-12  Score=115.94  Aligned_cols=129  Identities=14%  Similarity=0.043  Sum_probs=95.2

Q ss_pred             eecccCceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcE-eeeeeEEeeCCceEEEEeeccCCCHHH
Q 010309          232 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNL-VAVKGCCYDHGDRYIVYEFVVNGPLDR  310 (513)
Q Consensus       232 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lv~e~~~~gsL~~  310 (513)
                      .|+.|.++.||++.. .+..|++|+...... ....+.+|+.++..+.+.++ .+++...  ....++|||+++|.++..
T Consensus         5 ~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~~   80 (170)
T cd05151           5 PLKGGMTNKNYRVEV-ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELLT   80 (170)
T ss_pred             ecCCcccCceEEEEE-CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcccc
Confidence            468999999999987 478899999865432 23356789999998865444 3455443  334589999999988753


Q ss_pred             HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCceEcCCCCCceEecCCCCeEEeccccccc
Q 010309          311 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV--KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF  377 (513)
Q Consensus       311 ~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~  377 (513)
                      ..         .   ....++.+++.+|+.||+..  ...++|+|++|.||+++ ++.++++||+.+..
T Consensus        81 ~~---------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          81 ED---------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cc---------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            20         1   11345678999999999982  11259999999999999 56899999998764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.36  E-value=9.6e-12  Score=111.94  Aligned_cols=135  Identities=15%  Similarity=0.121  Sum_probs=99.0

Q ss_pred             eecccCceEEEEEEeCC-------CCEEEEEEecccc----------------------hhcHHHH----HHHHHHHhhc
Q 010309          232 LLGDSKTGGTYSGILPD-------GSRVAVKRLKRSS----------------------FQRKKEF----YSEIGRFARL  278 (513)
Q Consensus       232 ~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~----------------------~~~~~~~----~~E~~~l~~l  278 (513)
                      .||.|--+.||.|...+       +..+|||+.+...                      ....+.+    .+|++.|+++
T Consensus         4 ~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~rl   83 (197)
T cd05146           4 CISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKRM   83 (197)
T ss_pred             ccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHHH
Confidence            57999999999998653       4799999875210                      0012233    3799999998


Q ss_pred             CC--CcEeeeeeEEeeCCceEEEEeeccCCCHHH-HhccCCCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCceEcCC
Q 010309          279 HH--PNLVAVKGCCYDHGDRYIVYEFVVNGPLDR-WLHHIPRGGRSLDWAMRMKVATTLAQGIAFL-HDKVKPHVVHRDI  354 (513)
Q Consensus       279 ~h--~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~L-H~~~~~~ivH~Di  354 (513)
                      ..  -++++++++    ...+|||||+.+..+.. .+.+     ..++......+..+++.+|..| |..   +++|+||
T Consensus        84 ~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDL  151 (197)
T cd05146          84 QKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADL  151 (197)
T ss_pred             HHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence            43  466666654    46789999997654321 2221     2355566778889999999999 788   9999999


Q ss_pred             CCCceEecCCCCeEEecccccccCC
Q 010309          355 RASNVLLDEEFGAHLMGVGLSKFVP  379 (513)
Q Consensus       355 kp~NIll~~~~~~kl~Dfg~~~~~~  379 (513)
                      ++.|||++. +.+.|+|||.+....
T Consensus       152 s~~NIL~~~-~~v~iIDF~qav~~~  175 (197)
T cd05146         152 SEYNMLWHD-GKVWFIDVSQSVEPT  175 (197)
T ss_pred             CHHHEEEEC-CcEEEEECCCceeCC
Confidence            999999974 579999999887553

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.24  E-value=6.6e-12  Score=126.78  Aligned_cols=248  Identities=17%  Similarity=0.182  Sum_probs=174.7

Q ss_pred             HHhhCcccCCceecccCceEEEEEEeC--CCCEEEEEEecccchhcHHH--HHHHHHHHhhc-CCCcEeeeeeEEeeCCc
Q 010309          221 SITKNFSEGNRLLGDSKTGGTYSGILP--DGSRVAVKRLKRSSFQRKKE--FYSEIGRFARL-HHPNLVAVKGCCYDHGD  295 (513)
Q Consensus       221 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~h~nIv~l~~~~~~~~~  295 (513)
                      ..+.+|.+.. .||.|.|+.|+.....  ++..|++|.+.+.......+  -..|+.+...+ .|.+++..+..+.....
T Consensus       262 ~~~~df~~v~-~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~  340 (524)
T KOG0601|consen  262 CKLTDFGLVS-KISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ  340 (524)
T ss_pred             eecCCcceeE-EccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence            3445566554 4599999999987743  58899999887653333222  24566666666 68899998888888888


Q ss_pred             eEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCC-CCeEEecccc
Q 010309          296 RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE-FGAHLMGVGL  374 (513)
Q Consensus       296 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~-~~~kl~Dfg~  374 (513)
                      .|+-.||++++++...+.    ....+++...+.+..|++.++.++|+.   .++|+|+||+||++..+ +..++.|||.
T Consensus       341 ~~ip~e~~~~~s~~l~~~----~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~  413 (524)
T KOG0601|consen  341 GYIPLEFCEGGSSSLRSV----TSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGC  413 (524)
T ss_pred             ccCchhhhcCcchhhhhH----HHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccccc
Confidence            889999999998876552    234577788899999999999999999   99999999999999886 7789999999


Q ss_pred             cccCCccccccceeecCccccc-ccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccc
Q 010309          375 SKFVPWEVMQERTVMAGGTYGY-LAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHR  453 (513)
Q Consensus       375 ~~~~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  453 (513)
                      ...+.......    ...+..| .+|+......+-.+.|++|||..+.+.+++...-......                 
T Consensus       414 ~t~~~~~~~~~----~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~-----------------  472 (524)
T KOG0601|consen  414 WTRLAFSSGVF----HHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS-----------------  472 (524)
T ss_pred             ccccceecccc----cccccccccchhhccccccccccccccccccccccccCcccCcccccc-----------------
Confidence            87533222111    1123334 3555555667888999999999999999987543221110                 


Q ss_pred             ccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 010309          454 YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ  504 (513)
Q Consensus       454 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  504 (513)
                       ..+....+    ...+  +....+..+.+.+...++..||.+.++....+
T Consensus       473 -~~i~~~~~----p~~~--~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~  516 (524)
T KOG0601|consen  473 -LTIRSGDT----PNLP--GLKLQLQVLLKVMINPDRKRRPSAVELSLHSE  516 (524)
T ss_pred             -eeeecccc----cCCC--chHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence             01111111    1111  12256778888999999999999988765443

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.23  E-value=7.9e-11  Score=109.95  Aligned_cols=142  Identities=25%  Similarity=0.278  Sum_probs=109.7

Q ss_pred             ceecccCceEEEEEEeCCCCEEEEEEecccch-hcHHHHHHHHHHHhhcCC--CcEeeeeeEEeeC---CceEEEEeecc
Q 010309          231 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHH--PNLVAVKGCCYDH---GDRYIVYEFVV  304 (513)
Q Consensus       231 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~---~~~~lv~e~~~  304 (513)
                      +.|+.|..+.||++...+|+.+++|....... .....+.+|+++++.+.+  .++.+++.+....   +..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            35799999999999987778999999865432 234578899999999965  3456677776553   25689999999


Q ss_pred             CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC---------------------------------------
Q 010309          305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV---------------------------------------  345 (513)
Q Consensus       305 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---------------------------------------  345 (513)
                      |.++.+.+..     ..++......++.+++.+|..||+..                                       
T Consensus        84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (223)
T cd05154          84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME  158 (223)
T ss_pred             CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence            9888765421     34677778888888888888888531                                       


Q ss_pred             --------------CCCceEcCCCCCceEecC--CCCeEEeccccccc
Q 010309          346 --------------KPHVVHRDIRASNVLLDE--EFGAHLMGVGLSKF  377 (513)
Q Consensus       346 --------------~~~ivH~Dikp~NIll~~--~~~~kl~Dfg~~~~  377 (513)
                                    ...++|+|+.|.||+++.  ++.+.|+||+.+..
T Consensus       159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                          235799999999999998  56689999998864

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.23  E-value=1.2e-10  Score=101.13  Aligned_cols=130  Identities=20%  Similarity=0.250  Sum_probs=100.2

Q ss_pred             eecccCceEEEEEEeCCCCEEEEEEecccch--------hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeec
Q 010309          232 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSF--------QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  303 (513)
Q Consensus       232 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  303 (513)
                      ++++|+-+.+|.+.+ -|.++++|.-.+...        -....-.+|+.++.++.--.|...+=+..+.+...|+|||+
T Consensus         3 ~i~~GAEa~i~~~~~-~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I   81 (204)
T COG3642           3 LIKQGAEAIIYLTDF-LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI   81 (204)
T ss_pred             hhhCCcceeEEeeec-cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence            568999999999976 455677775432211        11245678999999986555555555556778888999999


Q ss_pred             cCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEeccccccc
Q 010309          304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF  377 (513)
Q Consensus       304 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~  377 (513)
                      +|..|.+++...           ...++..+-.-+.-||..   +|+|+||.++||++..+. +.++|||++..
T Consensus        82 ~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          82 EGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             CChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            999999888641           245677777788889999   999999999999998874 99999999974

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.21  E-value=1.6e-10  Score=99.82  Aligned_cols=142  Identities=19%  Similarity=0.221  Sum_probs=105.4

Q ss_pred             CceecccCceEEEEEEeCCCCEEEEEEec-cc-------chhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEe
Q 010309          230 NRLLGDSKTGGTYSGILPDGSRVAVKRLK-RS-------SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE  301 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~-~~-------~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  301 (513)
                      -.++-+|+-+.|+++.+ .|+...||.-. +.       ..-..+...+|+++|.++.--.|.-..-++.+...-.|+||
T Consensus        12 l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME   90 (229)
T KOG3087|consen   12 LELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME   90 (229)
T ss_pred             ceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence            34789999999999998 78887787532 21       11123567889999999865555544455667777789999


Q ss_pred             eccC-CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCC---eEEeccccccc
Q 010309          302 FVVN-GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG---AHLMGVGLSKF  377 (513)
Q Consensus       302 ~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~---~kl~Dfg~~~~  377 (513)
                      |++| .++.+++...-.  ..........++.+|-..+.-||..   +|+|+||..+||++.+++.   +.++|||++..
T Consensus        91 ~~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   91 FIDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             eccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence            9976 478888865322  2223333367889999999999999   9999999999999966543   58999999864

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.13  E-value=1.5e-09  Score=107.56  Aligned_cols=218  Identities=16%  Similarity=0.196  Sum_probs=153.4

Q ss_pred             CceEEEEEEe-CCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEee----CCceEEEEeeccC-CCHHH
Q 010309          237 KTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD----HGDRYIVYEFVVN-GPLDR  310 (513)
Q Consensus       237 ~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~~lv~e~~~~-gsL~~  310 (513)
                      .-.+.|++.. .||..|++|+++............-+++++++.|+|||++.+++..    +..+++|++|+++ ++|.+
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            4467899885 4799999999954433333333455788999999999999999873    4567999999986 46766


Q ss_pred             HhccCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCC
Q 010309          311 WLHHIP-----------RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP  379 (513)
Q Consensus       311 ~l~~~~-----------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~  379 (513)
                      +-....           ..+...++..++.++.|+..||.++|+.   |+.-+-|.|.+||++.+.+++|+..|+...+.
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeec
Confidence            543221           2234578899999999999999999999   99999999999999999999999888877654


Q ss_pred             ccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccccccc
Q 010309          380 WEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD  459 (513)
Q Consensus       380 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  459 (513)
                      .+..                |-+.+   -.+-|.=.||.+++.|.||..--...+..  ++.           .      
T Consensus       445 ~d~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~--~~s-----------~------  486 (655)
T KOG3741|consen  445 EDPT----------------EPLES---QQQNDLRDLGLLLLALATGTENSNRTDST--QSS-----------H------  486 (655)
T ss_pred             CCCC----------------cchhH---HhhhhHHHHHHHHHHHhhcccccccccch--HHH-----------H------
Confidence            3320                11111   23579999999999999996442111110  000           0      


Q ss_pred             ccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 010309          460 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQL  503 (513)
Q Consensus       460 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  503 (513)
                             ........+.++++++.-....++++ -++.+++..+
T Consensus       487 -------~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~  522 (655)
T KOG3741|consen  487 -------LTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI  522 (655)
T ss_pred             -------HHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence                   00012245566778888888888876 5677776543

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.11  E-value=2.4e-11  Score=129.01  Aligned_cols=242  Identities=19%  Similarity=0.176  Sum_probs=163.3

Q ss_pred             ceecccCceEEEEEEeC-CCCEEEEEEecccch---hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          231 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       231 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      +-+.+|.++.++.+.-. .|...++|+......   .+.+....+-.++-..+||-++...-.+......+||++|+.++
T Consensus       810 ~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~  889 (1205)
T KOG0606|consen  810 KPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGG  889 (1205)
T ss_pred             ccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccC
Confidence            35678889988877632 243344444432211   11122233333333345677776555555677889999999999


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcc-----
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE-----  381 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~-----  381 (513)
                      +|...|+..    ...+..-.+..+..+..++++||..   .+.|+|++|.|+++..++..+++|||.......-     
T Consensus       890 ~~~Skl~~~----~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~  962 (1205)
T KOG0606|consen  890 DLPSKLHNS----GCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTD  962 (1205)
T ss_pred             CchhhhhcC----CCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccccccCcCC
Confidence            999988752    2455556667777889999999998   8999999999999999999999999843221100     


Q ss_pred             ----------------c----cc----cceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccc
Q 010309          382 ----------------V----MQ----ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVC  437 (513)
Q Consensus       382 ----------------~----~~----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~  437 (513)
                                      .    ..    .......+|+.|.+||.+.+......+|.|++|++++|.++|.+||...... 
T Consensus       963 ~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq- 1041 (1205)
T KOG0606|consen  963 LSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQ- 1041 (1205)
T ss_pred             cccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchh-
Confidence                            0    00    0011223899999999999999999999999999999999999999876542 


Q ss_pred             cchhHHhhhHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 010309          438 WQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMS  497 (513)
Q Consensus       438 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  497 (513)
                        +.+            ..++.....   -..-+...+.+..+++...+..+|.+|..+.
T Consensus      1042 --~~f------------~ni~~~~~~---~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1042 --QIF------------ENILNRDIP---WPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             --hhh------------hccccCCCC---CCCCccccChhhhhhhhhhhccCchhccCcc
Confidence              111            111111110   0111234556788999999999999997765

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.07  E-value=8.5e-10  Score=99.01  Aligned_cols=125  Identities=24%  Similarity=0.302  Sum_probs=83.3

Q ss_pred             EEEEEEeCCCCEEEEEEecccc--h------------------------hcHHHHHHHHHHHhhcCCC--cEeeeeeEEe
Q 010309          240 GTYSGILPDGSRVAVKRLKRSS--F------------------------QRKKEFYSEIGRFARLHHP--NLVAVKGCCY  291 (513)
Q Consensus       240 ~Vy~~~~~~~~~vavK~~~~~~--~------------------------~~~~~~~~E~~~l~~l~h~--nIv~l~~~~~  291 (513)
                      .||.|...+|..+|||+.+...  .                        .......+|++.|.++..-  ++++++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            4899999899999999875320  0                        0013467899999999765  566666542 


Q ss_pred             eCCceEEEEeecc--CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHH-HhcCCCCCceEcCCCCCceEecCCCCeE
Q 010309          292 DHGDRYIVYEFVV--NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAF-LHDKVKPHVVHRDIRASNVLLDEEFGAH  368 (513)
Q Consensus       292 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~-LH~~~~~~ivH~Dikp~NIll~~~~~~k  368 (513)
                         ..+|||||++  |..+..+...      .++......++.+++..+.. +|..   ||+|+||.+.|||++++ .+.
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~------~~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~  146 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDV------DLSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY  146 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHC------GGGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred             ---CCEEEEEecCCCccchhhHHhc------cccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence               4579999998  6555443321      11234456677888885555 5687   99999999999999988 899


Q ss_pred             EecccccccC
Q 010309          369 LMGVGLSKFV  378 (513)
Q Consensus       369 l~Dfg~~~~~  378 (513)
                      |+|||.+...
T Consensus       147 iIDf~qav~~  156 (188)
T PF01163_consen  147 IIDFGQAVDS  156 (188)
T ss_dssp             E--GTTEEET
T ss_pred             EEecCcceec
Confidence            9999988654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.06  E-value=3.6e-09  Score=100.72  Aligned_cols=141  Identities=13%  Similarity=0.128  Sum_probs=102.0

Q ss_pred             ceecccCceEEEEEEeCCCCEEEEEEecccchh-----------cHHHHHHHHHHHhhcCCCc--EeeeeeEEee-----
Q 010309          231 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQ-----------RKKEFYSEIGRFARLHHPN--LVAVKGCCYD-----  292 (513)
Q Consensus       231 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~n--Iv~l~~~~~~-----  292 (513)
                      +++-......|++... +|+.|.||+.......           ....+.+|...+.+|...+  .++++++...     
T Consensus        28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            4455555566777766 7889999977543311           1124778998888884333  3334444433     


Q ss_pred             CCceEEEEeeccCC-CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecC-------C
Q 010309          293 HGDRYIVYEFVVNG-PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE-------E  364 (513)
Q Consensus       293 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~-------~  364 (513)
                      ....+||+|++++. +|.+++....  ....+......++.+++..+.-||..   ||+|+|+++.|||++.       +
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~  181 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREED  181 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCC
Confidence            23468999999876 8999885321  23456677889999999999999999   9999999999999975       4


Q ss_pred             CCeEEeccccccc
Q 010309          365 FGAHLMGVGLSKF  377 (513)
Q Consensus       365 ~~~kl~Dfg~~~~  377 (513)
                      ..+.|+||+.+..
T Consensus       182 ~~~~LIDl~r~~~  194 (268)
T PRK15123        182 LKLSVIDLHRAQI  194 (268)
T ss_pred             ceEEEEECCcccc
Confidence            6789999998864

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.98  E-value=5.2e-09  Score=101.34  Aligned_cols=267  Identities=17%  Similarity=0.160  Sum_probs=161.9

Q ss_pred             CCceecccCceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhc-CCCcEeeeeeE----Ee--e-CCceEEEE
Q 010309          229 GNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGC----CY--D-HGDRYIVY  300 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~----~~--~-~~~~~lv~  300 (513)
                      ..+-||+|+-+.+|..-  +-...+.|+..........+...   .|... .||-+..-+.+    ..  + ....-++|
T Consensus        15 ~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aqk~a---~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm   89 (637)
T COG4248          15 PGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQKVA---ELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM   89 (637)
T ss_pred             CCccccCCccceeeecc--hhhchhheeecCCCchHHHHHHH---HhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence            34567999999999643  22234567776553332222222   22333 45543321111    11  1 12256777


Q ss_pred             eeccCCC-HHHHhcc--CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEeccccccc
Q 010309          301 EFVVNGP-LDRWLHH--IPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF  377 (513)
Q Consensus       301 e~~~~gs-L~~~l~~--~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~  377 (513)
                      ..+.+.- ...++.-  .++.-....|...+..++.++.+.+-||..   |.+-+|+.++|+|+++++.+.|.|-..-..
T Consensus        90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi  166 (637)
T COG4248          90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQI  166 (637)
T ss_pred             ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccceee
Confidence            7776542 2222221  112224578899999999999999999999   999999999999999999999988654333


Q ss_pred             CCccccccceeecCcccccccccccc-----cCCCCchhhHHHHHHHHHHHHcC-CCCCCCCCcccc-chhHHhhhHHhh
Q 010309          378 VPWEVMQERTVMAGGTYGYLAPEFVY-----RNELTTKSDVYSFGVLLLEIVSG-RRPAQAVDSVCW-QSIFEWATPLVQ  450 (513)
Q Consensus       378 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~elltg-~~p~~~~~~~~~-~~~~~~~~~~~~  450 (513)
                      ...   ........|...|.+||.-.     +-..+...|.|.||+++++++.| ++||++...... ..-.+   ..+.
T Consensus       167 ~~n---g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E---~~Ia  240 (637)
T COG4248         167 NAN---GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE---TDIA  240 (637)
T ss_pred             ccC---CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch---hhhh
Confidence            221   11222334889999999764     23456789999999999999986 999987532100 00000   0011


Q ss_pred             ccccccccc--ccccCCCCCCCcHHHHHHHHHHHHHhcCCC--CCCCCCHHHHHHHHhcCcCC
Q 010309          451 SHRYLELLD--PLISSLSSDIPEAGVVQKVVDLVYACTQHV--PSMRPRMSHVVHQLQQLAQP  509 (513)
Q Consensus       451 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~li~~cl~~d--P~~RPs~~evl~~L~~~~~~  509 (513)
                      .+.+...-+  .-+...+...+-.-.++.+..|..+|+...  +.-|||++..+..|..+...
T Consensus       241 ~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~  303 (637)
T COG4248         241 HGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ  303 (637)
T ss_pred             cceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence            111111111  111122233444556678888999998753  56899999998888766543

>PF05473 Herpes_UL45: UL45 protein; InterPro: IPR008646 This family consists several UL45 proteins and homologues found in the herpes simplex virus family

Probab=98.92  E-value=3.3e-09  Score=95.48  Aligned_cols=58  Identities=19%  Similarity=0.507  Sum_probs=51.1

Q ss_pred             CCcCCCCCCCcccCCCCeeEEEECCCC-ChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhC
Q 010309            4 DWKAPCPPDWIINEEKSKCFGYIGNFR-SWDESETYCKEIGGHLAALTSYEEEHSAQKLCG   63 (513)
Q Consensus         4 ~~~~~Cp~~w~~~~~~~~Cy~~~~~~~-~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~   63 (513)
                      +.+++||+||.  .|+++||+|+...+ +|.+|+..|++++++|+.+++.+....+.....
T Consensus        80 ~~~~~CP~~Wi--~~~~~Cy~~~~~~~~t~~eA~~~C~~~~s~L~~~~~~~~L~~ll~~~~  138 (200)
T PF05473_consen   80 LGCGPCPKGWI--GYNNSCYRFSNSPKKTWEEARNICAAYNSTLANVNNAKSLLELLDVLN  138 (200)
T ss_pred             ccCCCCCccce--eeCCEEEEEeCCCCcCHHHHHHHHHhcCCcCCCchhHHHHHHHHHHhc
Confidence            35789999999  89999999999998 999999999999999999988887766666543

The herpes simplex virus UL45 gene encodes an 18 kDa virion envelope protein whose function remains unknown. It has been suggested that the 18 kDa UL45 gene product is required for efficient growth in the central nervous system at low doses and may play an important role under the conditions of a naturally acquired infection []. The Equine herpesvirus 1 UL45 protein represents a type II membrane glycoprotein which has found to be non-essential for EHV-1 growth in vitro but deletion reduces the viruses' replication efficiency [].

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.83  E-value=8.1e-10  Score=113.37  Aligned_cols=152  Identities=21%  Similarity=0.283  Sum_probs=104.2

Q ss_pred             HHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccc-------eeecCcccccccccccc
Q 010309          331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER-------TVMAGGTYGYLAPEFVY  403 (513)
Q Consensus       331 ~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~  403 (513)
                      +.+++.||.|+|...  ++||++|.|++|.++.++..||+.|+.+...........       .........|.|||++.
T Consensus       105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            345569999999875  999999999999999999999999998865543111000       00111356799999999


Q ss_pred             cCCCCchhhHHHHHHHHHHHH-cCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCCCCCcHHHHHHHHHHH
Q 010309          404 RNELTTKSDVYSFGVLLLEIV-SGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLV  482 (513)
Q Consensus       404 ~~~~~~~sDvwSlGvil~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  482 (513)
                      +...+.++|+||+|+++|.+. .|+.-+............            ....+..     ........+.++.+=+
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~------------~~~~~~~-----~~~~s~~~p~el~~~l  245 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFS------------RNLLNAG-----AFGYSNNLPSELRESL  245 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhh------------hcccccc-----cccccccCcHHHHHHH
Confidence            888889999999999999999 455554433211100000            0001111     1111234567899999


Q ss_pred             HHhcCCCCCCCCCHHHHHH
Q 010309          483 YACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       483 ~~cl~~dP~~RPs~~evl~  501 (513)
                      .+++..++.-||++.++..
T Consensus       246 ~k~l~~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  246 KKLLNGDSAVRPTLDLLLS  264 (700)
T ss_pred             HHHhcCCcccCcchhhhhc
Confidence            9999999999998777654

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.81  E-value=3.6e-08  Score=91.02  Aligned_cols=132  Identities=19%  Similarity=0.219  Sum_probs=96.0

Q ss_pred             CceecccCceEEEEEEeCCCCEEEEEEecccc----------------------hhcHHHHHHHHHHHhhcCCC--cEee
Q 010309          230 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSS----------------------FQRKKEFYSEIGRFARLHHP--NLVA  285 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------------~~~~~~~~~E~~~l~~l~h~--nIv~  285 (513)
                      ...||-|--+.||.|..++|.++|||.-+...                      .......++|.++|.+|...  .+++
T Consensus        96 G~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP~  175 (304)
T COG0478          96 GTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVPK  175 (304)
T ss_pred             ccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCCC
Confidence            45679999999999999999999999754211                      01123467899999999654  6666


Q ss_pred             eeeEEeeCCceEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCC
Q 010309          286 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF  365 (513)
Q Consensus       286 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~  365 (513)
                      .+++    +...+|||+++|-.|...         +++....-.++..|+.-+.-+-..   |+||+|+.+=||+++++|
T Consensus       176 P~~~----nRHaVvMe~ieG~eL~~~---------r~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~dg  239 (304)
T COG0478         176 PIAW----NRHAVVMEYIEGVELYRL---------RLDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTEDG  239 (304)
T ss_pred             cccc----ccceeeeehcccceeecc---------cCcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEecCC
Confidence            6553    566799999988655432         122334444555555555555566   999999999999999999


Q ss_pred             CeEEeccccccc
Q 010309          366 GAHLMGVGLSKF  377 (513)
Q Consensus       366 ~~kl~Dfg~~~~  377 (513)
                      .+.++||--+..
T Consensus       240 ~~~vIDwPQ~v~  251 (304)
T COG0478         240 DIVVIDWPQAVP  251 (304)
T ss_pred             CEEEEeCccccc
Confidence            999999976653

>PRK09902 hypothetical protein; Provisional

Probab=98.77  E-value=2e-07  Score=84.27  Aligned_cols=138  Identities=13%  Similarity=0.087  Sum_probs=103.4

Q ss_pred             cccCceEEEEEEeCCCCEEEEEEeccc---c---hhcHHHHHHHHHHHhhcCC--CcEeeeeeEEeeC----CceEEEEe
Q 010309          234 GDSKTGGTYSGILPDGSRVAVKRLKRS---S---FQRKKEFYSEIGRFARLHH--PNLVAVKGCCYDH----GDRYIVYE  301 (513)
Q Consensus       234 g~G~~g~Vy~~~~~~~~~vavK~~~~~---~---~~~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~----~~~~lv~e  301 (513)
                      |.||.+.|++... +|..+-+|+-...   +   ......|.+|+..|.+|..  -.+.++...-...    -..+||+|
T Consensus        27 ~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe  105 (216)
T PRK09902         27 RRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTE  105 (216)
T ss_pred             CCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEE
Confidence            7899999999887 5557889976421   1   2356789999999999953  2244444221111    12489999


Q ss_pred             eccC-CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCC--eEEeccccccc
Q 010309          302 FVVN-GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG--AHLMGVGLSKF  377 (513)
Q Consensus       302 ~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~--~kl~Dfg~~~~  377 (513)
                      -+++ -+|.+++.+.  ...+.+......++.+++..+.-||+.   |+.|+|+.+.|||++.++.  ++++||.-++.
T Consensus       106 ~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        106 DMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             eCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            7753 5898888542  223567778889999999999999999   9999999999999986667  99999987764

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.76  E-value=7.4e-08  Score=88.72  Aligned_cols=124  Identities=25%  Similarity=0.251  Sum_probs=91.1

Q ss_pred             CCCEEEEEEecccch-------hcHHHHHHHHHHHhhcCC--CcEeeeeeEEeeCC----ceEEEEeeccCC-CHHHHhc
Q 010309          248 DGSRVAVKRLKRSSF-------QRKKEFYSEIGRFARLHH--PNLVAVKGCCYDHG----DRYIVYEFVVNG-PLDRWLH  313 (513)
Q Consensus       248 ~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~----~~~lv~e~~~~g-sL~~~l~  313 (513)
                      .++.+.+|.....-.       .......+|...+..|..  -.+++.+++.+...    ..++|+|++++. +|.+++.
T Consensus        31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~  110 (206)
T PF06293_consen   31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ  110 (206)
T ss_pred             cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence            355666665432211       233567888888888743  33455556555432    348999999874 7999886


Q ss_pred             cCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCC---CeEEecccccccC
Q 010309          314 HIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF---GAHLMGVGLSKFV  378 (513)
Q Consensus       314 ~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~---~~kl~Dfg~~~~~  378 (513)
                      ...    ..+......++.+++..++-||..   ||+|+|+++.|||++.+.   .+.++||+.++..
T Consensus       111 ~~~----~~~~~~~~~ll~~l~~~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  111 QWE----QLDPSQRRELLRALARLIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             hhc----ccchhhHHHHHHHHHHHHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            421    266677889999999999999999   999999999999999887   7999999987754

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.70  E-value=1.5e-07  Score=97.17  Aligned_cols=143  Identities=15%  Similarity=0.160  Sum_probs=93.3

Q ss_pred             ceecccCceEEEEEEeCCCCEEEEEEecccchhc----------------------------------------HHHHHH
Q 010309          231 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQR----------------------------------------KKEFYS  270 (513)
Q Consensus       231 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~~~  270 (513)
                      .-|+.++-|.||+|++++|+.||||+.++.-...                                        +-++.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            4579999999999999999999999986431100                                        012345


Q ss_pred             HHHHHhhcC-----CCcEeeeeeEEeeCCceEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 010309          271 EIGRFARLH-----HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV  345 (513)
Q Consensus       271 E~~~l~~l~-----h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~  345 (513)
                      |+..+.+++     .|+|.-..=+.+-.+...|+|||++|..+.+......   ..++...+.....++.  +..+-.. 
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~---~g~d~k~ia~~~~~~f--~~q~~~d-  284 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS---AGIDRKELAELLVRAF--LRQLLRD-  284 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh---cCCCHHHHHHHHHHHH--HHHHHhc-
Confidence            665555552     3433222222233466789999999998888753211   2344333222222211  2222234 


Q ss_pred             CCCceEcCCCCCceEecCCCCeEEecccccccCCcc
Q 010309          346 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE  381 (513)
Q Consensus       346 ~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~  381 (513)
                        |+.|.|..|.||+++.++.+.+.|||+...++..
T Consensus       285 --gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         285 --GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             --CccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence              9999999999999999999999999999877643

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.54  E-value=1.4e-06  Score=81.36  Aligned_cols=139  Identities=14%  Similarity=0.205  Sum_probs=85.8

Q ss_pred             eecccCceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCc--EeeeeeEEeeCCceEEEEeeccCCC-H
Q 010309          232 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPN--LVAVKGCCYDHGDRYIVYEFVVNGP-L  308 (513)
Q Consensus       232 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~l~~~~~~~~~~~lv~e~~~~gs-L  308 (513)
                      .||+|..+.||+.   .+..+++|......  ......+|.++++.+..-.  +.+.+++....+...+|||+++|.+ +
T Consensus         8 ~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~   82 (226)
T TIGR02172         8 QTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF   82 (226)
T ss_pred             eecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence            5799999999983   35568899886543  3456789999999885433  4667777777777889999998863 2


Q ss_pred             HHHh---------------------ccCCCCCCCCCHHHHHHHHH----------HHHH-HHHHHhcC-CCCCceEcCCC
Q 010309          309 DRWL---------------------HHIPRGGRSLDWAMRMKVAT----------TLAQ-GIAFLHDK-VKPHVVHRDIR  355 (513)
Q Consensus       309 ~~~l---------------------~~~~~~~~~l~~~~~~~i~~----------qi~~-~L~~LH~~-~~~~ivH~Dik  355 (513)
                      ...+                     +........++... ..+..          .+.. ...+|... ..+.++|+|+.
T Consensus        83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~-~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~  161 (226)
T TIGR02172        83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYK-EKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ  161 (226)
T ss_pred             hhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHH-HHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence            1111                     11100111111100 00000          0111 12222211 13367899999


Q ss_pred             CCceEecCCCCeEEeccccccc
Q 010309          356 ASNVLLDEEFGAHLMGVGLSKF  377 (513)
Q Consensus       356 p~NIll~~~~~~kl~Dfg~~~~  377 (513)
                      |.||++++++ +.|+||+.+..
T Consensus       162 ~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       162 IGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CCcEEEcCCC-cEEEechhcCc
Confidence            9999999887 99999998764

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.43  E-value=2.4e-06  Score=78.39  Aligned_cols=154  Identities=19%  Similarity=0.196  Sum_probs=102.2

Q ss_pred             cCHHHHHHHhhCc--ccCCceecccCceEEEEEEeCCCCEEEEEEecccchh-------------------cHHH-----
Q 010309          214 FTTEELRSITKNF--SEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQ-------------------RKKE-----  267 (513)
Q Consensus       214 ~~~~~l~~~~~~~--~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------------------~~~~-----  267 (513)
                      .+.+.+..+....  .+....|+.|--+.||+|...++..+|||+++.....                   ...+     
T Consensus        35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W  114 (268)
T COG1718          35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW  114 (268)
T ss_pred             HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence            3444555554332  2233456778888999999888999999998643111                   0111     


Q ss_pred             HHHHHHHHhhcC--CCcEeeeeeEEeeCCceEEEEeeccCCCH-HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 010309          268 FYSEIGRFARLH--HPNLVAVKGCCYDHGDRYIVYEFVVNGPL-DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK  344 (513)
Q Consensus       268 ~~~E~~~l~~l~--h~nIv~l~~~~~~~~~~~lv~e~~~~gsL-~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~  344 (513)
                      ..+|+..|.++.  +-.+.+.+++.    +..|||||+....+ .-.|.     .-++...+...+..++++.+.-|-..
T Consensus       115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~Lk-----Dv~~e~~e~~~~~~~~v~~~~~l~~~  185 (268)
T COG1718         115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLK-----DVPLELEEAEGLYEDVVEYMRRLYKE  185 (268)
T ss_pred             HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcc-----cCCcCchhHHHHHHHHHHHHHHHHHh
Confidence            256888888873  44455555443    34699999954311 11111     12233446777888898888888773


Q ss_pred             CCCCceEcCCCCCceEecCCCCeEEecccccccCC
Q 010309          345 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP  379 (513)
Q Consensus       345 ~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~  379 (513)
                      +  ++||+||+.=|||+. ++.+.++|+|-|....
T Consensus       186 a--~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         186 A--GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             c--CcccccchhhheEEE-CCeEEEEECccccccC
Confidence            2  999999999999999 7789999999887654

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.42  E-value=2.7e-06  Score=77.21  Aligned_cols=140  Identities=14%  Similarity=0.192  Sum_probs=89.8

Q ss_pred             HHhhCcccCCceecccCceEEEEEEeCCCCEEEEEEecccchhcHHH---------HHHHHHHHhhcCC---CcEeeeee
Q 010309          221 SITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKE---------FYSEIGRFARLHH---PNLVAVKG  288 (513)
Q Consensus       221 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~h---~nIv~l~~  288 (513)
                      .+.++-....+++-......|.+-.. +|..+++|..+.......+.         ..+++..+.+++.   ..++.++.
T Consensus        27 ~i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl  105 (229)
T PF06176_consen   27 KILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL  105 (229)
T ss_pred             HHHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence            33444444445666766677766666 78999999887653222222         2334444444432   22222222


Q ss_pred             EEee-----CCceEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecC
Q 010309          289 CCYD-----HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE  363 (513)
Q Consensus       289 ~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~  363 (513)
                      +.+.     ....+|+|||++|..|.++..        +++    .++..+.+++.-||..   |++|+|..|.|++++.
T Consensus       106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~  170 (229)
T PF06176_consen  106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSN  170 (229)
T ss_pred             eeeeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEEC
Confidence            2221     234568999999988866432        222    2456677889999999   9999999999999986


Q ss_pred             CCCeEEeccccccc
Q 010309          364 EFGAHLMGVGLSKF  377 (513)
Q Consensus       364 ~~~~kl~Dfg~~~~  377 (513)
                      + .++++||+..+.
T Consensus       171 ~-~i~iID~~~k~~  183 (229)
T PF06176_consen  171 N-GIRIIDTQGKRM  183 (229)
T ss_pred             C-cEEEEECccccc
Confidence            6 599999987653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.33  E-value=1.9e-07  Score=95.19  Aligned_cols=180  Identities=17%  Similarity=0.127  Sum_probs=132.0

Q ss_pred             ecccCceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCc-EeeeeeEEeeCCceEEEEeeccCC-CHHH
Q 010309          233 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPN-LVAVKGCCYDHGDRYIVYEFVVNG-PLDR  310 (513)
Q Consensus       233 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~~~~lv~e~~~~g-sL~~  310 (513)
                      +++|+++.+++.+....+....+.+...     ....-++++|.+++||| .+..++-+..++...++++++.++ +-..
T Consensus       250 fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~  324 (829)
T KOG0576|consen  250 FVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSAL  324 (829)
T ss_pred             HHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccc
Confidence            4889999999887544444446665433     34556888999999999 777777777778889999999776 2211


Q ss_pred             HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccceeec
Q 010309          311 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA  390 (513)
Q Consensus       311 ~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  390 (513)
                      ..   ......+...+...+.+.-..+|++||+.   .=+|+|    ||+.++ +..+..||+....+....   .....
T Consensus       325 ~~---~~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t~  390 (829)
T KOG0576|consen  325 EM---TVSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPRTA  390 (829)
T ss_pred             cC---ChhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc---ccccC
Confidence            11   11122344555666777788999999987   568888    887766 478999999988776543   22233


Q ss_pred             CcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 010309          391 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQ  431 (513)
Q Consensus       391 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~  431 (513)
                      .+++.++|||+...+.+..+.|+|++|+-..++.-|.+|-.
T Consensus       391 ~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  391 IGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             CCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence            48999999999999999999999999987777777777644

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.29  E-value=8.5e-06  Score=77.23  Aligned_cols=140  Identities=17%  Similarity=0.153  Sum_probs=85.6

Q ss_pred             cccCc-eEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhcC-CCcEeeeeeEEeeCCceEEEEeeccCCCHHHH
Q 010309          234 GDSKT-GGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRW  311 (513)
Q Consensus       234 g~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~  311 (513)
                      ..|.. ..||+.... +..++||+.....   ...+.+|+.++..+. +--+.+++++....+..++|||+++|.+|...
T Consensus         7 ~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~   82 (244)
T cd05150           7 TEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL   82 (244)
T ss_pred             CCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence            34444 789999764 5789999886543   345678888888883 44566777777766678999999999877643


Q ss_pred             h-------------------ccCCCCCCCCCHH--HHHHHHH--------------------HHHHHHHHHhc----CCC
Q 010309          312 L-------------------HHIPRGGRSLDWA--MRMKVAT--------------------TLAQGIAFLHD----KVK  346 (513)
Q Consensus       312 l-------------------~~~~~~~~~l~~~--~~~~i~~--------------------qi~~~L~~LH~----~~~  346 (513)
                      .                   +..+....++...  .......                    .+...+..|-.    ...
T Consensus        83 ~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  162 (244)
T cd05150          83 WEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEED  162 (244)
T ss_pred             hcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCc
Confidence            2                   1111111111100  0000000                    01111222211    113


Q ss_pred             CCceEcCCCCCceEecCCCCeEEeccccccc
Q 010309          347 PHVVHRDIRASNVLLDEEFGAHLMGVGLSKF  377 (513)
Q Consensus       347 ~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~  377 (513)
                      +.++|+|+.|.|||++.+..+.|+||+.+..
T Consensus       163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             eEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence            4689999999999999987788999987753

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.28  E-value=4.4e-06  Score=86.10  Aligned_cols=141  Identities=16%  Similarity=0.106  Sum_probs=90.8

Q ss_pred             ceecccCceEEEEEEeCCCCEEEEEEecccchhc-------------------------------------HHHHHHHHH
Q 010309          231 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQR-------------------------------------KKEFYSEIG  273 (513)
Q Consensus       231 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------------------------------------~~~~~~E~~  273 (513)
                      +-||.-+.|.||+|++++|+.||||+-++.-...                                     +-+|.+|++
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            3579999999999999999999999876431100                                     012344544


Q ss_pred             HHhhc----CCCc------EeeeeeEEeeCCceEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 010309          274 RFARL----HHPN------LVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD  343 (513)
Q Consensus       274 ~l~~l----~h~n------Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~  343 (513)
                      -..++    .|-+      |.+++-.  -.....|+||||+|..+.+.-.-   ....++...+..-+.+...-+-+-  
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl~~i---~~~gi~~~~i~~~l~~~~~~qIf~--  319 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDLDAI---DKRGISPHDILNKLVEAYLEQIFK--  319 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCHHHH---HHcCCCHHHHHHHHHHHHHHHHHh--
Confidence            33333    3444      3333332  23467899999999877654321   123466555444444333222222  


Q ss_pred             CCCCCceEcCCCCCceEecC----CCCeEEecccccccCCcc
Q 010309          344 KVKPHVVHRDIRASNVLLDE----EFGAHLMGVGLSKFVPWE  381 (513)
Q Consensus       344 ~~~~~ivH~Dikp~NIll~~----~~~~kl~Dfg~~~~~~~~  381 (513)
                      .   |++|+|=.|.||+++.    ++.+.+-|||+.......
T Consensus       320 ~---GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~  358 (538)
T KOG1235|consen  320 T---GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK  358 (538)
T ss_pred             c---CCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence            2   9999999999999984    667999999999876543

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.28  E-value=1e-05  Score=75.85  Aligned_cols=142  Identities=17%  Similarity=0.203  Sum_probs=82.8

Q ss_pred             eecccCceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCC--cEeeeeeEEee---CCceEEEEeeccCC
Q 010309          232 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHP--NLVAVKGCCYD---HGDRYIVYEFVVNG  306 (513)
Q Consensus       232 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--nIv~l~~~~~~---~~~~~lv~e~~~~g  306 (513)
                      .|+.|..+.||+....+ ..+++|.....  .....+.+|..+++.+...  .+.+++.....   ....+++|+++++.
T Consensus         4 ~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~   80 (239)
T PF01636_consen    4 PLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR   80 (239)
T ss_dssp             EEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred             cCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence            46899999999999866 69999998655  4556778888888888422  35566654322   33468999999998


Q ss_pred             CHHH----------------Hhc---cCCCCCCCCCHHH---------HHHH------------HHHHHH-HHHHHhc--
Q 010309          307 PLDR----------------WLH---HIPRGGRSLDWAM---------RMKV------------ATTLAQ-GIAFLHD--  343 (513)
Q Consensus       307 sL~~----------------~l~---~~~~~~~~l~~~~---------~~~i------------~~qi~~-~L~~LH~--  343 (513)
                      ++..                .+.   ........+....         ....            ...+.. .+..++.  
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (239)
T PF01636_consen   81 PLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALL  160 (239)
T ss_dssp             EHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhh
Confidence            8777                111   1100111111100         0000            111222 2333332  


Q ss_pred             --CCCCCceEcCCCCCceEec-CCCCeEEecccccc
Q 010309          344 --KVKPHVVHRDIRASNVLLD-EEFGAHLMGVGLSK  376 (513)
Q Consensus       344 --~~~~~ivH~Dikp~NIll~-~~~~~kl~Dfg~~~  376 (513)
                        .....++|+|+.|.|||++ +++.+-|+||+.+.
T Consensus       161 ~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  161 PKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             ccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence              1234799999999999999 55566799998764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.20  E-value=3.8e-05  Score=69.64  Aligned_cols=134  Identities=18%  Similarity=0.291  Sum_probs=95.5

Q ss_pred             CceecccCceEEEEEEeCCCCEEEEEEecccc----------------hhcHHHHHHHHHHHhhcC------CCcEeeee
Q 010309          230 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSS----------------FQRKKEFYSEIGRFARLH------HPNLVAVK  287 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------h~nIv~l~  287 (513)
                      ..+||+|+.-.||.  +++.....||+.....                ....++..+|+.....+.      +.+|.+++
T Consensus         6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            44789999999996  4567778899987664                122456667776666555      88999999


Q ss_pred             eEEeeCCceEEEEeeccC------CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEe
Q 010309          288 GCCYDHGDRYIVYEFVVN------GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL  361 (513)
Q Consensus       288 ~~~~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll  361 (513)
                      |+.+++-..-+|+|.+.+      .+|.+++.+     ..++. ...   ..+-.-..||-+.   +|+.+||+|.||++
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-----~~~~~-~~~---~~L~~f~~~l~~~---~Iv~~dl~~~NIv~  151 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE-----GGLTE-ELR---QALDEFKRYLLDH---HIVIRDLNPHNIVV  151 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHHc-----CCccH-HHH---HHHHHHHHHHHHc---CCeecCCCcccEEE
Confidence            999999999999998753      368888853     33555 333   3334445677777   89999999999999


Q ss_pred             cCCC----CeEEec-cccccc
Q 010309          362 DEEF----GAHLMG-VGLSKF  377 (513)
Q Consensus       362 ~~~~----~~kl~D-fg~~~~  377 (513)
                      ....    .+.|+| ||....
T Consensus       152 ~~~~~~~~~lvlIDG~G~~~~  172 (199)
T PF10707_consen  152 QRRDSGEFRLVLIDGLGEKEL  172 (199)
T ss_pred             EecCCCceEEEEEeCCCCccc
Confidence            5432    466666 555443

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.11  E-value=1.3e-05  Score=72.36  Aligned_cols=105  Identities=18%  Similarity=0.178  Sum_probs=81.8

Q ss_pred             HHHHHHHhhcCC-CcEeeeeeEEeeCCceEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 010309          269 YSEIGRFARLHH-PNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKP  347 (513)
Q Consensus       269 ~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~  347 (513)
                      ..|.-+|+.+++ +++++++|+|    ..++|.||...+++...-... ..-...+|..+.+|+.++++.+.+|++....
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l-~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~   81 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPL-SQFLQSPWEQRAKIALQLLELLEELDHGPLG   81 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCcccccccccc-ccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            358888888865 6999999998    346899999877654210000 0113478999999999999999999985444


Q ss_pred             CceEcCCCCCceEecCCCCeEEecccccccC
Q 010309          348 HVVHRDIRASNVLLDEEFGAHLMGVGLSKFV  378 (513)
Q Consensus       348 ~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~  378 (513)
                      .+.-.|++|+|+-+++++++|++|.+.....
T Consensus        82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             cEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            6888999999999999999999999887654

Proteins in this uncharacterised family are described as transmembrane proteins.

>PLN02876 acyl-CoA dehydrogenase

Probab=98.10  E-value=4e-05  Score=85.42  Aligned_cols=149  Identities=18%  Similarity=0.266  Sum_probs=92.5

Q ss_pred             ceecccCceEEEEEEeCCC---CEEEEEEecccc-hhcHHHHHHHHHHHhhcC-CCcE--eeeeeEEeeC---CceEEEE
Q 010309          231 RLLGDSKTGGTYSGILPDG---SRVAVKRLKRSS-FQRKKEFYSEIGRFARLH-HPNL--VAVKGCCYDH---GDRYIVY  300 (513)
Q Consensus       231 ~~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~nI--v~l~~~~~~~---~~~~lv~  300 (513)
                      +.|+.|.+..+|+....++   ..+++|+..... ......+.+|+++|+.+. |++|  ++++.++.+.   +..|+||
T Consensus        44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVM  123 (822)
T PLN02876         44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIM  123 (822)
T ss_pred             EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEE
Confidence            4568999999999887554   468888765432 223457889999999995 6654  7778877664   4679999


Q ss_pred             eeccCCCHHH--------------------Hh---ccCCCC-------CCCCC--HHHHHHHH---------------HH
Q 010309          301 EFVVNGPLDR--------------------WL---HHIPRG-------GRSLD--WAMRMKVA---------------TT  333 (513)
Q Consensus       301 e~~~~gsL~~--------------------~l---~~~~~~-------~~~l~--~~~~~~i~---------------~q  333 (513)
                      ||++|..+.+                    .|   +.....       +.+..  ..++..+.               ..
T Consensus       124 E~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~~  203 (822)
T PLN02876        124 EYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNPK  203 (822)
T ss_pred             EecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCChh
Confidence            9998764321                    11   111000       00111  11121111               11


Q ss_pred             HHHHHHHHhcCCC--------CCceEcCCCCCceEecCC-CC-eEEecccccccCC
Q 010309          334 LAQGIAFLHDKVK--------PHVVHRDIRASNVLLDEE-FG-AHLMGVGLSKFVP  379 (513)
Q Consensus       334 i~~~L~~LH~~~~--------~~ivH~Dikp~NIll~~~-~~-~kl~Dfg~~~~~~  379 (513)
                      +...+.+|..+..        +.+||+|+++.|||++.+ .. +-|.|+.++..-+
T Consensus       204 ~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~Gd  259 (822)
T PLN02876        204 MLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGN  259 (822)
T ss_pred             HHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCC
Confidence            2334566644321        359999999999999853 33 5789999887543

>PRK10593 hypothetical protein; Provisional

Probab=98.10  E-value=7.2e-05  Score=72.93  Aligned_cols=76  Identities=9%  Similarity=0.034  Sum_probs=56.2

Q ss_pred             CceecccCceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhcCC---CcEeeeeeEEee---CCceEEEEeec
Q 010309          230 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHH---PNLVAVKGCCYD---HGDRYIVYEFV  303 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~nIv~l~~~~~~---~~~~~lv~e~~  303 (513)
                      .+-||.|..+.||+....++ .+++|..+..  .....+..|+..|+.|.-   -.++++++++..   .+..+||||++
T Consensus        19 ~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i   95 (297)
T PRK10593         19 VECISEQPYAALWALYDSQG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERL   95 (297)
T ss_pred             eeecCCccceeEEEEEcCCC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEecc
Confidence            34579999999999987555 4777875431  134578899999988842   467888887754   36689999999


Q ss_pred             cCCCH
Q 010309          304 VNGPL  308 (513)
Q Consensus       304 ~~gsL  308 (513)
                      ++.++
T Consensus        96 ~G~~~  100 (297)
T PRK10593         96 RGVSV  100 (297)
T ss_pred             CCEec
Confidence            98765

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.07  E-value=4.1e-05  Score=66.60  Aligned_cols=127  Identities=17%  Similarity=0.212  Sum_probs=87.7

Q ss_pred             CceecccCceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEee-eeeEEeeCCceEEEEeeccCCCH
Q 010309          230 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVA-VKGCCYDHGDRYIVYEFVVNGPL  308 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~-l~~~~~~~~~~~lv~e~~~~gsL  308 (513)
                      .+.|++|.+|.||++.+ .|..+|+|+-+.+  .....+..|+++|..+.-.++.+ ++.+    +..++.|||+.|-.|
T Consensus        27 ~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~y----g~~~i~me~i~G~~L   99 (201)
T COG2112          27 EKELAKGTTSVVYLGEW-RGGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFY----GEDFIRMEYIDGRPL   99 (201)
T ss_pred             hhhhhcccccEEEEeec-cCceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEe----chhhhhhhhhcCcch
Confidence            34679999999999998 5668999987655  35678999999999997665543 3333    233466999988888


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCC-CCceEecCCCCeEEeccccccc
Q 010309          309 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIR-ASNVLLDEEFGAHLMGVGLSKF  377 (513)
Q Consensus       309 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dik-p~NIll~~~~~~kl~Dfg~~~~  377 (513)
                      .+.-..       .+...+    ..++..---|-..   ||-|+.|. |..++|..+..+.|+||..|..
T Consensus       100 ~~~~~~-------~~rk~l----~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112         100 GKLEIG-------GDRKHL----LRVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hhhhhc-------ccHHHH----HHHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            765431       122333    3344443344455   89999886 4555555555899999998874

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.98  E-value=2.5e-05  Score=85.32  Aligned_cols=197  Identities=18%  Similarity=0.153  Sum_probs=136.8

Q ss_pred             HHHHHHHHHhhcCCCcEeeeeeEEeeCCce----EEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 010309          267 EFYSEIGRFARLHHPNLVAVKGCCYDHGDR----YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLH  342 (513)
Q Consensus       267 ~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~----~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH  342 (513)
                      ...-|+..+.++.|+|++.++.+..+....    .+..|++..-++...+..    -..++....+.+..++..||.|+|
T Consensus       228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~----v~~i~~~~~r~~~~~~~~GL~~~h  303 (1351)
T KOG1035|consen  228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS----VGSIPLETLRILHQKLLEGLAYLH  303 (1351)
T ss_pred             HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh----ccccCHHHHHHHHHHHhhhHHHHH
Confidence            345577788888999999999887654332    345577877788777754    356888899999999999999999


Q ss_pred             cCCCCCceEcCCCCC---ceEecCCCCeEEe--cccccccCCccccccceeecCcccccccccccccCCCCc--hhhHHH
Q 010309          343 DKVKPHVVHRDIRAS---NVLLDEEFGAHLM--GVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTT--KSDVYS  415 (513)
Q Consensus       343 ~~~~~~ivH~Dikp~---NIll~~~~~~kl~--Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~sDvwS  415 (513)
                      +.   ...|.-+..+   +--.+..+.+.++  ||+.+.............   -+..+.|||......+..  ..|+|.
T Consensus       304 ~~---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~---~~~~~~~~e~~~~~~~~~~r~~dL~~  377 (1351)
T KOG1035|consen  304 SL---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDL---LAEIRNADEDLKENTAKKSRLTDLWC  377 (1351)
T ss_pred             Hh---ccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhc---CccccccccccccccchhhhhhHHHH
Confidence            98   6666655555   4445566666666  888888765443322221   455678888877665544  479999


Q ss_pred             HHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCC
Q 010309          416 FGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPR  495 (513)
Q Consensus       416 lGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs  495 (513)
                      +|..+..+..|..+-.....                      ....+        +........+...+|+..++++|++
T Consensus       378 lgll~~~~~~~~~i~~~~~~----------------------~~~~l--------~~~~~~~~~d~~~~~~~~~~~~Rl~  427 (1351)
T KOG1035|consen  378 LGLLLLQLSQGEDISEKSAV----------------------PVSLL--------DVLSTSELLDALPKCLDEDSEERLS  427 (1351)
T ss_pred             HHHHHhhhhhcCcccccccc----------------------hhhhh--------ccccchhhhhhhhhhcchhhhhccc
Confidence            99999999988765321110                      00111        0011114778889999999999999


Q ss_pred             HHHHHHHH
Q 010309          496 MSHVVHQL  503 (513)
Q Consensus       496 ~~evl~~L  503 (513)
                      +.+++...
T Consensus       428 ~~~ll~~~  435 (1351)
T KOG1035|consen  428 ALELLTHP  435 (1351)
T ss_pred             hhhhhhch
Confidence            99998644

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.95  E-value=6.7e-05  Score=70.68  Aligned_cols=71  Identities=14%  Similarity=0.109  Sum_probs=44.4

Q ss_pred             ecccCce-EEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCC---cEeeeeeEEeeC---CceEEEEeeccC
Q 010309          233 LGDSKTG-GTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHP---NLVAVKGCCYDH---GDRYIVYEFVVN  305 (513)
Q Consensus       233 lg~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---nIv~l~~~~~~~---~~~~lv~e~~~~  305 (513)
                      |+.|+.. .||+.    +..+++|..+..  .....+.+|+++|..+...   .+.++++.....   ...+++|++++|
T Consensus         5 ~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~G   78 (235)
T cd05155           5 VDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLEG   78 (235)
T ss_pred             ccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeecC
Confidence            4666665 58875    345778875542  2345788999999887532   344444433322   234889999998


Q ss_pred             CCHH
Q 010309          306 GPLD  309 (513)
Q Consensus       306 gsL~  309 (513)
                      .++.
T Consensus        79 ~~l~   82 (235)
T cd05155          79 ETAT   82 (235)
T ss_pred             CCCC
Confidence            7763

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.81  E-value=0.00024  Score=66.85  Aligned_cols=72  Identities=13%  Similarity=0.013  Sum_probs=47.6

Q ss_pred             eecccCceEEEEEEeCC--CCEEEEEEecccchhcHHHHHHHHHHHhhcCC-CcEeeeeeEEeeCCceEEEEeeccCCCH
Q 010309          232 LLGDSKTGGTYSGILPD--GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHH-PNLVAVKGCCYDHGDRYIVYEFVVNGPL  308 (513)
Q Consensus       232 ~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~lv~e~~~~gsL  308 (513)
                      .|..|-...+|+....+  +..|++|+...... ...+..+|+.++..+.. .-.+++++...    ..++|||++|.++
T Consensus         5 ~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~l   79 (235)
T cd05157           5 RFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRTL   79 (235)
T ss_pred             EcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCcC
Confidence            45788888999998764  67899997764321 12234578888888843 33344444332    2489999998765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.80  E-value=0.00035  Score=70.30  Aligned_cols=75  Identities=17%  Similarity=0.024  Sum_probs=54.0

Q ss_pred             ceecccCceEEEEEEeCCC-CEEEEEEeccc------c-hhcHHHHHHHHHHHhhcC---CCcEeeeeeEEeeCCceEEE
Q 010309          231 RLLGDSKTGGTYSGILPDG-SRVAVKRLKRS------S-FQRKKEFYSEIGRFARLH---HPNLVAVKGCCYDHGDRYIV  299 (513)
Q Consensus       231 ~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~------~-~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~lv  299 (513)
                      +.||.|.+..||++...+| +.|+||+-...      . ....+....|.+.|..+.   -.++++++.+  +.+..++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence            3579999999999998777 48999985421      1 123456777888888762   3467777776  44667899


Q ss_pred             EeeccCCC
Q 010309          300 YEFVVNGP  307 (513)
Q Consensus       300 ~e~~~~gs  307 (513)
                      ||++++..
T Consensus       110 ME~L~~~~  117 (401)
T PRK09550        110 MEDLSDHK  117 (401)
T ss_pred             EecCCCcc
Confidence            99997643

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.80  E-value=0.00024  Score=69.84  Aligned_cols=161  Identities=15%  Similarity=0.195  Sum_probs=91.2

Q ss_pred             cCHHHHHHHhhCcccC----CceecccCceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCC--cEeeee
Q 010309          214 FTTEELRSITKNFSEG----NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHP--NLVAVK  287 (513)
Q Consensus       214 ~~~~~l~~~~~~~~~~----~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--nIv~l~  287 (513)
                      .+.+++..+...|...    .+.++.|....+|+....+| .+++|+.....  ..+.+..|+.++..|...  .+++++
T Consensus         7 ~~~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i   83 (307)
T TIGR00938         7 VSDEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPV   83 (307)
T ss_pred             CCHHHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccc
Confidence            3456777766665432    34567777789999876444 67889875532  234455677777776322  234443


Q ss_pred             eEE------eeCCceEEEEeeccCCCHH-----------HHh---ccCCC----CCC---C-CCHHHHH-----------
Q 010309          288 GCC------YDHGDRYIVYEFVVNGPLD-----------RWL---HHIPR----GGR---S-LDWAMRM-----------  328 (513)
Q Consensus       288 ~~~------~~~~~~~lv~e~~~~gsL~-----------~~l---~~~~~----~~~---~-l~~~~~~-----------  328 (513)
                      ...      ...+..++++||++|..+.           ..+   +....    ...   . -.|....           
T Consensus        84 ~t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~  163 (307)
T TIGR00938        84 KSRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLE  163 (307)
T ss_pred             cCCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccC
Confidence            321      1235568999999885431           111   11000    000   0 0111100           


Q ss_pred             -HHHHHHHHHHHHHhc----CCCCCceEcCCCCCceEecCCCCeEEeccccccc
Q 010309          329 -KVATTLAQGIAFLHD----KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF  377 (513)
Q Consensus       329 -~i~~qi~~~L~~LH~----~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~  377 (513)
                       .....+...++++..    ....+++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       164 ~~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       164 AHMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT  217 (307)
T ss_pred             HHHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence             011223344555542    2244899999999999999887678999998753

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.75  E-value=0.00043  Score=62.31  Aligned_cols=120  Identities=27%  Similarity=0.392  Sum_probs=84.3

Q ss_pred             CceecccCc-eEEEEEEeCCCCEEEEEEecc---cc-------h-----------hcHHHHHHHHHHHhhcC---CCcE-
Q 010309          230 NRLLGDSKT-GGTYSGILPDGSRVAVKRLKR---SS-------F-----------QRKKEFYSEIGRFARLH---HPNL-  283 (513)
Q Consensus       230 ~~~lg~G~~-g~Vy~~~~~~~~~vavK~~~~---~~-------~-----------~~~~~~~~E~~~l~~l~---h~nI-  283 (513)
                      -+.||.|.- |.||++.. +|+.+|+|++..   ..       .           .....|..|.+...+|+   +.++ 
T Consensus        42 lefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~e~~~  120 (207)
T PF13095_consen   42 LEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGREGLW  120 (207)
T ss_pred             eeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccccCce
Confidence            346799999 99999999 788999999432   00       0           11234778888777773   4566 


Q ss_pred             -eeeeeEEeeC------------------CceEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 010309          284 -VAVKGCCYDH------------------GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK  344 (513)
Q Consensus       284 -v~l~~~~~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~  344 (513)
                       |+.+|+..-.                  ....||.||++...             .+...    -+.+|.+-|..+|..
T Consensus       121 Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~~~----~~~~~~~dl~~~~k~  183 (207)
T PF13095_consen  121 AVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQIR----DIPQMLRDLKILHKL  183 (207)
T ss_pred             EEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccchh----HHHHHHHHHHHHHHC
Confidence             8999987432                  11257777765432             12222    345677778889999


Q ss_pred             CCCCceEcCCCCCceEecCCCCeEEeccccc
Q 010309          345 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLS  375 (513)
Q Consensus       345 ~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~  375 (513)
                         +|+-+|+++.|..     .-+|+|||.+
T Consensus       184 ---gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  184 ---GIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             ---CeeeccCcccccc-----CCEEEecccC
Confidence               9999999999986     4589999865

>PRK05231 homoserine kinase; Provisional

Probab=97.68  E-value=0.0013  Score=65.05  Aligned_cols=160  Identities=16%  Similarity=0.183  Sum_probs=86.1

Q ss_pred             cCHHHHHHHhhCcccC----CceecccCceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCC--cEeeee
Q 010309          214 FTTEELRSITKNFSEG----NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHP--NLVAVK  287 (513)
Q Consensus       214 ~~~~~l~~~~~~~~~~----~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--nIv~l~  287 (513)
                      .+.+++..+...|...    .+.|+.|....+|+....+| .+++|++...   ..+.+..|+.++..|...  .+.+.+
T Consensus         7 ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~---~~~~l~~~~~~l~~L~~~glpvP~~i   82 (319)
T PRK05231          7 VSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFERL---TAEDLPFFLGLMQHLAARGVPVPAPV   82 (319)
T ss_pred             CCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEeccC---ChHHhHHHHHHHHHHHHCCCCCCcce
Confidence            4566676666555431    23356777788999887555 6899987621   233444555555555211  122333


Q ss_pred             e------EEeeCCceEEEEeeccCCCHH-----------HHhccCCCC----------CCCCCH-HHHH-----------
Q 010309          288 G------CCYDHGDRYIVYEFVVNGPLD-----------RWLHHIPRG----------GRSLDW-AMRM-----------  328 (513)
Q Consensus       288 ~------~~~~~~~~~lv~e~~~~gsL~-----------~~l~~~~~~----------~~~l~~-~~~~-----------  328 (513)
                      .      +....+..++++||++|..+.           ..|.+....          ...+.+ ....           
T Consensus        83 ~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (319)
T PRK05231         83 ARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQ  162 (319)
T ss_pred             eCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhH
Confidence            2      112245678999999886431           111111000          001111 1111           


Q ss_pred             -HHHHH-HHHHHHHHhcC----CCCCceEcCCCCCceEecCCCCeEEeccccccc
Q 010309          329 -KVATT-LAQGIAFLHDK----VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF  377 (513)
Q Consensus       329 -~i~~q-i~~~L~~LH~~----~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~  377 (513)
                       ..+.+ +...++.+...    ...+++|+|+.|.||+++.+...-|+||+.+..
T Consensus       163 ~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        163 AALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             HHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence             01111 11222333211    344899999999999999765568999998864

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	513
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		4e-41
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-39
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		5e-31
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		5e-31
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		6e-31
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		3e-29
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		3e-29
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		4e-28
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-23
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		3e-23
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		9e-21
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		9e-20
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-19
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-19
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-19
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-19
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-19
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-19
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-19
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-19
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-19
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-19
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-19
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-19
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-19
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-19
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-19
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-19
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-19
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-19
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-19
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-19
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		6e-19
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		7e-19
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		8e-19
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		3e-17
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-16
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-16
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-16
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-16
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-16
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-16
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-16
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-16
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-16
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-16
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-16
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-16
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		3e-16
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		4e-16
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-15
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-15
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		3e-15
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		4e-15
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		4e-15
3a4o_X	286	Lyn Kinase Domain Length = 286		6e-15
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		7e-15
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		8e-15
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		8e-15
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		8e-15
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		8e-15
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		9e-15
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		9e-15
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		9e-15
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-14
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-14
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-14
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-14
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-14
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-14
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-14
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-14
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-14
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-14
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-14
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		3e-14
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		3e-14
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		4e-14
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-14
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		4e-14
1fvr_A	327	Tie2 Kinase Domain Length = 327		4e-14
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		4e-14
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-14
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		6e-14
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		7e-14
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		8e-14
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		8e-14
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		8e-14
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		9e-14
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-13
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-13
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-13
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-13
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-13
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-13
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-13
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-13
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-13
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-13
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-13
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-13
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-13
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-13
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-13
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-13
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-13
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-13
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-13
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		3e-13
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		3e-13
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		3e-13
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		3e-13
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-13
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		3e-13
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		3e-13
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		3e-13
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		4e-13
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		4e-13
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		4e-13
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		5e-13
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		5e-13
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		5e-13
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		5e-13
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		6e-13
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		6e-13
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		7e-13
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		7e-13
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		9e-13
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		9e-13
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-12
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-12
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-12
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-12
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-12
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-12
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		1e-12
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-12
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		1e-12
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-12
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-12
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-12
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-12
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-12
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-12
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-12
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-12
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-12
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-12
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-12
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-12
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		3e-12
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-12
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		3e-12
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-12
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-12
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-12
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-12
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-12
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		3e-12
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		3e-12
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-12
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-12
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		4e-12
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		4e-12
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		4e-12
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		4e-12
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		4e-12
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		4e-12
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		4e-12
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		4e-12
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		4e-12
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		4e-12
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		5e-12
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		5e-12
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		5e-12
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		5e-12
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		6e-12
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		6e-12
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		6e-12
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		7e-12
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		7e-12
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		7e-12
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		8e-12
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-12
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		9e-12
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		9e-12
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		9e-12
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		1e-11
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-11
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		1e-11
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-11
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-11
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		1e-11
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-11
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-11
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-11
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-11
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-11
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-11
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-11
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-11
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-11
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-11
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-11
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-11
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-11
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-11
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-11
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-11
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-11
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-11
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-11
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-11
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-11
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-11
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-11
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-11
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-11
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-11
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		3e-11
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		3e-11
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		3e-11
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		3e-11
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-11
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-11
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		3e-11
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-11
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		3e-11
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		3e-11
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		3e-11
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		3e-11
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		3e-11
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		3e-11
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-11
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-11
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		3e-11
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		3e-11
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-11
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		3e-11
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		3e-11
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		3e-11
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		3e-11
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		3e-11
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		3e-11
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-11
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-11
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		3e-11
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		3e-11
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		4e-11
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-11
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		4e-11
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		4e-11
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		4e-11
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		4e-11
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		4e-11
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		4e-11
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		4e-11
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		5e-11
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		5e-11
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		5e-11
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		5e-11
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		5e-11
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		5e-11
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		5e-11
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		5e-11
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		5e-11
4fie_A	423	Full-Length Human Pak4 Length = 423		6e-11
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		6e-11
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		6e-11
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		6e-11
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		6e-11
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		6e-11
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-11
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		7e-11
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		7e-11
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		7e-11
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-11
3b2t_A	311	Structure Of Phosphotransferase Length = 311		7e-11
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		7e-11
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		7e-11
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		7e-11
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		7e-11
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		7e-11
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		7e-11
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		8e-11
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		8e-11
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		8e-11
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		8e-11
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		8e-11
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		9e-11
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		9e-11
3g51_A	325	Structural Diversity Of The Active Conformation Of		9e-11
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		9e-11
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		9e-11
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		9e-11
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		9e-11
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		9e-11
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-10
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-10
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-10
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-10
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-10
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-10
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-10
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-10
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-10
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-10
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-10
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-10
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-10
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-10
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-10
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-10
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-10
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-10
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-10
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-10
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-10
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-10
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-10
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-10
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-10
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-10
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-10
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-10
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-10
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-10
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-10
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		2e-10
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-10
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-10
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		2e-10
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-10
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-10
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-10
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-10
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-10
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-10
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-10
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-10
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-10
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-10
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		3e-10
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-10
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		3e-10
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		3e-10
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-10
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		4e-10
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		4e-10
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		4e-10
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		4e-10
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		4e-10
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-10
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		4e-10
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		4e-10
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-10
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		4e-10
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		4e-10
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		4e-10
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-10
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-10
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		5e-10
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		5e-10
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		6e-10
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-10
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		6e-10
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-10
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-10
4h58_A	275	Braf In Complex With Compound 3 Length = 275		6e-10
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		6e-10
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		6e-10
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-10
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		7e-10
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		7e-10
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		7e-10
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		7e-10
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		7e-10
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		7e-10
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		7e-10
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		7e-10
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		7e-10
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		7e-10
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		7e-10
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		7e-10
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		8e-10
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-10
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		8e-10
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		8e-10
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		8e-10
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		8e-10
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		8e-10
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		9e-10
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		9e-10
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		9e-10
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		9e-10
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		9e-10
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		9e-10
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		9e-10
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		1e-09
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-09
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-09
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-09
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-09
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-09
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-09
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		1e-09
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-09
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-09
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-09
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-09
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-09
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-09
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-09
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-09
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-09
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-09
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-09
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-09
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-09
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		3e-09
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		3e-09
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		4e-09
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		4e-09
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		4e-09
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		4e-09
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		4e-09
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		4e-09
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		4e-09
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		4e-09
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		4e-09
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-09
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		4e-09
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		4e-09
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		4e-09
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-09
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		5e-09
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		5e-09
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		5e-09
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		5e-09
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		5e-09
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		5e-09
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		5e-09
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		5e-09
4fl2_A	636	Structural And Biophysical Characterization Of The		5e-09
4fl3_A	635	Structural And Biophysical Characterization Of The		6e-09
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		7e-09
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		7e-09
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		8e-09
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		8e-09
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		9e-09
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		9e-09
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		9e-09
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-08
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-08
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-08
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-08
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-08
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		1e-08
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-08
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-08
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-08
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-08
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-08
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-08
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-08
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-08
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-08
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-08
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-08
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-08
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-08
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-08
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		3e-08
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-08
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		3e-08
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		3e-08
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		3e-08
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		3e-08
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		3e-08
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		3e-08
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		4e-08
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-08
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		4e-08
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		4e-08
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		4e-08
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		5e-08
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		5e-08
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		5e-08
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		5e-08
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		5e-08
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-08
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		5e-08
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-08
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-08
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		5e-08
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		5e-08
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		6e-08
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		6e-08
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		6e-08
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		6e-08
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		6e-08
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		6e-08
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		6e-08
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		7e-08
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		7e-08
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		7e-08
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		7e-08
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		8e-08
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		8e-08
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		8e-08
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-08
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		8e-08
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		8e-08
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		8e-08
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		9e-08
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-08
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		9e-08
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-08
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		9e-08
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		9e-08
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		1e-07
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-07
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-07
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-07
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-07
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-07
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-07
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-07
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-07
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-07
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-07
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-07
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-07
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-07
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-07
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-07
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-07
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-07
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-07
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-07
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-07
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-07
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-07
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-07
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-07
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-07
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-07
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-07
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-07
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-07
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-07
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-07
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-07
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-07
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-07
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-07
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-07
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-07
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-07
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-07
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-07
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-07
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-07
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-07
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		3e-07
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		3e-07
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		3e-07
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		3e-07
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-07
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-07
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		3e-07
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-07
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		3e-07
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		3e-07
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		3e-07
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		3e-07
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		3e-07
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-07
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		3e-07
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-07
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		3e-07
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		3e-07
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-07
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		3e-07
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-07
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		3e-07
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		3e-07
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-07
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		3e-07
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		3e-07
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		3e-07
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		3e-07
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-07
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		3e-07
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		3e-07
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		3e-07
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-07
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-07
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		3e-07
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-07
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		3e-07
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		3e-07
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		4e-07
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		4e-07
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		4e-07
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		4e-07
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		4e-07
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		4e-07
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-07
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		4e-07
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-07
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		4e-07
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		4e-07
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-07
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		4e-07
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		4e-07
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		4e-07
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		4e-07
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		4e-07
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-07
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		4e-07
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-07
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		4e-07
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		4e-07
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		4e-07
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		4e-07
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-07
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-07
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		4e-07
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-07
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		5e-07
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		5e-07
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		5e-07
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		5e-07
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-07
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		6e-07
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		7e-07
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		7e-07
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		7e-07
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		8e-07
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		8e-07
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		8e-07
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		9e-07
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-06
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-06
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-06
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-06
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-06
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-06
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-06
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-06
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-06
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-06
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-06
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-06
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-06
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-06
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-06
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-06
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-06
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-06
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-06
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-06
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-06
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-06
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-06
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-06
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-06
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-06
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-06
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-06
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-06
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-06
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-06
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-06
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-06
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-06
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		3e-06
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		3e-06
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		3e-06
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		3e-06
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		3e-06
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-06
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		4e-06
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		4e-06
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		4e-06
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		4e-06
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-06
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		4e-06
1jwi_A	131	Crystal Structure Of Bitiscetin, A Von Willeband Fa		4e-06
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		5e-06
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		5e-06
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		5e-06
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		5e-06
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		5e-06
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		5e-06
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		5e-06
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		6e-06
3kk8_A	284	Camkii Substrate Complex A Length = 284		6e-06
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		6e-06
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		6e-06
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		6e-06
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		7e-06
3kk9_A	282	Camkii Substrate Complex B Length = 282		7e-06
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		7e-06
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		8e-06
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		8e-06
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		8e-06
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		9e-06
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		9e-06
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		9e-06
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		9e-06
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		9e-06
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		9e-06
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-05
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-05
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		1e-05
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-05
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-05
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-05
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-05
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-05
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-05
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-05
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-05
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-05
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-05
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-05
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-05
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-05
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-05
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-05
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-05
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-05
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-05
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-05
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-05
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-05
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-05
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-05
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-05
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-05
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-05
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-05
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-05
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-05
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		3e-05
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-05
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		3e-05
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		3e-05
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		3e-05
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		3e-05
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		3e-05
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		3e-05
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		4e-05
1k9i_A	156	Complex Of Dc-Sign And Glcnac2man3 Length = 156		4e-05
1sl4_A	155	Crystal Structure Of Dc-Sign Carbohydrate Recogniti		4e-05
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		4e-05
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-05
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		4e-05
2afp_A	129	The Solution Structure Of Type Ii Antifreeze Protei		4e-05
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		4e-05
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		4e-05
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		5e-05
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-05
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		5e-05
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		5e-05
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		5e-05
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		6e-05
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		6e-05
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		6e-05
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		6e-05
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		6e-05
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		7e-05
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		7e-05
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		7e-05
2oza_B	366	Structure Of P38alpha Complex Length = 366		7e-05
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		7e-05
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		7e-05
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		7e-05
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		7e-05
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		7e-05
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		7e-05
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		7e-05
3soa_A	444	Full-Length Human Camkii Length = 444		7e-05
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		7e-05
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		7e-05
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		7e-05
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		8e-05
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		8e-05
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		8e-05
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		8e-05
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		8e-05
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		8e-05
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		8e-05
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		8e-05
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		8e-05
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		8e-05
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		8e-05
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		8e-05
2zib_A	133	Crystal Structure Analysis Of Calcium-Independent T		8e-05
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		8e-05
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		8e-05
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		8e-05
3hec_A	348	P38 In Complex With Imatinib Length = 348		8e-05
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		8e-05
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		8e-05
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		9e-05
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		9e-05
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		9e-05
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		9e-05
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-05
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		9e-05
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		9e-05
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		9e-05
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		9e-05
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-04
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-04
1fvu_B	125	Crystal Structure Of Botrocetin Length = 125		1e-04
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-04
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-04
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-04
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		1e-04
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-04
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-04
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-04
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-04
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-04
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-04
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-04
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-04
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-04
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-04
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-04
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-04
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-04
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-04
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-04
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-04
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-04
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		3e-04
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		3e-04
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		3e-04
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		3e-04
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		3e-04
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		3e-04
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-04
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		3e-04
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		3e-04
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		3e-04
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		3e-04
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		3e-04
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		3e-04
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		3e-04
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		4e-04
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		4e-04
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		4e-04
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		4e-04
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-04
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		4e-04
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		4e-04
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		5e-04
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		5e-04
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		5e-04
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		5e-04
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		5e-04
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		6e-04
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		6e-04
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		6e-04
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		6e-04
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		7e-04
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		7e-04
2xr6_A	170	Crystal Structure Of The Complex Of The Carbohydrat		7e-04
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		7e-04
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		8e-04
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		8e-04
2b6b_D	175	Cryo Em Structure Of Dengue Complexed With Crd Of D		8e-04
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		8e-04
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		8e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  165 bits (418), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 97/299 (32%), Positives = 158/299 (52%), Gaps = 15/299 (5%)
Query: 212 KVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKK-EFYS 270
           K F+  EL+  + NFS  N +LG    G  Y G L DG+ VAVKRLK    Q  + +F +
Sbjct: 26  KRFSLRELQVASDNFSNKN-ILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQT 84
Query: 271 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 330
           E+   +   H NL+ ++G C    +R +VY ++ NG +   L   P     LDW  R ++
Sbjct: 85  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 144
Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 390
           A   A+G+A+LHD   P ++HRD++A+N+LLDEEF A +   GL+K + ++       + 
Sbjct: 145 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVR 204
Query: 391 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAV-----DSVCWQSIFEWA 445
            GT G++APE++   + + K+DV+ +GV+LLE+++G+R          D V    + +W 
Sbjct: 205 -GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM---LLDWV 260
Query: 446 TPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ 504
             L++  +                     V++++ +   CTQ  P  RP+MS VV  L+
Sbjct: 261 KGLLKEKKLEALVDVDLQGNYKDEE----VEQLIQVALLCTQSSPMERPKMSEVVRMLE 315

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  161 bits (407), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 95/299 (31%), Positives = 155/299 (51%), Gaps = 15/299 (5%)
Query: 212 KVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKK-EFYS 270
           K F+  EL+  + NF   N +LG    G  Y G L DG  VAVKRLK    Q  + +F +
Sbjct: 18  KRFSLRELQVASDNFXNKN-ILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQT 76
Query: 271 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 330
           E+   +   H NL+ ++G C    +R +VY ++ NG +   L   P     LDW  R ++
Sbjct: 77  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136
Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 390
           A   A+G+A+LHD   P ++HRD++A+N+LLDEEF A +   GL+K + ++       + 
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVR 196
Query: 391 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAV-----DSVCWQSIFEWA 445
            G  G++APE++   + + K+DV+ +GV+LLE+++G+R          D V    + +W 
Sbjct: 197 -GXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM---LLDWV 252
Query: 446 TPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ 504
             L++  +                     V++++ +   CTQ  P  RP+MS VV  L+
Sbjct: 253 KGLLKEKKLEALVDVDLQGNYKDEE----VEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  132 bits (332), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 89/225 (39%), Positives = 125/225 (55%), Gaps = 21/225 (9%)
Query: 214 FTTEELRSITKNFSE-----GNRLLGDSKTGGTYSGILPDGSRVAVKRLKR----SSFQR 264
           F+  EL+++T NF E     G   +G+   G  Y G + + + VAVK+L      ++ + 
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 73
Query: 265 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDW 324
           K++F  EI   A+  H NLV + G   D  D  +VY ++ NG L   L  +  G   L W
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSW 132
Query: 325 AMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGL---SKFVPWE 381
            MR K+A   A GI FLH+    H +HRDI+++N+LLDE F A +   GL   S+     
Sbjct: 133 HMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189
Query: 382 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSG 426
           VM  R V   GT  Y+APE   R E+T KSD+YSFGV+LLEI++G
Sbjct: 190 VMXSRIV---GTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITG 230

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  132 bits (331), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 89/225 (39%), Positives = 125/225 (55%), Gaps = 21/225 (9%)
Query: 214 FTTEELRSITKNFSE-----GNRLLGDSKTGGTYSGILPDGSRVAVKRLKR----SSFQR 264
           F+  EL+++T NF E     G   +G+   G  Y G + + + VAVK+L      ++ + 
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 67
Query: 265 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDW 324
           K++F  EI   A+  H NLV + G   D  D  +VY ++ NG L   L  +  G   L W
Sbjct: 68  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSW 126
Query: 325 AMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGL---SKFVPWE 381
            MR K+A   A GI FLH+    H +HRDI+++N+LLDE F A +   GL   S+     
Sbjct: 127 HMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQX 183
Query: 382 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSG 426
           VM  R V   GT  Y+APE   R E+T KSD+YSFGV+LLEI++G
Sbjct: 184 VMXXRIV---GTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITG 224

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  132 bits (331), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 89/225 (39%), Positives = 125/225 (55%), Gaps = 21/225 (9%)
Query: 214 FTTEELRSITKNFSE-----GNRLLGDSKTGGTYSGILPDGSRVAVKRLKR----SSFQR 264
           F+  EL+++T NF E     G   +G+   G  Y G + + + VAVK+L      ++ + 
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 73
Query: 265 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDW 324
           K++F  EI   A+  H NLV + G   D  D  +VY ++ NG L   L  +  G   L W
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSW 132
Query: 325 AMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGL---SKFVPWE 381
            MR K+A   A GI FLH+    H +HRDI+++N+LLDE F A +   GL   S+     
Sbjct: 133 HMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189
Query: 382 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSG 426
           VM  R V   GT  Y+APE   R E+T KSD+YSFGV+LLEI++G
Sbjct: 190 VMXXRIV---GTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITG 230

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  126 bits (317), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 85/253 (33%), Positives = 137/253 (54%), Gaps = 11/253 (4%)
Query: 202 AASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSS 261
           ++S LVP         +L   T NF +   L+G    G  Y G+L DG++VA+KR    S
Sbjct: 17  SSSYLVPFESYRVPLVDLEEATNNF-DHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES 75
Query: 262 FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS 321
            Q  +EF +EI   +   HP+LV++ G C +  +  ++Y+++ NG L R L+       S
Sbjct: 76  SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMS 135
Query: 322 LDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 381
           + W  R+++    A+G+ +LH +    ++HRD+++ N+LLDE F   +   G+SK     
Sbjct: 136 MSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTEL 192
Query: 382 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ-- 439
                  +  GT GY+ PE+  +  LT KSDVYSFGV+L E++  R  +  V S+  +  
Sbjct: 193 DQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR--SAIVQSLPREMV 250
Query: 440 SIFEWATPLVQSH 452
           ++ EWA   V+SH
Sbjct: 251 NLAEWA---VESH 260

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  126 bits (316), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 85/253 (33%), Positives = 137/253 (54%), Gaps = 11/253 (4%)
Query: 202 AASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSS 261
           ++S LVP         +L   T NF +   L+G    G  Y G+L DG++VA+KR    S
Sbjct: 17  SSSYLVPFESYRVPLVDLEEATNNF-DHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES 75
Query: 262 FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS 321
            Q  +EF +EI   +   HP+LV++ G C +  +  ++Y+++ NG L R L+       S
Sbjct: 76  SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMS 135
Query: 322 LDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 381
           + W  R+++    A+G+ +LH +    ++HRD+++ N+LLDE F   +   G+SK     
Sbjct: 136 MSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTEL 192
Query: 382 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ-- 439
                  +  GT GY+ PE+  +  LT KSDVYSFGV+L E++  R  +  V S+  +  
Sbjct: 193 GQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR--SAIVQSLPREMV 250
Query: 440 SIFEWATPLVQSH 452
           ++ EWA   V+SH
Sbjct: 251 NLAEWA---VESH 260

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  122 bits (307), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 87/224 (38%), Positives = 121/224 (54%), Gaps = 19/224 (8%)
Query: 214 FTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDG----SRVAVKRLKR----SSFQRK 265
           F+  EL+++T NF E    +G +K G    G++  G    + VAVK+L      ++ + K
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 65
Query: 266 KEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWA 325
           ++F  EI   A+  H NLV + G   D  D  +VY +  NG L   L  +  G   L W 
Sbjct: 66  QQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLD-GTPPLSWH 124
Query: 326 MRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGL---SKFVPWEV 382
            R K+A   A GI FLH+    H +HRDI+++N+LLDE F A +   GL   S+     V
Sbjct: 125 XRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV 181
Query: 383 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSG 426
              R V   GT  Y APE   R E+T KSD+YSFGV+LLEI++G
Sbjct: 182 XXSRIV---GTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITG 221

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 70/200 (35%), Positives = 108/200 (54%), Gaps = 14/200 (7%)
Query: 249 GSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 306
           GS VAVK L    F  +R  EF  E+    RL HPN+V   G      +  IV E++  G
Sbjct: 60  GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRG 119
Query: 307 PLDRWLHHIPRGGR-SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 365
            L R LH    G R  LD   R+ +A  +A+G+ +LH++  P +VHRD+++ N+L+D+++
Sbjct: 120 SLYRLLHK--SGAREQLDERRRLSMAYDVAKGMNYLHNR-NPPIVHRDLKSPNLLVDKKY 176
Query: 366 GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 425
              +   GLS+      +  +   A GT  ++APE +       KSDVYSFGV+L E+ +
Sbjct: 177 TVKVCDFGLSRLKASXFLXSKX--AAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELAT 234
Query: 426 GRR------PAQAVDSVCWQ 439
            ++      PAQ V +V ++
Sbjct: 235 LQQPWGNLNPAQVVAAVGFK 254

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  106 bits (265), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 69/200 (34%), Positives = 109/200 (54%), Gaps = 14/200 (7%)
Query: 249 GSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 306
           GS VAVK L    F  +R  EF  E+    RL HPN+V   G      +  IV E++  G
Sbjct: 60  GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRG 119
Query: 307 PLDRWLHHIPRGGR-SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 365
            L R LH    G R  LD   R+ +A  +A+G+ +LH++  P +VHR++++ N+L+D+++
Sbjct: 120 SLYRLLHK--SGAREQLDERRRLSMAYDVAKGMNYLHNR-NPPIVHRNLKSPNLLVDKKY 176
Query: 366 GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 425
              +   GLS+      +  ++  A GT  ++APE +       KSDVYSFGV+L E+ +
Sbjct: 177 TVKVCDFGLSRLKASTFLSSKS--AAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELAT 234
Query: 426 GRR------PAQAVDSVCWQ 439
            ++      PAQ V +V ++
Sbjct: 235 LQQPWGNLNPAQVVAAVGFK 254

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 98.2 bits (243), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 105/197 (53%), Gaps = 13/197 (6%)
Query: 249 GSRVAVKRLKRSS----FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 304
           G  VAVK  +        Q  +    E   FA L HPN++A++G C    +  +V EF  
Sbjct: 30  GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFAR 89
Query: 305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 364
            GPL+R L      G+ +   + +  A  +A+G+ +LHD+    ++HRD+++SN+L+ ++
Sbjct: 90  GGPLNRVL-----SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQK 144
Query: 365 FGAHLMGVGLSKFVPWEVMQE--RT--VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLL 420
                +   + K   + + +E  RT  + A G Y ++APE +  +  +  SDV+S+GVLL
Sbjct: 145 VENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLL 204
Query: 421 LEIVSGRRPAQAVDSVC 437
            E+++G  P + +D + 
Sbjct: 205 WELLTGEVPFRGIDGLA 221

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 95.1 bits (235), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 126/280 (45%), Gaps = 33/280 (11%)
Query: 233 LGDSKTGGTYSGILPDGS-RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 291
           LG  + G  Y G+    S  VAVK LK  + + + EF  E      + HPNLV + G C 
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 292 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 351
                YI+ EF+  G L  +L    R  + ++  + + +AT ++  + +L  K   + +H
Sbjct: 81  REPPFYIIIEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLEKK---NFIH 135
Query: 352 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTT 409
           RD+ A N L+ E     +   GLS+ +  +     T  AG  +   + APE +  N+ + 
Sbjct: 136 RDLAARNCLVGENHLVKVADFGLSRLMTGDTX---TAHAGAKFPIKWTAPESLAYNKFSI 192
Query: 410 KSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXX 468
           KSDV++FGVLL EI + G  P   +D      ++E      +  R               
Sbjct: 193 KSDVWAFGVLLWEIATYGMSPYPGID---LSQVYELLEKDYRMER--------------- 234
Query: 469 XXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 508
               G  +KV +L+ AC Q  PS RP  + +    + + Q
Sbjct: 235 --PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 272

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 126/280 (45%), Gaps = 33/280 (11%)
Query: 233 LGDSKTGGTYSGILPDGS-RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 291
           LG  + G  Y G+    S  VAVK LK  + + + EF  E      + HPNLV + G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 292 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 351
                YI+ EF+  G L  +L    R  + ++  + + +AT ++  + +L  K   + +H
Sbjct: 85  REPPFYIIIEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLEKK---NFIH 139
Query: 352 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTT 409
           RD+ A N L+ E     +   GLS+ +  +     T  AG  +   + APE +  N+ + 
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 410 KSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXX 468
           KSDV++FGVLL EI + G  P   +D      ++E      +  R               
Sbjct: 197 KSDVWAFGVLLWEIATYGMSPYPGID---LSQVYELLEKDYRMER--------------- 238
Query: 469 XXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 508
               G  +KV +L+ AC Q  PS RP  + +    + + Q
Sbjct: 239 --PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 276

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 126/280 (45%), Gaps = 33/280 (11%)
Query: 233 LGDSKTGGTYSGILPDGS-RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 291
           LG  + G  Y G+    S  VAVK LK  + + + EF  E      + HPNLV + G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 292 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 351
                YI+ EF+  G L  +L    R  + ++  + + +AT ++  + +L  K   + +H
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLEKK---NFIH 139
Query: 352 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTT 409
           RD+ A N L+ E     +   GLS+ +  +     T  AG  +   + APE +  N+ + 
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDT---XTAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 410 KSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXX 468
           KSDV++FGVLL EI + G  P   +D      ++E      +  R               
Sbjct: 197 KSDVWAFGVLLWEIATYGMSPYPGID---LSQVYELLEKDYRMER--------------- 238
Query: 469 XXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 508
               G  +KV +L+ AC Q  PS RP  + +    + + Q
Sbjct: 239 --PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 276

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 126/280 (45%), Gaps = 33/280 (11%)
Query: 233 LGDSKTGGTYSGILPDGS-RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 291
           LG  + G  Y G+    S  VAVK LK  + + + EF  E      + HPNLV + G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 292 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 351
                YI+ EF+  G L  +L    R  + ++  + + +AT ++  + +L  K   + +H
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLEKK---NFIH 134
Query: 352 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTT 409
           RD+ A N L+ E     +   GLS+ +  +     T  AG  +   + APE +  N+ + 
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 410 KSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXX 468
           KSDV++FGVLL EI + G  P   +D      ++E      +  R               
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPYPGID---LSQVYELLEKDYRMER--------------- 233
Query: 469 XXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 508
               G  +KV +L+ AC Q  PS RP  + +    + + Q
Sbjct: 234 --PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 126/280 (45%), Gaps = 33/280 (11%)
Query: 233 LGDSKTGGTYSGILPDGS-RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 291
           LG  + G  Y G+    S  VAVK LK  + + + EF  E      + HPNLV + G C 
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 292 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 351
                YI+ EF+  G L  +L    R  + ++  + + +AT ++  + +L  K   + +H
Sbjct: 81  REPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLEKK---NFIH 135
Query: 352 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTT 409
           RD+ A N L+ E     +   GLS+ +  +     T  AG  +   + APE +  N+ + 
Sbjct: 136 RDLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAPAGAKFPIKWTAPESLAYNKFSI 192
Query: 410 KSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXX 468
           KSDV++FGVLL EI + G  P   +D      ++E      +  R               
Sbjct: 193 KSDVWAFGVLLWEIATYGMSPYPGID---LSQVYELLEKDYRMER--------------- 234
Query: 469 XXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 508
               G  +KV +L+ AC Q  PS RP  + +    + + Q
Sbjct: 235 --PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 272

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 126/280 (45%), Gaps = 33/280 (11%)
Query: 233 LGDSKTGGTYSGILPDGS-RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 291
           LG  + G  Y G+    S  VAVK LK  + + + EF  E      + HPNLV + G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 292 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 351
                YI+ EF+  G L  +L    R  + ++  + + +AT ++  + +L  K   + +H
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLEKK---NFIH 139
Query: 352 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTT 409
           RD+ A N L+ E     +   GLS+ +  +     T  AG  +   + APE +  N+ + 
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 410 KSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXX 468
           KSDV++FGVLL EI + G  P   +D      ++E      +  R               
Sbjct: 197 KSDVWAFGVLLWEIATYGMSPYPGID---LSQVYELLEKDYRMER--------------- 238
Query: 469 XXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 508
               G  +KV +L+ AC Q  PS RP  + +    + + Q
Sbjct: 239 --PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 276

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 126/280 (45%), Gaps = 33/280 (11%)
Query: 233 LGDSKTGGTYSGILPDGS-RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 291
           LG  + G  Y G+    S  VAVK LK  + + + EF  E      + HPNLV + G C 
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 83
Query: 292 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 351
                YI+ EF+  G L  +L    R  + ++  + + +AT ++  + +L  K   + +H
Sbjct: 84  REPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLEKK---NFIH 138
Query: 352 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTT 409
           RD+ A N L+ E     +   GLS+ +  +     T  AG  +   + APE +  N+ + 
Sbjct: 139 RDLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLAYNKFSI 195
Query: 410 KSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXX 468
           KSDV++FGVLL EI + G  P   +D      ++E      +  R               
Sbjct: 196 KSDVWAFGVLLWEIATYGMSPYPGID---LSQVYELLEKDYRMER--------------- 237
Query: 469 XXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 508
               G  +KV +L+ AC Q  PS RP  + +    + + Q
Sbjct: 238 --PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 126/280 (45%), Gaps = 33/280 (11%)
Query: 233 LGDSKTGGTYSGILPDGS-RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 291
           LG  + G  Y G+    S  VAVK LK  + + + EF  E      + HPNLV + G C 
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 92
Query: 292 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 351
                YI+ EF+  G L  +L    R  + ++  + + +AT ++  + +L  K   + +H
Sbjct: 93  REPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLEKK---NFIH 147
Query: 352 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTT 409
           RD+ A N L+ E     +   GLS+ +  +     T  AG  +   + APE +  N+ + 
Sbjct: 148 RDLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLAYNKFSI 204
Query: 410 KSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXX 468
           KSDV++FGVLL EI + G  P   +D      ++E      +  R               
Sbjct: 205 KSDVWAFGVLLWEIATYGMSPYPGID---LSQVYELLEKDYRMER--------------- 246
Query: 469 XXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 508
               G  +KV +L+ AC Q  PS RP  + +    + + Q
Sbjct: 247 --PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 284

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 126/280 (45%), Gaps = 33/280 (11%)
Query: 233 LGDSKTGGTYSGILPDGS-RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 291
           LG  + G  Y G+    S  VAVK LK  + + + EF  E      + HPNLV + G C 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 292 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 351
                YI+ EF+  G L  +L    R  + ++  + + +AT ++  + +L  K   + +H
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLEKK---NFIH 136
Query: 352 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTT 409
           RD+ A N L+ E     +   GLS+ +  +     T  AG  +   + APE +  N+ + 
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLAYNKFSI 193
Query: 410 KSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXX 468
           KSDV++FGVLL EI + G  P   +D      ++E      +  R               
Sbjct: 194 KSDVWAFGVLLWEIATYGMSPYPGID---LSQVYELLEKDYRMER--------------- 235
Query: 469 XXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 508
               G  +KV +L+ AC Q  PS RP  + +    + + Q
Sbjct: 236 --PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 273

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 126/280 (45%), Gaps = 33/280 (11%)
Query: 233 LGDSKTGGTYSGILPDGS-RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 291
           LG  + G  Y G+    S  VAVK LK  + + + EF  E      + HPNLV + G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 292 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 351
                YI+ EF+  G L  +L    R  + ++  + + +AT ++  + +L  K   + +H
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLEKK---NFIH 139
Query: 352 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTT 409
           RD+ A N L+ E     +   GLS+ +  +     T  AG  +   + APE +  N+ + 
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 410 KSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXX 468
           KSDV++FGVLL EI + G  P   +D      ++E      +  R               
Sbjct: 197 KSDVWAFGVLLWEIATYGMSPYPGID---LSQVYELLEKDYRMER--------------- 238
Query: 469 XXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 508
               G  +KV +L+ AC Q  PS RP  + +    + + Q
Sbjct: 239 --PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 276

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 126/280 (45%), Gaps = 33/280 (11%)
Query: 233 LGDSKTGGTYSGILPDGS-RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 291
           LG  + G  Y G+    S  VAVK LK  + + + EF  E      + HPNLV + G C 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 292 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 351
                YI+ EF+  G L  +L    R  + ++  + + +AT ++  + +L  K   + +H
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLEKK---NFIH 136
Query: 352 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTT 409
           RD+ A N L+ E     +   GLS+ +  +     T  AG  +   + APE +  N+ + 
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLAYNKFSI 193
Query: 410 KSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXX 468
           KSDV++FGVLL EI + G  P   +D      ++E      +  R               
Sbjct: 194 KSDVWAFGVLLWEIATYGMSPYPGID---LSQVYELLEKDYRMER--------------- 235
Query: 469 XXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 508
               G  +KV +L+ AC Q  PS RP  + +    + + Q
Sbjct: 236 --PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 273

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 125/280 (44%), Gaps = 33/280 (11%)
Query: 233 LGDSKTGGTYSGILPDGS-RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 291
           LG  + G  Y G+    S  VAVK LK  + + + EF  E      + HPNLV + G C 
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 292 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 351
                YI+ EF+  G L  +L    R  + +   + + +AT ++  + +L  K   + +H
Sbjct: 78  REPPFYIIIEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIH 132
Query: 352 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTT 409
           RD+ A N L+ E     +   GLS+ +  +     T  AG  +   + APE +  N+ + 
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLMTGDTX---TAHAGAKFPIKWTAPESLAYNKFSI 189
Query: 410 KSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXX 468
           KSDV++FGVLL EI + G  P   +D      ++E      +  R               
Sbjct: 190 KSDVWAFGVLLWEIATYGMSPYPGIDP---SQVYELLEKDYRMER--------------- 231
Query: 469 XXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 508
               G  +KV +L+ AC Q  PS RP  + +    + + Q
Sbjct: 232 --PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 269

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 126/280 (45%), Gaps = 33/280 (11%)
Query: 233 LGDSKTGGTYSGILPDGS-RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 291
           LG  + G  Y G+    S  VAVK LK  + + + EF  E      + HPNLV + G C 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 292 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 351
                YI+ EF+  G L  +L    R  + ++  + + +AT ++  + +L  K   + +H
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLEKK---NFIH 136
Query: 352 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTT 409
           RD+ A N L+ E     +   GLS+ +  +     T  AG  +   + APE +  N+ + 
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAPAGAKFPIKWTAPESLAYNKFSI 193
Query: 410 KSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXX 468
           KSDV++FGVLL EI + G  P   +D      ++E      +  R               
Sbjct: 194 KSDVWAFGVLLWEIATYGMSPYPGID---LSQVYELLEKDYRMER--------------- 235
Query: 469 XXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 508
               G  +KV +L+ AC Q  PS RP  + +    + + Q
Sbjct: 236 --PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 273

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 125/280 (44%), Gaps = 33/280 (11%)
Query: 233 LGDSKTGGTYSGILPDGS-RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 291
           LG  + G  Y G+    S  VAVK LK  + + + EF  E      + HPNLV + G C 
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 292 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 351
                YI+ EF+  G L  +L    R  + +   + + +AT ++  + +L  K   + +H
Sbjct: 78  REPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIH 132
Query: 352 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTT 409
           RD+ A N L+ E     +   GLS+ +  +     T  AG  +   + APE +  N+ + 
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLMTGDTF---TAHAGAKFPIKWTAPESLAYNKFSI 189
Query: 410 KSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXX 468
           KSDV++FGVLL EI + G  P   +D      ++E      +  R               
Sbjct: 190 KSDVWAFGVLLWEIATYGMSPYPGIDP---SQVYELLEKDYRMER--------------- 231
Query: 469 XXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 508
               G  +KV +L+ AC Q  PS RP  + +    + + Q
Sbjct: 232 --PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 269

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 125/280 (44%), Gaps = 33/280 (11%)
Query: 233 LGDSKTGGTYSGILPDGS-RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 291
           LG  + G  Y G+    S  VAVK LK  + + + EF  E      + HPNLV + G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 292 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 351
                YI+ EF+  G L  +L    R  + +   + + +AT ++  + +L  K   + +H
Sbjct: 80  REPPFYIIIEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIH 134
Query: 352 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTT 409
           RD+ A N L+ E     +   GLS+ +  +     T  AG  +   + APE +  N+ + 
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 410 KSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXX 468
           KSDV++FGVLL EI + G  P   +D      ++E      +  R               
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPYPGID---LSQVYELLEKDYRMER--------------- 233
Query: 469 XXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 508
               G  +KV +L+ AC Q  PS RP  + +    + + Q
Sbjct: 234 --PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 125/280 (44%), Gaps = 33/280 (11%)
Query: 233 LGDSKTGGTYSGILPDGS-RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 291
           LG  + G  Y G+    S  VAVK LK  + + + EF  E      + HPNLV + G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 292 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 351
                YI+ EF+  G L  +L    R  + +   + + +AT ++  + +L  K   + +H
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIH 134
Query: 352 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTT 409
           RD+ A N L+ E     +   GLS+ +  +     T  AG  +   + APE +  N+ + 
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 410 KSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXX 468
           KSDV++FGVLL EI + G  P   +D      ++E      +  R               
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPYPGID---LSQVYELLEKDYRMER--------------- 233
Query: 469 XXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 508
               G  +KV +L+ AC Q  PS RP  + +    + + Q
Sbjct: 234 --PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 125/280 (44%), Gaps = 33/280 (11%)
Query: 233 LGDSKTGGTYSGILPDGS-RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 291
           LG  + G  Y G+    S  VAVK LK  + + + EF  E      + HPNLV + G C 
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 292 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 351
                YI+ EF+  G L  +L    R  + +   + + +AT ++  + +L  K   + +H
Sbjct: 78  REPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIH 132
Query: 352 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTT 409
           RD+ A N L+ E     +   GLS+ +  +     T  AG  +   + APE +  N+ + 
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLMTGDTX---TAHAGAKFPIKWTAPESLAYNKFSI 189
Query: 410 KSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXX 468
           KSDV++FGVLL EI + G  P   +D      ++E      +  R               
Sbjct: 190 KSDVWAFGVLLWEIATYGMSPYPGIDP---SQVYELLEKDYRMER--------------- 231
Query: 469 XXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 508
               G  +KV +L+ AC Q  PS RP  + +    + + Q
Sbjct: 232 --PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 269

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 125/280 (44%), Gaps = 33/280 (11%)
Query: 233 LGDSKTGGTYSGILPDGS-RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 291
           LG  + G  Y G+    S  VAVK LK  + + + EF  E      + HPNLV + G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 292 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 351
                YI+ EF+  G L  +L    R  + +   + + +AT ++  + +L  K   + +H
Sbjct: 80  REPPFYIIIEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIH 134
Query: 352 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTT 409
           RD+ A N L+ E     +   GLS+ +  +     T  AG  +   + APE +  N+ + 
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 410 KSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXX 468
           KSDV++FGVLL EI + G  P   +D      ++E      +  R               
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPYPGID---LSQVYELLEKDYRMER--------------- 233
Query: 469 XXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 508
               G  +KV +L+ AC Q  PS RP  + +    + + Q
Sbjct: 234 --PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 125/280 (44%), Gaps = 33/280 (11%)
Query: 233 LGDSKTGGTYSGILPDGS-RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 291
           LG  + G  Y G+    S  VAVK LK  + + + EF  E      + HPNLV + G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 292 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 351
                YI+ EF+  G L  +L    R  + +   + + +AT ++  + +L  K   + +H
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIH 134
Query: 352 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTT 409
           RD+ A N L+ E     +   GLS+ +  +     T  AG  +   + APE +  N+ + 
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 410 KSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXX 468
           KSDV++FGVLL EI + G  P   +D      ++E      +  R               
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPYPGID---LSQVYELLEKDYRMER--------------- 233
Query: 469 XXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 508
               G  +KV +L+ AC Q  PS RP  + +    + + Q
Sbjct: 234 --PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 125/280 (44%), Gaps = 33/280 (11%)
Query: 233 LGDSKTGGTYSGILPDGS-RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 291
           LG  + G  Y G+    S  VAVK LK  + + + EF  E      + HPNLV + G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 292 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 351
                YI+ EF+  G L  +L    R  + +   + + +AT ++  + +L  K   + +H
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIH 139
Query: 352 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTT 409
           RD+ A N L+ E     +   GLS+ +  +     T  AG  +   + APE +  N+ + 
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 410 KSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXX 468
           KSDV++FGVLL EI + G  P   +D      ++E      +  R               
Sbjct: 197 KSDVWAFGVLLWEIATYGMSPYPGID---LSQVYELLEKDYRMER--------------- 238
Query: 469 XXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 508
               G  +KV +L+ AC Q  PS RP  + +    + + Q
Sbjct: 239 --PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 276

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 80/274 (29%), Positives = 125/274 (45%), Gaps = 34/274 (12%)
Query: 233 LGDSKTGGTYSGILPDGS-RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 291
           LG  + G  Y G+    S  VAVK LK  + + + EF  E      + HPNLV + G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 292 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 351
                YI+ EF+  G L  +L    R  + ++  + + +AT ++  + +L  K   + +H
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLEKK---NFIH 134
Query: 352 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTT 409
           RD+ A N L+ E     +   GLS+ +  +     T  AG  +   + APE +  N+ + 
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 410 KSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXX 468
           KSDV++FGVLL EI + G  P   +D      ++E      +  R               
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPYPGID---LSQVYELLEKDYRMER--------------- 233
Query: 469 XXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 502
               G  +KV +L+ AC Q  PS RP  +  +HQ
Sbjct: 234 --PEGCPEKVYELMRACWQWNPSDRPSFAE-IHQ 264

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 127/280 (45%), Gaps = 33/280 (11%)
Query: 233 LGDSKTGGTYSGILPDGS-RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 291
           LG  + G  Y G+    S  VAVK LK  + +  +EF  E      + HPNLV + G C 
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 292 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 351
                YI+ EF+  G L  +L    R  + +   + + +AT ++  + +L  K   + +H
Sbjct: 287 REPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIH 341
Query: 352 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTT 409
           R++ A N L+ E     +   GLS+ +  +     T  AG  +   + APE +  N+ + 
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLAYNKFSI 398
Query: 410 KSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXX 468
           KSDV++FGVLL EI + G  P   +D      ++E    L + +R               
Sbjct: 399 KSDVWAFGVLLWEIATYGMSPYPGID---LSQVYEL---LEKDYR--------------M 438
Query: 469 XXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 508
               G  +KV +L+ AC Q  PS RP  + +    + + Q
Sbjct: 439 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 128/280 (45%), Gaps = 33/280 (11%)
Query: 233 LGDSKTGGTYSGILPDGS-RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 291
           LG  + G  Y G+    S  VAVK LK  + +  +EF  E      + HPNLV + G C 
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 325
Query: 292 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 351
                YI+ EF+  G L  +L    R  + ++  + + +AT ++  + +L  K   + +H
Sbjct: 326 REPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLEKK---NFIH 380
Query: 352 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTT 409
           R++ A N L+ E     +   GLS+ +  +     T  AG  +   + APE +  N+ + 
Sbjct: 381 RNLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLAYNKFSI 437
Query: 410 KSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXX 468
           KSDV++FGVLL EI + G  P   +D      ++E    L + +R               
Sbjct: 438 KSDVWAFGVLLWEIATYGMSPYPGID---LSQVYEL---LEKDYR--------------M 477
Query: 469 XXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 508
               G  +KV +L+ AC Q  PS RP  + +    + + Q
Sbjct: 478 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 517

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 125/280 (44%), Gaps = 35/280 (12%)
Query: 233 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 292
           LG  + G    G       VAVK +K  S   + EF+ E     +L HP LV   G C  
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 293 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 352
               YIV E++ NG L   L+++   G+ L+ +  +++   + +G+AFL        +HR
Sbjct: 75  EYPIYIVTEYISNGCL---LNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHR 128
Query: 353 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT---YGYLAPEFVYRNELTT 409
           D+ A N L+D +    +   G++++    V+ ++ V + GT     + APE  +  + ++
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRY----VLDDQYVSSVGTKFPVKWSAPEVFHYFKYSS 184
Query: 410 KSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXX 468
           KSDV++FG+L+ E+ S G+ P     +       E    + Q HR               
Sbjct: 185 KSDVWAFGILMWEVFSLGKMPYDLYTNS------EVVLKVSQGHRLYRPHLAS------- 231
Query: 469 XXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 508
                    +  ++Y+C   +P  RP    ++  ++ L +
Sbjct: 232 -------DTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 99/200 (49%), Gaps = 13/200 (6%)
Query: 233 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 292
           LG  + G  + G     ++VAVK LK+ S      F +E     +L H  LV +      
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 293 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 352
               YI+ E++ NG L  +L      G  L     + +A  +A+G+AF+ ++   + +HR
Sbjct: 80  E-PIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHR 133
Query: 353 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 410
           D+RA+N+L+ +     +   GL++ +      E T   G  +   + APE +     T K
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIE---DAEXTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 411 SDVYSFGVLLLEIVS-GRRP 429
           SDV+SFG+LL EIV+ GR P
Sbjct: 191 SDVWSFGILLTEIVTHGRIP 210

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/274 (28%), Positives = 119/274 (43%), Gaps = 34/274 (12%)
Query: 233 LGDSKTGGTYSGILPDGS-RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 291
           LG  + G  Y G+    S  VAVK LK  + + + EF  E      + HPNLV + G C 
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 98
Query: 292 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 351
                YIV E++  G L  +L    R    +   + + +AT ++  + +L  K   + +H
Sbjct: 99  LEPPFYIVTEYMPYGNLLDYLRECNR--EEVTAVVLLYMATQISSAMEYLEKK---NFIH 153
Query: 352 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTT 409
           RD+ A N L+ E     +   GLS+ +  +     T  AG  +   + APE +  N  + 
Sbjct: 154 RDLAARNCLVGENHVVKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLAYNTFSI 210
Query: 410 KSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXX 468
           KSDV++FGVLL EI + G  P   +D      + E    + Q                  
Sbjct: 211 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYDLLEKGYRMEQPE---------------- 254
Query: 469 XXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 502
               G   KV +L+ AC +  P+ RP  +   HQ
Sbjct: 255 ----GCPPKVYELMRACWKWSPADRPSFAE-THQ 283

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 99/200 (49%), Gaps = 13/200 (6%)
Query: 233 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 292
           LG  + G  + G     ++VAVK LK+ S      F +E     +L H  LV +      
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVTQ 85
Query: 293 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 352
               YI+ E++ NG L  +L      G  L     + +A  +A+G+AF+ ++   + +HR
Sbjct: 86  E-PIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHR 139
Query: 353 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 410
           D+RA+N+L+ +     +   GL++ +      E T   G  +   + APE +     T K
Sbjct: 140 DLRAANILVSDTLSCKIADFGLARLIE---DNEXTAREGAKFPIKWTAPEAINYGTFTIK 196
Query: 411 SDVYSFGVLLLEIVS-GRRP 429
           SDV+SFG+LL EIV+ GR P
Sbjct: 197 SDVWSFGILLTEIVTHGRIP 216

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 101/200 (50%), Gaps = 13/200 (6%)
Query: 233 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 292
           LG  + G  + G     ++VAVK LK+ S      F +E     +L H  LV +      
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVTQ 80
Query: 293 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 352
               YI+ E++ NG L  +L   P G + L     + +A  +A+G+AF+ ++   + +HR
Sbjct: 81  E-PIYIITEYMENGSLVDFLK-TPSGIK-LTINKLLDMAAQIAEGMAFIEER---NYIHR 134
Query: 353 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 410
           D+RA+N+L+ +     +   GL++ +      E T   G  +   + APE +     T K
Sbjct: 135 DLRAANILVSDTLSCKIADFGLARLIE---DNEXTAREGAKFPIKWTAPEAINYGTFTIK 191
Query: 411 SDVYSFGVLLLEIVS-GRRP 429
           SDV+SFG+LL EIV+ GR P
Sbjct: 192 SDVWSFGILLTEIVTHGRIP 211

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 99/200 (49%), Gaps = 13/200 (6%)
Query: 233 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 292
           LG  + G  + G     ++VAVK LK+ S      F +E     +L H  LV +      
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVTQ 81
Query: 293 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 352
               YI+ E++ NG L  +L      G  L     + +A  +A+G+AF+ ++   + +HR
Sbjct: 82  E-PIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHR 135
Query: 353 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 410
           D+RA+N+L+ +     +   GL++ +      E T   G  +   + APE +     T K
Sbjct: 136 DLRAANILVSDTLSCKIADFGLARLIE---DNEXTAREGAKFPIKWTAPEAINYGTFTIK 192
Query: 411 SDVYSFGVLLLEIVS-GRRP 429
           SDV+SFG+LL EIV+ GR P
Sbjct: 193 SDVWSFGILLTEIVTHGRIP 212

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 101/200 (50%), Gaps = 13/200 (6%)
Query: 233 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 292
           LG  + G  + G     ++VAVK LK+ S      F +E     +L H  LV +      
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 293 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 352
               YI+ E++ NG L  +L   P G + L     + +A  +A+G+AF+ ++   + +HR
Sbjct: 80  E-PIYIITEYMENGSLVDFLK-TPSGIK-LTINKLLDMAAQIAEGMAFIEER---NYIHR 133
Query: 353 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 410
           D+RA+N+L+ +     +   GL++ +      E T   G  +   + APE +     T K
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIE---DNEXTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 411 SDVYSFGVLLLEIVS-GRRP 429
           SDV+SFG+LL EIV+ GR P
Sbjct: 191 SDVWSFGILLTEIVTHGRIP 210

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 99/200 (49%), Gaps = 13/200 (6%)
Query: 233 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 292
           LG  + G  + G     ++VAVK LK+ S      F +E     +L H  LV +      
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVTQ 87
Query: 293 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 352
               YI+ E++ NG L  +L      G  L     + +A  +A+G+AF+ ++   + +HR
Sbjct: 88  E-PIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHR 141
Query: 353 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 410
           D+RA+N+L+ +     +   GL++ +      E T   G  +   + APE +     T K
Sbjct: 142 DLRAANILVSDTLSCKIADFGLARLIE---DNEXTAREGAKFPIKWTAPEAINYGTFTIK 198
Query: 411 SDVYSFGVLLLEIVS-GRRP 429
           SDV+SFG+LL EIV+ GR P
Sbjct: 199 SDVWSFGILLTEIVTHGRIP 218

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 99/200 (49%), Gaps = 13/200 (6%)
Query: 233 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 292
           LG  + G  + G     ++VAVK LK+ S      F +E     +L H  LV +      
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 293 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 352
               YI+ E++ NG L  +L      G  L     + +A  +A+G+AF+ ++   + +HR
Sbjct: 80  E-PIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHR 133
Query: 353 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 410
           D+RA+N+L+ +     +   GL++ +      E T   G  +   + APE +     T K
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIE---DNEXTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 411 SDVYSFGVLLLEIVS-GRRP 429
           SDV+SFG+LL EIV+ GR P
Sbjct: 191 SDVWSFGILLTEIVTHGRIP 210

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 101/200 (50%), Gaps = 13/200 (6%)
Query: 233 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 292
           LG  + G  + G     ++VAVK LK+ S      F +E     +L H  LV +      
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVTQ 85
Query: 293 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 352
               YI+ E++ NG L  +L   P G + L     + +A  +A+G+AF+ ++   + +HR
Sbjct: 86  E-PIYIITEYMENGSLVDFLK-TPSGIK-LTINKLLDMAAQIAEGMAFIEER---NYIHR 139
Query: 353 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 410
           D+RA+N+L+ +     +   GL++ +      E T   G  +   + APE +     T K
Sbjct: 140 DLRAANILVSDTLSCKIADFGLARLIE---DNEYTAREGAKFPIKWTAPEAINYGTFTIK 196
Query: 411 SDVYSFGVLLLEIVS-GRRP 429
           SDV+SFG+LL EIV+ GR P
Sbjct: 197 SDVWSFGILLTEIVTHGRIP 216

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 101/200 (50%), Gaps = 13/200 (6%)
Query: 233 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 292
           LG  + G  + G     ++VAVK LK+ S      F +E     +L H  LV +      
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVTQ 84
Query: 293 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 352
               YI+ E++ NG L  +L   P G + L     + +A  +A+G+AF+ ++   + +HR
Sbjct: 85  E-PIYIITEYMENGSLVDFLK-TPSGIK-LTINKLLDMAAQIAEGMAFIEER---NYIHR 138
Query: 353 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 410
           D+RA+N+L+ +     +   GL++ +      E T   G  +   + APE +     T K
Sbjct: 139 DLRAANILVSDTLSCKIADFGLARLIE---DNEYTAREGAKFPIKWTAPEAINYGTFTIK 195
Query: 411 SDVYSFGVLLLEIVS-GRRP 429
           SDV+SFG+LL EIV+ GR P
Sbjct: 196 SDVWSFGILLTEIVTHGRIP 215

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 99/200 (49%), Gaps = 13/200 (6%)
Query: 233 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 292
           LG  + G  + G     ++VAVK LK+ S      F +E     +L H  LV +      
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVTQ 88
Query: 293 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 352
               YI+ E++ NG L  +L      G  L     + +A  +A+G+AF+ ++   + +HR
Sbjct: 89  E-PIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHR 142
Query: 353 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 410
           D+RA+N+L+ +     +   GL++ +      E T   G  +   + APE +     T K
Sbjct: 143 DLRAANILVSDTLSCKIADFGLARLIE---DNEXTAREGAKFPIKWTAPEAINYGTFTIK 199
Query: 411 SDVYSFGVLLLEIVS-GRRP 429
           SDV+SFG+LL EIV+ GR P
Sbjct: 200 SDVWSFGILLTEIVTHGRIP 219

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 101/200 (50%), Gaps = 13/200 (6%)
Query: 233 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 292
           LG  + G  + G     ++VAVK LK+ S      F +E     +L H  LV +      
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVTQ 89
Query: 293 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 352
               YI+ E++ NG L  +L   P G + L     + +A  +A+G+AF+ ++   + +HR
Sbjct: 90  E-PIYIITEYMENGSLVDFLK-TPSGIK-LTINKLLDMAAQIAEGMAFIEER---NYIHR 143
Query: 353 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 410
           D+RA+N+L+ +     +   GL++ +      E T   G  +   + APE +     T K
Sbjct: 144 DLRAANILVSDTLSCKIADFGLARLIE---DNEYTAREGAKFPIKWTAPEAINYGTFTIK 200
Query: 411 SDVYSFGVLLLEIVS-GRRP 429
           SDV+SFG+LL EIV+ GR P
Sbjct: 201 SDVWSFGILLTEIVTHGRIP 220

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 101/200 (50%), Gaps = 13/200 (6%)
Query: 233 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 292
           LG  + G  + G     ++VAVK LK+ S      F +E     +L H  LV +      
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 293 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 352
               YI+ E++ NG L  +L   P G + L     + +A  +A+G+AF+ ++   + +HR
Sbjct: 80  E-PIYIITEYMENGSLVDFLK-TPSGIK-LTINKLLDMAAQIAEGMAFIEER---NYIHR 133
Query: 353 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 410
           D+RA+N+L+ +     +   GL++ +      E T   G  +   + APE +     T K
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIE---DNEYTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 411 SDVYSFGVLLLEIVS-GRRP 429
           SDV+SFG+LL EIV+ GR P
Sbjct: 191 SDVWSFGILLTEIVTHGRIP 210

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 101/200 (50%), Gaps = 13/200 (6%)
Query: 233 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 292
           LG  + G  + G     ++VAVK LK+ S      F +E     +L H  LV +      
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVTQ 74
Query: 293 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 352
               YI+ E++ NG L  +L   P G + L     + +A  +A+G+AF+ ++   + +HR
Sbjct: 75  E-PIYIITEYMENGSLVDFLK-TPSGIK-LTINKLLDMAAQIAEGMAFIEER---NYIHR 128
Query: 353 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 410
           D+RA+N+L+ +     +   GL++ +      E T   G  +   + APE +     T K
Sbjct: 129 DLRAANILVSDTLSCKIADFGLARLIE---DNEYTAREGAKFPIKWTAPEAINYGTFTIK 185
Query: 411 SDVYSFGVLLLEIVS-GRRP 429
           SDV+SFG+LL EIV+ GR P
Sbjct: 186 SDVWSFGILLTEIVTHGRIP 205

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 110/224 (49%), Gaps = 22/224 (9%)
Query: 209 PSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEF 268
           P W+V   E L+ + +        LG  + G  + G     ++VAVK LK+ S      F
Sbjct: 2   PEWEV-PRETLKLVER--------LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAF 51
Query: 269 YSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRM 328
            +E     +L H  LV +          YI+ E++ NG L  +L   P G + L     +
Sbjct: 52  LAEANLMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLK-TPSGIK-LTINKLL 108
Query: 329 KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 388
            +A  +A+G+AF+ ++   + +HR++RA+N+L+ +     +   GL++ +      E T 
Sbjct: 109 DMAAQIAEGMAFIEER---NYIHRNLRAANILVSDTLSCKIADFGLARLIE---DNEYTA 162
Query: 389 MAGGTY--GYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRP 429
             G  +   + APE +     T KSDV+SFG+LL EIV+ GR P
Sbjct: 163 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 206

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 92/180 (51%), Gaps = 9/180 (5%)
Query: 249 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVNG 306
           G  VAVK+L+ S+ +  ++F  EI     L H N+V  KG CY  G R   ++ EF+  G
Sbjct: 42  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYG 101
Query: 307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 366
            L  +L    +    +D    ++  + + +G+ +L  K     +HRD+   N+L++ E  
Sbjct: 102 SLREYLQ---KHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENR 155
Query: 367 AHLMGVGLSKFVPWEVMQERTVMAGGTYGY-LAPEFVYRNELTTKSDVYSFGVLLLEIVS 425
             +   GL+K +P +    +    G +  +  APE +  ++ +  SDV+SFGV+L E+ +
Sbjct: 156 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/181 (33%), Positives = 93/181 (51%), Gaps = 12/181 (6%)
Query: 249 GSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVN 305
           G  VAVK LK     Q +  +  EI     L+H +++  KGCC D G++   +V E+V  
Sbjct: 43  GEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYV-- 100
Query: 306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 365
            PL     ++PR   S+  A  +  A  + +G+A+LH +   H +HR++ A NVLLD + 
Sbjct: 101 -PLGSLRDYLPR--HSIGLAQLLLFAQQICEGMAYLHSQ---HYIHRNLAARNVLLDNDR 154
Query: 366 GAHLMGVGLSKFVPWEVMQERTVMAGGTYGY-LAPEFVYRNELTTKSDVYSFGVLLLEIV 424
              +   GL+K VP      R    G +  +  APE +   +    SDV+SFGV L E++
Sbjct: 155 LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELL 214
Query: 425 S 425
           +
Sbjct: 215 T 215

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 107/224 (47%), Gaps = 21/224 (9%)
Query: 209 PSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEF 268
           P+W++   E ++ + K        LG  + G  + G   + ++VAVK LK  +   +  F
Sbjct: 5   PAWEI-PRESIKLVKK--------LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA-F 54
Query: 269 YSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRM 328
             E      L H  LV +          YI+ EF+  G L  +L     GG+ L     +
Sbjct: 55  LEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKS-DEGGKVL-LPKLI 112
Query: 329 KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 388
             +  +A+G+A++  K   + +HRD+RA+NVL+ E     +   GL++ +      E T 
Sbjct: 113 DFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIE---DNEYTA 166
Query: 389 MAGGTY--GYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRP 429
             G  +   + APE +     T KS+V+SFG+LL EIV+ G+ P
Sbjct: 167 REGAKFPIKWTAPEAINFGCFTIKSNVWSFGILLYEIVTYGKIP 210

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/181 (33%), Positives = 93/181 (51%), Gaps = 12/181 (6%)
Query: 249 GSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVN 305
           G  VAVK LK     Q +  +  EI     L+H +++  KGCC D G++   +V E+V  
Sbjct: 43  GEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYV-- 100
Query: 306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 365
            PL     ++PR   S+  A  +  A  + +G+A+LH +   H +HR++ A NVLLD + 
Sbjct: 101 -PLGSLRDYLPR--HSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRNLAARNVLLDNDR 154
Query: 366 GAHLMGVGLSKFVPWEVMQERTVMAGGTYGY-LAPEFVYRNELTTKSDVYSFGVLLLEIV 424
              +   GL+K VP      R    G +  +  APE +   +    SDV+SFGV L E++
Sbjct: 155 LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELL 214
Query: 425 S 425
           +
Sbjct: 215 T 215

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 98/202 (48%), Gaps = 12/202 (5%)
Query: 231 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 290
           + LG  + G  + G   + ++VAVK LK  +   +  F  E      L H  LV +    
Sbjct: 19  KRLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA-FLEEANLMKTLQHDKLVRLYAVV 77
Query: 291 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 350
                 YI+ E++  G L  +L     GG+ L     +  +  +A+G+A++  K   + +
Sbjct: 78  TREEPIYIITEYMAKGSLLDFLKS-DEGGKVL-LPKLIDFSAQIAEGMAYIERK---NYI 132
Query: 351 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELT 408
           HRD+RA+NVL+ E     +   GL++ +      E T   G  +   + APE +     T
Sbjct: 133 HRDLRAANVLVSESLMCKIADFGLARVIE---DNEYTAREGAKFPIKWTAPEAINFGCFT 189
Query: 409 TKSDVYSFGVLLLEIVS-GRRP 429
            KSDV+SFG+LL EIV+ G+ P
Sbjct: 190 IKSDVWSFGILLYEIVTYGKIP 211

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/181 (33%), Positives = 92/181 (50%), Gaps = 12/181 (6%)
Query: 249 GSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG--DRYIVYEFVVN 305
           G  VAVK LK  +  Q +  +  EI     L+H +++  KGCC D G     +V E+V  
Sbjct: 60  GEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYV-- 117
Query: 306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 365
            PL     ++PR   S+  A  +  A  + +G+A+LH +   H +HRD+ A NVLLD + 
Sbjct: 118 -PLGSLRDYLPR--HSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDR 171
Query: 366 GAHLMGVGLSKFVPWEVMQERTVMAGGTYGY-LAPEFVYRNELTTKSDVYSFGVLLLEIV 424
              +   GL+K VP      R    G +  +  APE +   +    SDV+SFGV L E++
Sbjct: 172 LVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELL 231
Query: 425 S 425
           +
Sbjct: 232 T 232

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 92/180 (51%), Gaps = 9/180 (5%)
Query: 249 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVNG 306
           G  VAVK+L+ S+ +  ++F  EI     L H N+V  KG CY  G R   ++ E++  G
Sbjct: 39  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 98
Query: 307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 366
            L  +L    +    +D    ++  + + +G+ +L  K     +HRD+   N+L++ E  
Sbjct: 99  SLRDYLQ---KHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENR 152
Query: 367 AHLMGVGLSKFVPWEVMQERTVMAGGTYGY-LAPEFVYRNELTTKSDVYSFGVLLLEIVS 425
             +   GL+K +P +    +    G +  +  APE +  ++ +  SDV+SFGV+L E+ +
Sbjct: 153 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 92/180 (51%), Gaps = 9/180 (5%)
Query: 249 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVNG 306
           G  VAVK+L+ S+ +  ++F  EI     L H N+V  KG CY  G R   ++ E++  G
Sbjct: 37  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 96
Query: 307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 366
            L  +L    +    +D    ++  + + +G+ +L  K     +HRD+   N+L++ E  
Sbjct: 97  SLRDYLQ---KHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENR 150
Query: 367 AHLMGVGLSKFVPWEVMQERTVMAGGTYGY-LAPEFVYRNELTTKSDVYSFGVLLLEIVS 425
             +   GL+K +P +    +    G +  +  APE +  ++ +  SDV+SFGV+L E+ +
Sbjct: 151 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 92/180 (51%), Gaps = 9/180 (5%)
Query: 249 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVNG 306
           G  VAVK+L+ S+ +  ++F  EI     L H N+V  KG CY  G R   ++ E++  G
Sbjct: 38  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 97
Query: 307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 366
            L  +L    +    +D    ++  + + +G+ +L  K     +HRD+   N+L++ E  
Sbjct: 98  SLRDYLQ---KHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENR 151
Query: 367 AHLMGVGLSKFVPWEVMQERTVMAGGTYGY-LAPEFVYRNELTTKSDVYSFGVLLLEIVS 425
             +   GL+K +P +    +    G +  +  APE +  ++ +  SDV+SFGV+L E+ +
Sbjct: 152 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 113/233 (48%), Gaps = 30/233 (12%)
Query: 214 FTTEELRSITKNFSEGNRLLGDSKTGGTYSG-ILPDGSRVAVKRL-------KRSSFQRK 265
           F    L ++  N  E  + +G    G  + G ++ D S VA+K L       +    ++ 
Sbjct: 8   FPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKF 67
Query: 266 KEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWA 325
           +EF  E+   + L+HPN+V + G    H    +V EFV  G L    H +      + W+
Sbjct: 68  QEFQREVFIMSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDL---YHRLLDKAHPIKWS 122
Query: 326 MRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL---DEEFG--AHLMGVGLSKFVPW 380
           +++++   +A GI ++ ++  P +VHRD+R+ N+ L   DE     A +   GLS+    
Sbjct: 123 VKLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ---- 177
Query: 381 EVMQERTVMAG--GTYGYLAPEFVYRNE--LTTKSDVYSFGVLLLEIVSGRRP 429
              Q    ++G  G + ++APE +   E   T K+D YSF ++L  I++G  P
Sbjct: 178 ---QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP 227

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 92/180 (51%), Gaps = 9/180 (5%)
Query: 249 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVNG 306
           G  VAVK+L+ S+ +  ++F  EI     L H N+V  KG CY  G R   ++ E++  G
Sbjct: 39  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 98
Query: 307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 366
            L  +L    +    +D    ++  + + +G+ +L  K     +HRD+   N+L++ E  
Sbjct: 99  SLRDYLQ---KHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENR 152
Query: 367 AHLMGVGLSKFVPWEVMQERTVMAGGTYGY-LAPEFVYRNELTTKSDVYSFGVLLLEIVS 425
             +   GL+K +P +    +    G +  +  APE +  ++ +  SDV+SFGV+L E+ +
Sbjct: 153 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 92/180 (51%), Gaps = 9/180 (5%)
Query: 249 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVNG 306
           G  VAVK+L+ S+ +  ++F  EI     L H N+V  KG CY  G R   ++ E++  G
Sbjct: 70  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 129
Query: 307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 366
            L  +L    +    +D    ++  + + +G+ +L  K     +HRD+   N+L++ E  
Sbjct: 130 SLRDYLQ---KHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENR 183
Query: 367 AHLMGVGLSKFVPWEVMQERTVMAGGTYGY-LAPEFVYRNELTTKSDVYSFGVLLLEIVS 425
             +   GL+K +P +    +    G +  +  APE +  ++ +  SDV+SFGV+L E+ +
Sbjct: 184 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 92/180 (51%), Gaps = 9/180 (5%)
Query: 249 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVNG 306
           G  VAVK+L+ S+ +  ++F  EI     L H N+V  KG CY  G R   ++ E++  G
Sbjct: 42  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 101
Query: 307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 366
            L  +L    +    +D    ++  + + +G+ +L  K     +HRD+   N+L++ E  
Sbjct: 102 SLRDYLQ---KHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENR 155
Query: 367 AHLMGVGLSKFVPWEVMQERTVMAGGTYGY-LAPEFVYRNELTTKSDVYSFGVLLLEIVS 425
             +   GL+K +P +    +    G +  +  APE +  ++ +  SDV+SFGV+L E+ +
Sbjct: 156 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 93/181 (51%), Gaps = 11/181 (6%)
Query: 249 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVNG 306
           G  VAVK+L+ S+ +  ++F  EI     L H N+V  KG CY  G R   ++ E++  G
Sbjct: 42  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 101
Query: 307 PLDRWLH-HIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 365
            L  +L  H  R    +D    ++  + + +G+ +L  K     +HRD+   N+L++ E 
Sbjct: 102 SLRDYLQAHAER----IDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENEN 154
Query: 366 GAHLMGVGLSKFVPWEVMQERTVMAGGTYGY-LAPEFVYRNELTTKSDVYSFGVLLLEIV 424
              +   GL+K +P +    +    G +  +  APE +  ++ +  SDV+SFGV+L E+ 
Sbjct: 155 RVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 214
Query: 425 S 425
           +
Sbjct: 215 T 215

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 92/180 (51%), Gaps = 9/180 (5%)
Query: 249 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVNG 306
           G  VAVK+L+ S+ +  ++F  EI     L H N+V  KG CY  G R   ++ E++  G
Sbjct: 46  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 105
Query: 307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 366
            L  +L    +    +D    ++  + + +G+ +L  K     +HRD+   N+L++ E  
Sbjct: 106 SLRDYLQ---KHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENR 159
Query: 367 AHLMGVGLSKFVPWEVMQERTVMAGGTYGY-LAPEFVYRNELTTKSDVYSFGVLLLEIVS 425
             +   GL+K +P +    +    G +  +  APE +  ++ +  SDV+SFGV+L E+ +
Sbjct: 160 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 92/180 (51%), Gaps = 9/180 (5%)
Query: 249 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVNG 306
           G  VAVK+L+ S+ +  ++F  EI     L H N+V  KG CY  G R   ++ E++  G
Sbjct: 57  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 116
Query: 307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 366
            L  +L    +    +D    ++  + + +G+ +L  K     +HRD+   N+L++ E  
Sbjct: 117 SLRDYLQ---KHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENR 170
Query: 367 AHLMGVGLSKFVPWEVMQERTVMAGGTYGY-LAPEFVYRNELTTKSDVYSFGVLLLEIVS 425
             +   GL+K +P +    +    G +  +  APE +  ++ +  SDV+SFGV+L E+ +
Sbjct: 171 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 92/180 (51%), Gaps = 9/180 (5%)
Query: 249 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVNG 306
           G  VAVK+L+ S+ +  ++F  EI     L H N+V  KG CY  G R   ++ E++  G
Sbjct: 43  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 102
Query: 307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 366
            L  +L    +    +D    ++  + + +G+ +L  K     +HRD+   N+L++ E  
Sbjct: 103 SLRDYLQ---KHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENR 156
Query: 367 AHLMGVGLSKFVPWEVMQERTVMAGGTYGY-LAPEFVYRNELTTKSDVYSFGVLLLEIVS 425
             +   GL+K +P +    +    G +  +  APE +  ++ +  SDV+SFGV+L E+ +
Sbjct: 157 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 92/180 (51%), Gaps = 9/180 (5%)
Query: 249 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVNG 306
           G  VAVK+L+ S+ +  ++F  EI     L H N+V  KG CY  G R   ++ E++  G
Sbjct: 44  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 103
Query: 307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 366
            L  +L    +    +D    ++  + + +G+ +L  K     +HRD+   N+L++ E  
Sbjct: 104 SLRDYLQ---KHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENR 157
Query: 367 AHLMGVGLSKFVPWEVMQERTVMAGGTYGY-LAPEFVYRNELTTKSDVYSFGVLLLEIVS 425
             +   GL+K +P +    +    G +  +  APE +  ++ +  SDV+SFGV+L E+ +
Sbjct: 158 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 92/180 (51%), Gaps = 9/180 (5%)
Query: 249 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVNG 306
           G  VAVK+L+ S+ +  ++F  EI     L H N+V  KG CY  G R   ++ E++  G
Sbjct: 57  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 116
Query: 307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 366
            L  +L    +    +D    ++  + + +G+ +L  K     +HRD+   N+L++ E  
Sbjct: 117 SLRDYLQ---KHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENR 170
Query: 367 AHLMGVGLSKFVPWEVMQERTVMAGGTYGY-LAPEFVYRNELTTKSDVYSFGVLLLEIVS 425
             +   GL+K +P +    +    G +  +  APE +  ++ +  SDV+SFGV+L E+ +
Sbjct: 171 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 92/180 (51%), Gaps = 9/180 (5%)
Query: 249 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVNG 306
           G  VAVK+L+ S+ +  ++F  EI     L H N+V  KG CY  G R   ++ E++  G
Sbjct: 45  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 104
Query: 307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 366
            L  +L    +    +D    ++  + + +G+ +L  K     +HRD+   N+L++ E  
Sbjct: 105 SLRDYLQ---KHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENR 158
Query: 367 AHLMGVGLSKFVPWEVMQERTVMAGGTYGY-LAPEFVYRNELTTKSDVYSFGVLLLEIVS 425
             +   GL+K +P +    +    G +  +  APE +  ++ +  SDV+SFGV+L E+ +
Sbjct: 159 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 118/271 (43%), Gaps = 39/271 (14%)
Query: 251 RVAVKRLKRSSFQRKKE-FYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 308
           +VAVK LK ++   +KE   SE+   + L  H N+V + G C   G   ++ E+   G L
Sbjct: 70  KVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 129
Query: 309 DRWLHHIPRG------GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 362
             +L            GR L+    +  ++ +AQG+AFL  K   + +HRD+ A NVLL 
Sbjct: 130 LNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLT 186
Query: 363 EEFGAHLMGVGLSKFVPWEVMQERTVMAGGT----YGYLAPEFVYRNELTTKSDVYSFGV 418
               A +   GL++    ++M +   +  G       ++APE ++    T +SDV+S+G+
Sbjct: 187 NGHVAKIGDFGLAR----DIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGI 242
Query: 419 LLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQK 477
           LL EI S G  P   +              LV S  Y                 A   + 
Sbjct: 243 LLWEIFSLGLNPYPGI--------------LVNSKFY-----KLVKDGYQMAQPAFAPKN 283
Query: 478 VVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 508
           +  ++ AC    P+ RP    +   LQ+ AQ
Sbjct: 284 IYSIMQACWALEPTHRPTFQQICSFLQEQAQ 314

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 118/271 (43%), Gaps = 39/271 (14%)
Query: 251 RVAVKRLKRSSFQRKKE-FYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 308
           +VAVK LK ++   +KE   SE+   + L  H N+V + G C   G   ++ E+   G L
Sbjct: 78  KVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 137
Query: 309 DRWLHHIPRG------GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 362
             +L            GR L+    +  ++ +AQG+AFL  K   + +HRD+ A NVLL 
Sbjct: 138 LNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLT 194
Query: 363 EEFGAHLMGVGLSKFVPWEVMQERTVMAGGT----YGYLAPEFVYRNELTTKSDVYSFGV 418
               A +   GL++    ++M +   +  G       ++APE ++    T +SDV+S+G+
Sbjct: 195 NGHVAKIGDFGLAR----DIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGI 250
Query: 419 LLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQK 477
           LL EI S G  P   +              LV S  Y                 A   + 
Sbjct: 251 LLWEIFSLGLNPYPGI--------------LVNSKFY-----KLVKDGYQMAQPAFAPKN 291
Query: 478 VVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 508
           +  ++ AC    P+ RP    +   LQ+ AQ
Sbjct: 292 IYSIMQACWALEPTHRPTFQQICSFLQEQAQ 322

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 105/234 (44%), Gaps = 22/234 (9%)
Query: 199 SNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLK 258
           S P    L   +W++   E LR   K        LG    G  + G     +RVA+K LK
Sbjct: 167 SKPQTQGLAKDAWEI-PRESLRLEVK--------LGQGCFGEVWMGTWNGTTRVAIKTLK 217
Query: 259 RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRG 318
             +    + F  E     +L H  LV +     +    YIV E++  G L  +L      
Sbjct: 218 PGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKG--ET 273
Query: 319 GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 378
           G+ L     + +A  +A G+A++    + + VHRD+RA+N+L+ E     +   GL++ +
Sbjct: 274 GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI 330
Query: 379 PWEVMQERTVMAGGTY--GYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRP 429
                 E T   G  +   + APE       T KSDV+SFG+LL E+ + GR P
Sbjct: 331 E---DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 381

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 105/234 (44%), Gaps = 22/234 (9%)
Query: 199 SNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLK 258
           S P    L   +W++   E LR   K        LG    G  + G     +RVA+K LK
Sbjct: 167 SKPQTQGLAKDAWEI-PRESLRLEVK--------LGQGCFGEVWMGTWNGTTRVAIKTLK 217
Query: 259 RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRG 318
             +    + F  E     +L H  LV +     +    YIV E++  G L  +L      
Sbjct: 218 PGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKG--ET 273
Query: 319 GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 378
           G+ L     + +A  +A G+A++    + + VHRD+RA+N+L+ E     +   GL++ +
Sbjct: 274 GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI 330
Query: 379 PWEVMQERTVMAGGTY--GYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRP 429
                 E T   G  +   + APE       T KSDV+SFG+LL E+ + GR P
Sbjct: 331 E---DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 381

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 105/234 (44%), Gaps = 22/234 (9%)
Query: 199 SNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLK 258
           S P    L   +W++   E LR   K        LG    G  + G     +RVA+K LK
Sbjct: 167 SKPQTQGLAKDAWEI-PRESLRLEVK--------LGQGCFGEVWMGTWNGTTRVAIKTLK 217
Query: 259 RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRG 318
             +    + F  E     +L H  LV +     +    YIV E++  G L  +L      
Sbjct: 218 PGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVGEYMSKGSLLDFLKG--ET 273
Query: 319 GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 378
           G+ L     + +A  +A G+A++    + + VHRD+RA+N+L+ E     +   GL++ +
Sbjct: 274 GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI 330
Query: 379 PWEVMQERTVMAGGTY--GYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRP 429
                 E T   G  +   + APE       T KSDV+SFG+LL E+ + GR P
Sbjct: 331 E---DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 381

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 129/285 (45%), Gaps = 51/285 (17%)
Query: 245 ILPDGSRV--AVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVY 300
           I  DG R+  A+KR+K  +S    ++F  E+    +L HHPN++ + G C   G  Y+  
Sbjct: 36  IKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI 95
Query: 301 EFVVNGPLDRWLHHIPRGGRSLD----WAMRMKVATTL------------AQGIAFLHDK 344
           E+  +G L  +L    R  R L+    +A+    A+TL            A+G+ +L  K
Sbjct: 96  EYAPHGNLLDFL----RKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK 151
Query: 345 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR 404
                +HRD+ A N+L+ E + A +   GLS+    EV  ++T M      ++A E +  
Sbjct: 152 ---QFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKT-MGRLPVRWMAIESLNY 205
Query: 405 NELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXX 463
           +  TT SDV+S+GVLL EIVS G  P       C  +  E    L Q +R          
Sbjct: 206 SVYTTNSDVWSYGVLLWEIVSLGGTP------YCGMTCAELYEKLPQGYR---------- 249
Query: 464 XXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 508
                        +V DL+  C +  P  RP  + ++  L ++ +
Sbjct: 250 ----LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 290

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 112/233 (48%), Gaps = 30/233 (12%)
Query: 214 FTTEELRSITKNFSEGNRLLGDSKTGGTYSG-ILPDGSRVAVKRL-------KRSSFQRK 265
           F    L ++  N  E  + +G    G  + G ++ D S VA+K L       +    ++ 
Sbjct: 8   FPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKF 67
Query: 266 KEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWA 325
           +EF  E+   + L+HPN+V + G    H    +V EFV  G L    H +      + W+
Sbjct: 68  QEFQREVFIMSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDL---YHRLLDKAHPIKWS 122
Query: 326 MRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL---DEEFG--AHLMGVGLSKFVPW 380
           +++++   +A GI ++ ++  P +VHRD+R+ N+ L   DE     A +   G S+    
Sbjct: 123 VKLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ---- 177
Query: 381 EVMQERTVMAG--GTYGYLAPEFVYRNE--LTTKSDVYSFGVLLLEIVSGRRP 429
              Q    ++G  G + ++APE +   E   T K+D YSF ++L  I++G  P
Sbjct: 178 ---QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP 227

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/187 (33%), Positives = 93/187 (49%), Gaps = 24/187 (12%)
Query: 249 GSRVAVKRLK-------RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYI--V 299
           G  VAVK LK       RS +QR      EI     L+H ++V  KGCC D G++ +  V
Sbjct: 38  GEMVAVKALKEGCGPQLRSGWQR------EIEILRTLYHEHIVKYKGCCEDQGEKSVQLV 91
Query: 300 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNV 359
            E+V   PL     ++PR    +  A  +  A  + +G+A+LH +   H +HR + A NV
Sbjct: 92  MEYV---PLGSLRDYLPR--HCVGLAQLLLFAQQICEGMAYLHAQ---HYIHRALAARNV 143
Query: 360 LLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGY-LAPEFVYRNELTTKSDVYSFGV 418
           LLD +    +   GL+K VP      R    G +  +  APE +   +    SDV+SFGV
Sbjct: 144 LLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGV 203
Query: 419 LLLEIVS 425
            L E+++
Sbjct: 204 TLYELLT 210

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 92/180 (51%), Gaps = 9/180 (5%)
Query: 249 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVNG 306
           G  VAVK+L+ S+ +  ++F  EI     L H N+V  KG CY  G R   ++ E++  G
Sbjct: 39  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 98
Query: 307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 366
            L  +L    +    +D    ++  + + +G+ +L  K     +HRD+   N+L++ E  
Sbjct: 99  SLRDYLQ---KHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENR 152
Query: 367 AHLMGVGLSKFVPWEVMQERTVMAGGTYGY-LAPEFVYRNELTTKSDVYSFGVLLLEIVS 425
             +   GL+K +P +    +    G +  +  APE +  ++ +  SDV+SFGV+L E+ +
Sbjct: 153 VKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 82/289 (28%), Positives = 130/289 (44%), Gaps = 51/289 (17%)
Query: 245 ILPDGSRV--AVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVY 300
           I  DG R+  A+KR+K  +S    ++F  E+    +L HHPN++ + G C   G  Y+  
Sbjct: 46  IKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI 105
Query: 301 EFVVNGPLDRWLHHIPRGGRSLD----WAMRMKVATTL------------AQGIAFLHDK 344
           E+  +G L  +L    R  R L+    +A+    A+TL            A+G+ +L  K
Sbjct: 106 EYAPHGNLLDFL----RKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK 161
Query: 345 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR 404
                +HRD+ A N+L+ E + A +   GLS+    EV  ++T M      ++A E +  
Sbjct: 162 ---QFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKT-MGRLPVRWMAIESLNY 215
Query: 405 NELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXX 463
           +  TT SDV+S+GVLL EIVS G  P       C  +  E    L Q +R          
Sbjct: 216 SVYTTNSDVWSYGVLLWEIVSLGGTP------YCGMTCAELYEKLPQGYR---------- 259
Query: 464 XXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPVT 512
                        +V DL+  C +  P  RP  + ++  L ++ +   T
Sbjct: 260 ----LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 304

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 112/233 (48%), Gaps = 30/233 (12%)
Query: 214 FTTEELRSITKNFSEGNRLLGDSKTGGTYSG-ILPDGSRVAVKRL-------KRSSFQRK 265
           F    L ++  N  E  + +G    G  + G ++ D S VA+K L       +    ++ 
Sbjct: 8   FPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKF 67
Query: 266 KEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWA 325
           +EF  E+   + L+HPN+V + G    H    +V EFV  G L    H +      + W+
Sbjct: 68  QEFQREVFIMSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDL---YHRLLDKAHPIKWS 122
Query: 326 MRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL---DEEFG--AHLMGVGLSKFVPW 380
           +++++   +A GI ++ ++  P +VHRD+R+ N+ L   DE     A +    LS+    
Sbjct: 123 VKLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ---- 177
Query: 381 EVMQERTVMAG--GTYGYLAPEFVYRNE--LTTKSDVYSFGVLLLEIVSGRRP 429
              Q    ++G  G + ++APE +   E   T K+D YSF ++L  I++G  P
Sbjct: 178 ---QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP 227

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/187 (33%), Positives = 93/187 (49%), Gaps = 24/187 (12%)
Query: 249 GSRVAVKRLK-------RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYI--V 299
           G  VAVK LK       RS +QR      EI     L+H ++V  KGCC D G++ +  V
Sbjct: 37  GEMVAVKALKEGCGPQLRSGWQR------EIEILRTLYHEHIVKYKGCCEDQGEKSVQLV 90
Query: 300 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNV 359
            E+V   PL     ++PR    +  A  +  A  + +G+A+LH +   H +HR + A NV
Sbjct: 91  MEYV---PLGSLRDYLPR--HCVGLAQLLLFAQQICEGMAYLHAQ---HYIHRALAARNV 142
Query: 360 LLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGY-LAPEFVYRNELTTKSDVYSFGV 418
           LLD +    +   GL+K VP      R    G +  +  APE +   +    SDV+SFGV
Sbjct: 143 LLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGV 202
Query: 419 LLLEIVS 425
            L E+++
Sbjct: 203 TLYELLT 209

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 71/288 (24%), Positives = 128/288 (44%), Gaps = 51/288 (17%)
Query: 233 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 292
           +G  + G  + G   +  +VA+K +K  S   + +F  E     +L HP LV + G C +
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIKEGSMS-EDDFIEEAEVMMKLSHPKLVQLYGVCLE 93
Query: 293 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWA-MRMKVATTLAQGIAFLHDKVKPHVVH 351
                +V+EF+ +G L  +L    R  R L  A   + +   + +G+A+L +     V+H
Sbjct: 94  QAPICLVFEFMEHGCLSDYL----RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 146
Query: 352 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT---YGYLAPEFVYRNELT 408
           RD+ A N L+ E     +   G+++F    V+ ++   + GT     + +PE    +  +
Sbjct: 147 RDLAARNCLVGENQVIKVSDFGMTRF----VLDDQYTSSTGTKFPVKWASPEVFSFSRYS 202
Query: 409 TKSDVYSFGVLLLEIVS-------GRRPAQAVDSVCWQSIFEWATP-LVQSHRYXXXXXX 460
           +KSDV+SFGVL+ E+ S        R  ++ V+ +   + F    P L  +H Y      
Sbjct: 203 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI--STGFRLYKPRLASTHVY------ 254
Query: 461 XXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 508
                               ++  C +  P  RP  S ++ QL ++A+
Sbjct: 255 -------------------QIMNHCWKERPEDRPAFSRLLRQLAEIAE 283

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 104/234 (44%), Gaps = 22/234 (9%)
Query: 199 SNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLK 258
           S P    L   +W++   E LR   K        LG    G  + G     +RVA+K LK
Sbjct: 168 SKPQTQGLAKDAWEI-PRESLRLEVK--------LGQGCFGEVWMGTWNGTTRVAIKTLK 218
Query: 259 RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRG 318
             +    + F  E     +L H  LV +     +    YIV E++  G L  +L      
Sbjct: 219 PGNMS-PEAFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKG--EM 274
Query: 319 GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 378
           G+ L     + +A  +A G+A++    + + VHRD+RA+N+L+ E     +   GL + +
Sbjct: 275 GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLGRLI 331
Query: 379 PWEVMQERTVMAGGTY--GYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRP 429
                 E T   G  +   + APE       T KSDV+SFG+LL E+ + GR P
Sbjct: 332 E---DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 382

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 92/180 (51%), Gaps = 9/180 (5%)
Query: 249 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVNG 306
           G  VAVK+L+ S+ +  ++F  EI     L H N+V  KG CY  G R   ++ E++  G
Sbjct: 40  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 99
Query: 307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 366
            L  +L    +    +D    ++  + + +G+ +L  K     +HR++   N+L++ E  
Sbjct: 100 SLRDYLQ---KHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRNLATRNILVENENR 153
Query: 367 AHLMGVGLSKFVPWEVMQERTVMAGGTYGY-LAPEFVYRNELTTKSDVYSFGVLLLEIVS 425
             +   GL+K +P +    +    G +  +  APE +  ++ +  SDV+SFGV+L E+ +
Sbjct: 154 VKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 105/234 (44%), Gaps = 22/234 (9%)
Query: 199 SNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLK 258
           S P    L   +W++   E LR   K        LG    G  + G     +RVA+K LK
Sbjct: 250 SKPQTQGLAKDAWEI-PRESLRLEVK--------LGQGCFGEVWMGTWNGTTRVAIKTLK 300
Query: 259 RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRG 318
             +    + F  E     +L H  LV +     +    YIV E++  G L  +L      
Sbjct: 301 PGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKG--ET 356
Query: 319 GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 378
           G+ L     + +A  +A G+A++    + + VHRD+RA+N+L+ E     +   GL++ +
Sbjct: 357 GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI 413
Query: 379 PWEVMQERTVMAGGTY--GYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRP 429
                 E T   G  +   + APE       T KSDV+SFG+LL E+ + GR P
Sbjct: 414 E---DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 464

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 64/266 (24%), Positives = 119/266 (44%), Gaps = 45/266 (16%)
Query: 252 VAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRW 311
           VA+K+++  S   +K F  E+ + +R++HPN+V + G C +     +V E+   G L   
Sbjct: 34  VAIKQIESES--ERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNV 89
Query: 312 LHHIPRGGRSLDW---AMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 368
           LH    G   L +   A  M      +QG+A+LH      ++HRD++  N+LL    G  
Sbjct: 90  LH----GAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVA--GGT 143
Query: 369 LMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRR 428
           ++ +    F     +Q       G+  ++APE    +  + K DV+S+G++L E+++ R+
Sbjct: 144 VLKI--CDFGTACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRK 201
Query: 429 PAQAVDSVCWQSIFEWAT------PLVQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLV 482
           P   +    ++ +  WA       PL+++                      + + +  L+
Sbjct: 202 PFDEIGGPAFRIM--WAVHNGTRPPLIKN----------------------LPKPIESLM 237
Query: 483 YACTQHVPSMRPRMSHVVHQLQQLAQ 508
             C    PS RP M  +V  +  L +
Sbjct: 238 TRCWSKDPSQRPSMEEIVKIMTHLMR 263

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 64/266 (24%), Positives = 119/266 (44%), Gaps = 45/266 (16%)
Query: 252 VAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRW 311
           VA+K+++  S   +K F  E+ + +R++HPN+V + G C +     +V E+   G L   
Sbjct: 35  VAIKQIESES--ERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNV 90
Query: 312 LHHIPRGGRSLDW---AMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 368
           LH    G   L +   A  M      +QG+A+LH      ++HRD++  N+LL    G  
Sbjct: 91  LH----GAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVA--GGT 144
Query: 369 LMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRR 428
           ++ +    F     +Q       G+  ++APE    +  + K DV+S+G++L E+++ R+
Sbjct: 145 VLKI--CDFGTACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRK 202
Query: 429 PAQAVDSVCWQSIFEWAT------PLVQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLV 482
           P   +    ++ +  WA       PL+++                      + + +  L+
Sbjct: 203 PFDEIGGPAFRIM--WAVHNGTRPPLIKN----------------------LPKPIESLM 238
Query: 483 YACTQHVPSMRPRMSHVVHQLQQLAQ 508
             C    PS RP M  +V  +  L +
Sbjct: 239 TRCWSKDPSQRPSMEEIVKIMTHLMR 264

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 114/246 (46%), Gaps = 27/246 (10%)
Query: 201 PAASALVPPSWKVFTTEELRSITKNFSEG--------NRLLGDSKTGGTYSGILP-DGSR 251
           P     + P    FT E+     + F++          +++G  + G   SG L   G R
Sbjct: 5   PGMKIFIDP----FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKR 60
Query: 252 ---VAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 307
              VA+K LK   + +++++F SE     +  HPN++ ++G         I+ EF+ NG 
Sbjct: 61  EIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGS 120
Query: 308 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA 367
           LD +L    +          + +   +A G+ +L D    + VHRD+ A N+L++     
Sbjct: 121 LDSFLR---QNDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVC 174
Query: 368 HLMGVGLSKFVPWEVMQERTVMAGG---TYGYLAPEFVYRNELTTKSDVYSFGVLLLEIV 424
            +   GLS+F+  +        A G      + APE +   + T+ SDV+S+G+++ E++
Sbjct: 175 KVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVM 234
Query: 425 S-GRRP 429
           S G RP
Sbjct: 235 SYGERP 240

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 120/284 (42%), Gaps = 52/284 (18%)
Query: 251 RVAVKRLKRSSFQRKKE-FYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 308
           +VAVK LK ++   +KE   SE+   + L  H N+V + G C   G   ++ E+   G L
Sbjct: 63  KVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 122
Query: 309 DRWLH--------------HIPRG-----GRSLDWAMRMKVATTLAQGIAFLHDKVKPHV 349
             +L                 P G     GR L+    +  ++ +AQG+AFL  K   + 
Sbjct: 123 LNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASK---NC 179
Query: 350 VHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT----YGYLAPEFVYRN 405
           +HRD+ A NVLL     A +   GL++    ++M +   +  G       ++APE ++  
Sbjct: 180 IHRDVAARNVLLTNGHVAKIGDFGLAR----DIMNDSNYIVKGNARLPVKWMAPESIFDC 235
Query: 406 ELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXX 464
             T +SDV+S+G+LL EI S G  P   +              LV S  Y          
Sbjct: 236 VYTVQSDVWSYGILLWEIFSLGLNPYPGI--------------LVNSKFY-----KLVKD 276
Query: 465 XXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 508
                  A   + +  ++ AC    P+ RP    +   LQ+ AQ
Sbjct: 277 GYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 320

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 130/289 (44%), Gaps = 51/289 (17%)
Query: 245 ILPDGSRV--AVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVY 300
           I  DG R+  A+KR+K  +S    ++F  E+    +L HHPN++ + G C   G  Y+  
Sbjct: 43  IKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI 102
Query: 301 EFVVNGPLDRWLHHIPRGGRSLD----WAMRMKVATTL------------AQGIAFLHDK 344
           E+  +G L  +L    R  R L+    +A+    A+TL            A+G+ +L  K
Sbjct: 103 EYAPHGNLLDFL----RKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK 158
Query: 345 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR 404
                +HR++ A N+L+ E + A +   GLS+    EV  ++T M      ++A E +  
Sbjct: 159 ---QFIHRNLAARNILVGENYVAKIADFGLSR--GQEVYVKKT-MGRLPVRWMAIESLNY 212
Query: 405 NELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXX 463
           +  TT SDV+S+GVLL EIVS G  P       C  +  E    L Q +R          
Sbjct: 213 SVYTTNSDVWSYGVLLWEIVSLGGTP------YCGMTCAELYEKLPQGYRLEKPL----- 261
Query: 464 XXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPVT 512
                        +V DL+  C +  P  RP  + ++  L ++ +   T
Sbjct: 262 ---------NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 301

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/287 (23%), Positives = 129/287 (44%), Gaps = 49/287 (17%)
Query: 233 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 292
           +G  + G  + G   +  +VA+K ++  +   +++F  E     +L HP LV + G C +
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLE 76
Query: 293 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 352
                +V+EF+ +G L  +L    RG  + +  + M     + +G+A+L +     V+HR
Sbjct: 77  QAPICLVFEFMEHGCLSDYL-RTQRGLFAAETLLGM--CLDVCEGMAYLEEAC---VIHR 130
Query: 353 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT---YGYLAPEFVYRNELTT 409
           D+ A N L+ E     +   G+++F    V+ ++   + GT     + +PE    +  ++
Sbjct: 131 DLAARNCLVGENQVIKVSDFGMTRF----VLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 186
Query: 410 KSDVYSFGVLLLEIVS-------GRRPAQAVDSVCWQSIFEWATP-LVQSHRYXXXXXXX 461
           KSDV+SFGVL+ E+ S        R  ++ V+ +   + F    P L  +H Y       
Sbjct: 187 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI--STGFRLYKPRLASTHVY------- 237
Query: 462 XXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 508
                              ++  C +  P  RP  S ++ QL ++A+
Sbjct: 238 ------------------QIMNHCWRERPEDRPAFSRLLRQLAEIAE 266

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/287 (23%), Positives = 129/287 (44%), Gaps = 49/287 (17%)
Query: 233 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 292
           +G  + G  + G   +  +VA+K ++  +   +++F  E     +L HP LV + G C +
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 293 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 352
                +V+EF+ +G L  +L    RG  + +  + M     + +G+A+L +     V+HR
Sbjct: 74  QAPICLVFEFMEHGCLSDYL-RTQRGLFAAETLLGM--CLDVCEGMAYLEEAC---VIHR 127
Query: 353 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT---YGYLAPEFVYRNELTT 409
           D+ A N L+ E     +   G+++F    V+ ++   + GT     + +PE    +  ++
Sbjct: 128 DLAARNCLVGENQVIKVSDFGMTRF----VLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 183
Query: 410 KSDVYSFGVLLLEIVS-------GRRPAQAVDSVCWQSIFEWATP-LVQSHRYXXXXXXX 461
           KSDV+SFGVL+ E+ S        R  ++ V+ +   + F    P L  +H Y       
Sbjct: 184 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI--STGFRLYKPRLASTHVY------- 234
Query: 462 XXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 508
                              ++  C +  P  RP  S ++ QL ++A+
Sbjct: 235 ------------------QIMNHCWKERPEDRPAFSRLLRQLAEIAE 263

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/287 (23%), Positives = 129/287 (44%), Gaps = 49/287 (17%)
Query: 233 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 292
           +G  + G  + G   +  +VA+K ++  +   +++F  E     +L HP LV + G C +
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLE 71
Query: 293 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 352
                +V+EF+ +G L  +L    RG  + +  + M     + +G+A+L +     V+HR
Sbjct: 72  QAPICLVFEFMEHGCLSDYL-RTQRGLFAAETLLGM--CLDVCEGMAYLEEAC---VIHR 125
Query: 353 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT---YGYLAPEFVYRNELTT 409
           D+ A N L+ E     +   G+++F    V+ ++   + GT     + +PE    +  ++
Sbjct: 126 DLAARNCLVGENQVIKVSDFGMTRF----VLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 181
Query: 410 KSDVYSFGVLLLEIVS-------GRRPAQAVDSVCWQSIFEWATP-LVQSHRYXXXXXXX 461
           KSDV+SFGVL+ E+ S        R  ++ V+ +   + F    P L  +H Y       
Sbjct: 182 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI--STGFRLYKPRLASTHVY------- 232
Query: 462 XXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 508
                              ++  C +  P  RP  S ++ QL ++A+
Sbjct: 233 ------------------QIMNHCWKERPEDRPAFSRLLRQLAEIAE 261

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 100/206 (48%), Gaps = 13/206 (6%)
Query: 233 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 292
           LG+ + G  + G     ++VA+K LK  +    + F  E     +L H  LV +     +
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLKPGTMS-PESFLEEAQIMKKLKHDKLVQLYAVVSE 75
Query: 293 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 352
               YIV E++  G L  +L      GR+L     + +A  +A G+A++    + + +HR
Sbjct: 76  E-PIYIVTEYMNKGSLLDFLKD--GEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHR 129
Query: 353 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 410
           D+R++N+L+       +   GL++ +      E T   G  +   + APE       T K
Sbjct: 130 DLRSANILVGNGLICKIADFGLARLIE---DNEXTARQGAKFPIKWTAPEAALYGRFTIK 186
Query: 411 SDVYSFGVLLLEIVS-GRRPAQAVDS 435
           SDV+SFG+LL E+V+ GR P   +++
Sbjct: 187 SDVWSFGILLTELVTKGRVPYPGMNN 212

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 94/203 (46%), Gaps = 13/203 (6%)
Query: 230 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGC 289
            + LG  + G  +       ++VAVK +K  S   +  F +E      L H  LV +   
Sbjct: 20  EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLVKLHAV 78
Query: 290 CYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHV 349
                  YI+ EF+  G L  +L      G        +  +  +A+G+AF+  +   + 
Sbjct: 79  VTKE-PIYIITEFMAKGSLLDFLKS--DEGSKQPLPKLIDFSAQIAEGMAFIEQR---NY 132
Query: 350 VHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNEL 407
           +HRD+RA+N+L+       +   GL++ +      E T   G  +   + APE +     
Sbjct: 133 IHRDLRAANILVSASLVCKIADFGLARVIE---DNEYTAREGAKFPIKWTAPEAINFGSF 189
Query: 408 TTKSDVYSFGVLLLEIVS-GRRP 429
           T KSDV+SFG+LL+EIV+ GR P
Sbjct: 190 TIKSDVWSFGILLMEIVTYGRIP 212

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/277 (25%), Positives = 121/277 (43%), Gaps = 45/277 (16%)
Query: 248 DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 307
           D   VAVK LK +S   +K+F+ E      L H ++V   G C +     +V+E++ +G 
Sbjct: 42  DKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGD 101
Query: 308 LDRWLH-HIPRG--------GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASN 358
           L+++L  H P             L  +  + +A  +A G+ +L  +   H VHRD+   N
Sbjct: 102 LNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRN 158
Query: 359 VLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG----TYGYLAPEFVYRNELTTKSDVY 414
            L+ E     +   G+S+    +V        GG       ++ PE +   + TT+SDV+
Sbjct: 159 CLVGENLLVKIGDFGMSR----DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVW 214
Query: 415 SFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATP--LVQSHRYXXXXXXXXXXXXXXXXX 471
           S GV+L EI + G++P   + +     + E  T   ++Q  R                  
Sbjct: 215 SLGVVLWEIFTYGKQPWYQLSN---NEVIECITQGRVLQRPR------------------ 253
Query: 472 AGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 508
               Q+V +L+  C Q  P MR  +  +   LQ LA+
Sbjct: 254 -TCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 103/224 (45%), Gaps = 31/224 (13%)
Query: 246 LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFAR----LHHPNLVAVKGCCYDHGDR----- 296
           L D   VAVK L R+   R   FY    R A+    L+HP +VAV    YD G+      
Sbjct: 34  LRDHRDVAVKVL-RADLARDPSFYLRFRREAQNAAALNHPAIVAV----YDTGEAETPAG 88
Query: 297 ---YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRD 353
              YIV E+V    L   +H    G  +   A+  +V     Q + F H      ++HRD
Sbjct: 89  PLPYIVMEYVDGVTLRDIVHT--EGPMTPKRAI--EVIADACQALNFSHQN---GIIHRD 141
Query: 354 IRASNVLLDEEFGAHLMGVGLSKFVP---WEVMQERTVMAGGTYGYLAPEFVYRNELTTK 410
           ++ +N+++       +M  G+++ +      V Q   V+  GT  YL+PE    + +  +
Sbjct: 142 VKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI--GTAQYLSPEQARGDSVDAR 199
Query: 411 SDVYSFGVLLLEIVSGRRP--AQAVDSVCWQSIFEWATPLVQSH 452
           SDVYS G +L E+++G  P    + DSV +Q + E   P    H
Sbjct: 200 SDVYSLGCVLYEVLTGEPPFTGDSPDSVAYQHVREDPIPPSARH 243

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 94/200 (47%), Gaps = 13/200 (6%)
Query: 233 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 292
           LG    G  + G     +RVA+K LK  +    + F  E     +L H  LV +     +
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 293 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 352
               YIV E++  G L  +L      G+ L     + +A  +A G+A++    + + VHR
Sbjct: 85  E-PIYIVIEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 353 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 410
           D+RA+N+L+ E     +   GL++ +      E T   G  +   + APE       T K
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIE---DNEXTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 411 SDVYSFGVLLLEIVS-GRRP 429
           SDV+SFG+LL E+ + GR P
Sbjct: 196 SDVWSFGILLTELTTKGRVP 215

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 94/200 (47%), Gaps = 13/200 (6%)
Query: 233 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 292
           LG    G  + G     +RVA+K LK  +    + F  E     +L H  LV +     +
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVSE 77
Query: 293 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 352
               YIV E++  G L  +L      G+ L     + +A  +A G+A++    + + VHR
Sbjct: 78  E-PIYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 131
Query: 353 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 410
           D+RA+N+L+ E     +   GL++ +      E T   G  +   + APE       T K
Sbjct: 132 DLRAANILVGENLVCKVADFGLARLIE---DNEYTARQGAKFPIKWTAPEAALYGRFTIK 188
Query: 411 SDVYSFGVLLLEIVS-GRRP 429
           SDV+SFG+LL E+ + GR P
Sbjct: 189 SDVWSFGILLTELTTKGRVP 208

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 91/183 (49%), Gaps = 14/183 (7%)
Query: 249 GSRVAVKRLK-RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYI--VYEFVVN 305
           G +VAVK LK  S      +   EI     L+H N+V  KG C + G   I  + EF+ +
Sbjct: 50  GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 109
Query: 306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 365
           G L  +L   P+    ++   ++K A  + +G+ +L  +     VHRD+ A NVL++ E 
Sbjct: 110 GSLKEYL---PKNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEH 163
Query: 366 GAHLMGVGLSKFVPWEVMQERTVMAGGTYG---YLAPEFVYRNELTTKSDVYSFGVLLLE 422
              +   GL+K +  E  +E   +         + APE + +++    SDV+SFGV L E
Sbjct: 164 QVKIGDFGLTKAI--ETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHE 221
Query: 423 IVS 425
           +++
Sbjct: 222 LLT 224

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 77/278 (27%), Positives = 122/278 (43%), Gaps = 49/278 (17%)
Query: 251 RVAVKRLKRSSFQRKKE-FYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 308
           +VAVK LK ++   +KE   SE+   + L  H N+V + G C   G   ++ E+   G L
Sbjct: 78  KVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 137
Query: 309 DRWLHHIPRGGRSLD----WAMRMKVATT---------LAQGIAFLHDKVKPHVVHRDIR 355
              L+ + R  R L+    +A+    A+T         +AQG+AFL  K   + +HRD+ 
Sbjct: 138 ---LNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVA 191
Query: 356 ASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT----YGYLAPEFVYRNELTTKS 411
           A NVLL     A +   GL++    ++M +   +  G       ++APE ++    T +S
Sbjct: 192 ARNVLLTNGHVAKIGDFGLAR----DIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQS 247
Query: 412 DVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXX 470
           DV+S+G+LL EI S G  P   +              LV S  Y                
Sbjct: 248 DVWSYGILLWEIFSLGLNPYPGI--------------LVNSKFY-----KLVKDGYQMAQ 288
Query: 471 XAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 508
            A   + +  ++ AC    P+ RP    +   LQ+ AQ
Sbjct: 289 PAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 91/183 (49%), Gaps = 14/183 (7%)
Query: 249 GSRVAVKRLK-RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYI--VYEFVVN 305
           G +VAVK LK  S      +   EI     L+H N+V  KG C + G   I  + EF+ +
Sbjct: 38  GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 97
Query: 306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 365
           G L  +L   P+    ++   ++K A  + +G+ +L  +     VHRD+ A NVL++ E 
Sbjct: 98  GSLKEYL---PKNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEH 151
Query: 366 GAHLMGVGLSKFVPWEVMQERTVMAGGTYG---YLAPEFVYRNELTTKSDVYSFGVLLLE 422
              +   GL+K +  E  +E   +         + APE + +++    SDV+SFGV L E
Sbjct: 152 QVKIGDFGLTKAI--ETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHE 209
Query: 423 IVS 425
           +++
Sbjct: 210 LLT 212

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 94/200 (47%), Gaps = 13/200 (6%)
Query: 233 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 292
           LG    G  + G     +RVA+K LK  +    + F  E     +L H  LV +     +
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVSE 73
Query: 293 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 352
               YIV E++  G L  +L      G+ L     + +A  +A G+A++    + + VHR
Sbjct: 74  E-PIYIVTEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 127
Query: 353 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 410
           D+RA+N+L+ E     +   GL++ +      E T   G  +   + APE       T K
Sbjct: 128 DLRAANILVGENLVCKVADFGLARLIE---DNEYTARQGAKFPIKWTAPEAALYGRFTIK 184
Query: 411 SDVYSFGVLLLEIVS-GRRP 429
           SDV+SFG+LL E+ + GR P
Sbjct: 185 SDVWSFGILLTELTTKGRVP 204

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 94/200 (47%), Gaps = 13/200 (6%)
Query: 233 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 292
           LG    G  + G     +RVA+K LK  +    + F  E     +L H  LV +     +
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVSE 75
Query: 293 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 352
               YIV E++  G L  +L      G+ L     + +A  +A G+A++    + + VHR
Sbjct: 76  E-PIYIVTEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 129
Query: 353 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 410
           D+RA+N+L+ E     +   GL++ +      E T   G  +   + APE       T K
Sbjct: 130 DLRAANILVGENLVCKVADFGLARLIE---DNEYTARQGAKFPIKWTAPEAALYGRFTIK 186
Query: 411 SDVYSFGVLLLEIVS-GRRP 429
           SDV+SFG+LL E+ + GR P
Sbjct: 187 SDVWSFGILLTELTTKGRVP 206

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 104/203 (51%), Gaps = 15/203 (7%)
Query: 233 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 292
           +G  + G  + G   +  +VA+K ++  +   +++F  E     +L HP LV + G C +
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 293 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 352
                +V+EF+ +G L  +L    RG  + +  + M     + +G+A+L +     V+HR
Sbjct: 74  QAPICLVFEFMEHGCLSDYL-RTQRGLFAAETLLGM--CLDVCEGMAYLEE---ASVIHR 127
Query: 353 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT---YGYLAPEFVYRNELTT 409
           D+ A N L+ E     +   G+++F    V+ ++   + GT     + +PE    +  ++
Sbjct: 128 DLAARNCLVGENQVIKVSDFGMTRF----VLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 183
Query: 410 KSDVYSFGVLLLEIVS-GRRPAQ 431
           KSDV+SFGVL+ E+ S G+ P +
Sbjct: 184 KSDVWSFGVLMWEVFSEGKIPYE 206

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 94/200 (47%), Gaps = 13/200 (6%)
Query: 233 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 292
           LG    G  + G     +RVA+K LK  +    + F  E     +L H  LV +     +
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 293 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 352
               YIV E++  G L  +L      G+ L     + +A  +A G+A++    + + VHR
Sbjct: 85  E-PIYIVIEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 353 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 410
           D+RA+N+L+ E     +   GL++ +      E T   G  +   + APE       T K
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIE---DNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 411 SDVYSFGVLLLEIVS-GRRP 429
           SDV+SFG+LL E+ + GR P
Sbjct: 196 SDVWSFGILLTELTTKGRVP 215

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 94/199 (47%), Gaps = 24/199 (12%)
Query: 248 DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 307
           D   VAVK LK  +   +K+F  E      L H ++V   G C D     +V+E++ +G 
Sbjct: 44  DKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGD 103
Query: 308 LDRWLHH-----------IPRGGR-SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIR 355
           L+++L              PR  +  L  +  + +A+ +A G+ +L  +   H VHRD+ 
Sbjct: 104 LNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLA 160
Query: 356 ASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG----TYGYLAPEFVYRNELTTKS 411
             N L+       +   G+S+    +V        GG       ++ PE +   + TT+S
Sbjct: 161 TRNCLVGANLLVKIGDFGMSR----DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTES 216
Query: 412 DVYSFGVLLLEIVS-GRRP 429
           DV+SFGV+L EI + G++P
Sbjct: 217 DVWSFGVILWEIFTYGKQP 235

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 94/200 (47%), Gaps = 13/200 (6%)
Query: 233 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 292
           LG    G  + G     +RVA+K LK  +    + F  E     +L H  LV +     +
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 293 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 352
               YIV E++  G L  +L      G+ L     + +A  +A G+A++    + + VHR
Sbjct: 85  E-PIYIVTEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 353 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 410
           D+RA+N+L+ E     +   GL++ +      E T   G  +   + APE       T K
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIE---DNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 411 SDVYSFGVLLLEIVS-GRRP 429
           SDV+SFG+LL E+ + GR P
Sbjct: 196 SDVWSFGILLTELTTKGRVP 215

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/289 (22%), Positives = 126/289 (43%), Gaps = 34/289 (11%)
Query: 230 NRLLGDSKTGGTYSGILPDGS-----RVAVKRLKRSSFQRKK-EFYSEIGRFARLHHPNL 283
            +++G  + G  Y G+L   S      VA+K LK    ++++ +F  E G   +  H N+
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 284 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 343
           + ++G    +    I+ E++ NG LD++L         L     ++    +A G+ +L +
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLR---GIAAGMKYLAN 165
Query: 344 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT-YGYLAPEFV 402
               + VHRD+ A N+L++      +   GLS+ +  +     T   G     + APE +
Sbjct: 166 M---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 222
Query: 403 YRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXX 461
              + T+ SDV+SFG+++ E+++ G RP        W+         + +H         
Sbjct: 223 SYRKFTSASDVWSFGIVMWEVMTYGERP-------YWE---------LSNHEVMKAINDG 266
Query: 462 XXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 510
                     + + Q    L+  C Q   + RP+ + +V  L +L + P
Sbjct: 267 FRLPTPMDCPSAIYQ----LMMQCWQQERARRPKFADIVSILDKLIRAP 311

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 99/205 (48%), Gaps = 29/205 (14%)
Query: 229 GNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKG 288
           G+ +LGD +           G++VAVK +K  +    + F +E     +L H NLV + G
Sbjct: 207 GDVMLGDYR-----------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLG 253
Query: 289 CCYDH-GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKP 347
              +  G  YIV E++  G L  +L    RG   L     +K +  + + + +L      
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEGN--- 308
Query: 348 HVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRN 405
           + VHRD+ A NVL+ E+  A +   GL+K       +  +    G     + APE +   
Sbjct: 309 NFVHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREK 361
Query: 406 ELTTKSDVYSFGVLLLEIVS-GRRP 429
           + +TKSDV+SFG+LL EI S GR P
Sbjct: 362 KFSTKSDVWSFGILLWEIYSFGRVP 386

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 117/275 (42%), Gaps = 43/275 (15%)
Query: 251 RVAVKRLKRSSFQRKKE-FYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 308
           +VAVK LK ++   +KE   SE+   + L  H N+V + G C   G   ++ E+   G L
Sbjct: 78  KVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 137
Query: 309 DRWLHHIPR----------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASN 358
             +L    R             +L     +  ++ +AQG+AFL  K   + +HRD+ A N
Sbjct: 138 LNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARN 194
Query: 359 VLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT----YGYLAPEFVYRNELTTKSDVY 414
           VLL     A +   GL++    ++M +   +  G       ++APE ++    T +SDV+
Sbjct: 195 VLLTNGHVAKIGDFGLAR----DIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVW 250
Query: 415 SFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAG 473
           S+G+LL EI S G  P   +              LV S  Y                 A 
Sbjct: 251 SYGILLWEIFSLGLNPYPGI--------------LVNSKFY-----KLVKDGYQMAQPAF 291
Query: 474 VVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 508
             + +  ++ AC    P+ RP    +   LQ+ AQ
Sbjct: 292 APKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 93/203 (45%), Gaps = 14/203 (6%)
Query: 233 LGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 291
           LGD   G  Y     + G+  A K ++  S +  +++  EI   A   HP +V + G  Y
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 292 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 351
             G  +I+ EF   G +D  +  + RG   L       V   + + + FLH K    ++H
Sbjct: 79  HDGKLWIMIEFCPGGAVDAIMLELDRG---LTEPQIQVVCRQMLEALNFLHSK---RIIH 132
Query: 352 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTT-- 409
           RD++A NVL+  E    L   G+S     + +Q+R    G  Y ++APE V    +    
Sbjct: 133 RDLKAGNVLMTLEGDIRLADFGVSA-KNLKTLQKRDSFIGTPY-WMAPEVVMCETMKDTP 190
Query: 410 ---KSDVYSFGVLLLEIVSGRRP 429
              K+D++S G+ L+E+     P
Sbjct: 191 YDYKADIWSLGITLIEMAQIEPP 213

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 94/200 (47%), Gaps = 13/200 (6%)
Query: 233 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 292
           LG    G  + G     +RVA+K LK  +    + F  E     +L H  LV +     +
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 293 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 352
               YIV E++  G L  +L      G+ L     + +A  +A G+A++    + + VHR
Sbjct: 85  E-PIYIVCEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 353 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 410
           D+RA+N+L+ E     +   GL++ +      E T   G  +   + APE       T K
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIE---DNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 411 SDVYSFGVLLLEIVS-GRRP 429
           SDV+SFG+LL E+ + GR P
Sbjct: 196 SDVWSFGILLTELTTKGRVP 215

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 94/203 (46%), Gaps = 13/203 (6%)
Query: 230 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGC 289
            + LG  + G  +       ++VAVK +K  S   +  F +E      L H  LV +   
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLVKLHAV 251
Query: 290 CYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHV 349
                  YI+ EF+  G L  +L      G        +  +  +A+G+AF+  +   + 
Sbjct: 252 VTKE-PIYIITEFMAKGSLLDFLKS--DEGSKQPLPKLIDFSAQIAEGMAFIEQR---NY 305
Query: 350 VHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNEL 407
           +HRD+RA+N+L+       +   GL++ +      E T   G  +   + APE +     
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVIE---DNEYTAREGAKFPIKWTAPEAINFGSF 362
Query: 408 TTKSDVYSFGVLLLEIVS-GRRP 429
           T KSDV+SFG+LL+EIV+ GR P
Sbjct: 363 TIKSDVWSFGILLMEIVTYGRIP 385

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 94/200 (47%), Gaps = 13/200 (6%)
Query: 233 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 292
           LG    G  + G     +RVA+K LK  +    + F  E     +L H  LV +     +
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 293 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 352
               YIV E++  G L  +L      G+ L     + +A  +A G+A++    + + VHR
Sbjct: 85  E-PIYIVMEYMSKGCLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 353 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 410
           D+RA+N+L+ E     +   GL++ +      E T   G  +   + APE       T K
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIE---DNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 411 SDVYSFGVLLLEIVS-GRRP 429
           SDV+SFG+LL E+ + GR P
Sbjct: 196 SDVWSFGILLTELTTKGRVP 215

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 99/205 (48%), Gaps = 29/205 (14%)
Query: 229 GNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKG 288
           G+ +LGD +           G++VAVK +K  +    + F +E     +L H NLV + G
Sbjct: 20  GDVMLGDYR-----------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLG 66
Query: 289 CCYDH-GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKP 347
              +  G  YIV E++  G L  +L    RG   L     +K +  + + + +L      
Sbjct: 67  VIVEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEGN--- 121
Query: 348 HVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRN 405
           + VHRD+ A NVL+ E+  A +   GL+K       +  +    G     + APE +   
Sbjct: 122 NFVHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREK 174
Query: 406 ELTTKSDVYSFGVLLLEIVS-GRRP 429
           + +TKSDV+SFG+LL EI S GR P
Sbjct: 175 KFSTKSDVWSFGILLWEIYSFGRVP 199

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 93/203 (45%), Gaps = 14/203 (6%)
Query: 233 LGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 291
           LGD   G  Y     + G+  A K ++  S +  +++  EI   A   HP +V + G  Y
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 292 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 351
             G  +I+ EF   G +D  +  + RG   L       V   + + + FLH K    ++H
Sbjct: 87  HDGKLWIMIEFCPGGAVDAIMLELDRG---LTEPQIQVVCRQMLEALNFLHSK---RIIH 140
Query: 352 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTT-- 409
           RD++A NVL+  E    L   G+S     + +Q+R    G  Y ++APE V    +    
Sbjct: 141 RDLKAGNVLMTLEGDIRLADFGVSA-KNLKTLQKRDSFIGTPY-WMAPEVVMCETMKDTP 198
Query: 410 ---KSDVYSFGVLLLEIVSGRRP 429
              K+D++S G+ L+E+     P
Sbjct: 199 YDYKADIWSLGITLIEMAQIEPP 221

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 94/200 (47%), Gaps = 13/200 (6%)
Query: 233 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 292
           LG    G  + G     +RVA+K LK  +    + F  E     +L H  LV +     +
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 293 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 352
               YIV E++  G L  +L      G+ L     + +A  +A G+A++    + + VHR
Sbjct: 85  E-PIYIVTEYMSKGCLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 353 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 410
           D+RA+N+L+ E     +   GL++ +      E T   G  +   + APE       T K
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIE---DNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 411 SDVYSFGVLLLEIVS-GRRP 429
           SDV+SFG+LL E+ + GR P
Sbjct: 196 SDVWSFGILLTELTTKGRVP 215

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 68/287 (23%), Positives = 128/287 (44%), Gaps = 49/287 (17%)
Query: 233 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 292
           +G  + G  + G   +  +VA+K ++  +   +++F  E     +L HP LV + G C +
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 293 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 352
                +V EF+ +G L  +L    RG  + +  + M     + +G+A+L +     V+HR
Sbjct: 75  QAPICLVTEFMEHGCLSDYL-RTQRGLFAAETLLGM--CLDVCEGMAYLEEAC---VIHR 128
Query: 353 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT---YGYLAPEFVYRNELTT 409
           D+ A N L+ E     +   G+++F    V+ ++   + GT     + +PE    +  ++
Sbjct: 129 DLAARNCLVGENQVIKVSDFGMTRF----VLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 184
Query: 410 KSDVYSFGVLLLEIVS-------GRRPAQAVDSVCWQSIFEWATP-LVQSHRYXXXXXXX 461
           KSDV+SFGVL+ E+ S        R  ++ V+ +   + F    P L  +H Y       
Sbjct: 185 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI--STGFRLYKPRLASTHVY------- 235
Query: 462 XXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 508
                              ++  C +  P  RP  S ++ QL ++A+
Sbjct: 236 ------------------QIMNHCWRERPEDRPAFSRLLRQLAEIAE 264

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 94/200 (47%), Gaps = 13/200 (6%)
Query: 233 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 292
           LG    G  + G     +RVA+K LK  +    + F  E     ++ H  LV +     +
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKIRHEKLVQLYAVVSE 84
Query: 293 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 352
               YIV E++  G L  +L      G+ L     + +A  +A G+A++    + + VHR
Sbjct: 85  E-PIYIVTEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 353 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 410
           D+RA+N+L+ E     +   GL++ +      E T   G  +   + APE       T K
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIE---DNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 411 SDVYSFGVLLLEIVS-GRRP 429
           SDV+SFG+LL E+ + GR P
Sbjct: 196 SDVWSFGILLTELTTKGRVP 215

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 99/205 (48%), Gaps = 29/205 (14%)
Query: 229 GNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKG 288
           G+ +LGD +           G++VAVK +K  +    + F +E     +L H NLV + G
Sbjct: 35  GDVMLGDYR-----------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLG 81
Query: 289 CCYDH-GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKP 347
              +  G  YIV E++  G L  +L    RG   L     +K +  + + + +L      
Sbjct: 82  VIVEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEGN--- 136
Query: 348 HVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRN 405
           + VHRD+ A NVL+ E+  A +   GL+K       +  +    G     + APE +   
Sbjct: 137 NFVHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREK 189
Query: 406 ELTTKSDVYSFGVLLLEIVS-GRRP 429
           + +TKSDV+SFG+LL EI S GR P
Sbjct: 190 KFSTKSDVWSFGILLWEIYSFGRVP 214

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 94/200 (47%), Gaps = 13/200 (6%)
Query: 233 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 292
           LG    G  + G     +RVA+K LK  +    + F  E     +L H  LV +     +
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVSE 81
Query: 293 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 352
               YIV E++  G L  +L      G+ L     + ++  +A G+A++    + + VHR
Sbjct: 82  E-PIYIVTEYMNKGSLLDFLKG--ETGKYLRLPQLVDMSAQIASGMAYVE---RMNYVHR 135
Query: 353 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 410
           D+RA+N+L+ E     +   GL++ +      E T   G  +   + APE       T K
Sbjct: 136 DLRAANILVGENLVCKVADFGLARLIE---DNEYTARQGAKFPIKWTAPEAALYGRFTIK 192
Query: 411 SDVYSFGVLLLEIVS-GRRP 429
           SDV+SFG+LL E+ + GR P
Sbjct: 193 SDVWSFGILLTELTTKGRVP 212

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 94/200 (47%), Gaps = 13/200 (6%)
Query: 233 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 292
           LG    G  + G     +RVA+K LK  +    + F  E     +L H  LV +     +
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVSE 81
Query: 293 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 352
               YIV E++  G L  +L      G+ L     + ++  +A G+A++    + + VHR
Sbjct: 82  E-PIYIVTEYMNKGSLLDFLKG--ETGKYLRLPQLVDMSAQIASGMAYVE---RMNYVHR 135
Query: 353 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 410
           D+RA+N+L+ E     +   GL++ +      E T   G  +   + APE       T K
Sbjct: 136 DLRAANILVGENLVCKVADFGLARLIE---DNEWTARQGAKFPIKWTAPEAALYGRFTIK 192
Query: 411 SDVYSFGVLLLEIVS-GRRP 429
           SDV+SFG+LL E+ + GR P
Sbjct: 193 SDVWSFGILLTELTTKGRVP 212

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 93/180 (51%), Gaps = 9/180 (5%)
Query: 249 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG--DRYIVYEFVVNG 306
           G+ VAVK+L+ S   ++++F  EI     LH   +V  +G  Y  G  +  +V E++ +G
Sbjct: 36  GALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSG 95
Query: 307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 366
            L  +L    R    LD +  +  ++ + +G+ +L  +     VHRD+ A N+L++ E  
Sbjct: 96  CLRDFLQ---RHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAH 149
Query: 367 AHLMGVGLSKFVPWEVMQERTVMAGGTYGY-LAPEFVYRNELTTKSDVYSFGVLLLEIVS 425
             +   GL+K +P +         G +  +  APE +  N  + +SDV+SFGV+L E+ +
Sbjct: 150 VKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 128/291 (43%), Gaps = 56/291 (19%)
Query: 245 ILPDGSR--VAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 302
           +LP+  +  VAVK LK +S   +++F  E      L H ++V   G C +     +V+E+
Sbjct: 65  LLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEY 124
Query: 303 VVNGPLDRWLH-HIPR-----GGRS-----LDWAMRMKVATTLAQGIAFLHDKVKPHVVH 351
           + +G L+R+L  H P      GG       L     + VA+ +A G+ +L      H VH
Sbjct: 125 MRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVH 181
Query: 352 RDIRASNVLLDEEFGAHLMGVGLSKFV---PWEVMQERTVMAGGTYGYLAPEFVYRNELT 408
           RD+   N L+ +     +   G+S+ +    +  +  RT++      ++ PE +   + T
Sbjct: 182 RDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML---PIRWMPPESILYRKFT 238
Query: 409 TKSDVYSFGVLLLEIVS-GRRP------AQAVDSVCWQSIFEWATPLVQSHRYXXXXXXX 461
           T+SDV+SFGV+L EI + G++P       +A+D  C     E   P              
Sbjct: 239 TESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID--CITQGRELERP-------------- 282
Query: 462 XXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ-PPV 511
                          +V  ++  C Q  P  R  +  V  +LQ LAQ PPV
Sbjct: 283 ----------RACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPV 323

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 13/200 (6%)
Query: 233 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 292
           LG    G  + G     +RVA+K LK  +    + F  E     +L H  LV +     +
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVSE 74
Query: 293 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 352
                IV E++  G L  +L      G+ L     + +A  +A G+A++    + + VHR
Sbjct: 75  E-PIXIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 128
Query: 353 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 410
           D+RA+N+L+ E     +   GL++ +      E T   G  +   + APE       T K
Sbjct: 129 DLRAANILVGENLVCKVADFGLARLIE---DNEXTARQGAKFPIKWTAPEAALYGRFTIK 185
Query: 411 SDVYSFGVLLLEIVS-GRRP 429
           SDV+SFG+LL E+ + GR P
Sbjct: 186 SDVWSFGILLTELTTKGRVP 205

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 98/205 (47%), Gaps = 29/205 (14%)
Query: 229 GNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKG 288
           G+ +LGD +           G++VAVK +K  +    + F +E     +L H NLV + G
Sbjct: 26  GDVMLGDYR-----------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLG 72
Query: 289 CCYDH-GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKP 347
              +  G  YIV E++  G L  +L    RG   L     +K +  + + + +L      
Sbjct: 73  VIVEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEGN--- 127
Query: 348 HVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRN 405
           + VHRD+ A NVL+ E+  A +   GL+K       +  +    G     + APE +   
Sbjct: 128 NFVHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREA 180
Query: 406 ELTTKSDVYSFGVLLLEIVS-GRRP 429
             +TKSDV+SFG+LL EI S GR P
Sbjct: 181 AFSTKSDVWSFGILLWEIYSFGRVP 205

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/243 (25%), Positives = 109/243 (44%), Gaps = 17/243 (6%)
Query: 198 LSNPAASALVPPSWKVFTTEELRSITKNFSEGN----RLLGDSKTGGTYSGILPDGSR-- 251
           L  P     V P      T+ +    K     N    +++G  + G   SG L   S+  
Sbjct: 14  LKLPGLRTFVDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKE 73
Query: 252 --VAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 308
             VA+K LK   + +++++F  E     +  HPN++ ++G         IV E++ NG L
Sbjct: 74  ISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL 133
Query: 309 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 368
           D +L    +          + +   +A G+ +L D      VHRD+ A N+L++      
Sbjct: 134 DSFLR---KHDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCK 187
Query: 369 LMGVGLSKFVPWEVMQERTVMAGGT-YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-G 426
           +   GLS+ +  +     T   G     + +PE +   + T+ SDV+S+G++L E++S G
Sbjct: 188 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 247
Query: 427 RRP 429
            RP
Sbjct: 248 ERP 250

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 81/307 (26%), Positives = 133/307 (43%), Gaps = 60/307 (19%)
Query: 233 LGDSKTGGTY----SGILPDGSR--VAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAV 286
           LG+   G  +      +LP+  +  VAVK LK +S   +++F  E      L H ++V  
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 287 KGCCYDHGDRYIVYEFVVNGPLDRWLH-HIPR-----GGRS-----LDWAMRMKVATTLA 335
            G C +     +V+E++ +G L+R+L  H P      GG       L     + VA+ +A
Sbjct: 80  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 336 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV---PWEVMQERTVMAGG 392
            G+ +L      H VHRD+   N L+ +     +   G+S+ +    +  +  RT++   
Sbjct: 140 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML--- 193
Query: 393 TYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRP------AQAVDSVCWQSIFEWA 445
              ++ PE +   + TT+SDV+SFGV+L EI + G++P       +A+D  C     E  
Sbjct: 194 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID--CITQGRELE 251
Query: 446 TPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ 505
            P                             +V  ++  C Q  P  R  +  V  +LQ 
Sbjct: 252 RP------------------------RACPPEVYAIMRGCWQREPQQRHSIKDVHARLQA 287
Query: 506 LAQ-PPV 511
           LAQ PPV
Sbjct: 288 LAQAPPV 294

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 91/183 (49%), Gaps = 11/183 (6%)
Query: 252 VAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 310
           VA+K LK   + +++++F SE     +  HPN++ ++G         I+ EF+ NG LD 
Sbjct: 38  VAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDS 97
Query: 311 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLM 370
           +L    +          + +   +A G+ +L D    + VHR + A N+L++      + 
Sbjct: 98  FLR---QNDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRALAARNILVNSNLVCKVS 151
Query: 371 GVGLSKFVPWEVMQERTVMAGG---TYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-G 426
             GLS+F+  +        A G      + APE +   + T+ SDV+S+G+++ E++S G
Sbjct: 152 DFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYG 211
Query: 427 RRP 429
            RP
Sbjct: 212 ERP 214

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/243 (25%), Positives = 109/243 (44%), Gaps = 17/243 (6%)
Query: 198 LSNPAASALVPPSWKVFTTEELRSITKNFSEGN----RLLGDSKTGGTYSGILPDGSR-- 251
           L  P     V P      T+ +    K     N    +++G  + G   SG L   S+  
Sbjct: 14  LKLPGLRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKE 73
Query: 252 --VAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 308
             VA+K LK   + +++++F  E     +  HPN++ ++G         IV E++ NG L
Sbjct: 74  ISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL 133
Query: 309 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 368
           D +L    +          + +   +A G+ +L D      VHRD+ A N+L++      
Sbjct: 134 DSFLR---KHDAQFTVIQLVGMLRGIASGMKYLSDM---GFVHRDLAARNILINSNLVCK 187
Query: 369 LMGVGLSKFVPWEVMQERTVMAGGT-YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-G 426
           +   GLS+ +  +     T   G     + +PE +   + T+ SDV+S+G++L E++S G
Sbjct: 188 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 247
Query: 427 RRP 429
            RP
Sbjct: 248 ERP 250

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 81/307 (26%), Positives = 133/307 (43%), Gaps = 60/307 (19%)
Query: 233 LGDSKTGGTY----SGILPDGSR--VAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAV 286
           LG+   G  +      +LP+  +  VAVK LK +S   +++F  E      L H ++V  
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 287 KGCCYDHGDRYIVYEFVVNGPLDRWLH-HIPR-----GGRS-----LDWAMRMKVATTLA 335
            G C +     +V+E++ +G L+R+L  H P      GG       L     + VA+ +A
Sbjct: 86  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 336 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV---PWEVMQERTVMAGG 392
            G+ +L      H VHRD+   N L+ +     +   G+S+ +    +  +  RT++   
Sbjct: 146 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML--- 199
Query: 393 TYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRP------AQAVDSVCWQSIFEWA 445
              ++ PE +   + TT+SDV+SFGV+L EI + G++P       +A+D  C     E  
Sbjct: 200 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID--CITQGRELE 257
Query: 446 TPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ 505
            P                             +V  ++  C Q  P  R  +  V  +LQ 
Sbjct: 258 RP------------------------RACPPEVYAIMRGCWQREPQQRHSIKDVHARLQA 293
Query: 506 LAQ-PPV 511
           LAQ PPV
Sbjct: 294 LAQAPPV 300

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 101/207 (48%), Gaps = 13/207 (6%)
Query: 230 NRLLGDSKTGGTYSGILPDGSR----VAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLV 284
           ++++G  + G   SG L   S+    VA+K LK   + +++++F  E     +  HPN++
Sbjct: 21  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 80
Query: 285 AVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 344
            ++G         IV E++ NG LD +L    +          + +   +A G+ +L D 
Sbjct: 81  RLEGVVTKSKPVMIVTEYMENGSLDSFLR---KHDAQFTVIQLVGMLRGIASGMKYLSDM 137
Query: 345 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT-YGYLAPEFVY 403
                VHRD+ A N+L++      +   GLS+ +  +     T   G     + +PE + 
Sbjct: 138 ---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 194
Query: 404 RNELTTKSDVYSFGVLLLEIVS-GRRP 429
             + T+ SDV+S+G++L E++S G RP
Sbjct: 195 YRKFTSASDVWSYGIVLWEVMSYGERP 221

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 93/180 (51%), Gaps = 9/180 (5%)
Query: 249 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVNG 306
           G+ VAVK+L+ S   ++++F  EI     LH   +V  +G  Y  G +   +V E++ +G
Sbjct: 40  GALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSG 99
Query: 307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 366
            L  +L    R    LD +  +  ++ + +G+ +L  +     VHRD+ A N+L++ E  
Sbjct: 100 CLRDFLQ---RHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAH 153
Query: 367 AHLMGVGLSKFVPWEVMQERTVMAGGTYGY-LAPEFVYRNELTTKSDVYSFGVLLLEIVS 425
             +   GL+K +P +         G +  +  APE +  N  + +SDV+SFGV+L E+ +
Sbjct: 154 VKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 101/207 (48%), Gaps = 13/207 (6%)
Query: 230 NRLLGDSKTGGTYSGILPDGSR----VAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLV 284
           ++++G  + G   SG L   S+    VA+K LK   + +++++F  E     +  HPN++
Sbjct: 38  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 97
Query: 285 AVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 344
            ++G         IV E++ NG LD +L    +          + +   +A G+ +L D 
Sbjct: 98  RLEGVVTKSKPVMIVTEYMENGSLDSFLR---KHDAQFTVIQLVGMLRGIASGMKYLSDM 154
Query: 345 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT-YGYLAPEFVY 403
                VHRD+ A N+L++      +   GLS+ +  +     T   G     + +PE + 
Sbjct: 155 ---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 211
Query: 404 RNELTTKSDVYSFGVLLLEIVS-GRRP 429
             + T+ SDV+S+G++L E++S G RP
Sbjct: 212 YRKFTSASDVWSYGIVLWEVMSYGERP 238

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 75/313 (23%), Positives = 143/313 (45%), Gaps = 43/313 (13%)
Query: 216 TEELRS------ITKNFSEGNRLLGDSKTGGTYSGILP--DGS--RVAVK--RLKRSSFQ 263
           +EEL++      I +N     ++LG+ + G    G L   DG+  +VAVK  +L  SS +
Sbjct: 19  SEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQR 78
Query: 264 RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR-----YIVYEFVVNGPLDRWLHH--IP 316
             +EF SE        HPN++ + G C +   +      ++  F+  G L  +L +  + 
Sbjct: 79  EIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLE 138
Query: 317 RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK 376
            G + +     +K    +A G+ +L ++   + +HRD+ A N +L ++    +   GLSK
Sbjct: 139 TGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSK 195
Query: 377 FVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDS 435
            +       +  +A     ++A E +     T+KSDV++FGV + EI + G  P   V +
Sbjct: 196 KIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN 255
Query: 436 VCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPR 495
                ++++   L+  HR                     + ++ +++Y+C +  P  RP 
Sbjct: 256 ---HEMYDY---LLHGHRL--------------KQPEDCLDELYEIMYSCWRTDPLDRPT 295
Query: 496 MSHVVHQLQQLAQ 508
            S +  QL++L +
Sbjct: 296 FSVLRLQLEKLLE 308

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 87/190 (45%), Gaps = 8/190 (4%)
Query: 243 SGILPDGSRVAVKRLKRSSFQRKK---EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIV 299
           +  L DG  VA+K+++       K   +   EI    +L+HPN++       +  +  IV
Sbjct: 51  AACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110
Query: 300 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNV 359
            E    G L R + H  +  R +      K    L   +  +H +    V+HRDI+ +NV
Sbjct: 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANV 167
Query: 360 LLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVL 419
            +       L  +GL +F   +     +++  GT  Y++PE ++ N    KSD++S G L
Sbjct: 168 FITATGVVKLGDLGLGRFFSSKTTAAHSLV--GTPYYMSPERIHENGYNFKSDIWSLGCL 225
Query: 420 LLEIVSGRRP 429
           L E+ + + P
Sbjct: 226 LYEMAALQSP 235

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/243 (25%), Positives = 109/243 (44%), Gaps = 17/243 (6%)
Query: 198 LSNPAASALVPPSWKVFTTEELRSITKNFSEGN----RLLGDSKTGGTYSGILPDGSR-- 251
           L  P     V P      T+ +    K     N    +++G  + G   SG L   S+  
Sbjct: 14  LKLPGLRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKE 73
Query: 252 --VAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 308
             VA+K LK   + +++++F  E     +  HPN++ ++G         IV E++ NG L
Sbjct: 74  ISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL 133
Query: 309 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 368
           D +L    +          + +   +A G+ +L D      VHRD+ A N+L++      
Sbjct: 134 DSFLR---KHDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCK 187
Query: 369 LMGVGLSKFVPWEVMQERTVMAGGT-YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-G 426
           +   GLS+ +  +     T   G     + +PE +   + T+ SDV+S+G++L E++S G
Sbjct: 188 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 247
Query: 427 RRP 429
            RP
Sbjct: 248 ERP 250

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 93/180 (51%), Gaps = 9/180 (5%)
Query: 249 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVNG 306
           G+ VAVK+L+ S   ++++F  EI     LH   +V  +G  Y  G +   +V E++ +G
Sbjct: 39  GALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSG 98
Query: 307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 366
            L  +L    R    LD +  +  ++ + +G+ +L  +     VHRD+ A N+L++ E  
Sbjct: 99  CLRDFLQ---RHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAH 152
Query: 367 AHLMGVGLSKFVPWEVMQERTVMAGGTYGY-LAPEFVYRNELTTKSDVYSFGVLLLEIVS 425
             +   GL+K +P +         G +  +  APE +  N  + +SDV+SFGV+L E+ +
Sbjct: 153 VKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 93/180 (51%), Gaps = 9/180 (5%)
Query: 249 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVNG 306
           G+ VAVK+L+ S   ++++F  EI     LH   +V  +G  Y  G +   +V E++ +G
Sbjct: 52  GALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSG 111
Query: 307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 366
            L  +L    R    LD +  +  ++ + +G+ +L  +     VHRD+ A N+L++ E  
Sbjct: 112 CLRDFLQ---RHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAH 165
Query: 367 AHLMGVGLSKFVPWEVMQERTVMAGGTYGY-LAPEFVYRNELTTKSDVYSFGVLLLEIVS 425
             +   GL+K +P +         G +  +  APE +  N  + +SDV+SFGV+L E+ +
Sbjct: 166 VKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/243 (25%), Positives = 109/243 (44%), Gaps = 17/243 (6%)
Query: 198 LSNPAASALVPPSWKVFTTEELRSITKNFSEGN----RLLGDSKTGGTYSGILPDGSR-- 251
           L  P     V P      T+ +    K     N    +++G  + G   SG L   S+  
Sbjct: 12  LKLPGLRTYVDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKE 71
Query: 252 --VAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 308
             VA+K LK   + +++++F  E     +  HPN++ ++G         IV E++ NG L
Sbjct: 72  ISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL 131
Query: 309 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 368
           D +L    +          + +   +A G+ +L D      VHRD+ A N+L++      
Sbjct: 132 DSFLR---KHDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCK 185
Query: 369 LMGVGLSKFVPWEVMQERTVMAGGT-YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-G 426
           +   GLS+ +  +     T   G     + +PE +   + T+ SDV+S+G++L E++S G
Sbjct: 186 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 245
Query: 427 RRP 429
            RP
Sbjct: 246 ERP 248

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/243 (25%), Positives = 109/243 (44%), Gaps = 17/243 (6%)
Query: 198 LSNPAASALVPPSWKVFTTEELRSITKNFSEGN----RLLGDSKTGGTYSGILPDGSR-- 251
           L  P     V P      T+ +    K     N    +++G  + G   SG L   S+  
Sbjct: 14  LKLPGLRTYVDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKE 73
Query: 252 --VAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 308
             VA+K LK   + +++++F  E     +  HPN++ ++G         IV E++ NG L
Sbjct: 74  ISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL 133
Query: 309 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 368
           D +L    +          + +   +A G+ +L D      VHRD+ A N+L++      
Sbjct: 134 DSFLR---KHDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCK 187
Query: 369 LMGVGLSKFVPWEVMQERTVMAGGT-YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-G 426
           +   GLS+ +  +     T   G     + +PE +   + T+ SDV+S+G++L E++S G
Sbjct: 188 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 247
Query: 427 RRP 429
            RP
Sbjct: 248 ERP 250

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 13/200 (6%)
Query: 233 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 292
           LG    G  + G     +RVA+K LK  +    + F  E     +L H  LV +     +
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 293 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 352
               YIV E++  G L  +L      G+ L     + +A  +A G+A++    + + VHR
Sbjct: 85  E-PIYIVTEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 353 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 410
           D+ A+N+L+ E     +   GL++ +      E T   G  +   + APE       T K
Sbjct: 139 DLAAANILVGENLVCKVADFGLARLIE---DNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 411 SDVYSFGVLLLEIVS-GRRP 429
           SDV+SFG+LL E+ + GR P
Sbjct: 196 SDVWSFGILLTELTTKGRVP 215

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 101/207 (48%), Gaps = 13/207 (6%)
Query: 230 NRLLGDSKTGGTYSGILPDGSR----VAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLV 284
           ++++G  + G   SG L   S+    VA+K LK   + +++++F  E     +  HPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 285 AVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 344
            ++G         IV E++ NG LD +L    +          + +   +A G+ +L D 
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLR---KHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 345 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT-YGYLAPEFVY 403
                VHRD+ A N+L++      +   GLS+ +  +     T   G     + +PE + 
Sbjct: 167 ---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 404 RNELTTKSDVYSFGVLLLEIVS-GRRP 429
             + T+ SDV+S+G++L E++S G RP
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 93/181 (51%), Gaps = 10/181 (5%)
Query: 249 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 308
           G +VAVK++     QR++  ++E+      HH N+V +        + ++V EF+  G L
Sbjct: 70  GKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGAL 129
Query: 309 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 368
              + H       ++      V  ++ + +++LH++    V+HRDI++ ++LL  +    
Sbjct: 130 TDIVTHT-----RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIK 181
Query: 369 LMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRR 428
           L   G    V  EV + + ++  GT  ++APE + R    T+ D++S G++++E++ G  
Sbjct: 182 LSDFGFCAQVSKEVPKRKXLV--GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEP 239
Query: 429 P 429
           P
Sbjct: 240 P 240

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 13/206 (6%)
Query: 231 RLLGDSKTGGTYSGILP-DGSR---VAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVA 285
           R++G  + G   SG L   G R   VA+K LK   + +++++F  E     +  HPN++ 
Sbjct: 28  RVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIH 87
Query: 286 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 345
           ++G         IV E++ NG LD +L    +          + +   ++ G+ +L D  
Sbjct: 88  LEGVVTKSKPVMIVTEYMENGSLDTFLK---KNDGQFTVIQLVGMLRGISAGMKYLSDM- 143
Query: 346 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT-YGYLAPEFVYR 404
               VHRD+ A N+L++      +   GLS+ +  +     T   G     + APE +  
Sbjct: 144 --GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAF 201
Query: 405 NELTTKSDVYSFGVLLLEIVS-GRRP 429
            + T+ SDV+S+G+++ E+VS G RP
Sbjct: 202 RKFTSASDVWSYGIVMWEVVSYGERP 227

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 100/221 (45%), Gaps = 20/221 (9%)
Query: 217 EELRSIT------KNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFY 269
           E+LRSI       K ++   ++ G   +G  Y+ + +  G  VA++++      +K+   
Sbjct: 7   EKLRSIVSVGDPKKKYTRFEKI-GQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII 65
Query: 270 SEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMK 329
           +EI       +PN+V          + ++V E++  G L   +         +D      
Sbjct: 66  NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAA 120
Query: 330 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGL-SKFVPWEVMQERTV 388
           V     Q + FLH      V+HRDI++ N+LL  +    L   G  ++  P +   +R+ 
Sbjct: 121 VCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRST 175
Query: 389 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           M G  Y ++APE V R     K D++S G++ +E++ G  P
Sbjct: 176 MVGTPY-WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 102/224 (45%), Gaps = 31/224 (13%)
Query: 246 LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFAR----LHHPNLVAVKGCCYDHGDR----- 296
           L D   VAVK L R+   R   FY    R A+    L+HP +VAV    YD G+      
Sbjct: 34  LRDHRDVAVKVL-RADLARDPSFYLRFRREAQNAAALNHPAIVAV----YDTGEAETPAG 88
Query: 297 ---YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRD 353
              YIV E+V    L   +H    G  +   A+  +V     Q + F H      ++HRD
Sbjct: 89  PLPYIVMEYVDGVTLRDIVHT--EGPMTPKRAI--EVIADACQALNFSHQN---GIIHRD 141
Query: 354 IRASNVLLDEEFGAHLMGVGLSKFVP---WEVMQERTVMAGGTYGYLAPEFVYRNELTTK 410
           ++ +N+++       +M  G+++ +      V Q   V+  GT  YL+PE    + +  +
Sbjct: 142 VKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI--GTAQYLSPEQARGDSVDAR 199
Query: 411 SDVYSFGVLLLEIVSGRRP--AQAVDSVCWQSIFEWATPLVQSH 452
           SDVYS G +L E+++G  P    +  SV +Q + E   P    H
Sbjct: 200 SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 243

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 91/201 (45%), Gaps = 19/201 (9%)
Query: 230 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGC 289
            + LG  + G  +       ++VAVK +K  S   +  F +E      L H  LV +   
Sbjct: 187 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLVKLHAV 245
Query: 290 CYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHV 349
                  YI+ EF+  G L  +L      G        +  +  +A+G+AF+  +   + 
Sbjct: 246 VTKE-PIYIITEFMAKGSLLDFLKS--DEGSKQPLPKLIDFSAQIAEGMAFIEQR---NY 299
Query: 350 VHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTT 409
           +HRD+RA+N+L+       +   GL++           V A     + APE +     T 
Sbjct: 300 IHRDLRAANILVSASLVCKIADFGLAR-----------VGAKFPIKWTAPEAINFGSFTI 348
Query: 410 KSDVYSFGVLLLEIVS-GRRP 429
           KSDV+SFG+LL+EIV+ GR P
Sbjct: 349 KSDVWSFGILLMEIVTYGRIP 369

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 100/221 (45%), Gaps = 20/221 (9%)
Query: 217 EELRSIT------KNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFY 269
           E+LRSI       K ++   ++ G   +G  Y+ + +  G  VA++++      +K+   
Sbjct: 8   EKLRSIVSVGDPKKKYTRFEKI-GQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII 66
Query: 270 SEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMK 329
           +EI       +PN+V          + ++V E++  G L   +         +D      
Sbjct: 67  NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAA 121
Query: 330 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGL-SKFVPWEVMQERTV 388
           V     Q + FLH      V+HRDI++ N+LL  +    L   G  ++  P +   +R+ 
Sbjct: 122 VCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSX 176
Query: 389 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           M G  Y ++APE V R     K D++S G++ +E++ G  P
Sbjct: 177 MVGTPY-WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 100/221 (45%), Gaps = 20/221 (9%)
Query: 217 EELRSIT------KNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFY 269
           E+LRSI       K ++   ++ G   +G  Y+ + +  G  VA++++      +K+   
Sbjct: 7   EKLRSIVSVGDPKKKYTRFEKI-GQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII 65
Query: 270 SEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMK 329
           +EI       +PN+V          + ++V E++  G L   +         +D      
Sbjct: 66  NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAA 120
Query: 330 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGL-SKFVPWEVMQERTV 388
           V     Q + FLH      V+HRDI++ N+LL  +    L   G  ++  P +   +R+ 
Sbjct: 121 VCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSX 175
Query: 389 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           M G  Y ++APE V R     K D++S G++ +E++ G  P
Sbjct: 176 MVGTPY-WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/243 (25%), Positives = 108/243 (44%), Gaps = 17/243 (6%)
Query: 198 LSNPAASALVPPSWKVFTTEELRSITKNFSEGN----RLLGDSKTGGTYSGILPDGSR-- 251
           L  P     V P      T+ +    K     N    +++G  + G   SG L   S+  
Sbjct: 14  LKLPGLRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKE 73
Query: 252 --VAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 308
             VA+K LK   + +++++F  E     +  HPN++ ++G         IV E + NG L
Sbjct: 74  ISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSL 133
Query: 309 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 368
           D +L    +          + +   +A G+ +L D      VHRD+ A N+L++      
Sbjct: 134 DSFLR---KHDAQFTVIQLVGMLRGIASGMKYLSDM---GAVHRDLAARNILINSNLVCK 187
Query: 369 LMGVGLSKFVPWEVMQERTVMAGGT-YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-G 426
           +   GLS+ +  +     T   G     + +PE +   + T+ SDV+S+G++L E++S G
Sbjct: 188 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 247
Query: 427 RRP 429
            RP
Sbjct: 248 ERP 250

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/243 (25%), Positives = 109/243 (44%), Gaps = 17/243 (6%)
Query: 198 LSNPAASALVPPSWKVFTTEELRSITKNFSEGN----RLLGDSKTGGTYSGILPDGSR-- 251
           L  P     V P      T+ +    K     N    +++G  + G   SG L   S+  
Sbjct: 14  LKLPGLRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKE 73
Query: 252 --VAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 308
             VA+K LK   + +++++F  E     +  HPN++ ++G         IV E++ NG L
Sbjct: 74  ISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL 133
Query: 309 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 368
           D +L    +          + +   +A G+ +L D      VHRD+ A N+L++      
Sbjct: 134 DSFLR---KHDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCK 187
Query: 369 LMGVGLSKFVPWEVMQERTVMAGGT-YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-G 426
           +   GL++ +  +     T   G     + +PE +   + T+ SDV+S+G++L E++S G
Sbjct: 188 VSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 247
Query: 427 RRP 429
            RP
Sbjct: 248 ERP 250

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 82/325 (25%), Positives = 134/325 (41%), Gaps = 54/325 (16%)
Query: 203 ASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPD------GSRVAVKR 256
           +S  VP  W+V + E++  +        R LG    G  Y G   D       +RVAVK 
Sbjct: 1   SSVFVPDEWEV-SREKITLL--------RELGQGSFGMVYEGNARDIIKGEAETRVAVKT 51
Query: 257 LKRSSFQRKK-EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHI 315
           +  S+  R++ EF +E          ++V + G         +V E + +G L  +L  +
Sbjct: 52  VNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSL 111
Query: 316 -PRG----GRSLDWAMRM-KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHL 369
            P      GR       M ++A  +A G+A+L+ K     VHRD+ A N ++  +F   +
Sbjct: 112 RPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKI 168
Query: 370 MGVGLSKFVPWEVMQERTVMAGGT----YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 425
              G+++    ++ +      GG       ++APE +     TT SD++SFGV+L EI S
Sbjct: 169 GDFGMTR----DIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 224
Query: 426 -GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYA 484
              +P Q + +       E     V    Y                     ++V DL+  
Sbjct: 225 LAEQPYQGLSN-------EQVLKFVMDGGYLDQPD-------------NCPERVTDLMRM 264
Query: 485 CTQHVPSMRPRMSHVVHQLQQLAQP 509
           C Q  P MRP    +V+ L+    P
Sbjct: 265 CWQFNPKMRPTFLEIVNLLKDDLHP 289

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/237 (28%), Positives = 114/237 (48%), Gaps = 29/237 (12%)
Query: 230 NRLLGDSKTGGTYSGIL--PDGSRV--AVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLV 284
           N ++G    G  Y G L   DG ++  AVK L R +      +F +E        HPN++
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 285 AVKGCCY-DHGDRYIVYEFVVNGPLDRWLH---HIPRGGRSLDWAMRMKVATTLAQGIAF 340
           ++ G C    G   +V  ++ +G L  ++    H P     + + ++      +A+G+ F
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKF 207
Query: 341 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV---PWEVMQERTVMAGGTYGYL 397
           L  K     VHRD+ A N +LDE+F   +   GL++ +    ++ +  +T  A     ++
Sbjct: 208 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT-GAKLPVKWM 263
Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHR 453
           A E +   + TTKSDV+SFGVLL E+++ G  P   V++      F+    L+Q  R
Sbjct: 264 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT------FDITVYLLQGRR 314

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/237 (28%), Positives = 114/237 (48%), Gaps = 29/237 (12%)
Query: 230 NRLLGDSKTGGTYSGIL--PDGSRV--AVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLV 284
           N ++G    G  Y G L   DG ++  AVK L R +      +F +E        HPN++
Sbjct: 33  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 285 AVKGCCY-DHGDRYIVYEFVVNGPLDRWLH---HIPRGGRSLDWAMRMKVATTLAQGIAF 340
           ++ G C    G   +V  ++ +G L  ++    H P     + + ++      +A+G+ F
Sbjct: 93  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKF 146
Query: 341 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV---PWEVMQERTVMAGGTYGYL 397
           L  K     VHRD+ A N +LDE+F   +   GL++ +    ++ +  +T  A     ++
Sbjct: 147 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT-GAKLPVKWM 202
Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHR 453
           A E +   + TTKSDV+SFGVLL E+++ G  P   V++      F+    L+Q  R
Sbjct: 203 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT------FDITVYLLQGRR 253

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 93/183 (50%), Gaps = 11/183 (6%)
Query: 252 VAVKRLKRSSFQR-KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 310
           VA+K LK    +R ++EF SE     +  HPN++ ++G   +     I+ EF+ NG LD 
Sbjct: 47  VAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDS 106
Query: 311 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLM 370
           +L  +  G  ++   + M     +A G+ +L +      VHRD+ A N+L++      + 
Sbjct: 107 FL-RLNDGQFTVIQLVGM--LRGIASGMRYLAEM---SYVHRDLAARNILVNSNLVCKVS 160
Query: 371 GVGLSKFVPWEVMQE-RTVMAGGTYG--YLAPEFVYRNELTTKSDVYSFGVLLLEIVS-G 426
             GLS+F+         T   GG     + APE +   + T+ SD +S+G+++ E++S G
Sbjct: 161 DFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFG 220
Query: 427 RRP 429
            RP
Sbjct: 221 ERP 223

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 104/211 (49%), Gaps = 23/211 (10%)
Query: 246 LPDGSRVAVKRLKRS-SFQRKKEFYSEIGRFAR-LHHPNLVAVKGCCYDHGDRYIVYEFV 303
           +P G  +AVKR++ + + Q +K    ++    R +  P  V   G  +  GD +I  E +
Sbjct: 29  VPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICME-L 87
Query: 304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 363
           ++  LD++   +   G+++   +  K+A ++ + +  LH K+   V+HRD++ SNVL++ 
Sbjct: 88  MDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINA 145
Query: 364 EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFV----YRNELTTKSDVYSFGVL 419
                +   G+S ++  +V ++   +  G   Y+APE +     +   + KSD++S G+ 
Sbjct: 146 LGQVKMCDFGISGYLVDDVAKD---IDAGCKPYMAPERINPELNQKGYSVKSDIWSLGIT 202
Query: 420 LLEIVSGRRPAQAVDSVCWQSIFEWATPLVQ 450
           ++E+   R P  +           W TP  Q
Sbjct: 203 MIELAILRFPYDS-----------WGTPFQQ 222

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/237 (28%), Positives = 114/237 (48%), Gaps = 29/237 (12%)
Query: 230 NRLLGDSKTGGTYSGIL--PDGSRV--AVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLV 284
           N ++G    G  Y G L   DG ++  AVK L R +      +F +E        HPN++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 285 AVKGCCY-DHGDRYIVYEFVVNGPLDRWLH---HIPRGGRSLDWAMRMKVATTLAQGIAF 340
           ++ G C    G   +V  ++ +G L  ++    H P     + + ++      +A+G+ F
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKF 148
Query: 341 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV---PWEVMQERTVMAGGTYGYL 397
           L  K     VHRD+ A N +LDE+F   +   GL++ +    ++ +  +T  A     ++
Sbjct: 149 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT-GAKLPVKWM 204
Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHR 453
           A E +   + TTKSDV+SFGVLL E+++ G  P   V++      F+    L+Q  R
Sbjct: 205 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT------FDITVYLLQGRR 255

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 82/325 (25%), Positives = 134/325 (41%), Gaps = 54/325 (16%)
Query: 203 ASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPD------GSRVAVKR 256
           +S  VP  W+V + E++  +        R LG    G  Y G   D       +RVAVK 
Sbjct: 4   SSVFVPDEWEV-SREKITLL--------RELGQGSFGMVYEGNARDIIKGEAETRVAVKT 54
Query: 257 LKRSSFQRKK-EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHI 315
           +  S+  R++ EF +E          ++V + G         +V E + +G L  +L  +
Sbjct: 55  VNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSL 114
Query: 316 -PRG----GRSLDWAMRM-KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHL 369
            P      GR       M ++A  +A G+A+L+ K     VHRD+ A N ++  +F   +
Sbjct: 115 RPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKI 171
Query: 370 MGVGLSKFVPWEVMQERTVMAGGT----YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 425
              G+++    ++ +      GG       ++APE +     TT SD++SFGV+L EI S
Sbjct: 172 GDFGMTR----DIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227
Query: 426 -GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYA 484
              +P Q + +       E     V    Y                     ++V DL+  
Sbjct: 228 LAEQPYQGLSN-------EQVLKFVMDGGYLDQPD-------------NCPERVTDLMRM 267
Query: 485 CTQHVPSMRPRMSHVVHQLQQLAQP 509
           C Q  P MRP    +V+ L+    P
Sbjct: 268 CWQFNPKMRPTFLEIVNLLKDDLHP 292

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 117/279 (41%), Gaps = 49/279 (17%)
Query: 251 RVAVKRLKRSSFQRKKE-FYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 308
           +VAVK LK ++   +KE   SE+   + L  H N+V + G C   G   ++ E+   G L
Sbjct: 78  KVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 137
Query: 309 DRWLH--------------HIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDI 354
             +L               H P     L     +  ++ +AQG+AFL  K   + +HRD+
Sbjct: 138 LNFLRRKRPPGLEYSYNPSHNPE--EQLSSRDLLHFSSQVAQGMAFLASK---NCIHRDV 192
Query: 355 RASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT----YGYLAPEFVYRNELTTK 410
            A NVLL     A +   GL++    ++M +   +  G       ++APE ++    T +
Sbjct: 193 AARNVLLTNGHVAKIGDFGLAR----DIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQ 248
Query: 411 SDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXX 469
           SDV+S+G+LL EI S G  P   +              LV S  Y               
Sbjct: 249 SDVWSYGILLWEIFSLGLNPYPGI--------------LVNSKFY-----KLVKDGYQMA 289
Query: 470 XXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 508
             A   + +  ++ AC    P+ RP    +   LQ+ AQ
Sbjct: 290 QPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 328

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/237 (28%), Positives = 114/237 (48%), Gaps = 29/237 (12%)
Query: 230 NRLLGDSKTGGTYSGIL--PDGSRV--AVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLV 284
           N ++G    G  Y G L   DG ++  AVK L R +      +F +E        HPN++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 285 AVKGCCY-DHGDRYIVYEFVVNGPLDRWLH---HIPRGGRSLDWAMRMKVATTLAQGIAF 340
           ++ G C    G   +V  ++ +G L  ++    H P     + + ++      +A+G+ F
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKF 148
Query: 341 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV---PWEVMQERTVMAGGTYGYL 397
           L  K     VHRD+ A N +LDE+F   +   GL++ +    ++ +  +T  A     ++
Sbjct: 149 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT-GAKLPVKWM 204
Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHR 453
           A E +   + TTKSDV+SFGVLL E+++ G  P   V++      F+    L+Q  R
Sbjct: 205 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT------FDITVYLLQGRR 255

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 100/218 (45%), Gaps = 31/218 (14%)
Query: 252 VAVKRLKRSSFQRKKEFYSEIGRFAR----LHHPNLVAVKGCCYDHGDR--------YIV 299
           VAVK L R+   R   FY    R A+    L+HP +VAV    YD G+         YIV
Sbjct: 40  VAVKVL-RADLARDPSFYLRFRREAQNAAALNHPAIVAV----YDTGEAETPAGPLPYIV 94
Query: 300 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNV 359
            E+V    L   +H    G  +   A+  +V     Q + F H      ++HRD++ +N+
Sbjct: 95  MEYVDGVTLRDIVHT--EGPMTPKRAI--EVIADACQALNFSHQN---GIIHRDVKPANI 147
Query: 360 LLDEEFGAHLMGVGLSKFVP---WEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSF 416
           ++       +M  G+++ +      V Q   V+  GT  YL+PE    + +  +SDVYS 
Sbjct: 148 MISATNAVKVMDFGIARAIADSGNSVTQTAAVI--GTAQYLSPEQARGDSVDARSDVYSL 205
Query: 417 GVLLLEIVSGRRP--AQAVDSVCWQSIFEWATPLVQSH 452
           G +L E+++G  P    +  SV +Q + E   P    H
Sbjct: 206 GCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 243

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 88/193 (45%), Gaps = 28/193 (14%)
Query: 249 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 308
           G  + +K L R   + ++ F  E+     L HPN++   G  Y       + E++  G L
Sbjct: 35  GEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTL 94
Query: 309 DRWLHHIPRGGRSLD----WAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 364
              +       +S+D    W+ R+  A  +A G+A+LH     +++HRD+ + N L+ E 
Sbjct: 95  RGII-------KSMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVREN 144
Query: 365 FGAHLMGVGLSKFVPWEVMQ-------------ERTVMAGGTYGYLAPEFVYRNELTTKS 411
               +   GL++ +  E  Q             +R  + G  Y ++APE +       K 
Sbjct: 145 KNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPY-WMAPEMINGRSYDEKV 203
Query: 412 DVYSFGVLLLEIV 424
           DV+SFG++L EI+
Sbjct: 204 DVFSFGIVLCEII 216

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 100/207 (48%), Gaps = 13/207 (6%)
Query: 230 NRLLGDSKTGGTYSGILPDGSR----VAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLV 284
           ++++G  + G   SG L   S+    VA+K LK   + +++++F  E     +  HPN++
Sbjct: 21  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 80
Query: 285 AVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 344
            ++G         IV E + NG LD +L    +          + +   +A G+ +L D 
Sbjct: 81  RLEGVVTKSKPVMIVTEXMENGSLDSFLR---KHDAQFTVIQLVGMLRGIASGMKYLSDM 137
Query: 345 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT-YGYLAPEFVY 403
                VHRD+ A N+L++      +   GLS+ +  +     T   G     + +PE + 
Sbjct: 138 ---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 194
Query: 404 RNELTTKSDVYSFGVLLLEIVS-GRRP 429
             + T+ SDV+S+G++L E++S G RP
Sbjct: 195 YRKFTSASDVWSYGIVLWEVMSYGERP 221

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 93/183 (50%), Gaps = 11/183 (6%)
Query: 252 VAVKRLKRSSFQR-KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 310
           VA+K LK    +R ++EF SE     +  HPN++ ++G   +     I+ EF+ NG LD 
Sbjct: 45  VAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDS 104
Query: 311 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLM 370
           +L  +  G  ++   + M     +A G+ +L +      VHRD+ A N+L++      + 
Sbjct: 105 FL-RLNDGQFTVIQLVGM--LRGIASGMRYLAEM---SYVHRDLAARNILVNSNLVCKVS 158
Query: 371 GVGLSKFVPWEVMQER-TVMAGGTYG--YLAPEFVYRNELTTKSDVYSFGVLLLEIVS-G 426
             GLS+F+         T   GG     + APE +   + T+ SD +S+G+++ E++S G
Sbjct: 159 DFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFG 218
Query: 427 RRP 429
            RP
Sbjct: 219 ERP 221

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/237 (28%), Positives = 114/237 (48%), Gaps = 29/237 (12%)
Query: 230 NRLLGDSKTGGTYSGIL--PDGSRV--AVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLV 284
           N ++G    G  Y G L   DG ++  AVK L R +      +F +E        HPN++
Sbjct: 36  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 285 AVKGCCY-DHGDRYIVYEFVVNGPLDRWLH---HIPRGGRSLDWAMRMKVATTLAQGIAF 340
           ++ G C    G   +V  ++ +G L  ++    H P     + + ++      +A+G+ F
Sbjct: 96  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKF 149
Query: 341 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV---PWEVMQERTVMAGGTYGYL 397
           L  K     VHRD+ A N +LDE+F   +   GL++ +    ++ +  +T  A     ++
Sbjct: 150 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT-GAKLPVKWM 205
Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHR 453
           A E +   + TTKSDV+SFGVLL E+++ G  P   V++      F+    L+Q  R
Sbjct: 206 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT------FDITVYLLQGRR 256

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/237 (28%), Positives = 114/237 (48%), Gaps = 29/237 (12%)
Query: 230 NRLLGDSKTGGTYSGIL--PDGSRV--AVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLV 284
           N ++G    G  Y G L   DG ++  AVK L R +      +F +E        HPN++
Sbjct: 36  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 285 AVKGCCY-DHGDRYIVYEFVVNGPLDRWLH---HIPRGGRSLDWAMRMKVATTLAQGIAF 340
           ++ G C    G   +V  ++ +G L  ++    H P     + + ++      +A+G+ F
Sbjct: 96  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKF 149
Query: 341 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV---PWEVMQERTVMAGGTYGYL 397
           L  K     VHRD+ A N +LDE+F   +   GL++ +    ++ +  +T  A     ++
Sbjct: 150 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKT-GAKLPVKWM 205
Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHR 453
           A E +   + TTKSDV+SFGVLL E+++ G  P   V++      F+    L+Q  R
Sbjct: 206 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT------FDITVYLLQGRR 256

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/237 (28%), Positives = 114/237 (48%), Gaps = 29/237 (12%)
Query: 230 NRLLGDSKTGGTYSGIL--PDGSRV--AVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLV 284
           N ++G    G  Y G L   DG ++  AVK L R +      +F +E        HPN++
Sbjct: 40  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 99
Query: 285 AVKGCCY-DHGDRYIVYEFVVNGPLDRWLH---HIPRGGRSLDWAMRMKVATTLAQGIAF 340
           ++ G C    G   +V  ++ +G L  ++    H P     + + ++      +A+G+ F
Sbjct: 100 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKF 153
Query: 341 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV---PWEVMQERTVMAGGTYGYL 397
           L  K     VHRD+ A N +LDE+F   +   GL++ +    ++ +  +T  A     ++
Sbjct: 154 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT-GAKLPVKWM 209
Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHR 453
           A E +   + TTKSDV+SFGVLL E+++ G  P   V++      F+    L+Q  R
Sbjct: 210 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT------FDITVYLLQGRR 260

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 82/325 (25%), Positives = 135/325 (41%), Gaps = 54/325 (16%)
Query: 203 ASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPD------GSRVAVKR 256
           +S  VP  W+V + E++  +        R LG    G  Y G   D       +RVAVK 
Sbjct: 4   SSVYVPDEWEV-SREKITLL--------RELGQGSFGMVYEGNARDIIKGEAETRVAVKT 54
Query: 257 LKRSSFQRKK-EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHI 315
           +  S+  R++ EF +E          ++V + G         +V E + +G L  +L  +
Sbjct: 55  VNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSL 114
Query: 316 -PRG----GRSLDWAMRM-KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHL 369
            P      GR       M ++A  +A G+A+L+ K     VHRD+ A N ++  +F   +
Sbjct: 115 RPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKI 171
Query: 370 MGVGLSKFVPWEVMQERTVMAGGT----YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 425
              G+++    ++ +      GG       ++APE +     TT SD++SFGV+L EI S
Sbjct: 172 GDFGMTR----DIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227
Query: 426 -GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYA 484
              +P Q + +       E     V    Y                     ++V DL+  
Sbjct: 228 LAEQPYQGLSN-------EQVLKFVMDGGYLDQPD-------------NCPERVTDLMRM 267
Query: 485 CTQHVPSMRPRMSHVVHQLQQLAQP 509
           C Q  P+MRP    +V+ L+    P
Sbjct: 268 CWQFNPNMRPTFLEIVNLLKDDLHP 292

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 100/221 (45%), Gaps = 20/221 (9%)
Query: 217 EELRSIT------KNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFY 269
           E+LRSI       K ++   ++ G   +G  Y+ + +  G  VA++++      +K+   
Sbjct: 7   EKLRSIVSVGDPKKKYTRFEKI-GQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII 65
Query: 270 SEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMK 329
           +EI       +PN+V          + ++V E++  G L   +         +D      
Sbjct: 66  NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAA 120
Query: 330 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGL-SKFVPWEVMQERTV 388
           V     Q + FLH      V+HRDI++ N+LL  +    L   G  ++  P +   +R+ 
Sbjct: 121 VCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSE 175
Query: 389 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           M G  Y ++APE V R     K D++S G++ +E++ G  P
Sbjct: 176 MVGTPY-WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/243 (25%), Positives = 108/243 (44%), Gaps = 17/243 (6%)
Query: 198 LSNPAASALVPPSWKVFTTEELRSITKNFSEGN----RLLGDSKTGGTYSGILPDGSR-- 251
           L  P     V P      T+ +    K     N    +++G  + G   SG L   S+  
Sbjct: 14  LKLPGLRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKE 73
Query: 252 --VAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 308
             VA+K LK   + +++++F  E     +  HPN++ ++G         IV E++ NG L
Sbjct: 74  ISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL 133
Query: 309 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 368
           D +L    +          + +   +A G+ +L D      VHRD+ A N+L++      
Sbjct: 134 DSFLR---KHDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCK 187
Query: 369 LMGVGLSKFVPWEVMQERTVMAGGT-YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-G 426
           +   GL + +  +     T   G     + +PE +   + T+ SDV+S+G++L E++S G
Sbjct: 188 VSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 247
Query: 427 RRP 429
            RP
Sbjct: 248 ERP 250

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 100/207 (48%), Gaps = 13/207 (6%)
Query: 230 NRLLGDSKTGGTYSGILP-DGSR---VAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLV 284
            R++G  + G   SG L   G R   VA+K LK   + +++++F  E     +  HPN+V
Sbjct: 48  ERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVV 107
Query: 285 AVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 344
            ++G         IV EF+ NG LD +L    +          + +   +A G+ +L D 
Sbjct: 108 HLEGVVTRGKPVMIVIEFMENGALDAFLR---KHDGQFTVIQLVGMLRGIAAGMRYLADM 164
Query: 345 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT-YGYLAPEFVY 403
                VHRD+ A N+L++      +   GLS+ +  +     T   G     + APE + 
Sbjct: 165 ---GYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQ 221
Query: 404 RNELTTKSDVYSFGVLLLEIVS-GRRP 429
             + T+ SDV+S+G+++ E++S G RP
Sbjct: 222 YRKFTSASDVWSYGIVMWEVMSYGERP 248

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 100/207 (48%), Gaps = 13/207 (6%)
Query: 230 NRLLGDSKTGGTYSGILPDGSR----VAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLV 284
           ++++G  + G   SG L   S+    VA+K LK   + +++++F  E     +  HPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 285 AVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 344
            ++G         IV E + NG LD +L    +          + +   +A G+ +L D 
Sbjct: 110 RLEGVVTKSKPVMIVTEXMENGSLDSFLR---KHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 345 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT-YGYLAPEFVY 403
                VHRD+ A N+L++      +   GLS+ +  +     T   G     + +PE + 
Sbjct: 167 ---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 404 RNELTTKSDVYSFGVLLLEIVS-GRRP 429
             + T+ SDV+S+G++L E++S G RP
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 109/231 (47%), Gaps = 21/231 (9%)
Query: 214 FTTEELRSITKNFSEG--------NRLLGDSKTGGTYSGILP-DGSR---VAVKRLKRS- 260
           FT E+     + F++          +++G  + G   SG L   G R   VA+K LK   
Sbjct: 10  FTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGY 69
Query: 261 SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGR 320
           + +++++F SE     +  HPN++ ++G         I+ E++ NG LD +L      GR
Sbjct: 70  TDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRK--NDGR 127
Query: 321 SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 380
                  + +   +  G+ +L D      VHRD+ A N+L++      +   G+S+ +  
Sbjct: 128 -FTVIQLVGMLRGIGSGMKYLSDM---SAVHRDLAARNILVNSNLVCKVSDFGMSRVLED 183
Query: 381 EVMQERTVMAGGT-YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRP 429
           +     T   G     + APE +   + T+ SDV+S+G+++ E++S G RP
Sbjct: 184 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 234

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 100/219 (45%), Gaps = 13/219 (5%)
Query: 221 SITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRK-KEFYSEIGRFARL 278
           SI ++  E   ++G   T    +    P   +VA+KR+     Q    E   EI   ++ 
Sbjct: 6   SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQC 65
Query: 279 HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS----LDWAMRMKVATTL 334
           HHPN+V+         + ++V + +  G +   + HI   G      LD +    +   +
Sbjct: 66  HHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 125
Query: 335 AQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--- 391
            +G+ +LH   K   +HRD++A N+LL E+    +   G+S F+       R  +     
Sbjct: 126 LEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 182
Query: 392 GTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRP 429
           GT  ++APE + +      K+D++SFG+  +E+ +G  P
Sbjct: 183 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 221

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 100/218 (45%), Gaps = 31/218 (14%)
Query: 252 VAVKRLKRSSFQRKKEFYSEIGRFAR----LHHPNLVAVKGCCYDHGDR--------YIV 299
           VAVK L R+   R   FY    R A+    L+HP +VAV    YD G+         YIV
Sbjct: 57  VAVKVL-RADLARDPSFYLRFRREAQNAAALNHPAIVAV----YDTGEAETPAGPLPYIV 111
Query: 300 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNV 359
            E+V    L   +H    G  +   A+  +V     Q + F H      ++HRD++ +N+
Sbjct: 112 MEYVDGVTLRDIVHT--EGPMTPKRAI--EVIADACQALNFSHQN---GIIHRDVKPANI 164
Query: 360 LLDEEFGAHLMGVGLSKFVP---WEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSF 416
           ++       +M  G+++ +      V Q   V+  GT  YL+PE    + +  +SDVYS 
Sbjct: 165 MISATNAVKVMDFGIARAIADSGNSVTQTAAVI--GTAQYLSPEQARGDSVDARSDVYSL 222
Query: 417 GVLLLEIVSGRRP--AQAVDSVCWQSIFEWATPLVQSH 452
           G +L E+++G  P    +  SV +Q + E   P    H
Sbjct: 223 GCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 260

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 100/219 (45%), Gaps = 13/219 (5%)
Query: 221 SITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRK-KEFYSEIGRFARL 278
           SI ++  E   ++G   T    +    P   +VA+KR+     Q    E   EI   ++ 
Sbjct: 11  SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQC 70
Query: 279 HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS----LDWAMRMKVATTL 334
           HHPN+V+         + ++V + +  G +   + HI   G      LD +    +   +
Sbjct: 71  HHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 130
Query: 335 AQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--- 391
            +G+ +LH   K   +HRD++A N+LL E+    +   G+S F+       R  +     
Sbjct: 131 LEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187
Query: 392 GTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRP 429
           GT  ++APE + +      K+D++SFG+  +E+ +G  P
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 102/224 (45%), Gaps = 31/224 (13%)
Query: 246 LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFAR----LHHPNLVAVKGCCYDHGDR----- 296
           L D   VAVK L R+   R   FY    R A+    L+HP +VAV    YD G+      
Sbjct: 34  LRDHRDVAVKVL-RADLARDPSFYLRFRREAQNAAALNHPAIVAV----YDTGEAETPAG 88
Query: 297 ---YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRD 353
              YIV E+V    L   +H    G  +   A+  +V     Q + F H      ++HRD
Sbjct: 89  PLPYIVMEYVDGVTLRDIVHT--EGPMTPKRAI--EVIADACQALNFSHQN---GIIHRD 141
Query: 354 IRASNVLLDEEFGAHLMGVGLSKFVP---WEVMQERTVMAGGTYGYLAPEFVYRNELTTK 410
           ++ +N+L+       ++  G+++ +      V Q   V+  GT  YL+PE    + +  +
Sbjct: 142 VKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVI--GTAQYLSPEQARGDSVDAR 199
Query: 411 SDVYSFGVLLLEIVSGRRP--AQAVDSVCWQSIFEWATPLVQSH 452
           SDVYS G +L E+++G  P    +  SV +Q + E   P    H
Sbjct: 200 SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 243

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 105/234 (44%), Gaps = 31/234 (13%)
Query: 224 KNFSEGNRLLGDSKTGGTYS----GILP--DGSRVAVKRLKR-SSFQRKKEFYSEIGRFA 276
           +N  E  R +G+   G  +     G+LP    + VAVK LK  +S   + +F  E    A
Sbjct: 46  RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMA 105
Query: 277 RLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPR------------------- 317
              +PN+V + G C       +++E++  G L+ +L  +                     
Sbjct: 106 EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 165
Query: 318 -GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK 376
            G   L  A ++ +A  +A G+A+L ++     VHRD+   N L+ E     +   GLS+
Sbjct: 166 PGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSR 222
Query: 377 FVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRP 429
            +      +          ++ PE ++ N  TT+SDV+++GV+L EI S G +P
Sbjct: 223 NIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 77/167 (46%), Gaps = 8/167 (4%)
Query: 276 ARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLA 335
           +RL HP  V +  C  D    Y    +  NG L +++  I     S D          + 
Sbjct: 92  SRLDHPFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAEIV 147
Query: 336 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG 395
             + +LH K    ++HRD++  N+LL+E+    +   G +K +  E  Q R     GT  
Sbjct: 148 SALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 204
Query: 396 YLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS-VCWQSI 441
           Y++PE +        SD+++ G ++ ++V+G  P +A +  + +Q I
Sbjct: 205 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI 251

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 82/325 (25%), Positives = 134/325 (41%), Gaps = 54/325 (16%)
Query: 203 ASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPD------GSRVAVKR 256
           +S  VP  W+V + E++  +        R LG    G  Y G   D       +RVAVK 
Sbjct: 4   SSVFVPDEWEV-SREKITLL--------RELGQGSFGMVYEGNARDIIKGEAETRVAVKT 54
Query: 257 LKRSSFQRKK-EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHI 315
           +  S+  R++ EF +E          ++V + G         +V E + +G L  +L  +
Sbjct: 55  VNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSL 114
Query: 316 -PRG----GRSLDWAMRM-KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHL 369
            P      GR       M ++A  +A G+A+L+ K     VHRD+ A N ++  +F   +
Sbjct: 115 RPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKI 171
Query: 370 MGVGLSKFVPWEVMQERTVMAGGT----YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 425
              G+++    ++ +      GG       ++APE +     TT SD++SFGV+L EI S
Sbjct: 172 GDFGMTR----DIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227
Query: 426 -GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYA 484
              +P Q + +       E     V    Y                     ++V DL+  
Sbjct: 228 LAEQPYQGLSN-------EQVLKFVMDGGYLDQPD-------------NCPERVTDLMRM 267
Query: 485 CTQHVPSMRPRMSHVVHQLQQLAQP 509
           C Q  P MRP    +V+ L+    P
Sbjct: 268 CWQFNPKMRPTFLEIVNLLKDDLHP 292

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 112/231 (48%), Gaps = 28/231 (12%)
Query: 213 VFTTEELRSITKNF-SEGN-RLLGDS--KTGGTYSGIL------PDGSRVAVKRLKRSSF 262
           V T E+ ++  +    +G+ RLL DS  K G   +GI+        G +VAVK +     
Sbjct: 24  VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ 83
Query: 263 QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSL 322
           QR++  ++E+       H N+V +        + +++ EF+  G L   +  +      L
Sbjct: 84  QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV-----RL 138
Query: 323 DWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVG----LSKFV 378
           +      V   + Q +A+LH +    V+HRDI++ ++LL  +    L   G    +SK V
Sbjct: 139 NEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV 195
Query: 379 PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           P     +R  + G  Y ++APE + R+   T+ D++S G++++E+V G  P
Sbjct: 196 P-----KRKXLVGTPY-WMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 102/211 (48%), Gaps = 23/211 (10%)
Query: 246 LPDGSRVAVKRLKRS-SFQRKKEFYSEIGRFAR-LHHPNLVAVKGCCYDHGDRYIVYEFV 303
           +P G  +AVKR++ + + Q +K    ++    R +  P  V   G  +  GD +I  E +
Sbjct: 73  VPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICME-L 131
Query: 304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 363
           ++  LD++   +   G+++   +  K+A ++ + +  LH K+   V+HRD++ SNVL++ 
Sbjct: 132 MDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINA 189
Query: 364 EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFV----YRNELTTKSDVYSFGVL 419
                +   G+S ++   V +    +  G   Y+APE +     +   + KSD++S G+ 
Sbjct: 190 LGQVKMCDFGISGYLVDSVAK---TIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGIT 246
Query: 420 LLEIVSGRRPAQAVDSVCWQSIFEWATPLVQ 450
           ++E+   R P  +           W TP  Q
Sbjct: 247 MIELAILRFPYDS-----------WGTPFQQ 266

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 82/325 (25%), Positives = 134/325 (41%), Gaps = 54/325 (16%)
Query: 203 ASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPD------GSRVAVKR 256
           +S  VP  W+V + E++  +        R LG    G  Y G   D       +RVAVK 
Sbjct: 4   SSVFVPDEWEV-SREKITLL--------RELGQGSFGMVYEGNARDIIKGEAETRVAVKT 54
Query: 257 LKRSSFQRKK-EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHI 315
           +  S+  R++ EF +E          ++V + G         +V E + +G L  +L  +
Sbjct: 55  VNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSL 114
Query: 316 -PRG----GRSLDWAMRM-KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHL 369
            P      GR       M ++A  +A G+A+L+ K     VHRD+ A N ++  +F   +
Sbjct: 115 RPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKI 171
Query: 370 MGVGLSKFVPWEVMQERTVMAGGT----YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 425
              G+++    ++ +      GG       ++APE +     TT SD++SFGV+L EI S
Sbjct: 172 GDFGMTR----DIYETAYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227
Query: 426 -GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYA 484
              +P Q + +       E     V    Y                     ++V DL+  
Sbjct: 228 LAEQPYQGLSN-------EQVLKFVMDGGYLDQPD-------------NCPERVTDLMRM 267
Query: 485 CTQHVPSMRPRMSHVVHQLQQLAQP 509
           C Q  P MRP    +V+ L+    P
Sbjct: 268 CWQFNPKMRPTFLEIVNLLKDDLHP 292

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 101/206 (49%), Gaps = 13/206 (6%)
Query: 231 RLLGDSKTGGTYSGILP-DGSR---VAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVA 285
           +++G  + G   SG L   G R   VA+K LK   + +++++F SE     +  HPN++ 
Sbjct: 14  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIH 73
Query: 286 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 345
           ++G         I+ E++ NG LD +L      GR       + +   +  G+ +L D  
Sbjct: 74  LEGVVTKCKPVMIITEYMENGSLDAFLRK--NDGR-FTVIQLVGMLRGIGSGMKYLSDM- 129
Query: 346 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT-YGYLAPEFVYR 404
               VHRD+ A N+L++      +   G+S+ +  +     T   G     + APE +  
Sbjct: 130 --SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 187
Query: 405 NELTTKSDVYSFGVLLLEIVS-GRRP 429
            + T+ SDV+S+G+++ E++S G RP
Sbjct: 188 RKFTSASDVWSYGIVMWEVMSYGERP 213

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 79/314 (25%), Positives = 125/314 (39%), Gaps = 39/314 (12%)
Query: 212 KVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGIL------PDGSRVAVKRLKR-SSFQR 264
           K  +  +L+ + +      R LG    G  Y G +      P   +VAVK L    S Q 
Sbjct: 32  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 91
Query: 265 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHI-PRGGRSLD 323
           + +F  E    ++L+H N+V   G       R+I+ E +  G L  +L    PR  +   
Sbjct: 92  ELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 151
Query: 324 WAMR--MKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 381
            AM   + VA  +A G  +L +    H +HRDI A N LL       +  +G       +
Sbjct: 152 LAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA-RD 207
Query: 382 VMQERTVMAGG----TYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSV 436
           + +      GG       ++ PE       T+K+D +SFGVLL EI S G  P  +  + 
Sbjct: 208 IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN- 266
Query: 437 CWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRM 496
             Q + E+ T                          G V +++     C QH P  RP  
Sbjct: 267 --QEVLEFVT--------------SGGRMDPPKNCPGPVYRIMT---QCWQHQPEDRPNF 307
Query: 497 SHVVHQLQQLAQPP 510
           + ++ +++   Q P
Sbjct: 308 AIILERIEYCTQDP 321

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 101/206 (49%), Gaps = 13/206 (6%)
Query: 231 RLLGDSKTGGTYSGILP-DGSR---VAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVA 285
           +++G  + G   SG L   G R   VA+K LK   + +++++F SE     +  HPN++ 
Sbjct: 20  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIH 79
Query: 286 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 345
           ++G         I+ E++ NG LD +L      GR       + +   +  G+ +L D  
Sbjct: 80  LEGVVTKCKPVMIITEYMENGSLDAFLRK--NDGR-FTVIQLVGMLRGIGSGMKYLSDM- 135
Query: 346 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT-YGYLAPEFVYR 404
               VHRD+ A N+L++      +   G+S+ +  +     T   G     + APE +  
Sbjct: 136 --SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 193
Query: 405 NELTTKSDVYSFGVLLLEIVS-GRRP 429
            + T+ SDV+S+G+++ E++S G RP
Sbjct: 194 RKFTSASDVWSYGIVMWEVMSYGERP 219

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 20/212 (9%)
Query: 247 PDGSRVAVKRLKRSSFQR-KKEFYSEIGRFARLHH-PNLVAVKGCCYDHGDRYIVYEFVV 304
           P G  +AVKR++ +  ++ +K+   ++    R    P +V   G  +  GD +I  E + 
Sbjct: 45  PSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS 104
Query: 305 NGPLDRWLHHIPRGGRSLDWAMRMKV--ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 362
               D++  ++      LD  +  ++    TLA   A  H K    ++HRDI+ SN+LLD
Sbjct: 105 TS-FDKFYKYV---YSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLD 160
Query: 363 EEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFV----YRNELTTKSDVYSFGV 418
                 L   G+S  +   + + R     G   Y+APE +     R     +SDV+S G+
Sbjct: 161 RSGNIKLCDFGISGQLVDSIAKTRD---AGCRPYMAPERIDPSASRQGYDVRSDVWSLGI 217
Query: 419 LLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQ 450
            L E+ +GR P        W S+F+  T +V+
Sbjct: 218 TLYELATGRFPYPK-----WNSVFDQLTQVVK 244

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 110/280 (39%), Gaps = 42/280 (15%)
Query: 228 EGNRLLGDSKTGGTYSGILPDGSRV-AVKRLKRSSFQR---KKEFYSEIGRFARLHHPNL 283
           E  R LG  K G  Y     +   + A+K L ++  ++   + +   E+   + L HPN+
Sbjct: 11  EIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 70
Query: 284 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 343
           + + G  +D    Y++ E+   G + R L  + +     D        T LA  +++ H 
Sbjct: 71  LRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHS 126
Query: 344 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 403
           K    V+HRDI+  N+LL       +   G S   P      R     GT  YL PE + 
Sbjct: 127 K---KVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRAALCGTLDYLPPEMIE 179
Query: 404 RNELTTKSDVYSFGVLLLEIVSGRRPAQA---VDSVCWQSIFEWATPLVQSHRYXXXXXX 460
                 K D++S GVL  E + G+ P +A    D+    S  E+  P             
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFTFP------------- 226
Query: 461 XXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVV 500
                        V +   DL+    +H PS RP +  V+
Sbjct: 227 -----------DFVTEGARDLISRLLKHNPSQRPMLREVL 255

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 79/314 (25%), Positives = 125/314 (39%), Gaps = 39/314 (12%)
Query: 212 KVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGIL------PDGSRVAVKRLKR-SSFQR 264
           K  +  +L+ + +      R LG    G  Y G +      P   +VAVK L    S Q 
Sbjct: 18  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 77
Query: 265 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHI-PRGGRSLD 323
           + +F  E    ++L+H N+V   G       R+I+ E +  G L  +L    PR  +   
Sbjct: 78  ELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 137
Query: 324 WAMR--MKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 381
            AM   + VA  +A G  +L +    H +HRDI A N LL       +  +G       +
Sbjct: 138 LAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA-RD 193
Query: 382 VMQERTVMAGG----TYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSV 436
           + +      GG       ++ PE       T+K+D +SFGVLL EI S G  P  +  + 
Sbjct: 194 IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN- 252
Query: 437 CWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRM 496
             Q + E+ T                          G V +++     C QH P  RP  
Sbjct: 253 --QEVLEFVT--------------SGGRMDPPKNCPGPVYRIMT---QCWQHQPEDRPNF 293
Query: 497 SHVVHQLQQLAQPP 510
           + ++ +++   Q P
Sbjct: 294 AIILERIEYCTQDP 307

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 91/183 (49%), Gaps = 13/183 (7%)
Query: 252 VAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRW 311
           VA+K +K  S   + EF  E      L H  LV + G C      +I+ E++ NG L  +
Sbjct: 51  VAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNY 109
Query: 312 LHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMG 371
           L  +    ++      +++   + + + +L  K     +HRD+ A N L++++    +  
Sbjct: 110 LREMRHRFQT---QQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSD 163
Query: 372 VGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRR 428
            GLS++V   +  E T   G  +   +  PE +  ++ ++KSD+++FGVL+ EI S G+ 
Sbjct: 164 FGLSRYV---LDDEETSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKM 220
Query: 429 PAQ 431
           P +
Sbjct: 221 PYE 223

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 89/185 (48%), Gaps = 17/185 (9%)
Query: 252 VAVKRLKRSSFQR-KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 310
           VA+K LK    +R +++F SE     +  HPN++ ++G         IV E++ NG LD 
Sbjct: 80  VAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDT 139
Query: 311 WLHHIPRGGRSLDWAMRMKVATTLAQGIA----FLHDKVKPHVVHRDIRASNVLLDEEFG 366
           +L       R+ D    +     + +G+     +L D      VHRD+ A NVL+D    
Sbjct: 140 FL-------RTHDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLV 189
Query: 367 AHLMGVGLSKFVPWEVMQERTVMAGGT-YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 425
             +   GLS+ +  +     T   G     + APE +     ++ SDV+SFGV++ E+++
Sbjct: 190 CKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249
Query: 426 -GRRP 429
            G RP
Sbjct: 250 YGERP 254

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 230 NRLLGDSKTGGTYSGILPD--GSR--VAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLV 284
           NR+LG+   G  Y G+  +  G +  VAVK  K+  +   K++F SE      L HP++V
Sbjct: 13  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 72
Query: 285 AVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 344
            + G   +    +I+ E    G L    H++ R   SL     +  +  + + +A+L   
Sbjct: 73  KLIGII-EEEPTWIIMELYPYGELG---HYLERNKNSLKVLTLVLYSLQICKAMAYLESI 128
Query: 345 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR 404
              + VHRDI   N+L+       L   GLS+++  E   + +V       +++PE +  
Sbjct: 129 ---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASV-TRLPIKWMSPESINF 184
Query: 405 NELTTKSDVYSFGVLLLEIVS-GRRP 429
              TT SDV+ F V + EI+S G++P
Sbjct: 185 RRFTTASDVWMFAVCMWEILSFGKQP 210

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/199 (24%), Positives = 90/199 (45%), Gaps = 13/199 (6%)
Query: 233 LGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 291
           +G   +G  Y+ + +  G  VA++++      +K+   +EI       +PN+V       
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 292 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 351
              + ++V E++  G L   +         +D      V     Q + FLH      V+H
Sbjct: 89  VGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIH 140
Query: 352 RDIRASNVLLDEEFGAHLMGVGL-SKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 410
           R+I++ N+LL  +    L   G  ++  P +   +R+ M G  Y ++APE V R     K
Sbjct: 141 RNIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPY-WMAPEVVTRKAYGPK 197
Query: 411 SDVYSFGVLLLEIVSGRRP 429
            D++S G++ +E++ G  P
Sbjct: 198 VDIWSLGIMAIEMIEGEPP 216

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 79/320 (24%), Positives = 124/320 (38%), Gaps = 51/320 (15%)
Query: 212 KVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGIL------PDGSRVAVKRLKR-SSFQR 264
           K  +  +L+ + +      R LG    G  Y G +      P   +VAVK L    S Q 
Sbjct: 58  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 117
Query: 265 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHI-PRGGRSLD 323
           + +F  E    ++ +H N+V   G       R+I+ E +  G L  +L    PR  +   
Sbjct: 118 ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 177
Query: 324 WAMR--MKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 381
            AM   + VA  +A G  +L +    H +HRDI A N LL       +  +G       +
Sbjct: 178 LAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG-------D 227
Query: 382 VMQERTVMAGGTY----------GYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPA 430
               R +   G Y           ++ PE       T+K+D +SFGVLL EI S G  P 
Sbjct: 228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 287
Query: 431 QAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYACTQHVP 490
            +  +   Q + E+ T                          G V +++     C QH P
Sbjct: 288 PSKSN---QEVLEFVT--------------SGGRMDPPKNCPGPVYRIMT---QCWQHQP 327
Query: 491 SMRPRMSHVVHQLQQLAQPP 510
             RP  + ++ +++   Q P
Sbjct: 328 EDRPNFAIILERIEYCTQDP 347

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 114/274 (41%), Gaps = 42/274 (15%)
Query: 250 SRVAVKRLKRSSFQRK-KEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGP 307
           ++VAVK LK  + ++   +  SE+     +  H N++ + G C   G  Y++ E+   G 
Sbjct: 61  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 120
Query: 308 LDRWLH--------------HIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRD 353
           L  +L               H P     L     +  A  +A+G+ +L  K     +HRD
Sbjct: 121 LREYLQARRPPGLEFSFNPSHNPE--EQLSSKDLVSCAYQVARGMEYLASK---KCIHRD 175
Query: 354 IRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDV 413
           + A NVL+ E+    +   GL++ +      ++T        ++APE ++    T +SDV
Sbjct: 176 LAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDV 235
Query: 414 YSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXA 472
           +SFGVLL EI + G  P   V       + E    L + HR                  +
Sbjct: 236 WSFGVLLWEIFTLGGSPYPGV------PVEELFKLLKEGHRM--------------DKPS 275
Query: 473 GVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 506
               ++  ++  C   VPS RP    +V  L ++
Sbjct: 276 NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 309

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 79/320 (24%), Positives = 124/320 (38%), Gaps = 51/320 (15%)
Query: 212 KVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGIL------PDGSRVAVKRLKR-SSFQR 264
           K  +  +L+ + +      R LG    G  Y G +      P   +VAVK L    S Q 
Sbjct: 35  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 94
Query: 265 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHI-PRGGRSLD 323
           + +F  E    ++ +H N+V   G       R+I+ E +  G L  +L    PR  +   
Sbjct: 95  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 154
Query: 324 WAMR--MKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 381
            AM   + VA  +A G  +L +    H +HRDI A N LL       +  +G       +
Sbjct: 155 LAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG-------D 204
Query: 382 VMQERTVMAGGTY----------GYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPA 430
               R +   G Y           ++ PE       T+K+D +SFGVLL EI S G  P 
Sbjct: 205 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 264
Query: 431 QAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYACTQHVP 490
            +  +   Q + E+ T                          G V +++     C QH P
Sbjct: 265 PSKSN---QEVLEFVT--------------SGGRMDPPKNCPGPVYRIMT---QCWQHQP 304
Query: 491 SMRPRMSHVVHQLQQLAQPP 510
             RP  + ++ +++   Q P
Sbjct: 305 EDRPNFAIILERIEYCTQDP 324

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 114/274 (41%), Gaps = 42/274 (15%)
Query: 250 SRVAVKRLKRSSFQRK-KEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGP 307
           ++VAVK LK  + ++   +  SE+     +  H N++ + G C   G  Y++ E+   G 
Sbjct: 102 TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 161
Query: 308 LDRWLH--------------HIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRD 353
           L  +L               H P     L     +  A  +A+G+ +L  K     +HRD
Sbjct: 162 LREYLQARRPPGLEYSYNPSHNPE--EQLSSKDLVSCAYQVARGMEYLASK---KCIHRD 216
Query: 354 IRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDV 413
           + A NVL+ E+    +   GL++ +      ++T        ++APE ++    T +SDV
Sbjct: 217 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDV 276
Query: 414 YSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXA 472
           +SFGVLL EI + G  P   V       + E    L + HR                  +
Sbjct: 277 WSFGVLLWEIFTLGGSPYPGV------PVEELFKLLKEGHR--------------MDKPS 316
Query: 473 GVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 506
               ++  ++  C   VPS RP    +V  L ++
Sbjct: 317 NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 230 NRLLGDSKTGGTYSGILPD--GSR--VAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLV 284
           NR+LG+   G  Y G+  +  G +  VAVK  K+  +   K++F SE      L HP++V
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 285 AVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 344
            + G   +    +I+ E    G L    H++ R   SL     +  +  + + +A+L   
Sbjct: 77  KLIGII-EEEPTWIIMELYPYGELG---HYLERNKNSLKVLTLVLYSLQICKAMAYLE-- 130
Query: 345 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR 404
              + VHRDI   N+L+       L   GLS+++  E   + +V       +++PE +  
Sbjct: 131 -SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASV-TRLPIKWMSPESINF 188
Query: 405 NELTTKSDVYSFGVLLLEIVS-GRRP 429
              TT SDV+ F V + EI+S G++P
Sbjct: 189 RRFTTASDVWMFAVCMWEILSFGKQP 214

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 230 NRLLGDSKTGGTYSGILPD--GSR--VAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLV 284
           NR+LG+   G  Y G+  +  G +  VAVK  K+  +   K++F SE      L HP++V
Sbjct: 29  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 88
Query: 285 AVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 344
            + G   +    +I+ E    G L    H++ R   SL     +  +  + + +A+L   
Sbjct: 89  KLIGII-EEEPTWIIMELYPYGELG---HYLERNKNSLKVLTLVLYSLQICKAMAYLESI 144
Query: 345 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR 404
              + VHRDI   N+L+       L   GLS+++  E   + +V       +++PE +  
Sbjct: 145 ---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASV-TRLPIKWMSPESINF 200
Query: 405 NELTTKSDVYSFGVLLLEIVS-GRRP 429
              TT SDV+ F V + EI+S G++P
Sbjct: 201 RRFTTASDVWMFAVCMWEILSFGKQP 226

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 96/202 (47%), Gaps = 13/202 (6%)
Query: 233 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 292
           LG  + G    G       VA+K +K  S   + EF  E      L H  LV + G C  
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTK 74
Query: 293 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 352
               +I+ E++ NG L  +L  +    ++      +++   + + + +L  K     +HR
Sbjct: 75  QRPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESK---QFLHR 128
Query: 353 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 410
           D+ A N L++++    +   GLS++V   +  E T   G  +   +  PE +  ++ ++K
Sbjct: 129 DLAARNCLVNDQGVVKVSDFGLSRYV---LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 185
Query: 411 SDVYSFGVLLLEIVS-GRRPAQ 431
           SD+++FGVL+ EI S G+ P +
Sbjct: 186 SDIWAFGVLMWEIYSLGKMPYE 207

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/191 (24%), Positives = 95/191 (49%), Gaps = 17/191 (8%)
Query: 248 DGSRVAVKRLK--RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 305
           DG +  +K +   R S + ++E   E+   A + HPN+V  +    ++G  YIV ++   
Sbjct: 48  DGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEG 107
Query: 306 GPLDRWLHH----IPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL 361
           G L + ++     + +  + LDW +++ +A      +  +HD+    ++HRDI++ N+ L
Sbjct: 108 GDLFKRINAQKGVLFQEDQILDWFVQICLA------LKHVHDR---KILHRDIKSQNIFL 158
Query: 362 DEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLL 421
            ++    L   G+++ +   V   R  +  GT  YL+PE         KSD+++ G +L 
Sbjct: 159 TKDGTVQLGDFGIARVLNSTVELARACI--GTPYYLSPEICENKPYNNKSDIWALGCVLY 216
Query: 422 EIVSGRRPAQA 432
           E+ + +   +A
Sbjct: 217 ELCTLKHAFEA 227

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 114/274 (41%), Gaps = 42/274 (15%)
Query: 250 SRVAVKRLKRSSFQRK-KEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGP 307
           ++VAVK LK  + ++   +  SE+     +  H N++ + G C   G  Y++ E+   G 
Sbjct: 46  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 105
Query: 308 LDRWLH--------------HIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRD 353
           L  +L               H P     L     +  A  +A+G+ +L  K     +HRD
Sbjct: 106 LREYLQARRPPGLEYCYNPSHNPE--EQLSSKDLVSCAYQVARGMEYLASK---KCIHRD 160
Query: 354 IRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDV 413
           + A NVL+ E+    +   GL++ +      ++T        ++APE ++    T +SDV
Sbjct: 161 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDV 220
Query: 414 YSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXA 472
           +SFGVLL EI + G  P   V       + E    L + HR                  +
Sbjct: 221 WSFGVLLWEIFTLGGSPYPGV------PVEELFKLLKEGHR--------------MDKPS 260
Query: 473 GVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 506
               ++  ++  C   VPS RP    +V  L ++
Sbjct: 261 NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 96/202 (47%), Gaps = 13/202 (6%)
Query: 233 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 292
           LG  + G    G       VA+K +K  S   + EF  E      L H  LV + G C  
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 293 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 352
               +I+ E++ NG L  +L  +    ++      +++   + + + +L  K     +HR
Sbjct: 76  QRPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESK---QFLHR 129
Query: 353 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 410
           D+ A N L++++    +   GLS++V   +  E T   G  +   +  PE +  ++ ++K
Sbjct: 130 DLAARNCLVNDQGVVKVSDFGLSRYV---LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 186
Query: 411 SDVYSFGVLLLEIVS-GRRPAQ 431
           SD+++FGVL+ EI S G+ P +
Sbjct: 187 SDIWAFGVLMWEIYSLGKMPYE 208

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 114/274 (41%), Gaps = 42/274 (15%)
Query: 250 SRVAVKRLKRSSFQRK-KEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGP 307
           ++VAVK LK  + ++   +  SE+     +  H N++ + G C   G  Y++ E+   G 
Sbjct: 61  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 120
Query: 308 LDRWLH--------------HIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRD 353
           L  +L               H P     L     +  A  +A+G+ +L  K     +HRD
Sbjct: 121 LREYLQARRPPGLEYCYNPSHNPE--EQLSSKDLVSCAYQVARGMEYLASK---KCIHRD 175
Query: 354 IRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDV 413
           + A NVL+ E+    +   GL++ +      ++T        ++APE ++    T +SDV
Sbjct: 176 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDV 235
Query: 414 YSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXA 472
           +SFGVLL EI + G  P   V       + E    L + HR                  +
Sbjct: 236 WSFGVLLWEIFTLGGSPYPGV------PVEELFKLLKEGHR--------------MDKPS 275
Query: 473 GVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 506
               ++  ++  C   VPS RP    +V  L ++
Sbjct: 276 NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 309

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 91/197 (46%), Gaps = 29/197 (14%)
Query: 250 SRVAVKRLKRSSFQRKK-------------EFYSEIGRFARLHHPNLVAVKGCCYDHGDR 296
           S  A+K +K+S F + +             E Y+EI     L HPN++ +     D    
Sbjct: 62  SEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYF 121
Query: 297 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRA 356
           Y+V EF   G L  +   I R     D      +   +  GI +LH   K ++VHRDI+ 
Sbjct: 122 YLVTEFYEGGEL--FEQIINR--HKFDECDAANIMKQILSGICYLH---KHNIVHRDIKP 174
Query: 357 SNVLLDEE---FGAHLMGVGLSKFVPWEV-MQERTVMAGGTYGYLAPEFVYRNELTTKSD 412
            N+LL+ +       ++  GLS F   +  +++R     GT  Y+APE V + +   K D
Sbjct: 175 ENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL----GTAYYIAPE-VLKKKYNEKCD 229
Query: 413 VYSFGVLLLEIVSGRRP 429
           V+S GV++  ++ G  P
Sbjct: 230 VWSCGVIMYILLCGYPP 246

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 89/185 (48%), Gaps = 17/185 (9%)
Query: 252 VAVKRLKRSSFQR-KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 310
           VA+K LK    +R +++F SE     +  HPN++ ++G         IV E++ NG LD 
Sbjct: 80  VAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDT 139
Query: 311 WLHHIPRGGRSLDWAMRMKVATTLAQGIA----FLHDKVKPHVVHRDIRASNVLLDEEFG 366
           +L       R+ D    +     + +G+     +L D      VHRD+ A NVL+D    
Sbjct: 140 FL-------RTHDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLV 189
Query: 367 AHLMGVGLSKFVPWEVMQERTVMAGGT-YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 425
             +   GLS+ +  +     T   G     + APE +     ++ SDV+SFGV++ E+++
Sbjct: 190 CKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249
Query: 426 -GRRP 429
            G RP
Sbjct: 250 YGERP 254

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 113/237 (47%), Gaps = 29/237 (12%)
Query: 230 NRLLGDSKTGGTYSGIL--PDGSRV--AVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLV 284
           N ++G    G  Y G L   DG ++  AVK L R +      +F +E        HPN++
Sbjct: 54  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 113
Query: 285 AVKGCCY-DHGDRYIVYEFVVNGPLDRWLH---HIPRGGRSLDWAMRMKVATTLAQGIAF 340
           ++ G C    G   +V  ++ +G L  ++    H P     + + ++      +A+G+ +
Sbjct: 114 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKY 167
Query: 341 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV---PWEVMQERTVMAGGTYGYL 397
           L  K     VHRD+ A N +LDE+F   +   GL++ +    +  +  +T  A     ++
Sbjct: 168 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT-GAKLPVKWM 223
Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHR 453
           A E +   + TTKSDV+SFGVLL E+++ G  P   V++      F+    L+Q  R
Sbjct: 224 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT------FDITVYLLQGRR 274

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 114/274 (41%), Gaps = 42/274 (15%)
Query: 250 SRVAVKRLKRSSFQRK-KEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGP 307
           ++VAVK LK  + ++   +  SE+     +  H N++ + G C   G  Y++ E+   G 
Sbjct: 61  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 120
Query: 308 LDRWLH--------------HIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRD 353
           L  +L               H P     L     +  A  +A+G+ +L  K     +HRD
Sbjct: 121 LREYLQAREPPGLEYSYNPSHNPE--EQLSSKDLVSCAYQVARGMEYLASK---KCIHRD 175
Query: 354 IRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDV 413
           + A NVL+ E+    +   GL++ +      ++T        ++APE ++    T +SDV
Sbjct: 176 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDV 235
Query: 414 YSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXA 472
           +SFGVLL EI + G  P   V       + E    L + HR                  +
Sbjct: 236 WSFGVLLWEIFTLGGSPYPGV------PVEELFKLLKEGHR--------------MDKPS 275
Query: 473 GVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 506
               ++  ++  C   VPS RP    +V  L ++
Sbjct: 276 NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 309

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 113/237 (47%), Gaps = 29/237 (12%)
Query: 230 NRLLGDSKTGGTYSGIL--PDGSRV--AVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLV 284
           N ++G    G  Y G L   DG ++  AVK L R +      +F +E        HPN++
Sbjct: 53  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 112
Query: 285 AVKGCCY-DHGDRYIVYEFVVNGPLDRWLH---HIPRGGRSLDWAMRMKVATTLAQGIAF 340
           ++ G C    G   +V  ++ +G L  ++    H P     + + ++      +A+G+ +
Sbjct: 113 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKY 166
Query: 341 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV---PWEVMQERTVMAGGTYGYL 397
           L  K     VHRD+ A N +LDE+F   +   GL++ +    +  +  +T  A     ++
Sbjct: 167 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT-GAKLPVKWM 222
Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHR 453
           A E +   + TTKSDV+SFGVLL E+++ G  P   V++      F+    L+Q  R
Sbjct: 223 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT------FDITVYLLQGRR 273

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 114/274 (41%), Gaps = 42/274 (15%)
Query: 250 SRVAVKRLKRSSFQRK-KEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGP 307
           ++VAVK LK  + ++   +  SE+     +  H N++ + G C   G  Y++ E+   G 
Sbjct: 50  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 109
Query: 308 LDRWLH--------------HIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRD 353
           L  +L               H P     L     +  A  +A+G+ +L  K     +HRD
Sbjct: 110 LREYLQARRPPGLEYSYNPSHNPE--EQLSSKDLVSCAYQVARGMEYLASK---KCIHRD 164
Query: 354 IRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDV 413
           + A NVL+ E+    +   GL++ +      ++T        ++APE ++    T +SDV
Sbjct: 165 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDV 224
Query: 414 YSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXA 472
           +SFGVLL EI + G  P   V       + E    L + HR                  +
Sbjct: 225 WSFGVLLWEIFTLGGSPYPGV------PVEELFKLLKEGHR--------------MDKPS 264
Query: 473 GVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 506
               ++  ++  C   VPS RP    +V  L ++
Sbjct: 265 NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 298

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 99/211 (46%), Gaps = 15/211 (7%)
Query: 220 RSITKNFSEGNRLLGDSKTGGT-YSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL 278
           RS   NF +    +G+  TG    + +   G  VAVK++     QR++  ++E+      
Sbjct: 19  RSYLDNFIK----IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY 74
Query: 279 HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGI 338
            H N+V +        + ++V EF+  G L   + H       ++      V   + Q +
Sbjct: 75  QHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT-----RMNEEQIAAVCLAVLQAL 129
Query: 339 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLA 398
           + LH +    V+HRDI++ ++LL  +    L   G    V  EV + + ++  GT  ++A
Sbjct: 130 SVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV--GTPYWMA 184
Query: 399 PEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           PE + R     + D++S G++++E+V G  P
Sbjct: 185 PELISRLPYGPEVDIWSLGIMVIEMVDGEPP 215

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 96/202 (47%), Gaps = 13/202 (6%)
Query: 233 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 292
           LG  + G    G       VA+K +K  S   + EF  E      L H  LV + G C  
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTK 81
Query: 293 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 352
               +I+ E++ NG L  +L  +    ++      +++   + + + +L  K     +HR
Sbjct: 82  QRPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESK---QFLHR 135
Query: 353 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 410
           D+ A N L++++    +   GLS++V   +  E T   G  +   +  PE +  ++ ++K
Sbjct: 136 DLAARNCLVNDQGVVKVSDFGLSRYV---LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 192
Query: 411 SDVYSFGVLLLEIVS-GRRPAQ 431
           SD+++FGVL+ EI S G+ P +
Sbjct: 193 SDIWAFGVLMWEIYSLGKMPYE 214

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 99/211 (46%), Gaps = 15/211 (7%)
Query: 220 RSITKNFSEGNRLLGDSKTGGT-YSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL 278
           RS   NF +    +G+  TG    + +   G  VAVK++     QR++  ++E+      
Sbjct: 23  RSYLDNFIK----IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY 78
Query: 279 HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGI 338
            H N+V +        + ++V EF+  G L   + H       ++      V   + Q +
Sbjct: 79  QHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT-----RMNEEQIAAVCLAVLQAL 133
Query: 339 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLA 398
           + LH +    V+HRDI++ ++LL  +    L   G    V  EV + + ++  GT  ++A
Sbjct: 134 SVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV--GTPYWMA 188
Query: 399 PEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           PE + R     + D++S G++++E+V G  P
Sbjct: 189 PELISRLPYGPEVDIWSLGIMVIEMVDGEPP 219

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 91/183 (49%), Gaps = 13/183 (7%)
Query: 252 VAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRW 311
           VA+K +K  S   + EF  E      L H  LV + G C      +I+ E++ NG L  +
Sbjct: 51  VAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNY 109
Query: 312 LHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMG 371
           L  +    ++      +++   + + + +L  K     +HRD+ A N L++++    +  
Sbjct: 110 LREMRHRFQT---QQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSD 163
Query: 372 VGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRR 428
            GLS++V   +  E T   G  +   +  PE +  ++ ++KSD+++FGVL+ EI S G+ 
Sbjct: 164 FGLSRYV---LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKM 220
Query: 429 PAQ 431
           P +
Sbjct: 221 PYE 223

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 113/237 (47%), Gaps = 29/237 (12%)
Query: 230 NRLLGDSKTGGTYSGIL--PDGSRV--AVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLV 284
           N ++G    G  Y G L   DG ++  AVK L R +      +F +E        HPN++
Sbjct: 34  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 285 AVKGCCY-DHGDRYIVYEFVVNGPLDRWLH---HIPRGGRSLDWAMRMKVATTLAQGIAF 340
           ++ G C    G   +V  ++ +G L  ++    H P     + + ++      +A+G+ +
Sbjct: 94  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKY 147
Query: 341 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV---PWEVMQERTVMAGGTYGYL 397
           L  K     VHRD+ A N +LDE+F   +   GL++ +    +  +  +T  A     ++
Sbjct: 148 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT-GAKLPVKWM 203
Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHR 453
           A E +   + TTKSDV+SFGVLL E+++ G  P   V++      F+    L+Q  R
Sbjct: 204 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT------FDITVYLLQGRR 254

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 114/274 (41%), Gaps = 42/274 (15%)
Query: 250 SRVAVKRLKRSSFQRK-KEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGP 307
           ++VAVK LK  + ++   +  SE+     +  H N++ + G C   G  Y++ E+   G 
Sbjct: 53  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 112
Query: 308 LDRWLH--------------HIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRD 353
           L  +L               H P     L     +  A  +A+G+ +L  K     +HRD
Sbjct: 113 LREYLQARRPPGLEYSYNPSHNPE--EQLSSKDLVSCAYQVARGMEYLASK---KCIHRD 167
Query: 354 IRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDV 413
           + A NVL+ E+    +   GL++ +      ++T        ++APE ++    T +SDV
Sbjct: 168 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDV 227
Query: 414 YSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXA 472
           +SFGVLL EI + G  P   V       + E    L + HR                  +
Sbjct: 228 WSFGVLLWEIFTLGGSPYPGV------PVEELFKLLKEGHR--------------MDKPS 267
Query: 473 GVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 506
               ++  ++  C   VPS RP    +V  L ++
Sbjct: 268 NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 301

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 99/211 (46%), Gaps = 15/211 (7%)
Query: 220 RSITKNFSEGNRLLGDSKTGGT-YSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL 278
           RS   NF +    +G+  TG    + +   G  VAVK++     QR++  ++E+      
Sbjct: 30  RSYLDNFIK----IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY 85
Query: 279 HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGI 338
            H N+V +        + ++V EF+  G L   + H       ++      V   + Q +
Sbjct: 86  QHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT-----RMNEEQIAAVCLAVLQAL 140
Query: 339 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLA 398
           + LH +    V+HRDI++ ++LL  +    L   G    V  EV + + ++  GT  ++A
Sbjct: 141 SVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV--GTPYWMA 195
Query: 399 PEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           PE + R     + D++S G++++E+V G  P
Sbjct: 196 PELISRLPYGPEVDIWSLGIMVIEMVDGEPP 226

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 113/237 (47%), Gaps = 29/237 (12%)
Query: 230 NRLLGDSKTGGTYSGIL--PDGSRV--AVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLV 284
           N ++G    G  Y G L   DG ++  AVK L R +      +F +E        HPN++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 285 AVKGCCY-DHGDRYIVYEFVVNGPLDRWLH---HIPRGGRSLDWAMRMKVATTLAQGIAF 340
           ++ G C    G   +V  ++ +G L  ++    H P     + + ++      +A+G+ +
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKY 148
Query: 341 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV---PWEVMQERTVMAGGTYGYL 397
           L  K     VHRD+ A N +LDE+F   +   GL++ +    +  +  +T  A     ++
Sbjct: 149 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT-GAKLPVKWM 204
Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHR 453
           A E +   + TTKSDV+SFGVLL E+++ G  P   V++      F+    L+Q  R
Sbjct: 205 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT------FDITVYLLQGRR 255

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 78/314 (24%), Positives = 124/314 (39%), Gaps = 39/314 (12%)
Query: 212 KVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGIL------PDGSRVAVKRLKR-SSFQR 264
           K  +  +L+ + +      R LG    G  Y G +      P   +VAVK L    S Q 
Sbjct: 9   KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 68
Query: 265 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHI-PRGGRSLD 323
           + +F  E    ++ +H N+V   G       R+I+ E +  G L  +L    PR  +   
Sbjct: 69  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 128
Query: 324 WAMR--MKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 381
            AM   + VA  +A G  +L +    H +HRDI A N LL       +  +G       +
Sbjct: 129 LAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA-RD 184
Query: 382 VMQERTVMAGG----TYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSV 436
           + +      GG       ++ PE       T+K+D +SFGVLL EI S G  P  +  + 
Sbjct: 185 IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN- 243
Query: 437 CWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRM 496
             Q + E+ T                          G V +++     C QH P  RP  
Sbjct: 244 --QEVLEFVT--------------SGGRMDPPKNCPGPVYRIMT---QCWQHQPEDRPNF 284
Query: 497 SHVVHQLQQLAQPP 510
           + ++ +++   Q P
Sbjct: 285 AIILERIEYCTQDP 298

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 114/274 (41%), Gaps = 42/274 (15%)
Query: 250 SRVAVKRLKRSSFQRK-KEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGP 307
           ++VAVK LK  + ++   +  SE+     +  H N++ + G C   G  Y++ E+   G 
Sbjct: 54  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 113
Query: 308 LDRWLH--------------HIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRD 353
           L  +L               H P     L     +  A  +A+G+ +L  K     +HRD
Sbjct: 114 LREYLQARRPPGLEYSYNPSHNPE--EQLSSKDLVSCAYQVARGMEYLASK---KCIHRD 168
Query: 354 IRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDV 413
           + A NVL+ E+    +   GL++ +      ++T        ++APE ++    T +SDV
Sbjct: 169 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDV 228
Query: 414 YSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXA 472
           +SFGVLL EI + G  P   V       + E    L + HR                  +
Sbjct: 229 WSFGVLLWEIFTLGGSPYPGV------PVEELFKLLKEGHR--------------MDKPS 268
Query: 473 GVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 506
               ++  ++  C   VPS RP    +V  L ++
Sbjct: 269 NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 302

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 109/280 (38%), Gaps = 42/280 (15%)
Query: 228 EGNRLLGDSKTGGTYSGILPDGSRV-AVKRLKRSSFQR---KKEFYSEIGRFARLHHPNL 283
           E  R LG  K G  Y         + A+K L ++  ++   + +   E+   + L HPN+
Sbjct: 13  EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 72
Query: 284 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 343
           + + G  +D    Y++ E+   G + R L  + +     D        T LA  +++ H 
Sbjct: 73  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHS 128
Query: 344 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 403
           K    V+HRDI+  N+LL       +   G S   P      R     GT  YL PE + 
Sbjct: 129 K---RVIHRDIKPENLLLGSAGELKIANFGWSVHAP----SSRRTTLCGTLDYLPPEMIE 181
Query: 404 RNELTTKSDVYSFGVLLLEIVSGRRPAQA---VDSVCWQSIFEWATPLVQSHRYXXXXXX 460
                 K D++S GVL  E + G+ P +A    ++    S  E+  P             
Sbjct: 182 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----------- 230
Query: 461 XXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVV 500
                        V +   DL+    +H PS RP +  V+
Sbjct: 231 -------------VTEGARDLISRLLKHNPSQRPMLREVL 257

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 106/219 (48%), Gaps = 19/219 (8%)
Query: 227 SEGNRLLGDSKTGGTYSGILPDGSR----VAVKRLKRSSFQRKKEFYSEIGRFAR-LHHP 281
           +  +R++G    G  Y G   D ++     A+K L R +  ++ E +   G   R L+HP
Sbjct: 23  THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHP 82
Query: 282 NLVAVKGCCYD-HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAF 340
           N++A+ G      G  +++  ++ +G L +++    R     D    +     +A+G+ +
Sbjct: 83  NVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDL---ISFGLQVARGMEY 139
Query: 341 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP----WEVMQERTVMAGGTYGY 396
           L ++     VHRD+ A N +LDE F   +   GL++ +     + V Q R       +  
Sbjct: 140 LAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTA 196
Query: 397 LAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVD 434
           L     YR   TTKSDV+SFGVLL E+++ G  P + +D
Sbjct: 197 LESLQTYR--FTTKSDVWSFGVLLWELLTRGAPPYRHID 233

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 114/274 (41%), Gaps = 42/274 (15%)
Query: 250 SRVAVKRLKRSSFQRK-KEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGP 307
           ++VAVK LK  + ++   +  SE+     +  H N++ + G C   G  Y++ E+   G 
Sbjct: 61  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 120
Query: 308 LDRWLH--------------HIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRD 353
           L  +L               H P     L     +  A  +A+G+ +L  K     +HRD
Sbjct: 121 LREYLQARRPPGLEYSYNPSHNPE--EQLSSKDLVSCAYQVARGMEYLASK---KCIHRD 175
Query: 354 IRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDV 413
           + A NVL+ E+    +   GL++ +      ++T        ++APE ++    T +SDV
Sbjct: 176 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDV 235
Query: 414 YSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXA 472
           +SFGVLL EI + G  P   V       + E    L + HR                  +
Sbjct: 236 WSFGVLLWEIFTLGGSPYPGV------PVEELFKLLKEGHR--------------MDKPS 275
Query: 473 GVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 506
               ++  ++  C   VPS RP    +V  L ++
Sbjct: 276 NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 309

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 78/314 (24%), Positives = 124/314 (39%), Gaps = 39/314 (12%)
Query: 212 KVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGIL------PDGSRVAVKRLKR-SSFQR 264
           K  +  +L+ + +      R LG    G  Y G +      P   +VAVK L    S Q 
Sbjct: 18  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 77
Query: 265 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHI-PRGGRSLD 323
           + +F  E    ++ +H N+V   G       R+I+ E +  G L  +L    PR  +   
Sbjct: 78  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 137
Query: 324 WAMR--MKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 381
            AM   + VA  +A G  +L +    H +HRDI A N LL       +  +G       +
Sbjct: 138 LAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA-QD 193
Query: 382 VMQERTVMAGG----TYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSV 436
           + +      GG       ++ PE       T+K+D +SFGVLL EI S G  P  +  + 
Sbjct: 194 IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN- 252
Query: 437 CWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRM 496
             Q + E+ T                          G V +++     C QH P  RP  
Sbjct: 253 --QEVLEFVT--------------SGGRMDPPKNCPGPVYRIMT---QCWQHQPEDRPNF 293
Query: 497 SHVVHQLQQLAQPP 510
           + ++ +++   Q P
Sbjct: 294 AIILERIEYCTQDP 307

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 96/202 (47%), Gaps = 13/202 (6%)
Query: 233 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 292
           LG  + G    G       VA+K +K  S   + EF  E      L H  LV + G C  
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTK 70
Query: 293 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 352
               +I+ E++ NG L  +L  +    ++      +++   + + + +L  K     +HR
Sbjct: 71  QRPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESK---QFLHR 124
Query: 353 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 410
           D+ A N L++++    +   GLS++V   +  E T   G  +   +  PE +  ++ ++K
Sbjct: 125 DLAARNCLVNDQGVVKVSDFGLSRYV---LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 181
Query: 411 SDVYSFGVLLLEIVS-GRRPAQ 431
           SD+++FGVL+ EI S G+ P +
Sbjct: 182 SDIWAFGVLMWEIYSLGKMPYE 203

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 113/237 (47%), Gaps = 29/237 (12%)
Query: 230 NRLLGDSKTGGTYSGIL--PDGSRV--AVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLV 284
           N ++G    G  Y G L   DG ++  AVK L R +      +F +E        HPN++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 285 AVKGCCY-DHGDRYIVYEFVVNGPLDRWLH---HIPRGGRSLDWAMRMKVATTLAQGIAF 340
           ++ G C    G   +V  ++ +G L  ++    H P     + + ++      +A+G+ +
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKY 148
Query: 341 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV---PWEVMQERTVMAGGTYGYL 397
           L  K     VHRD+ A N +LDE+F   +   GL++ +    +  +  +T  A     ++
Sbjct: 149 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT-GAKLPVKWM 204
Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHR 453
           A E +   + TTKSDV+SFGVLL E+++ G  P   V++      F+    L+Q  R
Sbjct: 205 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT------FDITVYLLQGRR 255

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 96/202 (47%), Gaps = 13/202 (6%)
Query: 233 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 292
           LG  + G    G       VA+K +K  S   + EF  E      L H  LV + G C  
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 293 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 352
               +I+ E++ NG L  +L  +    ++      +++   + + + +L  K     +HR
Sbjct: 76  QRPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESK---QFLHR 129
Query: 353 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 410
           D+ A N L++++    +   GLS++V   +  E T   G  +   +  PE +  ++ ++K
Sbjct: 130 DLAARNCLVNDQGVVKVSDFGLSRYV---LDDEYTSSRGSKFPVRWSPPEVLMYSKFSSK 186
Query: 411 SDVYSFGVLLLEIVS-GRRPAQ 431
           SD+++FGVL+ EI S G+ P +
Sbjct: 187 SDIWAFGVLMWEIYSLGKMPYE 208

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 113/237 (47%), Gaps = 29/237 (12%)
Query: 230 NRLLGDSKTGGTYSGIL--PDGSRV--AVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLV 284
           N ++G    G  Y G L   DG ++  AVK L R +      +F +E        HPN++
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 285 AVKGCCY-DHGDRYIVYEFVVNGPLDRWLH---HIPRGGRSLDWAMRMKVATTLAQGIAF 340
           ++ G C    G   +V  ++ +G L  ++    H P     + + ++      +A+G+ +
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKY 145
Query: 341 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV---PWEVMQERTVMAGGTYGYL 397
           L  K     VHRD+ A N +LDE+F   +   GL++ +    +  +  +T  A     ++
Sbjct: 146 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT-GAKLPVKWM 201
Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHR 453
           A E +   + TTKSDV+SFGVLL E+++ G  P   V++      F+    L+Q  R
Sbjct: 202 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT------FDITVYLLQGRR 252

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 113/237 (47%), Gaps = 29/237 (12%)
Query: 230 NRLLGDSKTGGTYSGIL--PDGSRV--AVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLV 284
           N ++G    G  Y G L   DG ++  AVK L R +      +F +E        HPN++
Sbjct: 27  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 86
Query: 285 AVKGCCY-DHGDRYIVYEFVVNGPLDRWLH---HIPRGGRSLDWAMRMKVATTLAQGIAF 340
           ++ G C    G   +V  ++ +G L  ++    H P     + + ++      +A+G+ +
Sbjct: 87  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKY 140
Query: 341 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV---PWEVMQERTVMAGGTYGYL 397
           L  K     VHRD+ A N +LDE+F   +   GL++ +    +  +  +T  A     ++
Sbjct: 141 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT-GAKLPVKWM 196
Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHR 453
           A E +   + TTKSDV+SFGVLL E+++ G  P   V++      F+    L+Q  R
Sbjct: 197 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT------FDITVYLLQGRR 247

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 109/236 (46%), Gaps = 27/236 (11%)
Query: 230 NRLLGDSKTGGTYSGIL--PDGSRV--AVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLV 284
           N ++G    G  Y G L   DG ++  AVK L R +      +F +E        HPN++
Sbjct: 34  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 285 AVKGCCY-DHGDRYIVYEFVVNGPLDRWLH---HIPRGGRSLDWAMRMKVATTLAQGIAF 340
           ++ G C    G   +V  ++ +G L  ++    H P     + + ++      +A+G+ +
Sbjct: 94  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKY 147
Query: 341 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK--FVPWEVMQERTVMAGGTYGYLA 398
           L  K     VHRD+ A N +LDE+F   +   GL++  +            A     ++A
Sbjct: 148 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMA 204
Query: 399 PEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHR 453
            E +   + TTKSDV+SFGVLL E+++ G  P   V++      F+    L+Q  R
Sbjct: 205 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT------FDITVYLLQGRR 254

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 78/314 (24%), Positives = 124/314 (39%), Gaps = 39/314 (12%)
Query: 212 KVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGIL------PDGSRVAVKRLKR-SSFQR 264
           K  +  +L+ + +      R LG    G  Y G +      P   +VAVK L    S Q 
Sbjct: 32  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 91
Query: 265 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHI-PRGGRSLD 323
           + +F  E    ++ +H N+V   G       R+I+ E +  G L  +L    PR  +   
Sbjct: 92  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSS 151
Query: 324 WAMR--MKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 381
            AM   + VA  +A G  +L +    H +HRDI A N LL       +  +G       +
Sbjct: 152 LAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA-RD 207
Query: 382 VMQERTVMAGG----TYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSV 436
           + +      GG       ++ PE       T+K+D +SFGVLL EI S G  P  +  + 
Sbjct: 208 IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN- 266
Query: 437 CWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRM 496
             Q + E+ T                          G V +++     C QH P  RP  
Sbjct: 267 --QEVLEFVT--------------SGGRMDPPKNCPGPVYRIMT---QCWQHQPEDRPNF 307
Query: 497 SHVVHQLQQLAQPP 510
           + ++ +++   Q P
Sbjct: 308 AIILERIEYCTQDP 321

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 78/314 (24%), Positives = 124/314 (39%), Gaps = 39/314 (12%)
Query: 212 KVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGIL------PDGSRVAVKRLKR-SSFQR 264
           K  +  +L+ + +      R LG    G  Y G +      P   +VAVK L    S Q 
Sbjct: 17  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 76
Query: 265 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHI-PRGGRSLD 323
           + +F  E    ++ +H N+V   G       R+I+ E +  G L  +L    PR  +   
Sbjct: 77  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 136
Query: 324 WAMR--MKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 381
            AM   + VA  +A G  +L +    H +HRDI A N LL       +  +G       +
Sbjct: 137 LAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA-RD 192
Query: 382 VMQERTVMAGG----TYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSV 436
           + +      GG       ++ PE       T+K+D +SFGVLL EI S G  P  +  + 
Sbjct: 193 IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN- 251
Query: 437 CWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRM 496
             Q + E+ T                          G V +++     C QH P  RP  
Sbjct: 252 --QEVLEFVT--------------SGGRMDPPKNCPGPVYRIMT---QCWQHQPEDRPNF 292
Query: 497 SHVVHQLQQLAQPP 510
           + ++ +++   Q P
Sbjct: 293 AIILERIEYCTQDP 306

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 109/280 (38%), Gaps = 42/280 (15%)
Query: 228 EGNRLLGDSKTGGTYSGILPDGSRV-AVKRLKRSSFQR---KKEFYSEIGRFARLHHPNL 283
           E  R LG  K G  Y         + A+K L ++  ++   + +   E+   + L HPN+
Sbjct: 12  EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 71
Query: 284 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 343
           + + G  +D    Y++ E+   G + R L  + +     D        T LA  +++ H 
Sbjct: 72  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHS 127
Query: 344 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 403
           K    V+HRDI+  N+LL       +   G S   P      R     GT  YL PE + 
Sbjct: 128 K---RVIHRDIKPENLLLGSAGELKIADFGWSCHAP----SSRRTTLSGTLDYLPPEMIE 180
Query: 404 RNELTTKSDVYSFGVLLLEIVSGRRPAQA---VDSVCWQSIFEWATPLVQSHRYXXXXXX 460
                 K D++S GVL  E + G+ P +A    ++    S  E+  P             
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----------- 229
Query: 461 XXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVV 500
                        V +   DL+    +H PS RP +  V+
Sbjct: 230 -------------VTEGARDLISRLLKHNPSQRPMLREVL 256

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 78/314 (24%), Positives = 124/314 (39%), Gaps = 39/314 (12%)
Query: 212 KVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGIL------PDGSRVAVKRLKR-SSFQR 264
           K  +  +L+ + +      R LG    G  Y G +      P   +VAVK L    S Q 
Sbjct: 17  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 76
Query: 265 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHI-PRGGRSLD 323
           + +F  E    ++ +H N+V   G       R+I+ E +  G L  +L    PR  +   
Sbjct: 77  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSS 136
Query: 324 WAMR--MKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 381
            AM   + VA  +A G  +L +    H +HRDI A N LL       +  +G       +
Sbjct: 137 LAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA-RD 192
Query: 382 VMQERTVMAGG----TYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSV 436
           + +      GG       ++ PE       T+K+D +SFGVLL EI S G  P  +  + 
Sbjct: 193 IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN- 251
Query: 437 CWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRM 496
             Q + E+ T                          G V +++     C QH P  RP  
Sbjct: 252 --QEVLEFVT--------------SGGRMDPPKNCPGPVYRIMT---QCWQHQPEDRPNF 292
Query: 497 SHVVHQLQQLAQPP 510
           + ++ +++   Q P
Sbjct: 293 AIILERIEYCTQDP 306

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 99/211 (46%), Gaps = 15/211 (7%)
Query: 220 RSITKNFSEGNRLLGDSKTGGT-YSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL 278
           RS   NF +    +G+  TG    + +   G  VAVK++     QR++  ++E+      
Sbjct: 28  RSYLDNFIK----IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY 83
Query: 279 HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGI 338
            H N+V +        + ++V EF+  G L   + H       ++      V   + Q +
Sbjct: 84  QHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT-----RMNEEQIAAVCLAVLQAL 138
Query: 339 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLA 398
           + LH +    V+HRDI++ ++LL  +    L   G    V  EV + + ++  GT  ++A
Sbjct: 139 SVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV--GTPYWMA 193
Query: 399 PEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           PE + R     + D++S G++++E+V G  P
Sbjct: 194 PELISRLPYGPEVDIWSLGIMVIEMVDGEPP 224

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 109/280 (38%), Gaps = 42/280 (15%)
Query: 228 EGNRLLGDSKTGGTYSGILPDGSRV-AVKRLKRSSFQR---KKEFYSEIGRFARLHHPNL 283
           E  R LG  K G  Y         + A+K L ++  ++   + +   E+   + L HPN+
Sbjct: 28  EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 87
Query: 284 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 343
           + + G  +D    Y++ E+   G + R L  + +     D        T LA  +++ H 
Sbjct: 88  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHS 143
Query: 344 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 403
           K    V+HRDI+  N+LL       +   G S   P      R     GT  YL PE + 
Sbjct: 144 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPPEMIE 196
Query: 404 RNELTTKSDVYSFGVLLLEIVSGRRPAQA---VDSVCWQSIFEWATPLVQSHRYXXXXXX 460
                 K D++S GVL  E + G+ P +A    ++    S  E+  P             
Sbjct: 197 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----------- 245
Query: 461 XXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVV 500
                        V +   DL+    +H PS RP +  V+
Sbjct: 246 -------------VTEGARDLISRLLKHNPSQRPMLREVL 272

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 113/237 (47%), Gaps = 29/237 (12%)
Query: 230 NRLLGDSKTGGTYSGIL--PDGSRV--AVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLV 284
           N ++G    G  Y G L   DG ++  AVK L R +      +F +E        HPN++
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 285 AVKGCCY-DHGDRYIVYEFVVNGPLDRWLH---HIPRGGRSLDWAMRMKVATTLAQGIAF 340
           ++ G C    G   +V  ++ +G L  ++    H P     + + ++      +A+G+ +
Sbjct: 90  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKY 143
Query: 341 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV---PWEVMQERTVMAGGTYGYL 397
           L  K     VHRD+ A N +LDE+F   +   GL++ +    +  +  +T  A     ++
Sbjct: 144 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT-GAKLPVKWM 199
Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHR 453
           A E +   + TTKSDV+SFGVLL E+++ G  P   V++      F+    L+Q  R
Sbjct: 200 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT------FDITVYLLQGRR 250

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 109/280 (38%), Gaps = 42/280 (15%)
Query: 228 EGNRLLGDSKTGGTYSGILPDGSRV-AVKRLKRSSFQR---KKEFYSEIGRFARLHHPNL 283
           E  R LG  K G  Y         + A+K L ++  ++   + +   E+   + L HPN+
Sbjct: 16  EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 75
Query: 284 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 343
           + + G  +D    Y++ E+   G + R L  + +     D        T LA  +++ H 
Sbjct: 76  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHS 131
Query: 344 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 403
           K    V+HRDI+  N+LL       +   G S   P      R     GT  YL PE + 
Sbjct: 132 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPPEXIE 184
Query: 404 RNELTTKSDVYSFGVLLLEIVSGRRPAQA---VDSVCWQSIFEWATPLVQSHRYXXXXXX 460
                 K D++S GVL  E + G+ P +A    ++    S  E+  P             
Sbjct: 185 GRXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----------- 233
Query: 461 XXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVV 500
                        V +   DL+    +H PS RP +  V+
Sbjct: 234 -------------VTEGARDLISRLLKHNPSQRPXLREVL 260

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 81/325 (24%), Positives = 135/325 (41%), Gaps = 54/325 (16%)
Query: 203 ASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPD------GSRVAVKR 256
           +S  VP  W+V + E++  +        R LG    G  Y G   D       +RVAVK 
Sbjct: 5   SSVYVPDEWEV-SREKITLL--------RELGQGSFGMVYEGNARDIIKGEAETRVAVKT 55
Query: 257 LKRSSFQRKK-EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHI 315
           +  S+  R++ EF +E          ++V + G         +V E + +G L  +L  +
Sbjct: 56  VNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSL 115
Query: 316 -PRG----GRSLDWAMRM-KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHL 369
            P      GR       M ++A  +A G+A+L+ K     VHR++ A N ++  +F   +
Sbjct: 116 RPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKI 172
Query: 370 MGVGLSKFVPWEVMQERTVMAGGT----YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 425
              G+++    ++ +      GG       ++APE +     TT SD++SFGV+L EI S
Sbjct: 173 GDFGMTR----DIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 228
Query: 426 -GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYA 484
              +P Q + +       E     V    Y                     ++V DL+  
Sbjct: 229 LAEQPYQGLSN-------EQVLKFVMDGGYLDQPD-------------NCPERVTDLMRM 268
Query: 485 CTQHVPSMRPRMSHVVHQLQQLAQP 509
           C Q  P+MRP    +V+ L+    P
Sbjct: 269 CWQFNPNMRPTFLEIVNLLKDDLHP 293

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 109/280 (38%), Gaps = 42/280 (15%)
Query: 228 EGNRLLGDSKTGGTYSGILPDGSRV-AVKRLKRSSFQR---KKEFYSEIGRFARLHHPNL 283
           E  R LG  K G  Y         + A+K L ++  ++   + +   E+   + L HPN+
Sbjct: 14  EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 73
Query: 284 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 343
           + + G  +D    Y++ E+   G + R L  + +     D        T LA  +++ H 
Sbjct: 74  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHS 129
Query: 344 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 403
           K    V+HRDI+  N+LL       +   G S   P      R     GT  YL PE + 
Sbjct: 130 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPPEMIE 182
Query: 404 RNELTTKSDVYSFGVLLLEIVSGRRPAQA---VDSVCWQSIFEWATPLVQSHRYXXXXXX 460
                 K D++S GVL  E + G+ P +A    ++    S  E+  P             
Sbjct: 183 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----------- 231
Query: 461 XXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVV 500
                        V +   DL+    +H PS RP +  V+
Sbjct: 232 -------------VTEGARDLISRLLKHNPSQRPMLREVL 258

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 86/178 (48%), Gaps = 10/178 (5%)
Query: 265 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDW 324
           + +   E+      + P +V   G  Y  G+  I  E +  G LD+ L    R    +  
Sbjct: 58  RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR----IPE 113
Query: 325 AMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 384
            +  KV+  + +G+A+L +K +  ++HRD++ SN+L++      L   G+S     +++ 
Sbjct: 114 EILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVS----GQLID 167
Query: 385 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIF 442
                  GT  Y+APE +     + +SD++S G+ L+E+  GR P    D+   ++IF
Sbjct: 168 SMANSFVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYPIPPPDAKELEAIF 225

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 78/314 (24%), Positives = 124/314 (39%), Gaps = 39/314 (12%)
Query: 212 KVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGIL------PDGSRVAVKRLKR-SSFQR 264
           K  +  +L+ + +      R LG    G  Y G +      P   +VAVK L    S Q 
Sbjct: 24  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 83
Query: 265 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHI-PRGGRSLD 323
           + +F  E    ++ +H N+V   G       R+I+ E +  G L  +L    PR  +   
Sbjct: 84  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 143
Query: 324 WAMR--MKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 381
            AM   + VA  +A G  +L +    H +HRDI A N LL       +  +G       +
Sbjct: 144 LAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA-RD 199
Query: 382 VMQERTVMAGG----TYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSV 436
           + +      GG       ++ PE       T+K+D +SFGVLL EI S G  P  +  + 
Sbjct: 200 IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN- 258
Query: 437 CWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRM 496
             Q + E+ T                          G V +++     C QH P  RP  
Sbjct: 259 --QEVLEFVT--------------SGGRMDPPKNCPGPVYRIMT---QCWQHQPEDRPNF 299
Query: 497 SHVVHQLQQLAQPP 510
           + ++ +++   Q P
Sbjct: 300 AIILERIEYCTQDP 313

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 109/280 (38%), Gaps = 42/280 (15%)
Query: 228 EGNRLLGDSKTGGTYSGILPDGSRV-AVKRLKRSSFQR---KKEFYSEIGRFARLHHPNL 283
           E  R LG  K G  Y         + A+K L ++  ++   + +   E+   + L HPN+
Sbjct: 37  EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 96
Query: 284 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 343
           + + G  +D    Y++ E+   G + R L  + +     D        T LA  +++ H 
Sbjct: 97  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHS 152
Query: 344 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 403
           K    V+HRDI+  N+LL       +   G S   P      R     GT  YL PE + 
Sbjct: 153 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPPEMIE 205
Query: 404 RNELTTKSDVYSFGVLLLEIVSGRRPAQA---VDSVCWQSIFEWATPLVQSHRYXXXXXX 460
                 K D++S GVL  E + G+ P +A    ++    S  E+  P             
Sbjct: 206 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----------- 254
Query: 461 XXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVV 500
                        V +   DL+    +H PS RP +  V+
Sbjct: 255 -------------VTEGARDLISRLLKHNPSQRPMLREVL 281

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 99/218 (45%), Gaps = 31/218 (14%)
Query: 252 VAVKRLKRSSFQRKKEFYSEIGRFAR----LHHPNLVAVKGCCYDHGDR--------YIV 299
           VAVK L R+   R   FY    R A+    L+HP +VAV    Y  G+         YIV
Sbjct: 40  VAVKVL-RADLARDPSFYLRFRREAQNAAALNHPAIVAV----YATGEAETPAGPLPYIV 94
Query: 300 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNV 359
            E+V    L   +H    G  +   A+  +V     Q + F H      ++HRD++ +N+
Sbjct: 95  MEYVDGVTLRDIVHT--EGPMTPKRAI--EVIADACQALNFSHQN---GIIHRDVKPANI 147
Query: 360 LLDEEFGAHLMGVGLSKFVP---WEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSF 416
           ++       +M  G+++ +      V Q   V+  GT  YL+PE    + +  +SDVYS 
Sbjct: 148 MISATNAVKVMDFGIARAIADSGNSVTQTAAVI--GTAQYLSPEQARGDSVDARSDVYSL 205
Query: 417 GVLLLEIVSGRRP--AQAVDSVCWQSIFEWATPLVQSH 452
           G +L E+++G  P    +  SV +Q + E   P    H
Sbjct: 206 GCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 243

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 113/237 (47%), Gaps = 29/237 (12%)
Query: 230 NRLLGDSKTGGTYSGIL--PDGSRV--AVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLV 284
           N ++G    G  Y G L   DG ++  AVK L R +      +F +E        HPN++
Sbjct: 33  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 285 AVKGCCY-DHGDRYIVYEFVVNGPLDRWLH---HIPRGGRSLDWAMRMKVATTLAQGIAF 340
           ++ G C    G   +V  ++ +G L  ++    H P     + + ++      +A+G+ +
Sbjct: 93  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKY 146
Query: 341 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV---PWEVMQERTVMAGGTYGYL 397
           L  K     VHRD+ A N +LDE+F   +   GL++ +    +  +  +T  A     ++
Sbjct: 147 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT-GAKLPVKWM 202
Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHR 453
           A E +   + TTKSDV+SFGVLL E+++ G  P   V++      F+    L+Q  R
Sbjct: 203 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT------FDITVYLLQGRR 253

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 78/314 (24%), Positives = 124/314 (39%), Gaps = 39/314 (12%)
Query: 212 KVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGIL------PDGSRVAVKRLKR-SSFQR 264
           K  +  +L+ + +      R LG    G  Y G +      P   +VAVK L    S Q 
Sbjct: 18  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 77
Query: 265 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHI-PRGGRSLD 323
           + +F  E    ++ +H N+V   G       R+I+ E +  G L  +L    PR  +   
Sbjct: 78  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 137
Query: 324 WAMR--MKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 381
            AM   + VA  +A G  +L +    H +HRDI A N LL       +  +G       +
Sbjct: 138 LAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA-RD 193
Query: 382 VMQERTVMAGG----TYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSV 436
           + +      GG       ++ PE       T+K+D +SFGVLL EI S G  P  +  + 
Sbjct: 194 IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN- 252
Query: 437 CWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRM 496
             Q + E+ T                          G V +++     C QH P  RP  
Sbjct: 253 --QEVLEFVT--------------SGGRMDPPKNCPGPVYRIMT---QCWQHQPEDRPNF 293
Query: 497 SHVVHQLQQLAQPP 510
           + ++ +++   Q P
Sbjct: 294 AIILERIEYCTQDP 307

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 78/314 (24%), Positives = 124/314 (39%), Gaps = 39/314 (12%)
Query: 212 KVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGIL------PDGSRVAVKRLKRS-SFQR 264
           K  +  +L+ + +      R LG    G  Y G +      P   +VAVK L    S Q 
Sbjct: 32  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQD 91
Query: 265 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHI-PRGGRSLD 323
           + +F  E    ++ +H N+V   G       R+I+ E +  G L  +L    PR  +   
Sbjct: 92  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 151
Query: 324 WAMR--MKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 381
            AM   + VA  +A G  +L +    H +HRDI A N LL       +  +G       +
Sbjct: 152 LAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA-RD 207
Query: 382 VMQERTVMAGG----TYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSV 436
           + +      GG       ++ PE       T+K+D +SFGVLL EI S G  P  +  + 
Sbjct: 208 IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN- 266
Query: 437 CWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRM 496
             Q + E+ T                          G V +++     C QH P  RP  
Sbjct: 267 --QEVLEFVT--------------SGGRMDPPKNCPGPVYRIMT---QCWQHQPEDRPNF 307
Query: 497 SHVVHQLQQLAQPP 510
           + ++ +++   Q P
Sbjct: 308 AIILERIEYCTQDP 321

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 109/280 (38%), Gaps = 42/280 (15%)
Query: 228 EGNRLLGDSKTGGTYSGILPDGSRV-AVKRLKRSSFQR---KKEFYSEIGRFARLHHPNL 283
           E  R LG  K G  Y         + A+K L ++  ++   + +   E+   + L HPN+
Sbjct: 11  EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 70
Query: 284 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 343
           + + G  +D    Y++ E+   G + R L  + +     D        T LA  +++ H 
Sbjct: 71  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHS 126
Query: 344 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 403
           K    V+HRDI+  N+LL       +   G S   P      R     GT  YL PE + 
Sbjct: 127 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPPEMIE 179
Query: 404 RNELTTKSDVYSFGVLLLEIVSGRRPAQA---VDSVCWQSIFEWATPLVQSHRYXXXXXX 460
                 K D++S GVL  E + G+ P +A    ++    S  E+  P             
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----------- 228
Query: 461 XXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVV 500
                        V +   DL+    +H PS RP +  V+
Sbjct: 229 -------------VTEGARDLISRLLKHNPSQRPMLREVL 255

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 109/280 (38%), Gaps = 42/280 (15%)
Query: 228 EGNRLLGDSKTGGTYSGILPDGSRV-AVKRLKRSSFQR---KKEFYSEIGRFARLHHPNL 283
           E  R LG  K G  Y         + A+K L ++  ++   + +   E+   + L HPN+
Sbjct: 14  EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 73
Query: 284 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 343
           + + G  +D    Y++ E+   G + R L  + +     D        T LA  +++ H 
Sbjct: 74  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHS 129
Query: 344 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 403
           K    V+HRDI+  N+LL       +   G S   P      R     GT  YL PE + 
Sbjct: 130 K---RVIHRDIKPENLLLGSAGELKIANFGWSVHAP----SSRRTTLCGTLDYLPPEMIE 182
Query: 404 RNELTTKSDVYSFGVLLLEIVSGRRPAQA---VDSVCWQSIFEWATPLVQSHRYXXXXXX 460
                 K D++S GVL  E + G+ P +A    ++    S  E+  P             
Sbjct: 183 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP------------- 229
Query: 461 XXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVV 500
                        V +   DL+    +H PS RP +  V+
Sbjct: 230 -----------DFVTEGARDLISRLLKHNPSQRPMLREVL 258

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 81/325 (24%), Positives = 135/325 (41%), Gaps = 54/325 (16%)
Query: 203 ASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPD------GSRVAVKR 256
           +S  VP  W+V + E++  +        R LG    G  Y G   D       +RVAVK 
Sbjct: 4   SSVYVPDEWEV-SREKITLL--------RELGQGSFGMVYEGNARDIIKGEAETRVAVKT 54
Query: 257 LKRSSFQRKK-EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHI 315
           +  S+  R++ EF +E          ++V + G         +V E + +G L  +L  +
Sbjct: 55  VNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSL 114
Query: 316 -PRG----GRSLDWAMRM-KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHL 369
            P      GR       M ++A  +A G+A+L+ K     VHR++ A N ++  +F   +
Sbjct: 115 RPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKI 171
Query: 370 MGVGLSKFVPWEVMQERTVMAGGT----YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 425
              G+++    ++ +      GG       ++APE +     TT SD++SFGV+L EI S
Sbjct: 172 GDFGMTR----DIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227
Query: 426 -GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYA 484
              +P Q + +       E     V    Y                     ++V DL+  
Sbjct: 228 LAEQPYQGLSN-------EQVLKFVMDGGYLDQPD-------------NCPERVTDLMRM 267
Query: 485 CTQHVPSMRPRMSHVVHQLQQLAQP 509
           C Q  P+MRP    +V+ L+    P
Sbjct: 268 CWQFNPNMRPTFLEIVNLLKDDLHP 292

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 78/314 (24%), Positives = 124/314 (39%), Gaps = 39/314 (12%)
Query: 212 KVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGIL------PDGSRVAVKRLKR-SSFQR 264
           K  +  +L+ + +      R LG    G  Y G +      P   +VAVK L    S Q 
Sbjct: 34  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 93
Query: 265 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHI-PRGGRSLD 323
           + +F  E    ++ +H N+V   G       R+I+ E +  G L  +L    PR  +   
Sbjct: 94  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 153
Query: 324 WAMR--MKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 381
            AM   + VA  +A G  +L +    H +HRDI A N LL       +  +G       +
Sbjct: 154 LAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA-RD 209
Query: 382 VMQERTVMAGG----TYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSV 436
           + +      GG       ++ PE       T+K+D +SFGVLL EI S G  P  +  + 
Sbjct: 210 IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN- 268
Query: 437 CWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRM 496
             Q + E+ T                          G V +++     C QH P  RP  
Sbjct: 269 --QEVLEFVT--------------SGGRMDPPKNCPGPVYRIMT---QCWQHQPEDRPNF 309
Query: 497 SHVVHQLQQLAQPP 510
           + ++ +++   Q P
Sbjct: 310 AIILERIEYCTQDP 323

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 109/280 (38%), Gaps = 42/280 (15%)
Query: 228 EGNRLLGDSKTGGTYSGILPDGSRV-AVKRLKRSSFQR---KKEFYSEIGRFARLHHPNL 283
           E  R LG  K G  Y         + A+K L ++  ++   + +   E+   + L HPN+
Sbjct: 16  EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 75
Query: 284 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 343
           + + G  +D    Y++ E+   G + R L  + +     D        T LA  +++ H 
Sbjct: 76  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHS 131
Query: 344 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 403
           K    V+HRDI+  N+LL       +   G S   P      R     GT  YL PE + 
Sbjct: 132 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPPEMIE 184
Query: 404 RNELTTKSDVYSFGVLLLEIVSGRRPAQA---VDSVCWQSIFEWATPLVQSHRYXXXXXX 460
                 K D++S GVL  E + G+ P +A    ++    S  E+  P             
Sbjct: 185 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----------- 233
Query: 461 XXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVV 500
                        V +   DL+    +H PS RP +  V+
Sbjct: 234 -------------VTEGARDLISRLLKHNPSQRPMLREVL 260

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 67/280 (23%), Positives = 109/280 (38%), Gaps = 42/280 (15%)
Query: 228 EGNRLLGDSKTGGTYSGILPDGSRV-AVKRLKRSSFQR---KKEFYSEIGRFARLHHPNL 283
           E  R LG  K G  Y         + A+K L ++  ++   + +   E+   + L HPN+
Sbjct: 16  EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 75
Query: 284 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 343
           + + G  +D    Y++ E+   G + + L  + +     D        T LA  +++ H 
Sbjct: 76  LRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK----FDEQRTATYITELANALSYCHS 131
Query: 344 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 403
           K    V+HRDI+  N+LL       +   G S   P      R     GT  YL PE + 
Sbjct: 132 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPPEMIE 184
Query: 404 RNELTTKSDVYSFGVLLLEIVSGRRPAQA---VDSVCWQSIFEWATPLVQSHRYXXXXXX 460
                 K D++S GVL  E + G+ P +A    ++    S  E+  P             
Sbjct: 185 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----------- 233
Query: 461 XXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVV 500
                        V +   DL+    +H PS RP +  V+
Sbjct: 234 -------------VTEGARDLISRLLKHNPSQRPMLREVL 260

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 109/280 (38%), Gaps = 42/280 (15%)
Query: 228 EGNRLLGDSKTGGTYSGILPDGSRV-AVKRLKRSSFQR---KKEFYSEIGRFARLHHPNL 283
           E  R LG  K G  Y         + A+K L ++  ++   + +   E+   + L HPN+
Sbjct: 11  EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 70
Query: 284 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 343
           + + G  +D    Y++ E+   G + R L  + +     D        T LA  +++ H 
Sbjct: 71  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHS 126
Query: 344 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 403
           K    V+HRDI+  N+LL       +   G S   P      R     GT  YL PE + 
Sbjct: 127 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTELCGTLDYLPPEMIE 179
Query: 404 RNELTTKSDVYSFGVLLLEIVSGRRPAQA---VDSVCWQSIFEWATPLVQSHRYXXXXXX 460
                 K D++S GVL  E + G+ P +A    ++    S  E+  P             
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----------- 228
Query: 461 XXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVV 500
                        V +   DL+    +H PS RP +  V+
Sbjct: 229 -------------VTEGARDLISRLLKHNPSQRPMLREVL 255

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 67/280 (23%), Positives = 109/280 (38%), Gaps = 42/280 (15%)
Query: 228 EGNRLLGDSKTGGTYSGILPDGSRV-AVKRLKRSSFQR---KKEFYSEIGRFARLHHPNL 283
           E  R LG  K G  Y         + A+K L ++  ++   + +   E+   + L HPN+
Sbjct: 16  EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 75
Query: 284 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 343
           + + G  +D    Y++ E+   G + + L  + +     D        T LA  +++ H 
Sbjct: 76  LRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK----FDEQRTATYITELANALSYCHS 131
Query: 344 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 403
           K    V+HRDI+  N+LL       +   G S   P      R     GT  YL PE + 
Sbjct: 132 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRXXLXGTLDYLPPEMIE 184
Query: 404 RNELTTKSDVYSFGVLLLEIVSGRRPAQA---VDSVCWQSIFEWATPLVQSHRYXXXXXX 460
                 K D++S GVL  E + G+ P +A    ++    S  E+  P             
Sbjct: 185 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----------- 233
Query: 461 XXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVV 500
                        V +   DL+    +H PS RP +  V+
Sbjct: 234 -------------VTEGARDLISRLLKHNPSQRPMLREVL 260

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 99/211 (46%), Gaps = 15/211 (7%)
Query: 220 RSITKNFSEGNRLLGDSKTGGT-YSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL 278
           RS   NF +    +G+  TG    + +   G  VAVK++     QR++  ++E+      
Sbjct: 73  RSYLDNFIK----IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY 128
Query: 279 HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGI 338
            H N+V +        + ++V EF+  G L   + H       ++      V   + Q +
Sbjct: 129 QHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT-----RMNEEQIAAVCLAVLQAL 183
Query: 339 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLA 398
           + LH +    V+HRDI++ ++LL  +    L   G    V  EV + + ++  GT  ++A
Sbjct: 184 SVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV--GTPYWMA 238
Query: 399 PEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           PE + R     + D++S G++++E+V G  P
Sbjct: 239 PELISRLPYGPEVDIWSLGIMVIEMVDGEPP 269

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 109/280 (38%), Gaps = 42/280 (15%)
Query: 228 EGNRLLGDSKTGGTYSGILPDGSRV-AVKRLKRSSFQR---KKEFYSEIGRFARLHHPNL 283
           E  R LG  K G  Y         + A+K L ++  ++   + +   E+   + L HPN+
Sbjct: 14  EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 73
Query: 284 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 343
           + + G  +D    Y++ E+   G + R L  + +     D        T LA  +++ H 
Sbjct: 74  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHS 129
Query: 344 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 403
           K    V+HRDI+  N+LL       +   G S   P      R     GT  YL PE + 
Sbjct: 130 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRAALCGTLDYLPPEMIE 182
Query: 404 RNELTTKSDVYSFGVLLLEIVSGRRPAQA---VDSVCWQSIFEWATPLVQSHRYXXXXXX 460
                 K D++S GVL  E + G+ P +A    ++    S  E+  P             
Sbjct: 183 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----------- 231
Query: 461 XXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVV 500
                        V +   DL+    +H PS RP +  V+
Sbjct: 232 -------------VTEGARDLISRLLKHNPSQRPMLREVL 258

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 78/156 (50%), Gaps = 11/156 (7%)
Query: 290 CYDHGDR-YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH 348
           C+   DR Y V E+V  G L   ++HI + GR       +  A  +A G+ FL  K    
Sbjct: 410 CFQTMDRLYFVMEYVNGGDL---MYHIQQVGR-FKEPHAVFYAAEIAIGLFFLQSK---G 462
Query: 349 VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELT 408
           +++RD++  NV+LD E    +   G+ K   W+ +  +     GT  Y+APE +      
Sbjct: 463 IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFC--GTPDYIAPEIIAYQPYG 520
Query: 409 TKSDVYSFGVLLLEIVSGRRPAQAVD-SVCWQSIFE 443
              D ++FGVLL E+++G+ P +  D    +QSI E
Sbjct: 521 KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 556

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 97/192 (50%), Gaps = 14/192 (7%)
Query: 247 PD-GSRVAVKRLKRSSFQRKKEFYSEIGR--FARLHHPNLVAVKGCCYDHGDRYIVYEFV 303
           PD G   A+K LK+++ + +    +++ R   A ++HP +V +       G  Y++ +F+
Sbjct: 53  PDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVVKLHYAFQTEGKLYLILDFL 112
Query: 304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 363
             G L      + +     +  ++  +A  LA G+  LH      +++RD++  N+LLDE
Sbjct: 113 RGGDL---FTRLSKEVMFTEEDVKFYLAE-LALGLDHLHSL---GIIYRDLKPENILLDE 165
Query: 364 EFGAHLMGVGLSKFVPWEVMQERTVMAG-GTYGYLAPEFVYRNELTTKSDVYSFGVLLLE 422
           E    L   GLSK     +  E+   +  GT  Y+APE V R   +  +D +S+GVL+ E
Sbjct: 166 EGHIKLTDFGLSK---EAIDHEKKAYSFCGTVEYMAPEVVNRQGHSHSADWWSYGVLMFE 222
Query: 423 IVSGRRPAQAVD 434
           +++G  P Q  D
Sbjct: 223 MLTGSLPFQGKD 234

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 44/168 (26%), Positives = 85/168 (50%), Gaps = 12/168 (7%)
Query: 266 KEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWA 325
           ++  +EI     L HPN++ +     D+ + YIV E    G L   +      G++L   
Sbjct: 65  EQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEG 124
Query: 326 MRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH----LMGVGLSKFVPWE 381
              ++   +   +A+ H +   HVVH+D++  N+L  ++   H    ++  GL++    +
Sbjct: 125 YVAELMKQMMNALAYFHSQ---HVVHKDLKPENILF-QDTSPHSPIKIIDFGLAELFKSD 180
Query: 382 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
              E +  A GT  Y+APE V++ ++T K D++S GV++  +++G  P
Sbjct: 181 ---EHSTNAAGTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTGCLP 224

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 109/280 (38%), Gaps = 42/280 (15%)
Query: 228 EGNRLLGDSKTGGTYSGILPDGSRV-AVKRLKRSSFQR---KKEFYSEIGRFARLHHPNL 283
           E  R LG  K G  Y         + A+K L ++  ++   + +   E+   + L HPN+
Sbjct: 13  EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 72
Query: 284 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 343
           + + G  +D    Y++ E+   G + R L  + +     D        T LA  +++ H 
Sbjct: 73  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHS 128
Query: 344 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 403
           K    V+HRDI+  N+LL       +   G S   P      R     GT  YL PE + 
Sbjct: 129 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRXXLCGTLDYLPPEMIE 181
Query: 404 RNELTTKSDVYSFGVLLLEIVSGRRPAQA---VDSVCWQSIFEWATPLVQSHRYXXXXXX 460
                 K D++S GVL  E + G+ P +A    ++    S  E+  P             
Sbjct: 182 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----------- 230
Query: 461 XXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVV 500
                        V +   DL+    +H PS RP +  V+
Sbjct: 231 -------------VTEGARDLISRLLKHNPSQRPMLREVL 257

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 122/297 (41%), Gaps = 45/297 (15%)
Query: 231 RLLGDSKTGGTYSGILPD------GSRVAVKRLKRSSFQRKK-EFYSEIGRFARLHHPNL 283
           R LG    G  Y G   D       +RVAVK +  S+  R++ EF +E          ++
Sbjct: 22  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 81
Query: 284 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHI-PRG----GRSLDWAMRM-KVATTLAQG 337
           V + G         +V E + +G L  +L  + P      GR       M ++A  +A G
Sbjct: 82  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 141
Query: 338 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT---- 393
           +A+L+ K     VHRD+ A N ++  +F   +   G+++    ++ +      GG     
Sbjct: 142 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKGLLP 194
Query: 394 YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSH 452
             ++APE +     TT SD++SFGV+L EI S   +P Q + +       E     V   
Sbjct: 195 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-------EQVLKFVMDG 247
Query: 453 RYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 509
            Y                     ++V DL+  C Q  P MRP    +V+ L+    P
Sbjct: 248 GYLDQPD-------------NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHP 291

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 99/211 (46%), Gaps = 15/211 (7%)
Query: 220 RSITKNFSEGNRLLGDSKTGGT-YSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL 278
           RS   NF +    +G+  TG    + +   G  VAVK++     QR++  ++E+      
Sbjct: 150 RSYLDNFIK----IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY 205
Query: 279 HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGI 338
            H N+V +        + ++V EF+  G L   + H       ++      V   + Q +
Sbjct: 206 QHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT-----RMNEEQIAAVCLAVLQAL 260
Query: 339 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLA 398
           + LH +    V+HRDI++ ++LL  +    L   G    V  EV + + ++  GT  ++A
Sbjct: 261 SVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV--GTPYWMA 315
Query: 399 PEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           PE + R     + D++S G++++E+V G  P
Sbjct: 316 PELISRLPYGPEVDIWSLGIMVIEMVDGEPP 346

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 89/209 (42%), Gaps = 15/209 (7%)
Query: 228 EGNRLLGDSKTGGTYSGILPDGSRV-AVKRLKRSSFQR---KKEFYSEIGRFARLHHPNL 283
           E  R LG  K G  Y         + A+K L ++  ++   + +   E+   + L HPN+
Sbjct: 10  EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 69
Query: 284 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 343
           + + G  +D    Y++ E+   G + R L  + +     D        T LA  +++ H 
Sbjct: 70  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHS 125
Query: 344 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 403
           K    V+HRDI+  N+LL       +   G S   P      R     GT  YL PE + 
Sbjct: 126 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPPEMIE 178
Query: 404 RNELTTKSDVYSFGVLLLEIVSGRRPAQA 432
                 K D++S GVL  E + G+ P +A
Sbjct: 179 GRMHDEKVDLWSLGVLCYEFLVGKPPFEA 207

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 109/280 (38%), Gaps = 42/280 (15%)
Query: 228 EGNRLLGDSKTGGTYSGILPDGSRV-AVKRLKRSSFQR---KKEFYSEIGRFARLHHPNL 283
           E  R LG  K G  Y         + A+K L ++  ++   + +   E+   + L HPN+
Sbjct: 11  EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 70
Query: 284 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 343
           + + G  +D    Y++ E+   G + R L  + +     D        T LA  +++ H 
Sbjct: 71  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHS 126
Query: 344 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 403
           K    V+HRDI+  N+LL       +   G S   P      R     GT  YL PE + 
Sbjct: 127 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTXLCGTLDYLPPEMIE 179
Query: 404 RNELTTKSDVYSFGVLLLEIVSGRRPAQA---VDSVCWQSIFEWATPLVQSHRYXXXXXX 460
                 K D++S GVL  E + G+ P +A    ++    S  E+  P             
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP------------- 226
Query: 461 XXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVV 500
                        V +   DL+    +H PS RP +  V+
Sbjct: 227 -----------DFVTEGARDLISRLLKHNPSQRPMLREVL 255

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 109/280 (38%), Gaps = 42/280 (15%)
Query: 228 EGNRLLGDSKTGGTYSGILPDGSRV-AVKRLKRSSFQR---KKEFYSEIGRFARLHHPNL 283
           E  R LG  K G  Y         + A+K L ++  ++   + +   E+   + L HPN+
Sbjct: 15  EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 74
Query: 284 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 343
           + + G  +D    Y++ E+   G + R L  + +     D        T LA  +++ H 
Sbjct: 75  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHS 130
Query: 344 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 403
           K    V+HRDI+  N+LL       +   G S   P      R     GT  YL PE + 
Sbjct: 131 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPPEMIE 183
Query: 404 RNELTTKSDVYSFGVLLLEIVSGRRPAQA---VDSVCWQSIFEWATPLVQSHRYXXXXXX 460
                 K D++S GVL  E + G+ P +A    ++    S  E+  P             
Sbjct: 184 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----------- 232
Query: 461 XXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVV 500
                        V +   DL+    +H PS RP +  V+
Sbjct: 233 -------------VTEGARDLISRLLKHNPSQRPMLREVL 259

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 109/280 (38%), Gaps = 42/280 (15%)
Query: 228 EGNRLLGDSKTGGTYSGILPDGSRV-AVKRLKRSSFQR---KKEFYSEIGRFARLHHPNL 283
           E  R LG  K G  Y         + A+K L ++  ++   + +   E+   + L HPN+
Sbjct: 16  EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 75
Query: 284 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 343
           + + G  +D    Y++ E+   G + R L  + +     D        T LA  +++ H 
Sbjct: 76  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHS 131
Query: 344 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 403
           K    V+HRDI+  N+LL       +   G S   P      R     GT  YL PE + 
Sbjct: 132 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTDLCGTLDYLPPEMIE 184
Query: 404 RNELTTKSDVYSFGVLLLEIVSGRRPAQA---VDSVCWQSIFEWATPLVQSHRYXXXXXX 460
                 K D++S GVL  E + G+ P +A    ++    S  E+  P             
Sbjct: 185 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----------- 233
Query: 461 XXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVV 500
                        V +   DL+    +H PS RP +  V+
Sbjct: 234 -------------VTEGARDLISRLLKHNPSQRPMLREVL 260

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 67/270 (24%), Positives = 113/270 (41%), Gaps = 38/270 (14%)
Query: 252 VAVKRLKRSSFQRK-KEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 309
           VAVK LK  + ++   +  SE+     +  H N++ + G C   G  Y++ E+   G L 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 129
Query: 310 RWLH-HIPRG-------GRSLDWAMRMKVATT----LAQGIAFLHDKVKPHVVHRDIRAS 357
            +L    P G        R  +  M  K   +    LA+G+ +L  +     +HRD+ A 
Sbjct: 130 EYLRARRPPGMEXSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 186
Query: 358 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFG 417
           NVL+ E     +   GL++ +      ++T        ++APE ++    T +SDV+SFG
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 418 VLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQ 476
           VL+ EI + G  P   +       + E    L + HR                  A    
Sbjct: 247 VLMWEIFTLGGSPYPGI------PVEELFKLLKEGHRM--------------DKPANCTN 286
Query: 477 KVVDLVYACTQHVPSMRPRMSHVVHQLQQL 506
           ++  ++  C   VPS RP    +V  L ++
Sbjct: 287 ELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 78/314 (24%), Positives = 124/314 (39%), Gaps = 39/314 (12%)
Query: 212 KVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGIL------PDGSRVAVKRLKR-SSFQR 264
           K  +  +L+ + +      R LG    G  Y G +      P   +VAVK L    S Q 
Sbjct: 44  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 103
Query: 265 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHI-PRGGRSLD 323
           + +F  E    ++ +H N+V   G       R+I+ E +  G L  +L    PR  +   
Sbjct: 104 ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 163
Query: 324 WAMR--MKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 381
            AM   + VA  +A G  +L +    H +HRDI A N LL       +  +G       +
Sbjct: 164 LAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA-RD 219
Query: 382 VMQERTVMAGG----TYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSV 436
           + +      GG       ++ PE       T+K+D +SFGVLL EI S G  P  +  + 
Sbjct: 220 IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN- 278
Query: 437 CWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRM 496
             Q + E+ T                          G V +++     C QH P  RP  
Sbjct: 279 --QEVLEFVT--------------SGGRMDPPKNCPGPVYRIMT---QCWQHQPEDRPNF 319
Query: 497 SHVVHQLQQLAQPP 510
           + ++ +++   Q P
Sbjct: 320 AIILERIEYCTQDP 333

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 109/280 (38%), Gaps = 42/280 (15%)
Query: 228 EGNRLLGDSKTGGTYSGILPDGSRV-AVKRLKRSSFQR---KKEFYSEIGRFARLHHPNL 283
           E  R LG  K G  Y         + A+K L ++  ++   + +   E+   + L HPN+
Sbjct: 12  EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 71
Query: 284 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 343
           + + G  +D    Y++ E+   G + R L  + +     D        T LA  +++ H 
Sbjct: 72  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHS 127
Query: 344 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 403
           K    V+HRDI+  N+LL       +   G S   P      R     GT  YL PE + 
Sbjct: 128 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTDLCGTLDYLPPEMIE 180
Query: 404 RNELTTKSDVYSFGVLLLEIVSGRRPAQA---VDSVCWQSIFEWATPLVQSHRYXXXXXX 460
                 K D++S GVL  E + G+ P +A    ++    S  E+  P             
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----------- 229
Query: 461 XXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVV 500
                        V +   DL+    +H PS RP +  V+
Sbjct: 230 -------------VTEGARDLISRLLKHNPSQRPMLREVL 256

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 89/209 (42%), Gaps = 15/209 (7%)
Query: 228 EGNRLLGDSKTGGTYSGILPDGSRV-AVKRLKRSSFQR---KKEFYSEIGRFARLHHPNL 283
           E  R LG  K G  Y         + A+K L ++  ++   + +   E+   + L HPN+
Sbjct: 11  EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 70
Query: 284 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 343
           + + G  +D    Y++ E+   G + R L  + +     D        T LA  +++ H 
Sbjct: 71  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHS 126
Query: 344 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 403
           K    V+HRDI+  N+LL       +   G S   P      R     GT  YL PE + 
Sbjct: 127 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRAALCGTLDYLPPEMIE 179
Query: 404 RNELTTKSDVYSFGVLLLEIVSGRRPAQA 432
                 K D++S GVL  E + G+ P +A
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 67/270 (24%), Positives = 113/270 (41%), Gaps = 38/270 (14%)
Query: 252 VAVKRLKRSSFQRK-KEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 309
           VAVK LK  + ++   +  SE+     +  H N++ + G C   G  Y++ E+   G L 
Sbjct: 59  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 118
Query: 310 RWLH-HIPRG-------GRSLDWAMRMKVATT----LAQGIAFLHDKVKPHVVHRDIRAS 357
            +L    P G        R  +  M  K   +    LA+G+ +L  +     +HRD+ A 
Sbjct: 119 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 175
Query: 358 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFG 417
           NVL+ E     +   GL++ +      ++T        ++APE ++    T +SDV+SFG
Sbjct: 176 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 235
Query: 418 VLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQ 476
           VL+ EI + G  P   +       + E    L + HR                  A    
Sbjct: 236 VLMWEIFTLGGSPYPGI------PVEELFKLLKEGHR--------------MDKPANCTN 275
Query: 477 KVVDLVYACTQHVPSMRPRMSHVVHQLQQL 506
           ++  ++  C   VPS RP    +V  L ++
Sbjct: 276 ELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 305

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 67/270 (24%), Positives = 113/270 (41%), Gaps = 38/270 (14%)
Query: 252 VAVKRLKRSSFQRK-KEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 309
           VAVK LK  + ++   +  SE+     +  H N++ + G C   G  Y++ E+   G L 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLR 129
Query: 310 RWLH-HIPRG-------GRSLDWAMRMKVATT----LAQGIAFLHDKVKPHVVHRDIRAS 357
            +L    P G        R  +  M  K   +    LA+G+ +L  +     +HRD+ A 
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 186
Query: 358 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFG 417
           NVL+ E     +   GL++ +      ++T        ++APE ++    T +SDV+SFG
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 418 VLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQ 476
           VL+ EI + G  P   +       + E    L + HR                  A    
Sbjct: 247 VLMWEIFTLGGSPYPGI------PVEELFKLLKEGHR--------------MDKPANCTN 286
Query: 477 KVVDLVYACTQHVPSMRPRMSHVVHQLQQL 506
           ++  ++  C   VPS RP    +V  L ++
Sbjct: 287 ELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 67/270 (24%), Positives = 113/270 (41%), Gaps = 38/270 (14%)
Query: 252 VAVKRLKRSSFQRK-KEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 309
           VAVK LK  + ++   +  SE+     +  H N++ + G C   G  Y++ E+   G L 
Sbjct: 57  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 116
Query: 310 RWLH-HIPRG-------GRSLDWAMRMKVATT----LAQGIAFLHDKVKPHVVHRDIRAS 357
            +L    P G        R  +  M  K   +    LA+G+ +L  +     +HRD+ A 
Sbjct: 117 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLTAR 173
Query: 358 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFG 417
           NVL+ E     +   GL++ +      ++T        ++APE ++    T +SDV+SFG
Sbjct: 174 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 233
Query: 418 VLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQ 476
           VL+ EI + G  P   +       + E    L + HR                  A    
Sbjct: 234 VLMWEIFTLGGSPYPGI------PVEELFKLLKEGHR--------------MDKPANCTN 273
Query: 477 KVVDLVYACTQHVPSMRPRMSHVVHQLQQL 506
           ++  ++  C   VPS RP    +V  L ++
Sbjct: 274 ELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 303

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 109/280 (38%), Gaps = 42/280 (15%)
Query: 228 EGNRLLGDSKTGGTYSGILPDGSRV-AVKRLKRSSFQR---KKEFYSEIGRFARLHHPNL 283
           E  R LG  K G  Y         + A+K L ++  ++   + +   E+   + L HPN+
Sbjct: 14  EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 73
Query: 284 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 343
           + + G  +D    Y++ E+   G + R L  + +     D        T LA  +++ H 
Sbjct: 74  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHS 129
Query: 344 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 403
           K    V+HRDI+  N+LL       +   G S   P      R     GT  YL PE + 
Sbjct: 130 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPPEMIE 182
Query: 404 RNELTTKSDVYSFGVLLLEIVSGRRPAQA---VDSVCWQSIFEWATPLVQSHRYXXXXXX 460
                 K D++S GVL  E + G+ P +A    ++    S  E+  P             
Sbjct: 183 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP------------- 229
Query: 461 XXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVV 500
                        V +   DL+    +H PS RP +  V+
Sbjct: 230 -----------DFVTEGARDLISRLLKHNPSQRPMLREVL 258

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 67/270 (24%), Positives = 113/270 (41%), Gaps = 38/270 (14%)
Query: 252 VAVKRLKRSSFQRK-KEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 309
           VAVK LK  + ++   +  SE+     +  H N++ + G C   G  Y++ E+   G L 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 129
Query: 310 RWLH-HIPRG-------GRSLDWAMRMKVATT----LAQGIAFLHDKVKPHVVHRDIRAS 357
            +L    P G        R  +  M  K   +    LA+G+ +L  +     +HRD+ A 
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 186
Query: 358 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFG 417
           NVL+ E     +   GL++ +      ++T        ++APE ++    T +SDV+SFG
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 418 VLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQ 476
           VL+ EI + G  P   +       + E    L + HR                  A    
Sbjct: 247 VLMWEIFTLGGSPYPGI------PVEELFKLLKEGHR--------------MDKPANCTN 286
Query: 477 KVVDLVYACTQHVPSMRPRMSHVVHQLQQL 506
           ++  ++  C   VPS RP    +V  L ++
Sbjct: 287 ELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 109/280 (38%), Gaps = 42/280 (15%)
Query: 228 EGNRLLGDSKTGGTYSGILPDGSRV-AVKRLKRSSFQR---KKEFYSEIGRFARLHHPNL 283
           E  R LG  K G  Y         + A+K L ++  ++   + +   E+   + L HPN+
Sbjct: 11  EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 70
Query: 284 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 343
           + + G  +D    Y++ E+   G + R L  + +     D        T LA  +++ H 
Sbjct: 71  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHS 126
Query: 344 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 403
           K    V+HRDI+  N+LL       +   G S   P      R     GT  YL PE + 
Sbjct: 127 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTDLCGTLDYLPPEMIE 179
Query: 404 RNELTTKSDVYSFGVLLLEIVSGRRPAQA---VDSVCWQSIFEWATPLVQSHRYXXXXXX 460
                 K D++S GVL  E + G+ P +A    ++    S  E+  P             
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP------------- 226
Query: 461 XXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVV 500
                        V +   DL+    +H PS RP +  V+
Sbjct: 227 -----------DFVTEGARDLISRLLKHNPSQRPMLREVL 255

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 109/280 (38%), Gaps = 42/280 (15%)
Query: 228 EGNRLLGDSKTGGTYSGILPDGSRV-AVKRLKRSSFQR---KKEFYSEIGRFARLHHPNL 283
           E  R LG  K G  Y         + A+K L ++  ++   + +   E+   + L HPN+
Sbjct: 14  EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 73
Query: 284 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 343
           + + G  +D    Y++ E+   G + R L  + +     D        T LA  +++ H 
Sbjct: 74  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHS 129
Query: 344 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 403
           K    V+HRDI+  N+LL       +   G S   P      R     GT  YL PE + 
Sbjct: 130 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRXXLCGTLDYLPPEMIE 182
Query: 404 RNELTTKSDVYSFGVLLLEIVSGRRPAQA---VDSVCWQSIFEWATPLVQSHRYXXXXXX 460
                 K D++S GVL  E + G+ P +A    ++    S  E+  P             
Sbjct: 183 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP------------- 229
Query: 461 XXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVV 500
                        V +   DL+    +H PS RP +  V+
Sbjct: 230 -----------DFVTEGARDLISRLLKHNPSQRPMLREVL 258

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 67/270 (24%), Positives = 113/270 (41%), Gaps = 38/270 (14%)
Query: 252 VAVKRLKRSSFQRK-KEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 309
           VAVK LK  + ++   +  SE+     +  H N++ + G C   G  Y++ E+   G L 
Sbjct: 62  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 121
Query: 310 RWLH-HIPRG-------GRSLDWAMRMKVATT----LAQGIAFLHDKVKPHVVHRDIRAS 357
            +L    P G        R  +  M  K   +    LA+G+ +L  +     +HRD+ A 
Sbjct: 122 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 178
Query: 358 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFG 417
           NVL+ E     +   GL++ +      ++T        ++APE ++    T +SDV+SFG
Sbjct: 179 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 238
Query: 418 VLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQ 476
           VL+ EI + G  P   +       + E    L + HR                  A    
Sbjct: 239 VLMWEIFTLGGSPYPGI------PVEELFKLLKEGHR--------------MDKPANCTN 278
Query: 477 KVVDLVYACTQHVPSMRPRMSHVVHQLQQL 506
           ++  ++  C   VPS RP    +V  L ++
Sbjct: 279 ELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 308

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 89/209 (42%), Gaps = 15/209 (7%)
Query: 228 EGNRLLGDSKTGGTYSGILPDGSRV-AVKRLKRSSFQR---KKEFYSEIGRFARLHHPNL 283
           E  R LG  K G  Y         + A+K L ++  ++   + +   E+   + L HPN+
Sbjct: 11  EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 70
Query: 284 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 343
           + + G  +D    Y++ E+   G + R L  + +     D        T LA  +++ H 
Sbjct: 71  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHS 126
Query: 344 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 403
           K    V+HRDI+  N+LL       +   G S   P      R     GT  YL PE + 
Sbjct: 127 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTDLCGTLDYLPPEMIE 179
Query: 404 RNELTTKSDVYSFGVLLLEIVSGRRPAQA 432
                 K D++S GVL  E + G+ P +A
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 92/211 (43%), Gaps = 19/211 (9%)
Query: 228 EGNRLLGDSKTGGTYSGILPDGSR---VAVKRLKRSSFQR---KKEFYSEIGRFARLHHP 281
           E  R LG  K G  Y  +  +  R   +A+K L ++  ++   + +   E+   + L HP
Sbjct: 8   EIGRPLGKGKFGNVY--LAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 65
Query: 282 NLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 341
           N++ + G  +D    Y++ E+   G + R L  + +     D        T LA  +++ 
Sbjct: 66  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYC 121
Query: 342 HDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEF 401
           H K    V+HRDI+  N+LL       +   G S   P      R     GT  YL PE 
Sbjct: 122 HSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPPEM 174
Query: 402 VYRNELTTKSDVYSFGVLLLEIVSGRRPAQA 432
           +       K D++S GVL  E + G+ P +A
Sbjct: 175 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 205

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 109/280 (38%), Gaps = 42/280 (15%)
Query: 228 EGNRLLGDSKTGGTYSGILPDGSRV-AVKRLKRSSFQR---KKEFYSEIGRFARLHHPNL 283
           E  R LG  K G  Y         + A+K L ++  ++   + +   E+   + L HPN+
Sbjct: 11  EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 70
Query: 284 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 343
           + + G  +D    Y++ E+   G + R L  + +     D        T LA  +++ H 
Sbjct: 71  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHS 126
Query: 344 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 403
           K    V+HRDI+  N+LL       +   G S   P      R     GT  YL PE + 
Sbjct: 127 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRXXLCGTLDYLPPEMIE 179
Query: 404 RNELTTKSDVYSFGVLLLEIVSGRRPAQA---VDSVCWQSIFEWATPLVQSHRYXXXXXX 460
                 K D++S GVL  E + G+ P +A    ++    S  E+  P             
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP------------- 226
Query: 461 XXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVV 500
                        V +   DL+    +H PS RP +  V+
Sbjct: 227 -----------DFVTEGARDLISRLLKHNPSQRPMLREVL 255

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 109/280 (38%), Gaps = 42/280 (15%)
Query: 228 EGNRLLGDSKTGGTYSGILPDGSRV-AVKRLKRSSFQR---KKEFYSEIGRFARLHHPNL 283
           E  R LG  K G  Y         + A+K L ++  ++   + +   E+   + L HPN+
Sbjct: 12  EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 71
Query: 284 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 343
           + + G  +D    Y++ E+   G + R L  + +     D        T LA  +++ H 
Sbjct: 72  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHS 127
Query: 344 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 403
           K    V+HRDI+  N+LL       +   G S   P      R     GT  YL PE + 
Sbjct: 128 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRDTLCGTLDYLPPEMIE 180
Query: 404 RNELTTKSDVYSFGVLLLEIVSGRRPAQA---VDSVCWQSIFEWATPLVQSHRYXXXXXX 460
                 K D++S GVL  E + G+ P +A    ++    S  E+  P             
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----------- 229
Query: 461 XXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVV 500
                        V +   DL+    +H PS RP +  V+
Sbjct: 230 -------------VTEGARDLISRLLKHNPSQRPMLREVL 256

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 99/211 (46%), Gaps = 23/211 (10%)
Query: 246 LPDGSRVAVKRLKRS-SFQRKKEFYSEIGRFAR-LHHPNLVAVKGCCYDHGDRYIVYEFV 303
           +P G   AVKR++ + + Q +K    ++    R +  P  V   G  +  GD +I  E +
Sbjct: 56  VPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCPFTVTFYGALFREGDVWICXE-L 114
Query: 304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 363
            +  LD++   +   G+++   +  K+A ++ + +  LH K+   V+HRD++ SNVL++ 
Sbjct: 115 XDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINA 172
Query: 364 EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFV----YRNELTTKSDVYSFGVL 419
                    G+S ++  +V ++   +  G   Y APE +     +   + KSD++S G+ 
Sbjct: 173 LGQVKXCDFGISGYLVDDVAKD---IDAGCKPYXAPERINPELNQKGYSVKSDIWSLGIT 229
Query: 420 LLEIVSGRRPAQAVDSVCWQSIFEWATPLVQ 450
            +E+   R P  +           W TP  Q
Sbjct: 230 XIELAILRFPYDS-----------WGTPFQQ 249

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 76/167 (45%), Gaps = 8/167 (4%)
Query: 276 ARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLA 335
           +RL HP  V +     D    Y    +  NG L +++  I     S D          + 
Sbjct: 64  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAEIV 119
Query: 336 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG 395
             + +LH K    ++HRD++  N+LL+E+    +   G +K +  E  Q R     GT  
Sbjct: 120 SALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 176
Query: 396 YLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS-VCWQSI 441
           Y++PE +        SD+++ G ++ ++V+G  P +A +  + +Q I
Sbjct: 177 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI 223

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 76/167 (45%), Gaps = 8/167 (4%)
Query: 276 ARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLA 335
           +RL HP  V +     D    Y    +  NG L +++  I     S D          + 
Sbjct: 85  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAEIV 140
Query: 336 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG 395
             + +LH K    ++HRD++  N+LL+E+    +   G +K +  E  Q R     GT  
Sbjct: 141 SALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 197
Query: 396 YLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS-VCWQSI 441
           Y++PE +        SD+++ G ++ ++V+G  P +A +  + +Q I
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI 244

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 78/156 (50%), Gaps = 11/156 (7%)
Query: 290 CYDHGDR-YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH 348
           C+   DR Y V E+V  G L   ++HI + GR       +  A  +A G+ FL  K    
Sbjct: 89  CFQTMDRLYFVMEYVNGGDL---MYHIQQVGR-FKEPHAVFYAAEIAIGLFFLQSK---G 141
Query: 349 VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELT 408
           +++RD++  NV+LD E    +   G+ K   W+ +  +     GT  Y+APE +      
Sbjct: 142 IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFC--GTPDYIAPEIIAYQPYG 199
Query: 409 TKSDVYSFGVLLLEIVSGRRPAQAVD-SVCWQSIFE 443
              D ++FGVLL E+++G+ P +  D    +QSI E
Sbjct: 200 KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 235

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 92/185 (49%), Gaps = 13/185 (7%)
Query: 253 AVKRLKRSSFQRKKEFYSEIGR--FARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 310
           A+K LK+++ + +    +++ R     ++HP +V +       G  Y++ +F+  G L  
Sbjct: 56  AMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDL-- 113
Query: 311 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLM 370
               + +     +  ++  +A  LA  +  LH      +++RD++  N+LLDEE    L 
Sbjct: 114 -FTRLSKEVMFTEEDVKFYLAE-LALALDHLHSL---GIIYRDLKPENILLDEEGHIKLT 168
Query: 371 GVGLSKFVPWEVMQERTVMAG-GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
             GLSK     +  E+   +  GT  Y+APE V R   T  +D +SFGVL+ E+++G  P
Sbjct: 169 DFGLSK---ESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
Query: 430 AQAVD 434
            Q  D
Sbjct: 226 FQGKD 230

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 76/167 (45%), Gaps = 8/167 (4%)
Query: 276 ARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLA 335
           +RL HP  V +     D    Y    +  NG L +++  I     S D          + 
Sbjct: 62  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAEIV 117
Query: 336 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG 395
             + +LH K    ++HRD++  N+LL+E+    +   G +K +  E  Q R     GT  
Sbjct: 118 SALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 174
Query: 396 YLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS-VCWQSI 441
           Y++PE +        SD+++ G ++ ++V+G  P +A +  + +Q I
Sbjct: 175 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI 221

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 76/167 (45%), Gaps = 8/167 (4%)
Query: 276 ARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLA 335
           +RL HP  V +     D    Y    +  NG L +++  I     S D          + 
Sbjct: 65  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAEIV 120
Query: 336 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG 395
             + +LH K    ++HRD++  N+LL+E+    +   G +K +  E  Q R     GT  
Sbjct: 121 SALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 177
Query: 396 YLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS-VCWQSI 441
           Y++PE +        SD+++ G ++ ++V+G  P +A +  + +Q I
Sbjct: 178 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI 224

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 92/185 (49%), Gaps = 13/185 (7%)
Query: 253 AVKRLKRSSFQRKKEFYSEIGR--FARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 310
           A+K LK+++ + +    +++ R     ++HP +V +       G  Y++ +F+  G L  
Sbjct: 56  AMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDL-- 113
Query: 311 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLM 370
               + +     +  ++  +A  LA  +  LH      +++RD++  N+LLDEE    L 
Sbjct: 114 -FTRLSKEVMFTEEDVKFYLAE-LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLT 168
Query: 371 GVGLSKFVPWEVMQERTVMAG-GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
             GLSK     +  E+   +  GT  Y+APE V R   T  +D +SFGVL+ E+++G  P
Sbjct: 169 DFGLSK---ESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
Query: 430 AQAVD 434
            Q  D
Sbjct: 226 FQGKD 230

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 76/167 (45%), Gaps = 8/167 (4%)
Query: 276 ARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLA 335
           +RL HP  V +     D    Y    +  NG L +++  I     S D          + 
Sbjct: 88  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAEIV 143
Query: 336 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG 395
             + +LH K    ++HRD++  N+LL+E+    +   G +K +  E  Q R     GT  
Sbjct: 144 SALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 200
Query: 396 YLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS-VCWQSI 441
           Y++PE +        SD+++ G ++ ++V+G  P +A +  + +Q I
Sbjct: 201 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI 247

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 76/167 (45%), Gaps = 8/167 (4%)
Query: 276 ARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLA 335
           +RL HP  V +     D    Y    +  NG L +++  I     S D          + 
Sbjct: 87  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAEIV 142
Query: 336 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG 395
             + +LH K    ++HRD++  N+LL+E+    +   G +K +  E  Q R     GT  
Sbjct: 143 SALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 396 YLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS-VCWQSI 441
           Y++PE +        SD+++ G ++ ++V+G  P +A +  + +Q I
Sbjct: 200 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI 246

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 71/157 (45%), Gaps = 7/157 (4%)
Query: 276 ARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLA 335
           +RL HP  V +     D    Y    +  NG L +++  I     S D          + 
Sbjct: 87  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAEIV 142
Query: 336 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG 395
             + +LH K    ++HRD++  N+LL+E+    +   G +K +  E  Q R     GT  
Sbjct: 143 SALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 396 YLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQA 432
           Y++PE +        SD+++ G ++ ++V+G  P +A
Sbjct: 200 YVSPELLTEKSAXKSSDLWALGCIIYQLVAGLPPFRA 236

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 76/167 (45%), Gaps = 8/167 (4%)
Query: 276 ARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLA 335
           +RL HP  V +     D    Y    +  NG L +++  I     S D          + 
Sbjct: 63  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAEIV 118
Query: 336 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG 395
             + +LH K    ++HRD++  N+LL+E+    +   G +K +  E  Q R     GT  
Sbjct: 119 SALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 175
Query: 396 YLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS-VCWQSI 441
           Y++PE +        SD+++ G ++ ++V+G  P +A +  + +Q I
Sbjct: 176 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI 222

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 76/167 (45%), Gaps = 8/167 (4%)
Query: 276 ARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLA 335
           +RL HP  V +     D    Y    +  NG L +++  I     S D          + 
Sbjct: 85  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAEIV 140
Query: 336 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG 395
             + +LH K    ++HRD++  N+LL+E+    +   G +K +  E  Q R     GT  
Sbjct: 141 SALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 197
Query: 396 YLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS-VCWQSI 441
           Y++PE +        SD+++ G ++ ++V+G  P +A +  + +Q I
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI 244

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/270 (24%), Positives = 113/270 (41%), Gaps = 38/270 (14%)
Query: 252 VAVKRLKRSSFQRK-KEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 309
           VAVK LK  + ++   +  SE+     +  H N++ + G C   G  Y++ E+   G L 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 129
Query: 310 RWLH-HIPRG-------GRSLDWAMRMKVATT----LAQGIAFLHDKVKPHVVHRDIRAS 357
            +L    P G        R  +  M  K   +    LA+G+ +L  +     +HRD+ A 
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 186
Query: 358 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFG 417
           NVL+ E     +   GL++ +      ++T        ++APE ++    T +SDV+SFG
Sbjct: 187 NVLVTENNVMRIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 418 VLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQ 476
           VL+ EI + G  P   +       + E    L + HR                  A    
Sbjct: 247 VLMWEIFTLGGSPYPGI------PVEELFKLLKEGHR--------------MDKPANCTN 286
Query: 477 KVVDLVYACTQHVPSMRPRMSHVVHQLQQL 506
           ++  ++  C   VPS RP    +V  L ++
Sbjct: 287 ELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/270 (24%), Positives = 113/270 (41%), Gaps = 38/270 (14%)
Query: 252 VAVKRLKRSSFQRK-KEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 309
           VAVK LK  + ++   +  SE+     +  H N++ + G C   G  Y++ E+   G L 
Sbjct: 116 VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 175
Query: 310 RWLH-HIPRG-------GRSLDWAMRMKVATT----LAQGIAFLHDKVKPHVVHRDIRAS 357
            +L    P G        R  +  M  K   +    LA+G+ +L  +     +HRD+ A 
Sbjct: 176 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 232
Query: 358 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFG 417
           NVL+ E     +   GL++ +      ++T        ++APE ++    T +SDV+SFG
Sbjct: 233 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 292
Query: 418 VLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQ 476
           VL+ EI + G  P   +       + E    L + HR                  A    
Sbjct: 293 VLMWEIFTLGGSPYPGI------PVEELFKLLKEGHR--------------MDKPANCTN 332
Query: 477 KVVDLVYACTQHVPSMRPRMSHVVHQLQQL 506
           ++  ++  C   VPS RP    +V  L ++
Sbjct: 333 ELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 76/167 (45%), Gaps = 8/167 (4%)
Query: 276 ARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLA 335
           +RL HP  V +     D    Y    +  NG L +++  I     S D          + 
Sbjct: 85  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAEIV 140
Query: 336 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG 395
             + +LH K    ++HRD++  N+LL+E+    +   G +K +  E  Q R     GT  
Sbjct: 141 SALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 197
Query: 396 YLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS-VCWQSI 441
           Y++PE +        SD+++ G ++ ++V+G  P +A +  + +Q I
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI 244

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 92/185 (49%), Gaps = 13/185 (7%)
Query: 253 AVKRLKRSSFQRKKEFYSEIGR--FARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 310
           A+K LK+++ + +    +++ R     ++HP +V +       G  Y++ +F+  G L  
Sbjct: 57  AMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDL-- 114
Query: 311 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLM 370
               + +     +  ++  +A  LA  +  LH      +++RD++  N+LLDEE    L 
Sbjct: 115 -FTRLSKEVMFTEEDVKFYLAE-LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLT 169
Query: 371 GVGLSKFVPWEVMQERTVMAG-GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
             GLSK     +  E+   +  GT  Y+APE V R   T  +D +SFGVL+ E+++G  P
Sbjct: 170 DFGLSK---ESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 226
Query: 430 AQAVD 434
            Q  D
Sbjct: 227 FQGKD 231

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/169 (24%), Positives = 77/169 (45%), Gaps = 8/169 (4%)
Query: 276 ARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLA 335
           +RL HP  V +     D    Y    +  NG L +++  I     S D          + 
Sbjct: 90  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAEIV 145
Query: 336 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG 395
             + +LH K    ++HRD++  N+LL+E+    +   G +K +  E  Q R     GT  
Sbjct: 146 SALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 202
Query: 396 YLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS-VCWQSIFE 443
           Y++PE +        SD+++ G ++ ++V+G  P +A +  + +Q I +
Sbjct: 203 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK 251

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 76/167 (45%), Gaps = 8/167 (4%)
Query: 276 ARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLA 335
           +RL HP  V +     D    Y    +  NG L +++  I     S D          + 
Sbjct: 85  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAEIV 140
Query: 336 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG 395
             + +LH K    ++HRD++  N+LL+E+    +   G +K +  E  Q R     GT  
Sbjct: 141 SALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQ 197
Query: 396 YLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS-VCWQSI 441
           Y++PE +        SD+++ G ++ ++V+G  P +A +  + +Q I
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI 244

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 76/167 (45%), Gaps = 8/167 (4%)
Query: 276 ARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLA 335
           +RL HP  V +     D    Y    +  NG L +++  I     S D          + 
Sbjct: 87  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAEIV 142
Query: 336 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG 395
             + +LH K    ++HRD++  N+LL+E+    +   G +K +  E  Q R     GT  
Sbjct: 143 SALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 396 YLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS-VCWQSI 441
           Y++PE +        SD+++ G ++ ++V+G  P +A +  + +Q I
Sbjct: 200 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI 246

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 76/167 (45%), Gaps = 8/167 (4%)
Query: 276 ARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLA 335
           +RL HP  V +     D    Y    +  NG L +++  I     S D          + 
Sbjct: 87  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAEIV 142
Query: 336 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG 395
             + +LH K    ++HRD++  N+LL+E+    +   G +K +  E  Q R     GT  
Sbjct: 143 SALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 396 YLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS-VCWQSI 441
           Y++PE +        SD+++ G ++ ++V+G  P +A +  + +Q I
Sbjct: 200 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI 246

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 77/167 (46%), Gaps = 8/167 (4%)
Query: 276 ARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLA 335
           +RL HP  V +     D    Y    +  NG L +++  I     S D          + 
Sbjct: 87  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKI----GSFDETCTRFYTAEIV 142
Query: 336 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG 395
             + +LH K    ++HRD++  N+LL+E+    +   G +K +  E  Q R     GT  
Sbjct: 143 SALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 199
Query: 396 YLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS-VCWQSI 441
           Y++PE +     +  SD+++ G ++ ++V+G  P +A +  + +Q I
Sbjct: 200 YVSPELLTEKSASKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI 246

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 76/167 (45%), Gaps = 8/167 (4%)
Query: 276 ARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLA 335
           +RL HP  V +     D    Y    +  NG L +++  I     S D          + 
Sbjct: 69  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG----SFDETCTRFYTAEIV 124
Query: 336 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG 395
             + +LH K    ++HRD++  N+LL+E+    +   G +K +  E  Q R     GT  
Sbjct: 125 SALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 181
Query: 396 YLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS-VCWQSI 441
           Y++PE +        SD+++ G ++ ++V+G  P +A +  + +Q I
Sbjct: 182 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI 228

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 71/157 (45%), Gaps = 7/157 (4%)
Query: 276 ARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLA 335
           +RL HP  V +     D    Y    +  NG L +++  I     S D          + 
Sbjct: 87  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAEIV 142
Query: 336 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG 395
             + +LH K    ++HRD++  N+LL+E+    +   G +K +  E  Q R     GT  
Sbjct: 143 SALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 396 YLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQA 432
           Y++PE +        SD+++ G ++ ++V+G  P +A
Sbjct: 200 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 236

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 91/213 (42%), Gaps = 16/213 (7%)
Query: 224 KNFSEGNRLLGDSKTGGTYSGILPDGSRV-AVKRLKRSSFQR---KKEFYSEIGRFARLH 279
           ++F  G R LG  K G  Y         + A+K L ++  ++   + +   E+   + L 
Sbjct: 12  EDFDIG-RPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLR 70
Query: 280 HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA 339
           HPN++ + G  +D    Y++ E+   G + R L  + R     D        T LA  ++
Sbjct: 71  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSR----FDEQRTATYITELANALS 126
Query: 340 FLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAP 399
           + H K    V+HRDI+  N+LL       +   G S   P      R     GT  YL P
Sbjct: 127 YCHSK---RVIHRDIKPENLLLGSNGELKIADFGWSVHAP----SSRRTTLCGTLDYLPP 179
Query: 400 EFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQA 432
           E +       K D++S GVL  E + G  P +A
Sbjct: 180 EMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEA 212

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 76/167 (45%), Gaps = 8/167 (4%)
Query: 276 ARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLA 335
           +RL HP  V +     D    Y    +  NG L +++  I     S D          + 
Sbjct: 88  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAEIV 143
Query: 336 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG 395
             + +LH K    ++HRD++  N+LL+E+    +   G +K +  E  Q R     GT  
Sbjct: 144 SALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 200
Query: 396 YLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS-VCWQSI 441
           Y++PE +        SD+++ G ++ ++V+G  P +A +  + +Q I
Sbjct: 201 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI 247

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 109/280 (38%), Gaps = 42/280 (15%)
Query: 228 EGNRLLGDSKTGGTYSGILPDGSRV-AVKRLKRSSFQR---KKEFYSEIGRFARLHHPNL 283
           E  R LG  K G  Y         + A+K L ++  ++   + +   E+   + L HPN+
Sbjct: 37  EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 96
Query: 284 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 343
           + + G  +D    Y++ E+   G + R L  + +     D        T LA  +++ H 
Sbjct: 97  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHS 152
Query: 344 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 403
           K    V+HRDI+  N+LL       +   G S   P      R     GT  YL PE + 
Sbjct: 153 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRDDLCGTLDYLPPEMIE 205
Query: 404 RNELTTKSDVYSFGVLLLEIVSGRRPAQA---VDSVCWQSIFEWATPLVQSHRYXXXXXX 460
                 K D++S GVL  E + G+ P +A    ++    S  E+  P             
Sbjct: 206 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----------- 254
Query: 461 XXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVV 500
                        V +   DL+    +H PS RP +  V+
Sbjct: 255 -------------VTEGARDLISRLLKHNPSQRPMLREVL 281

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 76/167 (45%), Gaps = 8/167 (4%)
Query: 276 ARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLA 335
           +RL HP  V +     D    Y    +  NG L +++  I     S D          + 
Sbjct: 84  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG----SFDETCTRFYTAEIV 139
Query: 336 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG 395
             + +LH K    ++HRD++  N+LL+E+    +   G +K +  E  Q R     GT  
Sbjct: 140 SALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 196
Query: 396 YLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS-VCWQSI 441
           Y++PE +        SD+++ G ++ ++V+G  P +A +  + +Q I
Sbjct: 197 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI 243

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/193 (23%), Positives = 93/193 (48%), Gaps = 28/193 (14%)
Query: 248 DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGC--CYDHGDR--------- 296
           DG    +KR+K ++ + ++E    +   A+L H N+V   GC   +D+            
Sbjct: 35  DGKTYVIKRVKYNNEKAERE----VKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRS 90
Query: 297 -----YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 351
                +I  EF   G L++W+    R G  LD  + +++   + +G+ ++H K    +++
Sbjct: 91  KTKCLFIQMEFCDKGTLEQWIE--KRRGEKLDKVLALELFEQITKGVDYIHSK---KLIN 145
Query: 352 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKS 411
           RD++ SN+ L +     +   GL   +  +  + R   + GT  Y++PE +   +   + 
Sbjct: 146 RDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXR---SKGTLRYMSPEQISSQDYGKEV 202
Query: 412 DVYSFGVLLLEIV 424
           D+Y+ G++L E++
Sbjct: 203 DLYALGLILAELL 215

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/235 (28%), Positives = 111/235 (47%), Gaps = 31/235 (13%)
Query: 205 ALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSR----VAVKRLKRS 260
           A+  P WK    E++R I  +F +   +LG   TG     IL +  R    VA+K + + 
Sbjct: 4   AVEGPRWK--QAEDIRDIY-DFRD---VLG---TGAFSEVILAEDKRTQKLVAIKCIAKE 54
Query: 261 SFQRKK-EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL-DRWLHHIPRG 318
           + + K+    +EI    ++ HPN+VA+       G  Y++ + V  G L DR    + +G
Sbjct: 55  ALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKG 111
Query: 319 GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL---LDEEFGAHLMGVGLS 375
             +   A R+     +   + +LHD     +VHRD++  N+L   LDE+    +   GLS
Sbjct: 112 FYTERDASRL--IFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLS 166
Query: 376 KFV-PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           K   P  V+      A GT GY+APE + +   +   D +S GV+   ++ G  P
Sbjct: 167 KMEDPGSVLS----TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/235 (28%), Positives = 111/235 (47%), Gaps = 31/235 (13%)
Query: 205 ALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSR----VAVKRLKRS 260
           A+  P WK    E++R I  +F +   +LG   TG     IL +  R    VA+K + + 
Sbjct: 4   AVEGPRWK--QAEDIRDIY-DFRD---VLG---TGAFSEVILAEDKRTQKLVAIKCIAKE 54
Query: 261 SFQRKK-EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL-DRWLHHIPRG 318
           + + K+    +EI    ++ HPN+VA+       G  Y++ + V  G L DR    + +G
Sbjct: 55  ALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKG 111
Query: 319 GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL---LDEEFGAHLMGVGLS 375
             +   A R+     +   + +LHD     +VHRD++  N+L   LDE+    +   GLS
Sbjct: 112 FYTERDASRL--IFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLS 166
Query: 376 KFV-PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           K   P  V+      A GT GY+APE + +   +   D +S GV+   ++ G  P
Sbjct: 167 KMEDPGSVLS----TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 91/195 (46%), Gaps = 24/195 (12%)
Query: 252 VAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 310
           VAVK LK  +S    ++  SE     +++HP+++ + G C   G   ++ E+   G L  
Sbjct: 56  VAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRG 115
Query: 311 WLHHIPRGG--------------------RSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 350
           +L    + G                    R+L     +  A  ++QG+ +L +     +V
Sbjct: 116 FLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLV 172
Query: 351 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 410
           HRD+ A N+L+ E     +   GLS+ V  E    +         ++A E ++ +  TT+
Sbjct: 173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQ 232
Query: 411 SDVYSFGVLLLEIVS 425
           SDV+SFGVLL EIV+
Sbjct: 233 SDVWSFGVLLWEIVT 247

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 102/224 (45%), Gaps = 22/224 (9%)
Query: 222 ITKNFSEGNRLLGDSKTGGTYSGIL--PDGSR--VAVKRLKR-SSFQRKKEFYSEIGRFA 276
           I +   E  R +G+ + G  + GI   P+     VA+K  K  +S   +++F  E     
Sbjct: 7   IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMR 66
Query: 277 RLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ 336
           +  HP++V + G   ++   +I+ E    G L  +L        SLD A  +  A  L+ 
Sbjct: 67  QFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLST 122
Query: 337 GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT--- 393
            +A+L  K     VHRDI A NVL+       L   GLS++     M++ T         
Sbjct: 123 ALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY-----MEDSTXXKASKGKL 174
Query: 394 -YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDS 435
              ++APE +     T+ SDV+ FGV + EI+  G +P Q V +
Sbjct: 175 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 218

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 91/195 (46%), Gaps = 24/195 (12%)
Query: 252 VAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 310
           VAVK LK  +S    ++  SE     +++HP+++ + G C   G   ++ E+   G L  
Sbjct: 56  VAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRG 115
Query: 311 WLHHIPRGG--------------------RSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 350
           +L    + G                    R+L     +  A  ++QG+ +L +     +V
Sbjct: 116 FLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---SLV 172
Query: 351 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 410
           HRD+ A N+L+ E     +   GLS+ V  E    +         ++A E ++ +  TT+
Sbjct: 173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQ 232
Query: 411 SDVYSFGVLLLEIVS 425
           SDV+SFGVLL EIV+
Sbjct: 233 SDVWSFGVLLWEIVT 247

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 76/167 (45%), Gaps = 8/167 (4%)
Query: 276 ARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLA 335
           +RL HP  V +     D    Y    +  NG L +++  I     S D          + 
Sbjct: 84  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG----SFDETCTRFYTAEIV 139
Query: 336 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG 395
             + +LH K    ++HRD++  N+LL+E+    +   G +K +  E  Q R     GT  
Sbjct: 140 SALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 196
Query: 396 YLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS-VCWQSI 441
           Y++PE +        SD+++ G ++ ++V+G  P +A +  + +Q I
Sbjct: 197 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI 243

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/235 (28%), Positives = 111/235 (47%), Gaps = 31/235 (13%)
Query: 205 ALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSR----VAVKRLKRS 260
           A+  P WK    E++R I  +F +   +LG   TG     IL +  R    VA+K + + 
Sbjct: 4   AVEGPRWK--QAEDIRDIY-DFRD---VLG---TGAFSEVILAEDKRTQKLVAIKCIAKE 54
Query: 261 SFQRKK-EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL-DRWLHHIPRG 318
           + + K+    +EI    ++ HPN+VA+       G  Y++ + V  G L DR    + +G
Sbjct: 55  ALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKG 111
Query: 319 GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL---LDEEFGAHLMGVGLS 375
             +   A R+     +   + +LHD     +VHRD++  N+L   LDE+    +   GLS
Sbjct: 112 FYTERDASRL--IFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLS 166
Query: 376 KFV-PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           K   P  V+      A GT GY+APE + +   +   D +S GV+   ++ G  P
Sbjct: 167 KMEDPGSVLS----TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/270 (24%), Positives = 113/270 (41%), Gaps = 38/270 (14%)
Query: 252 VAVKRLKRSSFQRK-KEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 309
           VAVK LK  + ++   +  SE+     +  H N++ + G C   G  Y++ E+   G L 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLR 129
Query: 310 RWLH-HIPRG-------GRSLDWAMRMKVATT----LAQGIAFLHDKVKPHVVHRDIRAS 357
            +L    P G        R  +  M  K   +    LA+G+ +L  +     +HRD+ A 
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 186
Query: 358 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFG 417
           NVL+ E     +   GL++ +      ++T        ++APE ++    T +SDV+SFG
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 418 VLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQ 476
           VL+ EI + G  P   +       + E    L + HR                  A    
Sbjct: 247 VLMWEIFTLGGSPYPGI------PVEELFKLLKEGHR--------------MDKPANCTN 286
Query: 477 KVVDLVYACTQHVPSMRPRMSHVVHQLQQL 506
           ++  ++  C   VPS RP    +V  L ++
Sbjct: 287 ELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 102/224 (45%), Gaps = 22/224 (9%)
Query: 222 ITKNFSEGNRLLGDSKTGGTYSGIL--PDGSR--VAVKRLKR-SSFQRKKEFYSEIGRFA 276
           I +   E  R +G+ + G  + GI   P+     VA+K  K  +S   +++F  E     
Sbjct: 4   IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMR 63
Query: 277 RLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ 336
           +  HP++V + G   ++   +I+ E    G L  +L        SLD A  +  A  L+ 
Sbjct: 64  QFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLST 119
Query: 337 GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT--- 393
            +A+L  K     VHRDI A NVL+       L   GLS++     M++ T         
Sbjct: 120 ALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY-----MEDSTYYKASKGKL 171
Query: 394 -YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDS 435
              ++APE +     T+ SDV+ FGV + EI+  G +P Q V +
Sbjct: 172 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 215

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/252 (24%), Positives = 118/252 (46%), Gaps = 20/252 (7%)
Query: 209 PSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRV----AVKRLKRSSFQ 263
           PS       +LR + +   +  ++LG    G  Y GI +P+G  V    A+K L  ++  
Sbjct: 22  PSGTAPNQAQLRILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGP 81
Query: 264 RKK-EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLH-HIPRGGRS 321
           +   EF  E    A + HP+LV + G C     + +V + + +G L  ++H H    G  
Sbjct: 82  KANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQ 140
Query: 322 L--DWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP 379
           L  +W ++      +A+G+ +L ++    +VHRD+ A NVL+       +   GL++ + 
Sbjct: 141 LLLNWCVQ------IAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLE 191
Query: 380 WEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCW 438
            +  +           ++A E ++  + T +SDV+S+GV + E+++ G +P   + +   
Sbjct: 192 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI 251
Query: 439 QSIFEWATPLVQ 450
             + E    L Q
Sbjct: 252 PDLLEKGERLPQ 263

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/270 (24%), Positives = 112/270 (41%), Gaps = 38/270 (14%)
Query: 252 VAVKRLKRSSFQRK-KEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 309
           VAVK LK  + +    +  SE+     +  H N++ + G C   G  Y++ E+   G L 
Sbjct: 70  VAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 129
Query: 310 RWLH-HIPRG-------GRSLDWAMRMKVATT----LAQGIAFLHDKVKPHVVHRDIRAS 357
            +L    P G        R  +  M  K   +    LA+G+ +L  +     +HRD+ A 
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 186
Query: 358 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFG 417
           NVL+ E     +   GL++ +      ++T        ++APE ++    T +SDV+SFG
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 418 VLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQ 476
           VL+ EI + G  P   +       + E    L + HR                  A    
Sbjct: 247 VLMWEIFTLGGSPYPGI------PVEELFKLLKEGHR--------------MDKPANCTN 286
Query: 477 KVVDLVYACTQHVPSMRPRMSHVVHQLQQL 506
           ++  ++  C   VPS RP    +V  L ++
Sbjct: 287 ELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/270 (24%), Positives = 112/270 (41%), Gaps = 38/270 (14%)
Query: 252 VAVKRLKRSSFQRK-KEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 309
           VAVK LK  + ++   +  SE+     +  H N++ + G C   G  Y++ E+   G L 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 129
Query: 310 RWLH-HIPRG-------GRSLDWAMRMKVATT----LAQGIAFLHDKVKPHVVHRDIRAS 357
            +L    P G        R  +  M  K   +    LA+G+ +L  +     +HRD+ A 
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 186
Query: 358 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFG 417
           NVL+ E     +   GL++ +      + T        ++APE ++    T +SDV+SFG
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 418 VLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQ 476
           VL+ EI + G  P   +       + E    L + HR                  A    
Sbjct: 247 VLMWEIFTLGGSPYPGI------PVEELFKLLKEGHR--------------MDKPANCTN 286
Query: 477 KVVDLVYACTQHVPSMRPRMSHVVHQLQQL 506
           ++  ++  C   VPS RP    +V  L ++
Sbjct: 287 ELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/271 (23%), Positives = 113/271 (41%), Gaps = 46/271 (16%)
Query: 250 SRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 309
           + V +K L ++     + F+      ++L H +LV   G C+   +  +V EFV  G LD
Sbjct: 41  TEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCFCGDENILVQEFVKFGSLD 100
Query: 310 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL----DEEF 365
            +L    +    ++   +++VA  LA  + FL +     ++H ++ A N+LL    D + 
Sbjct: 101 TYLK---KNKNCINILWKLEVAKQLAWAMHFLEENT---LIHGNVCAKNILLIREEDRKT 154
Query: 366 G----AHLMGVGLS-KFVPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVL 419
           G      L   G+S   +P +++QER         ++ PE +     L   +D +SFG  
Sbjct: 155 GNPPFIKLSDPGISITVLPKDILQERI-------PWVPPECIENPKNLNLATDKWSFGTT 207
Query: 420 LLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQKV 478
           L EI S G +P  A+DS      +E        H+                  A    ++
Sbjct: 208 LWEICSGGDKPLSALDSQRKLQFYE------DRHQL----------------PAPKAAEL 245
Query: 479 VDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 509
            +L+  C  + P  RP    ++  L  L  P
Sbjct: 246 ANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 102/224 (45%), Gaps = 22/224 (9%)
Query: 222 ITKNFSEGNRLLGDSKTGGTYSGIL--PDGSR--VAVKRLKR-SSFQRKKEFYSEIGRFA 276
           I +   E  R +G+ + G  + GI   P+     VA+K  K  +S   +++F  E     
Sbjct: 7   IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMR 66
Query: 277 RLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ 336
           +  HP++V + G   ++   +I+ E    G L  +L        SLD A  +  A  L+ 
Sbjct: 67  QFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLST 122
Query: 337 GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT--- 393
            +A+L  K     VHRDI A NVL+       L   GLS++     M++ T         
Sbjct: 123 ALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY-----MEDSTYYKASKGKL 174
Query: 394 -YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDS 435
              ++APE +     T+ SDV+ FGV + EI+  G +P Q V +
Sbjct: 175 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 218

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 104/221 (47%), Gaps = 36/221 (16%)
Query: 253 AVKRLKRSSFQ--RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL-D 309
           A+K ++++S       +   E+     L HPN++ +     D  + Y+V E    G L D
Sbjct: 66  AIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFD 125
Query: 310 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHL 369
             +H +      +D A+ +K   +   G+ +LH   K ++VHRD++  N+LL+ +    L
Sbjct: 126 EIIHRMKFN--EVDAAVIIKQVLS---GVTYLH---KHNIVHRDLKPENLLLESKEKDAL 177
Query: 370 MGV---GLSK-FVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 425
           + +   GLS  F   + M+ER     GT  Y+APE V R +   K DV+S GV+L  +++
Sbjct: 178 IKIVDFGLSAVFENQKKMKERL----GTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLA 232
Query: 426 GRRP----------------AQAVDSVCWQSIFEWATPLVQ 450
           G  P                    DS  W+++ E A  L++
Sbjct: 233 GYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIK 273

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/235 (28%), Positives = 111/235 (47%), Gaps = 31/235 (13%)
Query: 205 ALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSR----VAVKRLKRS 260
           A+  P WK    E++R I  +F +   +LG   TG     IL +  R    VA+K + + 
Sbjct: 4   AVEGPRWK--QAEDIRDIY-DFRD---VLG---TGAFSEVILAEDKRTQKLVAIKCIAKK 54
Query: 261 SFQRKK-EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL-DRWLHHIPRG 318
           + + K+    +EI    ++ HPN+VA+       G  Y++ + V  G L DR    + +G
Sbjct: 55  ALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKG 111
Query: 319 GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL---LDEEFGAHLMGVGLS 375
             +   A R+     +   + +LHD     +VHRD++  N+L   LDE+    +   GLS
Sbjct: 112 FYTERDASRL--IFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLS 166
Query: 376 KFV-PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           K   P  V+      A GT GY+APE + +   +   D +S GV+   ++ G  P
Sbjct: 167 KMEDPGSVLS----TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 87/183 (47%), Gaps = 13/183 (7%)
Query: 251 RVAVKRL---KRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 307
           +VA+K +    R   +  K F  E+   ++L H N+V++     +    Y+V E++    
Sbjct: 38  KVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPT 97
Query: 308 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA 367
           L  ++     G  S+D A+       +  GI   HD     +VHRDI+  N+L+D     
Sbjct: 98  LSEYIE--SHGPLSVDTAINF--TNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTL 150
Query: 368 HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK-SDVYSFGVLLLEIVSG 426
            +   G++K +  E    +T    GT  Y +PE   + E T + +D+YS G++L E++ G
Sbjct: 151 KIFDFGIAKALS-ETSLTQTNHVLGTVQYFSPEQA-KGEATDECTDIYSIGIVLYEMLVG 208
Query: 427 RRP 429
             P
Sbjct: 209 EPP 211

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 102/224 (45%), Gaps = 22/224 (9%)
Query: 222 ITKNFSEGNRLLGDSKTGGTYSGIL--PDGSR--VAVKRLKR-SSFQRKKEFYSEIGRFA 276
           I +   E  R +G+ + G  + GI   P+     VA+K  K  +S   +++F  E     
Sbjct: 7   IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMR 66
Query: 277 RLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ 336
           +  HP++V + G   ++   +I+ E    G L  +L        SLD A  +  A  L+ 
Sbjct: 67  QFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLST 122
Query: 337 GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT--- 393
            +A+L  K     VHRDI A NVL+       L   GLS++     M++ T         
Sbjct: 123 ALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY-----MEDSTYYKASKGKL 174
Query: 394 -YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDS 435
              ++APE +     T+ SDV+ FGV + EI+  G +P Q V +
Sbjct: 175 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 218

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 85/171 (49%), Gaps = 12/171 (7%)
Query: 265 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDW 324
           + +   E+      + P +V   G  Y  G+  I  E +  G LD+ L    + GR  + 
Sbjct: 51  RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQ 107
Query: 325 AMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 384
            +  KV+  + +G+ +L +K K  ++HRD++ SN+L++      L   G+S  +  E+  
Sbjct: 108 ILG-KVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMAN 164
Query: 385 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGR--RPAQAV 433
           E      GT  Y++PE +     + +SD++S G+ L+E+  GR  RP  A+
Sbjct: 165 EFV----GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPRPPMAI 211

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 102/224 (45%), Gaps = 22/224 (9%)
Query: 222 ITKNFSEGNRLLGDSKTGGTYSGIL--PDGSR--VAVKRLKR-SSFQRKKEFYSEIGRFA 276
           I +   E  R +G+ + G  + GI   P+     VA+K  K  +S   +++F  E     
Sbjct: 35  IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMR 94
Query: 277 RLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ 336
           +  HP++V + G   ++   +I+ E    G L  +L        SLD A  +  A  L+ 
Sbjct: 95  QFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLST 150
Query: 337 GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT--- 393
            +A+L  K     VHRDI A NVL+       L   GLS++     M++ T         
Sbjct: 151 ALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY-----MEDSTYYKASKGKL 202
Query: 394 -YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDS 435
              ++APE +     T+ SDV+ FGV + EI+  G +P Q V +
Sbjct: 203 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 246

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 91/195 (46%), Gaps = 24/195 (12%)
Query: 252 VAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 310
           VAVK LK  +S    ++  SE     +++HP+++ + G C   G   ++ E+   G L  
Sbjct: 56  VAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRG 115
Query: 311 WLHHIPRGG--------------------RSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 350
           +L    + G                    R+L     +  A  ++QG+ +L +     +V
Sbjct: 116 FLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLV 172
Query: 351 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 410
           HRD+ A N+L+ E     +   GLS+ V  E    +         ++A E ++ +  TT+
Sbjct: 173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQ 232
Query: 411 SDVYSFGVLLLEIVS 425
           SDV+SFGVLL EIV+
Sbjct: 233 SDVWSFGVLLWEIVT 247

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 102/224 (45%), Gaps = 22/224 (9%)
Query: 222 ITKNFSEGNRLLGDSKTGGTYSGIL--PDGSR--VAVKRLKR-SSFQRKKEFYSEIGRFA 276
           I +   E  R +G+ + G  + GI   P+     VA+K  K  +S   +++F  E     
Sbjct: 10  IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMR 69
Query: 277 RLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ 336
           +  HP++V + G   ++   +I+ E    G L  +L        SLD A  +  A  L+ 
Sbjct: 70  QFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLST 125
Query: 337 GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT--- 393
            +A+L  K     VHRDI A NVL+       L   GLS++     M++ T         
Sbjct: 126 ALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY-----MEDSTYYKASKGKL 177
Query: 394 -YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDS 435
              ++APE +     T+ SDV+ FGV + EI+  G +P Q V +
Sbjct: 178 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 221

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 102/224 (45%), Gaps = 22/224 (9%)
Query: 222 ITKNFSEGNRLLGDSKTGGTYSGIL--PDGSR--VAVKRLKR-SSFQRKKEFYSEIGRFA 276
           I +   E  R +G+ + G  + GI   P+     VA+K  K  +S   +++F  E     
Sbjct: 9   IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMR 68
Query: 277 RLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ 336
           +  HP++V + G   ++   +I+ E    G L  +L        SLD A  +  A  L+ 
Sbjct: 69  QFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLST 124
Query: 337 GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT--- 393
            +A+L  K     VHRDI A NVL+       L   GLS++     M++ T         
Sbjct: 125 ALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY-----MEDSTYYKASKGKL 176
Query: 394 -YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDS 435
              ++APE +     T+ SDV+ FGV + EI+  G +P Q V +
Sbjct: 177 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 220

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 109/280 (38%), Gaps = 42/280 (15%)
Query: 228 EGNRLLGDSKTGGTYSGILPDGSRV-AVKRLKRSSFQR---KKEFYSEIGRFARLHHPNL 283
           E  R LG  K G  Y         + A+K L ++  ++   + +   E+   + L HPN+
Sbjct: 14  EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 73
Query: 284 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 343
           + + G  +D    Y++ E+   G + R L  + +     D        T LA  +++ H 
Sbjct: 74  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHS 129
Query: 344 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 403
           K    V+HRDI+  N+LL       +   G S   P      R     GT  YL PE + 
Sbjct: 130 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRDDLCGTLDYLPPEMIE 182
Query: 404 RNELTTKSDVYSFGVLLLEIVSGRRPAQA---VDSVCWQSIFEWATPLVQSHRYXXXXXX 460
                 K D++S GVL  E + G+ P +A    ++    S  E+  P             
Sbjct: 183 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----------- 231
Query: 461 XXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVV 500
                        V +   DL+    +H PS RP +  V+
Sbjct: 232 -------------VTEGARDLISRLLKHNPSQRPMLREVL 258

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 102/224 (45%), Gaps = 22/224 (9%)
Query: 222 ITKNFSEGNRLLGDSKTGGTYSGIL--PDGSR--VAVKRLKR-SSFQRKKEFYSEIGRFA 276
           I +   E  R +G+ + G  + GI   P+     VA+K  K  +S   +++F  E     
Sbjct: 12  IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMR 71
Query: 277 RLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ 336
           +  HP++V + G   ++   +I+ E    G L  +L        SLD A  +  A  L+ 
Sbjct: 72  QFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLST 127
Query: 337 GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT--- 393
            +A+L  K     VHRDI A NVL+       L   GLS++     M++ T         
Sbjct: 128 ALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY-----MEDSTYYKASKGKL 179
Query: 394 -YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDS 435
              ++APE +     T+ SDV+ FGV + EI+  G +P Q V +
Sbjct: 180 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 223

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 91/213 (42%), Gaps = 16/213 (7%)
Query: 224 KNFSEGNRLLGDSKTGGTYSGILPDGSRV-AVKRLKRSSFQR---KKEFYSEIGRFARLH 279
           ++F  G R LG  K G  Y         + A+K L ++  ++   + +   E+   + L 
Sbjct: 12  EDFDIG-RPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLR 70
Query: 280 HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA 339
           HPN++ + G  +D    Y++ E+   G + R L  + R     D        T LA  ++
Sbjct: 71  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSR----FDEQRTATYITELANALS 126
Query: 340 FLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAP 399
           + H K    V+HRDI+  N+LL       +   G S   P      R     GT  YL P
Sbjct: 127 YCHSK---RVIHRDIKPENLLLGSNGELKIADFGWSVHAP----SSRRDTLCGTLDYLPP 179
Query: 400 EFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQA 432
           E +       K D++S GVL  E + G  P +A
Sbjct: 180 EMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEA 212

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 92/209 (44%), Gaps = 18/209 (8%)
Query: 231 RLLGDSKTGGTY-SGILPDGSRVAVKRLKRSSFQRKKEFY-----SEIGRFARLHHPNLV 284
           R+LG    G    + +   G   AVK LK+    +  +         I   AR +HP L 
Sbjct: 29  RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLT 87
Query: 285 AVKGCCYDHGDR-YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 343
            +  CC+   DR + V EFV  G L   + HI +  R  D A     A  +   + FLHD
Sbjct: 88  QL-FCCFQTPDRLFFVMEFVNGGDL---MFHIQKS-RRFDEARARFYAAEIISALMFLHD 142
Query: 344 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 403
           K    +++RD++  NVLLD E    L   G+ K      +   T    GT  Y+APE + 
Sbjct: 143 K---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFC--GTPDYIAPEILQ 197
Query: 404 RNELTTKSDVYSFGVLLLEIVSGRRPAQA 432
                   D ++ GVLL E++ G  P +A
Sbjct: 198 EMLYGPAVDWWAMGVLLYEMLCGHAPFEA 226

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 102/224 (45%), Gaps = 22/224 (9%)
Query: 222 ITKNFSEGNRLLGDSKTGGTYSGIL--PD--GSRVAVKRLKR-SSFQRKKEFYSEIGRFA 276
           I +   E  R +G+ + G  + GI   P+     VA+K  K  +S   +++F  E     
Sbjct: 7   IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMR 66
Query: 277 RLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ 336
           +  HP++V + G   ++   +I+ E    G L  +L        SLD A  +  A  L+ 
Sbjct: 67  QFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLST 122
Query: 337 GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT--- 393
            +A+L  K     VHRDI A NVL+       L   GLS++     M++ T         
Sbjct: 123 ALAYLESK---RFVHRDIAARNVLVSATDCVKLGDFGLSRY-----MEDSTYYKASKGKL 174
Query: 394 -YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDS 435
              ++APE +     T+ SDV+ FGV + EI+  G +P Q V +
Sbjct: 175 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 218

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 86/203 (42%), Gaps = 14/203 (6%)
Query: 233 LGDSKTGGTYSGILPDGSRVAV-KRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 291
           LGD   G  Y     + S +A  K +   S +  +++  EI   A   HPN+V +    Y
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 292 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 351
              + +I+ EF   G +D  +  +    R L  +    V       + +LHD     ++H
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLHDN---KIIH 158
Query: 352 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY-----RNE 406
           RD++A N+L   +    L   G+S       +Q R    G  Y ++APE V         
Sbjct: 159 RDLKAGNILFTLDGDIKLADFGVSA-KNTRXIQRRDXFIGTPY-WMAPEVVMCETSKDRP 216
Query: 407 LTTKSDVYSFGVLLLEIVSGRRP 429
              K+DV+S G+ L+E+     P
Sbjct: 217 YDYKADVWSLGITLIEMAEIEPP 239

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 86/178 (48%), Gaps = 10/178 (5%)
Query: 265 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDW 324
           + +   E+      + P +V   G  Y  G+  I  E +  G LD+ L    + GR +  
Sbjct: 110 RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGR-IPE 165
Query: 325 AMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 384
            +  KV+  + +G+ +L +K K  ++HRD++ SN+L++      L   G+S     +++ 
Sbjct: 166 QILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS----GQLID 219
Query: 385 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIF 442
                  GT  Y++PE +     + +SD++S G+ L+E+  GR P    D+   + +F
Sbjct: 220 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMF 277

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 86/203 (42%), Gaps = 14/203 (6%)
Query: 233 LGDSKTGGTYSGILPDGSRVAV-KRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 291
           LGD   G  Y     + S +A  K +   S +  +++  EI   A   HPN+V +    Y
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 292 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 351
              + +I+ EF   G +D  +  +    R L  +    V       + +LHD     ++H
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLHDN---KIIH 158
Query: 352 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY-----RNE 406
           RD++A N+L   +    L   G+S       +Q R    G  Y ++APE V         
Sbjct: 159 RDLKAGNILFTLDGDIKLADFGVSA-KNTRTIQRRDSFIGTPY-WMAPEVVMCETSKDRP 216
Query: 407 LTTKSDVYSFGVLLLEIVSGRRP 429
              K+DV+S G+ L+E+     P
Sbjct: 217 YDYKADVWSLGITLIEMAEIEPP 239

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 95/210 (45%), Gaps = 13/210 (6%)
Query: 224 KNFSEGNRLLGDSKTGGTYSG-ILPDGSRVAVKRLKRSSFQRK---KEFYSEIGRFARLH 279
           ++F  GN LLG     G Y    +  G  VA+K + + +  +    +   +E+    +L 
Sbjct: 11  EDFKVGN-LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK 69
Query: 280 HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA 339
           HP+++ +     D    Y+V E   NG ++R+L +  +     +    M    T   G+ 
Sbjct: 70  HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIIT---GML 126
Query: 340 FLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAP 399
           +LH      ++HRD+  SN+LL       +   GL+     ++  E+     GT  Y++P
Sbjct: 127 YLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLA--TQLKMPHEKHYTLCGTPNYISP 181
Query: 400 EFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           E   R+    +SDV+S G +   ++ GR P
Sbjct: 182 EIATRSAHGLESDVWSLGCMFYTLLIGRPP 211

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 229 GNRLLGDSKTGGTYSGILP-----DGSRVAVKRLKRS---SFQRKKEFYSEIGRFARLHH 280
           G+ +LGD+   GT+  +        G +VAVK L R    S     +   EI       H
Sbjct: 16  GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRH 75
Query: 281 PNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAF 340
           P+++ +        D ++V E+V  G L     +I + GR LD     ++   +  G+ +
Sbjct: 76  PHIIKLYQVISTPSDIFMVMEYVSGGEL---FDYICKNGR-LDEKESRRLFQQILSGVDY 131
Query: 341 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 400
            H  +   VVHRD++  NVLLD    A +   GLS  +      E    + G+  Y APE
Sbjct: 132 CHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD---GEFLRXSCGSPNYAAPE 185
Query: 401 FVY-RNELTTKSDVYSFGVLLLEIVSGRRP 429
            +  R     + D++S GV+L  ++ G  P
Sbjct: 186 VISGRLYAGPEVDIWSSGVILYALLCGTLP 215

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 65/271 (23%), Positives = 112/271 (41%), Gaps = 46/271 (16%)
Query: 250 SRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 309
           + V +K L ++     + F+      ++L H +LV   G C    +  +V EFV  G LD
Sbjct: 41  TEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLD 100
Query: 310 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL----DEEF 365
            +L    +    ++   +++VA  LA  + FL +     ++H ++ A N+LL    D + 
Sbjct: 101 TYLK---KNKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKT 154
Query: 366 G----AHLMGVGLS-KFVPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVL 419
           G      L   G+S   +P +++QER         ++ PE +     L   +D +SFG  
Sbjct: 155 GNPPFIKLSDPGISITVLPKDILQERI-------PWVPPECIENPKNLNLATDKWSFGTT 207
Query: 420 LLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQKV 478
           L EI S G +P  A+DS      +E        H+                  A    ++
Sbjct: 208 LWEICSGGDKPLSALDSQRKLQFYE------DRHQL----------------PAPKAAEL 245
Query: 479 VDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 509
            +L+  C  + P  RP    ++  L  L  P
Sbjct: 246 ANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 85/191 (44%), Gaps = 8/191 (4%)
Query: 248 DGSRVAVKRLKRSSFQR--KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFV 303
           DG  +  K L   S     K+   SE+     L HPN+V       D  +   YIV E+ 
Sbjct: 30  DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYC 89
Query: 304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKP--HVVHRDIRASNVLL 361
             G L   +    +  + LD    ++V T L   +   H +      V+HRD++ +NV L
Sbjct: 90  EGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL 149
Query: 362 DEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLL 421
           D +    L   GL++ +  +    +T +  GT  Y++PE + R     KSD++S G LL 
Sbjct: 150 DGKQNVKLGDFGLARILNHDTSFAKTFV--GTPYYMSPEQMNRMSYNEKSDIWSLGCLLY 207
Query: 422 EIVSGRRPAQA 432
           E+ +   P  A
Sbjct: 208 ELCALMPPFTA 218

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/251 (25%), Positives = 112/251 (44%), Gaps = 18/251 (7%)
Query: 209 PSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRV----AVKRLKR-SSF 262
           PS +      LR + +   +  ++LG    G  Y G+ +P+G +V    A+K L+  +S 
Sbjct: 3   PSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP 62
Query: 263 QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS- 321
           +  KE   E    A + +P++  + G C     + I+        LD    H    G   
Sbjct: 63  KANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQY 122
Query: 322 -LDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 380
            L+W ++      +A+G+ +L D+    +VHRD+ A NVL+       +   GL+K +  
Sbjct: 123 LLNWCVQ------IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 173
Query: 381 EVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQ 439
           E  +           ++A E +     T +SDV+S+GV + E+++ G +P   + +    
Sbjct: 174 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 233
Query: 440 SIFEWATPLVQ 450
           SI E    L Q
Sbjct: 234 SILEKGERLPQ 244

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 78/341 (22%), Positives = 139/341 (40%), Gaps = 84/341 (24%)
Query: 202 AASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGIL-------PDGSRVAV 254
           AA   VP  W+V        IT +     R LG    G  Y G+        P+ +RVA+
Sbjct: 11  AADVYVPDEWEVAR----EKITMS-----RELGQGSFGMVYEGVAKGVVKDEPE-TRVAI 60
Query: 255 KRLKRSSFQRKK-EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLH 313
           K +  ++  R++ EF +E       +  ++V + G         ++ E +  G L  +L 
Sbjct: 61  KTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL- 119
Query: 314 HIPRGGRSLDWAM-------------RMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
                 RSL  AM              +++A  +A G+A+L+       VHRD+ A N +
Sbjct: 120 ------RSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCM 170
Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT----YGYLAPEFVYRNELTTKSDVYSF 416
           + E+F   +   G+++    ++ +      GG       +++PE +     TT SDV+SF
Sbjct: 171 VAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSF 226
Query: 417 GVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVV 475
           GV+L EI +   +P Q + +              Q  R+                  G++
Sbjct: 227 GVVLWEIATLAEQPYQGLSN-------------EQVLRF--------------VMEGGLL 259
Query: 476 QK-------VVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 509
            K       + +L+  C Q+ P MRP    ++  +++  +P
Sbjct: 260 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 77/341 (22%), Positives = 138/341 (40%), Gaps = 84/341 (24%)
Query: 202 AASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGIL-------PDGSRVAV 254
           AA   VP  W+V        IT +     R LG    G  Y G+        P+ +RVA+
Sbjct: 5   AADVYVPDEWEVAR----EKITMS-----RELGQGSFGMVYEGVAKGVVKDEPE-TRVAI 54
Query: 255 KRLKRSSFQRKK-EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLH 313
           K +  ++  R++ EF +E       +  ++V + G         ++ E +  G L  +L 
Sbjct: 55  KTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL- 113
Query: 314 HIPRGGRSLDWAMR-------------MKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
                 RSL   M              +++A  +A G+A+L+       VHRD+ A N +
Sbjct: 114 ------RSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCM 164
Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT----YGYLAPEFVYRNELTTKSDVYSF 416
           + E+F   +   G+++    ++ +      GG       +++PE +     TT SDV+SF
Sbjct: 165 VAEDFTVKIGDFGMTR----DIXETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSF 220
Query: 417 GVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVV 475
           GV+L EI +   +P Q + +              Q  R+                  G++
Sbjct: 221 GVVLWEIATLAEQPYQGLSN-------------EQVLRF--------------VMEGGLL 253
Query: 476 QK-------VVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 509
            K       + +L+  C Q+ P MRP    ++  +++  +P
Sbjct: 254 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 294

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 86/178 (48%), Gaps = 10/178 (5%)
Query: 265 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDW 324
           + +   E+      + P +V   G  Y  G+  I  E +  G LD+ L    + GR  + 
Sbjct: 48  RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQ 104
Query: 325 AMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 384
            +  KV+  + +G+ +L +K K  ++HRD++ SN+L++      L   G+S     +++ 
Sbjct: 105 ILG-KVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS----GQLID 157
Query: 385 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIF 442
                  GT  Y++PE +     + +SD++S G+ L+E+  GR P    D+   + +F
Sbjct: 158 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMF 215

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 86/195 (44%), Gaps = 8/195 (4%)
Query: 233 LGDSKTGGTYSGIL-PDGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCC 290
           +G    G  +SG L  D + VAVK  + +     K +F  E     +  HPN+V + G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 291 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 350
                 YIV E V  G    +L  +   G  L     +++    A G+ +L  K     +
Sbjct: 182 TQKQPIYIVMELVQGG---DFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CI 235
Query: 351 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 410
           HRD+ A N L+ E+    +   G+S+     V      +      + APE +     +++
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRYSSE 295
Query: 411 SDVYSFGVLLLEIVS 425
           SDV+SFG+LL E  S
Sbjct: 296 SDVWSFGILLWETFS 310

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 86/203 (42%), Gaps = 14/203 (6%)
Query: 233 LGDSKTGGTYSGILPDGSRVAV-KRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 291
           LGD   G  Y     + S +A  K +   S +  +++  EI   A   HPN+V +    Y
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 292 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 351
              + +I+ EF   G +D  +  +    R L  +    V       + +LHD     ++H
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLHDN---KIIH 158
Query: 352 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY-----RNE 406
           RD++A N+L   +    L   G+S       +Q R    G  Y ++APE V         
Sbjct: 159 RDLKAGNILFTLDGDIKLADFGVSA-KNTRXIQRRDSFIGTPY-WMAPEVVMCETSKDRP 216
Query: 407 LTTKSDVYSFGVLLLEIVSGRRP 429
              K+DV+S G+ L+E+     P
Sbjct: 217 YDYKADVWSLGITLIEMAEIEPP 239

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 78/341 (22%), Positives = 139/341 (40%), Gaps = 84/341 (24%)
Query: 202 AASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGIL-------PDGSRVAV 254
           AA   VP  W+V        IT +     R LG    G  Y G+        P+ +RVA+
Sbjct: 1   AADVYVPDEWEVAR----EKITMS-----RELGQGSFGMVYEGVAKGVVKDEPE-TRVAI 50
Query: 255 KRLKRSSFQRKK-EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLH 313
           K +  ++  R++ EF +E       +  ++V + G         ++ E +  G L  +L 
Sbjct: 51  KTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL- 109
Query: 314 HIPRGGRSLDWAM-------------RMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
                 RSL  AM              +++A  +A G+A+L+       VHRD+ A N +
Sbjct: 110 ------RSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCM 160
Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT----YGYLAPEFVYRNELTTKSDVYSF 416
           + E+F   +   G+++    ++ +      GG       +++PE +     TT SDV+SF
Sbjct: 161 VAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSF 216
Query: 417 GVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVV 475
           GV+L EI +   +P Q + +              Q  R+                  G++
Sbjct: 217 GVVLWEIATLAEQPYQGLSN-------------EQVLRF--------------VMEGGLL 249
Query: 476 QK-------VVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 509
            K       + +L+  C Q+ P MRP    ++  +++  +P
Sbjct: 250 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 290

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 86/178 (48%), Gaps = 10/178 (5%)
Query: 265 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDW 324
           + +   E+      + P +V   G  Y  G+  I  E +  G LD+ L    + GR  + 
Sbjct: 48  RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQ 104
Query: 325 AMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 384
            +  KV+  + +G+ +L +K K  ++HRD++ SN+L++      L   G+S     +++ 
Sbjct: 105 ILG-KVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS----GQLID 157
Query: 385 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIF 442
                  GT  Y++PE +     + +SD++S G+ L+E+  GR P    D+   + +F
Sbjct: 158 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMF 215

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 66/270 (24%), Positives = 112/270 (41%), Gaps = 38/270 (14%)
Query: 252 VAVKRLKRSSFQRK-KEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 309
           VAVK LK  + ++   +  SE+     +  H N++ + G C   G  Y++  +   G L 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLR 129
Query: 310 RWLH-HIPRG-------GRSLDWAMRMKVATT----LAQGIAFLHDKVKPHVVHRDIRAS 357
            +L    P G        R  +  M  K   +    LA+G+ +L  +     +HRD+ A 
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 186
Query: 358 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFG 417
           NVL+ E     +   GL++ +      ++T        ++APE ++    T +SDV+SFG
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 418 VLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQ 476
           VL+ EI + G  P   +       + E    L + HR                  A    
Sbjct: 247 VLMWEIFTLGGSPYPGI------PVEELFKLLKEGHR--------------MDKPANCTN 286
Query: 477 KVVDLVYACTQHVPSMRPRMSHVVHQLQQL 506
           ++  ++  C   VPS RP    +V  L ++
Sbjct: 287 ELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 86/178 (48%), Gaps = 10/178 (5%)
Query: 265 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDW 324
           + +   E+      + P +V   G  Y  G+  I  E +  G LD+ L    + GR  + 
Sbjct: 48  RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQ 104
Query: 325 AMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 384
            +  KV+  + +G+ +L +K K  ++HRD++ SN+L++      L   G+S     +++ 
Sbjct: 105 ILG-KVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS----GQLID 157
Query: 385 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIF 442
                  GT  Y++PE +     + +SD++S G+ L+E+  GR P    D+   + +F
Sbjct: 158 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMF 215

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 86/178 (48%), Gaps = 10/178 (5%)
Query: 265 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDW 324
           + +   E+      + P +V   G  Y  G+  I  E +  G LD+ L    + GR  + 
Sbjct: 48  RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQ 104
Query: 325 AMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 384
            +  KV+  + +G+ +L +K K  ++HRD++ SN+L++      L   G+S     +++ 
Sbjct: 105 ILG-KVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS----GQLID 157
Query: 385 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIF 442
                  GT  Y++PE +     + +SD++S G+ L+E+  GR P    D+   + +F
Sbjct: 158 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMF 215

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 86/195 (44%), Gaps = 8/195 (4%)
Query: 233 LGDSKTGGTYSGIL-PDGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCC 290
           +G    G  +SG L  D + VAVK  + +     K +F  E     +  HPN+V + G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 291 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 350
                 YIV E V  G    +L  +   G  L     +++    A G+ +L  K     +
Sbjct: 182 TQKQPIYIVMELVQGG---DFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CI 235
Query: 351 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 410
           HRD+ A N L+ E+    +   G+S+     V      +      + APE +     +++
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSE 295
Query: 411 SDVYSFGVLLLEIVS 425
           SDV+SFG+LL E  S
Sbjct: 296 SDVWSFGILLWETFS 310

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 109/241 (45%), Gaps = 18/241 (7%)
Query: 219 LRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRV----AVKRLKR-SSFQRKKEFYSEI 272
           LR + +   +  ++LG    G  Y G+ +P+G +V    A+K L+  +S +  KE   E 
Sbjct: 9   LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 68
Query: 273 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS--LDWAMRMKV 330
              A + +P++  + G C     + I+        LD    H    G    L+W ++   
Sbjct: 69  YVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--- 125
Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 390
              +A+G+ +L D+    +VHRD+ A NVL+       +   GL+K +  E  +      
Sbjct: 126 ---IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 391 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLV 449
                ++A E +     T +SDV+S+GV + E+++ G +P   + +    SI E    L 
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 239
Query: 450 Q 450
           Q
Sbjct: 240 Q 240

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 95/217 (43%), Gaps = 15/217 (6%)
Query: 220 RSITKNFSEGNRLLGDSKTGGTYSGILPDGSR-VAVKRLKRSSFQRK---KEFYSEIGRF 275
           R  T +  E  R LG  K G  Y          VA+K L +S  +++    +   EI   
Sbjct: 18  RHFTIDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQ 77
Query: 276 ARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLA 335
           A LHHPN++ +    YD    Y++ E+   G L + L    +   + D      +   LA
Sbjct: 78  AHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKEL----QKSCTFDEQRTATIMEELA 133
Query: 336 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG 395
             + + H K    V+HRDI+  N+LL  +    +   G S   P   ++ +T+   GT  
Sbjct: 134 DALMYCHGK---KVIHRDIKPENLLLGLKGELKIADFGWSVHAP--SLRRKTMC--GTLD 186
Query: 396 YLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQA 432
           YL PE +       K D++  GVL  E++ G  P ++
Sbjct: 187 YLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFES 223

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 109/241 (45%), Gaps = 18/241 (7%)
Query: 219 LRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRV----AVKRLKR-SSFQRKKEFYSEI 272
           LR + +   +  ++LG    G  Y G+ +P+G +V    A+K L+  +S +  KE   E 
Sbjct: 10  LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 69
Query: 273 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS--LDWAMRMKV 330
              A + +P++  + G C     + I+        LD    H    G    L+W ++   
Sbjct: 70  YVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--- 126
Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 390
              +A+G+ +L D+    +VHRD+ A NVL+       +   GL+K +  E  +      
Sbjct: 127 ---IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 180
Query: 391 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLV 449
                ++A E +     T +SDV+S+GV + E+++ G +P   + +    SI E    L 
Sbjct: 181 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 240
Query: 450 Q 450
           Q
Sbjct: 241 Q 241

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 109/241 (45%), Gaps = 18/241 (7%)
Query: 219 LRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRV----AVKRLKR-SSFQRKKEFYSEI 272
           LR + +   +  ++LG    G  Y G+ +P+G +V    A+K L+  +S +  KE   E 
Sbjct: 10  LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 69
Query: 273 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS--LDWAMRMKV 330
              A + +P++  + G C     + I+        LD    H    G    L+W ++   
Sbjct: 70  YVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQ--- 126
Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 390
              +A+G+ +L D+    +VHRD+ A NVL+       +   GL+K +  E  +      
Sbjct: 127 ---IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 180
Query: 391 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLV 449
                ++A E +     T +SDV+S+GV + E+++ G +P   + +    SI E    L 
Sbjct: 181 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 240
Query: 450 Q 450
           Q
Sbjct: 241 Q 241

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 96/210 (45%), Gaps = 11/210 (5%)
Query: 229 GNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKG 288
           G R+ G    G  Y G       V +  +   + Q+ + F +E+G   +  H N++   G
Sbjct: 13  GQRI-GSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 289 CCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH 348
                    IV ++     L   LH I       +    + +A   AQG+ +LH K    
Sbjct: 72  YS-TKPQLAIVTQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLHAK---S 124
Query: 349 VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY---RN 405
           ++HRD++++N+ L E+    +   GL+          +     G+  ++APE +    +N
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 406 ELTTKSDVYSFGVLLLEIVSGRRPAQAVDS 435
             + +SDVY+FG++L E+++G+ P   +++
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPYSNINN 214

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 77/341 (22%), Positives = 138/341 (40%), Gaps = 84/341 (24%)
Query: 202 AASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGIL-------PDGSRVAV 254
           AA   VP  W+V        IT +     R LG    G  Y G+        P+ +RVA+
Sbjct: 2   AADVFVPDEWEVAR----EKITMS-----RELGQGSFGMVYEGVAKGVVKDEPE-TRVAI 51
Query: 255 KRLKRSSFQRKK-EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLH 313
           K +  ++  R++ EF +E       +  ++V + G         ++ E +  G L  +L 
Sbjct: 52  KTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL- 110
Query: 314 HIPRGGRSLDWAMR-------------MKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
                 RSL   M              +++A  +A G+A+L+       VHRD+ A N +
Sbjct: 111 ------RSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCM 161
Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT----YGYLAPEFVYRNELTTKSDVYSF 416
           + E+F   +   G+++    ++ +      GG       +++PE +     TT SDV+SF
Sbjct: 162 VAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSF 217
Query: 417 GVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVV 475
           GV+L EI +   +P Q + +              Q  R+                  G++
Sbjct: 218 GVVLWEIATLAEQPYQGLSN-------------EQVLRF--------------VMEGGLL 250
Query: 476 QK-------VVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 509
            K       + +L+  C Q+ P MRP    ++  +++  +P
Sbjct: 251 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 291

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 96/210 (45%), Gaps = 11/210 (5%)
Query: 229 GNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKG 288
           G R+ G    G  Y G       V +  +   + Q+ + F +E+G   +  H N++   G
Sbjct: 15  GQRI-GSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 73
Query: 289 CCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH 348
                    IV ++     L   LH I       +    + +A   AQG+ +LH K    
Sbjct: 74  YS-TKPQLAIVTQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLHAK---S 126
Query: 349 VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY---RN 405
           ++HRD++++N+ L E+    +   GL+          +     G+  ++APE +    +N
Sbjct: 127 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 186
Query: 406 ELTTKSDVYSFGVLLLEIVSGRRPAQAVDS 435
             + +SDVY+FG++L E+++G+ P   +++
Sbjct: 187 PYSFQSDVYAFGIVLYELMTGQLPYSNINN 216

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 86/178 (48%), Gaps = 10/178 (5%)
Query: 265 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDW 324
           + +   E+      + P +V   G  Y  G+  I  E +  G LD+ L    + GR  + 
Sbjct: 75  RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQ 131
Query: 325 AMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 384
            +  KV+  + +G+ +L +K K  ++HRD++ SN+L++      L   G+S     +++ 
Sbjct: 132 ILG-KVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS----GQLID 184
Query: 385 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIF 442
                  GT  Y++PE +     + +SD++S G+ L+E+  GR P    D+   + +F
Sbjct: 185 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMF 242

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 83/171 (48%), Gaps = 10/171 (5%)
Query: 265 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDW 324
           + +   E+      + P +V   G  Y  G+  I  E +  G LD+ L    + GR  + 
Sbjct: 48  RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQ 104
Query: 325 AMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 384
            +  KV+  + +G+ +L +K K  ++HRD++ SN+L++      L   G+S     +++ 
Sbjct: 105 ILG-KVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS----GQLID 157
Query: 385 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS 435
                  GT  Y++PE +     + +SD++S G+ L+E+  GR P    D+
Sbjct: 158 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 108/241 (44%), Gaps = 18/241 (7%)
Query: 219 LRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRV----AVKRLKR-SSFQRKKEFYSEI 272
           LR + +   +  ++LG    G  Y G+ +P+G +V    A+K L+  +S +  KE   E 
Sbjct: 9   LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 68
Query: 273 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS--LDWAMRMKV 330
              A + +P++  + G C     + I         LD    H    G    L+W ++   
Sbjct: 69  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--- 125
Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 390
              +A+G+ +L D+    +VHRD+ A NVL+       +   GL+K +  E  +      
Sbjct: 126 ---IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 391 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLV 449
                ++A E +     T +SDV+S+GV + E+++ G +P   + +    SI E    L 
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 239
Query: 450 Q 450
           Q
Sbjct: 240 Q 240

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 109/241 (45%), Gaps = 18/241 (7%)
Query: 219 LRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRV----AVKRLKR-SSFQRKKEFYSEI 272
           LR + +   +  ++LG    G  Y G+ +P+G +V    A+K L+  +S +  KE   E 
Sbjct: 11  LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 70
Query: 273 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS--LDWAMRMKV 330
              A + +P++  + G C     + I+        LD    H    G    L+W ++   
Sbjct: 71  YVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--- 127
Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 390
              +A+G+ +L D+    +VHRD+ A NVL+       +   GL+K +  E  +      
Sbjct: 128 ---IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 181
Query: 391 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLV 449
                ++A E +     T +SDV+S+GV + E+++ G +P   + +    SI E    L 
Sbjct: 182 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 241
Query: 450 Q 450
           Q
Sbjct: 242 Q 242

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 94/206 (45%), Gaps = 10/206 (4%)
Query: 233 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 292
           +G    G  Y G       V +  +   + Q+ + F +E+G   +  H N++   G    
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T 79
Query: 293 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 352
                IV ++     L   LH I       +    + +A   AQG+ +LH K    ++HR
Sbjct: 80  KPQLAIVTQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLHAK---SIIHR 133
Query: 353 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY---RNELTT 409
           D++++N+ L E+    +   GL+          +     G+  ++APE +    +N  + 
Sbjct: 134 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 193
Query: 410 KSDVYSFGVLLLEIVSGRRPAQAVDS 435
           +SDVY+FG++L E+++G+ P   +++
Sbjct: 194 QSDVYAFGIVLYELMTGQLPYSNINN 219

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 98/211 (46%), Gaps = 13/211 (6%)
Query: 229 GNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKG 288
           G R+ G    G  Y G       V +  +   + Q+ + F +E+G   +  H N++   G
Sbjct: 13  GQRI-GSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 289 CCYDHGDRY-IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKP 347
             Y    +  IV ++     L   LH I       +    + +A   AQG+ +LH K   
Sbjct: 72  --YSTAPQLAIVTQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLHAK--- 123
Query: 348 HVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY---R 404
            ++HRD++++N+ L E+    +   GL+          +     G+  ++APE +    +
Sbjct: 124 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183
Query: 405 NELTTKSDVYSFGVLLLEIVSGRRPAQAVDS 435
           N  + +SDVY+FG++L E+++G+ P   +++
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQLPYSNINN 214

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 109/241 (45%), Gaps = 18/241 (7%)
Query: 219 LRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRV----AVKRLKR-SSFQRKKEFYSEI 272
           LR + +   +  ++LG    G  Y G+ +P+G +V    A+K L+  +S +  KE   E 
Sbjct: 12  LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 71
Query: 273 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS--LDWAMRMKV 330
              A + +P++  + G C     + I+        LD    H    G    L+W ++   
Sbjct: 72  YVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--- 128
Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 390
              +A+G+ +L D+    +VHRD+ A NVL+       +   GL+K +  E  +      
Sbjct: 129 ---IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 182
Query: 391 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLV 449
                ++A E +     T +SDV+S+GV + E+++ G +P   + +    SI E    L 
Sbjct: 183 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 242
Query: 450 Q 450
           Q
Sbjct: 243 Q 243

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 60/243 (24%), Positives = 116/243 (47%), Gaps = 20/243 (8%)
Query: 218 ELRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRV----AVKRLKRSSFQRKK-EFYSE 271
           +LR + +   +  ++LG    G  Y GI +P+G  V    A+K L  ++  +   EF  E
Sbjct: 8   QLRILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDE 67
Query: 272 IGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLH-HIPRGGRSL--DWAMRM 328
               A + HP+LV + G C     + +V + + +G L  ++H H    G  L  +W ++ 
Sbjct: 68  ALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQ- 125
Query: 329 KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 388
                +A+G+ +L ++    +VHRD+ A NVL+       +   GL++ +  +  +    
Sbjct: 126 -----IAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNAD 177
Query: 389 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATP 447
                  ++A E ++  + T +SDV+S+GV + E+++ G +P   + +     + E    
Sbjct: 178 GGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGER 237
Query: 448 LVQ 450
           L Q
Sbjct: 238 LPQ 240

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 101/223 (45%), Gaps = 22/223 (9%)
Query: 221 SITKNFSEGNRLLGDSKTGGTYSGIL--PDGSR--VAVKRLKR-SSFQRKKEFYSEIGRF 275
            I +   E  R +G+ + G  + GI   P+     VA+K  K  +S   +++F  E    
Sbjct: 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 445
Query: 276 ARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLA 335
            +  HP++V + G   ++   +I+ E    G L  +L        SLD A  +  A  L+
Sbjct: 446 RQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQ---VRKFSLDLASLILYAYQLS 501
Query: 336 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT-- 393
             +A+L  K     VHRDI A NVL+       L   GLS++     M++ T        
Sbjct: 502 TALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY-----MEDSTYYKASKGK 553
Query: 394 --YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAV 433
               ++APE +     T+ SDV+ FGV + EI+  G +P Q V
Sbjct: 554 LPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 596

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 94/206 (45%), Gaps = 10/206 (4%)
Query: 233 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 292
           +G    G  Y G       V +  +   + Q+ + F +E+G   +  H N++   G    
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T 79
Query: 293 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 352
                IV ++     L   LH I       +    + +A   AQG+ +LH K    ++HR
Sbjct: 80  KPQLAIVTQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLHAK---SIIHR 133
Query: 353 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY---RNELTT 409
           D++++N+ L E+    +   GL+          +     G+  ++APE +    +N  + 
Sbjct: 134 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 193
Query: 410 KSDVYSFGVLLLEIVSGRRPAQAVDS 435
           +SDVY+FG++L E+++G+ P   +++
Sbjct: 194 QSDVYAFGIVLYELMTGQLPYSNINN 219

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 94/202 (46%), Gaps = 25/202 (12%)
Query: 240 GTYSGILPDGSRV-----AVKRLKRSSFQRKKE--FYSEIGRFARLHHPNLVAVKGCCYD 292
           G++  +L    R+     AVK + ++S + K       E+    +L HPN++ +     D
Sbjct: 33  GSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED 92
Query: 293 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 352
               YIV E    G L  +   I R   S   A R  +   +  GI ++H   K ++VHR
Sbjct: 93  SSSFYIVGELYTGGEL--FDEIIKRKRFSEHDAAR--IIKQVFSGITYMH---KHNIVHR 145
Query: 353 DIRASNVLL---DEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNEL 407
           D++  N+LL   +++    ++  GLS        Q+ T M    GT  Y+APE V R   
Sbjct: 146 DLKPENILLESKEKDCDIKIIDFGLST-----CFQQNTKMKDRIGTAYYIAPE-VLRGTY 199
Query: 408 TTKSDVYSFGVLLLEIVSGRRP 429
             K DV+S GV+L  ++SG  P
Sbjct: 200 DEKCDVWSAGVILYILLSGTPP 221

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 108/241 (44%), Gaps = 18/241 (7%)
Query: 219 LRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRV----AVKRLKR-SSFQRKKEFYSEI 272
           LR + +   +  ++LG    G  Y G+ +P+G +V    A+K L+  +S +  KE   E 
Sbjct: 9   LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 68
Query: 273 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS--LDWAMRMKV 330
              A + +P++  + G C     + I         LD    H    G    L+W ++   
Sbjct: 69  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQ--- 125
Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 390
              +A+G+ +L D+    +VHRD+ A NVL+       +   GL+K +  E  +      
Sbjct: 126 ---IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 391 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLV 449
                ++A E +     T +SDV+S+GV + E+++ G +P   + +    SI E    L 
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 239
Query: 450 Q 450
           Q
Sbjct: 240 Q 240

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 108/241 (44%), Gaps = 18/241 (7%)
Query: 219 LRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRV----AVKRLKR-SSFQRKKEFYSEI 272
           LR + +   +  ++LG    G  Y G+ +P+G +V    A+K L+  +S +  KE   E 
Sbjct: 9   LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 68
Query: 273 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS--LDWAMRMKV 330
              A + +P++  + G C     + I         LD    H    G    L+W ++   
Sbjct: 69  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--- 125
Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 390
              +A+G+ +L D+    +VHRD+ A NVL+       +   GL+K +  E  +      
Sbjct: 126 ---IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 391 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLV 449
                ++A E +     T +SDV+S+GV + E+++ G +P   + +    SI E    L 
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 239
Query: 450 Q 450
           Q
Sbjct: 240 Q 240

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 95/201 (47%), Gaps = 23/201 (11%)
Query: 240 GTYSGILPDGSRV-----AVKRLKRSSFQRKKE--FYSEIGRFARLHHPNLVAVKGCCYD 292
           G++  +L    R+     AVK + ++S + K       E+    +L HPN++ +     D
Sbjct: 33  GSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED 92
Query: 293 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 352
               YIV E    G L  +   I R   S   A R  +   +  GI ++H   K ++VHR
Sbjct: 93  SSSFYIVGELYTGGEL--FDEIIKRKRFSEHDAAR--IIKQVFSGITYMH---KHNIVHR 145
Query: 353 DIRASNVLL---DEEFGAHLMGVGLSK-FVPWEVMQERTVMAGGTYGYLAPEFVYRNELT 408
           D++  N+LL   +++    ++  GLS  F     M++R     GT  Y+APE V R    
Sbjct: 146 DLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI----GTAYYIAPE-VLRGTYD 200
Query: 409 TKSDVYSFGVLLLEIVSGRRP 429
            K DV+S GV+L  ++SG  P
Sbjct: 201 EKCDVWSAGVILYILLSGTPP 221

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 66/270 (24%), Positives = 112/270 (41%), Gaps = 38/270 (14%)
Query: 252 VAVKRLKRSSFQRK-KEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 309
           VAVK LK  + ++   +  SE+     +  H N++ + G C   G  Y++  +   G L 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLR 129
Query: 310 RWLH-HIPRG-------GRSLDWAMRMKVATT----LAQGIAFLHDKVKPHVVHRDIRAS 357
            +L    P G        R  +  M  K   +    LA+G+ +L  +     +HRD+ A 
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 186
Query: 358 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFG 417
           NVL+ E     +   GL++ +      ++T        ++APE ++    T +SDV+SFG
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 418 VLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQ 476
           VL+ EI + G  P   +       + E    L + HR                  A    
Sbjct: 247 VLMWEIFTLGGSPYPGI------PVEELFKLLKEGHR--------------MDKPANCTN 286
Query: 477 KVVDLVYACTQHVPSMRPRMSHVVHQLQQL 506
           ++  ++  C   VPS RP    +V  L ++
Sbjct: 287 ELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 94/202 (46%), Gaps = 25/202 (12%)
Query: 240 GTYSGILPDGSRV-----AVKRLKRSSFQRKKE--FYSEIGRFARLHHPNLVAVKGCCYD 292
           G++  +L    R+     AVK + ++S + K       E+    +L HPN++ +     D
Sbjct: 33  GSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED 92
Query: 293 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 352
               YIV E    G L  +   I R   S   A R  +   +  GI ++H   K ++VHR
Sbjct: 93  SSSFYIVGELYTGGEL--FDEIIKRKRFSEHDAAR--IIKQVFSGITYMH---KHNIVHR 145
Query: 353 DIRASNVLL---DEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNEL 407
           D++  N+LL   +++    ++  GLS        Q+ T M    GT  Y+APE V R   
Sbjct: 146 DLKPENILLESKEKDCDIKIIDFGLST-----CFQQNTKMKDRIGTAYYIAPE-VLRGTY 199
Query: 408 TTKSDVYSFGVLLLEIVSGRRP 429
             K DV+S GV+L  ++SG  P
Sbjct: 200 DEKCDVWSAGVILYILLSGTPP 221

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 108/241 (44%), Gaps = 18/241 (7%)
Query: 219 LRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRV----AVKRLKR-SSFQRKKEFYSEI 272
           LR + +   +  ++LG    G  Y G+ +P+G +V    A+K L+  +S +  KE   E 
Sbjct: 6   LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 65
Query: 273 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS--LDWAMRMKV 330
              A + +P++  + G C     + I         LD    H    G    L+W ++   
Sbjct: 66  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--- 122
Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 390
              +A+G+ +L D+    +VHRD+ A NVL+       +   GL+K +  E  +      
Sbjct: 123 ---IAEGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 176
Query: 391 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLV 449
                ++A E +     T +SDV+S+GV + E+++ G +P   + +    SI E    L 
Sbjct: 177 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 236
Query: 450 Q 450
           Q
Sbjct: 237 Q 237

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 108/241 (44%), Gaps = 18/241 (7%)
Query: 219 LRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRV----AVKRLKR-SSFQRKKEFYSEI 272
           LR + +   +  ++LG    G  Y G+ +P+G +V    A+K L+  +S +  KE   E 
Sbjct: 15  LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 74
Query: 273 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS--LDWAMRMKV 330
              A + +P++  + G C     + I         LD    H    G    L+W ++   
Sbjct: 75  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--- 131
Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 390
              +A+G+ +L D+    +VHRD+ A NVL+       +   GL+K +  E  +      
Sbjct: 132 ---IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 185
Query: 391 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLV 449
                ++A E +     T +SDV+S+GV + E+++ G +P   + +    SI E    L 
Sbjct: 186 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 245
Query: 450 Q 450
           Q
Sbjct: 246 Q 246

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 108/241 (44%), Gaps = 18/241 (7%)
Query: 219 LRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRV----AVKRLKR-SSFQRKKEFYSEI 272
           LR + +   +  ++LG    G  Y G+ +P+G +V    A+K L+  +S +  KE   E 
Sbjct: 11  LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 70
Query: 273 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS--LDWAMRMKV 330
              A + +P++  + G C     + I         LD    H    G    L+W ++   
Sbjct: 71  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--- 127
Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 390
              +A+G+ +L D+    +VHRD+ A NVL+       +   GL+K +  E  +      
Sbjct: 128 ---IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 181
Query: 391 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLV 449
                ++A E +     T +SDV+S+GV + E+++ G +P   + +    SI E    L 
Sbjct: 182 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 241
Query: 450 Q 450
           Q
Sbjct: 242 Q 242

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 108/241 (44%), Gaps = 18/241 (7%)
Query: 219 LRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRV----AVKRLKR-SSFQRKKEFYSEI 272
           LR + +   +  ++LG    G  Y G+ +P+G +V    A+K L+  +S +  KE   E 
Sbjct: 19  LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 78
Query: 273 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS--LDWAMRMKV 330
              A + +P++  + G C     + I         LD    H    G    L+W ++   
Sbjct: 79  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--- 135
Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 390
              +A+G+ +L D+    +VHRD+ A NVL+       +   GL+K +  E  +      
Sbjct: 136 ---IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 189
Query: 391 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLV 449
                ++A E +     T +SDV+S+GV + E+++ G +P   + +    SI E    L 
Sbjct: 190 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 249
Query: 450 Q 450
           Q
Sbjct: 250 Q 250

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 108/241 (44%), Gaps = 18/241 (7%)
Query: 219 LRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRV----AVKRLKR-SSFQRKKEFYSEI 272
           LR + +   +  ++LG    G  Y G+ +P+G +V    A+K L+  +S +  KE   E 
Sbjct: 12  LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 71
Query: 273 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS--LDWAMRMKV 330
              A + +P++  + G C     + I         LD    H    G    L+W ++   
Sbjct: 72  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--- 128
Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 390
              +A+G+ +L D+    +VHRD+ A NVL+       +   GL+K +  E  +      
Sbjct: 129 ---IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 182
Query: 391 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLV 449
                ++A E +     T +SDV+S+GV + E+++ G +P   + +    SI E    L 
Sbjct: 183 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 242
Query: 450 Q 450
           Q
Sbjct: 243 Q 243

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 108/241 (44%), Gaps = 18/241 (7%)
Query: 219 LRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRV----AVKRLKR-SSFQRKKEFYSEI 272
           LR + +   +  ++LG    G  Y G+ +P+G +V    A+K L+  +S +  KE   E 
Sbjct: 12  LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 71
Query: 273 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS--LDWAMRMKV 330
              A + +P++  + G C     + I         LD    H    G    L+W ++   
Sbjct: 72  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--- 128
Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 390
              +A+G+ +L D+    +VHRD+ A NVL+       +   GL+K +  E  +      
Sbjct: 129 ---IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 182
Query: 391 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLV 449
                ++A E +     T +SDV+S+GV + E+++ G +P   + +    SI E    L 
Sbjct: 183 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 242
Query: 450 Q 450
           Q
Sbjct: 243 Q 243

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 77/341 (22%), Positives = 138/341 (40%), Gaps = 84/341 (24%)
Query: 202 AASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGIL-------PDGSRVAV 254
           AA   VP  W+V        IT +     R LG    G  Y G+        P+ +RVA+
Sbjct: 11  AADVYVPDEWEVAR----EKITMS-----RELGQGSFGMVYEGVAKGVVKDEPE-TRVAI 60
Query: 255 KRLKRSSFQRKK-EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLH 313
           K +  ++  R++ EF +E       +  ++V + G         ++ E +  G L  +L 
Sbjct: 61  KTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL- 119
Query: 314 HIPRGGRSLDWAMR-------------MKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
                 RSL   M              +++A  +A G+A+L+       VHRD+ A N +
Sbjct: 120 ------RSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCM 170
Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT----YGYLAPEFVYRNELTTKSDVYSF 416
           + E+F   +   G+++    ++ +      GG       +++PE +     TT SDV+SF
Sbjct: 171 VAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSF 226
Query: 417 GVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVV 475
           GV+L EI +   +P Q + +              Q  R+                  G++
Sbjct: 227 GVVLWEIATLAEQPYQGLSN-------------EQVLRF--------------VMEGGLL 259
Query: 476 QK-------VVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 509
            K       + +L+  C Q+ P MRP    ++  +++  +P
Sbjct: 260 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 108/241 (44%), Gaps = 18/241 (7%)
Query: 219 LRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRV----AVKRLKR-SSFQRKKEFYSEI 272
           LR + +   +  ++LG    G  Y G+ +P+G +V    A+K L+  +S +  KE   E 
Sbjct: 16  LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 75
Query: 273 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS--LDWAMRMKV 330
              A + +P++  + G C     + I         LD    H    G    L+W ++   
Sbjct: 76  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--- 132
Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 390
              +A+G+ +L D+    +VHRD+ A NVL+       +   GL+K +  E  +      
Sbjct: 133 ---IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 186
Query: 391 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLV 449
                ++A E +     T +SDV+S+GV + E+++ G +P   + +    SI E    L 
Sbjct: 187 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 246
Query: 450 Q 450
           Q
Sbjct: 247 Q 247

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 108/241 (44%), Gaps = 18/241 (7%)
Query: 219 LRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRV----AVKRLKR-SSFQRKKEFYSEI 272
           LR + +   +  ++LG    G  Y G+ +P+G +V    A+K L+  +S +  KE   E 
Sbjct: 12  LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 71
Query: 273 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS--LDWAMRMKV 330
              A + +P++  + G C     + I         LD    H    G    L+W ++   
Sbjct: 72  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--- 128
Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 390
              +A+G+ +L D+    +VHRD+ A NVL+       +   GL+K +  E  +      
Sbjct: 129 ---IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 182
Query: 391 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLV 449
                ++A E +     T +SDV+S+GV + E+++ G +P   + +    SI E    L 
Sbjct: 183 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 242
Query: 450 Q 450
           Q
Sbjct: 243 Q 243

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 77/341 (22%), Positives = 138/341 (40%), Gaps = 84/341 (24%)
Query: 202 AASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGIL-------PDGSRVAV 254
           AA   VP  W+V        IT +     R LG    G  Y G+        P+ +RVA+
Sbjct: 5   AADVYVPDEWEVAR----EKITMS-----RELGQGSFGMVYEGVAKGVVKDEPE-TRVAI 54
Query: 255 KRLKRSSFQRKK-EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLH 313
           K +  ++  R++ EF +E       +  ++V + G         ++ E +  G L  +L 
Sbjct: 55  KTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL- 113
Query: 314 HIPRGGRSLDWAMR-------------MKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
                 RSL   M              +++A  +A G+A+L+       VHRD+ A N +
Sbjct: 114 ------RSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCM 164
Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT----YGYLAPEFVYRNELTTKSDVYSF 416
           + E+F   +   G+++    ++ +      GG       +++PE +     TT SDV+SF
Sbjct: 165 VAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSF 220
Query: 417 GVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVV 475
           GV+L EI +   +P Q + +              Q  R+                  G++
Sbjct: 221 GVVLWEIATLAEQPYQGLSN-------------EQVLRF--------------VMEGGLL 253
Query: 476 QK-------VVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 509
            K       + +L+  C Q+ P MRP    ++  +++  +P
Sbjct: 254 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 294

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 108/241 (44%), Gaps = 18/241 (7%)
Query: 219 LRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRV----AVKRLKR-SSFQRKKEFYSEI 272
           LR + +   +  ++LG    G  Y G+ +P+G +V    A+K L+  +S +  KE   E 
Sbjct: 3   LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 62
Query: 273 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS--LDWAMRMKV 330
              A + +P++  + G C     + I         LD    H    G    L+W ++   
Sbjct: 63  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--- 119
Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 390
              +A+G+ +L D+    +VHRD+ A NVL+       +   GL+K +  E  +      
Sbjct: 120 ---IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 173
Query: 391 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLV 449
                ++A E +     T +SDV+S+GV + E+++ G +P   + +    SI E    L 
Sbjct: 174 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 233
Query: 450 Q 450
           Q
Sbjct: 234 Q 234

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 108/241 (44%), Gaps = 18/241 (7%)
Query: 219 LRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRV----AVKRLKR-SSFQRKKEFYSEI 272
           LR + +   +  ++LG    G  Y G+ +P+G +V    A+K L+  +S +  KE   E 
Sbjct: 34  LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 93
Query: 273 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS--LDWAMRMKV 330
              A + +P++  + G C     + I         LD    H    G    L+W ++   
Sbjct: 94  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--- 150
Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 390
              +A+G+ +L D+    +VHRD+ A NVL+       +   GL+K +  E  +      
Sbjct: 151 ---IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 204
Query: 391 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLV 449
                ++A E +     T +SDV+S+GV + E+++ G +P   + +    SI E    L 
Sbjct: 205 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 264
Query: 450 Q 450
           Q
Sbjct: 265 Q 265

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 97/207 (46%), Gaps = 12/207 (5%)
Query: 233 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 292
           +G    G  Y G       V +  +   + Q+ + F +E+G   +  H N++   G    
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T 74
Query: 293 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 352
                IV ++     L   LH I       +    + +A   AQG+ +LH K    ++HR
Sbjct: 75  KPQLAIVTQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLHAK---SIIHR 128
Query: 353 DIRASNVLLDEEFGAHLMGVGL-SKFVPWEVMQERTVMAGGTYGYLAPEFVY---RNELT 408
           D++++N+ L E+    +   GL ++   W    +   ++G    ++APE +    +N  +
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSIL-WMAPEVIRMQDKNPYS 187
Query: 409 TKSDVYSFGVLLLEIVSGRRPAQAVDS 435
            +SDVY+FG++L E+++G+ P   +++
Sbjct: 188 FQSDVYAFGIVLYELMTGQLPYSNINN 214

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 101/223 (45%), Gaps = 22/223 (9%)
Query: 221 SITKNFSEGNRLLGDSKTGGTYSGIL--PDGSR--VAVKRLKR-SSFQRKKEFYSEIGRF 275
            I +   E  R +G+ + G  + GI   P+     VA+K  K  +S   +++F  E    
Sbjct: 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 445
Query: 276 ARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLA 335
            +  HP++V + G   ++   +I+ E    G L  +L        SLD A  +  A  L+
Sbjct: 446 RQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQ---VRKFSLDLASLILYAYQLS 501
Query: 336 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT-- 393
             +A+L  K     VHRDI A NVL+       L   GLS++     M++ T        
Sbjct: 502 TALAYLESK---RFVHRDIAARNVLVSATDCVKLGDFGLSRY-----MEDSTYYKASKGK 553
Query: 394 --YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAV 433
               ++APE +     T+ SDV+ FGV + EI+  G +P Q V
Sbjct: 554 LPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 596

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 77/341 (22%), Positives = 138/341 (40%), Gaps = 84/341 (24%)
Query: 202 AASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGIL-------PDGSRVAV 254
           AA   VP  W+V        IT +     R LG    G  Y G+        P+ +RVA+
Sbjct: 4   AADVYVPDEWEVAR----EKITMS-----RELGQGSFGMVYEGVAKGVVKDEPE-TRVAI 53
Query: 255 KRLKRSSFQRKK-EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLH 313
           K +  ++  R++ EF +E       +  ++V + G         ++ E +  G L  +L 
Sbjct: 54  KTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL- 112
Query: 314 HIPRGGRSLDWAMR-------------MKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
                 RSL   M              +++A  +A G+A+L+       VHRD+ A N +
Sbjct: 113 ------RSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCM 163
Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT----YGYLAPEFVYRNELTTKSDVYSF 416
           + E+F   +   G+++    ++ +      GG       +++PE +     TT SDV+SF
Sbjct: 164 VAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSF 219
Query: 417 GVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVV 475
           GV+L EI +   +P Q + +              Q  R+                  G++
Sbjct: 220 GVVLWEIATLAEQPYQGLSN-------------EQVLRF--------------VMEGGLL 252
Query: 476 QK-------VVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 509
            K       + +L+  C Q+ P MRP    ++  +++  +P
Sbjct: 253 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 293

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 77/341 (22%), Positives = 138/341 (40%), Gaps = 84/341 (24%)
Query: 202 AASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGIL-------PDGSRVAV 254
           AA   VP  W+V        IT +     R LG    G  Y G+        P+ +RVA+
Sbjct: 4   AADVYVPDEWEVAR----EKITMS-----RELGQGSFGMVYEGVAKGVVKDEPE-TRVAI 53
Query: 255 KRLKRSSFQRKK-EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLH 313
           K +  ++  R++ EF +E       +  ++V + G         ++ E +  G L  +L 
Sbjct: 54  KTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL- 112
Query: 314 HIPRGGRSLDWAMR-------------MKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
                 RSL   M              +++A  +A G+A+L+       VHRD+ A N +
Sbjct: 113 ------RSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCM 163
Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT----YGYLAPEFVYRNELTTKSDVYSF 416
           + E+F   +   G+++    ++ +      GG       +++PE +     TT SDV+SF
Sbjct: 164 VAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSF 219
Query: 417 GVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVV 475
           GV+L EI +   +P Q + +              Q  R+                  G++
Sbjct: 220 GVVLWEIATLAEQPYQGLSN-------------EQVLRF--------------VMEGGLL 252
Query: 476 QK-------VVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 509
            K       + +L+  C Q+ P MRP    ++  +++  +P
Sbjct: 253 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 293

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/206 (22%), Positives = 93/206 (45%), Gaps = 41/206 (19%)
Query: 248 DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGC------------------ 289
           DG    ++R+K ++ + ++E    +   A+L H N+V   GC                  
Sbjct: 36  DGKTYVIRRVKYNNEKAERE----VKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESS 91
Query: 290 CYDHGDR-----------YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGI 338
            YD  +            +I  EF   G L++W+    R G  LD  + +++   + +G+
Sbjct: 92  DYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIE--KRRGEKLDKVLALELFEQITKGV 149
Query: 339 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLA 398
            ++H K    ++HRD++ SN+ L +     +   GL   +  +  + R   + GT  Y++
Sbjct: 150 DYIHSK---KLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTR---SKGTLRYMS 203
Query: 399 PEFVYRNELTTKSDVYSFGVLLLEIV 424
           PE +   +   + D+Y+ G++L E++
Sbjct: 204 PEQISSQDYGKEVDLYALGLILAELL 229

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 92/189 (48%), Gaps = 12/189 (6%)
Query: 252 VAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 309
           VAVK L  +  + Q+ + F +E+G   +  H N++   G         IV ++     L 
Sbjct: 60  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TKPQLAIVTQWCEGSSLY 118
Query: 310 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHL 369
             LH I       +    + +A   AQG+ +LH K    ++HRD++++N+ L E+    +
Sbjct: 119 HHLHIIET---KFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKI 172
Query: 370 MGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY---RNELTTKSDVYSFGVLLLEIVSG 426
              GL+          +     G+  ++APE +    +N  + +SDVY+FG++L E+++G
Sbjct: 173 GDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTG 232
Query: 427 RRPAQAVDS 435
           + P   +++
Sbjct: 233 QLPYSNINN 241

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 92/189 (48%), Gaps = 12/189 (6%)
Query: 252 VAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 309
           VAVK L  +  + Q+ + F +E+G   +  H N++   G         IV ++     L 
Sbjct: 61  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TKPQLAIVTQWCEGSSLY 119
Query: 310 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHL 369
             LH I       +    + +A   AQG+ +LH K    ++HRD++++N+ L E+    +
Sbjct: 120 HHLHIIET---KFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKI 173
Query: 370 MGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY---RNELTTKSDVYSFGVLLLEIVSG 426
              GL+          +     G+  ++APE +    +N  + +SDVY+FG++L E+++G
Sbjct: 174 GDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTG 233
Query: 427 RRPAQAVDS 435
           + P   +++
Sbjct: 234 QLPYSNINN 242

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 77/341 (22%), Positives = 139/341 (40%), Gaps = 84/341 (24%)
Query: 202 AASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGIL-------PDGSRVAV 254
           AA   VP  W+V   +    IT +     R LG    G  Y G+        P+ +RVA+
Sbjct: 33  AADVYVPDEWEVAREK----ITMS-----RELGQGSFGMVYEGVAKGVVKDEPE-TRVAI 82
Query: 255 KRLKRSSFQRKK-EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLH 313
           K +  ++  R++ EF +E       +  ++V + G         ++ E +  G L  +L 
Sbjct: 83  KTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL- 141
Query: 314 HIPRGGRSLDWAMR-------------MKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
                 RSL   M              +++A  +A G+A+L+       VHRD+ A N +
Sbjct: 142 ------RSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCM 192
Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT----YGYLAPEFVYRNELTTKSDVYSF 416
           + E+F   +   G+++    ++ +      GG       +++PE +     TT SDV+SF
Sbjct: 193 VAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSF 248
Query: 417 GVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXXXXXAGVV 475
           GV+L EI +   +P Q + +              Q  R+                  G++
Sbjct: 249 GVVLWEIATLAEQPYQGLSN-------------EQVLRF--------------VMEGGLL 281
Query: 476 QK-------VVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 509
            K       + +L+  C Q+ P MRP    ++  +++  +P
Sbjct: 282 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 322

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 69/313 (22%), Positives = 130/313 (41%), Gaps = 75/313 (23%)
Query: 230 NRLLGDSKTGGTYSGIL-------PDGSRVAVKRLKRSSFQRKK-EFYSEIGRFARLHHP 281
           +R LG    G  Y G+        P+ +RVA+K +  ++  R++ EF +E       +  
Sbjct: 15  SRELGQGSFGMVYEGVAKGVVKDEPE-TRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 73
Query: 282 NLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMR-------------M 328
           ++V + G         ++ E +  G L  +L       RSL   M              +
Sbjct: 74  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-------RSLRPEMENNPVLAPPSLSKMI 126
Query: 329 KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 388
           ++A  +A G+A+L+       VHRD+ A N ++ E+F   +   G+++    ++ +    
Sbjct: 127 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIXETDXX 179
Query: 389 MAGGT----YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFE 443
             GG       +++PE +     TT SDV+SFGV+L EI +   +P Q + +        
Sbjct: 180 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-------- 231
Query: 444 WATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQK-------VVDLVYACTQHVPSMRPRM 496
                 Q  R+                  G++ K       +++L+  C Q+ P MRP  
Sbjct: 232 -----EQVLRF--------------VMEGGLLDKPDNCPDMLLELMRMCWQYNPKMRPSF 272
Query: 497 SHVVHQLQQLAQP 509
             ++  +++  +P
Sbjct: 273 LEIISSIKEEMEP 285

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 84/191 (43%), Gaps = 8/191 (4%)
Query: 248 DGSRVAVKRLKRSSFQR--KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFV 303
           DG  +  K L   S     K+   SE+     L HPN+V       D  +   YIV E+ 
Sbjct: 30  DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYC 89
Query: 304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKP--HVVHRDIRASNVLL 361
             G L   +    +  + LD    ++V T L   +   H +      V+HRD++ +NV L
Sbjct: 90  EGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL 149
Query: 362 DEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLL 421
           D +    L   GL++ +  +    +  +  GT  Y++PE + R     KSD++S G LL 
Sbjct: 150 DGKQNVKLGDFGLARILNHDTSFAKAFV--GTPYYMSPEQMNRMSYNEKSDIWSLGCLLY 207
Query: 422 EIVSGRRPAQA 432
           E+ +   P  A
Sbjct: 208 ELCALMPPFTA 218

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 81/171 (47%), Gaps = 11/171 (6%)
Query: 275 FARLHHPNLVAVKGCCYDHGDR-YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATT 333
            A L  P  +     C+   DR Y V E+V  G L   ++HI + G+       +  A  
Sbjct: 73  LALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDL---MYHIQQVGK-FKEPQAVFYAAE 128
Query: 334 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT 393
           ++ G+ FLH   K  +++RD++  NV+LD E    +   G+ K    + +  R     GT
Sbjct: 129 ISIGLFFLH---KRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFC--GT 183
Query: 394 YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVD-SVCWQSIFE 443
             Y+APE +         D +++GVLL E+++G+ P    D    +QSI E
Sbjct: 184 PDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME 234

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 105/236 (44%), Gaps = 21/236 (8%)
Query: 199 SNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSR-VAVKRL 257
           + P  ++LVP  W   +    R    +F E    LG   T   Y        +  A+K L
Sbjct: 30  AAPGTASLVPDYWIDGSN---RDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVL 86
Query: 258 KRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL-DRWLHHIP 316
           K++    KK   +EIG   RL HPN++ +K       +  +V E V  G L DR +    
Sbjct: 87  KKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGY 144
Query: 317 RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE---EFGAHLMGVG 373
              R    A++      + + +A+LH+     +VHRD++  N+L      +    +   G
Sbjct: 145 YSERDAADAVKQ-----ILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFG 196
Query: 374 LSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           LSK V  +V+  +TV   GT GY APE +       + D++S G++   ++ G  P
Sbjct: 197 LSKIVEHQVLM-KTVC--GTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEP 249

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 97/207 (46%), Gaps = 12/207 (5%)
Query: 233 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 292
           +G    G  Y G       V +  +   + Q+ + F +E+G   +  H N++   G    
Sbjct: 36  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T 94
Query: 293 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 352
                IV ++     L   LH I       +    + +A   AQG+ +LH K    ++HR
Sbjct: 95  KPQLAIVTQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLHAK---SIIHR 148
Query: 353 DIRASNVLLDEEFGAHLMGVGL-SKFVPWEVMQERTVMAGGTYGYLAPEFVY---RNELT 408
           D++++N+ L E+    +   GL ++   W    +   ++G    ++APE +    +N  +
Sbjct: 149 DLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSIL-WMAPEVIRMQDKNPYS 207
Query: 409 TKSDVYSFGVLLLEIVSGRRPAQAVDS 435
            +SDVY+FG++L E+++G+ P   +++
Sbjct: 208 FQSDVYAFGIVLYELMTGQLPYSNINN 234

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 91/185 (49%), Gaps = 28/185 (15%)
Query: 259 RSSFQRKKEFYSEIGRFARLHHPNLV----AVKGCCYDHGDRYIVYEFVVNGPLDRWLHH 314
           + S+Q ++E +S  G    + H NL+    A K       + +++  F   G L  +L  
Sbjct: 51  KQSWQSEREIFSTPG----MKHENLLQFIAAEKRGSNLEVELWLITAFHDKGSLTDYLK- 105
Query: 315 IPRGGRSLDWAMRMKVATTLAQGIAFLHDKV--------KPHVVHRDIRASNVLLDEEFG 366
               G  + W     VA T+++G+++LH+ V        KP + HRD ++ NVLL  +  
Sbjct: 106 ----GNIITWNELCHVAETMSRGLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLT 161
Query: 367 AHLMGVGLS-KFVPWEVMQERTVMAGGTYGYLAPEFV-----YRNELTTKSDVYSFGVLL 420
           A L   GL+ +F P +   + T    GT  Y+APE +     ++ +   + D+Y+ G++L
Sbjct: 162 AVLADFGLAVRFEPGKPPGD-THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVL 220
Query: 421 LEIVS 425
            E+VS
Sbjct: 221 WELVS 225

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 95/190 (50%), Gaps = 14/190 (7%)
Query: 252 VAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 309
           VAVK L  +  + Q+ + F +E+G   +  H N++   G         IV ++     L 
Sbjct: 61  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TKPQLAIVTQWCEGSSLY 119
Query: 310 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHL 369
             LH I       +    + +A   AQG+ +LH K    ++HRD++++N+ L E+    +
Sbjct: 120 HHLHIIET---KFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKI 173
Query: 370 MGVGL-SKFVPWEVMQERTVMAGGTYGYLAPEFVY---RNELTTKSDVYSFGVLLLEIVS 425
              GL ++   W    +   ++G    ++APE +    +N  + +SDVY+FG++L E+++
Sbjct: 174 GDFGLATEKSRWSGSHQFEQLSGSIL-WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMT 232
Query: 426 GRRPAQAVDS 435
           G+ P   +++
Sbjct: 233 GQLPYSNINN 242

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 13/207 (6%)
Query: 229 GNRL-LGDSKTGGTYSG-ILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAV 286
           G+R+ LG    G  Y+G  L +  R+A+K +     +  +  + EI     L H N+V  
Sbjct: 25  GDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQY 84
Query: 287 KGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATT-LAQGIAFLHDKV 345
            G   ++G   I  E V  G L   L    + G   D    +   T  + +G+ +LHD  
Sbjct: 85  LGSFSENGFIKIFMEQVPGGSLSALLRS--KWGPLKDNEQTIGFYTKQILEGLKYLHDN- 141
Query: 346 KPHVVHRDIRASNVLLDEEFGA-HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR 404
              +VHRDI+  NVL++   G   +   G SK +    +   T    GT  Y+APE + +
Sbjct: 142 --QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG--INPCTETFTGTLQYMAPEIIDK 197
Query: 405 NE--LTTKSDVYSFGVLLLEIVSGRRP 429
                   +D++S G  ++E+ +G+ P
Sbjct: 198 GPRGYGKAADIWSLGCTIIEMATGKPP 224

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 84/183 (45%), Gaps = 16/183 (8%)
Query: 249 GSRVAVKRLKRSSFQR--KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 306
           G  VA+K+   S   +  KK    EI    +L H NLV +   C      Y+V+EFV + 
Sbjct: 50  GRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHT 109
Query: 307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 366
            LD  L   P G   LD+ +  K    +  GI F H     +++HRDI+  N+L+ +   
Sbjct: 110 ILDD-LELFPNG---LDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGV 162
Query: 367 AHLMGVGLSKFV--PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKS-DVYSFGVLLLEI 423
             L   G ++ +  P EV  +       T  Y APE +  +    K+ DV++ G L+ E+
Sbjct: 163 VKLCDFGFARTLAAPGEVYDDEV----ATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEM 218
Query: 424 VSG 426
             G
Sbjct: 219 FMG 221

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 81/165 (49%), Gaps = 10/165 (6%)
Query: 265 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDW 324
           + +   E+      + P +V   G  Y  G+  I  E +  G LD+ L    + GR  + 
Sbjct: 67  RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQ 123
Query: 325 AMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 384
            +  KV+  + +G+ +L +K K  ++HRD++ SN+L++      L   G+S     +++ 
Sbjct: 124 ILG-KVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS----GQLID 176
Query: 385 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
                  GT  Y++PE +     + +SD++S G+ L+E+  GR P
Sbjct: 177 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 221

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 13/207 (6%)
Query: 229 GNRL-LGDSKTGGTYSG-ILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAV 286
           G+R+ LG    G  Y+G  L +  R+A+K +     +  +  + EI     L H N+V  
Sbjct: 11  GDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQY 70
Query: 287 KGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVAT-TLAQGIAFLHDKV 345
            G   ++G   I  E V  G L   L    + G   D    +   T  + +G+ +LHD  
Sbjct: 71  LGSFSENGFIKIFMEQVPGGSLSALLRS--KWGPLKDNEQTIGFYTKQILEGLKYLHDN- 127
Query: 346 KPHVVHRDIRASNVLLDEEFGA-HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR 404
              +VHRDI+  NVL++   G   +   G SK +    +   T    GT  Y+APE + +
Sbjct: 128 --QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG--INPCTETFTGTLQYMAPEIIDK 183
Query: 405 NE--LTTKSDVYSFGVLLLEIVSGRRP 429
                   +D++S G  ++E+ +G+ P
Sbjct: 184 GPRGYGKAADIWSLGCTIIEMATGKPP 210

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 93/198 (46%), Gaps = 11/198 (5%)
Query: 233 LGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 291
           LG+   G  Y  I  + G  VA+K++   S    +E   EI    +   P++V   G  +
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYF 94
Query: 292 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 351
            + D +IV E+   G +   +       ++L       +  +  +G+ +LH   K   +H
Sbjct: 95  KNTDLWIVMEYCGAGSVSDIIR---LRNKTLTEDEIATILQSTLKGLEYLHFMRK---IH 148
Query: 352 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKS 411
           RDI+A N+LL+ E  A L   G++  +  + M +R  + G  + ++APE +        +
Sbjct: 149 RDIKAGNILLNTEGHAKLADFGVAGQL-TDXMAKRNXVIGTPF-WMAPEVIQEIGYNCVA 206
Query: 412 DVYSFGVLLLEIVSGRRP 429
           D++S G+  +E+  G+ P
Sbjct: 207 DIWSLGITAIEMAEGKPP 224

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 103/242 (42%), Gaps = 43/242 (17%)
Query: 218 ELRSITKNFSEGNRLLGDSKTGGTYSGIL------PDGSRVAVKRLK-RSSFQRKKEFYS 270
           +L+ I+ +       LG+ + G  Y G L           VA+K LK ++    ++EF  
Sbjct: 19  KLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRH 78
Query: 271 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWL----HHIPRGGRSLDWAM 326
           E    ARL HPN+V + G         +++ +  +G L  +L     H   G    D  +
Sbjct: 79  EAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTV 138
Query: 327 R--------MKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 378
           +        + +   +A G+ +L      HVVH+D+   NVL+ ++    +  +GL    
Sbjct: 139 KSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLF--- 192
Query: 379 PWEVMQERTVMAGGTYGYL----------APEFVYRNELTTKSDVYSFGVLLLEIVS-GR 427
                  R V A   Y  L          APE +   + +  SD++S+GV+L E+ S G 
Sbjct: 193 -------REVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGL 245
Query: 428 RP 429
           +P
Sbjct: 246 QP 247

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 108/241 (44%), Gaps = 18/241 (7%)
Query: 219 LRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRV----AVKRLKR-SSFQRKKEFYSEI 272
           LR + +   +  ++LG    G  Y G+ +P+G +V    A+K L+  +S +  KE   E 
Sbjct: 13  LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 72
Query: 273 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS--LDWAMRMKV 330
              A + +P++  + G C     + I+        LD    H    G    L+W ++   
Sbjct: 73  YVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--- 129
Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 390
              +A+G+ +L D+    +VHRD+ A NVL+       +   G +K +  E  +      
Sbjct: 130 ---IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 183
Query: 391 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLV 449
                ++A E +     T +SDV+S+GV + E+++ G +P   + +    SI E    L 
Sbjct: 184 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 243
Query: 450 Q 450
           Q
Sbjct: 244 Q 244

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 83/179 (46%), Gaps = 13/179 (7%)
Query: 266 KEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWA 325
           +  + E+     L HP LV +     D  D ++V + ++ G L    +H+ +     +  
Sbjct: 60  RNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDL---RYHLQQNVHFKEET 116
Query: 326 MRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 385
           +++ +   L   + +L ++    ++HRD++  N+LLDE    H+    ++  +P E   +
Sbjct: 117 VKLFICE-LVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET--Q 170
Query: 386 RTVMAGGTYGYLAPEFVYRNELTTKS---DVYSFGVLLLEIVSGRRPAQAVDSVCWQSI 441
            T MA GT  Y+APE     +    S   D +S GV   E++ GRRP     S   + I
Sbjct: 171 ITTMA-GTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEI 228

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 108/241 (44%), Gaps = 18/241 (7%)
Query: 219 LRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRV----AVKRLKR-SSFQRKKEFYSEI 272
           LR + +   +  ++L     G  Y G+ +P+G +V    A+K L+  +S +  KE   E 
Sbjct: 16  LRILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 75
Query: 273 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS--LDWAMRMKV 330
              A + +P++  + G C     + I+        LD    H    G    L+W ++   
Sbjct: 76  YVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--- 132
Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 390
              +A+G+ +L D+    +VHRD+ A NVL+       +   GL+K +  E  +      
Sbjct: 133 ---IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 186
Query: 391 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLV 449
                ++A E +     T +SDV+S+GV + E+++ G +P   + +    SI E    L 
Sbjct: 187 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 246
Query: 450 Q 450
           Q
Sbjct: 247 Q 247

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/251 (24%), Positives = 110/251 (43%), Gaps = 18/251 (7%)
Query: 209 PSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRV----AVKRLKR-SSF 262
           PS +      LR + +   +  ++LG    G  Y G+ +P+G +V    A+  L+  +S 
Sbjct: 33  PSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSP 92
Query: 263 QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS- 321
           +  KE   E    A + +P++  + G C     + I         LD    H    G   
Sbjct: 93  KANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQY 152
Query: 322 -LDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 380
            L+W ++      +A+G+ +L D+    +VHRD+ A NVL+       +   GL+K +  
Sbjct: 153 LLNWCVQ------IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 203
Query: 381 EVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQ 439
           E  +           ++A E +     T +SDV+S+GV + E+++ G +P   + +    
Sbjct: 204 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 263
Query: 440 SIFEWATPLVQ 450
           SI E    L Q
Sbjct: 264 SILEKGERLPQ 274

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 108/241 (44%), Gaps = 18/241 (7%)
Query: 219 LRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRV----AVKRLKR-SSFQRKKEFYSEI 272
           LR + +   +  ++LG    G  Y G+ +P+G +V    A+K L+  +S +  KE   E 
Sbjct: 11  LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 70
Query: 273 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS--LDWAMRMKV 330
              A + +P++  + G C     + I+        LD    H    G    L+W ++   
Sbjct: 71  YVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--- 127
Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 390
              +A+G+ +L D+    +VHRD+ A NVL+       +   G +K +  E  +      
Sbjct: 128 ---IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 181
Query: 391 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLV 449
                ++A E +     T +SDV+S+GV + E+++ G +P   + +    SI E    L 
Sbjct: 182 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 241
Query: 450 Q 450
           Q
Sbjct: 242 Q 242

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 101/229 (44%), Gaps = 38/229 (16%)
Query: 228 EGNRLLGDSKTG----GTYSGILPDGS--RVAVKRLKRSSFQRKKE-FYSEIGRFARL-H 279
           E  ++LG    G     T  GI   G   +VAVK LK  +   ++E   SE+    +L  
Sbjct: 48  EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGS 107
Query: 280 HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPR----------GGRSLDWAMRMK 329
           H N+V + G C   G  Y+++E+   G L  +L                 + L+    + 
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167
Query: 330 VAT---------TLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 380
           V T          +A+G+ FL  K     VHRD+ A NVL+       +   GL++    
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLAR---- 220
Query: 381 EVMQERTVMAGGT----YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 425
           ++M +   +  G       ++APE ++    T KSDV+S+G+LL EI S
Sbjct: 221 DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 107/241 (44%), Gaps = 18/241 (7%)
Query: 219 LRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRV----AVKRLKR-SSFQRKKEFYSEI 272
           LR + +   +  ++L     G  Y G+ +P+G +V    A+K L+  +S +  KE   E 
Sbjct: 9   LRILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 68
Query: 273 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS--LDWAMRMKV 330
              A + +P++  + G C     + I         LD    H    G    L+W ++   
Sbjct: 69  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--- 125
Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 390
              +A+G+ +L D+    +VHRD+ A NVL+       +   GL+K +  E  +      
Sbjct: 126 ---IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 391 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLV 449
                ++A E +     T +SDV+S+GV + E+++ G +P   + +    SI E    L 
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 239
Query: 450 Q 450
           Q
Sbjct: 240 Q 240

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 86/175 (49%), Gaps = 18/175 (10%)
Query: 265 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDW 324
           K E  +E     +L +P +V + G C +     +V E    GPL+++L       R +  
Sbjct: 72  KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKD 126
Query: 325 AMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 384
              +++   ++ G+ +L +    + VHRD+ A NVLL  +  A +   GLSK     +  
Sbjct: 127 KNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSK----ALRA 179
Query: 385 ERTVMAGGTYG-----YLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAV 433
           +       T+G     + APE +   + ++KSDV+SFGVL+ E  S G++P + +
Sbjct: 180 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 234

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 86/175 (49%), Gaps = 18/175 (10%)
Query: 265 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDW 324
           K E  +E     +L +P +V + G C +     +V E    GPL+++L       R +  
Sbjct: 72  KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKD 126
Query: 325 AMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 384
              +++   ++ G+ +L +    + VHRD+ A NVLL  +  A +   GLSK     +  
Sbjct: 127 KNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSK----ALRA 179
Query: 385 ERTVMAGGTYG-----YLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAV 433
           +       T+G     + APE +   + ++KSDV+SFGVL+ E  S G++P + +
Sbjct: 180 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 234

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 108/241 (44%), Gaps = 18/241 (7%)
Query: 219 LRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRV----AVKRLKR-SSFQRKKEFYSEI 272
           LR + +   +  ++LG    G  Y G+ +P+G +V    A+K L+  +S +  KE   E 
Sbjct: 11  LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 70
Query: 273 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS--LDWAMRMKV 330
              A + +P++  + G C     + I+        LD    H    G    L+W ++   
Sbjct: 71  YVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--- 127
Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 390
              +A+G+ +L D+    +VHRD+ A NVL+       +   G +K +  E  +      
Sbjct: 128 ---IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 181
Query: 391 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLV 449
                ++A E +     T +SDV+S+GV + E+++ G +P   + +    SI E    L 
Sbjct: 182 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 241
Query: 450 Q 450
           Q
Sbjct: 242 Q 242

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 86/175 (49%), Gaps = 18/175 (10%)
Query: 265 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDW 324
           K E  +E     +L +P +V + G C +     +V E    GPL+++L       R +  
Sbjct: 56  KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKD 110
Query: 325 AMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 384
              +++   ++ G+ +L +    + VHRD+ A NVLL  +  A +   GLSK     +  
Sbjct: 111 KNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSK----ALRA 163
Query: 385 ERTVMAGGTYG-----YLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAV 433
           +       T+G     + APE +   + ++KSDV+SFGVL+ E  S G++P + +
Sbjct: 164 DENXYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 218

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/242 (24%), Positives = 104/242 (42%), Gaps = 43/242 (17%)
Query: 218 ELRSITKNFSEGNRLLGDSKTGGTYSGIL------PDGSRVAVKRLK-RSSFQRKKEFYS 270
           +L+ I+ +       LG+ + G  Y G L           VA+K LK ++    ++EF  
Sbjct: 2   KLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRH 61
Query: 271 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWL----HHIPRGGRSLDWAM 326
           E    ARL HPN+V + G         +++ +  +G L  +L     H   G    D  +
Sbjct: 62  EAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTV 121
Query: 327 R--------MKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 378
           +        + +   +A G+ +L      HVVH+D+   NVL+ ++    +  +GL    
Sbjct: 122 KSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLF--- 175
Query: 379 PWEVMQERTVMAGGTYG----------YLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GR 427
                  R V A   Y           ++APE +   + +  SD++S+GV+L E+ S G 
Sbjct: 176 -------REVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGL 228
Query: 428 RP 429
           +P
Sbjct: 229 QP 230

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 86/175 (49%), Gaps = 18/175 (10%)
Query: 265 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDW 324
           K E  +E     +L +P +V + G C +     +V E    GPL+++L       R +  
Sbjct: 52  KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKD 106
Query: 325 AMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 384
              +++   ++ G+ +L +    + VHRD+ A NVLL  +  A +   GLSK     +  
Sbjct: 107 KNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSK----ALRA 159
Query: 385 ERTVMAGGTYG-----YLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAV 433
           +       T+G     + APE +   + ++KSDV+SFGVL+ E  S G++P + +
Sbjct: 160 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 214

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 107/241 (44%), Gaps = 18/241 (7%)
Query: 219 LRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRV----AVKRLKR-SSFQRKKEFYSEI 272
           LR + +   +  ++LG    G  Y G+ +P+G +V    A+K L+  +S +  KE   E 
Sbjct: 9   LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 68
Query: 273 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS--LDWAMRMKV 330
              A + +P++  + G C     + I         LD    H    G    L+W ++   
Sbjct: 69  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--- 125
Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 390
              +A+G+ +L D+    +VHRD+ A NVL+       +   G +K +  E  +      
Sbjct: 126 ---IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 179
Query: 391 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLV 449
                ++A E +     T +SDV+S+GV + E+++ G +P   + +    SI E    L 
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 239
Query: 450 Q 450
           Q
Sbjct: 240 Q 240

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 86/175 (49%), Gaps = 18/175 (10%)
Query: 265 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDW 324
           K E  +E     +L +P +V + G C +     +V E    GPL+++L       R +  
Sbjct: 56  KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKD 110
Query: 325 AMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 384
              +++   ++ G+ +L +    + VHRD+ A NVLL  +  A +   GLSK     +  
Sbjct: 111 KNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSK----ALRA 163
Query: 385 ERTVMAGGTYG-----YLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAV 433
           +       T+G     + APE +   + ++KSDV+SFGVL+ E  S G++P + +
Sbjct: 164 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 218

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 86/175 (49%), Gaps = 18/175 (10%)
Query: 265 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDW 324
           K E  +E     +L +P +V + G C +     +V E    GPL+++L       R +  
Sbjct: 70  KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKD 124
Query: 325 AMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 384
              +++   ++ G+ +L +    + VHRD+ A NVLL  +  A +   GLSK     +  
Sbjct: 125 KNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSK----ALRA 177
Query: 385 ERTVMAGGTYG-----YLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAV 433
           +       T+G     + APE +   + ++KSDV+SFGVL+ E  S G++P + +
Sbjct: 178 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 232

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 69/313 (22%), Positives = 129/313 (41%), Gaps = 75/313 (23%)
Query: 230 NRLLGDSKTGGTYSGIL-------PDGSRVAVKRLKRSSFQRKK-EFYSEIGRFARLHHP 281
           +R LG    G  Y G+        P+ +RVA+K +  ++  R++ EF +E       +  
Sbjct: 17  SRELGQGSFGMVYEGVAKGVVKDEPE-TRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 75
Query: 282 NLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMR-------------M 328
           ++V + G         ++ E +  G L  +L       RSL   M              +
Sbjct: 76  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-------RSLRPEMENNPVLAPPSLSKMI 128
Query: 329 KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 388
           ++A  +A G+A+L+       VHRD+ A N ++ E+F   +   G+++    ++ +    
Sbjct: 129 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYY 181
Query: 389 MAGGT----YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFE 443
             GG       +++PE +     TT SDV+SFGV+L EI +   +P Q + +        
Sbjct: 182 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-------- 233
Query: 444 WATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQK-------VVDLVYACTQHVPSMRPRM 496
                 Q  R+                  G++ K       + +L+  C Q+ P MRP  
Sbjct: 234 -----EQVLRF--------------VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSF 274
Query: 497 SHVVHQLQQLAQP 509
             ++  +++  +P
Sbjct: 275 LEIISSIKEEMEP 287

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 84/191 (43%), Gaps = 8/191 (4%)
Query: 248 DGSRVAVKRLKRSSFQR--KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFV 303
           DG  +  K L   S     K+   SE+     L HPN+V       D  +   YIV E+ 
Sbjct: 30  DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYC 89
Query: 304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKP--HVVHRDIRASNVLL 361
             G L   +    +  + LD    ++V T L   +   H +      V+HRD++ +NV L
Sbjct: 90  EGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL 149
Query: 362 DEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLL 421
           D +    L   GL++ +  +  ++      GT  Y++PE + R     KSD++S G LL 
Sbjct: 150 DGKQNVKLGDFGLARILNHD--EDFAKEFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLY 207
Query: 422 EIVSGRRPAQA 432
           E+ +   P  A
Sbjct: 208 ELCALMPPFTA 218

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 86/175 (49%), Gaps = 18/175 (10%)
Query: 265 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDW 324
           K E  +E     +L +P +V + G C +     +V E    GPL+++L       R +  
Sbjct: 62  KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKD 116
Query: 325 AMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 384
              +++   ++ G+ +L +    + VHRD+ A NVLL  +  A +   GLSK     +  
Sbjct: 117 KNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSK----ALRA 169
Query: 385 ERTVMAGGTYG-----YLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAV 433
           +       T+G     + APE +   + ++KSDV+SFGVL+ E  S G++P + +
Sbjct: 170 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 224

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 86/175 (49%), Gaps = 18/175 (10%)
Query: 265 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDW 324
           K E  +E     +L +P +V + G C +     +V E    GPL+++L       R +  
Sbjct: 50  KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKD 104
Query: 325 AMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 384
              +++   ++ G+ +L +    + VHRD+ A NVLL  +  A +   GLSK     +  
Sbjct: 105 KNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSK----ALRA 157
Query: 385 ERTVMAGGTYG-----YLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAV 433
           +       T+G     + APE +   + ++KSDV+SFGVL+ E  S G++P + +
Sbjct: 158 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 212

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 107/241 (44%), Gaps = 18/241 (7%)
Query: 219 LRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRV----AVKRLKR-SSFQRKKEFYSEI 272
           LR + +   +  ++L     G  Y G+ +P+G +V    A+K L+  +S +  KE   E 
Sbjct: 16  LRILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 75
Query: 273 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS--LDWAMRMKV 330
              A + +P++  + G C     + I         LD    H    G    L+W ++   
Sbjct: 76  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--- 132
Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 390
              +A+G+ +L D+    +VHRD+ A NVL+       +   GL+K +  E  +      
Sbjct: 133 ---IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 186
Query: 391 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLV 449
                ++A E +     T +SDV+S+GV + E+++ G +P   + +    SI E    L 
Sbjct: 187 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 246
Query: 450 Q 450
           Q
Sbjct: 247 Q 247

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 107/241 (44%), Gaps = 18/241 (7%)
Query: 219 LRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRV----AVKRLKR-SSFQRKKEFYSEI 272
           LR + +   +  ++LG    G  Y G+ +P+G +V    A+K L+  +S +  KE   E 
Sbjct: 11  LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 70
Query: 273 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS--LDWAMRMKV 330
              A + +P++  + G C     + I         LD    H    G    L+W ++   
Sbjct: 71  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--- 127
Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 390
              +A+G+ +L D+    +VHRD+ A NVL+       +   G +K +  E  +      
Sbjct: 128 ---IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 181
Query: 391 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLV 449
                ++A E +     T +SDV+S+GV + E+++ G +P   + +    SI E    L 
Sbjct: 182 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 241
Query: 450 Q 450
           Q
Sbjct: 242 Q 242

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 107/241 (44%), Gaps = 18/241 (7%)
Query: 219 LRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRV----AVKRLKR-SSFQRKKEFYSEI 272
           LR + +   +  ++LG    G  Y G+ +P+G +V    A+K L+  +S +  KE   E 
Sbjct: 16  LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 75
Query: 273 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS--LDWAMRMKV 330
              A + +P++  + G C     + I         LD    H    G    L+W ++   
Sbjct: 76  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ--- 132
Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 390
              +A+G+ +L D+    +VHRD+ A NVL+       +   G +K +  E  +      
Sbjct: 133 ---IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 186
Query: 391 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLV 449
                ++A E +     T +SDV+S+GV + E+++ G +P   + +    SI E    L 
Sbjct: 187 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 246
Query: 450 Q 450
           Q
Sbjct: 247 Q 247

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 86/175 (49%), Gaps = 18/175 (10%)
Query: 265 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDW 324
           K E  +E     +L +P +V + G C +     +V E    GPL+++L       R +  
Sbjct: 415 KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKD 469
Query: 325 AMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 384
              +++   ++ G+ +L +    + VHRD+ A NVLL  +  A +   GLSK     +  
Sbjct: 470 KNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSK----ALRA 522
Query: 385 ERTVMAGGTYG-----YLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAV 433
           +       T+G     + APE +   + ++KSDV+SFGVL+ E  S G++P + +
Sbjct: 523 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 577

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 86/175 (49%), Gaps = 18/175 (10%)
Query: 265 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDW 324
           K E  +E     +L +P +V + G C +     +V E    GPL+++L       R +  
Sbjct: 414 KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKD 468
Query: 325 AMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 384
              +++   ++ G+ +L +    + VHRD+ A NVLL  +  A +   GLSK     +  
Sbjct: 469 KNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSK----ALRA 521
Query: 385 ERTVMAGGTYG-----YLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAV 433
           +       T+G     + APE +   + ++KSDV+SFGVL+ E  S G++P + +
Sbjct: 522 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 576

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 91/189 (48%), Gaps = 12/189 (6%)
Query: 252 VAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 309
           VAVK L  +  + Q+ + F +E+G   +  H N++   G         IV ++     L 
Sbjct: 37  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TKPQLAIVTQWCEGSSL- 94
Query: 310 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHL 369
              HH+       +    + +A   A+G+ +LH K    ++HRD++++N+ L E+    +
Sbjct: 95  --YHHLHASETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKI 149
Query: 370 MGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY---RNELTTKSDVYSFGVLLLEIVSG 426
              GL+          +     G+  ++APE +     N  + +SDVY+FG++L E+++G
Sbjct: 150 GDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTG 209
Query: 427 RRPAQAVDS 435
           + P   +++
Sbjct: 210 QLPYSNINN 218

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 84/185 (45%), Gaps = 15/185 (8%)
Query: 248 DGSRVAVKRLKRSSFQRKKEFY---SEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 304
           +G   A+K LK+    R K+      E    + + HP ++ + G   D    +++ +++ 
Sbjct: 30  NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIE 89
Query: 305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 364
            G L   L    R  +     +    A  +   + +LH K    +++RD++  N+LLD+ 
Sbjct: 90  GGELFSLL----RKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKN 142
Query: 365 FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIV 424
               +   G +K+VP     + T    GT  Y+APE V         D +SFG+L+ E++
Sbjct: 143 GHIKITDFGFAKYVP-----DVTYXLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEML 197
Query: 425 SGRRP 429
           +G  P
Sbjct: 198 AGYTP 202

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 25/211 (11%)
Query: 249 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 308
           G   A+K +K+S   R     +EI    ++ H N+V ++         Y+V + V  G L
Sbjct: 34  GKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGEL 93
Query: 309 -DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL-LDEEFG 366
            DR L    RG  +   A    V   +   + +LH+     +VHRD++  N+L L  E  
Sbjct: 94  FDRILE---RGVYTEKDASL--VIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEEN 145
Query: 367 AHLM--GVGLSKFVPWEVMQERTVM--AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLE 422
           + +M    GLSK      M++  +M  A GT GY+APE + +   +   D +S GV+   
Sbjct: 146 SKIMITDFGLSK------MEQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYI 199
Query: 423 IVSGRRP-AQAVDSVCWQSI----FEWATPL 448
           ++ G  P  +  +S  ++ I    +E+ +P 
Sbjct: 200 LLCGYPPFYEETESKLFEKIKEGYYEFESPF 230

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 69/313 (22%), Positives = 129/313 (41%), Gaps = 75/313 (23%)
Query: 230 NRLLGDSKTGGTYSGIL-------PDGSRVAVKRLKRSSFQRKK-EFYSEIGRFARLHHP 281
           +R LG    G  Y G+        P+ +RVA+K +  ++  R++ EF +E       +  
Sbjct: 17  SRELGQGSFGMVYEGVAKGVVKDEPE-TRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 75
Query: 282 NLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMR-------------M 328
           ++V + G         ++ E +  G L  +L       RSL   M              +
Sbjct: 76  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-------RSLRPEMENNPVLAPPSLSKMI 128
Query: 329 KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 388
           ++A  +A G+A+L+       VHRD+ A N  + E+F   +   G+++    ++ +    
Sbjct: 129 QMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTR----DIYETDYY 181
Query: 389 MAGGT----YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFE 443
             GG       +++PE +     TT SDV+SFGV+L EI +   +P Q + +        
Sbjct: 182 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-------- 233
Query: 444 WATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQK-------VVDLVYACTQHVPSMRPRM 496
                 Q  R+                  G++ K       +++L+  C Q+ P MRP  
Sbjct: 234 -----EQVLRF--------------VMEGGLLDKPDNCPDMLLELMRMCWQYNPKMRPSF 274
Query: 497 SHVVHQLQQLAQP 509
             ++  +++  +P
Sbjct: 275 LEIISSIKEEMEP 287

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 61/248 (24%), Positives = 107/248 (43%), Gaps = 26/248 (10%)
Query: 212 KVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRV----AVKRLKR-SSFQRK 265
           ++    ELR +        ++LG    G  Y GI +PDG  V    A+K L+  +S +  
Sbjct: 12  RILKETELRKV--------KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKAN 63
Query: 266 KEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS--LD 323
           KE   E    A +  P +  + G C     + +         LD    +  R G    L+
Sbjct: 64  KEILDEAYVMAGVGSPYVSRLLGICLTSTVQLVTQLMPYGCLLDHVRENRGRLGSQDLLN 123
Query: 324 WAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 383
           W M+      +A+G+++L D     +VHRD+ A NVL+       +   GL++ +  +  
Sbjct: 124 WCMQ------IAKGMSYLEDV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET 174
Query: 384 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIF 442
           +           ++A E + R   T +SDV+S+GV + E+++ G +P   + +     + 
Sbjct: 175 EYHADGGKVPIKWMALESILRRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLL 234
Query: 443 EWATPLVQ 450
           E    L Q
Sbjct: 235 EKGERLPQ 242

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 60/189 (31%), Positives = 92/189 (48%), Gaps = 21/189 (11%)
Query: 249 GSRVAVKRLKRSSFQRKKE---FYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 305
           G+  A+K +K+SS            E+    +L HPN++ +     D  + Y+V E    
Sbjct: 29  GAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRG 88
Query: 306 GPLDRWLHHIPRGGRS-LDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 364
           G L  +   I R   S +D A+ MK   +   G  +LH   K ++VHRD++  N+LL+ +
Sbjct: 89  GEL--FDEIILRQKFSEVDAAVIMKQVLS---GTTYLH---KHNIVHRDLKPENLLLESK 140
Query: 365 FGAHLMGV---GLSK-FVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLL 420
               L+ +   GLS  F     M+ER     GT  Y+APE V R +   K DV+S GV+L
Sbjct: 141 SRDALIKIVDFGLSAHFEVGGKMKERL----GTAYYIAPE-VLRKKYDEKCDVWSCGVIL 195
Query: 421 LEIVSGRRP 429
             ++ G  P
Sbjct: 196 YILLCGYPP 204

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 92/189 (48%), Gaps = 21/189 (11%)
Query: 249 GSRVAVKRLKRSSFQRKKE---FYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 305
           G+  A+K +K+SS            E+    +L HPN++ +     D  + Y+V E    
Sbjct: 46  GAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRG 105
Query: 306 GPL-DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 364
           G L D  +  + +    +D A+ MK    +  G  +LH   K ++VHRD++  N+LL+ +
Sbjct: 106 GELFDEII--LRQKFSEVDAAVIMK---QVLSGTTYLH---KHNIVHRDLKPENLLLESK 157
Query: 365 FGAHLMGV---GLSK-FVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLL 420
               L+ +   GLS  F     M+ER     GT  Y+APE V R +   K DV+S GV+L
Sbjct: 158 SRDALIKIVDFGLSAHFEVGGKMKERL----GTAYYIAPE-VLRKKYDEKCDVWSCGVIL 212
Query: 421 LEIVSGRRP 429
             ++ G  P
Sbjct: 213 YILLCGYPP 221

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 93/201 (46%), Gaps = 44/201 (21%)
Query: 252 VAVKRL---KRSSFQRKKEFYSEIGRFARLHHPNLVAV-----KGCCYDHGDRYIVYEFV 303
           VAVK      + S+Q + E YS  G    + H N++       +G   D  D +++  F 
Sbjct: 50  VAVKIFPIQDKQSWQNEYEVYSLPG----MKHENILQFIGAEKRGTSVD-VDLWLITAFH 104
Query: 304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV-------KPHVVHRDIRA 356
             G L  +L         + W     +A T+A+G+A+LH+ +       KP + HRDI++
Sbjct: 105 EKGSLSDFLK-----ANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKS 159
Query: 357 SNVLLDEEFGAHLMGVGLS-KFVPWEVMQERTVMAGGTYG------YLAPEFV-----YR 404
            NVLL     A +   GL+ KF       E    AG T+G      Y+APE +     ++
Sbjct: 160 KNVLLKNNLTACIADFGLALKF-------EAGKSAGDTHGQVGTRRYMAPEVLEGAINFQ 212
Query: 405 NELTTKSDVYSFGVLLLEIVS 425
            +   + D+Y+ G++L E+ S
Sbjct: 213 RDAFLRIDMYAMGLVLWELAS 233

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/190 (24%), Positives = 94/190 (49%), Gaps = 14/190 (7%)
Query: 252 VAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 309
           VAVK L  +  + Q+ + F +E+G   +  H N++   G         IV ++     L 
Sbjct: 49  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-KPQLAIVTQWCEGSSL- 106
Query: 310 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHL 369
              HH+       +    + +A   A+G+ +LH K    ++HRD++++N+ L E+    +
Sbjct: 107 --YHHLHASETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKI 161
Query: 370 MGVGL-SKFVPWEVMQERTVMAGGTYGYLAPEFVY---RNELTTKSDVYSFGVLLLEIVS 425
              GL ++   W    +   ++G    ++APE +     N  + +SDVY+FG++L E+++
Sbjct: 162 GDFGLATEKSRWSGSHQFEQLSGSIL-WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMT 220
Query: 426 GRRPAQAVDS 435
           G+ P   +++
Sbjct: 221 GQLPYSNINN 230

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 96/191 (50%), Gaps = 16/191 (8%)
Query: 252 VAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRY-IVYEFVVNGPL 308
           VAVK L  +  + Q+ + F +E+G   +  H N++   G  Y    +  IV ++     L
Sbjct: 49  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG--YSTAPQLAIVTQWCEGSSL 106
Query: 309 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 368
               HH+       +    + +A   A+G+ +LH K    ++HRD++++N+ L E+    
Sbjct: 107 ---YHHLHASETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVK 160
Query: 369 LMGVGL-SKFVPWEVMQERTVMAGGTYGYLAPEFVY---RNELTTKSDVYSFGVLLLEIV 424
           +   GL ++   W    +   ++G    ++APE +     N  + +SDVY+FG++L E++
Sbjct: 161 IGDFGLATEKSRWSGSHQFEQLSGSIL-WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELM 219
Query: 425 SGRRPAQAVDS 435
           +G+ P   +++
Sbjct: 220 TGQLPYSNINN 230

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 87/185 (47%), Gaps = 14/185 (7%)
Query: 252 VAVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDR-YIVYEFVVNGPL 308
           VAVK LK  ++    +   SE+     + HH N+V + G C   G    ++ EF   G L
Sbjct: 60  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 119
Query: 309 DRWL-----HHIPRGGRSLDWAMR---MKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
             +L       +P      D+      +  +  +A+G+ FL  +     +HRD+ A N+L
Sbjct: 120 STYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVAKGMEFLASR---KXIHRDLAARNIL 176
Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLL 420
           L E+    +   GL++ +  +    R   A     ++APE ++    T +SDV+SFGVLL
Sbjct: 177 LSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 236
Query: 421 LEIVS 425
            EI S
Sbjct: 237 WEIFS 241

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 75/159 (47%), Gaps = 13/159 (8%)
Query: 279 HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGI 338
           +HP LV +  C       + V E+V  G L   + H+ R  +  +   R   A  ++  +
Sbjct: 79  NHPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAE-ISLAL 134
Query: 339 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK--FVPWEVMQERTVMAGGTYGY 396
            +LH++    +++RD++  NVLLD E    L   G+ K    P +     T    GT  Y
Sbjct: 135 NYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT----TSXFCGTPNY 187
Query: 397 LAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS 435
           +APE +   +     D ++ GVL+ E+++GR P   V S
Sbjct: 188 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGS 226

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 75/159 (47%), Gaps = 13/159 (8%)
Query: 279 HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGI 338
           +HP LV +  C       + V E+V  G L   + H+ R  +  +   R   A  ++  +
Sbjct: 111 NHPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAE-ISLAL 166
Query: 339 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK--FVPWEVMQERTVMAGGTYGY 396
            +LH++    +++RD++  NVLLD E    L   G+ K    P +     T    GT  Y
Sbjct: 167 NYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT----TSTFCGTPNY 219
Query: 397 LAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS 435
           +APE +   +     D ++ GVL+ E+++GR P   V S
Sbjct: 220 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGS 258

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 88/187 (47%), Gaps = 16/187 (8%)
Query: 252 VAVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDR-YIVYEFVVNGPL 308
           VAVK LK  ++    +   SE+     + HH N+V + G C   G    ++ EF   G L
Sbjct: 62  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 121
Query: 309 DRWL-----HHIPRGGRSL--DWAMR---MKVATTLAQGIAFLHDKVKPHVVHRDIRASN 358
             +L       +P     L  D+      +  +  +A+G+ FL  +     +HRD+ A N
Sbjct: 122 STYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQVAKGMEFLASR---KXIHRDLAARN 178
Query: 359 VLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGV 418
           +LL E+    +   GL++ +  +    R   A     ++APE ++    T +SDV+SFGV
Sbjct: 179 ILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 238
Query: 419 LLLEIVS 425
           LL EI S
Sbjct: 239 LLWEIFS 245

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 87/185 (47%), Gaps = 14/185 (7%)
Query: 252 VAVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDR-YIVYEFVVNGPL 308
           VAVK LK  ++    +   SE+     + HH N+V + G C   G    ++ EF   G L
Sbjct: 60  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 119
Query: 309 DRWL-----HHIPRGGRSLDWAMRMKV---ATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
             +L       +P      D+     +   +  +A+G+ FL  +     +HRD+ A N+L
Sbjct: 120 STYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVAKGMEFLASR---KXIHRDLAARNIL 176
Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLL 420
           L E+    +   GL++ +  +    R   A     ++APE ++    T +SDV+SFGVLL
Sbjct: 177 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 236
Query: 421 LEIVS 425
            EI S
Sbjct: 237 WEIFS 241

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/206 (21%), Positives = 93/206 (45%), Gaps = 10/206 (4%)
Query: 233 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 292
           +G    G  Y G       V + ++   + ++ + F +E+    +  H N++   G    
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYM-T 102
Query: 293 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 352
             +  IV ++     L + LH              + +A   AQG+ +LH K   +++HR
Sbjct: 103 KDNLAIVTQWCEGSSLYKHLH---VQETKFQMFQLIDIARQTAQGMDYLHAK---NIIHR 156
Query: 353 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY---RNELTT 409
           D++++N+ L E     +   GL+         ++     G+  ++APE +     N  + 
Sbjct: 157 DMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSF 216
Query: 410 KSDVYSFGVLLLEIVSGRRPAQAVDS 435
           +SDVYS+G++L E+++G  P   +++
Sbjct: 217 QSDVYSYGIVLYELMTGELPYSHINN 242

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 75/159 (47%), Gaps = 13/159 (8%)
Query: 279 HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGI 338
           +HP LV +  C       + V E+V  G L   + H+ R  +  +   R   A  ++  +
Sbjct: 64  NHPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAE-ISLAL 119
Query: 339 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK--FVPWEVMQERTVMAGGTYGY 396
            +LH++    +++RD++  NVLLD E    L   G+ K    P +     T    GT  Y
Sbjct: 120 NYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT----TSXFCGTPNY 172
Query: 397 LAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS 435
           +APE +   +     D ++ GVL+ E+++GR P   V S
Sbjct: 173 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGS 211

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 96/211 (45%), Gaps = 21/211 (9%)
Query: 229 GNRLLGDSKTGGTYSGI-----LPDGSRVAVKRLKRS---SFQRKKEFYSEIGRFARLHH 280
           G+ +LGD+   GT+  +        G +VAVK L R    S     +   EI       H
Sbjct: 11  GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRH 70
Query: 281 PNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAF 340
           P+++ +        D ++V E+V  G L     +I + GR  +   R ++   +   + +
Sbjct: 71  PHIIKLYQVISTPTDFFMVMEYVSGGEL---FDYICKHGRVEEMEAR-RLFQQILSAVDY 126
Query: 341 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV-PWEVMQERTVMAGGTYGYLAP 399
            H  +   VVHRD++  NVLLD    A +   GLS  +   E +++    + G+  Y AP
Sbjct: 127 CHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRD----SCGSPNYAAP 179
Query: 400 EFVY-RNELTTKSDVYSFGVLLLEIVSGRRP 429
           E +  R     + D++S GV+L  ++ G  P
Sbjct: 180 EVISGRLYAGPEVDIWSCGVILYALLCGTLP 210

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 75/159 (47%), Gaps = 13/159 (8%)
Query: 279 HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGI 338
           +HP LV +  C       + V E+V  G L   + H+ R  +  +   R   A  ++  +
Sbjct: 68  NHPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAE-ISLAL 123
Query: 339 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK--FVPWEVMQERTVMAGGTYGY 396
            +LH++    +++RD++  NVLLD E    L   G+ K    P +     T    GT  Y
Sbjct: 124 NYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT----TSXFCGTPNY 176
Query: 397 LAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS 435
           +APE +   +     D ++ GVL+ E+++GR P   V S
Sbjct: 177 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGS 215

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/272 (22%), Positives = 110/272 (40%), Gaps = 41/272 (15%)
Query: 231 RLLGDSKTGGTY-SGILPDGSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAV 286
           R +G    G  Y +  + +   VA+K++  S  Q     ++   E+    +L HPN +  
Sbjct: 60  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 287 KGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVK 346
           +GC       ++V E+ +    D    H     + L       V     QG+A+LH    
Sbjct: 120 RGCYLREHTAWLVMEYCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSH-- 173
Query: 347 PHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY--- 403
            +++HRD++A N+LL E  G     V L  F    +M       G  Y ++APE +    
Sbjct: 174 -NMIHRDVKAGNILLSEP-GL----VKLGDFGSASIMAPANXFVGTPY-WMAPEVILAMD 226
Query: 404 RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSV-CWQSIFEWATPLVQSHRYXXXXXXXX 462
             +   K DV+S G+  +E+   + P   ++++     I +  +P +QS  +        
Sbjct: 227 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWS------- 279
Query: 463 XXXXXXXXXAGVVQKVVDLVYACTQHVPSMRP 494
                        +   + V +C Q +P  RP
Sbjct: 280 -------------EYFRNFVDSCLQKIPQDRP 298

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 97/205 (47%), Gaps = 19/205 (9%)
Query: 231 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 290
           +++G+   G  +   L +   VA+K++ +    + +E   +I R  +  HPN+V +K   
Sbjct: 46  KVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNREL--QIMRIVK--HPNVVDLKAFF 101
Query: 291 YDHGDRY------IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 344
           Y +GD+       +V E+V    + R   H  +  +++   +       L + +A++H  
Sbjct: 102 YSNGDKKDEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI 160
Query: 345 VKPHVVHRDIRASNVLLDEEFGA-HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 403
               + HRDI+  N+LLD   G   L+  G +K +   +  E  V    +  Y APE ++
Sbjct: 161 ---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL---IAGEPNVSXICSRYYRAPELIF 214
Query: 404 -RNELTTKSDVYSFGVLLLEIVSGR 427
                TT  D++S G ++ E++ G+
Sbjct: 215 GATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/272 (22%), Positives = 112/272 (41%), Gaps = 41/272 (15%)
Query: 231 RLLGDSKTGGTY-SGILPDGSRVAVKRLK---RSSFQRKKEFYSEIGRFARLHHPNLVAV 286
           R +G    G  Y +  + +   VA+K++    + S ++ ++   E+    +L HPN +  
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 287 KGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVK 346
           +GC       ++V E+ +    D    H     + L       V     QG+A+LH    
Sbjct: 81  RGCYLREHTAWLVMEYCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSH-- 134
Query: 347 PHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY--- 403
            +++HRD++A N+LL E  G     V L  F    +M       G  Y ++APE +    
Sbjct: 135 -NMIHRDVKAGNILLSEP-GL----VKLGDFGSASIMAPANXFVGTPY-WMAPEVILAMD 187
Query: 404 RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSV-CWQSIFEWATPLVQSHRYXXXXXXXX 462
             +   K DV+S G+  +E+   + P   ++++     I +  +P +QS  +        
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWS------- 240
Query: 463 XXXXXXXXXAGVVQKVVDLVYACTQHVPSMRP 494
                        +   + V +C Q +P  RP
Sbjct: 241 -------------EYFRNFVDSCLQKIPQDRP 259

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/158 (22%), Positives = 74/158 (46%), Gaps = 5/158 (3%)
Query: 275 FARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTL 334
            A++H   +V++        D  +V   +  G +   ++++            +     +
Sbjct: 239 LAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQI 298
Query: 335 AQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY 394
             G+  LH +   ++++RD++  NVLLD++    +  +GL+  V  +  Q +T    GT 
Sbjct: 299 VSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQTKTKGYAGTP 353
Query: 395 GYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQA 432
           G++APE +   E     D ++ GV L E+++ R P +A
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRA 391

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 65/120 (54%), Gaps = 13/120 (10%)
Query: 318 GGRSLDWAM-----RMKVATTLAQ---GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHL 369
           GG +LD          ++AT L +   G+ +LH + K   +HRDI+A+NVLL E+    L
Sbjct: 105 GGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKL 161
Query: 370 MGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
              G++  +    ++  T +  GT  ++APE + ++   +K+D++S G+  +E+  G  P
Sbjct: 162 ADFGVAGQLTDTQIKRNTFV--GTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPP 219

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/158 (22%), Positives = 74/158 (46%), Gaps = 5/158 (3%)
Query: 275 FARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTL 334
            A++H   +V++        D  +V   +  G +   ++++            +     +
Sbjct: 239 LAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQI 298
Query: 335 AQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY 394
             G+  LH +   ++++RD++  NVLLD++    +  +GL+  V  +  Q +T    GT 
Sbjct: 299 VSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQTKTKGYAGTP 353
Query: 395 GYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQA 432
           G++APE +   E     D ++ GV L E+++ R P +A
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRA 391

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 67/136 (49%), Gaps = 12/136 (8%)
Query: 298 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 357
           +V   +  G L   ++H+ + G     A  +  A  +  G+  LH   +  +V+RD++  
Sbjct: 261 LVLTLMNGGDLKFHIYHMGQAG--FPEARAVFYAAEICCGLEDLH---RERIVYRDLKPE 315
Query: 358 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVYS 415
           N+LLD+     +  +GL+  VP     E   + G  GT GY+APE V     T   D ++
Sbjct: 316 NILLDDHGHIRISDLGLAVHVP-----EGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWA 370
Query: 416 FGVLLLEIVSGRRPAQ 431
            G LL E+++G+ P Q
Sbjct: 371 LGCLLYEMIAGQSPFQ 386

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/158 (22%), Positives = 74/158 (46%), Gaps = 5/158 (3%)
Query: 275 FARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTL 334
            A++H   +V++        D  +V   +  G +   ++++            +     +
Sbjct: 239 LAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQI 298
Query: 335 AQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY 394
             G+  LH +   ++++RD++  NVLLD++    +  +GL+  V  +  Q +T    GT 
Sbjct: 299 VSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQTKTKGYAGTP 353
Query: 395 GYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQA 432
           G++APE +   E     D ++ GV L E+++ R P +A
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRA 391

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/192 (23%), Positives = 92/192 (47%), Gaps = 19/192 (9%)
Query: 249 GSRVAVKRLKRSSFQRKKEFYS-EIGRFARLHHPNLVAVKGC------CYDHGDRYIVYE 301
           G +VA+K+ ++    + +E +  EI    +L+HPN+V+ +           +    +  E
Sbjct: 39  GEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAME 98
Query: 302 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL 361
           +   G L ++L+         +  +R  + + ++  + +LH+     ++HRD++  N++L
Sbjct: 99  YCEGGDLRKYLNQFENCCGLKEGPIRT-LLSDISSALRYLHEN---RIIHRDLKPENIVL 154
Query: 362 D---EEFGAHLMGVGLSKFVPWEVMQ-ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFG 417
               +     ++ +G +K    E+ Q E      GT  YLAPE + + + T   D +SFG
Sbjct: 155 QPGPQRLIHKIIDLGYAK----ELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFG 210
Query: 418 VLLLEIVSGRRP 429
            L  E ++G RP
Sbjct: 211 TLAFECITGFRP 222

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/158 (22%), Positives = 74/158 (46%), Gaps = 5/158 (3%)
Query: 275 FARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTL 334
            A++H   +V++        D  +V   +  G +   ++++            +     +
Sbjct: 239 LAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQI 298
Query: 335 AQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY 394
             G+  LH +   ++++RD++  NVLLD++    +  +GL+  V  +  Q +T    GT 
Sbjct: 299 VSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQTKTKGYAGTP 353
Query: 395 GYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQA 432
           G++APE +   E     D ++ GV L E+++ R P +A
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRA 391

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/192 (23%), Positives = 92/192 (47%), Gaps = 19/192 (9%)
Query: 249 GSRVAVKRLKRSSFQRKKEFYS-EIGRFARLHHPNLVAVKGC------CYDHGDRYIVYE 301
           G +VA+K+ ++    + +E +  EI    +L+HPN+V+ +           +    +  E
Sbjct: 40  GEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAME 99
Query: 302 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL 361
           +   G L ++L+         +  +R  + + ++  + +LH+     ++HRD++  N++L
Sbjct: 100 YCEGGDLRKYLNQFENCCGLKEGPIRT-LLSDISSALRYLHEN---RIIHRDLKPENIVL 155
Query: 362 D---EEFGAHLMGVGLSKFVPWEVMQ-ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFG 417
               +     ++ +G +K    E+ Q E      GT  YLAPE + + + T   D +SFG
Sbjct: 156 QPGPQRLIHKIIDLGYAK----ELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFG 211
Query: 418 VLLLEIVSGRRP 429
            L  E ++G RP
Sbjct: 212 TLAFECITGFRP 223

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 99/213 (46%), Gaps = 18/213 (8%)
Query: 249 GSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHH-PNLVAVKGCCYDHGDRYIVYEFVVNG 306
           G  +AVK+++RS + +  K    ++    + H  P +V   G    + D +I  E +  G
Sbjct: 50  GHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM--G 107
Query: 307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 366
                L    +G        +M VA  + + + +L  K K  V+HRD++ SN+LLDE   
Sbjct: 108 TCAEKLKKRMQGPIPERILGKMTVA--IVKALYYL--KEKHGVIHRDVKPSNILLDERGQ 163
Query: 367 AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFV-----YRNELTTKSDVYSFGVLLL 421
             L   G+S  +  +  ++R+    G   Y+APE +      + +   ++DV+S G+ L+
Sbjct: 164 IKLCDFGISGRLVDDKAKDRSA---GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLV 220
Query: 422 EIVSGRRPAQ--AVDSVCWQSIFEWATPLVQSH 452
           E+ +G+ P +    D      + +   PL+  H
Sbjct: 221 ELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGH 253

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 93/210 (44%), Gaps = 19/210 (9%)
Query: 229 GNRLLGDSKTGGTYSGI-----LPDGSRVAVKRLKRS---SFQRKKEFYSEIGRFARLHH 280
           G+ +LGD+   GT+  +        G +VAVK L R    S     +   EI       H
Sbjct: 11  GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRH 70
Query: 281 PNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAF 340
           P+++ +        D ++V E+V  G L     +I + GR  +   R ++   +   + +
Sbjct: 71  PHIIKLYQVISTPTDFFMVMEYVSGGEL---FDYICKHGRVEEMEAR-RLFQQILSAVDY 126
Query: 341 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 400
            H  +   VVHRD++  NVLLD    A +   GLS  +      E    + G+  Y APE
Sbjct: 127 CHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD---GEFLRTSCGSPNYAAPE 180
Query: 401 FVY-RNELTTKSDVYSFGVLLLEIVSGRRP 429
            +  R     + D++S GV+L  ++ G  P
Sbjct: 181 VISGRLYAGPEVDIWSCGVILYALLCGTLP 210

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 97/219 (44%), Gaps = 37/219 (16%)
Query: 232 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSE--IGRFARLHHPNL----VA 285
           L+G  + G  Y G L D   VAVK     SF  ++ F +E  I R   + H N+    V 
Sbjct: 20  LIGRGRYGAVYKGSL-DERPVAVKVF---SFANRQNFINEKNIYRVPLMEHDNIARFIVG 75
Query: 286 VKGCCYDHGDRYI-VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLH-- 342
            +    D    Y+ V E+  NG L ++L        + DW    ++A ++ +G+A+LH  
Sbjct: 76  DERVTADGRMEYLLVMEYYPNGSLXKYL-----SLHTSDWVSSCRLAHSVTRGLAYLHTE 130
Query: 343 ----DKVKPHVVHRDIRASNVLLDE-------EFGAHLMGVGLSKFVPWEVMQERTVMAG 391
               D  KP + HRD+ + NVL+         +FG  +   G     P E      +   
Sbjct: 131 LPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGE-EDNAAISEV 189
Query: 392 GTYGYLAPEFV-----YRNELTT--KSDVYSFGVLLLEI 423
           GT  Y+APE +      R+  +   + D+Y+ G++  EI
Sbjct: 190 GTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 67/136 (49%), Gaps = 12/136 (8%)
Query: 298 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 357
           +V   +  G L   ++H+ + G     A  +  A  +  G+  LH   +  +V+RD++  
Sbjct: 261 LVLTLMNGGDLKFHIYHMGQAG--FPEARAVFYAAEICCGLEDLH---RERIVYRDLKPE 315
Query: 358 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVYS 415
           N+LLD+     +  +GL+  VP     E   + G  GT GY+APE V     T   D ++
Sbjct: 316 NILLDDHGHIRISDLGLAVHVP-----EGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWA 370
Query: 416 FGVLLLEIVSGRRPAQ 431
            G LL E+++G+ P Q
Sbjct: 371 LGCLLYEMIAGQSPFQ 386

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 90/185 (48%), Gaps = 15/185 (8%)
Query: 249 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 308
           G ++A K +K    + K+E  +EI    +L H NL+ +        D  +V E+V  G L
Sbjct: 114 GLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173
Query: 309 -DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA 367
            DR +         LD  + MK    + +GI  +H   + +++H D++  N+L       
Sbjct: 174 FDRIIDE-SYNLTELDTILFMK---QICEGIRHMH---QMYILHLDLKPENILCVNRDAK 226
Query: 368 H--LMGVGLS-KFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIV 424
              ++  GL+ ++ P    +E+  +  GT  +LAPE V  + ++  +D++S GV+   ++
Sbjct: 227 QIKIIDFGLARRYKP----REKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLL 282
Query: 425 SGRRP 429
           SG  P
Sbjct: 283 SGLSP 287

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 84/189 (44%), Gaps = 18/189 (9%)
Query: 252 VAVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDR-YIVYEFVVNGPL 308
           VAVK LK  ++    +   SE+     + HH N+V + G C   G    ++ EF   G L
Sbjct: 60  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 119
Query: 309 DRWL-----HHIPRGGRSLDWAMRMKVATTL-------AQGIAFLHDKVKPHVVHRDIRA 356
             +L       +P      D          L       A+G+ FL  +     +HRD+ A
Sbjct: 120 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA 176
Query: 357 SNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSF 416
            N+LL E+    +   GL++ +  +    R   A     ++APE ++    T +SDV+SF
Sbjct: 177 RNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 236
Query: 417 GVLLLEIVS 425
           GVLL EI S
Sbjct: 237 GVLLWEIFS 245

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 28/211 (13%)
Query: 228 EGNRLLGDSKTGGTYSGIL-----PDGSRVAVKRLKRSSFQRKKEFYS---EIGRFARLH 279
           +G R+LG     G++  ++       G   AVK + +   ++K +  S   E+    +L 
Sbjct: 29  KGQRVLG----KGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 280 HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA 339
           HPN++ +     D G  Y+V E    G L  +   I R   S   A R  +   +  GI 
Sbjct: 85  HPNIMKLYEFFEDKGYFYLVGEVYTGGEL--FDEIISRKRFSEVDAAR--IIRQVLSGIT 140
Query: 340 FLHDKVKPHVVHRDIRASNVLLD---EEFGAHLMGVGLSK-FVPWEVMQERTVMAGGTYG 395
           ++H   K  +VHRD++  N+LL+   ++    ++  GLS  F   + M+++     GT  
Sbjct: 141 YMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI----GTAY 193
Query: 396 YLAPEFVYRNELTTKSDVYSFGVLLLEIVSG 426
           Y+APE V       K DV+S GV+L  ++SG
Sbjct: 194 YIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 85/181 (46%), Gaps = 17/181 (9%)
Query: 266 KEFYSEIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVNGPLDRWLHHIPRGGRSLD 323
           ++ Y EI    +L HPN+V +     D  +   Y+V+E V  GP+       P       
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQAR 140
Query: 324 WAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLS-KFVPWEV 382
           +  +      L +GI +LH +    ++HRDI+ SN+L+ E+    +   G+S +F   + 
Sbjct: 141 FYFQ-----DLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA 192
Query: 383 MQERTVMAGGTYGYLAPEFV--YRNELTTKS-DVYSFGVLLLEIVSGRRPAQAVDSVCWQ 439
           +   TV   GT  ++APE +   R   + K+ DV++ GV L   V G+ P      +C  
Sbjct: 193 LLSNTV---GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLH 249
Query: 440 S 440
           S
Sbjct: 250 S 250

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 87/192 (45%), Gaps = 25/192 (13%)
Query: 252 VAVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDR-YIVYEFVVNGPL 308
           VAVK LK  ++    +   SE+     + HH N+V + G C   G    ++ EF   G L
Sbjct: 61  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 120
Query: 309 DRWLHHIPRGGRS---------------LDWAMRMKVATTLAQGIAFLHDKVKPHVVHRD 353
             +L    R  R+               L     +  +  +A+G+ FL  +     +HRD
Sbjct: 121 STYL----RSKRNEFVPYKTPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 173
Query: 354 IRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDV 413
           + A N+LL E+    +   GL++ +  +    R   A     ++APE ++    T +SDV
Sbjct: 174 LAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDV 233
Query: 414 YSFGVLLLEIVS 425
           +SFGVLL EI S
Sbjct: 234 WSFGVLLWEIFS 245

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 278 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 337
           ++ P LV ++    D+ + Y+V E+V  G +     H+ R GR  +   R   A  +   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFSEPHARF-YAAQIVLT 153
Query: 338 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 397
             +LH      +++RD++  N+L+D++    +   G +K V     + RT    GT  YL
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLAGTPEYL 205
Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 86/193 (44%), Gaps = 40/193 (20%)
Query: 253 AVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRW 311
           AVK + +S    K++   EI    R   HPN++ +K    D    Y+V E +        
Sbjct: 56  AVKVIDKS----KRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELM-------- 103
Query: 312 LHHIPRGGRSLDWAMRMK---------VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 362
                RGG  LD  +R K         V  T+ + + +LH +    VVHRD++ SN+L  
Sbjct: 104 -----RGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQ---GVVHRDLKPSNILYV 155
Query: 363 EEFG----AHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTKSDVYSF 416
           +E G      +   G +K    ++  E  ++    Y   ++APE + R       D++S 
Sbjct: 156 DESGNPECLRICDFGFAK----QLRAENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSL 211
Query: 417 GVLLLEIVSGRRP 429
           G+LL  +++G  P
Sbjct: 212 GILLYTMLAGYTP 224

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 65/277 (23%), Positives = 114/277 (41%), Gaps = 51/277 (18%)
Query: 252 VAVKRLKRSSFQRKKE-FYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 309
           VAVK LK S+   ++E   SE+   + L +H N+V + G C   G   ++ E+   G L 
Sbjct: 56  VAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLL 115
Query: 310 RWLHH--------------IPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIR 355
            +L                +     +LD    +  +  +A+G+AFL  K   + +HRD+ 
Sbjct: 116 NFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLA 172
Query: 356 ASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT----YGYLAPEFVYRNELTTKS 411
           A N+LL       +   GL++    ++  +   +  G       ++APE ++    T +S
Sbjct: 173 ARNILLTHGRITKICDFGLAR----DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFES 228
Query: 412 DVYSFGVLLLEIV---SGRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXX 468
           DV+S+G+ L E+    S   P   VDS  ++ I E    L   H                
Sbjct: 229 DVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEH---------------- 272
Query: 469 XXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ 505
                   ++ D++  C    P  RP    +V  +++
Sbjct: 273 -----APAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 101/214 (47%), Gaps = 28/214 (13%)
Query: 228 EGNRLLGDSKTGGTYSGIL-----PDGSRVAVKRLKRSSFQRKKEFYS---EIGRFARLH 279
           +G R+LG     G++  ++       G   AVK + +   ++K +  S   E+    +L 
Sbjct: 35  KGQRVLGK----GSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 90
Query: 280 HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA 339
           HPN++ +     D G  Y+V E    G L  +   I R   S   A R  +   +  GI 
Sbjct: 91  HPNIMKLYEFFEDKGYFYLVGEVYTGGEL--FDEIISRKRFSEVDAAR--IIRQVLSGIT 146
Query: 340 FLHDKVKPHVVHRDIRASNVLLD---EEFGAHLMGVGLSK-FVPWEVMQERTVMAGGTYG 395
           ++H   K  +VHRD++  N+LL+   ++    ++  GLS  F   + M+++     GT  
Sbjct: 147 YMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI----GTAY 199
Query: 396 YLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           Y+APE V       K DV+S GV+L  ++SG  P
Sbjct: 200 YIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPP 232

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 278 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 337
           ++ P LV ++    D+ + Y+V E+V  G +     H+ R GR  +   R   A  +   
Sbjct: 85  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFSEPHARF-YAAQIVLT 140
Query: 338 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 397
             +LH      +++RD++  N+L+DE+    +   G +K V     + RT    GT  YL
Sbjct: 141 FEYLHS---LDLIYRDLKPENLLIDEQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYL 192
Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 193 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 224

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 86/193 (44%), Gaps = 40/193 (20%)
Query: 253 AVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRW 311
           AVK + +S    K++   EI    R   HPN++ +K    D    Y+V E +        
Sbjct: 56  AVKVIDKS----KRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELM-------- 103
Query: 312 LHHIPRGGRSLDWAMRMK---------VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 362
                RGG  LD  +R K         V  T+ + + +LH +    VVHRD++ SN+L  
Sbjct: 104 -----RGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQ---GVVHRDLKPSNILYV 155
Query: 363 EEFG----AHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTKSDVYSF 416
           +E G      +   G +K    ++  E  ++    Y   ++APE + R       D++S 
Sbjct: 156 DESGNPECLRICDFGFAK----QLRAENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSL 211
Query: 417 GVLLLEIVSGRRP 429
           G+LL  +++G  P
Sbjct: 212 GILLYTMLAGYTP 224

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/188 (28%), Positives = 84/188 (44%), Gaps = 21/188 (11%)
Query: 249 GSRVAVK-----RLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 303
           G  VAVK     +L  SS Q+    + E+     L+HPN+V +          Y+V E+ 
Sbjct: 39  GKEVAVKIIDKTQLNSSSLQK---LFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYA 95
Query: 304 VNGPL-DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 362
             G + D  + H    GR  +   R K    ++  + + H K    +VHRD++A N+LLD
Sbjct: 96  SGGEVFDYLVAH----GRMKEKEARAKFRQIVS-AVQYCHQKF---IVHRDLKAENLLLD 147
Query: 363 EEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE-FVYRNELTTKSDVYSFGVLLL 421
            +    +   G S    +     +     G+  Y APE F  +     + DV+S GV+L 
Sbjct: 148 ADMNIKIADFGFSNEFTF---GNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILY 204
Query: 422 EIVSGRRP 429
            +VSG  P
Sbjct: 205 TLVSGSLP 212

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 65/277 (23%), Positives = 114/277 (41%), Gaps = 51/277 (18%)
Query: 252 VAVKRLKRSSFQRKKE-FYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 309
           VAVK LK S+   ++E   SE+   + L +H N+V + G C   G   ++ E+   G L 
Sbjct: 72  VAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLL 131
Query: 310 RWLHH--------------IPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIR 355
            +L                +     +LD    +  +  +A+G+AFL  K   + +HRD+ 
Sbjct: 132 NFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLA 188
Query: 356 ASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT----YGYLAPEFVYRNELTTKS 411
           A N+LL       +   GL++    ++  +   +  G       ++APE ++    T +S
Sbjct: 189 ARNILLTHGRITKICDFGLAR----DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFES 244
Query: 412 DVYSFGVLLLEIV---SGRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXX 468
           DV+S+G+ L E+    S   P   VDS  ++ I E    L   H                
Sbjct: 245 DVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEH---------------- 288
Query: 469 XXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ 505
                   ++ D++  C    P  RP    +V  +++
Sbjct: 289 -----APAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 320

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 84/189 (44%), Gaps = 18/189 (9%)
Query: 252 VAVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDR-YIVYEFVVNGPL 308
           VAVK LK  ++    +   SE+     + HH N+V + G C   G    ++ EF   G L
Sbjct: 51  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 110
Query: 309 DRWL-----HHIPRGGRSLDWAMRMKVATTL-------AQGIAFLHDKVKPHVVHRDIRA 356
             +L       +P      D          L       A+G+ FL  +     +HRD+ A
Sbjct: 111 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA 167
Query: 357 SNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSF 416
            N+LL E+    +   GL++ +  +    R   A     ++APE ++    T +SDV+SF
Sbjct: 168 RNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 227
Query: 417 GVLLLEIVS 425
           GVLL EI S
Sbjct: 228 GVLLWEIFS 236

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/189 (29%), Positives = 84/189 (44%), Gaps = 18/189 (9%)
Query: 252 VAVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVY-EFVVNGPL 308
           VAVK LK  ++    +   SE+     + HH N+V + G C   G   +V  EF   G L
Sbjct: 51  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNL 110
Query: 309 DRWL-----HHIPRGGRSLDWAMRMKVATTL-------AQGIAFLHDKVKPHVVHRDIRA 356
             +L       +P      D          L       A+G+ FL  +     +HRD+ A
Sbjct: 111 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA 167
Query: 357 SNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSF 416
            N+LL E+    +   GL++ +  +    R   A     ++APE ++    T +SDV+SF
Sbjct: 168 RNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 227
Query: 417 GVLLLEIVS 425
           GVLL EI S
Sbjct: 228 GVLLWEIFS 236

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 65/277 (23%), Positives = 114/277 (41%), Gaps = 51/277 (18%)
Query: 252 VAVKRLKRSSFQRKKE-FYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 309
           VAVK LK S+   ++E   SE+   + L +H N+V + G C   G   ++ E+   G L 
Sbjct: 79  VAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLL 138
Query: 310 RWLHH--------------IPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIR 355
            +L                +     +LD    +  +  +A+G+AFL  K   + +HRD+ 
Sbjct: 139 NFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLA 195
Query: 356 ASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT----YGYLAPEFVYRNELTTKS 411
           A N+LL       +   GL++    ++  +   +  G       ++APE ++    T +S
Sbjct: 196 ARNILLTHGRITKICDFGLAR----DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFES 251
Query: 412 DVYSFGVLLLEIV---SGRRPAQAVDSVCWQSIFEWATPLVQSHRYXXXXXXXXXXXXXX 468
           DV+S+G+ L E+    S   P   VDS  ++ I E    L   H                
Sbjct: 252 DVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEH---------------- 295
Query: 469 XXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ 505
                   ++ D++  C    P  RP    +V  +++
Sbjct: 296 -----APAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 327

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 118/297 (39%), Gaps = 44/297 (14%)
Query: 229 GNRLLGDSKTGGTYSGILPDGSR-VAVKRLKRSSFQRKKE-FYSEIGRFARL-HHPNLVA 285
           G    G       Y  I  D +  VAVK LK S+   ++E   SE+   + L +H N+V 
Sbjct: 55  GAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVN 114
Query: 286 VKGCCYDHGDRYIVYEFVVNGPLDRWLHH--------------IPRGGRSLDWAMRMKVA 331
           + G C   G   ++ E+   G L  +L                +     +LD    +  +
Sbjct: 115 LLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFS 174
Query: 332 TTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG 391
             +A+G+AFL  K   + +HRD+ A N+LL       +   GL++ +  +        A 
Sbjct: 175 YQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNAR 231
Query: 392 GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIV---SGRRPAQAVDSVCWQSIFEWATPL 448
               ++APE ++    T +SDV+S+G+ L E+    S   P   VDS  ++ I E    L
Sbjct: 232 LPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRML 291
Query: 449 VQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ 505
              H                        ++ D++  C    P  RP    +V  +++
Sbjct: 292 SPEH---------------------APAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 327

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/188 (28%), Positives = 84/188 (44%), Gaps = 21/188 (11%)
Query: 249 GSRVAVK-----RLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 303
           G  VAVK     +L  SS Q+    + E+     L+HPN+V +          Y+V E+ 
Sbjct: 39  GKEVAVKIIDKTQLNSSSLQK---LFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYA 95
Query: 304 VNGPL-DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 362
             G + D  + H    GR  +   R K    ++  + + H K    +VHRD++A N+LLD
Sbjct: 96  SGGEVFDYLVAH----GRMKEKEARAKFRQIVS-AVQYCHQKF---IVHRDLKAENLLLD 147
Query: 363 EEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE-FVYRNELTTKSDVYSFGVLLL 421
            +    +   G S    +     +     G+  Y APE F  +     + DV+S GV+L 
Sbjct: 148 ADMNIKIADFGFSNEFTF---GNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILY 204
Query: 422 EIVSGRRP 429
            +VSG  P
Sbjct: 205 TLVSGSLP 212

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 88/214 (41%), Gaps = 15/214 (7%)
Query: 220 RSITKNFSEGNRLLGDSKTGGTYSGILPDGSRV-AVKRLKRSSFQRK---KEFYSEIGRF 275
           R  T +  +  R LG  K G  Y         + A+K L +S  +++    +   EI   
Sbjct: 10  RKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQ 69
Query: 276 ARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLA 335
           + L HPN++ +    +D    Y++ EF   G L + L    + GR  D          LA
Sbjct: 70  SHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQ---KHGR-FDEQRSATFMEELA 125
Query: 336 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG 395
             + + H++    V+HRDI+  N+L+  +    +   G S   P      R     GT  
Sbjct: 126 DALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAP----SLRRRXMCGTLD 178
Query: 396 YLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           YL PE +       K D++  GVL  E + G  P
Sbjct: 179 YLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 212

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 86/189 (45%), Gaps = 23/189 (12%)
Query: 249 GSRVAVK-----RLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 303
           G  VAV+     +L  SS Q+    + E+     L+HPN+V +          Y+V E+ 
Sbjct: 39  GKEVAVRIIDKTQLNSSSLQK---LFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYA 95
Query: 304 VNGPL-DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 362
             G + D  + H    GR  +   R K    ++  + + H K    +VHRD++A N+LLD
Sbjct: 96  SGGEVFDYLVAH----GRMKEKEARAKFRQIVS-AVQYCHQKF---IVHRDLKAENLLLD 147
Query: 363 EEFGAHLMGVGLS-KFVPWEVMQERTVMAGGTYGYLAPE-FVYRNELTTKSDVYSFGVLL 420
            +    +   G S +F     + E      G+  Y APE F  +     + DV+S GV+L
Sbjct: 148 ADMNIKIADFGFSNEFTFGNKLDEFC----GSPPYAAPELFQGKKYDGPEVDVWSLGVIL 203
Query: 421 LEIVSGRRP 429
             +VSG  P
Sbjct: 204 YTLVSGSLP 212

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 89/185 (48%), Gaps = 19/185 (10%)
Query: 249 GSRVAVKRLKRSSFQRKKEFYS---EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 305
           G   AVK + +   ++K +  S   E+    +L HPN++ +     D G  Y+V E    
Sbjct: 74  GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTG 133
Query: 306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD--- 362
           G L  +   I R   S   A R  +   +  GI ++H   K  +VHRD++  N+LL+   
Sbjct: 134 GEL--FDEIISRKRFSEVDAAR--IIRQVLSGITYMH---KNKIVHRDLKPENLLLESKS 186
Query: 363 EEFGAHLMGVGLSK-FVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLL 421
           ++    ++  GLS  F   + M+++     GT  Y+APE V       K DV+S GV+L 
Sbjct: 187 KDANIRIIDFGLSTHFEASKKMKDKI----GTAYYIAPE-VLHGTYDEKCDVWSTGVILY 241
Query: 422 EIVSG 426
            ++SG
Sbjct: 242 ILLSG 246

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 89/185 (48%), Gaps = 19/185 (10%)
Query: 249 GSRVAVKRLKRSSFQRKKEFYS---EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 305
           G   AVK + +   ++K +  S   E+    +L HPN++ +     D G  Y+V E    
Sbjct: 75  GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTG 134
Query: 306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD--- 362
           G L  +   I R   S   A R  +   +  GI ++H   K  +VHRD++  N+LL+   
Sbjct: 135 GEL--FDEIISRKRFSEVDAAR--IIRQVLSGITYMH---KNKIVHRDLKPENLLLESKS 187
Query: 363 EEFGAHLMGVGLSK-FVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLL 421
           ++    ++  GLS  F   + M+++     GT  Y+APE V       K DV+S GV+L 
Sbjct: 188 KDANIRIIDFGLSTHFEASKKMKDKI----GTAYYIAPE-VLHGTYDEKCDVWSTGVILY 242
Query: 422 EIVSG 426
            ++SG
Sbjct: 243 ILLSG 247

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 70/301 (23%), Positives = 120/301 (39%), Gaps = 52/301 (17%)
Query: 229 GNRLLGDSKTGGTYSGILPDGSR-VAVKRLKRSSFQRKKE-FYSEIGRFARL-HHPNLVA 285
           G    G       Y  I  D +  VAVK LK S+   ++E   SE+   + L +H N+V 
Sbjct: 50  GAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVN 109
Query: 286 VKGCCYDHGDRYIVYEFVVNGPLDRWLHH--------------IPRGGRSLDWAMRMKVA 331
           + G C   G   ++ E+   G L  +L                +     +LD    +  +
Sbjct: 110 LLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFS 169
Query: 332 TTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG 391
             +A+G+AFL  K   + +HRD+ A N+LL       +   GL++    ++  +   +  
Sbjct: 170 YQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLAR----DIKNDSNYVVK 222
Query: 392 GT----YGYLAPEFVYRNELTTKSDVYSFGVLLLEIV---SGRRPAQAVDSVCWQSIFEW 444
           G       ++APE ++    T +SDV+S+G+ L E+    S   P   VDS  ++ I E 
Sbjct: 223 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEG 282
Query: 445 ATPLVQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ 504
              L   H                        ++ D++  C    P  RP    +V  ++
Sbjct: 283 FRMLSPEH---------------------APAEMYDIMKTCWDADPLKRPTFKQIVQLIE 321
Query: 505 Q 505
           +
Sbjct: 322 K 322

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 84/189 (44%), Gaps = 18/189 (9%)
Query: 252 VAVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDR-YIVYEFVVNGPL 308
           VAVK LK  ++    +   SE+     + HH N+V + G C   G    ++ EF   G L
Sbjct: 60  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 119
Query: 309 DRWL-----HHIPRGGRSLDWAMRMKVATTL-------AQGIAFLHDKVKPHVVHRDIRA 356
             +L       +P      D          L       A+G+ FL  +     +HRD+ A
Sbjct: 120 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA 176
Query: 357 SNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSF 416
            N+LL E+    +   GL++ +  +    R   A     ++APE ++    T +SDV+SF
Sbjct: 177 RNILLSEKNVVKICDFGLARDIYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 236
Query: 417 GVLLLEIVS 425
           GVLL EI S
Sbjct: 237 GVLLWEIFS 245

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 38/169 (22%), Positives = 82/169 (48%), Gaps = 9/169 (5%)
Query: 263 QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSL 322
            +K++  +EI     L +P++V   G   D    Y+V E        R L  + +  +++
Sbjct: 84  HQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRR----RSLLELHKRRKAV 139
Query: 323 DWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 382
                        QG+ +LH+     V+HRD++  N+ L+++    +   GL+  + ++ 
Sbjct: 140 TEPEARYFMRQTIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDG 196
Query: 383 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQ 431
            +++T+   GT  Y+APE + +   + + D++S G +L  ++ G+ P +
Sbjct: 197 ERKKTLC--GTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE 243

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 84/189 (44%), Gaps = 18/189 (9%)
Query: 252 VAVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDR-YIVYEFVVNGPL 308
           VAVK LK  ++    +   SE+     + HH N+V + G C   G    ++ EF   G L
Sbjct: 62  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 121
Query: 309 DRWL-----HHIPRGGRSLDWAMRMKVATTL-------AQGIAFLHDKVKPHVVHRDIRA 356
             +L       +P      D          L       A+G+ FL  +     +HRD+ A
Sbjct: 122 STYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA 178
Query: 357 SNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSF 416
            N+LL E+    +   GL++ +  +    R   A     ++APE ++    T +SDV+SF
Sbjct: 179 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 238
Query: 417 GVLLLEIVS 425
           GVLL EI S
Sbjct: 239 GVLLWEIFS 247

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 73/158 (46%), Gaps = 13/158 (8%)
Query: 280 HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA 339
           HP L  +        + + V E++  G L   ++HI +     D +     A  +  G+ 
Sbjct: 77  HPFLTHMFCTFQTKENLFFVMEYLNGGDL---MYHI-QSCHKFDLSRATFYAAEIILGLQ 132
Query: 340 FLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM--QERTVMAGGTYGYL 397
           FLH K    +V+RD++  N+LLD++    +   G+ K    E M    +T    GT  Y+
Sbjct: 133 FLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCK----ENMLGDAKTNXFCGTPDYI 185
Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS 435
           APE +   +     D +SFGVLL E++ G+ P    D 
Sbjct: 186 APEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE 223

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 278 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 337
           ++ P LV ++    D+ + Y+V E+V  G +     H+ R GR  +   R   A  +   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFSEPHARF-YAAQIVLT 153
Query: 338 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 397
             +LH      +++RD++  N+L+D++    +   G +K V     + RT    GT  YL
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLXGTPEYL 205
Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 278 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 337
           ++ P LV ++    D+ + Y+V E+V  G +     H+ R GR  +   R   A  +   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFXEPHARF-YAAQIVLT 153
Query: 338 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 397
             +LH      +++RD++  N+L+D++    +   G +K V     + RT    GT  YL
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYL 205
Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 40/160 (25%), Positives = 74/160 (46%), Gaps = 10/160 (6%)
Query: 270 SEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMK 329
            EI   ++   P +    G        +I+ E++  G     L   P     LD      
Sbjct: 54  QEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-----LDETQIAT 108
Query: 330 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 389
           +   + +G+ +LH + K   +HRDI+A+NVLL E     L   G++  +    ++  T +
Sbjct: 109 ILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV 165
Query: 390 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
             GT  ++APE + ++   +K+D++S G+  +E+  G  P
Sbjct: 166 --GTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 203

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/188 (28%), Positives = 83/188 (44%), Gaps = 21/188 (11%)
Query: 249 GSRVAVK-----RLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 303
           G  VAVK     +L  SS Q+    + E+     L+HPN+V +          Y+V E+ 
Sbjct: 39  GKEVAVKIIDKTQLNSSSLQK---LFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYA 95
Query: 304 VNGPL-DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 362
             G + D  + H    GR  +   R K    ++  + + H K    +VHRD++A N+LLD
Sbjct: 96  SGGEVFDYLVAH----GRMKEKEARAKFRQIVS-AVQYCHQKF---IVHRDLKAENLLLD 147
Query: 363 EEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE-FVYRNELTTKSDVYSFGVLLL 421
            +    +   G S    +     +     G   Y APE F  +     + DV+S GV+L 
Sbjct: 148 ADMNIKIADFGFSNEFTF---GNKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILY 204
Query: 422 EIVSGRRP 429
            +VSG  P
Sbjct: 205 TLVSGSLP 212

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 278 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 337
           ++ P LV ++    D+ + Y+V E+V  G +     H+ R GR  +   R   A  +   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFXEPHARF-YAAQIVLT 153
Query: 338 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 397
             +LH      +++RD++  N+L+D++    +   G +K V     + RT    GT  YL
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYL 205
Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 84/185 (45%), Gaps = 15/185 (8%)
Query: 249 GSRVAVKRLKRSSFQRK--KEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 306
           G  VAVK + ++       ++ + E+     L+HPN+V +          Y+V E+   G
Sbjct: 40  GREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGG 99
Query: 307 PL-DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 365
            + D  + H    GR  +   R K    ++  + + H K   ++VHRD++A N+LLD + 
Sbjct: 100 EVFDYLVAH----GRMKEKEARAKFRQIVS-AVQYCHQK---YIVHRDLKAENLLLDGDM 151
Query: 366 GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE-FVYRNELTTKSDVYSFGVLLLEIV 424
              +   G S    + V  +     G    Y APE F  +     + DV+S GV+L  +V
Sbjct: 152 NIKIADFGFSN--EFTVGNKLDTFCGSP-PYAAPELFQGKKYDGPEVDVWSLGVILYTLV 208
Query: 425 SGRRP 429
           SG  P
Sbjct: 209 SGSLP 213

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 278 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 337
           ++ P LV ++    D+ + Y+V E+V  G +     H+ R GR  +   R   A  +   
Sbjct: 93  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFXEPHARF-YAAQIVLT 148
Query: 338 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 397
             +LH      +++RD++  N+L+D++    +   G +K V     + RT    GT  YL
Sbjct: 149 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYL 200
Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 201 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 232

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 76/161 (47%), Gaps = 26/161 (16%)
Query: 280 HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA 339
           HPN++ +K     +   ++V++ +  G L  +L        +L      K+   L + I 
Sbjct: 70  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVIC 125
Query: 340 FLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLS-KFVPWEVMQERTVMAGGTYGYLA 398
            LH   K ++VHRD++  N+LLD++    L   G S +  P E ++E      GT  YLA
Sbjct: 126 ALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE----VCGTPSYLA 178
Query: 399 PEFV----------YRNELTTKSDVYSFGVLLLEIVSGRRP 429
           PE +          Y  E+    D++S GV++  +++G  P
Sbjct: 179 PEIIECSMNDNHPGYGKEV----DMWSTGVIMYTLLAGSPP 215

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 56/189 (29%), Positives = 84/189 (44%), Gaps = 18/189 (9%)
Query: 252 VAVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVY-EFVVNGPL 308
           VAVK LK  ++    +   SE+     + HH N+V + G C   G   +V  EF   G L
Sbjct: 51  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNL 110
Query: 309 DRWL-----HHIPRGGRSLDWAMRMKVATTL-------AQGIAFLHDKVKPHVVHRDIRA 356
             +L       +P      D          L       A+G+ FL  +     +HRD+ A
Sbjct: 111 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA 167
Query: 357 SNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSF 416
            N+LL E+    +   GL++ +  +    R   A     ++APE ++    T +SDV+SF
Sbjct: 168 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 227
Query: 417 GVLLLEIVS 425
           GVLL EI S
Sbjct: 228 GVLLWEIFS 236

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 278 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 337
           ++ P LV ++    D+ + Y+V E+V  G +     H+ R GR  +   R   A  +   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFXEPHARF-YAAQIVLT 153
Query: 338 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 397
             +LH      +++RD++  N+L+D++    +   G +K V     + RT    GT  YL
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYL 205
Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 84/189 (44%), Gaps = 18/189 (9%)
Query: 252 VAVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHG-DRYIVYEFVVNGPL 308
           VAVK LK  ++    +   SE+     + HH N+V + G C   G    ++ EF   G L
Sbjct: 60  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 119
Query: 309 DRWL-----HHIPRGGRSLDWAMRMKVATTL-------AQGIAFLHDKVKPHVVHRDIRA 356
             +L       +P      D          L       A+G+ FL  +     +HRD+ A
Sbjct: 120 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA 176
Query: 357 SNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSF 416
            N+LL E+    +   GL++ +  +    R   A     ++APE ++    T +SDV+SF
Sbjct: 177 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 236
Query: 417 GVLLLEIVS 425
           GVLL EI S
Sbjct: 237 GVLLWEIFS 245

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 39/169 (23%), Positives = 79/169 (46%), Gaps = 9/169 (5%)
Query: 263 QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSL 322
            +K++  +EI     L +P++V   G   D    Y+V E        R L  + +  +++
Sbjct: 84  HQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRR----RSLLELHKRRKAV 139
Query: 323 DWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 382
                        QG+ +LH+     V+HRD++  N+ L+++    +   GL+  + ++ 
Sbjct: 140 TEPEARYFMRQTIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFD- 195
Query: 383 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQ 431
             ER     GT  Y+APE + +   + + D++S G +L  ++ G+ P +
Sbjct: 196 -GERKKXLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE 243

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 278 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 337
           ++ P LV ++    D+ + Y+V E+V  G +     H+ R GR  +   R   A  +   
Sbjct: 119 VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFXEPHARF-YAAQIVLT 174
Query: 338 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 397
             +LH      +++RD++  N+L+D++    +   G +K V     + RT    GT  YL
Sbjct: 175 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYL 226
Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 227 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 278 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 337
           ++ P LV ++    D+ + Y+V E+V  G +     H+ R GR  +   R   A  +   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFAEPHARF-YAAQIVLT 153
Query: 338 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 397
             +LH      +++RD++  N+L+D++    +   G +K V     + RT    GT  YL
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYL 205
Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 84/203 (41%), Gaps = 15/203 (7%)
Query: 231 RLLGDSKTGGTYSGILPDGSRV-AVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAV 286
           R LG  K G  Y         + A+K L +S  +++    +   EI   + L HPN++ +
Sbjct: 20  RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 79
Query: 287 KGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVK 346
               +D    Y++ EF   G L + L    + GR  D          LA  + + H++  
Sbjct: 80  YNYFHDRKRIYLMLEFAPRGELYKELQ---KHGR-FDEQRSATFMEELADALHYCHER-- 133
Query: 347 PHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNE 406
             V+HRDI+  N+L+  +    +   G S   P      R     GT  YL PE +    
Sbjct: 134 -KVIHRDIKPENLLMGYKGELKIADFGWSVHAP----SLRRRXMCGTLDYLPPEMIEGKT 188
Query: 407 LTTKSDVYSFGVLLLEIVSGRRP 429
              K D++  GVL  E + G  P
Sbjct: 189 HDEKVDLWCAGVLCYEFLVGMPP 211

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 74/159 (46%), Gaps = 10/159 (6%)
Query: 271 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 330
           EI   ++   P +    G        +I+ E++  G     L   P     LD      +
Sbjct: 75  EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-----LDETQIATI 129
Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 390
              + +G+ +LH + K   +HRDI+A+NVLL E     L   G++  +    ++  T + 
Sbjct: 130 LREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV- 185
Query: 391 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
            GT  ++APE + ++   +K+D++S G+  +E+  G  P
Sbjct: 186 -GTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 223

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 76/161 (47%), Gaps = 26/161 (16%)
Query: 280 HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA 339
           HPN++ +K     +   ++V++ +  G L  +L        +L      K+   L + I 
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVIC 138
Query: 340 FLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLS-KFVPWEVMQERTVMAGGTYGYLA 398
            LH   K ++VHRD++  N+LLD++    L   G S +  P E ++E      GT  YLA
Sbjct: 139 ALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE----VCGTPSYLA 191
Query: 399 PEFV----------YRNELTTKSDVYSFGVLLLEIVSGRRP 429
           PE +          Y  E+    D++S GV++  +++G  P
Sbjct: 192 PEIIECSMNDNHPGYGKEV----DMWSTGVIMYTLLAGSPP 228

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 84/189 (44%), Gaps = 18/189 (9%)
Query: 252 VAVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRY-IVYEFVVNGPL 308
           VAVK LK  ++    +   SE+     + HH N+V + G C   G    ++ EF   G L
Sbjct: 97  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 156
Query: 309 DRWL-----HHIPRGGRSLDWAMRMKVATTL-------AQGIAFLHDKVKPHVVHRDIRA 356
             +L       +P      D          L       A+G+ FL  +     +HRD+ A
Sbjct: 157 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA 213
Query: 357 SNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSF 416
            N+LL E+    +   GL++ +  +    R   A     ++APE ++    T +SDV+SF
Sbjct: 214 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 273
Query: 417 GVLLLEIVS 425
           GVLL EI S
Sbjct: 274 GVLLWEIFS 282

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 75/176 (42%), Gaps = 9/176 (5%)
Query: 270 SEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMK 329
            EI   A L+H N+V   G   +   +Y+  E+   G L   +   P  G     A R  
Sbjct: 54  KEICINAMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRF- 110
Query: 330 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 389
               L  G+ +LH      + HRDI+  N+LLDE     +   GL+    +   +     
Sbjct: 111 -FHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166
Query: 390 AGGTYGYLAPEFVYRNELTTKS-DVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEW 444
             GT  Y+APE + R E   +  DV+S G++L  +++G  P       C Q   +W
Sbjct: 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDW 221

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 84/188 (44%), Gaps = 21/188 (11%)
Query: 249 GSRVAVK-----RLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 303
           G  VAV+     +L  SS Q+    + E+     L+HPN+V +          Y+V E+ 
Sbjct: 39  GKEVAVRIIDKTQLNSSSLQK---LFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYA 95
Query: 304 VNGPL-DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 362
             G + D  + H    GR  +   R K    ++  + + H K    +VHRD++A N+LLD
Sbjct: 96  SGGEVFDYLVAH----GRMKEKEARAKFRQIVS-AVQYCHQKF---IVHRDLKAENLLLD 147
Query: 363 EEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE-FVYRNELTTKSDVYSFGVLLL 421
            +    +   G S    +     +     G+  Y APE F  +     + DV+S GV+L 
Sbjct: 148 ADMNIKIADFGFSNEFTF---GNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILY 204
Query: 422 EIVSGRRP 429
            +VSG  P
Sbjct: 205 TLVSGSLP 212

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 73/159 (45%), Gaps = 13/159 (8%)
Query: 279 HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGI 338
            HP L  +        + + V E++  G L   ++HI +     D +     A  +  G+
Sbjct: 77  EHPFLTHMFCTFQTKENLFFVMEYLNGGDL---MYHI-QSCHKFDLSRATFYAAEIILGL 132
Query: 339 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM--QERTVMAGGTYGY 396
            FLH K    +V+RD++  N+LLD++    +   G+ K    E M    +T    GT  Y
Sbjct: 133 QFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCK----ENMLGDAKTNEFCGTPDY 185
Query: 397 LAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS 435
           +APE +   +     D +SFGVLL E++ G+ P    D 
Sbjct: 186 IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE 224

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 278 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 337
           ++ P LV ++    D+ + Y+V E+V  G +     H+ R GR  +   R   A  +   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFSEPHARF-YAAQIVLT 153
Query: 338 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 397
             +LH      +++RD++  N+L+D++    +   G +K V     + RT    GT  YL
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYL 205
Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 88/198 (44%), Gaps = 19/198 (9%)
Query: 232 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 291
           L+   +TG  Y+  + D  +V   +    +   K+   +       ++ P LV ++    
Sbjct: 52  LVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-------VNFPFLVKLEFSFK 104
Query: 292 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 351
           D+ + Y+V E+V  G +     H+ R GR  +   R   A  +     +LH      +++
Sbjct: 105 DNSNLYMVMEYVPGGEM---FSHLRRIGRFXEPHARF-YAAQIVLTFEYLHS---LDLIY 157
Query: 352 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKS 411
           RD++  N+L+D++    +   G +K V     + RT    GT  YLAPE +         
Sbjct: 158 RDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYNKAV 212
Query: 412 DVYSFGVLLLEIVSGRRP 429
           D ++ GVL+ E+ +G  P
Sbjct: 213 DWWALGVLIYEMAAGYPP 230

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 68/297 (22%), Positives = 125/297 (42%), Gaps = 51/297 (17%)
Query: 225 NFSEGNRL--LGDSKTGGTYSGILPDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHH 280
           +F + N L  L ++ +G  + G    G+ + VK LK    S ++ ++F  E  R     H
Sbjct: 8   DFKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH 66
Query: 281 PNLVAVKGCCYDHGDRY--IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGI 338
           PN++ V G C      +  ++  ++  G L   LH        +D +  +K A  +A+G+
Sbjct: 67  PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHE--GTNFVVDQSQAVKFALDMARGM 124
Query: 339 AFLHDKVKPHVVHRDIRASNVLLDEEFGAH--LMGVGLSKFVPWEVMQERTVMAGGTY-- 394
           AFLH  ++P +    + + +V++DE+  A   +  V  S   P           G  Y  
Sbjct: 125 AFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP-----------GRMYAP 172
Query: 395 GYLAPEFVYRNELTTK---SDVYSFGVLLLEIVSGRRPAQAVDS--VCWQSIFEWATPLV 449
            ++APE + +    T    +D++SF VLL E+V+   P   + +  +  +   E   P +
Sbjct: 173 AWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTI 232
Query: 450 QSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 506
                                  G+   V  L+  C    P+ RP+   +V  L+++
Sbjct: 233 P---------------------PGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 278 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 337
           ++ P LV ++    D+ + Y+V E+V  G +     H+ R GR  +   R   A  +   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFSEPHARF-YAAQIVLT 153
Query: 338 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 397
             +LH      +++RD++  N+L+D++    +   G +K V     + RT    GT  YL
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYL 205
Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 75/159 (47%), Gaps = 12/159 (7%)
Query: 278 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 337
           ++ P LV ++    D+ + Y+V E+V  G +     H+ R GR  +   R   A  +   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFSEPHARF-YAAQIVLT 153
Query: 338 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 397
             +LH      +++RD++  N+L+D++    +   G +K V     + RT    GT  YL
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYL 205
Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSV 436
           APE +         D ++ GVL+ E+ +G  P  A + +
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADEPI 244

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/189 (29%), Positives = 84/189 (44%), Gaps = 18/189 (9%)
Query: 252 VAVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVY-EFVVNGPL 308
           VAVK LK  ++    +   SE+     + HH N+V + G C   G   +V  EF   G L
Sbjct: 51  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNL 110
Query: 309 DRWL-----HHIPRGGRSLDWAMRMKVATTL-------AQGIAFLHDKVKPHVVHRDIRA 356
             +L       +P      D          L       A+G+ FL  +     +HRD+ A
Sbjct: 111 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA 167
Query: 357 SNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSF 416
            N+LL E+    +   GL++ +  +    R   A     ++APE ++    T +SDV+SF
Sbjct: 168 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 227
Query: 417 GVLLLEIVS 425
           GVLL EI S
Sbjct: 228 GVLLWEIFS 236

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 278 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 337
           ++ P LV ++    D+ + Y+V E+V  G +     H+ R GR  +   R   A  +   
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFSEPHARF-YAAQIVLT 154
Query: 338 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 397
             +LH      +++RD++  N+L+D++    +   G +K V     + RT    GT  YL
Sbjct: 155 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYL 206
Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 278 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 337
           ++ P LV ++    D+ + Y+V E+V  G +     H+ R GR  +   R   A  +   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFSEPHARF-YAAQIVLT 153
Query: 338 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 397
             +LH      +++RD++  N+L+D++    +   G +K V     + RT    GT  YL
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYL 205
Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 278 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 337
           ++ P LV ++    D+ + Y+V E+V  G +     H+ R GR  +   R   A  +   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFSEPHARF-YAAQIVLT 153
Query: 338 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 397
             +LH      +++RD++  N+L+D++    +   G +K V     + RT    GT  YL
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYL 205
Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/188 (28%), Positives = 83/188 (44%), Gaps = 21/188 (11%)
Query: 249 GSRVAVK-----RLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 303
           G  VAVK     +L  SS Q+    + E+     L+HPN+V +          Y+V E+ 
Sbjct: 39  GKEVAVKIIDKTQLNSSSLQK---LFREVRIXKVLNHPNIVKLFEVIETEKTLYLVXEYA 95
Query: 304 VNGPL-DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 362
             G + D  + H    GR  +   R K    ++  + + H K    +VHRD++A N+LLD
Sbjct: 96  SGGEVFDYLVAH----GRXKEKEARAKFRQIVS-AVQYCHQKF---IVHRDLKAENLLLD 147
Query: 363 EEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE-FVYRNELTTKSDVYSFGVLLL 421
            +    +   G S    +     +     G   Y APE F  +     + DV+S GV+L 
Sbjct: 148 ADXNIKIADFGFSNEFTF---GNKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILY 204
Query: 422 EIVSGRRP 429
            +VSG  P
Sbjct: 205 TLVSGSLP 212

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 102/223 (45%), Gaps = 27/223 (12%)
Query: 212 KVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAV--------KRLKRSSF 262
           ++F   ELR +        ++LG    G  + G+ +P+G  + +         +  R SF
Sbjct: 26  RIFKETELRKL--------KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSF 77
Query: 263 QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSL 322
           Q   +    IG    L H ++V + G C       +V +++   PL   L H+ +   +L
Sbjct: 78  QAVTDHMLAIGS---LDHAHIVRLLGLC-PGSSLQLVTQYL---PLGSLLDHVRQHRGAL 130
Query: 323 DWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 382
              + +     +A+G+ +L +     +VHR++ A NVLL       +   G++  +P + 
Sbjct: 131 GPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD 187
Query: 383 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 425
            Q     A     ++A E ++  + T +SDV+S+GV + E+++
Sbjct: 188 KQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 102/223 (45%), Gaps = 27/223 (12%)
Query: 212 KVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAV--------KRLKRSSF 262
           ++F   ELR +        ++LG    G  + G+ +P+G  + +         +  R SF
Sbjct: 8   RIFKETELRKL--------KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSF 59
Query: 263 QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSL 322
           Q   +    IG    L H ++V + G C       +V +++   PL   L H+ +   +L
Sbjct: 60  QAVTDHMLAIGS---LDHAHIVRLLGLC-PGSSLQLVTQYL---PLGSLLDHVRQHRGAL 112
Query: 323 DWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 382
              + +     +A+G+ +L +     +VHR++ A NVLL       +   G++  +P + 
Sbjct: 113 GPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD 169
Query: 383 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 425
            Q     A     ++A E ++  + T +SDV+S+GV + E+++
Sbjct: 170 KQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/170 (22%), Positives = 79/170 (46%), Gaps = 9/170 (5%)
Query: 263 QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSL 322
            +K++  +EI     L +P++V   G   D    Y+V E        R L  + +  +++
Sbjct: 68  HQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRR----RSLLELHKRRKAV 123
Query: 323 DWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 382
                        QG+ +LH+     V+HRD++  N+ L+++    +   GL+  + ++ 
Sbjct: 124 TEPEARYFMRQTIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFD- 179
Query: 383 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQA 432
             ER     GT  Y+APE + +   + + D++S G +L  ++ G+ P + 
Sbjct: 180 -GERKKDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFET 228

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 86/193 (44%), Gaps = 40/193 (20%)
Query: 253 AVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRW 311
           AVK + +S    K++   EI    R   HPN++ +K    D    Y+V E +        
Sbjct: 51  AVKIIDKS----KRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELM-------- 98
Query: 312 LHHIPRGGRSLDWAMRMK---------VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 362
                +GG  LD  +R K         V  T+ + + +LH +    VVHRD++ SN+L  
Sbjct: 99  -----KGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYV 150
Query: 363 EEFG----AHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTKSDVYSF 416
           +E G      +   G +K    ++  E  ++    Y   ++APE + R       D++S 
Sbjct: 151 DESGNPESIRICDFGFAK----QLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSL 206
Query: 417 GVLLLEIVSGRRP 429
           GVLL  +++G  P
Sbjct: 207 GVLLYTMLTGYTP 219

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 278 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 337
           ++ P LV ++    D+ + Y+V E+V  G +     H+ R GR  +   R   A  +   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFSEPHARF-YAAQIVLT 153
Query: 338 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 397
             +LH      +++RD++  N+L+D++    +   G +K V     + RT    GT  YL
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYL 205
Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/169 (23%), Positives = 79/169 (46%), Gaps = 9/169 (5%)
Query: 263 QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSL 322
            +K++  +EI     L +P++V   G   D    Y+V E        R L  + +  +++
Sbjct: 84  HQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRR----RSLLELHKRRKAV 139
Query: 323 DWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 382
                        QG+ +LH+     V+HRD++  N+ L+++    +   GL+  + ++ 
Sbjct: 140 TEPEARYFMRQTIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFD- 195
Query: 383 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQ 431
             ER     GT  Y+APE + +   + + D++S G +L  ++ G+ P +
Sbjct: 196 -GERKKDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE 243

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 278 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 337
           ++ P LV ++    D+ + Y+V E+V  G +     H+ R GR  +   R   A  +   
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM---FSHLRRIGRFXEPHARF-YAAQIVLT 154
Query: 338 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 397
             +LH      +++RD++  N+L+D++    +   G +K V     + RT    GT  YL
Sbjct: 155 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYL 206
Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 278 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 337
           ++ P LV ++    D+ + Y+V E+V  G +     H+ R GR  +   R   A  +   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM---FSHLRRIGRFXEPHARF-YAAQIVLT 153
Query: 338 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 397
             +LH      +++RD++  N+L+D++    +   G +K V     + RT    GT  YL
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYL 205
Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 278 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 337
           ++ P LV ++    D+ + Y+V E+V  G +     H+ R GR  +   R   A  +   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM---FSHLRRIGRFXEPHARF-YAAQIVLT 153
Query: 338 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 397
             +LH      +++RD++  N+L+D++    +   G +K V     + RT    GT  YL
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYL 205
Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 88/198 (44%), Gaps = 19/198 (9%)
Query: 232 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 291
           L+   +TG  Y+  + D  +V   +    +   K+   +       ++ P LV ++    
Sbjct: 52  LVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-------VNFPFLVKLEFSFK 104
Query: 292 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 351
           D+ + Y+V E+V  G +     H+ R GR  +   R   A  +     +LH      +++
Sbjct: 105 DNSNLYMVMEYVPGGEM---FSHLRRIGRFSEPHARF-YAAQIVLTFEYLHS---LDLIY 157
Query: 352 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKS 411
           RD++  N+L+D++    +   G +K V     + RT    GT  YLAPE +         
Sbjct: 158 RDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYNKAV 212
Query: 412 DVYSFGVLLLEIVSGRRP 429
           D ++ GVL+ E+ +G  P
Sbjct: 213 DWWALGVLIYEMAAGYPP 230

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 9/168 (5%)
Query: 278 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 337
           L+H N+V   G   +   +Y+  E+   G L   +   P  G     A R      L  G
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRF--FHQLMAG 117
Query: 338 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 397
           + +LH      + HRDI+  N+LLDE     +   GL+    +   +       GT  Y+
Sbjct: 118 VVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 398 APEFVYRNELTTKS-DVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEW 444
           APE + R E   +  DV+S G++L  +++G  P       C Q   +W
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDW 221

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 9/168 (5%)
Query: 278 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 337
           L+H N+V   G   +   +Y+  E+   G L   +   P  G     A R      L  G
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRF--FHQLMAG 116
Query: 338 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 397
           + +LH      + HRDI+  N+LLDE     +   GL+    +   +       GT  Y+
Sbjct: 117 VVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 398 APEFVYRNELTTKS-DVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEW 444
           APE + R E   +  DV+S G++L  +++G  P       C Q   +W
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDW 220

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 88/198 (44%), Gaps = 19/198 (9%)
Query: 232 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 291
           L+   +TG  Y+  + D  +V   +    +   K+   +       ++ P LV ++    
Sbjct: 60  LVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-------VNFPFLVKLEFSFK 112
Query: 292 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 351
           D+ + Y+V E+V  G +     H+ R GR  +   R   A  +     +LH      +++
Sbjct: 113 DNSNLYMVMEYVPGGEM---FSHLRRIGRFSEPHARF-YAAQIVLTFEYLHS---LDLIY 165
Query: 352 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKS 411
           RD++  N+L+D++    +   G +K V     + RT    GT  YLAPE +         
Sbjct: 166 RDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYNKAV 220
Query: 412 DVYSFGVLLLEIVSGRRP 429
           D ++ GVL+ E+ +G  P
Sbjct: 221 DWWALGVLIYEMAAGYPP 238

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 88/198 (44%), Gaps = 19/198 (9%)
Query: 232 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 291
           L+   +TG  Y+  + D  +V   +    +   K+   +       ++ P LV ++    
Sbjct: 60  LVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-------VNFPFLVKLEFSFK 112
Query: 292 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 351
           D+ + Y+V E+V  G +     H+ R GR  +   R   A  +     +LH      +++
Sbjct: 113 DNSNLYMVMEYVPGGEM---FSHLRRIGRFSEPHARF-YAAQIVLTFEYLHS---LDLIY 165
Query: 352 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKS 411
           RD++  N+L+D++    +   G +K V     + RT    GT  YLAPE +         
Sbjct: 166 RDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYNKAV 220
Query: 412 DVYSFGVLLLEIVSGRRP 429
           D ++ GVL+ E+ +G  P
Sbjct: 221 DWWALGVLIYEMAAGYPP 238

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/158 (24%), Positives = 71/158 (44%), Gaps = 12/158 (7%)
Query: 280 HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA 339
           HPN+V +    +D    ++V E +  G L   +    +  +         +   L   ++
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERI----KKKKHFSETEASYIMRKLVSAVS 120
Query: 340 FLHDKVKPHVVHRDIRASNVLLDEE---FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGY 396
            +HD     VVHRD++  N+L  +E       ++  G ++  P +    +T     T  Y
Sbjct: 121 HMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFTLHY 175
Query: 397 LAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVD 434
            APE + +N      D++S GV+L  ++SG+ P Q+ D
Sbjct: 176 AAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHD 213

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 9/168 (5%)
Query: 278 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 337
           L+H N+V   G   +   +Y+  E+   G L   +   P  G     A R      L  G
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRF--FHQLMAG 116
Query: 338 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 397
           + +LH      + HRDI+  N+LLDE     +   GL+    +   +       GT  Y+
Sbjct: 117 VVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYV 173
Query: 398 APEFVYRNELTTKS-DVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEW 444
           APE + R E   +  DV+S G++L  +++G  P       C Q   +W
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDW 220

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 112/252 (44%), Gaps = 31/252 (12%)
Query: 198 LSNPAASALVPPSWKVFTT-----EELRSITKNFSEGNRLLGDSKTG-GTYSGILPDGSR 251
           +++P     +P    VF +     EEL+         N L+ D + G G +  +     R
Sbjct: 299 ITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYR 358
Query: 252 -------VAVKRLKRSSFQRK-KEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 303
                  VA+K LK+ + +   +E   E     +L +P +V + G C       +V E  
Sbjct: 359 MRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMA 417
Query: 304 VNGPLDRWL----HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNV 359
             GPL ++L      IP    +       ++   ++ G+ +L +K   + VHR++ A NV
Sbjct: 418 GGGPLHKFLVGKREEIPVSNVA-------ELLHQVSMGMKYLEEK---NFVHRNLAARNV 467
Query: 360 LLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG-TYGYLAPEFVYRNELTTKSDVYSFGV 418
           LL     A +   GLSK +  +        AG     + APE +   + +++SDV+S+GV
Sbjct: 468 LLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGV 527
Query: 419 LLLEIVS-GRRP 429
            + E +S G++P
Sbjct: 528 TMWEALSYGQKP 539

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 88/198 (44%), Gaps = 19/198 (9%)
Query: 232 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 291
           L+   +TG  Y+  + D  +V   +    +   K+   +       ++ P LV ++    
Sbjct: 60  LVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-------VNFPFLVKLEFSFK 112
Query: 292 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 351
           D+ + Y+V E+V  G +     H+ R GR  +   R   A  +     +LH      +++
Sbjct: 113 DNSNLYMVMEYVPGGEM---FSHLRRIGRFSEPHARF-YAAQIVLTFEYLHS---LDLIY 165
Query: 352 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKS 411
           RD++  N+L+D++    +   G +K V     + RT    GT  YLAPE +         
Sbjct: 166 RDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYNKAV 220
Query: 412 DVYSFGVLLLEIVSGRRP 429
           D ++ GVL+ E+ +G  P
Sbjct: 221 DWWALGVLIYEMAAGYPP 238

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 74/176 (42%), Gaps = 9/176 (5%)
Query: 270 SEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMK 329
            EI     L+H N+V   G   +   +Y+  E+   G L   +   P  G     A R  
Sbjct: 54  KEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRF- 110
Query: 330 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 389
               L  G+ +LH      + HRDI+  N+LLDE     +   GL+    +   +     
Sbjct: 111 -FHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166
Query: 390 AGGTYGYLAPEFVYRNELTTKS-DVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEW 444
             GT  Y+APE + R E   +  DV+S G++L  +++G  P       C Q   +W
Sbjct: 167 MXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDW 221

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 9/168 (5%)
Query: 278 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 337
           L+H N+V   G   +   +Y+  E+   G L   +   P  G     A R      L  G
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRF--FHQLMAG 116
Query: 338 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 397
           + +LH      + HRDI+  N+LLDE     +   GL+    +   +       GT  Y+
Sbjct: 117 VVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYV 173
Query: 398 APEFVYRNELTTKS-DVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEW 444
           APE + R E   +  DV+S G++L  +++G  P       C Q   +W
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDW 220

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/161 (24%), Positives = 74/161 (45%), Gaps = 12/161 (7%)
Query: 270 SEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMK 329
            EI   ++   P +    G        +I+ E++  G     L   P     LD      
Sbjct: 69  QEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-----LDETQIAT 123
Query: 330 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLS-KFVPWEVMQERTV 388
           +   + +G+ +LH + K   +HRDI+A+NVLL E     L   G++ +    ++ +   V
Sbjct: 124 ILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFV 180
Query: 389 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
              GT  ++APE + ++   +K+D++S G+  +E+  G  P
Sbjct: 181 ---GTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 218

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 95/197 (48%), Gaps = 28/197 (14%)
Query: 251 RVAVK---RLKRSSFQRKKEFYSEIGRFAR-------LHHPNLVAVKGCCYDHGDRYIVY 300
           ++AV+   R++R++ +  K F  ++ RF +       L HPN++ +     D+ D Y+V 
Sbjct: 26  KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 85
Query: 301 EFVVNGPL-DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNV 359
           E    G L +R +H   R  R  D A  MK    +   +A+ H   K +V HRD++  N 
Sbjct: 86  ELCTGGELFERVVHK--RVFRESDAARIMK---DVLSAVAYCH---KLNVAHRDLKPENF 137
Query: 360 LL---DEEFGAHLMGVGL-SKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYS 415
           L      +    L+  GL ++F P ++M+ +     GT  Y++P+ V       + D +S
Sbjct: 138 LFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV----GTPYYVSPQ-VLEGLYGPECDEWS 192
Query: 416 FGVLLLEIVSGRRPAQA 432
            GV++  ++ G  P  A
Sbjct: 193 AGVMMYVLLCGYPPFSA 209

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 74/176 (42%), Gaps = 9/176 (5%)
Query: 270 SEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMK 329
            EI     L+H N+V   G   +   +Y+  E+   G L   +   P  G     A R  
Sbjct: 53  KEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRF- 109
Query: 330 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 389
               L  G+ +LH      + HRDI+  N+LLDE     +   GL+    +   +     
Sbjct: 110 -FHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 165
Query: 390 AGGTYGYLAPEFVYRNELTTKS-DVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEW 444
             GT  Y+APE + R E   +  DV+S G++L  +++G  P       C Q   +W
Sbjct: 166 MXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDW 220

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 87/193 (45%), Gaps = 40/193 (20%)
Query: 253 AVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRW 311
           AVK + +S    K++   EI    R   HPN++ +K   YD G     Y +VV       
Sbjct: 51  AVKIIDKS----KRDPTEEIEILLRYGQHPNIITLKDV-YDDGK----YVYVVT------ 95
Query: 312 LHHIPRGGRSLDWAMRMK---------VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 362
              + +GG  LD  +R K         V  T+ + + +LH +    VVHRD++ SN+L  
Sbjct: 96  --ELXKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYV 150
Query: 363 EEFG----AHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTKSDVYSF 416
           +E G      +   G +K    ++  E  ++    Y   ++APE + R       D++S 
Sbjct: 151 DESGNPESIRICDFGFAK----QLRAENGLLXTPCYTANFVAPEVLERQGYDAACDIWSL 206
Query: 417 GVLLLEIVSGRRP 429
           GVLL   ++G  P
Sbjct: 207 GVLLYTXLTGYTP 219

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 9/168 (5%)
Query: 278 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 337
           L+H N+V   G   +   +Y+  E+   G L   +   P  G     A R      L  G
Sbjct: 60  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRF--FHQLMAG 115
Query: 338 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 397
           + +LH      + HRDI+  N+LLDE     +   GL+    +   +       GT  Y+
Sbjct: 116 VVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 172
Query: 398 APEFVYRNELTTKS-DVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEW 444
           APE + R E   +  DV+S G++L  +++G  P       C Q   +W
Sbjct: 173 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDW 219

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 278 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 337
           ++ P LV ++    D+ + Y+V E+V  G +     H+ R GR  +   R   A  +   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFSEPHARF-YAAQIVLT 153
Query: 338 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 397
             +LH      +++RD++  N+++D++    +   G +K V     + RT    GT  YL
Sbjct: 154 FEYLHS---LDLIYRDLKPENLIIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYL 205
Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 206 APEIIISKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 88/198 (44%), Gaps = 19/198 (9%)
Query: 232 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 291
           L+   +TG  Y+  + D  +V   +    +   K+   +       ++ P LV ++    
Sbjct: 45  LVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-------VNFPFLVKLEFSFK 97
Query: 292 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 351
           D+ + Y+V E+V  G +     H+ R GR  +   R   A  +     +LH      +++
Sbjct: 98  DNSNLYMVMEYVPGGEM---FSHLRRIGRFSEPHARF-YAAQIVLTFEYLHS---LDLIY 150
Query: 352 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKS 411
           RD++  N+L+D++    +   G +K V     + RT    GT  YLAPE +         
Sbjct: 151 RDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWTLCGTPEYLAPEIILSKGYNKAV 205
Query: 412 DVYSFGVLLLEIVSGRRP 429
           D ++ GVL+ E+ +G  P
Sbjct: 206 DWWALGVLIYEMAAGYPP 223

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 9/168 (5%)
Query: 278 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 337
           L+H N+V   G   +   +Y+  E+   G L   +   P  G     A R      L  G
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRF--FHQLMAG 117
Query: 338 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 397
           + +LH      + HRDI+  N+LLDE     +   GL+    +   +       GT  Y+
Sbjct: 118 VVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 398 APEFVYRNELTTKS-DVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEW 444
           APE + R E   +  DV+S G++L  +++G  P       C Q   +W
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDW 221

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 9/168 (5%)
Query: 278 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 337
           L+H N+V   G   +   +Y+  E+   G L   +   P  G     A R      L  G
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRF--FHQLMAG 117
Query: 338 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 397
           + +LH      + HRDI+  N+LLDE     +   GL+    +   +       GT  Y+
Sbjct: 118 VVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 398 APEFVYRNELTTKS-DVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEW 444
           APE + R E   +  DV+S G++L  +++G  P       C Q   +W
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDW 221

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 9/168 (5%)
Query: 278 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 337
           L+H N+V   G   +   +Y+  E+   G L   +   P  G     A R      L  G
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRF--FHQLMAG 117
Query: 338 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 397
           + +LH      + HRDI+  N+LLDE     +   GL+    +   +       GT  Y+
Sbjct: 118 VVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 398 APEFVYRNELTTKS-DVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEW 444
           APE + R E   +  DV+S G++L  +++G  P       C Q   +W
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDW 221

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 278 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 337
           ++ P LV ++    D+ + Y+V E+V  G +     H+ R GR  +   R   A  +   
Sbjct: 98  VNFPFLVKLEYSFKDNSNLYMVMEYVPGGEM---FSHLRRIGRFSEPHARF-YAAQIVLT 153
Query: 338 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 397
             +LH      +++RD++  N+L+D++    +   G +K V     + RT    GT  YL
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYL 205
Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 40/161 (24%), Positives = 74/161 (45%), Gaps = 12/161 (7%)
Query: 270 SEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMK 329
            EI   ++   P +    G        +I+ E++  G     L   P     LD      
Sbjct: 54  QEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-----LDETQIAT 108
Query: 330 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLS-KFVPWEVMQERTV 388
           +   + +G+ +LH + K   +HRDI+A+NVLL E     L   G++ +    ++ +   V
Sbjct: 109 ILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFV 165
Query: 389 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
              GT  ++APE + ++   +K+D++S G+  +E+  G  P
Sbjct: 166 ---GTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 203

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 278 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 337
           ++ P LV ++    D+ + Y+V E+V  G +     H+ R GR  +   R   A  +   
Sbjct: 98  VNFPFLVKLEYSFKDNSNLYMVMEYVPGGEM---FSHLRRIGRFSEPHARF-YAAQIVLT 153
Query: 338 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 397
             +LH      +++RD++  N+L+D++    +   G +K V     + RT    GT  YL
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYL 205
Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 278 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 337
           ++ P LV ++    D+ + Y+V E+V  G +     H+ R GR  +   R   A  +   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM---FSHLRRIGRFSEPHARF-YAAQIVLT 153
Query: 338 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 397
             +LH      +++RD++  N+L+D++    +   G +K V     + RT    GT  YL
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYL 205
Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 9/168 (5%)
Query: 278 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 337
           L+H N+V   G   +   +Y+  E+   G L   +   P  G     A R      L  G
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRF--FHQLMAG 116
Query: 338 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 397
           + +LH      + HRDI+  N+LLDE     +   GL+    +   +       GT  Y+
Sbjct: 117 VVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 398 APEFVYRNELTTKS-DVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEW 444
           APE + R E   +  DV+S G++L  +++G  P       C Q   +W
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDW 220

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 9/168 (5%)
Query: 278 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 337
           L+H N+V   G   +   +Y+  E+   G L   +   P  G     A R      L  G
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRF--FHQLMAG 116
Query: 338 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 397
           + +LH      + HRDI+  N+LLDE     +   GL+    +   +       GT  Y+
Sbjct: 117 VVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 398 APEFVYRNELTTKS-DVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEW 444
           APE + R E   +  DV+S G++L  +++G  P       C Q   +W
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDW 220

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 278 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 337
           ++ P LV ++    D+ + Y+V E+V  G +     H+ R GR  +   R   A  +   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM---FSHLRRIGRFSEPHARF-YAAQIVLT 153
Query: 338 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 397
             +LH      +++RD++  N+L+D++    +   G +K V     + RT    GT  YL
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYL 205
Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 9/168 (5%)
Query: 278 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 337
           L+H N+V   G   +   +Y+  E+   G L   +   P  G     A R      L  G
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRF--FHQLMAG 117
Query: 338 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 397
           + +LH      + HRDI+  N+LLDE     +   GL+    +   +       GT  Y+
Sbjct: 118 VVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 398 APEFVYRNELTTKS-DVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEW 444
           APE + R E   +  DV+S G++L  +++G  P       C Q   +W
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDW 221

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 278 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 337
           ++ P LV ++    D+ + Y+V E+V  G +     H+ R GR  +   R   A  +   
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM---FSHLRRIGRFSEPHARF-YAAQIVLT 154
Query: 338 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 397
             +LH      +++RD++  N+L+D++    +   G +K V     + RT    GT  YL
Sbjct: 155 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWTLCGTPEYL 206
Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 88/198 (44%), Gaps = 19/198 (9%)
Query: 232 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 291
           L+   +TG  Y+  + D  +V   +    +   K+   +       ++ P LV ++    
Sbjct: 80  LVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-------VNFPFLVKLEFSFK 132
Query: 292 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 351
           D+ + Y+V E+V  G +     H+ R GR  +   R   A  +     +LH      +++
Sbjct: 133 DNSNLYMVMEYVPGGEM---FSHLRRIGRFSEPHARF-YAAQIVLTFEYLHS---LDLIY 185
Query: 352 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKS 411
           RD++  N+L+D++    +   G +K V     + RT    GT  YLAPE +         
Sbjct: 186 RDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYNKAV 240
Query: 412 DVYSFGVLLLEIVSGRRP 429
           D ++ GVL+ E+ +G  P
Sbjct: 241 DWWALGVLIYEMAAGYPP 258

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 278 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 337
           ++ P LV ++    D+ + Y+V E+V  G +     H+ R GR  +   R   A  +   
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM---FSHLRRIGRFSEPHARF-YAAQIVLT 154
Query: 338 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 397
             +LH      +++RD++  N+L+D++    +   G +K V     + RT    GT  YL
Sbjct: 155 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYL 206
Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 278 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 337
           ++ P LV ++    D+ + Y+V E+V  G +     H+ R GR  +   R   A  +   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM---FSHLRRIGRFSEPHARF-YAAQIVLT 153
Query: 338 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 397
             +LH      +++RD++  N+L+D++    +   G +K V     + RT    GT  YL
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYL 205
Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 9/168 (5%)
Query: 278 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 337
           L+H N+V   G   +   +Y+  E+   G L   +   P  G     A R      L  G
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRF--FHQLMAG 116
Query: 338 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 397
           + +LH      + HRDI+  N+LLDE     +   GL+    +   +       GT  Y+
Sbjct: 117 VVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 398 APEFVYRNELTTKS-DVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEW 444
           APE + R E   +  DV+S G++L  +++G  P       C Q   +W
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDW 220

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 74/176 (42%), Gaps = 9/176 (5%)
Query: 270 SEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMK 329
            EI     L+H N+V   G   +   +Y+  E+   G L   +   P  G     A R  
Sbjct: 53  KEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRF- 109
Query: 330 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 389
               L  G+ +LH      + HRDI+  N+LLDE     +   GL+    +   +     
Sbjct: 110 -FHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 165
Query: 390 AGGTYGYLAPEFVYRNELTTKS-DVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEW 444
             GT  Y+APE + R E   +  DV+S G++L  +++G  P       C Q   +W
Sbjct: 166 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDW 220

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 95/197 (48%), Gaps = 28/197 (14%)
Query: 251 RVAVK---RLKRSSFQRKKEFYSEIGRFAR-------LHHPNLVAVKGCCYDHGDRYIVY 300
           ++AV+   R++R++ +  K F  ++ RF +       L HPN++ +     D+ D Y+V 
Sbjct: 43  KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 102
Query: 301 EFVVNGPL-DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNV 359
           E    G L +R +H   R  R  D A  MK    +   +A+ H   K +V HRD++  N 
Sbjct: 103 ELCTGGELFERVVHK--RVFRESDAARIMK---DVLSAVAYCH---KLNVAHRDLKPENF 154
Query: 360 LL---DEEFGAHLMGVGL-SKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYS 415
           L      +    L+  GL ++F P ++M+ +     GT  Y++P+ V       + D +S
Sbjct: 155 LFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV----GTPYYVSPQ-VLEGLYGPECDEWS 209
Query: 416 FGVLLLEIVSGRRPAQA 432
            GV++  ++ G  P  A
Sbjct: 210 AGVMMYVLLCGYPPFSA 226

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 9/168 (5%)
Query: 278 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 337
           L+H N+V   G   +   +Y+  E+   G L   +   P  G     A R      L  G
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRF--FHQLMAG 116
Query: 338 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 397
           + +LH      + HRDI+  N+LLDE     +   GL+    +   +       GT  Y+
Sbjct: 117 VVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 398 APEFVYRNELTTKS-DVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEW 444
           APE + R E   +  DV+S G++L  +++G  P       C Q   +W
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDW 220

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 16/200 (8%)
Query: 233 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 292
           + D+ T   ++G      ++  K L     QR+K    EI     L H ++V   G   D
Sbjct: 34  ISDADTKEVFAG------KIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFHGFFED 86
Query: 293 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 352
           +   ++V E        R L  + +  ++L           +  G  +LH   +  V+HR
Sbjct: 87  NDFVFVVLELCRR----RSLLELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVIHR 139
Query: 353 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSD 412
           D++  N+ L+E+    +   GL+  V ++   ER  +  GT  Y+APE + +   + + D
Sbjct: 140 DLKLGNLFLNEDLEVKIGDFGLATKVEYD--GERKKVLCGTPNYIAPEVLSKKGHSFEVD 197
Query: 413 VYSFGVLLLEIVSGRRPAQA 432
           V+S G ++  ++ G+ P + 
Sbjct: 198 VWSIGCIMYTLLVGKPPFET 217

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 74/160 (46%), Gaps = 13/160 (8%)
Query: 271 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 330
           EI     L+HPN+V +    +     Y+V+EF ++  L +++      G  L   +    
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-LHQDLKKFMDASALTGIPL--PLIKSY 108
Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 388
              L QG+AF H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 109 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 165
Query: 389 MAGGTYGYLAPEFVYRNE-LTTKSDVYSFGVLLLEIVSGR 427
               T  Y APE +   +  +T  D++S G +  E+V+ R
Sbjct: 166 ----TLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 278 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 337
           ++ P LV ++    D+ + Y+V E+V  G +     H+ R GR  +   R   A  +   
Sbjct: 98  VNFPFLVKLEYSFKDNSNLYMVMEYVPGGEM---FSHLRRIGRFSEPHARF-YAAQIVLT 153
Query: 338 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 397
             +LH      +++RD++  N+L+D++    +   G +K V     + RT    GT  YL
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYL 205
Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 278 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 337
           ++ P LV ++    D+ + Y+V E+V  G +     H+ R GR  +   R   A  +   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFSEPHARF-YAAQIVLT 153
Query: 338 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 397
             +LH      +++RD++  N+L+D++    +   G +K V     + RT    GT  YL
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYL 205
Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           APE +         D ++ GVL+ ++ +G  P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYQMAAGYPP 237

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/200 (23%), Positives = 91/200 (45%), Gaps = 16/200 (8%)
Query: 233 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 292
           + D+ T   ++G      ++  K L     QR+K    EI     L H ++V   G   D
Sbjct: 36  ISDADTKEVFAG------KIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFHGFFED 88
Query: 293 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 352
           +   ++V E        R L  + +  ++L           +  G  +LH   +  V+HR
Sbjct: 89  NDFVFVVLELCRR----RSLLELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVIHR 141
Query: 353 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSD 412
           D++  N+ L+E+    +   GL+  V ++  +++T+   GT  Y+APE + +   + + D
Sbjct: 142 DLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLC--GTPNYIAPEVLSKKGHSFEVD 199
Query: 413 VYSFGVLLLEIVSGRRPAQA 432
           V+S G ++  ++ G+ P + 
Sbjct: 200 VWSIGCIMYTLLVGKPPFET 219

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 74/160 (46%), Gaps = 13/160 (8%)
Query: 271 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 330
           EI     L+HPN+V +    +     Y+V+EF ++  L +++      G  L   +    
Sbjct: 59  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-LHQDLKKFMDASALTGIPL--PLIKSY 115
Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 388
              L QG+AF H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 116 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 172
Query: 389 MAGGTYGYLAPEFVYRNE-LTTKSDVYSFGVLLLEIVSGR 427
               T  Y APE +   +  +T  D++S G +  E+V+ R
Sbjct: 173 ----TLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 9/168 (5%)
Query: 278 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 337
           L+H N+V   G   +   +Y+  E+   G L   +   P  G     A R      L  G
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRF--FHQLMAG 116
Query: 338 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 397
           + +LH      + HRDI+  N+LLDE     +   GL+    +   +       GT  Y+
Sbjct: 117 VVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 398 APEFVYRNELTTKS-DVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEW 444
           APE + R E   +  DV+S G++L  +++G  P       C Q   +W
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDW 220

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 9/168 (5%)
Query: 278 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 337
           L+H N+V   G   +   +Y+  E+   G L   +   P  G     A R      L  G
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRF--FHQLMAG 116
Query: 338 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 397
           + +LH      + HRDI+  N+LLDE     +   GL+    +   +       GT  Y+
Sbjct: 117 VVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 398 APEFVYRNELTTKS-DVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEW 444
           APE + R E   +  DV+S G++L  +++G  P       C Q   +W
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDW 220

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 16/200 (8%)
Query: 233 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 292
           + D+ T   ++G      ++  K L     QR+K    EI     L H ++V   G   D
Sbjct: 60  ISDADTKEVFAG------KIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFHGFFED 112
Query: 293 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 352
           +   ++V E        R L  + +  ++L           +  G  +LH   +  V+HR
Sbjct: 113 NDFVFVVLELCRR----RSLLELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVIHR 165
Query: 353 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSD 412
           D++  N+ L+E+    +   GL+  V ++   ER  +  GT  Y+APE + +   + + D
Sbjct: 166 DLKLGNLFLNEDLEVKIGDFGLATKVEYD--GERKKVLCGTPNYIAPEVLSKKGHSFEVD 223
Query: 413 VYSFGVLLLEIVSGRRPAQA 432
           V+S G ++  ++ G+ P + 
Sbjct: 224 VWSIGCIMYTLLVGKPPFET 243

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 9/168 (5%)
Query: 278 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 337
           L+H N+V   G   +   +Y+  E+   G L   +   P  G     A R      L  G
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRF--FHQLMAG 117
Query: 338 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 397
           + +LH      + HRDI+  N+LLDE     +   GL+    +   +       GT  Y+
Sbjct: 118 VVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 398 APEFVYRNELTTKS-DVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEW 444
           APE + R E   +  DV+S G++L  +++G  P       C Q   +W
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDW 221

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 84/184 (45%), Gaps = 15/184 (8%)
Query: 249 GSRVAVKRLKRSSFQRKKEF---YSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 305
           G+  A+K L +    + KE     +E      ++ P LV ++    D+ + Y+V E+   
Sbjct: 66  GNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPG 125
Query: 306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 365
           G +     H+ R GR  +   R   A  +     +LH      +++RD++  N+++D++ 
Sbjct: 126 GEM---FSHLRRIGRFSEPHARF-YAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQG 178
Query: 366 GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 425
              +   GL+K V     + RT    GT  YLAPE +         D ++ GVL+ E+ +
Sbjct: 179 YIQVTDFGLAKRV-----KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233
Query: 426 GRRP 429
           G  P
Sbjct: 234 GYPP 237

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 84/190 (44%), Gaps = 25/190 (13%)
Query: 249 GSRVAVKRLKRSSFQRK--KEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 306
           G  VA+K + ++       ++ + E+     L+HPN+V +          Y++ E+   G
Sbjct: 37  GREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGG 96
Query: 307 PL-DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 365
            + D  + H    GR  +   R K    ++  + + H K    +VHRD++A N+LLD + 
Sbjct: 97  EVFDYLVAH----GRMKEKEARSKFRQIVS-AVQYCHQK---RIVHRDLKAENLLLDADM 148
Query: 366 GAHLMGVGLSKFVPWEVMQERTVMAG-----GTYGYLAPE-FVYRNELTTKSDVYSFGVL 419
              +   G S         E TV        G+  Y APE F  +     + DV+S GV+
Sbjct: 149 NIKIADFGFS--------NEFTVGGKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVI 200
Query: 420 LLEIVSGRRP 429
           L  +VSG  P
Sbjct: 201 LYTLVSGSLP 210

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 16/200 (8%)
Query: 233 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 292
           + D+ T   ++G      ++  K L     QR+K    EI     L H ++V   G   D
Sbjct: 58  ISDADTKEVFAG------KIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFHGFFED 110
Query: 293 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 352
           +   ++V E        R L  + +  ++L           +  G  +LH   +  V+HR
Sbjct: 111 NDFVFVVLELCRR----RSLLELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVIHR 163
Query: 353 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSD 412
           D++  N+ L+E+    +   GL+  V ++   ER  +  GT  Y+APE + +   + + D
Sbjct: 164 DLKLGNLFLNEDLEVKIGDFGLATKVEYD--GERKKVLCGTPNYIAPEVLSKKGHSFEVD 221
Query: 413 VYSFGVLLLEIVSGRRPAQA 432
           V+S G ++  ++ G+ P + 
Sbjct: 222 VWSIGCIMYTLLVGKPPFET 241

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/200 (23%), Positives = 91/200 (45%), Gaps = 16/200 (8%)
Query: 233 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 292
           + D+ T   ++G      ++  K L     QR+K    EI     L H ++V   G   D
Sbjct: 36  ISDADTKEVFAG------KIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFHGFFED 88
Query: 293 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 352
           +   ++V E        R L  + +  ++L           +  G  +LH   +  V+HR
Sbjct: 89  NDFVFVVLELCRR----RSLLELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVIHR 141
Query: 353 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSD 412
           D++  N+ L+E+    +   GL+  V ++  +++T+   GT  Y+APE + +   + + D
Sbjct: 142 DLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLC--GTPNYIAPEVLSKKGHSFEVD 199
Query: 413 VYSFGVLLLEIVSGRRPAQA 432
           V+S G ++  ++ G+ P + 
Sbjct: 200 VWSIGCIMYTLLVGKPPFET 219

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/200 (23%), Positives = 91/200 (45%), Gaps = 16/200 (8%)
Query: 233 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 292
           + D+ T   ++G      ++  K L     QR+K    EI     L H ++V   G   D
Sbjct: 40  ISDADTKEVFAG------KIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFHGFFED 92
Query: 293 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 352
           +   ++V E        R L  + +  ++L           +  G  +LH   +  V+HR
Sbjct: 93  NDFVFVVLELCRR----RSLLELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVIHR 145
Query: 353 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSD 412
           D++  N+ L+E+    +   GL+  V ++  +++T+   GT  Y+APE + +   + + D
Sbjct: 146 DLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLC--GTPNYIAPEVLSKKGHSFEVD 203
Query: 413 VYSFGVLLLEIVSGRRPAQA 432
           V+S G ++  ++ G+ P + 
Sbjct: 204 VWSIGCIMYTLLVGKPPFET 223

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 271 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 330
           EI     L+HPN+V +    +     Y+V+EF ++  L +++      G  L   +    
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-LHQDLKKFMDASALTGIPL--PLIKSY 108
Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 388
              L QG+AF H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 109 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 165
Query: 389 MAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR 427
               T  Y APE +      +T  D++S G +  E+V+ R
Sbjct: 166 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 271 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 330
           EI     L+HPN+V +    +     Y+V+EF ++  L +++      G  L   +    
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-LHQDLKKFMDASALTGIPL--PLIKSY 107
Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 388
              L QG+AF H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 108 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 164
Query: 389 MAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR 427
               T  Y APE +      +T  D++S G +  E+V+ R
Sbjct: 165 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 271 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 330
           EI     L+HPN+V +    +     Y+V+EF ++  L +++      G  L   +    
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-LHQDLKKFMDASALTGIPL--PLIKSY 108
Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 388
              L QG+AF H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 109 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 165
Query: 389 MAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR 427
               T  Y APE +      +T  D++S G +  E+V+ R
Sbjct: 166 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 83/185 (44%), Gaps = 15/185 (8%)
Query: 249 GSRVAVKRLKRSSFQRK--KEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 306
           G  VA+K + ++       ++ + E+     L+HPN+V +          Y++ E+   G
Sbjct: 40  GREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGG 99
Query: 307 PL-DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 365
            + D  + H    GR  +   R K    ++  + + H K    +VHRD++A N+LLD + 
Sbjct: 100 EVFDYLVAH----GRMKEKEARSKFRQIVS-AVQYCHQK---RIVHRDLKAENLLLDADM 151
Query: 366 GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE-FVYRNELTTKSDVYSFGVLLLEIV 424
              +   G S    + V  +     G    Y APE F  +     + DV+S GV+L  +V
Sbjct: 152 NIKIADFGFSN--EFTVGGKLDAFCGAP-PYAAPELFQGKKYDGPEVDVWSLGVILYTLV 208
Query: 425 SGRRP 429
           SG  P
Sbjct: 209 SGSLP 213

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 89/185 (48%), Gaps = 18/185 (9%)
Query: 252 VAVKRLKRSSFQRK-KEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 310
           VA+K LK+ + +   +E   E     +L +P +V + G C       +V E    GPL +
Sbjct: 40  VAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHK 98
Query: 311 WL----HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 366
           +L      IP    +       ++   ++ G+ +L +K   + VHRD+ A NVLL     
Sbjct: 99  FLVGKREEIPVSNVA-------ELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHY 148
Query: 367 AHLMGVGLSKFVPWEVMQERTVMAGG-TYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 425
           A +   GLSK +  +        AG     + APE +   + +++SDV+S+GV + E +S
Sbjct: 149 AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 208
Query: 426 -GRRP 429
            G++P
Sbjct: 209 YGQKP 213

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 271 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 330
           EI     L+HPN+V +    +     Y+V+EF ++  L +++      G  L   +    
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-LHQDLKKFMDASALTGIPL--PLIKSY 108
Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 388
              L QG+AF H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 109 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 165
Query: 389 MAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR 427
               T  Y APE +      +T  D++S G +  E+V+ R
Sbjct: 166 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 271 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 330
           EI     L+HPN+V +    +     Y+V+EF ++  L +++      G  L   +    
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-LHQDLKKFMDASALTGIPL--PLIKSY 109
Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 388
              L QG+AF H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 110 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 166
Query: 389 MAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR 427
               T  Y APE +      +T  D++S G +  E+V+ R
Sbjct: 167 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 271 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 330
           EI     L+HPN+V +    +     Y+V+EF ++  L +++      G  L   +    
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-LHQDLKKFMDASALTGIPL--PLIKSY 108
Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 388
              L QG+AF H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 109 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 165
Query: 389 MAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR 427
               T  Y APE +      +T  D++S G +  E+V+ R
Sbjct: 166 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 278 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 337
           ++ P LV ++    D+ + Y+V E+V  G +     H+ R GR  +   R   A  +   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM---FSHLRRIGRFSEPHARF-YAAQIVLT 153
Query: 338 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 397
             +LH      +++RD++  N+L+D++    +   G +K V     + RT    GT  YL
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRV-----KGRTWXLCGTPEYL 205
Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 271 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 330
           EI     L+HPN+V +    +     Y+V+EF ++  L +++      G  L   +    
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-LHQDLKKFMDASALTGIPL--PLIKSY 108
Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 388
              L QG+AF H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 109 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 165
Query: 389 MAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR 427
               T  Y APE +      +T  D++S G +  E+V+ R
Sbjct: 166 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 271 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 330
           EI     L+HPN+V +    +     Y+V+EF ++  L +++      G  L   +    
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-LHQDLKKFMDASALTGIPL--PLIKSY 111
Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 388
              L QG+AF H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 112 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168
Query: 389 MAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR 427
               T  Y APE +      +T  D++S G +  E+V+ R
Sbjct: 169 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 271 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 330
           EI     L+HPN+V +    +     Y+V+EF ++  L +++      G  L   +    
Sbjct: 54  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-LHQDLKKFMDASALTGIPL--PLIKSY 110
Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 388
              L QG+AF H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 111 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 167
Query: 389 MAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR 427
               T  Y APE +      +T  D++S G +  E+V+ R
Sbjct: 168 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 271 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 330
           EI     L+HPN+V +    +     Y+V+EF ++  L +++      G  L   +    
Sbjct: 54  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-LHQDLKKFMDASALTGIPL--PLIKSY 110
Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 388
              L QG+AF H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 111 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 167
Query: 389 MAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR 427
               T  Y APE +      +T  D++S G +  E+V+ R
Sbjct: 168 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 271 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 330
           EI     L+HPN+V +    +     Y+V+EF ++  L +++      G  L   +    
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-LHQDLKKFMDASALTGIPL--PLIKSY 111
Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 388
              L QG+AF H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 112 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168
Query: 389 MAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR 427
               T  Y APE +      +T  D++S G +  E+V+ R
Sbjct: 169 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 271 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 330
           EI     L+HPN+V +    +     Y+V+EF ++  L +++      G  L   +    
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-LHQDLKKFMDASALTGIPL--PLIKSY 109
Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 388
              L QG+AF H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 110 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 166
Query: 389 MAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR 427
               T  Y APE +      +T  D++S G +  E+V+ R
Sbjct: 167 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 271 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 330
           EI     L+HPN+V +    +     Y+V+EF ++  L +++      G  L   +    
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-LHQDLKKFMDASALTGIPL--PLIKSY 108
Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 388
              L QG+AF H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 109 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 165
Query: 389 MAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR 427
               T  Y APE +      +T  D++S G +  E+V+ R
Sbjct: 166 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 271 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 330
           EI     L+HPN+V +    +     Y+V+EF ++  L +++      G  L   +    
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-LHQDLKKFMDASALTGIPL--PLIKSY 107
Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 388
              L QG+AF H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 108 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 164
Query: 389 MAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR 427
               T  Y APE +      +T  D++S G +  E+V+ R
Sbjct: 165 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 271 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 330
           EI     L+HPN+V +    +     Y+V+EF ++  L +++      G  L   +    
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-LHQDLKKFMDASALTGIPL--PLIKSY 107
Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 388
              L QG+AF H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 108 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 164
Query: 389 MAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR 427
               T  Y APE +      +T  D++S G +  E+V+ R
Sbjct: 165 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 271 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 330
           EI     L+HPN+V +    +     Y+V+EF ++  L +++      G  L   +    
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-LHQDLKKFMDASALTGIPL--PLIKSY 107
Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 388
              L QG+AF H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 108 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 164
Query: 389 MAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR 427
               T  Y APE +      +T  D++S G +  E+V+ R
Sbjct: 165 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 271 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 330
           EI     L+HPN+V +    +     Y+V+EF ++  L +++      G  L   +    
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-LHQDLKKFMDASALTGIPL--PLIKSY 108
Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 388
              L QG+AF H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 109 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 165
Query: 389 MAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR 427
               T  Y APE +      +T  D++S G +  E+V+ R
Sbjct: 166 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 271 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 330
           EI     L+HPN+V +    +     Y+V+EF ++  L +++      G  L   +    
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-LHQDLKKFMDASALTGIPL--PLIKSY 107
Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 388
              L QG+AF H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 108 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 164
Query: 389 MAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR 427
               T  Y APE +      +T  D++S G +  E+V+ R
Sbjct: 165 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 271 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 330
           EI     L+HPN+V +    +     Y+V+EF ++  L +++      G  L   +    
Sbjct: 54  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-LHQDLKKFMDASALTGIPL--PLIKSY 110
Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 388
              L QG+AF H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 111 LFQLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 167
Query: 389 MAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR 427
               T  Y APE +      +T  D++S G +  E+V+ R
Sbjct: 168 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 271 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 330
           EI     L+HPN+V +    +     Y+V+EF ++  L +++      G  L   +    
Sbjct: 56  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-LHQDLKKFMDASALTGIPL--PLIKSY 112
Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 388
              L QG+AF H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 113 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 169
Query: 389 MAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR 427
               T  Y APE +      +T  D++S G +  E+V+ R
Sbjct: 170 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 271 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 330
           EI     L+HPN+V +    +     Y+V+EF ++  L +++      G  L   +    
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-LHQDLKKFMDASALTGIPL--PLIKSY 109
Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 388
              L QG+AF H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 110 LFQLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 166
Query: 389 MAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR 427
               T  Y APE +      +T  D++S G +  E+V+ R
Sbjct: 167 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 271 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 330
           EI     L+HPN+V +    +     Y+V+EF ++  L +++      G  L   +    
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-LHQDLKKFMDASALTGIPL--PLIKSY 109
Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 388
              L QG+AF H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 110 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 166
Query: 389 MAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR 427
               T  Y APE +      +T  D++S G +  E+V+ R
Sbjct: 167 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 271 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 330
           EI     L+HPN+V +    +     Y+V+EF ++  L +++      G  L   +    
Sbjct: 59  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-LHQDLKKFMDASALTGIPL--PLIKSY 115
Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 388
              L QG+AF H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 116 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 172
Query: 389 MAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR 427
               T  Y APE +      +T  D++S G +  E+V+ R
Sbjct: 173 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 77/161 (47%), Gaps = 26/161 (16%)
Query: 280 HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA 339
           HPN++ +K     +   ++V++ +  G L  +L        +L      K+   L + I 
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVIC 138
Query: 340 FLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLS-KFVPWEVMQERTVMAGGTYGYLA 398
            LH   K ++VHRD++  N+LLD++    L   G S +  P E +  R+V   GT  YLA
Sbjct: 139 ALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--RSVC--GTPSYLA 191
Query: 399 PEFV----------YRNELTTKSDVYSFGVLLLEIVSGRRP 429
           PE +          Y  E+    D++S GV++  +++G  P
Sbjct: 192 PEIIECSMNDNHPGYGKEV----DMWSTGVIMYTLLAGSPP 228

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 71/160 (44%), Gaps = 9/160 (5%)
Query: 278 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 337
           L+H N+V   G   +   +Y+  E+   G L   +   P  G     A R      L  G
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRF--FHQLMAG 116
Query: 338 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 397
           + +LH      + HRDI+  N+LLDE     +   GL+    +   +       GT  Y+
Sbjct: 117 VVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYV 173
Query: 398 APEFVYRNELTTKS-DVYSFGVLLLEIVSGRRP-AQAVDS 435
           APE + R E   +  DV+S G++L  +++G  P  Q  DS
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 213

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 271 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 330
           EI     L+HPN+V +    +     Y+V+EF ++  L +++      G  L   +    
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-LSMDLKKFMDASALTGIPL--PLIKSY 111
Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 388
              L QG+AF H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 112 LFQLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168
Query: 389 MAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR 427
               T  Y APE +      +T  D++S G +  E+V+ R
Sbjct: 169 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 84/184 (45%), Gaps = 15/184 (8%)
Query: 249 GSRVAVKRLKRSSFQRKKEF---YSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 305
           G+  A+K L +    + KE     +E      ++ P LV ++    D+ + Y+V E+   
Sbjct: 66  GNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPG 125
Query: 306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 365
           G +     H+ R GR  +   R   A  +     +LH      +++RD++  N+++D++ 
Sbjct: 126 GEM---FSHLRRIGRFSEPHARF-YAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQG 178
Query: 366 GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 425
              +   GL+K V     + RT    GT  YLAPE +         D ++ GVL+ E+ +
Sbjct: 179 YIKVTDFGLAKRV-----KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233
Query: 426 GRRP 429
           G  P
Sbjct: 234 GYPP 237

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 91/202 (45%), Gaps = 15/202 (7%)
Query: 233 LGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQ-RKKEFYSEIGRFARLHHPNLVAVKGCC 290
           LG+      Y G+    G  VA+K +K  S +        EI     L H N+V +    
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI 72
Query: 291 YDHGDRYIVYEFVVNGPLDRWLHHIPRGG--RSLDWAMRMKVATTLAQGIAFLHDKVKPH 348
           +      +V+EF+ N  L +++     G   R L+  +       L QG+AF H+     
Sbjct: 73  HTENKLTLVFEFMDND-LKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---K 128
Query: 349 VVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTVMAGGTYGYLAPEFVYRNE 406
           ++HRD++  N+L+++     L   GL++   +P        V    T  Y AP+ +  + 
Sbjct: 129 ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV----TLWYRAPDVLMGSR 184
Query: 407 -LTTKSDVYSFGVLLLEIVSGR 427
             +T  D++S G +L E+++G+
Sbjct: 185 TYSTSIDIWSCGCILAEMITGK 206

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 271 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 330
           EI     L+HPN+V +    +     Y+V+EF ++  L +++      G  L   +    
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-LSMDLKKFMDASALTGIPL--PLIKSY 109
Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 388
              L QG+AF H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 110 LFQLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 166
Query: 389 MAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR 427
               T  Y APE +      +T  D++S G +  E+V+ R
Sbjct: 167 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 46/232 (19%), Positives = 108/232 (46%), Gaps = 41/232 (17%)
Query: 222 ITKNFSEGNRLLGDSK-----TGGTYSGIL---PDGSRVAVKRLKRSSFQRKKEF----- 268
           + K   E ++ + D +       G ++ I+    D    A+K+ ++S  ++K++F     
Sbjct: 19  LNKYVKEKDKYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNN 78
Query: 269 ------------YSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIP 316
                        +E+     + +   +  +G   ++ + YI+YE++ N  + ++  +  
Sbjct: 79  DKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFF 138
Query: 317 RGGRSLDWAMRMKVATTLAQGI----AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV 372
              ++    + ++V   + + +    +++H++   ++ HRD++ SN+L+D+        V
Sbjct: 139 VLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNE--KNICHRDVKPSNILMDKN-----GRV 191
Query: 373 GLSKFVPWEVMQERTVMAG-GTYGYLAPEFVYRNELT---TKSDVYSFGVLL 420
            LS F   E M ++ +    GTY ++ PEF + NE +    K D++S G+ L
Sbjct: 192 KLSDFGESEYMVDKKIKGSRGTYEFMPPEF-FSNESSYNGAKVDIWSLGICL 242

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 271 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 330
           EI     L+HPN+V +    +     Y+V+EF ++  L +++      G  L   +    
Sbjct: 56  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-LHQDLKKFMDASALTGIPL--PLIKSY 112
Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 388
              L QG+AF H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 113 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 169
Query: 389 MAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR 427
               T  Y APE +      +T  D++S G +  E+V+ R
Sbjct: 170 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 68/298 (22%), Positives = 124/298 (41%), Gaps = 39/298 (13%)
Query: 224 KNFSEGNRLLGDSKTGGTYSGILP--DGS--RVAVKRLKRSSFQRK--KEFYSEIGRFAR 277
           + F+ G R+LG  + G      L   DGS  +VAVK LK         +EF  E      
Sbjct: 23  QQFTLG-RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKE 81
Query: 278 LHHPNLVAVKGCCYDHGDR------YIVYEFVVNGPLDRWL--HHIPRGGRSLDWAMRMK 329
             HP++  + G       +       ++  F+ +G L  +L    I     +L     ++
Sbjct: 82  FDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVR 141
Query: 330 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 389
               +A G+ +L  +   + +HRD+ A N +L E+    +   GLS+ +       +   
Sbjct: 142 FMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCA 198
Query: 390 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPL 448
           +     +LA E +  N  T  SDV++FGV + EI++ G+ P   +++     I+ +   L
Sbjct: 199 SKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA---EIYNY---L 252
Query: 449 VQSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 506
           +  +R                     +++V DL+Y C    P  RP  + +  +L+ +
Sbjct: 253 IGGNRLKQPPE--------------CMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 81/187 (43%), Gaps = 19/187 (10%)
Query: 249 GSRVAVK-----RLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 303
           G  VAVK     +L  SS Q+    + E+     L+HPN+V +          Y+V E+ 
Sbjct: 32  GKEVAVKIIDKTQLNSSSLQK---LFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYA 88
Query: 304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 363
             G +  +L  +  G     W    +      Q ++ +    +  +VHRD++A N+LLD 
Sbjct: 89  SGGEVFDYL--VAHG-----WMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDA 141
Query: 364 EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE-FVYRNELTTKSDVYSFGVLLLE 422
           +    +   G S    +     +     G+  Y APE F  +     + DV+S GV+L  
Sbjct: 142 DMNIKIADFGFSNEFTF---GNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYT 198
Query: 423 IVSGRRP 429
           +VSG  P
Sbjct: 199 LVSGSLP 205

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 26/210 (12%)
Query: 228 EGNRLLGDSKTGGTYSGIL-----PDGSRVAVKRLKRSSFQRKKEFYS---EIGRFARLH 279
           +G R+LG     G++  ++       G   AVK + +   ++K +  S   E+    +L 
Sbjct: 29  KGQRVLG----KGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 280 HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA 339
           HPN+  +     D G  Y+V E    G L  +   I R   S   A R  +   +  GI 
Sbjct: 85  HPNIXKLYEFFEDKGYFYLVGEVYTGGEL--FDEIISRKRFSEVDAAR--IIRQVLSGIT 140
Query: 340 FLHDKVKPHVVHRDIRASNVLLD---EEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGY 396
           + H   K  +VHRD++  N+LL+   ++    ++  GLS    +E  ++     G  Y Y
Sbjct: 141 YXH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS--THFEASKKXKDKIGTAY-Y 194
Query: 397 LAPEFVYRNELTTKSDVYSFGVLLLEIVSG 426
           +APE V       K DV+S GV+L  ++SG
Sbjct: 195 IAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 93/239 (38%), Gaps = 30/239 (12%)
Query: 198 LSNPAASALVPPSWKVFTTEELRSITKNFSEGN----RLLGDSKTGGTYSGILPDGSRVA 253
           +  PA S   P    +    +   + K+   GN    RL+ D ++             VA
Sbjct: 1   MDRPAVSG--PMDLPIMHDSDRYELVKDIGSGNFGVARLMRDKQSN----------ELVA 48
Query: 254 VKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLH 313
           VK ++R   +  +    EI     L HPN+V  K          IV E+   G L     
Sbjct: 49  VKYIERGE-KIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL---FE 104
Query: 314 HIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLM--G 371
            I   GR  +   R      L  G+++ H      V HRD++  N LLD      L    
Sbjct: 105 RICNAGRFSEDEARF-FFQQLISGVSYCHAM---QVCHRDLKLENTLLDGSPAPRLKICA 160
Query: 372 VGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK-SDVYSFGVLLLEIVSGRRP 429
            G SK     V+  +     GT  Y+APE + + E   K +DV+S GV L  ++ G  P
Sbjct: 161 FGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYP 216

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 65/239 (27%), Positives = 93/239 (38%), Gaps = 30/239 (12%)
Query: 198 LSNPAASALVPPSWKVFTTEELRSITKNFSEGN----RLLGDSKTGGTYSGILPDGSRVA 253
           +  PA S   P    +    +   + K+   GN    RL+ D ++             VA
Sbjct: 1   MDRPAVSG--PMDLPIMHDSDRYELVKDIGSGNFGVARLMRDKQSN----------ELVA 48
Query: 254 VKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLH 313
           VK ++R   +  +    EI     L HPN+V  K          IV E+   G L     
Sbjct: 49  VKYIERGE-KIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL---FE 104
Query: 314 HIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLM--G 371
            I   GR  +   R      L  G+++ H      V HRD++  N LLD      L    
Sbjct: 105 RICNAGRFSEDEARF-FFQQLISGVSYCHAM---QVCHRDLKLENTLLDGSPAPRLKICA 160
Query: 372 VGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK-SDVYSFGVLLLEIVSGRRP 429
            G SK        + TV   GT  Y+APE + + E   K +DV+S GV L  ++ G  P
Sbjct: 161 FGYSKSSVLHSQPKDTV---GTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYP 216

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 71/152 (46%), Gaps = 12/152 (7%)
Query: 278 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 337
           ++ P LV ++    D+ + Y+V E+V  G +     H+ R GR  +   R   A  +   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFSEPHARF-YAAQIVLT 153
Query: 338 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 397
             +LH      +++RD++  N+L+D++    +   G +K V     + RT    GT  YL
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYL 205
Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           AP  +         D ++ GVL+ E+ +G  P
Sbjct: 206 APAIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 84/183 (45%), Gaps = 17/183 (9%)
Query: 253 AVKRLKRSSFQRKKE---FYSEIGRFAR-LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 308
           AVK L++ +  +KKE     SE     + + HP LV +          Y V +++  G L
Sbjct: 67  AVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGEL 126
Query: 309 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 368
               +H+ R    L+   R   A  +A  + +LH     ++V+RD++  N+LLD +    
Sbjct: 127 ---FYHLQRERCFLEPRARF-YAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIV 179
Query: 369 LMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSG 426
           L   GL K    E ++  +  +   GT  YLAPE +++       D +  G +L E++ G
Sbjct: 180 LTDFGLCK----ENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 235
Query: 427 RRP 429
             P
Sbjct: 236 LPP 238

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 271 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 330
           EI     L+HPN+V +    +     Y+V+EF ++  L +++      G  L   +    
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-LHQDLKKFMDASALTGIPL--PLIKSY 108
Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 388
              L QG++F H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 109 LFQLLQGLSFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 165
Query: 389 MAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR 427
               T  Y APE +      +T  D++S G +  E+V+ R
Sbjct: 166 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 278 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 337
           ++ P LV ++    D+ + Y+V E++  G +     H+ R GR  +   R   A  +   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYMPGGDM---FSHLRRIGRFSEPHARF-YAAQIVLT 153
Query: 338 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 397
             +LH      +++RD++  N+L+D++    +   G +K V     + RT    GT  YL
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRV-----KGRTWXLCGTPEYL 205
Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 278 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 337
           ++ P LV ++    D+ + Y+V E++  G +     H+ R GR  +   R   A  +   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYMPGGDM---FSHLRRIGRFSEPHARF-YAAQIVLT 153
Query: 338 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 397
             +LH      +++RD++  N+L+D++    +   G +K V     + RT    GT  YL
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRV-----KGRTWXLCGTPEYL 205
Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 93/239 (38%), Gaps = 30/239 (12%)
Query: 198 LSNPAASALVPPSWKVFTTEELRSITKNFSEGN----RLLGDSKTGGTYSGILPDGSRVA 253
           +  PA +   P    +    +   + K+   GN    RL+ D +              VA
Sbjct: 1   MDRPAVAG--PMDLPIMHDSDRYELVKDIGAGNFGVARLMRDKQAN----------ELVA 48
Query: 254 VKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLH 313
           VK ++R   +  +    EI     L HPN+V  K          IV E+   G L     
Sbjct: 49  VKYIERGE-KIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL---FE 104
Query: 314 HIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHL--MG 371
            I   GR  +   R      L  G+++ H      V HRD++  N LLD      L    
Sbjct: 105 RICNAGRFSEDEARF-FFQQLISGVSYAHAM---QVAHRDLKLENTLLDGSPAPRLKIAD 160
Query: 372 VGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK-SDVYSFGVLLLEIVSGRRP 429
            G SK     V+  +   A GT  Y+APE + + E   K +DV+S GV L  ++ G  P
Sbjct: 161 FGYSK---ASVLHSQPKSAVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYP 216

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 72/160 (45%), Gaps = 13/160 (8%)
Query: 271 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 330
           EI     L+HPN+V +    +     Y+V+EF ++  L  ++      G  L   +    
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-LHQDLKDFMDASALTGIPL--PLIKSY 108
Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 388
              L QG+AF H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 109 LFQLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 165
Query: 389 MAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR 427
               T  Y APE +      +T  D++S G +  E+V+ R
Sbjct: 166 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 71/152 (46%), Gaps = 12/152 (7%)
Query: 278 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 337
           ++ P LV ++    D+ + Y+V E+V  G +     H+ R GR  +   R   A  +   
Sbjct: 119 VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFSEPHARF-YAAQIVLT 174
Query: 338 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 397
             +LH      +++RD++  N+L+D++    +   G +K V     +  T    GT  YL
Sbjct: 175 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGATWTLCGTPEYL 226
Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 227 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 89/210 (42%), Gaps = 19/210 (9%)
Query: 232 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCC 290
           L+G+   G  Y G      ++A  ++   +   ++E   EI    +  HH N+    G  
Sbjct: 31  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 90
Query: 291 YDHG------DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 344
                       ++V EF   G +   + +        +W     +   + +G++ LH  
Sbjct: 91  IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLSHLH-- 146
Query: 345 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR 404
            +  V+HRDI+  NVLL E     L+  G+S  +   V +  T +  GT  ++APE +  
Sbjct: 147 -QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI--GTPYWMAPEVIAC 203
Query: 405 NE-----LTTKSDVYSFGVLLLEIVSGRRP 429
           +E        KSD++S G+  +E+  G  P
Sbjct: 204 DENPDATYDFKSDLWSLGITAIEMAEGAPP 233

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/152 (25%), Positives = 71/152 (46%), Gaps = 12/152 (7%)
Query: 278 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 337
           ++ P LV ++    D+ + Y+V E+   G +     H+ R GR  +   R   A  +   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM---FSHLRRIGRFXEPHARF-YAAQIVLT 153
Query: 338 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 397
             +LH      +++RD++  N+++D++    +   G +K V     + RT    GT  YL
Sbjct: 154 FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV-----KGRTWXLCGTPEYL 205
Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 72/160 (45%), Gaps = 13/160 (8%)
Query: 271 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 330
           EI     L+HPN+V +    +     Y+V+EF ++  L  ++      G  L   +    
Sbjct: 54  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-LSMDLKDFMDASALTGIPL--PLIKSY 110
Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 388
              L QG+AF H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 111 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 167
Query: 389 MAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR 427
               T  Y APE +      +T  D++S G +  E+V+ R
Sbjct: 168 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 27/212 (12%)
Query: 249 GSRVAVKRLKRSSFQRKKE-FYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 307
           G   AVK + + + + K+    +EI    ++ H N+VA++         Y+V + V  G 
Sbjct: 47  GKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGE 106
Query: 308 LDRWLHHIPRGGRSLDWAMRMKVATTLAQ----GIAFLHDKVKPHVVHRDIRASNVLL-- 361
           L      I   G   +     K A+TL +     + +LH   +  +VHRD++  N+L   
Sbjct: 107 L---FDRIVEKGFYTE-----KDASTLIRQVLDAVYYLH---RMGIVHRDLKPENLLYYS 155
Query: 362 -DEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLL 420
            DEE    +   GLSK    E   +    A GT GY+APE + +   +   D +S GV+ 
Sbjct: 156 QDEESKIMISDFGLSKM---EGKGDVMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIA 212
Query: 421 LEIVSGRRP-AQAVDSVCWQSI----FEWATP 447
             ++ G  P     DS  ++ I    +E+ +P
Sbjct: 213 YILLCGYPPFYDENDSKLFEQILKAEYEFDSP 244

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 72/160 (45%), Gaps = 13/160 (8%)
Query: 271 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 330
           EI     L+HPN+V +    +     Y+V+EF ++  L  ++      G  L   +    
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-LHQDLKTFMDASALTGIPL--PLIKSY 111
Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 388
              L QG+AF H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 112 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168
Query: 389 MAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR 427
               T  Y APE +      +T  D++S G +  E+V+ R
Sbjct: 169 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 72/160 (45%), Gaps = 13/160 (8%)
Query: 271 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 330
           EI     L+HPN+V +    +     Y+V+EF ++  L  ++      G  L   +    
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-LSMDLKDFMDASALTGIPL--PLIKSY 111
Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 388
              L QG+AF H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 112 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168
Query: 389 MAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR 427
               T  Y APE +      +T  D++S G +  E+V+ R
Sbjct: 169 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 71/152 (46%), Gaps = 12/152 (7%)
Query: 278 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 337
           ++ P LV ++    D+ + Y+V E+   G +     H+ R GR  +   R   A  +   
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVLEYAPGGEM---FSHLRRIGRFSEPHARF-YAAQIVLT 154
Query: 338 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 397
             +LH      +++RD++  N+L+D++    +   G +K V     + RT    GT  YL
Sbjct: 155 FEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRV-----KGRTWXLCGTPEYL 206
Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/152 (25%), Positives = 71/152 (46%), Gaps = 12/152 (7%)
Query: 278 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 337
           ++ P LV ++    D+ + Y+V E+   G +     H+ R GR  +   R   A  +   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM---FSHLRRIGRFSEPHARF-YAAQIVLT 153
Query: 338 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 397
             +LH      +++RD++  N+++D++    +   G +K V     + RT    GT  YL
Sbjct: 154 FEYLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYL 205
Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 92/218 (42%), Gaps = 24/218 (11%)
Query: 222 ITKNFSEGNRLLGDSKTGGTYSGIL-----PDGSRVAVKRLKRSSFQRKKEF---YSEIG 273
           +T N  E  +LLG     GT+  ++       G   A+K LK+     K E     +E  
Sbjct: 145 VTMNEFEYLKLLGK----GTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENR 200
Query: 274 RFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATT 333
                 HP L A+K     H     V E+   G L     H+ R  R             
Sbjct: 201 VLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRE-RVFSEDRARFYGAE 256
Query: 334 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG-- 391
           +   + +LH +   +VV+RD++  N++LD++    +   GL K    E +++   M    
Sbjct: 257 IVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCK----EGIKDGATMKTFC 310
Query: 392 GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           GT  YLAPE +  N+     D +  GV++ E++ GR P
Sbjct: 311 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 72/160 (45%), Gaps = 13/160 (8%)
Query: 271 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 330
           EI     L+HPN+V +    +     Y+V+E  V+  L +++      G  L   +    
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEH-VDQDLKKFMDASALTGIPL--PLIKSY 111
Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 388
              L QG+AF H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 112 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168
Query: 389 MAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR 427
               T  Y APE +      +T  D++S G +  E+V+ R
Sbjct: 169 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/121 (29%), Positives = 63/121 (52%), Gaps = 15/121 (12%)
Query: 318 GGRSLDWAM-----RMKVATTLAQ---GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHL 369
           GG +LD           +AT L +   G+ +LH + K   +HRDI+A+NVLL E+    L
Sbjct: 101 GGSALDLLKPGPLEETYIATILREILKGLDYLHSERK---IHRDIKAANVLLSEQGDVKL 157
Query: 370 MGVGLS-KFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRR 428
              G++ +    ++ +   V   GT  ++APE + ++    K+D++S G+  +E+  G  
Sbjct: 158 ADFGVAGQLTDTQIKRNXFV---GTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEP 214
Query: 429 P 429
           P
Sbjct: 215 P 215

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 71/152 (46%), Gaps = 12/152 (7%)
Query: 278 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 337
           ++ P LV ++    D+ + Y+V E+V  G +     H+ R GR  +   R   A  +   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFSEPHARF-YAAQIVLT 153
Query: 338 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 397
             +LH      +++RD++  N+L+D++    +   G +K V     + RT    GT   L
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEAL 205
Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 74/157 (47%), Gaps = 18/157 (11%)
Query: 280 HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA 339
           HP+++ +          ++V++ +  G L  +L        +L       +  +L + ++
Sbjct: 159 HPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVS 214
Query: 340 FLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLS-KFVPWEVMQERTVMAGGTYGYLA 398
           FLH     ++VHRD++  N+LLD+     L   G S    P E ++E      GT GYLA
Sbjct: 215 FLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE----LCGTPGYLA 267
Query: 399 PEFVYRNELTT------KSDVYSFGVLLLEIVSGRRP 429
           PE +  +   T      + D+++ GV+L  +++G  P
Sbjct: 268 PEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 92/218 (42%), Gaps = 24/218 (11%)
Query: 222 ITKNFSEGNRLLGDSKTGGTYSGIL-----PDGSRVAVKRLKRSSFQRKKEF---YSEIG 273
           +T N  E  +LLG     GT+  ++       G   A+K LK+     K E     +E  
Sbjct: 148 VTMNEFEYLKLLGK----GTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENR 203
Query: 274 RFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATT 333
                 HP L A+K     H     V E+   G L     H+ R  R             
Sbjct: 204 VLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRE-RVFSEDRARFYGAE 259
Query: 334 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG-- 391
           +   + +LH +   +VV+RD++  N++LD++    +   GL K    E +++   M    
Sbjct: 260 IVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCK----EGIKDGATMKTFC 313
Query: 392 GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           GT  YLAPE +  N+     D +  GV++ E++ GR P
Sbjct: 314 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 351

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/198 (23%), Positives = 87/198 (43%), Gaps = 19/198 (9%)
Query: 232 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 291
           L+   +TG  Y+  + D  +V   +    +   K+   +       ++ P LV ++    
Sbjct: 60  LVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-------VNFPFLVKLEFSFK 112
Query: 292 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 351
           D+ + Y+V E+   G +     H+ R GR  +   R   A  +     +LH      +++
Sbjct: 113 DNSNLYMVMEYAPGGEM---FSHLRRIGRFSEPHARF-YAAQIVLTFEYLHS---LDLIY 165
Query: 352 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKS 411
           RD++  N+++D++    +   G +K V     + RT    GT  YLAPE +         
Sbjct: 166 RDLKPENLMIDQQGYIKVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYNKAV 220
Query: 412 DVYSFGVLLLEIVSGRRP 429
           D ++ GVL+ E+ +G  P
Sbjct: 221 DWWALGVLIYEMAAGYPP 238

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 51/92 (55%), Gaps = 3/92 (3%)
Query: 334 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT 393
           +A+G+ FL  +     +HRD+ A N+LL E+    +   GL++ +  +    R   A   
Sbjct: 202 VAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 394 YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 425
             ++APE ++    T +SDV+SFGVLL EI S
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/152 (25%), Positives = 71/152 (46%), Gaps = 12/152 (7%)
Query: 278 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 337
           ++ P LV ++    D+ + Y+V E+   G +     H+ R GR  +   R   A  +   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM---FSHLRRIGRFSEPHARF-YAAQIVLT 153
Query: 338 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 397
             +LH      +++RD++  N+++D++    +   G +K V     + RT    GT  YL
Sbjct: 154 FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV-----KGRTWXLCGTPEYL 205
Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 51/92 (55%), Gaps = 3/92 (3%)
Query: 334 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT 393
           +A+G+ FL  +     +HRD+ A N+LL E+    +   GL++ +  +    R   A   
Sbjct: 207 VAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 394 YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 425
             ++APE ++    T +SDV+SFGVLL EI S
Sbjct: 264 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 295

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 51/92 (55%), Gaps = 3/92 (3%)
Query: 334 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT 393
           +A+G+ FL  +     +HRD+ A N+LL E+    +   GL++ +  +    R   A   
Sbjct: 200 VAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 394 YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 425
             ++APE ++    T +SDV+SFGVLL EI S
Sbjct: 257 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 288

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 92/239 (38%), Gaps = 30/239 (12%)
Query: 198 LSNPAASALVPPSWKVFTTEELRSITKNFSEGN----RLLGDSKTGGTYSGILPDGSRVA 253
           +  PA S   P    +    +   + K+   GN    RL+ D ++             VA
Sbjct: 1   MDRPAVSG--PMDLPIMHDSDRYELVKDIGSGNFGVARLMRDKQSN----------ELVA 48
Query: 254 VKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLH 313
           VK ++R   +       EI     L HPN+V  K          IV E+   G L     
Sbjct: 49  VKYIERGE-KIAANVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL---FE 104
Query: 314 HIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLM--G 371
            I   GR  +   R      L  G+++ H      V HRD++  N LLD      L    
Sbjct: 105 RICNAGRFSEDEARF-FFQQLISGVSYCHAM---QVCHRDLKLENTLLDGSPAPRLKICD 160
Query: 372 VGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK-SDVYSFGVLLLEIVSGRRP 429
            G SK     V+  +     GT  Y+APE + + E   K +DV+S GV L  ++ G  P
Sbjct: 161 FGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYP 216

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/169 (25%), Positives = 74/169 (43%), Gaps = 8/169 (4%)
Query: 278 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 337
           L HP++V +       G  Y+V+EF+    L   +      G     A+       + + 
Sbjct: 83  LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142
Query: 338 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG-- 395
           + + HD    +++HRD++  NVLL  +  +    V L  F     + E  ++AGG  G  
Sbjct: 143 LRYCHDN---NIIHRDVKPENVLLASKENS--APVKLGDFGVAIQLGESGLVAGGRVGTP 197
Query: 396 -YLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFE 443
            ++APE V R       DV+  GV+L  ++SG  P        ++ I +
Sbjct: 198 HFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIK 246

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 51/92 (55%), Gaps = 3/92 (3%)
Query: 334 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT 393
           +A+G+ FL  +     +HRD+ A N+LL E+    +   GL++ +  +    R   A   
Sbjct: 209 VAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 394 YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 425
             ++APE ++    T +SDV+SFGVLL EI S
Sbjct: 266 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 297

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 78/166 (46%), Gaps = 17/166 (10%)
Query: 270 SEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL-DRWLHHIPRGGRSLDWAMRM 328
           +EI    +L+HP ++ +K   +D  D YIV E +  G L D+ +     G + L  A   
Sbjct: 64  TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVV-----GNKRLKEATCK 117
Query: 329 KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 388
                +   + +LH+     ++HRD++  NVLL  +    L  + ++ F   +++ E ++
Sbjct: 118 LYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCL--IKITDFGHSKILGETSL 172
Query: 389 MAG--GTYGYLAPEF---VYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           M    GT  YLAPE    V         D +S GV+L   +SG  P
Sbjct: 173 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 78/166 (46%), Gaps = 17/166 (10%)
Query: 270 SEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL-DRWLHHIPRGGRSLDWAMRM 328
           +EI    +L+HP ++ +K   +D  D YIV E +  G L D+ +     G + L  A   
Sbjct: 63  TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVV-----GNKRLKEATCK 116
Query: 329 KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 388
                +   + +LH+     ++HRD++  NVLL  +    L  + ++ F   +++ E ++
Sbjct: 117 LYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCL--IKITDFGHSKILGETSL 171
Query: 389 MAG--GTYGYLAPEF---VYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           M    GT  YLAPE    V         D +S GV+L   +SG  P
Sbjct: 172 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 217

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 78/166 (46%), Gaps = 17/166 (10%)
Query: 270 SEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL-DRWLHHIPRGGRSLDWAMRM 328
           +EI    +L+HP ++ +K   +D  D YIV E +  G L D+ +     G + L  A   
Sbjct: 64  TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVV-----GNKRLKEATCK 117
Query: 329 KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 388
                +   + +LH+     ++HRD++  NVLL  +    L  + ++ F   +++ E ++
Sbjct: 118 LYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCL--IKITDFGHSKILGETSL 172
Query: 389 MAG--GTYGYLAPEF---VYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           M    GT  YLAPE    V         D +S GV+L   +SG  P
Sbjct: 173 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 92/218 (42%), Gaps = 24/218 (11%)
Query: 222 ITKNFSEGNRLLGDSKTGGTYSGIL-----PDGSRVAVKRLKRSSFQRKKEF---YSEIG 273
           +T N  E  +LLG     GT+  ++       G   A+K LK+     K E     +E  
Sbjct: 5   VTMNEFEYLKLLGK----GTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENR 60
Query: 274 RFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATT 333
                 HP L A+K     H     V E+   G L     H+ R  R             
Sbjct: 61  VLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRE-RVFSEDRARFYGAE 116
Query: 334 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG-- 391
           +   + +LH +   +VV+RD++  N++LD++    +   GL K    E +++   M    
Sbjct: 117 IVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCK----EGIKDGATMKXFC 170
Query: 392 GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           GT  YLAPE +  N+     D +  GV++ E++ GR P
Sbjct: 171 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 208

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 76/181 (41%), Gaps = 14/181 (7%)
Query: 252 VAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRW 311
           VAVK ++R +    +    EI     L HPN+V  K          I+ E+   G L   
Sbjct: 48  VAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGEL--- 103
Query: 312 LHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLM- 370
              I   GR  +   R      L+ G+++ H      + HRD++  N LLD      L  
Sbjct: 104 YERICNAGRFSEDEARFFFQQLLS-GVSYCHSM---QICHRDLKLENTLLDGSPAPRLKI 159
Query: 371 -GVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK-SDVYSFGVLLLEIVSGRR 428
              G SK     V+  +     GT  Y+APE + R E   K +DV+S GV L  ++ G  
Sbjct: 160 CDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAY 216
Query: 429 P 429
           P
Sbjct: 217 P 217

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 78/166 (46%), Gaps = 17/166 (10%)
Query: 270 SEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL-DRWLHHIPRGGRSLDWAMRM 328
           +EI    +L+HP ++ +K   +D  D YIV E +  G L D+ +     G + L  A   
Sbjct: 64  TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVV-----GNKRLKEATCK 117
Query: 329 KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 388
                +   + +LH+     ++HRD++  NVLL  +    L  + ++ F   +++ E ++
Sbjct: 118 LYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCL--IKITDFGHSKILGETSL 172
Query: 389 MAG--GTYGYLAPEF---VYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           M    GT  YLAPE    V         D +S GV+L   +SG  P
Sbjct: 173 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 78/166 (46%), Gaps = 17/166 (10%)
Query: 270 SEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL-DRWLHHIPRGGRSLDWAMRM 328
           +EI    +L+HP ++ +K   +D  D YIV E +  G L D+ +     G + L  A   
Sbjct: 70  TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVV-----GNKRLKEATCK 123
Query: 329 KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 388
                +   + +LH+     ++HRD++  NVLL  +    L  + ++ F   +++ E ++
Sbjct: 124 LYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCL--IKITDFGHSKILGETSL 178
Query: 389 MAG--GTYGYLAPEF---VYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           M    GT  YLAPE    V         D +S GV+L   +SG  P
Sbjct: 179 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 224

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 78/177 (44%), Gaps = 29/177 (16%)
Query: 334 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV---PWEVMQERTVMA 390
           +A+G+ FL  +     +HRD+ A N+LL E     +   GL++ +   P  V +  T + 
Sbjct: 208 VARGMEFLSSR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLP 264
Query: 391 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLV 449
                ++APE ++    +TKSDV+S+GVLL EI S G  P   V     Q   ++ + L 
Sbjct: 265 ---LKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGV-----QMDEDFCSRLR 316
Query: 450 QSHRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 506
           +  R                       ++  ++  C    P  RPR + +V +L  L
Sbjct: 317 EGMRMRAPEYS--------------TPEIYQIMLDCWHRDPKERPRFAELVEKLGDL 359

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/170 (24%), Positives = 77/170 (45%), Gaps = 13/170 (7%)
Query: 270 SEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMK 329
           +EI    +LHHP L+ +     D  +  ++ EF+  G L      I      +  A  + 
Sbjct: 97  NEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGEL---FDRIAAEDYKMSEAEVIN 153
Query: 330 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA--HLMGVGL-SKFVPWEVMQER 386
                 +G+  +H+     +VH DI+  N++ + +  +   ++  GL +K  P E+++  
Sbjct: 154 YMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT 210
Query: 387 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSV 436
           T  A     + APE V R  +   +D+++ GVL   ++SG  P    D +
Sbjct: 211 TATA----EFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL 256

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 92/218 (42%), Gaps = 24/218 (11%)
Query: 222 ITKNFSEGNRLLGDSKTGGTYSGIL-----PDGSRVAVKRLKRSSFQRKKEF---YSEIG 273
           +T N  E  +LLG     GT+  ++       G   A+K LK+     K E     +E  
Sbjct: 6   VTMNEFEYLKLLGK----GTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENR 61
Query: 274 RFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATT 333
                 HP L A+K     H     V E+   G L     H+ R  R             
Sbjct: 62  VLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRE-RVFSEDRARFYGAE 117
Query: 334 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG-- 391
           +   + +LH +   +VV+RD++  N++LD++    +   GL K    E +++   M    
Sbjct: 118 IVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCK----EGIKDGATMKXFC 171
Query: 392 GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           GT  YLAPE +  N+     D +  GV++ E++ GR P
Sbjct: 172 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 78/166 (46%), Gaps = 17/166 (10%)
Query: 270 SEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL-DRWLHHIPRGGRSLDWAMRM 328
           +EI    +L+HP ++ +K   +D  D YIV E +  G L D+ +     G + L  A   
Sbjct: 189 TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVV-----GNKRLKEATCK 242
Query: 329 KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 388
                +   + +LH+     ++HRD++  NVLL  +    L  + ++ F   +++ E ++
Sbjct: 243 LYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCL--IKITDFGHSKILGETSL 297
Query: 389 MAG--GTYGYLAPEF---VYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           M    GT  YLAPE    V         D +S GV+L   +SG  P
Sbjct: 298 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 92/218 (42%), Gaps = 24/218 (11%)
Query: 222 ITKNFSEGNRLLGDSKTGGTYSGIL-----PDGSRVAVKRLKRSSFQRKKEF---YSEIG 273
           +T N  E  +LLG     GT+  ++       G   A+K LK+     K E     +E  
Sbjct: 7   VTMNEFEYLKLLGK----GTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENR 62
Query: 274 RFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATT 333
                 HP L A+K     H     V E+   G L     H+ R  R             
Sbjct: 63  VLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRE-RVFSEDRARFYGAE 118
Query: 334 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG-- 391
           +   + +LH +   +VV+RD++  N++LD++    +   GL K    E +++   M    
Sbjct: 119 IVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCK----EGIKDGATMKXFC 172
Query: 392 GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           GT  YLAPE +  N+     D +  GV++ E++ GR P
Sbjct: 173 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 210

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 78/166 (46%), Gaps = 17/166 (10%)
Query: 270 SEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL-DRWLHHIPRGGRSLDWAMRM 328
           +EI    +L+HP ++ +K   +D  D YIV E +  G L D+ +     G + L  A   
Sbjct: 203 TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVV-----GNKRLKEATCK 256
Query: 329 KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 388
                +   + +LH+     ++HRD++  NVLL  +    L  + ++ F   +++ E ++
Sbjct: 257 LYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCL--IKITDFGHSKILGETSL 311
Query: 389 MAG--GTYGYLAPEF---VYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           M    GT  YLAPE    V         D +S GV+L   +SG  P
Sbjct: 312 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 357

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 86/216 (39%), Gaps = 28/216 (12%)
Query: 221 SITKNFSEGN----RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFA 276
            + K+   GN    RL+ D ++             VAVK ++R   +  +    EI    
Sbjct: 21  ELVKDIGSGNFGVARLMRDKQSN----------ELVAVKYIERGE-KIDENVKREIINHR 69
Query: 277 RLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ 336
            L HPN+V  K          IV E+   G L      I   GR  +   R      L  
Sbjct: 70  SLRHPNIVRFKEVILTPTHLAIVMEYASGGEL---FERICNAGRFSEDEARF-FFQQLIS 125
Query: 337 GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLM--GVGLSKFVPWEVMQERTVMAGGTY 394
           G+++ H      V HRD++  N LLD      L     G SK     V+  +     GT 
Sbjct: 126 GVSYCHAM---QVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTP 179
Query: 395 GYLAPEFVYRNELTTK-SDVYSFGVLLLEIVSGRRP 429
            Y+APE + + E   K +DV+S GV L  ++ G  P
Sbjct: 180 AYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYP 215

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/152 (25%), Positives = 70/152 (46%), Gaps = 12/152 (7%)
Query: 278 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 337
           ++ P L  ++    D+ + Y+V E+   G +     H+ R GR  +   R   A  +   
Sbjct: 99  VNFPFLTKLEFSFKDNSNLYMVMEYAPGGEM---FSHLRRIGRFXEPHARF-YAAQIVLT 154
Query: 338 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 397
             +LH      +++RD++  N+++D++    +   G +K V     + RT    GT  YL
Sbjct: 155 FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV-----KGRTWXLCGTPEYL 206
Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/201 (22%), Positives = 91/201 (45%), Gaps = 18/201 (8%)
Query: 233 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQR--KKEFYSEIGRFARLHHPNLVAVKGCC 290
           +G+   G  Y      G  VA+KR++  +           EI     LHHPN+V++    
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 291 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVAT-TLAQGIAFLHDKVKPHV 349
           +      +V+EF     +++ L  +    ++     ++K+    L +G+A  H   +  +
Sbjct: 89  HSERCLTLVFEF-----MEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH---QHRI 140
Query: 350 VHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTVMAGGTYGYLAPEFVY-RNE 406
           +HRD++  N+L++ +    L   GL++   +P        V    T  Y AP+ +    +
Sbjct: 141 LHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV----TLWYRAPDVLMGSKK 196
Query: 407 LTTKSDVYSFGVLLLEIVSGR 427
            +T  D++S G +  E+++G+
Sbjct: 197 YSTSVDIWSIGCIFAEMITGK 217

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 71/160 (44%), Gaps = 13/160 (8%)
Query: 271 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 330
           EI     L+HPN+V +    +     Y+V+E  V+  L  ++      G  L   +    
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEH-VHQDLKTFMDASALTGIPL--PLIKSY 107
Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 388
              L QG+AF H      V+HRD++  N+L++ E    L   GL++   VP        V
Sbjct: 108 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 164
Query: 389 MAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR 427
               T  Y APE +      +T  D++S G +  E+V+ R
Sbjct: 165 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 93/219 (42%), Gaps = 25/219 (11%)
Query: 221 SITKNFSEGNRLLGDSKTGGTYSGIL-----PDGSRVAVKRLKRSSFQRKKEF---YSEI 272
            +T N  +  +LLG     GT+  ++       G   A+K L++     K E     +E 
Sbjct: 1   KVTMNDFDYLKLLG----KGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTES 56
Query: 273 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVAT 332
                  HP L A+K     H     V E+   G L     H+ R     +   R   A 
Sbjct: 57  RVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAE 113
Query: 333 TLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG- 391
            ++  + +LH +    VV+RDI+  N++LD++    +   GL K    E + +   M   
Sbjct: 114 IVS-ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK----EGISDGATMKXF 165
Query: 392 -GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
            GT  YLAPE +  N+     D +  GV++ E++ GR P
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 91/219 (41%), Gaps = 25/219 (11%)
Query: 221 SITKNFSEGNRLLGDSKTGGTYSGIL-----PDGSRVAVKRLKRSSFQRKKEF---YSEI 272
            +T N  +  +LLG     GT+  ++       G   A+K L++     K E     +E 
Sbjct: 1   KVTMNDFDYLKLLGK----GTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTES 56
Query: 273 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVAT 332
                  HP L A+K     H     V E+   G L     H+ R     +   R     
Sbjct: 57  RVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARF-YGA 112
Query: 333 TLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG- 391
            +   + +LH +    VV+RDI+  N++LD++    +   GL K    E + +   M   
Sbjct: 113 EIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK----EGISDGATMKTF 165
Query: 392 -GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
            GT  YLAPE +  N+     D +  GV++ E++ GR P
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 93/219 (42%), Gaps = 25/219 (11%)
Query: 221 SITKNFSEGNRLLGDSKTGGTYSGIL-----PDGSRVAVKRLKRSSFQRKKEF---YSEI 272
            +T N  +  +LLG     GT+  ++       G   A+K L++     K E     +E 
Sbjct: 6   KVTMNDFDYLKLLG----KGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTES 61
Query: 273 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVAT 332
                  HP L A+K     H     V E+   G L     H+ R     +   R   A 
Sbjct: 62  RVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAE 118
Query: 333 TLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG- 391
            ++  + +LH +    VV+RDI+  N++LD++    +   GL K    E + +   M   
Sbjct: 119 IVS-ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK----EGISDGATMKXF 170
Query: 392 -GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
            GT  YLAPE +  N+     D +  GV++ E++ GR P
Sbjct: 171 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/201 (22%), Positives = 91/201 (45%), Gaps = 18/201 (8%)
Query: 233 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQR--KKEFYSEIGRFARLHHPNLVAVKGCC 290
           +G+   G  Y      G  VA+KR++  +           EI     LHHPN+V++    
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 291 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVAT-TLAQGIAFLHDKVKPHV 349
           +      +V+EF     +++ L  +    ++     ++K+    L +G+A  H   +  +
Sbjct: 89  HSERCLTLVFEF-----MEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH---QHRI 140
Query: 350 VHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTVMAGGTYGYLAPEFVY-RNE 406
           +HRD++  N+L++ +    L   GL++   +P        V    T  Y AP+ +    +
Sbjct: 141 LHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV----TLWYRAPDVLMGSKK 196
Query: 407 LTTKSDVYSFGVLLLEIVSGR 427
            +T  D++S G +  E+++G+
Sbjct: 197 YSTSVDIWSIGCIFAEMITGK 217

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 91/219 (41%), Gaps = 25/219 (11%)
Query: 221 SITKNFSEGNRLLGDSKTGGTYSGIL-----PDGSRVAVKRLKRSSFQRKKEF---YSEI 272
            +T N  +  +LLG     GT+  ++       G   A+K L++     K E     +E 
Sbjct: 1   KVTMNDFDYLKLLGK----GTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTES 56
Query: 273 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVAT 332
                  HP L A+K     H     V E+   G L     H+ R     +   R     
Sbjct: 57  RVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARF-YGA 112
Query: 333 TLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG- 391
            +   + +LH +    VV+RDI+  N++LD++    +   GL K    E + +   M   
Sbjct: 113 EIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK----EGISDGATMKTF 165
Query: 392 -GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
            GT  YLAPE +  N+     D +  GV++ E++ GR P
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1JWI|A Chain A, Crystal Structure Of Bitiscetin, A Von Willeband Factor- Dependent Platelet Aggregation Inducer. Length = 131

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 57/140 (40%), Gaps = 22/140 (15%)
Query: 9   CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCG----K 64
           C PDW  +  K  C+       +W+++E +C E  GHLA++ S EE     KL      K
Sbjct: 4   CLPDW--SSYKGHCYKVFKKVGTWEDAEKFCVENSGHLASIDSKEEADFVTKLASQTLTK 61
Query: 65  NVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLV 124
            V   W+G R  + T   S +W+D  S   E++       + C  L  H           
Sbjct: 62  FVYDAWIGLRDESKTQQCSPQWTDGSSVVYENVDEP----TKCFGLDVHTEY-------- 109
Query: 125 SNGSRSLVTERCNTSHPFIC 144
               R+     C   +PFIC
Sbjct: 110 ----RTWTDLPCGEKNPFIC 125

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 67/152 (44%), Gaps = 13/152 (8%)
Query: 280 HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA 339
           HP L A+K     H     V E+   G L     H+ R     +   R      +   + 
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARF-YGAEIVSALE 119
Query: 340 FLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYL 397
           +LH +    VV+RDI+  N++LD++    +   GL K    E + +   M    GT  YL
Sbjct: 120 YLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK----EGISDGATMKXFCGTPEYL 172
Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           APE +  N+     D +  GV++ E++ GR P
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 67/152 (44%), Gaps = 13/152 (8%)
Query: 280 HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA 339
           HP L A+K     H     V E+   G L     H+ R     +   R      +   + 
Sbjct: 67  HPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARF-YGAEIVSALE 122
Query: 340 FLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYL 397
           +LH +    VV+RDI+  N++LD++    +   GL K    E + +   M    GT  YL
Sbjct: 123 YLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK----EGISDGATMKTFCGTPEYL 175
Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           APE +  N+     D +  GV++ E++ GR P
Sbjct: 176 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 207

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 67/152 (44%), Gaps = 13/152 (8%)
Query: 280 HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA 339
           HP L A+K     H     V E+   G L     H+ R     +   R      +   + 
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARF-YGAEIVSALE 119
Query: 340 FLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYL 397
           +LH +    VV+RDI+  N++LD++    +   GL K    E + +   M    GT  YL
Sbjct: 120 YLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK----EGISDGATMKXFCGTPEYL 172
Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           APE +  N+     D +  GV++ E++ GR P
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/230 (21%), Positives = 96/230 (41%), Gaps = 29/230 (12%)
Query: 228 EGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVK 287
           E   L+G  + G  Y G       + +  ++R +  + K F  E+  + +  H N+V   
Sbjct: 36  EIGELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 288 GCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGR-SLDWAMRMKVATTLAQGIAFLHDKVK 346
           G C       I+          R L+ + R  +  LD     ++A  + +G+ +LH K  
Sbjct: 96  GACMSPPHLAIITSLCKG----RTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK-- 149
Query: 347 PHVVHRDIRASNVLLDE------EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 400
             ++H+D+++ NV  D       +FG       +S  +     +++  +  G   +LAPE
Sbjct: 150 -GILHKDLKSKNVFYDNGKVVITDFGL----FSISGVLQAGRREDKLRIQNGWLCHLAPE 204
Query: 401 FVYRNELTTK---------SDVYSFGVLLLEIVSGRRP--AQAVDSVCWQ 439
            + +    T+         SDV++ G +  E+ +   P   Q  +++ WQ
Sbjct: 205 IIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQ 254

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 38/152 (25%), Positives = 70/152 (46%), Gaps = 12/152 (7%)
Query: 278 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 337
           ++ P L  ++    D+ + Y+V E+   G +     H+ R GR  +   R   A  +   
Sbjct: 99  VNFPFLTKLEFSFKDNSNLYMVMEYAPGGEM---FSHLRRIGRFSEPHARF-YAAQIVLT 154
Query: 338 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 397
             +LH      +++RD++  N+++D++    +   G +K V     + RT    GT  YL
Sbjct: 155 FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV-----KGRTWXLCGTPEYL 206
Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 68/156 (43%), Gaps = 13/156 (8%)
Query: 278 LHHPNLVAV-KGCCYDHGDRYIVYEFV---VNGPLDRWLHHIPRGGRSLDWAMRMKVATT 333
             HPN+V +   C     DR      V   V+  L  +L  +P  G   +    M     
Sbjct: 71  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ-- 128
Query: 334 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT 393
           L +G+ FLH      VVHRD++  N+L+       L   GL++   +++     V+   T
Sbjct: 129 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV---T 182
Query: 394 YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
             Y APE + ++   T  D++S G +  E+   R+P
Sbjct: 183 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKP 217

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 38/152 (25%), Positives = 70/152 (46%), Gaps = 12/152 (7%)
Query: 278 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 337
           ++ P L  ++    D+ + Y+V E+   G +     H+ R GR  +   R   A  +   
Sbjct: 99  VNFPFLTKLEFSFKDNSNLYMVMEYAPGGEM---FSHLRRIGRFSEPHARF-YAAQIVLT 154
Query: 338 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 397
             +LH      +++RD++  N+++D++    +   G +K V     + RT    GT  YL
Sbjct: 155 FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV-----KGRTWXLCGTPEYL 206
Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           APE +         D ++ GVL+ E+ +G  P
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 83/180 (46%), Gaps = 14/180 (7%)
Query: 252 VAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRW 311
           +  K+L    FQ K E  + I R  +L HPN+V +     +    Y+V++ V  G L  +
Sbjct: 39  INTKKLSARDFQ-KLEREARICR--KLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL--F 93
Query: 312 LHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMG 371
              + R   S   A        + + IA+ H      +VHR+++  N+LL  +  A    
Sbjct: 94  EDIVAREFYS--EADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASK--AKGAA 146
Query: 372 VGLSKF-VPWEVMQERTVMA-GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           V L+ F +  EV          GT GYL+PE + ++  +   D+++ GV+L  ++ G  P
Sbjct: 147 VKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 83/180 (46%), Gaps = 14/180 (7%)
Query: 252 VAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRW 311
           +  K+L    FQ K E  + I R  +L HPN+V +     +    Y+V++ V  G L  +
Sbjct: 39  INTKKLSARDFQ-KLEREARICR--KLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL--F 93
Query: 312 LHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMG 371
              + R   S   A        + + IA+ H      +VHR+++  N+LL  +  A    
Sbjct: 94  EDIVAREFYS--EADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASK--AKGAA 146
Query: 372 VGLSKF-VPWEVMQERTVMA-GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           V L+ F +  EV          GT GYL+PE + ++  +   D+++ GV+L  ++ G  P
Sbjct: 147 VKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 31/118 (26%), Positives = 64/118 (54%), Gaps = 9/118 (7%)
Query: 313 HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV 372
           +H+ + G   +  MR   A  +  G+  +H++    VV+RD++ +N+LLDE     +  +
Sbjct: 281 YHLSQHGVFSEADMRFYAAEIIL-GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDL 336
Query: 373 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRP 429
           GL+     +  +++   + GT+GY+APE + +     + +D +S G +L +++ G  P
Sbjct: 337 GLA----CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 31/118 (26%), Positives = 64/118 (54%), Gaps = 9/118 (7%)
Query: 313 HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV 372
           +H+ + G   +  MR   A  +  G+  +H++    VV+RD++ +N+LLDE     +  +
Sbjct: 281 YHLSQHGVFSEADMRFYAAEIIL-GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDL 336
Query: 373 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRP 429
           GL+     +  +++   + GT+GY+APE + +     + +D +S G +L +++ G  P
Sbjct: 337 GLA----CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 31/118 (26%), Positives = 64/118 (54%), Gaps = 9/118 (7%)
Query: 313 HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV 372
           +H+ + G   +  MR   A  +  G+  +H++    VV+RD++ +N+LLDE     +  +
Sbjct: 280 YHLSQHGVFSEADMRFYAAEIIL-GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDL 335
Query: 373 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRP 429
           GL+     +  +++   + GT+GY+APE + +     + +D +S G +L +++ G  P
Sbjct: 336 GLA----CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 389

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 31/118 (26%), Positives = 64/118 (54%), Gaps = 9/118 (7%)
Query: 313 HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV 372
           +H+ + G   +  MR   A  +  G+  +H++    VV+RD++ +N+LLDE     +  +
Sbjct: 281 YHLSQHGVFSEADMRFYAAEIIL-GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDL 336
Query: 373 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRP 429
           GL+     +  +++   + GT+GY+APE + +     + +D +S G +L +++ G  P
Sbjct: 337 GLA----CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 83/180 (46%), Gaps = 14/180 (7%)
Query: 252 VAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRW 311
           +  K+L    FQ K E  + I R  +L HPN+V +     +    Y+V++ V  G L  +
Sbjct: 38  INTKKLSARDFQ-KLEREARICR--KLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL--F 92
Query: 312 LHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMG 371
              + R   S   A        + + IA+ H      +VHR+++  N+LL  +  A    
Sbjct: 93  EDIVAREFYS--EADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASK--AKGAA 145
Query: 372 VGLSKF-VPWEVMQERTVMA-GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           V L+ F +  EV          GT GYL+PE + ++  +   D+++ GV+L  ++ G  P
Sbjct: 146 VKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 205

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 80/191 (41%), Gaps = 40/191 (20%)
Query: 255 KRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD------HGDRYIVY--EFVVNG 306
           ++L +S  QR   F  E      L HPN+V      YD       G + IV   E   +G
Sbjct: 62  RKLTKSERQR---FKEEAEXLKGLQHPNIVRF----YDSWESTVKGKKCIVLVTELXTSG 114
Query: 307 PLDRWLHHIPRGGRSLDWAMRMKVATT----LAQGIAFLHDKVKPHVVHRDIRASNVLLD 362
            L  +L              ++KV  +    + +G+ FLH +  P ++HRD++  N+ + 
Sbjct: 115 TLKTYLKRFK--------VXKIKVLRSWCRQILKGLQFLHTRTPP-IIHRDLKCDNIFIT 165
Query: 363 EEFGAHLMG-VGLSKFVPWEVMQERTVMAG---GTYGYLAPEFVYRNELTTKSDVYSFGV 418
              G+  +G +GL+         +R   A    GT  + APE  Y  +     DVY+FG 
Sbjct: 166 GPTGSVKIGDLGLATL-------KRASFAKAVIGTPEFXAPE-XYEEKYDESVDVYAFGX 217
Query: 419 LLLEIVSGRRP 429
             LE  +   P
Sbjct: 218 CXLEXATSEYP 228

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 71/157 (45%), Gaps = 15/157 (9%)
Query: 278 LHHPNLVAV-KGCCYDHGDR----YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVAT 332
             HPN+V +   C     DR     +V+E V +  L  +L  +P  G   +    M    
Sbjct: 71  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQ- 128
Query: 333 TLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG 392
            L +G+ FLH      VVHRD++  N+L+       L   GL++   +++     V+   
Sbjct: 129 -LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--- 181
Query: 393 TYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           T  Y APE + ++   T  D++S G +  E+   R+P
Sbjct: 182 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKP 217

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 71/157 (45%), Gaps = 15/157 (9%)
Query: 278 LHHPNLVAV-KGCCYDHGDR----YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVAT 332
             HPN+V +   C     DR     +V+E V +  L  +L  +P  G   +    M    
Sbjct: 71  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQ- 128
Query: 333 TLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG 392
            L +G+ FLH      VVHRD++  N+L+       L   GL++   +++     V+   
Sbjct: 129 -LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--- 181
Query: 393 TYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           T  Y APE + ++   T  D++S G +  E+   R+P
Sbjct: 182 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKP 217

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 24/209 (11%)
Query: 230 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKG 288
            +++G+   G  Y   L D G  VA+K++     Q K+    E+    +L H N+V ++ 
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRY 80
Query: 289 CCYDHGDRY-IVYEFVVNGPLD-------RWLHHIPRGGRSLDWAMRMKVATTLAQGIAF 340
             Y  G++  +VY   +N  LD       R   H  R  ++L           L + +A+
Sbjct: 81  FFYSSGEKKDVVY---LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 341 LHDKVKPHVVHRDIRASNVLLDEEFGA-HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAP 399
           +H      + HRDI+  N+LLD +     L   G +K +   V  E  V    +  Y AP
Sbjct: 138 IHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---VRGEPNVSXICSRYYRAP 191
Query: 400 EFVY-RNELTTKSDVYSFGVLLLEIVSGR 427
           E ++   + T+  DV+S G +L E++ G+
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 230 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKG 288
            +++G+   G  Y   L D G  VA+K++     Q K+    E+    +L H N+V ++ 
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRY 80
Query: 289 CCYDHGDRYIVYEFVVNGPLD-------RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 341
             Y  G++    E  +N  LD       R   H  R  ++L           L + +A++
Sbjct: 81  FFYSSGEKKD--EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 342 HDKVKPHVVHRDIRASNVLLDEEFGA-HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 400
           H      + HRDI+  N+LLD +     L   G +K +   V  E  V    +  Y APE
Sbjct: 139 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---VRGEPNVSXICSRYYRAPE 192
Query: 401 FVY-RNELTTKSDVYSFGVLLLEIVSGR 427
            ++   + T+  DV+S G +L E++ G+
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 83/180 (46%), Gaps = 14/180 (7%)
Query: 252 VAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRW 311
           +  K+L    FQ K E  + I R  +L HPN+V +     +    Y+V++ V  G L  +
Sbjct: 62  INTKKLSARDFQ-KLEREARICR--KLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL--F 116
Query: 312 LHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMG 371
              + R   S   A        + + IA+ H      +VHR+++  N+LL  +  A    
Sbjct: 117 EDIVAREFYS--EADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASK--AKGAA 169
Query: 372 VGLSKF-VPWEVMQERTVMA-GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           V L+ F +  EV          GT GYL+PE + ++  +   D+++ GV+L  ++ G  P
Sbjct: 170 VKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 230 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKG 288
            +++G+   G  Y   L D G  VA+K++     Q K+    E+    +L H N+V ++ 
Sbjct: 44  TKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRY 99
Query: 289 CCYDHGDRYIVYEFVVNGPLD-------RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 341
             Y  G++    E  +N  LD       R   H  R  ++L           L + +A++
Sbjct: 100 FFYSSGEKKD--EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 157
Query: 342 HDKVKPHVVHRDIRASNVLLDEEFGA-HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 400
           H      + HRDI+  N+LLD +     L   G +K +   V  E  V    +  Y APE
Sbjct: 158 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---VRGEPNVSXICSRYYRAPE 211
Query: 401 FVY-RNELTTKSDVYSFGVLLLEIVSGR 427
            ++   + T+  DV+S G +L E++ G+
Sbjct: 212 LIFGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 230 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKG 288
            +++G+   G  Y   L D G  VA+K++     Q K+    E+    +L H N+V ++ 
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRY 80
Query: 289 CCYDHGDRYIVYEFVVNGPLD-------RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 341
             Y  G++    E  +N  LD       R   H  R  ++L           L + +A++
Sbjct: 81  FFYSSGEKKD--EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 342 HDKVKPHVVHRDIRASNVLLDEEFGA-HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 400
           H      + HRDI+  N+LLD +     L   G +K +   V  E  V    +  Y APE
Sbjct: 139 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---VRGEPNVSXICSRYYRAPE 192
Query: 401 FVY-RNELTTKSDVYSFGVLLLEIVSGR 427
            ++   + T+  DV+S G +L E++ G+
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 230 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKG 288
            +++G+   G  Y   L D G  VA+K++     Q K+    E+    +L H N+V ++ 
Sbjct: 26  TKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRY 81
Query: 289 CCYDHGDRYIVYEFVVNGPLD-------RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 341
             Y  G++    E  +N  LD       R   H  R  ++L           L + +A++
Sbjct: 82  FFYSSGEKKD--EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 139
Query: 342 HDKVKPHVVHRDIRASNVLLDEEFGA-HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 400
           H      + HRDI+  N+LLD +     L   G +K +   V  E  V    +  Y APE
Sbjct: 140 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---VRGEPNVSXICSRYYRAPE 193
Query: 401 FVY-RNELTTKSDVYSFGVLLLEIVSGR 427
            ++   + T+  DV+S G +L E++ G+
Sbjct: 194 LIFGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 230 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKG 288
            +++G+   G  Y   L D G  VA+K++     Q K+    E+    +L H N+V ++ 
Sbjct: 33  TKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRY 88
Query: 289 CCYDHGDRYIVYEFVVNGPLD-------RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 341
             Y  G++    E  +N  LD       R   H  R  ++L           L + +A++
Sbjct: 89  FFYSSGEKKD--EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 146
Query: 342 HDKVKPHVVHRDIRASNVLLDEEFGA-HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 400
           H      + HRDI+  N+LLD +     L   G +K +   V  E  V    +  Y APE
Sbjct: 147 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---VRGEPNVSXICSRYYRAPE 200
Query: 401 FVY-RNELTTKSDVYSFGVLLLEIVSGR 427
            ++   + T+  DV+S G +L E++ G+
Sbjct: 201 LIFGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 230 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKG 288
            +++G+   G  Y   L D G  VA+K++     Q K+    E+    +L H N+V ++ 
Sbjct: 29  TKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRY 84
Query: 289 CCYDHGDRYIVYEFVVNGPLD-------RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 341
             Y  G++    E  +N  LD       R   H  R  ++L           L + +A++
Sbjct: 85  FFYSSGEKKD--EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 142
Query: 342 HDKVKPHVVHRDIRASNVLLDEEFGA-HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 400
           H      + HRDI+  N+LLD +     L   G +K +   V  E  V    +  Y APE
Sbjct: 143 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---VRGEPNVSXICSRYYRAPE 196
Query: 401 FVY-RNELTTKSDVYSFGVLLLEIVSGR 427
            ++   + T+  DV+S G +L E++ G+
Sbjct: 197 LIFGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 93/198 (46%), Gaps = 35/198 (17%)
Query: 249 GSRVAVKRL---KRSSFQRKKEFYSEIGRFARLHHPNLVA-----VKGCCYDHGDRYIVY 300
           G +VAVK     + +S+ R+ E Y  +     + H N++      +KG        Y++ 
Sbjct: 60  GEKVAVKVFFTTEEASWFRETEIYQTV----LMRHENILGFIAADIKGTG-SWTQLYLIT 114
Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV-----KPHVVHRDIR 355
           ++  NG L  +L        +LD    +K+A +   G+  LH ++     KP + HRD++
Sbjct: 115 DYHENGSLYDYLK-----STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLK 169
Query: 356 ASNVLLDEEFGAHLMGVGLS-KFVPWEVMQERTVMAG---GTYGYLAPEF----VYRNEL 407
           + N+L+ +     +  +GL+ KF+      E  +      GT  Y+ PE     + RN  
Sbjct: 170 SKNILVKKNGTCCIADLGLAVKFI--SDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHF 227
Query: 408 TT--KSDVYSFGVLLLEI 423
            +   +D+YSFG++L E+
Sbjct: 228 QSYIMADMYSFGLILWEV 245

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/186 (30%), Positives = 86/186 (46%), Gaps = 13/186 (6%)
Query: 249 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG--DRYIVYEFVVNG 306
           G  VA+K++ +    R +E    +   A LHHPN+V ++   Y  G  DR  +Y  VV  
Sbjct: 48  GMSVAIKKVIQDPRFRNREL-QIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVME 106
Query: 307 PLDRWLHHIPRGGRSLDWA---MRMKVAT-TLAQGIAFLHDKVKPHVVHRDIRASNVLLD 362
            +   LH   R       A   + +KV    L + I  LH     +V HRDI+  NVL++
Sbjct: 107 YVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLH-LPSVNVCHRDIKPHNVLVN 165
Query: 363 EEFGA-HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNE-LTTKSDVYSFGVLL 420
           E  G   L   G +K +      E  V    +  Y APE ++ N+  TT  D++S G + 
Sbjct: 166 EADGTLKLCDFGSAKKLSP---SEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIF 222
Query: 421 LEIVSG 426
            E++ G
Sbjct: 223 AEMMLG 228

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 87/209 (41%), Gaps = 22/209 (10%)
Query: 233 LGDSKTGGTYSG--ILPDGS--RVAVKRLKRSSFQRKK---EFYSEIGRFARLHHPNLVA 285
           LGD   G    G    P G    VAVK LK     + +   +F  E+     L H NL+ 
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 286 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 345
           + G       + +     +   LDR   H    G  L   +  + A  +A+G+ +L  K 
Sbjct: 80  LYGVVLTPPMKMVTELAPLGSLLDRLRKH---QGHFLLGTLS-RYAVQVAEGMGYLESK- 134
Query: 346 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE----VMQERTVMAGGTYGYLAPEF 401
               +HRD+ A N+LL       +   GL + +P      VMQE   +    + + APE 
Sbjct: 135 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP---FAWCAPES 189
Query: 402 VYRNELTTKSDVYSFGVLLLEIVS-GRRP 429
           +     +  SD + FGV L E+ + G+ P
Sbjct: 190 LKTRTFSHASDTWMFGVTLWEMFTYGQEP 218

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 230 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKG 288
            +++G+   G  Y   L D G  VA+K++     Q K+    E+    +L H N+V ++ 
Sbjct: 37  TKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRY 92
Query: 289 CCYDHGDRYIVYEFVVNGPLD-------RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 341
             Y  G++    E  +N  LD       R   H  R  ++L           L + +A++
Sbjct: 93  FFYSSGEKKD--EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 150
Query: 342 HDKVKPHVVHRDIRASNVLLDEEFGA-HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 400
           H      + HRDI+  N+LLD +     L   G +K +   V  E  V    +  Y APE
Sbjct: 151 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---VRGEPNVSXICSRYYRAPE 204
Query: 401 FVY-RNELTTKSDVYSFGVLLLEIVSGR 427
            ++   + T+  DV+S G +L E++ G+
Sbjct: 205 LIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 230 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKG 288
            +++G+   G  Y   L D G  VA+K++     Q K+    E+    +L H N+V ++ 
Sbjct: 37  TKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRY 92
Query: 289 CCYDHGDRYIVYEFVVNGPLD-------RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 341
             Y  G++    E  +N  LD       R   H  R  ++L           L + +A++
Sbjct: 93  FFYSSGEKKD--EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 150
Query: 342 HDKVKPHVVHRDIRASNVLLDEEFGA-HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 400
           H      + HRDI+  N+LLD +     L   G +K +   V  E  V    +  Y APE
Sbjct: 151 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---VRGEPNVSXICSRYYRAPE 204
Query: 401 FVY-RNELTTKSDVYSFGVLLLEIVSGR 427
            ++   + T+  DV+S G +L E++ G+
Sbjct: 205 LIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 87/209 (41%), Gaps = 22/209 (10%)
Query: 233 LGDSKTGGTYSG--ILPDGS--RVAVKRLKRSSFQRKK---EFYSEIGRFARLHHPNLVA 285
           LGD   G    G    P G    VAVK LK     + +   +F  E+     L H NL+ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 286 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 345
           + G       + +     +   LDR   H    G  L   +  + A  +A+G+ +L  K 
Sbjct: 76  LYGVVLTPPMKMVTELAPLGSLLDRLRKH---QGHFLLGTLS-RYAVQVAEGMGYLESK- 130
Query: 346 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE----VMQERTVMAGGTYGYLAPEF 401
               +HRD+ A N+LL       +   GL + +P      VMQE   +    + + APE 
Sbjct: 131 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVP---FAWCAPES 185
Query: 402 VYRNELTTKSDVYSFGVLLLEIVS-GRRP 429
           +     +  SD + FGV L E+ + G+ P
Sbjct: 186 LKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 230 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKG 288
            +++G+   G  Y   L D G  VA+K++     Q K+    E+    +L H N+V ++ 
Sbjct: 59  TKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRY 114
Query: 289 CCYDHGDRYIVYEFVVNGPLD-------RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 341
             Y  G++    E  +N  LD       R   H  R  ++L           L + +A++
Sbjct: 115 FFYSSGEKKD--EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 172
Query: 342 HDKVKPHVVHRDIRASNVLLDEEFGA-HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 400
           H      + HRDI+  N+LLD +     L   G +K +   V  E  V    +  Y APE
Sbjct: 173 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---VRGEPNVSXICSRYYRAPE 226
Query: 401 FVY-RNELTTKSDVYSFGVLLLEIVSGR 427
            ++   + T+  DV+S G +L E++ G+
Sbjct: 227 LIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 87/209 (41%), Gaps = 22/209 (10%)
Query: 233 LGDSKTGGTYSG--ILPDGS--RVAVKRLKRSSFQRKK---EFYSEIGRFARLHHPNLVA 285
           LGD   G    G    P G    VAVK LK     + +   +F  E+     L H NL+ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 286 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 345
           + G       + +     +   LDR   H    G  L   +  + A  +A+G+ +L  K 
Sbjct: 76  LYGVVLTPPMKMVTELAPLGSLLDRLRKH---QGHFLLGTLS-RYAVQVAEGMGYLESK- 130
Query: 346 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE----VMQERTVMAGGTYGYLAPEF 401
               +HRD+ A N+LL       +   GL + +P      VMQE   +    + + APE 
Sbjct: 131 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP---FAWCAPES 185
Query: 402 VYRNELTTKSDVYSFGVLLLEIVS-GRRP 429
           +     +  SD + FGV L E+ + G+ P
Sbjct: 186 LKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 230 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKG 288
            +++G+   G  Y   L D G  VA+K++     Q K+    E+    +L H N+V ++ 
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRY 80
Query: 289 CCYDHGDRYIVYEFVVNGPLD-------RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 341
             Y  G++    E  +N  LD       R   H  R  ++L           L + +A++
Sbjct: 81  FFYSSGEKKD--EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 342 HDKVKPHVVHRDIRASNVLLDEEFGA-HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 400
           H      + HRDI+  N+LLD +     L   G +K +   V  E  V    +  Y APE
Sbjct: 139 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---VRGEPNVSYICSRYYRAPE 192
Query: 401 FVY-RNELTTKSDVYSFGVLLLEIVSGR 427
            ++   + T+  DV+S G +L E++ G+
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 84/181 (46%), Gaps = 15/181 (8%)
Query: 252 VAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRW 311
           +  K+L     Q K E  + I R   L HPN+V +     + G  Y+V++ V  G L   
Sbjct: 64  INTKKLSARDHQ-KLEREARICRL--LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFED 120
Query: 312 LHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMG 371
           +  + R     ++      +  + Q +  ++   +  +VHRD++  N+LL  +       
Sbjct: 121 I--VAR-----EYYSEADASHCIHQILESVNHIHQHDIVHRDLKPENLLLASKCKG--AA 171
Query: 372 VGLSKF-VPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRR 428
           V L+ F +  EV  E+    G  GT GYL+PE + ++      D+++ GV+L  ++ G  
Sbjct: 172 VKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYP 231
Query: 429 P 429
           P
Sbjct: 232 P 232

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 87/209 (41%), Gaps = 22/209 (10%)
Query: 233 LGDSKTGGTYSG--ILPDGS--RVAVKRLKRSSFQRKK---EFYSEIGRFARLHHPNLVA 285
           LGD   G    G    P G    VAVK LK     + +   +F  E+     L H NL+ 
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 286 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 345
           + G       + +     +   LDR   H    G  L   +  + A  +A+G+ +L  K 
Sbjct: 86  LYGVVLTPPMKMVTELAPLGSLLDRLRKH---QGHFLLGTLS-RYAVQVAEGMGYLESK- 140
Query: 346 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE----VMQERTVMAGGTYGYLAPEF 401
               +HRD+ A N+LL       +   GL + +P      VMQE   +    + + APE 
Sbjct: 141 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP---FAWCAPES 195
Query: 402 VYRNELTTKSDVYSFGVLLLEIVS-GRRP 429
           +     +  SD + FGV L E+ + G+ P
Sbjct: 196 LKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 230 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKG 288
            +++G+   G  Y   L D G  VA+K++     Q K+    E+    +L H N+V ++ 
Sbjct: 38  TKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRY 93
Query: 289 CCYDHGDRYIVYEFVVNGPLD-------RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 341
             Y  G++    E  +N  LD       R   H  R  ++L           L + +A++
Sbjct: 94  FFYSSGEKKD--EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 151
Query: 342 HDKVKPHVVHRDIRASNVLLDEEFGA-HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 400
           H      + HRDI+  N+LLD +     L   G +K +   V  E  V    +  Y APE
Sbjct: 152 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---VRGEPNVSYICSRYYRAPE 205
Query: 401 FVY-RNELTTKSDVYSFGVLLLEIVSGR 427
            ++   + T+  DV+S G +L E++ G+
Sbjct: 206 LIFGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 86/203 (42%), Gaps = 26/203 (12%)
Query: 235 DSKTGGTYSGILPDGSRVAVKRLKRSSFQRKK---EFYSEIGRFARLHHPNLVAVKGCCY 291
           D+ +G T S        VAVK LK     + +   +F  E+     L H NL+ + G   
Sbjct: 40  DAPSGKTVS--------VAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL 91
Query: 292 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 351
               + +     +   LDR   H    G  L   +  + A  +A+G+ +L  K     +H
Sbjct: 92  TPPMKMVTELAPLGSLLDRLRKH---QGHFLLGTLS-RYAVQVAEGMGYLESK---RFIH 144
Query: 352 RDIRASNVLLDEEFGAHLMGVGLSKFVPWE----VMQERTVMAGGTYGYLAPEFVYRNEL 407
           RD+ A N+LL       +   GL + +P      VMQE   +    + + APE +     
Sbjct: 145 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVP---FAWCAPESLKTRTF 201
Query: 408 TTKSDVYSFGVLLLEIVS-GRRP 429
           +  SD + FGV L E+ + G+ P
Sbjct: 202 SHASDTWMFGVTLWEMFTYGQEP 224

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/190 (24%), Positives = 86/190 (45%), Gaps = 27/190 (14%)
Query: 249 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 300
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 107 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 157
Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 417
           ++E+    ++G GL++    E       M G   T  Y APE +          D++S G
Sbjct: 158 VNEDCELKILGFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 210
Query: 418 VLLLEIVSGR 427
            ++ E+++GR
Sbjct: 211 CIMAELLTGR 220

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 90/205 (43%), Gaps = 24/205 (11%)
Query: 249 GSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAV------KGCCYDHGDRYIV 299
           G  VAVK+L R  FQ +   K  Y E+     ++H N++++      +    +  D Y+V
Sbjct: 47  GINVAVKKLSRP-FQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLV 105
Query: 300 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNV 359
            E +++  L + +H        LD      +   +  GI  LH      ++HRD++ SN+
Sbjct: 106 ME-LMDANLCQVIH------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNI 155
Query: 360 LLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVL 419
           ++  +    ++  GL++      M    V+   T  Y APE +         D++S G +
Sbjct: 156 VVKSDCTLKILDFGLARTASTNFMMTPYVV---TRYYRAPEVILGMGYKENVDIWSVGCI 212
Query: 420 LLEIVSGRRPAQAVDSV-CWQSIFE 443
           + E+V G    Q  D +  W  + E
Sbjct: 213 MGELVKGSVIFQGTDHIDQWNKVIE 237

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 95/208 (45%), Gaps = 22/208 (10%)
Query: 230 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKG 288
            +++G+   G  Y   L D G  VA+K++ +    + +E   +I R  +L H N+V ++ 
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNREL--QIMR--KLDHCNIVRLRY 80
Query: 289 CCYDHGDRYIVYEFVVNGPLD-------RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 341
             Y  G++    E  +N  LD       R   H  R  ++L           L + +A++
Sbjct: 81  FFYSSGEKKD--EVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 342 HDKVKPHVVHRDIRASNVLLDEEFGA-HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 400
           H      + HRDI+  N+LLD +     L   G +K +   V  E  V    +  Y APE
Sbjct: 139 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---VRGEPNVSXICSRYYRAPE 192
Query: 401 FVY-RNELTTKSDVYSFGVLLLEIVSGR 427
            ++   + T+  DV+S G +L E++ G+
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 87/209 (41%), Gaps = 22/209 (10%)
Query: 233 LGDSKTGGTYSG--ILPDGS--RVAVKRLKRSSFQRKK---EFYSEIGRFARLHHPNLVA 285
           LGD   G    G    P G    VAVK LK     + +   +F  E+     L H NL+ 
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 286 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 345
           + G       + +     +   LDR   H    G  L   +  + A  +A+G+ +L  K 
Sbjct: 80  LYGVVLTPPMKMVTELAPLGSLLDRLRKH---QGHFLLGTLS-RYAVQVAEGMGYLESK- 134
Query: 346 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE----VMQERTVMAGGTYGYLAPEF 401
               +HRD+ A N+LL       +   GL + +P      VMQE   +    + + APE 
Sbjct: 135 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP---FAWCAPES 189
Query: 402 VYRNELTTKSDVYSFGVLLLEIVS-GRRP 429
           +     +  SD + FGV L E+ + G+ P
Sbjct: 190 LKTRTFSHASDTWMFGVTLWEMFTYGQEP 218

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 87/209 (41%), Gaps = 22/209 (10%)
Query: 233 LGDSKTGGTYSG--ILPDGS--RVAVKRLKRSSFQRKK---EFYSEIGRFARLHHPNLVA 285
           LGD   G    G    P G    VAVK LK     + +   +F  E+     L H NL+ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 286 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 345
           + G       + +     +   LDR   H    G  L   +  + A  +A+G+ +L  K 
Sbjct: 76  LYGVVLTPPMKMVTELAPLGSLLDRLRKH---QGHFLLGTLS-RYAVQVAEGMGYLESK- 130
Query: 346 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE----VMQERTVMAGGTYGYLAPEF 401
               +HRD+ A N+LL       +   GL + +P      VMQE   +    + + APE 
Sbjct: 131 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP---FAWCAPES 185
Query: 402 VYRNELTTKSDVYSFGVLLLEIVS-GRRP 429
           +     +  SD + FGV L E+ + G+ P
Sbjct: 186 LKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 230 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKG 288
            +++G+   G  Y   L D G  VA+K++     Q K+    E+    +L H N+V ++ 
Sbjct: 53  TKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRY 108
Query: 289 CCYDHGDRYIVYEFVVNGPLD-------RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 341
             Y  G++    E  +N  LD       R   H  R  ++L           L + +A++
Sbjct: 109 FFYSSGEKKD--EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 166
Query: 342 HDKVKPHVVHRDIRASNVLLDEEFGA-HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 400
           H      + HRDI+  N+LLD +     L   G +K +   V  E  V    +  Y APE
Sbjct: 167 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---VRGEPNVSYICSRYYRAPE 220
Query: 401 FVY-RNELTTKSDVYSFGVLLLEIVSGR 427
            ++   + T+  DV+S G +L E++ G+
Sbjct: 221 LIFGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 67/294 (22%), Positives = 118/294 (40%), Gaps = 47/294 (15%)
Query: 225 NFSEGNRL--LGDSKTGGTYSGILPDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHH 280
           +F + N L  L ++ +G  + G    G+ + VK LK    S ++ ++F  E  R     H
Sbjct: 8   DFKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH 66
Query: 281 PNLVAVKGCCYDHGDRY--IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGI 338
           PN++ V G C      +  ++  +   G L   LH        +D +  +K A   A+G 
Sbjct: 67  PNVLPVLGACQSPPAPHPTLITHWXPYGSLYNVLHE--GTNFVVDQSQAVKFALDXARGX 124
Query: 339 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GY 396
           AFLH  ++P +    + + +V +DE+  A +    + KF             G  Y   +
Sbjct: 125 AFLH-TLEPLIPRHALNSRSVXIDEDXTARISXADV-KF--------SFQSPGRXYAPAW 174
Query: 397 LAPEFVYRNELTTK---SDVYSFGVLLLEIVSGRRPAQAVDS--VCWQSIFEWATPLVQS 451
           +APE + +    T    +D +SF VLL E+V+   P   + +  +  +   E   P +  
Sbjct: 175 VAPEALQKKPEDTNRRSADXWSFAVLLWELVTREVPFADLSNXEIGXKVALEGLRPTIP- 233
Query: 452 HRYXXXXXXXXXXXXXXXXXAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ 505
                                G+   V  L   C    P+ RP+   +V  L++
Sbjct: 234 --------------------PGISPHVSKLXKICXNEDPAKRPKFDXIVPILEK 267

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/191 (23%), Positives = 88/191 (46%), Gaps = 29/191 (15%)
Query: 249 GSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAV------KGCCYDHGDRYIV 299
           G++VA+K+L R  FQ +   K  Y E+     + H N++ +           D  D Y+V
Sbjct: 50  GAKVAIKKLYRP-FQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLV 108
Query: 300 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNV 359
             F+    L + + H   G   + +     +   + +G+ ++H      ++HRD++  N+
Sbjct: 109 MPFM-GTDLGKLMKHEKLGEDRIQF-----LVYQMLKGLRYIH---AAGIIHRDLKPGNL 159
Query: 360 LLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG--TYGYLAPEFVYR-NELTTKSDVYSF 416
            ++E+    ++  GL++       Q  + M G   T  Y APE +      T   D++S 
Sbjct: 160 AVNEDCELKILDFGLAR-------QADSEMXGXVVTRWYRAPEVILNWMRYTQTVDIWSV 212
Query: 417 GVLLLEIVSGR 427
           G ++ E+++G+
Sbjct: 213 GCIMAEMITGK 223

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 230 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKG 288
            +++G+   G  Y   L D G  VA+K++     Q K+    E+    +L H N+V ++ 
Sbjct: 30  TKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRY 85
Query: 289 CCYDHGDRYIVYEFVVNGPLD-------RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 341
             Y  G++    E  +N  LD       R   H  R  ++L           L + +A++
Sbjct: 86  FFYSSGEKKD--EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 143
Query: 342 HDKVKPHVVHRDIRASNVLLDEEFGA-HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 400
           H      + HRDI+  N+LLD +     L   G +K +   V  E  V    +  Y APE
Sbjct: 144 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---VRGEPNVSYICSRYYRAPE 197
Query: 401 FVY-RNELTTKSDVYSFGVLLLEIVSGR 427
            ++   + T+  DV+S G +L E++ G+
Sbjct: 198 LIFGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 230 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKG 288
            +++G+   G  Y   L D G  VA+K++     Q K+    E+    +L H N+V ++ 
Sbjct: 59  TKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRY 114
Query: 289 CCYDHGDRYIVYEFVVNGPLD-------RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 341
             Y  G++    E  +N  LD       R   H  R  ++L           L + +A++
Sbjct: 115 FFYSSGEKKD--EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 172
Query: 342 HDKVKPHVVHRDIRASNVLLDEEFGA-HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 400
           H      + HRDI+  N+LLD +     L   G +K +   V  E  V    +  Y APE
Sbjct: 173 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---VRGEPNVSYICSRYYRAPE 226
Query: 401 FVY-RNELTTKSDVYSFGVLLLEIVSGR 427
            ++   + T+  DV+S G +L E++ G+
Sbjct: 227 LIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/190 (24%), Positives = 86/190 (45%), Gaps = 27/190 (14%)
Query: 249 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 300
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 47  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 107 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 157
Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 417
           ++E+    ++  GL++    E       MAG   T  Y APE +          D++S G
Sbjct: 158 VNEDCELKILDFGLARHTDDE-------MAGFVATRWYRAPEIMLNWMHYNQTVDIWSVG 210
Query: 418 VLLLEIVSGR 427
            ++ E+++GR
Sbjct: 211 CIMAELLTGR 220

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/190 (24%), Positives = 86/190 (45%), Gaps = 27/190 (14%)
Query: 249 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 300
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 47  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 107 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 157
Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 417
           ++E+    ++  GL++    E       MAG   T  Y APE +          D++S G
Sbjct: 158 VNEDCELKILDFGLARHTDDE-------MAGFVATRWYRAPEIMLNWMHYNQTVDIWSVG 210
Query: 418 VLLLEIVSGR 427
            ++ E+++GR
Sbjct: 211 CIMAELLTGR 220

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 95/208 (45%), Gaps = 22/208 (10%)
Query: 230 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKG 288
            +++G+   G  Y   L D G  VA+K++ +    + +E   +I R  +L H N+V ++ 
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNREL--QIMR--KLDHCNIVRLRY 80
Query: 289 CCYDHGDRYIVYEFVVNGPLD-------RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 341
             Y  G++    E  +N  LD       R   H  R  ++L           L + +A++
Sbjct: 81  FFYSSGEKKD--EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 342 HDKVKPHVVHRDIRASNVLLDEEFGA-HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 400
           H      + HRDI+  N+LLD +     L   G +K +   V  E  V    +  Y APE
Sbjct: 139 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---VRGEPNVSYICSRYYRAPE 192
Query: 401 FVY-RNELTTKSDVYSFGVLLLEIVSGR 427
            ++   + T+  DV+S G +L E++ G+
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 95/208 (45%), Gaps = 22/208 (10%)
Query: 230 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKG 288
            +++G+   G  Y   L D G  VA+K++ +    + +E   +I R  +L H N+V ++ 
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNREL--QIMR--KLDHCNIVRLRY 80
Query: 289 CCYDHGDRYIVYEFVVNGPLD-------RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 341
             Y  G++    E  +N  LD       R   H  R  ++L           L + +A++
Sbjct: 81  FFYSSGEKKD--EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 342 HDKVKPHVVHRDIRASNVLLDEEFGA-HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 400
           H      + HRDI+  N+LLD +     L   G +K +   V  E  V    +  Y APE
Sbjct: 139 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---VRGEPNVSYICSRYYRAPE 192
Query: 401 FVY-RNELTTKSDVYSFGVLLLEIVSGR 427
            ++   + T+  DV+S G +L E++ G+
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 230 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKG 288
            +++G+   G  Y   L D G  VA+K++     Q K+    E+    +L H N+V ++ 
Sbjct: 61  TKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRY 116
Query: 289 CCYDHGDRYIVYEFVVNGPLD-------RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 341
             Y  G++    E  +N  LD       R   H  R  ++L           L + +A++
Sbjct: 117 FFYSSGEKKD--EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 174
Query: 342 HDKVKPHVVHRDIRASNVLLDEEFGA-HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 400
           H      + HRDI+  N+LLD +     L   G +K +   V  E  V    +  Y APE
Sbjct: 175 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---VRGEPNVSYICSRYYRAPE 228
Query: 401 FVY-RNELTTKSDVYSFGVLLLEIVSGR 427
            ++   + T+  DV+S G +L E++ G+
Sbjct: 229 LIFGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 69/160 (43%), Gaps = 13/160 (8%)
Query: 274 RFARLHHPNLVAVKG-CCYDHGDRYIVYEFV---VNGPLDRWLHHIPRGGRSLDWAMRMK 329
           R     HPN+V +   C     DR I    V   V+  L  +L   P  G  L       
Sbjct: 59  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG--LPAETIKD 116
Query: 330 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 389
           +     +G+ FLH      +VHRD++  N+L+       L   GL++   +++  +  V+
Sbjct: 117 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVV 173
Query: 390 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
              T  Y APE + ++   T  D++S G +  E+   R+P
Sbjct: 174 ---TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKP 209

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 230 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKG 288
            +++G+   G  Y   L D G  VA+K++     Q K+    E+    +L H N+V ++ 
Sbjct: 63  TKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRY 118
Query: 289 CCYDHGDRYIVYEFVVNGPLD-------RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 341
             Y  G++    E  +N  LD       R   H  R  ++L           L + +A++
Sbjct: 119 FFYSSGEKKD--EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 176
Query: 342 HDKVKPHVVHRDIRASNVLLDEEFGA-HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 400
           H      + HRDI+  N+LLD +     L   G +K +   V  E  V    +  Y APE
Sbjct: 177 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---VRGEPNVSYICSRYYRAPE 230
Query: 401 FVY-RNELTTKSDVYSFGVLLLEIVSGR 427
            ++   + T+  DV+S G +L E++ G+
Sbjct: 231 LIFGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 83/181 (45%), Gaps = 15/181 (8%)
Query: 252 VAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRW 311
           +  K+L     Q K E  + I R   L HPN+V +     + G  Y++++ V  G L   
Sbjct: 55  INTKKLSARDHQ-KLEREARICRL--LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFED 111
Query: 312 LHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMG 371
           +  + R     ++      +  + Q +  +    +  VVHRD++  N+LL  +       
Sbjct: 112 I--VAR-----EYYSEADASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKLKG--AA 162
Query: 372 VGLSKF-VPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRR 428
           V L+ F +  EV  E+    G  GT GYL+PE + ++      D+++ GV+L  ++ G  
Sbjct: 163 VKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYP 222
Query: 429 P 429
           P
Sbjct: 223 P 223

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 46/190 (24%), Positives = 86/190 (45%), Gaps = 27/190 (14%)
Query: 249 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 300
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 43  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 102
Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 103 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 153
Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 417
           ++E+    ++  GL++    E       MAG   T  Y APE +          D++S G
Sbjct: 154 VNEDCELKILDFGLARHTDDE-------MAGFVATRWYRAPEIMLNWMHYNQTVDIWSVG 206
Query: 418 VLLLEIVSGR 427
            ++ E+++GR
Sbjct: 207 CIMAELLTGR 216

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 230 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKG 288
            +++G+   G  Y   L D G  VA+K++     Q K+    E+    +L H N+V ++ 
Sbjct: 104 TKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRY 159
Query: 289 CCYDHGDRYIVYEFVVNGPLD-------RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 341
             Y  G++    E  +N  LD       R   H  R  ++L           L + +A++
Sbjct: 160 FFYSSGEKKD--EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 217
Query: 342 HDKVKPHVVHRDIRASNVLLDEEFGA-HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 400
           H      + HRDI+  N+LLD +     L   G +K +   V  E  V    +  Y APE
Sbjct: 218 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---VRGEPNVSYICSRYYRAPE 271
Query: 401 FVY-RNELTTKSDVYSFGVLLLEIVSGR 427
            ++   + T+  DV+S G +L E++ G+
Sbjct: 272 LIFGATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/169 (24%), Positives = 73/169 (43%), Gaps = 8/169 (4%)
Query: 278 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 337
           L HP++V +       G  Y+V+EF+    L   +      G     A+       + + 
Sbjct: 85  LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 144
Query: 338 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG-- 395
           + + HD    +++HRD++   VLL  +  +    V L  F     + E  ++AGG  G  
Sbjct: 145 LRYCHDN---NIIHRDVKPHCVLLASKENS--APVKLGGFGVAIQLGESGLVAGGRVGTP 199
Query: 396 -YLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFE 443
            ++APE V R       DV+  GV+L  ++SG  P        ++ I +
Sbjct: 200 HFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIK 248

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 86/187 (45%), Gaps = 17/187 (9%)
Query: 249 GSRVAVKRLKRSSFQR--KKEFYSEIGR--FARLHHPNLVAVKGCCYDHGDRYIVYEFVV 304
           G   A+K LK++   R  K   +++  R     + HP +V +       G  Y++ E++ 
Sbjct: 45  GKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLS 104
Query: 305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 364
            G L      + R G  ++      +A  ++  +  LH K    +++RD++  N++L+ +
Sbjct: 105 GGEL---FMQLEREGIFMEDTACFYLAE-ISMALGHLHQK---GIIYRDLKPENIMLNHQ 157
Query: 365 FGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVYSFGVLLLE 422
               L   GL K    E + + TV     GT  Y+APE + R+      D +S G L+ +
Sbjct: 158 GHVKLTDFGLCK----ESIHDGTVTHXFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYD 213
Query: 423 IVSGRRP 429
           +++G  P
Sbjct: 214 MLTGAPP 220

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 47/109 (43%), Gaps = 28/109 (25%)
Query: 349 VVHRDIRASNVLLDEEF------------GAHLMGVGLSKFVPWEVMQER---------- 386
           +VHRD++ SN L +               G H   + L KFV  E  QER          
Sbjct: 138 IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICL 197
Query: 387 -----TVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRP 429
                     GT G+ APE + +    TT  D++S GV+ L ++SGR P
Sbjct: 198 SRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 86/187 (45%), Gaps = 17/187 (9%)
Query: 249 GSRVAVKRLKRSSFQR--KKEFYSEIGR--FARLHHPNLVAVKGCCYDHGDRYIVYEFVV 304
           G   A+K LK++   R  K   +++  R     + HP +V +       G  Y++ E++ 
Sbjct: 45  GKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLS 104
Query: 305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 364
            G L      + R G  ++      +A  ++  +  LH K    +++RD++  N++L+ +
Sbjct: 105 GGEL---FMQLEREGIFMEDTACFYLAE-ISMALGHLHQK---GIIYRDLKPENIMLNHQ 157
Query: 365 FGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVYSFGVLLLE 422
               L   GL K    E + + TV     GT  Y+APE + R+      D +S G L+ +
Sbjct: 158 GHVKLTDFGLCK----ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYD 213
Query: 423 IVSGRRP 429
           +++G  P
Sbjct: 214 MLTGAPP 220

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/169 (24%), Positives = 73/169 (43%), Gaps = 8/169 (4%)
Query: 278 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 337
           L HP++V +       G  Y+V+EF+    L   +      G     A+       + + 
Sbjct: 83  LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142
Query: 338 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG-- 395
           + + HD    +++HRD++   VLL  +  +    V L  F     + E  ++AGG  G  
Sbjct: 143 LRYCHDN---NIIHRDVKPHCVLLASKENS--APVKLGGFGVAIQLGESGLVAGGRVGTP 197
Query: 396 -YLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFE 443
            ++APE V R       DV+  GV+L  ++SG  P        ++ I +
Sbjct: 198 HFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIK 246

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 90/205 (43%), Gaps = 24/205 (11%)
Query: 249 GSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAV------KGCCYDHGDRYIV 299
           G  VAVK+L R  FQ +   K  Y E+     ++H N++++      +    +  D Y+V
Sbjct: 49  GINVAVKKLSRP-FQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLV 107
Query: 300 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNV 359
            E +++  L + +H        LD      +   +  GI  LH      ++HRD++ SN+
Sbjct: 108 ME-LMDANLCQVIH------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNI 157
Query: 360 LLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVL 419
           ++  +    ++  GL++      M    V+   T  Y APE +         D++S G +
Sbjct: 158 VVKSDCTLKILDFGLARTACTNFMMTPYVV---TRYYRAPEVILGMGYAANVDIWSVGCI 214
Query: 420 LLEIVSGRRPAQAVDSV-CWQSIFE 443
           + E+V G    Q  D +  W  + E
Sbjct: 215 MGELVKGCVIFQGTDHIDQWNKVIE 239

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/192 (23%), Positives = 81/192 (42%), Gaps = 35/192 (18%)
Query: 254 VKRLKRSSFQR---KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 310
           +K+ + SS +R   ++E   E+     + HPN++ +     +  D  ++ E V  G L  
Sbjct: 45  IKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFD 104
Query: 311 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLM 370
           +L        SL      +    +  G+ +LH K    + H D++  N++L         
Sbjct: 105 FLAE----KESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIML--------- 148
Query: 371 GVGLSKFVPWEVMQ------ERTVMAG-------GTYGYLAPEFVYRNELTTKSDVYSFG 417
              L K VP   ++         + AG       GT  ++APE V    L  ++D++S G
Sbjct: 149 ---LDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIG 205
Query: 418 VLLLEIVSGRRP 429
           V+   ++SG  P
Sbjct: 206 VITYILLSGASP 217

>pdb|1K9I|A Chain A, Complex Of Dc-Sign And Glcnac2man3 Length = 156

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 24/81 (29%), Positives = 40/81 (49%), Gaps = 4/81 (4%)
Query: 8  PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 67
          PCP +W   +    C+    + R+W +S T CKE+G  L  + S EE++  Q    ++  
Sbjct: 7  PCPWEWTFFQ--GNCYFMSNSQRNWHDSITACKEVGAQLVVIKSAEEQNFLQLQSSRSNR 64
Query: 68 GCWVGGRSINTTVGLSWKWSD 88
            W+G   +N     +W+W D
Sbjct: 65 FTWMGLSDLNQEG--TWQWVD 83

>pdb|1SL4|A Chain A, Crystal Structure Of Dc-Sign Carbohydrate Recognition Domain Complexed With Man4 Length = 155

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 24/81 (29%), Positives = 40/81 (49%), Gaps = 4/81 (4%)
Query: 8  PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 67
          PCP +W   +    C+    + R+W +S T CKE+G  L  + S EE++  Q    ++  
Sbjct: 6  PCPWEWTFFQ--GNCYFMSNSQRNWHDSITACKEVGAQLVVIKSAEEQNFLQLQSSRSNR 63
Query: 68 GCWVGGRSINTTVGLSWKWSD 88
            W+G   +N     +W+W D
Sbjct: 64 FTWMGLSDLNQEG--TWQWVD 82

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/192 (23%), Positives = 81/192 (42%), Gaps = 35/192 (18%)
Query: 254 VKRLKRSSFQR---KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 310
           +K+ + SS +R   ++E   E+     + HPN++ +     +  D  ++ E V  G L  
Sbjct: 38  IKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFD 97
Query: 311 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLM 370
           +L        SL      +    +  G+ +LH K    + H D++  N++L         
Sbjct: 98  FLAE----KESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIML--------- 141
Query: 371 GVGLSKFVPWEVMQ------ERTVMAG-------GTYGYLAPEFVYRNELTTKSDVYSFG 417
              L K VP   ++         + AG       GT  ++APE V    L  ++D++S G
Sbjct: 142 ---LDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIG 198
Query: 418 VLLLEIVSGRRP 429
           V+   ++SG  P
Sbjct: 199 VITYILLSGASP 210

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 249 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 300
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 107 HLMGAD-----LNNIVKXQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 157
Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 417
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 158 VNEDXELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 210
Query: 418 VLLLEIVSGR 427
            ++ E+++GR
Sbjct: 211 CIMAELLTGR 220

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 88/192 (45%), Gaps = 20/192 (10%)
Query: 246 LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFAR----LHHPNLVAVKGCCYDHGDRYIVYE 301
           +P G   A K +       +   + ++ R AR    L HPN+V +     + G  Y+V++
Sbjct: 26  IPTGQEYAAKIINTKKLSARD--HQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFD 83
Query: 302 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL 361
            V  G L  +   + R     ++      +  + Q +  ++      +VHRD++  N+LL
Sbjct: 84  LVTGGEL--FEDIVAR-----EYYSEADASHCIQQILESVNHCHLNGIVHRDLKPENLLL 136
Query: 362 -DEEFGAHLMGVGLSKF-VPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVYSFG 417
             +  GA    V L+ F +  EV  ++    G  GT GYL+PE + ++      D+++ G
Sbjct: 137 ASKSKGA---AVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACG 193
Query: 418 VLLLEIVSGRRP 429
           V+L  ++ G  P
Sbjct: 194 VILYILLVGYPP 205

>pdb|2AFP|A Chain A, The Solution Structure Of Type Ii Antifreeze Protein Reveals A New Member Of The Lectin Family Length = 129

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 39/136 (28%), Positives = 56/136 (41%), Gaps = 17/136 (12%)
Query: 9   CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 68
           CP  W       +C  Y     +W  +ET C ++GGHLA++ S EE    Q L   N   
Sbjct: 7   CPAGW--QPLGDRCIYYETTAMTWALAETNCMKLGGHLASIHSQEEHSFIQTL---NAGV 61
Query: 69  CWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS 128
            W+GG S     G +W WSD             +F S C++ P  V A   +  + +   
Sbjct: 62  VWIGG-SACLQAG-AWTWSDGTPM---------NFRSWCSTKPDDVLAACCM-QMTAAAD 109
Query: 129 RSLVTERCNTSHPFIC 144
           +      C  SH  +C
Sbjct: 110 QCWDDLPCPASHKSVC 125

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 88/192 (45%), Gaps = 20/192 (10%)
Query: 246 LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFAR----LHHPNLVAVKGCCYDHGDRYIVYE 301
           +P G   A K +       +   + ++ R AR    L HPN+V +     + G  Y+V++
Sbjct: 26  IPTGQEYAAKIINTKKLSARD--HQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFD 83
Query: 302 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL 361
            V  G L  +   + R     ++      +  + Q +  ++      +VHRD++  N+LL
Sbjct: 84  LVTGGEL--FEDIVAR-----EYYSEADASHCIQQILESVNHCHLNGIVHRDLKPENLLL 136
Query: 362 -DEEFGAHLMGVGLSKF-VPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVYSFG 417
             +  GA    V L+ F +  EV  ++    G  GT GYL+PE + ++      D+++ G
Sbjct: 137 ASKSKGA---AVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACG 193
Query: 418 VLLLEIVSGRRP 429
           V+L  ++ G  P
Sbjct: 194 VILYILLVGYPP 205

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 249 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 300
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 43  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 102
Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 103 HLMGAD-----LNNIVKCAKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 153
Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 417
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 154 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 206
Query: 418 VLLLEIVSGR 427
            ++ E+++GR
Sbjct: 207 CIMAELLTGR 216

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 68/160 (42%), Gaps = 13/160 (8%)
Query: 274 RFARLHHPNLVAVKG-CCYDHGDRYIVYEFV---VNGPLDRWLHHIPRGGRSLDWAMRMK 329
           R     HPN+V +   C     DR I    V   V+  L  +L   P  G  L       
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG--LPAETIKD 124
Query: 330 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 389
           +     +G+ FLH      +VHRD++  N+L+       L   GL++   +++     V+
Sbjct: 125 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVV 181
Query: 390 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
              T  Y APE + ++   T  D++S G +  E+   R+P
Sbjct: 182 ---TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKP 217

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 68/160 (42%), Gaps = 13/160 (8%)
Query: 274 RFARLHHPNLVAVKG-CCYDHGDRYIVYEFV---VNGPLDRWLHHIPRGGRSLDWAMRMK 329
           R     HPN+V +   C     DR I    V   V+  L  +L   P  G  L       
Sbjct: 59  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG--LPAETIKD 116
Query: 330 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 389
           +     +G+ FLH      +VHRD++  N+L+       L   GL++   +++     V+
Sbjct: 117 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVV 173
Query: 390 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
              T  Y APE + ++   T  D++S G +  E+   R+P
Sbjct: 174 ---TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKP 209

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/169 (23%), Positives = 77/169 (45%), Gaps = 14/169 (8%)
Query: 265 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDW 324
           ++E   E+    ++ HPN++ +     +  D  ++ E V  G L  +L        SL  
Sbjct: 59  REEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQ----KESLSE 114
Query: 325 AMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNV-LLDEEFGA---HLMGVGLSKFVPW 380
                    +  G+ +LH K    + H D++  N+ LLD+        L+  GL+  +  
Sbjct: 115 EEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE- 170
Query: 381 EVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           + ++ + +   GT  ++APE V    L  ++D++S GV+   ++SG  P
Sbjct: 171 DGVEFKNIF--GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 249 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 300
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 52  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 111
Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 112 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 162
Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 417
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 163 VNEDXELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 215
Query: 418 VLLLEIVSGR 427
            ++ E+++GR
Sbjct: 216 CIMAELLTGR 225

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 249 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 300
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 52  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 111
Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 112 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 162
Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 417
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 163 VNEDXELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 215
Query: 418 VLLLEIVSGR 427
            ++ E+++GR
Sbjct: 216 CIMAELLTGR 225

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 44/204 (21%), Positives = 88/204 (43%), Gaps = 35/204 (17%)
Query: 248 DGSRVAVKRLKRSSFQRKKE-FYSEIGRFARLHHPNLVAVKGCCYDHGDR---------- 296
           D    A+KR++  + +  +E    E+   A+L HP +V       +              
Sbjct: 29  DDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKV 88
Query: 297 --YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMR---MKVATTLAQGIAFLHDKVKPHVVH 351
             YI  +      L  W++    G  +++   R   + +   +A+ + FLH K    ++H
Sbjct: 89  YLYIQMQLCRKENLKDWMN----GRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMH 141
Query: 352 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG-----------GTYGYLAPE 400
           RD++ SN+    +    +   GL   +  +  +E+TV+             GT  Y++PE
Sbjct: 142 RDLKPSNIFFTMDDVVKVGDFGLVTAMDQD-EEEQTVLTPMPAYARHTGQVGTKLYMSPE 200
Query: 401 FVYRNELTTKSDVYSFGVLLLEIV 424
            ++ N  + K D++S G++L E++
Sbjct: 201 QIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 249 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 300
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 107 HLMGAD-----LNNIVKXQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 157
Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 417
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 158 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 210
Query: 418 VLLLEIVSGR 427
            ++ E+++GR
Sbjct: 211 CIMAELLTGR 220

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 249 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 300
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 58  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 117
Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 118 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 168
Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 417
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 169 VNEDXELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 221
Query: 418 VLLLEIVSGR 427
            ++ E+++GR
Sbjct: 222 CIMAELLTGR 231

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 249 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 300
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 47  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 107 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 157
Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 417
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 158 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 210
Query: 418 VLLLEIVSGR 427
            ++ E+++GR
Sbjct: 211 CIMAELLTGR 220

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 249 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 300
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 107 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 157
Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 417
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 158 VNEDCELKILDAGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 210
Query: 418 VLLLEIVSGR 427
            ++ E+++GR
Sbjct: 211 CIMAELLTGR 220

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 249 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 300
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 54  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 113
Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 114 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 164
Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 417
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 165 VNEDCELKILDFGLARHTADE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 217
Query: 418 VLLLEIVSGR 427
            ++ E+++GR
Sbjct: 218 CIMAELLTGR 227

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 249 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 300
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 57  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 116
Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 117 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 167
Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 417
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 168 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 220
Query: 418 VLLLEIVSGR 427
            ++ E+++GR
Sbjct: 221 CIMAELLTGR 230

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 84/190 (44%), Gaps = 27/190 (14%)
Query: 249 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 300
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 107 HLMGAD-----LNNIVKSQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 157
Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 417
           ++E+    ++  GL +    E       M G   T  Y APE +          D++S G
Sbjct: 158 VNEDSELKILDFGLCRHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 210
Query: 418 VLLLEIVSGR 427
            ++ E+++GR
Sbjct: 211 CIMAELLTGR 220

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 249 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 300
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 53  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 112
Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 113 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 163
Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 417
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 164 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 216
Query: 418 VLLLEIVSGR 427
            ++ E+++GR
Sbjct: 217 CIMAELLTGR 226

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 249 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 300
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 43  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 102
Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 103 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 153
Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 417
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 154 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 206
Query: 418 VLLLEIVSGR 427
            ++ E+++GR
Sbjct: 207 CIMAELLTGR 216

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 249 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 300
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 107 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 157
Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 417
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 158 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 210
Query: 418 VLLLEIVSGR 427
            ++ E+++GR
Sbjct: 211 CIMAELLTGR 220

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 249 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 300
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 54  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 113
Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 114 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 164
Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 417
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 165 VNEDCELKILDFGLARHTADE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 217
Query: 418 VLLLEIVSGR 427
            ++ E+++GR
Sbjct: 218 CIMAELLTGR 227

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 249 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 300
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 49  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 108
Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 109 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 159
Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 417
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 160 VNEDSELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 212
Query: 418 VLLLEIVSGR 427
            ++ E+++GR
Sbjct: 213 CIMAELLTGR 222

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 84/196 (42%), Gaps = 25/196 (12%)
Query: 240 GTYSGILPDGSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAV------KGCC 290
             Y  IL     VA+K+L R  FQ +   K  Y E+     ++H N++ +      +   
Sbjct: 42  AAYDAIL--ERNVAIKKLSRP-FQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSL 98
Query: 291 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 350
            +  D YIV E      +D  L  + +    LD      +   +  GI  LH      ++
Sbjct: 99  EEFQDVYIVMEL-----MDANLSQVIQ--MELDHERMSYLLYQMLVGIKHLHSA---GII 148
Query: 351 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 410
           HRD++ SN+++  +    ++  GL++      M    V+   T  Y APE +        
Sbjct: 149 HRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVV---TRYYRAPEVILGMGYKEN 205
Query: 411 SDVYSFGVLLLEIVSG 426
            D++S GV++ E++ G
Sbjct: 206 VDIWSVGVIMGEMIKG 221

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 249 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 300
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 66  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 125
Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 126 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 176
Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 417
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 177 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 229
Query: 418 VLLLEIVSGR 427
            ++ E+++GR
Sbjct: 230 CIMAELLTGR 239

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 249 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 300
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 52  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 111
Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 112 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 162
Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 417
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 163 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 215
Query: 418 VLLLEIVSGR 427
            ++ E+++GR
Sbjct: 216 CIMAELLTGR 225

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 45/195 (23%), Positives = 89/195 (45%), Gaps = 20/195 (10%)
Query: 238 TGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRY 297
            G  Y+ ++ +  +++ +        +K E  + I R   L HPN+V +     + G  Y
Sbjct: 35  AGQEYAAMIINTKKLSARD------HQKLEREARICRL--LKHPNIVRLHDSISEEGHHY 86
Query: 298 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 357
           ++++ V  G L   +  + R     ++      +  + Q +  +    +  VVHR+++  
Sbjct: 87  LIFDLVTGGELFEDI--VAR-----EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPE 139
Query: 358 NVLLDEEFGAHLMGVGLSKF-VPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVY 414
           N+LL  +       V L+ F +  EV  E+    G  GT GYL+PE + ++      D++
Sbjct: 140 NLLLASKLKG--AAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLW 197
Query: 415 SFGVLLLEIVSGRRP 429
           + GV+L  ++ G  P
Sbjct: 198 ACGVILYILLVGYPP 212

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 249 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 300
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 67  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 126
Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 127 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 177
Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 417
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 178 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 230
Query: 418 VLLLEIVSGR 427
            ++ E+++GR
Sbjct: 231 CIMAELLTGR 240

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 87/190 (45%), Gaps = 27/190 (14%)
Query: 249 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 300
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 107 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 157
Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKS-DVYSFG 417
           ++E+    ++  GL++    E       M G   T  Y APE +       ++ D++S G
Sbjct: 158 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNAMHYNQTVDIWSVG 210
Query: 418 VLLLEIVSGR 427
            ++ E+++GR
Sbjct: 211 CIMAELLTGR 220

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 249 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 300
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 54  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 113
Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 114 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 164
Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 417
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 165 VNEDCELKILDFGLARHTADE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 217
Query: 418 VLLLEIVSGR 427
            ++ E+++GR
Sbjct: 218 CIMAELLTGR 227

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 249 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 300
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 49  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 108
Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 109 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 159
Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 417
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 160 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 212
Query: 418 VLLLEIVSGR 427
            ++ E+++GR
Sbjct: 213 CIMAELLTGR 222

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 249 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 300
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 52  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 111
Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 112 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 162
Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 417
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 163 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 215
Query: 418 VLLLEIVSGR 427
            ++ E+++GR
Sbjct: 216 CIMAELLTGR 225

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 249 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 300
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 107 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 157
Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 417
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 158 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 210
Query: 418 VLLLEIVSGR 427
            ++ E+++GR
Sbjct: 211 CIMAELLTGR 220

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 249 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 300
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 46  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 105
Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 106 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 156
Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 417
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 157 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 209
Query: 418 VLLLEIVSGR 427
            ++ E+++GR
Sbjct: 210 CIMAELLTGR 219

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 249 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 300
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 107 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 157
Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 417
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 158 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 210
Query: 418 VLLLEIVSGR 427
            ++ E+++GR
Sbjct: 211 CIMAELLTGR 220

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 249 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 300
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 44  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 103
Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 104 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 154
Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 417
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 155 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 207
Query: 418 VLLLEIVSGR 427
            ++ E+++GR
Sbjct: 208 CIMAELLTGR 217

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 249 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 300
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 53  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 112
Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 113 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 163
Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 417
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 164 VNEDSELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 216
Query: 418 VLLLEIVSGR 427
            ++ E+++GR
Sbjct: 217 CIMAELLTGR 226

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 249 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 300
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 54  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 113
Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 114 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 164
Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 417
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 165 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 217
Query: 418 VLLLEIVSGR 427
            ++ E+++GR
Sbjct: 218 CIMAELLTGR 227

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 249 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 300
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 107 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 157
Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 417
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 158 VNEDCELKILDFGLARHTDDE-------MTGXVATRWYRAPEIMLNWMHYNQTVDIWSVG 210
Query: 418 VLLLEIVSGR 427
            ++ E+++GR
Sbjct: 211 CIMAELLTGR 220

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 249 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 300
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 107 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 157
Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 417
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 158 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 210
Query: 418 VLLLEIVSGR 427
            ++ E+++GR
Sbjct: 211 CIMAELLTGR 220

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 249 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 300
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 49  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 108
Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 109 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 159
Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 417
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 160 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 212
Query: 418 VLLLEIVSGR 427
            ++ E+++GR
Sbjct: 213 CIMAELLTGR 222

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 249 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 300
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 107 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 157
Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 417
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 158 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 210
Query: 418 VLLLEIVSGR 427
            ++ E+++GR
Sbjct: 211 CIMAELLTGR 220

>pdb|2ZIB|A Chain A, Crystal Structure Analysis Of Calcium-Independent Type Ii Antifreeze Protein Length = 133

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Composition-based stats.
 Identities = 25/80 (31%), Positives = 40/80 (50%), Gaps = 7/80 (8%)
Query: 9  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 68
          CP  W ++ ++  CF       +WD +E  C   GGHLA++ S EE+   + +    V  
Sbjct: 10 CPAGWTLHGQR--CFYSEATAMTWDLAEANCVNKGGHLASIHSLEEQLYIKDIVAGIV-- 65
Query: 69 CWVGGRSINTTVGLSWKWSD 88
           W+GG +    V  +W W+D
Sbjct: 66 -WIGGSACK--VAGAWSWTD 82

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 249 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 300
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 107 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 157
Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 417
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 158 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 210
Query: 418 VLLLEIVSGR 427
            ++ E+++GR
Sbjct: 211 CIMAELLTGR 220

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 249 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 300
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 44  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 103
Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 104 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 154
Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 417
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 155 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 207
Query: 418 VLLLEIVSGR 427
            ++ E+++GR
Sbjct: 208 CIMAELLTGR 217

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 249 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 300
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 53  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 112
Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 113 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 163
Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 417
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 164 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 216
Query: 418 VLLLEIVSGR 427
            ++ E+++GR
Sbjct: 217 CIMAELLTGR 226

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 249 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 300
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 43  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 102
Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 103 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 153
Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 417
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 154 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 206
Query: 418 VLLLEIVSGR 427
            ++ E+++GR
Sbjct: 207 CIMAELLTGR 216

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 249 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 300
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 53  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 112
Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 113 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 163
Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 417
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 164 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 216
Query: 418 VLLLEIVSGR 427
            ++ E+++GR
Sbjct: 217 CIMAELLTGR 226

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 249 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 300
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 45  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 104
Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 105 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 155
Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 417
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 156 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 208
Query: 418 VLLLEIVSGR 427
            ++ E+++GR
Sbjct: 209 CIMAELLTGR 218

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 249 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 300
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 49  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 108
Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 109 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 159
Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 417
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 160 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 212
Query: 418 VLLLEIVSGR 427
            ++ E+++GR
Sbjct: 213 CIMAELLTGR 222

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 249 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 300
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 59  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 118
Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 119 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 169
Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 417
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 170 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 222
Query: 418 VLLLEIVSGR 427
            ++ E+++GR
Sbjct: 223 CIMAELLTGR 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 249 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 300
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 59  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 118
Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 119 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 169
Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 417
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 170 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 222
Query: 418 VLLLEIVSGR 427
            ++ E+++GR
Sbjct: 223 CIMAELLTGR 232

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 249 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 300
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 107 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 157
Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 417
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 158 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 210
Query: 418 VLLLEIVSGR 427
            ++ E+++GR
Sbjct: 211 CIMAELLTGR 220

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 68/160 (42%), Gaps = 13/160 (8%)
Query: 274 RFARLHHPNLVAVKG-CCYDHGDRYIVYEFV---VNGPLDRWLHHIPRGGRSLDWAMRMK 329
           R     HPN+V +   C     DR I    V   V+  L  +L   P  G  L       
Sbjct: 59  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG--LPAETIKD 116
Query: 330 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 389
           +     +G+ FLH      +VHRD++  N+L+       L   GL++   +++     V+
Sbjct: 117 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVV 173
Query: 390 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
              T  Y APE + ++   T  D++S G +  E+   R+P
Sbjct: 174 ---TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKP 209

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 84/196 (42%), Gaps = 25/196 (12%)
Query: 240 GTYSGILPDGSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAV------KGCC 290
             Y  IL     VA+K+L R  FQ +   K  Y E+     ++H N++ +      +   
Sbjct: 42  AAYDAIL--ERNVAIKKLSRP-FQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSL 98
Query: 291 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 350
            +  D YIV E      +D  L  + +    LD      +   +  GI  LH      ++
Sbjct: 99  EEFQDVYIVMEL-----MDANLSQVIQ--MELDHERMSYLLYQMLVGIKHLHSA---GII 148
Query: 351 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 410
           HRD++ SN+++  +    ++  GL++      M    V+   T  Y APE +        
Sbjct: 149 HRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVV---TRYYRAPEVILGMGYKEN 205
Query: 411 SDVYSFGVLLLEIVSG 426
            D++S GV++ E++ G
Sbjct: 206 VDIWSVGVIMGEMIKG 221

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 249 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 300
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 58  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 117
Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 118 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 168
Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 417
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 169 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 221
Query: 418 VLLLEIVSGR 427
            ++ E+++GR
Sbjct: 222 CIMAELLTGR 231

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 249 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 300
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 70  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 129
Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 130 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 180
Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 417
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 181 VNEDCELKILDFGLARHTDDE-------MXGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 233
Query: 418 VLLLEIVSGR 427
            ++ E+++GR
Sbjct: 234 CIMAELLTGR 243

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 249 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 300
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 67  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 126
Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 127 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 177
Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 417
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 178 VNEDCELKILDFGLARHTDDE-------MXGXVATRWYRAPEIMLNWMHYNQTVDIWSVG 230
Query: 418 VLLLEIVSGR 427
            ++ E+++GR
Sbjct: 231 CIMAELLTGR 240

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 249 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 300
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 107 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 157
Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 417
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 158 VNEDCELKILDYGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 210
Query: 418 VLLLEIVSGR 427
            ++ E+++GR
Sbjct: 211 CIMAELLTGR 220

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 249 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 300
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 67  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 126
Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 127 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 177
Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 417
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 178 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 230
Query: 418 VLLLEIVSGR 427
            ++ E+++GR
Sbjct: 231 CIMAELLTGR 240

>pdb|1FVU|B Chain B, Crystal Structure Of Botrocetin Length = 125

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 24/86 (27%), Positives = 41/86 (47%), Gaps = 8/86 (9%)
Query: 9  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 66
          CPPDW  +  +  C+ +   +  WD++E +C E   G HL +  S EE    + L  + +
Sbjct: 2  CPPDW--SSYEGHCYRFFKEWMHWDDAEEFCTEQQTGAHLVSFQSKEEADFVRSLTSEML 59
Query: 67 NG--CWVGGRSINTTVGLSWKWSDNM 90
           G   W+G   +       ++W+D M
Sbjct: 60 KGDVVWIGLSDVWNKC--RFEWTDGM 83

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 249 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 300
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 70  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 129
Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 130 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 180
Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 417
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 181 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 233
Query: 418 VLLLEIVSGR 427
            ++ E+++GR
Sbjct: 234 CIMAELLTGR 243

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 249 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 300
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 66  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 125
Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 126 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 176
Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 417
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 177 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 229
Query: 418 VLLLEIVSGR 427
            ++ E+++GR
Sbjct: 230 CIMAELLTGR 239

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/205 (22%), Positives = 81/205 (39%), Gaps = 36/205 (17%)
Query: 238 TGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRY 297
           TG  Y+       R+   R   S    ++E   E+     + HPN++ +     +  D  
Sbjct: 50  TGKEYAAKFIKKRRLXSSRRGVS----REEIEREVNILREIRHPNIITLHDIFENKTDVV 105
Query: 298 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 357
           ++ E V  G L  +L        SL      +    +  G+ +LH K    + H D++  
Sbjct: 106 LILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPE 158
Query: 358 NVLLDEEFGAHLMGVGLSKFVPWEVMQ------ERTVMAG-------GTYGYLAPEFVYR 404
           N++L            L K VP   ++         + AG       GT  ++APE V  
Sbjct: 159 NIML------------LDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNY 206
Query: 405 NELTTKSDVYSFGVLLLEIVSGRRP 429
             L  ++D++S GV+   ++SG  P
Sbjct: 207 EPLGLEADMWSIGVITYILLSGASP 231

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/108 (25%), Positives = 55/108 (50%), Gaps = 15/108 (13%)
Query: 328 MKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 387
           + +   +A+ + FLH K    ++HRD++ SN+    +    +   GL   +  +  +E+T
Sbjct: 167 LHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDE-EEQT 222
Query: 388 VMAG-----------GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIV 424
           V+             GT  Y++PE ++ N  + K D++S G++L E++
Sbjct: 223 VLTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 249 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 300
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 107 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 157
Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 417
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 158 VNEDCELKILDRGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 210
Query: 418 VLLLEIVSGR 427
            ++ E+++GR
Sbjct: 211 CIMAELLTGR 220

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 88/190 (46%), Gaps = 19/190 (10%)
Query: 249 GSRVAVKRLKRSSFQRKKEFYSEIGRFAR--LHH----PNLVAVKGCCYDHGDRYIVYEF 302
           G   A+K LK+++  +K +  +E  R  R  L H    P LV +          +++ ++
Sbjct: 82  GKLYAMKVLKKATIVQKAK-TTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDY 140
Query: 303 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 362
           +  G L     H+ +  R  +  +++ V   +   +  LH   K  +++RDI+  N+LLD
Sbjct: 141 INGGEL---FTHLSQRERFTEHEVQIYVGE-IVLALEHLH---KLGIIYRDIKLENILLD 193
Query: 363 EEFGAHLMGVGLSK-FVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDV--YSFGVL 419
                 L   GLSK FV  E   ER     GT  Y+AP+ V   +      V  +S GVL
Sbjct: 194 SNGHVVLTDFGLSKEFVADET--ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVL 251
Query: 420 LLEIVSGRRP 429
           + E+++G  P
Sbjct: 252 MYELLTGASP 261

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 249 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 300
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 107 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 157
Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 417
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 158 VNEDCELKILDGGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 210
Query: 418 VLLLEIVSGR 427
            ++ E+++GR
Sbjct: 211 CIMAELLTGR 220

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 81/189 (42%), Gaps = 23/189 (12%)
Query: 249 GSRVAVK-----RLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 303
           G +VA+K      L +S  Q + E   EI     L HP+++ +        +  +V E+ 
Sbjct: 29  GQKVALKIINKKVLAKSDMQGRIE--REISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA 86
Query: 304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 363
            N   D   + + R   S   A R      +   + + H   +  +VHRD++  N+LLDE
Sbjct: 87  GNELFD---YIVQRDKMSEQEARRF--FQQIISAVEYCH---RHKIVHRDLKPENLLLDE 138
Query: 364 EFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVY-RNELTTKSDVYSFGVLL 420
                +   GLS      +M +   +    G+  Y APE +  +     + DV+S GV+L
Sbjct: 139 HLNVKIADFGLS-----NIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVIL 193
Query: 421 LEIVSGRRP 429
             ++  R P
Sbjct: 194 YVMLCRRLP 202

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 81/189 (42%), Gaps = 23/189 (12%)
Query: 249 GSRVAVK-----RLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 303
           G +VA+K      L +S  Q + E   EI     L HP+++ +        +  +V E+ 
Sbjct: 38  GQKVALKIINKKVLAKSDMQGRIE--REISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA 95
Query: 304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 363
            N   D   + + R   S   A R      +   + + H   +  +VHRD++  N+LLDE
Sbjct: 96  GNELFD---YIVQRDKMSEQEARRF--FQQIISAVEYCH---RHKIVHRDLKPENLLLDE 147
Query: 364 EFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVY-RNELTTKSDVYSFGVLL 420
                +   GLS      +M +   +    G+  Y APE +  +     + DV+S GV+L
Sbjct: 148 HLNVKIADFGLS-----NIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVIL 202
Query: 421 LEIVSGRRP 429
             ++  R P
Sbjct: 203 YVMLCRRLP 211

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 81/189 (42%), Gaps = 23/189 (12%)
Query: 249 GSRVAVK-----RLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 303
           G +VA+K      L +S  Q + E   EI     L HP+++ +        +  +V E+ 
Sbjct: 39  GQKVALKIINKKVLAKSDMQGRIE--REISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA 96
Query: 304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 363
            N   D   + + R   S   A R      +   + + H   +  +VHRD++  N+LLDE
Sbjct: 97  GNELFD---YIVQRDKMSEQEARRF--FQQIISAVEYCH---RHKIVHRDLKPENLLLDE 148
Query: 364 EFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVY-RNELTTKSDVYSFGVLL 420
                +   GLS      +M +   +    G+  Y APE +  +     + DV+S GV+L
Sbjct: 149 HLNVKIADFGLS-----NIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVIL 203
Query: 421 LEIVSGRRP 429
             ++  R P
Sbjct: 204 YVMLCRRLP 212

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 79/189 (41%), Gaps = 34/189 (17%)
Query: 252 VAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRW 311
           ++ + LK+S    + E   EI     L HP+++ +        D  +V E+         
Sbjct: 42  ISRQLLKKSDMHMRVE--REISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-------- 91
Query: 312 LHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV-------KPHVVHRDIRASNVLLDEE 364
                 GG   D+ +  K  T   +G  F    +       +  +VHRD++  N+LLD+ 
Sbjct: 92  ------GGELFDYIVEKKRMTE-DEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDN 144
Query: 365 FGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTT--KSDVYSFGVLL 420
               +   GLS      +M +   +    G+  Y APE V   +L    + DV+S G++L
Sbjct: 145 LNVKIADFGLSN-----IMTDGNFLKTSCGSPNYAAPE-VINGKLYAGPEVDVWSCGIVL 198
Query: 421 LEIVSGRRP 429
             ++ GR P
Sbjct: 199 YVMLVGRLP 207

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 81/189 (42%), Gaps = 23/189 (12%)
Query: 249 GSRVAVK-----RLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 303
           G +VA+K      L +S  Q + E   EI     L HP+++ +        +  +V E+ 
Sbjct: 33  GQKVALKIINKKVLAKSDMQGRIE--REISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA 90
Query: 304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 363
            N   D   + + R   S   A R      +   + + H   +  +VHRD++  N+LLDE
Sbjct: 91  GNELFD---YIVQRDKMSEQEARRF--FQQIISAVEYCH---RHKIVHRDLKPENLLLDE 142
Query: 364 EFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVY-RNELTTKSDVYSFGVLL 420
                +   GLS      +M +   +    G+  Y APE +  +     + DV+S GV+L
Sbjct: 143 HLNVKIADFGLSN-----IMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVIL 197
Query: 421 LEIVSGRRP 429
             ++  R P
Sbjct: 198 YVMLCRRLP 206

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 249 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 300
           G RVAVK+L +   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 59  GLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 118
Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 119 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 169
Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 417
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 170 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 222
Query: 418 VLLLEIVSGR 427
            ++ E+++GR
Sbjct: 223 CIMAELLTGR 232

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/202 (23%), Positives = 82/202 (40%), Gaps = 17/202 (8%)
Query: 246 LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVA-VKGCCYDHGDRY---IVYE 301
           L DG   A+KR+     Q ++E   E       +HPN++  V  C  + G ++   ++  
Sbjct: 51  LHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLP 110
Query: 302 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL 361
           F   G L   +  +   G  L     + +   + +G+  +H K      HRD++ +N+LL
Sbjct: 111 FFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILL 167
Query: 362 DEEFGAHLMGVGLSKFVPWEVMQERTVMAGG-------TYGYLAPEFVYRNE---LTTKS 411
            +E    LM +G        V   R  +          T  Y APE         +  ++
Sbjct: 168 GDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERT 227
Query: 412 DVYSFGVLLLEIVSGRRPAQAV 433
           DV+S G +L  ++ G  P   V
Sbjct: 228 DVWSLGCVLYAMMFGEGPYDMV 249

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/181 (21%), Positives = 72/181 (39%), Gaps = 7/181 (3%)
Query: 249 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 308
           G+  A K +       K+    EI   + L HP LV +     D  +  ++YEF+  G L
Sbjct: 182 GNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGEL 241
Query: 309 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 368
                 +      +     ++    + +G+  +H+    + VH D++  N++   +    
Sbjct: 242 ---FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNE 295
Query: 369 LMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRR 428
           L  +        +  Q   V   GT  + APE      +   +D++S GVL   ++SG  
Sbjct: 296 LKLIDFGLTAHLDPKQSVKVTT-GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLS 354
Query: 429 P 429
           P
Sbjct: 355 P 355

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 94/198 (47%), Gaps = 35/198 (17%)
Query: 249 GSRVAVK----RLKRSSFQRKKEFYSEIGRFARLHHPNLVA-VKGCCYDHG---DRYIVY 300
           G  VAVK    R +RS F R+ E Y  +     L H N++  +     D+G     ++V 
Sbjct: 52  GEEVAVKIFSSREERSWF-REAEIYQTV----MLRHENILGFIAADNKDNGTWTQLWLVS 106
Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV-----KPHVVHRDIR 355
           ++  +G L  +L+        +     +K+A + A G+A LH ++     KP + HRD++
Sbjct: 107 DYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLK 161
Query: 356 ASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG----GTYGYLAPEFVYRN------ 405
           + N+L+ +     +  +GL+  V  +   +   +A     GT  Y+APE +  +      
Sbjct: 162 SKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHF 219
Query: 406 ELTTKSDVYSFGVLLLEI 423
           E   ++D+Y+ G++  EI
Sbjct: 220 ESFKRADIYAMGLVFWEI 237

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/168 (24%), Positives = 72/168 (42%), Gaps = 14/168 (8%)
Query: 271 EIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRM 328
           EI    RL H N++ +    Y+   +  Y+V E+ V G +   L  +P   +        
Sbjct: 56  EIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPE--KRFPVCQAH 112
Query: 329 KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 388
                L  G+ +LH +    +VH+DI+  N+LL       +  +G+++ +      +   
Sbjct: 113 GYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCR 169
Query: 389 MAGGTYGYLAPEFVYRNELTT----KSDVYSFGVLLLEIVSGRRPAQA 432
            + G+  +  PE    N L T    K D++S GV L  I +G  P + 
Sbjct: 170 TSQGSPAFQPPEIA--NGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG 215

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/188 (23%), Positives = 84/188 (44%), Gaps = 13/188 (6%)
Query: 249 GSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGC---CYDHGDRYIVYEFV 303
           G +VA+K++  +       K    E+       H N++A+K        +G+   VY  V
Sbjct: 80  GQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVY--V 137
Query: 304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 363
           V   ++  LH I    + L           L +G+ ++H      V+HRD++ SN+L++E
Sbjct: 138 VLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNE 194
Query: 364 EFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFGVLL 420
                +   G+++ +     + +  M     T  Y APE +   +E T   D++S G + 
Sbjct: 195 NCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIF 254
Query: 421 LEIVSGRR 428
            E+++ R+
Sbjct: 255 GEMLARRQ 262

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 94/198 (47%), Gaps = 35/198 (17%)
Query: 249 GSRVAVK----RLKRSSFQRKKEFYSEIGRFARLHHPNLVA-VKGCCYDHG---DRYIVY 300
           G  VAVK    R +RS F R+ E Y  +     L H N++  +     D+G     ++V 
Sbjct: 27  GEEVAVKIFSSREERSWF-REAEIYQTV----MLRHENILGFIAADNKDNGTWTQLWLVS 81
Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV-----KPHVVHRDIR 355
           ++  +G L  +L+        +     +K+A + A G+A LH ++     KP + HRD++
Sbjct: 82  DYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLK 136
Query: 356 ASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG----GTYGYLAPEFVYRN------ 405
           + N+L+ +     +  +GL+  V  +   +   +A     GT  Y+APE +  +      
Sbjct: 137 SKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHF 194
Query: 406 ELTTKSDVYSFGVLLLEI 423
           E   ++D+Y+ G++  EI
Sbjct: 195 ESFKRADIYAMGLVFWEI 212

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 94/198 (47%), Gaps = 35/198 (17%)
Query: 249 GSRVAVK----RLKRSSFQRKKEFYSEIGRFARLHHPNLVA-VKGCCYDHG---DRYIVY 300
           G  VAVK    R +RS F R+ E Y  +     L H N++  +     D+G     ++V 
Sbjct: 32  GEEVAVKIFSSREERSWF-REAEIYQTV----MLRHENILGFIAADNKDNGTWTQLWLVS 86
Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV-----KPHVVHRDIR 355
           ++  +G L  +L+        +     +K+A + A G+A LH ++     KP + HRD++
Sbjct: 87  DYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLK 141
Query: 356 ASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG----GTYGYLAPEFVYRN------ 405
           + N+L+ +     +  +GL+  V  +   +   +A     GT  Y+APE +  +      
Sbjct: 142 SKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHF 199
Query: 406 ELTTKSDVYSFGVLLLEI 423
           E   ++D+Y+ G++  EI
Sbjct: 200 ESFKRADIYAMGLVFWEI 217

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/190 (22%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 249 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAV------KGCCYDHGDRYIVY 300
           G ++AVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 76  GLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPATSLEEFNDVYLVT 135
Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 136 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIHSA---DIIHRDLKPSNLA 186
Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 417
           ++E+    ++  GL++    E       M G   T  Y APE +          D++S G
Sbjct: 187 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNMTVDIWSVG 239
Query: 418 VLLLEIVSGR 427
            ++ E+++GR
Sbjct: 240 CIMAELLTGR 249

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 94/198 (47%), Gaps = 35/198 (17%)
Query: 249 GSRVAVK----RLKRSSFQRKKEFYSEIGRFARLHHPNLVA-VKGCCYDHG---DRYIVY 300
           G  VAVK    R +RS F R+ E Y  +     L H N++  +     D+G     ++V 
Sbjct: 65  GEEVAVKIFSSREERSWF-REAEIYQTV----MLRHENILGFIAADNKDNGTWTQLWLVS 119
Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV-----KPHVVHRDIR 355
           ++  +G L  +L+        +     +K+A + A G+A LH ++     KP + HRD++
Sbjct: 120 DYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLK 174
Query: 356 ASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG----GTYGYLAPEFVYRN------ 405
           + N+L+ +     +  +GL+  V  +   +   +A     GT  Y+APE +  +      
Sbjct: 175 SKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHF 232
Query: 406 ELTTKSDVYSFGVLLLEI 423
           E   ++D+Y+ G++  EI
Sbjct: 233 ESFKRADIYAMGLVFWEI 250

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 85/199 (42%), Gaps = 16/199 (8%)
Query: 233 LGDSKTGGTYSGILPDGSRVAVK--RLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 290
           +G+   G  Y      G   A+K  RL++           EI     L H N+V +    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 291 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 350
           +      +V+E + +  L + L  +  GG  L+          L  GIA+ HD+    V+
Sbjct: 70  HTKKRLVLVFEHL-DQDLKKLLD-VCEGG--LESVTAKSFLLQLLNGIAYCHDR---RVL 122
Query: 351 HRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTVMAGGTYGYLAPEFVY-RNEL 407
           HRD++  N+L++ E    +   GL++   +P        V    T  Y AP+ +    + 
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV----TLWYRAPDVLMGSKKY 178
Query: 408 TTKSDVYSFGVLLLEIVSG 426
           +T  D++S G +  E+V+G
Sbjct: 179 STTIDIWSVGCIFAEMVNG 197

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 94/198 (47%), Gaps = 35/198 (17%)
Query: 249 GSRVAVK----RLKRSSFQRKKEFYSEIGRFARLHHPNLVA-VKGCCYDHG---DRYIVY 300
           G  VAVK    R +RS F R+ E Y  +     L H N++  +     D+G     ++V 
Sbjct: 29  GEEVAVKIFSSREERSWF-REAEIYQTV----MLRHENILGFIAADNKDNGTWTQLWLVS 83
Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV-----KPHVVHRDIR 355
           ++  +G L  +L+        +     +K+A + A G+A LH ++     KP + HRD++
Sbjct: 84  DYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLK 138
Query: 356 ASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG----GTYGYLAPEFVYRN------ 405
           + N+L+ +     +  +GL+  V  +   +   +A     GT  Y+APE +  +      
Sbjct: 139 SKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHF 196
Query: 406 ELTTKSDVYSFGVLLLEI 423
           E   ++D+Y+ G++  EI
Sbjct: 197 ESFKRADIYAMGLVFWEI 214

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 85/199 (42%), Gaps = 16/199 (8%)
Query: 233 LGDSKTGGTYSGILPDGSRVAVK--RLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 290
           +G+   G  Y      G   A+K  RL++           EI     L H N+V +    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 291 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 350
           +      +V+E + +  L + L  +  GG  L+          L  GIA+ HD+    V+
Sbjct: 70  HTKKRLVLVFEHL-DQDLKKLLD-VCEGG--LESVTAKSFLLQLLNGIAYCHDR---RVL 122
Query: 351 HRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTVMAGGTYGYLAPEFVY-RNEL 407
           HRD++  N+L++ E    +   GL++   +P        V    T  Y AP+ +    + 
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV----TLWYRAPDVLMGSKKY 178
Query: 408 TTKSDVYSFGVLLLEIVSG 426
           +T  D++S G +  E+V+G
Sbjct: 179 STTIDIWSVGCIFAEMVNG 197

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/191 (21%), Positives = 83/191 (43%), Gaps = 33/191 (17%)
Query: 254 VKRLKRSSFQR---KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 310
           +K+ +  S +R   +++   E+     + HPN++ +     +  D  ++ E V  G L  
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 103
Query: 311 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE------- 363
           +L        SL      +    +  G+ +LH      + H D++  N++L +       
Sbjct: 104 FLAE----KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPR 156
Query: 364 ----EFG-AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGV 418
               +FG AH +  G ++F        + +   GT  ++APE V    L  ++D++S GV
Sbjct: 157 IKIIDFGLAHKIDFG-NEF--------KNIF--GTPAFVAPEIVNYEPLGLEADMWSIGV 205
Query: 419 LLLEIVSGRRP 429
           +   ++SG  P
Sbjct: 206 ITYILLSGASP 216

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 46/200 (23%), Positives = 83/200 (41%), Gaps = 21/200 (10%)
Query: 240 GTYSGILPDGSR-----VAVKRLKRSSFQR--KKEFYSEIGRFARLHHPNLVAVKGCCYD 292
           GTY  +    +R     VA+KR++              EI     L H N+V +    + 
Sbjct: 13  GTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS 72
Query: 293 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 352
                +V+EF  +  L ++          LD  +       L +G+ F H +   +V+HR
Sbjct: 73  DKKLTLVFEFC-DQDLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHR 125
Query: 353 DIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTVMAGGTYGYLAPEFVYRNEL-TT 409
           D++  N+L++      L   GL++   +P        V    T  Y  P+ ++  +L +T
Sbjct: 126 DLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV----TLWYRPPDVLFGAKLYST 181
Query: 410 KSDVYSFGVLLLEIVSGRRP 429
             D++S G +  E+ +  RP
Sbjct: 182 SIDMWSAGCIFAELANAGRP 201

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 46/200 (23%), Positives = 83/200 (41%), Gaps = 21/200 (10%)
Query: 240 GTYSGILPDGSR-----VAVKRLKRSSFQR--KKEFYSEIGRFARLHHPNLVAVKGCCYD 292
           GTY  +    +R     VA+KR++              EI     L H N+V +    + 
Sbjct: 13  GTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS 72
Query: 293 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 352
                +V+EF  +  L ++          LD  +       L +G+ F H +   +V+HR
Sbjct: 73  DKKLTLVFEFC-DQDLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHR 125
Query: 353 DIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTVMAGGTYGYLAPEFVYRNEL-TT 409
           D++  N+L++      L   GL++   +P        V    T  Y  P+ ++  +L +T
Sbjct: 126 DLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVV----TLWYRPPDVLFGAKLYST 181
Query: 410 KSDVYSFGVLLLEIVSGRRP 429
             D++S G +  E+ +  RP
Sbjct: 182 SIDMWSAGCIFAELANAARP 201

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 94/198 (47%), Gaps = 35/198 (17%)
Query: 249 GSRVAVK----RLKRSSFQRKKEFYSEIGRFARLHHPNLVA-VKGCCYDHG---DRYIVY 300
           G  VAVK    R +RS F R+ E Y  +     L H N++  +     D+G     ++V 
Sbjct: 26  GEEVAVKIFSSREERSWF-REAEIYQTV----MLRHENILGFIAADNKDNGTWTQLWLVS 80
Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV-----KPHVVHRDIR 355
           ++  +G L  +L+        +     +K+A + A G+A LH ++     KP + HRD++
Sbjct: 81  DYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLK 135
Query: 356 ASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG----GTYGYLAPEFVYRN------ 405
           + N+L+ +     +  +GL+  V  +   +   +A     GT  Y+APE +  +      
Sbjct: 136 SKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHF 193
Query: 406 ELTTKSDVYSFGVLLLEI 423
           E   ++D+Y+ G++  EI
Sbjct: 194 ESFKRADIYAMGLVFWEI 211

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 73/164 (44%), Gaps = 18/164 (10%)
Query: 271 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG-PLDRWLHHIPRGGRSLDWAMRMK 329
           EI   +R+ H N++ V     + G   +V E   +G  L  ++   PR    LD  +   
Sbjct: 79  EIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR----LDEPLASY 134
Query: 330 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 389
           +   L   + +L  K    ++HRDI+  N+++ E+F   L+  G + ++      ER  +
Sbjct: 135 IFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYL------ERGKL 185
Query: 390 ---AGGTYGYLAPEFVYRNELT-TKSDVYSFGVLLLEIVSGRRP 429
                GT  Y APE +  N     + +++S GV L  +V    P
Sbjct: 186 FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENP 229

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 85/199 (42%), Gaps = 16/199 (8%)
Query: 233 LGDSKTGGTYSGILPDGSRVAVK--RLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 290
           +G+   G  Y      G   A+K  RL++           EI     L H N+V +    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 291 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 350
           +      +V+E + +  L + L  +  GG  L+          L  GIA+ HD+    V+
Sbjct: 70  HTKKRLVLVFEHL-DQDLKKLLD-VCEGG--LESVTAKSFLLQLLNGIAYCHDR---RVL 122
Query: 351 HRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTVMAGGTYGYLAPEFVY-RNEL 407
           HRD++  N+L++ E    +   GL++   +P        V    T  Y AP+ +    + 
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV----TLWYRAPDVLMGSKKY 178
Query: 408 TTKSDVYSFGVLLLEIVSG 426
           +T  D++S G +  E+V+G
Sbjct: 179 STTIDIWSVGCIFAEMVNG 197

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 83/196 (42%), Gaps = 25/196 (12%)
Query: 240 GTYSGILPDGSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAV------KGCC 290
             Y  IL     VA+K+L R  FQ +   K  Y E+     ++H N++ +      +   
Sbjct: 42  AAYDAIL--ERNVAIKKLSRP-FQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSL 98
Query: 291 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 350
            +  D YIV E      +D  L  + +    LD      +   +  GI  LH      ++
Sbjct: 99  EEFQDVYIVMEL-----MDANLSQVIQ--MELDHERMSYLLYQMLVGIKHLHSA---GII 148
Query: 351 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 410
           HRD++ SN+++  +    ++  GL++      M    V+   T  Y APE +        
Sbjct: 149 HRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVV---TRYYRAPEVILGMGYKEN 205
Query: 411 SDVYSFGVLLLEIVSG 426
            D++S G ++ E++ G
Sbjct: 206 VDIWSVGCIMGEMIKG 221

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/188 (23%), Positives = 84/188 (44%), Gaps = 13/188 (6%)
Query: 249 GSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGC---CYDHGDRYIVYEFV 303
           G +VA+K++  +       K    E+       H N++A+K        +G+   VY  V
Sbjct: 79  GQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVY--V 136
Query: 304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 363
           V   ++  LH I    + L           L +G+ ++H      V+HRD++ SN+L++E
Sbjct: 137 VLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNE 193
Query: 364 EFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFGVLL 420
                +   G+++ +     + +  M     T  Y APE +   +E T   D++S G + 
Sbjct: 194 NCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIF 253
Query: 421 LEIVSGRR 428
            E+++ R+
Sbjct: 254 GEMLARRQ 261

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/183 (24%), Positives = 77/183 (42%), Gaps = 16/183 (8%)
Query: 249 GSRVAVKRLKRSSFQR--KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 306
           G  VA+K+   S      KK    EI    +L HPNLV +          ++V+E+  + 
Sbjct: 28  GQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHT 87
Query: 307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 366
                LH + R  R +   +   +     Q + F H   K + +HRD++  N+L+ +   
Sbjct: 88  ----VLHELDRYQRGVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSV 140
Query: 367 AHLMGVGLSKFV--PWEVMQERTVMAGGTYGYLAPE-FVYRNELTTKSDVYSFGVLLLEI 423
             L   G ++ +  P +   +       T  Y +PE  V   +     DV++ G +  E+
Sbjct: 141 IKLCDFGFARLLTGPSDYYDDEV----ATRWYRSPELLVGDTQYGPPVDVWAIGCVFAEL 196
Query: 424 VSG 426
           +SG
Sbjct: 197 LSG 199

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 39/181 (21%), Positives = 72/181 (39%), Gaps = 7/181 (3%)
Query: 249 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 308
           G+  A K +       K+    EI   + L HP LV +     D  +  ++YEF+  G L
Sbjct: 76  GNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGEL 135
Query: 309 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 368
                 +      +     ++    + +G+  +H+    + VH D++  N++   +    
Sbjct: 136 ---FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNE 189
Query: 369 LMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRR 428
           L  +        +  Q   V   GT  + APE      +   +D++S GVL   ++SG  
Sbjct: 190 LKLIDFGLTAHLDPKQSVKVTT-GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLS 248
Query: 429 P 429
           P
Sbjct: 249 P 249

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 42/191 (21%), Positives = 83/191 (43%), Gaps = 33/191 (17%)
Query: 254 VKRLKRSSFQR---KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 310
           +K+ +  S +R   +++   E+     + HPN++ +     +  D  ++ E V  G L  
Sbjct: 43  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 102
Query: 311 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE------- 363
           +L        SL      +    +  G+ +LH      + H D++  N++L +       
Sbjct: 103 FLAE----KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPR 155
Query: 364 ----EFG-AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGV 418
               +FG AH +  G ++F        + +   GT  ++APE V    L  ++D++S GV
Sbjct: 156 IKIIDFGLAHKIDFG-NEF--------KNIF--GTPEFVAPEIVNYEPLGLEADMWSIGV 204
Query: 419 LLLEIVSGRRP 429
           +   ++SG  P
Sbjct: 205 ITYILLSGASP 215

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 42/191 (21%), Positives = 83/191 (43%), Gaps = 33/191 (17%)
Query: 254 VKRLKRSSFQR---KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 310
           +K+ +  S +R   +++   E+     + HPN++ +     +  D  ++ E V  G L  
Sbjct: 43  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 102
Query: 311 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE------- 363
           +L        SL      +    +  G+ +LH      + H D++  N++L +       
Sbjct: 103 FLAE----KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPR 155
Query: 364 ----EFG-AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGV 418
               +FG AH +  G ++F        + +   GT  ++APE V    L  ++D++S GV
Sbjct: 156 IKIIDFGLAHKIDFG-NEF--------KNIF--GTPEFVAPEIVNYEPLGLEADMWSIGV 204
Query: 419 LLLEIVSGRRP 429
           +   ++SG  P
Sbjct: 205 ITYILLSGASP 215

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 42/191 (21%), Positives = 83/191 (43%), Gaps = 33/191 (17%)
Query: 254 VKRLKRSSFQR---KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 310
           +K+ +  S +R   +++   E+     + HPN++ +     +  D  ++ E V  G L  
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 103
Query: 311 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE------- 363
           +L        SL      +    +  G+ +LH      + H D++  N++L +       
Sbjct: 104 FLAE----KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPR 156
Query: 364 ----EFG-AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGV 418
               +FG AH +  G ++F        + +   GT  ++APE V    L  ++D++S GV
Sbjct: 157 IKIIDFGLAHKIDFG-NEF--------KNIF--GTPEFVAPEIVNYEPLGLEADMWSIGV 205
Query: 419 LLLEIVSGRRP 429
           +   ++SG  P
Sbjct: 206 ITYILLSGASP 216

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 83/196 (42%), Gaps = 25/196 (12%)
Query: 240 GTYSGILPDGSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAV------KGCC 290
             Y  IL     VA+K+L R  FQ +   K  Y E+     ++H N++ +      +   
Sbjct: 42  AAYDAIL--ERNVAIKKLSRP-FQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSL 98
Query: 291 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 350
            +  D YIV E      +D  L  + +    LD      +   +  GI  LH      ++
Sbjct: 99  EEFQDVYIVMEL-----MDANLSQVIQ--MELDHERMSYLLYQMLCGIKHLHSA---GII 148
Query: 351 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 410
           HRD++ SN+++  +    ++  GL++      M    V+   T  Y APE +        
Sbjct: 149 HRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVV---TRYYRAPEVILGMGYKEN 205
Query: 411 SDVYSFGVLLLEIVSG 426
            D++S G ++ E++ G
Sbjct: 206 VDIWSVGCIMGEMIKG 221

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 42/191 (21%), Positives = 83/191 (43%), Gaps = 33/191 (17%)
Query: 254 VKRLKRSSFQR---KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 310
           +K+ +  S +R   +++   E+     + HPN++ +     +  D  ++ E V  G L  
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 103
Query: 311 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE------- 363
           +L        SL      +    +  G+ +LH      + H D++  N++L +       
Sbjct: 104 FLAE----KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPR 156
Query: 364 ----EFG-AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGV 418
               +FG AH +  G ++F        + +   GT  ++APE V    L  ++D++S GV
Sbjct: 157 IKIIDFGLAHKIDFG-NEF--------KNIF--GTPEFVAPEIVNYEPLGLEADMWSIGV 205
Query: 419 LLLEIVSGRRP 429
           +   ++SG  P
Sbjct: 206 ITYILLSGASP 216

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 42/191 (21%), Positives = 83/191 (43%), Gaps = 33/191 (17%)
Query: 254 VKRLKRSSFQR---KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 310
           +K+ +  S +R   +++   E+     + HPN++ +     +  D  ++ E V  G L  
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 103
Query: 311 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE------- 363
           +L        SL      +    +  G+ +LH      + H D++  N++L +       
Sbjct: 104 FLAE----KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPR 156
Query: 364 ----EFG-AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGV 418
               +FG AH +  G ++F        + +   GT  ++APE V    L  ++D++S GV
Sbjct: 157 IKIIDFGLAHKIDFG-NEF--------KNIF--GTPEFVAPEIVNYEPLGLEADMWSIGV 205
Query: 419 LLLEIVSGRRP 429
           +   ++SG  P
Sbjct: 206 ITYILLSGASP 216

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/191 (21%), Positives = 83/191 (43%), Gaps = 33/191 (17%)
Query: 254 VKRLKRSSFQR---KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 310
           +K+ +  S +R   +++   E+     + HPN++ +     +  D  ++ E V  G L  
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 103
Query: 311 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE------- 363
           +L        SL      +    +  G+ +LH      + H D++  N++L +       
Sbjct: 104 FLAE----KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPR 156
Query: 364 ----EFG-AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGV 418
               +FG AH +  G ++F        + +   GT  ++APE V    L  ++D++S GV
Sbjct: 157 IKIIDFGLAHKIDFG-NEF--------KNIF--GTPEFVAPEIVNYEPLGLEADMWSIGV 205
Query: 419 LLLEIVSGRRP 429
           +   ++SG  P
Sbjct: 206 ITYILLSGASP 216

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/191 (21%), Positives = 83/191 (43%), Gaps = 33/191 (17%)
Query: 254 VKRLKRSSFQR---KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 310
           +K+ +  S +R   +++   E+     + HPN++ +     +  D  ++ E V  G L  
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 103
Query: 311 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE------- 363
           +L        SL      +    +  G+ +LH      + H D++  N++L +       
Sbjct: 104 FLAE----KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPR 156
Query: 364 ----EFG-AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGV 418
               +FG AH +  G ++F        + +   GT  ++APE V    L  ++D++S GV
Sbjct: 157 IKIIDFGLAHKIDFG-NEF--------KNIF--GTPEFVAPEIVNYEPLGLEADMWSIGV 205
Query: 419 LLLEIVSGRRP 429
           +   ++SG  P
Sbjct: 206 ITYILLSGASP 216

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/191 (21%), Positives = 83/191 (43%), Gaps = 33/191 (17%)
Query: 254 VKRLKRSSFQR---KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 310
           +K+ +  S +R   +++   E+     + HPN++ +     +  D  ++ E V  G L  
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 103
Query: 311 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE------- 363
           +L        SL      +    +  G+ +LH      + H D++  N++L +       
Sbjct: 104 FLAE----KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPR 156
Query: 364 ----EFG-AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGV 418
               +FG AH +  G ++F        + +   GT  ++APE V    L  ++D++S GV
Sbjct: 157 IKIIDFGLAHKIDFG-NEF--------KNIF--GTPEFVAPEIVNYEPLGLEADMWSIGV 205
Query: 419 LLLEIVSGRRP 429
           +   ++SG  P
Sbjct: 206 ITYILLSGASP 216

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/191 (21%), Positives = 83/191 (43%), Gaps = 33/191 (17%)
Query: 254 VKRLKRSSFQR---KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 310
           +K+ +  S +R   +++   E+     + HPN++ +     +  D  ++ E V  G L  
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 103
Query: 311 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE------- 363
           +L        SL      +    +  G+ +LH      + H D++  N++L +       
Sbjct: 104 FLAE----KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPR 156
Query: 364 ----EFG-AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGV 418
               +FG AH +  G ++F        + +   GT  ++APE V    L  ++D++S GV
Sbjct: 157 IKIIDFGLAHKIDFG-NEF--------KNIF--GTPEFVAPEIVNYEPLGLEADMWSIGV 205
Query: 419 LLLEIVSGRRP 429
           +   ++SG  P
Sbjct: 206 ITYILLSGASP 216

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 48/194 (24%), Positives = 83/194 (42%), Gaps = 25/194 (12%)
Query: 240 GTYSGILPDGSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAV------KGCC 290
             Y  IL     VA+K+L R  FQ +   K  Y E+     ++H N++ +      +   
Sbjct: 42  AAYDAIL--ERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 98
Query: 291 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 350
            +  D YIV E      +D  L  + +    LD      +   +  GI  LH      ++
Sbjct: 99  EEFQDVYIVMEL-----MDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSA---GII 148
Query: 351 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 410
           HRD++ SN+++  +    ++  GL++      M E  V+   T  Y APE +        
Sbjct: 149 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVV---TRYYRAPEVILGMGYKEN 205
Query: 411 SDVYSFGVLLLEIV 424
            D++S G ++ E+V
Sbjct: 206 VDIWSVGCIMGEMV 219

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 46/195 (23%), Positives = 87/195 (44%), Gaps = 20/195 (10%)
Query: 238 TGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRY 297
           TG  Y+  + +  +++ +        +K E  + I R   L H N+V +     + G  Y
Sbjct: 28  TGHEYAAKIINTKKLSARD------HQKLEREARICRL--LKHSNIVRLHDSISEEGFHY 79
Query: 298 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 357
           +V++ V  G L   +  + R     ++      +  + Q +  +    +  VVHRD++  
Sbjct: 80  LVFDLVTGGELFEDI--VAR-----EYYSEADASHCIQQILEAVLHCHQMGVVHRDLKPE 132
Query: 358 NVLLDEEFGAHLMGVGLSKF-VPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVY 414
           N+LL  +       V L+ F +  EV  ++    G  GT GYL+PE + +       D++
Sbjct: 133 NLLLASKCKG--AAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKEAYGKPVDIW 190
Query: 415 SFGVLLLEIVSGRRP 429
           + GV+L  ++ G  P
Sbjct: 191 ACGVILYILLVGYPP 205

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 42/191 (21%), Positives = 83/191 (43%), Gaps = 33/191 (17%)
Query: 254 VKRLKRSSFQR---KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 310
           +K+ +  S +R   +++   E+     + HPN++ +     +  D  ++ E V  G L  
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 103
Query: 311 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE------- 363
           +L        SL      +    +  G+ +LH      + H D++  N++L +       
Sbjct: 104 FLAE----KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPR 156
Query: 364 ----EFG-AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGV 418
               +FG AH +  G ++F        + +   GT  ++APE V    L  ++D++S GV
Sbjct: 157 IKIIDFGLAHKIDFG-NEF--------KNIF--GTPEFVAPEIVNYEPLGLEADMWSIGV 205
Query: 419 LLLEIVSGRRP 429
           +   ++SG  P
Sbjct: 206 ITYILLSGASP 216

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 42/191 (21%), Positives = 83/191 (43%), Gaps = 33/191 (17%)
Query: 254 VKRLKRSSFQR---KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 310
           +K+ +  S +R   +++   E+     + HPN++ +     +  D  ++ E V  G L  
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 103
Query: 311 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE------- 363
           +L        SL      +    +  G+ +LH      + H D++  N++L +       
Sbjct: 104 FLAE----KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPR 156
Query: 364 ----EFG-AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGV 418
               +FG AH +  G ++F        + +   GT  ++APE V    L  ++D++S GV
Sbjct: 157 IKIIDFGLAHKIDFG-NEF--------KNIF--GTPEFVAPEIVNYEPLGLEADMWSIGV 205
Query: 419 LLLEIVSGRRP 429
           +   ++SG  P
Sbjct: 206 ITYILLSGASP 216

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 44/190 (23%), Positives = 84/190 (44%), Gaps = 27/190 (14%)
Query: 249 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIVY 300
           G RVAVK+L R   S    K  Y E+     + H N++ +           +  D Y+V 
Sbjct: 47  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
             +        L++I +  +  D  ++  +   L +G+ ++H      ++HRD++ SN+ 
Sbjct: 107 HLMGAD-----LNNIVKCQKLTDDHVQFLIYQIL-RGLKYIH---SADIIHRDLKPSNLA 157
Query: 361 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 417
           ++E+    ++   L++    E       M G   T  Y APE +          D++S G
Sbjct: 158 VNEDCELKILDFYLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 210
Query: 418 VLLLEIVSGR 427
            ++ E+++GR
Sbjct: 211 CIMAELLTGR 220

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 83/196 (42%), Gaps = 25/196 (12%)
Query: 240 GTYSGILPDGSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAV------KGCC 290
             Y  IL     VA+K+L R  FQ +   K  Y E+     ++H N++ +      +   
Sbjct: 42  AAYDAIL--ERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 98
Query: 291 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 350
            +  D YIV E      +D  L  + +    LD      +   +  GI  LH      ++
Sbjct: 99  EEFQDVYIVMEL-----MDANLSQVIQ--MELDHERMSYLLYQMLCGIKHLHSA---GII 148
Query: 351 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 410
           HRD++ SN+++  +    ++  GL++      M    V+   T  Y APE +        
Sbjct: 149 HRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVV---TRYYRAPEVILGMGYKEN 205
Query: 411 SDVYSFGVLLLEIVSG 426
            D++S G ++ E++ G
Sbjct: 206 VDIWSVGCIMGEMIKG 221

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 83/196 (42%), Gaps = 25/196 (12%)
Query: 240 GTYSGILPDGSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAV------KGCC 290
             Y  IL     VA+K+L R  FQ +   K  Y E+     ++H N++ +      +   
Sbjct: 42  AAYDAIL--ERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 98
Query: 291 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 350
            +  D YIV E      +D  L  + +    LD      +   +  GI  LH      ++
Sbjct: 99  EEFQDVYIVMEL-----MDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSA---GII 148
Query: 351 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 410
           HRD++ SN+++  +    ++  GL++      M    V+   T  Y APE +        
Sbjct: 149 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPEVV---TRYYRAPEVILGMGYKEN 205
Query: 411 SDVYSFGVLLLEIVSG 426
            D++S G ++ E++ G
Sbjct: 206 VDIWSVGCIMGEMIKG 221

>pdb|2XR6|A Chain A, Crystal Structure Of The Complex Of The Carbohydrate Recognition Domain Of Human Dc-Sign With Pseudo Trimannoside Mimic Length = 170

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 24/81 (29%), Positives = 40/81 (49%), Gaps = 4/81 (4%)
Query: 8  PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 67
          PCP +W   +    C+    + R+W +S T CKE+G  L  + S EE++  Q    ++  
Sbjct: 21 PCPWEWTFFQ--GNCYFMSNSQRNWHDSITACKEVGAQLVVIKSAEEQNFLQLQSSRSNR 78
Query: 68 GCWVGGRSINTTVGLSWKWSD 88
            W+G   +N     +W+W D
Sbjct: 79 FTWMGLSDLNQEG--TWQWVD 97

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 83/196 (42%), Gaps = 25/196 (12%)
Query: 240 GTYSGILPDGSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAV------KGCC 290
             Y  IL     VA+K+L R  FQ +   K  Y E+     ++H N++ +      +   
Sbjct: 42  AAYDAIL--ERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 98
Query: 291 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 350
            +  D YIV E      +D  L  + +    LD      +   +  GI  LH      ++
Sbjct: 99  EEFQDVYIVMEL-----MDANLSQVIQ--MELDHERMSYLLYQMLCGIKHLHSA---GII 148
Query: 351 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 410
           HRD++ SN+++  +    ++  GL++      M    V+   T  Y APE +        
Sbjct: 149 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV---TRYYRAPEVILGMGYKEN 205
Query: 411 SDVYSFGVLLLEIVSG 426
            D++S G ++ E++ G
Sbjct: 206 VDIWSVGCIMGEMIKG 221

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 45/194 (23%), Positives = 83/194 (42%), Gaps = 25/194 (12%)
Query: 240 GTYSGILPDGSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAV------KGCC 290
             Y  +L     VA+K+L R  FQ +   K  Y E+     ++H N++++      +   
Sbjct: 42  AAYDAVL--DRNVAIKKLSRP-FQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTL 98
Query: 291 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 350
            +  D Y+V E      +D  L  + +    LD      +   +  GI  LH      ++
Sbjct: 99  EEFQDVYLVMEL-----MDANLXQVIQ--MELDHERMSYLLYQMLXGIKHLHSA---GII 148
Query: 351 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 410
           HRD++ SN+++  +    ++  GL++      M    V+   T  Y APE +        
Sbjct: 149 HRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVV---TRYYRAPEVILGMGYKEN 205
Query: 411 SDVYSFGVLLLEIV 424
            D++S G ++ E+V
Sbjct: 206 VDIWSVGCIMGEMV 219

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 42/191 (21%), Positives = 83/191 (43%), Gaps = 33/191 (17%)
Query: 254 VKRLKRSSFQR---KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 310
           +K+ +  S +R   +++   E+     + HPN++ +     +  D  ++ E V  G L  
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 103
Query: 311 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE------- 363
           +L        SL      +    +  G+ +LH      + H D++  N++L +       
Sbjct: 104 FLAE----KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPR 156
Query: 364 ----EFG-AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGV 418
               +FG AH +  G ++F        + +   GT  ++APE V    L  ++D++S GV
Sbjct: 157 IKIIDFGLAHKIDFG-NEF--------KNIF--GTPEFVAPEIVNYEPLGLEADMWSIGV 205
Query: 419 LLLEIVSGRRP 429
           +   ++SG  P
Sbjct: 206 ITYILLSGASP 216

>pdb|2B6B|D Chain D, Cryo Em Structure Of Dengue Complexed With Crd Of Dc-Sign Length = 175

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 24/81 (29%), Positives = 40/81 (49%), Gaps = 4/81 (4%)
Query: 8   PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 67
           PCP +W   +    C+    + R+W +S T CKE+G  L  + S EE++  Q    ++  
Sbjct: 26  PCPWEWTFFQ--GNCYFMSNSQRNWHDSITACKEVGAQLVVIKSAEEQNFLQLQSSRSNR 83
Query: 68  GCWVGGRSINTTVGLSWKWSD 88
             W+G   +N     +W+W D
Sbjct: 84  FTWMGLSDLNQEG--TWQWVD 102

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 26/111 (23%), Positives = 60/111 (54%), Gaps = 9/111 (8%)
Query: 328 MKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF---GAHLMGVGLSKFVPWEVMQ 384
           +++   + +G+ +LH   + ++VH D++  N+LL   +      ++  G+S+ +     +
Sbjct: 134 IRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI-GHACE 189
Query: 385 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS 435
            R +M  GT  YLAPE +  + +TT +D+++ G++   +++   P    D+
Sbjct: 190 LREIM--GTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN 238

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 42/191 (21%), Positives = 83/191 (43%), Gaps = 33/191 (17%)
Query: 254 VKRLKRSSFQR---KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 310
           +K+ +  S +R   +++   E+     + HPN++ +     +  D  ++ E V  G L  
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFD 103
Query: 311 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE------- 363
           +L        SL      +    +  G+ +LH      + H D++  N++L +       
Sbjct: 104 FLAE----KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPR 156
Query: 364 ----EFG-AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGV 418
               +FG AH +  G ++F        + +   GT  ++APE V    L  ++D++S GV
Sbjct: 157 IKIIDFGLAHKIDFG-NEF--------KNIF--GTPEFVAPEIVNYEPLGLEADMWSIGV 205
Query: 419 LLLEIVSGRRP 429
           +   ++SG  P
Sbjct: 206 ITYILLSGASP 216

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	513
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-108
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-104
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-97
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-57
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-50
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-50
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-49
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-47
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-47
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	7e-45
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	5e-44
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-42
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	4e-42
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-39
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-38
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-38
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	8e-38
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-37
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	6e-33
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	4e-32
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-31
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-31
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-31
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	5e-31
4aoj_A	329	High affinity nerve growth factor receptor; transf	9e-31
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-30
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-30
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-30
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-30
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-30
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-29
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-29
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-29
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-29
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-29
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	3e-29
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	4e-29
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	8e-29
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-28
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-28
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-28
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	3e-28
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-28
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-28
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	4e-28
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	4e-28
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	4e-28
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	5e-28
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	7e-28
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	8e-28
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-27
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-27
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-27
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-27
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	5e-27
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	5e-27
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	6e-27
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	8e-27
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	9e-27
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	9e-27
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-26
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-26
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-26
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-26
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-26
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	3e-26
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	3e-26
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	4e-26
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-25
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-25
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	5e-25
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	9e-25
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-24
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-24
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-24
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-24
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-24
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	5e-24
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	6e-24
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	6e-24
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-23
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	8e-23
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-22
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-22
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-22
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	6e-22
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	8e-22
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-21
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-21
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	3e-21
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-21
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	4e-21
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	8e-21
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-20
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-20
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-20
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-20
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-20
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-20
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-20
3an0_A	340	Dual specificity mitogen-activated protein kinase;	5e-20
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	6e-20
3uqc_A	286	Probable conserved transmembrane protein; structur	9e-20
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	9e-20
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-19
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-19
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	3e-19
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-19
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	5e-19
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-18
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-18
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-18
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-18
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-18
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	3e-18
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	5e-18
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	7e-18
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	8e-18
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	9e-18
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-17
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-17
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-17
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-17
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-17
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-17
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	5e-17
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	6e-17
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	6e-17
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	8e-17
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-16
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-16
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-16
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-16
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-16
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-16
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-16
3bhy_A	283	Death-associated protein kinase 3; death associate	4e-16
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	4e-16
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	5e-16
3rs1_A	122	C-type lectin domain family 2 member I; C-type lec	6e-16
3aln_A	327	Dual specificity mitogen-activated protein kinase;	7e-16
1ypq_A	135	Oxidised low density lipoprotein (lectin-like) rec	7e-16
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	8e-16
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	8e-16
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-15
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	3e-15
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	4e-15
1jwi_A	131	Bitiscetin; domain swapping, C-type lectin, toxin;	4e-15
1hq8_A	123	NKG2-D; homodimer, CIS-proline, apoptosis; 1.95A {	6e-15
2yhf_A	118	C-type lectin domain family 5 member A; immune sys	6e-15
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	7e-15
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	7e-15
3hup_A	130	Early activation antigen CD69; C-type lectin-like	8e-15
1mpu_A	138	NKG2-D type II integral membrane protein; C-type l	9e-15
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-14
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-14
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-14
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-14
3vpp_A	132	C-type lectin domain family 9 member A; dendritic	3e-14
1fm5_A	199	Early activation antigen CD69; C-type lectin-like	3e-14
3m9z_A	139	Killer cell lectin-like receptor subfamily B MEMB;	4e-14
3c8j_A	203	Natural killer cell receptor LY49C; MHC, virus, im	4e-14
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	5e-14
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	5e-14
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	5e-14
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	6e-14
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	7e-14
2bpd_A	142	Dectin-1; receptor, beta-glucan, fungal recognitio	7e-14
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	8e-14
3ff9_A	115	Killer cell lectin-like receptor subfamily G membe	8e-14
1egg_A	147	Macrophage mannose receptor; C-type lectin, sugar	9e-14
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	9e-14
1sb2_A	133	Rhodocetin alpha subunit; C-type lectin, domain sw	1e-13
1oz7_A	131	Echicetin A-chain; platelet aggregation, dimer, to	1e-13
3bdw_B	120	NKG2-A/NKG2-B type II integral membrane protein; N	1e-13
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-13
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-13
3bdw_A	123	Natural killer cells antigen CD94; NK cells, recep	1e-13
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-13
2c6u_A	122	CLEC1B protein; lectin, rhodocytin, aggretin, C-ty	2e-13
1c3a_A	135	Flavocetin-A: alpha subunit; C-type lectin-like do	2e-13
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-13
3ff7_C	112	Killer cell lectin-like receptor subfamily G membe	3e-13
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-13
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	4e-13
1umr_C	125	Convulxin beta, CVX beta; lectin, C-type lectin, p	5e-13
1ukm_B	128	EMS16 B chain, EMS16 subunit B; domain swapping, C	5e-13
2dyl_A	318	Dual specificity mitogen-activated protein kinase	6e-13
3g8k_A	130	Lectin-related NK cell receptor LY49L1; natural ki	7e-13
2e3x_C	122	Coagulation factor X-activating enzyme light CHAI;	7e-13
1sb2_B	129	Rhodocetin beta subunit; C-type lectin, domain swa	7e-13
3ubu_A	131	Agglucetin subunit alpha-1; platelet inhibiting, a	7e-13
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	8e-13
2py2_A	136	Antifreeze protein type II; type II antifreeze pro	8e-13
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	8e-13
3gpr_D	124	Rhodocetin subunit delta; disulfide bond, lectin,	9e-13
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	9e-13
1umr_A	135	Convulxin alpha, CVX alpha; lectin, C-type lectin,	1e-12
1tdq_B	130	Aggrecan core protein; extracellular matrix, lecti	1e-12
1jwi_B	125	Platelet aggregation inducer; domain swapping, C-t	1e-12
3bx4_B	146	Aggretin beta chain; toxin; 1.70A {Agkistrodon rho	1e-12
3g8l_A	190	Lectin-related NK cell receptor LY49L1; natural ki	1e-12
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-12
1oz7_B	123	Echicetin B-chain; platelet aggregation, dimer, to	1e-12
1fvu_A	133	Botrocetin alpha chain; VON WILLBRAND factor modul	2e-12
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-12
2kv3_A	131	Regenerating islet-derived protein 4; GISP, C-type	3e-12
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	4e-12
1j34_A	129	Coagulation factor IX-binding protein A chain; mag	4e-12
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	5e-12
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-06
3gpr_C	134	Rhodocetin subunit gamma; disulfide bond, lectin,	5e-12
1fvu_B	125	Botrocetin beta chain; VON WILLBRAND factor modula	6e-12
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	6e-12
1j34_B	123	Coagulation factor IX-binding protein B chain; mag	7e-12
1c3a_B	125	Flavocetin-A: beta subunit; C-type lectin-like dom	7e-12
2xr6_A	170	CD209 antigen; sugar binding protein, carbohydrate	7e-12
3bx4_A	136	Aggretin alpha chain; toxin; 1.70A {Agkistrodon rh	9e-12
2afp_A	129	Protein (SEA raven type II antifreeze protein); re	9e-12
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-11
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-11
3ubu_B	126	Agglucetin subunit beta-2; platelet inhibiting, ag	1e-11
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-11
1sl6_A	184	C-type lectin DC-signr; sugar binding protein; HET	1e-11
2b6b_D	175	CD209 antigen; cryo EM dengue CRD DC-SIGN, icosahe	1e-11
1pwb_A	177	SP-D, PSP-D, pulmonary surfactant-associated prote	2e-11
2e3x_B	134	Coagulation factor X-activating enzyme light CHAI;	2e-11
1qdd_A	144	Lithostathine; pancreatic stone inhibitor, metal b	2e-11
1jzn_A	135	Galactose-specific lectin; C-type lectin, protein-	2e-11
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-11
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-11
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	3e-11
2ox9_A	140	Collectin placenta 1; C-type lectin, sugar binding	3e-11
3kqg_A	182	Langerin, C-type lectin domain family 4 member K;	3e-11
1ukm_A	134	EMS16 A chain, EMS16 subunit A; domain swapping, C	3e-11
1dv8_A	128	Asialoglycoprotein receptor 1; C-type lectin CRD,	3e-11
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	3e-11
3c22_A	156	C-type lectin domain family 4 member K; coiled coi	3e-11
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	4e-11
2h2t_B	175	Low affinity immunoglobulin epsilon FC receptor (	4e-11
2ls8_A	156	C-type lectin domain family 4 member D; structural	4e-11
1uv0_A	149	Pancreatitis-associated protein 1; lectin, C-type,	5e-11
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	5e-11
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	6e-11
2zib_A	133	Type II antifreeze protein; thermal hysteresis, le	7e-11
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	8e-11
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	9e-11
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-10
1gz2_A	142	Ovocleidin-17, OC-17 ovocleidin; structural protei	1e-10
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-10
3pbf_A	148	Pulmonary surfactant-associated protein A; collect	2e-10
1tn3_A	137	Tetranectin; plasminogen binding, kringle 4, C-typ	3e-10
2vuv_A	129	Codakine; sugar-binding protein, C-type, lectin, m	3e-10
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	5e-10
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	5e-10
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	7e-10
1htn_A	182	Tetranectin; plasminogen binding, kringle 4, alpha	8e-10
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	8e-10
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-09
1h8u_A	117	MBP, eosinophil granule major basic protein 1; lec	2e-09
3cfw_A	164	L-selectin; EGF, cell adhesion, EGF-like domain, g	2e-09
1byf_A	125	TC14, protein (polyandrocarpa lectin); C-type lect	2e-09
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-09
3alu_A	157	Lectin CEL-IV, C-type; C-type lectin, raffinose, s	3e-09
1buu_A	168	Protein (mannose-binding protein A); lectin, HOST	3e-09
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	4e-09
3o0g_A	292	Cell division protein kinase 5; kinase activator c	4e-09
1rtm_1	149	Mannose-binding protein-A; lectin; 1.80A {Rattus n	5e-09
1g1t_A	157	E-selectin; EGF, adhesion molecule, SLEX, immune s	5e-09
1g1s_A	162	P-selectin; selectin, lectin, EGF, sulphated, SLEX	5e-09
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	6e-09
1hup_A	141	Mannose-binding protein; alpha-helical coiled-coil	1e-08
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-08
1wmz_A	140	Lectin CEL-I, N-acetyl-D-galactosamine-specific C-	2e-08
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-08
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-08
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-08
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-08
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	4e-08
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	4e-08
2msb_A	115	Mannose-binding protein-A; lectin; HET: BMA MAN; 1	4e-08
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	6e-08
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	8e-08
3niz_A	311	Rhodanese family protein; structural genomics, str	8e-08
1rdl_1	113	SUB-MBP-C, mannose-binding protein-C; C-type lecti	1e-07
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-07
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	3e-07
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	7e-07
1wk1_A	150	Hypothetical protein YK1067A12; lectin C-type doma	8e-07
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-06
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	5e-06
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	8e-06
3fd4_A	191	Glycoprotein GP42; C type lectin, virus entry, mem	9e-06
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-05
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-05
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-05
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	4e-05
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	4e-05
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	4e-05
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	9e-05
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	4e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  323 bits (831), Expect = e-108
 Identities = 101/299 (33%), Positives = 165/299 (55%), Gaps = 13/299 (4%)

Query: 210 SWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQ-RKKEF 268
             K F+  EL+  + NFS  N +LG    G  Y G L DG+ VAVKRLK    Q  + +F
Sbjct: 16  QLKRFSLRELQVASDNFSNKN-ILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQF 74

Query: 269 YSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRM 328
            +E+   +   H NL+ ++G C    +R +VY ++ NG +   L   P     LDW  R 
Sbjct: 75  QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQ 134

Query: 329 KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT- 387
           ++A   A+G+A+LHD   P ++HRD++A+N+LLDEEF A +   GL+K + ++     T 
Sbjct: 135 RIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 194

Query: 388 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP---AQAVDSVCWQSIFEW 444
           V   GT G++APE++   + + K+DV+ +GV+LLE+++G+R    A+  +      + +W
Sbjct: 195 VR--GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD-VMLLDW 251

Query: 445 ATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQL 503
              L++  +   L+D     L  +  +   V++++ +   CTQ  P  RP+MS VV  L
Sbjct: 252 VKGLLKEKKLEALVDV---DLQGNYKDEE-VEQLIQVALLCTQSSPMERPKMSEVVRML 306

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  314 bits (807), Expect = e-104
 Identities = 94/326 (28%), Positives = 160/326 (49%), Gaps = 19/326 (5%)

Query: 189 SKRRRKSRKLSNPAASALVPPSW-KVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILP 247
           SK  + +  +++  +S+ + P         +L   T NF     L+G    G  Y G+L 
Sbjct: 3   SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKF-LIGHGVFGKVYKGVLR 61

Query: 248 DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 307
           DG++VA+KR    S Q  +EF +EI   +   HP+LV++ G C +  +  ++Y+++ NG 
Sbjct: 62  DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGN 121

Query: 308 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA 367
           L R L+       S+ W  R+++    A+G+ +LH      ++HRD+++ N+LLDE F  
Sbjct: 122 LKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVP 178

Query: 368 HLMGVGLSKFVPWEVMQERT-----VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLE 422
            +   G+SK        ++T     V   GT GY+ PE+  +  LT KSDVYSFGV+L E
Sbjct: 179 KITDFGISKKGTEL---DQTHLSTVVK--GTLGYIDPEYFIKGRLTEKSDVYSFGVVLFE 233

Query: 423 IVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLV 482
           ++  R            ++ EWA     + +  +++DP   +L+  I     ++K  D  
Sbjct: 234 VLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDP---NLADKIRPES-LRKFGDTA 289

Query: 483 YACTQHVPSMRPRMSHVVHQLQQLAQ 508
             C       RP M  V+ +L+   +
Sbjct: 290 VKCLALSSEDRPSMGDVLWKLEYALR 315

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  296 bits (759), Expect = 2e-97
 Identities = 99/309 (32%), Positives = 153/309 (49%), Gaps = 29/309 (9%)

Query: 212 KVFTTEELRSITKNFSEGNRLLGDSKTG----GT-YSGILPDGSRVAVKRLK----RSSF 262
             F+  EL+++T NF E    +G +K G    G  Y G + + + VAVK+L      ++ 
Sbjct: 13  HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTE 71

Query: 263 QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSL 322
           + K++F  EI   A+  H NLV + G   D  D  +VY ++ NG L   L     G   L
Sbjct: 72  ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC-LDGTPPL 130

Query: 323 DWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 382
            W MR K+A   A GI FLH+    H +HRDI+++N+LLDE F A +   GL++      
Sbjct: 131 SWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187

Query: 383 MQERT--VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVD-SVCWQ 439
               T  ++  GT  Y+APE + R E+T KSD+YSFGV+LLEI++G      VD     Q
Sbjct: 188 QTVMTSRIV--GTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPA---VDEHREPQ 241

Query: 440 SIFEWATPLVQSHRYLE-LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSH 498
            + +    +    + +E  +D  ++   S       V+ +  +   C     + RP +  
Sbjct: 242 LLLDIKEEIEDEEKTIEDYIDKKMNDADST-----SVEAMYSVASQCLHEKKNKRPDIKK 296

Query: 499 VVHQLQQLA 507
           V   LQ++ 
Sbjct: 297 VQQLLQEMT 305

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  193 bits (493), Expect = 1e-57
 Identities = 66/320 (20%), Positives = 113/320 (35%), Gaps = 40/320 (12%)

Query: 214 FTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLK---RSSFQRKKEFYS 270
             TE L   +             + G  +         VAVK      + S+Q + E YS
Sbjct: 14  LGTENLYFQSMPLQLLEVK-ARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQSWQNEYEVYS 71

Query: 271 EIGRFARLHHPNLVAVKGCC----YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAM 326
                  + H N++   G          D +++  F   G L  +L         + W  
Sbjct: 72  ----LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA-----NVVSWNE 122

Query: 327 RMKVATTLAQGIAFLH-------DKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP 379
              +A T+A+G+A+LH       D  KP + HRDI++ NVLL     A +   GL+    
Sbjct: 123 LCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFE 182

Query: 380 WEVMQERTVMAGGTYGYLAPE-----FVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVD 434
                  T    GT  Y+APE       ++ +   + D+Y+ G++L E+ S    A    
Sbjct: 183 AGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242

Query: 435 SVCWQSIFEWATPL------VQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQH 488
                  FE           +Q     +   P++        +   +  + + +  C  H
Sbjct: 243 DEY-MLPFEEEIGQHPSLEDMQEVVVHKKKRPVL---RDYWQKHAGMAMLCETIEECWDH 298

Query: 489 VPSMRPRMSHVVHQLQQLAQ 508
               R     V  ++ Q+ +
Sbjct: 299 DAEARLSAGCVGERITQMQR 318

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  174 bits (443), Expect = 1e-50
 Identities = 79/275 (28%), Positives = 130/275 (47%), Gaps = 41/275 (14%)

Query: 249 GSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 306
           GS VAVK L    F  +R  EF  E+    RL HPN+V   G      +  IV E++  G
Sbjct: 60  GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRG 119

Query: 307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 366
            L R LH        LD   R+ +A  +A+G+ +LH++  P +VHR++++ N+L+D+++ 
Sbjct: 120 SLYRLLHK-SGAREQLDERRRLSMAYDVAKGMNYLHNR-NPPIVHRNLKSPNLLVDKKYT 177

Query: 367 AHLMGVGLSKFVPWEVMQERTVMAG-GTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEIV 424
             +   GLS+    +     +  +  GT  ++APE V R+E    KSDVYSFGV+L E+ 
Sbjct: 178 VKVCDFGLSRL---KASTFLSSKSAAGTPEWMAPE-VLRDEPSNEKSDVYSFGVILWELA 233

Query: 425 SGRRP------AQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKV 478
           + ++P      AQ V +V ++                            +IP   +  +V
Sbjct: 234 TLQQPWGNLNPAQVVAAVGFK------------------------CKRLEIPR-NLNPQV 268

Query: 479 VDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPVTK 513
             ++  C  + P  RP  + ++  L+ L +  V  
Sbjct: 269 AAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP 303

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  172 bits (439), Expect = 2e-50
 Identities = 73/282 (25%), Positives = 125/282 (44%), Gaps = 45/282 (15%)

Query: 239 GGTYSGILPDGSRVAVKRLKRSSFQ----RKKEFYSEIGRFARLHHPNLVAVKGCCYDHG 294
           G  Y      G  VAVK  +    +      +    E   FA L HPN++A++G C    
Sbjct: 21  GKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEP 79

Query: 295 DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDI 354
           +  +V EF   GPL+R L      G+ +   + +  A  +A+G+ +LHD+    ++HRD+
Sbjct: 80  NLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDL 134

Query: 355 RASNVLLDEEFGAHLMGV--------GLSKFVPWEVMQERTVMAG-GTYGYLAPEFVYRN 405
           ++SN+L+ ++     +          GL++          T M+  G Y ++APE V R 
Sbjct: 135 KSSNILILQKVENGDLSNKILKITDFGLAR-----EWHRTTKMSAAGAYAWMAPE-VIRA 188

Query: 406 EL-TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS 464
            + +  SDV+S+GVLL E+++G  P + +D          A  +  +   L         
Sbjct: 189 SMFSKGSDVWSYGVLLWELLTGEVPFRGIDG------LAVAYGVAMNKLALP-------- 234

Query: 465 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 506
           + S  PE         L+  C    P  RP  ++++ QL  +
Sbjct: 235 IPSTCPEP-----FAKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  170 bits (433), Expect = 1e-49
 Identities = 62/290 (21%), Positives = 114/290 (39%), Gaps = 51/290 (17%)

Query: 233 LGDSKTGGTYSGILPDGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCC 290
           L ++ +G  + G    G+ + VK LK   +  ++ ++F  E  R     HPN++ V G C
Sbjct: 18  LNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76

Query: 291 YD--HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH 348
                    ++  ++  G L   LH        +D +  +K A  +A+G+AFLH   +P 
Sbjct: 77  QSPPAPHPTLITHWMPYGSLYNVLHE--GTNFVVDQSQAVKFALDMARGMAFLHTL-EPL 133

Query: 349 VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNE-- 406
           +    + + +V++DE+  A +    +         Q    M      ++APE   + +  
Sbjct: 134 IPRHALNSRSVMIDEDMTARISMADVKFS-----FQSPGRM--YAPAWVAPE-ALQKKPE 185

Query: 407 --LTTKSDVYSFGVLLLEIVSGRRP------AQAVDSVCWQSIFEWATPLVQSHRYLELL 458
                 +D++SF VLL E+V+   P       +    V  +                   
Sbjct: 186 DTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALE------------------- 226

Query: 459 DPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 508
                 L   IP  G+   V  L+  C    P+ RP+   +V  L+++  
Sbjct: 227 -----GLRPTIPP-GISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  165 bits (419), Expect = 2e-47
 Identities = 65/281 (23%), Positives = 119/281 (42%), Gaps = 45/281 (16%)

Query: 242 YSGI-LPDGSRVAVKRLKRSSFQ-------RKKEFYSEIGRFARLHHPNLVAVKGCCYDH 293
           + G  + D S VA+K L     +       + +EF  E+   + L+HPN+V + G  ++ 
Sbjct: 36  HKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN- 94

Query: 294 GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRD 353
               +V EFV  G L   L         + W++++++   +A GI ++ ++  P +VHRD
Sbjct: 95  -PPRMVMEFVPCGDLYHRLL---DKAHPIKWSVKLRLMLDIALGIEYMQNQ-NPPIVHRD 149

Query: 354 IRASNVLLDEEFGAHLMGV-----GLSKFVPWEVMQERTVMAG-GTYGYLAPE-FVYRNE 406
           +R+ N+ L        +       GLS+          +V    G + ++APE      E
Sbjct: 150 LRSPNIFLQSLDENAPVCAKVADFGLSQ------QSVHSVSGLLGNFQWMAPETIGAEEE 203

Query: 407 L-TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL 465
             T K+D YSF ++L  I++G  P         +  F     + +              +
Sbjct: 204 SYTEKADTYSFAMILYTILTGEGPFDEYSYG--KIKFINM--IREEGLRPT--------I 251

Query: 466 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 506
             D P      ++ +++  C    P  RP  S++V +L +L
Sbjct: 252 PEDCPP-----RLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  165 bits (419), Expect = 3e-47
 Identities = 64/276 (23%), Positives = 114/276 (41%), Gaps = 46/276 (16%)

Query: 242 YSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE 301
                     VA+K+++  S   +K F  E+ + +R++HPN+V + G C +     +V E
Sbjct: 25  CKAKW-RAKDVAIKQIESESE--RKAFIVELRQLSRVNHPNIVKLYGACLNP--VCLVME 79

Query: 302 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL 361
           +   G L   LH           A  M      +QG+A+LH      ++HRD++  N+LL
Sbjct: 80  YAEGGSLYNVLHG-AEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLL 138

Query: 362 DEE--------FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL-TTKSD 412
                      FG        +       +Q       G+  ++APE V+     + K D
Sbjct: 139 VAGGTVLKICDFG-------TACD-----IQTHMTNNKGSAAWMAPE-VFEGSNYSEKCD 185

Query: 413 VYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEA 472
           V+S+G++L E+++ R+P   +    ++    WA   V +             L  ++P+ 
Sbjct: 186 VFSWGIILWEVITRRKPFDEIGGPAFR--IMWA---VHNGTRPP--------LIKNLPKP 232

Query: 473 GVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 508
                +  L+  C    PS RP M  +V  +  L +
Sbjct: 233 -----IESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  158 bits (402), Expect = 7e-45
 Identities = 62/282 (21%), Positives = 120/282 (42%), Gaps = 49/282 (17%)

Query: 240 GTYSGILPDGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRY 297
           G + G       VAVK L  ++   Q+ + F +E+G   +  H N++   G         
Sbjct: 43  GKWHG------DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAP-QLA 95

Query: 298 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 357
           IV ++     L   LH         +    + +A   A+G+ +LH K    ++HRD++++
Sbjct: 96  IVTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSN 149

Query: 358 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL----TTKSDV 413
           N+ L E+    +   GL+          +     G+  ++APE V R +     + +SDV
Sbjct: 150 NIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE-VIRMQDSNPYSFQSDV 208

Query: 414 YSFGVLLLEIVSGRRP-------AQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 466
           Y+FG++L E+++G+ P        Q ++ V                     L P +S + 
Sbjct: 209 YAFGIVLYELMTGQLPYSNINNRDQIIEMVGRG-----------------SLSPDLSKVR 251

Query: 467 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 508
           S+ P+      +  L+  C +     RP    ++ ++++LA+
Sbjct: 252 SNCPKR-----MKRLMAECLKKKRDERPSFPRILAEIEELAR 288

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  153 bits (388), Expect = 1e-42
 Identities = 51/292 (17%), Positives = 105/292 (35%), Gaps = 64/292 (21%)

Query: 240 GTYSGILPDGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRY 297
           G + G       VA++ +        + K F  E+  + +  H N+V   G C       
Sbjct: 52  GRWHG------EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLA 105

Query: 298 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 357
           I+        L   +         LD     ++A  + +G+ +LH K    ++H+D+++ 
Sbjct: 106 IITSLCKGRTLYSVVR---DAKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSK 159

Query: 358 NVLLDEE------FGAHLMGVGLSKFV-PWEVMQERTVMAG--GTYGYLAPEFVYRNEL- 407
           NV  D        F       GL       +  +    +    G   +LAPE + R    
Sbjct: 160 NVFYDNGKVVITDF-------GLFSISGVLQAGRREDKLRIQNGWLCHLAPE-IIRQLSP 211

Query: 408 ---------TTKSDVYSFGVLLLEIVSGRRP--AQAVDSVCWQSIFEWATPLVQSHRYLE 456
                    +  SDV++ G +  E+ +   P   Q  +++ WQ        +    +   
Sbjct: 212 DTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQ--------MGTGMK--- 260

Query: 457 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 508
                      ++ + G+ +++ D++  C       RP  + ++  L++L +
Sbjct: 261 ----------PNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPK 302

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  151 bits (384), Expect = 4e-42
 Identities = 58/283 (20%), Positives = 103/283 (36%), Gaps = 39/283 (13%)

Query: 240 GTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIV 299
            T+      G  + +K L R   + ++ F  E+     L HPN++   G  Y       +
Sbjct: 29  VTHRE---TGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFI 85

Query: 300 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNV 359
            E++  G L   +           W+ R+  A  +A G+A+LH     +++HRD+ + N 
Sbjct: 86  TEYIKGGTLRGIIK---SMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNC 139

Query: 360 LLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG------------GTYGYLAPEFVYRNEL 407
           L+ E     +   GL++ +  E  Q   + +             G   ++APE +     
Sbjct: 140 LVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSY 199

Query: 408 TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS 467
             K DV+SFG++L EI+                 F      +    +L+   P       
Sbjct: 200 DEKVDVFSFGIVLCEIIGRVNADPDYLPR--TMDF-----GLNVRGFLDRYCP------P 246

Query: 468 DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 510
           + P +        +   C    P  RP    + H L+ L    
Sbjct: 247 NCPPS-----FFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  145 bits (368), Expect = 1e-39
 Identities = 71/330 (21%), Positives = 117/330 (35%), Gaps = 49/330 (14%)

Query: 214 FTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLK---RSSFQRKKEFYS 270
               E      N      + G  + G  Y G L D   VAVK      R +F  +K  Y 
Sbjct: 3   AAASEPSLDLDNLKLLELI-GRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKNIY- 59

Query: 271 EIGRFARLHHPNLVAVKGCCY-----DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWA 325
              R   + H N+                +  +V E+  NG L ++L        + DW 
Sbjct: 60  ---RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-----HTSDWV 111

Query: 326 MRMKVATTLAQGIAFLH------DKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP 379
              ++A ++ +G+A+LH      D  KP + HRD+ + NVL+  +    +   GLS  + 
Sbjct: 112 SSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLT 171

Query: 380 WEVMQERTVMAG------GTYGYLAPE-------FVYRNELTTKSDVYSFGVLLLEIVSG 426
              +              GT  Y+APE                + D+Y+ G++  EI   
Sbjct: 172 GNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231

Query: 427 RRPAQAVDSVC-WQSIFEWATPLVQSHRYLELLDPLISS--LSSDIPEA-----GVVQKV 478
                  +SV  +Q  F+     V +H   E +  L+S        PEA       V+ +
Sbjct: 232 CTDLFPGESVPEYQMAFQT---EVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSL 288

Query: 479 VDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 508
            + +  C       R        ++ +L  
Sbjct: 289 KETIEDCWDQDAEARLTAQXAEERMAELMM 318

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  142 bits (361), Expect = 1e-38
 Identities = 57/289 (19%), Positives = 115/289 (39%), Gaps = 33/289 (11%)

Query: 242 YSGILPDGSRVAVKRLK---RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR-- 296
           + G    G +VAVK       +S+ R+ E Y        + H N++              
Sbjct: 54  WMGKW-RGEKVAVKVFFTTEEASWFRETEIYQ----TVLMRHENILGFIAADIKGTGSWT 108

Query: 297 --YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV-----KPHV 349
             Y++ ++  NG L  +L        +LD    +K+A +   G+  LH ++     KP +
Sbjct: 109 QLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAI 163

Query: 350 VHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPE------F 401
            HRD+++ N+L+ +     +  +GL+     +  +         GT  Y+ PE       
Sbjct: 164 AHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLN 223

Query: 402 VYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS--VCWQSIFEWATPLVQSHRYLELLD 459
               +    +D+YSFG++L E+         V+   + +  +   + P  +  R +  + 
Sbjct: 224 RNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV-PSDPSYEDMREIVCIK 282

Query: 460 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 508
            L  S  +       ++++  L+  C  H P+ R     V   L ++++
Sbjct: 283 KLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  142 bits (359), Expect = 3e-38
 Identities = 57/296 (19%), Positives = 108/296 (36%), Gaps = 47/296 (15%)

Query: 242 YSGILPDGSRVAVKRLK---RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR-- 296
           + G    G  VAVK        S+ R+ E Y        L H N++              
Sbjct: 59  WRGKW-RGEEVAVKIFSSREERSWFREAEIYQT----VMLRHENILGFIAADNKDNGTWT 113

Query: 297 --YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV-----KPHV 349
             ++V ++  +G L  +L+       ++     +K+A + A G+A LH ++     KP +
Sbjct: 114 QLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAI 168

Query: 350 VHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNEL 407
            HRD+++ N+L+ +     +  +GL+                  GT  Y+APE V  + +
Sbjct: 169 AHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE-VLDDSI 227

Query: 408 -------TTKSDVYSFGVLLLEIVSGRRPAQAVDS--------VCWQSIFEWATPLVQSH 452
                    ++D+Y+ G++  EI          +         V      E    +V   
Sbjct: 228 NMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQ 287

Query: 453 RYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 508
           +    L P I +          ++ +  ++  C     + R     +   L QL+Q
Sbjct: 288 K----LRPNIPNRWQSCE---ALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 336

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  139 bits (351), Expect = 2e-37
 Identities = 63/318 (19%), Positives = 118/318 (37%), Gaps = 52/318 (16%)

Query: 220 RSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLK---RSSFQRKKEFYSEIGRFA 276
           R++ ++ +    + G  + G  + G    G  VAVK        S+ R+ E Y+      
Sbjct: 4   RTVARDITLLECV-GKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNT----V 57

Query: 277 RLHHPNLV----AVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVAT 332
            L H N++    +     +     +++  +   G L  +L        +LD    +++  
Sbjct: 58  MLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL-----TTLDTVSCLRIVL 112

Query: 333 TLAQGIAFLH-----DKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 387
           ++A G+A LH      + KP + HRD+++ N+L+ +     +  +GL+        Q   
Sbjct: 113 SIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDV 172

Query: 388 VMAG--GTYGYLAPEFVYRNEL-------TTKSDVYSFGVLLLEIVSGRRPAQAV----- 433
                 GT  Y+APE V    +         + D+++FG++L E+         V     
Sbjct: 173 GNNPRVGTKRYMAPE-VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP 231

Query: 434 ---DSVCWQSIFEWATPLV--QSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQH 488
              D V     FE    +V     R      P I    +       +  +  L+  C   
Sbjct: 232 PFYDVVPNDPSFEDMRKVVCVDQQR------PNI---PNRWFSDPTLTSLAKLMKECWYQ 282

Query: 489 VPSMRPRMSHVVHQLQQL 506
            PS R     +   L ++
Sbjct: 283 NPSARLTALRIKKTLTKI 300

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  128 bits (323), Expect = 6e-33
 Identities = 73/294 (24%), Positives = 110/294 (37%), Gaps = 51/294 (17%)

Query: 231 RLLGDSKTGGTYSGIL-PDGSRVAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAVKG 288
             +G    G  +SG L  D + VAVK  +       K +F  E     +  HPN+V + G
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179

Query: 289 CCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH 348
            C      YIV E V  G    +L      G  L     +++    A G+ +L  K    
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLR---TEGARLRVKTLLQMVGDAAAGMEYLESK---C 233

Query: 349 VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL-----APEFVY 403
            +HRD+ A N L+ E+    +   G+S+        +    A G    +     APE + 
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSR-----EEADGVYAASGGLRQVPVKWTAPEALN 288

Query: 404 RNELTTKSDVYSFGVLLLEIVS-GRRP------AQAVDSVCWQSIFEWATPLVQSHRYLE 456
               +++SDV+SFG+LL E  S G  P       Q  + V             +  R   
Sbjct: 289 YGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE------------KGGR--- 333

Query: 457 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 510
            L           PE      V  L+  C  + P  RP  S +  +LQ + +  
Sbjct: 334 -LPC---------PE-LCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH 376

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  124 bits (314), Expect = 4e-32
 Identities = 76/286 (26%), Positives = 118/286 (41%), Gaps = 43/286 (15%)

Query: 240 GTYSGILPDGS--RVAVKRLK-RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR 296
           G  SG+  D S  +VAVK L    S Q + +F  E    ++ +H N+V   G       R
Sbjct: 49  GQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108

Query: 297 YIVYEFVVNGPLDRWL-HHIPRGGRSLDWAMR--MKVATTLAQGIAFLHDKVKPHVVHRD 353
           +I+ E +  G L  +L    PR  +    AM   + VA  +A G  +L +    H +HRD
Sbjct: 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRD 165

Query: 354 IRASNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGTYGYL-----APEFVYRN 405
           I A N LL       +  +   G+++ +        +    G    L      PE     
Sbjct: 166 IAARNCLLTCPGPGRVAKIGDFGMARDI-----YRASYYRKGGCAMLPVKWMPPEAFMEG 220

Query: 406 ELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS 464
             T+K+D +SFGVLL EI S G  P  +      Q + E+   +    R    +DP    
Sbjct: 221 IFTSKTDTWSFGVLLWEIFSLGYMPYPSKS---NQEVLEF---VTSGGR----MDP---- 266

Query: 465 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 510
                P+      V  ++  C QH P  RP  + ++ +++   Q P
Sbjct: 267 -----PK-NCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  124 bits (313), Expect = 1e-31
 Identities = 76/286 (26%), Positives = 117/286 (40%), Gaps = 43/286 (15%)

Query: 240 GTYSGILPDGS--RVAVKRLK-RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR 296
           G  SG+  D S  +VAVK L    S Q + +F  E    ++ +H N+V   G       R
Sbjct: 90  GQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149

Query: 297 YIVYEFVVNGPLDRWL-HHIPRGGRSLDWAMR--MKVATTLAQGIAFLHDKVKPHVVHRD 353
           +I+ E +  G L  +L    PR  +    AM   + VA  +A G  +L +    H +HRD
Sbjct: 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRD 206

Query: 354 IRASNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGTYGYL-----APEFVYRN 405
           I A N LL       +  +   G+++ +             G    L      PE     
Sbjct: 207 IAARNCLLTCPGPGRVAKIGDFGMARDI-----YRAGYYRKGGCAMLPVKWMPPEAFMEG 261

Query: 406 ELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS 464
             T+K+D +SFGVLL EI S G  P  +      Q + E+   +    R    +DP    
Sbjct: 262 IFTSKTDTWSFGVLLWEIFSLGYMPYPSKS---NQEVLEF---VTSGGR----MDP---- 307

Query: 465 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 510
                P+      V  ++  C QH P  RP  + ++ +++   Q P
Sbjct: 308 -----PK-NCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  126 bits (319), Expect = 1e-31
 Identities = 75/280 (26%), Positives = 122/280 (43%), Gaps = 29/280 (10%)

Query: 231 RLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGC 289
             LG  + G  Y G+       VAVK LK  + + + EF  E      + HPNLV + G 
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 284

Query: 290 CYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHV 349
           C      YI+ EF+  G L  +L       + +   + + +AT ++  + +L  K   + 
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKK---NF 339

Query: 350 VHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTT 409
           +HR++ A N L+ E     +   GLS+ +  +        A     + APE +  N+ + 
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA-GAKFPIKWTAPESLAYNKFSI 398

Query: 410 KSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD 468
           KSDV++FGVLL EI + G  P   +D                     ++ + L      +
Sbjct: 399 KSDVWAFGVLLWEIATYGMSPYPGIDLS-------------------QVYELLEKDYRME 439

Query: 469 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 508
            PE G  +KV +L+ AC Q  PS RP  + +    + + Q
Sbjct: 440 RPE-GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  121 bits (306), Expect = 3e-31
 Identities = 68/296 (22%), Positives = 114/296 (38%), Gaps = 58/296 (19%)

Query: 240 GTYSGILPDGS--RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRY 297
                + P      VAVK LK  +   +K+F  E      L H ++V   G C D     
Sbjct: 34  AECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 93

Query: 298 IVYEFVVNGPLDRWL------------HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 345
           +V+E++ +G L+++L                +    L  +  + +A+ +A G+ +L  + 
Sbjct: 94  MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ- 152

Query: 346 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY-----GYL--- 397
             H VHRD+   N L+       +   G+S          R V +   Y       L   
Sbjct: 153 --HFVHRDLATRNCLVGANLLVKIGDFGMS----------RDVYSTDYYRVGGHTMLPIR 200

Query: 398 --APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRY 454
              PE +   + TT+SDV+SFGV+L EI + G++P   +       + E     +   R 
Sbjct: 201 WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS---NTEVIE----CITQGRV 253

Query: 455 LELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 510
           LE             P     ++V D++  C Q  P  R  +  +   L  L +  
Sbjct: 254 LE------------RPR-VCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALGKAT 296

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  120 bits (304), Expect = 5e-31
 Identities = 63/290 (21%), Positives = 124/290 (42%), Gaps = 44/290 (15%)

Query: 240 GTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR-- 296
             Y  +  + G  VAVK+L+ S+ +  ++F  EI     L H N+V  KG CY  G R  
Sbjct: 29  CRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88

Query: 297 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRA 356
            ++ E++  G L  +L    +    +D    ++  + + +G+ +L  K     +HRD+  
Sbjct: 89  KLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLAT 142

Query: 357 SNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGT------YGYLAPEFVYRNEL 407
            N+L++ E   + + +   GL+K +P +  +E   +          Y   APE +  ++ 
Sbjct: 143 RNILVENE---NRVKIGDFGLTKVLPQD--KEFFKVKEPGESPIFWY---APESLTESKF 194

Query: 408 TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD-------P 460
           +  SDV+SFGV+L E+ +    +++  +   + I       +     +ELL        P
Sbjct: 195 SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRP 254

Query: 461 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 510
                    P+      +  ++  C  +  + RP    +  ++ Q+    
Sbjct: 255 ------DGCPDE-----IYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  120 bits (304), Expect = 9e-31
 Identities = 72/295 (24%), Positives = 116/295 (39%), Gaps = 57/295 (19%)

Query: 240 GTYSGILPDGS--RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRY 297
                +LP+     VAVK LK +S   +++F  E      L H ++V   G C +     
Sbjct: 60  AECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119

Query: 298 IVYEFVVNGPLDRWL-----------HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVK 346
           +V+E++ +G L+R+L                    L     + VA+ +A G+ +L     
Sbjct: 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL-- 177

Query: 347 PHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY-----GYL---- 397
            H VHRD+   N L+ +     +   G+S          R + +   Y       L    
Sbjct: 178 -HFVHRDLATRNCLVGQGLVVKIGDFGMS----------RDIYSTDYYRVGGRTMLPIRW 226

Query: 398 -APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYL 455
             PE +   + TT+SDV+SFGV+L EI + G++P   +         +     +   R L
Sbjct: 227 MPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS---NTEAID----CITQGREL 279

Query: 456 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 510
           E             P      +V  ++  C Q  P  R  +  V  +LQ LAQ P
Sbjct: 280 E------------RPR-ACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP 321

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  119 bits (300), Expect = 1e-30
 Identities = 63/298 (21%), Positives = 104/298 (34%), Gaps = 68/298 (22%)

Query: 240 GTYSGILPDGS----RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD 295
           G    +   G      V +K L ++     + F+      ++L H +LV   G C    +
Sbjct: 27  GVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86

Query: 296 RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIR 355
             +V EFV  G LD +L    +    ++   +++VA  LA  + FL +     ++H ++ 
Sbjct: 87  NILVQEFVKFGSLDTYLK---KNKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVC 140

Query: 356 ASNVLLDEEFGAHLMGV--------GLSKF----------VPWEVMQERTVMAGGTYGYL 397
           A N+LL  E                G+S            +PW                +
Sbjct: 141 AKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPW----------------V 184

Query: 398 APE-FVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYL 455
            PE       L   +D +SFG  L EI S G +P  A+DS   Q   +      +    L
Sbjct: 185 PPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS---QRKLQ----FYEDRHQL 237

Query: 456 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPVTK 513
                          E      + +L+  C  + P  RP    ++  L  L  P +  
Sbjct: 238 PAPKA---------AE------LANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVP 280

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  119 bits (301), Expect = 2e-30
 Identities = 72/291 (24%), Positives = 125/291 (42%), Gaps = 47/291 (16%)

Query: 240 GTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR-- 296
             Y  +  + G+ VAVK+L+ S   ++++F  EI     LH   +V  +G  Y  G +  
Sbjct: 42  CRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101

Query: 297 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRA 356
            +V E++ +G L  +L    R    LD +  +  ++ + +G+ +L  +     VHRD+ A
Sbjct: 102 RLVMEYLPSGCLRDFL---QRHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAA 155

Query: 357 SNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGT------YGYLAPEFVYRNEL 407
            N+L++ E     + +   GL+K +P +  ++  V+          Y   APE +  N  
Sbjct: 156 RNILVESE---AHVKIADFGLAKLLPLD--KDYYVVREPGQSPIFWY---APESLSDNIF 207

Query: 408 TTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD------- 459
           + +SDV+SFGV+L E+ +   +      S  +  +      +    R LELL+       
Sbjct: 208 SRQSDVWSFGVVLYELFTYCDKSCS--PSAEFLRMMGCERDVPALSRLLELLEEGQRLPA 265

Query: 460 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 510
           P         P       V +L+  C    P  RP  S +  QL  L    
Sbjct: 266 P------PACPAE-----VHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  119 bits (301), Expect = 2e-30
 Identities = 63/286 (22%), Positives = 124/286 (43%), Gaps = 44/286 (15%)

Query: 240 GTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR-- 296
             Y  +  + G  VAVK+L+ S+ +  ++F  EI     L H N+V  KG CY  G R  
Sbjct: 60  CRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119

Query: 297 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRA 356
            ++ E++  G L  +L    +    +D    ++  + + +G+ +L  K     +HRD+  
Sbjct: 120 KLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLAT 173

Query: 357 SNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGT------YGYLAPEFVYRNEL 407
            N+L++ E   + + +   GL+K +P +  +E   +          Y   APE +  ++ 
Sbjct: 174 RNILVENE---NRVKIGDFGLTKVLPQD--KEYYKVKEPGESPIFWY---APESLTESKF 225

Query: 408 TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD-------P 460
           +  SDV+SFGV+L E+ +    +++  +   + I       +     +ELL        P
Sbjct: 226 SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRP 285

Query: 461 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 506
                    P+      +  ++  C  +  + RP    +  ++ Q+
Sbjct: 286 ------DGCPDE-----IYMIMTECWNNNVNQRPSFRDLALRVDQI 320

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  118 bits (298), Expect = 3e-30
 Identities = 54/258 (20%), Positives = 106/258 (41%), Gaps = 47/258 (18%)

Query: 251 RVAVKRLKRSSFQRKKEFYSEIGRF-------ARLHHPNLVAVKGCCYDHGD----RYIV 299
           +VA+K +     + K+E    + RF       ++L H N+V++     D  +     Y+V
Sbjct: 38  KVAIKAI-FIPPREKEET---LKRFEREVHNSSQLSHQNIVSM----IDVDEEDDCYYLV 89

Query: 300 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNV 359
            E++    L  ++      G  L     +     +  GI   HD     +VHRDI+  N+
Sbjct: 90  MEYIEGPTLSEYIE---SHGP-LSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNI 142

Query: 360 LLDEEFGAHLMGVGLSKFVPWEVM-QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGV 418
           L+D      +   G++K +    + Q   V+  GT  Y +PE          +D+YS G+
Sbjct: 143 LIDSNKTLKIFDFGIAKALSETSLTQTNHVL--GTVQYFSPEQAKGEATDECTDIYSIGI 200

Query: 419 LLLEIVSGRRPAQAVDSVCWQSIFEWATPL-VQSHRYLELLDPLISSLSSDIPEAGVVQK 477
           +L E++ G  P            F   T + +      + +  + + +  DIP++     
Sbjct: 201 VLYEMLVGEPP------------FNGETAVSIAIKHIQDSVPNVTTDVRKDIPQS----- 243

Query: 478 VVDLVYACTQHVPSMRPR 495
           + +++   T+   + R +
Sbjct: 244 LSNVILRATEKDKANRYK 261

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  119 bits (300), Expect = 3e-30
 Identities = 62/291 (21%), Positives = 115/291 (39%), Gaps = 53/291 (18%)

Query: 240 GTYSGILPDGS--RVAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR 296
           G   G++ D    RVA+K +   +S + + EF +E       +  ++V + G        
Sbjct: 44  GVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 103

Query: 297 YIVYEFVVNGPLDRWL------HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 350
            ++ E +  G L  +L                  +  +++A  +A G+A+L+       V
Sbjct: 104 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFV 160

Query: 351 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY-----GYL-----APE 400
           HRD+ A N ++ E+F   +   G++          R +     Y     G L     +PE
Sbjct: 161 HRDLAARNCMVAEDFTVKIGDFGMT----------RDIYETDYYRKGGKGLLPVRWMSPE 210

Query: 401 FVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD 459
            +     TT SDV+SFGV+L EI +   +P Q +     + +       V     L+   
Sbjct: 211 SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS---NEQVLR----FVMEGGLLD--- 260

Query: 460 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 510
                     P+      + +L+  C Q+ P MRP    ++  +++  +P 
Sbjct: 261 ---------KPD-NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 301

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  118 bits (298), Expect = 1e-29
 Identities = 42/357 (11%), Positives = 85/357 (23%), Gaps = 65/357 (18%)

Query: 183 LLAYRRSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTY 242
           L+ Y R +  ++   +     + + P + +      L    +        L        +
Sbjct: 21  LIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLV-EPLRVGDRSVVF 79

Query: 243 SGI-LPDGSRVAVKRLKRSSFQRKKE---FYSEIGRFARLHHPNLVAVKGCC-------- 290
               +      A+K     +   + E    +      ARL   +    +           
Sbjct: 80  LVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDA 139

Query: 291 ------------------YDHGDRYIVYEFVV--NGPLDRWLHHIPRGGRSLDWAMRMKV 330
                             Y   +  ++          L   L  +              +
Sbjct: 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHIL 199

Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 390
              L +  A L  K    +VH      N+ +  +    L  V     V       R   +
Sbjct: 200 TAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG-----TRGPAS 251

Query: 391 GGTYGYLAPEFVYRNEL--TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPL 448
                Y   EF+  +    T   + +  G+ +  +     P            F   TP 
Sbjct: 252 SVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP------------FGLVTPG 299

Query: 449 VQSHRYLELL-----DPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVV 500
           ++       L     D L     + +P+      V  L+          R      +
Sbjct: 300 IKGSWKRPSLRVPGTDSLAFGSCTPLPDF-----VKTLIGRFLNFDRRRRLLPLEAM 351

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  117 bits (294), Expect = 1e-29
 Identities = 67/288 (23%), Positives = 120/288 (41%), Gaps = 44/288 (15%)

Query: 240 GTYSGILPD-GSRVAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR- 296
             Y     + G +VAVK LK  S      +   EI     L+H N+V  KG C + G   
Sbjct: 40  CRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99

Query: 297 -YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIR 355
             ++ EF+ +G L  +L   P+    ++   ++K A  + +G+ +L  +     VHRD+ 
Sbjct: 100 IKLIMEFLPSGSLKEYL---PKNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLA 153

Query: 356 ASNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGT------YGYLAPEFVYRNE 406
           A NVL++ E   H + +   GL+K +  +  +E   +          Y   APE + +++
Sbjct: 154 ARNVLVESE---HQVKIGDFGLTKAIETD--KEYYTVKDDRDSPVFWY---APECLMQSK 205

Query: 407 LTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFE-WATPLVQSHRYLE----LLDP 460
               SDV+SFGV L E+++     +  +               + +    L+    L  P
Sbjct: 206 FYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCP 265

Query: 461 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 508
                  + P+      V  L+  C +  PS R    +++   + L +
Sbjct: 266 ------PNCPDE-----VYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  116 bits (292), Expect = 1e-29
 Identities = 66/288 (22%), Positives = 121/288 (42%), Gaps = 41/288 (14%)

Query: 231 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 290
           + +G  + G  + G   +  +VA+K ++  +   +++F  E     +L HP LV + G C
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVC 72

Query: 291 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 350
            +     +V EF+ +G L  +L               + +   + +G+A+L +     V+
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEEA---CVI 126

Query: 351 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG------TYGYLAPEFVYR 404
           HRD+ A N L+ E     +   G+++FV  +   + T   G            +PE    
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDD---QYTSSTGTKFPVKWA----SPEVFSF 179

Query: 405 NELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS 463
           +  ++KSDV+SFGVL+ E+ S G+ P +        S  E    +    R    L     
Sbjct: 180 SRYSSKSDVWSFGVLMWEVFSEGKIPYENR------SNSEVVEDISTGFR----LYK--- 226

Query: 464 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPV 511
                 P       V  ++  C +  P  RP  S ++ QL ++A+  +
Sbjct: 227 ------PR-LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESGL 267

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  117 bits (294), Expect = 2e-29
 Identities = 63/292 (21%), Positives = 113/292 (38%), Gaps = 54/292 (18%)

Query: 240 GTYSGILPDGSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR- 296
                      +VAVK LK    +    +EF  E        HP++  + G       + 
Sbjct: 42  AQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101

Query: 297 -----YIVYEFVVNGPLDRWL--HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHV 349
                 ++  F+ +G L  +L    I     +L     ++    +A G+ +L  +   + 
Sbjct: 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NF 158

Query: 350 VHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY-----GYL-----AP 399
           +HRD+ A N +L E+    +   GLS          R + +G  Y       L     A 
Sbjct: 159 IHRDLAARNCMLAEDMTVCVADFGLS----------RKIYSGDYYRQGCASKLPVKWLAL 208

Query: 400 EFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELL 458
           E +  N  T  SDV++FGV + EI++ G+ P   +++     I+ +   L+  +R    L
Sbjct: 209 ESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN---AEIYNY---LIGGNR----L 258

Query: 459 DPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 510
                      P    +++V DL+Y C    P  RP  + +  +L+ +    
Sbjct: 259 KQ---------PP-ECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  118 bits (299), Expect = 3e-29
 Identities = 72/284 (25%), Positives = 120/284 (42%), Gaps = 39/284 (13%)

Query: 231 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 290
           + +G  + G    G    G++VAVK +K  +    + F +E     +L H NLV + G  
Sbjct: 199 QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 255

Query: 291 YDHGDR-YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHV 349
            +     YIV E++  G L  +L    RG   L     +K +  + + + +L      + 
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEGN---NF 310

Query: 350 VHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGY--LAPEFVYRNEL 407
           VHRD+ A NVL+ E+  A +   GL+K       +  +    G       APE +   + 
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKF 363

Query: 408 TTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 466
           +TKSDV+SFG+LL EI S GR P   +     + +      + + ++   +  P      
Sbjct: 364 STKSDVWSFGILLWEIYSFGRVPYPRIP---LKDVVPR---VEKGYK---MDAP------ 408

Query: 467 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 510
              P A     V D++  C     + RP    +  QL+ +    
Sbjct: 409 DGCPPA-----VYDVMKNCWHLDAATRPTFLQLREQLEHIRTHE 447

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  116 bits (292), Expect = 3e-29
 Identities = 67/290 (23%), Positives = 124/290 (42%), Gaps = 53/290 (18%)

Query: 240 GTYSGILPDGSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR- 296
           G          +VAVK +K   SS +  +EF SE        HPN++ + G C +   + 
Sbjct: 53  GNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG 112

Query: 297 ----YIVYEFVVNGPLDRWL--HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 350
                ++  F+  G L  +L    +  G + +     +K    +A G+ +L ++   + +
Sbjct: 113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFL 169

Query: 351 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY-----GYL-----APE 400
           HRD+ A N +L ++    +   GLS          + + +G  Y       +     A E
Sbjct: 170 HRDLAARNCMLRDDMTVCVADFGLS----------KKIYSGDYYRQGRIAKMPVKWIAIE 219

Query: 401 FVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD 459
            +     T+KSDV++FGV + EI + G  P   V +     ++++   L+  HR    L 
Sbjct: 220 SLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN---HEMYDY---LLHGHR----LK 269

Query: 460 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 509
                     PE   + ++ +++Y+C +  P  RP  S +  QL++L + 
Sbjct: 270 Q---------PE-DCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  115 bits (290), Expect = 4e-29
 Identities = 82/288 (28%), Positives = 129/288 (44%), Gaps = 41/288 (14%)

Query: 231 RLLGDSKTGGTYSGILPDGS-RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGC 289
             LG  + G  Y G+    S  VAVK LK  + + + EF  E      + HPNLV + G 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 77

Query: 290 CYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHV 349
           C      YI+ EF+  G L  +L       + +   + + +AT ++  + +L  K   + 
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKK---NF 132

Query: 350 VHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG------TYGYLAPEFVY 403
           +HRD+ A N L+ E     +   GLS+ +  +     T  AG       T    APE + 
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAHAGAKFPIKWT----APESLA 185

Query: 404 RNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI 462
            N+ + KSDV++FGVLL EI + G  P   +D      ++E    L + +R    ++   
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYEL---LEKDYR----MER-- 233

Query: 463 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 510
                  PE G  +KV +L+ AC Q  PS RP  + +    + + Q  
Sbjct: 234 -------PE-GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  117 bits (296), Expect = 8e-29
 Identities = 69/281 (24%), Positives = 117/281 (41%), Gaps = 29/281 (10%)

Query: 231 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 290
             LG    G  + G     +RVA+K LK  +    + F  E     +L H  LV +    
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVV 248

Query: 291 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 350
            +    YIV E++  G L  +L      G+ L     + +A  +A G+A++      + V
Sbjct: 249 SEEP-IYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERM---NYV 302

Query: 351 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 410
           HRD+RA+N+L+ E     +   GL++ +       R         + APE       T K
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIK 361

Query: 411 SDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDI 469
           SDV+SFG+LL E+ + GR P   +     + + +    + + +R   +  P       + 
Sbjct: 362 SDVWSFGILLTELTTKGRVPYPGMV---NREVLDQ---VERGYR---MPCP------PEC 406

Query: 470 PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 510
           PE+     + DL+  C +  P  RP   ++   L+      
Sbjct: 407 PES-----LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  117 bits (295), Expect = 1e-28
 Identities = 67/250 (26%), Positives = 110/250 (44%), Gaps = 17/250 (6%)

Query: 183 LLAYRRSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTY 242
           L+ + +       +KLS P  S+     W+    E    I +   +  + LG  + G  +
Sbjct: 150 LVDHYKKGNDGLCQKLSVPCMSSKPQKPWEKDAWE----IPRESLKLEKKLGAGQFGEVW 205

Query: 243 SGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 302
                  ++VAVK +K  S   +  F +E      L H  LV +          YI+ EF
Sbjct: 206 MATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHAVVTKEP-IYIITEF 263

Query: 303 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 362
           +  G L  +L      G        +  +  +A+G+AF+  +   + +HRD+RA+N+L+ 
Sbjct: 264 MAKGSLLDFLKS--DEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVS 318

Query: 363 EEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGY--LAPEFVYRNELTTKSDVYSFGVLL 420
                 +   GL++ +      E T   G  +     APE +     T KSDV+SFG+LL
Sbjct: 319 ASLVCKIADFGLARVIEDN---EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILL 375

Query: 421 LEIVS-GRRP 429
           +EIV+ GR P
Sbjct: 376 MEIVTYGRIP 385

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  113 bits (285), Expect = 1e-28
 Identities = 70/285 (24%), Positives = 122/285 (42%), Gaps = 41/285 (14%)

Query: 231 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 290
           + LG  + G    G       VAVK +K  S   + EF+ E     +L HP LV   G C
Sbjct: 14  KELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVC 72

Query: 291 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 350
                 YIV E++ NG L  +L      G+ L+ +  +++   + +G+AFL        +
Sbjct: 73  SKEYPIYIVTEYISNGCLLNYLR---SHGKGLEPSQLLEMCYDVCEGMAFLESH---QFI 126

Query: 351 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG------TYGYLAPEFVYR 404
           HRD+ A N L+D +    +   G++++V  +   +     G       +    APE  + 
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDD---QYVSSVGTKFPVKWS----APEVFHY 179

Query: 405 NELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS 463
            + ++KSDV++FG+L+ E+ S G+ P          +  E    + Q HR    L     
Sbjct: 180 FKYSSKSDVWAFGILMWEVFSLGKMPYDLY------TNSEVVLKVSQGHR----LYR--- 226

Query: 464 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 508
                 P       +  ++Y+C   +P  RP    ++  ++ L +
Sbjct: 227 ------PH-LASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  113 bits (286), Expect = 2e-28
 Identities = 63/263 (23%), Positives = 107/263 (40%), Gaps = 52/263 (19%)

Query: 251 RVAVKRLKRSSFQRKKEFYSEIGRF-------ARLHHPNLVAVKGCCYDHGD-------- 295
            VAVK L R+   R   F     RF       A L+HP +VAV    YD G+        
Sbjct: 39  DVAVKVL-RADLARDPSF---YLRFRREAQNAAALNHPAIVAV----YDTGEAETPAGPL 90

Query: 296 RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIR 355
            YIV E+V    L   +H     G  +     ++V     Q + F H      ++HRD++
Sbjct: 91  PYIVMEYVDGVTLRDIVH---TEGP-MTPKRAIEVIADACQALNFSHQN---GIIHRDVK 143

Query: 356 ASNVLLDEEFGAHLMGVGLSKFVPWE---VMQERTVMAGGTYGYLAPEFVYRNELTTKSD 412
            +N+++       +M  G+++ +      V Q   V+  GT  YL+PE    + +  +SD
Sbjct: 144 PANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI--GTAQYLSPEQARGDSVDARSD 201

Query: 413 VYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEA 472
           VYS G +L E+++G  P            F   +P+  +++++       S+    +   
Sbjct: 202 VYSLGCVLYEVLTGEPP------------FTGDSPVSVAYQHVREDPIPPSARHEGLSAD 249

Query: 473 GVVQKVVDLVYACTQHVPSMRPR 495
                +  +V       P  R +
Sbjct: 250 -----LDAVVLKALAKNPENRYQ 267

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  113 bits (284), Expect = 3e-28
 Identities = 70/281 (24%), Positives = 117/281 (41%), Gaps = 43/281 (15%)

Query: 240 GTYSGILPDGSRVAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD-HGDRY 297
           GT           AVK L R +      +F +E        HPN++++ G C    G   
Sbjct: 44  GTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103

Query: 298 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 357
           +V  ++ +G L  ++        +      +     +A+G+ +L  K     VHRD+ A 
Sbjct: 104 VVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAAR 157

Query: 358 NVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGTYGYL-----APEFVYRNELTT 409
           N +LDE+F    + V   GL++ +     +E   +   T   L     A E +   + TT
Sbjct: 158 NCMLDEKF---TVKVADFGLARDM---YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTT 211

Query: 410 KSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD 468
           KSDV+SFGVLL E+++ G  P   V++     I  +   L+Q  R   LL P        
Sbjct: 212 KSDVWSFGVLLWELMTRGAPPYPDVNT---FDITVY---LLQGRR---LLQP------EY 256

Query: 469 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 509
            P+      + +++  C      MRP  S +V ++  +   
Sbjct: 257 CPDP-----LYEVMLKCWHPKAEMRPSFSELVSRISAIFST 292

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  114 bits (288), Expect = 3e-28
 Identities = 83/376 (22%), Positives = 141/376 (37%), Gaps = 53/376 (14%)

Query: 156 HCHREYLITLGVVSGLILLTTFAIVIWLLAYRRSKRRRKSRKLSNPAASAL------VPP 209
           H  R   +  G++          I           ++  S  L    A+ +      + P
Sbjct: 14  HGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNP 73

Query: 210 SWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGS----RVAVKRLKR-SSFQR 264
                    +   +      N ++G    G  Y G L D        AVK L R +    
Sbjct: 74  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 133

Query: 265 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGD-RYIVYEFVVNGPLDRWLHHIPRGGRSLD 323
             +F +E        HPN++++ G C        +V  ++ +G L  ++        +  
Sbjct: 134 VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPT 190

Query: 324 WAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV---GLSKFVPW 380
               +     +A+G+ FL  K     VHRD+ A N +LDE+F    + V   GL++ +  
Sbjct: 191 VKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKF---TVKVADFGLARDM-- 242

Query: 381 EVMQERTVMAGGTYGYL-----APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVD 434
              +E   +   T   L     A E +   + TTKSDV+SFGVLL E+++ G  P   V+
Sbjct: 243 -YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 301

Query: 435 SVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP 494
           +     I  +   L+Q  R   LL P         P+      + +++  C      MRP
Sbjct: 302 T---FDITVY---LLQGRR---LLQP------EYCPDP-----LYEVMLKCWHPKAEMRP 341

Query: 495 RMSHVVHQLQQLAQPP 510
             S +V ++  +    
Sbjct: 342 SFSELVSRISAIFSTF 357

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  112 bits (283), Expect = 3e-28
 Identities = 73/288 (25%), Positives = 123/288 (42%), Gaps = 47/288 (16%)

Query: 231 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 290
           + +G  + G    G    G++VAVK +K  +    + F +E     +L H NLV + G  
Sbjct: 27  QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVI 83

Query: 291 YDHGDR-YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHV 349
            +     YIV E++  G L  +L    RG   L     +K +  + + + +L      + 
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEGN---NF 138

Query: 350 VHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG------TYGYLAPEFVY 403
           VHRD+ A NVL+ E+  A +   GL+K       +  +    G      T    APE + 
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWT----APEALR 187

Query: 404 RNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI 462
             + +TKSDV+SFG+LL EI S GR P   +     + +      + + ++    +D   
Sbjct: 188 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP---LKDVVPR---VEKGYK----MDA-- 235

Query: 463 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 510
                  P+ G    V +++  C     +MRP    +  QL+ +    
Sbjct: 236 -------PD-GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  116 bits (293), Expect = 4e-28
 Identities = 69/277 (24%), Positives = 117/277 (42%), Gaps = 29/277 (10%)

Query: 231 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 290
             LG    G  + G     +RVA+K LK  +    + F  E     +L H  LV +    
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVV 331

Query: 291 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 350
            +    YIV E++  G L  +L      G+ L     + +A  +A G+A++      + V
Sbjct: 332 SEEP-IYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERM---NYV 385

Query: 351 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 410
           HRD+RA+N+L+ E     +   GL++ +       R         + APE       T K
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIK 444

Query: 411 SDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDI 469
           SDV+SFG+LL E+ + GR P   +     + + +    + + +R   +  P       + 
Sbjct: 445 SDVWSFGILLTELTTKGRVPYPGMV---NREVLDQ---VERGYR---MPCP------PEC 489

Query: 470 PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 506
           PE+     + DL+  C +  P  RP   ++   L+  
Sbjct: 490 PES-----LHDLMCQCWRKEPEERPTFEYLQAFLEDY 521

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  113 bits (284), Expect = 4e-28
 Identities = 73/282 (25%), Positives = 114/282 (40%), Gaps = 34/282 (12%)

Query: 240 GTYSGILPD-GSRVAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR- 296
             Y       G  VAVK LK  +  Q +  +  EI     L+H +++  KGCC D G   
Sbjct: 50  YCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109

Query: 297 -YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIR 355
             +V E+V  G L  +L        S+  A  +  A  + +G+A+LH +   H +HRD+ 
Sbjct: 110 LQLVMEYVPLGSLRDYLP-----RHSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLA 161

Query: 356 ASNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGTYGYL-----APEFVYRNEL 407
           A NVLLD +    L+ +   GL+K VP     E   +     G       APE +   + 
Sbjct: 162 ARNVLLDND---RLVKIGDFGLAKAVPEG--HEYYRVRED--GDSPVFWYAPECLKEYKF 214

Query: 408 TTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 466
              SDV+SFGV L E+++                        V       L + L     
Sbjct: 215 YYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVL-----RLTELLERGER 269

Query: 467 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 508
              P+     +V  L+  C +   S RP   +++  L+ + +
Sbjct: 270 LPRPD-KCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  113 bits (286), Expect = 4e-28
 Identities = 69/308 (22%), Positives = 121/308 (39%), Gaps = 73/308 (23%)

Query: 240 GTYSGILPDGS--RVAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR 296
               G+LP      VAVK LK  +S   + +F  E    A   +PN+V + G C      
Sbjct: 66  ARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 125

Query: 297 YIVYEFVVNGPLDRWL--------------------HHIPRGGRSLDWAMRMKVATTLAQ 336
            +++E++  G L+ +L                         G   L  A ++ +A  +A 
Sbjct: 126 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAA 185

Query: 337 GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGT 393
           G+A+L ++     VHRD+   N L+ E     ++ +   GLS          R + +   
Sbjct: 186 GMAYLSER---KFVHRDLATRNCLVGEN---MVVKIADFGLS----------RNIYSADY 229

Query: 394 Y-----GYL-----APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIF 442
           Y       +      PE ++ N  TT+SDV+++GV+L EI S G +P   +     + + 
Sbjct: 230 YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA---HEEVI 286

Query: 443 EWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 502
                 V+    L              PE     ++ +L+  C   +P+ RP    +   
Sbjct: 287 Y----YVRDGNILA------------CPE-NCPLELYNLMRLCWSKLPADRPSFCSIHRI 329

Query: 503 LQQLAQPP 510
           LQ++ +  
Sbjct: 330 LQRMCERA 337

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  113 bits (285), Expect = 5e-28
 Identities = 71/295 (24%), Positives = 114/295 (38%), Gaps = 57/295 (19%)

Query: 240 GTYSGILPDGS--RVAVKRLKRS-SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGD 295
            T  G+  + +  +VAVK LK +     K+   SE+   + L  H N+V + G C   G 
Sbjct: 65  ATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124

Query: 296 RYIVYEFVVNGPLDRWL----------HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 345
             ++ E+   G L  +L                  +      +  ++ +AQG+AFL  K 
Sbjct: 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK- 183

Query: 346 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY-----GYL--- 397
             + +HRD+ A NVLL     A +   GL+          R +M    Y       L   
Sbjct: 184 --NCIHRDVAARNVLLTNGHVAKIGDFGLA----------RDIMNDSNYIVKGNARLPVK 231

Query: 398 --APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRY 454
             APE ++    T +SDV+S+G+LL EI S G  P                 P +  +  
Sbjct: 232 WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP----------------YPGILVNS- 274

Query: 455 LELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 509
            +    +        P     + +  ++ AC    P+ RP    +   LQ+ AQ 
Sbjct: 275 -KFYKLVKDGYQMAQPA-FAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  111 bits (281), Expect = 7e-28
 Identities = 63/291 (21%), Positives = 113/291 (38%), Gaps = 53/291 (18%)

Query: 231 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 290
           + LG  + G    G       VA+K +K  S     EF  E      L H  LV + G C
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQLYGVC 88

Query: 291 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 350
                 +I+ E++ NG L  +L               +++   + + + +L  K     +
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLR---EMRHRFQTQQLLEMCKDVCEAMEYLESK---QFL 142

Query: 351 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG------TYGYLAPEFVYR 404
           HRD+ A N L++++    +   GLS++V  +   E T   G       +     PE +  
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDD---EYTSSVGSKFPVRWS----PPEVLMY 195

Query: 405 NELTTKSDVYSFGVLLLEIVS-GRRP------AQAVDSVCWQSIFEWATPLVQSHRYLEL 457
           ++ ++KSD+++FGVL+ EI S G+ P      ++  + +             Q  R    
Sbjct: 196 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI------------AQGLR---- 239

Query: 458 LDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 508
           L           P     +KV  ++Y+C       RP    ++  +  +  
Sbjct: 240 LYR---------PH-LASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  111 bits (280), Expect = 8e-28
 Identities = 63/206 (30%), Positives = 98/206 (47%), Gaps = 21/206 (10%)

Query: 231 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 290
             LG  + G  + G     ++VAVK LK+ S      F +E     +L H  LV +    
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 77

Query: 291 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 350
                 YI+ E++ NG L  +L      G  L     + +A  +A+G+AF+ ++   + +
Sbjct: 78  TQEP-IYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEER---NYI 131

Query: 351 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG------TYGYLAPEFVYR 404
           HRD+RA+N+L+ +     +   GL++ +      E T   G       T    APE +  
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDN---EYTAREGAKFPIKWT----APEAINY 184

Query: 405 NELTTKSDVYSFGVLLLEIVS-GRRP 429
              T KSDV+SFG+LL EIV+ GR P
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIP 210

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  111 bits (279), Expect = 2e-27
 Identities = 66/278 (23%), Positives = 125/278 (44%), Gaps = 37/278 (13%)

Query: 240 GTYSGILPDGSRVAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD-HGDRY 297
           G Y     +  + A+K L R +  Q+ + F  E      L+HPN++A+ G      G  +
Sbjct: 40  GEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH 99

Query: 298 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 357
           ++  ++ +G L +++       R+      +     +A+G+ +L ++     VHRD+ A 
Sbjct: 100 VLLPYMCHGDLLQFIR---SPQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAAR 153

Query: 358 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL-----APEFVYRNELTTKSD 412
           N +LDE F   +   GL++ +   + +E   +    +  L     A E +     TTKSD
Sbjct: 154 NCMLDESFTVKVADFGLARDI---LDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSD 210

Query: 413 VYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPE 471
           V+SFGVLL E+++ G  P + +D      +  +   L Q  R   L  P         P+
Sbjct: 211 VWSFGVLLWELLTRGAPPYRHIDP---FDLTHF---LAQGRR---LPQP------EYCPD 255

Query: 472 AGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 509
           +     +  ++  C +  P++RP    +V +++Q+   
Sbjct: 256 S-----LYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA 288

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  110 bits (278), Expect = 2e-27
 Identities = 67/294 (22%), Positives = 113/294 (38%), Gaps = 65/294 (22%)

Query: 240 GTYSGILPDGS--RVAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR 296
           G   G  P      VA+K LK  +    ++EF  E    ARL HPN+V + G        
Sbjct: 28  GHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL 87

Query: 297 YIVYEFVVNGPLDRWL------------HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 344
            +++ +  +G L  +L                    +L+    + +   +A G+ +L   
Sbjct: 88  SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH 147

Query: 345 VKPHVVHRDIRASNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGTY-----GY 396
              HVVH+D+   NVL+ ++     + +   GL           R V A   Y       
Sbjct: 148 ---HVVHKDLATRNVLVYDK---LNVKISDLGLF----------REVYAADYYKLLGNSL 191

Query: 397 L-----APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQ 450
           L     APE +   + +  SD++S+GV+L E+ S G +P         Q + E    +++
Sbjct: 192 LPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS---NQDVVE----MIR 244

Query: 451 SHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ 504
           + + L              P+      V  L+  C    PS RPR   +  +L+
Sbjct: 245 NRQVLP------------CPD-DCPAWVYALMIECWNEFPSRRPRFKDIHSRLR 285

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  111 bits (279), Expect = 2e-27
 Identities = 69/284 (24%), Positives = 112/284 (39%), Gaps = 49/284 (17%)

Query: 240 GTYSGILPDGSRVAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYI 298
           G           VA+K LK   + +++++F SE     +  HPN++ ++G         I
Sbjct: 68  GRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127

Query: 299 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASN 358
           V E++ NG LD +L               + +   +  G+ +L D      VHRD+ A N
Sbjct: 128 VTEYMENGSLDTFLR---THDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARN 181

Query: 359 VLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG-----TYGYLAPEFVYRNELTTKSDV 413
           VL+D      +   GLS+ +  +     T   G      T    APE +     ++ SDV
Sbjct: 182 VLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT----APEAIAFRTFSSASDV 237

Query: 414 YSFGVLLLEIVS-GRRP------AQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 466
           +SFGV++ E+++ G RP         + SV             + +R    L        
Sbjct: 238 WSFGVVMWEVLAYGERPYWNMTNRDVISSV------------EEGYR----LPA------ 275

Query: 467 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 510
              P  G    +  L+  C     + RPR S +V  L  L + P
Sbjct: 276 ---PM-GCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  110 bits (277), Expect = 3e-27
 Identities = 53/282 (18%), Positives = 102/282 (36%), Gaps = 36/282 (12%)

Query: 221 SITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRK--KEFYSEIGRFAR 277
           S    F + +  +G       Y G+       VA   L+     +   + F  E      
Sbjct: 22  SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKG 81

Query: 278 LHHPNLVAVKGCCYDHGDR----YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATT 333
           L HPN+V                 +V E + +G L        +  + +   +       
Sbjct: 82  LQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTL----KTYLKRFKVMKIKVLRSWCRQ 137

Query: 334 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMG-VGLSKFVPWEVMQERTVMAGG 392
           + +G+ FLH +  P ++HRD++  N+ +    G+  +G +GL+          + V+  G
Sbjct: 138 ILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK--RASFAKAVI--G 192

Query: 393 TYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSH 452
           T  ++APE +Y  +     DVY+FG+ +LE+ +   P     +     I+   T      
Sbjct: 193 TPEFMAPE-MYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQIYRRVTS----- 244

Query: 453 RYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP 494
               +       ++   PE        +++  C +     R 
Sbjct: 245 ---GVKPASFDKVAI--PEV------KEIIEGCIRQNKDERY 275

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  109 bits (275), Expect = 5e-27
 Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 19/210 (9%)

Query: 229 GNRLLGDSKTGGTYSGILPDGSR---VAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNL 283
            ++ LG    G    G          VAVK LK   +    K E  +E     +L +P +
Sbjct: 21  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80

Query: 284 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 343
           V + G C       +V E    GPL+++L    +  R +     +++   ++ G+ +L +
Sbjct: 81  VRMIGICEAES-WMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLEE 135

Query: 344 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT---YGYLAPE 400
               + VHRD+ A NVLL  +  A +   GLSK +  +  +              + APE
Sbjct: 136 S---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD--ENYYKAQTHGKWPVKWYAPE 190

Query: 401 FVYRNELTTKSDVYSFGVLLLEIVS-GRRP 429
            +   + ++KSDV+SFGVL+ E  S G++P
Sbjct: 191 CINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  111 bits (279), Expect = 5e-27
 Identities = 71/295 (24%), Positives = 126/295 (42%), Gaps = 49/295 (16%)

Query: 231 RLLGDSKTGGTYSGILPDGSR----VAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVA 285
           +++G  + G   SG L   S+    VA+K LK   + +++++F  E     +  HPN++ 
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110

Query: 286 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 345
           ++G         IV E++ NG LD +L    +          + +   +A G+ +L D  
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLR---KHDAQFTVIQLVGMLRGIASGMKYLSDM- 166

Query: 346 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT---YGYLAPEFV 402
               VHRD+ A N+L++      +   GL + +  E   E      G      + +PE +
Sbjct: 167 --GYVHRDLAARNILINSNLVCKVSDFGLGRVL--EDDPEAAYTTRGGKIPIRWTSPEAI 222

Query: 403 YRNELTTKSDVYSFGVLLLEIVS-GRRP------AQAVDSVCWQSIFEWATPLVQSHRYL 455
              + T+ SDV+S+G++L E++S G RP         + +V             + +R  
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV------------DEGYR-- 268

Query: 456 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 510
             L P       D P A     +  L+  C Q   + RP+   +V  L +L + P
Sbjct: 269 --LPP-----PMDCPAA-----LYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  109 bits (275), Expect = 6e-27
 Identities = 56/250 (22%), Positives = 99/250 (39%), Gaps = 25/250 (10%)

Query: 248 DGSRVAVKRLK---RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 304
           DG  VA+K+++       + + +   EI    +L+HPN++       +  +  IV E   
Sbjct: 56  DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELAD 115

Query: 305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 364
            G L R + H  +  R +      K    L   +  +H +    V+HRDI+ +NV +   
Sbjct: 116 AGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITAT 172

Query: 365 FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIV 424
               L  +GL +F   +     +++  GT  Y++PE ++ N    KSD++S G LL E+ 
Sbjct: 173 GVVKLGDLGLGRFFSSKTTAAHSLV--GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA 230

Query: 425 SGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYA 484
           + + P                           L   +       +P     +++  LV  
Sbjct: 231 ALQSPFYG-----------------DKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNM 273

Query: 485 CTQHVPSMRP 494
           C    P  RP
Sbjct: 274 CINPDPEKRP 283

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  109 bits (275), Expect = 8e-27
 Identities = 67/298 (22%), Positives = 108/298 (36%), Gaps = 56/298 (18%)

Query: 240 GTYSGILPDGS--RVAVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGD 295
               GI    +   VAVK LK  ++    +   SE+     + HH N+V + G C   G 
Sbjct: 46  ADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 105

Query: 296 -RYIVYEFVVNGPL------------DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLH 342
              ++ EF   G L               +         L     +  +  +A+G+ FL 
Sbjct: 106 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA 165

Query: 343 DKVKPHVVHRDIRASNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGTYGYL-- 397
            +     +HRD+ A N+LL E+    ++ +   GL++      + +           L  
Sbjct: 166 SR---KCIHRDLAARNILLSEKN---VVKICDFGLAR-----DIYKDPDYVRKGDARLPL 214

Query: 398 ---APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHR 453
              APE ++    T +SDV+SFGVLL EI S G  P   V     +         ++   
Sbjct: 215 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI--DEEFCR----RLKEGT 268

Query: 454 YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPV 511
            +              P+     ++   +  C    PS RP  S +V  L  L Q   
Sbjct: 269 RMR------------APD-YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  110 bits (277), Expect = 9e-27
 Identities = 68/299 (22%), Positives = 110/299 (36%), Gaps = 68/299 (22%)

Query: 240 GTYSGILPDGS----RVAVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDH 293
               GI  D       VAVK LK  ++ +   +  SE+     +  H N++ + G C   
Sbjct: 100 AEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159

Query: 294 GDRYIVYEFVVNGPL------------DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 341
           G  Y++ E+   G L            +            + +   +     LA+G+ +L
Sbjct: 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL 219

Query: 342 HDKVKPHVVHRDIRASNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGTY---- 394
             +     +HRD+ A NVL+ E    ++M +   GL+          R +     Y    
Sbjct: 220 ASQ---KCIHRDLAARNVLVTEN---NVMKIADFGLA----------RDINNIDYYKKTT 263

Query: 395 -GYL-----APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATP 447
            G L     APE ++    T +SDV+SFGVL+ EI + G  P   +              
Sbjct: 264 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE----------- 312

Query: 448 LVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 506
                   EL   L      D P      ++  ++  C   VPS RP    +V  L ++
Sbjct: 313 --------ELFKLLKEGHRMDKPA-NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  109 bits (275), Expect = 9e-27
 Identities = 67/297 (22%), Positives = 110/297 (37%), Gaps = 58/297 (19%)

Query: 240 GTYSGILPDGS----RVAVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDH 293
               GI  D       VAVK LK  ++ +   +  SE+     +  H N++ + G C   
Sbjct: 54  AEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113

Query: 294 GDRYIVYEFVVNGPL------------DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 341
           G  Y++ E+   G L            +            + +   +     LA+G+ +L
Sbjct: 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL 173

Query: 342 HDKVKPHVVHRDIRASNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGTYGYL- 397
             +     +HRD+ A NVL+ E    ++M +   GL++      +         T G L 
Sbjct: 174 ASQ---KCIHRDLAARNVLVTEN---NVMKIADFGLAR-----DINNIDYYKKTTNGRLP 222

Query: 398 ----APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSH 452
               APE ++    T +SDV+SFGVL+ EI + G  P   +                   
Sbjct: 223 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---------------- 266

Query: 453 RYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 509
              EL   L      D P      ++  ++  C   VPS RP    +V  L ++   
Sbjct: 267 ---ELFKLLKEGHRMDKPA-NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  109 bits (274), Expect = 1e-26
 Identities = 62/293 (21%), Positives = 122/293 (41%), Gaps = 46/293 (15%)

Query: 231 RLLGDSKTGGTYSGIL-PDGSR----VAVKRLKRSSFQR-KKEFYSEIGRFARLHHPNLV 284
           ++LG    G  Y G+  P+G +    VA+K L+ ++  +  KE   E    A + +P++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 285 AVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 344
            + G C       ++ + +  G L  ++        ++     +     +A+G+ +L D+
Sbjct: 81  RLLGICLTS-TVQLITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYLEDR 136

Query: 345 VKPHVVHRDIRASNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGT---YGYLA 398
               +VHRD+ A NVL+        + +   GL+K +  E   E+   A G      ++A
Sbjct: 137 ---RLVHRDLAARNVLVKTP---QHVKITDFGLAKLLGAE---EKEYHAEGGKVPIKWMA 187

Query: 399 PEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLEL 457
            E +     T +SDV+S+GV + E+++ G +P   + +     I      L +  R   L
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA---SEISSI---LEKGER---L 238

Query: 458 LDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 510
             P                 V  ++  C       RP+   ++ +  ++A+ P
Sbjct: 239 PQP------PICTID-----VYMIMRKCWMIDADSRPKFRELIIEFSKMARDP 280

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  108 bits (271), Expect = 1e-26
 Identities = 55/270 (20%), Positives = 101/270 (37%), Gaps = 34/270 (12%)

Query: 248 DGSRVAVK--RLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFV 303
           DG  +  K       +   K+   SE+     L HPN+V       D  +   YIV E+ 
Sbjct: 30  DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYC 89

Query: 304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK--VKPHVVHRDIRASNVLL 361
             G L   +    +  + LD    ++V T L   +   H +      V+HRD++ +NV L
Sbjct: 90  EGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL 149

Query: 362 DEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLL 421
           D +    L   GL++ +  +    +T +  GT  Y++PE + R     KSD++S G LL 
Sbjct: 150 DGKQNVKLGDFGLARILNHDTSFAKTFV--GTPYYMSPEQMNRMSYNEKSDIWSLGCLLY 207

Query: 422 EIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDL 481
           E+ +   P  A      + +       ++  ++      +    S ++          ++
Sbjct: 208 ELCALMPPFTAFS---QKELAG----KIREGKF----RRIPYRYSDEL---------NEI 247

Query: 482 VYACTQHVPSMRP------RMSHVVHQLQQ 505
           +          RP          ++     
Sbjct: 248 ITRMLNLKDYHRPSVEEILENPLILEHHHH 277

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  108 bits (273), Expect = 2e-26
 Identities = 64/287 (22%), Positives = 120/287 (41%), Gaps = 54/287 (18%)

Query: 242 YSGIL--PDGSR---VAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD 295
           Y G+L    G +   VA+K LK   + +++ +F  E G   +  H N++ ++G    +  
Sbjct: 61  YKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 120

Query: 296 RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIR 355
             I+ E++ NG LD++L               + +   +A G+ +L +    + VHRD+ 
Sbjct: 121 MMIITEYMENGALDKFLR---EKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLA 174

Query: 356 ASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG-----TYGYLAPEFVYRNELTTK 410
           A N+L++      +   GLS+ +  +     T   G      T    APE +   + T+ 
Sbjct: 175 ARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT----APEAISYRKFTSA 230

Query: 411 SDVYSFGVLLLEIVS-GRRP------AQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS 463
           SDV+SFG+++ E+++ G RP       + + ++                R    L     
Sbjct: 231 SDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI------------NDGFR----LPT--- 271

Query: 464 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 510
                 P       +  L+  C Q   + RP+ + +V  L +L + P
Sbjct: 272 ------PM-DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  109 bits (273), Expect = 2e-26
 Identities = 54/274 (19%), Positives = 112/274 (40%), Gaps = 35/274 (12%)

Query: 248 DGSRVAVK--RLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 305
           DG +  +K   + R S + ++E   E+   A + HPN+V  +    ++G  YIV ++   
Sbjct: 48  DGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEG 107

Query: 306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 365
           G L + ++   + G        +     +   +  +HD+    ++HRDI++ N+ L ++ 
Sbjct: 108 GDLFKRINA--QKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDG 162

Query: 366 GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 425
              L   G+++ +   V   R  +  GT  YL+PE         KSD+++ G +L E+ +
Sbjct: 163 TVQLGDFGIARVLNSTVELARACI--GTPYYLSPEICENKPYNNKSDIWALGCVLYELCT 220

Query: 426 GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYAC 485
            +   +A      +++       + S  +     P+    S D+           LV   
Sbjct: 221 LKHAFEAGS---MKNLVL----KIISGSF----PPVSLHYSYDL---------RSLVSQL 260

Query: 486 TQHVPSMRP------RMSHVVHQLQQLAQPPVTK 513
            +  P  RP          +  ++++   P +  
Sbjct: 261 FKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIA 294

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  107 bits (270), Expect = 3e-26
 Identities = 50/257 (19%), Positives = 95/257 (36%), Gaps = 47/257 (18%)

Query: 251 RVAVKRLKRSSFQRKKEFYSEIGRF-------ARLHHPNLVAVKGCCYDHGD----RYIV 299
            VA+K +   +      F     R         RL  P++V +    +D G+     Y+ 
Sbjct: 61  IVALKLM-SETLSSDPVF---RTRMQREARTAGRLQEPHVVPI----HDFGEIDGQLYVD 112

Query: 300 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNV 359
              +    L   L    +G  +   A+   +   +   +   H        HRD++  N+
Sbjct: 113 MRLINGVDLAAMLRR--QGPLAPPRAVA--IVRQIGSALDAAHAA---GATHRDVKPENI 165

Query: 360 LLDEEFGAHLMGVGLSKFVPWEVM-QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGV 418
           L+  +  A+L+  G++     E + Q    +  GT  Y+APE    +  T ++D+Y+   
Sbjct: 166 LVSADDFAYLVDFGIASATTDEKLTQLGNTV--GTLYYMAPERFSESHATYRADIYALTC 223

Query: 419 LLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKV 478
           +L E ++G  P Q  D +           ++ +H    +  P  S++   IP A      
Sbjct: 224 VLYECLTGSPPYQG-DQL----------SVMGAHINQAI--PRPSTVRPGIPVA-----F 265

Query: 479 VDLVYACTQHVPSMRPR 495
             ++       P  R  
Sbjct: 266 DAVIARGMAKNPEDRYV 282

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  108 bits (271), Expect = 3e-26
 Identities = 68/304 (22%), Positives = 118/304 (38%), Gaps = 73/304 (24%)

Query: 240 GTYSGILPDGS--RVAVKRLK-RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR 296
            T   +        VAVK LK  +S    ++  SE     +++HP+++ + G C   G  
Sbjct: 42  ATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101

Query: 297 YIVYEFVVNGPLDRWL--------------------HHIPRGGRSLDWAMRMKVATTLAQ 336
            ++ E+   G L  +L                           R+L     +  A  ++Q
Sbjct: 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQ 161

Query: 337 GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGT 393
           G+ +L +     +VHRD+ A N+L+ E      M +   GLS          R V    +
Sbjct: 162 GMQYLAEM---KLVHRDLAARNILVAEG---RKMKISDFGLS----------RDVYEEDS 205

Query: 394 Y-----GYL-----APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIF 442
           Y     G +     A E ++ +  TT+SDV+SFGVLL EIV+ G  P   +         
Sbjct: 206 YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI--------- 256

Query: 443 EWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 502
                         L + L +    + P+    +++  L+  C +  P  RP  + +   
Sbjct: 257 --------PPE--RLFNLLKTGHRMERPD-NCSEEMYRLMLQCWKQEPDKRPVFADISKD 305

Query: 503 LQQL 506
           L+++
Sbjct: 306 LEKM 309

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  107 bits (270), Expect = 3e-26
 Identities = 63/302 (20%), Positives = 110/302 (36%), Gaps = 67/302 (22%)

Query: 240 GTYSGILPDGS--RVAVKRLKRS-SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGD 295
            T  G++   +   VAVK LK S     ++   SE+   + L +H N+V + G C   G 
Sbjct: 42  ATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101

Query: 296 RYIVYEFVVNGPLDRWL-HHIPRGGRSLDWAMR-------------MKVATTLAQGIAFL 341
             ++ E+   G L  +L         S                   +  +  +A+G+AFL
Sbjct: 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL 161

Query: 342 HDKVKPHVVHRDIRASNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGTY---- 394
             K   + +HRD+ A N+LL       +  +   GL+          R +     Y    
Sbjct: 162 ASK---NCIHRDLAARNILLTHG---RITKICDFGLA----------RDIKNDSNYVVKG 205

Query: 395 -GYL-----APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATP 447
              L     APE ++    T +SDV+S+G+ L E+ S G  P        +  +   +  
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP--------YPGMPVDS-- 255

Query: 448 LVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA 507
                   +    +        PE     ++ D++  C    P  RP    +V  +++  
Sbjct: 256 --------KFYKMIKEGFRMLSPE-HAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306

Query: 508 QP 509
             
Sbjct: 307 SE 308

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  108 bits (272), Expect = 4e-26
 Identities = 71/303 (23%), Positives = 113/303 (37%), Gaps = 68/303 (22%)

Query: 240 GTYSGILPDGS----RVAVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDH 293
               G+  D      +VAVK LK  ++ +   +  SE+     +  H N++ + G C   
Sbjct: 88  AEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147

Query: 294 GDRYIVYEFVVNGPL------------DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 341
           G  Y++ E+   G L            +   +        L     +  A  +A+G+ +L
Sbjct: 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL 207

Query: 342 HDKVKPHVVHRDIRASNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGTY---- 394
             K     +HRD+ A NVL+ E+   ++M +   GL+          R +     Y    
Sbjct: 208 ASK---KCIHRDLAARNVLVTED---NVMKIADFGLA----------RDIHHIDYYKKTT 251

Query: 395 -GYL-----APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATP 447
            G L     APE ++    T +SDV+SFGVLL EI + G  P   V              
Sbjct: 252 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE----------- 300

Query: 448 LVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA 507
                   EL   L      D P      ++  ++  C   VPS RP    +V  L ++ 
Sbjct: 301 --------ELFKLLKEGHRMDKPS-NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 351

Query: 508 QPP 510
              
Sbjct: 352 ALT 354

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  105 bits (263), Expect = 2e-25
 Identities = 49/197 (24%), Positives = 77/197 (39%), Gaps = 16/197 (8%)

Query: 240 GTYSGILPDGSRVAVKRLKR---SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR 296
           G +         VAVK LK    S  +   +F  E+     L H NL+ + G        
Sbjct: 37  GEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95

Query: 297 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRA 356
            +V E    G L   L    +           + A  +A+G+ +L  K     +HRD+ A
Sbjct: 96  KMVTELAPLGSLLDRLR---KHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAA 149

Query: 357 SNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT---YGYLAPEFVYRNELTTKSDV 413
            N+LL       +   GL + +P     +  VM       + + APE +     +  SD 
Sbjct: 150 RNLLLATRDLVKIGDFGLMRALPQN--DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDT 207

Query: 414 YSFGVLLLEIVS-GRRP 429
           + FGV L E+ + G+ P
Sbjct: 208 WMFGVTLWEMFTYGQEP 224

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  104 bits (262), Expect = 2e-25
 Identities = 49/196 (25%), Positives = 88/196 (44%), Gaps = 17/196 (8%)

Query: 242 YSGILPDGSR---VAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRY 297
             G+     +   VA+K LK+ +     +E   E     +L +P +V + G C       
Sbjct: 27  RQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA-LM 85

Query: 298 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 357
           +V E    GPL ++L         +  +   ++   ++ G+ +L +K   + VHRD+ A 
Sbjct: 86  LVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAAR 139

Query: 358 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT---YGYLAPEFVYRNELTTKSDVY 414
           NVLL     A +   GLSK +  +                 + APE +   + +++SDV+
Sbjct: 140 NVLLVNRHYAKISDFGLSKALGAD--DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVW 197

Query: 415 SFGVLLLEIVS-GRRP 429
           S+GV + E +S G++P
Sbjct: 198 SYGVTMWEALSYGQKP 213

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  105 bits (263), Expect = 5e-25
 Identities = 69/304 (22%), Positives = 115/304 (37%), Gaps = 72/304 (23%)

Query: 240 GTYSGILPDGS--RVAVKRLKRS-SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGD 295
            T  GI   G   +VAVK LK       ++   SE+    +L  H N+V + G C   G 
Sbjct: 64  ATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123

Query: 296 RYIVYEFVVNGPLDRWL-------------------HHIPRGGRSLDWAMRMKVATTLAQ 336
            Y+++E+   G L  +L                            L +   +  A  +A+
Sbjct: 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAK 183

Query: 337 GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGT 393
           G+ FL  K     VHRD+ A NVL+       ++ +   GL+          R +M+   
Sbjct: 184 GMEFLEFK---SCVHRDLAARNVLVTHG---KVVKICDFGLA----------RDIMSDSN 227

Query: 394 Y-----GYL-----APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIF 442
           Y       L     APE ++    T KSDV+S+G+LL EI S G  P   +      + +
Sbjct: 228 YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV--DANFY 285

Query: 443 EWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 502
           +    L+Q+   ++             P     +++  ++ +C       RP   ++   
Sbjct: 286 K----LIQNGFKMD------------QPF-YATEEIYIIMQSCWAFDSRKRPSFPNLTSF 328

Query: 503 LQQL 506
           L   
Sbjct: 329 LGCQ 332

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  103 bits (260), Expect = 9e-25
 Identities = 53/290 (18%), Positives = 118/290 (40%), Gaps = 40/290 (13%)

Query: 231 RLLGDSKTGGTYSGILPDGSR-----VAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLV 284
           ++LG    G  + G+           V +K ++  S  Q  +     +     L H ++V
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78

Query: 285 AVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 344
            + G C       +V +++  G L   +    +   +L   + +     +A+G+ +L + 
Sbjct: 79  RLLGLCPGSS-LQLVTQYLPLGSLLDHVR---QHRGALGPQLLLNWGVQIAKGMYYLEEH 134

Query: 345 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT---YGYLAPEF 401
               +VHR++ A NVLL       +   G++  +P +   ++ ++         ++A E 
Sbjct: 135 ---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD---DKQLLYSEAKTPIKWMALES 188

Query: 402 VYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP 460
           ++  + T +SDV+S+GV + E+++ G  P   +       + +    L +  R   L  P
Sbjct: 189 IHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL---AEVPDL---LEKGER---LAQP 239

Query: 461 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 510
            I +             V  ++  C     ++RP    + ++  ++A+ P
Sbjct: 240 QICT-----------IDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP 278

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  106 bits (267), Expect = 1e-24
 Identities = 42/195 (21%), Positives = 76/195 (38%), Gaps = 37/195 (18%)

Query: 248 DGSRVAVKRLKRS---SFQRKKEFYSEIGRF-ARLHHPNLVAVKGCCYDHGDR------- 296
           +G  V +K L  S     Q      +E  +F A + HP++V +    ++  +        
Sbjct: 105 NGRPVVLKGLVHSGDAEAQAM--AMAE-RQFLAEVVHPSIVQI----FNFVEHTDRHGDP 157

Query: 297 --YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDI 354
             YIV E+V    L R           +  A+       +   +++LH      +V+ D+
Sbjct: 158 VGYIVMEYVGGQSLKRSK----GQKLPVAEAIA--YLLEILPALSYLHSI---GLVYNDL 208

Query: 355 RASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVY 414
           +  N++L EE    L+ +G        +     +   GT G+ APE + R   T  +D+Y
Sbjct: 209 KPENIMLTEE-QLKLIDLGAVS----RINSFGYLY--GTPGFQAPE-IVRTGPTVATDIY 260

Query: 415 SFGVLLLEIVSGRRP 429
           + G  L  +      
Sbjct: 261 TVGRTLAALTLDLPT 275

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  103 bits (259), Expect = 1e-24
 Identities = 64/290 (22%), Positives = 123/290 (42%), Gaps = 40/290 (13%)

Query: 231 RLLGDSKTGGTYSGIL-PDGSR----VAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLV 284
           ++LG    G  Y G+  P+G +    VA+K L+  +S +  KE   E    A + +P++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 285 AVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 344
            + G C       ++ + +  G L  ++        ++     +     +A+G+ +L D+
Sbjct: 81  RLLGICLTS-TVQLITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYLEDR 136

Query: 345 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT---YGYLAPEF 401
               +VHRD+ A NVL+       +   GL+K +  E   E+   A G      ++A E 
Sbjct: 137 ---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE---EKEYHAEGGKVPIKWMALES 190

Query: 402 VYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP 460
           +     T +SDV+S+GV + E+++ G +P   + +     I      L +  R   L  P
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA---SEISSI---LEKGER---LPQP 241

Query: 461 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 510
            I +             V  ++  C       RP+   ++ +  ++A+ P
Sbjct: 242 PICT-----------IDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 280

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  103 bits (258), Expect = 2e-24
 Identities = 72/295 (24%), Positives = 120/295 (40%), Gaps = 60/295 (20%)

Query: 242 YSGILPDGS---RVAVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDR 296
               +         A+KR+K  +S    ++F  E+    +L HHPN++ + G C   G  
Sbjct: 42  LKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 101

Query: 297 YIVYEFVVNGPLDRWL------------HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 344
           Y+  E+  +G L  +L                    +L     +  A  +A+G+ +L  K
Sbjct: 102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK 161

Query: 345 VKPHVVHRDIRASNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGTYGYL---- 397
                +HRD+ A N+L+ E    ++  +   GLS+         + V    T G L    
Sbjct: 162 ---QFIHRDLAARNILVGEN---YVAKIADFGLSR--------GQEVYVKKTMGRLPVRW 207

Query: 398 -APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYL 455
            A E +  +  TT SDV+S+GVLL EIVS G  P   +       ++E    L Q +R  
Sbjct: 208 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT---CAELYEK---LPQGYR-- 259

Query: 456 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 510
             L+          P      +V DL+  C +  P  RP  + ++  L ++ +  
Sbjct: 260 --LEK---------PL-NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  101 bits (255), Expect = 2e-24
 Identities = 74/291 (25%), Positives = 116/291 (39%), Gaps = 44/291 (15%)

Query: 231 RLLGDSKTGGTYSGILPDGSR----VAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVA 285
           R +G+ + G  + GI          VA+K  K  +S   +++F  E     +  HP++V 
Sbjct: 21  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80

Query: 286 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 345
           + G   ++   +I+ E    G L  +L        SLD A  +  A  L+  +A+L  K 
Sbjct: 81  LIGVITEN-PVWIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLESK- 135

Query: 346 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL-----APE 400
               VHRDI A NVL+       L   GLS+++           A    G L     APE
Sbjct: 136 --RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM----EDSTYYKASK--GKLPIKWMAPE 187

Query: 401 FVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD 459
            +     T+ SDV+ FGV + EI+  G +P Q V +     +      +    R    L 
Sbjct: 188 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---NDVIGR---IENGER----LP 237

Query: 460 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 510
                     P       +  L+  C  + PS RPR + +  QL  + +  
Sbjct: 238 M---------PP-NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  101 bits (255), Expect = 2e-24
 Identities = 54/197 (27%), Positives = 86/197 (43%), Gaps = 20/197 (10%)

Query: 240 GTYSGILPDGSRVAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYI 298
           G Y+    +   VAVK  K+  +   K++F SE      L HP++V + G   +    +I
Sbjct: 31  GVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWI 89

Query: 299 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASN 358
           + E    G L  +L    R   SL     +  +  + + +A+L      + VHRDI   N
Sbjct: 90  IMELYPYGELGHYLE---RNKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRN 143

Query: 359 VLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL-----APEFVYRNELTTKSDV 413
           +L+       L   GLS+++      E    A      L     +PE +     TT SDV
Sbjct: 144 ILVASPECVKLGDFGLSRYI----EDEDYYKASV--TRLPIKWMSPESINFRRFTTASDV 197

Query: 414 YSFGVLLLEIVS-GRRP 429
           + F V + EI+S G++P
Sbjct: 198 WMFAVCMWEILSFGKQP 214

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  104 bits (262), Expect = 5e-24
 Identities = 75/291 (25%), Positives = 117/291 (40%), Gaps = 44/291 (15%)

Query: 231 RLLGDSKTGGTYSGILPDGSR----VAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVA 285
           R +G+ + G  + GI          VA+K  K  +S   +++F  E     +  HP++V 
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455

Query: 286 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 345
           + G   ++   +I+ E    G L  +L        SLD A  +  A  L+  +A+L  K 
Sbjct: 456 LIGVITEN-PVWIIMELCTLGELRSFLQ---VRKFSLDLASLILYAYQLSTALAYLESK- 510

Query: 346 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL-----APE 400
               VHRDI A NVL+       L   GLS+      M++ T       G L     APE
Sbjct: 511 --RFVHRDIAARNVLVSSNDCVKLGDFGLSR-----YMEDSTYYKASK-GKLPIKWMAPE 562

Query: 401 FVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD 459
            +     T+ SDV+ FGV + EI+  G +P Q V +     +      +    R    L 
Sbjct: 563 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---NDVIGR---IENGER----LP 612

Query: 460 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 510
                     P       +  L+  C  + PS RPR + +  QL  + +  
Sbjct: 613 M---------PP-NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  104 bits (261), Expect = 6e-24
 Identities = 67/309 (21%), Positives = 118/309 (38%), Gaps = 36/309 (11%)

Query: 148 HENKCYYLHCHREYL--ITLGVVSGLILLTTFAIVIWLLAYRRSKRRRKSRKLSNPAASA 205
                  ++C +E     +    SG    T  A    L   +R      S   +   A  
Sbjct: 240 KLKADGLIYCLKEACPNSSASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPARI 299

Query: 206 LVPPSWKVFTT------------EELRSITKNFSEGNRLLGDSKTG----GT-YSGILPD 248
             P   +                EEL+         N L+ D + G    G+   G+   
Sbjct: 300 TSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRM 359

Query: 249 GSR---VAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 304
             +   VA+K LK+ +     +E   E     +L +P +V + G C       +V E   
Sbjct: 360 RKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAG 418

Query: 305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 364
            GPL ++L         +  +   ++   ++ G+ +L +K   + VHR++ A NVLL   
Sbjct: 419 GGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNR 472

Query: 365 FGAHLMGVGLSKFVPWEVMQERTVMAGGT---YGYLAPEFVYRNELTTKSDVYSFGVLLL 421
             A +   GLSK +  +                 + APE +   + +++SDV+S+GV + 
Sbjct: 473 HYAKISDFGLSKALGAD--DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMW 530

Query: 422 EIVS-GRRP 429
           E +S G++P
Sbjct: 531 EALSYGQKP 539

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  101 bits (253), Expect = 6e-24
 Identities = 55/278 (19%), Positives = 100/278 (35%), Gaps = 37/278 (13%)

Query: 248 DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR----YIVYEFV 303
           DG   A+KR+     Q ++E   E       +HPN++ +   C          +++  F 
Sbjct: 53  DGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFF 112

Query: 304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 363
             G L   +  +   G  L     + +   + +G+  +H        HRD++ +N+LL +
Sbjct: 113 KRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGD 169

Query: 364 EFGAHLMGVGLSKFVPWEVMQERTVMAG-------GTYGYLAPEFV--YRNE-LTTKSDV 413
           E    LM +G        V   R  +          T  Y APE      +  +  ++DV
Sbjct: 170 EGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDV 229

Query: 414 YSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAG 473
           +S G +L  ++ G  P            ++       S         L       IP++ 
Sbjct: 230 WSLGCVLYAMMFGEGP------------YDMVFQKGDSVA-------LAVQNQLSIPQSP 270

Query: 474 VV-QKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 510
                +  L+ +     P  RP +  ++ QL+ L  P 
Sbjct: 271 RHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPA 308

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  100 bits (251), Expect = 1e-23
 Identities = 63/323 (19%), Positives = 108/323 (33%), Gaps = 58/323 (17%)

Query: 186 YRRSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI 245
           Y +S  + + R++S    ++    S     +       ++F      LG     G+Y  +
Sbjct: 19  YFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRL-SRLGH----GSYGEV 73

Query: 246 L-----PDGSRVAVKRLKRSSFQRK--KEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRY 297
                  DG   AVKR        K      +E+G   ++  HP  V ++    + G  Y
Sbjct: 74  FKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILY 133

Query: 298 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 357
           +  E      L     H    G SL  A            +A LH +    +VH D++ +
Sbjct: 134 LQTELC-GPSL---QQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPA 186

Query: 358 NVLLDEEFGAHLMGV------GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKS 411
           N+ L         G       GL             V  G    Y+APE + +    T +
Sbjct: 187 NIFLGPR------GRCKLGDFGLLVE--LGTAGAGEVQEGDPR-YMAPE-LLQGSYGTAA 236

Query: 412 DVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPE 471
           DV+S G+ +LE+          +   WQ + +             L     + LSS++  
Sbjct: 237 DVFSLGLTILEVACNMELPHGGEG--WQQLRQ-----------GYLPPEFTAGLSSEL-- 281

Query: 472 AGVVQKVVDLVYACTQHVPSMRP 494
                    ++    +  P +R 
Sbjct: 282 -------RSVLVMMLEPDPKLRA 297

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 98.7 bits (246), Expect = 8e-23
 Identities = 53/263 (20%), Positives = 96/263 (36%), Gaps = 38/263 (14%)

Query: 187 RRSKRRRKSRKLSNPAASALVPPSW---KVFTTEELRSITKNFSEGNR------LLGDSK 237
                  K+    +     L P +     V  TE+L+ +   + E          +G   
Sbjct: 11  HSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGS 70

Query: 238 TGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR 296
            G  +       G + AVK+++   F+ +     E+   A L  P +V + G   +    
Sbjct: 71  FGEVHRMKDKQTGFQCAVKKVRLEVFRVE-----ELVACAGLSSPRIVPLYGAVREGPWV 125

Query: 297 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRA 356
            I  E +  G L      + +    L     +       +G+ +LH +    ++H D++A
Sbjct: 126 NIFMELLEGGSL----GQLIKQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKA 178

Query: 357 SNVLLDEE--------FG--AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNE 406
            NVLL  +        FG    L   GL K      +     + G    ++APE V    
Sbjct: 179 DNVLLSSDGSRAALCDFGHALCLQPDGLGK-----SLLTGDYIPGTET-HMAPEVVMGKP 232

Query: 407 LTTKSDVYSFGVLLLEIVSGRRP 429
              K D++S   ++L +++G  P
Sbjct: 233 CDAKVDIWSSCCMMLHMLNGCHP 255

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 96.6 bits (241), Expect = 2e-22
 Identities = 43/266 (16%), Positives = 86/266 (32%), Gaps = 47/266 (17%)

Query: 248 DGSRVAVKRLKR--SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVV 304
           DG   A+KR K+  +    ++    E+   A L  H ++V       +     I  E+  
Sbjct: 35  DGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCN 94

Query: 305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 364
            G L   +    R       A    +   + +G+ ++H      +VH DI+ SN+ +   
Sbjct: 95  GGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRT 151

Query: 365 --------------FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL--T 408
                         + ++ +   +        +    V  G +  +LA E V +      
Sbjct: 152 SIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSR-FLANE-VLQENYTHL 209

Query: 409 TKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD 468
            K+D+++  + ++         +  D   W  I +   P             +   LS +
Sbjct: 210 PKADIFALALTVVCAAGAEPLPRNGDQ--WHEIRQGRLP------------RIPQVLSQE 255

Query: 469 IPEAGVVQKVVDLVYACTQHVPSMRP 494
                      +L+       P  RP
Sbjct: 256 F---------TELLKVMIHPDPERRP 272

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score = 96.2 bits (240), Expect = 2e-22
 Identities = 59/287 (20%), Positives = 109/287 (37%), Gaps = 69/287 (24%)

Query: 248 DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR----------- 296
           DG    +KR+K +     ++   E+   A+L H N+V   GC                  
Sbjct: 35  DGKTYVIKRVKYN----NEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRS 90

Query: 297 -----YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 351
                +I  EF   G L++W+    R G  LD  + +++   + +G+ ++H K    +++
Sbjct: 91  KTKCLFIQMEFCDKGTLEQWIEK--RRGEKLDKVLALELFEQITKGVDYIHSK---KLIN 145

Query: 352 RDIRASNVLLDEEFGAHLMGV-----GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNE 406
           RD++ SN+ L +        V     GL   +  +  + R+    GT  Y++PE +   +
Sbjct: 146 RDLKPSNIFLVDT-----KQVKIGDFGLVTSLKNDGKRTRSK---GTLRYMSPEQISSQD 197

Query: 407 LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 466
              + D+Y+ G++L E++     A                       + +L D +IS + 
Sbjct: 198 YGKEVDLYALGLILAELLHVCDTAFETSKF-----------------FTDLRDGIISDIF 240

Query: 467 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPVTK 513
                    +K   L+       P  RP  S +      L    V K
Sbjct: 241 D--------KKEKTLLQKLLSKKPEDRPNTSEI------LRTLTVWK 273

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 96.7 bits (241), Expect = 2e-22
 Identities = 46/277 (16%), Positives = 96/277 (34%), Gaps = 63/277 (22%)

Query: 248 DGSRVAVKRLKRSSFQR-KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR---------- 296
           D    A+KR++  + +  +++   E+   A+L HP +V       +              
Sbjct: 29  DDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKV 88

Query: 297 --YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDI 354
             YI  +      L  W++         + ++ + +   +A+ + FLH K    ++HRD+
Sbjct: 89  YLYIQMQLCRKENLKDWMNGR-CTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDL 144

Query: 355 RASNVLLDEEFGAHLMGV-----GLSKFVPWEVMQERTVMAG----------GTYGYLAP 399
           + SN+    +       V     GL   +  +  ++  +             GT  Y++P
Sbjct: 145 KPSNIFFTMD-----DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSP 199

Query: 400 EFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVD--SVCWQSIFEWATPLVQSHRYLEL 457
           E ++ N  + K D++S G++L E++    P             +     P + + +Y   
Sbjct: 200 EQIHGNSYSHKVDIFSLGLILFELL---YPFSTQMERVRTLTDVRNLKFPPLFTQKYPCE 256

Query: 458 LDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP 494
                                  +V       P  RP
Sbjct: 257 ---------------------YVMVQDMLSPSPMERP 272

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 95.1 bits (237), Expect = 6e-22
 Identities = 61/273 (22%), Positives = 108/273 (39%), Gaps = 38/273 (13%)

Query: 231 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGC 289
            +LG    G  Y+G  L +  R+A+K +     +  +  + EI     L H N+V   G 
Sbjct: 28  VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87

Query: 290 CYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATT-LAQGIAFLHDKVKPH 348
             ++G   I  E V  G L   L    + G   D    +   T  + +G+ +LHD     
Sbjct: 88  FSENGFIKIFMEQVPGGSLSALLRS--KWGPLKDNEQTIGFYTKQILEGLKYLHDN---Q 142

Query: 349 VVHRDIRASNVLLDEEFGAHLMGV-----GLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 403
           +VHRDI+  NVL++   G     +     G SK +        T    GT  Y+APE + 
Sbjct: 143 IVHRDIKGDNVLINTYSGV----LKISDFGTSKRLAGINPCTETFT--GTLQYMAPEIID 196

Query: 404 RNEL--TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL 461
           +        +D++S G  ++E+ +G+ P   +      ++F+            ++   +
Sbjct: 197 KGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE-PQAAMFKVGM--------FKVHPEI 247

Query: 462 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP 494
             S+S++             +  C +  P  R 
Sbjct: 248 PESMSAE---------AKAFILKCFEPDPDKRA 271

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 94.6 bits (236), Expect = 8e-22
 Identities = 46/184 (25%), Positives = 78/184 (42%), Gaps = 14/184 (7%)

Query: 249 GSRVAVKRLKRSSFQRKK---EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 305
              +A+K L +S  +++    +   EI   + L HPN++ +    +D    Y++ EF   
Sbjct: 39  KFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPR 98

Query: 306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 365
           G L      + + GR  +      +   LA  + + H++    V+HRDI+  N+L+  + 
Sbjct: 99  GEL---YKELQKHGRFDEQRSATFMEE-LADALHYCHER---KVIHRDIKPENLLMGYKG 151

Query: 366 GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 425
              +   G S   P      R     GT  YL PE +       K D++  GVL  E + 
Sbjct: 152 ELKIADFGWSVHAP----SLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLV 207

Query: 426 GRRP 429
           G  P
Sbjct: 208 GMPP 211

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 93.8 bits (234), Expect = 1e-21
 Identities = 44/184 (23%), Positives = 78/184 (42%), Gaps = 14/184 (7%)

Query: 249 GSRVAVKRLKRSSFQRKK---EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 305
              +A+K L ++  ++     +   E+   + L HPN++ + G  +D    Y++ E+   
Sbjct: 34  KFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPL 93

Query: 306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 365
           G +      + +  +  +      +   LA  +++ H K    V+HRDI+  N+LL    
Sbjct: 94  GTV---YRELQKLSKFDEQRTATYITE-LANALSYCHSK---RVIHRDIKPENLLLGSAG 146

Query: 366 GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 425
              +   G S   P      R     GT  YL PE +       K D++S GVL  E + 
Sbjct: 147 ELKIADFGWSVHAP----SSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLV 202

Query: 426 GRRP 429
           G+ P
Sbjct: 203 GKPP 206

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 95.6 bits (238), Expect = 1e-21
 Identities = 53/249 (21%), Positives = 97/249 (38%), Gaps = 19/249 (7%)

Query: 189 SKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEG---NRLLGDSKTGGTYSGI 245
           SK R K                WK +  + +     +  +       LG    G  +  +
Sbjct: 12  SKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCV 71

Query: 246 -LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 304
               G     K +       K    +EI    +LHHP L+ +     D  +  ++ EF+ 
Sbjct: 72  EKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 131

Query: 305 NGPL-DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 363
            G L DR    I      +  A  +       +G+  +H+     +VH DI+  N++ + 
Sbjct: 132 GGELFDR----IAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCET 184

Query: 364 EFGAHLMGV--GLSKFV-PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLL 420
           +  + +  +  GL+  + P E+++  T     T  + APE V R  +   +D+++ GVL 
Sbjct: 185 KKASSVKIIDFGLATKLNPDEIVKVTT----ATAEFAAPEIVDREPVGFYTDMWAIGVLG 240

Query: 421 LEIVSGRRP 429
             ++SG  P
Sbjct: 241 YVLLSGLSP 249

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 94.0 bits (234), Expect = 3e-21
 Identities = 37/212 (17%), Positives = 91/212 (42%), Gaps = 43/212 (20%)

Query: 248 DGSRVAVKRLKRSSFQRKKEFYS-----------------EIGRFARLHHPNLVAVKGCC 290
           D    A+K+ ++S  ++K++F                   E+     + +   +  +G  
Sbjct: 53  DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGII 112

Query: 291 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ----GIAFLHDKVK 346
            ++ + YI+YE++ N  + ++  +     ++    + ++V   + +      +++H++  
Sbjct: 113 TNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK- 171

Query: 347 PHVVHRDIRASNVLLDEE-------FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAP 399
            ++ HRD++ SN+L+D+        F       G S+++  + +  +     GTY ++ P
Sbjct: 172 -NICHRDVKPSNILMDKNGRVKLSDF-------GESEYMVDKKI--KGSR--GTYEFMPP 219

Query: 400 EFVYRNELT--TKSDVYSFGVLLLEIVSGRRP 429
           EF          K D++S G+ L  +     P
Sbjct: 220 EFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 95.5 bits (238), Expect = 3e-21
 Identities = 58/250 (23%), Positives = 98/250 (39%), Gaps = 22/250 (8%)

Query: 187 RRSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI- 245
                    R+           P    F T +   +++ +    + LG    G       
Sbjct: 2   HHHHHHSSGRENLYFQGDLQATPGM--FITSKKGHLSEMYQRV-KKLGSGAYGEVLLCRD 58

Query: 246 LPDGSRVAVKRLKRSSFQRKKE--FYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 303
                  A+K ++++S           E+     L HPN++ +     D  + Y+V E  
Sbjct: 59  KVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECY 118

Query: 304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL-D 362
             G L      I    +  +      +   +  G+ +LH     ++VHRD++  N+LL  
Sbjct: 119 KGGEL---FDEIIHRMK-FNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLES 171

Query: 363 EEFGAHLMGV--GLSKFV-PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVL 419
           +E  A +  V  GLS      + M+ER     GT  Y+APE V R +   K DV+S GV+
Sbjct: 172 KEKDALIKIVDFGLSAVFENQKKMKERL----GTAYYIAPE-VLRKKYDEKCDVWSIGVI 226

Query: 420 LLEIVSGRRP 429
           L  +++G  P
Sbjct: 227 LFILLAGYPP 236

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 95.1 bits (237), Expect = 4e-21
 Identities = 56/226 (24%), Positives = 93/226 (41%), Gaps = 21/226 (9%)

Query: 212 KVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKE--- 267
            +F        +  +    R+LG    G          G   AVK + +   ++K +   
Sbjct: 14  GMFVQHSTAIFSDRYKGQ-RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKES 72

Query: 268 FYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMR 327
              E+    +L HPN++ +     D G  Y+V E    G L      I    R       
Sbjct: 73  LLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL---FDEIISRKR-FSEVDA 128

Query: 328 MKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL-DEEFGAHLMGV--GLSKFV-PWEVM 383
            ++   +  GI ++H      +VHRD++  N+LL  +   A++  +  GLS      + M
Sbjct: 129 ARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM 185

Query: 384 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           +++     GT  Y+APE V       K DV+S GV+L  ++SG  P
Sbjct: 186 KDKI----GTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPP 226

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 94.4 bits (235), Expect = 8e-21
 Identities = 63/258 (24%), Positives = 106/258 (41%), Gaps = 33/258 (12%)

Query: 190 KRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI-LPD 248
                S + +       + P    +  ++   I +++ +  R LG    G          
Sbjct: 4   HHHHSSGRENLYFQGIAINPGM--YVRKKEGKIGESYFKV-RKLGSGAYGEVLLCKEKNG 60

Query: 249 GSRVAVKRLKRSSF-------------QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD 295
            S  A+K +K+S F             +  +E Y+EI     L HPN++ +     D   
Sbjct: 61  HSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKY 120

Query: 296 RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIR 355
            Y+V EF   G L      I    +  D      +   +  GI +LH     ++VHRDI+
Sbjct: 121 FYLVTEFYEGGEL---FEQIINRHK-FDECDAANIMKQILSGICYLHKH---NIVHRDIK 173

Query: 356 ASNVLL-DEEFGAHLMGV--GLSKFV-PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKS 411
             N+LL ++    ++  V  GLS F      +++R     GT  Y+APE V + +   K 
Sbjct: 174 PENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL----GTAYYIAPE-VLKKKYNEKC 228

Query: 412 DVYSFGVLLLEIVSGRRP 429
           DV+S GV++  ++ G  P
Sbjct: 229 DVWSCGVIMYILLCGYPP 246

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 93.2 bits (231), Expect = 1e-20
 Identities = 47/354 (13%), Positives = 88/354 (24%), Gaps = 74/354 (20%)

Query: 188 RSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI-L 246
           R+          +  +++L           EL    +    G  +LG             
Sbjct: 42  RTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRG-TVLGQEDPYAYLEATDQ 100

Query: 247 PDGSRVAVKRL---KRSSFQRKKEFYSEIGRFARL----------------------HHP 281
             G    V      +R      K+   E+ R   L                        P
Sbjct: 101 ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDP 160

Query: 282 NLVAVKGCCYDHGDRYIVYEFVV-------NGPLDRWLHHIPRGGRSLDWAMRMKVATTL 334
               +     D  D +++  F +              L       +SL    R+++   +
Sbjct: 161 QKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQV 220

Query: 335 AQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY 394
            + +A LH      +VH  +R  +++LD+  G  L G                   G  +
Sbjct: 221 IRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLV----RDGASAVSPIGRGF 273

Query: 395 G---YLAPEFVY-----RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWAT 446
                 A   +         +T   D ++ G+ +  I     P                 
Sbjct: 274 APPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP------------NTDDA 321

Query: 447 PLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVV 500
            L             I     +IP+      V  L+    ++    R      +
Sbjct: 322 AL--------GGSEWIFRSCKNIPQP-----VRALLEGFLRYPKEDRLLPLQAM 362

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 91.2 bits (227), Expect = 1e-20
 Identities = 43/274 (15%), Positives = 93/274 (33%), Gaps = 54/274 (19%)

Query: 248 DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR----------- 296
           D    A+K+++ +  ++     SE+   A L+H  +V       +  +            
Sbjct: 30  DSRYYAIKKIRHTE-EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKS 88

Query: 297 --YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDI 354
             +I  E+  NG L      I     +       ++   + + ++++H +    ++HRD+
Sbjct: 89  TLFIQMEYCENGTL---YDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDL 142

Query: 355 RASNVLLDEE-------FG---AHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFV 402
           +  N+ +DE        FG        + + K     +      +    GT  Y+A E V
Sbjct: 143 KPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATE-V 201

Query: 403 YRNELT--TKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP 460
                    K D+YS G++  E++          ++  + +             +E    
Sbjct: 202 LDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNI-LKKLRS---------VSIEFPPD 251

Query: 461 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP 494
              +           +K   ++     H P+ RP
Sbjct: 252 FDDNKMKV-------EK--KIIRLLIDHDPNKRP 276

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 91.6 bits (228), Expect = 2e-20
 Identities = 51/252 (20%), Positives = 92/252 (36%), Gaps = 27/252 (10%)

Query: 191 RRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGN----RLLGDSKTGGTYSGI- 245
                 K   P  +A   P+      E    +    S       R LG       +    
Sbjct: 3   APADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISD 62

Query: 246 LPDGSRVAVKRLKRSSFQRKK---EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 302
                  A K + +S   +     +   EI     L H ++V   G   D+   ++V E 
Sbjct: 63  ADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLEL 122

Query: 303 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 362
                L   L    R     +   R      +  G  +LH      V+HRD++  N+ L+
Sbjct: 123 CRRRSL---LELHKRRKALTEPEAR-YYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLN 175

Query: 363 EEFGAHLMGV-----GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFG 417
           E+     + V     GL+  V ++  +++ +   GT  Y+APE + +   + + DV+S G
Sbjct: 176 ED-----LEVKIGDFGLATKVEYDGERKKVL--CGTPNYIAPEVLSKKGHSFEVDVWSIG 228

Query: 418 VLLLEIVSGRRP 429
            ++  ++ G+ P
Sbjct: 229 CIMYTLLVGKPP 240

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 92.5 bits (230), Expect = 2e-20
 Identities = 51/259 (19%), Positives = 83/259 (32%), Gaps = 41/259 (15%)

Query: 248 DGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNG 306
           D   VAVKR+    F        E+        HPN++       D   +YI  E     
Sbjct: 47  DNRDVAVKRILPECFSFAD---REVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AA 102

Query: 307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 366
            L  +   + +   +      + +      G+A LH     ++VHRD++  N+L+     
Sbjct: 103 TLQEY---VEQKDFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNA 156

Query: 367 AHLMGV-----GLSK-FVPWEVMQERTVMAGGTYGYLAPEFVYRNE---LTTKSDVYSFG 417
              +       GL K          R     GT G++APE +  +     T   D++S G
Sbjct: 157 HGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAG 216

Query: 418 VLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS--SLSSDIPEAGVV 475
            +   ++S                F                + L+   SL    PE    
Sbjct: 217 CVFYYVISEGSH-----------PF--------GKSLQRQANILLGACSLDCLHPEKHED 257

Query: 476 QKVVDLVYACTQHVPSMRP 494
               +L+       P  RP
Sbjct: 258 VIARELIEKMIAMDPQKRP 276

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 91.6 bits (227), Expect = 2e-20
 Identities = 25/206 (12%), Positives = 59/206 (28%), Gaps = 19/206 (9%)

Query: 248 DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 307
           +  +  +K  K ++          + R         +             +V E    G 
Sbjct: 94  NKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGT 153

Query: 308 L-DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 366
           L +    +     + +   + +  A  +   I  +HD     ++H DI+  N +L   F 
Sbjct: 154 LLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFL 210

Query: 367 AHLMGV-----------GLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDV 413
                            G S  +  ++  + T+      T G+   E +       + D 
Sbjct: 211 EQDDEDDLSAGLALIDLGQSIDM--KLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDY 268

Query: 414 YSFGVLLLEIVSGRRPAQAVDSVCWQ 439
           +     +  ++ G       +    +
Sbjct: 269 FGVAATVYCMLFGTYMKVKNEGGECK 294

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 91.6 bits (227), Expect = 3e-20
 Identities = 46/351 (13%), Positives = 87/351 (24%), Gaps = 79/351 (22%)

Query: 188 RSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI-L 246
           R+          +  +++L           EL    +    G  +LG             
Sbjct: 37  RTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRG-TVLGQEDPYAYLEATDQ 95

Query: 247 PDGSRVAVKRLKRSSFQRKKE----------------------------FYSEIGRFARL 278
             G    V     +                                   F          
Sbjct: 96  ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDP 155

Query: 279 HHPNLVAVKGCCYDHG--DRYIVYEFVV--NGPLDRWLHHIPRGGRSLDWAMRMKVATTL 334
               ++ V+    D     R+ +Y  +          L       +SL    R+++   +
Sbjct: 156 QKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQV 215

Query: 335 AQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY 394
            + +A LH      +VH  +R  +++LD+  G  L G          V     V++  + 
Sbjct: 216 IRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHL------VRDGARVVSSVSR 266

Query: 395 GYLAPEFVYRNEL-----------TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFE 443
           G+  PE   R              T   D ++ G+++  I     P              
Sbjct: 267 GFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP------------IT 314

Query: 444 WATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP 494
                             I     +IP+      V  L+    ++    R 
Sbjct: 315 --------KDAALGGSEWIFRSCKNIPQP-----VRALLEGFLRYPKEDRL 352

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 89.5 bits (223), Expect = 3e-20
 Identities = 51/212 (24%), Positives = 88/212 (41%), Gaps = 30/212 (14%)

Query: 231 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQR---KKEFYSEIGRFARLHHPNLVAV 286
            LLG     G Y    +  G  VA+K + + +  +    +   +E+    +L HP+++ +
Sbjct: 17  NLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILEL 76

Query: 287 KGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVK 346
                D    Y+V E   NG ++R+L +  R     +   R  +   +  G+ +LH    
Sbjct: 77  YNYFEDSNYVYLVLEMCHNGEMNRYLKN--RVKPFSENEARHFMHQ-IITGMLYLHSH-- 131

Query: 347 PHVVHRDIRASNVLLDEE-------FG--AHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 397
             ++HRD+  SN+LL          FG    L                 T+   GT  Y+
Sbjct: 132 -GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH---------YTLC--GTPNYI 179

Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           +PE   R+    +SDV+S G +   ++ GR P
Sbjct: 180 SPEIATRSAHGLESDVWSLGCMFYTLLIGRPP 211

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 89.2 bits (222), Expect = 6e-20
 Identities = 57/218 (26%), Positives = 95/218 (43%), Gaps = 21/218 (9%)

Query: 221 SITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKE-FYSEIGRFARL 278
           +I   F    R LG    G  +       G    +K + +   Q   E   +EI     L
Sbjct: 19  TIDDLFIFK-RKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL 77

Query: 279 HHPNLVAVKGCCYDHGDRYIVYEFVVNGPL-DRWLHHIPRGGR--SLDWAMRMKVATTLA 335
            HPN++ +     D+ + YIV E    G L +R +    RG        A  MK    + 
Sbjct: 78  DHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMK---QMM 134

Query: 336 QGIAFLHDKVKPHVVHRDIRASNVLL-DEEFGAHLMGV--GLSKFV-PWEVMQERTVMAG 391
             +A+ H +   HVVH+D++  N+L  D    + +  +  GL++     E          
Sbjct: 135 NALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA---- 187

Query: 392 GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           GT  Y+APE V++ ++T K D++S GV++  +++G  P
Sbjct: 188 GTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTGCLP 224

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 88.6 bits (220), Expect = 9e-20
 Identities = 37/266 (13%), Positives = 68/266 (25%), Gaps = 64/266 (24%)

Query: 252 VAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR----YIVYEFVV 304
           VA+  +           +E  S   R +R+  P +  V     D         +V E++ 
Sbjct: 59  VALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV----LDVVHTRAGGLVVAEWIR 114

Query: 305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 364
            G L            S   A+R     +LA      H      V       S V +  +
Sbjct: 115 GGSLQEVA----DTSPSPVGAIR--AMQSLAAAADAAHRA---GVALSIDHPSRVRVSID 165

Query: 365 FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIV 424
               L                           +            + D+   G  L  ++
Sbjct: 166 GDVVL----------------------AYPATMPDA-------NPQDDIRGIGASLYALL 196

Query: 425 SGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYA 484
             R P                    +     + ++P  + +  DIP       +  +   
Sbjct: 197 VNRWPLPEAGV-------RSGLAPAERDTAGQPIEP--ADIDRDIPFQ-----ISAVAAR 242

Query: 485 CTQHVPSMRPRMSHVVHQLQQLAQPP 510
             Q    +R   S +++ +QQ     
Sbjct: 243 SVQGDGGIRSA-STLLNLMQQATAVA 267

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 91.4 bits (227), Expect = 9e-20
 Identities = 47/250 (18%), Positives = 97/250 (38%), Gaps = 19/250 (7%)

Query: 188 RSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEG---NRLLGDSKTGGTYSG 244
              +  + +   +      V   WK +  + +     +  +    +  LG    G  +  
Sbjct: 117 EQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRV 176

Query: 245 I-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 303
                G+  A K +       K+    EI   + L HP LV +     D  +  ++YEF+
Sbjct: 177 TERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236

Query: 304 VNGPL-DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 362
             G L ++    +      +     ++    + +G+  +H+    + VH D++  N++  
Sbjct: 237 SGGELFEK----VADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFT 289

Query: 363 EEFGAHLMGV--GLSKFV-PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVL 419
            +    L  +  GL+  + P + ++  T    GT  + APE      +   +D++S GVL
Sbjct: 290 TKRSNELKLIDFGLTAHLDPKQSVKVTT----GTAEFAAPEVAEGKPVGYYTDMWSVGVL 345

Query: 420 LLEIVSGRRP 429
              ++SG  P
Sbjct: 346 SYILLSGLSP 355

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 89.0 bits (221), Expect = 2e-19
 Identities = 51/243 (20%), Positives = 96/243 (39%), Gaps = 21/243 (8%)

Query: 188 RSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSE-----GNRLLGDSKTGGTY 242
               R   +     A +  +P     F    + +     +         +LG  + G  +
Sbjct: 47  DLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVH 106

Query: 243 SGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE 301
                  G ++A K +K    + K+E  +EI    +L H NL+ +        D  +V E
Sbjct: 107 KCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVME 166

Query: 302 FVVNGPL-DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
           +V  G L DR    I     +L     +     + +GI  +H     +++H D++  N+L
Sbjct: 167 YVDGGELFDR----IIDESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENIL 219

Query: 361 LDEEFGAHLMGV--GLSKFV-PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFG 417
                   +  +  GL++   P E ++       GT  +LAPE V  + ++  +D++S G
Sbjct: 220 CVNRDAKQIKIIDFGLARRYKPREKLKVNF----GTPEFLAPEVVNYDFVSFPTDMWSVG 275

Query: 418 VLL 420
           V+ 
Sbjct: 276 VIA 278

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 90.1 bits (224), Expect = 2e-19
 Identities = 56/217 (25%), Positives = 91/217 (41%), Gaps = 20/217 (9%)

Query: 220 RSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRK--KEFYSEIGRFA 276
            +  + ++    +LG    G              AVK + ++S + K       E+    
Sbjct: 18  GTFAERYNIV-CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK 76

Query: 277 RLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ 336
           +L HPN++ +     D    YIV E    G L      I +  R        ++   +  
Sbjct: 77  KLDHPNIMKLFEILEDSSSFYIVGELYTGGEL---FDEIIKRKR-FSEHDAARIIKQVFS 132

Query: 337 GIAFLHDKVKPHVVHRDIRASNVLL-DEEFGAHLMGV--GLSKFV-PWEVMQERTVMAGG 392
           GI ++H     ++VHRD++  N+LL  +E    +  +  GLS        M++R     G
Sbjct: 133 GITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI----G 185

Query: 393 TYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           T  Y+APE V R     K DV+S GV+L  ++SG  P
Sbjct: 186 TAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPP 221

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 87.7 bits (218), Expect = 3e-19
 Identities = 33/188 (17%), Positives = 71/188 (37%), Gaps = 22/188 (11%)

Query: 249 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 308
                 K +K      +     EI       H N++ +        +  +++EF+    +
Sbjct: 30  KKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDI 88

Query: 309 -DRWLHHIPRGGRSL---DWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 364
            +R    I      L   +    +     + + + FLH     ++ H DIR  N++    
Sbjct: 89  FER----INTSAFELNEREIVSYVH---QVCEALQFLHSH---NIGHFDIRPENIIYQTR 138

Query: 365 FGAHLMGV--GLSKFV-PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLL 421
             + +  +  G ++ + P +  +           Y APE    + ++T +D++S G L+ 
Sbjct: 139 RSSTIKIIEFGQARQLKPGDNFRLLF----TAPEYYAPEVHQHDVVSTATDMWSLGTLVY 194

Query: 422 EIVSGRRP 429
            ++SG  P
Sbjct: 195 VLLSGINP 202

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 87.2 bits (217), Expect = 3e-19
 Identities = 52/212 (24%), Positives = 89/212 (41%), Gaps = 22/212 (10%)

Query: 216 TEELRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGR 274
           + +  +I K F     +LG       +       G   A+K +K+S   R     +EI  
Sbjct: 1   SMQTTNIRKTFIFM-EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAV 59

Query: 275 FARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL-DRWLHHIPRGGR--SLDWAMRMKVA 331
             ++ H N+V ++         Y+V + V  G L DR    I   G     D ++ ++  
Sbjct: 60  LKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDR----ILERGVYTEKDASLVIQ-- 113

Query: 332 TTLAQGIAFLHDKVKPHVVHRDIRASNVLL-DEEFGAHLMGV--GLSKFVPWEVMQERTV 388
             +   + +LH+     +VHRD++  N+L    E  + +M    GLSK     +M     
Sbjct: 114 -QVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTAC- 168

Query: 389 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLL 420
              GT GY+APE + +   +   D +S GV+ 
Sbjct: 169 ---GTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 86.1 bits (214), Expect = 5e-19
 Identities = 49/217 (22%), Positives = 88/217 (40%), Gaps = 24/217 (11%)

Query: 221 SITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH 279
            I + ++     +G    G     +      R A K++ +   +    F  EI     L 
Sbjct: 6   DINQYYTLE-NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLD 64

Query: 280 HPNLVAVKGCCYDHGDRYIVYEFVVNGPL-DRWLHHIPRGGR--SLDWAMRMKVATTLAQ 336
           HPN++ +     D+ D Y+V E    G L +R    +         D A  MK    +  
Sbjct: 65  HPNIIRLYETFEDNTDIYLVMELCTGGELFER----VVHKRVFRESDAARIMK---DVLS 117

Query: 337 GIAFLHDKVKPHVVHRDIRASNVLL-DEEFGAHLMGV--GLSKFV-PWEVMQERTVMAGG 392
            +A+ H     +V HRD++  N L   +   + L  +  GL+    P ++M+ +     G
Sbjct: 118 AVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV----G 170

Query: 393 TYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           T  Y++P+ V       + D +S GV++  ++ G  P
Sbjct: 171 TPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCGYPP 206

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 85.7 bits (213), Expect = 1e-18
 Identities = 42/189 (22%), Positives = 79/189 (41%), Gaps = 22/189 (11%)

Query: 249 GSRVAVKRLKRSSFQRKK---EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 305
               A K + +S   +     +   EI     L H ++V   G   D+   ++V E    
Sbjct: 40  KEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRR 99

Query: 306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 365
             L   L    R     +   R      +  G  +LH      V+HRD++  N+ L+E+ 
Sbjct: 100 RSL---LELHKRRKALTEPEAR-YYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNED- 151

Query: 366 GAHLMGV-----GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLL 420
               + V     GL+  V ++  +++ +   GT  Y+APE + +   + + DV+S G ++
Sbjct: 152 ----LEVKIGDFGLATKVEYDGERKKVL--CGTPNYIAPEVLSKKGHSFEVDVWSIGCIM 205

Query: 421 LEIVSGRRP 429
             ++ G+ P
Sbjct: 206 YTLLVGKPP 214

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 85.4 bits (212), Expect = 1e-18
 Identities = 60/264 (22%), Positives = 107/264 (40%), Gaps = 50/264 (18%)

Query: 247 PDGSRVAVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVV 304
           P G  +AVKR++   + Q +K    ++    R    P  V   G  +  GD +I  E + 
Sbjct: 30  PSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELM- 88

Query: 305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 364
           +  LD++   +   G+++   +  K+A ++ + +  LH K+   V+HRD++ SNVL++  
Sbjct: 89  DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINAL 146

Query: 365 -------FG--AHLMG-VGLSKFVPWEVMQERTVMAGGTYGYLAPE----FVYRNELTTK 410
                  FG   +L+  V                   G   Y+APE     + +   + K
Sbjct: 147 GQVKMCDFGISGYLVDDVAKDIDA-------------GCKPYMAPERINPELNQKGYSVK 193

Query: 411 SDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIP 470
           SD++S G+ ++E+   R P              W TP        + L  ++   S  +P
Sbjct: 194 SDIWSLGITMIELAILRFP-----------YDSWGTP-------FQQLKQVVEEPSPQLP 235

Query: 471 EAGVVQKVVDLVYACTQHVPSMRP 494
                 + VD    C +     RP
Sbjct: 236 ADKFSAEFVDFTSQCLKKNSKERP 259

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 86.0 bits (213), Expect = 1e-18
 Identities = 58/289 (20%), Positives = 104/289 (35%), Gaps = 56/289 (19%)

Query: 248 DGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDH-----------GD 295
            G   A+KRL  +  ++ +    E+    +L  HPN+V                      
Sbjct: 52  SGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQ----FCSAASIGKEESDTGQA 107

Query: 296 RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIR 355
            +++   +  G L  +L  +   G  L     +K+     + +  +H + KP ++HRD++
Sbjct: 108 EFLLLTELCKGQLVEFLKKMESRGP-LSCDTVLKIFYQTCRAVQHMHRQ-KPPIIHRDLK 165

Query: 356 ASNVLLDEE-------FG---AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFV--Y 403
             N+LL  +       FG           S       + E  +    T  Y  PE +  Y
Sbjct: 166 VENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLY 225

Query: 404 RNE-LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPL-VQSHRYLELLDPL 461
            N  +  K D+++ G +L  +   + P            FE    L + + +Y     P 
Sbjct: 226 SNFPIGEKQDIWALGCILYLLCFRQHP------------FEDGAKLRIVNGKYSI---PP 270

Query: 462 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 510
             +  +             L+ A  Q  P  R  ++ VVHQLQ++A   
Sbjct: 271 HDTQYTVF---------HSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 88.2 bits (218), Expect = 1e-18
 Identities = 43/193 (22%), Positives = 86/193 (44%), Gaps = 21/193 (10%)

Query: 249 GSRVAVKRLKRSSFQRKKE-FYSEIGRFARLHHPNLVAV------KGCCYDHGDRYIVYE 301
           G +VA+K+ ++    + +E +  EI    +L+HPN+V+             +    +  E
Sbjct: 39  GEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAME 98

Query: 302 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL 361
           +   G L ++L+        L       + + ++  + +LH+     ++HRD++  N++L
Sbjct: 99  YCEGGDLRKYLNQFENCCG-LKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVL 154

Query: 362 DEEFGAHLMGV---GLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVYSF 416
                  +  +   G +K      + +  +     GT  YLAPE + + + T   D +SF
Sbjct: 155 QPGPQRLIHKIIDLGYAKE-----LDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSF 209

Query: 417 GVLLLEIVSGRRP 429
           G L  E ++G RP
Sbjct: 210 GTLAFECITGFRP 222

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 86.8 bits (215), Expect = 2e-18
 Identities = 48/209 (22%), Positives = 70/209 (33%), Gaps = 34/209 (16%)

Query: 248 DGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNG 306
            G  VAVKR+             EI        HPN++            YI  E   N 
Sbjct: 38  QGRPVAVKRMLIDFCDIAL---MEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL-CNL 93

Query: 307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQ---GIAFLHDKVKPHVVHRDIRASNVLLDE 363
            L   +        +L         + L Q   G+A LH      ++HRD++  N+L+  
Sbjct: 94  NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVST 150

Query: 364 EFGAHLMGV-------------GLSKFVPWEVMQERTVM--AGGTYGYLAPE-------F 401
                                 GL K +       RT +    GT G+ APE        
Sbjct: 151 SSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNL 210

Query: 402 VYRNELTTKSDVYSFGVLLLEIVS-GRRP 429
             +  LT   D++S G +   I+S G+ P
Sbjct: 211 QTKRRLTRSIDIFSMGCVFYYILSKGKHP 239

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 83.8 bits (208), Expect = 3e-18
 Identities = 60/219 (27%), Positives = 94/219 (42%), Gaps = 26/219 (11%)

Query: 221 SITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKE--FYSEIGRFAR 277
           +  + ++    +LG    G              AVK + ++S + K       E+    +
Sbjct: 19  TFAERYNIV-CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKK 77

Query: 278 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL-DRWLHHIPRGGR--SLDWAMRMKVATTL 334
           L HPN++ +     D    YIV E    G L D     I +  R    D A  +K    +
Sbjct: 78  LDHPNIMKLFEILEDSSSFYIVGELYTGGELFDE----IIKRKRFSEHDAARIIK---QV 130

Query: 335 AQGIAFLHDKVKPHVVHRDIRASNVLL-DEEFGAHLMGV--GLSKFV-PWEVMQERTVMA 390
             GI ++H     ++VHRD++  N+LL  +E    +  +  GLS        M++R    
Sbjct: 131 FSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--- 184

Query: 391 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
            GT  Y+APE V R     K DV+S GV+L  ++SG  P
Sbjct: 185 -GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPP 221

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 85.0 bits (210), Expect = 5e-18
 Identities = 43/209 (20%), Positives = 81/209 (38%), Gaps = 21/209 (10%)

Query: 234 GDSKTGGTYSGI-LPDGSRVAVKR--LKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 290
           G             P G  V V+R  L+  S +       E+      +HPN+V  +   
Sbjct: 36  GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95

Query: 291 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLA---QGIAFLHDKVKP 347
               + ++V  F+  G     +      G +        +A  L    + + ++H     
Sbjct: 96  IADNELWVVTSFMAYGSAKDLICTHFMDGMNELA-----IAYILQGVLKALDYIHHM--- 147

Query: 348 HVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG-----GTYGYLAPEFV 402
             VHR ++AS++L+  +   +L G+  +  +     ++R V            +L+PE +
Sbjct: 148 GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVL 207

Query: 403 YRNEL--TTKSDVYSFGVLLLEIVSGRRP 429
            +N      KSD+YS G+   E+ +G  P
Sbjct: 208 QQNLQGYDAKSDIYSVGITACELANGHVP 236

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 83.1 bits (206), Expect = 7e-18
 Identities = 49/207 (23%), Positives = 88/207 (42%), Gaps = 29/207 (14%)

Query: 233 LGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 291
           +G   +G  Y+ + +  G  VA++++      +K+   +EI       +PN+V       
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87

Query: 292 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 351
              + ++V E++  G L   +         +D      V     Q + FLH      V+H
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTETC-----MDEGQIAAVCRECLQALEFLHSN---QVIH 139

Query: 352 RDIRASNVLLDEE-------FG--AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFV 402
           RDI++ N+LL  +       FG  A +               +R+ M G  Y ++APE V
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQIT----------PEQSKRSTMVGTPY-WMAPEVV 188

Query: 403 YRNELTTKSDVYSFGVLLLEIVSGRRP 429
            R     K D++S G++ +E++ G  P
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 83.9 bits (208), Expect = 8e-18
 Identities = 50/247 (20%), Positives = 90/247 (36%), Gaps = 35/247 (14%)

Query: 201 PAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVK---- 255
           P  S        +   ++       +     ++G          I    G + AVK    
Sbjct: 3   PGISGGGGGILDM--ADDDVLFEDVYELC-EVIGKGPFSVVRRCINRETGQQFAVKIVDV 59

Query: 256 -RLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL-DRWLH 313
            +   S     ++   E      L HP++V +       G  Y+V+EF+    L      
Sbjct: 60  AKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFE--- 116

Query: 314 HIPRGGRSLDW------AMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL-DEEFG 366
            I +   +         +  M+    + + + + HD    +++HRD++   VLL  +E  
Sbjct: 117 -IVKRADAGFVYSEAVASHYMR---QILEALRYCHDN---NIIHRDVKPHCVLLASKENS 169

Query: 367 AHLMGV--GLSKFV--PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLE 422
           A +     G++  +     V   R     GT  ++APE V R       DV+  GV+L  
Sbjct: 170 APVKLGGFGVAIQLGESGLVAGGRV----GTPHFMAPEVVKREPYGKPVDVWGCGVILFI 225

Query: 423 IVSGRRP 429
           ++SG  P
Sbjct: 226 LLSGCLP 232

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 83.2 bits (206), Expect = 9e-18
 Identities = 49/207 (23%), Positives = 95/207 (45%), Gaps = 29/207 (14%)

Query: 233 LGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 291
           +G+  TG          G +VAVK +     QR++  ++E+       H N+V +     
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112

Query: 292 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 351
              + +++ EF+  G L   +  +      L+      V   + Q +A+LH +    V+H
Sbjct: 113 VGEELWVLMEFLQGGALTDIVSQVR-----LNEEQIATVCEAVLQALAYLHAQ---GVIH 164

Query: 352 RDIRASNVLLDEE-------FG--AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFV 402
           RDI++ ++LL  +       FG  A +           + + +R  + G  Y ++APE +
Sbjct: 165 RDIKSDSILLTLDGRVKLSDFGFCAQIS----------KDVPKRKSLVGTPY-WMAPEVI 213

Query: 403 YRNELTTKSDVYSFGVLLLEIVSGRRP 429
            R+   T+ D++S G++++E+V G  P
Sbjct: 214 SRSLYATEVDIWSLGIMVIEMVDGEPP 240

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 83.5 bits (207), Expect = 1e-17
 Identities = 66/250 (26%), Positives = 106/250 (42%), Gaps = 25/250 (10%)

Query: 187 RRSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI- 245
              +        + P  ++LVP  W   +  +  +++  F      LG   T   Y    
Sbjct: 18  LYFQSMSSVTASAAPGTASLVPDYWIDGSNRD--ALSDFFEVE-SELGRGATSIVYRCKQ 74

Query: 246 LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 305
                  A+K LK++    KK   +EIG   RL HPN++ +K       +  +V E V  
Sbjct: 75  KGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTG 132

Query: 306 GPL-DRWLHHIPRGGRS-LDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL-D 362
           G L DR    + +G  S  D A  +K    + + +A+LH+     +VHRD++  N+L   
Sbjct: 133 GELFDRI---VEKGYYSERDAADAVK---QILEAVAYLHEN---GIVHRDLKPENLLYAT 183

Query: 363 EEFGAHLMGV--GLSKFV-PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVL 419
               A L     GLSK V    +M+       GT GY APE +       + D++S G++
Sbjct: 184 PAPDAPLKIADFGLSKIVEHQVLMKTVC----GTPGYCAPEILRGCAYGPEVDMWSVGII 239

Query: 420 LLEIVSGRRP 429
              ++ G  P
Sbjct: 240 TYILLCGFEP 249

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 82.7 bits (205), Expect = 1e-17
 Identities = 49/294 (16%), Positives = 106/294 (36%), Gaps = 55/294 (18%)

Query: 242 YSGILPDGSRVAVKRLKRSSFQRK--KEFYSEIGRFARLHHPNLVAVK--GCCYDHGDRY 297
           +  +       A+K +       +    + +EI    +L   +   ++           Y
Sbjct: 45  FQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 104

Query: 298 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 357
           +V E   N  L+ WL       +S+D   R      + + +  +H      +VH D++ +
Sbjct: 105 MVMECG-NIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPA 156

Query: 358 NVLLDEEFGAHLMGV------GLSKFVPWEVMQERTVMAGGTYGYLAPE----------- 400
           N L+ +       G+      G++  +  +          GT  Y+ PE           
Sbjct: 157 NFLIVD-------GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSREN 209

Query: 401 FVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP 460
              +++++ KSDV+S G +L  +  G+ P              +   + Q  +   ++DP
Sbjct: 210 GKSKSKISPKSDVWSLGCILYYMTYGKTP--------------FQQIINQISKLHAIIDP 255

Query: 461 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHV-VHQLQQLAQPPVTK 513
              +   + P+    + + D++  C +  P  R  +  +  H   Q+   PV +
Sbjct: 256 ---NHEIEFPD-IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQ 305

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 83.7 bits (207), Expect = 1e-17
 Identities = 40/264 (15%), Positives = 91/264 (34%), Gaps = 37/264 (14%)

Query: 187 RRSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGIL 246
             +  + + + + +P               E +    + +S   + +G   +   +  + 
Sbjct: 19  ETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSIL-KQIGSGGSSKVFQVLN 77

Query: 247 PDGSRVAVKRLKRSSFQRK--KEFYSEIGRFARLHHPNLVAVK--GCCYDHGDRYIVYEF 302
                 A+K +       +    + +EI    +L   +   ++           Y+V E 
Sbjct: 78  EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC 137

Query: 303 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 362
             N  L+ WL       +S+D   R      + + +  +H      +VH D++ +N L+ 
Sbjct: 138 G-NIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV 189

Query: 363 EE------FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE-----------FVYRN 405
           +       FG       ++  +  +          G   Y+ PE              ++
Sbjct: 190 DGMLKLIDFG-------IANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKS 242

Query: 406 ELTTKSDVYSFGVLLLEIVSGRRP 429
           +++ KSDV+S G +L  +  G+ P
Sbjct: 243 KISPKSDVWSLGCILYYMTYGKTP 266

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 83.0 bits (205), Expect = 2e-17
 Identities = 56/281 (19%), Positives = 103/281 (36%), Gaps = 52/281 (18%)

Query: 247 PDGSRVAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 305
           P G  +A K +        + +   E+      + P +V   G  Y  G+  I  E +  
Sbjct: 56  PSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDG 115

Query: 306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE- 364
           G LD+ L    +    +   +  KV+  + +G+ +L +K K  ++HRD++ SN+L++   
Sbjct: 116 GSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRG 169

Query: 365 ------FG--AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSF 416
                 FG    L+    + FV             GT  Y++PE +     + +SD++S 
Sbjct: 170 EIKLCDFGVSGQLIDSMANSFV-------------GTRSYMSPERLQGTHYSVQSDIWSM 216

Query: 417 GVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAG--- 473
           G+ L+E+  GR P    D+   + +F        +        P        +       
Sbjct: 217 GLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMA 276

Query: 474 ---VVQKVV-----------------DLVYACTQHVPSMRP 494
              ++  +V                 D V  C    P+ R 
Sbjct: 277 IFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERA 317

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 81.9 bits (203), Expect = 2e-17
 Identities = 47/183 (25%), Positives = 82/183 (44%), Gaps = 16/183 (8%)

Query: 253 AVKRLKRSSFQRKKEF---YSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 309
           A+K L++    ++ +      E    +RL HP  V +     D    Y    +  NG L 
Sbjct: 59  AIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL- 117

Query: 310 RWLHHIPRGGRSLDWAMRMKVAT-TLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 368
             L +I + G   +   R   A    A  + +LH K    ++HRD++  N+LL+E+   H
Sbjct: 118 --LKYIRKIGSFDETCTRFYTAEIVSA--LEYLHGK---GIIHRDLKPENILLNED--MH 168

Query: 369 LMGV--GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSG 426
           +     G +K +  E  Q R     GT  Y++PE +        SD+++ G ++ ++V+G
Sbjct: 169 IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

Query: 427 RRP 429
             P
Sbjct: 229 LPP 231

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 81.7 bits (202), Expect = 3e-17
 Identities = 47/228 (20%), Positives = 81/228 (35%), Gaps = 27/228 (11%)

Query: 220 RSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKE-FYSEIGRFAR 277
           +S + +    + +LG   T   + G     G   A+K     SF R  +    E     +
Sbjct: 4   QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKK 63

Query: 278 LHHPNLVAVKGCCYDHGDR--YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLA 335
           L+H N+V +     +   R   ++ EF   G L   L   P     L  +  + V   + 
Sbjct: 64  LNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEE-PSNAYGLPESEFLIVLRDVV 122

Query: 336 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH----LMGVGLSKFVPWEVMQERTVMAG 391
            G+  L +     +VHR+I+  N++            L   G ++      +++      
Sbjct: 123 GGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE-----LEDDEQFVS 174

Query: 392 --GTYGYLAPEFVYRNELTT--------KSDVYSFGVLLLEIVSGRRP 429
             GT  YL P+   R  L            D++S GV      +G  P
Sbjct: 175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 81.1 bits (201), Expect = 5e-17
 Identities = 42/221 (19%), Positives = 87/221 (39%), Gaps = 25/221 (11%)

Query: 212 KVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRK--KEF 268
           +    + + +    +   ++ LG  K       I    G   A K LK+    +    E 
Sbjct: 16  ENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEI 75

Query: 269 YSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPL-DRWLHHIPRGGRSL---D 323
             EI         P ++ +     +  +  ++ E+   G +       +P     +   D
Sbjct: 76  LHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLC---LPELAEMVSEND 132

Query: 324 WAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL-DEEFGAHLMGV--GLSKFV-P 379
               +K    + +G+ +LH     ++VH D++  N+LL        +  V  G+S+ +  
Sbjct: 133 VIRLIK---QILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH 186

Query: 380 WEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLL 420
              ++E      GT  YLAPE +  + +TT +D+++ G++ 
Sbjct: 187 ACELREIM----GTPEYLAPEILNYDPITTATDMWNIGIIA 223

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 80.3 bits (199), Expect = 6e-17
 Identities = 49/218 (22%), Positives = 87/218 (39%), Gaps = 23/218 (10%)

Query: 223 TKNFSEG---NRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRK--KEFYSEIGRFA 276
           +  FS+       LG          +    G   A K +       +  ++   E     
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60

Query: 277 RLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL-DRWLHHIPRGGRSLDWAMRMKVATTLA 335
           +L HPN+V +     +    Y+V++ V  G L +     + R   S   A        + 
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI---VAREFYSEADAS--HCIQQIL 115

Query: 336 QGIAFLHDKVKPHVVHRDIRASNVLL-DEEFGAHLMGV--GLSKFV-PWEVMQERTVMAG 391
           + IA+ H      +VHR+++  N+LL  +  GA +     GL+  V   E          
Sbjct: 116 ESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA---- 168

Query: 392 GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           GT GYL+PE + ++  +   D+++ GV+L  ++ G  P
Sbjct: 169 GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 80.9 bits (200), Expect = 6e-17
 Identities = 50/295 (16%), Positives = 108/295 (36%), Gaps = 57/295 (19%)

Query: 242 YSGILPDGSRVAVKRLKRSSFQRK--KEFYSEIGRFARLHHPNLVAVK--GCCYDHGDRY 297
           +  +       A+K +       +    + +EI    +L   +   ++           Y
Sbjct: 26  FQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 85

Query: 298 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 357
           +V E   N  L+ WL       +S+D   R      + + +  +H      +VH D++ +
Sbjct: 86  MVMECG-NIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPA 137

Query: 358 NVLLDEEFGAHLMGV------GLSKFV-PWEVMQERTVMAGGTYGYLAPE---------- 400
           N L+ +       G+      G++  + P      +    G T  Y+ PE          
Sbjct: 138 NFLIVD-------GMLKLIDFGIANQMQPDTTSVVKDSQVG-TVNYMPPEAIKDMSSSRE 189

Query: 401 -FVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD 459
               +++++ KSDV+S G +L  +  G+ P              +   + Q  +   ++D
Sbjct: 190 NGKSKSKISPKSDVWSLGCILYYMTYGKTP--------------FQQIINQISKLHAIID 235

Query: 460 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVV-HQLQQLAQPPVTK 513
           P   +   + P+    + + D++  C +  P  R  +  ++ H   Q+   PV +
Sbjct: 236 P---NHEIEFPD-IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQ 286

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 81.4 bits (201), Expect = 8e-17
 Identities = 43/232 (18%), Positives = 79/232 (34%), Gaps = 35/232 (15%)

Query: 220 RSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKE-FYSEIGRFAR 277
           +S + +    + +LG   T   + G     G   A+K     SF R  +    E     +
Sbjct: 4   QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKK 63

Query: 278 LHHPNLVAVKGCCYDHGDR--YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATT-- 333
           L+H N+V +     +   R   ++ EF   G L      +     +  + +         
Sbjct: 64  LNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSL---YTVLEEPSNA--YGLPESEFLIVL 118

Query: 334 --LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH----LMGVGLSKFVPWEVMQERT 387
             +  G+  L +     +VHR+I+  N++            L   G ++      +++  
Sbjct: 119 RDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE-----LEDDE 170

Query: 388 VMAG--GTYGYLAPEFVYRNELTT--------KSDVYSFGVLLLEIVSGRRP 429
                 GT  YL P+   R  L            D++S GV      +G  P
Sbjct: 171 QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 80.8 bits (200), Expect = 1e-16
 Identities = 43/183 (23%), Positives = 84/183 (45%), Gaps = 16/183 (8%)

Query: 253 AVKRLKRSSFQRKKEF---YSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 309
           A+K + +     + E    + E+     L HP LV +     D  D ++V + ++ G L 
Sbjct: 44  AMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDL- 102

Query: 310 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHL 369
              +H+ +     +  +++ +   L   + +L ++    ++HRD++  N+LLDE    H+
Sbjct: 103 --RYHLQQNVHFKEETVKLFICE-LVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHI 156

Query: 370 MGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELT--TKS-DVYSFGVLLLEIVSG 426
               ++  +P E    +     GT  Y+APE     +    + + D +S GV   E++ G
Sbjct: 157 TDFNIAAMLPRE---TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRG 213

Query: 427 RRP 429
           RRP
Sbjct: 214 RRP 216

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 80.1 bits (198), Expect = 1e-16
 Identities = 46/219 (21%), Positives = 85/219 (38%), Gaps = 25/219 (11%)

Query: 221 SITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL- 278
           ++T ++    ++LG    G          G + A+K L  S   R+     E+    +  
Sbjct: 25  AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ-----EVDHHWQAS 79

Query: 279 HHPNLVAVKGCCYDHGDR----YIVYEFVVNGPLDRWLHHI-PRGGRSLDWAMRMKVATT 333
             P++V +     +         I+ E +  G L      I  RG ++       ++   
Sbjct: 80  GGPHIVCILDVYENMHHGKRCLLIIMECMEGGEL---FSRIQERGDQAFTEREAAEIMRD 136

Query: 334 LAQGIAFLHDKVKPHVVHRDIRASNVLL-DEEFGAHLMGV--GLSKFVPWEVMQERTVMA 390
           +   I FLH     ++ HRD++  N+L   +E  A L     G +K      +Q      
Sbjct: 137 IGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPC--- 190

Query: 391 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
             T  Y+APE +   +     D++S GV++  ++ G  P
Sbjct: 191 -YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 79.9 bits (197), Expect = 2e-16
 Identities = 47/247 (19%), Positives = 80/247 (32%), Gaps = 51/247 (20%)

Query: 231 RLLGDSKTGGTYSGI-LPDGSRVAVK-----RLKRSSFQRKKEFYSEIGRFARLHHPNLV 284
             +G    G     I     +  A+K     ++++ + +  +   +E+    +LHHPN+ 
Sbjct: 32  GAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIA 91

Query: 285 AVKGCCYDHGDRYIVYEFVVNGPL-DRWLHHIPRGGRSLDWAMRM--------------- 328
            +     D     +V E    G L D+    I          +                 
Sbjct: 92  RLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAIN 151

Query: 329 --------------------KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 368
                                +   +   + +LH++    + HRDI+  N L        
Sbjct: 152 GSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFE 208

Query: 369 LMGV--GLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNEL--TTKSDVYSFGVLLLE 422
           +  V  GLSK        E   M    GT  ++APE +         K D +S GVLL  
Sbjct: 209 IKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHL 268

Query: 423 IVSGRRP 429
           ++ G  P
Sbjct: 269 LLMGAVP 275

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 80.8 bits (200), Expect = 2e-16
 Identities = 48/223 (21%), Positives = 87/223 (39%), Gaps = 20/223 (8%)

Query: 215 TTEELRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKE--FYSE 271
            T      T+ +      LG          + +  G   A   +       +       E
Sbjct: 2   ATITCTRFTEEYQLF-EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLERE 60

Query: 272 IGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL-DRWLHHIPRGGRS-LDWAMRMK 329
                 L HPN+V +     + G  Y++++ V  G L +     + R   S  D +  ++
Sbjct: 61  ARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDI---VAREYYSEADASHCIQ 117

Query: 330 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLL-DEEFGAHLMGV--GLSKFVPWEVMQER 386
               + + +   H      VVHR+++  N+LL  +  GA +     GL+  V  E  Q+ 
Sbjct: 118 ---QILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE--QQA 169

Query: 387 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
                GT GYL+PE + ++      D+++ GV+L  ++ G  P
Sbjct: 170 WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 79.3 bits (196), Expect = 3e-16
 Identities = 49/225 (21%), Positives = 90/225 (40%), Gaps = 23/225 (10%)

Query: 214 FTTEELRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRK--KEFYS 270
           F        + N+      LG          +    G   A K +       +  ++   
Sbjct: 19  FMMNASTKFSDNYDVK-EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER 77

Query: 271 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL-DRWLHHIPRGGRS-LDWAMRM 328
           E     +L HPN+V +     +    Y+V++ V  G L +     + R   S  D +  +
Sbjct: 78  EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI---VAREFYSEADASHCI 134

Query: 329 KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL-DEEFGAHLMGV--GLSKFV-PWEVMQ 384
           +    + + IA+ H      +VHR+++  N+LL  +  GA +     GL+  V   E   
Sbjct: 135 Q---QILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH 188

Query: 385 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
                  GT GYL+PE + ++  +   D+++ GV+L  ++ G  P
Sbjct: 189 GFA----GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 78.5 bits (194), Expect = 3e-16
 Identities = 38/185 (20%), Positives = 75/185 (40%), Gaps = 26/185 (14%)

Query: 249 GSRVAVKRLKRSSFQR------KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 302
           G   A K +K+   +       ++E   E+    ++ H N++ +     +  D  ++ E 
Sbjct: 37  GLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILEL 96

Query: 303 VVNGPL-DRWLHHIPRGGRS-LDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
           V  G L D       +   S  +    +K    +  G+ +LH K    + H D++  N++
Sbjct: 97  VSGGELFDFL---AQKESLSEEEATSFIK---QILDGVNYLHTK---KIAHFDLKPENIM 147

Query: 361 LD--EEFGAHLMGV--GLSKFV-PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYS 415
           L        H+  +  GL+  +      +       GT  ++APE V    L  ++D++S
Sbjct: 148 LLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF----GTPEFVAPEIVNYEPLGLEADMWS 203

Query: 416 FGVLL 420
            GV+ 
Sbjct: 204 IGVIT 208

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 78.1 bits (193), Expect = 3e-16
 Identities = 51/208 (24%), Positives = 91/208 (43%), Gaps = 15/208 (7%)

Query: 233 LGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQ-RKKEFYSEIGRFARLHHPNLVAVKGCC 290
           +G   T    +    P   +VA+KR+     Q    E   EI   ++ HHPN+V+     
Sbjct: 23  IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82

Query: 291 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMR-MKVATTLAQ---GIAFLHDKVK 346
               + ++V + +  G +   + HI   G      +    +AT L +   G+ +LH    
Sbjct: 83  VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN-- 140

Query: 347 PHVVHRDIRASNVLLDEEFGAHLM--GVG--LSKFVPWEVMQERTVMAGGTYGYLAPEFV 402
              +HRD++A N+LL E+    +   GV   L+        + R    G    ++APE +
Sbjct: 141 -GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC-WMAPEVM 198

Query: 403 YRNEL-TTKSDVYSFGVLLLEIVSGRRP 429
            +      K+D++SFG+  +E+ +G  P
Sbjct: 199 EQVRGYDFKADIWSFGITAIELATGAAP 226

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 77.6 bits (192), Expect = 4e-16
 Identities = 38/185 (20%), Positives = 72/185 (38%), Gaps = 26/185 (14%)

Query: 249 GSRVAVK-----RLKRSSFQRKKE-FYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 302
           G   A K     RL  S     +E    E+     + HPN++ +     +  D  ++ E 
Sbjct: 30  GKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILEL 89

Query: 303 VVNGPL-DRWLHHIPRGGRS-LDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
           V  G L D       +   +  +    +K    +  G+ +LH K    + H D++  N++
Sbjct: 90  VSGGELFDFL---AEKESLTEDEATQFLK---QILDGVHYLHSK---RIAHFDLKPENIM 140

Query: 361 LD--EEFGAHLMGV--GLSKFV-PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYS 415
           L         +  +  G++  +      +       GT  ++APE V    L  ++D++S
Sbjct: 141 LLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF----GTPEFVAPEIVNYEPLGLEADMWS 196

Query: 416 FGVLL 420
            GV+ 
Sbjct: 197 IGVIT 201

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 79.4 bits (196), Expect = 4e-16
 Identities = 62/255 (24%), Positives = 99/255 (38%), Gaps = 40/255 (15%)

Query: 192 RRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGN--------RLLGDSKTGGTYS 243
           + K R L+N +  AL     KVF   +L    ++             + LG    G    
Sbjct: 94  KGKRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKL 153

Query: 244 GI-LPDGSRVAVKRLKRSSFQRKKE--------FYSEIGRFARLHHPNLVAVKGCCYDHG 294
                   +VA++ + +  F               +EI    +L+HP ++ +K   +D  
Sbjct: 154 AFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAE 212

Query: 295 DRYIVYEFVVNGPL-DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRD 353
           D YIV E +  G L D+    +    R L  A        +   + +LH+     ++HRD
Sbjct: 213 DYYIVLELMEGGELFDK----VVGNKR-LKEATCKLYFYQMLLAVQYLHEN---GIIHRD 264

Query: 354 IRASNVLLD-EEFGAHLMGV--GLSKFVPWEVMQERTVMAG--GTYGYLAPE---FVYRN 405
           ++  NVLL  +E    +     G SK      + E ++M    GT  YLAPE    V   
Sbjct: 265 LKPENVLLSSQEEDCLIKITDFGHSKI-----LGETSLMRTLCGTPTYLAPEVLVSVGTA 319

Query: 406 ELTTKSDVYSFGVLL 420
                 D +S GV+L
Sbjct: 320 GYNRAVDCWSLGVIL 334

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 78.5 bits (194), Expect = 5e-16
 Identities = 39/185 (21%), Positives = 75/185 (40%), Gaps = 26/185 (14%)

Query: 249 GSRVAVKRLKRSS------FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 302
           G   A K +K+           ++E   E+    ++ HPN++ +     +  D  ++ E 
Sbjct: 37  GLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILEL 96

Query: 303 VVNGPL-DRWLHHIPRGGRS-LDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
           V  G L D       +   S  +    +K    +  G+ +LH K    + H D++  N++
Sbjct: 97  VSGGELFDFL---AQKESLSEEEATSFIK---QILDGVNYLHTK---KIAHFDLKPENIM 147

Query: 361 LD--EEFGAHLMGV--GLSKFV-PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYS 415
           L        H+  +  GL+  +      +       GT  ++APE V    L  ++D++S
Sbjct: 148 LLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF----GTPEFVAPEIVNYEPLGLEADMWS 203

Query: 416 FGVLL 420
            GV+ 
Sbjct: 204 IGVIT 208

>3rs1_A C-type lectin domain family 2 member I; C-type lectin-like, ligand of NK receptor, natural killer CE receptors, surface of activated T lymphocytes; 1.94A {Mus musculus} Length = 122

 Score = 73.2 bits (180), Expect = 6e-16
 Identities = 30/144 (20%), Positives = 56/144 (38%), Gaps = 26/144 (18%)

Query: 1   MNKDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQK 60
           MNK + A C  +W      +KCF + G  R+W  ++ +C      LA   + EE    ++
Sbjct: 1   MNKTY-AACSKNWTGVG--NKCFYFSGYPRNWTFAQAFCMAQEAQLARFDNEEELIFLKR 57

Query: 61  LCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDL 120
             G      W+G    ++     WKW++N +++N     +G                   
Sbjct: 58  FKGD--FDSWIGLHRESS--EHPWKWTNN-TEYNNMNPILGVGR---------------- 96

Query: 121 CTLVSNGSRSLVTERCNTSHPFIC 144
              +S+    + + R   +  +IC
Sbjct: 97  YAYLSSD--RISSSRSYINRMWIC 118

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 77.7 bits (192), Expect = 7e-16
 Identities = 50/210 (23%), Positives = 89/210 (42%), Gaps = 33/210 (15%)

Query: 247 PDGSRVAVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVV 304
           P G  +AVKR++     + +K+   ++    R    P +V   G  +  GD +I  E + 
Sbjct: 45  PSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM- 103

Query: 305 NGPLDRWLHHI-PRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 363
           +   D++  ++       +   +  K+     + +  L + +K  ++HRDI+ SN+LLD 
Sbjct: 104 STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDR 161

Query: 364 E-------FG--AHLMG-VGLSKFVPWEVMQERTVMAGGTYGYLAPE----FVYRNELTT 409
                   FG    L+  +  ++               G   Y+APE       R     
Sbjct: 162 SGNIKLCDFGISGQLVDSIAKTRDA-------------GCRPYMAPERIDPSASRQGYDV 208

Query: 410 KSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ 439
           +SDV+S G+ L E+ +GR P    +SV  Q
Sbjct: 209 RSDVWSLGITLYELATGRFPYPKWNSVFDQ 238

>1ypq_A Oxidised low density lipoprotein (lectin-like) receptor 1; oxidized low density lipoprotein receptor, LOX-1, CTLD, C- type lectin like domain; 1.40A {Homo sapiens} SCOP: d.169.1.1 PDB: 1ypu_A 1yxk_A 3vlg_A 1ypo_A 1yxj_A Length = 135

 Score = 73.2 bits (180), Expect = 7e-16
 Identities = 28/139 (20%), Positives = 48/139 (34%), Gaps = 17/139 (12%)

Query: 7   APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNV 66
           APCP DWI +     C+ +     +W++S+  C  +   L  + S  +    Q+    + 
Sbjct: 7   APCPQDWIWHG--ENCYLFSSGSFNWEKSQEKCLSLDAKLLKINSTADLDFIQQAISYSS 64

Query: 67  NGCWVGGRSINTTVGLSWKWSDNMSKWNESI-HAVGSFNSSCTSLPCHVHATVDLCTLVS 125
              W+G    N      W W D  S     +    G+ + +  S  C             
Sbjct: 65  FPFWMGLSRRNP--SYPWLWEDG-SPLMPHLFRVRGAVSQTYPSGTC-----------AY 110

Query: 126 NGSRSLVTERCNTSHPFIC 144
               ++  E C  +   IC
Sbjct: 111 IQRGAVYAENCILAAFSIC 129

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 77.7 bits (192), Expect = 8e-16
 Identities = 38/194 (19%), Positives = 78/194 (40%), Gaps = 26/194 (13%)

Query: 249 GSRVAVKRLKRS------SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 302
           G + A K +K+           +++   E+     + HPN++ +     +  D  ++ E 
Sbjct: 36  GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 95

Query: 303 VVNGPL-DRWLHHIPRGGRS-LDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
           V  G L D       +   +  +    +K    +  G+ +LH      + H D++  N++
Sbjct: 96  VAGGELFDFL---AEKESLTEEEATEFLK---QILNGVYYLHSL---QIAHFDLKPENIM 146

Query: 361 L--DEEFGAHLMGV--GLSKFV-PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYS 415
           L         +  +  GL+  +      +       GT  ++APE V    L  ++D++S
Sbjct: 147 LLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF----GTPEFVAPEIVNYEPLGLEADMWS 202

Query: 416 FGVLLLEIVSGRRP 429
            GV+   ++SG  P
Sbjct: 203 IGVITYILLSGASP 216

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 78.2 bits (193), Expect = 8e-16
 Identities = 47/256 (18%), Positives = 90/256 (35%), Gaps = 32/256 (12%)

Query: 188 RSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI-L 246
                    +   P          K     +  +I  ++   +++LG    G        
Sbjct: 25  TPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNK 84

Query: 247 PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDR----YIVYE 301
               + A+K L+     R+     E+    R    P++V +     +         IV E
Sbjct: 85  RTQEKFALKMLQDCPKARR-----EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME 139

Query: 302 FVVNGPLDRWLHHI-PRGGRSL---DWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 357
            +  G L      I  RG ++    + +  MK   ++ + I +LH     ++ HRD++  
Sbjct: 140 CLDGGEL---FSRIQDRGDQAFTEREASEIMK---SIGEAIQYLHSI---NIAHRDVKPE 190

Query: 358 NVLL-DEEFGAHLMGV--GLSKFV-PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDV 413
           N+L   +   A L     G +K       +         T  Y+APE +   +     D+
Sbjct: 191 NLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC----YTPYYVAPEVLGPEKYDKSCDM 246

Query: 414 YSFGVLLLEIVSGRRP 429
           +S GV++  ++ G  P
Sbjct: 247 WSLGVIMYILLCGYPP 262

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 77.6 bits (191), Expect = 3e-15
 Identities = 40/184 (21%), Positives = 83/184 (45%), Gaps = 18/184 (9%)

Query: 253 AVKRLKRSSFQRKKEFYSEIG------RFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 306
           A+K L +   + K+     +         +    P +V +    +       + + +  G
Sbjct: 218 AMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGG 277

Query: 307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 366
            L    +H+ + G   +  MR   A  +  G+  +H++    VV+RD++ +N+LLDE   
Sbjct: 278 DL---HYHLSQHGVFSEADMRFYAAE-IILGLEHMHNR---FVVYRDLKPANILLDEHGH 330

Query: 367 AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKS-DVYSFGVLLLEIVS 425
             +  +GL+     +  +++   + GT+GY+APE + +      S D +S G +L +++ 
Sbjct: 331 VRISDLGLAC----DFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR 386

Query: 426 GRRP 429
           G  P
Sbjct: 387 GHSP 390

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 75.4 bits (186), Expect = 3e-15
 Identities = 57/212 (26%), Positives = 92/212 (43%), Gaps = 32/212 (15%)

Query: 233 LGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 291
           LGD   G  Y       G+  A K ++  S +  +++  EI   A   HP +V + G  Y
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86

Query: 292 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 351
             G  +I+ EF   G +D  +  + RG   L       V   + + + FLH K    ++H
Sbjct: 87  HDGKLWIMIEFCPGGAVDAIMLELDRG---LTEPQIQVVCRQMLEALNFLHSK---RIIH 140

Query: 352 RDIRASNVLLDEE-------FG--AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFV 402
           RD++A NVL+  E       FG  A  +          + +Q+R    G  Y ++APE V
Sbjct: 141 RDLKAGNVLMTLEGDIRLADFGVSAKNL----------KTLQKRDSFIGTPY-WMAPEVV 189

Query: 403 YRNELT-----TKSDVYSFGVLLLEIVSGRRP 429
               +       K+D++S G+ L+E+     P
Sbjct: 190 MCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 75.7 bits (186), Expect = 4e-15
 Identities = 42/252 (16%), Positives = 83/252 (32%), Gaps = 50/252 (19%)

Query: 260 SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGG 319
           SS         +I R       N V            YI  +      L  W++      
Sbjct: 100 SSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR-CSL 158

Query: 320 RSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE-------FGAHLMGV 372
              +  + + +   +A+ + FLH K    ++HRD++ SN+    +       FG      
Sbjct: 159 EDREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFG------ 209

Query: 373 GLSKFVPWEVMQERTVMAG----------GTYGYLAPEFVYRNELTTKSDVYSFGVLLLE 422
            L   +  +  ++  +             GT  Y++PE ++ N  + K D++S G++L E
Sbjct: 210 -LVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFE 268

Query: 423 IVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLV 482
           ++           +    +     PL+ + +Y +                        +V
Sbjct: 269 LLYSFSTQMERVRI-ITDVRNLKFPLLFTQKYPQE---------------------HMMV 306

Query: 483 YACTQHVPSMRP 494
                  P+ RP
Sbjct: 307 QDMLSPSPTERP 318

>1jwi_A Bitiscetin; domain swapping, C-type lectin, toxin; 2.00A {Bitis arietans} SCOP: d.169.1.1 PDB: 1uex_A Length = 131

 Score = 71.3 bits (175), Expect = 4e-15
 Identities = 36/144 (25%), Positives = 55/144 (38%), Gaps = 30/144 (20%)

Query: 9   CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 68
           C PDW   +    C+       +W+++E +C E  GHLA++ S EE     KL  + +  
Sbjct: 4   CLPDWSSYK--GHCYKVFKKVGTWEDAEKFCVENSGHLASIDSKEEADFVTKLASQTLTK 61

Query: 69  ----CWVGGRSINTTVGLSWKWSDNMS----KWNESIHAVGSFNSSCTSLPCHVHATVDL 120
                W+G R  + T   S +W+D  S      +E         + C  L  H       
Sbjct: 62  FVYDAWIGLRDESKTQQCSPQWTDGSSVVYENVDE--------PTKCFGLDVHT------ 107

Query: 121 CTLVSNGSRSLVTERCNTSHPFIC 144
                   R+     C   +PFIC
Sbjct: 108 ------EYRTWTDLPCGEKNPFIC 125

>1hq8_A NKG2-D; homodimer, CIS-proline, apoptosis; 1.95A {Mus musculus} SCOP: d.169.1.1 PDB: 1jsk_A 1kcg_A* Length = 123

 Score = 70.5 bits (173), Expect = 6e-15
 Identities = 27/137 (19%), Positives = 47/137 (34%), Gaps = 23/137 (16%)

Query: 8   PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 67
           PCP +WI +   + C+ +    ++W++S+  C      L  + S EE    Q       +
Sbjct: 5   PCPNNWICHR--NNCYQFFNEEKTWNQSQASCLSQNSSLLKIYSKEE----QDFLKLVKS 58

Query: 68  GCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG 127
             W+G          SW+W D  S  + +   +                        S+ 
Sbjct: 59  YHWMGLV--QIPANGSWQWEDG-SSLSYNQLTLVEIPKG------------SCAVYGSSF 103

Query: 128 SRSLVTERCNTSHPFIC 144
                TE C   + +IC
Sbjct: 104 --KAYTEDCANLNTYIC 118

>2yhf_A C-type lectin domain family 5 member A; immune system; 1.90A {Homo sapiens} Length = 118

 Score = 70.1 bits (172), Expect = 6e-15
 Identities = 29/136 (21%), Positives = 55/136 (40%), Gaps = 23/136 (16%)

Query: 9   CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 68
           CP DW   +  ++CF    +  SW+ES  +CK  G  LA + + E+    Q +   +   
Sbjct: 2   CPKDWEFYQ--ARCFFLSTSESSWNESRDFCKGKGSTLAIVNTPEKLKFLQDI--TDAEK 57

Query: 69  CWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS 128
            ++G           W+W +N S +N ++      N +C ++                 +
Sbjct: 58  YFIGLIYHRE--EKRWRWINN-SVFNGNVTNQNQ-NFNCATI---------------GLT 98

Query: 129 RSLVTERCNTSHPFIC 144
           ++     C+ S+  IC
Sbjct: 99  KTFDAASCDISYRRIC 114

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 74.3 bits (183), Expect = 7e-15
 Identities = 46/199 (23%), Positives = 86/199 (43%), Gaps = 12/199 (6%)

Query: 233 LGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYS-EIGRFARLHHPNLVAVKGCC 290
           +G    G  + GI       VA+K +     + + E    EI   ++   P +    G  
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89

Query: 291 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 350
                 +I+ E++  G     L   P     LD      +   + +G+ +LH +     +
Sbjct: 90  LKDTKLWIIMEYLGGGSALDLLEPGP-----LDETQIATILREILKGLDYLHSE---KKI 141

Query: 351 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 410
           HRDI+A+NVLL E     L   G++  +  +   +R    G  + ++APE + ++   +K
Sbjct: 142 HRDIKAANVLLSEHGEVKLADFGVAGQL-TDTQIKRNTFVGTPF-WMAPEVIKQSAYDSK 199

Query: 411 SDVYSFGVLLLEIVSGRRP 429
           +D++S G+  +E+  G  P
Sbjct: 200 ADIWSLGITAIELARGEPP 218

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 74.3 bits (183), Expect = 7e-15
 Identities = 48/207 (23%), Positives = 87/207 (42%), Gaps = 29/207 (14%)

Query: 233 LGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 291
           LG+   G  Y  I    G  VA+K++        +E   EI    +   P++V   G  +
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYF 94

Query: 292 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 351
            + D +IV E+   G +   +    +   +L       +  +  +G+ +LH       +H
Sbjct: 95  KNTDLWIVMEYCGAGSVSDIIRLRNK---TLTEDEIATILQSTLKGLEYLHFM---RKIH 148

Query: 352 RDIRASNVLLDEE-------FG--AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFV 402
           RDI+A N+LL+ E       FG    L           + M +R  + G  + ++APE +
Sbjct: 149 RDIKAGNILLNTEGHAKLADFGVAGQLT----------DTMAKRNTVIGTPF-WMAPEVI 197

Query: 403 YRNELTTKSDVYSFGVLLLEIVSGRRP 429
                   +D++S G+  +E+  G+ P
Sbjct: 198 QEIGYNCVADIWSLGITAIEMAEGKPP 224

>3hup_A Early activation antigen CD69; C-type lectin-like domain, disulfide bond, glycoprotein, LEC membrane, phosphoprotein, signal-anchor, transmembrane; 1.37A {Homo sapiens} PDB: 1e87_A 1e8i_A 3cck_A Length = 130

 Score = 70.1 bits (172), Expect = 8e-15
 Identities = 31/138 (22%), Positives = 54/138 (39%), Gaps = 26/138 (18%)

Query: 7   APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNV 66
           + C  DW+  +   KC+      RSW  ++  C E G  LA + S ++ +  ++  G+  
Sbjct: 14  SSCSEDWVGYQ--RKCYFISTVKRSWTSAQNACSEHGATLAVIDSEKDMNFLKRYAGR-- 69

Query: 67  NGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN 126
              WVG   +    G  WKWS+   ++N   +  GS                  C  + N
Sbjct: 70  EEHWVG---LKKEPGHPWKWSNG-KEFNNWFNVTGSDK----------------CVFLKN 109

Query: 127 GSRSLVTERCNTSHPFIC 144
               + +  C  +  +IC
Sbjct: 110 T--EVSSMECEKNLYWIC 125

>1mpu_A NKG2-D type II integral membrane protein; C-type lectin-like domain, immune system; 2.50A {Homo sapiens} SCOP: d.169.1.1 PDB: 1hyr_B Length = 138

 Score = 70.2 bits (172), Expect = 9e-15
 Identities = 29/138 (21%), Positives = 51/138 (36%), Gaps = 23/138 (16%)

Query: 7   APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNV 66
            PCP +WI  +  + C+ +    ++W ES+  C      L  + S E+    Q L     
Sbjct: 19  GPCPKNWICYK--NNCYQFFDESKNWYESQASCMSQNASLLKVYSKED----QDLLKLVK 72

Query: 67  NGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN 126
           +  W+G    +     SW+W D  S  + ++  +                  D     S+
Sbjct: 73  SYHWMGLV--HIPTNGSWQWEDG-SILSPNLLTIIEMQKG------------DCALYASS 117

Query: 127 GSRSLVTERCNTSHPFIC 144
                  E C+T + +IC
Sbjct: 118 F--KGYIENCSTPNTYIC 133

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 74.8 bits (184), Expect = 1e-14
 Identities = 49/264 (18%), Positives = 102/264 (38%), Gaps = 37/264 (14%)

Query: 187 RRSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI- 245
              K      K +       + P  ++      +   + +     ++G   +      + 
Sbjct: 57  EAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPK-DVIGRGVSSVVRRCVH 115

Query: 246 LPDGSRVAVKRLKRSSFQRKKE--------FYSEIGRFARLH-HPNLVAVKGCCYDHGDR 296
              G   AVK ++ ++ +   E           E     ++  HP+++ +          
Sbjct: 116 RATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFM 175

Query: 297 YIVYEFVVNGPL-DRWLHHIPRGGR-SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDI 354
           ++V++ +  G L D     +      S        +  +L + ++FLH     ++VHRD+
Sbjct: 176 FLVFDLMRKGELFDY----LTEKVALSEKET--RSIMRSLLEAVSFLHAN---NIVHRDL 226

Query: 355 RASNVLLDEEFGAHLMGV--GLSKFV-PWEVMQERTVMAGGTYGYLAPEFVYRNELTT-- 409
           +  N+LLD+     +     G S  + P E ++E      GT GYLAPE +  +   T  
Sbjct: 227 KPENILLDDN--MQIRLSDFGFSCHLEPGEKLRELC----GTPGYLAPEILKCSMDETHP 280

Query: 410 ----KSDVYSFGVLLLEIVSGRRP 429
               + D+++ GV+L  +++G  P
Sbjct: 281 GYGKEVDLWACGVILFTLLAGSPP 304

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 74.2 bits (183), Expect = 1e-14
 Identities = 48/230 (20%), Positives = 91/230 (39%), Gaps = 25/230 (10%)

Query: 225 NFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPN 282
           +    ++ LG+         +        AVK + +      ++   EI        HPN
Sbjct: 11  DLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPN 67

Query: 283 LVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGR--SLDWAMRMKVATTLAQGIAF 340
           +V +    +D    ++V E +  G L      I +       + +  M+    L   ++ 
Sbjct: 68  IVKLHEVFHDQLHTFLVMELLNGGEL---FERIKKKKHFSETEASYIMR---KLVSAVSH 121

Query: 341 LHDKVKPHVVHRDIRASNVLL-DEEFGAHLMGV--GLSKFVPWEVMQERTVMAGGTYGYL 397
           +HD     VVHRD++  N+L  DE     +  +  G ++  P +    +T     T  Y 
Sbjct: 122 MHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC--FTLHYA 176

Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP----AQAVDSVCWQSIFE 443
           APE + +N      D++S GV+L  ++SG+ P     +++       I +
Sbjct: 177 APELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMK 226

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 75.2 bits (185), Expect = 1e-14
 Identities = 46/183 (25%), Positives = 86/183 (46%), Gaps = 17/183 (9%)

Query: 253 AVKRLKRSSFQRKKEF---YSEIGRFARLHHPNLVAVKGCCYDHGDR-YIVYEFVVNGPL 308
           A K+L++   +++K      +E     +++   +V++    Y+  D   +V   +  G L
Sbjct: 213 ACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA-YAYETKDALCLVLTLMNGGDL 271

Query: 309 DRWLHHIPRGGRSLDWAMRMKV-ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA 367
                HI   G++     R    A  +  G+  LH +    +V+RD++  N+LLD+    
Sbjct: 272 ---KFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHI 325

Query: 368 HLMGVGLSKFVPWEVMQERTVMA-GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSG 426
            +  +GL+      V + +T+    GT GY+APE V     T   D ++ G LL E+++G
Sbjct: 326 RISDLGLAV----HVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAG 381

Query: 427 RRP 429
           + P
Sbjct: 382 QSP 384

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 74.8 bits (184), Expect = 2e-14
 Identities = 50/182 (27%), Positives = 80/182 (43%), Gaps = 15/182 (8%)

Query: 253 AVKRLKRSSFQRKKEF---YSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 309
           A+K LK+     K E     +E        HP L A+K     H     V E+   G L 
Sbjct: 177 AMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL- 235

Query: 310 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHL 369
               H+ R     +   R   A  +   + +LH +   +VV+RD++  N++LD++    +
Sbjct: 236 --FFHLSRERVFSEDRARFYGAE-IVSALDYLHSEK--NVVYRDLKLENLMLDKDGHIKI 290

Query: 370 MGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGR 427
              GL K    E +++   M    GT  YLAPE +  N+     D +  GV++ E++ GR
Sbjct: 291 TDFGLCK----EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

Query: 428 RP 429
            P
Sbjct: 347 LP 348

>3vpp_A C-type lectin domain family 9 member A; dendritic cell, C-type lectin-like domain, membrane, immune; 1.64A {Homo sapiens} Length = 132

 Score = 69.0 bits (169), Expect = 3e-14
 Identities = 34/142 (23%), Positives = 44/142 (30%), Gaps = 24/142 (16%)

Query: 7   APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNV 66
           +PCP +WI N     C+     +  W  S+  C + G  L  + S EE         K  
Sbjct: 2   SPCPNNWIQNR--ESCYYVSEIWSIWHTSQENCLKEGSTLLQIESKEEMDFITGSLRKIK 59

Query: 67  NG--CWVGGRSINTTVGLSWKWSDN--MSKWNESIHAVGSFNSSCTSLPCHVHATVDLCT 122
                WVG           W W D    S          S N  C               
Sbjct: 60  GSYDYWVGLSQDGH--SGRWLWQDGSSPSPGLLPAERSQSANQVC--------------- 102

Query: 123 LVSNGSRSLVTERCNTSHPFIC 144
                S SL++  C+T   FIC
Sbjct: 103 -GYVKSNSLLSSNCDTWKYFIC 123

>1fm5_A Early activation antigen CD69; C-type lectin-like domain, natural killer cell receptor, lectin, C-type lectin, immune system; 2.27A {Homo sapiens} SCOP: d.169.1.1 Length = 199

 Score = 70.4 bits (172), Expect = 3e-14
 Identities = 31/138 (22%), Positives = 54/138 (39%), Gaps = 26/138 (18%)

Query: 7   APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNV 66
           + C  DW+  +   KC+      RSW  ++  C E G  LA + S ++ +  ++  G+  
Sbjct: 83  SSCSEDWVGYQ--RKCYFISTVKRSWTSAQNACSEHGATLAVIDSEKDMNFLKRYAGR-- 138

Query: 67  NGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN 126
              WVG   +    G  WKWS+   ++N   +  GS                  C  + N
Sbjct: 139 EEHWVG---LKKEPGHPWKWSNG-KEFNNWFNVTGSDK----------------CVFLKN 178

Query: 127 GSRSLVTERCNTSHPFIC 144
               + +  C  +  +IC
Sbjct: 179 T--EVSSMECEKNLYWIC 194

>3m9z_A Killer cell lectin-like receptor subfamily B MEMB; C-type lectin-like domain, domain swapping, disulfide bond, transmembrane protein; 1.70A {Mus musculus} PDB: 3t3a_A Length = 139

 Score = 68.6 bits (168), Expect = 4e-14
 Identities = 30/136 (22%), Positives = 49/136 (36%), Gaps = 19/136 (13%)

Query: 9   CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 68
           CP DW+ +    KCF       +W+E    C   G  L  +   EE         +  N 
Sbjct: 6   CPQDWLSHR--DKCFHVSQVSNTWEEGLVDCDGKGATLMLIQDQEELRFLLDSIKEKYNS 63

Query: 69  CWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS 128
            W+G R       ++WKW +  S  N  +  +     + +            C  +S   
Sbjct: 64  FWIGLRYTLP--DMNWKWING-STLNSDVLKITGDTENDS------------CAAISGD- 107

Query: 129 RSLVTERCNTSHPFIC 144
             +  E CN+ + +IC
Sbjct: 108 -KVTFESCNSDNRWIC 122

>3c8j_A Natural killer cell receptor LY49C; MHC, virus, immune system; 2.60A {Mus musculus} SCOP: d.169.1.1 PDB: 3c8k_D 1p4l_D 1ja3_A 1p1z_D Length = 203

 Score = 70.3 bits (172), Expect = 4e-14
 Identities = 25/152 (16%), Positives = 43/152 (28%), Gaps = 25/152 (16%)

Query: 3   KDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLC 62
                     W      +KC+ +I N  +W   +  C+  G  +  +   +E    Q+  
Sbjct: 74  SRDTGRGVKYWFCYS--TKCYYFIMNKTTWSGCKANCQHYGVPILKIEDEDELKFLQRHV 131

Query: 63  GKNVNGCWVGGRSINTTVGLSWKWSDN-MSKWNESIHAVGSFNSSCTSLPCHVHATVDLC 121
                  W+G           W W DN  SK +  I  +   +  C              
Sbjct: 132 IP--GNYWIGLSYDKK--KKEWAWIDNGPSKLDMKIKKMNFKSRGC-------------- 173

Query: 122 TLVSNGSRSLVTERCNTSHPFICMVEHENKCY 153
             V      +    CN  +  IC    +   +
Sbjct: 174 --VFLSKARIEDIDCNIPYYCIC--GKKLDKF 201

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 71.9 bits (177), Expect = 5e-14
 Identities = 50/211 (23%), Positives = 85/211 (40%), Gaps = 21/211 (9%)

Query: 231 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEF----YSEIGRFARLHHPNLVA 285
            LLG+   G     +      R AVK LK+   +R          EI    RL H N++ 
Sbjct: 11  DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70

Query: 286 VKGCCYDHGDR--YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ---GIAF 340
           +    Y+   +  Y+V E+ V G  +  L  +P     +  A          Q   G+ +
Sbjct: 71  LVDVLYNEEKQKMYMVMEYCVCGMQEM-LDSVPEKRFPVCQAHGY-----FCQLIDGLEY 124

Query: 341 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 400
           LH +    +VH+DI+  N+LL       +  +G+++ +      +    + G+  +  PE
Sbjct: 125 LHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE 181

Query: 401 FVYRNEL--TTKSDVYSFGVLLLEIVSGRRP 429
                +     K D++S GV L  I +G  P
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 72.8 bits (179), Expect = 5e-14
 Identities = 45/192 (23%), Positives = 75/192 (39%), Gaps = 27/192 (14%)

Query: 253 AVKRLKRSSFQRKKE---FYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 309
           A+K + +    ++ E   F  E           +  +     D    Y+V E+ V G L 
Sbjct: 90  AMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDL- 148

Query: 310 RWLHHIPRGGRSL--DWAMRMKVA-TTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 366
             L  + + G  +  + A R  +A   +A  I  +H       VHRDI+  N+LLD    
Sbjct: 149 --LTLLSKFGERIPAEMA-RFYLAEIVMA--IDSVHRL---GYVHRDIKPDNILLDRC-- 198

Query: 367 AHLMGV--GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVY-------SFG 417
            H+     G    +  +    R+++A GT  YL+PE +        +  Y       + G
Sbjct: 199 GHIRLADFGSCLKLRAD-GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALG 257

Query: 418 VLLLEIVSGRRP 429
           V   E+  G+ P
Sbjct: 258 VFAYEMFYGQTP 269

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 71.9 bits (177), Expect = 5e-14
 Identities = 45/230 (19%), Positives = 89/230 (38%), Gaps = 30/230 (13%)

Query: 221 SITKNFSE----GNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRF 275
           S +  F +       +LG+       + I L      AVK +++     +   + E+   
Sbjct: 5   SFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEML 64

Query: 276 ARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGR--SLDWAMRMKVAT 332
            +   H N++ +     +    Y+V+E +  G +   L HI +      L+ ++ ++   
Sbjct: 65  YQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI---LSHIHKRRHFNELEASVVVQ--- 118

Query: 333 TLAQGIAFLHDKVKPHVVHRDIRASNVLL-DEEFGAHLMGV--GLSKFVPWE---VMQER 386
            +A  + FLH+K    + HRD++  N+L       + +      L   +           
Sbjct: 119 DVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIST 175

Query: 387 TVMAG--GTYGYLAPEFVYRNELTTKS-----DVYSFGVLLLEIVSGRRP 429
             +    G+  Y+APE V              D++S GV+L  ++SG  P
Sbjct: 176 PELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 71.9 bits (177), Expect = 6e-14
 Identities = 47/189 (24%), Positives = 82/189 (43%), Gaps = 23/189 (12%)

Query: 249 GSRVAVKRLKRSSFQRK--KEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 306
           G  VA+K + ++       ++ + E+     L+HPN+V +          Y++ E+   G
Sbjct: 40  GREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGG 99

Query: 307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQ----GIAFLHDKVKPHVVHRDIRASNVLLD 362
            +     ++   GR     M+ K A +  +     + + H K    +VHRD++A N+LLD
Sbjct: 100 EV---FDYLVAHGR-----MKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLD 148

Query: 363 EEFGAHLMGVGLS-KFVPWEVMQERTVMAGGTYGYLAPEFVYRNELT-TKSDVYSFGVLL 420
            +    +   G S +F     +        G   Y APE     +    + DV+S GV+L
Sbjct: 149 ADMNIKIADFGFSNEFTVGGKLDA----FCGAPPYAAPELFQGKKYDGPEVDVWSLGVIL 204

Query: 421 LEIVSGRRP 429
             +VSG  P
Sbjct: 205 YTLVSGSLP 213

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 72.9 bits (179), Expect = 7e-14
 Identities = 40/184 (21%), Positives = 84/184 (45%), Gaps = 16/184 (8%)

Query: 253 AVKRLKRSSFQRKKEF---YSEIGRFARLHHPNLVAVKGCCYDHGDR-YIVYEFVVNGPL 308
           A K+L +   +++K +     E    A++H   +V++    ++      +V   +  G +
Sbjct: 214 ACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDI 272

Query: 309 DRWLHHIPRGGRSLDWAMRMKV-ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA 367
              ++++           R       +  G+  LH +   ++++RD++  NVLLD++   
Sbjct: 273 RYHIYNVDEDNPGFQEP-RAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNV 328

Query: 368 HLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 425
            +  +GL+     E+   +T   G  GT G++APE +   E     D ++ GV L E+++
Sbjct: 329 RISDLGLAV----ELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIA 384

Query: 426 GRRP 429
            R P
Sbjct: 385 ARGP 388

>2bpd_A Dectin-1; receptor, beta-glucan, fungal recognition, C-type lectin-like domain, CTLD, carbohydrate; 1.5A {Mus musculus} PDB: 2bph_A 2bpe_A 2cl8_A* Length = 142

 Score = 67.9 bits (166), Expect = 7e-14
 Identities = 28/139 (20%), Positives = 50/139 (35%), Gaps = 18/139 (12%)

Query: 8   PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHS--AQKLCGKN 65
            C P+WI++     C+ +  +  SW  S+ +C ++G HL  + +  +E      +     
Sbjct: 16  SCLPNWIMHG--KSCYLFSFSGNSWYGSKRHCSQLGAHLLKIDN-SKEFEFIESQTSSHR 72

Query: 66  VNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVS 125
           +N  W+G     +     W W D  + +  S     +         C           V 
Sbjct: 73  INAFWIGLSRNQS--EGPWFWEDGSAFFPNSFQVRNAVPQESLLHNC-----------VW 119

Query: 126 NGSRSLVTERCNTSHPFIC 144
                +  + CNTS   IC
Sbjct: 120 IHGSEVYNQICNTSSYSIC 138

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 71.1 bits (175), Expect = 8e-14
 Identities = 44/201 (21%), Positives = 83/201 (41%), Gaps = 34/201 (16%)

Query: 249 GSRVAVKRLKRSSFQ---------RKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYI 298
               AVK +  +             ++    E+    ++  HPN++ +K     +   ++
Sbjct: 42  CKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL 101

Query: 299 VYEFVVNGPL-DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 357
           V++ +  G L D       +   S       K+   L + I  LH     ++VHRD++  
Sbjct: 102 VFDLMKKGELFDYL---TEKVTLSEKET--RKIMRALLEVICALHKL---NIVHRDLKPE 153

Query: 358 NVLLDEEFGAHLMGV--GLSKFV-PWEVMQERTVMAGGTYGYLAPE------FVYRNELT 408
           N+LLD++   ++     G S  + P E ++E      GT  YLAPE              
Sbjct: 154 NILLDDD--MNIKLTDFGFSCQLDPGEKLREVC----GTPSYLAPEIIECSMNDNHPGYG 207

Query: 409 TKSDVYSFGVLLLEIVSGRRP 429
            + D++S GV++  +++G  P
Sbjct: 208 KEVDMWSTGVIMYTLLAGSPP 228

>3ff9_A Killer cell lectin-like receptor subfamily G member 1; natural killer cell receptor KLTG1, glycoprotein, membrane, phosphoprotein, signal-anchor; 1.80A {Mus musculus} PDB: 3ff8_C Length = 115

 Score = 66.6 bits (163), Expect = 8e-14
 Identities = 25/136 (18%), Positives = 44/136 (32%), Gaps = 27/136 (19%)

Query: 9   CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 68
           CP  W  N   S C+ +    + W+ S  +C + G HL      +      +  G+  + 
Sbjct: 2   CPILWTRNG--SHCYYFSMEKKDWNSSLKFCADKGSHLLTFPDNQGVKLFGEYLGQ--DF 57

Query: 69  CWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS 128
            W+G R+I+      W+W       +  I         C ++                  
Sbjct: 58  YWIGLRNID-----GWRWEGG-PALSLRILTNSL-IQRCGAI----------------HR 94

Query: 129 RSLVTERCNTSHPFIC 144
             L    C  +  +IC
Sbjct: 95  NGLQASSCEVALQWIC 110

>1egg_A Macrophage mannose receptor; C-type lectin, sugar binding protein; 2.30A {Homo sapiens} SCOP: d.169.1.1 PDB: 1egi_A Length = 147

 Score = 67.8 bits (166), Expect = 9e-14
 Identities = 32/148 (21%), Positives = 56/148 (37%), Gaps = 26/148 (17%)

Query: 8   PCPPDWIINEEKSKCFGYIGNF----RSWDESETYCKEIGGHLAALTSYEEEHSAQKLCG 63
            CP DW  +   S CF          ++W ES  +C+ +GG LA++ + EE+ +  +L  
Sbjct: 4   KCPEDWGASSRTSLCFKLYAKGKHEKKTWFESRDFCRALGGDLASINNKEEQQTIWRLIT 63

Query: 64  KNVNG---CWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHA 116
            + +     W+G    + +    + WSD    +   W       G  N+      C    
Sbjct: 64  ASGSYHKLFWLGLTYGSPS-E-GFTWSDGSPVSYENWAY-----GEPNNYQNVEYC-GE- 114

Query: 117 TVDLCTLVSNGSRSLVTERCNTSHPFIC 144
                 L  + + S     C   + +IC
Sbjct: 115 ------LKGDPTMSWNDINCEHLNNWIC 136

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 71.5 bits (176), Expect = 9e-14
 Identities = 51/183 (27%), Positives = 80/183 (43%), Gaps = 18/183 (9%)

Query: 253 AVKRLKRSSFQRKKEF---YSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 309
           A+K L++     K E     +E        HP L A+K     H     V E+   G L 
Sbjct: 34  AMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL- 92

Query: 310 RWLHHIPRGGR-SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 368
               H+ R    + + A R   A  +   + +LH +    VV+RDI+  N++LD++    
Sbjct: 93  --FFHLSRERVFTEERA-RFYGAE-IVSALEYLHSR---DVVYRDIKLENLMLDKDGHIK 145

Query: 369 LMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSG 426
           +   GL K    E + +   M    GT  YLAPE +  N+     D +  GV++ E++ G
Sbjct: 146 ITDFGLCK----EGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 201

Query: 427 RRP 429
           R P
Sbjct: 202 RLP 204

>1sb2_A Rhodocetin alpha subunit; C-type lectin, domain swapping, toxin; 1.90A {Calloselasma rhodostoma} SCOP: d.169.1.1 PDB: 3gpr_A Length = 133

 Score = 67.1 bits (164), Expect = 1e-13
 Identities = 27/146 (18%), Positives = 48/146 (32%), Gaps = 30/146 (20%)

Query: 9   CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 66
           CP  W   +  S C+      ++W+E+E +C E     HL ++ +  E      +   N 
Sbjct: 2   CPDGWSSTK--SYCYRPFKEKKTWEEAERFCTEQEKEAHLVSMENRLEAVFVDMVMENNF 59

Query: 67  NG----CWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATV 118
                  W+G +  N     + +WSD    +     E       +   C  +        
Sbjct: 60  ENKIYRSWIGLKIENKGQRSNLEWSDGSSISYENLYE------PYMEKCFLM-------- 105

Query: 119 DLCTLVSNGSRSLVTERCNTSHPFIC 144
                  +G     T  C   + F+C
Sbjct: 106 ----DHQSGLPKWHTADCEEKNVFMC 127

>1oz7_A Echicetin A-chain; platelet aggregation, dimer, toxin; 2.40A {Echis carinatus} SCOP: d.169.1.1 Length = 131

 Score = 67.1 bits (164), Expect = 1e-13
 Identities = 34/145 (23%), Positives = 53/145 (36%), Gaps = 30/145 (20%)

Query: 9   CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIG--GHLAALTSYEEEHSAQKLCGKNV 66
           CPP W  N     C+      ++WDE+E +C + G  GHL ++ S +EE     +  +N+
Sbjct: 2   CPPGWSSNG--VYCYMLFKEPKTWDEAEKFCNKQGKDGHLLSIESKKEEILVDIVVSENI 59

Query: 67  NG---CWVGGRSINTTVGLSWKWSDNMS----KWNESIHAVGSFNSSCTSLPCHVHATVD 119
                 W G    +     S +WSD       +            S C  L         
Sbjct: 60  GKMYKIWTGLSERSKEQHCSSRWSDGSFFRSYEIAIR-------YSECFVL--------- 103

Query: 120 LCTLVSNGSRSLVTERCNTSHPFIC 144
                 +  R+ V   C  + PF+C
Sbjct: 104 ---EKQSVFRTWVATPCENTFPFMC 125

>3bdw_B NKG2-A/NKG2-B type II integral membrane protein; NK cells, receptor, glycoprotein, lectin, signal-A transmembrane, immune system receptor; 2.50A {Homo sapiens} PDB: 3cdg_K 3cii_H Length = 120

 Score = 66.7 bits (163), Expect = 1e-13
 Identities = 24/137 (17%), Positives = 43/137 (31%), Gaps = 25/137 (18%)

Query: 8   PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 67
            CP +WI     + C+      R+W+ES   C      L ++ + EE     K       
Sbjct: 6   HCPEEWITYS--NSCYYIGKERRTWEESLLACTSKNSSLLSIDNEEE----MKFLSIISP 59

Query: 68  GCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG 127
             W+G    ++     W   +    +   I    +   +C  L                 
Sbjct: 60  SSWIGVFRNSS--HHPWVTMNG-LAFKHEIKDSDNAELNCAVL----------------Q 100

Query: 128 SRSLVTERCNTSHPFIC 144
              L + +C +S  + C
Sbjct: 101 VNRLKSAQCGSSIIYHC 117

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 71.2 bits (175), Expect = 1e-13
 Identities = 46/183 (25%), Positives = 81/183 (44%), Gaps = 21/183 (11%)

Query: 253 AVKRLKRSSFQRKKEF---YSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 309
           A+K L +    + K+     +E      ++ P LV ++    D+ + Y+V E+V  G + 
Sbjct: 70  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM- 128

Query: 310 RWLHHIPRGGRSLDWAMRMKVA-TTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 368
               H+ R GR  +   R   A   L     +LH      +++RD++  N+L+D++   +
Sbjct: 129 --FSHLRRIGRFSEPHARFYAAQIVLT--FEYLHSL---DLIYRDLKPENLLIDQQ--GY 179

Query: 369 LMGV--GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSG 426
           +     G +K V       RT    GT   LAPE +         D ++ GVL+ E+ +G
Sbjct: 180 IQVTDFGFAKRVK-----GRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

Query: 427 RRP 429
             P
Sbjct: 235 YPP 237

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 70.8 bits (174), Expect = 1e-13
 Identities = 50/189 (26%), Positives = 79/189 (41%), Gaps = 31/189 (16%)

Query: 249 GSRVAVKRLKRSSFQRKKE--------FYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY 300
             +VA+K + +  F               +EI    +L+HP ++ +K   +D  D YIV 
Sbjct: 35  CKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVL 93

Query: 301 EFVVNGPL-DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNV 359
           E +  G L D+    +    R L  A        +   + +LH+     ++HRD++  NV
Sbjct: 94  ELMEGGELFDK----VVGNKR-LKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENV 145

Query: 360 LLD-EEFGAHLMGV--GLSKFVPWEVMQERTVMAG--GTYGYLAPE---FVYRNELTTKS 411
           LL  +E    +     G SK      + E ++M    GT  YLAPE    V         
Sbjct: 146 LLSSQEEDCLIKITDFGHSKI-----LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAV 200

Query: 412 DVYSFGVLL 420
           D +S GV+L
Sbjct: 201 DCWSLGVIL 209

>3bdw_A Natural killer cells antigen CD94; NK cells, receptor, glycoprotein, lectin, signal-A transmembrane, immune system receptor; 2.50A {Homo sapiens} SCOP: d.169.1.1 PDB: 3cdg_J 1b6e_A 3cii_G Length = 123

 Score = 66.3 bits (162), Expect = 1e-13
 Identities = 22/139 (15%), Positives = 42/139 (30%), Gaps = 26/139 (18%)

Query: 8   PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 67
            C   W+       C+      ++W+ES   C      L  L + +E          +  
Sbjct: 4   SCQEKWVGYR--CNCYFISSEQKTWNESRHLCASQKSSLLQLQNTDE----LDFMSSSQQ 57

Query: 68  GCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSS--CTSLPCHVHATVDLCTLVS 125
             W+G          +W W +  S  ++ +       ++  C                  
Sbjct: 58  FYWIGLSYSEE--HTAWLWENG-SALSQYLFPSFETFNTKNC-------------IAYNP 101

Query: 126 NGSRSLVTERCNTSHPFIC 144
           NG  + + E C   + +IC
Sbjct: 102 NG--NALDESCEDKNRYIC 118

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 70.9 bits (174), Expect = 2e-13
 Identities = 53/188 (28%), Positives = 73/188 (38%), Gaps = 22/188 (11%)

Query: 249 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 308
              VAVK ++R +   +     EI     L HPN+V  K          I+ E+   G L
Sbjct: 45  KELVAVKYIERGAAIDEN-VQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGEL 103

Query: 309 DRWLHHIPRGGRSLDWAMRMKVATTLAQ----GIAFLHDKVKPHVVHRDIRASNVLLDEE 364
                 I   GR          A    Q    G+++ H      + HRD++  N LLD  
Sbjct: 104 ---YERICNAGR-----FSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGS 152

Query: 365 FGAHLMGV--GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELT-TKSDVYSFGVLLL 421
               L     G SK        + TV   GT  Y+APE + R E     +DV+S GV L 
Sbjct: 153 PAPRLKICDFGYSKSSVLHSQPKSTV---GTPAYIAPEVLLRQEYDGKIADVWSCGVTLY 209

Query: 422 EIVSGRRP 429
            ++ G  P
Sbjct: 210 VMLVGAYP 217

>2c6u_A CLEC1B protein; lectin, rhodocytin, aggretin, C-type lectin-like, platelets, thrombosis; 1.6A {Homo sapiens} Length = 122

 Score = 65.9 bits (161), Expect = 2e-13
 Identities = 26/142 (18%), Positives = 45/142 (31%), Gaps = 29/142 (20%)

Query: 7   APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNV 66
           +PC  +W        C+G+  +  +W+ES+ YC ++   L  + +       +       
Sbjct: 1   SPCDTNWRYYG--DSCYGFFRHNLTWEESKQYCTDMNATLLKIDNRNIVEYIKARTHLIR 58

Query: 67  NGCWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCT 122
              WVG           WKW D    + + +       G+ N                C 
Sbjct: 59  ---WVGLS--RQKSNEVWKWEDGSVISENMFEFLEDGKGNMN----------------CA 97

Query: 123 LVSNGSRSLVTERCNTSHPFIC 144
              NG   +    C   H  +C
Sbjct: 98  YFHNG--KMHPTFCENKHYLMC 117

>1c3a_A Flavocetin-A: alpha subunit; C-type lectin-like domains, membrane protein; 2.50A {Trimeresurus flavoviridis} SCOP: d.169.1.1 PDB: 1v4l_A Length = 135

 Score = 66.0 bits (161), Expect = 2e-13
 Identities = 29/146 (19%), Positives = 52/146 (35%), Gaps = 30/146 (20%)

Query: 9   CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKNV 66
           C P W   +    C+      ++W+++E++C+E     HL ++ S  E     +L  + +
Sbjct: 4   CIPGWSAYD--RYCYQAFSKPKNWEDAESFCEEGVKTSHLVSIESSGEGDFVAQLVAEKI 61

Query: 67  NG----CWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATV 118
                  W+G R  N       +WSD    N     +       F+  C +L        
Sbjct: 62  KTSFQYVWIGLRIQNKEQQCRSEWSDASSVNYENLVK------QFSKKCYAL-------- 107

Query: 119 DLCTLVSNGSRSLVTERCNTSHPFIC 144
                     R+     C T +P +C
Sbjct: 108 ----KKGTELRTWFNVYCGTENPEVC 129

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 70.1 bits (172), Expect = 3e-13
 Identities = 43/199 (21%), Positives = 77/199 (38%), Gaps = 30/199 (15%)

Query: 246 LPDGSRVAVKRLKRS--------SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRY 297
                 V VK +K+            +  +   EI   +R+ H N++ V     + G   
Sbjct: 46  KEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQ 105

Query: 298 IVYEFVVNGP--LDRWLHHIPRGGRSLDWAMRMKVATT----LAQGIAFLHDKVKPHVVH 351
           +V E   +G          I R  R     +   +A+     L   + +L  K    ++H
Sbjct: 106 LVMEKHGSGLDLFA----FIDRHPR-----LDEPLASYIFRQLVSAVGYLRLK---DIIH 153

Query: 352 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELT-TK 410
           RDI+  N+++ E+F   L+  G + ++    +        GT  Y APE +  N     +
Sbjct: 154 RDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC---GTIEYCAPEVLMGNPYRGPE 210

Query: 411 SDVYSFGVLLLEIVSGRRP 429
            +++S GV L  +V    P
Sbjct: 211 LEMWSLGVTLYTLVFEENP 229

>3ff7_C Killer cell lectin-like receptor subfamily G member 1; KLRG1-cadherin complex, calcium, cell adhesion, cell junction, cell membrane; 1.80A {Homo sapiens} Length = 112

 Score = 65.1 bits (159), Expect = 3e-13
 Identities = 27/136 (19%), Positives = 47/136 (34%), Gaps = 26/136 (19%)

Query: 9   CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 68
           CP  W+     + C+ +    + W+ S  +C     HL  +T  +E    Q    +    
Sbjct: 1   CPDRWMKYG--NHCYYFSVEEKDWNSSLEFCLARDSHLLVITDNQEMSLLQVFLSE--AF 56

Query: 69  CWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS 128
            W+G R+ +      W+W D  S  N S  +  SF  +C ++                  
Sbjct: 57  SWIGLRNNS-----GWRWEDG-SPLNFSRISSNSFVQTCGAI----------------NK 94

Query: 129 RSLVTERCNTSHPFIC 144
             L    C     ++C
Sbjct: 95  NGLQASSCEVPLHWVC 110

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 69.8 bits (171), Expect = 3e-13
 Identities = 49/204 (24%), Positives = 86/204 (42%), Gaps = 20/204 (9%)

Query: 233 LGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYS---EIGRFARLHHPNLVAVKG 288
           +G    G  Y    + +   VA+K++  S  Q  +++     E+    +L HPN +  +G
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121

Query: 289 CCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH 348
           C       ++V E+ +    D    H     + L       V     QG+A+LH     +
Sbjct: 122 CYLREHTAWLVMEYCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSH---N 174

Query: 349 VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY---RN 405
           ++HRD++A N+LL E     L   G +      +M       G  Y ++APE +      
Sbjct: 175 MIHRDVKAGNILLSEPGLVKLGDFGSA-----SIMAPANSFVGTPY-WMAPEVILAMDEG 228

Query: 406 ELTTKSDVYSFGVLLLEIVSGRRP 429
           +   K DV+S G+  +E+   + P
Sbjct: 229 QYDGKVDVWSLGITCIELAERKPP 252

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 69.6 bits (171), Expect = 4e-13
 Identities = 45/179 (25%), Positives = 77/179 (43%), Gaps = 22/179 (12%)

Query: 249 GSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGP 307
               AVK + +     K++   EI    R   HPN++ +K    D    Y+V E +  G 
Sbjct: 47  NMEFAVKIIDK----SKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGE 102

Query: 308 L-DRWLHHIPRGGRS-LDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL--DE 363
           L D+    + +   S  + +  +    T+ + + +LH +    VVHRD++ SN+L   + 
Sbjct: 103 LLDKI---LRQKFFSEREASAVLF---TITKTVEYLHAQ---GVVHRDLKPSNILYVDES 153

Query: 364 EFGAHLMGV--GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLL 420
                +     G +K +  E     T     T  ++APE + R       D++S GVLL
Sbjct: 154 GNPESIRICDFGFAKQLRAENGLLMTPC--YTANFVAPEVLERQGYDAACDIWSLGVLL 210

>1umr_C Convulxin beta, CVX beta; lectin, C-type lectin, platelet, sugar-binding protein, activator, snake venom; 2.40A {Crotalus durissus terrificus} SCOP: d.169.1.1 PDB: 1uos_B Length = 125

 Score = 65.1 bits (159), Expect = 5e-13
 Identities = 27/144 (18%), Positives = 51/144 (35%), Gaps = 34/144 (23%)

Query: 9   CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 66
           CP  W   +    C+       +W ++E +C +   G HL +  S EE     K+  +++
Sbjct: 4   CPSHWSSYD--RYCYKVFKQEMTWADAEKFCTQQHTGSHLVSFHSTEEVDFVVKMTHQSL 61

Query: 67  NG--CWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATVDL 120
                W+G    N     +W+WSD       +W+E                         
Sbjct: 62  KSTFFWIGAN--NIWNKCNWQWSDGTKPEYKEWHEEFE---------------------- 97

Query: 121 CTLVSNGSRSLVTERCNTSHPFIC 144
           C +        ++  C+ ++ F+C
Sbjct: 98  CLISRTFDNQWLSAPCSDTYSFVC 121

>1ukm_B EMS16 B chain, EMS16 subunit B; domain swapping, C-type lectin, toxin; HET: NAG; 1.90A {Echis multisquamatus} SCOP: d.169.1.1 PDB: 1v7p_B* Length = 128

 Score = 65.2 bits (159), Expect = 5e-13
 Identities = 34/144 (23%), Positives = 49/144 (34%), Gaps = 32/144 (22%)

Query: 9   CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 66
           CP  W   +    C+      ++W E+E  C +   G  LA++ S EEE    KL  K +
Sbjct: 1   CPLGWSSFD--QHCYKVFEPVKNWTEAEEICMQQHKGSRLASIHSSEEEAFVSKLASKAL 58

Query: 67  NG--CWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATVDL 120
                W+G    N      W+WSD    +   W             CT +          
Sbjct: 59  KFTSMWIGLN--NPWKDCKWEWSDNARFDYKAWKR--------RPYCTVM---------- 98

Query: 121 CTLVSNGSRSLVTERCNTSHPFIC 144
             +V        T  C  S  F+C
Sbjct: 99  --VVKPDRIFWFTRGCEKSVSFVC 120

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 68.9 bits (169), Expect = 6e-13
 Identities = 44/214 (20%), Positives = 88/214 (41%), Gaps = 41/214 (19%)

Query: 247 PDGSRVAVKRLKR-SSFQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVYEFVV 304
             G  +AVK+++R  + +  K    ++    + H  P +V   G    + D +I  E + 
Sbjct: 48  KTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM- 106

Query: 305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 364
               ++    +      +   +  K+   + + + +L +K    V+HRD++ SN+LLDE 
Sbjct: 107 GTCAEKLKKRMQGP---IPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDER 161

Query: 365 -------FG--AHLMG-VGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL-----TT 409
                  FG    L+      +               G   Y+APE +   +        
Sbjct: 162 GQIKLCDFGISGRLVDDKAKDRSA-------------GCAAYMAPERIDPPDPTKPDYDI 208

Query: 410 KSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFE 443
           ++DV+S G+ L+E+ +G+ P +       ++ FE
Sbjct: 209 RADVWSLGISLVELATGQFPYKN-----CKTDFE 237

>2e3x_C Coagulation factor X-activating enzyme light CHAI; disintegrin, metalloproteinase, C-type lectin, hydrolase, BL clotting, toxin; HET: NAG MAN GM6; 2.91A {Daboia russellii siamensis} Length = 122

 Score = 64.3 bits (157), Expect = 7e-13
 Identities = 32/144 (22%), Positives = 49/144 (34%), Gaps = 34/144 (23%)

Query: 9   CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 66
           CP  W+  E    C+    + ++W ++E +C E   G HL +L S EEE     L  +N+
Sbjct: 3   CPSGWLSYE--QHCYKGFNDLKNWTDAEKFCTEQKKGSHLVSLHSREEEKFVVNLISENL 60

Query: 67  N--GCWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATVDL 120
                W+G    N       +WSD          E         S C  +          
Sbjct: 61  EYPATWIGLG--NMWKDCRMEWSDRGNVKYKALAE--------ESYCLIM---------- 100

Query: 121 CTLVSNGSRSLVTERCNTSHPFIC 144
                   +   +  CN   P +C
Sbjct: 101 ----ITHEKVWKSMTCNFIAPVVC 120

>1sb2_B Rhodocetin beta subunit; C-type lectin, domain swapping, toxin; 1.90A {Calloselasma rhodostoma} SCOP: d.169.1.1 PDB: 3gpr_B Length = 129

 Score = 64.4 bits (157), Expect = 7e-13
 Identities = 25/146 (17%), Positives = 43/146 (29%), Gaps = 36/146 (24%)

Query: 9   CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 66
           CP  W  ++    C+      ++W E+E +C +    GHL ++ S  E      +   N 
Sbjct: 4   CPTTWSASK--LYCYKPFKEKKTWIEAERFCAKQAENGHLVSIGSAAEADFLDLVIVVNF 61

Query: 67  NGC----WVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATV 118
           +      W G    N       KW++    +     E       +   C           
Sbjct: 62  DKQRYRAWTGLTERN------LKWTNGASVSYENLYE------PYIRKC----------- 98

Query: 119 DLCTLVSNGSRSLVTERCNTSHPFIC 144
                   G        C   + F+C
Sbjct: 99  -FVVQPWEGKSKWYKADCEEKNAFLC 123

>3ubu_A Agglucetin subunit alpha-1; platelet inhibiting, agkisacucetin, dimer, toxin, C-type LEC GPIB inhibitor, GPIB binding; 1.91A {Deinagkistrodon acutus} Length = 131

 Score = 64.8 bits (158), Expect = 7e-13
 Identities = 30/145 (20%), Positives = 56/145 (38%), Gaps = 28/145 (19%)

Query: 8   PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN 65
            C P W   +    C+      ++WD++E +C E   GGHL ++ S  E     +L  +N
Sbjct: 3   DCLPGWSAYD--QSCYRVFKLLKTWDDAEKFCTERPKGGHLVSIESAGERDFVAQLVSEN 60

Query: 66  VNG--CWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATVD 119
                 W+G +  +     S +W+D    +   ++E        +  C  L         
Sbjct: 61  KQTDNVWLGLKIQSKGQQCSTEWTDGSSVSYENFSE------YQSKKCFVL--------- 105

Query: 120 LCTLVSNGSRSLVTERCNTSHPFIC 144
                + G R+ +   C + + F+C
Sbjct: 106 ---EKNTGFRTWLNLNCGSEYSFVC 127

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 68.3 bits (168), Expect = 8e-13
 Identities = 50/189 (26%), Positives = 89/189 (47%), Gaps = 31/189 (16%)

Query: 253 AVKRLKRSSFQRKKEFYSEIGR--FARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 310
           A+K LK+++ + +    +++ R     ++HP +V +       G  Y++ +F+  G L  
Sbjct: 56  AMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDL-- 113

Query: 311 WLHHIPRGGR-SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE----- 364
               + +    + +   +  +A  LA  +  LH      +++RD++  N+LLDEE     
Sbjct: 114 -FTRLSKEVMFTEEDV-KFYLAE-LALALDHLHSL---GIIYRDLKPENILLDEEGHIKL 167

Query: 365 --FGAHLMGVGLSKFVPWEVMQE--RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLL 420
             FG       LSK    E +    +     GT  Y+APE V R   T  +D +SFGVL+
Sbjct: 168 TDFG-------LSK----ESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLM 216

Query: 421 LEIVSGRRP 429
            E+++G  P
Sbjct: 217 FEMLTGTLP 225

>2py2_A Antifreeze protein type II; type II antifreeze protein; 1.70A {Clupea harengus} Length = 136

 Score = 64.7 bits (158), Expect = 8e-13
 Identities = 21/81 (25%), Positives = 38/81 (46%), Gaps = 4/81 (4%)

Query: 9  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 68
          CP DW +     +CF +      W +++  C + G +LA++ S EE    ++L   ++  
Sbjct: 4  CPTDWKMFN--GRCFLFNPLQLHWADAQESCMKEGANLASIHSLEESTFVKELTSADLIP 61

Query: 69 CWVGGRSINTTVGLSWKWSDN 89
           W+GG     +    W W D+
Sbjct: 62 SWIGGTDCQVS-T-RWFWMDS 80

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 68.3 bits (168), Expect = 8e-13
 Identities = 48/183 (26%), Positives = 86/183 (46%), Gaps = 21/183 (11%)

Query: 253 AVKRLKRSSFQRKKEF---YSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 309
           A+K LK+    R K+      E    + + HP ++ + G   D    +++ +++  G L 
Sbjct: 35  AMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGEL- 93

Query: 310 RWLHHIPRGGRSLDWAMRMKVA-TTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 368
                + +  R  +   +   A   LA  + +LH K    +++RD++  N+LLD+  G H
Sbjct: 94  --FSLLRKSQRFPNPVAKFYAAEVCLA--LEYLHSK---DIIYRDLKPENILLDKN-G-H 144

Query: 369 LMGV--GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSG 426
           +     G +K+VP     + T    GT  Y+APE V         D +SFG+L+ E+++G
Sbjct: 145 IKITDFGFAKYVP-----DVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199

Query: 427 RRP 429
             P
Sbjct: 200 YTP 202

>3gpr_D Rhodocetin subunit delta; disulfide bond, lectin, secreted, toxin, cell adhesion; 3.20A {Calloselasma rhodostoma} Length = 124

 Score = 64.0 bits (156), Expect = 9e-13
 Identities = 29/144 (20%), Positives = 49/144 (34%), Gaps = 32/144 (22%)

Query: 9   CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 66
           CP  W        C+      ++W+++E++C     G  LA++ S EEE    KL  + +
Sbjct: 1   CPLHWSSYN--GYCYRVFSELKTWEDAESFCYAQHKGSRLASIHSREEEAFVGKLASQTL 58

Query: 67  N--GCWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATVDL 120
                W+G    N      W+WSD    +   W           + C  +          
Sbjct: 59  KYTSMWLGLN--NAWAACKWEWSDDAKLDYKVWLR--------RAYCAVM---------- 98

Query: 121 CTLVSNGSRSLVTERCNTSHPFIC 144
             +V           C  +  F+C
Sbjct: 99  --VVKTDRIFWYNRGCEKTVSFLC 120

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 69.0 bits (169), Expect = 9e-13
 Identities = 46/187 (24%), Positives = 77/187 (41%), Gaps = 22/187 (11%)

Query: 253 AVKRLKRSSFQRKKE---FYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 309
           A+K L +    ++ +   F+ E    A  + P +V +     D    Y+V E++  G L 
Sbjct: 98  AMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL- 156

Query: 310 RWLHHIPRGGRSLDWAMRMKVA-TTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 368
             ++ +        WA R   A   LA  +  +H       +HRD++  N+LLD+    H
Sbjct: 157 --VNLMSNYDVPEKWA-RFYTAEVVLA--LDAIHSM---GFIHRDVKPDNMLLDKS--GH 206

Query: 369 LMGV--GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELT---TKS-DVYSFGVLLLE 422
           L     G    +  +    R   A GT  Y++PE +          +  D +S GV L E
Sbjct: 207 LKLADFGTCMKMN-KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYE 265

Query: 423 IVSGRRP 429
           ++ G  P
Sbjct: 266 MLVGDTP 272

>1umr_A Convulxin alpha, CVX alpha; lectin, C-type lectin, platelet, sugar-binding protein, activator, snake venom; 2.40A {Crotalus durissus terrificus} SCOP: d.169.1.1 PDB: 1uos_A Length = 135

 Score = 64.4 bits (157), Expect = 1e-12
 Identities = 30/146 (20%), Positives = 51/146 (34%), Gaps = 30/146 (20%)

Query: 9   CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 66
           CP DW   +    C+       +W+++E +C +   G HL ++ S +E      +  +N+
Sbjct: 4   CPSDWYYYD--QHCYRIFNEEMNWEDAEWFCTKQAKGAHLVSIKSAKEADFVAWMVTQNI 61

Query: 67  NG----CWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATV 118
                   +G R  N     S KWSD    +     +       + + C+ L        
Sbjct: 62  EESFSHVSIGLRVQNKEKQCSTKWSDGSSVSYDNLLD------LYITKCSLL-------- 107

Query: 119 DLCTLVSNGSRSLVTERCNTSHPFIC 144
                   G R      C    PF+C
Sbjct: 108 ----KKETGFRKWFVASCIGKIPFVC 129

>1tdq_B Aggrecan core protein; extracellular matrix, lecticans, tenascins, protein-protein interactions, C-type lectin domain; 2.60A {Rattus norvegicus} SCOP: d.169.1.1 Length = 130

 Score = 64.3 bits (157), Expect = 1e-12
 Identities = 29/142 (20%), Positives = 50/142 (35%), Gaps = 25/142 (17%)

Query: 8   PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 67
            C   W   +    C+ +  +  +W ++E  C+E   HL+++ + EE+    K       
Sbjct: 6   QCEEGWTKFQ--GHCYRHFPDRETWVDAERRCREQQSHLSSIVTPEEQEFVNKNAQDYQ- 62

Query: 68  GCWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTL 123
             W+G           ++WSD       KW               + P +  AT + C +
Sbjct: 63  --WIGLNDRTIEG--DFRWSDGHSLQFEKWRP-------------NQPDNFFATGEDCVV 105

Query: 124 VSNGSRSL-VTERCNTSHPFIC 144
           +    R       CN   PF C
Sbjct: 106 MIWHERGEWNDVPCNYQLPFTC 127

>1jwi_B Platelet aggregation inducer; domain swapping, C-type lectin, toxin; 2.00A {Bitis arietans} SCOP: d.169.1.1 PDB: 1uex_B Length = 125

 Score = 63.6 bits (155), Expect = 1e-12
 Identities = 29/144 (20%), Positives = 52/144 (36%), Gaps = 34/144 (23%)

Query: 9   CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKNV 66
           C PDW   +    C+      ++W ++E +CKE+  GGHL ++ S EE     KL  + +
Sbjct: 4   CLPDWSSYK--GHCYKVFKVEKTWADAEKFCKELVNGGHLMSVNSREEGEFISKLALEKM 61

Query: 67  NG--CWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATVDL 120
                W+G    +       +W+D    +    ++               P         
Sbjct: 62  RIVLVWIGLS--HFWRICPLRWTDGARLDYRALSDE--------------PI-------- 97

Query: 121 CTLVSNGSRSLVTERCNTSHPFIC 144
           C +  +     +   CN    F+C
Sbjct: 98  CFVAESFHNKWIQWTCNRKKSFVC 121

>3bx4_B Aggretin beta chain; toxin; 1.70A {Agkistrodon rhodostoma} PDB: 2vrp_B Length = 146

 Score = 64.4 bits (157), Expect = 1e-12
 Identities = 33/146 (22%), Positives = 50/146 (34%), Gaps = 34/146 (23%)

Query: 7   APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGK 64
           A CP  W   E    C+      ++W ++E +CK      HL +  S EE     KL   
Sbjct: 23  ADCPSGWSSYE--GHCYKPFNEPKNWADAERFCKLQPKHSHLVSFQSAEEADFVVKLTRP 80

Query: 65  NVNG--CWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATV 118
            +     W+G    N   G +W+WSD    N   W E         S C +         
Sbjct: 81  RLKANLVWMGLS--NIWHGCNWQWSDGARLNYKDWQE--------QSECLAF-------- 122

Query: 119 DLCTLVSNGSRSLVTERCNTSHPFIC 144
                        +   C+++  F+C
Sbjct: 123 ------RGVHTEWLNMDCSSTCSFVC 142

>3g8l_A Lectin-related NK cell receptor LY49L1; natural killer cell receptor, immune system; 2.50A {Mus musculus} Length = 190

 Score = 65.7 bits (160), Expect = 1e-12
 Identities = 23/140 (16%), Positives = 43/140 (30%), Gaps = 27/140 (19%)

Query: 8   PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 67
                W       KC+ ++ + ++W   +  C+     L  + + +E    + L     +
Sbjct: 66  GFEKYWFCYG--IKCYYFVMDRKTWSGCKQTCQISSLSLLKIDNEDELKFLKLLVPS--D 121

Query: 68  GCWVGGRSINTTVGLSWKWSDN---MSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLV 124
             W+G    N      W W +N       N   + +                    C L+
Sbjct: 122 SYWIGLSYDNK--KKDWAWINNGPSKLALNTMKYNIRDGG----------------CMLL 163

Query: 125 SNGSRSLVTERCNTSHPFIC 144
           S     L  + C+ S   IC
Sbjct: 164 SKT--RLDNDNCDKSFICIC 181

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 68.6 bits (168), Expect = 1e-12
 Identities = 47/193 (24%), Positives = 79/193 (40%), Gaps = 31/193 (16%)

Query: 253 AVKRLKRSSFQRKKE---FYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 309
           A+K L +    ++ E   F  E           +  +     D  + Y+V ++ V G L 
Sbjct: 103 AMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDL- 161

Query: 310 RWLHHIPRGGRSL--DWAMRMKVA-TTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 366
             L  + +    L  + A R  +A   +A  I  +H     H VHRDI+  N+L+D    
Sbjct: 162 --LTLLSKFEDRLPEEMA-RFYLAEMVIA--IDSVHQL---HYVHRDIKPDNILMDMN-- 211

Query: 367 AHLMGV--GLSKFVPWEVMQERTVMAG---GTYGYLAPEFVYRNELTTKS-----DVYSF 416
            H+     G       ++M++ TV +    GT  Y++PE +   E          D +S 
Sbjct: 212 GHIRLADFGSCL----KLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSL 267

Query: 417 GVLLLEIVSGRRP 429
           GV + E++ G  P
Sbjct: 268 GVCMYEMLYGETP 280

>1oz7_B Echicetin B-chain; platelet aggregation, dimer, toxin; 2.40A {Echis carinatus} SCOP: d.169.1.1 Length = 123

 Score = 63.5 bits (155), Expect = 1e-12
 Identities = 27/144 (18%), Positives = 47/144 (32%), Gaps = 34/144 (23%)

Query: 9   CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 66
           C PDW + E    C+       +W ++E +C +    GHL +  + +E      L    +
Sbjct: 2   CLPDWSVYE--GYCYKVFKERMNWADAEKFCTKQHKDGHLVSFRNSKEVDFVISLAFPML 59

Query: 67  NG--CWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATVDL 120
                W+G    +     +W+WSD    +   W+   H                      
Sbjct: 60  KNDLVWIGLT--DYWRDCNWEWSDGAQLDYKAWDNERH---------------------- 95

Query: 121 CTLVSNGSRSLVTERCNTSHPFIC 144
           C +  N         C  +  F+C
Sbjct: 96  CFIYKNTDNQWTRRDCTWTFSFVC 119

>1fvu_A Botrocetin alpha chain; VON WILLBRAND factor modulator, C-type lectin, metal- binding, loop exchanged dimer, toxin; 1.80A {Bothrops jararaca} SCOP: d.169.1.1 PDB: 1ijk_B 1u0n_B 1u0o_A Length = 133

 Score = 63.3 bits (154), Expect = 2e-12
 Identities = 34/147 (23%), Positives = 51/147 (34%), Gaps = 31/147 (21%)

Query: 9   CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHS-AQKLCGKN 65
           CP  W   E    C+ +     +W ++E +C E   GGHL ++  Y +E      L  KN
Sbjct: 2   CPSGWSSYE--GNCYKFFQQKMNWADAERFCSEQAKGGHLVSIKIYSKEKDFVGDLVTKN 59

Query: 66  VNG----CWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHAT 117
           +       W+G R  N     S +WSD    +     E           C +L       
Sbjct: 60  IQSSDLYAWIGLRVENKEKQCSSEWSDGSSVSYENVVE------RTVKKCFAL------- 106

Query: 118 VDLCTLVSNGSRSLVTERCNTSHPFIC 144
                    G    +   C   +PF+C
Sbjct: 107 -----EKDLGFVLWINLYCAQKNPFVC 128

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 66.5 bits (163), Expect = 2e-12
 Identities = 48/187 (25%), Positives = 72/187 (38%), Gaps = 17/187 (9%)

Query: 249 GSRVAVKRLKRSSFQRKKE-FYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 307
              VAVK +         E    EI     L+H N+V   G   +   +Y+  E+   G 
Sbjct: 32  EEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 91

Query: 308 LDRWLHHIPRGGRSLDWAMRMKVATTLAQ----GIAFLHDKVKPHVVHRDIRASNVLLDE 363
           L      I          M    A         G+ +LH      + HRDI+  N+LLDE
Sbjct: 92  L---FDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDE 140

Query: 364 EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELT-TKSDVYSFGVLLLE 422
                +   GL+    +   +       GT  Y+APE + R E      DV+S G++L  
Sbjct: 141 RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTA 200

Query: 423 IVSGRRP 429
           +++G  P
Sbjct: 201 MLAGELP 207

>2kv3_A Regenerating islet-derived protein 4; GISP, C-type lectin, REG IV, disulfide bond, glycoPro lectin, secreted, sugar binding protein; NMR {Homo sapiens} Length = 131

 Score = 62.8 bits (153), Expect = 3e-12
 Identities = 30/147 (20%), Positives = 52/147 (35%), Gaps = 31/147 (21%)

Query: 8   PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKN 65
            C P W  ++  S C+GY    R+W ++E  C+    G HLA++ S +E  +  +     
Sbjct: 2   SCAPGWFYHK--SNCYGYFRKLRNWSDAELECQSYGNGAHLASILSLKEASTIAEYISGY 59

Query: 66  VNG--CWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSS--CTSLPCHVHAT 117
                 W+G    +      W+W D        W+       S   +  C  +       
Sbjct: 60  QRSQSIWIGLH--DPQKRQQWQWIDGAMYLYRSWSG-----KSMGGNKHCAEM------- 105

Query: 118 VDLCTLVSNGSRSLVTERCNTSHPFIC 144
                  +N   +  +  CN    F+C
Sbjct: 106 -----SSNNNFLTWSSNECNKRQHFLC 127

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 66.2 bits (162), Expect = 4e-12
 Identities = 53/249 (21%), Positives = 85/249 (34%), Gaps = 47/249 (18%)

Query: 208 PPSWKVFTTEELRSITKNFSEGN----RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSF 262
           PP+     T       +   E       LLG    G  ++G  L D  +VA+K + R+  
Sbjct: 10  PPAPPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRV 69

Query: 263 QRKKEF------YSEIGRFARLH----HPNLVAVKGCCYDHGDRYIVYEFVVNGP-LDRW 311
                         E+    ++     HP ++ +           +V E  +    L   
Sbjct: 70  LGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDL--- 126

Query: 312 LHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE------- 364
             +I   G  L           +   I   H +    VVHRDI+  N+L+D         
Sbjct: 127 FDYITEKGP-LGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLI 182

Query: 365 ---FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELT-TKSDVYSFGVLL 420
               GA L     + F              GT  Y  PE++ R++     + V+S G+LL
Sbjct: 183 DFGSGALLHDEPYTDFD-------------GTRVYSPPEWISRHQYHALPATVWSLGILL 229

Query: 421 LEIVSGRRP 429
            ++V G  P
Sbjct: 230 YDMVCGDIP 238

>1j34_A Coagulation factor IX-binding protein A chain; magnesium ION, calcium ION, GLA domain, protein binding/blood clotting complex; HET: CGU; 1.55A {Trimeresurus flavoviridis} SCOP: d.169.1.1 PDB: 1bj3_A* 1j35_A* 1x2t_A* 1x2w_A 1ixx_A 1y17_A 1wt9_A 1iod_A* Length = 129

 Score = 62.4 bits (152), Expect = 4e-12
 Identities = 37/148 (25%), Positives = 55/148 (37%), Gaps = 34/148 (22%)

Query: 9   CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 66
           CP  W   E    C+     +++WD++E +C E   GGHL ++ S  E     +L  +N+
Sbjct: 2   CPSGWSSYE--GHCYKPFKLYKTWDDAERFCTEQAKGGHLVSIESAGEADFVAQLVTENI 59

Query: 67  NGC----WVGGRSINTTVGLSWKWSD----NMSKW--NESIHAVGSFNSSCTSLPCHVHA 116
                  W+G R        S +WSD    +   W   ES   +G      T        
Sbjct: 60  QNTKSYVWIGLRVQGKEKQCSSEWSDGSSVSYENWIEAESKTCLG--LEKET-------- 109

Query: 117 TVDLCTLVSNGSRSLVTERCNTSHPFIC 144
                     G R  V   C   +PF+C
Sbjct: 110 ----------GFRKWVNIYCGQQNPFVC 127

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 66.5 bits (162), Expect = 5e-12
 Identities = 49/190 (25%), Positives = 74/190 (38%), Gaps = 43/190 (22%)

Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 390
           +  +A+G+ FL  +     +HRD+ A N+LL E+    +   GL+          R +  
Sbjct: 199 SFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLA----------RDIYK 245

Query: 391 GGTY-----GYL-----APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQ 439
              Y       L     APE ++    T +SDV+SFGVLL EI S G  P   V     +
Sbjct: 246 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI--DE 303

Query: 440 SIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHV 499
                   L +  R   +  P  ++            ++   +  C    PS RP  S +
Sbjct: 304 EFCRR---LKEGTR---MRAPDYTT-----------PEMYQTMLDCWHGEPSQRPTFSEL 346

Query: 500 VHQLQQLAQP 509
           V  L  L Q 
Sbjct: 347 VEHLGNLLQA 356

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 48.4 bits (115), Expect = 3e-06
 Identities = 30/155 (19%), Positives = 49/155 (31%), Gaps = 16/155 (10%)

Query: 240 GTYSGILPDGS--RVAVKRLKRSSFQR-KKEFYSEIGRFARL-HHPNLVAVKGCCYDHGD 295
               GI    +   VAVK LK  +     +   SE+     + HH N+V + G C   G 
Sbjct: 41  ADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 100

Query: 296 R-YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDI 354
              ++ EF   G L  +L              R +      +G  F   K     +  D+
Sbjct: 101 PLMVIVEFCKFGNLSTYLRS-----------KRNEFVPYKTKGARFRQGKDYVGAIPVDL 149

Query: 355 RASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 389
           +     +     +   G    K +     +E    
Sbjct: 150 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPED 184

>3gpr_C Rhodocetin subunit gamma; disulfide bond, lectin, secreted, toxin, cell adhesion; 3.20A {Calloselasma rhodostoma} Length = 134

 Score = 62.5 bits (152), Expect = 5e-12
 Identities = 33/148 (22%), Positives = 48/148 (32%), Gaps = 34/148 (22%)

Query: 9   CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 66
           C P W   +    C+      ++WDE+E +C E    GHL ++ S  E     +L   N+
Sbjct: 3   CLPGWSAYD--QHCYQAFNEPKTWDEAERFCTEQAKRGHLVSIGSDGEADFVAQLVTNNI 60

Query: 67  NG----CWVGGRSINTTVGLSWKWSD----NMSKW--NESIHAVGSFNSSCTSLPCHVHA 116
                  W+G R        S +WS         W   ES    G    +          
Sbjct: 61  KRPELYVWIGLRDRRKEQQCSSEWSMSASIIYVNWNTGESQMCQGLARWT---------- 110

Query: 117 TVDLCTLVSNGSRSLVTERCNTSHPFIC 144
                     G R      C   +PF+C
Sbjct: 111 ----------GFRKWDYSDCQAKNPFVC 128

>1fvu_B Botrocetin beta chain; VON WILLBRAND factor modulator, C-type lectin, metal- binding, loop exchanged dimer, toxin; 1.80A {Bothrops jararaca} SCOP: d.169.1.1 PDB: 1ijk_C 1u0n_C 1u0o_B Length = 125

 Score = 61.7 bits (150), Expect = 6e-12
 Identities = 28/144 (19%), Positives = 48/144 (33%), Gaps = 32/144 (22%)

Query: 9   CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 66
           CPPDW   E    C+ +   +  WD++E +C E   G HL +  S EE    + L  + +
Sbjct: 2   CPPDWSSYE--GHCYRFFKEWMHWDDAEEFCTEQQTGAHLVSFQSKEEADFVRSLTSEML 59

Query: 67  NG--CWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATVDL 120
            G   W+G    +      ++W+D    +   +         +                 
Sbjct: 60  KGDVVWIGLS--DVWNKCRFEWTDGMEFDYDDYYLI----AEYE---------------- 97

Query: 121 CTLVSNGSRSLVTERCNTSHPFIC 144
           C      +       C     F+C
Sbjct: 98  CVASKPTNNKWWIIPCTRFKNFVC 121

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 65.8 bits (161), Expect = 6e-12
 Identities = 48/187 (25%), Positives = 72/187 (38%), Gaps = 17/187 (9%)

Query: 249 GSRVAVKRLKRSSFQRKKE-FYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 307
              VAVK +         E    EI     L+H N+V   G   +   +Y+  E+   G 
Sbjct: 32  EEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 91

Query: 308 LDRWLHHIPRGGRSLDWAMRMKVATTLAQ----GIAFLHDKVKPHVVHRDIRASNVLLDE 363
           L      I          M    A         G+ +LH      + HRDI+  N+LLDE
Sbjct: 92  L---FDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDE 140

Query: 364 EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELT-TKSDVYSFGVLLLE 422
                +   GL+    +   +       GT  Y+APE + R E      DV+S G++L  
Sbjct: 141 RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTA 200

Query: 423 IVSGRRP 429
           +++G  P
Sbjct: 201 MLAGELP 207

>1j34_B Coagulation factor IX-binding protein B chain; magnesium ION, calcium ION, GLA domain, protein binding/blood clotting complex; HET: CGU; 1.55A {Trimeresurus flavoviridis} SCOP: d.169.1.1 PDB: 1bj3_B 1ixx_B* 1j35_B* 1x2t_B* 1x2w_B 1wt9_B 1iod_B 1y17_B Length = 123

 Score = 61.6 bits (150), Expect = 7e-12
 Identities = 30/144 (20%), Positives = 48/144 (33%), Gaps = 34/144 (23%)

Query: 9   CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 66
           CP DW   E    C+      ++W ++E +C +   GGHL +  S EE     KL  +  
Sbjct: 2   CPSDWSSYE--GHCYKPFSEPKNWADAENFCTQQHAGGHLVSFQSSEEADFVVKLAFQTF 59

Query: 67  NGC--WVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATVDL 120
                W+G    N     +W+WS+        W E  +                      
Sbjct: 60  GHSIFWMGLS--NVWNQCNWQWSNAAMLRYKAWAEESY---------------------- 95

Query: 121 CTLVSNGSRSLVTERCNTSHPFIC 144
           C    + +    +  C     F+C
Sbjct: 96  CVYFKSTNNKWRSRACRMMAQFVC 119

>1c3a_B Flavocetin-A: beta subunit; C-type lectin-like domains, membrane protein; 2.50A {Trimeresurus flavoviridis} SCOP: d.169.1.1 PDB: 1v4l_B Length = 125

 Score = 61.7 bits (150), Expect = 7e-12
 Identities = 23/144 (15%), Positives = 45/144 (31%), Gaps = 34/144 (23%)

Query: 9   CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 66
           CP  W   +    C+       +W+++E +C +   G HL +  S EE           +
Sbjct: 4   CPLGWSSYD--EHCYQVFQQKMNWEDAEKFCTQQHKGSHLVSFHSSEEVDFVTSKTFPIL 61

Query: 67  NG--CWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATVDL 120
                W+G    N     + +WSD    +   W+                          
Sbjct: 62  KYDFVWIGLS--NVWNECTKEWSDGTKLDYKAWSGGSD---------------------- 97

Query: 121 CTLVSNGSRSLVTERCNTSHPFIC 144
           C +        ++  C++ +  +C
Sbjct: 98  CIVSKTTDNQWLSMDCSSKYYVVC 121

>2xr6_A CD209 antigen; sugar binding protein, carbohydrate binding, mannose; HET: MAN 07B; 1.35A {Homo sapiens} PDB: 1sl4_A* 2it6_A* 1k9i_A* 2xr5_A* 1sl5_A* 2it5_A* 1xph_A 1k9j_A* Length = 170

 Score = 62.9 bits (153), Expect = 7e-12
 Identities = 24/81 (29%), Positives = 40/81 (49%), Gaps = 4/81 (4%)

Query: 8  PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 67
          PCP +W   +    C+    + R+W +S T CKE+G  L  + S EE++  Q    ++  
Sbjct: 21 PCPWEWTFFQ--GNCYFMSNSQRNWHDSITACKEVGAQLVVIKSAEEQNFLQLQSSRSNR 78

Query: 68 GCWVGGRSINTTVGLSWKWSD 88
            W+G   +N     +W+W D
Sbjct: 79 FTWMGLSDLNQE--GTWQWVD 97

>3bx4_A Aggretin alpha chain; toxin; 1.70A {Agkistrodon rhodostoma} PDB: 2vrp_A Length = 136

 Score = 61.7 bits (150), Expect = 9e-12
 Identities = 33/150 (22%), Positives = 51/150 (34%), Gaps = 35/150 (23%)

Query: 8   PCPPDWIINEEKSKCFGYIGNFRSWDESETYCK--EIGGHLAALTSYEE-----EHSAQK 60
            C   W   +    C+      ++WDE+E +C+  E G HLA++ S  E        +QK
Sbjct: 4   DCDFGWSPYD--QHCYQAFNEQKTWDEAEKFCRAQENGAHLASIESNGEADFVSWLISQK 61

Query: 61  LCGKNVNGCWVGGRSINTTVGLSWKWSD----NMSKW--NESIHAVGSFNSSCTSLPCHV 114
               + +  W+G R+ N     S +WSD    +        +           T      
Sbjct: 62  DELADEDYVWIGLRAQNKEQQCSSEWSDGSSVSYENLIDLHTKKCGA--LEKLT------ 113

Query: 115 HATVDLCTLVSNGSRSLVTERCNTSHPFIC 144
                       G R  V   C   H F+C
Sbjct: 114 ------------GFRKWVNYYCEQMHAFVC 131

>2afp_A Protein (SEA raven type II antifreeze protein); recombinant SEA raven protein, solution backbone fold, C- type lectin; NMR {Hemitripterus americanus} SCOP: d.169.1.1 Length = 129

 Score = 61.6 bits (150), Expect = 9e-12
 Identities = 35/145 (24%), Positives = 51/145 (35%), Gaps = 33/145 (22%)

Query: 8   PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 67
            CP  W       +C  Y     +W  +ET C ++GGHLA++ S EE    Q L    V 
Sbjct: 6   NCPAGWQPLG--DRCIYYETTAMTWALAETNCMKLGGHLASIHSQEEHSFIQTLNAGVV- 62

Query: 68  GCWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVG----SFNSSCTSLPCHVHATVD 119
             W+GG +     G +W WSD    N   W               + C      +     
Sbjct: 63  --WIGGSACLQA-G-AWTWSDGTPMNFRSWCS-----TKPDDVLAACC------MQ---- 103

Query: 120 LCTLVSNGSRSLVTERCNTSHPFIC 144
              + +   +      C  SH  +C
Sbjct: 104 ---MTAAADQCWDDLPCPASHKSVC 125

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 65.4 bits (160), Expect = 1e-11
 Identities = 49/203 (24%), Positives = 89/203 (43%), Gaps = 37/203 (18%)

Query: 242 YSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR----- 296
           +   L +   VA+K++     Q K+    E+     + HPN+V +K   Y +GD+     
Sbjct: 57  FQAKLVESDEVAIKKV----LQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF 112

Query: 297 -YIVYEFVVNGPLD--RWLHHIPRGGRSLDWAMRMKVAT-TLAQGIAFLHDKVKPHVVHR 352
             +V E+V   P    R   H  +  +++   + +K+    L + +A++H      + HR
Sbjct: 113 LNLVLEYV---PETVYRASRHYAKLKQTMP-MLLIKLYMYQLLRSLAYIHSI---GICHR 165

Query: 353 DIRASNVLLDEEFGAHLMGV------GLSK-FVPWEVMQERTVMAGGTYGYLAPEFVYR- 404
           DI+  N+LLD        GV      G +K  +  E           +  Y APE ++  
Sbjct: 166 DIKPQNLLLDPP-----SGVLKLIDFGSAKILIAGEPNVSYIC----SRYYRAPELIFGA 216

Query: 405 NELTTKSDVYSFGVLLLEIVSGR 427
              TT  D++S G ++ E++ G+
Sbjct: 217 TNYTTNIDIWSTGCVMAELMQGQ 239

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 64.9 bits (159), Expect = 1e-11
 Identities = 49/187 (26%), Positives = 90/187 (48%), Gaps = 25/187 (13%)

Query: 253 AVKRLKRSSFQRKKEF---YSEIGRFAR-LHHPNLVAVKGCCYDHGDR-YIVYEFVVNGP 307
           A+K +K+      ++     +E   F +  +HP LV +   C+    R + V E+V  G 
Sbjct: 38  AMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGD 96

Query: 308 LDRWLHHIPRGGR-SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 366
           L   + H+ R  +   + A R   A  ++  + +LH++    +++RD++  NVLLD E  
Sbjct: 97  L---MFHMQRQRKLPEEHA-RFYSAE-ISLALNYLHER---GIIYRDLKLDNVLLDSE-- 146

Query: 367 AHLMGV--GLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVYSFGVLLLE 422
            H+     G+ K    E ++     +   GT  Y+APE +   +     D ++ GVL+ E
Sbjct: 147 GHIKLTDYGMCK----EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFE 202

Query: 423 IVSGRRP 429
           +++GR P
Sbjct: 203 MMAGRSP 209

>3ubu_B Agglucetin subunit beta-2; platelet inhibiting, agkisacucetin, dimer, toxin, C-type LEC GPIB inhibitor, GPIB binding; 1.91A {Deinagkistrodon acutus} Length = 126

 Score = 60.9 bits (148), Expect = 1e-11
 Identities = 32/144 (22%), Positives = 52/144 (36%), Gaps = 33/144 (22%)

Query: 9   CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 66
           CP  W   E    C+  +   ++WD++E +C E   GGHL ++ S EE      L    +
Sbjct: 4   CPLRWSAYE--GHCYLVVKEKKTWDDAEKFCTEQRKGGHLVSVHSREEADFLVHLAYPIL 61

Query: 67  NG--CWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATVDL 120
           +    W+G    N       +WSD    +   W +         S C             
Sbjct: 62  DLSLIWMGLS--NMWNDCKREWSDGTKLDFKSWAK--------TSDC------------- 98

Query: 121 CTLVSNGSRSLVTERCNTSHPFIC 144
               ++G    +   C+  H F+C
Sbjct: 99  LIGKTDGDNQWLNMDCSKKHYFVC 122

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 64.7 bits (158), Expect = 1e-11
 Identities = 50/266 (18%), Positives = 85/266 (31%), Gaps = 45/266 (16%)

Query: 189 SKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGN----RLLGDSKTGGTYSG 244
           S               + + P   +  T+      K   E       LLG    G  YSG
Sbjct: 3   SSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSG 62

Query: 245 I-LPDGSRVAVKRLKRSSFQRKKEF------YSEIGRFARLHH--PNLVAVKGCCYDHGD 295
           I + D   VA+K +++       E         E+    ++      ++ +         
Sbjct: 63  IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 122

Query: 296 RYIVYEFVVN-GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDI 354
             ++ E       L      I   G  L   +       + + +   H+     V+HRDI
Sbjct: 123 FVLILERPEPVQDL---FDFITERGA-LQEELARSFFWQVLEAVRHCHNC---GVLHRDI 175

Query: 355 RASNVLLDEE----------FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR 404
           +  N+L+D             GA L     + F              GT  Y  PE++  
Sbjct: 176 KDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-------------GTRVYSPPEWIRY 222

Query: 405 NELT-TKSDVYSFGVLLLEIVSGRRP 429
           +      + V+S G+LL ++V G  P
Sbjct: 223 HRYHGRSAAVWSLGILLYDMVCGDIP 248

>1sl6_A C-type lectin DC-signr; sugar binding protein; HET: GAL NDG FUC; 2.25A {Homo sapiens} SCOP: d.169.1.1 PDB: 1xar_A Length = 184

 Score = 62.2 bits (151), Expect = 1e-11
 Identities = 31/143 (21%), Positives = 54/143 (37%), Gaps = 26/143 (18%)

Query: 8   PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 67
            CP DW   +    C+    + R+W +S T C+E+   L  + + EE++  Q    ++  
Sbjct: 52  HCPKDWTFFQGN--CYFMSNSQRNWHDSVTACQEVRAQLVVIKTAEEQNFLQLQTSRSNR 109

Query: 68  GCWVGGRSINTTVGLSWKWSDN--MSKWNESIHAVGSFNSS----CTSLPCHVHATVDLC 121
             W+G   +N   G +W+W D   +S   +     G  N+S    C              
Sbjct: 110 FSWMGLSDLNQE-G-TWQWVDGSPLSPSFQRYWNSGEPNNSGNEDC-------------- 153

Query: 122 TLVSNGSRSLVTERCNTSHPFIC 144
                        RC+  + +IC
Sbjct: 154 --AEFSGSGWNDNRCDVDNYWIC 174

>2b6b_D CD209 antigen; cryo EM dengue CRD DC-SIGN, icosahedral virus, virus-recepto; 25.00A {Homo sapiens} SCOP: d.169.1.1 Length = 175

 Score = 62.2 bits (151), Expect = 1e-11
 Identities = 24/82 (29%), Positives = 40/82 (48%), Gaps = 4/82 (4%)

Query: 8   PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 67
           PCP +W   +    C+    + R+W +S T CKE+G  L  + S EE++  Q    ++  
Sbjct: 26  PCPWEWTFFQ--GNCYFMSNSQRNWHDSITACKEVGAQLVVIKSAEEQNFLQLQSSRSNR 83

Query: 68  GCWVGGRSINTTVGLSWKWSDN 89
             W+G   +N     +W+W D 
Sbjct: 84  FTWMGLSDLNQE--GTWQWVDG 103

>1pwb_A SP-D, PSP-D, pulmonary surfactant-associated protein D; collectin, C-type lectin, alpha-helical coiled coil, carbohydrate recognition domain; HET: GLC; 1.40A {Homo sapiens} SCOP: d.169.1.1 h.1.1.1 PDB: 1pw9_A* 3ikn_A* 3ikp_A* 3ikq_A* 3ikr_A* 2rie_A* 2ggx_A* 2ggu_A* 2ork_A* 2orj_A* 2ria_A* 2rib_A* 2ric_A* 2rid_A* 2os9_A* 3dbz_A 3g81_A* 3g83_A* 1b08_A 3g84_A* ... Length = 177

 Score = 62.1 bits (151), Expect = 2e-11
 Identities = 20/94 (21%), Positives = 33/94 (35%), Gaps = 8/94 (8%)

Query: 6   KAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN 65
           K    P+     EK   F   G  + + E++  C + GG LA+  S  E  + Q+L    
Sbjct: 52  KVELFPNGQSVGEK--IFKTAGFVKPFTEAQLLCTQAGGQLASPRSAAENAALQQLVVAK 109

Query: 66  VNGCWVGGRSINTTVGLSWKWSD----NMSKWNE 95
               ++      T  G  + +        S W  
Sbjct: 110 NEAAFLSMTDSKTE-G-KFTYPTGESLVYSNWAP 141

>2e3x_B Coagulation factor X-activating enzyme light CHAI; disintegrin, metalloproteinase, C-type lectin, hydrolase, BL clotting, toxin; HET: NAG MAN GM6; 2.91A {Daboia russellii siamensis} Length = 134

 Score = 60.9 bits (148), Expect = 2e-11
 Identities = 32/146 (21%), Positives = 49/146 (33%), Gaps = 30/146 (20%)

Query: 9   CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 66
           CPPD  +      C+      ++W+ +E +C E    GHL ++ S EE     KL     
Sbjct: 3   CPPDSSLYR--YFCYRVFKEHKTWEAAERFCMEHPNNGHLVSIESMEEAEFVAKLLSNTT 60

Query: 67  NGC----WVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATV 118
                  W+G    +     S +WSD    +  K  +       F   C  L        
Sbjct: 61  GKFITHFWIGLMIKDKEQECSSEWSDGSSVSYDKLGK-----QEFR-KCFVL-------- 106

Query: 119 DLCTLVSNGSRSLVTERCNTSHPFIC 144
                  +G R      C   + F+C
Sbjct: 107 ----EKESGYRMWFNRNCEERYLFVC 128

>1qdd_A Lithostathine; pancreatic stone inhibitor, metal binding protein; HET: SIA NDG GAL; 1.30A {Homo sapiens} SCOP: d.169.1.1 PDB: 1lit_A Length = 144

 Score = 61.3 bits (149), Expect = 2e-11
 Identities = 25/140 (17%), Positives = 50/140 (35%), Gaps = 17/140 (12%)

Query: 9   CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI-GGHLAALTSYEEEHSAQKLCGKNVN 67
           CP         S C+ +  +  +W +++ YC+ +  G+L ++ +  E      L  ++  
Sbjct: 14  CPEGTNAYR--SYCYYFNEDRETWVDADLYCQNMNSGNLVSVLTQAEGAFVASLIKESGT 71

Query: 68  G---CWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLV 124
                W+G    +     +W WS           ++ S+ S     P  V+    +    
Sbjct: 72  DDFNVWIGLH--DPKKNRAWHWSSG---------SLVSYKSWGIGAPSSVNPGYCVSLTS 120

Query: 125 SNGSRSLVTERCNTSHPFIC 144
           S G +      C     F+C
Sbjct: 121 STGFQKWKDVPCEDKFSFVC 140

>1jzn_A Galactose-specific lectin; C-type lectin, protein-disaccharide complex, sugar binding P; HET: BGC GAL; 2.20A {Crotalus atrox} SCOP: d.169.1.1 PDB: 1muq_A* Length = 135

 Score = 60.9 bits (148), Expect = 2e-11
 Identities = 32/147 (21%), Positives = 54/147 (36%), Gaps = 29/147 (19%)

Query: 9   CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKNV 66
           CP DW+       C+      ++W+++E +C++   G HLA+   Y E     +      
Sbjct: 3   CPLDWLPMN--GLCYKIFNQLKTWEDAEMFCRKYKPGCHLASFHRYGESLEIAEYISDYH 60

Query: 67  NG---CWVGGRSINTTVGLSWKWSD----NMSKW--NESIHAVGSFNSSCTSLPCHVHAT 117
            G    W+G R  +     SW+W+D    +   W  N+  H        C  L       
Sbjct: 61  KGQENVWIGLR--DKKKDFSWEWTDRSCTDYLTWDKNQPDHYQN--KEFCVEL------- 109

Query: 118 VDLCTLVSNGSRSLVTERCNTSHPFIC 144
                +   G R    + C +   F+C
Sbjct: 110 -----VSLTGYRLWNDQVCESKDAFLC 131

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 64.7 bits (158), Expect = 2e-11
 Identities = 48/187 (25%), Positives = 90/187 (48%), Gaps = 25/187 (13%)

Query: 253 AVKRLKRSSFQRKKEF---YSEIGRFAR-LHHPNLVAVKGCCYDHGDR-YIVYEFVVNGP 307
           A++ +K+      ++     +E   F +  +HP LV +   C+    R + V E+V  G 
Sbjct: 81  AMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGD 139

Query: 308 LDRWLHHIPRGGR-SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 366
           L   + H+ R  +   + A R   A  ++  + +LH++    +++RD++  NVLLD E  
Sbjct: 140 L---MFHMQRQRKLPEEHA-RFYSAE-ISLALNYLHER---GIIYRDLKLDNVLLDSE-- 189

Query: 367 AHLMGV--GLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVYSFGVLLLE 422
            H+     G+ K    E ++     +   GT  Y+APE +   +     D ++ GVL+ E
Sbjct: 190 GHIKLTDYGMCK----EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFE 245

Query: 423 IVSGRRP 429
           +++GR P
Sbjct: 246 MMAGRSP 252

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 63.9 bits (156), Expect = 2e-11
 Identities = 60/253 (23%), Positives = 97/253 (38%), Gaps = 41/253 (16%)

Query: 193 RKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSR 251
             +R L     SAL  P+  +F   EL             +G+   G  Y G  +  G  
Sbjct: 6   SPARSLDEIDLSALRDPA-GIFELVEL-------------VGNGTYGQVYKGRHVKTGQL 51

Query: 252 VAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRY------IVYEFVV 304
            A+K +  +    ++E   EI    +  HH N+    G               +V EF  
Sbjct: 52  AAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCG 110

Query: 305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ---GIAFLHDKVKPHVVHRDIRASNVLL 361
            G +   + +        +W     +A    +   G++ LH      V+HRDI+  NVLL
Sbjct: 111 AGSVTDLIKNTKGNTLKEEW-----IAYICREILRGLSHLHQH---KVIHRDIKGQNVLL 162

Query: 362 DEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELT-----TKSDVYSF 416
            E     L+  G+S  +    +  R    G  Y ++APE +  +E        KSD++S 
Sbjct: 163 TENAEVKLVDFGVSAQLD-RTVGRRNTFIGTPY-WMAPEVIACDENPDATYDFKSDLWSL 220

Query: 417 GVLLLEIVSGRRP 429
           G+  +E+  G  P
Sbjct: 221 GITAIEMAEGAPP 233

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 64.2 bits (157), Expect = 3e-11
 Identities = 56/187 (29%), Positives = 85/187 (45%), Gaps = 25/187 (13%)

Query: 253 AVKRLKRSSFQRKKEF---YSEIGRFAR-LHHPNLVAVKGCCYDHGDR-YIVYEFVVNGP 307
           AVK LK+    +  +      E    A     P L  +   C+   DR Y V E+V  G 
Sbjct: 49  AVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGD 107

Query: 308 LDRWLHHIPRGGR-SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 366
           L   ++HI + GR     A     A  +A G+ FL  K    +++RD++  NV+LD E G
Sbjct: 108 L---MYHIQQVGRFKEPHA-VFYAAE-IAIGLFFLQSK---GIIYRDLKLDNVMLDSE-G 158

Query: 367 AHLMGV--GLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVYSFGVLLLE 422
            H+     G+ K    E + +        GT  Y+APE +         D ++FGVLL E
Sbjct: 159 -HIKIADFGMCK----ENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYE 213

Query: 423 IVSGRRP 429
           +++G+ P
Sbjct: 214 MLAGQAP 220

>2ox9_A Collectin placenta 1; C-type lectin, sugar binding protein; HET: GAL NAG FUC; 1.95A {Mus musculus} PDB: 2ox8_A Length = 140

 Score = 60.5 bits (147), Expect = 3e-11
 Identities = 26/140 (18%), Positives = 49/140 (35%), Gaps = 20/140 (14%)

Query: 9   CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 68
           CPP W       KC+ +      +++++ +C++   HL  + S EE+   +K        
Sbjct: 5   CPPHWKNFT--DKCYYFSLEKEIFEDAKLFCEDKSSHLVFINSREEQQWIKKHTVGR-ES 61

Query: 69  CWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLV 124
            W+G           WKW D    +   W       G  ++  +            C  +
Sbjct: 62  HWIGLTDSEQE-S-EWKWLDGSPVDYKNWKA-----GQPDNWGSGHGPGED-----CAGL 109

Query: 125 SNGSRSLVTERCNTSHPFIC 144
               +     +C+  + FIC
Sbjct: 110 IYAGQ-WNDFQCDEINNFIC 128

>3kqg_A Langerin, C-type lectin domain family 4 member K; trimer, NECK and CRD, coiled coil, immune system; 2.30A {Homo sapiens} Length = 182

 Score = 61.4 bits (149), Expect = 3e-11
 Identities = 17/82 (20%), Positives = 29/82 (35%), Gaps = 6/82 (7%)

Query: 8   PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 67
                W   +     + +    ++W  +E +C     HL ++TS  E+    K  G    
Sbjct: 48  VVSQGWKYFK--GNFYYFSLIPKTWYSAEQFCVSRNSHLTSVTSESEQEFLYKTAGG--L 103

Query: 68  GCWVGGRSINTTVGLSWKWSDN 89
             W+G        G  W W D+
Sbjct: 104 IYWIGLTKAGME-G-DWSWVDD 123

>1ukm_A EMS16 A chain, EMS16 subunit A; domain swapping, C-type lectin, toxin; HET: NAG; 1.90A {Echis multisquamatus} SCOP: d.169.1.1 PDB: 1v7p_A* Length = 134

 Score = 60.1 bits (146), Expect = 3e-11
 Identities = 33/148 (22%), Positives = 52/148 (35%), Gaps = 34/148 (22%)

Query: 9   CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 66
           CP DW   +    C+  IG  ++W E+E +C E    GHL ++ S EE +   +L    +
Sbjct: 4   CPSDWTAYD--QHCYLAIGEPQNWYEAERFCTEQAKDGHLVSIQSREEGNFVAQLVSGFM 61

Query: 67  NG----CWVGGRSINTTVGLSWKWSD----NMSKW--NESIHAVGSFNSSCTSLPCHVHA 116
           +      W+G R        + +W+D        W   ES    G   +  T        
Sbjct: 62  HRSEIYVWIGLRDRREEQQCNPEWNDGSKIIYVNWKEGESKMCQG--LTKWT-------- 111

Query: 117 TVDLCTLVSNGSRSLVTERCNTSHPFIC 144
                              C   +PF+C
Sbjct: 112 ----------NFHDWNNINCEDLYPFVC 129

>1dv8_A Asialoglycoprotein receptor 1; C-type lectin CRD, signaling protein; 2.30A {Homo sapiens} SCOP: d.169.1.1 Length = 128

 Score = 60.1 bits (146), Expect = 3e-11
 Identities = 27/147 (18%), Positives = 49/147 (33%), Gaps = 34/147 (23%)

Query: 9   CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 68
           CP +W+ +E    C+ +  + ++W +++ YC+    HL  +TS+EE+   Q   G     
Sbjct: 1   CPVNWVEHE--RSCYWFSRSGKAWADADNYCRLEDAHLVVVTSWEEQKFVQHHIGP--VN 56

Query: 69  CWVGGRSINTTVGLSWKWSD------NMSKW-----NESIHAVGSFNSSCTSLPCHVHAT 117
            W+G    N      WKW D          W     ++           C          
Sbjct: 57  TWMGLHDQNGP----WKWVDGTDYETGFKNWRPEQPDDWYGHGLGGGEDCAHF------- 105

Query: 118 VDLCTLVSNGSRSLVTERCNTSHPFIC 144
                           + C   + ++C
Sbjct: 106 --------TDDGRWNDDVCQRPYRWVC 124

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 63.0 bits (154), Expect = 3e-11
 Identities = 52/195 (26%), Positives = 80/195 (41%), Gaps = 34/195 (17%)

Query: 249 GSRVAVKRLKRSSFQRKKEF---YSEIGRFARLHHPNLVAVKGCCYD----HGDRYIVYE 301
           G +VAVK L R   +          EI       HP+++ +    Y       D ++V E
Sbjct: 36  GHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL----YQVISTPTDFFMVME 91

Query: 302 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ----GIAFLHDKVKPHVVHRDIRAS 357
           +V  G L     +I + GR     +    A  L Q     + + H      VVHRD++  
Sbjct: 92  YVSGGEL---FDYICKHGR-----VEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPE 140

Query: 358 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM--AGGTYGYLAPEFVYRNELT-TKSDVY 414
           NVLLD    A +   GLS       M +   +  + G+  Y APE +        + D++
Sbjct: 141 NVLLDAHMNAKIADFGLSNM-----MSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIW 195

Query: 415 SFGVLLLEIVSGRRP 429
           S GV+L  ++ G  P
Sbjct: 196 SCGVILYALLCGTLP 210

>3c22_A C-type lectin domain family 4 member K; coiled coil, glycoprotein, membrane, signal-anchor, transmembrane, immune system, sugar binding protein; 1.50A {Homo sapiens} PDB: 3p5g_A* 3p5d_A* 3p5f_A* 3p5e_A* 3p5h_A* 3p5i_A* 3p7g_A* 3p7f_A* 3p7h_A* 3bc7_A* 3bbs_A* 3bc6_A* Length = 156

 Score = 60.5 bits (147), Expect = 3e-11
 Identities = 17/82 (20%), Positives = 29/82 (35%), Gaps = 6/82 (7%)

Query: 8  PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 67
               W   +     + +    ++W  +E +C     HL ++TS  E+    K  G    
Sbjct: 22 VVSQGWKYFK--GNFYYFSLIPKTWYSAEQFCVSRNSHLTSVTSESEQEFLYKTAGG--L 77

Query: 68 GCWVGGRSINTTVGLSWKWSDN 89
            W+G        G  W W D+
Sbjct: 78 IYWIGLTKAGME-G-DWSWVDD 97

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 63.8 bits (156), Expect = 4e-11
 Identities = 54/186 (29%), Positives = 79/186 (42%), Gaps = 23/186 (12%)

Query: 253 AVKRLKRSSFQRKKEF---YSEIGRFAR-LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 308
           AVK LK+    +  +     +E    +   +HP L  +  C       + V EFV  G L
Sbjct: 52  AVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDL 111

Query: 309 DRWLHHIPRGGR-SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA 367
              + HI +  R     A R   A  +   + FLHDK    +++RD++  NVLLD E   
Sbjct: 112 ---MFHIQKSRRFDEARA-RFYAAE-IISALMFLHDK---GIIYRDLKLDNVLLDHE--G 161

Query: 368 HLMGV--GLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 423
           H      G+ K    E +      A   GT  Y+APE +         D ++ GVLL E+
Sbjct: 162 HCKLADFGMCK----EGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEM 217

Query: 424 VSGRRP 429
           + G  P
Sbjct: 218 LCGHAP 223

>2h2t_B Low affinity immunoglobulin epsilon FC receptor ( IGE receptor) (FC-epsilon-RII)...; C-type lectin, calcium-bound, lectin domain; 1.30A {Homo sapiens} PDB: 2h2r_A 1t8c_A 1t8d_A Length = 175

 Score = 60.9 bits (148), Expect = 4e-11
 Identities = 22/92 (23%), Positives = 38/92 (41%), Gaps = 10/92 (10%)

Query: 8   PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 67
            CP  WI  +   KC+ +    + W  +   C ++ G L ++ S EE+    K       
Sbjct: 16  TCPEKWINFQ--RKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKRASH--T 71

Query: 68  GCWVGGRSINTTVGLSWKWSD----NMSKWNE 95
           G W+G R+++      + W D    + S W  
Sbjct: 72  GSWIGLRNLDLK--GEFIWVDGSHVDYSNWAP 101

>2ls8_A C-type lectin domain family 4 member D; structural genomics, NEW YORK structural genomics research consortium, nysgrc, PSI-biology, immune system; NMR {Homo sapiens} Length = 156

 Score = 60.1 bits (146), Expect = 4e-11
 Identities = 22/81 (27%), Positives = 41/81 (50%), Gaps = 5/81 (6%)

Query: 9  CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 68
          CP DW   +  S C+  + + ++W ESE  C  +G HL  +++  E++   +   + ++ 
Sbjct: 3  CPIDWRAFQ--SNCYFPLTDNKTWAESERNCSGMGAHLMTISTEAEQNFIIQFLDRRLS- 59

Query: 69 CWVGGRSINTTVGLSWKWSDN 89
           ++G R  N   G  W+W D 
Sbjct: 60 YFLGLRDENAK-G-QWRWVDQ 78

>1uv0_A Pancreatitis-associated protein 1; lectin, C-type, secreted, inflammatory response, acute phase; 1.78A {Homo sapiens} SCOP: d.169.1.1 PDB: 2go0_A Length = 149

 Score = 59.8 bits (145), Expect = 5e-11
 Identities = 29/149 (19%), Positives = 49/149 (32%), Gaps = 30/149 (20%)

Query: 9   CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE-IGGHLAALTSYEEEHSAQKLCGKNVN 67
           CP         S C+    + +SW +++  C++   G+L ++ S  E      L     N
Sbjct: 14  CPKGSKAYG--SHCYALFLSPKSWTDADLACQKRPSGNLVSVLSGAEGSFVSSLVKSIGN 71

Query: 68  G---CWVGGRSIN---TTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHAT 117
                W+G           G  W+WS     N   W  +              P  + + 
Sbjct: 72  SYSYVWIGLHDPTQGTEPNGEGWEWSSSDVMNYFAWERN--------------PSTISSP 117

Query: 118 VDLCTLVSNGSRSL--VTERCNTSHPFIC 144
              C  +S  +  L      CN   P++C
Sbjct: 118 GH-CASLSRSTAFLRWKDYNCNVRLPYVC 145

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 63.1 bits (154), Expect = 5e-11
 Identities = 43/160 (26%), Positives = 74/160 (46%), Gaps = 24/160 (15%)

Query: 279 HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGR-SLDWAMRMKVA-TTLAQ 336
             P LV +          +++ +++  G L     H+ +  R +     ++ V    LA 
Sbjct: 117 QSPFLVTLHYAFQTETKLHLILDYINGGEL---FTHLSQRERFTEHEV-QIYVGEIVLA- 171

Query: 337 GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV--GLSKFVPWEVMQERTVMAG--- 391
            +  LH      +++RDI+  N+LLD   G H++    GLSK    E + + T  A    
Sbjct: 172 -LEHLHKL---GIIYRDIKLENILLDSN-G-HVVLTDFGLSK----EFVADETERAYDFC 221

Query: 392 GTYGYLAPEFVYRNEL-TTKS-DVYSFGVLLLEIVSGRRP 429
           GT  Y+AP+ V   +    K+ D +S GVL+ E+++G  P
Sbjct: 222 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 62.9 bits (154), Expect = 6e-11
 Identities = 45/191 (23%), Positives = 83/191 (43%), Gaps = 33/191 (17%)

Query: 253 AVKRLKRSS-FQRKKEFY---SEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 308
           A+K LK++   +  K+     +E      + HP +V +       G  Y++ E++  G L
Sbjct: 49  AMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGEL 108

Query: 309 DRWLHHIPRGGR-SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE--- 364
                 + R G    D A    +A  ++  +  LH K    +++RD++  N++L+ +   
Sbjct: 109 ---FMQLEREGIFMEDTA-CFYLAE-ISMALGHLHQK---GIIYRDLKPENIMLNHQGHV 160

Query: 365 ----FGAHLMGVGLSKFVPWEVMQE--RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGV 418
               FG       L K    E + +   T    GT  Y+APE + R+      D +S G 
Sbjct: 161 KLTDFG-------LCK----ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGA 209

Query: 419 LLLEIVSGRRP 429
           L+ ++++G  P
Sbjct: 210 LMYDMLTGAPP 220

>2zib_A Type II antifreeze protein; thermal hysteresis, lectin; 1.34A {Brachyopsis rostratus} Length = 133

 Score = 58.9 bits (143), Expect = 7e-11
 Identities = 32/144 (22%), Positives = 51/144 (35%), Gaps = 33/144 (22%)

Query: 9   CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 68
           CP  W ++    +CF       +WD +E  C   GGHLA++ S EE+   + +    V  
Sbjct: 10  CPAGWTLHG--QRCFYSEATAMTWDLAEANCVNKGGHLASIHSLEEQLYIKDIVAGIV-- 65

Query: 69  CWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVG----SFNSSCTSLPCHVHATVDL 120
            W+GG +     G +W W+D    +   W              +  C             
Sbjct: 66  -WIGGSACKVA-G-AWSWTDGTPVDYRTWCP-----TKPNDILSDCC------------- 104

Query: 121 CTLVSNGSRSLVTERCNTSHPFIC 144
             + +   +      C  SH  IC
Sbjct: 105 MQMTAAVDKCWDDLPCPASHASIC 128

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 62.2 bits (152), Expect = 8e-11
 Identities = 50/191 (26%), Positives = 79/191 (41%), Gaps = 33/191 (17%)

Query: 253 AVKRLKRSSFQRKKEF---YSEIGRFAR-LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 308
           A+K LK+       +      E    +    HP L  +        + + V E++  G L
Sbjct: 46  AIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL 105

Query: 309 DRWLHHIPRGGR-SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE--- 364
              ++HI    +  L  A     A  +  G+ FLH K    +V+RD++  N+LLD++   
Sbjct: 106 ---MYHIQSCHKFDLSRA-TFYAAE-IILGLQFLHSK---GIVYRDLKLDNILLDKDGHI 157

Query: 365 ----FGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVYSFGV 418
               FG       + K    E M          GT  Y+APE +   +     D +SFGV
Sbjct: 158 KIADFG-------MCK----ENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGV 206

Query: 419 LLLEIVSGRRP 429
           LL E++ G+ P
Sbjct: 207 LLYEMLIGQSP 217

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 63.1 bits (153), Expect = 9e-11
 Identities = 52/183 (28%), Positives = 81/183 (44%), Gaps = 17/183 (9%)

Query: 253 AVKRLKRSSFQRKKEF---YSEIGRFAR-LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 308
           AVK LK+    +  +      E    A     P L  +  C       Y V E+V  G L
Sbjct: 370 AVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL 429

Query: 309 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 368
              ++HI + GR  +       A  +A G+ FL  K    +++RD++  NV+LD E    
Sbjct: 430 ---MYHIQQVGRFKEPHAVFYAAE-IAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIK 482

Query: 369 LMGVGLSKFVPWEVMQE--RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSG 426
           +   G+ K    E + +   T    GT  Y+APE +         D ++FGVLL E+++G
Sbjct: 483 IADFGMCK----ENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 538

Query: 427 RRP 429
           + P
Sbjct: 539 QAP 541

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 61.9 bits (151), Expect = 1e-10
 Identities = 52/192 (27%), Positives = 85/192 (44%), Gaps = 35/192 (18%)

Query: 253 AVKRLKRSSFQRKKEF---YSEIGRFAR-LHHPNLVAVKGCCYDHGDR-YIVYEFVVNGP 307
           AVK L++ +  +KKE     SE     + + HP LV +    +   D+ Y V +++  G 
Sbjct: 67  AVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH-FSFQTADKLYFVLDYINGGE 125

Query: 308 LDRWLHHIPRGGR-SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE-- 364
           L    +H+ R        A R   A  +A  + +LH     ++V+RD++  N+LLD +  
Sbjct: 126 L---FYHLQRERCFLEPRA-RFYAAE-IASALGYLHSL---NIVYRDLKPENILLDSQGH 177

Query: 365 -----FGAHLMGVGLSKFVPWEVMQE--RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFG 417
                FG       L K    E ++    T    GT  YLAPE +++       D +  G
Sbjct: 178 IVLTDFG-------LCK----ENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLG 226

Query: 418 VLLLEIVSGRRP 429
            +L E++ G  P
Sbjct: 227 AVLYEMLYGLPP 238

>1gz2_A Ovocleidin-17, OC-17 ovocleidin; structural protein, CTLD, eggshell structural protein, phosphoprotein, sugar-binding protein, glycoprotein; HET: SEP; 1.5A {Gallus gallus} SCOP: d.169.1.1 Length = 142

 Score = 58.3 bits (141), Expect = 1e-10
 Identities = 32/153 (20%), Positives = 50/153 (32%), Gaps = 36/153 (23%)

Query: 9   CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKNV 66
           C P W+       C G+     SW  +E++C+    G HLAA+ S  E     +L   + 
Sbjct: 5   CGPGWVPTP--GGCLGFFSRELSWSRAESFCRRWGPGSHLAAVRSAAELRLLAELLNASR 62

Query: 67  NGCWVGGRSINTT-VGLS-------WKWSD----NMSKWNESIHAVGSFNSS---CTSLP 111
            G   G  +     +GL        W+WSD      + W+       +       C +L 
Sbjct: 63  GGDGSGEGADGRVWIGLHRPAGSRSWRWSDGTAPRFASWHR-----TAKARRGGRCAAL- 116

Query: 112 CHVHATVDLCTLVSNGSRSLVTERCNTSHPFIC 144
                             S     C   + F+C
Sbjct: 117 -----------RDEEAFTSWAARPCTERNAFVC 138

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 62.0 bits (151), Expect = 1e-10
 Identities = 51/211 (24%), Positives = 92/211 (43%), Gaps = 44/211 (20%)

Query: 240 GTYSGI------LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH 293
           G++ G+         G  VA+K++     Q K+    E+    +L H N+V ++   Y  
Sbjct: 65  GSF-GVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSS 119

Query: 294 GDR------YIVYEFVVNGPLD--RWLHHIPRGGRSLDWAMRMKVAT-TLAQGIAFLHDK 344
           G++       +V ++V   P    R   H  R  ++L   + +K+    L + +A++H  
Sbjct: 120 GEKKDEVYLNLVLDYV---PETVYRVARHYSRAKQTLP-VIYVKLYMYQLFRSLAYIHSF 175

Query: 345 VKPHVVHRDIRASNVLLDEEFGAHLMGV------GLSK-FVPWEVMQERTVMAGGTYGYL 397
               + HRDI+  N+LLD +       V      G +K  V  E           +  Y 
Sbjct: 176 ---GICHRDIKPQNLLLDPD-----TAVLKLCDFGSAKQLVRGEPNVSYIC----SRYYR 223

Query: 398 APEFVYR-NELTTKSDVYSFGVLLLEIVSGR 427
           APE ++   + T+  DV+S G +L E++ G+
Sbjct: 224 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>3pbf_A Pulmonary surfactant-associated protein A; collectin, carbohydrate binding, lectin, mannose, sugar BIND protein; 1.80A {Rattus norvegicus} PDB: 1r14_A* 1r13_A* 3paq_A* 3par_A 3pak_A Length = 148

 Score = 58.1 bits (141), Expect = 2e-10
 Identities = 17/91 (18%), Positives = 32/91 (35%), Gaps = 8/91 (8%)

Query: 9   CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 68
                +   +K   F   G   ++D  +  C   GG++A   + EE  +   +  K  N 
Sbjct: 27  LQGSMLSVGDK--VFSTNGQSVNFDTIKEMCTRAGGNIAVPRTPEENEAIASIAKKYNNY 84

Query: 69  CWVGGRSINTTVGLSWKWSDNM----SKWNE 95
            ++G     T  G  + + D      + W  
Sbjct: 85  VYLGMIEDQTP-G-DFHYLDGASVSYTNWYP 113

>1tn3_A Tetranectin; plasminogen binding, kringle 4, C-type lectin, carbohydrate recognition domain; 2.00A {Homo sapiens} SCOP: d.169.1.1 PDB: 1rjh_A 3l9j_C Length = 137

 Score = 57.4 bits (139), Expect = 3e-10
 Identities = 15/85 (17%), Positives = 30/85 (35%), Gaps = 8/85 (9%)

Query: 8  PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 67
           C     ++    KCF      +++ E+   C   GG L+   +  E  +  +   ++V 
Sbjct: 5  VCLKGTKVHM---KCFLAFTQTKTFHEASEDCISRGGTLSTPQTGSENDALYEYLRQSVG 61

Query: 68 G---CWVGGRSINTTVGLSWKWSDN 89
               W+G   +    G +W     
Sbjct: 62 NEAEIWLGLNDMAAE-G-TWVDMTG 84

>2vuv_A Codakine; sugar-binding protein, C-type, lectin, mannose, invertebrate; HET: CIT; 1.3A {Codakia orbicularis} PDB: 2vuz_A* Length = 129

 Score = 57.3 bits (139), Expect = 3e-10
 Identities = 28/140 (20%), Positives = 52/140 (37%), Gaps = 21/140 (15%)

Query: 9   CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 68
           CP  W        C+ Y     SW  +++ C+ +GG LA   +  E      +C +N + 
Sbjct: 2   CPDGWTQFL--DLCYIYQSAKASWASAQSSCQALGGILAEPDTACENEVLIHMCKENGDA 59

Query: 69  ----CWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLV 124
                W+GG+ +      +W+WS + +           +     + P +     D C  +
Sbjct: 60  GSFGPWLGGQKVGG----AWQWSSSGAA--------FDYLRWGPNEPNNSGGNED-C--L 104

Query: 125 SNGSRSLVTERCNTSHPFIC 144
                S    RC+    ++C
Sbjct: 105 HYNWLSWNDLRCHYQASYLC 124

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 59.6 bits (145), Expect = 5e-10
 Identities = 54/225 (24%), Positives = 85/225 (37%), Gaps = 65/225 (28%)

Query: 248 DGSRVAVKRLKRSSFQRKKEFYS--------------------------EIGRFARLHHP 281
           D +  A+K L +    R+  F                            EI    +L HP
Sbjct: 37  DNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHP 96

Query: 282 NLVAVKGCCYDHGDR--YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ--- 336
           N+V +     D  +   Y+V+E V  GP+      +P         +    A    Q   
Sbjct: 97  NVVKLVEVLDDPNEDHLYMVFELVNQGPV----MEVPTLKP-----LSEDQARFYFQDLI 147

Query: 337 -GIAFLHDKVKPHVVHRDIRASNVLLDEE-------FGAHLMGVGLS-KFVPWEVMQERT 387
            GI +LH +    ++HRDI+ SN+L+ E+       F       G+S +F   + +   T
Sbjct: 148 KGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADF-------GVSNEFKGSDALLSNT 197

Query: 388 VMAGGTYGYLAPEFVYRNELT---TKSDVYSFGVLLLEIVSGRRP 429
           V   GT  ++APE +            DV++ GV L   V G+ P
Sbjct: 198 V---GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 60.0 bits (146), Expect = 5e-10
 Identities = 55/219 (25%), Positives = 82/219 (37%), Gaps = 54/219 (24%)

Query: 240 GTYSGI------LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH 293
           GT+ G          G  VA+K++     + +      +   A LHHPN+V ++   Y  
Sbjct: 34  GTF-GTVQLGKEKSTGMSVAIKKV-IQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTL 91

Query: 294 GDR-------YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATT----LAQGIAFLH 342
           G+R        +V E+V   P    LH   R       A    +       L + I  LH
Sbjct: 92  GERDRRDIYLNVVMEYV---PDT--LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLH 146

Query: 343 DKVKPHVVHRDIRASNVLLDEE--------FGAHLMGVGLSK-FVPWEVMQERTVMAGGT 393
                +V HRDI+  NVL++E         F       G +K   P E           +
Sbjct: 147 LPSV-NVCHRDIKPHNVLVNEADGTLKLCDF-------GSAKKLSPSEPNVAYIC----S 194

Query: 394 YGYLAPEFV-----YRNELTTKSDVYSFGVLLLEIVSGR 427
             Y APE +     Y    TT  D++S G +  E++ G 
Sbjct: 195 RYYRAPELIFGNQHY----TTAVDIWSVGCIFAEMMLGE 229

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 59.6 bits (145), Expect = 7e-10
 Identities = 48/206 (23%), Positives = 85/206 (41%), Gaps = 24/206 (11%)

Query: 231 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKG 288
           R LG  K    +  I + +  +V VK LK     +KK+   EI     L   PN++ +  
Sbjct: 42  RKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLAD 98

Query: 289 CCYDHGDR--YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVK 346
              D   R   +V+E V N    +    +       D+ +R  +   L + + + H    
Sbjct: 99  IVKDPVSRTPALVFEHVNNTDFKQLYQTLT------DYDIRFYMYEIL-KALDYCHSM-- 149

Query: 347 PHVVHRDIRASNVLLDEEFGA-HLMGVGLSKF-VPWEVMQERTVMAGGTYGYLAPE-FVY 403
             ++HRD++  NV++D E     L+  GL++F  P +    R      +  +  PE  V 
Sbjct: 150 -GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA----SRYFKGPELLVD 204

Query: 404 RNELTTKSDVYSFGVLLLEIVSGRRP 429
                   D++S G +L  ++  + P
Sbjct: 205 YQMYDYSLDMWSLGCMLASMIFRKEP 230

>1htn_A Tetranectin; plasminogen binding, kringle 4, alpha-helical coiled coil, C-type lectin, carbohydrate recognition domain; 2.80A {Homo sapiens} SCOP: d.169.1.1 h.1.1.1 Length = 182

 Score = 57.1 bits (138), Expect = 8e-10
 Identities = 15/86 (17%), Positives = 30/86 (34%), Gaps = 8/86 (9%)

Query: 7   APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNV 66
             C     ++    KCF      +++ E+   C   GG L+   +  E  +  +   ++V
Sbjct: 49  TVCLKGTKVHM---KCFLAFTQTKTFHEASEDCISRGGTLSTPQTGSENDALYEYLRQSV 105

Query: 67  NG---CWVGGRSINTTVGLSWKWSDN 89
                 W+G   +    G +W     
Sbjct: 106 GNEAEIWLGLNDMAAE-G-TWVDMTG 129

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 59.8 bits (145), Expect = 8e-10
 Identities = 55/197 (27%), Positives = 83/197 (42%), Gaps = 38/197 (19%)

Query: 249 GSRVAVKRLKRSSFQRKKEF---YSEIGRFARLHHPNLVAVKGCCYD----HGDRYIVYE 301
           G +VAVK L R   +          EI       HP+++ +    Y       D ++V E
Sbjct: 41  GHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL----YQVISTPSDIFMVME 96

Query: 302 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ----GIAFLHDKVKPHVVHRDIRAS 357
           +V  G L     +I + GR     +  K +  L Q    G+ + H      VVHRD++  
Sbjct: 97  YVSGGEL---FDYICKNGR-----LDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPE 145

Query: 358 NVLLDEEFGAHLMGVGLSKFVPWEVMQE----RTVMAGGTYGYLAPEFVYRNELT-TKSD 412
           NVLLD    A +   GLS       M +    RT  + G+  Y APE +        + D
Sbjct: 146 NVLLDAHMNAKIADFGLSNM-----MSDGEFLRT--SCGSPNYAAPEVISGRLYAGPEVD 198

Query: 413 VYSFGVLLLEIVSGRRP 429
           ++S GV+L  ++ G  P
Sbjct: 199 IWSSGVILYALLCGTLP 215

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 58.4 bits (142), Expect = 1e-09
 Identities = 47/195 (24%), Positives = 77/195 (39%), Gaps = 35/195 (17%)

Query: 249 GSRVAVKRLKRSSFQRKKEF---YSEIGRFARLHHPNLVAVKGCCYD----HGDRYIVYE 301
             +VA+K + R   ++         EI     L HP+++ +    YD      D  +V E
Sbjct: 34  QQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL----YDVITTPTDIVMVIE 89

Query: 302 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ----GIAFLHDKVKPHVVHRDIRAS 357
           +   G L     +I    R     M         Q     I + H      +VHRD++  
Sbjct: 90  YA-GGEL---FDYIVEKKR-----MTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPE 137

Query: 358 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM--AGGTYGYLAPEFVYRNELT-TKSDVY 414
           N+LLD+     +   GLS       M +   +  + G+  Y APE +        + DV+
Sbjct: 138 NLLLDDNLNVKIADFGLSNI-----MTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVW 192

Query: 415 SFGVLLLEIVSGRRP 429
           S G++L  ++ GR P
Sbjct: 193 SCGIVLYVMLVGRLP 207

>1h8u_A MBP, eosinophil granule major basic protein 1; lectin, eosinophil granule protein, EMBP; 1.8A {Homo sapiens} SCOP: d.169.1.1 PDB: 2brs_A* Length = 117

 Score = 54.7 bits (132), Expect = 2e-09
 Identities = 22/125 (17%), Positives = 43/125 (34%), Gaps = 14/125 (11%)

Query: 22  CFGYIGNFRSWDESETYCKEI-GGHLAALTSYEEEHSAQKLCGK-NVNGCWVGGRSINTT 79
            +  + + +++ ++   C+    G+L ++ ++   +  Q      N    W+GGR   + 
Sbjct: 3   RYLLVRSLQTFSQAWFTCRRCYRGNLVSIHNFNINYRIQCSVSALNQGQVWIGGRITGSG 62

Query: 80  VGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTS 139
               ++W D  S+WN        F       P         C  +           C   
Sbjct: 63  RCRRFQWVDG-SRWN--------FAYWAAHQPWSRGGH---CVALCTRGGYWRRAHCLRR 110

Query: 140 HPFIC 144
            PFIC
Sbjct: 111 LPFIC 115

>3cfw_A L-selectin; EGF, cell adhesion, EGF-like domain, glycoprotein, membrane, sushi, transmembrane; HET: NAG MAN BMA; 2.20A {Homo sapiens} Length = 164

 Score = 56.0 bits (135), Expect = 2e-09
 Identities = 18/123 (14%), Positives = 41/123 (33%), Gaps = 7/123 (5%)

Query: 22  CFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVG 81
            + Y     +W  +  +C++    L A+ +  E    +K    + +  W+G R I     
Sbjct: 2   TYHYSEKPMNWQRARRFCRDNYTDLVAIQNKAEIEYLEKTLPFSRSYYWIGIRKIGGI-- 59

Query: 82  LSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHP 141
            +W  ++            G  N+      C     V++    +  +     + C+    
Sbjct: 60  WTWVGTNKSLTEEAENWGDGEPNNKKNKEDC-----VEIYIKRNKDAGKWNDDACHKLKA 114

Query: 142 FIC 144
            +C
Sbjct: 115 ALC 117

>1byf_A TC14, protein (polyandrocarpa lectin); C-type lectin, galactose-specific, sugar binding protein; 2.00A {Polyandrocarpa misakiensis} SCOP: d.169.1.1 PDB: 1tlg_A* Length = 125

 Score = 54.7 bits (132), Expect = 2e-09
 Identities = 10/71 (14%), Positives = 25/71 (35%), Gaps = 3/71 (4%)

Query: 21 KCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEE--HSAQKLCGKNVNGCWVGGRSINT 78
              +     ++ ++ TYC+  G  L +    +     +         +  WVG  ++  
Sbjct: 3  YEILFSDETMNYADAGTYCQSRGMALVSSAMRDSTMVKAILAFTEVKGHDYWVGADNLQD 62

Query: 79 TVGLSWKWSDN 89
              ++ W+D 
Sbjct: 63 G-AYNFLWNDG 72

>3alu_A Lectin CEL-IV, C-type; C-type lectin, raffinose, sugar binding protein; HET: RAF; 1.65A {Cucumaria echinata} PDB: 3als_A* 3alt_A* Length = 157

 Score = 55.3 bits (133), Expect = 3e-09
 Identities = 29/155 (18%), Positives = 52/155 (33%), Gaps = 29/155 (18%)

Query: 8   PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIG-----------GHLAALTSYEEEH 56
            CPP W       KCF    N  ++D +E  C++ G           GHLA++ S E + 
Sbjct: 4   SCPPLWTGFN--GKCFRLFHNHLNFDNAENACRQFGLASCSGDELATGHLASIHSAESQA 61

Query: 57  SAQKLCGKNVNGCWVGGRSINTTVGLS-------WKWSDNMSKWNESIHAVGSFNSSCTS 109
              +L   ++     GG +    +G+          W+D  S  +        ++   + 
Sbjct: 62  FLTELVKTSLPDLITGGWAPQVYIGMKVGSTNSDQTWTDG-SSVD--------YDGWVSG 112

Query: 110 LPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFIC 144
            P +   +                   N +  +IC
Sbjct: 113 EPNNGPNSRGAIAAGDYSRGFWADVYSNNNFKYIC 147

>1buu_A Protein (mannose-binding protein A); lectin, HOST defense, metalloprotein, sugar binding protein; 1.90A {Rattus norvegicus} SCOP: d.169.1.1 h.1.1.1 Length = 168

 Score = 55.1 bits (133), Expect = 3e-09
 Identities = 14/94 (14%), Positives = 30/94 (31%), Gaps = 10/94 (10%)

Query: 6   KAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN 65
                      +   K F        + + +  C E+ G +A   + EE  + Q++   +
Sbjct: 43  NKLHAFSMG-KKSGKKFFVTNHERMPFSKVKALCSELRGTVAIPRNAEENKAIQEVAKTS 101

Query: 66  VNGCWVGGRSINTTVGLSWKWSD----NMSKWNE 95
               ++G     T  G  + +        S W +
Sbjct: 102 A---FLGITDEVTE-G-QFMYVTGGRLTYSNWKK 130

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 56.9 bits (138), Expect = 4e-09
 Identities = 43/222 (19%), Positives = 81/222 (36%), Gaps = 51/222 (22%)

Query: 221 SITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL- 278
           +I  ++   +++LG    G            + A+K L+     R+     E+    R  
Sbjct: 14  AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-----EVELHWRAS 68

Query: 279 HHPNLVAVKGCCYDHGDR----YIVYEFVVNGPL-DRWLHHIPRGGRSL---DWAMRMKV 330
             P++V +     +         IV E +  G L  R      RG ++    + +  MK 
Sbjct: 69  QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI---QDRGDQAFTEREASEIMK- 124

Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLL-DEEFGAHLMGV--GLSKFVPWEVMQERT 387
             ++ + I +LH     ++ HRD++  N+L   +   A L     G +K    E   E+ 
Sbjct: 125 --SIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK----ETTGEK- 174

Query: 388 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 429
                 Y                 D++S GV++  ++ G  P
Sbjct: 175 ------YD-------------KSCDMWSLGVIMYILLCGYPP 197

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 56.8 bits (138), Expect = 4e-09
 Identities = 48/213 (22%), Positives = 84/213 (39%), Gaps = 47/213 (22%)

Query: 240 GTYSGI------LPDGSRVAVKRLKRSSFQ--------RKKEFYSEIGRFARLHHPNLVA 285
           GTY G             VA+KR++             R      EI     L H N+V 
Sbjct: 13  GTY-GTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR------EICLLKELKHKNIVR 65

Query: 286 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 345
           +    +      +V+EF  +  L ++          LD  +       L +G+ F H + 
Sbjct: 66  LHDVLHSDKKLTLVFEF-CDQDLKKYFDSCNGD---LDPEIVKSFLFQLLKGLGFCHSR- 120

Query: 346 KPHVVHRDIRASNVLLDEE-------FG-AHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 397
             +V+HRD++  N+L++         FG A   G+ +  +   EV+         T  Y 
Sbjct: 121 --NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA-EVV---------TLWYR 168

Query: 398 APEFVYRNEL-TTKSDVYSFGVLLLEIVSGRRP 429
            P+ ++  +L +T  D++S G +  E+ +  RP
Sbjct: 169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201

>1rtm_1 Mannose-binding protein-A; lectin; 1.80A {Rattus norvegicus} SCOP: d.169.1.1 h.1.1.1 PDB: 1kwu_A* 1kwv_A* 1kwt_A* 1kwx_A* 1kwy_A* 1kx1_A* 1kww_A 1kwz_A* 1kx0_A* 3kmb_1* 1kmb_1* 2kmb_1* 4kmb_1* 1afb_1* 1afa_1* 1afd_1 1bch_1* 1bcj_1* 1fif_A 1fih_A* Length = 149

 Score = 54.3 bits (131), Expect = 5e-09
 Identities = 15/94 (15%), Positives = 31/94 (32%), Gaps = 11/94 (11%)

Query: 6   KAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN 65
           K          +   K F        + + +  C E+ G +A   + EE  + Q++   +
Sbjct: 25  KLHAFSMG--KKSGKKFFVTNHERMPFSKVKALCSELRGTVAIPRNAEENKAIQEVAKTS 82

Query: 66  VNGCWVGGRSINTTVGLSWKWSD----NMSKWNE 95
               ++G     T  G  + +        S W +
Sbjct: 83  A---FLGITDEVTE-G-QFMYVTGGRLTYSNWKK 111

>1g1t_A E-selectin; EGF, adhesion molecule, SLEX, immune system, membrane protein; HET: SIA GAL MAG FUC; 1.50A {Homo sapiens} SCOP: d.169.1.1 g.3.11.1 PDB: 1esl_A Length = 157

 Score = 54.4 bits (131), Expect = 5e-09
 Identities = 24/130 (18%), Positives = 42/130 (32%), Gaps = 21/130 (16%)

Query: 22  CFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVG 81
            +       ++DE+  YC++   HL A+ + EE      +   + +  W+G R +N    
Sbjct: 2   SYNTSTEAMTYDEASAYCQQRYTHLVAIQNKEEIEYLNSILSYSPSYYWIGIRKVNNV-- 59

Query: 82  LSWKWSD-------NMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTE 134
             W W             W       G  N+      C     V++             E
Sbjct: 60  --WVWVGTQKPLTEEAKNWAP-----GEPNNRQKDEDC-----VEIYIKREKDVGMWNDE 107

Query: 135 RCNTSHPFIC 144
           RC+     +C
Sbjct: 108 RCSKKKLALC 117

>1g1s_A P-selectin; selectin, lectin, EGF, sulphated, SLEX, immune system, membr protein; HET: TYS SIA GAL NAG FUC NGA; 1.90A {Homo sapiens} SCOP: d.169.1.1 g.3.11.1 PDB: 1g1r_A* 1g1q_A* 1fsb_A Length = 162

 Score = 54.4 bits (131), Expect = 5e-09
 Identities = 16/67 (23%), Positives = 25/67 (37%), Gaps = 4/67 (5%)

Query: 22 CFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVG 81
           + Y     SW+ S  YC+     L A+ +  E     K+     +  W+G R  N    
Sbjct: 2  TYHYSTKAYSWNISRKYCQNRYTDLVAIQNKNEIDYLNKVLPYYSSYYWIGIRKNNK--- 58

Query: 82 LSWKWSD 88
           +W W  
Sbjct: 59 -TWTWVG 64

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 57.1 bits (138), Expect = 6e-09
 Identities = 29/145 (20%), Positives = 60/145 (41%), Gaps = 32/145 (22%)

Query: 240 GTYSGI-------LPDGSRVAVKRLKRSSF----QRKKEFYSEIGRFARLHHPNLVAVKG 288
           GTY  +         D    A+K+++ +       R      EI     L HPN+++++ 
Sbjct: 32  GTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR------EIALLRELKHPNVISLQK 85

Query: 289 CCYDHGDR--YIVYEFVVNGPLD-RWLHHIPRGGRSLDWAMRMKVATT------LAQGIA 339
               H DR  ++++++      D   +    R  ++    +++           +  GI 
Sbjct: 86  VFLSHADRKVWLLFDYA---EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 142

Query: 340 FLHDKVKPHVVHRDIRASNVLLDEE 364
           +LH      V+HRD++ +N+L+  E
Sbjct: 143 YLHAN---WVLHRDLKPANILVMGE 164

>1hup_A Mannose-binding protein; alpha-helical coiled-coil, C-type lectin; 2.50A {Homo sapiens} SCOP: d.169.1.1 h.1.1.1 Length = 141

 Score = 52.7 bits (127), Expect = 1e-08
 Identities = 16/99 (16%), Positives = 33/99 (33%), Gaps = 11/99 (11%)

Query: 1   MNKDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQK 60
           M +  K          +  +K F   G   ++++ +  C +    +A   +  E  + Q 
Sbjct: 12  MARIKKWLTFSLG--KQVGNKFFLTNGEIMTFEKVKALCVKFQASVATPRNAAENGAIQN 69

Query: 61  LCGKNVNGCWVGGRSINTTVGLSWKWSDNM----SKWNE 95
           L  +     ++G      T G  +          + WNE
Sbjct: 70  LIKEEA---FLGITDEK-TEG-QFVDLTGNRLTYTNWNE 103

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 55.3 bits (134), Expect = 1e-08
 Identities = 35/120 (29%), Positives = 53/120 (44%), Gaps = 13/120 (10%)

Query: 249 GSRVAVKRLKRSSFQRKKEFYS----EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 304
           G  VA+K+   S     K        EI    +L H NLV +   C      Y+V+EF V
Sbjct: 50  GRIVAIKKFLESDD--DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEF-V 106

Query: 305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 364
           +  +   L   P G   LD+ +  K    +  GI F H     +++HRDI+  N+L+ + 
Sbjct: 107 DHTILDDLELFPNG---LDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQS 160

>1wmz_A Lectin CEL-I, N-acetyl-D-galactosamine-specific C-type; C-type lectin, N-acetylgalactosamine, invertebrate, sugar binding protein; HET: NGA A2G; 1.70A {Cucumaria echinata} SCOP: d.169.1.1 PDB: 1wmy_A* Length = 140

 Score = 52.1 bits (125), Expect = 2e-08
 Identities = 19/155 (12%), Positives = 40/155 (25%), Gaps = 31/155 (20%)

Query: 9   CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIG-------GHLAALTSYEEEHSAQKL 61
           CP DW        C+ +     +W+ +   C             L ++ S  E+      
Sbjct: 3   CPTDWEAEG--DHCYRFFNTLTTWENAHHECVSYSCSTLNVRSDLVSVHSAAEQAYVFNY 60

Query: 62  CGKNVNG---CWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHV 114
                +     W+G    +      + W+D      +KW       G  ++   +     
Sbjct: 61  WRGIDSQAGQLWIGLY--DKYNEGDFIWTDGSKVGYTKWAG-----GQPDNWNNAEDY-- 111

Query: 115 HATVDLCTLVSNGSRSLVTERCNTSHPFICMVEHE 149
                          +           ++C +  E
Sbjct: 112 ------GQFRHTEGGAWNDNSAAAQAKYMCKLTFE 140

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 55.3 bits (134), Expect = 2e-08
 Identities = 31/146 (21%), Positives = 55/146 (37%), Gaps = 39/146 (26%)

Query: 240 GTYSGI------LPDGSRVAVKRLKRSSFQRKKE-FYS----EIGRFARLHHPNLVAVKG 288
           G +               VA+K++K       K+        EI     L HPN++ +  
Sbjct: 21  GQF-ATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLD 79

Query: 289 CCYDHGDRYIVYEFV----------VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGI 338
                 +  +V++F+           +  L     HI    ++    M M       QG+
Sbjct: 80  AFGHKSNISLVFDFMETDLEVIIKDNSLVLT--PSHI----KAY---MLM-----TLQGL 125

Query: 339 AFLHDKVKPHVVHRDIRASNVLLDEE 364
            +LH      ++HRD++ +N+LLDE 
Sbjct: 126 EYLHQH---WILHRDLKPNNLLLDEN 148

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 55.6 bits (134), Expect = 2e-08
 Identities = 42/193 (21%), Positives = 81/193 (41%), Gaps = 33/193 (17%)

Query: 249 GSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAVK------GCCYDHGDRYIV 299
              VA+K+L R  FQ +   K  Y E+     ++H N++++           +  D Y+V
Sbjct: 87  DRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLV 145

Query: 300 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ---GIAFLHDKVKPHVVHRDIRA 356
            E      +D  L  + +     +     +++  L Q   GI  LH      ++HRD++ 
Sbjct: 146 MEL-----MDANLCQVIQMELDHE-----RMSYLLYQMLCGIKHLHSA---GIIHRDLKP 192

Query: 357 SNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVY 414
           SN+++  +    ++  GL++           +M     T  Y APE +         D++
Sbjct: 193 SNIVVKSDCTLKILDFGLAR-----TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIW 247

Query: 415 SFGVLLLEIVSGR 427
           S G ++ E+V  +
Sbjct: 248 SVGCIMGEMVRHK 260

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 54.5 bits (132), Expect = 2e-08
 Identities = 27/119 (22%), Positives = 50/119 (42%), Gaps = 11/119 (9%)

Query: 249 GSRVAVKRLKRSSFQRKKEFYS--EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 306
           G  VA+K+   S      +  +  EI    +L HPNLV +          ++V+E+    
Sbjct: 28  GQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEY---- 83

Query: 307 PLDRWL-HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 364
             D  + H + R  R +   +   +     Q + F H     + +HRD++  N+L+ + 
Sbjct: 84  -CDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKH 138

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 54.1 bits (131), Expect = 3e-08
 Identities = 50/214 (23%), Positives = 89/214 (41%), Gaps = 49/214 (22%)

Query: 240 GTYSGI------LPDGSRVAVKRLKRSSFQRKKEFYS----EIGRFARLHHPNLVAVKGC 289
           GTY            G  VA+K +K      ++   S    EI     L H N+V +   
Sbjct: 16  GTY-ATVYKGLNKTTGVYVALKEVK---LDSEEGTPSTAIREISLMKELKHENIVRLYDV 71

Query: 290 CYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ---GIAFLHDKVK 346
            +      +V+EF ++  L +++     G       + + V     Q   G+AF H+   
Sbjct: 72  IHTENKLTLVFEF-MDNDLKKYMDSRTVGNTPRGLELNL-VKYFQWQLLQGLAFCHEN-- 127

Query: 347 PHVVHRDIRASNVLLDEE-------FG-AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLA 398
             ++HRD++  N+L+++        FG A   G+ ++ F   EV+         T  Y A
Sbjct: 128 -KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS-EVV---------TLWYRA 176

Query: 399 PEF-----VYRNELTTKSDVYSFGVLLLEIVSGR 427
           P+       Y    +T  D++S G +L E+++G+
Sbjct: 177 PDVLMGSRTY----STSIDIWSCGCILAEMITGK 206

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 54.3 bits (131), Expect = 4e-08
 Identities = 43/193 (22%), Positives = 80/193 (41%), Gaps = 33/193 (17%)

Query: 249 GSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAVK------GCCYDHGDRYIV 299
              VA+K+L R  FQ +   K  Y E+     ++H N++ +           +  D YIV
Sbjct: 50  ERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIV 108

Query: 300 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ---GIAFLHDKVKPHVVHRDIRA 356
            E      +D  L  + +     +     +++  L Q   GI  LH      ++HRD++ 
Sbjct: 109 MEL-----MDANLCQVIQMELDHE-----RMSYLLYQMLCGIKHLHSA---GIIHRDLKP 155

Query: 357 SNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVY 414
           SN+++  +    ++  GL++           +M     T  Y APE +         D++
Sbjct: 156 SNIVVKSDCTLKILDFGLAR-----TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIW 210

Query: 415 SFGVLLLEIVSGR 427
           S G ++ E++ G 
Sbjct: 211 SVGCIMGEMIKGG 223

>2msb_A Mannose-binding protein-A; lectin; HET: BMA MAN; 1.70A {Rattus rattus} SCOP: d.169.1.1 PDB: 1msb_A 1ytt_A* Length = 115

 Score = 50.3 bits (121), Expect = 4e-08
 Identities = 14/80 (17%), Positives = 29/80 (36%), Gaps = 9/80 (11%)

Query: 20 SKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTT 79
           K F        + + +  C E+ G +A   + EE  + Q++   +    ++G     T 
Sbjct: 3  KKFFVTNHERMPFSKVKALCSELRGTVAIPRNAEENKAIQEVAKTSA---FLGITDEVTE 59

Query: 80 VGLSWKWSD----NMSKWNE 95
           G  + +        S W +
Sbjct: 60 -G-QFMYVTGGRLTYSNWKK 77

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 53.4 bits (129), Expect = 6e-08
 Identities = 40/220 (18%), Positives = 79/220 (35%), Gaps = 61/220 (27%)

Query: 240 GTYSGI------LPDGSRVAVKRLKRSSFQRKKE-FYS----EIGRFARLHHPNLVAVKG 288
           GTY G             VA+KR++    + ++E        E+     L H N++ +K 
Sbjct: 45  GTY-GEVYKAIDTVTNETVAIKRIR---LEHEEEGVPGTAIREVSLLKELQHRNIIELKS 100

Query: 289 CCYDHGDRYIVYEFV---------VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA 339
             + +   ++++E+           N  +   +  I    +S    +       L  G+ 
Sbjct: 101 VIHHNHRLHLIFEYAENDLKKYMDKNPDVS--MRVI----KSF---LYQ-----LINGVN 146

Query: 340 FLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV-----GLSKF--VPWEVMQERTVMAGG 392
           F H +     +HRD++  N+LL     +    +     GL++   +P        +    
Sbjct: 147 FCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII---- 199

Query: 393 TYGYLAPEF-----VYRNELTTKSDVYSFGVLLLEIVSGR 427
           T  Y  PE       Y    +T  D++S   +  E++   
Sbjct: 200 TLWYRPPEILLGSRHY----STSVDIWSIACIWAEMLMKT 235

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 52.9 bits (128), Expect = 8e-08
 Identities = 46/203 (22%), Positives = 85/203 (41%), Gaps = 54/203 (26%)

Query: 249 GSRVAVKRLKRSSFQRKKE-FYS----EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 303
           G   A+K+++    +++ E   S    EI     L H N+V +    +      +V+E +
Sbjct: 26  GETFALKKIR---LEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL 82

Query: 304 ----------VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRD 353
                       G L+          +S    +       L  GIA+ HD+    V+HRD
Sbjct: 83  DQDLKKLLDVCEGGLE--SVTA----KSF---LLQ-----LLNGIAYCHDR---RVLHRD 125

Query: 354 IRASNVLLDEE-------FG-AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN 405
           ++  N+L++ E       FG A   G+ + K+   E++         T  Y AP+ +  +
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVRKYTH-EIV---------TLWYRAPDVLMGS 175

Query: 406 EL-TTKSDVYSFGVLLLEIVSGR 427
           +  +T  D++S G +  E+V+G 
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGT 198

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 52.9 bits (128), Expect = 8e-08
 Identities = 46/196 (23%), Positives = 85/196 (43%), Gaps = 40/196 (20%)

Query: 249 GSRVAVKRLKRSSFQ--------RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY 300
           G  VA+KR++  +          R      EI     LHHPN+V++    +      +V+
Sbjct: 45  GRIVALKRIRLDAEDEGIPSTAIR------EISLLKELHHPNIVSLIDVIHSERCLTLVF 98

Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 360
           EF +   L + L     G   L  +        L +G+A  H      ++HRD++  N+L
Sbjct: 99  EF-MEKDLKKVLDENKTG---LQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLL 151

Query: 361 LDEE-------FG-AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL-TTKS 411
           ++ +       FG A   G+ +  +   EV+         T  Y AP+ +  ++  +T  
Sbjct: 152 INSDGALKLADFGLARAFGIPVRSYTH-EVV---------TLWYRAPDVLMGSKKYSTSV 201

Query: 412 DVYSFGVLLLEIVSGR 427
           D++S G +  E+++G+
Sbjct: 202 DIWSIGCIFAEMITGK 217

>1rdl_1 SUB-MBP-C, mannose-binding protein-C; C-type lectin, calcium-binding protein; HET: MMA; 1.70A {Rattus rattus} SCOP: d.169.1.1 PDB: 1rdj_1* 1rdk_1* 1rdi_1* 1rdm_1* 1rdn_1* 1rdo_1 1bv4_A 1kza_1* 1kzb_1* 1kzc_1* 1kzd_1* 1kze_1* Length = 113

 Score = 48.8 bits (117), Expect = 1e-07
 Identities = 15/80 (18%), Positives = 28/80 (35%), Gaps = 11/80 (13%)

Query: 21 KCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSA-QKLCGKNVNGCWVGGRSINTT 79
          K F         + ++  C E+ G +A   +  EE+ A Q +        ++G     T 
Sbjct: 2  KYFMSSVRRMPLNRAKALCSELQGTVATPRN-AEENRAIQNVAKDVA---FLGITDQRTE 57

Query: 80 VGLSWKWSD----NMSKWNE 95
              ++         + WNE
Sbjct: 58 -N-VFEDLTGNRVRYTNWNE 75

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 51.8 bits (125), Expect = 2e-07
 Identities = 37/192 (19%), Positives = 80/192 (41%), Gaps = 33/192 (17%)

Query: 249 GSRVAVKRLKRSSFQRKKEFYS----EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 304
            + VA+K ++    + ++        E+     L H N+V +    +      +V+E++ 
Sbjct: 27  DNLVALKEIR---LEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL- 82

Query: 305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 364
           +  L ++L         ++          L +G+A+ H +    V+HRD++  N+L++E 
Sbjct: 83  DKDLKQYLDDCGNI---INMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINER 136

Query: 365 -------FG-AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY-RNELTTKSDVYS 415
                  FG A    +    +   EV+         T  Y  P+ +    + +T+ D++ 
Sbjct: 137 GELKLADFGLARAKSIPTKTYDN-EVV---------TLWYRPPDILLGSTDYSTQIDMWG 186

Query: 416 FGVLLLEIVSGR 427
            G +  E+ +GR
Sbjct: 187 VGCIFYEMATGR 198

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 51.6 bits (124), Expect = 3e-07
 Identities = 50/247 (20%), Positives = 101/247 (40%), Gaps = 49/247 (19%)

Query: 205 ALVPPSWKVFTTEELRSITKNFSEGNR-----LLGDSKTGGTYSGI-LPDGSRVAVKRLK 258
           +  PP+   F  +E+      +           +G    G   S +    G++VA+K+L 
Sbjct: 2   SSPPPARSGFYRQEVTKTA--WEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLY 59

Query: 259 RSSFQRK---KEFYSEIGRFARLHHPNLVAVK------GCCYDHGDRYIVYEFVVNGPLD 309
           R  FQ +   K  Y E+     + H N++ +           D  D Y+V  F     + 
Sbjct: 60  RP-FQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPF-----MG 113

Query: 310 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE----- 364
             L  + +  +  +  ++  V   L +G+ ++H      ++HRD++  N+ ++E+     
Sbjct: 114 TDLGKLMKHEKLGEDRIQFLVYQML-KGLRYIHAA---GIIHRDLKPGNLAVNEDCELKI 169

Query: 365 --FG-AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKS-DVYSFGVLL 420
             FG A      ++ +V              T  Y APE +      T++ D++S G ++
Sbjct: 170 LDFGLARQADSEMTGYV-------------VTRWYRAPEVILNWMRYTQTVDIWSVGCIM 216

Query: 421 LEIVSGR 427
            E+++G+
Sbjct: 217 AEMITGK 223

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 50.3 bits (121), Expect = 7e-07
 Identities = 34/153 (22%), Positives = 60/153 (39%), Gaps = 48/153 (31%)

Query: 240 GTYSGI-----LPDGSRVAVKRLKRSSFQRKKE-FYS----EIGRFARLHHPNLVAVKGC 289
           GT+  +        G +VA+K++     + +KE F      EI     L H N+V +   
Sbjct: 28  GTFGEVFKARHRKTGQKVALKKVL---MENEKEGFPITALREIKILQLLKHENVVNLIEI 84

Query: 290 CYDHGDR--------YIVYEFV----------VNGPLDRWLHHIPRGGRSLDWAMRMKVA 331
           C              Y+V++F           V       L  I    + +   M+M   
Sbjct: 85  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFT--LSEI----KRV---MQM--- 132

Query: 332 TTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 364
             L  G+ ++H      ++HRD++A+NVL+  +
Sbjct: 133 --LLNGLYYIHRN---KILHRDMKAANVLITRD 160

>1wk1_A Hypothetical protein YK1067A12; lectin C-type domain, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Caenorhabditis elegans} SCOP: d.169.1.1 Length = 150

 Score = 47.9 bits (114), Expect = 8e-07
 Identities = 11/70 (15%), Positives = 23/70 (32%), Gaps = 5/70 (7%)

Query: 20 SKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTT 79
           K      +  S  ++  +C   GG+LA     ++ +    +        W+G      +
Sbjct: 8  VKFLTVNDDILSMPQARNFCASAGGYLADDLGDDKNNFYSSIAAN--TQFWIGLF--KNS 63

Query: 80 VGLSWKWSDN 89
           G  + W   
Sbjct: 64 DG-QFYWDRG 72

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 49.1 bits (118), Expect = 2e-06
 Identities = 39/165 (23%), Positives = 64/165 (38%), Gaps = 36/165 (21%)

Query: 279 HHPNLVAVKGCCYDHGDR-----YIVYEFVVNGPLDRWLHHIPRGGRSLDWA---MRMKV 330
            HPN+V +   C            +V+E V +  L  +L  +P  G   +     M    
Sbjct: 72  EHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQ-- 128

Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE-------FG-AHLMGVGLSKFVPWEV 382
              L +G+ FLH      VVHRD++  N+L+          FG A +    +       V
Sbjct: 129 ---LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM-ALTS-VV 180

Query: 383 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGR 427
           +         T  Y APE + ++   T  D++S G +  E+   +
Sbjct: 181 V---------TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 47.6 bits (114), Expect = 5e-06
 Identities = 49/221 (22%), Positives = 78/221 (35%), Gaps = 57/221 (25%)

Query: 240 GTYSGI------LPDGSRVAVKRLKRSSFQRKKEFYS--------EIGRFARLH---HPN 282
           G Y G          G  VA+K ++                    E+    RL    HPN
Sbjct: 20  GAY-GTVYKARDPHSGHFVALKSVR---VPNGGGGGGGLPISTVREVALLRRLEAFEHPN 75

Query: 283 LVAVKGCCYDHGDR-----YIVYEFVVNGPLDRWLHHIPRGGRSLDWA---MRMKVATTL 334
           +V +   C            +V+E V +  L  +L   P  G   +     MR       
Sbjct: 76  VVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQ-----F 129

Query: 335 AQGIAFLHDKVKPHVVHRDIRASNVLLDEE-------FG-AHLMGVGLSKFVPWEVMQER 386
            +G+ FLH      +VHRD++  N+L+          FG A +    +    P  V+   
Sbjct: 130 LRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM-ALTP-VVV--- 181

Query: 387 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGR 427
                 T  Y APE + ++   T  D++S G +  E+   +
Sbjct: 182 ------TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 46.9 bits (112), Expect = 8e-06
 Identities = 49/219 (22%), Positives = 88/219 (40%), Gaps = 49/219 (22%)

Query: 231 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAV 286
             +G    G   S I    G +VA+K+L R  FQ +   K  Y E+     + H N++ +
Sbjct: 30  THVGSGAYGSVCSAIDKRSGEKVAIKKLSRP-FQSEIFAKRAYRELLLLKHMQHENVIGL 88

Query: 287 K------GCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ---G 337
                      +  D Y+V  F     +   L  I     S +     K+   + Q   G
Sbjct: 89  LDVFTPASSLRNFYDFYLVMPF-----MQTDLQKIMGLKFSEE-----KIQYLVYQMLKG 138

Query: 338 IAFLHDKVKPHVVHRDIRASNVLLDEE-------FG-AHLMGVGLSKFVPWEVMQERTVM 389
           + ++H      VVHRD++  N+ ++E+       FG A      ++ +V           
Sbjct: 139 LKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYV----------- 184

Query: 390 AGGTYGYLAPEFVYRNELTTKS-DVYSFGVLLLEIVSGR 427
              T  Y APE +       ++ D++S G ++ E+++G+
Sbjct: 185 --VTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>3fd4_A Glycoprotein GP42; C type lectin, virus entry, membrane fusion, HOST-virus interaction, lectin, membrane, transmembrane, viral protein; 2.40A {Human herpesvirus 4} PDB: 1kg0_C Length = 191

 Score = 45.6 bits (107), Expect = 9e-06
 Identities = 21/146 (14%), Positives = 36/146 (24%), Gaps = 25/146 (17%)

Query: 6   KAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN 65
                      +    CF +     +W+     C E+           +           
Sbjct: 69  YCNTREYTFSYK--GCCFYFTKKKHTWNGCFQACAELYPCTYFYGPTPDILPVVTRNLNA 126

Query: 66  VNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVS 125
           +   WVG   +      +W   D  +     I                       CT VS
Sbjct: 127 IESLWVG---VYRVGEGNWTSLDGGTFKVYQIFGSH-------------------CTYVS 164

Query: 126 NGSRSLVTE-RCNTSHPFICMVEHEN 150
             S   V+   C+   P +C+ +  N
Sbjct: 165 KFSTVPVSHHECSFLKPCLCVSQRSN 190

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 46.2 bits (110), Expect = 2e-05
 Identities = 46/203 (22%), Positives = 90/203 (44%), Gaps = 30/203 (14%)

Query: 240 GTYSGIL-----PDGSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAVK---- 287
           G Y  +        G RVAVK+L R  FQ     K  Y E+     + H N++ +     
Sbjct: 40  GAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 98

Query: 288 --GCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 345
                 +  D Y+V        +   L++I +  +  D  ++  +   L +G+ ++H   
Sbjct: 99  PARSLEEFNDVYLVTHL-----MGADLNNIVKCQKLTDDHVQFLIYQIL-RGLKYIHSA- 151

Query: 346 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN 405
              ++HRD++ SN+ ++E+    ++  GL++    + M         T  Y APE +   
Sbjct: 152 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTA-DEMTGYVA----TRWYRAPEIMLNW 204

Query: 406 ELTTKS-DVYSFGVLLLEIVSGR 427
               ++ D++S G ++ E+++GR
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGR 227

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 45.0 bits (107), Expect = 3e-05
 Identities = 45/205 (21%), Positives = 83/205 (40%), Gaps = 44/205 (21%)

Query: 249 GSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAVK--------------GCCY 291
             RVA+K++           K    EI    RL H N+V V               G   
Sbjct: 36  DKRVAIKKI---VLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLT 92

Query: 292 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 351
           +    YIV E+     ++  L ++   G  L+   R+ +   L +G+ ++H     +V+H
Sbjct: 93  ELNSVYIVQEY-----METDLANVLEQGPLLEEHARLFMYQLL-RGLKYIHSA---NVLH 143

Query: 352 RDIRASNVLLDEE--------FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE-FV 402
           RD++ +N+ ++ E        FG  L  +    +     + E  V    T  Y +P   +
Sbjct: 144 RDLKPANLFINTEDLVLKIGDFG--LARIMDPHYSHKGHLSEGLV----TKWYRSPRLLL 197

Query: 403 YRNELTTKSDVYSFGVLLLEIVSGR 427
             N  T   D+++ G +  E+++G+
Sbjct: 198 SPNNYTKAIDMWAAGCIFAEMLTGK 222

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 45.2 bits (107), Expect = 3e-05
 Identities = 31/142 (21%), Positives = 57/142 (40%), Gaps = 30/142 (21%)

Query: 240 GTYSGI------LPDGSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAVKGCC 290
           G+Y G         +   VA+K++ R  F+     K    EI    RL+H ++V V    
Sbjct: 64  GSY-GHVCEAYDKLEKRVVAIKKILRV-FEDLIDCKRILREIAILNRLNHDHVVKVLDIV 121

Query: 291 YDHG-----DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ---GIAFLH 342
                    + Y+V E       D     + R    L     + + T L     G+ ++H
Sbjct: 122 IPKDVEKFDELYVVLEI-----ADSDFKKLFRTPVYLT---ELHIKTLLYNLLVGVKYVH 173

Query: 343 DKVKPHVVHRDIRASNVLLDEE 364
                 ++HRD++ +N L++++
Sbjct: 174 SA---GILHRDLKPANCLVNQD 192

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 44.7 bits (106), Expect = 4e-05
 Identities = 48/245 (19%), Positives = 85/245 (34%), Gaps = 80/245 (32%)

Query: 240 GTYSGI------LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH 293
           G++ GI      +  G R A+K++     Q  +    E+     L H N++ +    Y  
Sbjct: 18  GSF-GIVCEVFDIESGKRFALKKV----LQDPRYKNRELDIMKVLDHVNIIKLVDYFYTT 72

Query: 294 GDR--------------------------------------YIVYEFVVNGPLD--RWLH 313
           GD                                        ++ E+V   P    + L 
Sbjct: 73  GDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV---PDTLHKVLK 129

Query: 314 HIPRGGRSLDWAMRMKVAT-TLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE-------- 364
              R GRS+     + +    L + + F+H      + HRDI+  N+L++ +        
Sbjct: 130 SFIRSGRSIP-MNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNSKDNTLKLCD 185

Query: 365 FGAHLMGVGLSK-FVPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLE 422
           F       G +K  +P E           +  Y APE +    E T   D++S G +  E
Sbjct: 186 F-------GSAKKLIPSEPSVAYIC----SRFYRAPELMLGATEYTPSIDLWSIGCVFGE 234

Query: 423 IVSGR 427
           ++ G+
Sbjct: 235 LILGK 239

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 45.1 bits (107), Expect = 4e-05
 Identities = 43/216 (19%), Positives = 77/216 (35%), Gaps = 44/216 (20%)

Query: 249 GSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAVKGCCY-----DHGDRYIVY 300
              VA+K++ R  F+     K    EI    RL    ++ +             + YIV 
Sbjct: 51  EKNVAIKKVNRM-FEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVL 109

Query: 301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ---GIAFLHDKVKPHVVHRDIRAS 357
           E       D  L  + +    L       + T L     G  F+H+     ++HRD++ +
Sbjct: 110 EI-----ADSDLKKLFKTPIFLT---EEHIKTILYNLLLGENFIHES---GIIHRDLKPA 158

Query: 358 NVLLDEE-------FG-AHLMGVGLSKFVPWEVMQERTVMAGGTYG------------YL 397
           N LL+++       FG A  +       +  ++ +                       Y 
Sbjct: 159 NCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYR 218

Query: 398 APEFVYRNELTTKS-DVYSFGVLLLEIVSGRRPAQA 432
           APE +   E  TKS D++S G +  E+++  +    
Sbjct: 219 APELILLQENYTKSIDIWSTGCIFAELLNMLQSHIN 254

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 44.6 bits (106), Expect = 4e-05
 Identities = 51/214 (23%), Positives = 89/214 (41%), Gaps = 34/214 (15%)

Query: 231 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAV 286
             +G+   G   S     +  RVA+K  K S F+ +   +    EI    R  H N++ +
Sbjct: 33  SYIGEGAYGMVCSAYDNLNKVRVAIK--KISPFEHQTYCQRTLREIKILLRFRHENIIGI 90

Query: 287 K-----GCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 341
                        D YIV +      ++  L+ + +     +  +   +   L +G+ ++
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDL-----METDLYKLLKTQHLSNDHICYFLYQIL-RGLKYI 144

Query: 342 HDKVKPHVVHRDIRASNVLLDEE-------FGAHLMGVGLSKFVPWEVMQERTVMAGGTY 394
           H     +V+HRD++ SN+LL+         FG  L  V          + E       T 
Sbjct: 145 HSA---NVLHRDLKPSNLLLNTTCDLKICDFG--LARVADPDHDHTGFLTEYVA----TR 195

Query: 395 GYLAPEFVYRNELTTKS-DVYSFGVLLLEIVSGR 427
            Y APE +  ++  TKS D++S G +L E++S R
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 43.8 bits (104), Expect = 9e-05
 Identities = 44/213 (20%), Positives = 79/213 (37%), Gaps = 39/213 (18%)

Query: 240 GTY----SGILPDGSRVAVKRLKRSS--------FQRK---KEFYSEIGRFARLHHPNLV 284
           G+Y    +G+  +G  VA+KR+  +                K    EI      HHPN++
Sbjct: 33  GSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92

Query: 285 AVK-----GCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSL--DWAMRMKVATTLAQG 337
            ++              Y+V E      +   L  +    R +     ++  +   L  G
Sbjct: 93  GLRDIFVHFEEPAMHKLYLVTEL-----MRTDLAQVIHDQRIVISPQHIQYFMYHIL-LG 146

Query: 338 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYG 395
           +  LH+     VVHRD+   N+LL +     +    L++                     
Sbjct: 147 LHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAR-----EDTADANKTHYVTHRW 198

Query: 396 YLAPEFVYRNELTTKS-DVYSFGVLLLEIVSGR 427
           Y APE V + +  TK  D++S G ++ E+ + +
Sbjct: 199 YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 41.8 bits (99), Expect = 4e-04
 Identities = 45/200 (22%), Positives = 81/200 (40%), Gaps = 32/200 (16%)

Query: 247 PDGSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAVK-----GCCYDHGDRYI 298
           P G  VA+K++    F +         EI       H N++ +          +  + YI
Sbjct: 34  PTGEIVAIKKI--EPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYI 91

Query: 299 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASN 358
           + E      +   LH +       D  ++  +  TL + +  LH     +V+HRD++ SN
Sbjct: 92  IQEL-----MQTDLHRVISTQMLSDDHIQYFIYQTL-RAVKVLHGS---NVIHRDLKPSN 142

Query: 359 VLLDEE-------FG-AHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELT 408
           +L++         FG A    +  S     E   +++ M     T  Y APE +  +   
Sbjct: 143 LLINSNCDLKVCDFGLAR--IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKY 200

Query: 409 TKS-DVYSFGVLLLEIVSGR 427
           +++ DV+S G +L E+   R
Sbjct: 201 SRAMDVWSCGCILAELFLRR 220

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	513
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3vpp_A	132	C-type lectin domain family 9 member A; dendritic	99.96
2py2_A	136	Antifreeze protein type II; type II antifreeze pro	99.96
1ypq_A	135	Oxidised low density lipoprotein (lectin-like) rec	99.96
3rs1_A	122	C-type lectin domain family 2 member I; C-type lec	99.95
2c6u_A	122	CLEC1B protein; lectin, rhodocytin, aggretin, C-ty	99.95
1gz2_A	142	Ovocleidin-17, OC-17 ovocleidin; structural protei	99.95
2afp_A	129	Protein (SEA raven type II antifreeze protein); re	99.95
1sl6_A	184	C-type lectin DC-signr; sugar binding protein; HET	99.95
2b6b_D	175	CD209 antigen; cryo EM dengue CRD DC-SIGN, icosahe	99.95
1dv8_A	128	Asialoglycoprotein receptor 1; C-type lectin CRD,	99.95
3bdw_A	123	Natural killer cells antigen CD94; NK cells, recep	99.95
1tdq_B	130	Aggrecan core protein; extracellular matrix, lecti	99.95
2kv3_A	131	Regenerating islet-derived protein 4; GISP, C-type	99.95
2ox9_A	140	Collectin placenta 1; C-type lectin, sugar binding	99.95
3kqg_A	182	Langerin, C-type lectin domain family 4 member K;	99.95
1qdd_A	144	Lithostathine; pancreatic stone inhibitor, metal b	99.95
1hq8_A	123	NKG2-D; homodimer, CIS-proline, apoptosis; 1.95A {	99.95
1egg_A	147	Macrophage mannose receptor; C-type lectin, sugar	99.95
1wmz_A	140	Lectin CEL-I, N-acetyl-D-galactosamine-specific C-	99.95
3g8k_A	130	Lectin-related NK cell receptor LY49L1; natural ki	99.94
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.94
1uv0_A	149	Pancreatitis-associated protein 1; lectin, C-type,	99.94
1jzn_A	135	Galactose-specific lectin; C-type lectin, protein-	99.94
3bdw_B	120	NKG2-A/NKG2-B type II integral membrane protein; N	99.94
2bpd_A	142	Dectin-1; receptor, beta-glucan, fungal recognitio	99.94
3c22_A	156	C-type lectin domain family 4 member K; coiled coi	99.94
1jwi_B	125	Platelet aggregation inducer; domain swapping, C-t	99.94
1fvu_B	125	Botrocetin beta chain; VON WILLBRAND factor modula	99.94
2h2t_B	175	Low affinity immunoglobulin epsilon FC receptor (	99.94
1tn3_A	137	Tetranectin; plasminogen binding, kringle 4, C-typ	99.94
2zib_A	133	Type II antifreeze protein; thermal hysteresis, le	99.94
1oz7_B	123	Echicetin B-chain; platelet aggregation, dimer, to	99.94
1umr_C	125	Convulxin beta, CVX beta; lectin, C-type lectin, p	99.94
2yhf_A	118	C-type lectin domain family 5 member A; immune sys	99.94
1mpu_A	138	NKG2-D type II integral membrane protein; C-type l	99.94
3gpr_C	134	Rhodocetin subunit gamma; disulfide bond, lectin,	99.94
3alu_A	157	Lectin CEL-IV, C-type; C-type lectin, raffinose, s	99.94
2xr6_A	170	CD209 antigen; sugar binding protein, carbohydrate	99.94
1j34_B	123	Coagulation factor IX-binding protein B chain; mag	99.94
2e3x_C	122	Coagulation factor X-activating enzyme light CHAI;	99.94
1c3a_A	135	Flavocetin-A: alpha subunit; C-type lectin-like do	99.94
3ubu_A	131	Agglucetin subunit alpha-1; platelet inhibiting, a	99.94
3m9z_A	139	Killer cell lectin-like receptor subfamily B MEMB;	99.94
1c3a_B	125	Flavocetin-A: beta subunit; C-type lectin-like dom	99.94
3bx4_A	136	Aggretin alpha chain; toxin; 1.70A {Agkistrodon rh	99.94
3hup_A	130	Early activation antigen CD69; C-type lectin-like	99.94
3ff7_C	112	Killer cell lectin-like receptor subfamily G membe	99.94
3bx4_B	146	Aggretin beta chain; toxin; 1.70A {Agkistrodon rho	99.94
1hup_A	141	Mannose-binding protein; alpha-helical coiled-coil	99.93
1ukm_A	134	EMS16 A chain, EMS16 subunit A; domain swapping, C	99.93
1fvu_A	133	Botrocetin alpha chain; VON WILLBRAND factor modul	99.93
1sb2_A	133	Rhodocetin alpha subunit; C-type lectin, domain sw	99.93
1ukm_B	128	EMS16 B chain, EMS16 subunit B; domain swapping, C	99.93
1rtm_1	149	Mannose-binding protein-A; lectin; 1.80A {Rattus n	99.93
3gpr_D	124	Rhodocetin subunit delta; disulfide bond, lectin,	99.93
3ubu_B	126	Agglucetin subunit beta-2; platelet inhibiting, ag	99.93
1umr_A	135	Convulxin alpha, CVX alpha; lectin, C-type lectin,	99.93
1htn_A	182	Tetranectin; plasminogen binding, kringle 4, alpha	99.93
1buu_A	168	Protein (mannose-binding protein A); lectin, HOST	99.93
3ff9_A	115	Killer cell lectin-like receptor subfamily G membe	99.93
1jwi_A	131	Bitiscetin; domain swapping, C-type lectin, toxin;	99.93
1j34_A	129	Coagulation factor IX-binding protein A chain; mag	99.93
2ls8_A	156	C-type lectin domain family 4 member D; structural	99.88
2vuv_A	129	Codakine; sugar-binding protein, C-type, lectin, m	99.93
2e3x_B	134	Coagulation factor X-activating enzyme light CHAI;	99.93
3c8j_A	203	Natural killer cell receptor LY49C; MHC, virus, im	99.93
1sb2_B	129	Rhodocetin beta subunit; C-type lectin, domain swa	99.93
1oz7_A	131	Echicetin A-chain; platelet aggregation, dimer, to	99.93
2msb_A	115	Mannose-binding protein-A; lectin; HET: BMA MAN; 1	99.92
1h8u_A	117	MBP, eosinophil granule major basic protein 1; lec	99.92
1wk1_A	150	Hypothetical protein YK1067A12; lectin C-type doma	99.92
3g8l_A	190	Lectin-related NK cell receptor LY49L1; natural ki	99.92
1rdl_1	113	SUB-MBP-C, mannose-binding protein-C; C-type lecti	99.92
1fm5_A	199	Early activation antigen CD69; C-type lectin-like	99.91
1pwb_A	177	SP-D, PSP-D, pulmonary surfactant-associated prote	99.91
3pbf_A	148	Pulmonary surfactant-associated protein A; collect	99.91
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.9
1byf_A	125	TC14, protein (polyandrocarpa lectin); C-type lect	99.9
3cfw_A	164	L-selectin; EGF, cell adhesion, EGF-like domain, g	99.86
1g1t_A	157	E-selectin; EGF, adhesion molecule, SLEX, immune s	99.86
1g1s_A	162	P-selectin; selectin, lectin, EGF, sulphated, SLEX	99.86
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.82
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.7
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.37
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.23
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.15
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.02
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.74
3k7b_A	96	Protein A33; C-type lectin-like domain, homodimer,	98.71
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.68
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.57
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.47
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.41
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.36
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.14
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.13
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.07
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.97
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.88
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.7
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.61
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.6
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.45
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.38
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.27
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.22
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.14
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.94
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	96.77
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.75
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.74
3fd4_A	191	Glycoprotein GP42; C type lectin, virus entry, mem	96.53
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	96.16
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	96.16
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.44
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	93.55
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	88.48
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	87.82
2k1k_A	38	Ephrin type-A receptor 1; EPHA1, receptor tyrosine	82.53

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=5.5e-58  Score=451.00  Aligned_cols=258  Identities=26%  Similarity=0.390  Sum_probs=206.7

Q ss_pred             CceecccCceEEEEEEeC------CCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeec
Q 010309          230 NRLLGDSKTGGTYSGILP------DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  303 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  303 (513)
                      .+.||+|+||.||+|++.      +++.||||+++..+....++|.+|+++|++++|||||+++|++.+.+..+||||||
T Consensus        46 ~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~  125 (329)
T 4aoj_A           46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYM  125 (329)
T ss_dssp             EEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             EEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            456899999999999864      47889999998877677788999999999999999999999999999999999999


Q ss_pred             cCCCHHHHhccCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecc
Q 010309          304 VNGPLDRWLHHIPR-----------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV  372 (513)
Q Consensus       304 ~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df  372 (513)
                      ++|+|.++|.....           ...++++.+++.|+.||+.||+|||++   +||||||||+||||+.++.+||+||
T Consensus       126 ~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~Ki~DF  202 (329)
T 4aoj_A          126 RHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDF  202 (329)
T ss_dssp             TTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCC
T ss_pred             CCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcEEEccc
Confidence            99999999975322           134699999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhc
Q 010309          373 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQS  451 (513)
Q Consensus       373 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  451 (513)
                      |+|+...............||+.|||||++.+..++.++|||||||+||||+| |+.||...+...   +...    +..
T Consensus       203 Gla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~---~~~~----i~~  275 (329)
T 4aoj_A          203 GMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE---AIDC----ITQ  275 (329)
T ss_dssp             C----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH---HHHH----HHH
T ss_pred             ccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH---HHHH----HHc
Confidence            99987654433333333459999999999999999999999999999999999 899998765421   1111    111


Q ss_pred             ccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcCCC
Q 010309          452 HRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP  510 (513)
Q Consensus       452 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  510 (513)
                      ...            . ..+..+++++.+||.+||+.||++|||++||++.|+.+.+.|
T Consensus       276 g~~------------~-~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~p  321 (329)
T 4aoj_A          276 GRE------------L-ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP  321 (329)
T ss_dssp             TCC------------C-CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSC
T ss_pred             CCC------------C-CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCC
Confidence            110            0 112235668999999999999999999999999999886654

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=7.3e-58  Score=444.06  Aligned_cols=258  Identities=27%  Similarity=0.398  Sum_probs=211.6

Q ss_pred             cCCceecccCceEEEEEEeC------CCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEe
Q 010309          228 EGNRLLGDSKTGGTYSGILP------DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE  301 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  301 (513)
                      ...+.||+|+||.||+|++.      ++..||||+++..+....++|.+|+++|++++|||||+++|++.+++..+||||
T Consensus        16 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~E   95 (299)
T 4asz_A           16 VLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFE   95 (299)
T ss_dssp             EEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             EEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEE
Confidence            34567899999999999863      477899999988776677889999999999999999999999999999999999


Q ss_pred             eccCCCHHHHhccCC---------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecc
Q 010309          302 FVVNGPLDRWLHHIP---------RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV  372 (513)
Q Consensus       302 ~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df  372 (513)
                      ||++|+|.++|....         .....+++.+++.|+.||+.||+|||++   +|+||||||+||||+.++.+||+||
T Consensus        96 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki~DF  172 (299)
T 4asz_A           96 YMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDF  172 (299)
T ss_dssp             CCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCC
T ss_pred             cCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEECCc
Confidence            999999999997532         2345799999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhc
Q 010309          373 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQS  451 (513)
Q Consensus       373 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  451 (513)
                      |+|+...............||+.|||||++.+..++.++|||||||+||||+| |+.||...+..+   +...    +..
T Consensus       173 Gla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~---~~~~----i~~  245 (299)
T 4asz_A          173 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VIEC----ITQ  245 (299)
T ss_dssp             SCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HHHH----HHH
T ss_pred             ccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH----HHc
Confidence            99987654433222222338999999999999999999999999999999999 899998765421   1111    111


Q ss_pred             ccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcC
Q 010309          452 HRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  508 (513)
Q Consensus       452 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  508 (513)
                      +..            . ..+..+++++.+||.+||+.||++|||+++|++.|+++.+
T Consensus       246 ~~~------------~-~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~  289 (299)
T 4asz_A          246 GRV------------L-QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK  289 (299)
T ss_dssp             TCC------------C-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCC------------C-CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            110            0 1122356689999999999999999999999999988754

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.7e-56  Score=436.36  Aligned_cols=254  Identities=25%  Similarity=0.375  Sum_probs=208.5

Q ss_pred             ceecccCceEEEEEEeC------CCCEEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeec
Q 010309          231 RLLGDSKTGGTYSGILP------DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  303 (513)
Q Consensus       231 ~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  303 (513)
                      +.||+|+||+||+|.+.      +++.||||+++... ....++|.+|+.+|++++|||||+++|++.+++..+||||||
T Consensus        32 ~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~  111 (308)
T 4gt4_A           32 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYC  111 (308)
T ss_dssp             EEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             eEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcC
Confidence            45899999999999863      46789999997543 334578999999999999999999999999999999999999


Q ss_pred             cCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEec
Q 010309          304 VNGPLDRWLHHIPR------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMG  371 (513)
Q Consensus       304 ~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~D  371 (513)
                      ++|+|.++|.....            ....+++.+++.|+.|||.||+|||++   +||||||||+||||++++.+||+|
T Consensus       112 ~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~~Ki~D  188 (308)
T 4gt4_A          112 SHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISD  188 (308)
T ss_dssp             SSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECC
T ss_pred             CCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCCEEECC
Confidence            99999999964321            124699999999999999999999999   999999999999999999999999


Q ss_pred             ccccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhh
Q 010309          372 VGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQ  450 (513)
Q Consensus       372 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  450 (513)
                      ||+++...............||+.|||||++.++.++.++|||||||+||||+| |..||.+.+...   +...    +.
T Consensus       189 FGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~---~~~~----i~  261 (308)
T 4gt4_A          189 LGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---VVEM----IR  261 (308)
T ss_dssp             SCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH---HHHH----HH
T ss_pred             cccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH---HHHH----HH
Confidence            999987654433333333458999999999999999999999999999999999 899998765421   1111    11


Q ss_pred             cccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCc
Q 010309          451 SHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  507 (513)
Q Consensus       451 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  507 (513)
                      ....             ...+..+++++.+||.+||+.||++|||+.||++.|+...
T Consensus       262 ~~~~-------------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~  305 (308)
T 4gt4_A          262 NRQV-------------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG  305 (308)
T ss_dssp             TTCC-------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             cCCC-------------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence            1110             0112245667999999999999999999999999998753

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=4.3e-56  Score=431.67  Aligned_cols=256  Identities=23%  Similarity=0.387  Sum_probs=200.1

Q ss_pred             CCceecccCceEEEEEEeCCCCEEEEEEeccc--chhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          229 GNRLLGDSKTGGTYSGILPDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      ..+.||+|+||+||+|++.  ..||||+++..  +....+.|.+|+.+|++++|||||+++|++.+ +..+||||||++|
T Consensus        40 l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gG  116 (307)
T 3omv_A           40 LSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGS  116 (307)
T ss_dssp             EEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSC
T ss_pred             EeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCC
Confidence            3456899999999999874  36999999754  23445789999999999999999999998764 5789999999999


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  386 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  386 (513)
                      +|.++|..   ....+++.+++.|+.||+.||+|||++   +||||||||+||||++++.+||+|||+|+..........
T Consensus       117 sL~~~l~~---~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~  190 (307)
T 3omv_A          117 SLYKHLHV---QETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQ  190 (307)
T ss_dssp             BHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC---------
T ss_pred             CHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCccee
Confidence            99999964   235699999999999999999999999   999999999999999999999999999987654433333


Q ss_pred             eeecCccccccccccccc---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccccccccccc
Q 010309          387 TVMAGGTYGYLAPEFVYR---NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS  463 (513)
Q Consensus       387 ~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  463 (513)
                      .....||+.|||||++.+   ++|+.++|||||||+||||+||+.||.+.+...  .    ........    ...+.+.
T Consensus       191 ~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~--~----~~~~~~~~----~~~p~~~  260 (307)
T 3omv_A          191 VEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD--Q----IIFMVGRG----YASPDLS  260 (307)
T ss_dssp             ---CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--H----HHHHHHTT----CCCCCST
T ss_pred             ecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH--H----HHHHHhcC----CCCCCcc
Confidence            334459999999999864   468999999999999999999999998654321  1    11111111    1111111


Q ss_pred             CCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcC
Q 010309          464 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  508 (513)
Q Consensus       464 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  508 (513)
                      .     .+..+++++.+||.+||+.||++|||+.||++.|+.+..
T Consensus       261 ~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~  300 (307)
T 3omv_A          261 K-----LYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH  300 (307)
T ss_dssp             T-----SCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred             c-----ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence            1     122355679999999999999999999999999987654

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.5e-55  Score=433.12  Aligned_cols=246  Identities=22%  Similarity=0.329  Sum_probs=206.7

Q ss_pred             cCCceecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          228 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      +..+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++..|||||||++|
T Consensus        77 ~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg  156 (346)
T 4fih_A           77 DNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG  156 (346)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTE
T ss_pred             EEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCC
Confidence            33456799999999999975 69999999998766666678899999999999999999999999999999999999999


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  386 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  386 (513)
                      +|.+++.+     ..+++..+..++.||+.||+|||++   +|+||||||+||||+.++.+||+|||+|+........  
T Consensus       157 ~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~--  226 (346)
T 4fih_A          157 ALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--  226 (346)
T ss_dssp             EHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC--
T ss_pred             cHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCCc--
Confidence            99999975     4599999999999999999999999   9999999999999999999999999999876543322  


Q ss_pred             eeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCC
Q 010309          387 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  466 (513)
Q Consensus       387 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  466 (513)
                      ....+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+...   .....   ..      ...+.     
T Consensus       227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~~~i---~~------~~~~~-----  289 (346)
T 4fih_A          227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---AMKMI---RD------NLPPR-----  289 (346)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHH---HH------SSCCC-----
T ss_pred             ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HHHHH---Hc------CCCCC-----
Confidence            223459999999999999999999999999999999999999998754321   11111   00      00111     


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          467 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       467 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                       ......+++++.+||.+||+.||++|||++|+++
T Consensus       290 -~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          290 -LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             -CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence             1112345678999999999999999999999987

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1e-55  Score=427.97  Aligned_cols=245  Identities=22%  Similarity=0.302  Sum_probs=205.9

Q ss_pred             ccCCceecccCceEEEEEEeC-CCCEEEEEEecccc---hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEee
Q 010309          227 SEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF  302 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  302 (513)
                      ++..+.||+|+||+||+|+.. +|+.||||++.+..   ....+.+.+|+++|++++|||||++++++.+++..||||||
T Consensus        34 y~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy  113 (311)
T 4aw0_A           34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY  113 (311)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence            345567899999999999964 69999999997642   23457899999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccc
Q 010309          303 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV  382 (513)
Q Consensus       303 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~  382 (513)
                      ++||+|.+++..    ...+++..+..++.||+.||+|||++   +|+||||||+||||+.++.+||+|||+|+.+....
T Consensus       114 ~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~  186 (311)
T 4aw0_A          114 AKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES  186 (311)
T ss_dssp             CTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred             CCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence            999999999964    35699999999999999999999999   99999999999999999999999999999876544


Q ss_pred             cccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccc
Q 010309          383 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI  462 (513)
Q Consensus       383 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  462 (513)
                      ........+||+.|||||++.+..|+.++|||||||+||||+||++||.+.+...   +....   .. ..+        
T Consensus       187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~~~i---~~-~~~--------  251 (311)
T 4aw0_A          187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL---IFAKI---IK-LEY--------  251 (311)
T ss_dssp             TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH---HH-TCC--------
T ss_pred             CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHH---Hc-CCC--------
Confidence            3333444569999999999999999999999999999999999999998754321   11111   11 100        


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Q 010309          463 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHV  499 (513)
Q Consensus       463 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev  499 (513)
                            ..+..+++++.+||.+||+.||++|||++|+
T Consensus       252 ------~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~  282 (311)
T 4aw0_A          252 ------DFPEKFFPKARDLVEKLLVLDATKRLGCEEM  282 (311)
T ss_dssp             ------CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGG
T ss_pred             ------CCCcccCHHHHHHHHHHccCCHhHCcChHHH
Confidence                  0112345679999999999999999999986

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=3.7e-55  Score=431.10  Aligned_cols=247  Identities=20%  Similarity=0.333  Sum_probs=199.4

Q ss_pred             cCCceecccCceEEEEEEeC-CCCEEEEEEecccc--hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeecc
Q 010309          228 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV  304 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  304 (513)
                      +..+.||+|+||.||+|+.. +|+.||||++....  ....+.+.+|+.+|++|+|||||++++++.+++..|||||||+
T Consensus        27 ~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~  106 (350)
T 4b9d_A           27 VRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCE  106 (350)
T ss_dssp             EEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             EEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCC
Confidence            34456799999999999974 69999999997653  3345789999999999999999999999999999999999999


Q ss_pred             CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccc
Q 010309          305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  384 (513)
Q Consensus       305 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  384 (513)
                      ||+|.++|..  .....+++.+++.|+.||+.||+|||++   +|+||||||+||||+.++.+||+|||+|+........
T Consensus       107 gg~L~~~i~~--~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~  181 (350)
T 4b9d_A          107 GGDLFKRINA--QKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL  181 (350)
T ss_dssp             TCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHH
T ss_pred             CCcHHHHHHH--cCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCCccc
Confidence            9999999975  3345689999999999999999999999   9999999999999999999999999999987543221


Q ss_pred             cceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccC
Q 010309          385 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS  464 (513)
Q Consensus       385 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  464 (513)
                        ....+||+.|||||++.+..|+.++|||||||+||||+||++||.+.+...   +.   ..... ...          
T Consensus       182 --~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~---~~---~~i~~-~~~----------  242 (350)
T 4b9d_A          182 --ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN---LV---LKIIS-GSF----------  242 (350)
T ss_dssp             --HHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HH---HHHHH-TCC----------
T ss_pred             --ccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HH---HHHHc-CCC----------
Confidence              122349999999999999999999999999999999999999998754321   11   11111 110          


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          465 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       465 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                        . ..+..+++++.+||.+||+.||++|||++|+++
T Consensus       243 --~-~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          243 --P-PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             --C-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --C-CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              0 112235667999999999999999999999986

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=8.6e-55  Score=419.53  Aligned_cols=247  Identities=19%  Similarity=0.341  Sum_probs=197.5

Q ss_pred             CcccCCceecccCceEEEEEEeC-CCCEEEEEEecccc--hhcHHHHHHHHHHHhhcCCCcEeeeeeEEee----CCceE
Q 010309          225 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYD----HGDRY  297 (513)
Q Consensus       225 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~~  297 (513)
                      .|....+.||+|+||.||+|.+. ++..||||++....  ....+.|.+|+.+|++|+|||||++++++.+    .+..|
T Consensus        26 r~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~  105 (290)
T 3fpq_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             SEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             ceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEE
Confidence            34444556899999999999975 58999999997542  3345679999999999999999999999875    34579


Q ss_pred             EEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--ceEcCCCCCceEecC-CCCeEEecccc
Q 010309          298 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH--VVHRDIRASNVLLDE-EFGAHLMGVGL  374 (513)
Q Consensus       298 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--ivH~Dikp~NIll~~-~~~~kl~Dfg~  374 (513)
                      ||||||++|+|.+++..    ...+++..+..++.||+.||+|||++   +  |+||||||+||||+. ++.+||+|||+
T Consensus       106 lvmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGl  178 (290)
T 3fpq_A          106 LVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGL  178 (290)
T ss_dssp             EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTG
T ss_pred             EEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcC
Confidence            99999999999999965    35699999999999999999999998   6  999999999999985 78999999999


Q ss_pred             cccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccc
Q 010309          375 SKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRY  454 (513)
Q Consensus       375 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  454 (513)
                      |+......    ....+||+.|||||++. ++|+.++|||||||+||||+||++||......  ..+..    ...... 
T Consensus       179 a~~~~~~~----~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~--~~~~~----~i~~~~-  246 (290)
T 3fpq_A          179 ATLKRASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQIYR----RVTSGV-  246 (290)
T ss_dssp             GGGCCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--HHHHH----HHTTTC-
T ss_pred             CEeCCCCc----cCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH--HHHHH----HHHcCC-
Confidence            98654322    22345999999999886 46999999999999999999999999764432  11111    111100 


Q ss_pred             cccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          455 LELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       455 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                          .       +...+...++++.+||.+||+.||++|||++|+++
T Consensus       247 ----~-------~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          247 ----K-------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             ----C-------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ----C-------CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                0       11111223457999999999999999999999985

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=2.4e-54  Score=423.50  Aligned_cols=248  Identities=19%  Similarity=0.225  Sum_probs=200.7

Q ss_pred             cCCceecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          228 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      ...+.||+|+||.||+|+.. +|+.||||+++....     ..+|+.+|++++|||||++++++.+++..||||||++||
T Consensus        61 ~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg  135 (336)
T 4g3f_A           61 THQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGG  135 (336)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTC
T ss_pred             EeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCC
Confidence            33456799999999999974 599999999976532     246999999999999999999999999999999999999


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCC-CeEEecccccccCCcccccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF-GAHLMGVGLSKFVPWEVMQE  385 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~-~~kl~Dfg~~~~~~~~~~~~  385 (513)
                      +|.++|..    ...+++..++.++.||+.||+|||++   +|+||||||+||||+.++ .+||+|||+|+.........
T Consensus       136 ~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~  208 (336)
T 4g3f_A          136 SLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK  208 (336)
T ss_dssp             BHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred             cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence            99999965    25699999999999999999999999   999999999999999987 59999999998775432211


Q ss_pred             ---ceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccc
Q 010309          386 ---RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI  462 (513)
Q Consensus       386 ---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  462 (513)
                         .....+||+.|||||++.+..|+.++|||||||++|||+||++||...+.......+      ....       +..
T Consensus       209 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i------~~~~-------~~~  275 (336)
T 4g3f_A          209 SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKI------ASEP-------PPI  275 (336)
T ss_dssp             -----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHH------HHSC-------CGG
T ss_pred             ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH------HcCC-------CCc
Confidence               122345999999999999999999999999999999999999999876543221111      0000       000


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 010309          463 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ  505 (513)
Q Consensus       463 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  505 (513)
                      ..     .+..+++.+.+||.+||+.||++|||+.||++.|..
T Consensus       276 ~~-----~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~  313 (336)
T 4g3f_A          276 RE-----IPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK  313 (336)
T ss_dssp             GG-----SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             hh-----cCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence            00     112355679999999999999999999999987754

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.9e-54  Score=434.39  Aligned_cols=247  Identities=22%  Similarity=0.332  Sum_probs=207.1

Q ss_pred             ccCCceecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccC
Q 010309          227 SEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  305 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  305 (513)
                      ++..+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..|||||||+|
T Consensus       153 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~g  232 (423)
T 4fie_A          153 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG  232 (423)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             cEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCC
Confidence            444556799999999999975 6999999999877666677899999999999999999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccc
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  385 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  385 (513)
                      |+|.+++..     ..+++.++..++.||+.||+|||++   +||||||||+||||+.++.+||+|||+|+.+.......
T Consensus       233 G~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~  304 (423)
T 4fie_A          233 GALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR  304 (423)
T ss_dssp             EEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCB
T ss_pred             CcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCccc
Confidence            999999964     4599999999999999999999999   99999999999999999999999999998765443222


Q ss_pred             ceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCC
Q 010309          386 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  465 (513)
Q Consensus       386 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  465 (513)
                        ...+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+....   ....   ..      ...+.+   
T Consensus       305 --~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~---~~~i---~~------~~~~~~---  367 (423)
T 4fie_A          305 --KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA---MKMI---RD------NLPPRL---  367 (423)
T ss_dssp             --CCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHHH---HH------SCCCCC---
T ss_pred             --cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH---HHHH---Hc------CCCCCC---
Confidence              233499999999999999999999999999999999999999987543211   1111   00      001111   


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          466 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       466 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                         .....+++++.+||.+||+.||++|||++|+++
T Consensus       368 ---~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          368 ---KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             ---SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence               111234667999999999999999999999987

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.5e-53  Score=407.34  Aligned_cols=242  Identities=19%  Similarity=0.296  Sum_probs=189.2

Q ss_pred             cCCceecccCceEEEEEEeC-CCCEEEEEEecccc---hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeec
Q 010309          228 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  303 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  303 (513)
                      +..+.||+|+||.||+|... +|+.||||++++..   ....+.+.+|+.+|++++|||||++++++.+++..|+||||+
T Consensus        16 ~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   95 (275)
T 3hyh_A           16 QIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA   95 (275)
T ss_dssp             EEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             EEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC
Confidence            44567899999999999964 69999999997653   233567999999999999999999999999999999999999


Q ss_pred             cCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccc
Q 010309          304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM  383 (513)
Q Consensus       304 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~  383 (513)
                       +|+|.+++..    ...+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+.......
T Consensus        96 -~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~  167 (275)
T 3hyh_A           96 -GNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF  167 (275)
T ss_dssp             -CEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred             -CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCCCc
Confidence             7899999865    35699999999999999999999999   999999999999999999999999999987654322


Q ss_pred             ccceeecCcccccccccccccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccc
Q 010309          384 QERTVMAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI  462 (513)
Q Consensus       384 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  462 (513)
                      .   ...+||+.|||||++.+..+ +.++|||||||++|||+||+.||.+.+..   .+....    .....        
T Consensus       168 ~---~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~---~~~~~i----~~~~~--------  229 (275)
T 3hyh_A          168 L---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP---VLFKNI----SNGVY--------  229 (275)
T ss_dssp             ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH----HHTCC--------
T ss_pred             c---CCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH---HHHHHH----HcCCC--------
Confidence            2   22349999999999998876 57999999999999999999999765432   111111    11100        


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          463 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       463 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                            ..+...++++.+||.+||+.||++|||++|+++
T Consensus       230 ------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          230 ------TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             ------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                  011234567999999999999999999999987

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=3.4e-54  Score=427.38  Aligned_cols=262  Identities=26%  Similarity=0.338  Sum_probs=209.7

Q ss_pred             CcccCCceecccCceEEEEEEeCC------CCEEEEEEecccch-hcHHHHHHHHHHHhhcCC-CcEeeeeeEEeeC-Cc
Q 010309          225 NFSEGNRLLGDSKTGGTYSGILPD------GSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHH-PNLVAVKGCCYDH-GD  295 (513)
Q Consensus       225 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~-~~  295 (513)
                      +-++..+.||+|+||.||+|.+..      ++.||||+++.... ...+.|.+|+.+|.+++| ||||+++|+|.+. +.
T Consensus        64 ~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~  143 (353)
T 4ase_A           64 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP  143 (353)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSC
T ss_pred             HHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCE
Confidence            334556778999999999998642      35899999976533 345679999999999965 9999999999765 56


Q ss_pred             eEEEEeeccCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecC
Q 010309          296 RYIVYEFVVNGPLDRWLHHIPR------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE  363 (513)
Q Consensus       296 ~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~  363 (513)
                      .+||||||++|+|.++|+....            ....+++..++.++.|||.||+|||++   +||||||||+|||+++
T Consensus       144 ~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NILl~~  220 (353)
T 4ase_A          144 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSE  220 (353)
T ss_dssp             CEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECG
T ss_pred             EEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccceeeCC
Confidence            8999999999999999975321            134589999999999999999999999   9999999999999999


Q ss_pred             CCCeEEecccccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhH
Q 010309          364 EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIF  442 (513)
Q Consensus       364 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~  442 (513)
                      ++.+||+|||+|+...............||+.|||||++.+..++.++|||||||+||||+| |+.||.+.....  .+.
T Consensus       221 ~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~--~~~  298 (353)
T 4ase_A          221 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFC  298 (353)
T ss_dssp             GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--HHH
T ss_pred             CCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH--HHH
Confidence            99999999999997755433333333448999999999999999999999999999999998 999998754321  111


Q ss_pred             HhhhHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcC
Q 010309          443 EWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  508 (513)
Q Consensus       443 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  508 (513)
                          ..+..+..            . ..+..+++++.+||.+||+.||++|||++||++.|+++.+
T Consensus       299 ----~~i~~g~~------------~-~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq  347 (353)
T 4ase_A          299 ----RRLKEGTR------------M-RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  347 (353)
T ss_dssp             ----HHHHHTCC------------C-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----HHHHcCCC------------C-CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence                11111110            1 1122345679999999999999999999999999987654

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=8.9e-54  Score=417.91  Aligned_cols=268  Identities=21%  Similarity=0.276  Sum_probs=200.6

Q ss_pred             cCCceecccCceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCC----ceEEEEeec
Q 010309          228 EGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG----DRYIVYEFV  303 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----~~~lv~e~~  303 (513)
                      ...+.||+|+||+||+|++ +|+.||||+++.... ....+..|+..+.+++|||||++++++.+++    ..||||||+
T Consensus         6 ~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~   83 (303)
T 3hmm_A            6 VLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH   83 (303)
T ss_dssp             EEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECC
T ss_pred             EEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCC
Confidence            3456789999999999998 789999999975432 2223345666777899999999999998764    469999999


Q ss_pred             cCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCceEcCCCCCceEecCCCCeEEecccccccC
Q 010309          304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK-----VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV  378 (513)
Q Consensus       304 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-----~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~  378 (513)
                      ++|+|.++|+.     ..+++..+.+++.|++.||+|||++     ..++|+||||||+||||+.++.+||+|||+|+..
T Consensus        84 ~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~  158 (303)
T 3hmm_A           84 EHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  158 (303)
T ss_dssp             TTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             CCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence            99999999975     4589999999999999999999975     2458999999999999999999999999999866


Q ss_pred             Cccccc--cceeecCcccccccccccccC------CCCchhhHHHHHHHHHHHHcCCCCCCCCCccccc--h------hH
Q 010309          379 PWEVMQ--ERTVMAGGTYGYLAPEFVYRN------ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ--S------IF  442 (513)
Q Consensus       379 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~--~------~~  442 (513)
                      ......  .......||+.|||||++.+.      .++.++|||||||+||||+||.+||.........  .      ..
T Consensus       159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~  238 (303)
T 3hmm_A          159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV  238 (303)
T ss_dssp             ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred             cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH
Confidence            433221  112223499999999999764      3678999999999999999999887654322100  0      00


Q ss_pred             HhhhHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcCC
Q 010309          443 EWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP  509 (513)
Q Consensus       443 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  509 (513)
                      +........    ..+++.+   +........+..+.+|+.+||+.||++||||.||++.|+++.+.
T Consensus       239 ~~~~~~~~~----~~~rp~~---p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          239 EEMRKVVCE----QKLRPNI---PNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             HHHHHHHTT----SCCCCCC---CGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHHHHhc----ccCCCCC---CccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence            111111111    1111111   11112235677899999999999999999999999999988654

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=8.4e-54  Score=414.62  Aligned_cols=245  Identities=24%  Similarity=0.278  Sum_probs=194.2

Q ss_pred             ccCCceecccCceEEEEEEeC----CCCEEEEEEecccch--hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEE
Q 010309          227 SEGNRLLGDSKTGGTYSGILP----DGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY  300 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  300 (513)
                      ++..+.||+|+||.||+|+..    +++.||||++++...  .....+.+|+.+|++++|||||++++++.+++..||||
T Consensus        26 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm  105 (304)
T 3ubd_A           26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLIL  105 (304)
T ss_dssp             EEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEE
T ss_pred             cEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            344567899999999999852    478999999976532  23456889999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCc
Q 010309          301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW  380 (513)
Q Consensus       301 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~  380 (513)
                      ||++||+|.++|..    ...+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+....
T Consensus       106 Ey~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  178 (304)
T 3ubd_A          106 DFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESID  178 (304)
T ss_dssp             CCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred             EcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence            99999999999965    35699999999999999999999999   999999999999999999999999999986543


Q ss_pred             cccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccc
Q 010309          381 EVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP  460 (513)
Q Consensus       381 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  460 (513)
                      ....  ....+||+.|||||++.+..++.++|||||||++|||+||++||.+.+...   +..   .... ..       
T Consensus       179 ~~~~--~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~---~~~---~i~~-~~-------  242 (304)
T 3ubd_A          179 HEKK--AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE---TMT---MILK-AK-------  242 (304)
T ss_dssp             --CC--CCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---HHHH-CC-------
T ss_pred             CCcc--ccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH---HHH---HHHc-CC-------
Confidence            3221  223459999999999999999999999999999999999999998755421   111   1111 00       


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHH
Q 010309          461 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRM-----SHVVH  501 (513)
Q Consensus       461 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~  501 (513)
                            . ..+..+++++.+||.+||+.||++|||+     +|+++
T Consensus       243 ------~-~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          243 ------L-GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             ------C-CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             ------C-CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence                  0 1122356779999999999999999984     67764

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=4.1e-51  Score=397.31  Aligned_cols=252  Identities=20%  Similarity=0.306  Sum_probs=187.4

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCc------------
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD------------  295 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~------------  295 (513)
                      .+.||+|+||.||+|+.. +|+.||||+++... ....+.+.+|+.+|++|+|||||++++++.+.+.            
T Consensus        10 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~   89 (299)
T 4g31_A           10 IQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVY   89 (299)
T ss_dssp             EEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEE
T ss_pred             eeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcE
Confidence            457899999999999974 69999999997543 2345678999999999999999999999876543            


Q ss_pred             eEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEeccccc
Q 010309          296 RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLS  375 (513)
Q Consensus       296 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~  375 (513)
                      .||||||+++|+|.+++.... .....++..++.++.||+.||+|||++   +|+||||||+||||+.++.+||+|||+|
T Consensus        90 l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~DFGla  165 (299)
T 4g31_A           90 LYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLV  165 (299)
T ss_dssp             EEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCCCC
T ss_pred             EEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEccCccc
Confidence            689999999999999997522 123456677899999999999999999   9999999999999999999999999999


Q ss_pred             ccCCcccccc----------ceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhh
Q 010309          376 KFVPWEVMQE----------RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWA  445 (513)
Q Consensus       376 ~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~  445 (513)
                      +.........          .....+||+.|||||++.+..|+.++|||||||++|||++   ||....+.     ....
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~-----~~~~  237 (299)
T 4g31_A          166 TAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMER-----VRTL  237 (299)
T ss_dssp             --------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHH-----HHHH
T ss_pred             eecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHH-----HHHH
Confidence            8765432211          1122359999999999999999999999999999999996   77532110     0000


Q ss_pred             hHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcCc
Q 010309          446 TPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH--QLQQLA  507 (513)
Q Consensus       446 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~  507 (513)
                      .. .....             ........++.+.+||.+||+.||++|||+.|+++  .++.+.
T Consensus       238 ~~-~~~~~-------------~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~  287 (299)
T 4g31_A          238 TD-VRNLK-------------FPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD  287 (299)
T ss_dssp             HH-HHTTC-------------CCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred             HH-HhcCC-------------CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence            00 00000             00011234556789999999999999999999987  455543

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-49  Score=401.24  Aligned_cols=266  Identities=20%  Similarity=0.269  Sum_probs=198.4

Q ss_pred             cCCceecccCceEEEEEEeC-CCCEEEEEEecccc--hhcHHHHHHHHHHHhhcCCCcEeeeeeEEee------CCceEE
Q 010309          228 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYD------HGDRYI  298 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~------~~~~~l  298 (513)
                      +..+.||+|+||.||+|+.. +|+.||||+++...  ....+.+.+|+.+|+.|+|||||++++++..      .+..||
T Consensus        57 ~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~i  136 (398)
T 4b99_A           57 EIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYV  136 (398)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEE
T ss_pred             EEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEE
Confidence            44567899999999999974 69999999997642  2334678899999999999999999999764      357899


Q ss_pred             EEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccC
Q 010309          299 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV  378 (513)
Q Consensus       299 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~  378 (513)
                      |||||+ |+|.+++..    ...+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+.+
T Consensus       137 vmE~~~-g~L~~~i~~----~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~  208 (398)
T 4b99_A          137 VLDLME-SDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGL  208 (398)
T ss_dssp             EEECCS-EEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred             EEeCCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeeec
Confidence            999995 689999854    46799999999999999999999999   9999999999999999999999999999876


Q ss_pred             Ccccc--ccceeecCcccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccc
Q 010309          379 PWEVM--QERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL  455 (513)
Q Consensus       379 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  455 (513)
                      .....  .......+||+.|+|||++.+. .++.++||||+||++|||++|++||.+.+.......+.............
T Consensus       209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~  288 (398)
T 4b99_A          209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQ  288 (398)
T ss_dssp             -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC
T ss_pred             ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence            44321  1222334599999999998875 56999999999999999999999998765432221111100000000000


Q ss_pred             c----cccccccCCCCCC--Cc----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          456 E----LLDPLISSLSSDI--PE----AGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       456 ~----~~~~~~~~~~~~~--~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      .    .....+.......  +.    ...++++.+||.+||+.||++|||++|+|+
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          289 AVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             -----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             hhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            0    0000000000000  00    123567899999999999999999999986

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.2e-48  Score=390.11  Aligned_cols=197  Identities=22%  Similarity=0.324  Sum_probs=167.1

Q ss_pred             ccCCceecccCceEEEEEEeC----CCCEEEEEEecccchhcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCCceEEEEe
Q 010309          227 SEGNRLLGDSKTGGTYSGILP----DGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYE  301 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e  301 (513)
                      ++..+.||+|+||.||+|+.+    .++.||||++....  ....+.+|+++|+.+ +||||+++++++.+.+..|||||
T Consensus        23 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE  100 (361)
T 4f9c_A           23 FKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMP  100 (361)
T ss_dssp             CEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEE
T ss_pred             EEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEe
Confidence            445667899999999999853    46789999997653  456788999999998 69999999999999999999999


Q ss_pred             eccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCC-CCeEEecccccccCCc
Q 010309          302 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE-FGAHLMGVGLSKFVPW  380 (513)
Q Consensus       302 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~-~~~kl~Dfg~~~~~~~  380 (513)
                      |+++|+|.+++.       .+++.++..++.||+.||+|||++   +|+||||||+|||++.+ +.+||+|||+|+....
T Consensus       101 ~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~  170 (361)
T 4f9c_A          101 YLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD  170 (361)
T ss_dssp             CCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred             CCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence            999999999983       489999999999999999999999   99999999999999877 7899999999976543


Q ss_pred             cccc--------------------------cceeecCcccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 010309          381 EVMQ--------------------------ERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAV  433 (513)
Q Consensus       381 ~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~  433 (513)
                      ....                          ......+||+.|+|||++.+. .++.++||||+||++|||+||+.||...
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~  250 (361)
T 4f9c_A          171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA  250 (361)
T ss_dssp             CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred             ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence            2110                          111223599999999999875 4899999999999999999999999654


Q ss_pred             Cc
Q 010309          434 DS  435 (513)
Q Consensus       434 ~~  435 (513)
                      .+
T Consensus       251 ~~  252 (361)
T 4f9c_A          251 SD  252 (361)
T ss_dssp             SS
T ss_pred             CC
Confidence            43

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.6e-48  Score=385.40  Aligned_cols=283  Identities=31%  Similarity=0.529  Sum_probs=235.0

Q ss_pred             HHHHHHhhCcccCCceecccCceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCce
Q 010309          217 EELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR  296 (513)
Q Consensus       217 ~~l~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  296 (513)
                      .++..++++|.. .++||+|+||.||+|...+++.||||++........+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        32 ~~~~~~~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  110 (321)
T 2qkw_B           32 VDLEEATNNFDH-KFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM  110 (321)
T ss_dssp             SCCCCCCCCCSC-CCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred             HHHHHHHhccCc-cceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence            344455666655 4567999999999999888999999999877666678899999999999999999999999999999


Q ss_pred             EEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccc
Q 010309          297 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK  376 (513)
Q Consensus       297 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~  376 (513)
                      ++||||+++|+|.+++.........+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++.
T Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~  187 (321)
T 2qkw_B          111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISK  187 (321)
T ss_dssp             EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred             EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccccc
Confidence            999999999999999976544445799999999999999999999999   99999999999999999999999999998


Q ss_pred             cCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccc
Q 010309          377 FVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLE  456 (513)
Q Consensus       377 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  456 (513)
                      ...............||+.|+|||++.+..++.++||||||+++|||++|+.||.............+............
T Consensus       188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (321)
T 2qkw_B          188 KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQ  267 (321)
T ss_dssp             ECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCS
T ss_pred             ccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHH
Confidence            65433222222223389999999999989999999999999999999999999987766555555555554444444444


Q ss_pred             cccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCc
Q 010309          457 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  507 (513)
Q Consensus       457 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  507 (513)
                      .+++.+    ........+..+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus       268 ~~~~~~----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l  314 (321)
T 2qkw_B          268 IVDPNL----ADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL  314 (321)
T ss_dssp             SSSSSC----TTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hcChhh----ccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            444433    23345678889999999999999999999999999998764

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=4e-48  Score=409.06  Aligned_cols=248  Identities=19%  Similarity=0.287  Sum_probs=206.3

Q ss_pred             cCCceecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          228 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      +..+.||+|+||.||+|... +|+.||||++........+.+.+|+.+|+.|+|||||++++++.+.+..|||||||+||
T Consensus       160 ~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg  239 (573)
T 3uto_A          160 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGG  239 (573)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCC
T ss_pred             EEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCC
Confidence            34567899999999999975 69999999998776666788999999999999999999999999999999999999999


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCC--CCeEEecccccccCCccccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE--FGAHLMGVGLSKFVPWEVMQ  384 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~--~~~kl~Dfg~~~~~~~~~~~  384 (513)
                      +|.++|..   ....+++.++..++.||+.||+|||++   +|+||||||+|||++.+  +.+||+|||+++.+..... 
T Consensus       240 ~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~-  312 (573)
T 3uto_A          240 ELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS-  312 (573)
T ss_dssp             BHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE-
T ss_pred             cHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCCCc-
Confidence            99999863   235699999999999999999999999   99999999999999854  7899999999998754432 


Q ss_pred             cceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccC
Q 010309          385 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS  464 (513)
Q Consensus       385 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  464 (513)
                        ....+||+.|||||++.+..|+.++|||||||++|||++|.+||.+.+....   ..   .... ... ..       
T Consensus       313 --~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~---~~---~i~~-~~~-~~-------  375 (573)
T 3uto_A          313 --VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET---LR---NVKS-CDW-NM-------  375 (573)
T ss_dssp             --EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---HH---HHHT-TCC-CC-------
T ss_pred             --eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH---HH---HHHh-CCC-CC-------
Confidence              2234599999999999999999999999999999999999999987654211   11   1000 000 00       


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          465 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       465 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                        .......+++++.+||.+||+.||.+|||++|+++
T Consensus       376 --~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          376 --DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             --CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             --CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              11111235667999999999999999999999987

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=3.2e-47  Score=376.85  Aligned_cols=292  Identities=33%  Similarity=0.590  Sum_probs=236.5

Q ss_pred             CccccCHHHHHHHhhCcccCCceecccCceEEEEEEeCCCCEEEEEEecccch-hcHHHHHHHHHHHhhcCCCcEeeeee
Q 010309          210 SWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKG  288 (513)
Q Consensus       210 ~~~~~~~~~l~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~  288 (513)
                      ....++..++....++|... +.||+|+||.||+|...+|+.||||++..... .....+.+|+.+++.++||||+++++
T Consensus        16 ~~~~~~~~~~~~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~   94 (326)
T 3uim_A           16 QLKRFSLRELQVASDNFSNK-NILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG   94 (326)
T ss_dssp             CCEECCTHHHHTTTTSSCST-TEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred             ccceecHHHHHHHhhccccc-eeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence            45668888988888887664 56799999999999988899999999976532 22346899999999999999999999


Q ss_pred             EEeeCCceEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeE
Q 010309          289 CCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH  368 (513)
Q Consensus       289 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~k  368 (513)
                      ++.+.+..++||||+++|+|.+++.........+++..+..++.|++.||+|||+.+.++|+||||||+|||++.++.+|
T Consensus        95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k  174 (326)
T 3uim_A           95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV  174 (326)
T ss_dssp             EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred             EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence            99999999999999999999999987655566799999999999999999999998777999999999999999999999


Q ss_pred             EecccccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCc--cccchhHHhhh
Q 010309          369 LMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS--VCWQSIFEWAT  446 (513)
Q Consensus       369 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~--~~~~~~~~~~~  446 (513)
                      |+|||++.......... .....||+.|+|||++.+..++.++||||||+++|+|++|..||.....  ........+..
T Consensus       175 l~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  253 (326)
T 3uim_A          175 VGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK  253 (326)
T ss_dssp             ECCCSSCEECCSSSSCE-ECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred             eccCccccccCcccccc-cccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence            99999998765433222 2223389999999999888899999999999999999999999963211  11122334444


Q ss_pred             HHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCc
Q 010309          447 PLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  507 (513)
Q Consensus       447 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  507 (513)
                      ............+..+    ........+..+.+++.+||+.||++|||+.+|++.|+...
T Consensus       254 ~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  310 (326)
T 3uim_A          254 GLLKEKKLEALVDVDL----QGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG  310 (326)
T ss_dssp             TTTSSCCSTTSSCTTC----TTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred             HHhhchhhhhhcChhh----ccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence            4334444444444333    33445678889999999999999999999999999998654

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.3e-47  Score=402.75  Aligned_cols=245  Identities=19%  Similarity=0.238  Sum_probs=197.0

Q ss_pred             cCCceecccCceEEEEEEeC-CCCEEEEEEecccch---hcHHHHH---HHHHHHhhcCCCcEeeeeeEEeeCCceEEEE
Q 010309          228 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFY---SEIGRFARLHHPNLVAVKGCCYDHGDRYIVY  300 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~---~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  300 (513)
                      +..++||+|+||.||+|+.. +|+.||||++.+...   .....+.   .++.+++.++|||||++++++.+.+..||||
T Consensus       192 ~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVm  271 (689)
T 3v5w_A          192 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFIL  271 (689)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEE
T ss_pred             EEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEE
Confidence            44578899999999999975 599999999975421   2223333   3466777889999999999999999999999


Q ss_pred             eeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCc
Q 010309          301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW  380 (513)
Q Consensus       301 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~  380 (513)
                      ||++||+|.++|..    ...+++..++.++.||+.||+|||++   +||||||||+||||+.+|++||+|||+|+....
T Consensus       272 Ey~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~  344 (689)
T 3v5w_A          272 DLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSK  344 (689)
T ss_dssp             CCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             ecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence            99999999999965    35699999999999999999999999   999999999999999999999999999987654


Q ss_pred             cccccceeecCccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccccccc
Q 010309          381 EVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD  459 (513)
Q Consensus       381 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  459 (513)
                      ...    ...+||+.|||||++.. ..|+.++|+|||||+||||++|.+||.+........+....   .. .       
T Consensus       345 ~~~----~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i---~~-~-------  409 (689)
T 3v5w_A          345 KKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---LT-M-------  409 (689)
T ss_dssp             CCC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHH---HH-C-------
T ss_pred             CCC----CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhh---cC-C-------
Confidence            322    23459999999999975 57999999999999999999999999765432211111111   00 0       


Q ss_pred             ccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 010309          460 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPR-----MSHVVH  501 (513)
Q Consensus       460 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  501 (513)
                             ....+..+++++.+||.+||+.||++|++     ++||++
T Consensus       410 -------~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          410 -------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             -------CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             -------CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence                   00112235678999999999999999998     677764

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.4e-45  Score=360.30  Aligned_cols=247  Identities=21%  Similarity=0.333  Sum_probs=205.9

Q ss_pred             ccCCceecccCceEEEEEEe-CCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccC
Q 010309          227 SEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  305 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  305 (513)
                      +...+.||+|+||.||+|.. .+|+.||||++........+.+.+|+.+++.++||||+++++++...+..++||||+++
T Consensus        22 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~  101 (297)
T 3fxz_A           22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG  101 (297)
T ss_dssp             BCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             eeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCC
Confidence            34456789999999999996 46999999999876666678899999999999999999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccc
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  385 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  385 (513)
                      |+|.+++..     ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++..........
T Consensus       102 ~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  173 (297)
T 3fxz_A          102 GSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR  173 (297)
T ss_dssp             CBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred             CCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCccccc
Confidence            999999975     3589999999999999999999999   99999999999999999999999999998765433221


Q ss_pred             ceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCC
Q 010309          386 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  465 (513)
Q Consensus       386 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  465 (513)
                        ....||+.|+|||++.+..++.++||||||+++|||++|..||...+....      .........      +     
T Consensus       174 --~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------~~~~~~~~~------~-----  234 (297)
T 3fxz_A          174 --STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIATNGT------P-----  234 (297)
T ss_dssp             --CCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHHCS------C-----
T ss_pred             --CCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhCCC------C-----
Confidence              223489999999999999999999999999999999999999976543211      000000000      0     


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          466 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       466 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                       ....+...++.+.+||.+||+.||++|||++|+++
T Consensus       235 -~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          235 -ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             -CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -CCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence             11112345667999999999999999999999987

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.1e-45  Score=362.96  Aligned_cols=256  Identities=27%  Similarity=0.444  Sum_probs=199.8

Q ss_pred             cCCceecccCceEEEEEEeCCCCEEEEEEecccc--hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccC
Q 010309          228 EGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  305 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  305 (513)
                      ...+.||+|+||.||+|.. +|+.||||++....  ....+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus        40 ~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~  118 (309)
T 3p86_A           40 NIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSR  118 (309)
T ss_dssp             EEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTT
T ss_pred             eeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCC
Confidence            3456789999999999987 78899999997653  23346789999999999999999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--ceEcCCCCCceEecCCCCeEEecccccccCCcccc
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH--VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM  383 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~  383 (513)
                      |+|.+++.... ....+++..++.++.|++.||+|||+.   +  |+||||||+|||++.++.+||+|||+++.......
T Consensus       119 ~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~  194 (309)
T 3p86_A          119 GSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFL  194 (309)
T ss_dssp             CBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC----------
T ss_pred             CcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCcccccccc
Confidence            99999997421 112489999999999999999999999   8  99999999999999999999999999986543322


Q ss_pred             ccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccccccccccc
Q 010309          384 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS  463 (513)
Q Consensus       384 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  463 (513)
                      .  .....||+.|+|||++.+..++.++||||||+++|||++|..||...+......      .......          
T Consensus       195 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~------~~~~~~~----------  256 (309)
T 3p86_A          195 S--SKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVA------AVGFKCK----------  256 (309)
T ss_dssp             ---------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH------HHHHSCC----------
T ss_pred             c--cccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHHhcCC----------
Confidence            1  122348999999999999999999999999999999999999998654321110      0000000          


Q ss_pred             CCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcCC
Q 010309          464 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP  509 (513)
Q Consensus       464 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  509 (513)
                         ....+...++++.+||.+||+.||.+|||+++|++.|+.+...
T Consensus       257 ---~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          257 ---RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             ---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             ---CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence               0111223456799999999999999999999999999877554

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.5e-44  Score=354.52  Aligned_cols=285  Identities=32%  Similarity=0.509  Sum_probs=226.9

Q ss_pred             ccccCHHHHHHHhhCcccC-----CceecccCceEEEEEEeCCCCEEEEEEecccc----hhcHHHHHHHHHHHhhcCCC
Q 010309          211 WKVFTTEELRSITKNFSEG-----NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSS----FQRKKEFYSEIGRFARLHHP  281 (513)
Q Consensus       211 ~~~~~~~~l~~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~  281 (513)
                      ...|+.+++..++++|...     .+.||+|+||.||+|.. +++.||||++....    ....+.+.+|+.++++++||
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   90 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE   90 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence            4668899999999998875     25679999999999997 78999999997532    23357789999999999999


Q ss_pred             cEeeeeeEEeeCCceEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEe
Q 010309          282 NLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL  361 (513)
Q Consensus       282 nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll  361 (513)
                      ||+++++++.+.+..++||||+++++|.+++.... ....+++..++.++.|++.||.|||+.   +|+||||||+|||+
T Consensus        91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili  166 (307)
T 2nru_A           91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILL  166 (307)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred             CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEE
Confidence            99999999999999999999999999999986422 235699999999999999999999999   99999999999999


Q ss_pred             cCCCCeEEecccccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchh
Q 010309          362 DEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSI  441 (513)
Q Consensus       362 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~  441 (513)
                      +.++.+||+|||++................||+.|+|||++.+ .++.++||||||+++|+|++|..||.......... 
T Consensus       167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-  244 (307)
T 2nru_A          167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL-  244 (307)
T ss_dssp             CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTT-
T ss_pred             cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHH-
Confidence            9999999999999987654322222222348999999998864 57899999999999999999999998755432111 


Q ss_pred             HHhhhHHhh-cccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcC
Q 010309          442 FEWATPLVQ-SHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  508 (513)
Q Consensus       442 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  508 (513)
                       ........ ...+.+.+++.+     .......++.+.+++.+||+.||.+|||+.+|++.|+++..
T Consensus       245 -~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          245 -DIKEEIEDEEKTIEDYIDKKM-----NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             -HHHHHHHTTSCCHHHHSCSSC-----SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             -HHHHHhhhhhhhhhhhccccc-----cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence             11111111 111122222222     12345678899999999999999999999999999998754

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=5.2e-45  Score=360.18  Aligned_cols=262  Identities=22%  Similarity=0.330  Sum_probs=214.7

Q ss_pred             cccCHHHHHHHhhCc---------ccCCceecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhcCCC
Q 010309          212 KVFTTEELRSITKNF---------SEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHP  281 (513)
Q Consensus       212 ~~~~~~~l~~~~~~~---------~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  281 (513)
                      ..++.+++..+++..         ....+.||+|+||.||+|... +|+.||||++........+.+.+|+.++++++||
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            457788888887653         233457899999999999976 6999999999877666678899999999999999


Q ss_pred             cEeeeeeEEeeCCceEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEe
Q 010309          282 NLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL  361 (513)
Q Consensus       282 nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll  361 (513)
                      ||+++++++...+..++||||+++++|.+++..     ..+++..+..++.|++.||.|||+.   +|+||||||+|||+
T Consensus       103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll  174 (321)
T 2c30_A          103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILL  174 (321)
T ss_dssp             TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEE
T ss_pred             CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEE
Confidence            999999999999999999999999999999863     4599999999999999999999999   99999999999999


Q ss_pred             cCCCCeEEecccccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchh
Q 010309          362 DEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSI  441 (513)
Q Consensus       362 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~  441 (513)
                      +.++.+||+|||++..........  ....||+.|+|||++.+..++.++||||||+++|||++|+.||.......   .
T Consensus       175 ~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~---~  249 (321)
T 2c30_A          175 TLDGRVKLSDFGFCAQISKDVPKR--KSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ---A  249 (321)
T ss_dssp             CTTCCEEECCCTTCEECCSSSCCB--CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---H
T ss_pred             CCCCcEEEeeeeeeeecccCcccc--ccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---H
Confidence            999999999999998765432221  22348999999999999999999999999999999999999997654321   1


Q ss_pred             HHhhhHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          442 FEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       442 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      ..   ....      ...+.+      ......++.+.+++.+||+.||++|||++++++
T Consensus       250 ~~---~~~~------~~~~~~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          250 MK---RLRD------SPPPKL------KNSHKVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             HH---HHHH------SSCCCC------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HH---HHhc------CCCCCc------CccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            11   1100      000100      112234567999999999999999999999987

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2e-45  Score=370.19  Aligned_cols=258  Identities=24%  Similarity=0.396  Sum_probs=208.5

Q ss_pred             ccCCceecccCceEEEEEEeC--------CCCEEEEEEecccc-hhcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCCce
Q 010309          227 SEGNRLLGDSKTGGTYSGILP--------DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDR  296 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~  296 (513)
                      +...+.||+|+||.||+|...        ++..||||+++... ....+.+.+|+.+++++ +||||+++++++.+.+..
T Consensus        83 ~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~  162 (370)
T 2psq_A           83 LTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPL  162 (370)
T ss_dssp             EEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSC
T ss_pred             CEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCE
Confidence            344567899999999999852        35579999997653 33456799999999999 899999999999999999


Q ss_pred             EEEEeeccCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCC
Q 010309          297 YIVYEFVVNGPLDRWLHHIPR------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE  364 (513)
Q Consensus       297 ~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~  364 (513)
                      |+||||+++|+|.+++.....            ....+++..++.++.||+.||+|||++   +|+||||||+|||++.+
T Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~  239 (370)
T 2psq_A          163 YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTEN  239 (370)
T ss_dssp             EEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTT
T ss_pred             EEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEECCC
Confidence            999999999999999976432            124589999999999999999999999   99999999999999999


Q ss_pred             CCeEEecccccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHH
Q 010309          365 FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFE  443 (513)
Q Consensus       365 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~  443 (513)
                      +.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||+| |..||.......   +..
T Consensus       240 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~---~~~  316 (370)
T 2psq_A          240 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---LFK  316 (370)
T ss_dssp             CCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHH
T ss_pred             CCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH
Confidence            9999999999986654332222222337889999999999999999999999999999999 999997654321   111


Q ss_pred             hhhHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCc
Q 010309          444 WATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  507 (513)
Q Consensus       444 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  507 (513)
                      .    .....             ....+..++.++.+||.+||+.||++|||+.|+++.|+++.
T Consensus       317 ~----~~~~~-------------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il  363 (370)
T 2psq_A          317 L----LKEGH-------------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  363 (370)
T ss_dssp             H----HHTTC-------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             H----HhcCC-------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            1    11000             00112234567999999999999999999999999998764

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.8e-45  Score=361.67  Aligned_cols=256  Identities=23%  Similarity=0.383  Sum_probs=207.6

Q ss_pred             cCCceecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          228 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      ...+.||+|+||.||+|... +++.||+|++........+.+.+|+.++++++||||+++++++.+++..++||||++++
T Consensus        13 ~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~   92 (310)
T 3s95_A           13 IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGG   92 (310)
T ss_dssp             EEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTC
T ss_pred             eccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCC
Confidence            34567899999999999975 58999999997776677788999999999999999999999999999999999999999


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  386 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  386 (513)
                      +|.+++...   ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++...........
T Consensus        93 ~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  166 (310)
T 3s95_A           93 TLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPE  166 (310)
T ss_dssp             BHHHHHHHC---CTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC-------
T ss_pred             cHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccccccc
Confidence            999999752   35699999999999999999999999   999999999999999999999999999987654322111


Q ss_pred             ------------eeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccc
Q 010309          387 ------------TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRY  454 (513)
Q Consensus       387 ------------~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  454 (513)
                                  .....||+.|+|||++.+..++.++||||||+++|||++|..|+............. ..        
T Consensus       167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~-~~--------  237 (310)
T 3s95_A          167 GLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN-VR--------  237 (310)
T ss_dssp             -------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC-HH--------
T ss_pred             ccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh-hh--------
Confidence                        112348999999999999999999999999999999999999987643321110000 00        


Q ss_pred             cccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCc
Q 010309          455 LELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  507 (513)
Q Consensus       455 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  507 (513)
                       ...+...        +..+++.+.+++.+||+.||++|||+.++++.|+.+.
T Consensus       238 -~~~~~~~--------~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~  281 (310)
T 3s95_A          238 -GFLDRYC--------PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR  281 (310)
T ss_dssp             -HHHHHTC--------CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -ccccccC--------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence             0000000        1123345899999999999999999999999998764

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=3.6e-45  Score=361.96  Aligned_cols=243  Identities=20%  Similarity=0.293  Sum_probs=201.0

Q ss_pred             cCCceecccCceEEEEEEe-CCCCEEEEEEecccc--hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeecc
Q 010309          228 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV  304 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  304 (513)
                      ...+.||+|+||.||+|.. .+|+.||||++....  ....+.+.+|+.+|+.++||||+++++++.+.+..++||||++
T Consensus        18 ~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~   97 (328)
T 3fe3_A           18 RLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYAS   97 (328)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred             EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCC
Confidence            3456779999999999997 579999999997652  3345678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccc
Q 010309          305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  384 (513)
Q Consensus       305 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  384 (513)
                      +|+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++.........
T Consensus        98 ~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~  170 (328)
T 3fe3_A           98 GGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL  170 (328)
T ss_dssp             TCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGG
T ss_pred             CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCcc
Confidence            9999999964    24599999999999999999999999   9999999999999999999999999999866433222


Q ss_pred             cceeecCcccccccccccccCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccccccccccc
Q 010309          385 ERTVMAGGTYGYLAPEFVYRNELT-TKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS  463 (513)
Q Consensus       385 ~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  463 (513)
                         ....||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+...   +..   ... ....         
T Consensus       171 ---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~---~i~-~~~~---------  231 (328)
T 3fe3_A          171 ---DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE---LRE---RVL-RGKY---------  231 (328)
T ss_dssp             ---GTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---HHH-HCCC---------
T ss_pred             ---ccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH---HHH---HHH-hCCC---------
Confidence               223499999999999888765 79999999999999999999998754321   111   111 0100         


Q ss_pred             CCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          464 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       464 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                           ..+...++++.+|+.+||+.||.+|||++|+++
T Consensus       232 -----~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          232 -----RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             -----CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             -----CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                 011124567899999999999999999999986

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.9e-45  Score=363.95  Aligned_cols=257  Identities=25%  Similarity=0.411  Sum_probs=206.8

Q ss_pred             cCCceecccCceEEEEEEeC----CCCEEEEEEeccc-chhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEee
Q 010309          228 EGNRLLGDSKTGGTYSGILP----DGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF  302 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  302 (513)
                      ...+.||+|+||.||+|...    .+..||||+++.. .....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        52 ~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  131 (325)
T 3kul_A           52 HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEY  131 (325)
T ss_dssp             EEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEEC
T ss_pred             EEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeC
Confidence            34567899999999999974    3456999999865 334457899999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccc
Q 010309          303 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV  382 (513)
Q Consensus       303 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~  382 (513)
                      +++++|.+++..   ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++.......
T Consensus       132 ~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  205 (325)
T 3kul_A          132 MENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP  205 (325)
T ss_dssp             CTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC---
T ss_pred             CCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccccCc
Confidence            999999999964   235699999999999999999999999   99999999999999999999999999998765432


Q ss_pred             ccc-ceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccccc
Q 010309          383 MQE-RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP  460 (513)
Q Consensus       383 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  460 (513)
                      ... ......+|+.|+|||++.+..++.++||||||+++|||++ |..||........   ..   ......        
T Consensus       206 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~---~~---~~~~~~--------  271 (325)
T 3kul_A          206 DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV---IS---SVEEGY--------  271 (325)
T ss_dssp             -CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH---HH---HHHTTC--------
T ss_pred             cceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHH---HH---HHHcCC--------
Confidence            211 1112226788999999998999999999999999999999 9999976543211   11   100000        


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcCCC
Q 010309          461 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP  510 (513)
Q Consensus       461 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  510 (513)
                            ....+..+++.+.+||.+||+.||++|||+.+|++.|+.+...+
T Consensus       272 ------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~  315 (325)
T 3kul_A          272 ------RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP  315 (325)
T ss_dssp             ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred             ------CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence                  01112234567999999999999999999999999999876543

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.9e-45  Score=354.02  Aligned_cols=253  Identities=24%  Similarity=0.414  Sum_probs=208.9

Q ss_pred             CCceecccCceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCCH
Q 010309          229 GNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  308 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL  308 (513)
                      ..+.||+|+||.||+|...+++.||||++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||+++++|
T Consensus        14 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   92 (269)
T 4hcu_A           14 FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCL   92 (269)
T ss_dssp             EEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBH
T ss_pred             eeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcH
Confidence            345789999999999999889999999998653 3457799999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccccee
Q 010309          309 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  388 (513)
Q Consensus       309 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  388 (513)
                      .+++..   ....+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++............ 
T Consensus        93 ~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~-  165 (269)
T 4hcu_A           93 SDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST-  165 (269)
T ss_dssp             HHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTT-
T ss_pred             HHHHHh---cCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccccccccc-
Confidence            999964   235699999999999999999999999   9999999999999999999999999999876543322221 


Q ss_pred             ecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCC
Q 010309          389 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS  467 (513)
Q Consensus       389 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  467 (513)
                      ...+|+.|+|||++.+..++.++||||||+++|+|++ |..||.......   ...   .....      .        .
T Consensus       166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~---~~~---~~~~~------~--------~  225 (269)
T 4hcu_A          166 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---VVE---DISTG------F--------R  225 (269)
T ss_dssp             STTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHH---HHHTT------C--------C
T ss_pred             CcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH---HHH---HHhcC------c--------c
Confidence            2236788999999998999999999999999999999 999997654321   111   11100      0        0


Q ss_pred             CCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcCC
Q 010309          468 DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP  509 (513)
Q Consensus       468 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  509 (513)
                      ...+...++.+.+++.+||+.||++|||+.++++.|+++.+.
T Consensus       226 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          226 LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence            111122356799999999999999999999999999987653

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.2e-45  Score=364.92  Aligned_cols=271  Identities=21%  Similarity=0.283  Sum_probs=205.3

Q ss_pred             cCCceecccCceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCc----eEEEEeec
Q 010309          228 EGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD----RYIVYEFV  303 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~----~~lv~e~~  303 (513)
                      ...+.||+|+||.||+|.. .++.||||++.... .......+|+.++++++||||+++++++.+...    .++||||+
T Consensus        27 ~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~  104 (322)
T 3soc_A           27 QLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFH  104 (322)
T ss_dssp             EEEEEEECSTTCEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECC
T ss_pred             hhhheecccCceEEEEEEE-CCCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecC
Confidence            3456789999999999998 48999999997653 334556679999999999999999999988554    69999999


Q ss_pred             cCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-------CCCCceEcCCCCCceEecCCCCeEEecccccc
Q 010309          304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK-------VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK  376 (513)
Q Consensus       304 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-------~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~  376 (513)
                      ++|+|.+++..     ..+++..++.++.|++.||+|||+.       +.++|+||||||+|||++.++.+||+|||+++
T Consensus       105 ~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~  179 (322)
T 3soc_A          105 EKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLAL  179 (322)
T ss_dssp             TTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             CCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCccc
Confidence            99999999975     3599999999999999999999975       13389999999999999999999999999998


Q ss_pred             cCCccccccceeecCcccccccccccccC-----CCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhH----
Q 010309          377 FVPWEVMQERTVMAGGTYGYLAPEFVYRN-----ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATP----  447 (513)
Q Consensus       377 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~----  447 (513)
                      ...............||+.|+|||++.+.     .++.++||||||+++|||+||+.||.+...............    
T Consensus       180 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~  259 (322)
T 3soc_A          180 KFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSL  259 (322)
T ss_dssp             EECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCH
T ss_pred             ccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCch
Confidence            76544332222223489999999999763     456688999999999999999999987544322111110000    


Q ss_pred             -HhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcC
Q 010309          448 -LVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  508 (513)
Q Consensus       448 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  508 (513)
                       ............+.+   .........++++.+||.+||+.||++|||+.+|++.|+++.+
T Consensus       260 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~  318 (322)
T 3soc_A          260 EDMQEVVVHKKKRPVL---RDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR  318 (322)
T ss_dssp             HHHHHHHTTSCCCCCC---CGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hhhhhhhhcccCCCCc---cccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence             000000000011111   0111223567789999999999999999999999999988753

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=4.6e-45  Score=351.02  Aligned_cols=254  Identities=26%  Similarity=0.436  Sum_probs=208.9

Q ss_pred             cCCceecccCceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCC
Q 010309          228 EGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  307 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs  307 (513)
                      ...+.||+|+||.||+|...++..||||+++... ...+.+.+|+.++.+++||||+++++++.+.+..++||||+++++
T Consensus        11 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   89 (268)
T 3sxs_A           11 TLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGC   89 (268)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCB
T ss_pred             eeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCc
Confidence            3456789999999999999888899999997653 345779999999999999999999999999999999999999999


Q ss_pred             HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccce
Q 010309          308 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  387 (513)
Q Consensus       308 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  387 (513)
                      |.+++...   ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++........... 
T Consensus        90 L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~-  162 (268)
T 3sxs_A           90 LLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS-  162 (268)
T ss_dssp             HHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEEC-
T ss_pred             HHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhhcc-
Confidence            99999652   24599999999999999999999999   999999999999999999999999999987654432222 


Q ss_pred             eecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCC
Q 010309          388 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  466 (513)
Q Consensus       388 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  466 (513)
                      ....+|+.|+|||++.+..++.++||||||+++|+|+| |..||.........      .......              
T Consensus       163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~------~~~~~~~--------------  222 (268)
T 3sxs_A          163 VGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVV------LKVSQGH--------------  222 (268)
T ss_dssp             CSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH------HHHHTTC--------------
T ss_pred             cCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHH------HHHHcCC--------------
Confidence            12236778999999998889999999999999999999 99999765432111      0100000              


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcCC
Q 010309          467 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP  509 (513)
Q Consensus       467 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  509 (513)
                      ....+...++.+.+++.+||+.||++|||+.++++.|+.+.+.
T Consensus       223 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          223 RLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             CCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             CCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence            0011122345799999999999999999999999999998754

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.1e-45  Score=373.14  Aligned_cols=255  Identities=26%  Similarity=0.371  Sum_probs=206.8

Q ss_pred             cCCceecccCceEEEEEEeC-CCCEEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccC
Q 010309          228 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  305 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  305 (513)
                      ...+.||+|+||.||+|... +++.||||+++... ....+.+.+|+.+|++++||||+++++++.+.+..++||||+++
T Consensus       117 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~  196 (377)
T 3cbl_A          117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQG  196 (377)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred             EEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCC
Confidence            44567899999999999986 68999999997652 23345688999999999999999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccc
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  385 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  385 (513)
                      |+|.+++...   ...+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++.........
T Consensus       197 g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~  270 (377)
T 3cbl_A          197 GDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAA  270 (377)
T ss_dssp             CBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEEC
T ss_pred             CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceee
Confidence            9999999642   24589999999999999999999999   99999999999999999999999999998654332221


Q ss_pred             ceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccccccccC
Q 010309          386 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS  464 (513)
Q Consensus       386 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  464 (513)
                      ......+++.|+|||++.+..++.++||||||+++|||+| |..||..........       ......           
T Consensus       271 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~-------~~~~~~-----------  332 (377)
T 3cbl_A          271 SGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTRE-------FVEKGG-----------  332 (377)
T ss_dssp             CSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHH-------HHHTTC-----------
T ss_pred             cCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-------HHHcCC-----------
Confidence            1111225778999999998899999999999999999998 999998754321111       111110           


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcC
Q 010309          465 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  508 (513)
Q Consensus       465 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  508 (513)
                        ....+..+++++.+||.+||+.||++|||+++|++.|+++..
T Consensus       333 --~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~  374 (377)
T 3cbl_A          333 --RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK  374 (377)
T ss_dssp             --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence              001112245679999999999999999999999999988753

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=2.1e-44  Score=360.74  Aligned_cols=249  Identities=20%  Similarity=0.278  Sum_probs=202.5

Q ss_pred             cccCCceecccCceEEEEEEeC-CCCEEEEEEecccchh------cHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEE
Q 010309          226 FSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQ------RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYI  298 (513)
Q Consensus       226 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l  298 (513)
                      .+...+.||+|+||.||++... +|+.||||+++.....      ..+.+.+|+.+|++++||||+++++++.+.+..++
T Consensus        13 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l   92 (361)
T 2yab_A           13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVL   92 (361)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEE
Confidence            3444567899999999999975 5899999999765322      35789999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCC----CeEEecccc
Q 010309          299 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF----GAHLMGVGL  374 (513)
Q Consensus       299 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~----~~kl~Dfg~  374 (513)
                      ||||+++|+|.+++..    ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++    .+||+|||+
T Consensus        93 v~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~  165 (361)
T 2yab_A           93 ILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGL  165 (361)
T ss_dssp             EEECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred             EEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence            9999999999999954    35699999999999999999999999   999999999999998876    799999999


Q ss_pred             cccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccc
Q 010309          375 SKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRY  454 (513)
Q Consensus       375 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  454 (513)
                      +.........   ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+....   ..   .. .....
T Consensus       166 a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~---~~---~i-~~~~~  235 (361)
T 2yab_A          166 AHEIEDGVEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET---LA---NI-TAVSY  235 (361)
T ss_dssp             CEECCTTCCC---CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---HH---HH-HTTCC
T ss_pred             ceEcCCCCcc---ccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH---HH---HH-HhcCC
Confidence            9876543221   223499999999999998999999999999999999999999987543211   11   00 00000


Q ss_pred             cccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          455 LELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       455 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                       . +.+        ......++.+.+||.+||..||++|||+.|+++
T Consensus       236 -~-~~~--------~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          236 -D-FDE--------EFFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             -C-CCH--------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -C-CCc--------hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence             0 000        001124567999999999999999999999985

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=7.1e-45  Score=376.24  Aligned_cols=254  Identities=25%  Similarity=0.410  Sum_probs=208.7

Q ss_pred             cCCceecccCceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCC
Q 010309          228 EGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  307 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs  307 (513)
                      ...+.||+|+||.||+|.+.++..||||+++... ...+.+.+|+.+|++++||||+++++++. .+..++||||+++|+
T Consensus       191 ~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~  268 (454)
T 1qcf_A          191 KLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGS  268 (454)
T ss_dssp             EEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCB
T ss_pred             EEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCc
Confidence            4456789999999999999888999999998654 45678999999999999999999999986 667899999999999


Q ss_pred             HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccce
Q 010309          308 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  387 (513)
Q Consensus       308 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  387 (513)
                      |.+++...  ....+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++...........
T Consensus       269 L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~  343 (454)
T 1qcf_A          269 LLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE  343 (454)
T ss_dssp             HHHHHHSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTC
T ss_pred             HHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccC
Confidence            99999642  123588999999999999999999999   9999999999999999999999999999876543222211


Q ss_pred             eecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCC
Q 010309          388 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  466 (513)
Q Consensus       388 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  466 (513)
                       ...+|+.|+|||++....++.++||||||+++|||+| |+.||.+.+....   ..   ......              
T Consensus       344 -~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~---~~---~i~~~~--------------  402 (454)
T 1qcf_A          344 -GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV---IR---ALERGY--------------  402 (454)
T ss_dssp             -SSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH---HH---HHHHTC--------------
T ss_pred             -CCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHH---HH---HHHcCC--------------
Confidence             2226789999999998999999999999999999999 9999986543211   11   111100              


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcCC
Q 010309          467 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP  509 (513)
Q Consensus       467 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  509 (513)
                      ....+..+++++.+||.+||+.||++|||+++|++.|+.+...
T Consensus       403 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~  445 (454)
T 1qcf_A          403 RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA  445 (454)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred             CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence            0011223456799999999999999999999999999988653

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.6e-45  Score=359.45  Aligned_cols=275  Identities=21%  Similarity=0.340  Sum_probs=205.4

Q ss_pred             CcccCCceecccCceEEEEEEe-----CCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeC--CceE
Q 010309          225 NFSEGNRLLGDSKTGGTYSGIL-----PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDRY  297 (513)
Q Consensus       225 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~  297 (513)
                      +.++..+.||+|+||.||++++     .+++.||||++........+.+.+|+.++++++||||+++++++...  ...+
T Consensus        10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (295)
T 3ugc_A           10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK   89 (295)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred             HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence            3344556789999999999984     35889999999877666678899999999999999999999998653  5689


Q ss_pred             EEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEeccccccc
Q 010309          298 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF  377 (513)
Q Consensus       298 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~  377 (513)
                      +||||+++++|.+++...   ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++..
T Consensus        90 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~  163 (295)
T 3ugc_A           90 LIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKV  163 (295)
T ss_dssp             EEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred             EEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence            999999999999999752   24599999999999999999999999   999999999999999999999999999987


Q ss_pred             CCccccc-cceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccc
Q 010309          378 VPWEVMQ-ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLE  456 (513)
Q Consensus       378 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  456 (513)
                      ....... .......++..|+|||++.+..++.++||||||+++|||+||..|+.....................   ..
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~---~~  240 (295)
T 3ugc_A          164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV---FH  240 (295)
T ss_dssp             ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHH---HH
T ss_pred             ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhH---HH
Confidence            6543221 1122233778899999999999999999999999999999999998653211000000000000000   00


Q ss_pred             cccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcCC
Q 010309          457 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP  509 (513)
Q Consensus       457 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  509 (513)
                      ...... .......+..+++++.+|+.+||+.||++|||+.||++.|+++...
T Consensus       241 ~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~  292 (295)
T 3ugc_A          241 LIELLK-NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN  292 (295)
T ss_dssp             HHHHHH-TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHHh-ccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence            000000 0001111234567899999999999999999999999999987543

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=6.6e-45  Score=366.69  Aligned_cols=256  Identities=24%  Similarity=0.407  Sum_probs=196.4

Q ss_pred             ccCCceecccCceEEEEEEeC----CCCEEEEEEeccc-chhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEe
Q 010309          227 SEGNRLLGDSKTGGTYSGILP----DGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE  301 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  301 (513)
                      +...++||+|+||.||+|+..    ++..||||+++.. .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        47 ~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  126 (373)
T 2qol_A           47 ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTE  126 (373)
T ss_dssp             CCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             ceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEe
Confidence            345678899999999999864    5778999999765 33445689999999999999999999999999999999999


Q ss_pred             eccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcc
Q 010309          302 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE  381 (513)
Q Consensus       302 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~  381 (513)
                      |+++|+|.+++..   ....+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus       127 ~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  200 (373)
T 2qol_A          127 YMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD  200 (373)
T ss_dssp             CCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             CCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence            9999999999974   235699999999999999999999999   9999999999999999999999999999876543


Q ss_pred             cccc-ceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhccccccccc
Q 010309          382 VMQE-RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD  459 (513)
Q Consensus       382 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  459 (513)
                      .... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||.......   +...    .....      
T Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~---~~~~----i~~~~------  267 (373)
T 2qol_A          201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD---VIKA----VDEGY------  267 (373)
T ss_dssp             -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH---HHHH----HHTTE------
T ss_pred             CccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH----HHcCC------
Confidence            2211 1111225778999999999999999999999999999998 999997654321   1111    11000      


Q ss_pred             ccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcC
Q 010309          460 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  508 (513)
Q Consensus       460 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  508 (513)
                             ....+..++..+.+|+.+||+.||++||++.+|++.|+++..
T Consensus       268 -------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~  309 (373)
T 2qol_A          268 -------RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR  309 (373)
T ss_dssp             -------ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -------CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence                   001112345679999999999999999999999999987643

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=5e-44  Score=354.79  Aligned_cols=243  Identities=23%  Similarity=0.264  Sum_probs=200.8

Q ss_pred             CCceecccCceEEEEEEeC-CCCEEEEEEecccc---hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeecc
Q 010309          229 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV  304 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  304 (513)
                      ..+.||+|+||.||++... +|+.||||++++..   ......+.+|+.+|+.++||||+++++++.+.+..++||||++
T Consensus         9 ~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~   88 (337)
T 1o6l_A            9 YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYAN   88 (337)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             EEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCC
Confidence            3467899999999999975 59999999997642   2345678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccc
Q 010309          305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  384 (513)
Q Consensus       305 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  384 (513)
                      +|+|..++..    ...+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++........
T Consensus        89 gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~  161 (337)
T 1o6l_A           89 GGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT  161 (337)
T ss_dssp             TCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred             CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCc
Confidence            9999999864    24689999999999999999999999   9999999999999999999999999999864332211


Q ss_pred             cceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccC
Q 010309          385 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS  464 (513)
Q Consensus       385 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  464 (513)
                        .....||+.|+|||++.+..++.++||||||+++|||++|..||...+...   +..   .... ..           
T Consensus       162 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~~---~i~~-~~-----------  221 (337)
T 1o6l_A          162 --MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---LFE---LILM-EE-----------  221 (337)
T ss_dssp             --BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---HHHH-CC-----------
T ss_pred             --ccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH---HHH---HHHc-CC-----------
Confidence              122348999999999999999999999999999999999999997654321   111   1110 00           


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 010309          465 LSSDIPEAGVVQKVVDLVYACTQHVPSMRP-----RMSHVVH  501 (513)
Q Consensus       465 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  501 (513)
                         ...+...++++.+||.+||+.||++||     +++||++
T Consensus       222 ---~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          222 ---IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             ---CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ---CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence               001123456799999999999999999     8999875

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=9.6e-45  Score=356.93  Aligned_cols=259  Identities=24%  Similarity=0.390  Sum_probs=209.7

Q ss_pred             ccCCceecccCceEEEEEEe------CCCCEEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEE
Q 010309          227 SEGNRLLGDSKTGGTYSGIL------PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIV  299 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv  299 (513)
                      +...+.||+|+||.||+|..      .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        25 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  104 (314)
T 2ivs_A           25 LVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLI  104 (314)
T ss_dssp             EEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             eeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEE
Confidence            34456789999999999986      245789999997653 34457789999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCce
Q 010309          300 YEFVVNGPLDRWLHHIPR--------------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNV  359 (513)
Q Consensus       300 ~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NI  359 (513)
                      |||+++++|.+++.....                    ....+++..++.++.||+.||.|||++   +|+||||||+||
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp~NI  181 (314)
T 2ivs_A          105 VEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNI  181 (314)
T ss_dssp             EECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred             EeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccchheE
Confidence            999999999999976432                    123489999999999999999999999   999999999999


Q ss_pred             EecCCCCeEEecccccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccc
Q 010309          360 LLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCW  438 (513)
Q Consensus       360 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~  438 (513)
                      |++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|||++ |..||........
T Consensus       182 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~  261 (314)
T 2ivs_A          182 LVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERL  261 (314)
T ss_dssp             EEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred             EEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            999999999999999987654433222223337889999999998889999999999999999999 9999977554321


Q ss_pred             chhHHhhhHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcC
Q 010309          439 QSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  508 (513)
Q Consensus       439 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  508 (513)
                      ...       .....             ....+...++.+.+++.+||+.||++|||+.+|++.|+++..
T Consensus       262 ~~~-------~~~~~-------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  311 (314)
T 2ivs_A          262 FNL-------LKTGH-------------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV  311 (314)
T ss_dssp             HHH-------HHTTC-------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHH-------hhcCC-------------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            111       11100             001112345679999999999999999999999999998754

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-44  Score=360.69  Aligned_cols=261  Identities=25%  Similarity=0.408  Sum_probs=209.2

Q ss_pred             ccCCceecccCceEEEEEEeC------CCCEEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEE
Q 010309          227 SEGNRLLGDSKTGGTYSGILP------DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIV  299 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv  299 (513)
                      +...+.||+|+||.||+|...      +++.||||+++... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        49 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  128 (343)
T 1luf_A           49 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLL  128 (343)
T ss_dssp             CEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             CeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEE
Confidence            344567899999999999974      34789999998653 33457799999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCce
Q 010309          300 YEFVVNGPLDRWLHHIPRG--------------------GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNV  359 (513)
Q Consensus       300 ~e~~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NI  359 (513)
                      |||+++++|.+++......                    ...+++..++.++.||+.||.|||++   +|+||||||+||
T Consensus       129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NI  205 (343)
T 1luf_A          129 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNC  205 (343)
T ss_dssp             EECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred             EecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceE
Confidence            9999999999999763211                    25699999999999999999999999   999999999999


Q ss_pred             EecCCCCeEEecccccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccc
Q 010309          360 LLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCW  438 (513)
Q Consensus       360 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~  438 (513)
                      |++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|||+| |..||....... 
T Consensus       206 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-  284 (343)
T 1luf_A          206 LVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE-  284 (343)
T ss_dssp             EECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-
T ss_pred             EECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHH-
Confidence            999999999999999986644332222223347899999999999999999999999999999999 999997654321 


Q ss_pred             chhHHhhhHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcCCC
Q 010309          439 QSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP  510 (513)
Q Consensus       439 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  510 (513)
                        ...    ........             ..+..+++.+.+|+.+||+.||++|||+.+|++.|+++.+..
T Consensus       285 --~~~----~~~~~~~~-------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~  337 (343)
T 1luf_A          285 --VIY----YVRDGNIL-------------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA  337 (343)
T ss_dssp             --HHH----HHHTTCCC-------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred             --HHH----HHhCCCcC-------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence              111    11111100             011234567999999999999999999999999999987653

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2e-44  Score=364.74  Aligned_cols=258  Identities=26%  Similarity=0.402  Sum_probs=208.7

Q ss_pred             ccCCceecccCceEEEEEEeC--------CCCEEEEEEecccc-hhcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCCce
Q 010309          227 SEGNRLLGDSKTGGTYSGILP--------DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDR  296 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~  296 (513)
                      +...+.||+|+||.||+|...        .+..||||+++... ......+.+|+++++++ +||||+++++++.+.+..
T Consensus        71 y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~  150 (382)
T 3tt0_A           71 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPL  150 (382)
T ss_dssp             EEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             eEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCce
Confidence            344567899999999999852        24579999997653 33457789999999999 999999999999999999


Q ss_pred             EEEEeeccCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCC
Q 010309          297 YIVYEFVVNGPLDRWLHHIPR------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE  364 (513)
Q Consensus       297 ~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~  364 (513)
                      ++||||+++|+|.+++.....            ....+++..++.++.||+.||+|||+.   +|+||||||+|||++.+
T Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~  227 (382)
T 3tt0_A          151 YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTED  227 (382)
T ss_dssp             EEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTT
T ss_pred             EEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEEcCC
Confidence            999999999999999976431            124599999999999999999999999   99999999999999999


Q ss_pred             CCeEEecccccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHH
Q 010309          365 FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFE  443 (513)
Q Consensus       365 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~  443 (513)
                      +.+||+|||++................+|+.|+|||++.+..++.++||||||+++|||++ |..||...+...   +..
T Consensus       228 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~---~~~  304 (382)
T 3tt0_A          228 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---LFK  304 (382)
T ss_dssp             CCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HHH
T ss_pred             CcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH
Confidence            9999999999987654332222223337889999999999999999999999999999999 999997654321   111


Q ss_pred             hhhHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCc
Q 010309          444 WATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  507 (513)
Q Consensus       444 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  507 (513)
                          ......             ....+..+++++.+|+.+||+.||++|||+++|++.|+++.
T Consensus       305 ----~~~~~~-------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  351 (382)
T 3tt0_A          305 ----LLKEGH-------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  351 (382)
T ss_dssp             ----HHHTTC-------------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----HHHcCC-------------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                111110             00011234567999999999999999999999999998764

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.8e-45  Score=362.95  Aligned_cols=261  Identities=25%  Similarity=0.346  Sum_probs=205.3

Q ss_pred             ccCCceecccCceEEEEEEe------CCCCEEEEEEecccc-hhcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCCceEE
Q 010309          227 SEGNRLLGDSKTGGTYSGIL------PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYI  298 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~l  298 (513)
                      +...+.||+|+||.||+|..      .++..||||++.... ....+.+.+|+.++.++ +||||+++++++...+..++
T Consensus        47 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l  126 (344)
T 1rjb_A           47 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYL  126 (344)
T ss_dssp             EEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             ceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEE
Confidence            34456789999999999996      245689999997542 23457899999999999 89999999999999999999


Q ss_pred             EEeeccCCCHHHHhccCCCC-------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCce
Q 010309          299 VYEFVVNGPLDRWLHHIPRG-------------------GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNV  359 (513)
Q Consensus       299 v~e~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NI  359 (513)
                      ||||+++|+|.+++......                   ...+++..++.++.||+.||.|||+.   +|+||||||+||
T Consensus       127 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NI  203 (344)
T 1rjb_A          127 IFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNV  203 (344)
T ss_dssp             EEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGGE
T ss_pred             EEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhE
Confidence            99999999999999753211                   13489999999999999999999999   999999999999


Q ss_pred             EecCCCCeEEecccccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccc
Q 010309          360 LLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCW  438 (513)
Q Consensus       360 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~  438 (513)
                      |++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|||+| |..||....... 
T Consensus       204 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-  282 (344)
T 1rjb_A          204 LVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA-  282 (344)
T ss_dssp             EEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-
T ss_pred             EEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHH-
Confidence            999999999999999987644332222222337889999999999999999999999999999998 999997754321 


Q ss_pred             chhHHhhhHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcCC
Q 010309          439 QSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP  509 (513)
Q Consensus       439 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  509 (513)
                       ...    ......     .        ....+...++++.+|+.+||+.||.+|||+.+|++.|+.+...
T Consensus       283 -~~~----~~~~~~-----~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  335 (344)
T 1rjb_A          283 -NFY----KLIQNG-----F--------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD  335 (344)
T ss_dssp             -HHH----HHHHTT-----C--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             -HHH----HHHhcC-----C--------CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence             111    111110     0        0011122456799999999999999999999999999887654

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=3e-45  Score=368.60  Aligned_cols=259  Identities=28%  Similarity=0.371  Sum_probs=206.4

Q ss_pred             ccCCceecccCceEEEEEEeC------CCCEEEEEEeccc-chhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEE
Q 010309          227 SEGNRLLGDSKTGGTYSGILP------DGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIV  299 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv  299 (513)
                      +...+.||+|+||.||+|...      +++.||||+++.. .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus        73 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  152 (367)
T 3l9p_A           73 ITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFIL  152 (367)
T ss_dssp             EEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             eEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEE
Confidence            344567899999999999953      4668999999754 334456789999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCC---CeEEeccc
Q 010309          300 YEFVVNGPLDRWLHHIPR---GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF---GAHLMGVG  373 (513)
Q Consensus       300 ~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~---~~kl~Dfg  373 (513)
                      |||+++|+|.+++.....   ....+++..++.++.||+.||+|||++   +|+||||||+|||++.++   .+||+|||
T Consensus       153 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~DFG  229 (367)
T 3l9p_A          153 LELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFG  229 (367)
T ss_dssp             EECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECCCH
T ss_pred             EEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEECCCc
Confidence            999999999999975432   224599999999999999999999999   999999999999999554   49999999


Q ss_pred             ccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcc
Q 010309          374 LSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSH  452 (513)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  452 (513)
                      +++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||.......   +...    ....
T Consensus       230 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~---~~~~----i~~~  302 (367)
T 3l9p_A          230 MARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---VLEF----VTSG  302 (367)
T ss_dssp             HHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HHHH----HHTT
T ss_pred             cccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH----HHcC
Confidence            9975433222222223347899999999999999999999999999999998 999997654321   1111    1110


Q ss_pred             cccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcC
Q 010309          453 RYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  508 (513)
Q Consensus       453 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  508 (513)
                      .             ....+..++..+.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus       303 ~-------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~  345 (367)
T 3l9p_A          303 G-------------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  345 (367)
T ss_dssp             C-------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             C-------------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence            0             011122345679999999999999999999999999976643

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=7.8e-44  Score=347.34  Aligned_cols=259  Identities=20%  Similarity=0.319  Sum_probs=204.3

Q ss_pred             ccCCceecccCceEEEEEEeC-CCCEEEEEEecccc---hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEee
Q 010309          227 SEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF  302 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  302 (513)
                      +...+.||+|+||.||++... +++.||||++....   ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        13 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   92 (294)
T 4eqm_A           13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEY   92 (294)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEEC
T ss_pred             EEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeC
Confidence            344567899999999999964 68999999986542   23346789999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccc
Q 010309          303 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV  382 (513)
Q Consensus       303 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~  382 (513)
                      +++++|.+++..    ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++.......
T Consensus        93 ~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  165 (294)
T 4eqm_A           93 IEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS  165 (294)
T ss_dssp             CCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred             CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence            999999999965    24699999999999999999999999   99999999999999999999999999998765432


Q ss_pred             cccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccc
Q 010309          383 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI  462 (513)
Q Consensus       383 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  462 (513)
                      .... ....||+.|+|||++.+..++.++||||||+++|+|+||+.||.......      ........     ......
T Consensus       166 ~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~------~~~~~~~~-----~~~~~~  233 (294)
T 4eqm_A          166 LTQT-NHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS------IAIKHIQD-----SVPNVT  233 (294)
T ss_dssp             ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH------HHHHHHSS-----CCCCHH
T ss_pred             cccc-CccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhhc-----cCCCcc
Confidence            2221 22338999999999999999999999999999999999999998754321      00011100     000000


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHhcCcCC
Q 010309          463 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP-RMSHVVHQLQQLAQP  509 (513)
Q Consensus       463 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~~~  509 (513)
                      ...     ....++.+.++|.+||+.||++|| +++++.+.|+.+...
T Consensus       234 ~~~-----~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~  276 (294)
T 4eqm_A          234 TDV-----RKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE  276 (294)
T ss_dssp             HHS-----CTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred             hhc-----ccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence            000     112456799999999999999998 999999999887654

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2.2e-44  Score=349.10  Aligned_cols=252  Identities=23%  Similarity=0.376  Sum_probs=204.9

Q ss_pred             cCCceecccCceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCC
Q 010309          228 EGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  307 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs  307 (513)
                      ...+.||+|+||.||++...++..||||+++... ...+++.+|+.++.+++||||+++++++.+.+..++||||+++++
T Consensus        27 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~  105 (283)
T 3gen_A           27 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGC  105 (283)
T ss_dssp             EEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCB
T ss_pred             HhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCc
Confidence            3346789999999999999888899999998653 345779999999999999999999999999999999999999999


Q ss_pred             HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccce
Q 010309          308 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  387 (513)
Q Consensus       308 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  387 (513)
                      |.+++...   ...+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++............
T Consensus       106 L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~  179 (283)
T 3gen_A          106 LLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV  179 (283)
T ss_dssp             HHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTT
T ss_pred             HHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccccccccc
Confidence            99999642   34699999999999999999999999   9999999999999999999999999999876543322221


Q ss_pred             eecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCC
Q 010309          388 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  466 (513)
Q Consensus       388 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  466 (513)
                       ...+|+.|+|||++.+..++.++||||||+++|+|+| |+.||.........      ......      .        
T Consensus       180 -~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~------~~~~~~------~--------  238 (283)
T 3gen_A          180 -GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA------EHIAQG------L--------  238 (283)
T ss_dssp             -STTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH------HHHHTT------C--------
T ss_pred             -CCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHH------HHHhcc------c--------
Confidence             2226788999999998999999999999999999998 99999865532111      111100      0        


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCc
Q 010309          467 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  507 (513)
Q Consensus       467 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  507 (513)
                      ....+...++.+.+++.+||+.||++|||++++++.|+++.
T Consensus       239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~  279 (283)
T 3gen_A          239 RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM  279 (283)
T ss_dssp             CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence            00111223457999999999999999999999999998764

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.5e-44  Score=361.33  Aligned_cols=253  Identities=22%  Similarity=0.294  Sum_probs=202.3

Q ss_pred             cccCCceecccCceEEEEEEeC-CCCEEEEEEecccc-----hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEE
Q 010309          226 FSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-----FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIV  299 (513)
Q Consensus       226 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv  299 (513)
                      .++..+.||+|+||.||++... +|+.||||++....     ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        25 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  104 (351)
T 3c0i_A           25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMV  104 (351)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            3455667899999999999974 68999999996432     12457899999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCC---eEEecccccc
Q 010309          300 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG---AHLMGVGLSK  376 (513)
Q Consensus       300 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~---~kl~Dfg~~~  376 (513)
                      |||+++++|.+++.........+++..+..++.||+.||+|||++   +|+||||||+|||++.++.   +||+|||++.
T Consensus       105 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~  181 (351)
T 3c0i_A          105 FEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAI  181 (351)
T ss_dssp             EECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred             EeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCccee
Confidence            999999999988865433345689999999999999999999999   9999999999999987655   9999999998


Q ss_pred             cCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccc
Q 010309          377 FVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLE  456 (513)
Q Consensus       377 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  456 (513)
                      ........  .....||+.|+|||++.+..++.++|||||||++|+|++|..||......    +...   ... .... 
T Consensus       182 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~---i~~-~~~~-  250 (351)
T 3c0i_A          182 QLGESGLV--AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER----LFEG---IIK-GKYK-  250 (351)
T ss_dssp             ECCTTSCB--CCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH----HHHH---HHH-TCCC-
T ss_pred             EecCCCee--ecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH----HHHH---HHc-CCCC-
Confidence            76543221  12234899999999999999999999999999999999999999764321    1110   000 0000 


Q ss_pred             cccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          457 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       457 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                       ..+.        .....++++.+||.+||+.||++|||+.++++
T Consensus       251 -~~~~--------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          251 -MNPR--------QWSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             -CCHH--------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -CCcc--------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence             0000        00123567999999999999999999999985

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=6.3e-45  Score=365.29  Aligned_cols=261  Identities=26%  Similarity=0.361  Sum_probs=206.5

Q ss_pred             cccCCceecccCceEEEEEEe------CCCCEEEEEEecccc-hhcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCCc-e
Q 010309          226 FSEGNRLLGDSKTGGTYSGIL------PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGD-R  296 (513)
Q Consensus       226 ~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~-~  296 (513)
                      .+...+.||+|+||.||+|.+      .+++.||||+++... ....+.+.+|+.++.++ +||||+++++++.+.+. .
T Consensus        23 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~  102 (359)
T 3vhe_A           23 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL  102 (359)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCC
T ss_pred             ceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCce
Confidence            344466789999999999984      246799999997653 23456799999999999 89999999999987654 8


Q ss_pred             EEEEeeccCCCHHHHhccCCCC----------------------------------------------------------
Q 010309          297 YIVYEFVVNGPLDRWLHHIPRG----------------------------------------------------------  318 (513)
Q Consensus       297 ~lv~e~~~~gsL~~~l~~~~~~----------------------------------------------------------  318 (513)
                      ++||||+++|+|.+++......                                                          
T Consensus       103 ~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  182 (359)
T 3vhe_A          103 MVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAP  182 (359)
T ss_dssp             EEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------------------
T ss_pred             EEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccc
Confidence            9999999999999999754321                                                          


Q ss_pred             ----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccceeecCccc
Q 010309          319 ----GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY  394 (513)
Q Consensus       319 ----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~  394 (513)
                          ...+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++................+|+
T Consensus       183 ~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~  259 (359)
T 3vhe_A          183 EDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL  259 (359)
T ss_dssp             -CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECG
T ss_pred             cchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCc
Confidence                12289999999999999999999999   99999999999999999999999999998764433222222334889


Q ss_pred             ccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCCCCCcHH
Q 010309          395 GYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAG  473 (513)
Q Consensus       395 ~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  473 (513)
                      .|+|||++.+..++.++||||||+++|||+| |..||.......  ....    ......             ....+..
T Consensus       260 ~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~----~~~~~~-------------~~~~~~~  320 (359)
T 3vhe_A          260 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCR----RLKEGT-------------RMRAPDY  320 (359)
T ss_dssp             GGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--HHHH----HHHHTC-------------CCCCCTT
T ss_pred             eeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH--HHHH----HHHcCC-------------CCCCCCC
Confidence            9999999999999999999999999999998 999997654321  1111    111110             0011122


Q ss_pred             HHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcC
Q 010309          474 VVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  508 (513)
Q Consensus       474 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  508 (513)
                      .++++.+++.+||+.||++|||+.+|++.|+++.+
T Consensus       321 ~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  355 (359)
T 3vhe_A          321 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  355 (359)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence            44679999999999999999999999999987653

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2e-44  Score=356.18  Aligned_cols=248  Identities=22%  Similarity=0.315  Sum_probs=199.2

Q ss_pred             CCceecccCceEEEEEEeC-CCCEEEEEEecccch-hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          229 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      ..+.||+|+||.||+|... +++.||||++..... ...+.+.+|+.+++.++||||+++++++.+.+..++||||++++
T Consensus        11 i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~   90 (323)
T 3tki_A           11 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGG   90 (323)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred             eeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCC
Confidence            3457799999999999975 689999999975432 23467889999999999999999999999999999999999999


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  386 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  386 (513)
                      +|.+++..    ...+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++...........
T Consensus        91 ~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  163 (323)
T 3tki_A           91 ELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL  163 (323)
T ss_dssp             EGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred             cHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCcccc
Confidence            99999853    35699999999999999999999999   999999999999999999999999999986643332222


Q ss_pred             eeecCcccccccccccccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCC
Q 010309          387 TVMAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  465 (513)
Q Consensus       387 ~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  465 (513)
                      .....||+.|+|||++.+..+ +.++||||||+++|+|++|..||........ ....+.    ...   .         
T Consensus       164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~----~~~---~---------  226 (323)
T 3tki_A          164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWK----EKK---T---------  226 (323)
T ss_dssp             BCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HHHHHH----TTC---T---------
T ss_pred             cCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHHh----ccc---c---------
Confidence            223458999999999987765 7799999999999999999999976543211 111100    000   0         


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          466 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       466 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                       ...+....++.+.+|+.+||+.||++|||++|+++
T Consensus       227 -~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~  261 (323)
T 3tki_A          227 -YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (323)
T ss_dssp             -TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -cCCccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence             11112334567899999999999999999999986

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=2.6e-44  Score=346.23  Aligned_cols=247  Identities=27%  Similarity=0.480  Sum_probs=192.4

Q ss_pred             cCCceecccCceEEEEEEeCCCCEEEEEEecccch----hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeec
Q 010309          228 EGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSF----QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  303 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  303 (513)
                      ...+.||+|+||.||+|.. .++.||||+++....    ...+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus        10 ~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   88 (271)
T 3dtc_A           10 TLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFA   88 (271)
T ss_dssp             EEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECC
T ss_pred             eeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcC
Confidence            3456789999999999998 589999999875432    23467899999999999999999999999999999999999


Q ss_pred             cCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC---ceEcCCCCCceEecC--------CCCeEEecc
Q 010309          304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH---VVHRDIRASNVLLDE--------EFGAHLMGV  372 (513)
Q Consensus       304 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~---ivH~Dikp~NIll~~--------~~~~kl~Df  372 (513)
                      ++++|.+++..     ..+++..++.++.|++.||.|||++   +   |+||||||+|||++.        ++.+||+||
T Consensus        89 ~~~~L~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~---~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           89 RGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHDE---AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             TTEEHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHHS---SSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             CCCCHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            99999999853     4699999999999999999999999   7   999999999999986        677999999


Q ss_pred             cccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcc
Q 010309          373 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSH  452 (513)
Q Consensus       373 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  452 (513)
                      |++.........    ...||+.|+|||++.+..++.++||||||+++|+|++|+.||...+....      ...... .
T Consensus       161 g~~~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------~~~~~~-~  229 (271)
T 3dtc_A          161 GLAREWHRTTKM----SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV------AYGVAM-N  229 (271)
T ss_dssp             CC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH------HHHHHT-S
T ss_pred             Cccccccccccc----CCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHhhhc-C
Confidence            999865433221    22389999999999999999999999999999999999999986543210      000000 0


Q ss_pred             cccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q 010309          453 RYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  506 (513)
Q Consensus       453 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  506 (513)
                      ..            ....+...++.+.+++.+||+.||++|||+.|+++.|+++
T Consensus       230 ~~------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          230 KL------------ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             CC------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             CC------------CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            00            0111223456799999999999999999999999999864

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=5.1e-44  Score=351.49  Aligned_cols=263  Identities=20%  Similarity=0.269  Sum_probs=197.6

Q ss_pred             CCceecccCceEEEEEEeCCCCEEEEEEecccch--hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          229 GNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      ..+.||+|+||.||+|...+|+.||||++.....  .....+.+|+.++++++||||+++++++.+.+..++||||++ +
T Consensus        25 ~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~  103 (311)
T 3niz_A           25 KLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME-K  103 (311)
T ss_dssp             EEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCS-E
T ss_pred             hhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCC-C
Confidence            3456799999999999998899999999975432  224678899999999999999999999999999999999997 4


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  386 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  386 (513)
                      +|.+++..   ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++.......... 
T Consensus       104 ~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~-  176 (311)
T 3niz_A          104 DLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY-  176 (311)
T ss_dssp             EHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---
T ss_pred             CHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCcccc-
Confidence            88887764   235699999999999999999999999   99999999999999999999999999998764332211 


Q ss_pred             eeecCccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccccc------cc
Q 010309          387 TVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLEL------LD  459 (513)
Q Consensus       387 ~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~  459 (513)
                       ....+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||...........................      ..
T Consensus       177 -~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  255 (311)
T 3niz_A          177 -THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ  255 (311)
T ss_dssp             --CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHS
T ss_pred             -cCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhh
Confidence             12238999999999876 56899999999999999999999999876543221111000000000000000      00


Q ss_pred             ccccCCCCCCC----cHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          460 PLISSLSSDIP----EAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       460 ~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      .... .....+    ....++++.+||.+||+.||++|||++|+++
T Consensus       256 ~~~~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          256 RTFQ-VFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             CCCC-CCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             cccc-cccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            0000 000000    1123467899999999999999999999987

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-44  Score=353.92  Aligned_cols=246  Identities=17%  Similarity=0.207  Sum_probs=200.9

Q ss_pred             CCceecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCC
Q 010309          229 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  307 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs  307 (513)
                      ..+.||+|+||.||++... +++.||+|.+.... .....+.+|+.+++.++||||+++++++.+.+..++||||+++++
T Consensus         9 ~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~   87 (321)
T 1tki_A            9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLD   87 (321)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCB
T ss_pred             eeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCC
Confidence            3456799999999999975 58899999997553 445678999999999999999999999999999999999999999


Q ss_pred             HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecC--CCCeEEecccccccCCcccccc
Q 010309          308 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE--EFGAHLMGVGLSKFVPWEVMQE  385 (513)
Q Consensus       308 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~--~~~~kl~Dfg~~~~~~~~~~~~  385 (513)
                      |.+++..   ....+++..+..++.||+.||.|||+.   +|+||||||+|||++.  ++.+||+|||++......... 
T Consensus        88 L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~-  160 (321)
T 1tki_A           88 IFERINT---SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF-  160 (321)
T ss_dssp             HHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE-
T ss_pred             HHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCcc-
Confidence            9999964   234699999999999999999999999   9999999999999987  789999999999876543322 


Q ss_pred             ceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCC
Q 010309          386 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  465 (513)
Q Consensus       386 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  465 (513)
                        ....||+.|+|||++.+..++.++||||||+++|+|++|..||.......   ...   .... ... . .       
T Consensus       161 --~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~---~i~~-~~~-~-~-------  222 (321)
T 1tki_A          161 --RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ---IIE---NIMN-AEY-T-F-------  222 (321)
T ss_dssp             --EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHH---HHHH-TCC-C-C-------
T ss_pred             --ccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH---HHH---HHHc-CCC-C-C-------
Confidence              22338999999999998888999999999999999999999997654321   111   1111 000 0 0       


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          466 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       466 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                       ........++++.+|+.+||+.||.+|||+.|+++
T Consensus       223 -~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          223 -DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             -CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -ChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence             00001124567999999999999999999999997

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.6e-44  Score=356.99  Aligned_cols=260  Identities=23%  Similarity=0.374  Sum_probs=194.8

Q ss_pred             ccCCceecccCceEEEEEEeCC-C---CEEEEEEeccc--chhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCce----
Q 010309          227 SEGNRLLGDSKTGGTYSGILPD-G---SRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR----  296 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~----  296 (513)
                      +...+.||+|+||.||+|.... +   ..||||+++..  .....+.+.+|+.++++++||||+++++++......    
T Consensus        25 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  104 (323)
T 3qup_A           25 FTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLP  104 (323)
T ss_dssp             CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------
T ss_pred             eEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCC
Confidence            3445678999999999999654 2   28999999765  334457899999999999999999999999887655    


Q ss_pred             --EEEEeeccCCCHHHHhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecc
Q 010309          297 --YIVYEFVVNGPLDRWLHHIP--RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV  372 (513)
Q Consensus       297 --~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df  372 (513)
                        ++||||+++|+|.+++....  .....+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+||
T Consensus       105 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~kl~Df  181 (323)
T 3qup_A          105 IPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADF  181 (323)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCC
T ss_pred             ccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEEEeec
Confidence              99999999999999986432  2223699999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhc
Q 010309          373 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQS  451 (513)
Q Consensus       373 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  451 (513)
                      |++................+++.|+|||++.+..++.++||||||+++|||++ |..||...........      ....
T Consensus       182 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~------~~~~  255 (323)
T 3qup_A          182 GLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNY------LIGG  255 (323)
T ss_dssp             CC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH------HHTT
T ss_pred             cccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHH------HhcC
Confidence            99987654433222223337889999999999999999999999999999999 9999987554321111      0000


Q ss_pred             ccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcCC
Q 010309          452 HRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP  509 (513)
Q Consensus       452 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  509 (513)
                      .              ....+...++++.+|+.+||+.||++|||+.++++.|+++...
T Consensus       256 ~--------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~  299 (323)
T 3qup_A          256 N--------------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH  299 (323)
T ss_dssp             C--------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             C--------------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            0              0011123456799999999999999999999999999877544

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2.7e-44  Score=375.50  Aligned_cols=255  Identities=29%  Similarity=0.466  Sum_probs=210.3

Q ss_pred             cCCceecccCceEEEEEEeCC-CCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          228 EGNRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      ...+.||+|+||.||+|.+.. +..||||+++... ...+.+.+|+.+|++++||||+++++++.+.+..++||||+++|
T Consensus       223 ~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g  301 (495)
T 1opk_A          223 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG  301 (495)
T ss_dssp             EEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred             eeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCC
Confidence            345678999999999999865 8899999997653 35678999999999999999999999999999999999999999


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  386 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  386 (513)
                      +|.+++...  ....+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++..........
T Consensus       302 ~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~  376 (495)
T 1opk_A          302 NLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH  376 (495)
T ss_dssp             BHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECC
T ss_pred             CHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCceeec
Confidence            999999753  235689999999999999999999999   999999999999999999999999999987654322211


Q ss_pred             eeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccccccccCC
Q 010309          387 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  465 (513)
Q Consensus       387 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  465 (513)
                       ....+++.|+|||++.+..++.++||||||+++|||+| |..||...+...   +...    .....            
T Consensus       377 -~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~---~~~~----~~~~~------------  436 (495)
T 1opk_A          377 -AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYEL----LEKDY------------  436 (495)
T ss_dssp             -TTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHH----HHTTC------------
T ss_pred             -CCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH---HHHH----HHcCC------------
Confidence             11226789999999998999999999999999999999 999998765322   1111    11000            


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcCC
Q 010309          466 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP  509 (513)
Q Consensus       466 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  509 (513)
                       ....+..+++.+.+||.+||+.||++|||+.+|++.|+.+...
T Consensus       437 -~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~  479 (495)
T 1opk_A          437 -RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  479 (495)
T ss_dssp             -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred             -CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence             0011223456799999999999999999999999999988654

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.6e-44  Score=354.17  Aligned_cols=248  Identities=19%  Similarity=0.281  Sum_probs=201.7

Q ss_pred             ccCCceecccCceEEEEEEeC-CCCEEEEEEecccchh------cHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEE
Q 010309          227 SEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQ------RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIV  299 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv  299 (513)
                      +...+.||+|+||.||++... +|+.||||++......      ..+.+.+|+.+|++++||||+++++++.+.+..++|
T Consensus        13 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   92 (326)
T 2y0a_A           13 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILI   92 (326)
T ss_dssp             EEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            344567899999999999975 5899999999764321      357899999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCC----CeEEeccccc
Q 010309          300 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF----GAHLMGVGLS  375 (513)
Q Consensus       300 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~----~~kl~Dfg~~  375 (513)
                      |||+++++|.+++..    ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++    .+||+|||++
T Consensus        93 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a  165 (326)
T 2y0a_A           93 LELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  165 (326)
T ss_dssp             EECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence            999999999999954    35699999999999999999999999   999999999999998887    7999999999


Q ss_pred             ccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccc
Q 010309          376 KFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL  455 (513)
Q Consensus       376 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  455 (513)
                      .........   ....||+.|+|||++.+..++.++||||||+++|+|++|..||........   ..   .... ... 
T Consensus       166 ~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~---~~~~-~~~-  234 (326)
T 2y0a_A          166 HKIDFGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET---LA---NVSA-VNY-  234 (326)
T ss_dssp             EECCTTSCC---CCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---HH---HHHH-TCC-
T ss_pred             eECCCCCcc---ccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH---HH---HHHh-cCC-
Confidence            876533221   123489999999999989999999999999999999999999976543211   11   0000 000 


Q ss_pred             ccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          456 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       456 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      .....         .....++.+.+||.+||+.||++|||++++++
T Consensus       235 ~~~~~---------~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          235 EFEDE---------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             CCCHH---------HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CcCcc---------ccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            00000         01123467899999999999999999999986

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.6e-44  Score=357.61  Aligned_cols=254  Identities=22%  Similarity=0.367  Sum_probs=198.7

Q ss_pred             cCCceecccCceEEEEEEeC-CCC----EEEEEEeccc-chhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEe
Q 010309          228 EGNRLLGDSKTGGTYSGILP-DGS----RVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE  301 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  301 (513)
                      ...+.||+|+||.||+|.+. +++    +||+|.+... .....+.+.+|+.++++++||||+++++++.+. ..++|+|
T Consensus        18 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~v~e   96 (327)
T 3poz_A           18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQ   96 (327)
T ss_dssp             EEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEEEEEE
T ss_pred             ccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEEEEE
Confidence            44567899999999999964 344    4688888644 234567899999999999999999999999875 4789999


Q ss_pred             eccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcc
Q 010309          302 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE  381 (513)
Q Consensus       302 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~  381 (513)
                      |+.+|+|.+++...   ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        97 ~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~  170 (327)
T 3poz_A           97 LMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  170 (327)
T ss_dssp             CCTTCBHHHHHHHS---TTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTT
T ss_pred             ecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEccCC
Confidence            99999999999752   35699999999999999999999999   9999999999999999999999999999876544


Q ss_pred             ccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccccc
Q 010309          382 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP  460 (513)
Q Consensus       382 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  460 (513)
                      ..........+|+.|+|||++.+..++.++||||||+++|||+| |+.||.............       ...       
T Consensus       171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-------~~~-------  236 (327)
T 3poz_A          171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-------KGE-------  236 (327)
T ss_dssp             CC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-------TTC-------
T ss_pred             cccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHH-------cCC-------
Confidence            33333333337889999999999999999999999999999999 999998765432111111       000       


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcC
Q 010309          461 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  508 (513)
Q Consensus       461 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  508 (513)
                            ....+...+..+.+++.+||+.||++|||+.+|++.|+.+..
T Consensus       237 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          237 ------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             ------CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             ------CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                  001112245579999999999999999999999999987654

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2.8e-44  Score=353.43  Aligned_cols=260  Identities=23%  Similarity=0.373  Sum_probs=209.3

Q ss_pred             ccCCceecccCceEEEEEEe------CCCCEEEEEEecccch-hcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCCceEE
Q 010309          227 SEGNRLLGDSKTGGTYSGIL------PDGSRVAVKRLKRSSF-QRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYI  298 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~l  298 (513)
                      +...+.||+|+||.||+|..      .+++.||||+++.... ...+.+.+|+.+++++ +||||+++++++.+.+..++
T Consensus        25 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l  104 (313)
T 1t46_A           25 LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLV  104 (313)
T ss_dssp             EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             hhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEE
Confidence            34456789999999999985      3467999999976532 3457899999999999 99999999999999999999


Q ss_pred             EEeeccCCCHHHHhccCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCC
Q 010309          299 VYEFVVNGPLDRWLHHIPR--------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE  364 (513)
Q Consensus       299 v~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~  364 (513)
                      ||||+++|+|.+++.....              ....+++..++.++.||+.||.|||++   +|+||||||+|||++.+
T Consensus       105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~  181 (313)
T 1t46_A          105 ITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHG  181 (313)
T ss_dssp             EEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEETT
T ss_pred             EEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEcCC
Confidence            9999999999999976322              123589999999999999999999999   99999999999999999


Q ss_pred             CCeEEecccccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHH
Q 010309          365 FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFE  443 (513)
Q Consensus       365 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~  443 (513)
                      +.+||+|||++................+|+.|+|||++.+..++.++||||||+++|||+| |..||.......  ....
T Consensus       182 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~  259 (313)
T 1t46_A          182 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS--KFYK  259 (313)
T ss_dssp             TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH--HHHH
T ss_pred             CCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh--HHHH
Confidence            9999999999987755433222222337789999999999999999999999999999999 999997654321  1111


Q ss_pred             hhhHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcC
Q 010309          444 WATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  508 (513)
Q Consensus       444 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  508 (513)
                          .....     .        ....+...++.+.+++.+||+.||.+|||+.++++.|+++..
T Consensus       260 ----~~~~~-----~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  307 (313)
T 1t46_A          260 ----MIKEG-----F--------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS  307 (313)
T ss_dssp             ----HHHHT-----C--------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----HhccC-----C--------CCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence                11100     0        001112345679999999999999999999999999987654

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=4.6e-43  Score=345.96  Aligned_cols=275  Identities=16%  Similarity=0.180  Sum_probs=209.6

Q ss_pred             cccCCceecccCceEEEEEEeC-CCCEEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCC--ceEEEEe
Q 010309          226 FSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG--DRYIVYE  301 (513)
Q Consensus       226 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--~~~lv~e  301 (513)
                      .+...++||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++...+  ..++|||
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e   89 (319)
T 4euu_A           10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIME   89 (319)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEE
T ss_pred             CEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEe
Confidence            3455678899999999999975 48999999997653 234577889999999999999999999988765  7799999


Q ss_pred             eccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEe----cCCCCeEEeccccccc
Q 010309          302 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL----DEEFGAHLMGVGLSKF  377 (513)
Q Consensus       302 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll----~~~~~~kl~Dfg~~~~  377 (513)
                      |+++++|.+++.... ....+++..++.++.||+.||+|||+.   +|+||||||+|||+    +.++.+||+|||++..
T Consensus        90 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~  165 (319)
T 4euu_A           90 FCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (319)
T ss_dssp             CCTTCBHHHHHHSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred             CCCCCCHHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence            999999999997532 223499999999999999999999999   99999999999999    7788899999999987


Q ss_pred             CCccccccceeecCcccccccccccc--------cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccc-chhHHhhhHH
Q 010309          378 VPWEVMQERTVMAGGTYGYLAPEFVY--------RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW-QSIFEWATPL  448 (513)
Q Consensus       378 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~-~~~~~~~~~~  448 (513)
                      ........   ...||+.|+|||++.        +..++.++|||||||++|||++|..||........ ..........
T Consensus       166 ~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  242 (319)
T 4euu_A          166 LEDDEQFV---SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (319)
T ss_dssp             CCTTCCBC---CCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred             cCCCCcee---ecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence            65443222   233899999999986        46789999999999999999999999975443211 1111111110


Q ss_pred             hhcccccccc---ccc---ccC-CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCc
Q 010309          449 VQSHRYLELL---DPL---ISS-LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  507 (513)
Q Consensus       449 ~~~~~~~~~~---~~~---~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  507 (513)
                      ..........   ...   ... ..........+..+.+++.+||+.||++|||++|+++...+.+
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~  308 (319)
T 4euu_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (319)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred             CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence            0000000000   000   000 0112334678889999999999999999999999999876543

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=3e-44  Score=371.16  Aligned_cols=254  Identities=26%  Similarity=0.396  Sum_probs=203.1

Q ss_pred             cCCceecccCceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCC
Q 010309          228 EGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  307 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs  307 (513)
                      ...+.||+|+||.||+|.+.++..||||+++... ...+.+.+|+.+|++++||||+++++++.+ +..++||||+++|+
T Consensus       187 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gs  264 (452)
T 1fmk_A          187 RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGS  264 (452)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCB
T ss_pred             eeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCC
Confidence            4456789999999999999888889999998654 345789999999999999999999999876 67899999999999


Q ss_pred             HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccce
Q 010309          308 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  387 (513)
Q Consensus       308 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  387 (513)
                      |.+++...  ....+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.......... 
T Consensus       265 L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~-  338 (452)
T 1fmk_A          265 LLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR-  338 (452)
T ss_dssp             HHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-----------
T ss_pred             HHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCceecc-
Confidence            99999642  224589999999999999999999999   999999999999999999999999999987654322211 


Q ss_pred             eecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCC
Q 010309          388 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  466 (513)
Q Consensus       388 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  466 (513)
                      ....+++.|+|||++.+..++.++||||||+++|||+| |+.||.+.....   ...   .. ....             
T Consensus       339 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~~---~i-~~~~-------------  398 (452)
T 1fmk_A          339 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VLD---QV-ERGY-------------  398 (452)
T ss_dssp             ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHH---HH-HTTC-------------
T ss_pred             cCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH---HHH---HH-HcCC-------------
Confidence            12236789999999999999999999999999999999 999997654321   111   11 1000             


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcCC
Q 010309          467 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP  509 (513)
Q Consensus       467 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  509 (513)
                      ....+..+++.+.+||.+||+.||++|||+++|++.|+.+...
T Consensus       399 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~  441 (452)
T 1fmk_A          399 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  441 (452)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence            0011223456799999999999999999999999999988643

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=4.5e-44  Score=344.28  Aligned_cols=249  Identities=23%  Similarity=0.387  Sum_probs=201.9

Q ss_pred             cCCceecccCceEEEEEEeCCCCEEEEEEecccc--hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeC--CceEEEEeec
Q 010309          228 EGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDRYIVYEFV  303 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lv~e~~  303 (513)
                      ...+.||+|+||.||+|.. +++.||||++....  ....+.+.+|+.++++++||||+++++++.+.  +..++||||+
T Consensus        13 ~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~   91 (271)
T 3kmu_A           13 NFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWM   91 (271)
T ss_dssp             EEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECC
T ss_pred             HHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeeccc
Confidence            3345789999999999998 58999999997653  33456799999999999999999999999887  7789999999


Q ss_pred             cCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--ceEcCCCCCceEecCCCCeEEecccccccCCcc
Q 010309          304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH--VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE  381 (513)
Q Consensus       304 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~  381 (513)
                      ++|+|.+++..  .....+++..++.++.|++.||+|||+.   +  ++||||||+|||++.++.++|.|||++......
T Consensus        92 ~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~~  166 (271)
T 3kmu_A           92 PYGSLYNVLHE--GTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP  166 (271)
T ss_dssp             TTCBHHHHHHS--CSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSCT
T ss_pred             CCCcHHHHHhh--cccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeeeccc
Confidence            99999999975  2234699999999999999999999998   8  999999999999999999999999987653322


Q ss_pred             ccccceeecCcccccccccccccCCCCc---hhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccc
Q 010309          382 VMQERTVMAGGTYGYLAPEFVYRNELTT---KSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELL  458 (513)
Q Consensus       382 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  458 (513)
                      .       ..+|+.|+|||++.+..++.   ++||||||+++|||++|..||........      ........     .
T Consensus       167 ~-------~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~~-----~  228 (271)
T 3kmu_A          167 G-------RMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI------GMKVALEG-----L  228 (271)
T ss_dssp             T-------CBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH------HHHHHHSC-----C
T ss_pred             C-------ccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH------HHHHHhcC-----C
Confidence            1       22899999999998765443   89999999999999999999976543211      11111110     0


Q ss_pred             cccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcC
Q 010309          459 DPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  508 (513)
Q Consensus       459 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  508 (513)
                      .+        ..+...++.+.+++.+||+.||++|||++++++.|+++.+
T Consensus       229 ~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          229 RP--------TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             CC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             CC--------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            00        1112345679999999999999999999999999998764

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=9e-44  Score=367.40  Aligned_cols=249  Identities=28%  Similarity=0.394  Sum_probs=204.5

Q ss_pred             cCCceecccCceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCC-ceEEEEeeccCC
Q 010309          228 EGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG-DRYIVYEFVVNG  306 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-~~~lv~e~~~~g  306 (513)
                      ...+.||+|+||.||+|.. .|+.||||+++...  ..+.+.+|+.+|++++||||+++++++.+.+ ..++||||+++|
T Consensus       196 ~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g  272 (450)
T 1k9a_A          196 KLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG  272 (450)
T ss_dssp             EEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTC
T ss_pred             EEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCC
Confidence            3456789999999999998 57899999998653  4578999999999999999999999987765 789999999999


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  386 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  386 (513)
                      +|.+++...  ....+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.......   
T Consensus       273 ~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~---  344 (450)
T 1k9a_A          273 SLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD---  344 (450)
T ss_dssp             BHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred             cHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccccccc---
Confidence            999999753  234579999999999999999999999   999999999999999999999999999985533211   


Q ss_pred             eeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccccccccCC
Q 010309          387 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  465 (513)
Q Consensus       387 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  465 (513)
                        ...+++.|+|||++.+..++.++||||||+++|||+| |..||...........       .....            
T Consensus       345 --~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~-------i~~~~------------  403 (450)
T 1k9a_A          345 --TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-------VEKGY------------  403 (450)
T ss_dssp             ----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHH-------HHTTC------------
T ss_pred             --CCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-------HHcCC------------
Confidence              1237889999999999999999999999999999998 9999987654321111       11100            


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcCC
Q 010309          466 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP  509 (513)
Q Consensus       466 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  509 (513)
                       ....+..+++.+.+||.+||+.||++|||+.+|++.|+.+...
T Consensus       404 -~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~  446 (450)
T 1k9a_A          404 -KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH  446 (450)
T ss_dssp             -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             -CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence             0011223556799999999999999999999999999987543

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=3.6e-44  Score=350.62  Aligned_cols=258  Identities=21%  Similarity=0.347  Sum_probs=197.1

Q ss_pred             cCCceecccCceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhh--cCCCcEeeeeeEEeeC----CceEEEEe
Q 010309          228 EGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFAR--LHHPNLVAVKGCCYDH----GDRYIVYE  301 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~l~~~~~~~----~~~~lv~e  301 (513)
                      ...+.||+|+||.||+|.. +++.||||++...   ....+.+|.+++..  ++||||+++++++...    ...++|||
T Consensus        11 ~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e   86 (301)
T 3q4u_A           11 TLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITH   86 (301)
T ss_dssp             EEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEEC
T ss_pred             EEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehh
Confidence            3456789999999999998 7899999999654   34556667776666  7999999999987653    45799999


Q ss_pred             eccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHh--------cCCCCCceEcCCCCCceEecCCCCeEEeccc
Q 010309          302 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLH--------DKVKPHVVHRDIRASNVLLDEEFGAHLMGVG  373 (513)
Q Consensus       302 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH--------~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg  373 (513)
                      |+++|+|.+++..     ..+++..++.++.|++.||+|||        +.   +|+||||||+|||++.++.+||+|||
T Consensus        87 ~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg  158 (301)
T 3q4u_A           87 YHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIADLG  158 (301)
T ss_dssp             CCTTCBHHHHHTT-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             hccCCCHHHHHhh-----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEeeCC
Confidence            9999999999953     46999999999999999999999        87   99999999999999999999999999


Q ss_pred             ccccCCcccccc--ceeecCcccccccccccccC------CCCchhhHHHHHHHHHHHHcC----------CCCCCCCCc
Q 010309          374 LSKFVPWEVMQE--RTVMAGGTYGYLAPEFVYRN------ELTTKSDVYSFGVLLLEIVSG----------RRPAQAVDS  435 (513)
Q Consensus       374 ~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlGvil~elltg----------~~p~~~~~~  435 (513)
                      ++..........  ......||+.|+|||++.+.      .++.++||||||+++|||+||          ..||.....
T Consensus       159 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~  238 (301)
T 3q4u_A          159 LAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP  238 (301)
T ss_dssp             TCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred             CeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCC
Confidence            997654332211  11122489999999999876      445799999999999999999          778765433


Q ss_pred             cccchhHHhhhHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q 010309          436 VCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  506 (513)
Q Consensus       436 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  506 (513)
                      ....  ............    ..+   ...........++.+.+|+.+||+.||++|||+.+|++.|+++
T Consensus       239 ~~~~--~~~~~~~~~~~~----~~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          239 NDPS--FEDMRKVVCVDQ----QRP---NIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             SSCC--HHHHHHHHTTSC----CCC---CCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCcc--hhhhhHHHhccC----CCC---CCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            2111  111111111000    000   0111112345778899999999999999999999999999875

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=5.7e-44  Score=354.09  Aligned_cols=242  Identities=19%  Similarity=0.265  Sum_probs=198.8

Q ss_pred             cCCceecccCceEEEEEEe-CCCCEEEEEEecccc---hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeec
Q 010309          228 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  303 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  303 (513)
                      ...+.||+|+||.||+|.. .+++.||||++....   ......+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus        12 ~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~   91 (336)
T 3h4j_B           12 IIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA   91 (336)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC
Confidence            4456789999999999997 568999999997542   223467899999999999999999999999999999999999


Q ss_pred             cCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccc
Q 010309          304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM  383 (513)
Q Consensus       304 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~  383 (513)
                       +|+|.+++..    ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++........
T Consensus        92 -~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~  163 (336)
T 3h4j_B           92 -GGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF  163 (336)
T ss_dssp             -CEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT
T ss_pred             -CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCCcc
Confidence             7899888864    24699999999999999999999999   999999999999999999999999999987654332


Q ss_pred             ccceeecCcccccccccccccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccc
Q 010309          384 QERTVMAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI  462 (513)
Q Consensus       384 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  462 (513)
                      .   ....||+.|+|||++.+..+ +.++||||||+++|+|++|..||........                   .....
T Consensus       164 ~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~-------------------~~~i~  221 (336)
T 3h4j_B          164 L---KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL-------------------FKKVN  221 (336)
T ss_dssp             T---CCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC-------------------BCCCC
T ss_pred             c---ccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH-------------------HHHHH
Confidence            2   22349999999999988776 7899999999999999999999976433211                   01100


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          463 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       463 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      ..  ....+...++.+.+||.+||+.||.+|||++|+++
T Consensus       222 ~~--~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          222 SC--VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             SS--CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             cC--CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            00  01112234567999999999999999999999986

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.3e-44  Score=344.72  Aligned_cols=254  Identities=24%  Similarity=0.398  Sum_probs=208.6

Q ss_pred             cCCceecccCceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCC
Q 010309          228 EGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  307 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs  307 (513)
                      ...+.||+|+||.||++...+++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||+++++
T Consensus        11 ~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   89 (267)
T 3t9t_A           11 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGC   89 (267)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCB
T ss_pred             eeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCc
Confidence            3345789999999999999888999999998654 345789999999999999999999999999999999999999999


Q ss_pred             HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccce
Q 010309          308 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  387 (513)
Q Consensus       308 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  387 (513)
                      |.+++...   ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++........... 
T Consensus        90 L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~-  162 (267)
T 3t9t_A           90 LSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS-  162 (267)
T ss_dssp             HHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST-
T ss_pred             HHHHHhhC---cccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccccccccc-
Confidence            99999752   34689999999999999999999999   999999999999999999999999999987654322111 


Q ss_pred             eecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCC
Q 010309          388 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  466 (513)
Q Consensus       388 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  466 (513)
                      ....+++.|+|||++.+..++.++||||||+++|+|++ |..||.......   ...   .....      .        
T Consensus       163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~---~i~~~------~--------  222 (267)
T 3t9t_A          163 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---VVE---DISTG------F--------  222 (267)
T ss_dssp             TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHH---HHHTT------C--------
T ss_pred             ccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH---HHH---HHhcC------C--------
Confidence            12236788999999998899999999999999999999 899997654321   111   11100      0        


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcCC
Q 010309          467 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP  509 (513)
Q Consensus       467 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  509 (513)
                      ....+...++.+.+++.+||+.||++|||++++++.|+++.+.
T Consensus       223 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (267)
T 3t9t_A          223 RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  265 (267)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             cCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            0011122356799999999999999999999999999987653

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-43  Score=358.69  Aligned_cols=249  Identities=19%  Similarity=0.287  Sum_probs=203.8

Q ss_pred             ccCCceecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccC
Q 010309          227 SEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  305 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  305 (513)
                      +...+.||+|+||.||+|... +|+.||+|++..........+.+|+.+|+.++||||+++++++.+.+..++||||+++
T Consensus        53 y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~g  132 (387)
T 1kob_A           53 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG  132 (387)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred             eEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCC
Confidence            344567899999999999975 6899999999876655667899999999999999999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecC--CCCeEEecccccccCCcccc
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE--EFGAHLMGVGLSKFVPWEVM  383 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~--~~~~kl~Dfg~~~~~~~~~~  383 (513)
                      |+|.+++..   ....+++..+..++.||+.||+|||+.   +|+||||||+|||++.  ++.+||+|||++........
T Consensus       133 g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~  206 (387)
T 1kob_A          133 GELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI  206 (387)
T ss_dssp             CBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred             CcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence            999999864   234699999999999999999999999   9999999999999974  46799999999987654322


Q ss_pred             ccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccccccccccc
Q 010309          384 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS  463 (513)
Q Consensus       384 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  463 (513)
                      .   ....||+.|+|||++.+..++.++|||||||++|||++|..||...+...   ...   .... ... . .     
T Consensus       207 ~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~---~~~---~i~~-~~~-~-~-----  269 (387)
T 1kob_A          207 V---KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE---TLQ---NVKR-CDW-E-F-----  269 (387)
T ss_dssp             E---EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHH---HHHH-CCC-C-C-----
T ss_pred             e---eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH---HHH---HHHh-CCC-C-C-----
Confidence            2   22349999999999999999999999999999999999999998754321   111   1100 000 0 0     


Q ss_pred             CCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          464 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       464 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                         ........++++.+||.+||+.||++|||+.++++
T Consensus       270 ---~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          270 ---DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             ---CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             ---CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence               00111234567999999999999999999999987

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=2.6e-44  Score=349.65  Aligned_cols=252  Identities=25%  Similarity=0.415  Sum_probs=200.8

Q ss_pred             ccCCceecccCceEEEEEEeCC-C-------CEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEE
Q 010309          227 SEGNRLLGDSKTGGTYSGILPD-G-------SRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYI  298 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l  298 (513)
                      +...+.||+|+||.||+|.... +       ..||+|++........+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        10 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   89 (289)
T 4fvq_A           10 LIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENIL   89 (289)
T ss_dssp             EEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEE
T ss_pred             eeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEE
Confidence            3445678999999999998643 3       5799999987766677889999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCC--------eEEe
Q 010309          299 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG--------AHLM  370 (513)
Q Consensus       299 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~--------~kl~  370 (513)
                      ||||+++++|.+++...   ...+++..++.++.||+.||.|||++   +|+||||||+|||++.++.        +||+
T Consensus        90 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~  163 (289)
T 4fvq_A           90 VQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLS  163 (289)
T ss_dssp             EEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred             EEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeeec
Confidence            99999999999999752   24499999999999999999999999   9999999999999998887        9999


Q ss_pred             cccccccCCccccccceeecCccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCC-CCCCCCccccchhHHhhhHH
Q 010309          371 GVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRR-PAQAVDSVCWQSIFEWATPL  448 (513)
Q Consensus       371 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~-p~~~~~~~~~~~~~~~~~~~  448 (513)
                      |||++........      ..+|+.|+|||++.+ ..++.++||||||+++|||++|.. |+...+...   ..    ..
T Consensus       164 Dfg~~~~~~~~~~------~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~---~~----~~  230 (289)
T 4fvq_A          164 DPGISITVLPKDI------LQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR---KL----QF  230 (289)
T ss_dssp             CCCSCTTTSCHHH------HHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HH----HH
T ss_pred             cCcccccccCccc------cCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH---HH----HH
Confidence            9999976543221      127889999999987 678999999999999999999554 444332211   00    00


Q ss_pred             hhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcCCCCC
Q 010309          449 VQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPVT  512 (513)
Q Consensus       449 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~t  512 (513)
                      ....       ...   ..     ..++++.+|+.+||+.||++|||++++++.|+++..|..+
T Consensus       231 ~~~~-------~~~---~~-----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~  279 (289)
T 4fvq_A          231 YEDR-------HQL---PA-----PKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLV  279 (289)
T ss_dssp             HHTT-------CCC---CC-----CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-----
T ss_pred             hhcc-------CCC---CC-----CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCC
Confidence            0000       000   01     1133588999999999999999999999999999887554

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.3e-43  Score=355.67  Aligned_cols=251  Identities=20%  Similarity=0.293  Sum_probs=202.2

Q ss_pred             hhCcccCCceecccCceEEEEEEeC-CCCEEEEEEecccc--hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEE
Q 010309          223 TKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIV  299 (513)
Q Consensus       223 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv  299 (513)
                      .++|. ..+.||+|+||.||++... +|+.||||++....  ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        28 ~~~y~-~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           28 SDNYD-VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHHEE-EEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCeE-EeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            34444 3456799999999999975 58999999997653  23456789999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCC---CeEEecccccc
Q 010309          300 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF---GAHLMGVGLSK  376 (513)
Q Consensus       300 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~---~~kl~Dfg~~~  376 (513)
                      |||+++|+|.+++..    ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++   .+||+|||++.
T Consensus       107 ~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~  179 (362)
T 2bdw_A          107 FDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI  179 (362)
T ss_dssp             ECCCCSCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred             EecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence            999999999998854    35689999999999999999999999   999999999999998654   59999999998


Q ss_pred             cCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccc
Q 010309          377 FVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLE  456 (513)
Q Consensus       377 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  456 (513)
                      ........   ....||+.|+|||++.+..++.++|||||||++|+|++|.+||...+...   +...    ...... .
T Consensus       180 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~---~~~~----i~~~~~-~  248 (362)
T 2bdw_A          180 EVNDSEAW---HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---LYAQ----IKAGAY-D  248 (362)
T ss_dssp             CCTTCCSC---CCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH----HHHTCC-C
T ss_pred             EecCCccc---ccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HHHH----HHhCCC-C
Confidence            76533221   12349999999999999899999999999999999999999997654321   1111    011100 0


Q ss_pred             cccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          457 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       457 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      .         .......+++++.+||.+||+.||++|||+.++++
T Consensus       249 ~---------~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  284 (362)
T 2bdw_A          249 Y---------PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  284 (362)
T ss_dssp             C---------CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             C---------CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            0         01111234567999999999999999999999986

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=5.4e-44  Score=356.87  Aligned_cols=245  Identities=26%  Similarity=0.331  Sum_probs=198.0

Q ss_pred             ccCCceecccCceEEEEEEeC-CCCEEEEEEecccc---hhcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCCceEEEEe
Q 010309          227 SEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYE  301 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e  301 (513)
                      ++..+.||+|+||.||+|+.. +|+.||||++++..   ....+.+.+|..++..+ +||||+++++++.+.+..|+|||
T Consensus        25 y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E  104 (353)
T 3txo_A           25 FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVME  104 (353)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred             eEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEe
Confidence            344567899999999999975 58999999997642   23456788999999988 79999999999999999999999


Q ss_pred             eccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcc
Q 010309          302 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE  381 (513)
Q Consensus       302 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~  381 (513)
                      |+++|+|.+++..    ...+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.....
T Consensus       105 ~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~  177 (353)
T 3txo_A          105 FVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN  177 (353)
T ss_dssp             CCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred             CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence            9999999999965    25699999999999999999999999   9999999999999999999999999999864332


Q ss_pred             ccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccccccccc
Q 010309          382 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL  461 (513)
Q Consensus       382 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  461 (513)
                      ..  .....+||+.|+|||++.+..++.++|||||||++|||++|..||...+...   +..   .... ..        
T Consensus       178 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~---~~~---~i~~-~~--------  240 (353)
T 3txo_A          178 GV--TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD---LFE---AILN-DE--------  240 (353)
T ss_dssp             ----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---HHHH-CC--------
T ss_pred             Cc--cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH---HHH---HHHc-CC--------
Confidence            22  1223349999999999998889999999999999999999999998765421   111   1111 00        


Q ss_pred             ccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCH------HHHHH
Q 010309          462 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRM------SHVVH  501 (513)
Q Consensus       462 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~  501 (513)
                            ...+...++.+.+||.+||+.||++||++      +++++
T Consensus       241 ------~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          241 ------VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             ------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             ------CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence                  01112245679999999999999999998      66664

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.6e-43  Score=344.14  Aligned_cols=260  Identities=20%  Similarity=0.278  Sum_probs=196.7

Q ss_pred             CceecccCceEEEEEEeCCCCEEEEEEecccch--hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCC
Q 010309          230 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  307 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs  307 (513)
                      .+.||+|+||.||+|...+|+.||||++.....  ...+.+.+|+.++++++||||+++++++.+.+..++||||+++ +
T Consensus         7 ~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~   85 (288)
T 1ob3_A            7 LEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-D   85 (288)
T ss_dssp             EEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-E
T ss_pred             hhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-C
Confidence            456899999999999998899999999975532  2346788999999999999999999999999999999999975 9


Q ss_pred             HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccce
Q 010309          308 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  387 (513)
Q Consensus       308 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  387 (513)
                      |.+++...   ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++.........  .
T Consensus        86 l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~  157 (288)
T 1ob3_A           86 LKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK--Y  157 (288)
T ss_dssp             HHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred             HHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccccc--c
Confidence            99988642   35689999999999999999999999   9999999999999999999999999999765432211  1


Q ss_pred             eecCcccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhc---cccc-----ccc
Q 010309          388 VMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQS---HRYL-----ELL  458 (513)
Q Consensus       388 ~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~-----~~~  458 (513)
                      ....+|+.|+|||++.+. .++.++||||||+++|||++|..||...+......  . .......   ....     ...
T Consensus       158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~--~-~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T 1ob3_A          158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLM--R-IFRILGTPNSKNWPNVTELPKY  234 (288)
T ss_dssp             ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--H-HHHHHCCCCTTTSTTGGGSTTC
T ss_pred             ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH--H-HHHHHCCCChhhchhhhccccc
Confidence            122389999999999764 58999999999999999999999998755321111  1 1000000   0000     000


Q ss_pred             cccccCCCC---CCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          459 DPLISSLSS---DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       459 ~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      ++.......   .......++++.+||.+||+.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            000000000   0001234567899999999999999999999985

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=8.4e-44  Score=347.79  Aligned_cols=245  Identities=23%  Similarity=0.321  Sum_probs=191.4

Q ss_pred             cCCceecccCceEEEEEEeC-CCCEEEEEEecccchh--------------------------cHHHHHHHHHHHhhcCC
Q 010309          228 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQ--------------------------RKKEFYSEIGRFARLHH  280 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~h  280 (513)
                      ...+.||+|+||.||+|... +++.||||++......                          ..+.+.+|+.++++++|
T Consensus        16 ~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h   95 (298)
T 2zv2_A           16 TLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDH   95 (298)
T ss_dssp             EEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCC
T ss_pred             EEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCC
Confidence            44567899999999999974 5889999999754321                          13568899999999999


Q ss_pred             CcEeeeeeEEee--CCceEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCc
Q 010309          281 PNLVAVKGCCYD--HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASN  358 (513)
Q Consensus       281 ~nIv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~N  358 (513)
                      |||+++++++.+  .+..++||||+++++|.+++.     ...+++..+..++.||+.||+|||+.   +|+||||||+|
T Consensus        96 ~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~N  167 (298)
T 2zv2_A           96 PNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-----LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSN  167 (298)
T ss_dssp             TTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-----SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGG
T ss_pred             CCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHH
Confidence            999999999987  567899999999999987653     25699999999999999999999999   99999999999


Q ss_pred             eEecCCCCeEEecccccccCCccccccceeecCcccccccccccccCC---CCchhhHHHHHHHHHHHHcCCCCCCCCCc
Q 010309          359 VLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNE---LTTKSDVYSFGVLLLEIVSGRRPAQAVDS  435 (513)
Q Consensus       359 Ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlGvil~elltg~~p~~~~~~  435 (513)
                      ||++.++.+||+|||++.........  .....||+.|+|||++.+..   ++.++||||||+++|+|++|..||.....
T Consensus       168 il~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~  245 (298)
T 2zv2_A          168 LLVGEDGHIKIADFGVSNEFKGSDAL--LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI  245 (298)
T ss_dssp             EEECTTSCEEECCCTTCEECSSSSCE--ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             EEECCCCCEEEecCCCcccccccccc--ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence            99999999999999999876543221  12234899999999998765   37889999999999999999999976432


Q ss_pred             cccchhHHhhhHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          436 VCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       436 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      ..   .   .... .....            ........++++.+||.+||+.||++|||+.|+++
T Consensus       246 ~~---~---~~~~-~~~~~------------~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          246 MC---L---HSKI-KSQAL------------EFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             HH---H---HHHH-HHCCC------------CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HH---H---HHHH-hcccC------------CCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            11   1   1111 10000            00001124467999999999999999999999874

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2e-43  Score=362.86  Aligned_cols=252  Identities=20%  Similarity=0.290  Sum_probs=201.2

Q ss_pred             hhCcccCCceecccCceEEEEEEeC-CCCEEEEEEecccch--hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEE
Q 010309          223 TKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIV  299 (513)
Q Consensus       223 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv  299 (513)
                      .++|. ..+.||+|+||.||++... +|+.||+|++.....  ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        10 ~~~Y~-i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A           10 TEEYQ-LFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHEE-EEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             cCCeE-EEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            33443 3457799999999999864 689999999976532  3356789999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEec---CCCCeEEecccccc
Q 010309          300 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD---EEFGAHLMGVGLSK  376 (513)
Q Consensus       300 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~---~~~~~kl~Dfg~~~  376 (513)
                      |||+++|+|.+++..    ...+++..+..++.||+.||.|||++   +|+||||||+|||++   .++.+||+|||++.
T Consensus        89 ~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~  161 (444)
T 3soa_A           89 FDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAI  161 (444)
T ss_dssp             ECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred             EEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence            999999999999865    35699999999999999999999999   999999999999998   45789999999998


Q ss_pred             cCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccc
Q 010309          377 FVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLE  456 (513)
Q Consensus       377 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  456 (513)
                      ........  .....||+.|+|||++.+..++.++|||||||++|+|++|.+||...+....   ...    ...... .
T Consensus       162 ~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~---~~~----i~~~~~-~  231 (444)
T 3soa_A          162 EVEGEQQA--WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRL---YQQ----IKAGAY-D  231 (444)
T ss_dssp             CCCTTCCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHH----HHHTCC-C
T ss_pred             EecCCCce--eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHH---HHH----HHhCCC-C
Confidence            76543222  1223499999999999998999999999999999999999999976543211   111    111100 0


Q ss_pred             cccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          457 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       457 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      .         ........++++.+||.+||+.||++|||+.|+++
T Consensus       232 ~---------~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          232 F---------PSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             C---------CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             C---------CccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            0         00111234567999999999999999999999986

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=7.8e-44  Score=358.73  Aligned_cols=246  Identities=21%  Similarity=0.298  Sum_probs=197.8

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCCH
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  308 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL  308 (513)
                      .++||+|+||.||+|... +|+.||||+++.......+.+.+|+.++++++||||+++++++.+.+..++||||+++++|
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L  173 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL  173 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence            356899999999999964 6999999999887666778899999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEe--cCCCCeEEecccccccCCccccccc
Q 010309          309 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL--DEEFGAHLMGVGLSKFVPWEVMQER  386 (513)
Q Consensus       309 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll--~~~~~~kl~Dfg~~~~~~~~~~~~~  386 (513)
                      .+++..   ....+++..++.++.||+.||+|||+.   +|+||||||+|||+  +.++.+||+|||++.......... 
T Consensus       174 ~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~-  246 (373)
T 2x4f_A          174 FDRIID---ESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLK-  246 (373)
T ss_dssp             HHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCC-
T ss_pred             HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccc-
Confidence            998864   234699999999999999999999999   99999999999999  567789999999998765433221 


Q ss_pred             eeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCC
Q 010309          387 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  466 (513)
Q Consensus       387 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  466 (513)
                        ...||+.|+|||++.+..++.++|||||||++|||++|..||...+....      ....... .. ..         
T Consensus       247 --~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~------~~~i~~~-~~-~~---------  307 (373)
T 2x4f_A          247 --VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET------LNNILAC-RW-DL---------  307 (373)
T ss_dssp             --CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHHT-CC-CS---------
T ss_pred             --cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhc-cC-CC---------
Confidence              22389999999999988999999999999999999999999987553211      1111110 00 00         


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          467 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       467 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      ........++++.+||.+||+.||.+|||++|+++
T Consensus       308 ~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          308 EDEEFQDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            00011234567999999999999999999999987

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.9e-43  Score=343.78  Aligned_cols=261  Identities=23%  Similarity=0.405  Sum_probs=195.5

Q ss_pred             hCcccCCceecccCceEEEEEEeCCCCEEEEEEecccc--hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEe
Q 010309          224 KNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE  301 (513)
Q Consensus       224 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  301 (513)
                      ++-+...+.||+|+||.||+|...  ..||||+++...  ....+.+.+|+.++++++||||++++++. ..+..++|||
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e   99 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ   99 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence            444455677899999999999863  369999997543  33457789999999999999999999964 5567899999


Q ss_pred             eccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcc
Q 010309          302 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE  381 (513)
Q Consensus       302 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~  381 (513)
                      |+++++|.+++..   ....+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++......
T Consensus       100 ~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  173 (289)
T 3og7_A          100 WCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW  173 (289)
T ss_dssp             CCCEEEHHHHHTT---C---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred             ecCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccccc
Confidence            9999999999964   235699999999999999999999999   9999999999999999999999999999865533


Q ss_pred             ccccceeecCcccccccccccc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccc
Q 010309          382 VMQERTVMAGGTYGYLAPEFVY---RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELL  458 (513)
Q Consensus       382 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  458 (513)
                      ..........||+.|+|||++.   +..++.++||||||+++|+|++|+.||.......  .+.    ........    
T Consensus       174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~----~~~~~~~~----  243 (289)
T 3og7_A          174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QII----EMVGRGSL----  243 (289)
T ss_dssp             ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH--HHH----HHHHHTSC----
T ss_pred             cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH--HHH----HHhccccc----
Confidence            2222222334899999999986   5678899999999999999999999997654321  111    11111111    


Q ss_pred             cccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcC
Q 010309          459 DPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  508 (513)
Q Consensus       459 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  508 (513)
                      .+....     ....+++.+.+|+.+||+.||.+|||+.++++.|+++..
T Consensus       244 ~~~~~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          244 SPDLSK-----VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             CCCTTS-----SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             Ccchhh-----ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence            111111     112345679999999999999999999999999998865

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.3e-43  Score=350.72  Aligned_cols=249  Identities=22%  Similarity=0.318  Sum_probs=180.7

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhcC-CCcEeeeeeEEeeCCceEEEEeeccCCC
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVYEFVVNGP  307 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~~gs  307 (513)
                      .+.||+|+||.||++... +++.||||++...   ....+.+|+.+++.+. ||||+++++++.+.+..++||||+++|+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            467899999999999975 5899999999654   3467789999999996 9999999999999999999999999999


Q ss_pred             HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCC---CeEEecccccccCCccccc
Q 010309          308 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF---GAHLMGVGLSKFVPWEVMQ  384 (513)
Q Consensus       308 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~---~~kl~Dfg~~~~~~~~~~~  384 (513)
                      |.+++..    ...+++..+..++.||+.||+|||++   +|+||||||+|||++.++   .+||+|||++.........
T Consensus        93 L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~  165 (325)
T 3kn6_A           93 LFERIKK----KKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP  165 (325)
T ss_dssp             HHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred             HHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc
Confidence            9999975    35699999999999999999999999   999999999999997765   7999999999865443222


Q ss_pred             cceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccc-hhHHhhhHHhhccccccccccccc
Q 010309          385 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ-SIFEWATPLVQSHRYLELLDPLIS  463 (513)
Q Consensus       385 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  463 (513)
                        .....||+.|+|||++.+..++.++||||||+++|+|++|..||...+..... ...+.... .......      . 
T Consensus       166 --~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-i~~~~~~------~-  235 (325)
T 3kn6_A          166 --LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKK-IKKGDFS------F-  235 (325)
T ss_dssp             --------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHH-HTTTCCC------C-
T ss_pred             --ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHH-HHcCCCC------C-
Confidence              12233899999999999999999999999999999999999999865432111 11111111 1110000      0 


Q ss_pred             CCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          464 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       464 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                         ........++++.+||.+||+.||++|||++++++
T Consensus       236 ---~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          236 ---EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             ---CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             ---CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence               00011235678999999999999999999999884

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=9.1e-44  Score=344.52  Aligned_cols=254  Identities=27%  Similarity=0.367  Sum_probs=194.5

Q ss_pred             ccCCceecccCceEEEEEEeCC----CCEEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEe
Q 010309          227 SEGNRLLGDSKTGGTYSGILPD----GSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE  301 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  301 (513)
                      +...+.||+|+||.||+|....    +..||||++.... ....+.+.+|+.++++++||||+++++++ ..+..++|||
T Consensus        17 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e   95 (281)
T 1mp8_A           17 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIME   95 (281)
T ss_dssp             EEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred             eEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccEEEEe
Confidence            4455678999999999999743    4579999987643 33456789999999999999999999997 4567899999


Q ss_pred             eccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcc
Q 010309          302 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE  381 (513)
Q Consensus       302 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~  381 (513)
                      |+++++|.+++...   ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++......
T Consensus        96 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  169 (281)
T 1mp8_A           96 LCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  169 (281)
T ss_dssp             CCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred             cCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccCcc
Confidence            99999999999742   34699999999999999999999999   9999999999999999999999999999876543


Q ss_pred             ccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccccc
Q 010309          382 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP  460 (513)
Q Consensus       382 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  460 (513)
                      ..... ....+|+.|+|||++.+..++.++||||||+++|||++ |..||........   ....    ....       
T Consensus       170 ~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~---~~~i----~~~~-------  234 (281)
T 1mp8_A          170 TYYKA-SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IGRI----ENGE-------  234 (281)
T ss_dssp             ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HHHH----HTTC-------
T ss_pred             ccccc-ccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH---HHHH----HcCC-------
Confidence            22211 12236789999999998999999999999999999997 9999986554311   1110    0000       


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcC
Q 010309          461 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  508 (513)
Q Consensus       461 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  508 (513)
                            ....+..+++.+.+++.+||+.||++|||+.++++.|+++.+
T Consensus       235 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  276 (281)
T 1mp8_A          235 ------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  276 (281)
T ss_dssp             ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence                  001112345679999999999999999999999999987653

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.4e-44  Score=358.91  Aligned_cols=259  Identities=27%  Similarity=0.381  Sum_probs=205.6

Q ss_pred             ccCCceecccCceEEEEEEeCC------CCEEEEEEecccc-hhcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCCceEE
Q 010309          227 SEGNRLLGDSKTGGTYSGILPD------GSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYI  298 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~l  298 (513)
                      +...+.||+|+||.||+|....      ...||+|.+.... ....+.+.+|+.+++++ +||||+++++++.+.+..++
T Consensus        48 ~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l  127 (333)
T 2i1m_A           48 LQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLV  127 (333)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             ceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEE
Confidence            3445678999999999999642      3489999997653 33456789999999999 89999999999999999999


Q ss_pred             EEeeccCCCHHHHhccCCC----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeE
Q 010309          299 VYEFVVNGPLDRWLHHIPR----------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH  368 (513)
Q Consensus       299 v~e~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~k  368 (513)
                      ||||+++|+|.+++.....          ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+|
T Consensus       128 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~k  204 (333)
T 2i1m_A          128 ITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAK  204 (333)
T ss_dssp             EEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGGGEEE
T ss_pred             EEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCCCeEE
Confidence            9999999999999864211          134589999999999999999999999   999999999999999999999


Q ss_pred             EecccccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhH
Q 010309          369 LMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATP  447 (513)
Q Consensus       369 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~  447 (513)
                      |+|||++................+|+.|+|||++.+..++.++||||||+++|||+| |..||.......  ....    
T Consensus       205 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~~~----  278 (333)
T 2i1m_A          205 IGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS--KFYK----  278 (333)
T ss_dssp             BCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH--HHHH----
T ss_pred             ECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH--HHHH----
Confidence            999999986543322222222236789999999999999999999999999999999 999997654321  1111    


Q ss_pred             HhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCc
Q 010309          448 LVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  507 (513)
Q Consensus       448 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  507 (513)
                      ......             ....+...++.+.+|+.+||+.||.+|||+.+|++.|+++.
T Consensus       279 ~~~~~~-------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~  325 (333)
T 2i1m_A          279 LVKDGY-------------QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA  325 (333)
T ss_dssp             HHHHTC-------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHhcCC-------------CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence            111000             00011123457999999999999999999999999998764

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=2.8e-44  Score=355.62  Aligned_cols=255  Identities=20%  Similarity=0.303  Sum_probs=201.4

Q ss_pred             cCCceecccCceEEEEEEeC-CCC----EEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEe
Q 010309          228 EGNRLLGDSKTGGTYSGILP-DGS----RVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE  301 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  301 (513)
                      ...+.||+|+||.||+|.+. +++    +||+|.+.... ......+.+|+.++++++||||+++++++. .+..++|||
T Consensus        16 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e   94 (325)
T 3kex_A           16 RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQ   94 (325)
T ss_dssp             EEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEE
T ss_pred             eeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEE
Confidence            34567899999999999964 344    38888875442 233456788999999999999999999886 567899999


Q ss_pred             eccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcc
Q 010309          302 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE  381 (513)
Q Consensus       302 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~  381 (513)
                      |+++|+|.+++...   ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        95 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  168 (325)
T 3kex_A           95 YLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD  168 (325)
T ss_dssp             CCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred             eCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence            99999999999642   35689999999999999999999999   9999999999999999999999999999987554


Q ss_pred             ccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccccc
Q 010309          382 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP  460 (513)
Q Consensus       382 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  460 (513)
                      ..........+|+.|+|||++.+..++.++||||||+++|||+| |..||............       .....      
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-------~~~~~------  235 (325)
T 3kex_A          169 DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL-------EKGER------  235 (325)
T ss_dssp             TTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHH-------HTTCB------
T ss_pred             cccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHH-------HcCCC------
Confidence            43333333447889999999999999999999999999999999 99999876543211111       11000      


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcCC
Q 010309          461 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP  509 (513)
Q Consensus       461 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  509 (513)
                             ...+...+.++.+++.+||+.||++|||+.++++.|+++...
T Consensus       236 -------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~  277 (325)
T 3kex_A          236 -------LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD  277 (325)
T ss_dssp             -------CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred             -------CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence                   000111233588999999999999999999999999887643

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=3.4e-43  Score=341.50  Aligned_cols=250  Identities=26%  Similarity=0.416  Sum_probs=199.0

Q ss_pred             ccCCceecccCceEEEEEEeC-CCCEEEEEEecccchhc-------HHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEE
Q 010309          227 SEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQR-------KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYI  298 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l  298 (513)
                      +...+.||+|+||.||+|... +++.||||++.......       .+.+.+|+.++++++||||+++++++.+..  ++
T Consensus        21 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~l   98 (287)
T 4f0f_A           21 IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RM   98 (287)
T ss_dssp             EEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EE
T ss_pred             ceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eE
Confidence            444567899999999999974 68999999996543221       167899999999999999999999986554  79


Q ss_pred             EEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--ceEcCCCCCceEecCCCC-----eEEec
Q 010309          299 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH--VVHRDIRASNVLLDEEFG-----AHLMG  371 (513)
Q Consensus       299 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--ivH~Dikp~NIll~~~~~-----~kl~D  371 (513)
                      ||||+++++|.+++..   ....+++..++.++.|++.||+|||+.   +  |+||||||+|||++.++.     +||+|
T Consensus        99 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           99 VMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             EEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             EEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence            9999999999988864   335799999999999999999999999   8  999999999999988776     99999


Q ss_pred             ccccccCCccccccceeecCcccccccccccc--cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHh
Q 010309          372 VGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY--RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLV  449 (513)
Q Consensus       372 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  449 (513)
                      ||++......     .....||+.|+|||++.  ...++.++||||||+++|||++|+.||...........    ....
T Consensus       173 fg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~----~~~~  243 (287)
T 4f0f_A          173 FGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFI----NMIR  243 (287)
T ss_dssp             CTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHH----HHHH
T ss_pred             CCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHH----HHHh
Confidence            9999854332     12234899999999984  45678999999999999999999999976544321110    0000


Q ss_pred             hcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q 010309          450 QSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  506 (513)
Q Consensus       450 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  506 (513)
                      . ..    .        ....+..+++.+.+++.+||+.||++|||++++++.|+++
T Consensus       244 ~-~~----~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          244 E-EG----L--------RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             H-SC----C--------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             c-cC----C--------CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            0 00    0        0111223456799999999999999999999999999875

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2.6e-43  Score=355.01  Aligned_cols=246  Identities=22%  Similarity=0.321  Sum_probs=200.4

Q ss_pred             cCCceecccCceEEEEEEeC-CCCEEEEEEecccc---hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeec
Q 010309          228 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  303 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  303 (513)
                      ...+.||+|+||.||++... +++.||||++.+..   ....+.+.+|+.+|+.++||||+++++++.+.+..++||||+
T Consensus        18 ~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~   97 (384)
T 4fr4_A           18 EILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLL   97 (384)
T ss_dssp             EEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecC
Confidence            44567899999999999975 58899999997542   234577899999999999999999999999999999999999


Q ss_pred             cCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccc
Q 010309          304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM  383 (513)
Q Consensus       304 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~  383 (513)
                      .+|+|.+++..    ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++........
T Consensus        98 ~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~  170 (384)
T 4fr4_A           98 LGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ  170 (384)
T ss_dssp             TTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred             CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCCCc
Confidence            99999999964    35699999999999999999999999   999999999999999999999999999987653322


Q ss_pred             ccceeecCccccccccccccc---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccc
Q 010309          384 QERTVMAGGTYGYLAPEFVYR---NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP  460 (513)
Q Consensus       384 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  460 (513)
                         .....||+.|+|||++..   ..++.++|||||||++|||++|..||..........+......    .        
T Consensus       171 ---~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~----~--------  235 (384)
T 4fr4_A          171 ---ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET----T--------  235 (384)
T ss_dssp             ---BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH----C--------
T ss_pred             ---eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh----c--------
Confidence               223349999999999974   4589999999999999999999999976544322222111110    0        


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCC-HHHHHH
Q 010309          461 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPR-MSHVVH  501 (513)
Q Consensus       461 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~  501 (513)
                            ....+...++.+.+||.+||+.||.+||+ +++|++
T Consensus       236 ------~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          236 ------VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             ------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             ------ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence                  00112234567999999999999999998 777664

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.7e-43  Score=351.36  Aligned_cols=259  Identities=24%  Similarity=0.391  Sum_probs=207.1

Q ss_pred             cccCCceecccCceEEEEEEeC--------CCCEEEEEEecccc-hhcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCCc
Q 010309          226 FSEGNRLLGDSKTGGTYSGILP--------DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGD  295 (513)
Q Consensus       226 ~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~  295 (513)
                      .+...+.||+|+||.||+|...        ++..||||+++... ....+.+.+|+.+++++ +||||+++++++.+.+.
T Consensus        36 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~  115 (334)
T 2pvf_A           36 KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP  115 (334)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSC
T ss_pred             HeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCc
Confidence            3445567899999999999863        47789999997653 33456789999999999 89999999999999999


Q ss_pred             eEEEEeeccCCCHHHHhccCCCC------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecC
Q 010309          296 RYIVYEFVVNGPLDRWLHHIPRG------------GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE  363 (513)
Q Consensus       296 ~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~  363 (513)
                      .++||||+++|+|.+++......            ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.
T Consensus       116 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~  192 (334)
T 2pvf_A          116 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTE  192 (334)
T ss_dssp             CEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECT
T ss_pred             eEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEEcC
Confidence            99999999999999999753321            23489999999999999999999999   9999999999999999


Q ss_pred             CCCeEEecccccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhH
Q 010309          364 EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIF  442 (513)
Q Consensus       364 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~  442 (513)
                      ++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|||++ |..||.......   +.
T Consensus       193 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~  269 (334)
T 2pvf_A          193 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---LF  269 (334)
T ss_dssp             TCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HH
T ss_pred             CCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH---HH
Confidence            99999999999987654432222223337889999999988889999999999999999999 999997654321   11


Q ss_pred             HhhhHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCc
Q 010309          443 EWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  507 (513)
Q Consensus       443 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  507 (513)
                      ..    ......             ...+..++.++.+++.+||+.||.+|||+.++++.|+++.
T Consensus       270 ~~----~~~~~~-------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~  317 (334)
T 2pvf_A          270 KL----LKEGHR-------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  317 (334)
T ss_dssp             HH----HHHTCC-------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HH----HhcCCC-------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            11    111100             0011234567999999999999999999999999998764

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=7.8e-44  Score=346.08  Aligned_cols=253  Identities=28%  Similarity=0.453  Sum_probs=208.2

Q ss_pred             cCCceecccCceEEEEEEeCC-CCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          228 EGNRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      ...+.||+|+||.||+|.... +..||||++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||++++
T Consensus        16 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~   94 (288)
T 3kfa_A           16 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG   94 (288)
T ss_dssp             EEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTE
T ss_pred             eEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCC
Confidence            344578999999999999764 8899999997653 45678999999999999999999999999999999999999999


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  386 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  386 (513)
                      +|.+++...  ....+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++...........
T Consensus        95 ~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  169 (288)
T 3kfa_A           95 NLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH  169 (288)
T ss_dssp             EHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEE
T ss_pred             cHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCccccc
Confidence            999999752  345699999999999999999999999   999999999999999999999999999987654432211


Q ss_pred             eeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccccccccCC
Q 010309          387 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  465 (513)
Q Consensus       387 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  465 (513)
                       ....+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+.......   .    ...     .       
T Consensus       170 -~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~---~----~~~-----~-------  229 (288)
T 3kfa_A          170 -AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL---L----EKD-----Y-------  229 (288)
T ss_dssp             -TTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH---H----HTT-----C-------
T ss_pred             -cCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---H----hcc-----C-------
Confidence             11226788999999999999999999999999999999 9999976554321111   1    000     0       


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCc
Q 010309          466 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  507 (513)
Q Consensus       466 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  507 (513)
                       ....+...++.+.+|+.+||+.||.+|||+.++++.|+.+.
T Consensus       230 -~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~  270 (288)
T 3kfa_A          230 -RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  270 (288)
T ss_dssp             -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence             01112234567999999999999999999999999998754

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.2e-43  Score=351.24  Aligned_cols=256  Identities=22%  Similarity=0.358  Sum_probs=198.7

Q ss_pred             ccCCceecccCceEEEEEEeC-CCC----EEEEEEeccc-chhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEE
Q 010309          227 SEGNRLLGDSKTGGTYSGILP-DGS----RVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY  300 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  300 (513)
                      +...+.||+|+||.||+|... +++    +||+|.+... .....+.+.+|+.++++++||||+++++++... ..++|+
T Consensus        17 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~v~   95 (327)
T 3lzb_A           17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT   95 (327)
T ss_dssp             EEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-SEEEEE
T ss_pred             ceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-CceEEE
Confidence            344567899999999999964 344    4677877543 334567899999999999999999999998875 488999


Q ss_pred             eeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCc
Q 010309          301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW  380 (513)
Q Consensus       301 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~  380 (513)
                      ||+.+|+|.+++...   ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++.....
T Consensus        96 ~~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~  169 (327)
T 3lzb_A           96 QLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             CCCSSCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred             EecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence            999999999999752   35699999999999999999999999   999999999999999999999999999987654


Q ss_pred             cccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhccccccccc
Q 010309          381 EVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD  459 (513)
Q Consensus       381 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  459 (513)
                      ...........+|+.|+|||++.+..++.++||||||+++|||++ |..||.............       ...      
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~-------~~~------  236 (327)
T 3lzb_A          170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-------KGE------  236 (327)
T ss_dssp             ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-------TTC------
T ss_pred             ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-------cCC------
Confidence            433333333337889999999999999999999999999999999 999998765432111111       000      


Q ss_pred             ccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcCC
Q 010309          460 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP  509 (513)
Q Consensus       460 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  509 (513)
                             ....+...+.++.+|+.+||+.||.+|||+.|+++.|+++...
T Consensus       237 -------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          237 -------RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             -------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             -------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence                   0111122455799999999999999999999999999987654

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=4e-43  Score=354.79  Aligned_cols=246  Identities=22%  Similarity=0.281  Sum_probs=194.8

Q ss_pred             cCCceecccCceEEEEEEeC-CCCEEEEEEecccch---hcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCCceEEEEee
Q 010309          228 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEF  302 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~  302 (513)
                      +..++||+|+||.||+++.. +++.||||++++...   ...+.+.+|..++.++ +||||+++++++.+.+..++||||
T Consensus        55 ~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~  134 (396)
T 4dc2_A           55 DLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEY  134 (396)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEc
Confidence            44567899999999999975 478999999986532   2234578899999887 899999999999999999999999


Q ss_pred             ccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccc
Q 010309          303 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV  382 (513)
Q Consensus       303 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~  382 (513)
                      +++|+|..++..    ...+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++......
T Consensus       135 ~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~  207 (396)
T 4dc2_A          135 VNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG  207 (396)
T ss_dssp             CTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             CCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecccCC
Confidence            999999999864    25699999999999999999999999   99999999999999999999999999998633222


Q ss_pred             cccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccc--chhHHhhhHHhhcccccccccc
Q 010309          383 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW--QSIFEWATPLVQSHRYLELLDP  460 (513)
Q Consensus       383 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  460 (513)
                      .  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||........  ...............       
T Consensus       208 ~--~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~-------  278 (396)
T 4dc2_A          208 D--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-------  278 (396)
T ss_dssp             C--CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC-------
T ss_pred             C--ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc-------
Confidence            1  12234599999999999999999999999999999999999999975432110  000111111111100       


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCH
Q 010309          461 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRM  496 (513)
Q Consensus       461 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  496 (513)
                             ...+...++++.+||.+||+.||++||++
T Consensus       279 -------~~~p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          279 -------IRIPRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             -------CCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             -------cCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence                   01122345679999999999999999996

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-43  Score=345.99  Aligned_cols=240  Identities=22%  Similarity=0.314  Sum_probs=200.1

Q ss_pred             CCceecccCceEEEEEEeC-CCCEEEEEEecccc---hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeecc
Q 010309          229 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV  304 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  304 (513)
                      ..+.||+|+||.||+++.. +|+.||+|++++..   ....+.+.+|..+++.++||||+++++++.+.+..|+||||++
T Consensus        10 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~   89 (318)
T 1fot_A           10 ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIE   89 (318)
T ss_dssp             EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCC
Confidence            3467899999999999975 69999999997642   2345678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccc
Q 010309          305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  384 (513)
Q Consensus       305 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  384 (513)
                      +|+|.+++..    ...+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++......   
T Consensus        90 gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~---  159 (318)
T 1fot_A           90 GGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---  159 (318)
T ss_dssp             SCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred             CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCCc---
Confidence            9999999965    35699999999999999999999999   9999999999999999999999999999865432   


Q ss_pred             cceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccC
Q 010309          385 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS  464 (513)
Q Consensus       385 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  464 (513)
                        .....||+.|+|||++.+..++.++||||||+++|||++|..||...+...   .   ....... .        .  
T Consensus       160 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~---~~~i~~~-~--------~--  220 (318)
T 1fot_A          160 --TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK---T---YEKILNA-E--------L--  220 (318)
T ss_dssp             --BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---H---HHHHHHC-C--------C--
T ss_pred             --cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---H---HHHHHhC-C--------C--
Confidence              122349999999999999999999999999999999999999997654321   1   1111110 0        0  


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 010309          465 LSSDIPEAGVVQKVVDLVYACTQHVPSMRP-----RMSHVVH  501 (513)
Q Consensus       465 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  501 (513)
                          ..+...++++.+||.+||+.||++||     ++++|++
T Consensus       221 ----~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          221 ----RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             ----CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             ----CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence                01123456799999999999999999     8899884

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1e-43  Score=353.58  Aligned_cols=243  Identities=23%  Similarity=0.304  Sum_probs=199.3

Q ss_pred             cCCceecccCceEEEEEEeC-CCCEEEEEEecccc---hhcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCCceEEEEee
Q 010309          228 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEF  302 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~  302 (513)
                      ...++||+|+||.||+|+.. +|+.||||++++..   ....+.+..|..++..+ +||||+++++++.+.+..|+||||
T Consensus        20 ~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~   99 (345)
T 1xjd_A           20 ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEY   99 (345)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeC
Confidence            44567899999999999975 58899999997642   23456788899999887 999999999999999999999999


Q ss_pred             ccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccc
Q 010309          303 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV  382 (513)
Q Consensus       303 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~  382 (513)
                      +++|+|.+++..    ...+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++......
T Consensus       100 ~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  172 (345)
T 1xjd_A          100 LNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD  172 (345)
T ss_dssp             CTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             CCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC
Confidence            999999999964    24699999999999999999999999   99999999999999999999999999998643222


Q ss_pred             cccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccc
Q 010309          383 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI  462 (513)
Q Consensus       383 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  462 (513)
                      ..  .....||+.|+|||++.+..++.++|||||||++|||++|..||...+...   +....   .. ..      +  
T Consensus       173 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~~~i---~~-~~------~--  235 (345)
T 1xjd_A          173 AK--TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE---LFHSI---RM-DN------P--  235 (345)
T ss_dssp             CC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH---HH-CC------C--
T ss_pred             Cc--ccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH---Hh-CC------C--
Confidence            11  223449999999999999999999999999999999999999998654321   11111   00 00      0  


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHH-HHH
Q 010309          463 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMS-HVV  500 (513)
Q Consensus       463 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl  500 (513)
                            ..+...++++.+||.+||+.||++||++. +|+
T Consensus       236 ------~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          236 ------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             ------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             ------CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence                  01122456799999999999999999997 665

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-43  Score=342.37  Aligned_cols=256  Identities=23%  Similarity=0.331  Sum_probs=206.5

Q ss_pred             CcccCCceecccCceEEEEEEeC---CCCEEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEE
Q 010309          225 NFSEGNRLLGDSKTGGTYSGILP---DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY  300 (513)
Q Consensus       225 ~~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  300 (513)
                      ++....+.||+|+||.||+|...   ++..||||+++... ....+.+.+|+.++++++||||+++++++ ..+..++||
T Consensus        10 ~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~   88 (287)
T 1u59_A           10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVM   88 (287)
T ss_dssp             GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEE
T ss_pred             HhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEE
Confidence            34444557899999999999853   57789999998753 34457799999999999999999999998 566789999


Q ss_pred             eeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCc
Q 010309          301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW  380 (513)
Q Consensus       301 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~  380 (513)
                      ||+++++|.+++..   ....+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++.....
T Consensus        89 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~  162 (287)
T 1u59_A           89 EMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGA  162 (287)
T ss_dssp             ECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EeCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence            99999999999963   235699999999999999999999999   999999999999999999999999999987653


Q ss_pred             cccc-cceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccc
Q 010309          381 EVMQ-ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELL  458 (513)
Q Consensus       381 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  458 (513)
                      .... .......+|+.|+|||++.+..++.++||||||+++|||+| |..||.........   .    ......     
T Consensus       163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~---~----~i~~~~-----  230 (287)
T 1u59_A          163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM---A----FIEQGK-----  230 (287)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH---H----HHHTTC-----
T ss_pred             CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH---H----HHhcCC-----
Confidence            3221 11122236889999999988889999999999999999999 99999765542111   1    111110     


Q ss_pred             cccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCc
Q 010309          459 DPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  507 (513)
Q Consensus       459 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  507 (513)
                              ....+...++++.++|.+||+.||++||++.++++.|+++.
T Consensus       231 --------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  271 (287)
T 1u59_A          231 --------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  271 (287)
T ss_dssp             --------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --------cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                    00111234567999999999999999999999999998763

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2.9e-44  Score=367.82  Aligned_cols=256  Identities=19%  Similarity=0.222  Sum_probs=201.7

Q ss_pred             HhhCcccCCceecccCceEEEEEEeCC-CCEEEEEEecccch---hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceE
Q 010309          222 ITKNFSEGNRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRY  297 (513)
Q Consensus       222 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  297 (513)
                      ..++|.. .++||+|+||.||+|+..+ ++.||||++++...   .....+.+|..++..++||||+++++++.+.+..|
T Consensus        72 ~~~~y~~-~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~  150 (437)
T 4aw2_A           72 HREDFEI-LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLY  150 (437)
T ss_dssp             CGGGEEE-EEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred             ChhheEE-EEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEE
Confidence            3445544 5677999999999999764 78999999976422   12234889999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEeccccccc
Q 010309          298 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF  377 (513)
Q Consensus       298 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~  377 (513)
                      +||||+++|+|.+++..   ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus       151 lV~Ey~~gg~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGla~~  224 (437)
T 4aw2_A          151 LVMDYYVGGDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLK  224 (437)
T ss_dssp             EEECCCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEecCCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhhhhh
Confidence            99999999999999964   235699999999999999999999999   999999999999999999999999999976


Q ss_pred             CCccccccceeecCcccccccccccc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcc
Q 010309          378 VPWEVMQERTVMAGGTYGYLAPEFVY-----RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSH  452 (513)
Q Consensus       378 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  452 (513)
                      ........ .....||+.|+|||++.     ...++.++|||||||++|||++|+.||...+....   ...........
T Consensus       225 ~~~~~~~~-~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~---~~~i~~~~~~~  300 (437)
T 4aw2_A          225 LMEDGTVQ-SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET---YGKIMNHKERF  300 (437)
T ss_dssp             CCTTSCEE-CCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHHHHTHHHHC
T ss_pred             cccCCCcc-cccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH---HHhhhhccccc
Confidence            65433221 12234999999999987     45789999999999999999999999987553211   11110000000


Q ss_pred             cccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHH
Q 010309          453 RYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSM--RPRMSHVVH  501 (513)
Q Consensus       453 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~  501 (513)
                      .        .    +. .....++++.+||.+||..+|++  ||+++|+++
T Consensus       301 ~--------~----p~-~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          301 Q--------F----PT-QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             C--------C----CS-SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             c--------C----Cc-ccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence            0        0    00 00124567999999999998888  999999986

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=6.2e-43  Score=341.35  Aligned_cols=259  Identities=18%  Similarity=0.228  Sum_probs=206.3

Q ss_pred             ccCCceecccCceEEEEEEe-CCCCEEEEEEecccchhcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCCceEEEEeecc
Q 010309          227 SEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVV  304 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~  304 (513)
                      +...+.||+|+||.||+|.. .+|+.||||++....  ..+.+.+|+.++..+ +|+||+++++++.+....++||||+ 
T Consensus        12 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-   88 (298)
T 1csn_A           12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-   88 (298)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             eEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-
Confidence            44456789999999999996 568999999987543  334688899999999 8999999999999999999999999 


Q ss_pred             CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCC-----eEEecccccccCC
Q 010309          305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG-----AHLMGVGLSKFVP  379 (513)
Q Consensus       305 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~-----~kl~Dfg~~~~~~  379 (513)
                      +++|.+++...   ...+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.     +||+|||++....
T Consensus        89 ~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~  162 (298)
T 1csn_A           89 GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  162 (298)
T ss_dssp             CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             CCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence            99999999752   34699999999999999999999999   9999999999999987766     9999999998765


Q ss_pred             cccccc-----ceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccc
Q 010309          380 WEVMQE-----RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRY  454 (513)
Q Consensus       380 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  454 (513)
                      ......     ......||+.|+|||++.+..++.++||||||+++|||++|+.||........................
T Consensus       163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (298)
T 1csn_A          163 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL  242 (298)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred             cccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccH
Confidence            432211     122334899999999999999999999999999999999999999876543222222111111000000


Q ss_pred             cccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCc
Q 010309          455 LELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  507 (513)
Q Consensus       455 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  507 (513)
                      ..     +        ...+++++.+++.+||+.||++|||+++|++.|+++.
T Consensus       243 ~~-----~--------~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~  282 (298)
T 1csn_A          243 RE-----L--------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL  282 (298)
T ss_dssp             HH-----H--------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred             HH-----H--------HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHH
Confidence            00     0        0123467999999999999999999999999998764

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=6e-43  Score=354.90  Aligned_cols=268  Identities=18%  Similarity=0.236  Sum_probs=200.8

Q ss_pred             ccCCceeccc--CceEEEEEEeC-CCCEEEEEEecccc--hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEe
Q 010309          227 SEGNRLLGDS--KTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE  301 (513)
Q Consensus       227 ~~~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  301 (513)
                      ++..+.||+|  +||.||+|... +|+.||||++....  ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus        27 y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  106 (389)
T 3gni_B           27 YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS  106 (389)
T ss_dssp             EEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             EEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEE
Confidence            3445678999  99999999976 69999999997653  2334678899999999999999999999999999999999


Q ss_pred             eccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcc
Q 010309          302 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE  381 (513)
Q Consensus       302 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~  381 (513)
                      |+++|+|.+++...  ....+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||.+......
T Consensus       107 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~  181 (389)
T 3gni_B          107 FMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISH  181 (389)
T ss_dssp             CCTTCBHHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEET
T ss_pred             ccCCCCHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeeccc
Confidence            99999999999763  235699999999999999999999999   9999999999999999999999999998654322


Q ss_pred             ccc-----cceeecCccccccccccccc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhh----
Q 010309          382 VMQ-----ERTVMAGGTYGYLAPEFVYR--NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQ----  450 (513)
Q Consensus       382 ~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~----  450 (513)
                      ...     .......||+.|+|||++.+  ..++.++|||||||++|||++|+.||.+.+....  +.........    
T Consensus       182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~  259 (389)
T 3gni_B          182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGTVPCLLD  259 (389)
T ss_dssp             TEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTH--HHHC----------
T ss_pred             cccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHhcCCCCcccc
Confidence            111     11112248899999999987  5789999999999999999999999977544321  1100000000    


Q ss_pred             c-----c-------------ccccccc-----ccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          451 S-----H-------------RYLELLD-----PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       451 ~-----~-------------~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      .     .             ...+.+.     +..............++.+.+||.+||+.||++|||++|+++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~  333 (389)
T 3gni_B          260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN  333 (389)
T ss_dssp             ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            0     0             0000000     000000001122345677999999999999999999999985

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2e-43  Score=354.36  Aligned_cols=249  Identities=21%  Similarity=0.243  Sum_probs=190.7

Q ss_pred             ccCCceecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccC
Q 010309          227 SEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  305 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  305 (513)
                      +...+.||+|+||.||++... +++.||||++.... ...+.+.+|+.+++.++||||+++++++.+.+..++||||+++
T Consensus        22 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~  100 (361)
T 3uc3_A           22 YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASG  100 (361)
T ss_dssp             EEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred             EEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCC
Confidence            344567899999999999975 68999999997653 3346788999999999999999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCC--eEEecccccccCCcccc
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG--AHLMGVGLSKFVPWEVM  383 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~--~kl~Dfg~~~~~~~~~~  383 (513)
                      |+|.+++..    ...+++..++.++.|++.||+|||++   +|+||||||+|||++.++.  +||+|||+++.......
T Consensus       101 ~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~  173 (361)
T 3uc3_A          101 GELYERICN----AGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ  173 (361)
T ss_dssp             CBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred             CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccccCC
Confidence            999999864    24699999999999999999999999   9999999999999987765  99999999975432221


Q ss_pred             ccceeecCcccccccccccccCCCCch-hhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccc
Q 010309          384 QERTVMAGGTYGYLAPEFVYRNELTTK-SDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI  462 (513)
Q Consensus       384 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  462 (513)
                      .   ....||+.|+|||++.+..++.+ +||||||+++|+|++|+.||........  ...........         ..
T Consensus       174 ~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~~~~~~~~~---------~~  239 (361)
T 3uc3_A          174 P---KSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD--YRKTIQRILSV---------KY  239 (361)
T ss_dssp             ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC--HHHHHHHHHTT---------CC
T ss_pred             C---CCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH--HHHHHHHHhcC---------CC
Confidence            1   12338999999999988887655 8999999999999999999986543211  11111111100         00


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          463 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       463 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                          ........++++.+||.+||+.||++|||+.|+++
T Consensus       240 ----~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  274 (361)
T 3uc3_A          240 ----SIPDDIRISPECCHLISRIFVADPATRISIPEIKT  274 (361)
T ss_dssp             ----CCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             ----CCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence                00111124567999999999999999999999986

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.2e-43  Score=349.83  Aligned_cols=265  Identities=22%  Similarity=0.262  Sum_probs=207.3

Q ss_pred             cccCCceecccCceEEEEEEe-CCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEee----CCceEEEE
Q 010309          226 FSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD----HGDRYIVY  300 (513)
Q Consensus       226 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~~lv~  300 (513)
                      -+...+.||+|+||.||++.. .+|+.||||++........+.+.+|+.+++.++||||+++++++..    ....++||
T Consensus        30 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~  109 (317)
T 2buj_A           30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLL  109 (317)
T ss_dssp             EEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEE
T ss_pred             EEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEE
Confidence            344556789999999999997 5799999999977666667889999999999999999999999873    34679999


Q ss_pred             eeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCc
Q 010309          301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW  380 (513)
Q Consensus       301 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~  380 (513)
                      ||+++++|.+++.........+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++.....
T Consensus       110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~  186 (317)
T 2buj_A          110 PFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACI  186 (317)
T ss_dssp             ECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEESCE
T ss_pred             EeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhccc
Confidence            99999999999976544557799999999999999999999999   999999999999999999999999999876543


Q ss_pred             ccccc-------ceeecCcccccccccccccCC---CCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhh
Q 010309          381 EVMQE-------RTVMAGGTYGYLAPEFVYRNE---LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQ  450 (513)
Q Consensus       381 ~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  450 (513)
                      .....       ......||+.|+|||++.+..   ++.++||||||+++|||++|..||........ ....    ...
T Consensus       187 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~----~~~  261 (317)
T 2buj_A          187 HVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVAL----AVQ  261 (317)
T ss_dssp             EEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHHH----HHH
T ss_pred             ccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhhH----Hhh
Confidence            21110       001122689999999987654   68899999999999999999999854211100 0000    000


Q ss_pred             cccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcCCCC
Q 010309          451 SHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPV  511 (513)
Q Consensus       451 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~  511 (513)
                      .         ..    ........++.+.++|.+||+.||.+|||+++|++.|+.+..++.
T Consensus       262 ~---------~~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~  309 (317)
T 2buj_A          262 N---------QL----SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP  309 (317)
T ss_dssp             C---------C------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCC
T ss_pred             c---------cC----CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCC
Confidence            0         00    001112345679999999999999999999999999999877653

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=6.1e-44  Score=349.26  Aligned_cols=272  Identities=24%  Similarity=0.343  Sum_probs=205.0

Q ss_pred             CcccCCceecccCceEEEEEEe-----CCCCEEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeC--Cce
Q 010309          225 NFSEGNRLLGDSKTGGTYSGIL-----PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDR  296 (513)
Q Consensus       225 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~  296 (513)
                      +++...+.||+|+||.||++.+     .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+.  +..
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            4455567889999999999983     368899999997543 33457899999999999999999999999876  668


Q ss_pred             EEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccc
Q 010309          297 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK  376 (513)
Q Consensus       297 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~  376 (513)
                      ++||||+++++|.+++...   ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++.
T Consensus       101 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~  174 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK  174 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             EEEEEeCCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccc
Confidence            9999999999999999542   24599999999999999999999999   99999999999999999999999999998


Q ss_pred             cCCccccc-cceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccc
Q 010309          377 FVPWEVMQ-ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL  455 (513)
Q Consensus       377 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  455 (513)
                      ........ .......+|..|+|||++.+..++.++||||||+++|+|+||..|+......    ......+........
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~  250 (302)
T 4e5w_A          175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMAL----FLKMIGPTHGQMTVT  250 (302)
T ss_dssp             ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH----HHHHHCSCCGGGHHH
T ss_pred             cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhH----HhhccCCcccccCHH
Confidence            76544321 1122234788899999999999999999999999999999999986432110    000000000000000


Q ss_pred             ccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCc
Q 010309          456 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  507 (513)
Q Consensus       456 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  507 (513)
                      ....... .......+..+++.+.+|+.+||+.||++|||+.++++.|+++.
T Consensus       251 ~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          251 RLVNTLK-EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HHHHHHH-TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHh-ccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            0000000 00011112345567999999999999999999999999998764

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=3.5e-43  Score=348.53  Aligned_cols=257  Identities=14%  Similarity=0.165  Sum_probs=204.2

Q ss_pred             cCCceecccCceEEEEEEe-CCCCEEEEEEecccchhcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCCceEEEEeeccC
Q 010309          228 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVN  305 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~  305 (513)
                      ...+.||+|+||.||+|.. .+|+.||||++....  ..+.+.+|+.+++++ +||||+++++++...+..++||||+ +
T Consensus        12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~   88 (330)
T 2izr_A           12 RVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-G   88 (330)
T ss_dssp             EEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-C
T ss_pred             EEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-C
Confidence            3456789999999999996 468999999997553  234688999999999 9999999999999999999999999 9


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCC-----eEEecccccccCCc
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG-----AHLMGVGLSKFVPW  380 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~-----~kl~Dfg~~~~~~~  380 (513)
                      ++|.+++...   ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.     +||+|||++.....
T Consensus        89 ~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~  162 (330)
T 2izr_A           89 PSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID  162 (330)
T ss_dssp             CBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBC
T ss_pred             CCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeec
Confidence            9999999753   35799999999999999999999999   9999999999999998887     99999999987543


Q ss_pred             ccccc-----ceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccc
Q 010309          381 EVMQE-----RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL  455 (513)
Q Consensus       381 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  455 (513)
                      .....     ......||+.|+|||++.+..++.++||||||+++|||++|..||.......................  
T Consensus       163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~--  240 (330)
T 2izr_A          163 PETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP--  240 (330)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC--
T ss_pred             CCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC--
Confidence            32211     11233499999999999999999999999999999999999999987654332222221111000000  


Q ss_pred             ccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCc
Q 010309          456 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  507 (513)
Q Consensus       456 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  507 (513)
                        . ..+        ....+ ++.+++..||+.||.+||++++|++.|+++.
T Consensus       241 --~-~~~--------~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~  280 (330)
T 2izr_A          241 --I-EVL--------CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLF  280 (330)
T ss_dssp             --H-HHH--------TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred             --H-HHH--------hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence              0 000        00123 7999999999999999999999999997553

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=3.6e-43  Score=350.98  Aligned_cols=247  Identities=24%  Similarity=0.313  Sum_probs=186.3

Q ss_pred             ccCCceecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccC
Q 010309          227 SEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  305 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  305 (513)
                      ++..+.||+|+||.||+|... +++.||||+++...  ..+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus        55 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  132 (349)
T 2w4o_A           55 FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTG  132 (349)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             EEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCC
Confidence            344567899999999999986 48899999997653  446788999999999999999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecC---CCCeEEecccccccCCccc
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE---EFGAHLMGVGLSKFVPWEV  382 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~---~~~~kl~Dfg~~~~~~~~~  382 (513)
                      ++|.+++..    ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.   ++.+||+|||++.......
T Consensus       133 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~  205 (349)
T 2w4o_A          133 GELFDRIVE----KGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV  205 (349)
T ss_dssp             CBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred             CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCccc
Confidence            999999964    35699999999999999999999999   9999999999999975   8899999999998764332


Q ss_pred             cccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccc
Q 010309          383 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI  462 (513)
Q Consensus       383 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  462 (513)
                      ..   ....||+.|+|||++.+..++.++|||||||++|||++|..||.......  ....   .... ... ...    
T Consensus       206 ~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~---~i~~-~~~-~~~----  271 (349)
T 2w4o_A          206 LM---KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ--FMFR---RILN-CEY-YFI----  271 (349)
T ss_dssp             ----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH--HHHH---HHHT-TCC-CCC----
T ss_pred             cc---ccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH--HHHH---HHHh-CCC-ccC----
Confidence            21   12338999999999999999999999999999999999999997654321  0111   0000 000 000    


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          463 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       463 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                           .......+.++.+||.+||+.||++|||+.++++
T Consensus       272 -----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          272 -----SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             -----TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -----CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                 0111234567999999999999999999999987

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=2.4e-43  Score=348.32  Aligned_cols=259  Identities=22%  Similarity=0.372  Sum_probs=207.7

Q ss_pred             cCCceecccCceEEEEEEeC------CCCEEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEE
Q 010309          228 EGNRLLGDSKTGGTYSGILP------DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY  300 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  300 (513)
                      ...+.||+|+||.||+|...      +++.||||++.... ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        28 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  107 (322)
T 1p4o_A           28 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIM  107 (322)
T ss_dssp             EEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             eeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEE
Confidence            44567899999999999864      37789999997653 234567899999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCC------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccc
Q 010309          301 EFVVNGPLDRWLHHIP------RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGL  374 (513)
Q Consensus       301 e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~  374 (513)
                      ||+++|+|.+++....      .....+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+
T Consensus       108 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~kl~Dfg~  184 (322)
T 1p4o_A          108 ELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGM  184 (322)
T ss_dssp             ECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCTTC
T ss_pred             EeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeEEECcCcc
Confidence            9999999999986421      1124578999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhccc
Q 010309          375 SKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHR  453 (513)
Q Consensus       375 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  453 (513)
                      +................+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+...   ...   . .....
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~---~-~~~~~  257 (322)
T 1p4o_A          185 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ---VLR---F-VMEGG  257 (322)
T ss_dssp             CCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH---HHH---H-HHTTC
T ss_pred             ccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH---HHH---H-HHcCC
Confidence            986644332222222236889999999999999999999999999999999 899987654321   111   1 11110


Q ss_pred             ccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcCC
Q 010309          454 YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP  509 (513)
Q Consensus       454 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  509 (513)
                      .             ...+...+..+.+|+.+||+.||++|||+.++++.|+++..+
T Consensus       258 ~-------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~  300 (322)
T 1p4o_A          258 L-------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP  300 (322)
T ss_dssp             C-------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred             c-------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence            0             001123456799999999999999999999999999987654

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.6e-43  Score=342.36  Aligned_cols=252  Identities=27%  Similarity=0.443  Sum_probs=204.1

Q ss_pred             cCCceecccCceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCC
Q 010309          228 EGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  307 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs  307 (513)
                      ...+.||+|+||.||+|...++..||||++.... ...+.+.+|+.++++++||||+++++++. .+..++||||+++++
T Consensus        16 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~   93 (279)
T 1qpc_A           16 KLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGS   93 (279)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCB
T ss_pred             hheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCCCCC
Confidence            3456789999999999999888899999997653 34678999999999999999999999976 456899999999999


Q ss_pred             HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccce
Q 010309          308 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  387 (513)
Q Consensus       308 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  387 (513)
                      |.+++...  ....+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++........... 
T Consensus        94 L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~-  167 (279)
T 1qpc_A           94 LVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR-  167 (279)
T ss_dssp             HHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECC-
T ss_pred             HHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccc-
Confidence            99999641  123699999999999999999999999   999999999999999999999999999987654322211 


Q ss_pred             eecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCC
Q 010309          388 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  466 (513)
Q Consensus       388 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  466 (513)
                      ....+++.|+|||++.+..++.++||||||+++|||++ |..||.......   ...   .... .     .        
T Consensus       168 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~---~~~~-~-----~--------  227 (279)
T 1qpc_A          168 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---VIQ---NLER-G-----Y--------  227 (279)
T ss_dssp             TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHH---HHHT-T-----C--------
T ss_pred             cCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH---HHH---HHhc-c-----c--------
Confidence            12226788999999988889999999999999999999 999997654321   111   1100 0     0        


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCc
Q 010309          467 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  507 (513)
Q Consensus       467 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  507 (513)
                      ....+...++++.+++.+||+.||++|||++++++.|+++.
T Consensus       228 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  268 (279)
T 1qpc_A          228 RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF  268 (279)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence            00111234567999999999999999999999999998764

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.2e-43  Score=350.06  Aligned_cols=271  Identities=28%  Similarity=0.375  Sum_probs=207.4

Q ss_pred             hCcccCCceecccCceEEEEEEeC-----CCCEEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeC--Cc
Q 010309          224 KNFSEGNRLLGDSKTGGTYSGILP-----DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GD  295 (513)
Q Consensus       224 ~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~  295 (513)
                      +++....+.||+|+||.||++.+.     +++.||||+++... ....+.+.+|+.++++++||||+++++++.+.  ..
T Consensus        30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (318)
T 3lxp_A           30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS  109 (318)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred             HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence            445566678899999999998742     58899999998653 23457789999999999999999999999874  56


Q ss_pred             eEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEeccccc
Q 010309          296 RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLS  375 (513)
Q Consensus       296 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~  375 (513)
                      .++||||+++++|.+++..     ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus       110 ~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a  181 (318)
T 3lxp_A          110 LQLVMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLA  181 (318)
T ss_dssp             EEEEECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGC
T ss_pred             EEEEEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccc
Confidence            7999999999999999965     3499999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCccccc-cceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccc
Q 010309          376 KFVPWEVMQ-ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRY  454 (513)
Q Consensus       376 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  454 (513)
                      ......... .......+|..|+|||++.+..++.++||||||+++|+|+||..||....... ................
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~  260 (318)
T 3lxp_A          182 KAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGIAQGQMTVLRL  260 (318)
T ss_dssp             EECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-HHHHCSCCHHHHHHHH
T ss_pred             ccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh-hhhhcccccchhHHHH
Confidence            877543221 11222337888999999998889999999999999999999999986532210 0000000000000000


Q ss_pred             cccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCc
Q 010309          455 LELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  507 (513)
Q Consensus       455 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  507 (513)
                      .+.+....    ....+..+++++.+||.+||+.||++|||++++++.|+.+.
T Consensus       261 ~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~  309 (318)
T 3lxp_A          261 TELLERGE----RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH  309 (318)
T ss_dssp             HHHHHTTC----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHhccc----CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence            01111100    11112335567999999999999999999999999998764

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=6.3e-43  Score=355.44  Aligned_cols=252  Identities=18%  Similarity=0.273  Sum_probs=192.8

Q ss_pred             hhCcccCCceecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhh-cCCCcEeeeeeEEee----CCce
Q 010309          223 TKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFAR-LHHPNLVAVKGCCYD----HGDR  296 (513)
Q Consensus       223 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~nIv~l~~~~~~----~~~~  296 (513)
                      ..+|....++||+|+||.||++... +|+.||||+++..     ..+.+|+.++.+ .+||||+++++++..    .+..
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~  134 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL  134 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence            3455555567899999999999975 5899999999643     456788888754 489999999999876    5678


Q ss_pred             EEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecC---CCCeEEeccc
Q 010309          297 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE---EFGAHLMGVG  373 (513)
Q Consensus       297 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~---~~~~kl~Dfg  373 (513)
                      |+||||+++|+|.+++..  .....+++..+..++.||+.||.|||+.   +|+||||||+|||++.   ++.+||+|||
T Consensus       135 ~lv~E~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG  209 (400)
T 1nxk_A          135 LIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG  209 (400)
T ss_dssp             EEEEECCCSEEHHHHHHC--C---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred             EEEEEeCCCCcHHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecc
Confidence            999999999999999975  2235699999999999999999999999   9999999999999997   7889999999


Q ss_pred             ccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccch-hHHhhhHHhhcc
Q 010309          374 LSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS-IFEWATPLVQSH  452 (513)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~  452 (513)
                      +++.......   .....||+.|+|||++.+..++.++|||||||++|||++|..||.......... ....    ....
T Consensus       210 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~----i~~~  282 (400)
T 1nxk_A          210 FAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR----IRMG  282 (400)
T ss_dssp             TCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHH----HHHT
T ss_pred             cccccCCCCc---cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHH----HHcC
Confidence            9986643322   122348999999999999999999999999999999999999997654432110 1110    0000


Q ss_pred             cccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          453 RYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       453 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      .+ ..         .......+++++.+||.+||+.||++|||+.++++
T Consensus       283 ~~-~~---------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  321 (400)
T 1nxk_A          283 QY-EF---------PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  321 (400)
T ss_dssp             CC-CC---------CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             cc-cC---------CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            00 00         00011234567999999999999999999999997

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=5.2e-43  Score=349.52  Aligned_cols=240  Identities=21%  Similarity=0.284  Sum_probs=200.1

Q ss_pred             CCceecccCceEEEEEEeC-CCCEEEEEEecccc---hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeecc
Q 010309          229 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV  304 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  304 (513)
                      ..+.||+|+||.||++... +|+.||||++.+..   ....+.+.+|+.+|+.++||||+++++++.+.+..|+||||++
T Consensus        45 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~  124 (350)
T 1rdq_E           45 RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA  124 (350)
T ss_dssp             EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             EEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCC
Confidence            3467899999999999975 69999999997642   2345678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccc
Q 010309          305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  384 (513)
Q Consensus       305 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  384 (513)
                      +|+|.+++...    ..+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++......  
T Consensus       125 gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~--  195 (350)
T 1rdq_E          125 GGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT--  195 (350)
T ss_dssp             TCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB--
T ss_pred             CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCCc--
Confidence            99999999652    4599999999999999999999999   99999999999999999999999999998764321  


Q ss_pred             cceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccC
Q 010309          385 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS  464 (513)
Q Consensus       385 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  464 (513)
                         ....||+.|+|||++.+..++.++|||||||++|||++|..||...+...   ..   ..... ..        .  
T Consensus       196 ---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~---~~i~~-~~--------~--  255 (350)
T 1rdq_E          196 ---WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ---IY---EKIVS-GK--------V--  255 (350)
T ss_dssp             ---CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH---HHHHH-CC--------C--
T ss_pred             ---ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH---HH---HHHHc-CC--------C--
Confidence               12348999999999999999999999999999999999999998654321   11   11111 00        0  


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 010309          465 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPR-----MSHVVH  501 (513)
Q Consensus       465 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  501 (513)
                          ..+...++++.+||.+||+.||++||+     +++|++
T Consensus       256 ----~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          256 ----RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             ----CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             ----CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence                011234567999999999999999998     888875

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.4e-43  Score=373.32  Aligned_cols=255  Identities=26%  Similarity=0.393  Sum_probs=208.3

Q ss_pred             ccCCceecccCceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          227 SEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      ....+.||+|+||.||+|.+.++..||||+++... ...+.+.+|+.+|++++||||+++++++.+ +..+|||||+++|
T Consensus       269 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~g  346 (535)
T 2h8h_A          269 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKG  346 (535)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTE
T ss_pred             hhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCC
Confidence            34456789999999999999888889999998654 345789999999999999999999999876 6789999999999


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  386 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  386 (513)
                      +|.++|...  ....+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++..........
T Consensus       347 sL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~  421 (535)
T 2h8h_A          347 SLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR  421 (535)
T ss_dssp             EHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTT
T ss_pred             cHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecc
Confidence            999999642  224589999999999999999999999   999999999999999999999999999987654322211


Q ss_pred             eeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccccccccCC
Q 010309          387 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  465 (513)
Q Consensus       387 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  465 (513)
                       ....++..|+|||++.+..++.++||||||++||||++ |+.||......+   +..   . +....            
T Consensus       422 -~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~---~~~---~-i~~~~------------  481 (535)
T 2h8h_A          422 -QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VLD---Q-VERGY------------  481 (535)
T ss_dssp             -CSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH---HHH---H-HHTTC------------
T ss_pred             -cCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH---H-HHcCC------------
Confidence             12236789999999999999999999999999999999 999997654321   111   1 11100            


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcCC
Q 010309          466 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP  509 (513)
Q Consensus       466 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  509 (513)
                       ....+..+++.+.+||.+||+.||++|||+++|++.|+.+...
T Consensus       482 -~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  524 (535)
T 2h8h_A          482 -RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  524 (535)
T ss_dssp             -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred             -CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence             0011123456799999999999999999999999999988653

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=4.7e-43  Score=347.10  Aligned_cols=245  Identities=20%  Similarity=0.270  Sum_probs=191.0

Q ss_pred             ccCCceecccCceEEEEEEe----CCCCEEEEEEecccc----hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEE
Q 010309          227 SEGNRLLGDSKTGGTYSGIL----PDGSRVAVKRLKRSS----FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYI  298 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l  298 (513)
                      ++..+.||+|+||.||++..    .+|+.||||++++..    ......+.+|+.+|+.++||||+++++++.+.+..++
T Consensus        19 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   98 (327)
T 3a62_A           19 FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYL   98 (327)
T ss_dssp             EEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEE
T ss_pred             eEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEE
Confidence            34456789999999999997    478999999998653    2234567889999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccC
Q 010309          299 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV  378 (513)
Q Consensus       299 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~  378 (513)
                      ||||+++++|.+++..    ...+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++...
T Consensus        99 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~  171 (327)
T 3a62_A           99 ILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKES  171 (327)
T ss_dssp             EEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred             EEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence            9999999999999964    24689999999999999999999999   9999999999999999999999999999754


Q ss_pred             CccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccc
Q 010309          379 PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELL  458 (513)
Q Consensus       379 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  458 (513)
                      .....  ......||+.|+|||++.+..++.++||||||+++|||++|..||...+...   ..   ..... ..     
T Consensus       172 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~---~~i~~-~~-----  237 (327)
T 3a62_A          172 IHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK---TI---DKILK-CK-----  237 (327)
T ss_dssp             ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HH---HHHHH-TC-----
T ss_pred             ccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH---HH---HHHHh-CC-----
Confidence            32221  1122348999999999999999999999999999999999999998654321   11   11111 00     


Q ss_pred             cccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 010309          459 DPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP-----RMSHVVH  501 (513)
Q Consensus       459 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  501 (513)
                         .      ..+...++++.+||.+||+.||++||     +++++++
T Consensus       238 ---~------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          238 ---L------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             ---C------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             ---C------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence               0      01122456799999999999999999     7778875

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=3.4e-43  Score=345.88  Aligned_cols=259  Identities=25%  Similarity=0.433  Sum_probs=195.5

Q ss_pred             ccCCceecccCceEEEEEEeC----CCCEEEEEEecccc--hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCc-----
Q 010309          227 SEGNRLLGDSKTGGTYSGILP----DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD-----  295 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-----  295 (513)
                      +...++||+|+||.||+|...    .+..||||+++...  ....+.+.+|+.++++++||||+++++++.+.+.     
T Consensus        36 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  115 (313)
T 3brb_A           36 LILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPK  115 (313)
T ss_dssp             EEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------C
T ss_pred             eeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcc
Confidence            344567899999999999864    24589999997542  3345678999999999999999999999987653     


Q ss_pred             eEEEEeeccCCCHHHHhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEeccc
Q 010309          296 RYIVYEFVVNGPLDRWLHHIP--RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVG  373 (513)
Q Consensus       296 ~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg  373 (513)
                      .++||||+++++|.+++....  .....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||
T Consensus       116 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl~Dfg  192 (313)
T 3brb_A          116 PMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFG  192 (313)
T ss_dssp             EEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEECSCS
T ss_pred             cEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEEeecC
Confidence            499999999999999985322  2346699999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcc
Q 010309          374 LSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSH  452 (513)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  452 (513)
                      ++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||........   ...   .....
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~~~---~~~~~  266 (313)
T 3brb_A          193 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM---YDY---LLHGH  266 (313)
T ss_dssp             CC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---HHH---HHTTC
T ss_pred             cceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH---HHH---HHcCC
Confidence            9987654332222223337889999999999999999999999999999999 8999876544211   110   00000


Q ss_pred             cccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcC
Q 010309          453 RYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  508 (513)
Q Consensus       453 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  508 (513)
                                    ....+...++.+.+++.+||+.||.+|||+.++++.|+++..
T Consensus       267 --------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~  308 (313)
T 3brb_A          267 --------------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE  308 (313)
T ss_dssp             --------------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --------------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                          001122345679999999999999999999999999988753

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.4e-42  Score=345.89  Aligned_cols=246  Identities=22%  Similarity=0.288  Sum_probs=195.3

Q ss_pred             cCCceecccCceEEEEEEeC-CCCEEEEEEecccch---hcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCCceEEEEee
Q 010309          228 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEF  302 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~  302 (513)
                      +..+.||+|+||.||+++.. +++.||||++++...   ...+.+.+|..++.++ +||||+++++++.+.+..|+||||
T Consensus        12 ~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~   91 (345)
T 3a8x_A           12 DLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEY   91 (345)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC
T ss_pred             EEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeC
Confidence            33567899999999999975 588999999986532   3345688999999988 899999999999999999999999


Q ss_pred             ccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccc
Q 010309          303 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV  382 (513)
Q Consensus       303 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~  382 (513)
                      +++|+|.+++..    ...+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++......
T Consensus        92 ~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~  164 (345)
T 3a8x_A           92 VNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG  164 (345)
T ss_dssp             CCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred             CCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence            999999999964    24699999999999999999999999   99999999999999999999999999998643222


Q ss_pred             cccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccc--hhHHhhhHHhhcccccccccc
Q 010309          383 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ--SIFEWATPLVQSHRYLELLDP  460 (513)
Q Consensus       383 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  460 (513)
                      .  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.........  ..............       
T Consensus       165 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~-------  235 (345)
T 3a8x_A          165 D--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-------  235 (345)
T ss_dssp             C--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC-------
T ss_pred             C--cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC-------
Confidence            1  122334999999999999999999999999999999999999999753221100  00011111111100       


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCH
Q 010309          461 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRM  496 (513)
Q Consensus       461 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  496 (513)
                       .      ..+...+.++.+||.+||+.||++||++
T Consensus       236 -~------~~p~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          236 -I------RIPRSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             -C------CCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             -C------CCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence             0      0112345679999999999999999996

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=3.3e-43  Score=345.48  Aligned_cols=258  Identities=23%  Similarity=0.379  Sum_probs=197.0

Q ss_pred             cCCceecccCceEEEEEEe-CCCCEEEEEEeccc---chhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeec
Q 010309          228 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS---SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  303 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  303 (513)
                      ...+.||+|+||.||+|.. .+|+.||||++...   .......+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus        35 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  114 (310)
T 2wqm_A           35 RIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELA  114 (310)
T ss_dssp             EEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             EEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecC
Confidence            3456789999999999996 46999999999753   2334567899999999999999999999999999999999999


Q ss_pred             cCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccc
Q 010309          304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM  383 (513)
Q Consensus       304 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~  383 (513)
                      ++++|.+++.........+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++........
T Consensus       115 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~  191 (310)
T 2wqm_A          115 DAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT  191 (310)
T ss_dssp             CSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-----------
T ss_pred             CCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCc
Confidence            99999999975434456799999999999999999999999   999999999999999999999999999986643322


Q ss_pred             ccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccccccccccc
Q 010309          384 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS  463 (513)
Q Consensus       384 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  463 (513)
                      ..  ....+++.|+|||++.+..++.++||||||+++|+|++|..||......    ....... ......         
T Consensus       192 ~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~-~~~~~~---------  255 (310)
T 2wqm_A          192 AA--HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKK-IEQCDY---------  255 (310)
T ss_dssp             ---------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC----HHHHHHH-HHTTCS---------
T ss_pred             cc--cccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh----HHHHHHH-hhcccC---------
Confidence            11  1223899999999999999999999999999999999999999754321    1111111 111110         


Q ss_pred             CCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCc
Q 010309          464 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  507 (513)
Q Consensus       464 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  507 (513)
                         ...+....++++.+|+.+||+.||++|||+++|++.|+++.
T Consensus       256 ---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~  296 (310)
T 2wqm_A          256 ---PPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMH  296 (310)
T ss_dssp             ---CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---CCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence               11111234567999999999999999999999999998774

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=6e-43  Score=344.84  Aligned_cols=266  Identities=21%  Similarity=0.289  Sum_probs=191.8

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccch-hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCC
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  307 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs  307 (513)
                      .+.||+|+||.||+|... +|+.||||+++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||++ ++
T Consensus        10 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~   88 (317)
T 2pmi_A           10 LEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-ND   88 (317)
T ss_dssp             ---------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CB
T ss_pred             eeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-CC
Confidence            456799999999999964 589999999976532 334678899999999999999999999999999999999997 69


Q ss_pred             HHHHhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccc
Q 010309          308 LDRWLHHIP--RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  385 (513)
Q Consensus       308 L~~~l~~~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  385 (513)
                      |.+++....  .....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++......... 
T Consensus        89 L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~-  164 (317)
T 2pmi_A           89 LKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNT-  164 (317)
T ss_dssp             HHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCCC-
T ss_pred             HHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecCCCccc-
Confidence            999886432  2224589999999999999999999999   9999999999999999999999999999876432211 


Q ss_pred             ceeecCccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccc-----cccc
Q 010309          386 RTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL-----ELLD  459 (513)
Q Consensus       386 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~  459 (513)
                       .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||...+.......+.............     ....
T Consensus       165 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  243 (317)
T 2pmi_A          165 -FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYN  243 (317)
T ss_dssp             -CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCC
T ss_pred             -CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcc
Confidence             112238999999999976 468999999999999999999999998765432111110000000000000     0000


Q ss_pred             ccccCCCCC--------CCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          460 PLISSLSSD--------IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       460 ~~~~~~~~~--------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      +........        ......++++.+||.+||+.||++|||++|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          244 PNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             TTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence            000000000        001123567999999999999999999999986

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=5.2e-43  Score=349.58  Aligned_cols=244  Identities=23%  Similarity=0.321  Sum_probs=199.3

Q ss_pred             cCCceecccCceEEEEEEeCC-CCEEEEEEecccc---hhcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCCceEEEEee
Q 010309          228 EGNRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSS---FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEF  302 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~  302 (513)
                      +..++||+|+||.||++.... |+.||||++++..   ....+.+..|..++..+ +||||+++++++.+.+..|+||||
T Consensus        23 ~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~  102 (353)
T 2i0e_A           23 NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEY  102 (353)
T ss_dssp             EEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeC
Confidence            445678999999999999864 7899999997652   23456788999999988 899999999999999999999999


Q ss_pred             ccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccc
Q 010309          303 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV  382 (513)
Q Consensus       303 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~  382 (513)
                      +++|+|.+++..    ...+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++......
T Consensus       103 ~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  175 (353)
T 2i0e_A          103 VNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG  175 (353)
T ss_dssp             CCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC
Confidence            999999999964    24699999999999999999999999   99999999999999999999999999998643222


Q ss_pred             cccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccc
Q 010309          383 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI  462 (513)
Q Consensus       383 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  462 (513)
                      .  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+...   +..   .... ..        .
T Consensus       176 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~---~~~---~i~~-~~--------~  238 (353)
T 2i0e_A          176 V--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LFQ---SIME-HN--------V  238 (353)
T ss_dssp             C--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---HHHH-CC--------C
T ss_pred             c--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH---HHH---HHHh-CC--------C
Confidence            1  1223449999999999999999999999999999999999999998654321   111   1111 00        0


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 010309          463 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPR-----MSHVVH  501 (513)
Q Consensus       463 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  501 (513)
                            ..+...++++.+||.+||+.||.+||+     +++|++
T Consensus       239 ------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          239 ------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             ------CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             ------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence                  011234567999999999999999995     466664

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=7.9e-43  Score=342.56  Aligned_cols=266  Identities=18%  Similarity=0.218  Sum_probs=196.7

Q ss_pred             ccCCceecccCceEEEEEEe-CCCCEEEEEEecccch-----hcHHHHHHHHHHHhhc---CCCcEeeeeeEEeeCC---
Q 010309          227 SEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSF-----QRKKEFYSEIGRFARL---HHPNLVAVKGCCYDHG---  294 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~~~---  294 (513)
                      ++..+.||+|+||.||+|.. .+++.||||++.....     .....+.+|+.+++.+   +||||+++++++....   
T Consensus        11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~   90 (308)
T 3g33_A           11 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDR   90 (308)
T ss_dssp             CEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSS
T ss_pred             eEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCC
Confidence            44456789999999999996 4689999999974321     1234667777777766   4999999999998765   


Q ss_pred             --ceEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecc
Q 010309          295 --DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV  372 (513)
Q Consensus       295 --~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df  372 (513)
                        ..++||||+. ++|.+++...  ....+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+||
T Consensus        91 ~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Df  164 (308)
T 3g33_A           91 EIKVTLVFEHVD-QDLRTYLDKA--PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADF  164 (308)
T ss_dssp             EEEEEEEEECCC-CBHHHHHHTC--CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEECSC
T ss_pred             ceeEEEEehhhh-cCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEEeeC
Confidence              4799999996 6999999752  234599999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcc
Q 010309          373 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSH  452 (513)
Q Consensus       373 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  452 (513)
                      |++..........   ...||+.|+|||++.+..++.++|||||||++|||++|++||...+..................
T Consensus       165 g~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  241 (308)
T 3g33_A          165 GLARIYSYQMALT---PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED  241 (308)
T ss_dssp             SCTTTSTTCCCSG---GGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             ccccccCCCcccC---CccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            9998765432221   2238999999999999999999999999999999999999998765432111110000000000


Q ss_pred             cccccc---cccccCCCCCC---CcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          453 RYLELL---DPLISSLSSDI---PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       453 ~~~~~~---~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      ......   ...........   .....++.+.+||.+||+.||++|||+.|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          242 DWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             TSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            000000   00000000000   00124567899999999999999999999986

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=2.8e-43  Score=346.96  Aligned_cols=256  Identities=19%  Similarity=0.272  Sum_probs=197.5

Q ss_pred             cccCCceecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCCceEEEEeec
Q 010309          226 FSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFV  303 (513)
Q Consensus       226 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~  303 (513)
                      |....++||+|+||.||+|... +++.||||++........+.+.+|+.++.++ +||||+++++++.+.+..++||||+
T Consensus        14 y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   93 (316)
T 2ac3_A           14 YQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKM   93 (316)
T ss_dssp             CEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             EEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcC
Confidence            3333567899999999999964 6999999999877656678899999999985 7999999999999999999999999


Q ss_pred             cCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCC---eEEecccccccCCc
Q 010309          304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG---AHLMGVGLSKFVPW  380 (513)
Q Consensus       304 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~---~kl~Dfg~~~~~~~  380 (513)
                      ++++|.+++..    ...+++..+..++.||+.||+|||++   +|+||||||+|||++.++.   +||+|||++.....
T Consensus        94 ~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  166 (316)
T 2ac3_A           94 RGGSILSHIHK----RRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL  166 (316)
T ss_dssp             TTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred             CCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence            99999999965    24689999999999999999999999   9999999999999988776   99999999986542


Q ss_pred             ccc-----ccceeecCccccccccccccc-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchh--------H
Q 010309          381 EVM-----QERTVMAGGTYGYLAPEFVYR-----NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSI--------F  442 (513)
Q Consensus       381 ~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~--------~  442 (513)
                      ...     ........||+.|+|||++.+     ..++.++||||||+++|||++|+.||...........        .
T Consensus       167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  246 (316)
T 2ac3_A          167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ  246 (316)
T ss_dssp             ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred             CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence            211     111122348999999999875     4578899999999999999999999987543210000        0


Q ss_pred             HhhhHHhhcccccccccccccCCCCCCCc---HHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          443 EWATPLVQSHRYLELLDPLISSLSSDIPE---AGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       443 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      ...........             ...+.   ...++.+.+||.+||+.||++|||++|+++
T Consensus       247 ~~~~~~i~~~~-------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          247 NMLFESIQEGK-------------YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             HHHHHHHHHCC-------------CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHhccC-------------cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            00000000000             01111   124567999999999999999999999997

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=8.1e-43  Score=339.77  Aligned_cols=262  Identities=19%  Similarity=0.259  Sum_probs=196.0

Q ss_pred             CCceecccCceEEEEEEeC-CCCEEEEEEecccch--hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccC
Q 010309          229 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  305 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  305 (513)
                      ..+.||+|+||+||+|... +++.||||++.....  .....+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus         6 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   85 (292)
T 3o0g_A            6 KLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ   85 (292)
T ss_dssp             EEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred             eeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC
Confidence            3456799999999999975 589999999975532  2346788999999999999999999999999999999999975


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccc
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  385 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  385 (513)
                       +|.+++..   ....+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++..........
T Consensus        86 -~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  158 (292)
T 3o0g_A           86 -DLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY  158 (292)
T ss_dssp             -EHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCC
T ss_pred             -CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCccccc
Confidence             56555543   235699999999999999999999999   99999999999999999999999999998764332211


Q ss_pred             ceeecCcccccccccccccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhc---ccccc---cc
Q 010309          386 RTVMAGGTYGYLAPEFVYRNE-LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQS---HRYLE---LL  458 (513)
Q Consensus       386 ~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~---~~  458 (513)
                        ....+|+.|+|||++.+.. ++.++||||||+++|||++|..||.......  ............   .....   ..
T Consensus       159 --~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~  234 (292)
T 3o0g_A          159 --SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEEQWPSMTKLP  234 (292)
T ss_dssp             --CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred             --cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH--HHHHHHHHHhCCCChhhhhhhcccc
Confidence              1223899999999998765 7999999999999999999888865433211  111111110000   00000   00


Q ss_pred             cc----cc-cCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          459 DP----LI-SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       459 ~~----~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      +.    .. ............++++.+|+.+||+.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence            00    00 000000111235567899999999999999999999986

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=7.2e-43  Score=361.09  Aligned_cols=244  Identities=23%  Similarity=0.349  Sum_probs=201.6

Q ss_pred             ccCCceecccCceEEEEEEeC-CCCEEEEEEecccch---hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEee
Q 010309          227 SEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF  302 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  302 (513)
                      +...+.||+|+||.||+|... +|+.||||++.....   .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus        18 Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~   97 (476)
T 2y94_A           18 YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEY   97 (476)
T ss_dssp             EEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence            344567899999999999975 699999999975422   2346789999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccc
Q 010309          303 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV  382 (513)
Q Consensus       303 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~  382 (513)
                      +++|+|.+++..    ...+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++.......
T Consensus        98 ~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~  170 (476)
T 2y94_A           98 VSGGELFDYICK----NGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  170 (476)
T ss_dssp             CSSEEHHHHTTS----SSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred             CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence            999999999963    35699999999999999999999999   99999999999999999999999999998765432


Q ss_pred             cccceeecCcccccccccccccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccccccccc
Q 010309          383 MQERTVMAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL  461 (513)
Q Consensus       383 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  461 (513)
                      .   ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.......   +..   .... ..        
T Consensus       171 ~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~---~~~---~i~~-~~--------  232 (476)
T 2y94_A          171 F---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT---LFK---KICD-GI--------  232 (476)
T ss_dssp             C---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH---HHH---HHHT-TC--------
T ss_pred             c---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH---HHH---HHhc-CC--------
Confidence            2   122349999999999988765 689999999999999999999998654321   111   1110 00        


Q ss_pred             ccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          462 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       462 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      .      ..+...++++.+||.+||+.||++|||++++++
T Consensus       233 ~------~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          233 F------YTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             C------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             c------CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence            0      011123457999999999999999999999997

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=4.4e-43  Score=339.63  Aligned_cols=252  Identities=26%  Similarity=0.377  Sum_probs=199.9

Q ss_pred             cCCceecccCceEEEEEEeCC----CCEEEEEEeccc-chhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEee
Q 010309          228 EGNRLLGDSKTGGTYSGILPD----GSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF  302 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  302 (513)
                      ...+.||+|+||.||+|...+    +..||||++... .....+.+.+|+.++++++||||+++++++.+ +..++||||
T Consensus        15 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~   93 (281)
T 3cc6_A           15 VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMEL   93 (281)
T ss_dssp             EEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             EEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEEec
Confidence            345678999999999998643    336999999865 33446789999999999999999999999765 467899999


Q ss_pred             ccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccc
Q 010309          303 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV  382 (513)
Q Consensus       303 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~  382 (513)
                      +++++|.+++...   ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++.......
T Consensus        94 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  167 (281)
T 3cc6_A           94 YPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED  167 (281)
T ss_dssp             CTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC----
T ss_pred             CCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCccccccc
Confidence            9999999999642   34589999999999999999999999   99999999999999999999999999998765432


Q ss_pred             cccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhccccccccccc
Q 010309          383 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL  461 (513)
Q Consensus       383 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  461 (513)
                      ... .....+++.|+|||++.+..++.++||||||+++|||+| |+.||...........       .....        
T Consensus       168 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~-------~~~~~--------  231 (281)
T 3cc6_A          168 YYK-ASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGV-------LEKGD--------  231 (281)
T ss_dssp             ------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHH-------HHHTC--------
T ss_pred             ccc-cccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHH-------HhcCC--------
Confidence            221 122337889999999998999999999999999999998 9999976544321111       00000        


Q ss_pred             ccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCc
Q 010309          462 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  507 (513)
Q Consensus       462 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  507 (513)
                           ....+...++.+.+++.+||+.||++|||+.++++.|+++.
T Consensus       232 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~  272 (281)
T 3cc6_A          232 -----RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY  272 (281)
T ss_dssp             -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -----CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence                 00011224467999999999999999999999999998764

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.8e-43  Score=351.16  Aligned_cols=250  Identities=18%  Similarity=0.279  Sum_probs=193.4

Q ss_pred             CcccCCceecccCceEEEEEEeCCCCEEEEEEecccc--hhcHHHHHHHHHHHhhcCC--CcEeeeeeEEeeCCceEEEE
Q 010309          225 NFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHH--PNLVAVKGCCYDHGDRYIVY  300 (513)
Q Consensus       225 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~~~~lv~  300 (513)
                      +.+...+.||+|+||.||++...+++.||||++....  ....+.+.+|+.+|.+++|  |||+++++++.+.+..++||
T Consensus         9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~   88 (343)
T 3dbq_A            9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM   88 (343)
T ss_dssp             CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEE
Confidence            3345566789999999999999889999999997543  3334778999999999976  99999999999999999999


Q ss_pred             eeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCc
Q 010309          301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW  380 (513)
Q Consensus       301 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~  380 (513)
                      |+ .+++|.+++..    ...+++..+..++.||+.||.|||+.   +|+||||||+|||++ ++.+||+|||++.....
T Consensus        89 e~-~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~  159 (343)
T 3dbq_A           89 EC-GNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  159 (343)
T ss_dssp             CC-CSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred             eC-CCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence            94 58899999975    35689999999999999999999999   999999999999997 56899999999987754


Q ss_pred             cccccceeecCccccccccccccc-----------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHh
Q 010309          381 EVMQERTVMAGGTYGYLAPEFVYR-----------NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLV  449 (513)
Q Consensus       381 ~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  449 (513)
                      ...........||+.|+|||++.+           ..++.++|||||||++|||++|+.||......     ........
T Consensus       160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~~~~~~  234 (343)
T 3dbq_A          160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKLHAII  234 (343)
T ss_dssp             ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHHHH
T ss_pred             ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH-----HHHHHHHh
Confidence            433222223449999999999865           67889999999999999999999999754321     01111111


Q ss_pred             hcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          450 QSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       450 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                               ++..    ....+...+.++.+|+.+||+.||.+|||+.|+++
T Consensus       235 ---------~~~~----~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~  273 (343)
T 3dbq_A          235 ---------DPNH----EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  273 (343)
T ss_dssp             ---------CTTS----CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ---------cCCc----ccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence                     1111    00011112356899999999999999999999986

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.1e-42  Score=339.72  Aligned_cols=256  Identities=26%  Similarity=0.419  Sum_probs=200.9

Q ss_pred             cCCceecccCceEEEEEEeCC----CCEEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEe-eCCceEEEEe
Q 010309          228 EGNRLLGDSKTGGTYSGILPD----GSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCY-DHGDRYIVYE  301 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~-~~~~~~lv~e  301 (513)
                      ...+.||+|+||.||+|...+    ...||+|.+.... ....+.+.+|+.++++++||||+++++++. .++..++|||
T Consensus        28 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e  107 (298)
T 3f66_A           28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP  107 (298)
T ss_dssp             EEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEE
T ss_pred             hhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEe
Confidence            345678999999999999643    2368999997643 344577899999999999999999999865 4567899999


Q ss_pred             eccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcc
Q 010309          302 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE  381 (513)
Q Consensus       302 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~  381 (513)
                      |+++++|.+++..   ....+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++......
T Consensus       108 ~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  181 (298)
T 3f66_A          108 YMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  181 (298)
T ss_dssp             CCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred             CCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECccccccccccc
Confidence            9999999999964   335689999999999999999999999   9999999999999999999999999999876543


Q ss_pred             ccc--cceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccc
Q 010309          382 VMQ--ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELL  458 (513)
Q Consensus       382 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  458 (513)
                      ...  .......+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||...........      .... .     
T Consensus       182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~------~~~~-~-----  249 (298)
T 3f66_A          182 EYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY------LLQG-R-----  249 (298)
T ss_dssp             GGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHH------HHTT-C-----
T ss_pred             chhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHH------HhcC-C-----
Confidence            321  11222337889999999999999999999999999999999 5666655443211110      0000 0     


Q ss_pred             cccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcCC
Q 010309          459 DPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP  509 (513)
Q Consensus       459 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  509 (513)
                              ....+...++.+.+++.+||+.||++|||++++++.|+++...
T Consensus       250 --------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~  292 (298)
T 3f66_A          250 --------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  292 (298)
T ss_dssp             --------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             --------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence                    0111122345799999999999999999999999999887543

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=2.5e-43  Score=347.15  Aligned_cols=261  Identities=26%  Similarity=0.355  Sum_probs=206.3

Q ss_pred             cccCCceecccCceEEEEEEe------CCCCEEEEEEecccch-hcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCC-ce
Q 010309          226 FSEGNRLLGDSKTGGTYSGIL------PDGSRVAVKRLKRSSF-QRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHG-DR  296 (513)
Q Consensus       226 ~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~-~~  296 (513)
                      .+...+.||+|+||.||+|..      .+++.||||+++.... ...+.+.+|+.++.++ +||||+++++++...+ ..
T Consensus        28 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~  107 (316)
T 2xir_A           28 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL  107 (316)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCC
T ss_pred             heeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCce
Confidence            344556789999999999984      3468999999976532 3446789999999999 7999999999988765 48


Q ss_pred             EEEEeeccCCCHHHHhccCCCC------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCC
Q 010309          297 YIVYEFVVNGPLDRWLHHIPRG------------GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE  364 (513)
Q Consensus       297 ~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~  364 (513)
                      ++||||+++++|.+++......            ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.+
T Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~  184 (316)
T 2xir_A          108 MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEK  184 (316)
T ss_dssp             EEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGG
T ss_pred             EEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCC
Confidence            9999999999999999753321            12388999999999999999999999   99999999999999999


Q ss_pred             CCeEEecccccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHH
Q 010309          365 FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFE  443 (513)
Q Consensus       365 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~  443 (513)
                      +.+||+|||++................+|+.|+|||++.+..++.++||||||+++|||+| |..||.......  ....
T Consensus       185 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--~~~~  262 (316)
T 2xir_A          185 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCR  262 (316)
T ss_dssp             GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH--HHHH
T ss_pred             CCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhH--HHHH
Confidence            9999999999987654332222222337889999999999999999999999999999998 999997654321  1111


Q ss_pred             hhhHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcC
Q 010309          444 WATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  508 (513)
Q Consensus       444 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  508 (513)
                          .......             ...+...++.+.+++.+||+.||.+|||+.+|++.|+.+.+
T Consensus       263 ----~~~~~~~-------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  310 (316)
T 2xir_A          263 ----RLKEGTR-------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  310 (316)
T ss_dssp             ----HHHHTCC-------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----HhccCcc-------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                0111000             00111234579999999999999999999999999987653

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=4e-43  Score=340.77  Aligned_cols=249  Identities=23%  Similarity=0.336  Sum_probs=195.9

Q ss_pred             cCCceecccCceEEEEEEeC-CCCEEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccC
Q 010309          228 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  305 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  305 (513)
                      ...+.||+|+||.||++... ++..||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus        25 ~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~  104 (285)
T 3is5_A           25 IFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEG  104 (285)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSC
T ss_pred             eecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCC
Confidence            33567799999999999974 58999999997653 33467899999999999999999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEe---cCCCCeEEecccccccCCccc
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL---DEEFGAHLMGVGLSKFVPWEV  382 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll---~~~~~~kl~Dfg~~~~~~~~~  382 (513)
                      ++|.+++.........+++..++.++.|++.||+|||+.   +|+||||||+|||+   +.++.+||+|||++.......
T Consensus       105 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~  181 (285)
T 3is5_A          105 GELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE  181 (285)
T ss_dssp             CBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-----
T ss_pred             CcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcc
Confidence            999999865333346799999999999999999999999   99999999999999   456789999999998765432


Q ss_pred             cccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccc
Q 010309          383 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI  462 (513)
Q Consensus       383 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  462 (513)
                      ..   ....||+.|+|||++. ..++.++||||||+++|||++|+.||............      ....       +..
T Consensus       182 ~~---~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~------~~~~-------~~~  244 (285)
T 3is5_A          182 HS---TNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKA------TYKE-------PNY  244 (285)
T ss_dssp             --------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHCC-------CCC
T ss_pred             cC---cCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhh------ccCC-------ccc
Confidence            22   2233899999999875 56899999999999999999999999875432111100      0000       000


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          463 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       463 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                           .......++++.+|+.+||+.||++|||+.|+++
T Consensus       245 -----~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          245 -----AVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             -----CC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             -----ccccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                 0000113457899999999999999999999985

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-42  Score=338.55  Aligned_cols=253  Identities=25%  Similarity=0.381  Sum_probs=200.7

Q ss_pred             CceecccCceEEEEEEeCC-C---CEEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCce-EEEEeec
Q 010309          230 NRLLGDSKTGGTYSGILPD-G---SRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR-YIVYEFV  303 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~-~lv~e~~  303 (513)
                      .++||+|+||.||+|...+ +   ..||+|++.... ....+.+.+|+.++++++||||+++++++.+.+.. ++||||+
T Consensus        26 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~  105 (298)
T 3pls_A           26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYM  105 (298)
T ss_dssp             EEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCC
T ss_pred             CceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecc
Confidence            4678999999999998532 2   379999997643 33457889999999999999999999999877665 9999999


Q ss_pred             cCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccc
Q 010309          304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM  383 (513)
Q Consensus       304 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~  383 (513)
                      .+++|.+++..   ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++........
T Consensus       106 ~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  179 (298)
T 3pls_A          106 CHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREY  179 (298)
T ss_dssp             TTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred             cCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence            99999999964   345689999999999999999999999   999999999999999999999999999986654321


Q ss_pred             c--cceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCC-CCCCCccccchhHHhhhHHhhcccccccccc
Q 010309          384 Q--ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP-AQAVDSVCWQSIFEWATPLVQSHRYLELLDP  460 (513)
Q Consensus       384 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  460 (513)
                      .  .......+|+.|+|||.+.+..++.++||||||+++|+|++|..| |...+.......       .....       
T Consensus       180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~-------~~~~~-------  245 (298)
T 3pls_A          180 YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHF-------LAQGR-------  245 (298)
T ss_dssp             GCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHH-------HHTTC-------
T ss_pred             cccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHH-------hhcCC-------
Confidence            1  112223478899999999999999999999999999999995555 443332211110       00000       


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcC
Q 010309          461 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  508 (513)
Q Consensus       461 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  508 (513)
                            ....+...++.+.+++.+||+.||.+|||++++++.|+++..
T Consensus       246 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  287 (298)
T 3pls_A          246 ------RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVS  287 (298)
T ss_dssp             ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence                  011112245679999999999999999999999999987643

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=7e-43  Score=337.47  Aligned_cols=243  Identities=21%  Similarity=0.284  Sum_probs=200.5

Q ss_pred             cCCceecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          228 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      ...+.||+|+||.||+|... ++..||+|++........+.+.+|+.++++++||||+++++++.+.+..++||||++++
T Consensus        12 ~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   91 (277)
T 3f3z_A           12 TLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGG   91 (277)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSC
T ss_pred             EeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCC
Confidence            44557799999999999975 47799999998776667788999999999999999999999999999999999999999


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEe---cCCCCeEEecccccccCCcccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL---DEEFGAHLMGVGLSKFVPWEVM  383 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll---~~~~~~kl~Dfg~~~~~~~~~~  383 (513)
                      +|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||+   +.++.+||+|||++........
T Consensus        92 ~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~  164 (277)
T 3f3z_A           92 ELFERVVH----KRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM  164 (277)
T ss_dssp             BHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC
T ss_pred             cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccc
Confidence            99998864    24589999999999999999999999   99999999999999   7888999999999987654332


Q ss_pred             ccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccccccccccc
Q 010309          384 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS  463 (513)
Q Consensus       384 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  463 (513)
                      ..   ...+|+.|+|||++.+ .++.++||||||+++|+|++|..||.........      ..... ..          
T Consensus       165 ~~---~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~------~~~~~-~~----------  223 (277)
T 3f3z_A          165 MR---TKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVM------LKIRE-GT----------  223 (277)
T ss_dssp             BC---CCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHHH-CC----------
T ss_pred             hh---ccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHH------HHHHh-CC----------
Confidence            22   2338999999998865 4899999999999999999999999875432110      00000 00          


Q ss_pred             CCCCCCCc---HHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          464 SLSSDIPE---AGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       464 ~~~~~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                         ...+.   ...++.+.+|+.+||+.||++|||+.++++
T Consensus       224 ---~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          224 ---FTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             ---CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             ---CCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence               00011   124567999999999999999999999985

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2.9e-43  Score=353.97  Aligned_cols=265  Identities=14%  Similarity=0.131  Sum_probs=200.8

Q ss_pred             cccCCceecccCceEEEEEEeCC------CCEEEEEEecccchhc-----------HHHHHHHHHHHhhcCCCcEeeeee
Q 010309          226 FSEGNRLLGDSKTGGTYSGILPD------GSRVAVKRLKRSSFQR-----------KKEFYSEIGRFARLHHPNLVAVKG  288 (513)
Q Consensus       226 ~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~nIv~l~~  288 (513)
                      -+...+.||+|+||.||+|.+..      ++.||||++.......           ...+..|+..+..++||||+++++
T Consensus        36 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~  115 (364)
T 3op5_A           36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWG  115 (364)
T ss_dssp             EEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEE
T ss_pred             eEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEe
Confidence            34456678999999999999754      4789999987653211           123445666778889999999999


Q ss_pred             EEeeC----CceEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEec--
Q 010309          289 CCYDH----GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD--  362 (513)
Q Consensus       289 ~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~--  362 (513)
                      ++...    ...+|||||+ +++|.+++..   ....+++..++.++.||+.||+|||+.   +|+||||||+|||++  
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~  188 (364)
T 3op5_A          116 SGLHDKNGKSYRFMIMDRF-GSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYK  188 (364)
T ss_dssp             EEEEEETTEEEEEEEEECE-EEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESS
T ss_pred             eeeeccCCcceEEEEEeCC-CCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecC
Confidence            98875    4479999999 9999999975   235699999999999999999999999   999999999999999  


Q ss_pred             CCCCeEEecccccccCCccccccc-----eeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccc
Q 010309          363 EEFGAHLMGVGLSKFVPWEVMQER-----TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVC  437 (513)
Q Consensus       363 ~~~~~kl~Dfg~~~~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~  437 (513)
                      .++.+||+|||+++..........     .....||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus       189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~  268 (364)
T 3op5_A          189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP  268 (364)
T ss_dssp             CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred             CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence            889999999999987654322111     122338999999999999999999999999999999999999998643321


Q ss_pred             cchhHHhhhHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCc
Q 010309          438 WQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  507 (513)
Q Consensus       438 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  507 (513)
                        .......... .....+++++.+.       ....++++.+++..||+.||.+||++++|++.|+++.
T Consensus       269 --~~~~~~~~~~-~~~~~~~~~~~~~-------~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~  328 (364)
T 3op5_A          269 --KYVRDSKIRY-RENIASLMDKCFP-------AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGL  328 (364)
T ss_dssp             --HHHHHHHHHH-HHCHHHHHHHHSC-------TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred             --HHHHHHHHHh-hhhHHHHHHHhcc-------cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Confidence              1111111100 1111222222210       1123467999999999999999999999999997654

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=6.3e-43  Score=346.49  Aligned_cols=246  Identities=19%  Similarity=0.308  Sum_probs=193.6

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCc------------
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD------------  295 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~------------  295 (513)
                      .+.||+|+||.||+|+.. +|+.||||+++... ....+.+.+|+.+|++++||||+++++++.+.+.            
T Consensus        11 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~   90 (332)
T 3qd2_B           11 IQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWL   90 (332)
T ss_dssp             EEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC---
T ss_pred             eeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhh
Confidence            456799999999999986 79999999997543 2345789999999999999999999999866543            


Q ss_pred             ---------------------------------------------eEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHH
Q 010309          296 ---------------------------------------------RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV  330 (513)
Q Consensus       296 ---------------------------------------------~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i  330 (513)
                                                                   .++||||+++++|.+++.... .....++..++.+
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~i  169 (332)
T 3qd2_B           91 KDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLEDREHGVCLHI  169 (332)
T ss_dssp             -----------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-SGGGSCHHHHHHH
T ss_pred             ccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-CccchhhHHHHHH
Confidence                                                         799999999999999997532 2244677789999


Q ss_pred             HHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccc----------ceeecCccccccccc
Q 010309          331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE----------RTVMAGGTYGYLAPE  400 (513)
Q Consensus       331 ~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~----------~~~~~~gt~~y~aPE  400 (513)
                      +.||+.||+|||++   +|+||||||+|||++.++.+||+|||++..........          ......||+.|+|||
T Consensus       170 ~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE  246 (332)
T 3qd2_B          170 FIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPE  246 (332)
T ss_dssp             HHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHH
T ss_pred             HHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccChH
Confidence            99999999999999   99999999999999999999999999998765432111          112234899999999


Q ss_pred             ccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCCCCCcHHHHHHHHH
Q 010309          401 FVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVD  480 (513)
Q Consensus       401 ~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  480 (513)
                      ++.+..++.++||||||+++|||++|..|+....        ..... .....             ........++++.+
T Consensus       247 ~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~--------~~~~~-~~~~~-------------~~~~~~~~~~~~~~  304 (332)
T 3qd2_B          247 QIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV--------RIITD-VRNLK-------------FPLLFTQKYPQEHM  304 (332)
T ss_dssp             HHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH--------HHHHH-HHTTC-------------CCHHHHHHCHHHHH
T ss_pred             HhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH--------HHHHH-hhccC-------------CCcccccCChhHHH
Confidence            9999999999999999999999999877642110        00000 00000             11112345567899


Q ss_pred             HHHHhcCCCCCCCCCHHHHHH
Q 010309          481 LVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       481 li~~cl~~dP~~RPs~~evl~  501 (513)
                      ||.+||+.||++|||++|+++
T Consensus       305 li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          305 MVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHHHHHCSSGGGSCCHHHHHH
T ss_pred             HHHHHccCCCCcCCCHHHHhh
Confidence            999999999999999999986

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=2.1e-43  Score=358.77  Aligned_cols=251  Identities=19%  Similarity=0.240  Sum_probs=200.5

Q ss_pred             hCcccCCceecccCceEEEEEEeC-CCCEEEEEEecccch---hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEE
Q 010309          224 KNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIV  299 (513)
Q Consensus       224 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv  299 (513)
                      ++|. ..+.||+|+||.||+|+.. +++.||+|++++...   ...+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus        69 ~~y~-~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV  147 (410)
T 3v8s_A           69 EDYE-VVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV  147 (410)
T ss_dssp             GGEE-EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccE-EEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            3443 3567899999999999975 588999999975321   2234588999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCC
Q 010309          300 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP  379 (513)
Q Consensus       300 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~  379 (513)
                      |||+++|+|.+++..     ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus       148 ~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~~~  219 (410)
T 3v8s_A          148 MEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN  219 (410)
T ss_dssp             ECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEeec
Confidence            999999999999964     3589999999999999999999999   99999999999999999999999999998765


Q ss_pred             ccccccceeecCcccccccccccccCC----CCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccc
Q 010309          380 WEVMQERTVMAGGTYGYLAPEFVYRNE----LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL  455 (513)
Q Consensus       380 ~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  455 (513)
                      ...... .....||+.|+|||++.+..    ++.++|||||||++|||++|+.||...+....   ..   .......  
T Consensus       220 ~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~---~~---~i~~~~~--  290 (410)
T 3v8s_A          220 KEGMVR-CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT---YS---KIMNHKN--  290 (410)
T ss_dssp             TTSEEE-CCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HH---HHHTHHH--
T ss_pred             cCCccc-ccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhH---HH---HHHhccc--
Confidence            433211 12344999999999998765    78899999999999999999999986553211   11   1100000  


Q ss_pred             ccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHH
Q 010309          456 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSM--RPRMSHVVH  501 (513)
Q Consensus       456 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~  501 (513)
                      ..         ........++++.+||.+||+.+|.+  ||+++||++
T Consensus       291 ~~---------~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~  329 (410)
T 3v8s_A          291 SL---------TFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR  329 (410)
T ss_dssp             HC---------CCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred             cc---------cCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence            00         00001124567999999999999988  999999986

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.1e-43  Score=351.76  Aligned_cols=271  Identities=24%  Similarity=0.328  Sum_probs=207.4

Q ss_pred             ccCCceecccCceEEEEEEe-----CCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEe--eCCceEEE
Q 010309          227 SEGNRLLGDSKTGGTYSGIL-----PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY--DHGDRYIV  299 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~--~~~~~~lv  299 (513)
                      +...+.||+|+||.||++.+     .+++.||||++........+.+.+|+.++++++||||+++++++.  +.+..++|
T Consensus        25 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv  104 (327)
T 3lxl_A           25 LKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLV  104 (327)
T ss_dssp             EEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEE
T ss_pred             hhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEE
Confidence            34456789999999999984     358899999998876666778999999999999999999999987  44568999


Q ss_pred             EeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCC
Q 010309          300 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP  379 (513)
Q Consensus       300 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~  379 (513)
                      |||+++++|.+++...   ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++....
T Consensus       105 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  178 (327)
T 3lxl_A          105 MEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLP  178 (327)
T ss_dssp             EECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred             EeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceecc
Confidence            9999999999999642   24599999999999999999999999   99999999999999999999999999998765


Q ss_pred             cccccc-ceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccc
Q 010309          380 WEVMQE-RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELL  458 (513)
Q Consensus       380 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  458 (513)
                      ...... ......+|+.|+|||++.+..++.++||||||+++|+|++|..||........... ....   .........
T Consensus       179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~-~~~~---~~~~~~~~~  254 (327)
T 3lxl_A          179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMM-GCER---DVPALSRLL  254 (327)
T ss_dssp             TTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHC-C-------CCHHHHHH
T ss_pred             cCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhc-cccc---ccccHHHHH
Confidence            432211 11223378889999999988899999999999999999999999865332100000 0000   000000000


Q ss_pred             cccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcC
Q 010309          459 DPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  508 (513)
Q Consensus       459 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  508 (513)
                      ...... .....+..+++.+.+|+.+||+.||++|||+++|++.|+.+..
T Consensus       255 ~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  303 (327)
T 3lxl_A          255 ELLEEG-QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS  303 (327)
T ss_dssp             HHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred             HHhhcc-cCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            000000 0111223456779999999999999999999999999987754

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=5.7e-43  Score=343.43  Aligned_cols=251  Identities=23%  Similarity=0.396  Sum_probs=194.5

Q ss_pred             cCCceecccCceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCC
Q 010309          228 EGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  307 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs  307 (513)
                      +..+.||+|+||.||+|.. .++.||||++...  ...+.+.+|+.++++++||||+++++++.  +..++||||+++++
T Consensus        11 ~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~~~   85 (307)
T 2eva_A           11 EVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGS   85 (307)
T ss_dssp             EEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTTCB
T ss_pred             eeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCCCC
Confidence            3456789999999999998 5789999999754  34578999999999999999999999876  45899999999999


Q ss_pred             HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCC-eEEecccccccCCccccccc
Q 010309          308 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG-AHLMGVGLSKFVPWEVMQER  386 (513)
Q Consensus       308 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~-~kl~Dfg~~~~~~~~~~~~~  386 (513)
                      |.+++.... ....+++..++.++.|++.||+|||+....+|+||||||+|||++.++. +||+|||++.......    
T Consensus        86 L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~----  160 (307)
T 2eva_A           86 LYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM----  160 (307)
T ss_dssp             HHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------------
T ss_pred             HHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc----
Confidence            999997522 1234789999999999999999999932129999999999999998887 7999999997654321    


Q ss_pred             eeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCC
Q 010309          387 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  466 (513)
Q Consensus       387 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  466 (513)
                       ....||+.|+|||++.+..++.++||||||+++|||++|+.||..........    .... .....            
T Consensus       161 -~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~----~~~~-~~~~~------------  222 (307)
T 2eva_A          161 -TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRI----MWAV-HNGTR------------  222 (307)
T ss_dssp             -----CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHH----HHHH-HTTCC------------
T ss_pred             -ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHH----HHHH-hcCCC------------
Confidence             12238999999999999999999999999999999999999997644321110    0000 00000            


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCc
Q 010309          467 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  507 (513)
Q Consensus       467 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  507 (513)
                       .......++.+.+++.+||+.||++|||++++++.|+.+.
T Consensus       223 -~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  262 (307)
T 2eva_A          223 -PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM  262 (307)
T ss_dssp             -CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred             -CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence             0011224457999999999999999999999999998764

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=5.6e-43  Score=344.11  Aligned_cols=241  Identities=21%  Similarity=0.276  Sum_probs=189.3

Q ss_pred             cCCceecccCceEEEEEEeC-CCCEEEEEEecccc--hhcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCCceEEEEeec
Q 010309          228 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFV  303 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~  303 (513)
                      ...+.||+|+||+||+|... +|+.||||++....  .........|+..+.++ +||||+++++++.+.+..++||||+
T Consensus        60 ~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~  139 (311)
T 3p1a_A           60 QRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC  139 (311)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             eeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc
Confidence            33456799999999999986 69999999986542  23334556666666555 9999999999999999999999999


Q ss_pred             cCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccc
Q 010309          304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM  383 (513)
Q Consensus       304 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~  383 (513)
                       +++|.+++...   ...+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++........
T Consensus       140 -~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~  212 (311)
T 3p1a_A          140 -GPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA  212 (311)
T ss_dssp             -CCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred             -CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecccCCC
Confidence             77999988653   35699999999999999999999999   999999999999999999999999999987654322


Q ss_pred             ccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccccccccccc
Q 010309          384 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS  463 (513)
Q Consensus       384 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  463 (513)
                      .   ....||+.|+|||++.+ .++.++||||||+++|||++|..|+......          ......    ...+.  
T Consensus       213 ~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~----------~~~~~~----~~~~~--  272 (311)
T 3p1a_A          213 G---EVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGW----------QQLRQG----YLPPE--  272 (311)
T ss_dssp             -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH----------HHHTTT----CCCHH--
T ss_pred             C---cccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHH----------HHHhcc----CCCcc--
Confidence            2   22338999999998875 7899999999999999999997776542110          000000    00000  


Q ss_pred             CCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          464 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       464 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                            .....++++.+||.+||+.||++|||++|+++
T Consensus       273 ------~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          273 ------FTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             ------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ------cccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence                  11124567999999999999999999999986

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=9.4e-43  Score=344.10  Aligned_cols=248  Identities=19%  Similarity=0.255  Sum_probs=201.6

Q ss_pred             ccCCceecccCceEEEEEEeC-CCCEEEEEEecccchh------cHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEE
Q 010309          227 SEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQ------RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIV  299 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv  299 (513)
                      +...+.||+|+||.||++... +|+.||||++......      ..+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        14 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (321)
T 2a2a_A           14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLI   93 (321)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             EEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence            344567899999999999975 5899999999765322      357899999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCC----CeEEeccccc
Q 010309          300 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF----GAHLMGVGLS  375 (513)
Q Consensus       300 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~----~~kl~Dfg~~  375 (513)
                      |||+++++|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++    .+||+|||++
T Consensus        94 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~  166 (321)
T 2a2a_A           94 LELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (321)
T ss_dssp             ECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred             EEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence            999999999999964    35689999999999999999999999   999999999999999887    7999999999


Q ss_pred             ccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccc
Q 010309          376 KFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL  455 (513)
Q Consensus       376 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  455 (513)
                      .........   ....||+.|+|||++.+..++.++||||||+++|+|++|..||........   .   ..... ... 
T Consensus       167 ~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~---~~i~~-~~~-  235 (321)
T 2a2a_A          167 HEIEDGVEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET---L---ANITS-VSY-  235 (321)
T ss_dssp             EECCTTCCC---CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---H---HHHHT-TCC-
T ss_pred             eecCccccc---cccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHH---H---HHHHh-ccc-
Confidence            876543221   122389999999999999999999999999999999999999976543211   1   00000 000 


Q ss_pred             ccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          456 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       456 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                       ...+..        ....++.+.+||.+||+.||++|||++|+++
T Consensus       236 -~~~~~~--------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          236 -DFDEEF--------FSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             -CCCHHH--------HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             -ccChhh--------hcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence             000000        0123457999999999999999999999986

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=5.2e-43  Score=349.50  Aligned_cols=240  Identities=23%  Similarity=0.390  Sum_probs=195.5

Q ss_pred             CceecccCceEEEEEEe-CCCCEEEEEEecccc---hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccC
Q 010309          230 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  305 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  305 (513)
                      .+.||+|+||.||+|.. .+|+.||||++....   ....+.+.+|+.++++++||||+++++++.+.+..++||||+. 
T Consensus        59 ~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~-  137 (348)
T 1u5q_A           59 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-  137 (348)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS-
T ss_pred             eeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC-
Confidence            45679999999999996 468999999997542   2234678999999999999999999999999999999999996 


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccc
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  385 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  385 (513)
                      |+|.+++...   ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++.......   
T Consensus       138 g~l~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~---  208 (348)
T 1u5q_A          138 GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN---  208 (348)
T ss_dssp             EEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBC---
T ss_pred             CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCCC---
Confidence            6888877532   35699999999999999999999999   99999999999999999999999999998764321   


Q ss_pred             ceeecCcccccccccccc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccc
Q 010309          386 RTVMAGGTYGYLAPEFVY---RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI  462 (513)
Q Consensus       386 ~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  462 (513)
                         ...||+.|+|||++.   ...++.++||||||+++|||++|+.||...+...      .........      .   
T Consensus       209 ---~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~------~~~~~~~~~------~---  270 (348)
T 1u5q_A          209 ---SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQNE------S---  270 (348)
T ss_dssp             ---CCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHSC------C---
T ss_pred             ---cccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHHhcC------C---
Confidence               223899999999985   5678999999999999999999999997654321      111111110      0   


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          463 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       463 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                          ........++.+.+||.+||+.||++|||++++++
T Consensus       271 ----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~  305 (348)
T 1u5q_A          271 ----PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  305 (348)
T ss_dssp             ----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ----CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence                11111234567899999999999999999999986

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.7e-43  Score=346.93  Aligned_cols=253  Identities=23%  Similarity=0.421  Sum_probs=198.3

Q ss_pred             CceecccCceEEEEEEeCC-----CCEEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeec
Q 010309          230 NRLLGDSKTGGTYSGILPD-----GSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  303 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  303 (513)
                      .++||+|+||.||+|....     +..||||+++... ......+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus        49 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  128 (333)
T 1mqb_A           49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYM  128 (333)
T ss_dssp             EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             ccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCC
Confidence            4678999999999998643     2369999997653 334567899999999999999999999999999999999999


Q ss_pred             cCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccc
Q 010309          304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM  383 (513)
Q Consensus       304 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~  383 (513)
                      ++++|.+++...   ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++........
T Consensus       129 ~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  202 (333)
T 1mqb_A          129 ENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE  202 (333)
T ss_dssp             TTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred             CCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhccccc
Confidence            999999999742   35699999999999999999999999   999999999999999999999999999987654322


Q ss_pred             cc-ceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhccccccccccc
Q 010309          384 QE-RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL  461 (513)
Q Consensus       384 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  461 (513)
                      .. ......+|+.|+|||++.+..++.++||||||+++|||++ |..||.......   +..   . .....        
T Consensus       203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~---~~~---~-~~~~~--------  267 (333)
T 1mqb_A          203 ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE---VMK---A-INDGF--------  267 (333)
T ss_dssp             --------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHH---H-HHTTC--------
T ss_pred             cccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH---HHH---H-HHCCC--------
Confidence            11 1112226788999999999999999999999999999999 999997654321   111   1 11000        


Q ss_pred             ccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcC
Q 010309          462 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  508 (513)
Q Consensus       462 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  508 (513)
                           ....+...+..+.+++.+||+.||++||++.++++.|+++..
T Consensus       268 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~  309 (333)
T 1mqb_A          268 -----RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  309 (333)
T ss_dssp             -----CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             -----cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                 000112345679999999999999999999999999987643

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1e-42  Score=336.53  Aligned_cols=244  Identities=22%  Similarity=0.351  Sum_probs=180.5

Q ss_pred             CCceecccCceEEEEEEe-CCCCEEEEEEecccch---hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeecc
Q 010309          229 GNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV  304 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  304 (513)
                      ..+.||+|+||.||+|.. .+|+.||||++.....   ...+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus        15 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   94 (278)
T 3cok_A           15 VGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCH   94 (278)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             eeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCC
Confidence            345789999999999997 4799999999975422   234678999999999999999999999999999999999999


Q ss_pred             CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccc
Q 010309          305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  384 (513)
Q Consensus       305 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  384 (513)
                      +++|.+++..   ....+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++.........
T Consensus        95 ~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~  168 (278)
T 3cok_A           95 NGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK  168 (278)
T ss_dssp             TEEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred             CCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCc
Confidence            9999999974   235699999999999999999999999   9999999999999999999999999999876533221


Q ss_pred             cceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccC
Q 010309          385 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS  464 (513)
Q Consensus       385 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  464 (513)
                      .  ....||+.|+|||++.+..++.++||||||+++|+|++|+.||..........               .....    
T Consensus       169 ~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---------------~~~~~----  227 (278)
T 3cok_A          169 H--YTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN---------------KVVLA----  227 (278)
T ss_dssp             -------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------CCSS----
T ss_pred             c--eeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH---------------HHhhc----
Confidence            1  12338999999999998889999999999999999999999997654321000               00000    


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          465 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       465 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                        ....+...+.++.+||.+||+.||++|||++++++
T Consensus       228 --~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          228 --DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             --CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             --ccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence              00011224567999999999999999999999986

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.4e-43  Score=373.15  Aligned_cols=248  Identities=23%  Similarity=0.336  Sum_probs=199.6

Q ss_pred             eecccCceEEEEEEeC---CCCEEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCC
Q 010309          232 LLGDSKTGGTYSGILP---DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  307 (513)
Q Consensus       232 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs  307 (513)
                      .||+|+||.||+|.+.   ++..||||+++... ....+.+.+|+.+|++++||||+++++++.. +..++||||+++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            5799999999999864   46679999998653 3356789999999999999999999999876 56899999999999


Q ss_pred             HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccc-cc
Q 010309          308 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ-ER  386 (513)
Q Consensus       308 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~-~~  386 (513)
                      |.+++..   ....+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++........ ..
T Consensus       422 L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~  495 (613)
T 2ozo_A          422 LHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA  495 (613)
T ss_dssp             HHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------
T ss_pred             HHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeee
Confidence            9999964   245699999999999999999999999   9999999999999999999999999999876543221 11


Q ss_pred             eeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccccccccCC
Q 010309          387 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  465 (513)
Q Consensus       387 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  465 (513)
                      .....+++.|+|||++.+..++.++|||||||++|||+| |+.||...+..+..   .    .+....            
T Consensus       496 ~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~---~----~i~~~~------------  556 (613)
T 2ozo_A          496 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM---A----FIEQGK------------  556 (613)
T ss_dssp             ------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHH---H----HHHTTC------------
T ss_pred             ccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH---H----HHHcCC------------
Confidence            112225689999999999999999999999999999998 99999876543211   1    111110            


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q 010309          466 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  506 (513)
Q Consensus       466 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  506 (513)
                       ....+..+++++.+||.+||+.||++||++.+|++.|+.+
T Consensus       557 -~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  596 (613)
T 2ozo_A          557 -RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  596 (613)
T ss_dssp             -CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred             -CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence             0011223556799999999999999999999999999865

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=7.2e-43  Score=353.92  Aligned_cols=248  Identities=18%  Similarity=0.275  Sum_probs=193.1

Q ss_pred             ccCCceecccCceEEEEEEeCCCCEEEEEEecccc--hhcHHHHHHHHHHHhhcC--CCcEeeeeeEEeeCCceEEEEee
Q 010309          227 SEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLH--HPNLVAVKGCCYDHGDRYIVYEF  302 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~~~~lv~e~  302 (513)
                      +...+.||+|+||.||++...+++.||||++....  ....+.+.+|+.+|.+++  ||||+++++++...+..++||| 
T Consensus        58 y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-  136 (390)
T 2zmd_A           58 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-  136 (390)
T ss_dssp             EEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-
T ss_pred             eEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-
Confidence            44556789999999999998889999999997543  334577899999999996  5999999999999999999999 


Q ss_pred             ccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccc
Q 010309          303 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV  382 (513)
Q Consensus       303 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~  382 (513)
                      +.+++|.+++..    ...+++..+..++.||+.||.|||+.   +|+||||||+|||++ ++.+||+|||++.......
T Consensus       137 ~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~  208 (390)
T 2zmd_A          137 CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  208 (390)
T ss_dssp             CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred             cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence            568899999975    24689999999999999999999999   999999999999996 5789999999998765443


Q ss_pred             cccceeecCccccccccccccc-----------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhc
Q 010309          383 MQERTVMAGGTYGYLAPEFVYR-----------NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQS  451 (513)
Q Consensus       383 ~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  451 (513)
                      .........||+.|+|||++.+           ..++.++|||||||++|||++|+.||......     .......   
T Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-----~~~~~~~---  280 (390)
T 2zmd_A          209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKLHAI---  280 (390)
T ss_dssp             -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-----HHHHHHH---
T ss_pred             ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-----HHHHHHH---
Confidence            2222223449999999999865           36889999999999999999999999754321     0111111   


Q ss_pred             ccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          452 HRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       452 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                            +++...    ...+...+.++.+||.+||+.||.+|||+.|+++
T Consensus       281 ------~~~~~~----~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  320 (390)
T 2zmd_A          281 ------IDPNHE----IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  320 (390)
T ss_dssp             ------HCTTSC----CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ------hCcccc----CCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence                  111100    0001112456899999999999999999999986

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=3.6e-43  Score=362.82  Aligned_cols=245  Identities=23%  Similarity=0.257  Sum_probs=192.1

Q ss_pred             ccCCceecccCceEEEEEEeC-CCCEEEEEEecccc---hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEee
Q 010309          227 SEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF  302 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  302 (513)
                      ++..+.||+|+||.||++... +|+.||||++....   ......+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus       150 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~  229 (446)
T 4ejn_A          150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEY  229 (446)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECC
T ss_pred             cEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEee
Confidence            344567899999999999964 68999999997642   23345678899999999999999999999999999999999


Q ss_pred             ccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCceEcCCCCCceEecCCCCeEEecccccccCCcc
Q 010309          303 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD-KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE  381 (513)
Q Consensus       303 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~  381 (513)
                      +++|+|.+++..    ...+++..+..++.||+.||+|||+ .   +|+||||||+|||++.++.+||+|||+++.....
T Consensus       230 ~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  302 (446)
T 4ejn_A          230 ANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD  302 (446)
T ss_dssp             CSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred             CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence            999999999864    3469999999999999999999998 8   9999999999999999999999999999864332


Q ss_pred             ccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccccccccc
Q 010309          382 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL  461 (513)
Q Consensus       382 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  461 (513)
                      ...  .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+...   +....   .. ..        
T Consensus       303 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~~~i---~~-~~--------  365 (446)
T 4ejn_A          303 GAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFELI---LM-EE--------  365 (446)
T ss_dssp             ------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH---HH-CC--------
T ss_pred             Ccc--cccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH---HHHHH---Hh-CC--------
Confidence            221  223449999999999999999999999999999999999999997654321   11111   00 00        


Q ss_pred             ccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 010309          462 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP-----RMSHVVH  501 (513)
Q Consensus       462 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  501 (513)
                            ...+...++++.+||.+||+.||.+||     +++|+++
T Consensus       366 ------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          366 ------IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             ------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ------CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence                  001122456799999999999999999     9999985

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.7e-43  Score=351.75  Aligned_cols=253  Identities=27%  Similarity=0.435  Sum_probs=192.9

Q ss_pred             CceecccCceEEEEEEeCC----CCEEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEee-CCceEEEEeec
Q 010309          230 NRLLGDSKTGGTYSGILPD----GSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYD-HGDRYIVYEFV  303 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~lv~e~~  303 (513)
                      .+.||+|+||.||+|...+    +..||||.++... ....+.+.+|+.++++++||||+++++++.+ .+..++||||+
T Consensus        94 ~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~  173 (373)
T 3c1x_A           94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  173 (373)
T ss_dssp             EEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECC
T ss_pred             CcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECC
Confidence            4678999999999998632    2368999987542 3445789999999999999999999998754 56789999999


Q ss_pred             cCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccc
Q 010309          304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM  383 (513)
Q Consensus       304 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~  383 (513)
                      ++|+|.+++..   ....+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......
T Consensus       174 ~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~  247 (373)
T 3c1x_A          174 KHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF  247 (373)
T ss_dssp             TTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred             CCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccccccc
Confidence            99999999964   235688999999999999999999999   999999999999999999999999999986643321


Q ss_pred             cc--ceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccccc
Q 010309          384 QE--RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP  460 (513)
Q Consensus       384 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  460 (513)
                      ..  ......+|+.|+|||++.+..++.++||||||+++|||+| |.+||...........      ... ..       
T Consensus       248 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~------~~~-~~-------  313 (373)
T 3c1x_A          248 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY------LLQ-GR-------  313 (373)
T ss_dssp             ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHH------HHT-TC-------
T ss_pred             ccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHH------HHc-CC-------
Confidence            11  1122237789999999999999999999999999999999 7778776544321111      000 00       


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcC
Q 010309          461 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  508 (513)
Q Consensus       461 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  508 (513)
                            ....+..++..+.+++.+||+.||++|||+.++++.|+++..
T Consensus       314 ------~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~  355 (373)
T 3c1x_A          314 ------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  355 (373)
T ss_dssp             ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                  001112345679999999999999999999999999987653

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.1e-42  Score=364.77  Aligned_cols=250  Identities=22%  Similarity=0.275  Sum_probs=203.3

Q ss_pred             ccCCceecccCceEEEEEEeC-CCCEEEEEEecccc---hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEee
Q 010309          227 SEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF  302 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  302 (513)
                      +...++||+|+||.||++... +|+.||||++.+..   ......+.+|+.+|+.++||||+++++++.+.+..|+||||
T Consensus       186 f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy  265 (576)
T 2acx_A          186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL  265 (576)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             eEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEc
Confidence            344567899999999999975 69999999997642   23456788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccc
Q 010309          303 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV  382 (513)
Q Consensus       303 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~  382 (513)
                      +++|+|.+++...  ....+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++.......
T Consensus       266 ~~gg~L~~~l~~~--~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~  340 (576)
T 2acx_A          266 MNGGDLKFHIYHM--GQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ  340 (576)
T ss_dssp             CCSCBHHHHHHSS--SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred             CCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecccCc
Confidence            9999999999752  234599999999999999999999999   99999999999999999999999999998765432


Q ss_pred             cccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccc
Q 010309          383 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI  462 (513)
Q Consensus       383 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  462 (513)
                      .   .....||+.|+|||++.+..++.++|||||||++|||++|..||............   .......          
T Consensus       341 ~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i---~~~i~~~----------  404 (576)
T 2acx_A          341 T---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV---ERLVKEV----------  404 (576)
T ss_dssp             C---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHH---HHHHHHC----------
T ss_pred             c---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHH---HHHhhcc----------
Confidence            2   12234999999999999989999999999999999999999999875432111110   0101000          


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 010309          463 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP-----RMSHVVH  501 (513)
Q Consensus       463 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  501 (513)
                          ....+...++++.+||.+||+.||.+||     +++||++
T Consensus       405 ----~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          405 ----PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             ----CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             ----cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence                0011123456799999999999999999     7888875

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.9e-42  Score=334.09  Aligned_cols=247  Identities=23%  Similarity=0.332  Sum_probs=200.3

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCC
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  307 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs  307 (513)
                      .+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||+++++
T Consensus        12 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   91 (276)
T 2yex_A           12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE   91 (276)
T ss_dssp             EEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred             EEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCc
Confidence            456799999999999975 68999999997543 2345778999999999999999999999999999999999999999


Q ss_pred             HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccce
Q 010309          308 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  387 (513)
Q Consensus       308 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  387 (513)
                      |.+++..    ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||.+............
T Consensus        92 L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  164 (276)
T 2yex_A           92 LFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL  164 (276)
T ss_dssp             GGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred             HHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcc
Confidence            9998853    35699999999999999999999999   9999999999999999999999999999866433222222


Q ss_pred             eecCcccccccccccccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCC
Q 010309          388 VMAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  466 (513)
Q Consensus       388 ~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  466 (513)
                      ....||+.|+|||++.+..+ +.++||||||+++|+|++|..||....... .....+.    ....             
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~----~~~~-------------  226 (276)
T 2yex_A          165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWK----EKKT-------------  226 (276)
T ss_dssp             CCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS-HHHHHHH----TTCT-------------
T ss_pred             cCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH-HHHHHhh----hccc-------------
Confidence            23348999999999987665 779999999999999999999997654321 0111100    0000             


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          467 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       467 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      ........++.+.+|+.+||+.||++|||++++++
T Consensus       227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          227 YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence            00112234567899999999999999999999986

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=6.4e-43  Score=340.35  Aligned_cols=254  Identities=26%  Similarity=0.378  Sum_probs=201.5

Q ss_pred             cccCCceecccCceEEEEEEeC---CCCEEEEEEecccch--hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEE
Q 010309          226 FSEGNRLLGDSKTGGTYSGILP---DGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY  300 (513)
Q Consensus       226 ~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  300 (513)
                      |....+.||+|+||.||+|.+.   +++.||||+++....  ...+.+.+|+.+++.++||||+++++++ ..+..++||
T Consensus        18 y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~   96 (291)
T 1xbb_A           18 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVM   96 (291)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEE
T ss_pred             hhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEE
Confidence            3333447899999999999642   468899999976532  2357799999999999999999999998 667889999


Q ss_pred             eeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCc
Q 010309          301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW  380 (513)
Q Consensus       301 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~  380 (513)
                      ||+++++|.+++..    ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++.....
T Consensus        97 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  169 (291)
T 1xbb_A           97 EMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRA  169 (291)
T ss_dssp             ECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred             EeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence            99999999999975    34599999999999999999999999   999999999999999999999999999987654


Q ss_pred             ccccc-ceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccc
Q 010309          381 EVMQE-RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELL  458 (513)
Q Consensus       381 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  458 (513)
                      ..... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||........   ..    .......    
T Consensus       170 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~----~~~~~~~----  238 (291)
T 1xbb_A          170 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV---TA----MLEKGER----  238 (291)
T ss_dssp             TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---HH----HHHTTCC----
T ss_pred             CCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH---HH----HHHcCCC----
Confidence            32211 1122236789999999988889999999999999999999 9999987543211   11    1111100    


Q ss_pred             cccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCc
Q 010309          459 DPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  507 (513)
Q Consensus       459 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  507 (513)
                               ...+..+++.+.+++.+||+.||++|||+.+|++.|+++.
T Consensus       239 ---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  278 (291)
T 1xbb_A          239 ---------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  278 (291)
T ss_dssp             ---------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             ---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                     0111234567999999999999999999999999998764

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.5e-42  Score=335.50  Aligned_cols=241  Identities=26%  Similarity=0.355  Sum_probs=196.5

Q ss_pred             CCceecccCceEEEEEEeC-CCCEEEEEEecccc---hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeecc
Q 010309          229 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV  304 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  304 (513)
                      ..+.||+|+||.||+|... ++..||||++....   ......+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus        13 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   92 (279)
T 3fdn_A           13 IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP   92 (279)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred             EeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCC
Confidence            3457899999999999875 47799999996542   2235678999999999999999999999999999999999999


Q ss_pred             CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccc
Q 010309          305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  384 (513)
Q Consensus       305 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  384 (513)
                      +++|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++........ 
T Consensus        93 ~~~l~~~l~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~~-  164 (279)
T 3fdn_A           93 LGTVYRELQKL----SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR-  164 (279)
T ss_dssp             TEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC------
T ss_pred             CCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCcccc-
Confidence            99999998652    4589999999999999999999999   999999999999999999999999999865543321 


Q ss_pred             cceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccC
Q 010309          385 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS  464 (513)
Q Consensus       385 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  464 (513)
                         ....||+.|+|||++.+..++.++||||||+++|+|++|..||...+....   ..   .. ...            
T Consensus       165 ---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~---~~-~~~------------  222 (279)
T 3fdn_A          165 ---TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET---YK---RI-SRV------------  222 (279)
T ss_dssp             ------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HH---HH-HHT------------
T ss_pred             ---cccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHH---HH---HH-HhC------------
Confidence               123389999999999999999999999999999999999999976543211   10   00 000            


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          465 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       465 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                        ....+...++.+.+||.+||+.||++|||++|+++
T Consensus       223 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  257 (279)
T 3fdn_A          223 --EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  257 (279)
T ss_dssp             --CCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             --CCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence              00011224457899999999999999999999996

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=8.4e-43  Score=347.87  Aligned_cols=268  Identities=19%  Similarity=0.228  Sum_probs=203.4

Q ss_pred             HHHHhhCcccCCceecccCceEEEEEEeC-CCCEEEEEEecccc-----hhcHHHHHHHHHHHhhcCCCcEeeeeeEEee
Q 010309          219 LRSITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-----FQRKKEFYSEIGRFARLHHPNLVAVKGCCYD  292 (513)
Q Consensus       219 l~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  292 (513)
                      +..+.++|.. .+.||+|+||.||+|... +++.||||++....     ....+.+.+|+.++++++||||+++++++.+
T Consensus        21 ~~~~~~~y~~-~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   99 (345)
T 3hko_A           21 LLELQKKYHL-KGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED   99 (345)
T ss_dssp             HHHHHHHEEE-EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhhhhhheee-cceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence            3455566654 456799999999999974 58899999997542     2345789999999999999999999999999


Q ss_pred             CCceEEEEeeccCCCHHHHhccCCCC------------------------------------CCCCCHHHHHHHHHHHHH
Q 010309          293 HGDRYIVYEFVVNGPLDRWLHHIPRG------------------------------------GRSLDWAMRMKVATTLAQ  336 (513)
Q Consensus       293 ~~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~qi~~  336 (513)
                      .+..++||||+++|+|.+++......                                    ...+++..+..++.||+.
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  179 (345)
T 3hko_A          100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS  179 (345)
T ss_dssp             SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence            99999999999999999998531110                                    123467788899999999


Q ss_pred             HHHHHhcCCCCCceEcCCCCCceEecCCC--CeEEecccccccCCcccccc--ceeecCccccccccccccc--CCCCch
Q 010309          337 GIAFLHDKVKPHVVHRDIRASNVLLDEEF--GAHLMGVGLSKFVPWEVMQE--RTVMAGGTYGYLAPEFVYR--NELTTK  410 (513)
Q Consensus       337 ~L~~LH~~~~~~ivH~Dikp~NIll~~~~--~~kl~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~  410 (513)
                      ||+|||+.   +|+||||||+|||++.++  .+||+|||++..........  ......||+.|+|||++.+  ..++.+
T Consensus       180 ~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  256 (345)
T 3hko_A          180 ALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK  256 (345)
T ss_dssp             HHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred             HHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence            99999999   999999999999998776  89999999998653321111  1223348999999999875  678999


Q ss_pred             hhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCC
Q 010309          411 SDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVP  490 (513)
Q Consensus       411 sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP  490 (513)
                      +||||||+++|||++|+.||........      .........  ..         ........++.+.+||.+||+.||
T Consensus       257 ~DiwslG~il~el~~g~~pf~~~~~~~~------~~~~~~~~~--~~---------~~~~~~~~~~~~~~li~~~l~~~p  319 (345)
T 3hko_A          257 CDAWSAGVLLHLLLMGAVPFPGVNDADT------ISQVLNKKL--CF---------ENPNYNVLSPLARDLLSNLLNRNV  319 (345)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHCCC--CT---------TSGGGGGSCHHHHHHHHHHSCSCT
T ss_pred             HHHHHHHHHHHHHHHCCCCCCCCChHHH------HHHHHhccc--cc---------CCcccccCCHHHHHHHHHHcCCCh
Confidence            9999999999999999999976553211      111111000  00         001112245679999999999999


Q ss_pred             CCCCCHHHHHH--HHhcCc
Q 010309          491 SMRPRMSHVVH--QLQQLA  507 (513)
Q Consensus       491 ~~RPs~~evl~--~L~~~~  507 (513)
                      .+|||+.++++  .++++.
T Consensus       320 ~~Rps~~~~l~hp~~~~~~  338 (345)
T 3hko_A          320 DERFDAMRALQHPWISQFS  338 (345)
T ss_dssp             TTSCCHHHHHHSHHHHTTS
T ss_pred             hHCCCHHHHhcChhhccCh
Confidence            99999999987  344443

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.7e-42  Score=340.62  Aligned_cols=261  Identities=19%  Similarity=0.267  Sum_probs=196.4

Q ss_pred             CCceecccCceEEEEEEeC-CCCEEEEEEecccch--hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccC
Q 010309          229 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  305 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  305 (513)
                      ..+.||+|+||.||+|... +|+.||||++.....  ...+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus         7 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   86 (311)
T 4agu_A            7 KIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH   86 (311)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred             EeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCC
Confidence            3456799999999999975 489999999866532  2346788999999999999999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccc
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  385 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  385 (513)
                      ++|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++..........
T Consensus        87 ~~l~~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  159 (311)
T 4agu_A           87 TVLHELDRY----QRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY  159 (311)
T ss_dssp             EHHHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred             chHHHHHhh----hcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccccc
Confidence            999998753    35699999999999999999999999   99999999999999999999999999998765332211


Q ss_pred             ceeecCccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhh--------hHHhhcccccc
Q 010309          386 RTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWA--------TPLVQSHRYLE  456 (513)
Q Consensus       386 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~  456 (513)
                        ....+|+.|+|||++.+ ..++.++||||||+++|+|++|..||...............        ...........
T Consensus       160 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (311)
T 4agu_A          160 --DDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS  237 (311)
T ss_dssp             --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGT
T ss_pred             --CCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccc
Confidence              12238999999999976 56899999999999999999999999876543211111100        00000000000


Q ss_pred             cccccccCCCCCCC-----cHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          457 LLDPLISSLSSDIP-----EAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       457 ~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      ...  ... .....     ....++.+.+|+.+||+.||++|||++|+++
T Consensus       238 ~~~--~~~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          238 GVK--IPD-PEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             TCC--CCC-CSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             cCc--CCC-ccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            000  000 00000     0134567999999999999999999999985

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=2.3e-42  Score=334.96  Aligned_cols=247  Identities=20%  Similarity=0.276  Sum_probs=199.9

Q ss_pred             cCCceecccCceEEEEEEeC-CCCEEEEEEecccc--hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeecc
Q 010309          228 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV  304 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  304 (513)
                      ...+.||+|+||.||+|... +|+.||+|++....  ....+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus         9 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~   88 (284)
T 3kk8_A            9 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVT   88 (284)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             hhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCC
Confidence            33456799999999999975 58999999997543  2344678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCC---eEEecccccccCCcc
Q 010309          305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG---AHLMGVGLSKFVPWE  381 (513)
Q Consensus       305 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~---~kl~Dfg~~~~~~~~  381 (513)
                      +++|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.   +||+|||++......
T Consensus        89 ~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~  161 (284)
T 3kk8_A           89 GGELFEDIVA----REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS  161 (284)
T ss_dssp             SCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred             CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence            9999888864    25699999999999999999999999   9999999999999987655   999999999776543


Q ss_pred             ccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccccccccc
Q 010309          382 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL  461 (513)
Q Consensus       382 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  461 (513)
                      ....   ...||+.|+|||++.+..++.++||||||+++|+|++|..||...+.....   .   . ...... ..    
T Consensus       162 ~~~~---~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~---~---~-~~~~~~-~~----  226 (284)
T 3kk8_A          162 EAWH---GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY---A---Q-IKAGAY-DY----  226 (284)
T ss_dssp             CBCC---CSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---H---H-HHHTCC-CC----
T ss_pred             cccc---CCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHH---H---H-HHhccc-cC----
Confidence            3221   233899999999999999999999999999999999999999765432111   1   0 000000 00    


Q ss_pred             ccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          462 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       462 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                           ........++++.+|+.+||+.||++|||++|+++
T Consensus       227 -----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          227 -----PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             -----CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -----CchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                 00011234567999999999999999999999987

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.4e-43  Score=351.02  Aligned_cols=264  Identities=28%  Similarity=0.382  Sum_probs=203.5

Q ss_pred             HhhCcccCCceecccCceEEEEEEe------CCCCEEEEEEeccc-chhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCC
Q 010309          222 ITKNFSEGNRLLGDSKTGGTYSGIL------PDGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG  294 (513)
Q Consensus       222 ~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  294 (513)
                      +..+.+...+.||+|+||.||+|..      .++..||||++... .......+.+|+.++++++||||+++++++.+.+
T Consensus        27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  106 (327)
T 2yfx_A           27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL  106 (327)
T ss_dssp             CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence            3334445567789999999999984      24779999999754 3344567899999999999999999999999999


Q ss_pred             ceEEEEeeccCCCHHHHhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecC---CCCeE
Q 010309          295 DRYIVYEFVVNGPLDRWLHHIPR---GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE---EFGAH  368 (513)
Q Consensus       295 ~~~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~---~~~~k  368 (513)
                      ..++||||+++++|.+++.....   ....+++..++.++.|++.||.|||+.   +|+||||||+|||++.   +..+|
T Consensus       107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~k  183 (327)
T 2yfx_A          107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAK  183 (327)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEE
Confidence            99999999999999999976432   124589999999999999999999999   9999999999999984   44699


Q ss_pred             EecccccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhH
Q 010309          369 LMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATP  447 (513)
Q Consensus       369 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~  447 (513)
                      |+|||++................+|+.|+|||++.+..++.++||||||+++|+|+| |..||.......   ....   
T Consensus       184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~---  257 (327)
T 2yfx_A          184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---VLEF---  257 (327)
T ss_dssp             ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HHHH---
T ss_pred             ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH---HHHH---
Confidence            999999875432222222222337889999999999999999999999999999998 999997654321   1111   


Q ss_pred             HhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcC
Q 010309          448 LVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  508 (513)
Q Consensus       448 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  508 (513)
                       .....             ....+..++..+.++|.+||+.||.+|||+.+|++.|+.+..
T Consensus       258 -~~~~~-------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  304 (327)
T 2yfx_A          258 -VTSGG-------------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  304 (327)
T ss_dssp             -HHTTC-------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -HhcCC-------------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence             11110             001112345679999999999999999999999999986543

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=6.5e-43  Score=346.14  Aligned_cols=256  Identities=28%  Similarity=0.467  Sum_probs=202.3

Q ss_pred             cCCceecccCceEEEEEEeC-CCCE--EEEEEeccc-chhcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCCceEEEEee
Q 010309          228 EGNRLLGDSKTGGTYSGILP-DGSR--VAVKRLKRS-SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEF  302 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~-~~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~  302 (513)
                      ...+.||+|+||.||+|... ++..  ||||.++.. .....+.+.+|+.+++++ +||||+++++++.+.+..++||||
T Consensus        28 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~  107 (327)
T 1fvr_A           28 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY  107 (327)
T ss_dssp             EEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             cceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEec
Confidence            34567899999999999964 4554  599998754 223456789999999999 999999999999999999999999


Q ss_pred             ccCCCHHHHhccCC------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEe
Q 010309          303 VVNGPLDRWLHHIP------------RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLM  370 (513)
Q Consensus       303 ~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~  370 (513)
                      +++++|.+++....            .....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+
T Consensus       108 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kL~  184 (327)
T 1fvr_A          108 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIA  184 (327)
T ss_dssp             CTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEEC
T ss_pred             CCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeEEEc
Confidence            99999999997532            2235799999999999999999999999   99999999999999999999999


Q ss_pred             cccccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHh
Q 010309          371 GVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLV  449 (513)
Q Consensus       371 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  449 (513)
                      |||++.........   ....+++.|+|||++.+..++.++||||||+++|||+| |..||.......   +..   .. 
T Consensus       185 Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~---~~~---~~-  254 (327)
T 1fvr_A          185 DFGLSRGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYE---KL-  254 (327)
T ss_dssp             CTTCEESSCEECCC-------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHH---HG-
T ss_pred             ccCcCccccccccc---cCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH---HHH---Hh-
Confidence            99999754332211   12237889999999988889999999999999999998 999997654321   111   10 


Q ss_pred             hcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcCC
Q 010309          450 QSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP  509 (513)
Q Consensus       450 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  509 (513)
                      ...     .        ....+...++.+.+||.+||+.||.+|||++++++.|+++...
T Consensus       255 ~~~-----~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  301 (327)
T 1fvr_A          255 PQG-----Y--------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  301 (327)
T ss_dssp             GGT-----C--------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             hcC-----C--------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            000     0        0011123456799999999999999999999999999876443

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.1e-42  Score=351.49  Aligned_cols=277  Identities=16%  Similarity=0.181  Sum_probs=209.9

Q ss_pred             cccCCceecccCceEEEEEEeC-CCCEEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCC--ceEEEEe
Q 010309          226 FSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG--DRYIVYE  301 (513)
Q Consensus       226 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--~~~lv~e  301 (513)
                      .+...++||+|+||.||+|... +|+.||||++.... ....+.+.+|+.++++++||||+++++++...+  ..++|||
T Consensus        10 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e   89 (396)
T 4eut_A           10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIME   89 (396)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEC
T ss_pred             ceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEe
Confidence            3455678899999999999975 48999999997653 234577889999999999999999999998765  6799999


Q ss_pred             eccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEe----cCCCCeEEeccccccc
Q 010309          302 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL----DEEFGAHLMGVGLSKF  377 (513)
Q Consensus       302 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll----~~~~~~kl~Dfg~~~~  377 (513)
                      |+++|+|.+++..... ...+++..++.++.||+.||+|||+.   +|+||||||+|||+    +.++.+||+|||+++.
T Consensus        90 ~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~  165 (396)
T 4eut_A           90 FCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (396)
T ss_dssp             CCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred             cCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence            9999999999975321 23499999999999999999999999   99999999999999    7777899999999987


Q ss_pred             CCccccccceeecCccccccccccccc--------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccc-chhHHhhhHH
Q 010309          378 VPWEVMQERTVMAGGTYGYLAPEFVYR--------NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW-QSIFEWATPL  448 (513)
Q Consensus       378 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~-~~~~~~~~~~  448 (513)
                      ........   ...||+.|+|||++.+        ..++.++|||||||++|||++|+.||........ ..........
T Consensus       166 ~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  242 (396)
T 4eut_A          166 LEDDEQFV---SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (396)
T ss_dssp             CCCGGGSS---CSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred             ccCCCccc---cccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence            65443221   2348999999999865        4567899999999999999999999975443211 1111111100


Q ss_pred             hhccccccc---cccc---ccC-CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcCC
Q 010309          449 VQSHRYLEL---LDPL---ISS-LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP  509 (513)
Q Consensus       449 ~~~~~~~~~---~~~~---~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  509 (513)
                      .........   ....   ... ..........+..+.+++.+||+.||++||+++++++.++.+...
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence            000000000   0000   000 001223467888999999999999999999999999999876553

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=8.8e-43  Score=347.82  Aligned_cols=267  Identities=16%  Similarity=0.150  Sum_probs=198.6

Q ss_pred             CcccCCceecccCceEEEEEEeC----CCCEEEEEEecccchh-----------cHHHHHHHHHHHhhcCCCcEeeeeeE
Q 010309          225 NFSEGNRLLGDSKTGGTYSGILP----DGSRVAVKRLKRSSFQ-----------RKKEFYSEIGRFARLHHPNLVAVKGC  289 (513)
Q Consensus       225 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~nIv~l~~~  289 (513)
                      +-+...+.||+|+||.||+|...    ++..||||++......           ....+.+|+..+..++||||++++++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            33455667899999999999975    5789999999765321           12346778899999999999999999


Q ss_pred             Eee----CCceEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCC
Q 010309          290 CYD----HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF  365 (513)
Q Consensus       290 ~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~  365 (513)
                      +..    ....++||||+ +++|.+++...    ..+++..++.++.||+.||+|||+.   +|+||||||+|||++.++
T Consensus       117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~  188 (345)
T 2v62_A          117 GLTEFKGRSYRFMVMERL-GIDLQKISGQN----GTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKN  188 (345)
T ss_dssp             EEEESSSCEEEEEEEECE-EEEHHHHCBGG----GBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSS
T ss_pred             cccccCCCcEEEEEEecc-CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCC
Confidence            988    67889999999 99999999652    3799999999999999999999999   999999999999998887


Q ss_pred             --CeEEecccccccCCcccccc-----ceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccc
Q 010309          366 --GAHLMGVGLSKFVPWEVMQE-----RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW  438 (513)
Q Consensus       366 --~~kl~Dfg~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~  438 (513)
                        .+||+|||+++.........     ......||+.|+|||++.+..++.++||||||+++|||++|+.||........
T Consensus       189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~  268 (345)
T 2v62_A          189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV  268 (345)
T ss_dssp             TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred             CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence              99999999998765332111     11223489999999999999999999999999999999999999965322110


Q ss_pred             chhHHhhhHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcCC
Q 010309          439 QSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP  509 (513)
Q Consensus       439 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  509 (513)
                       ...........  .....+....       +....++++.+++.+||+.||++|||+++|++.|+++..+
T Consensus       269 -~~~~~~~~~~~--~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  329 (345)
T 2v62_A          269 -AVQTAKTNLLD--ELPQSVLKWA-------PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIP  329 (345)
T ss_dssp             -HHHHHHHHHHH--TTTHHHHHHS-------CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCC
T ss_pred             -HHHHHHHhhcc--cccHHHHhhc-------cccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCc
Confidence             01000000000  0000000000       0113455799999999999999999999999999987654

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=6.5e-42  Score=343.58  Aligned_cols=267  Identities=17%  Similarity=0.224  Sum_probs=200.2

Q ss_pred             HhhCcccCCceecccCceEEEEEEe-CCCCEEEEEEecccchhcHHHHHHHHHHHhhcC-----CCcEeeeeeEEeeCCc
Q 010309          222 ITKNFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-----HPNLVAVKGCCYDHGD  295 (513)
Q Consensus       222 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~nIv~l~~~~~~~~~  295 (513)
                      +.++|. ..+.||+|+||.||+|.. .+++.||||+++.. ......+..|+.+++.+.     ||||+++++++...+.
T Consensus        33 ~~~~y~-~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~  110 (360)
T 3llt_A           33 LNNAFL-VIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDH  110 (360)
T ss_dssp             ETTTEE-EEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTE
T ss_pred             ecCEEE-EEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCe
Confidence            344444 345679999999999997 46899999999754 234566788999999986     9999999999999999


Q ss_pred             eEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecC------------
Q 010309          296 RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE------------  363 (513)
Q Consensus       296 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~------------  363 (513)
                      .++||||+ +++|.+++...  ....+++..++.++.||+.||+|||+.   +|+||||||+|||++.            
T Consensus       111 ~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~~~~~  184 (360)
T 3llt_A          111 MCLIFEPL-GPSLYEIITRN--NYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRR  184 (360)
T ss_dssp             EEEEECCC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEEEEEC
T ss_pred             eEEEEcCC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccccchhc
Confidence            99999999 99999999763  234599999999999999999999999   9999999999999975            


Q ss_pred             -------------CCCeEEecccccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCC
Q 010309          364 -------------EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPA  430 (513)
Q Consensus       364 -------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~  430 (513)
                                   ++.+||+|||++.......     ....||+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus       185 ~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf  259 (360)
T 3llt_A          185 VTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLF  259 (360)
T ss_dssp             TTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred             ccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCC
Confidence                         7889999999998654322     1233899999999999999999999999999999999999999


Q ss_pred             CCCCccccchhHHhhhHH-----h---hcccccccccc-cc-cCCCCCCCc---------------HHHHHHHHHHHHHh
Q 010309          431 QAVDSVCWQSIFEWATPL-----V---QSHRYLELLDP-LI-SSLSSDIPE---------------AGVVQKVVDLVYAC  485 (513)
Q Consensus       431 ~~~~~~~~~~~~~~~~~~-----~---~~~~~~~~~~~-~~-~~~~~~~~~---------------~~~~~~l~~li~~c  485 (513)
                      ...+..............     .   ........... .. .........               ...++.+.+||.+|
T Consensus       260 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  339 (360)
T 3llt_A          260 RTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSI  339 (360)
T ss_dssp             CCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHH
T ss_pred             CCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHH
Confidence            876543221111110000     0   00000000000 00 000000000               01125688999999


Q ss_pred             cCCCCCCCCCHHHHHH
Q 010309          486 TQHVPSMRPRMSHVVH  501 (513)
Q Consensus       486 l~~dP~~RPs~~evl~  501 (513)
                      |+.||++|||++|+++
T Consensus       340 L~~dP~~Rpta~elL~  355 (360)
T 3llt_A          340 LQIDPTLRPSPAELLK  355 (360)
T ss_dssp             CCSSGGGSCCHHHHTT
T ss_pred             hcCChhhCCCHHHHhc
Confidence            9999999999999975

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.5e-43  Score=350.55  Aligned_cols=272  Identities=22%  Similarity=0.357  Sum_probs=206.6

Q ss_pred             CcccCCceecccCceEEEEEEe-----CCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCC--ceE
Q 010309          225 NFSEGNRLLGDSKTGGTYSGIL-----PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG--DRY  297 (513)
Q Consensus       225 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--~~~  297 (513)
                      +.+...+.||+|+||.||++..     .+++.||||++........+.+.+|+.++++++||||+++++++...+  ..+
T Consensus        41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  120 (326)
T 2w1i_A           41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK  120 (326)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred             HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence            3344556789999999999984     358899999998776666778999999999999999999999987654  789


Q ss_pred             EEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEeccccccc
Q 010309          298 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF  377 (513)
Q Consensus       298 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~  377 (513)
                      +||||+++++|.+++...   ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++..
T Consensus       121 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~  194 (326)
T 2w1i_A          121 LIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKV  194 (326)
T ss_dssp             EEECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence            999999999999999752   24589999999999999999999999   999999999999999999999999999987


Q ss_pred             CCcccccc-ceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhh-hHHhhccccc
Q 010309          378 VPWEVMQE-RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWA-TPLVQSHRYL  455 (513)
Q Consensus       378 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~  455 (513)
                      ........ ......++..|+|||++.+..++.++||||||+++|||+||..|+...... ........ ..........
T Consensus       195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  273 (326)
T 2w1i_A          195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE-FMRMIGNDKQGQMIVFHLI  273 (326)
T ss_dssp             CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH-HHHHHCTTCCTHHHHHHHH
T ss_pred             ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH-HHHhhccccchhhhHHHHH
Confidence            65432211 111223678899999999888999999999999999999999987643110 00000000 0000000000


Q ss_pred             ccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCc
Q 010309          456 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  507 (513)
Q Consensus       456 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  507 (513)
                      +.+....    ....+..+++++.+||.+||+.||++|||+.+|++.|+++.
T Consensus       274 ~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~  321 (326)
T 2w1i_A          274 ELLKNNG----RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR  321 (326)
T ss_dssp             HHHHTTC----CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHhhcCC----CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            0000000    01112235567999999999999999999999999998765

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=3.1e-42  Score=360.47  Aligned_cols=251  Identities=20%  Similarity=0.286  Sum_probs=203.3

Q ss_pred             CCceecccCceEEEEEEeC-CCCEEEEEEecccch---hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeecc
Q 010309          229 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV  304 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  304 (513)
                      ..++||+|+||.||+++.. +|+.||||++.+...   .....+.+|+.+|++++||||+++++++.+.+..|+||||++
T Consensus       189 ~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~  268 (543)
T 3c4z_A          189 DFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMN  268 (543)
T ss_dssp             EEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred             EEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEecc
Confidence            3467899999999999975 599999999976432   334678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccc
Q 010309          305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  384 (513)
Q Consensus       305 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  384 (513)
                      +|+|.+++.........+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++.........
T Consensus       269 gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~  345 (543)
T 3c4z_A          269 GGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK  345 (543)
T ss_dssp             TCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCC
T ss_pred             CCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccCCCcc
Confidence            9999999976544456799999999999999999999999   9999999999999999999999999999876543222


Q ss_pred             cceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccC
Q 010309          385 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS  464 (513)
Q Consensus       385 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  464 (513)
                        .....||+.|+|||++.+..++.++|||||||++|||++|..||.........  ......... .        .   
T Consensus       346 --~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~--~~~~~~i~~-~--------~---  409 (543)
T 3c4z_A          346 --TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KELKQRVLE-Q--------A---  409 (543)
T ss_dssp             --BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH--HHHHHHHHH-C--------C---
T ss_pred             --cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhH--HHHHHHHhh-c--------c---
Confidence              12234999999999999999999999999999999999999999865432111  011111111 0        0   


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHH
Q 010309          465 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRM-----SHVVH  501 (513)
Q Consensus       465 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~  501 (513)
                         ...+...++.+.+||.+||+.||++||++     ++|++
T Consensus       410 ---~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          410 ---VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             ---CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             ---cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence               01112345679999999999999999975     66653

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=5.5e-43  Score=351.43  Aligned_cols=264  Identities=22%  Similarity=0.352  Sum_probs=202.7

Q ss_pred             cCCceecccCceEEEEEEeC-CCCEEEEEEeccc-chhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccC
Q 010309          228 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  305 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  305 (513)
                      ...+.||+|+||.||++... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus        36 ~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  115 (360)
T 3eqc_A           36 EKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDG  115 (360)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred             eeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCC
Confidence            44567899999999999975 6899999999765 233457789999999999999999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccc
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  385 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  385 (513)
                      ++|.+++..    ...+++..+..++.|++.||.|||+..  +|+||||||+|||++.++.+||+|||++.......   
T Consensus       116 ~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---  186 (360)
T 3eqc_A          116 GSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---  186 (360)
T ss_dssp             CBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC---
T ss_pred             CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCccccccc---
Confidence            999999965    246899999999999999999999831  79999999999999999999999999987543221   


Q ss_pred             ceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhH------------------
Q 010309          386 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATP------------------  447 (513)
Q Consensus       386 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~------------------  447 (513)
                       .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...+.............                  
T Consensus       187 -~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (360)
T 3eqc_A          187 -ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLN  265 (360)
T ss_dssp             -----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------------
T ss_pred             -ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccc
Confidence             1123489999999999999999999999999999999999999986543321111100000                  


Q ss_pred             -----HhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          448 -----LVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       448 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                           ........+.++..........+....+.++.+||.+||+.||++|||++|+++
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          266 KFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             --------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             ccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                 000000001111111111122223335667999999999999999999999986

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.2e-42  Score=372.56  Aligned_cols=249  Identities=27%  Similarity=0.386  Sum_probs=199.8

Q ss_pred             ceecccCceEEEEEEeC---CCCEEEEEEecccch--hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccC
Q 010309          231 RLLGDSKTGGTYSGILP---DGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  305 (513)
Q Consensus       231 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  305 (513)
                      +.||+|+||.||+|.+.   .++.||||+++....  ...+.+.+|+.+|++++||||+++++++. .+..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence            46899999999999753   467899999986532  33578999999999999999999999986 4568999999999


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccc-
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ-  384 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~-  384 (513)
                      |+|.+++..    ...+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++........ 
T Consensus       454 g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  526 (635)
T 4fl3_A          454 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  526 (635)
T ss_dssp             EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred             CCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence            999999964    35699999999999999999999999   9999999999999999999999999999876543221 


Q ss_pred             cceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhccccccccccccc
Q 010309          385 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS  463 (513)
Q Consensus       385 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  463 (513)
                      .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+.......       .....          
T Consensus       527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~-------i~~~~----------  589 (635)
T 4fl3_A          527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM-------LEKGE----------  589 (635)
T ss_dssp             --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-------HHTTC----------
T ss_pred             ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-------HHcCC----------
Confidence            11222236789999999999999999999999999999998 9999987654321111       11110          


Q ss_pred             CCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCc
Q 010309          464 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  507 (513)
Q Consensus       464 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  507 (513)
                         ....+..+++++.+||.+||+.||++|||+++|++.|+++.
T Consensus       590 ---~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~  630 (635)
T 4fl3_A          590 ---RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  630 (635)
T ss_dssp             ---CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             ---CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence               00112234567999999999999999999999999998753

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=8.3e-43  Score=346.36  Aligned_cols=242  Identities=23%  Similarity=0.364  Sum_probs=198.7

Q ss_pred             hhCcccCCceecccCceEEEEEEe-CCCCEEEEEEecccch--------hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeC
Q 010309          223 TKNFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSF--------QRKKEFYSEIGRFARLHHPNLVAVKGCCYDH  293 (513)
Q Consensus       223 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  293 (513)
                      .++|. ..+.||+|+||.||+|.. .+++.||||++.....        .....+.+|+.++++++||||+++++++.+.
T Consensus        23 ~~~y~-~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           23 SQKYS-TMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHEE-EEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             ccceE-EEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            33443 445779999999999996 4688999999976532        1234577899999999999999999999999


Q ss_pred             CceEEEEeeccCC-CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecc
Q 010309          294 GDRYIVYEFVVNG-PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV  372 (513)
Q Consensus       294 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df  372 (513)
                      +..++||||+.+| +|.+++..    ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df  174 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDF  174 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHT----CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCC
T ss_pred             CEEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeec
Confidence            9999999999777 99999864    34699999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCccccccceeecCcccccccccccccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhc
Q 010309          373 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQS  451 (513)
Q Consensus       373 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  451 (513)
                      |++..........   ...||+.|+|||++.+..+ +.++||||||+++|+|++|..||......               
T Consensus       175 g~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------------  236 (335)
T 3dls_A          175 GSAAYLERGKLFY---TFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET---------------  236 (335)
T ss_dssp             TTCEECCTTCCBC---EECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG---------------
T ss_pred             ccceECCCCCcee---ccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH---------------
Confidence            9998765433222   2338999999999988776 78999999999999999999999653211               


Q ss_pred             ccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010309          452 HRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  502 (513)
Q Consensus       452 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  502 (513)
                            .....      ..+...++++.+||.+||+.||++|||++++++.
T Consensus       237 ------~~~~~------~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          237 ------VEAAI------HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             ------TTTCC------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             ------Hhhcc------CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                  00000      0111245679999999999999999999999973

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=2.2e-42  Score=342.29  Aligned_cols=257  Identities=18%  Similarity=0.270  Sum_probs=203.1

Q ss_pred             HHHhhCcccCCceecccCceEEEEEEeC-CCCEEEEEEecccc--hhcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCCc
Q 010309          220 RSITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGD  295 (513)
Q Consensus       220 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~  295 (513)
                      ..+.+.|....+.||+|+||.||+|... +++.||||++....  ......+.+|+.++..+ +||||+++++++.+.+.
T Consensus        24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~  103 (327)
T 3lm5_A           24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE  103 (327)
T ss_dssp             HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence            3444555555578899999999999975 59999999997643  23357899999999999 56999999999999999


Q ss_pred             eEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecC---CCCeEEecc
Q 010309          296 RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE---EFGAHLMGV  372 (513)
Q Consensus       296 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~---~~~~kl~Df  372 (513)
                      .++||||+++|+|.+++..  .....+++..++.++.||+.||+|||+.   +|+||||||+|||++.   ++.+||+||
T Consensus       104 ~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~Df  178 (327)
T 3lm5_A          104 IILILEYAAGGEIFSLCLP--ELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDF  178 (327)
T ss_dssp             EEEEEECCTTEEGGGGGSS--CC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred             EEEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEeeC
Confidence            9999999999999999864  2345699999999999999999999999   9999999999999988   789999999


Q ss_pred             cccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcc
Q 010309          373 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSH  452 (513)
Q Consensus       373 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  452 (513)
                      |++.........   ....||+.|+|||++.+..++.++||||||+++|+|++|+.||...+.....   .   .... .
T Consensus       179 g~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~---~i~~-~  248 (327)
T 3lm5_A          179 GMSRKIGHACEL---REIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETY---L---NISQ-V  248 (327)
T ss_dssp             GGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---H---HHHH-T
T ss_pred             ccccccCCcccc---ccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH---H---HHHh-c
Confidence            999876533221   1234899999999999999999999999999999999999999765432110   0   0000 0


Q ss_pred             cccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          453 RYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       453 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      . ...         ........++.+.+||.+||+.||++|||++++++
T Consensus       249 ~-~~~---------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          249 N-VDY---------SEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             C-CCC---------CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             c-ccc---------CchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence            0 000         01111234567999999999999999999999986

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=3.2e-42  Score=335.19  Aligned_cols=246  Identities=20%  Similarity=0.339  Sum_probs=195.8

Q ss_pred             cccCCceecccCceEEEEEEeC-CCCEEEEEEecccc--hhcHHHHHHHHHHHhhcCCCcEeeeeeEEee----CCceEE
Q 010309          226 FSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYD----HGDRYI  298 (513)
Q Consensus       226 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~~l  298 (513)
                      ++...+.||+|+||.||+|... ++..||+|.+....  ....+.+.+|+.++++++||||+++++++..    ....++
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  106 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence            4445567899999999999974 58899999997542  3345778999999999999999999999875    345799


Q ss_pred             EEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--ceEcCCCCCceEec-CCCCeEEeccccc
Q 010309          299 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH--VVHRDIRASNVLLD-EEFGAHLMGVGLS  375 (513)
Q Consensus       299 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--ivH~Dikp~NIll~-~~~~~kl~Dfg~~  375 (513)
                      ||||+++++|.+++..    ...+++..++.++.||+.||.|||+.   +  |+||||||+|||++ .++.+||+|||++
T Consensus       107 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~  179 (290)
T 1t4h_A          107 VTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA  179 (290)
T ss_dssp             EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred             EEEecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence            9999999999999964    25689999999999999999999998   8  99999999999998 7889999999999


Q ss_pred             ccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccc
Q 010309          376 KFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL  455 (513)
Q Consensus       376 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  455 (513)
                      ........    ....||+.|+|||++. +.++.++||||||+++|+|++|..||.......  ...   .. ...... 
T Consensus       180 ~~~~~~~~----~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~---~~-~~~~~~-  247 (290)
T 1t4h_A          180 TLKRASFA----KAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIY---RR-VTSGVK-  247 (290)
T ss_dssp             GGCCTTSB----EESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HHH---HH-HTTTCC-
T ss_pred             cccccccc----ccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH--HHH---HH-HhccCC-
Confidence            76543322    2234899999999886 568999999999999999999999997644321  111   00 000000 


Q ss_pred             ccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          456 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       456 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                                 ....+...++++.+||.+||+.||.+|||++++++
T Consensus       248 -----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          248 -----------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             -----------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -----------ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence                       00111123356999999999999999999999986

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=2.7e-42  Score=338.10  Aligned_cols=246  Identities=22%  Similarity=0.319  Sum_probs=198.2

Q ss_pred             cCCceecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          228 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      ...+.||+|+||.||++... +|+.||||++........+.+.+|+.++++++||||+++++++.+.+..++||||++++
T Consensus        12 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   91 (304)
T 2jam_A           12 IFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGG   91 (304)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred             eeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCc
Confidence            34567899999999999975 69999999998765555677899999999999999999999999999999999999999


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEe---cCCCCeEEecccccccCCcccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL---DEEFGAHLMGVGLSKFVPWEVM  383 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll---~~~~~~kl~Dfg~~~~~~~~~~  383 (513)
                      +|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+||++   +.++.+||+|||++........
T Consensus        92 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~  164 (304)
T 2jam_A           92 ELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM  164 (304)
T ss_dssp             BHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBTT
T ss_pred             cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCcc
Confidence            99999864    24689999999999999999999999   99999999999999   7788999999999976543221


Q ss_pred             ccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccccccccccc
Q 010309          384 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS  463 (513)
Q Consensus       384 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  463 (513)
                      .    ...||+.|+|||++.+..++.++||||||+++|+|++|..||.......   +...    ...... ..      
T Consensus       165 ~----~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~----i~~~~~-~~------  226 (304)
T 2jam_A          165 S----TACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK---LFEK----IKEGYY-EF------  226 (304)
T ss_dssp             H----HHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHH----HHHCCC-CC------
T ss_pred             c----cccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HHHH----HHcCCC-CC------
Confidence            1    1238999999999999999999999999999999999999997654321   1111    111100 00      


Q ss_pred             CCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          464 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       464 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                         ........++.+.+||.+||+.||++|||++++++
T Consensus       227 ---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          227 ---ESPFWDDISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             ---CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             ---CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence               00111234567999999999999999999999986

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=8.6e-43  Score=342.81  Aligned_cols=255  Identities=24%  Similarity=0.321  Sum_probs=193.1

Q ss_pred             ccCCceecccCceEEEEEEe-CCCCEEEEEEecccch---hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCce----EE
Q 010309          227 SEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR----YI  298 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~----~l  298 (513)
                      +...+.||+|+||.||++.. .+++.||||+++....   .....+.+|+.++++++||||+++++++......    ++
T Consensus        14 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~l   93 (311)
T 3ork_A           14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI   93 (311)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred             EEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEE
Confidence            34456789999999999996 4688999999976532   2345788999999999999999999998876544    99


Q ss_pred             EEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccC
Q 010309          299 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV  378 (513)
Q Consensus       299 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~  378 (513)
                      ||||+++++|.+++..    ...+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++...
T Consensus        94 v~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  166 (311)
T 3ork_A           94 VMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAI  166 (311)
T ss_dssp             EEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred             EEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence            9999999999999964    24699999999999999999999999   9999999999999999999999999999876


Q ss_pred             Cccccc-cceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccccc
Q 010309          379 PWEVMQ-ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLEL  457 (513)
Q Consensus       379 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  457 (513)
                      ...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||........      .........    
T Consensus       167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~------~~~~~~~~~----  236 (311)
T 3ork_A          167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVREDP----  236 (311)
T ss_dssp             ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHCCC----
T ss_pred             cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhcCCC----
Confidence            543221 112223489999999999999999999999999999999999999976543211      111111000    


Q ss_pred             ccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHH-HHHhc
Q 010309          458 LDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVV-HQLQQ  505 (513)
Q Consensus       458 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl-~~L~~  505 (513)
                      ..+.       ......++++.+||.+||+.||++||++.+++ +.|.+
T Consensus       237 ~~~~-------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  278 (311)
T 3ork_A          237 IPPS-------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  278 (311)
T ss_dssp             CCHH-------HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             CCcc-------cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence            0000       00112456799999999999999999665544 45543

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.9e-43  Score=356.28  Aligned_cols=254  Identities=20%  Similarity=0.257  Sum_probs=199.7

Q ss_pred             hhCcccCCceecccCceEEEEEEeC-CCCEEEEEEecccch---hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEE
Q 010309          223 TKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYI  298 (513)
Q Consensus       223 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l  298 (513)
                      .++|. ..+.||+|+||.||+++.. +|+.||||++++...   ...+.+.+|..++..++||||+++++++.+.+..|+
T Consensus        60 ~~~f~-~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l  138 (412)
T 2vd5_A           60 RDDFE-ILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYL  138 (412)
T ss_dssp             GGGEE-EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred             hhhEE-EEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence            34443 4567899999999999975 699999999976422   223457899999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccC
Q 010309          299 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV  378 (513)
Q Consensus       299 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~  378 (513)
                      ||||+++|+|.+++...   +..+++..++.++.||+.||+|||+.   +|+||||||+|||++.++++||+|||+++..
T Consensus       139 VmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGla~~~  212 (412)
T 2vd5_A          139 VMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKL  212 (412)
T ss_dssp             EECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechhheec
Confidence            99999999999999742   24699999999999999999999999   9999999999999999999999999999876


Q ss_pred             CccccccceeecCcccccccccccc-------cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhc
Q 010309          379 PWEVMQERTVMAGGTYGYLAPEFVY-------RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQS  451 (513)
Q Consensus       379 ~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  451 (513)
                      ....... .....||+.|+|||++.       ...++.++|||||||++|||++|+.||...+....   ..   .....
T Consensus       213 ~~~~~~~-~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~---~~---~i~~~  285 (412)
T 2vd5_A          213 RADGTVR-SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET---YG---KIVHY  285 (412)
T ss_dssp             CTTSCEE-CSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HH---HHHTH
T ss_pred             cCCCccc-cceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH---HH---HHHhc
Confidence            5432211 12235999999999997       35689999999999999999999999987553211   11   11000


Q ss_pred             ccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCC---CCHHHHHH
Q 010309          452 HRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMR---PRMSHVVH  501 (513)
Q Consensus       452 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~evl~  501 (513)
                      ..  ....+        ......++++.+||.+||. +|.+|   |+++||++
T Consensus       286 ~~--~~~~p--------~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          286 KE--HLSLP--------LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             HH--HCCCC------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             cc--CcCCC--------ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence            00  00000        0012345679999999999 99998   58999875

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=4.8e-43  Score=338.89  Aligned_cols=255  Identities=23%  Similarity=0.297  Sum_probs=202.2

Q ss_pred             CCceecccCceEEEEEEeC-CCCEEEEEEecccc--hhcHHHHHHHHHHHhhcCCCcEeeeeeEEee--CCceEEEEeec
Q 010309          229 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYD--HGDRYIVYEFV  303 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lv~e~~  303 (513)
                      ..+.||+|+||.||++... +++.||+|++....  ....+.+.+|+.++++++||||+++++++.+  .+..++||||+
T Consensus        10 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~   89 (279)
T 2w5a_A           10 VLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYC   89 (279)
T ss_dssp             EEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECC
T ss_pred             eehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCC
Confidence            3457899999999999975 68999999997643  3345678999999999999999999998754  56789999999


Q ss_pred             cCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-----ceEcCCCCCceEecCCCCeEEecccccccC
Q 010309          304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH-----VVHRDIRASNVLLDEEFGAHLMGVGLSKFV  378 (513)
Q Consensus       304 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~-----ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~  378 (513)
                      ++++|.+++.........+++..++.++.|++.||.|||+.   +     |+||||||+|||++.++.+||+|||++...
T Consensus        90 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~  166 (279)
T 2w5a_A           90 EGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL  166 (279)
T ss_dssp             TTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCCHHHHC
T ss_pred             CCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCchheee
Confidence            99999999976444445699999999999999999999998   7     999999999999999999999999999876


Q ss_pred             CccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccc
Q 010309          379 PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELL  458 (513)
Q Consensus       379 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  458 (513)
                      .......  ....|++.|+|||++.+..++.++||||||+++|+|++|..||...+...   +..   . .......   
T Consensus       167 ~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~---~-i~~~~~~---  234 (279)
T 2w5a_A          167 NHDTSFA--KTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---LAG---K-IREGKFR---  234 (279)
T ss_dssp             ---CHHH--HHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---H-HHHTCCC---
T ss_pred             ccccccc--cccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH---HHH---H-Hhhcccc---
Confidence            4332111  11238999999999999899999999999999999999999998654321   111   1 1111110   


Q ss_pred             cccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcC
Q 010309          459 DPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  508 (513)
Q Consensus       459 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  508 (513)
                                ..+...++++.++|.+||+.||++|||+++|++.+.....
T Consensus       235 ----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~  274 (279)
T 2w5a_A          235 ----------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH  274 (279)
T ss_dssp             ----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred             ----------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence                      0112345679999999999999999999999987765443

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=8.3e-43  Score=337.18  Aligned_cols=248  Identities=28%  Similarity=0.423  Sum_probs=195.7

Q ss_pred             cCCceecccCceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeC-CceEEEEeeccCC
Q 010309          228 EGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH-GDRYIVYEFVVNG  306 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-~~~~lv~e~~~~g  306 (513)
                      ...+.||+|+||.||++.. +|+.||||+++...  ..+.+.+|+.++++++||||+++++++.+. +..++||||++++
T Consensus        24 ~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~  100 (278)
T 1byg_A           24 KLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG  100 (278)
T ss_dssp             EEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTE
T ss_pred             eEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCC
Confidence            3456789999999999988 58899999997653  457789999999999999999999997654 5789999999999


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  386 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  386 (513)
                      +|.+++...  ....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++........   
T Consensus       101 ~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~---  172 (278)
T 1byg_A          101 SLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD---  172 (278)
T ss_dssp             EHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------------
T ss_pred             CHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccccccc---
Confidence            999999642  122388999999999999999999999   999999999999999999999999999986543211   


Q ss_pred             eeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccccccccCC
Q 010309          387 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  465 (513)
Q Consensus       387 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  465 (513)
                        ...+++.|+|||++.+..++.++||||||+++|+|+| |..||.......   ....    ....     .       
T Consensus       173 --~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~~----~~~~-----~-------  231 (278)
T 1byg_A          173 --TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPR----VEKG-----Y-------  231 (278)
T ss_dssp             -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHHH----HTTT-----C-------
T ss_pred             --CCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH----HhcC-----C-------
Confidence              1237889999999999999999999999999999998 999997654321   1110    0000     0       


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcC
Q 010309          466 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  508 (513)
Q Consensus       466 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  508 (513)
                       ....+...++.+.+++.+||+.||++|||+.++++.|+++..
T Consensus       232 -~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~  273 (278)
T 1byg_A          232 -KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  273 (278)
T ss_dssp             -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence             001112345679999999999999999999999999988754

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2e-42  Score=339.83  Aligned_cols=256  Identities=18%  Similarity=0.236  Sum_probs=196.7

Q ss_pred             cCCceecccCceEEEEEEeC-CCCEEEEEEecccchh---cHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeec
Q 010309          228 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQ---RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  303 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  303 (513)
                      ...+.||+|+||.||++... +++.||||++......   ..+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus        37 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~  116 (309)
T 2h34_A           37 RLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLI  116 (309)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             EEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEec
Confidence            44567899999999999975 6889999999765322   2467899999999999999999999999999999999999


Q ss_pred             cCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccc
Q 010309          304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM  383 (513)
Q Consensus       304 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~  383 (513)
                      ++++|.+++..    ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++........
T Consensus       117 ~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  189 (309)
T 2h34_A          117 NGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKL  189 (309)
T ss_dssp             CCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred             CCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccccccc
Confidence            99999999965    24699999999999999999999999   999999999999999999999999999987654322


Q ss_pred             ccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccccccccccc
Q 010309          384 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS  463 (513)
Q Consensus       384 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  463 (513)
                      ... ....+++.|+|||++.+..++.++||||||+++|||++|+.||.......       ........ .     +...
T Consensus       190 ~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~~~~~-~-----~~~~  255 (309)
T 2h34_A          190 TQL-GNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV-------MGAHINQA-I-----PRPS  255 (309)
T ss_dssp             --------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH-------HHHHHHSC-C-----CCGG
T ss_pred             ccc-cccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH-------HHHHhccC-C-----CCcc
Confidence            211 12338999999999999899999999999999999999999997643210       00111100 0     0000


Q ss_pred             CCCCCCCcHHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHhcCcCC
Q 010309          464 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRP-RMSHVVHQLQQLAQP  509 (513)
Q Consensus       464 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~~~  509 (513)
                      .     .....++++.++|.+||+.||++|| +++++++.|+++...
T Consensus       256 ~-----~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~  297 (309)
T 2h34_A          256 T-----VRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT  297 (309)
T ss_dssp             G-----TSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred             c-----cCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence            0     1122345699999999999999999 999999999877654

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.2e-42  Score=349.29  Aligned_cols=243  Identities=21%  Similarity=0.274  Sum_probs=188.7

Q ss_pred             cCCceecccCceEEEEEEeC-CCCEEEEEEecccch---hcHHHHHHHHHH-HhhcCCCcEeeeeeEEeeCCceEEEEee
Q 010309          228 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGR-FARLHHPNLVAVKGCCYDHGDRYIVYEF  302 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~h~nIv~l~~~~~~~~~~~lv~e~  302 (513)
                      +..++||+|+||.||+++.. +++.||||++++...   .....+.+|..+ ++.++||||+++++++.+.+..|+||||
T Consensus        41 ~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~  120 (373)
T 2r5t_A           41 HFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDY  120 (373)
T ss_dssp             EEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             EEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeC
Confidence            44567899999999999975 588999999976532   233456677776 5678999999999999999999999999


Q ss_pred             ccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccc
Q 010309          303 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV  382 (513)
Q Consensus       303 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~  382 (513)
                      +++|+|.+++..    ...+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++......
T Consensus       121 ~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~  193 (373)
T 2r5t_A          121 INGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN  193 (373)
T ss_dssp             CCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC
T ss_pred             CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccccCC
Confidence            999999999964    24689999999999999999999999   99999999999999999999999999998532221


Q ss_pred             cccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccc
Q 010309          383 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI  462 (513)
Q Consensus       383 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  462 (513)
                      .  .....+||+.|+|||++.+..++.++|||||||++|||++|..||...+...   +..   .....         .+
T Consensus       194 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~---~~~---~i~~~---------~~  256 (373)
T 2r5t_A          194 S--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE---MYD---NILNK---------PL  256 (373)
T ss_dssp             C--CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH---HHH---HHHHS---------CC
T ss_pred             C--ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH---HHH---HHHhc---------cc
Confidence            1  1223449999999999999999999999999999999999999997654321   111   11110         00


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 010309          463 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVV  500 (513)
Q Consensus       463 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  500 (513)
                            ..+...+..+.+||.+||+.||.+||++.+.+
T Consensus       257 ------~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~  288 (373)
T 2r5t_A          257 ------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDF  288 (373)
T ss_dssp             ------CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred             ------CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence                  01112456799999999999999999985433

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=6e-42  Score=333.96  Aligned_cols=260  Identities=17%  Similarity=0.238  Sum_probs=201.0

Q ss_pred             ccCCceecccCceEEEEEEe-CCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEE-eeCCceEEEEeecc
Q 010309          227 SEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC-YDHGDRYIVYEFVV  304 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~-~~~~~~~lv~e~~~  304 (513)
                      +...+.||+|+||.||+|.. .+++.||||++....  ....+.+|+.+++.++|++++..+..+ ...+..++||||+ 
T Consensus        11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-   87 (296)
T 4hgt_A           11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-   87 (296)
T ss_dssp             CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             eEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-
Confidence            34456789999999999996 568899999876543  224578899999999888777666655 5667789999999 


Q ss_pred             CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEe---cCCCCeEEecccccccCCcc
Q 010309          305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL---DEEFGAHLMGVGLSKFVPWE  381 (513)
Q Consensus       305 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll---~~~~~~kl~Dfg~~~~~~~~  381 (513)
                      +++|.+++...   ...+++..++.++.||+.||.|||++   +|+||||||+|||+   +.++.+||+|||++......
T Consensus        88 ~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~  161 (296)
T 4hgt_A           88 GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             CCBHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence            99999999742   34699999999999999999999999   99999999999999   78899999999999876543


Q ss_pred             cccc-----ceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccc
Q 010309          382 VMQE-----RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLE  456 (513)
Q Consensus       382 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  456 (513)
                      ....     ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.......................   
T Consensus       162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---  238 (296)
T 4hgt_A          162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP---  238 (296)
T ss_dssp             TTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC---
T ss_pred             ccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch---
Confidence            2211     11223489999999999999999999999999999999999999987654433222221111100000   


Q ss_pred             cccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcC
Q 010309          457 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  508 (513)
Q Consensus       457 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  508 (513)
                       ... .        ....++++.+|+.+||+.||++|||+++|++.|+++..
T Consensus       239 -~~~-~--------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~  280 (296)
T 4hgt_A          239 -IEV-L--------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  280 (296)
T ss_dssp             -HHH-H--------TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred             -hhh-h--------hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence             000 0        01234579999999999999999999999999987643

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.9e-43  Score=354.32  Aligned_cols=267  Identities=23%  Similarity=0.305  Sum_probs=189.9

Q ss_pred             hhCcccCCceecccCceEEEEEEeC-CCCEEEEEEeccc--chhcHHHHHHHHHHHhhcC-CCcEeeeeeEEeeCC--ce
Q 010309          223 TKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHG--DR  296 (513)
Q Consensus       223 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~--~~  296 (513)
                      .++|. ..+.||+|+||.||+|... +|+.||||++...  .....+.+.+|+.++..+. ||||+++++++...+  ..
T Consensus         8 ~~~y~-~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~   86 (388)
T 3oz6_A            8 LRKYE-LVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV   86 (388)
T ss_dssp             HTTEE-EEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred             cCceE-EEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence            34443 3456799999999999964 6899999999654  2344567889999999997 999999999997654  68


Q ss_pred             EEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccc
Q 010309          297 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK  376 (513)
Q Consensus       297 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~  376 (513)
                      |+||||++ ++|..++..     ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus        87 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~  157 (388)
T 3oz6_A           87 YLVFDYME-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSR  157 (388)
T ss_dssp             EEEEECCS-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEecccC-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence            99999996 689999864     4689999999999999999999999   99999999999999999999999999998


Q ss_pred             cCCccc-------------------cccceeecCccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcc
Q 010309          377 FVPWEV-------------------MQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSV  436 (513)
Q Consensus       377 ~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~  436 (513)
                      ......                   .........||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~  237 (388)
T 3oz6_A          158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM  237 (388)
T ss_dssp             ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            653210                   0111122348999999999986 67899999999999999999999999876543


Q ss_pred             ccchhHHhhhHHhhccc---ccccccc--------c---c---cCCCCC------------CCcHHHHHHHHHHHHHhcC
Q 010309          437 CWQSIFEWATPLVQSHR---YLELLDP--------L---I---SSLSSD------------IPEAGVVQKVVDLVYACTQ  487 (513)
Q Consensus       437 ~~~~~~~~~~~~~~~~~---~~~~~~~--------~---~---~~~~~~------------~~~~~~~~~l~~li~~cl~  487 (513)
                      .....+   ........   ......+        .   .   ......            .+....++++.+|+.+||+
T Consensus       238 ~~~~~i---~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~  314 (388)
T 3oz6_A          238 NQLERI---IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQ  314 (388)
T ss_dssp             HHHHHH---HHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCC
T ss_pred             HHHHHH---HHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhc
Confidence            211111   00000000   0000000        0   0   000000            0011235679999999999


Q ss_pred             CCCCCCCCHHHHHHH
Q 010309          488 HVPSMRPRMSHVVHQ  502 (513)
Q Consensus       488 ~dP~~RPs~~evl~~  502 (513)
                      .||++|||++|+++-
T Consensus       315 ~dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          315 FNPNKRISANDALKH  329 (388)
T ss_dssp             SSGGGSCCHHHHTTS
T ss_pred             cCcccCCCHHHHhCC
Confidence            999999999999864

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.8e-42  Score=348.37  Aligned_cols=249  Identities=15%  Similarity=0.171  Sum_probs=199.6

Q ss_pred             ccCCceecccCceEEEEEE------eCCCCEEEEEEecccchhcHHHHHHHHHHHhhcC---CCcEeeeeeEEeeCCceE
Q 010309          227 SEGNRLLGDSKTGGTYSGI------LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH---HPNLVAVKGCCYDHGDRY  297 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~  297 (513)
                      +...+.||+|+||.||+|.      ..+++.||||+++..   ...++..|+.++..++   |+||+++++++...+..+
T Consensus        67 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~  143 (365)
T 3e7e_A           67 VYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSV  143 (365)
T ss_dssp             EEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEE
T ss_pred             EEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcE
Confidence            3445678999999999994      446899999999765   3456778888888876   999999999999999999


Q ss_pred             EEEeeccCCCHHHHhccCCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecC-----------CC
Q 010309          298 IVYEFVVNGPLDRWLHHIPR-GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE-----------EF  365 (513)
Q Consensus       298 lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~-----------~~  365 (513)
                      +||||+++|+|.+++..... ....+++..++.++.||+.||+|||+.   +|+||||||+|||++.           ++
T Consensus       144 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~~~~  220 (365)
T 3e7e_A          144 LVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSA  220 (365)
T ss_dssp             EEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC------CT
T ss_pred             EEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccccccccC
Confidence            99999999999999964322 346799999999999999999999999   9999999999999998           89


Q ss_pred             CeEEecccccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhh
Q 010309          366 GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWA  445 (513)
Q Consensus       366 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~  445 (513)
                      .+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+||+.||........       
T Consensus       221 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-------  293 (365)
T 3e7e_A          221 GLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC-------  293 (365)
T ss_dssp             TEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE-------
T ss_pred             CEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce-------
Confidence            9999999999765432222233334599999999999999999999999999999999999999865332110       


Q ss_pred             hHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHhcC
Q 010309          446 TPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMR-PRMSHVVHQLQQL  506 (513)
Q Consensus       446 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-Ps~~evl~~L~~~  506 (513)
                                 .+....    ...+   ..+.+.+++..||+.+|.+| |+++++.+.|++.
T Consensus       294 -----------~~~~~~----~~~~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~  337 (365)
T 3e7e_A          294 -----------KPEGLF----RRLP---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV  337 (365)
T ss_dssp             -----------EECSCC----TTCS---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred             -----------eechhc----cccC---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence                       011111    1111   24568899999999999999 6788888877654

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=6.9e-43  Score=338.50  Aligned_cols=246  Identities=23%  Similarity=0.428  Sum_probs=199.6

Q ss_pred             cCCceecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEee--------------
Q 010309          228 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD--------------  292 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--------------  292 (513)
                      ...+.||+|+||.||+|... +++.||||++....    +.+.+|+.++++++||||+++++++..              
T Consensus        14 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~   89 (284)
T 2a19_B           14 KEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSR   89 (284)
T ss_dssp             EEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------C
T ss_pred             ceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccc
Confidence            33457899999999999985 69999999997653    356789999999999999999998864              


Q ss_pred             --CCceEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEe
Q 010309          293 --HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLM  370 (513)
Q Consensus       293 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~  370 (513)
                        ....++||||+++++|.+++...  ....+++..++.++.||+.||.|||+.   +|+|+||||+|||++.++.+||+
T Consensus        90 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~  164 (284)
T 2a19_B           90 SKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIG  164 (284)
T ss_dssp             CEEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEEC
T ss_pred             cCcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCCEEEC
Confidence              34579999999999999999752  235699999999999999999999999   99999999999999999999999


Q ss_pred             cccccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhh
Q 010309          371 GVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQ  450 (513)
Q Consensus       371 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  450 (513)
                      |||++..........   ...+|+.|+|||++.+..++.++||||||+++|+|++|..|+.....     .   ... ..
T Consensus       165 Dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~-----~---~~~-~~  232 (284)
T 2a19_B          165 DFGLVTSLKNDGKRT---RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK-----F---FTD-LR  232 (284)
T ss_dssp             CCTTCEESSCCSCCC---CCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH-----H---HHH-HH
T ss_pred             cchhheecccccccc---ccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHH-----H---HHH-hh
Confidence            999998765432221   22389999999999999999999999999999999999988642110     0   000 00


Q ss_pred             cccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcCCC
Q 010309          451 SHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP  510 (513)
Q Consensus       451 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  510 (513)
                              ...+        +...+..+.++|.+||+.||++|||+.|+++.|..+...+
T Consensus       233 --------~~~~--------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~  276 (284)
T 2a19_B          233 --------DGII--------SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP  276 (284)
T ss_dssp             --------TTCC--------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred             --------cccc--------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence                    0001        1123456899999999999999999999999998876654

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=7.2e-42  Score=353.91  Aligned_cols=260  Identities=19%  Similarity=0.258  Sum_probs=191.8

Q ss_pred             cCCceecccCceEEEEEEeC-CCCEEEEEEeccc--chhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCC------ceEE
Q 010309          228 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG------DRYI  298 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------~~~l  298 (513)
                      +..+.||+|+||.||+|... +|+.||||++...  .....+.+.+|+.+|+.++||||+++++++...+      ..|+
T Consensus        65 ~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~l  144 (464)
T 3ttj_A           65 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL  144 (464)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEE
T ss_pred             EEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEE
Confidence            34557799999999999864 5889999999764  3344567889999999999999999999997653      4699


Q ss_pred             EEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccC
Q 010309          299 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV  378 (513)
Q Consensus       299 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~  378 (513)
                      ||||+++ +|.+.+.      ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus       145 v~E~~~~-~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~  214 (464)
T 3ttj_A          145 VMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (464)
T ss_dssp             EEECCSE-EHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred             EEeCCCC-CHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence            9999965 5666664      2489999999999999999999999   9999999999999999999999999999876


Q ss_pred             CccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccch-hHHhh------------
Q 010309          379 PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS-IFEWA------------  445 (513)
Q Consensus       379 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~-~~~~~------------  445 (513)
                      ......   ....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+...... +....            
T Consensus       215 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~  291 (464)
T 3ttj_A          215 GTSFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ  291 (464)
T ss_dssp             --CCCC-------CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred             CCCccc---CCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence            543221   22348999999999999999999999999999999999999998765322111 10000            


Q ss_pred             ---hHHhhcc-c-----ccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          446 ---TPLVQSH-R-----YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       446 ---~~~~~~~-~-----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                         ....... .     +...+...+.. .........++++.+||.+||+.||++|||++|+++
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          292 PTVRNYVENRPKYAGLTFPKLFPDSLFP-ADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             HHHHHHHTTSCCCCCCCHHHHSCGGGSC-CSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhhhhHhhcccccCCCChHHhCcccccc-cccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence               0000000 0     00000000000 000011223678999999999999999999999986

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-41  Score=337.39  Aligned_cols=271  Identities=21%  Similarity=0.373  Sum_probs=200.4

Q ss_pred             HhhCcccCCceecccCceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhc--CCCcEeeeeeEEeeC----Cc
Q 010309          222 ITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL--HHPNLVAVKGCCYDH----GD  295 (513)
Q Consensus       222 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~nIv~l~~~~~~~----~~  295 (513)
                      +.++| ...+.||+|+||.||+|.. .++.||||++...   ....+..|.+++..+  +||||+++++++...    ..
T Consensus        35 ~~~~y-~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~  109 (337)
T 3mdy_A           35 IAKQI-QMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ  109 (337)
T ss_dssp             HHHHC-EEEEEEEEETTEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred             cccce-EEEeEeecCCCeEEEEEEE-CCceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence            33444 4456779999999999998 4899999999654   234455566655554  999999999999887    67


Q ss_pred             eEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCCceEcCCCCCceEecCCCCeEEe
Q 010309          296 RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV-----KPHVVHRDIRASNVLLDEEFGAHLM  370 (513)
Q Consensus       296 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-----~~~ivH~Dikp~NIll~~~~~~kl~  370 (513)
                      .++||||+++|+|.+++..     ..+++..++.++.|++.||.|||+..     .++|+||||||+|||++.++.+||+
T Consensus       110 ~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~  184 (337)
T 3mdy_A          110 LYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA  184 (337)
T ss_dssp             EEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred             eEEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence            8999999999999999965     35999999999999999999999752     3489999999999999999999999


Q ss_pred             cccccccCCccccccc--eeecCcccccccccccccCCCCch------hhHHHHHHHHHHHHcC----------CCCCCC
Q 010309          371 GVGLSKFVPWEVMQER--TVMAGGTYGYLAPEFVYRNELTTK------SDVYSFGVLLLEIVSG----------RRPAQA  432 (513)
Q Consensus       371 Dfg~~~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~------sDvwSlGvil~elltg----------~~p~~~  432 (513)
                      |||++...........  .....||+.|+|||++.+...+.+      +|||||||++|||+||          ..||..
T Consensus       185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~  264 (337)
T 3mdy_A          185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD  264 (337)
T ss_dssp             CCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             eCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence            9999976644322211  112348999999999987766554      9999999999999999          555544


Q ss_pred             CCccccchhHHhhhHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcCCCC
Q 010309          433 VDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPV  511 (513)
Q Consensus       433 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~  511 (513)
                      .......  ............    ..+..   ........+++++.+|+.+||+.||++|||+.+|++.|+++.+..-
T Consensus       265 ~~~~~~~--~~~~~~~~~~~~----~~~~~---~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~  334 (337)
T 3mdy_A          265 LVPSDPS--YEDMREIVCIKK----LRPSF---PNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD  334 (337)
T ss_dssp             TSCSSCC--HHHHHHHHTTSC----CCCCC---CGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred             hcCCCCc--hhhhHHHHhhhc----cCccc---cccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcc
Confidence            3221100  011111111110    01100   0111234678899999999999999999999999999998876543

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=6.5e-42  Score=340.94  Aligned_cols=268  Identities=21%  Similarity=0.317  Sum_probs=205.1

Q ss_pred             HHhhCcccCCceecccCceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhh--cCCCcEeeeeeEEeeCC----
Q 010309          221 SITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFAR--LHHPNLVAVKGCCYDHG----  294 (513)
Q Consensus       221 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~l~~~~~~~~----  294 (513)
                      .+.++| ...+.||+|+||.||+|.. +|+.||||++...   ....+.+|.+++..  ++||||+++++++...+    
T Consensus        39 ~~~~~y-~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~  113 (342)
T 1b6c_B           39 TIARTI-VLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT  113 (342)
T ss_dssp             HHHHHC-EEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred             cccccE-EEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence            344444 4456779999999999998 6899999999654   34667888888887  79999999999998876    


Q ss_pred             ceEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHh--------cCCCCCceEcCCCCCceEecCCCC
Q 010309          295 DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLH--------DKVKPHVVHRDIRASNVLLDEEFG  366 (513)
Q Consensus       295 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH--------~~~~~~ivH~Dikp~NIll~~~~~  366 (513)
                      ..++||||+++|+|.+++..     ..+++..++.++.|++.||.|||        +.   +|+||||||+|||++.++.
T Consensus       114 ~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~~  185 (342)
T 1b6c_B          114 QLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNGT  185 (342)
T ss_dssp             CEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTSC
T ss_pred             eeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCCC
Confidence            78999999999999999965     35899999999999999999999        77   9999999999999999999


Q ss_pred             eEEecccccccCCcccccc--ceeecCcccccccccccccCC------CCchhhHHHHHHHHHHHHcC----------CC
Q 010309          367 AHLMGVGLSKFVPWEVMQE--RTVMAGGTYGYLAPEFVYRNE------LTTKSDVYSFGVLLLEIVSG----------RR  428 (513)
Q Consensus       367 ~kl~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwSlGvil~elltg----------~~  428 (513)
                      +||+|||++..........  ......||+.|+|||++.+..      ++.++||||||+++|||+||          ..
T Consensus       186 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~  265 (342)
T 1b6c_B          186 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL  265 (342)
T ss_dssp             EEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred             EEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccccc
Confidence            9999999997654332111  112234899999999997652      33689999999999999999          67


Q ss_pred             CCCCCCccccchhHHhhhHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcC
Q 010309          429 PAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  508 (513)
Q Consensus       429 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  508 (513)
                      ||........ ..... .......    ...+.+   .........+..+.+|+.+||+.||++|||+.+|++.|+++.+
T Consensus       266 p~~~~~~~~~-~~~~~-~~~~~~~----~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~  336 (342)
T 1b6c_B          266 PYYDLVPSDP-SVEEM-RKVVCEQ----KLRPNI---PNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  336 (342)
T ss_dssp             TTTTTSCSSC-CHHHH-HHHHTTS----CCCCCC---CGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CccccCcCcc-cHHHH-HHHHHHH----HhCCCC---cccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence            7765432210 00111 1111111    011111   0111123677889999999999999999999999999998865


Q ss_pred             CC
Q 010309          509 PP  510 (513)
Q Consensus       509 ~~  510 (513)
                      ..
T Consensus       337 ~~  338 (342)
T 1b6c_B          337 QE  338 (342)
T ss_dssp             TT
T ss_pred             Hh
Confidence            53

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=5.3e-42  Score=332.26  Aligned_cols=247  Identities=20%  Similarity=0.297  Sum_probs=198.4

Q ss_pred             cCCceecccCceEEEEEEeC-CCCEEEEEEecccch------hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEE
Q 010309          228 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF------QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY  300 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  300 (513)
                      ...+.||+|+||.||++... +|+.||||+++....      ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         8 ~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   87 (283)
T 3bhy_A            8 EMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLIL   87 (283)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEE
Confidence            34567899999999999976 589999999976432      13678999999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCC----CeEEecccccc
Q 010309          301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF----GAHLMGVGLSK  376 (513)
Q Consensus       301 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~----~~kl~Dfg~~~  376 (513)
                      ||+++++|.+++..    ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++    .+||+|||++.
T Consensus        88 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~  160 (283)
T 3bhy_A           88 ELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH  160 (283)
T ss_dssp             ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             eecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence            99999999999964    24689999999999999999999999   999999999999998877    79999999998


Q ss_pred             cCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccc
Q 010309          377 FVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLE  456 (513)
Q Consensus       377 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  456 (513)
                      ........   ....+++.|+|||++.+..++.++||||||+++|+|++|..||........   .   ... ..... .
T Consensus       161 ~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~---~~~-~~~~~-~  229 (283)
T 3bhy_A          161 KIEAGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQET---L---TNI-SAVNY-D  229 (283)
T ss_dssp             ECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---H---HHH-HTTCC-C
T ss_pred             eccCCCcc---cccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHH---H---HHh-Hhccc-C
Confidence            76543221   122389999999999989999999999999999999999999976543211   0   000 00000 0


Q ss_pred             cccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          457 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       457 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                       ....        .....++.+.+|+.+||+.||++|||+.++++
T Consensus       230 -~~~~--------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          230 -FDEE--------YFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             -CCHH--------HHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -Ccch--------hcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence             0000        00123457899999999999999999999997

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.5e-42  Score=347.22  Aligned_cols=261  Identities=16%  Similarity=0.174  Sum_probs=201.8

Q ss_pred             cccCCceecccCceEEEEEEeCC---------CCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEee-----------
Q 010309          226 FSEGNRLLGDSKTGGTYSGILPD---------GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVA-----------  285 (513)
Q Consensus       226 ~~~~~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~-----------  285 (513)
                      -+...+.||+|+||.||+|....         ++.||||++...     +.+.+|+.++++++||||++           
T Consensus        43 ~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  117 (352)
T 2jii_A           43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLL  117 (352)
T ss_dssp             EEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTC
T ss_pred             eEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCcc
Confidence            34455678999999999999763         789999999754     35789999999999999987           


Q ss_pred             ----eeeEEee-CCceEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceE
Q 010309          286 ----VKGCCYD-HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL  360 (513)
Q Consensus       286 ----l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIl  360 (513)
                          +++++.. .+..++||||+ +++|.+++...  ....+++..++.++.||+.||.|||++   +|+||||||+|||
T Consensus       118 ~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl  191 (352)
T 2jii_A          118 AIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIF  191 (352)
T ss_dssp             SCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEE
T ss_pred             CccchhhccccCCcEEEEEecCC-CcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEE
Confidence                5677766 67789999999 99999999752  235699999999999999999999999   9999999999999


Q ss_pred             ecCCC--CeEEecccccccCCcccccc-----ceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 010309          361 LDEEF--GAHLMGVGLSKFVPWEVMQE-----RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAV  433 (513)
Q Consensus       361 l~~~~--~~kl~Dfg~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~  433 (513)
                      ++.++  .+||+|||++..........     ......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus       192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  271 (352)
T 2jii_A          192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC  271 (352)
T ss_dssp             EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence            99998  89999999998765432211     112224899999999999989999999999999999999999999865


Q ss_pred             CccccchhHHhhhHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCc
Q 010309          434 DSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  507 (513)
Q Consensus       434 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  507 (513)
                      .... ..+.........  ........       .......++++.+|+.+||+.||++|||+++|++.|+++.
T Consensus       272 ~~~~-~~~~~~~~~~~~--~~~~~~~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  335 (352)
T 2jii_A          272 LPNT-EDIMKQKQKFVD--KPGPFVGP-------CGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALL  335 (352)
T ss_dssp             TTCH-HHHHHHHHHHHH--SCCCEECT-------TSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred             CcCH-HHHHHHHHhccC--Chhhhhhh-------ccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHH
Confidence            4221 111111111111  00111110       0011123467999999999999999999999999998765

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=7e-43  Score=345.46  Aligned_cols=263  Identities=17%  Similarity=0.225  Sum_probs=191.6

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccchhc-HHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCC
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQR-KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  307 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs  307 (513)
                      .+.||+|+||.||+|... +++.||||++....... ...+.+|+.++++++||||+++++++.+.+..++||||++ |+
T Consensus         7 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~   85 (324)
T 3mtl_A            7 LDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KD   85 (324)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-EE
T ss_pred             EEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-cC
Confidence            456799999999999975 68999999997543221 2245679999999999999999999999999999999996 58


Q ss_pred             HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccce
Q 010309          308 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  387 (513)
Q Consensus       308 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  387 (513)
                      |.+++...   ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++..........  
T Consensus        86 l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~--  157 (324)
T 3mtl_A           86 LKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY--  157 (324)
T ss_dssp             HHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC---------
T ss_pred             HHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCcccc--
Confidence            99988752   35699999999999999999999999   99999999999999999999999999998654332211  


Q ss_pred             eecCccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccc------
Q 010309          388 VMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP------  460 (513)
Q Consensus       388 ~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------  460 (513)
                      ....+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+..........................      
T Consensus       158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  237 (324)
T 3mtl_A          158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTY  237 (324)
T ss_dssp             -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHT
T ss_pred             ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccc
Confidence            12238999999999876 56899999999999999999999999876543211111100000000000000000      


Q ss_pred             cccCCCCC---CCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          461 LISSLSSD---IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       461 ~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      ........   ......++++.+||.+||+.||++|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          238 NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             CCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            00000000   001124567899999999999999999999987

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=2.8e-42  Score=334.73  Aligned_cols=245  Identities=18%  Similarity=0.267  Sum_probs=196.0

Q ss_pred             hCcccCCceecccCceEEEEEEeC-CCCEEEEEEecccc--hhcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCCceEEE
Q 010309          224 KNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIV  299 (513)
Q Consensus       224 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv  299 (513)
                      ++|.. .+.||+|+||.||+|... +++.||||++....  ......+.+|+..+..+ +||||+++++++.+.+..++|
T Consensus        11 ~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           11 TEFHE-LEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHEEE-EEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             chhhh-hhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            34433 457799999999999975 69999999997642  33456788999999999 999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCC---------------
Q 010309          300 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE---------------  364 (513)
Q Consensus       300 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~---------------  364 (513)
                      |||+++++|.+++.........+++..++.++.||+.||+|||++   +|+||||||+|||++.+               
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~  166 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDW  166 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----------------
T ss_pred             EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence            999999999999975433335689999999999999999999999   99999999999999844               


Q ss_pred             ----CCeEEecccccccCCccccccceeecCcccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCccccc
Q 010309          365 ----FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ  439 (513)
Q Consensus       365 ----~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~  439 (513)
                          ..+||+|||.+........      ..||+.|+|||++.+. .++.++||||||+++|+|++|.+|+.....    
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~~------~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~----  236 (289)
T 1x8b_A          167 ASNKVMFKIGDLGHVTRISSPQV------EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ----  236 (289)
T ss_dssp             ---CCCEEECCCTTCEETTCSCC------CCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH----
T ss_pred             cCCceEEEEcccccccccCCccc------cCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH----
Confidence                4799999999987654321      2389999999999766 566899999999999999999987653221    


Q ss_pred             hhHHhhhHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          440 SIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       440 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                        ..    ......        ...     .+...++.+.+|+.+||+.||++|||+.++++
T Consensus       237 --~~----~~~~~~--------~~~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          237 --WH----EIRQGR--------LPR-----IPQVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             --HH----HHHTTC--------CCC-----CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --HH----HHHcCC--------CCC-----CCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence              00    001111        100     11124467999999999999999999999985

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=2.4e-42  Score=343.72  Aligned_cols=247  Identities=24%  Similarity=0.274  Sum_probs=195.0

Q ss_pred             cCCceecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCCceEEEEeeccC
Q 010309          228 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVN  305 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~  305 (513)
                      +..+.||+|+||.||++... +|+.||||++.+...    ...+|++++.++ +||||+++++++.+.+..|+||||+++
T Consensus        25 ~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~g  100 (342)
T 2qr7_A           25 EVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKG  100 (342)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCC
Confidence            33457899999999999975 588999999976532    235688888888 799999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCC-C---CeEEecccccccCCcc
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE-F---GAHLMGVGLSKFVPWE  381 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~-~---~~kl~Dfg~~~~~~~~  381 (513)
                      |+|.+++..    ...+++..+..++.||+.||+|||++   +|+||||||+|||+..+ +   .+||+|||++......
T Consensus       101 g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~  173 (342)
T 2qr7_A          101 GELLDKILR----QKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE  173 (342)
T ss_dssp             CBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred             CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence            999999864    35699999999999999999999999   99999999999998543 2   4999999999865433


Q ss_pred             ccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccccccccc
Q 010309          382 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL  461 (513)
Q Consensus       382 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  461 (513)
                      ..  ......||+.|+|||++.+..++.++|||||||++|||++|..||..........+....    ......      
T Consensus       174 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i----~~~~~~------  241 (342)
T 2qr7_A          174 NG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARI----GSGKFS------  241 (342)
T ss_dssp             TC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHH----HHCCCC------
T ss_pred             CC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHH----ccCCcc------
Confidence            21  122334899999999998888899999999999999999999999864332212221111    111100      


Q ss_pred             ccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          462 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       462 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      .    ........++++.+||.+||+.||++|||+.++++
T Consensus       242 ~----~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          242 L----SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             C----CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             c----CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            0    01111234567999999999999999999999986

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=7.6e-42  Score=334.68  Aligned_cols=245  Identities=22%  Similarity=0.367  Sum_probs=201.6

Q ss_pred             ccCCceecccCceEEEEEEeC-CCCEEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeecc
Q 010309          227 SEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV  304 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  304 (513)
                      +...+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus        24 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~  103 (303)
T 3a7i_A           24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG  103 (303)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             HHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCC
Confidence            344567899999999999864 68999999997653 3345789999999999999999999999999999999999999


Q ss_pred             CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccc
Q 010309          305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  384 (513)
Q Consensus       305 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  384 (513)
                      +++|.+++..     ..+++..+..++.|++.||.|||+.   +|+|+||||+||+++.++.+||+|||++.........
T Consensus       104 ~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  175 (303)
T 3a7i_A          104 GGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK  175 (303)
T ss_dssp             TEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCC
T ss_pred             CCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCccccc
Confidence            9999999863     4699999999999999999999999   9999999999999999999999999999876433221


Q ss_pred             cceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccC
Q 010309          385 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS  464 (513)
Q Consensus       385 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  464 (513)
                        .....||+.|+|||++.+..++.++||||||+++|+|++|..||........   ..    ......     .+    
T Consensus       176 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~----~~~~~~-----~~----  237 (303)
T 3a7i_A          176 --RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKV---LF----LIPKNN-----PP----  237 (303)
T ss_dssp             --BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HH----HHHHSC-----CC----
T ss_pred             --cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHH---HH----HhhcCC-----CC----
Confidence              1223489999999999999999999999999999999999999976543211   00    011000     00    


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          465 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       465 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                          ......+..+.+|+.+||+.||++|||+.++++
T Consensus       238 ----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  270 (303)
T 3a7i_A          238 ----TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK  270 (303)
T ss_dssp             ----CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             ----CCccccCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                011123456999999999999999999999986

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2.1e-41  Score=330.22  Aligned_cols=258  Identities=17%  Similarity=0.241  Sum_probs=201.0

Q ss_pred             cCCceecccCceEEEEEEe-CCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEE-eeCCceEEEEeeccC
Q 010309          228 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC-YDHGDRYIVYEFVVN  305 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~-~~~~~~~lv~e~~~~  305 (513)
                      ...+.||+|+||.||+|.. .+|+.||||++....  ..+.+.+|+.+++.++|++++..+..+ ...+..++||||+ +
T Consensus        12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~   88 (296)
T 3uzp_A           12 RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-G   88 (296)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred             EEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-C
Confidence            4456789999999999996 578999999987653  234688999999999988766665555 5667779999999 9


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEe---cCCCCeEEecccccccCCccc
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL---DEEFGAHLMGVGLSKFVPWEV  382 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll---~~~~~~kl~Dfg~~~~~~~~~  382 (513)
                      ++|.+++...   ...+++..++.++.|++.||+|||++   +|+||||||+|||+   +.++.+||+|||++.......
T Consensus        89 ~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~  162 (296)
T 3uzp_A           89 PSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  162 (296)
T ss_dssp             CBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred             CCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence            9999999642   35699999999999999999999999   99999999999999   488899999999998765432


Q ss_pred             ccc-----ceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccccc
Q 010309          383 MQE-----RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLEL  457 (513)
Q Consensus       383 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  457 (513)
                      ...     ......||+.|+|||++.+..++.++||||||+++|||++|+.||.......................    
T Consensus       163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~----  238 (296)
T 3uzp_A          163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP----  238 (296)
T ss_dssp             TCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC----
T ss_pred             cccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc----
Confidence            211     11223489999999999999999999999999999999999999987544322222221111000000    


Q ss_pred             ccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCc
Q 010309          458 LDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  507 (513)
Q Consensus       458 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  507 (513)
                      . +.+        ...+++++.+++.+||+.||++|||+++|++.|+++.
T Consensus       239 ~-~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~  279 (296)
T 3uzp_A          239 I-EVL--------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF  279 (296)
T ss_dssp             H-HHH--------TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred             h-HHH--------HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHH
Confidence            0 000        0123457999999999999999999999999998764

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=9.4e-42  Score=332.49  Aligned_cols=247  Identities=23%  Similarity=0.331  Sum_probs=196.6

Q ss_pred             ceecccCceEEEEEEe-CCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCCHH
Q 010309          231 RLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD  309 (513)
Q Consensus       231 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~  309 (513)
                      .+||+|+||.||+|.. .+++.||||.+........+.+.+|+.+++.++||||+++++++.+.+..++||||+++++|.
T Consensus        28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  107 (295)
T 2clq_A           28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS  107 (295)
T ss_dssp             CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred             EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence            4789999999999996 468899999998776566788999999999999999999999999999999999999999999


Q ss_pred             HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecC-CCCeEEecccccccCCcccccccee
Q 010309          310 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE-EFGAHLMGVGLSKFVPWEVMQERTV  388 (513)
Q Consensus       310 ~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~-~~~~kl~Dfg~~~~~~~~~~~~~~~  388 (513)
                      +++.... ....+++..+..++.|++.||.|||+.   +|+|+||||+||+++. ++.+||+|||++.........  ..
T Consensus       108 ~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~--~~  181 (295)
T 2clq_A          108 ALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC--TE  181 (295)
T ss_dssp             HHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------C
T ss_pred             HHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCCc--cc
Confidence            9997532 234577899999999999999999999   9999999999999987 889999999999876433211  11


Q ss_pred             ecCcccccccccccccCC--CCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCC
Q 010309          389 MAGGTYGYLAPEFVYRNE--LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  466 (513)
Q Consensus       389 ~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  466 (513)
                      ...||+.|+|||++.+..  ++.++||||||+++|+|++|+.||........ ....  .. ..      ...+      
T Consensus       182 ~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~--~~-~~------~~~~------  245 (295)
T 2clq_A          182 TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA-AMFK--VG-MF------KVHP------  245 (295)
T ss_dssp             CCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH-HHHH--HH-HH------CCCC------
T ss_pred             ccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH-HHHh--hc-cc------cccc------
Confidence            234899999999997653  78999999999999999999999975433210 0000  00 00      0000      


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          467 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       467 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                        ..+...++++.+||.+||+.||++|||++++++
T Consensus       246 --~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          246 --EIPESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             --CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             --cccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence              011234567999999999999999999999985

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=6.2e-42  Score=333.81  Aligned_cols=245  Identities=19%  Similarity=0.291  Sum_probs=201.3

Q ss_pred             ccCCceecccCceEEEEEEeC-CCCEEEEEEecccc---hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEee
Q 010309          227 SEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF  302 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  302 (513)
                      +...+.||+|+||.||++... +++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus        17 y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   96 (294)
T 2rku_A           17 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLEL   96 (294)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             eEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEec
Confidence            344567899999999999975 48899999997642   23456788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccc
Q 010309          303 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV  382 (513)
Q Consensus       303 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~  382 (513)
                      +++++|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++.......
T Consensus        97 ~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  169 (294)
T 2rku_A           97 CRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  169 (294)
T ss_dssp             CTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence            999999998864    24689999999999999999999999   99999999999999999999999999998764332


Q ss_pred             cccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccc
Q 010309          383 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI  462 (513)
Q Consensus       383 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  462 (513)
                      ..  .....||+.|+|||++.+..++.++||||||+++|+|++|..||.......   .   .... ....        .
T Consensus       170 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~---~~~~-~~~~--------~  232 (294)
T 2rku_A          170 ER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE---T---YLRI-KKNE--------Y  232 (294)
T ss_dssp             CC--BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---H---HHHH-HTTC--------C
T ss_pred             cc--cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---H---HHHH-hhcc--------C
Confidence            21  122348999999999998889999999999999999999999997654321   0   0000 0000        0


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          463 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       463 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                            ..+...++.+.+++.+||+.||++|||++++++
T Consensus       233 ------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  265 (294)
T 2rku_A          233 ------SIPKHINPVAASLIQKMLQTDPTARPTINELLN  265 (294)
T ss_dssp             ------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             ------CCccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence                  011123457899999999999999999999997

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=8.1e-42  Score=349.53  Aligned_cols=251  Identities=24%  Similarity=0.335  Sum_probs=189.2

Q ss_pred             hhCcccCCceecccCceEEEEEEeC-CCCEEEEEEecccch--------hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeC
Q 010309          223 TKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF--------QRKKEFYSEIGRFARLHHPNLVAVKGCCYDH  293 (513)
Q Consensus       223 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  293 (513)
                      .++| ...+.||+|+||.||+|... +++.||||++.....        .....+.+|+.+|++++||||+++++++. .
T Consensus       134 ~~~y-~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~  211 (419)
T 3i6u_A          134 RDEY-IMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A  211 (419)
T ss_dssp             HTTE-EEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S
T ss_pred             hccE-EEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence            3444 44567899999999999975 589999999975421        11235789999999999999999999975 4


Q ss_pred             CceEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCC---CeEEe
Q 010309          294 GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF---GAHLM  370 (513)
Q Consensus       294 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~---~~kl~  370 (513)
                      +..++||||+++|+|.+++..    ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++   .+||+
T Consensus       212 ~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~  284 (419)
T 3i6u_A          212 EDYYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT  284 (419)
T ss_dssp             SEEEEEEECCTTCBGGGGTSS----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred             CceEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEe
Confidence            568999999999999998853    35699999999999999999999999   999999999999997544   59999


Q ss_pred             cccccccCCccccccceeecCccccccccccccc---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhH
Q 010309          371 GVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR---NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATP  447 (513)
Q Consensus       371 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  447 (513)
                      |||+++........   ....||+.|+|||++.+   ..++.++||||||+++|+|++|..||.......  .+...   
T Consensus       285 DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~~~~---  356 (419)
T 3i6u_A          285 DFGHSKILGETSLM---RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQ---  356 (419)
T ss_dssp             CSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--CHHHH---
T ss_pred             ecccceecCCCccc---cccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--HHHHH---
Confidence            99999876543221   22348999999999864   567889999999999999999999997644321  11110   


Q ss_pred             HhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          448 LVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       448 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                       ...... ......         ....++.+.+||.+||+.||++|||++|+++
T Consensus       357 -i~~~~~-~~~~~~---------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          357 -ITSGKY-NFIPEV---------WAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             -HHTTCC-CCCHHH---------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             -HhcCCC-CCCchh---------hcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence             000000 000000         0124567999999999999999999999986

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=3.1e-42  Score=342.50  Aligned_cols=267  Identities=23%  Similarity=0.355  Sum_probs=194.1

Q ss_pred             cCCceecccCceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHH--HhhcCCCcEeeeeeEEee-----CCceEEEE
Q 010309          228 EGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGR--FARLHHPNLVAVKGCCYD-----HGDRYIVY  300 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~nIv~l~~~~~~-----~~~~~lv~  300 (513)
                      ...+.||+|+||.||+|.. +++.||||++....   ...+..|.++  +..++||||+++++.+..     ....++||
T Consensus        16 ~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~   91 (336)
T 3g2f_A           16 KLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVM   91 (336)
T ss_dssp             EEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEE
T ss_pred             heeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEE
Confidence            4456789999999999987 78999999997542   3344444444  556899999999986543     23568999


Q ss_pred             eeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC------CCCceEcCCCCCceEecCCCCeEEecccc
Q 010309          301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV------KPHVVHRDIRASNVLLDEEFGAHLMGVGL  374 (513)
Q Consensus       301 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~------~~~ivH~Dikp~NIll~~~~~~kl~Dfg~  374 (513)
                      ||+++|+|.+++..     ...++..+..++.||+.||+|||+..      .++|+||||||+|||++.++.+||+|||+
T Consensus        92 e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~  166 (336)
T 3g2f_A           92 EYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGL  166 (336)
T ss_dssp             CCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTT
T ss_pred             ecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccc
Confidence            99999999999965     34588999999999999999999863      33899999999999999999999999999


Q ss_pred             cccCCcccc------ccceeecCccccccccccccc-------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcc-ccch
Q 010309          375 SKFVPWEVM------QERTVMAGGTYGYLAPEFVYR-------NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSV-CWQS  440 (513)
Q Consensus       375 ~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlGvil~elltg~~p~~~~~~~-~~~~  440 (513)
                      +........      ........||+.|+|||++.+       ..++.++||||||+++|||++|..||...... ....
T Consensus       167 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~  246 (336)
T 3g2f_A          167 SMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQM  246 (336)
T ss_dssp             CEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCC
T ss_pred             eeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHH
Confidence            987643211      111122348999999999976       35567899999999999999997776543322 1111


Q ss_pred             hHH----------hhhHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcCC
Q 010309          441 IFE----------WATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP  509 (513)
Q Consensus       441 ~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  509 (513)
                      ...          .........    ...+.+..  ........++.+.+||.+||+.||++|||++|+++.|+++..+
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~  319 (336)
T 3g2f_A          247 AFQTEVGNHPTFEDMQVLVSRE----KQRPKFPE--AWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI  319 (336)
T ss_dssp             TTHHHHCSSCCHHHHHHHHTTS----CCCCCCCT--TCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             hhhcccCCCchHHHHHhhhccc----ccCCCCCc--ccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence            100          000000000    00111100  1112335777899999999999999999999999999887643

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.4e-42  Score=341.27  Aligned_cols=264  Identities=20%  Similarity=0.254  Sum_probs=196.0

Q ss_pred             cCCceecccCceEEEEEEeC-CCCEEEEEEecccchhc-----HHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEe
Q 010309          228 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQR-----KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE  301 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  301 (513)
                      ...+.||+|+||.||+|... +|+.||||++.......     .+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus        13 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   92 (346)
T 1ua2_A           13 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD   92 (346)
T ss_dssp             CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred             EEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEE
Confidence            34467899999999999975 58999999997542211     2467899999999999999999999999999999999


Q ss_pred             eccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcc
Q 010309          302 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE  381 (513)
Q Consensus       302 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~  381 (513)
                      |+++ +|.+++..   ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++......
T Consensus        93 ~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  165 (346)
T 1ua2_A           93 FMET-DLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP  165 (346)
T ss_dssp             CCSE-EHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred             cCCC-CHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence            9975 89888864   335688999999999999999999999   9999999999999999999999999999876433


Q ss_pred             ccccceeecCcccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHh--hcccccc--
Q 010309          382 VMQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLV--QSHRYLE--  456 (513)
Q Consensus       382 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~--  456 (513)
                      ...  .....+|+.|+|||++.+. .++.++||||||+++|||++|.+||.+.+....  +........  ......+  
T Consensus       166 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~--~~~i~~~~~~~~~~~~~~~~  241 (346)
T 1ua2_A          166 NRA--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ--LTRIFETLGTPTEEQWPDMC  241 (346)
T ss_dssp             CCC--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCTTTSSSTT
T ss_pred             ccc--CCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHcCCCChhhhhhhc
Confidence            221  1223489999999998764 589999999999999999999999977553211  111000000  0000000  


Q ss_pred             -cccccccCCCCCCCc----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 010309          457 -LLDPLISSLSSDIPE----AGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ  502 (513)
Q Consensus       457 -~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  502 (513)
                       ..+..........+.    ...++++.+||.+||+.||++|||++|+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          242 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             cCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence             000000000001110    2235679999999999999999999999973

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=6.5e-42  Score=340.15  Aligned_cols=245  Identities=20%  Similarity=0.310  Sum_probs=201.4

Q ss_pred             ccCCceecccCceEEEEEEeC-CCCEEEEEEecccc---hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEee
Q 010309          227 SEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF  302 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  302 (513)
                      +...+.||+|+||.||++... +++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus        43 y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  122 (335)
T 2owb_A           43 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLEL  122 (335)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             eEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEec
Confidence            344567899999999999975 48899999997642   23456789999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccc
Q 010309          303 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV  382 (513)
Q Consensus       303 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~  382 (513)
                      +++++|.+++..    ...+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++.......
T Consensus       123 ~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  195 (335)
T 2owb_A          123 CRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  195 (335)
T ss_dssp             CTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             CCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence            999999998864    24689999999999999999999999   99999999999999999999999999998764332


Q ss_pred             cccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccc
Q 010309          383 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI  462 (513)
Q Consensus       383 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  462 (513)
                      ..  .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.......   ..   ..... ...        
T Consensus       196 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~---~~~~~-~~~--------  258 (335)
T 2owb_A          196 ER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE---TY---LRIKK-NEY--------  258 (335)
T ss_dssp             CC--BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HH---HHHHH-TCC--------
T ss_pred             cc--ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH---HH---HHHhc-CCC--------
Confidence            21  122348999999999998889999999999999999999999997654221   10   00000 000        


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          463 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       463 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                            ..+...++.+.+||.+||+.||++|||++++++
T Consensus       259 ------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          259 ------SIPKHINPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             ------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             ------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                  001123456899999999999999999999997

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1e-41  Score=329.02  Aligned_cols=243  Identities=22%  Similarity=0.336  Sum_probs=192.6

Q ss_pred             cCCceecccCceEEEEEEeC-CCCEEEEEEecccc---hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeec
Q 010309          228 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  303 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  303 (513)
                      ...+.||+|+||.||+|... +|+.||||++....   ....+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus        14 ~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   93 (276)
T 2h6d_A           14 VLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYV   93 (276)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             EEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEecc
Confidence            34567899999999999975 69999999997542   233567899999999999999999999999999999999999


Q ss_pred             cCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccc
Q 010309          304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM  383 (513)
Q Consensus       304 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~  383 (513)
                      ++++|.+++...    ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++........
T Consensus        94 ~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  166 (276)
T 2h6d_A           94 SGGELFDYICKH----GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF  166 (276)
T ss_dssp             CSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred             CCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCCcc
Confidence            999999999652    4589999999999999999999999   999999999999999999999999999987654322


Q ss_pred             ccceeecCcccccccccccccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccc
Q 010309          384 QERTVMAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI  462 (513)
Q Consensus       384 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  462 (513)
                      .   ....+++.|+|||++.+..+ +.++||||||+++|+|++|..||.......   ....    ......        
T Consensus       167 ~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~----~~~~~~--------  228 (276)
T 2h6d_A          167 L---RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT---LFKK----IRGGVF--------  228 (276)
T ss_dssp             -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH----HHHCCC--------
T ss_pred             e---ecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH---HHHH----hhcCcc--------
Confidence            1   12238999999999987765 689999999999999999999997643221   1111    000000        


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          463 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       463 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                            ..+...+..+.+++.+||+.||++|||++++++
T Consensus       229 ------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~  261 (276)
T 2h6d_A          229 ------YIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE  261 (276)
T ss_dssp             ------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------cCchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence                  011123456899999999999999999999997

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=9e-42  Score=330.97  Aligned_cols=242  Identities=24%  Similarity=0.294  Sum_probs=199.6

Q ss_pred             cCCceecccCceEEEEEEeC-CCCEEEEEEecccc---hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeec
Q 010309          228 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  303 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  303 (513)
                      ...+.||+|+||.||+|... +++.||||++....   ....+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus        17 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   96 (284)
T 2vgo_A           17 DIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFA   96 (284)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             eeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeC
Confidence            44567899999999999975 57889999996542   223567899999999999999999999999999999999999


Q ss_pred             cCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccc
Q 010309          304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM  383 (513)
Q Consensus       304 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~  383 (513)
                      ++++|.+++...    ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++........
T Consensus        97 ~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~  169 (284)
T 2vgo_A           97 PRGELYKELQKH----GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR  169 (284)
T ss_dssp             TTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSSCB
T ss_pred             CCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCccccc
Confidence            999999999652    4589999999999999999999999   999999999999999999999999999876543221


Q ss_pred             ccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccccccccccc
Q 010309          384 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS  463 (513)
Q Consensus       384 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  463 (513)
                          ....|++.|+|||++.+..++.++||||||+++|+|++|..||........      ...... ..      .   
T Consensus       170 ----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~~~~-~~------~---  229 (284)
T 2vgo_A          170 ----RTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET------HRRIVN-VD------L---  229 (284)
T ss_dssp             ----CCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHT-TC------C---
T ss_pred             ----ccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH------HHHHhc-cc------c---
Confidence                123489999999999998999999999999999999999999976543211      111110 00      0   


Q ss_pred             CCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          464 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       464 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                           ..+...+..+.++|.+||+.||.+|||++++++
T Consensus       230 -----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          230 -----KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             -----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -----CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence                 011224567899999999999999999999986

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.1e-41  Score=355.52  Aligned_cols=249  Identities=22%  Similarity=0.315  Sum_probs=199.6

Q ss_pred             hCcccCCceecccCceEEEEEEeC-CCCEEEEEEecccc--hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEE
Q 010309          224 KNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY  300 (513)
Q Consensus       224 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  300 (513)
                      +.|. ..+.||+|+||.||++... +++.||||++....  ......+.+|+.++++++||||+++++++.+.+..++||
T Consensus        22 ~~y~-~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  100 (486)
T 3mwu_A           22 ERYN-IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (486)
T ss_dssp             HHEE-EEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceE-EeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence            3443 3557899999999999975 68999999996542  234678999999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEec---CCCCeEEeccccccc
Q 010309          301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD---EEFGAHLMGVGLSKF  377 (513)
Q Consensus       301 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~---~~~~~kl~Dfg~~~~  377 (513)
                      ||+.+++|.+++..    ...+++..+..++.||+.||.|||+.   +|+||||||+|||++   .++.+||+|||++..
T Consensus       101 e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  173 (486)
T 3mwu_A          101 ELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (486)
T ss_dssp             CCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred             EcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence            99999999998864    24699999999999999999999999   999999999999995   456799999999987


Q ss_pred             CCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccccc
Q 010309          378 VPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLEL  457 (513)
Q Consensus       378 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  457 (513)
                      ......   .....||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+......      .. ....... 
T Consensus       174 ~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~------~i-~~~~~~~-  241 (486)
T 3mwu_A          174 FQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILK------RV-ETGKYAF-  241 (486)
T ss_dssp             BCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HH-HHTCCCS-
T ss_pred             CCCCCc---cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HH-HhCCCCC-
Confidence            654322   122349999999999865 58999999999999999999999998754321111      11 1111000 


Q ss_pred             ccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          458 LDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       458 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                               ........++++.+||.+||+.||++|||+.++++
T Consensus       242 ---------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~  276 (486)
T 3mwu_A          242 ---------DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (486)
T ss_dssp             ---------CSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ---------CCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                     00111235667999999999999999999999997

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=8.6e-42  Score=336.01  Aligned_cols=255  Identities=22%  Similarity=0.342  Sum_probs=198.6

Q ss_pred             HHHHhhCcccCCceecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceE
Q 010309          219 LRSITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRY  297 (513)
Q Consensus       219 l~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  297 (513)
                      +.....+.++..+.||+|+||.||+|... +|+.||||++....  ..+.+.+|+.+++.++||||+++++++...+..+
T Consensus        23 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  100 (314)
T 3com_A           23 LTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLW  100 (314)
T ss_dssp             -------CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             hhhcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence            33334444455667899999999999975 48999999997653  4567899999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEeccccccc
Q 010309          298 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF  377 (513)
Q Consensus       298 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~  377 (513)
                      +||||+++++|.+++..   ....+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++..
T Consensus       101 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~  174 (314)
T 3com_A          101 IVMEYCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQ  174 (314)
T ss_dssp             EEEECCTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEeecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchh
Confidence            99999999999999863   135699999999999999999999999   999999999999999999999999999976


Q ss_pred             CCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccccc
Q 010309          378 VPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLEL  457 (513)
Q Consensus       378 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  457 (513)
                      .......  .....||+.|+|||++.+..++.++||||||+++|+|++|..||........      .... ....    
T Consensus       175 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~-~~~~----  241 (314)
T 3com_A          175 LTDTMAK--RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA------IFMI-PTNP----  241 (314)
T ss_dssp             CBTTBSC--BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHH-HHSC----
T ss_pred             hhhhccc--cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH------HHHH-hcCC----
Confidence            5433221  1223389999999999998999999999999999999999999976543210      0000 0000    


Q ss_pred             ccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          458 LDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       458 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                       .+      ....+...+..+.+||.+||+.||.+|||+.++++
T Consensus       242 -~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          242 -PP------TFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             -CC------CCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             -Cc------ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence             00      00112234567999999999999999999999986

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=3.6e-42  Score=336.70  Aligned_cols=248  Identities=24%  Similarity=0.361  Sum_probs=196.4

Q ss_pred             cCCceecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          228 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      +..+.||+|+||.||+|... +++.||+|++........+.+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus        22 ~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~  101 (302)
T 2j7t_A           22 EIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGG  101 (302)
T ss_dssp             EEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTE
T ss_pred             eecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCC
Confidence            44556899999999999985 58999999998776667788999999999999999999999999999999999999999


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  386 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  386 (513)
                      +|.+++...   ...+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||++........  .
T Consensus       102 ~l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~  173 (302)
T 2j7t_A          102 AVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ--K  173 (302)
T ss_dssp             EHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH--C
T ss_pred             cHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccccccc--c
Confidence            999988642   35699999999999999999999999   999999999999999999999999998754321111  1


Q ss_pred             eeecCcccccccccccc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccccccccc
Q 010309          387 TVMAGGTYGYLAPEFVY-----RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL  461 (513)
Q Consensus       387 ~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  461 (513)
                      .....||+.|+|||++.     +..++.++||||||+++|+|++|..||...+...      ......... ..      
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~-~~------  240 (302)
T 2j7t_A          174 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR------VLLKIAKSD-PP------  240 (302)
T ss_dssp             -----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHSC-CC------
T ss_pred             cccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH------HHHHHhccC-Cc------
Confidence            11223899999999983     5678999999999999999999999997654321      011111100 00      


Q ss_pred             ccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          462 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       462 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                           ....+...+..+.++|.+||+.||++|||++++++
T Consensus       241 -----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          241 -----TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             -----CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             -----ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                 11122334567999999999999999999999985

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=6.2e-43  Score=353.19  Aligned_cols=239  Identities=17%  Similarity=0.177  Sum_probs=185.1

Q ss_pred             cCCceecccCceEEEEEEe-CCCCEEEEEEeccc---chhcHHHHHHHH---HHHhhcCCCcEeeee-------eEEeeC
Q 010309          228 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS---SFQRKKEFYSEI---GRFARLHHPNLVAVK-------GCCYDH  293 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~h~nIv~l~-------~~~~~~  293 (513)
                      ...+.||+|+||.||+|.. .+|+.||||++...   .....+.+.+|+   +++++++||||++++       +++.+.
T Consensus        76 ~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~  155 (377)
T 3byv_A           76 VRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDP  155 (377)
T ss_dssp             EEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECT
T ss_pred             EEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhcc
Confidence            3356789999999999996 46999999999743   334457889999   455556899999998       666655


Q ss_pred             Cc-----------------eEEEEeeccCCCHHHHhccCC---CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcC
Q 010309          294 GD-----------------RYIVYEFVVNGPLDRWLHHIP---RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRD  353 (513)
Q Consensus       294 ~~-----------------~~lv~e~~~~gsL~~~l~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~D  353 (513)
                      +.                 .|+||||+ +|+|.+++....   .....+++..++.|+.||+.||+|||++   +|+|||
T Consensus       156 ~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrD  231 (377)
T 3byv_A          156 QKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTY  231 (377)
T ss_dssp             TSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred             CCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence            32                 78999999 689999997421   1112344588889999999999999999   999999


Q ss_pred             CCCCceEecCCCCeEEecccccccCCccccccceeecCcccccccccccccC-----------CCCchhhHHHHHHHHHH
Q 010309          354 IRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN-----------ELTTKSDVYSFGVLLLE  422 (513)
Q Consensus       354 ikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDvwSlGvil~e  422 (513)
                      |||+|||++.++.+||+|||+++....     ......| +.|+|||++.+.           .++.++|||||||++||
T Consensus       232 ikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~e  305 (377)
T 3byv_A          232 LRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW  305 (377)
T ss_dssp             CCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHH
T ss_pred             CCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHH
Confidence            999999999999999999999986432     1222337 999999999887           89999999999999999


Q ss_pred             HHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          423 IVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       423 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      |++|+.||.........                   ......      ....++++.+||.+||+.||++|||+.++++
T Consensus       306 lltg~~Pf~~~~~~~~~-------------------~~~~~~------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          306 IWCADLPITKDAALGGS-------------------EWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HHHSSCCC------CCS-------------------GGGGSS------CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             HHHCCCCCcccccccch-------------------hhhhhh------ccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            99999999764432110                   000100      0123457999999999999999999999986

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=4.3e-42  Score=341.26  Aligned_cols=254  Identities=20%  Similarity=0.307  Sum_probs=186.0

Q ss_pred             ccCCceecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhcC-CCcEeeeeeEEe--------eCCce
Q 010309          227 SEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-HPNLVAVKGCCY--------DHGDR  296 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~--------~~~~~  296 (513)
                      +...+.||+|+||.||+|... +++.||||++........+.+.+|+.++.++. ||||+++++++.        .....
T Consensus        30 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~  109 (337)
T 3ll6_A           30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEF  109 (337)
T ss_dssp             EEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEE
T ss_pred             EEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceE
Confidence            344567899999999999964 68999999997776666778999999999995 999999999984        33447


Q ss_pred             EEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--ceEcCCCCCceEecCCCCeEEecccc
Q 010309          297 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH--VVHRDIRASNVLLDEEFGAHLMGVGL  374 (513)
Q Consensus       297 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--ivH~Dikp~NIll~~~~~~kl~Dfg~  374 (513)
                      ++||||+. |+|.+++.... ....+++..++.++.||+.||.|||+.   +  |+||||||+|||++.++.+||+|||+
T Consensus       110 ~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~  184 (337)
T 3ll6_A          110 LLLTELCK-GQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCDFGS  184 (337)
T ss_dssp             EEEEECCS-EEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred             EEEEEecC-CCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEecCcc
Confidence            99999995 79999886422 234699999999999999999999998   8  99999999999999999999999999


Q ss_pred             cccCCcccccc----------ceeecCccccccccccc---ccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchh
Q 010309          375 SKFVPWEVMQE----------RTVMAGGTYGYLAPEFV---YRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSI  441 (513)
Q Consensus       375 ~~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~  441 (513)
                      +..........          ......+|+.|+|||++   .+..++.++||||||+++|+|++|..||.......    
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~----  260 (337)
T 3ll6_A          185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR----  260 (337)
T ss_dssp             CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred             ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH----
Confidence            98765432211          11123389999999998   56678999999999999999999999997543211    


Q ss_pred             HHhhhHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcC
Q 010309          442 FEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  508 (513)
Q Consensus       442 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  508 (513)
                                     ......    ........+..+.+|+.+||+.||.+|||+.|+++.|+.+..
T Consensus       261 ---------------~~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~  308 (337)
T 3ll6_A          261 ---------------IVNGKY----SIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA  308 (337)
T ss_dssp             --------------------C----CCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---------------hhcCcc----cCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence                           000000    000111122348899999999999999999999999987643

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=4.2e-42  Score=340.62  Aligned_cols=266  Identities=18%  Similarity=0.266  Sum_probs=191.5

Q ss_pred             hhCcccCCceecccCceEEEEEEeC-CCCEEEEEEecccchh--cHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEE
Q 010309          223 TKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQ--RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIV  299 (513)
Q Consensus       223 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv  299 (513)
                      .++|. ..+.||+|+||.||+|... +++.||||+++.....  ..+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        33 ~~~y~-~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  111 (329)
T 3gbz_A           33 IDRYR-RITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI  111 (329)
T ss_dssp             GGGEE-EEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhhEE-EEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence            33443 4557799999999999964 6889999999765322  245678999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEec-----CCCCeEEecccc
Q 010309          300 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD-----EEFGAHLMGVGL  374 (513)
Q Consensus       300 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~-----~~~~~kl~Dfg~  374 (513)
                      |||++ |+|.+++..    ...+++..+..++.||+.||+|||+.   +|+||||||+|||++     .++.+||+|||+
T Consensus       112 ~e~~~-~~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~  183 (329)
T 3gbz_A          112 FEYAE-NDLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGL  183 (329)
T ss_dssp             EECCS-EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred             EecCC-CCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence            99997 599999965    24599999999999999999999999   999999999999994     445599999999


Q ss_pred             cccCCccccccceeecCcccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHH--hhc
Q 010309          375 SKFVPWEVMQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPL--VQS  451 (513)
Q Consensus       375 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~--~~~  451 (513)
                      +.........  .....+|+.|+|||++.+. .++.++|||||||++|||++|..||........  +.......  ...
T Consensus       184 a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~~  259 (329)
T 3gbz_A          184 ARAFGIPIRQ--FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQ--LFKIFEVLGLPDD  259 (329)
T ss_dssp             HHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCT
T ss_pred             ccccCCcccc--cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHH--HHHHHHHhCCCch
Confidence            9865433221  1122379999999999874 489999999999999999999999987554211  11111000  000


Q ss_pred             cccccc--c---cccccCCCCCC----CcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          452 HRYLEL--L---DPLISSLSSDI----PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       452 ~~~~~~--~---~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      ......  .   ...........    .....++++.+||.+||+.||++|||++|+++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          260 TTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             TTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            000000  0   00000000000    01114567899999999999999999999987

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.2e-42  Score=343.46  Aligned_cols=250  Identities=20%  Similarity=0.244  Sum_probs=197.9

Q ss_pred             cCCceecccCceEEEEEEe----CCCCEEEEEEecccc----hhcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCCceEE
Q 010309          228 EGNRLLGDSKTGGTYSGIL----PDGSRVAVKRLKRSS----FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYI  298 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~l  298 (513)
                      ...+.||+|+||.||++..    .+++.||||+++...    ....+.+.+|+.++..+ +||||+++++++...+..++
T Consensus        57 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l  136 (355)
T 1vzo_A           57 ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHL  136 (355)
T ss_dssp             EEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEE
T ss_pred             EEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEE
Confidence            3456789999999999997    368999999997542    22345677899999999 79999999999999999999


Q ss_pred             EEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccC
Q 010309          299 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV  378 (513)
Q Consensus       299 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~  378 (513)
                      ||||+++++|.+++..    ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus       137 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~  209 (355)
T 1vzo_A          137 ILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF  209 (355)
T ss_dssp             EECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred             EeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence            9999999999999965    24689999999999999999999999   9999999999999999999999999999876


Q ss_pred             CccccccceeecCccccccccccccc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccc
Q 010309          379 PWEVMQERTVMAGGTYGYLAPEFVYR--NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLE  456 (513)
Q Consensus       379 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  456 (513)
                      ........ ....||+.|+|||++.+  ..++.++||||||+++|||++|+.||..........  .........     
T Consensus       210 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~--~~~~~~~~~-----  281 (355)
T 1vzo_A          210 VADETERA-YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA--EISRRILKS-----  281 (355)
T ss_dssp             CGGGGGGG-CGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH--HHHHHHHHC-----
T ss_pred             ccCCCCcc-cCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHH--HHHHHHhcc-----
Confidence            54332222 22348999999999986  347899999999999999999999997644321111  111111100     


Q ss_pred             cccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 010309          457 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP-----RMSHVVHQ  502 (513)
Q Consensus       457 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  502 (513)
                                ....+...+..+.+||.+||+.||++||     +++++++.
T Consensus       282 ----------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h  322 (355)
T 1vzo_A          282 ----------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  322 (355)
T ss_dssp             ----------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             ----------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence                      0011123456789999999999999999     99999863

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=4.6e-42  Score=358.40  Aligned_cols=247  Identities=25%  Similarity=0.345  Sum_probs=201.1

Q ss_pred             ccCCceecccCceEEEEEEeC-CCCEEEEEEecccc---hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEee
Q 010309          227 SEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF  302 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  302 (513)
                      +...+.||+|+||.||++... +|+.||||++....   ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        28 y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  107 (484)
T 3nyv_A           28 YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEV  107 (484)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             eEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEec
Confidence            344567899999999999975 68999999997542   34567899999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEe---cCCCCeEEecccccccCC
Q 010309          303 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL---DEEFGAHLMGVGLSKFVP  379 (513)
Q Consensus       303 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll---~~~~~~kl~Dfg~~~~~~  379 (513)
                      +.+|+|.+++..    ...+++..+..++.||+.||.|||++   +|+||||||+|||+   +.++.+||+|||++....
T Consensus       108 ~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  180 (484)
T 3nyv_A          108 YTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE  180 (484)
T ss_dssp             CCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred             CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence            999999998864    35699999999999999999999999   99999999999999   567889999999998765


Q ss_pred             ccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccccccc
Q 010309          380 WEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD  459 (513)
Q Consensus       380 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  459 (513)
                      ......   ...||+.|+|||++.+ .++.++|||||||++|+|++|.+||...+......      . +.......   
T Consensus       181 ~~~~~~---~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~------~-i~~~~~~~---  246 (484)
T 3nyv_A          181 ASKKMK---DKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILK------K-VEKGKYTF---  246 (484)
T ss_dssp             CCCSHH---HHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------H-HHHCCCCC---
T ss_pred             cccccc---cCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHH------H-HHcCCCCC---
Confidence            432211   2238999999999865 68999999999999999999999998765421111      1 11111000   


Q ss_pred             ccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          460 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       460 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                             ........++.+.+||.+||+.||++|||+.|+++
T Consensus       247 -------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          247 -------ELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             -------CSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -------CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence                   00111235677999999999999999999999986

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-41  Score=342.62  Aligned_cols=255  Identities=21%  Similarity=0.301  Sum_probs=191.1

Q ss_pred             cCCceecccCceEEEEEEeC-CCCEEEEEEeccc--chhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCC------ceEE
Q 010309          228 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG------DRYI  298 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------~~~l  298 (513)
                      ...+.||+|+||.||+|... +|+.||||++...  .....+.+.+|+.+|+.++||||+++++++...+      ..|+
T Consensus        28 ~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~l  107 (367)
T 1cm8_A           28 RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYL  107 (367)
T ss_dssp             EEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEE
T ss_pred             EEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEE
Confidence            34567899999999999974 6999999999654  2233567899999999999999999999998653      4599


Q ss_pred             EEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccC
Q 010309          299 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV  378 (513)
Q Consensus       299 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~  378 (513)
                      ||||+ +++|.+++..     ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus       108 v~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  178 (367)
T 1cm8_A          108 VMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQA  178 (367)
T ss_dssp             EEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence            99999 8899999875     4589999999999999999999999   9999999999999999999999999999875


Q ss_pred             CccccccceeecCccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhH-Hhhh----HHhh--
Q 010309          379 PWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIF-EWAT----PLVQ--  450 (513)
Q Consensus       379 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~-~~~~----~~~~--  450 (513)
                      ....     ....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.......+ ....    ....  
T Consensus       179 ~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~  253 (367)
T 1cm8_A          179 DSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL  253 (367)
T ss_dssp             CSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred             cccc-----CcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence            4321     12238999999999887 67899999999999999999999999876542211110 0000    0000  


Q ss_pred             -ccc-------ccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          451 -SHR-------YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       451 -~~~-------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                       ...       ...........     .....++.+.+|+.+||+.||++|||++++++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          254 QSDEAKNYMKGLPELEKKDFAS-----ILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             SCHHHHHHHHHSCCCCCCCGGG-----TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hhHHHHHHHHhCCCCCCCCHHH-----HCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence             000       00000000000     01134567999999999999999999999987

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.7e-41  Score=339.44  Aligned_cols=267  Identities=18%  Similarity=0.233  Sum_probs=196.5

Q ss_pred             cCCceecccCceEEEEEEe-CCCCEEEEEEecccch--hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeC--------Cce
Q 010309          228 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--------GDR  296 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--------~~~  296 (513)
                      ...+.||+|+||.||+|.. .+|+.||||++.....  .....+.+|+.+++.++||||+++++++...        +..
T Consensus        20 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~   99 (351)
T 3mi9_A           20 EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSI   99 (351)
T ss_dssp             EEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEE
T ss_pred             eEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceE
Confidence            3345789999999999997 4689999999865532  2346788999999999999999999999874        457


Q ss_pred             EEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccc
Q 010309          297 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK  376 (513)
Q Consensus       297 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~  376 (513)
                      ++||||+++ +|.+.+..   ....+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++.
T Consensus       100 ~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~  172 (351)
T 3mi9_A          100 YLVFDFCEH-DLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR  172 (351)
T ss_dssp             EEEEECCSE-EHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEeccCC-CHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence            999999965 77777753   235699999999999999999999999   99999999999999999999999999998


Q ss_pred             cCCccccc--cceeecCccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccc
Q 010309          377 FVPWEVMQ--ERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHR  453 (513)
Q Consensus       377 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  453 (513)
                      ........  .......||+.|+|||++.+ ..++.++||||||+++|||++|.+||.......................
T Consensus       173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  252 (351)
T 3mi9_A          173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV  252 (351)
T ss_dssp             ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence            76432211  11222348999999999876 4579999999999999999999999987654322111111100000000


Q ss_pred             ccc-----cccccccCCCCCCCcH------HHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          454 YLE-----LLDPLISSLSSDIPEA------GVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       454 ~~~-----~~~~~~~~~~~~~~~~------~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      ...     ................      ..++.+.+||.+||+.||++|||++|+++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             STTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            000     0000000000000000      11456899999999999999999999986

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=3.5e-41  Score=330.18  Aligned_cols=247  Identities=22%  Similarity=0.322  Sum_probs=195.0

Q ss_pred             cCCceecccCceEEEEEEeC-CCCEEEEEEecccc----hhcHHHHHHHHHHHhhcCCCcEeeeeeEEe--eCCceEEEE
Q 010309          228 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS----FQRKKEFYSEIGRFARLHHPNLVAVKGCCY--DHGDRYIVY  300 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~--~~~~~~lv~  300 (513)
                      ...+.||+|+||.||++... +++.||||++....    ....+.+.+|+.++++++||||+++++++.  +.+..++||
T Consensus         8 ~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~   87 (305)
T 2wtk_C            8 LMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVM   87 (305)
T ss_dssp             CCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEE
T ss_pred             eEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEe
Confidence            34567799999999999974 68899999997642    234577999999999999999999999984  456789999


Q ss_pred             eeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCc
Q 010309          301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW  380 (513)
Q Consensus       301 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~  380 (513)
                      ||++++ |.+++...  ....+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++.....
T Consensus        88 e~~~~~-l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~  161 (305)
T 2wtk_C           88 EYCVCG-MQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHP  161 (305)
T ss_dssp             ECCSEE-HHHHHHHS--TTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred             hhccCC-HHHHHHhC--cccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence            999776 77777653  245699999999999999999999999   999999999999999999999999999987654


Q ss_pred             cccccceeecCcccccccccccccCC--CCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccc
Q 010309          381 EVMQERTVMAGGTYGYLAPEFVYRNE--LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELL  458 (513)
Q Consensus       381 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  458 (513)
                      ...........||+.|+|||++.+..  ++.++||||||+++|||++|..||...+...   ...   .. .....    
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~---~i-~~~~~----  230 (305)
T 2wtk_C          162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK---LFE---NI-GKGSY----  230 (305)
T ss_dssp             TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHH---HH-HHCCC----
T ss_pred             cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH---HHH---HH-hcCCC----
Confidence            33222233344899999999987654  3789999999999999999999998654321   111   11 11100    


Q ss_pred             cccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          459 DPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       459 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                                ..+...++.+.+||.+||+.||++|||++++++
T Consensus       231 ----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  263 (305)
T 2wtk_C          231 ----------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ  263 (305)
T ss_dssp             ----------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ----------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                      001123457899999999999999999999996

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=4.3e-42  Score=340.83  Aligned_cols=261  Identities=25%  Similarity=0.327  Sum_probs=195.6

Q ss_pred             CCceecccCceEEEEEEeC-CCCEEEEEEecccch--hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccC
Q 010309          229 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  305 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  305 (513)
                      ..+.||+|+||.||++... +|+.||||++.....  ...+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus        29 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  108 (331)
T 4aaa_A           29 NLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH  108 (331)
T ss_dssp             EEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred             eeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCc
Confidence            3457899999999999975 489999999865532  2345688999999999999999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccc
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  385 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  385 (513)
                      ++|.+++..    ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++......... 
T Consensus       109 ~~l~~~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-  180 (331)
T 4aaa_A          109 TILDDLELF----PNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV-  180 (331)
T ss_dssp             EHHHHHHHS----TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred             chHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCccc-
Confidence            999887653    34699999999999999999999999   9999999999999999999999999999866433221 


Q ss_pred             ceeecCcccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCccccch-hHHh-------hhHHhhcc-ccc
Q 010309          386 RTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS-IFEW-------ATPLVQSH-RYL  455 (513)
Q Consensus       386 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~-~~~~-------~~~~~~~~-~~~  455 (513)
                       .....+|+.|+|||++.+. .++.++||||||+++|+|++|+.||.......... ....       ........ ...
T Consensus       181 -~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (331)
T 4aaa_A          181 -YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFA  259 (331)
T ss_dssp             ----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGT
T ss_pred             -cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccc
Confidence             1123389999999999875 78999999999999999999999998765432111 0000       00000000 000


Q ss_pred             ccccccccCCCCCCC----cHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          456 ELLDPLISSLSSDIP----EAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       456 ~~~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      ....+..   ....+    ....++.+.+||.+||+.||++|||++|+++
T Consensus       260 ~~~~~~~---~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          260 GVRLPEI---KEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             TCCCCCC---SSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             cccCccc---cccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            0000000   01111    1134677999999999999999999999885

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=4.1e-42  Score=334.21  Aligned_cols=250  Identities=24%  Similarity=0.397  Sum_probs=184.3

Q ss_pred             cCCceecccCceEEEEEEe-CCCCEEEEEEecccch-hc-HHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeecc
Q 010309          228 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSF-QR-KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV  304 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~-~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  304 (513)
                      +..+.||+|+||.||++.. .+|+.||||+++.... .. .+.+.++...++.++||||+++++++.+.+..++||||++
T Consensus        10 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~   89 (290)
T 3fme_A           10 EPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD   89 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCS
T ss_pred             hhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhc
Confidence            3456789999999999997 4689999999976522 22 2334455556888899999999999999999999999996


Q ss_pred             CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccc
Q 010309          305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  384 (513)
Q Consensus       305 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  384 (513)
                       |+|.+++.........+++..++.++.|++.||+|||++.  +|+||||||+|||++.++.+||+|||++.........
T Consensus        90 -~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  166 (290)
T 3fme_A           90 -TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK  166 (290)
T ss_dssp             -EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC------------
T ss_pred             -cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCcccccccccc
Confidence             5888887653334567999999999999999999999842  8999999999999999999999999999876543222


Q ss_pred             cceeecCccccccccccc----ccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccc
Q 010309          385 ERTVMAGGTYGYLAPEFV----YRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP  460 (513)
Q Consensus       385 ~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  460 (513)
                      .   ...||+.|+|||++    .+..++.++||||||+++|+|++|..||.......     ..........        
T Consensus       167 ~---~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~~--------  230 (290)
T 3fme_A          167 D---IDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF-----QQLKQVVEEP--------  230 (290)
T ss_dssp             ------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH-----HHHHHHHHSC--------
T ss_pred             c---ccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH-----HHHHHHhccC--------
Confidence            2   22389999999996    45678999999999999999999999997543210     1111111100        


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          461 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       461 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                           ....+....++++.+|+.+||+.||++|||+.|+++
T Consensus       231 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          231 -----SPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             -----CCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             -----CCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence                 011122234567999999999999999999999986

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2e-41  Score=340.43  Aligned_cols=254  Identities=20%  Similarity=0.338  Sum_probs=200.9

Q ss_pred             HHHhhCcccCCceecccCceEEEEEEeC-CCCEEEEEEecccch--------hcHHHHHHHHHHHhhc-CCCcEeeeeeE
Q 010309          220 RSITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF--------QRKKEFYSEIGRFARL-HHPNLVAVKGC  289 (513)
Q Consensus       220 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~nIv~l~~~  289 (513)
                      ..+..+|.. .+.||+|+||.||+|... +|+.||||++.....        ...+.+.+|+.++.++ +||||++++++
T Consensus        90 ~~~~~~y~~-~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  168 (365)
T 2y7j_A           90 KEFYQKYDP-KDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS  168 (365)
T ss_dssp             HHHHHHEEE-EEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             hhhhhhccc-ceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence            344444544 457799999999999985 699999999975431        1135678999999999 79999999999


Q ss_pred             EeeCCceEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEE
Q 010309          290 CYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHL  369 (513)
Q Consensus       290 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl  369 (513)
                      +...+..++||||+++++|.+++..    ...+++..+..++.||+.||.|||+.   +|+|+||||+|||++.++.+||
T Consensus       169 ~~~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl  241 (365)
T 2y7j_A          169 YESSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRL  241 (365)
T ss_dssp             EEBSSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEE
T ss_pred             EeeCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEE
Confidence            9999999999999999999999964    24699999999999999999999999   9999999999999999999999


Q ss_pred             ecccccccCCccccccceeecCccccccccccccc------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHH
Q 010309          370 MGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR------NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFE  443 (513)
Q Consensus       370 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~  443 (513)
                      +|||++.........   ....||+.|+|||++.+      ..++.++||||||+++|+|++|..||.......   ...
T Consensus       242 ~DfG~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~---~~~  315 (365)
T 2y7j_A          242 SDFGFSCHLEPGEKL---RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL---MLR  315 (365)
T ss_dssp             CCCTTCEECCTTCCB---CCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH
T ss_pred             EecCcccccCCCccc---ccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH---HHH
Confidence            999999876543222   22348999999999863      357889999999999999999999997654321   110


Q ss_pred             hhhHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          444 WATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       444 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                         . ...... ....+.         ....+..+.+||.+||+.||++|||++++++
T Consensus       316 ---~-i~~~~~-~~~~~~---------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          316 ---M-IMEGQY-QFSSPE---------WDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             ---H-HHHTCC-CCCHHH---------HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ---H-HHhCCC-CCCCcc---------cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence               0 000000 000000         0123456999999999999999999999986

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=7.2e-42  Score=368.90  Aligned_cols=244  Identities=23%  Similarity=0.315  Sum_probs=200.3

Q ss_pred             cCCceecccCceEEEEEEeC-CCCEEEEEEecccc---hhcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCCceEEEEee
Q 010309          228 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEF  302 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~  302 (513)
                      +..++||+|+||.||+|... +++.||||++++..   ....+.+..|..+|..+ +||+|+++++++.+.+..||||||
T Consensus       344 ~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~  423 (674)
T 3pfq_A          344 NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEY  423 (674)
T ss_dssp             EEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEEC
T ss_pred             EEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeC
Confidence            34467899999999999975 58899999997642   23456788899999988 799999999999999999999999


Q ss_pred             ccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccc
Q 010309          303 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV  382 (513)
Q Consensus       303 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~  382 (513)
                      +++|+|.+++...    ..+++..++.++.||+.||+|||+.   +|+||||||+||||+.++.+||+|||+++......
T Consensus       424 ~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~  496 (674)
T 3pfq_A          424 VNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG  496 (674)
T ss_dssp             CCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT
T ss_pred             cCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeeccccCC
Confidence            9999999999752    4699999999999999999999999   99999999999999999999999999998643322


Q ss_pred             cccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccc
Q 010309          383 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI  462 (513)
Q Consensus       383 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  462 (513)
                      ..  .....||+.|+|||++.+..++.++|||||||+||||++|..||.+.+...   +..   ....         .  
T Consensus       497 ~~--~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~---~~~---~i~~---------~--  557 (674)
T 3pfq_A          497 VT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LFQ---SIME---------H--  557 (674)
T ss_dssp             CC--BCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---HHHS---------S--
T ss_pred             cc--cccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH---HHH---HHHh---------C--
Confidence            21  223459999999999999999999999999999999999999998755421   111   1110         0  


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHH
Q 010309          463 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRM-----SHVVH  501 (513)
Q Consensus       463 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~  501 (513)
                          ....+...++++.+||.+||+.||++||++     +||++
T Consensus       558 ----~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          558 ----NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             ----CCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             ----CCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence                001122356679999999999999999997     66664

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=3.3e-41  Score=349.43  Aligned_cols=190  Identities=22%  Similarity=0.362  Sum_probs=150.2

Q ss_pred             cCCceecccCceEEEEEEeC-CCCEEEEEEeccc--chhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeC-----CceEEE
Q 010309          228 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH-----GDRYIV  299 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~~lv  299 (513)
                      +..+.||+|+||.||+|... +++.||||++...  .....+.+.+|+.+|+.++||||+++++++...     ...|+|
T Consensus        56 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  135 (458)
T 3rp9_A           56 EIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVV  135 (458)
T ss_dssp             EECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEE
T ss_pred             EEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEE
Confidence            44567799999999999965 6899999999754  233457789999999999999999999998543     568999


Q ss_pred             EeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCC
Q 010309          300 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP  379 (513)
Q Consensus       300 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~  379 (513)
                      |||+ +++|.+++..    ...+++..+..++.||+.||+|||+.   +|+||||||+||||+.++.+||+|||+++...
T Consensus       136 ~e~~-~~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  207 (458)
T 3rp9_A          136 LEIA-DSDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVD  207 (458)
T ss_dssp             ECCC-SEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred             Eecc-ccchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence            9998 6799998864    35699999999999999999999999   99999999999999999999999999998764


Q ss_pred             ccccc-------------------------cceeecCccccccccccc-ccCCCCchhhHHHHHHHHHHHHc
Q 010309          380 WEVMQ-------------------------ERTVMAGGTYGYLAPEFV-YRNELTTKSDVYSFGVLLLEIVS  425 (513)
Q Consensus       380 ~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlGvil~ellt  425 (513)
                      .....                         .......||+.|+|||++ ....++.++|||||||++|||++
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt  279 (458)
T 3rp9_A          208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN  279 (458)
T ss_dssp             SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred             CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence            32111                         111223479999999986 45679999999999999999999

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2e-42  Score=336.53  Aligned_cols=257  Identities=23%  Similarity=0.303  Sum_probs=194.5

Q ss_pred             cCCceecccCceEEEEEEeC--CCC--EEEEEEecccc---hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEE
Q 010309          228 EGNRLLGDSKTGGTYSGILP--DGS--RVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY  300 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  300 (513)
                      ...+.||+|+||.||+|.+.  +++  .||||+++...   ....+.+.+|+.++++++||||+++++++.+.+ .++||
T Consensus        21 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~   99 (291)
T 1u46_A           21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVT   99 (291)
T ss_dssp             EEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEE
T ss_pred             eeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeE
Confidence            44567899999999999853  333  69999987542   234578899999999999999999999988764 89999


Q ss_pred             eeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCc
Q 010309          301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW  380 (513)
Q Consensus       301 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~  380 (513)
                      ||+++++|.+++...   ...+++..+..++.|++.||.|||+.   +++|+||||+|||++.++.+||+|||++.....
T Consensus       100 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  173 (291)
T 1u46_A          100 ELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  173 (291)
T ss_dssp             ECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             ecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccccccc
Confidence            999999999999642   24589999999999999999999999   999999999999999999999999999987654


Q ss_pred             ccccc-ceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccc
Q 010309          381 EVMQE-RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELL  458 (513)
Q Consensus       381 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  458 (513)
                      ..... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+...   ..   ........     
T Consensus       174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~---~~~~~~~~-----  242 (291)
T 1u46_A          174 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---IL---HKIDKEGE-----  242 (291)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HH---HHHHTSCC-----
T ss_pred             cccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH---HH---HHHHccCC-----
Confidence            32211 1122337888999999988889999999999999999999 999997654321   11   11111000     


Q ss_pred             cccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcCCC
Q 010309          459 DPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP  510 (513)
Q Consensus       459 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  510 (513)
                              ....+...++++.+++.+||+.||++|||+.++++.|+++....
T Consensus       243 --------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  286 (291)
T 1u46_A          243 --------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD  286 (291)
T ss_dssp             --------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             --------CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence                    00111234567999999999999999999999999999876543

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.3e-41  Score=355.65  Aligned_cols=246  Identities=22%  Similarity=0.314  Sum_probs=194.1

Q ss_pred             cCCceecccCceEEEEEEeC-CCCEEEEEEecccc--hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeecc
Q 010309          228 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV  304 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  304 (513)
                      ...+.||+|+||.||+|... ++..||||++....  ......+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus        40 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~  119 (494)
T 3lij_A           40 QRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYK  119 (494)
T ss_dssp             EEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             EEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCC
Confidence            33557799999999999975 68899999997653  2335778999999999999999999999999999999999999


Q ss_pred             CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCC---CCeEEecccccccCCcc
Q 010309          305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE---FGAHLMGVGLSKFVPWE  381 (513)
Q Consensus       305 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~---~~~kl~Dfg~~~~~~~~  381 (513)
                      +|+|.+++..    ...+++..+..++.||+.||.|||+.   +|+||||||+|||++..   +.+||+|||++......
T Consensus       120 ~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~  192 (494)
T 3lij_A          120 GGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ  192 (494)
T ss_dssp             SCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred             CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence            9999998864    25699999999999999999999999   99999999999999764   45999999999876543


Q ss_pred             ccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccccccccc
Q 010309          382 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL  461 (513)
Q Consensus       382 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  461 (513)
                      ...   ....||+.|+|||++. ..++.++|||||||++|+|++|.+||..........      . ...... ....+ 
T Consensus       193 ~~~---~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~------~-i~~~~~-~~~~~-  259 (494)
T 3lij_A          193 KKM---KERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILR------K-VEKGKY-TFDSP-  259 (494)
T ss_dssp             BCB---CCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------H-HHHTCC-CCCSG-
T ss_pred             ccc---cccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------H-HHhCCC-CCCch-
Confidence            221   2234999999999885 568999999999999999999999998765421111      1 111100 00000 


Q ss_pred             ccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          462 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       462 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                              .....++.+.+||.+||+.||.+|||+.++++
T Consensus       260 --------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          260 --------EWKNVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             --------GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             --------hcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence                    11234567999999999999999999999985

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=4.3e-41  Score=333.41  Aligned_cols=257  Identities=18%  Similarity=0.245  Sum_probs=197.0

Q ss_pred             cCCceecccCceEEEEEEe-CCCCEEEEEEecccchhcHHHHHHHHHHHhhcC-CCcEeeeeeEEee--CCceEEEEeec
Q 010309          228 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-HPNLVAVKGCCYD--HGDRYIVYEFV  303 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~--~~~~~lv~e~~  303 (513)
                      ...+.||+|+||.||+|.. .+++.||||+++..   ..+.+.+|+.++++++ ||||+++++++.+  ....++||||+
T Consensus        39 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~  115 (330)
T 3nsz_A           39 QLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV  115 (330)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECC
T ss_pred             EEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEecc
Confidence            3456789999999999986 46899999999754   3567899999999997 9999999999988  66789999999


Q ss_pred             cCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCC-CeEEecccccccCCccc
Q 010309          304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF-GAHLMGVGLSKFVPWEV  382 (513)
Q Consensus       304 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~-~~kl~Dfg~~~~~~~~~  382 (513)
                      ++++|.+++.       .+++..+..++.||+.||+|||+.   +|+||||||+|||++.++ .+||+|||++.......
T Consensus       116 ~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~  185 (330)
T 3nsz_A          116 NNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ  185 (330)
T ss_dssp             CCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred             CchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence            9999999884       389999999999999999999999   999999999999999776 79999999998765433


Q ss_pred             cccceeecCccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhH--------Hhhccc
Q 010309          383 MQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATP--------LVQSHR  453 (513)
Q Consensus       383 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~--------~~~~~~  453 (513)
                      ...   ...+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||....... ..+......        ......
T Consensus       186 ~~~---~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~-~~l~~~~~~~~~~~~~~~~~~~~  261 (330)
T 3nsz_A          186 EYN---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY-DQLVRIAKVLGTEDLYDYIDKYN  261 (330)
T ss_dssp             CCC---SCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH-HHHHHHHHHHCHHHHHHHHHHTT
T ss_pred             ccc---cccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchH-HHHHHHHHhcCCchhhhHHHHhc
Confidence            221   2238999999999877 678999999999999999999999996543221 111110000        000000


Q ss_pred             c------cccc----cccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          454 Y------LELL----DPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       454 ~------~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      .      .+..    ................++++.+||.+||+.||++|||++|+++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            0      0000    0000001111222335678999999999999999999999987

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=2.4e-41  Score=347.52  Aligned_cols=196  Identities=21%  Similarity=0.313  Sum_probs=162.0

Q ss_pred             cCCceecccCceEEEEEEeC-CCCEEEEEEeccc--chhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeC-----CceEEE
Q 010309          228 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH-----GDRYIV  299 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~~lv  299 (513)
                      ...+.||+|+||.||+|... +++.||||++...  .....+.+.+|+.+|+.++||||+++++++...     +..|+|
T Consensus        29 ~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv  108 (432)
T 3n9x_A           29 IIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIV  108 (432)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEE
T ss_pred             EEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEE
Confidence            34567899999999999975 5889999999764  233457889999999999999999999999876     578999


Q ss_pred             EeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCC
Q 010309          300 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP  379 (513)
Q Consensus       300 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~  379 (513)
                      |||+. ++|.+++..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus       109 ~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~~~  180 (432)
T 3n9x_A          109 LEIAD-SDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTIN  180 (432)
T ss_dssp             EECCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred             EecCC-cCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence            99985 699999964    35699999999999999999999999   99999999999999999999999999998765


Q ss_pred             ccccc--------------------cceeecCccccccccccc-ccCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 010309          380 WEVMQ--------------------ERTVMAGGTYGYLAPEFV-YRNELTTKSDVYSFGVLLLEIVSGRRPAQ  431 (513)
Q Consensus       380 ~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlGvil~elltg~~p~~  431 (513)
                      .....                    .......||+.|+|||++ ....++.++|||||||++|||++|..||.
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            43211                    112234489999999986 45679999999999999999998655543

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=3.4e-41  Score=338.64  Aligned_cols=275  Identities=19%  Similarity=0.270  Sum_probs=197.5

Q ss_pred             HHHHHHHhhCcccCCceecccCceEEEEEEeCCCCEEEEEEecccchh-----------cHHHHHHHHHHHhhcCCCcEe
Q 010309          216 TEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQ-----------RKKEFYSEIGRFARLHHPNLV  284 (513)
Q Consensus       216 ~~~l~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~nIv  284 (513)
                      ..++..+.++|.. .+.||+|+||.||+|...+|+.||||++......           ..+.+.+|+.++++++||||+
T Consensus        14 ~~~~~~~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   92 (362)
T 3pg1_A           14 IAELHAMQSPYTV-QRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL   92 (362)
T ss_dssp             HHHHHHTTCSCEE-EEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             HHHHHHhccceEE-eEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence            3466666666655 4577999999999999888999999999653221           137789999999999999999


Q ss_pred             eeeeEEeeC-----CceEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCce
Q 010309          285 AVKGCCYDH-----GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNV  359 (513)
Q Consensus       285 ~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NI  359 (513)
                      ++++++...     ...++||||++ |+|.+++..   ....+++..+..++.||+.||.|||+.   +|+||||||+||
T Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NI  165 (362)
T 3pg1_A           93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNI  165 (362)
T ss_dssp             CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred             ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHE
Confidence            999998543     35799999997 688888863   335699999999999999999999999   999999999999


Q ss_pred             EecCCCCeEEecccccccCCccccccceeecCccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCcccc
Q 010309          360 LLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW  438 (513)
Q Consensus       360 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~  438 (513)
                      |++.++.+||+|||++..........   ...+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||........
T Consensus       166 l~~~~~~~kl~Dfg~~~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~  242 (362)
T 3pg1_A          166 LLADNNDITICDFNLAREDTADANKT---HYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ  242 (362)
T ss_dssp             EECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             EEcCCCCEEEEecCcccccccccccc---eecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence            99999999999999998554332221   2238999999999877 6789999999999999999999999987553221


Q ss_pred             ch-hHHhhhH-------HhhcccccccccccccCCCCCC---CcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          439 QS-IFEWATP-------LVQSHRYLELLDPLISSLSSDI---PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       439 ~~-~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      .. +......       ........+.+...........   .....++.+.+||.+||+.||++|||++|+++
T Consensus       243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          243 LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence            11 1100000       0000000011111111000000   01123567999999999999999999999986

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-41  Score=336.49  Aligned_cols=247  Identities=23%  Similarity=0.377  Sum_probs=192.4

Q ss_pred             cCCceecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhc-CCCcEeeeeeEEee------CCceEEE
Q 010309          228 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYD------HGDRYIV  299 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~------~~~~~lv  299 (513)
                      ...+.||+|+||.||+|... +|+.||||++.... ...+.+.+|+.+++++ +||||+++++++..      .+..++|
T Consensus        27 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv  105 (326)
T 2x7f_A           27 ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLV  105 (326)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEE
T ss_pred             EEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEE
Confidence            34567899999999999974 68999999997653 3457889999999999 89999999999987      4578999


Q ss_pred             EeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCC
Q 010309          300 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP  379 (513)
Q Consensus       300 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~  379 (513)
                      |||+++++|.+++...  ....+++..+..++.||+.||.|||+.   +|+|+||||+|||++.++.+||+|||++....
T Consensus       106 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  180 (326)
T 2x7f_A          106 MEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD  180 (326)
T ss_dssp             EECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCTTTC---
T ss_pred             EEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCcCceecC
Confidence            9999999999999753  235689999999999999999999999   99999999999999999999999999998764


Q ss_pred             ccccccceeecCcccccccccccc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccc
Q 010309          380 WEVMQERTVMAGGTYGYLAPEFVY-----RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRY  454 (513)
Q Consensus       380 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  454 (513)
                      .....  .....||+.|+|||++.     +..++.++||||||+++|+|++|..||........  .    .. ......
T Consensus       181 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~----~~-~~~~~~  251 (326)
T 2x7f_A          181 RTVGR--RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA--L----FL-IPRNPA  251 (326)
T ss_dssp             ------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH--H----HH-HHHSCC
T ss_pred             cCccc--cccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH--H----HH-hhcCcc
Confidence            32211  11223899999999987     46688999999999999999999999976543210  0    00 000000


Q ss_pred             cccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          455 LELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       455 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                                  ........+..+.+||.+||+.||.+|||++++++
T Consensus       252 ------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          252 ------------PRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             ------------CCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ------------ccCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence                        01111223457999999999999999999999987

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=5.7e-42  Score=345.41  Aligned_cols=249  Identities=12%  Similarity=-0.026  Sum_probs=177.9

Q ss_pred             CCceecccCceEEEEEEeC-CCCEEEEEEecccch---hcHHHHHHHHHHHhhc--CCCcEeeee-------eEEeeCC-
Q 010309          229 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARL--HHPNLVAVK-------GCCYDHG-  294 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~h~nIv~l~-------~~~~~~~-  294 (513)
                      ..+.||+|+||.||+|.+. +|+.||||++.....   ...+.+.+|+.+++.|  +||||++++       +++...+ 
T Consensus        66 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~  145 (371)
T 3q60_A           66 LVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQ  145 (371)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTS
T ss_pred             eeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCC
Confidence            4567899999999999975 689999999987543   3345677885555544  699988755       4444332 


Q ss_pred             ----------------ceEEEEeeccCCCHHHHhccCCCCCCCCCHHHH------HHHHHHHHHHHHHHhcCCCCCceEc
Q 010309          295 ----------------DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMR------MKVATTLAQGIAFLHDKVKPHVVHR  352 (513)
Q Consensus       295 ----------------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~------~~i~~qi~~~L~~LH~~~~~~ivH~  352 (513)
                                      ..++||||++ |+|.+++...   +..+++..+      ..++.||+.||+|||++   +|+||
T Consensus       146 ~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ivHr  218 (371)
T 3q60_A          146 PPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL---DFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHG  218 (371)
T ss_dssp             CSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH---HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEEET
T ss_pred             CCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh---ccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCccC
Confidence                            3799999998 8999999753   123455555      67889999999999999   99999


Q ss_pred             CCCCCceEecCCCCeEEecccccccCCccccccceeecCccccccccccccc--CCCCchhhHHHHHHHHHHHHcCCCCC
Q 010309          353 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR--NELTTKSDVYSFGVLLLEIVSGRRPA  430 (513)
Q Consensus       353 Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvil~elltg~~p~  430 (513)
                      ||||+|||++.++.+||+|||+++.......     ...+|+.|+|||++.+  ..++.++|||||||++|||++|+.||
T Consensus       219 Dikp~NIll~~~~~~kL~DFG~a~~~~~~~~-----~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf  293 (371)
T 3q60_A          219 HFTPDNLFIMPDGRLMLGDVSALWKVGTRGP-----ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF  293 (371)
T ss_dssp             TCSGGGEEECTTSCEEECCGGGEEETTCEEE-----GGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred             cCCHHHEEECCCCCEEEEecceeeecCCCcc-----CccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence            9999999999999999999999987643221     2237799999999987  67899999999999999999999999


Q ss_pred             CCCCccccchhHHhhhHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          431 QAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       431 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      ...........        .............    ........++.+.+||.+||+.||++|||+.++++
T Consensus       294 ~~~~~~~~~~~--------~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          294 GLVTPGIKGSW--------KRPSLRVPGTDSL----AFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             TBCCTTCTTCC--------CBCCTTSCCCCSC----CCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CCcCcccccch--------hhhhhhhcccccc----chhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            87643211000        0000000000000    00111234667999999999999999999999974

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=2e-41  Score=355.05  Aligned_cols=250  Identities=24%  Similarity=0.343  Sum_probs=197.3

Q ss_pred             hhCcccCCceecccCceEEEEEEeC-CCCEEEEEEecccch-------------hcHHHHHHHHHHHhhcCCCcEeeeee
Q 010309          223 TKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF-------------QRKKEFYSEIGRFARLHHPNLVAVKG  288 (513)
Q Consensus       223 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~nIv~l~~  288 (513)
                      .+.|.. .+.||+|+||.||+|... +++.||||++.....             ...+.+.+|+.+|++++||||+++++
T Consensus        35 ~~~Y~~-~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           35 GESYFK-VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGTEEE-EEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             ccceEE-EeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            344444 567799999999999975 588999999976432             23467899999999999999999999


Q ss_pred             EEeeCCceEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCC---
Q 010309          289 CCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF---  365 (513)
Q Consensus       289 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~---  365 (513)
                      ++.+.+..++||||+++|+|.+++..    ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++   
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~  186 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLL  186 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCS
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCc
Confidence            99999999999999999999998864    24699999999999999999999999   999999999999998776   


Q ss_pred             CeEEecccccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhh
Q 010309          366 GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWA  445 (513)
Q Consensus       366 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~  445 (513)
                      .+||+|||++.........   ....||+.|+|||++. ..++.++|||||||++|+|++|.+||.+.+....   ... 
T Consensus       187 ~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~-  258 (504)
T 3q5i_A          187 NIKIVDFGLSSFFSKDYKL---RDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDI---IKK-  258 (504)
T ss_dssp             SEEECCCTTCEECCTTSCB---CCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHH-
T ss_pred             cEEEEECCCCEEcCCCCcc---ccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHH-
Confidence            6999999999876543222   2233999999999986 5689999999999999999999999987654211   111 


Q ss_pred             hHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          446 TPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       446 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                         +.......          ........++++.+||.+||+.||.+|||++|+++
T Consensus       259 ---i~~~~~~~----------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          259 ---VEKGKYYF----------DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             ---HHHCCCCC----------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ---HHcCCCCC----------CccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence               11110000          00001124567999999999999999999999986

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=3.1e-41  Score=339.95  Aligned_cols=260  Identities=19%  Similarity=0.267  Sum_probs=189.3

Q ss_pred             cCCceecccCceEEEEEEeC-CCCEEEEEEeccc--chhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCC------ceEE
Q 010309          228 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG------DRYI  298 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------~~~l  298 (513)
                      ...+.||+|+||.||+|... +++.||||++...  .....+.+.+|+.+++.++||||+++++++...+      ..++
T Consensus        28 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~l  107 (371)
T 2xrw_A           28 QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI  107 (371)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEE
T ss_pred             eEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEE
Confidence            33457899999999999964 5889999999754  2334567889999999999999999999998765      6799


Q ss_pred             EEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccC
Q 010309          299 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV  378 (513)
Q Consensus       299 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~  378 (513)
                      ||||++ ++|.+++.      ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++...
T Consensus       108 v~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~  177 (371)
T 2xrw_A          108 VMELMD-ANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA  177 (371)
T ss_dssp             EEECCS-EEHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred             EEEcCC-CCHHHHHh------hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence            999996 57888875      3489999999999999999999999   9999999999999999999999999999866


Q ss_pred             CccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccch-hHHh-------------
Q 010309          379 PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS-IFEW-------------  444 (513)
Q Consensus       379 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~-~~~~-------------  444 (513)
                      ......   ....||+.|+|||++.+..++.++|||||||++|||++|..||.+.+...... +...             
T Consensus       178 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  254 (371)
T 2xrw_A          178 GTSFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ  254 (371)
T ss_dssp             ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred             cccccc---CCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence            433211   12338999999999999999999999999999999999999998765421100 0000             


Q ss_pred             --hhHHhhc-cc-----ccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          445 --ATPLVQS-HR-----YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       445 --~~~~~~~-~~-----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                        ....... ..     +.......... .........+.++.+||.+||+.||++|||++|+++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          255 PTVRTYVENRPKYAGYSFEKLFPDVLFP-ADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             HHHHHHHHSSCCCCCCCHHHHSCGGGSC-CSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hHHHHHHhhCccccccchhhhcccccCc-ccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence              0000000 00     00000000000 000012234678999999999999999999999987

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=8e-42  Score=348.44  Aligned_cols=205  Identities=18%  Similarity=0.320  Sum_probs=156.6

Q ss_pred             hCcccCCceecccCceEEEEEEeC---CCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEee--CCceEE
Q 010309          224 KNFSEGNRLLGDSKTGGTYSGILP---DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD--HGDRYI  298 (513)
Q Consensus       224 ~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~l  298 (513)
                      +.|....++||+|+||.||+|...   +++.||||++....  ....+.+|+.+|++++||||+++++++..  ....++
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l   97 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL   97 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence            345544667899999999999965   57899999997653  33568899999999999999999999954  667899


Q ss_pred             EEeeccCCCHHHHhccCC-----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEe----cCCCCeEE
Q 010309          299 VYEFVVNGPLDRWLHHIP-----RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL----DEEFGAHL  369 (513)
Q Consensus       299 v~e~~~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll----~~~~~~kl  369 (513)
                      ||||+. ++|.+++....     .....+++..++.++.||+.||+|||+.   +|+||||||+|||+    +.++.+||
T Consensus        98 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl  173 (405)
T 3rgf_A           98 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKI  173 (405)
T ss_dssp             EEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred             EEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEE
Confidence            999995 58887775321     1223599999999999999999999999   99999999999999    67789999


Q ss_pred             ecccccccCCccccc-cceeecCcccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 010309          370 MGVGLSKFVPWEVMQ-ERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVD  434 (513)
Q Consensus       370 ~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~  434 (513)
                      +|||+++........ .......||+.|+|||++.+. .++.++|||||||++|||++|.+||....
T Consensus       174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  240 (405)
T 3rgf_A          174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  240 (405)
T ss_dssp             CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred             EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence            999999876533211 112223489999999999874 58999999999999999999999997654

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.2e-41  Score=344.63  Aligned_cols=261  Identities=20%  Similarity=0.251  Sum_probs=192.7

Q ss_pred             cCCceecccCceEEEEEEe-CCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeC-------------
Q 010309          228 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH-------------  293 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-------------  293 (513)
                      ...+.||+|+||.||+|.. .+|+.||||++.....    ...+|+.+++.++||||+++++++...             
T Consensus        10 ~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~   85 (383)
T 3eb0_A           10 SLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDD   85 (383)
T ss_dssp             EEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-------------
T ss_pred             EEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccccccccccc
Confidence            4456789999999999996 4699999999965432    234799999999999999999998543             


Q ss_pred             -------------------------CceEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 010309          294 -------------------------GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH  348 (513)
Q Consensus       294 -------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~  348 (513)
                                               ...++||||++ ++|.+.+.........+++..+..++.||+.||+|||+.   +
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---g  161 (383)
T 3eb0_A           86 HNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---G  161 (383)
T ss_dssp             ------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---T
T ss_pred             cccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---c
Confidence                                     23789999997 588887765434456799999999999999999999999   9


Q ss_pred             ceEcCCCCCceEec-CCCCeEEecccccccCCccccccceeecCcccccccccccccC-CCCchhhHHHHHHHHHHHHcC
Q 010309          349 VVHRDIRASNVLLD-EEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSG  426 (513)
Q Consensus       349 ivH~Dikp~NIll~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg  426 (513)
                      |+||||||+|||++ .++.+||+|||++..........   ...+|+.|+|||++.+. .++.++|||||||++|||++|
T Consensus       162 i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g  238 (383)
T 3eb0_A          162 ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSV---AYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILG  238 (383)
T ss_dssp             EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCC---CCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHS
T ss_pred             CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCc---CcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhC
Confidence            99999999999997 67889999999998764433222   22389999999998775 489999999999999999999


Q ss_pred             CCCCCCCCccccchhHHhhhHHh---------hcccccccccccccCC-CCCCCcHHHHHHHHHHHHHhcCCCCCCCCCH
Q 010309          427 RRPAQAVDSVCWQSIFEWATPLV---------QSHRYLELLDPLISSL-SSDIPEAGVVQKVVDLVYACTQHVPSMRPRM  496 (513)
Q Consensus       427 ~~p~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  496 (513)
                      +.||.+.+....  +........         ......+..-+..... .....+...++++.+||.+||+.||++|||+
T Consensus       239 ~~pf~~~~~~~~--~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  316 (383)
T 3eb0_A          239 KPLFSGETSIDQ--LVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINP  316 (383)
T ss_dssp             SCSSCCSSHHHH--HHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred             CCCCCCCChHHH--HHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCH
Confidence            999987654321  111110000         0000000000000000 0000112345679999999999999999999


Q ss_pred             HHHHH
Q 010309          497 SHVVH  501 (513)
Q Consensus       497 ~evl~  501 (513)
                      .|+++
T Consensus       317 ~e~l~  321 (383)
T 3eb0_A          317 YEAMA  321 (383)
T ss_dssp             HHHHT
T ss_pred             HHHhc
Confidence            99985

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=6.8e-41  Score=343.62  Aligned_cols=197  Identities=18%  Similarity=0.238  Sum_probs=168.7

Q ss_pred             ccCCceecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhc------CCCcEeeeeeEEeeCCceEEE
Q 010309          227 SEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARL------HHPNLVAVKGCCYDHGDRYIV  299 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~nIv~l~~~~~~~~~~~lv  299 (513)
                      ++..+.||+|+||.||+|... +++.||||+++... .....+.+|+.+++.+      +|+||+++++++...+..++|
T Consensus        99 y~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv  177 (429)
T 3kvw_A           99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMT  177 (429)
T ss_dssp             EEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEE
T ss_pred             EEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEE
Confidence            344567899999999999875 48899999997642 3346677888888877      577999999999999999999


Q ss_pred             EeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCC--eEEeccccccc
Q 010309          300 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG--AHLMGVGLSKF  377 (513)
Q Consensus       300 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~--~kl~Dfg~~~~  377 (513)
                      |||+. ++|.+++...  ....+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.  +||+|||++..
T Consensus       178 ~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~  251 (429)
T 3kvw_A          178 FELLS-MNLYELIKKN--KFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCY  251 (429)
T ss_dssp             ECCCC-CBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred             EeccC-CCHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeeccccee
Confidence            99995 6999998763  234599999999999999999999999   9999999999999999887  99999999976


Q ss_pred             CCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCc
Q 010309          378 VPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS  435 (513)
Q Consensus       378 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~  435 (513)
                      .....     ....||+.|+|||++.+..++.++|||||||++|||++|.+||...+.
T Consensus       252 ~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~  304 (429)
T 3kvw_A          252 EHQRV-----YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE  304 (429)
T ss_dssp             TTCCC-----CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             cCCcc-----cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence            54321     123489999999999999999999999999999999999999987654

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2.2e-41  Score=340.18  Aligned_cols=265  Identities=20%  Similarity=0.254  Sum_probs=197.3

Q ss_pred             cCCceecccCceEEEEEEeC-CCCEEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeC-----CceEEEE
Q 010309          228 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH-----GDRYIVY  300 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~~lv~  300 (513)
                      ...+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++.+++||||+++++++...     ...++||
T Consensus        30 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~  109 (364)
T 3qyz_A           30 TNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQ  109 (364)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEE
T ss_pred             EEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEE
Confidence            34457799999999999975 58899999997543 23347789999999999999999999998765     3679999


Q ss_pred             eeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCc
Q 010309          301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW  380 (513)
Q Consensus       301 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~  380 (513)
                      ||+. ++|.+++..     ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++.....
T Consensus       110 e~~~-~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  180 (364)
T 3qyz_A          110 DLME-TDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADP  180 (364)
T ss_dssp             ECCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred             cccC-cCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence            9996 599999864     4599999999999999999999999   999999999999999999999999999987654


Q ss_pred             cccccc-eeecCccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccc
Q 010309          381 EVMQER-TVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELL  458 (513)
Q Consensus       381 ~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  458 (513)
                      ...... .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...+........................
T Consensus       181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  260 (364)
T 3qyz_A          181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII  260 (364)
T ss_dssp             GGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCC
T ss_pred             CCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence            432211 122348999999998764 458999999999999999999999998765432211110000000000000000


Q ss_pred             c----ccccCCC--CCCC----cHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          459 D----PLISSLS--SDIP----EAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       459 ~----~~~~~~~--~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      .    .......  ...+    ....++++.+||.+||+.||++|||++|+++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0    0000000  0000    0123567999999999999999999999986

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.4e-41  Score=339.50  Aligned_cols=257  Identities=19%  Similarity=0.314  Sum_probs=199.7

Q ss_pred             cCCceecccCceEEEEEEeCCCCEEEEEEecccchhc-----------------HHHHHHHHHHHhhcCCCcEeeeeeEE
Q 010309          228 EGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQR-----------------KKEFYSEIGRFARLHHPNLVAVKGCC  290 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~nIv~l~~~~  290 (513)
                      ...+.||+|+||.||+|.. +|+.||||++.......                 .+.+.+|+.++++++||||+++++++
T Consensus        34 ~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~  112 (348)
T 2pml_X           34 RIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGII  112 (348)
T ss_dssp             EEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEE
T ss_pred             EEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence            3456789999999999999 99999999997543221                 17899999999999999999999999


Q ss_pred             eeCCceEEEEeeccCCCHHHH------hccCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCceEcCCCCCceEecC
Q 010309          291 YDHGDRYIVYEFVVNGPLDRW------LHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD-KVKPHVVHRDIRASNVLLDE  363 (513)
Q Consensus       291 ~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dikp~NIll~~  363 (513)
                      .+.+..++||||+++++|.++      +..  .....+++..++.++.|++.||.|||+ .   +|+||||||+|||++.
T Consensus       113 ~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~~~  187 (348)
T 2pml_X          113 TNYDEVYIIYEYMENDSILKFDEYFFVLDK--NYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILMDK  187 (348)
T ss_dssp             ESSSEEEEEEECCTTCBSSEESSSEESSCS--SSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEECT
T ss_pred             eeCCeEEEEEeccCCCcHHHHHHHhhhhhh--ccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEEcC
Confidence            999999999999999999998      432  224679999999999999999999999 8   9999999999999999


Q ss_pred             CCCeEEecccccccCCccccccceeecCcccccccccccccC-CCCc-hhhHHHHHHHHHHHHcCCCCCCCCCccccchh
Q 010309          364 EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN-ELTT-KSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSI  441 (513)
Q Consensus       364 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDvwSlGvil~elltg~~p~~~~~~~~~~~~  441 (513)
                      ++.+||+|||++......    ......+|+.|+|||++.+. .++. ++||||||+++|||++|..||......  ...
T Consensus       188 ~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~  261 (348)
T 2pml_X          188 NGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL--VEL  261 (348)
T ss_dssp             TSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS--HHH
T ss_pred             CCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHH
Confidence            999999999999875433    12223489999999999877 5666 999999999999999999999875542  111


Q ss_pred             HHhhhHHhhcccc--cc----cccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          442 FEWATPLVQSHRY--LE----LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       442 ~~~~~~~~~~~~~--~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      ....    .....  ..    ...+.. ...........+.++.+|+.+||+.||.+|||++|+++
T Consensus       262 ~~~i----~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          262 FNNI----RTKNIEYPLDRNHFLYPLT-NKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             HHHH----TSCCCCCCCSSSSSTTTTC-C--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHH----hccCcCCccchhhhhcccc-ccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1111    10100  00    000000 00000011335567999999999999999999999986

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=5.3e-42  Score=338.20  Aligned_cols=255  Identities=20%  Similarity=0.373  Sum_probs=195.4

Q ss_pred             ccCCceecccCceEEEEEEeCCCCEEEEEEecccc--hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeecc
Q 010309          227 SEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV  304 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  304 (513)
                      +...+.||+|+||.||+|...+  .||+|+++...  ....+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus        35 ~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~  112 (319)
T 2y4i_B           35 LEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCK  112 (319)
T ss_dssp             EECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCC
T ss_pred             eEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeeccc
Confidence            3445678999999999999743  49999997542  2234567889999999999999999999999999999999999


Q ss_pred             CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccc--
Q 010309          305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV--  382 (513)
Q Consensus       305 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--  382 (513)
                      +++|.+++..   ....+++..++.++.||+.||+|||+.   +|+||||||+|||++ ++.+||+|||++.......  
T Consensus       113 ~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~  185 (319)
T 2y4i_B          113 GRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAG  185 (319)
T ss_dssp             SEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC--------
T ss_pred             CCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCcccccccccc
Confidence            9999999964   234689999999999999999999999   999999999999998 6799999999987653221  


Q ss_pred             -cccceeecCccccccccccccc---------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcc
Q 010309          383 -MQERTVMAGGTYGYLAPEFVYR---------NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSH  452 (513)
Q Consensus       383 -~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  452 (513)
                       .........||+.|+|||++.+         ..++.++||||||+++|||++|..||.......   ..   ... ...
T Consensus       186 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~---~~~-~~~  258 (319)
T 2y4i_B          186 RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA---II---WQM-GTG  258 (319)
T ss_dssp             --CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH---HH---HHH-HTT
T ss_pred             ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HH---HHh-ccC
Confidence             1111222348999999999874         357889999999999999999999997654321   11   010 000


Q ss_pred             cccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcCC
Q 010309          453 RYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP  509 (513)
Q Consensus       453 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  509 (513)
                           ..+       .......+.++.+++.+||+.||++|||+.++++.|+++...
T Consensus       259 -----~~~-------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~  303 (319)
T 2y4i_B          259 -----MKP-------NLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR  303 (319)
T ss_dssp             -----CCC-------CCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred             -----CCC-------CCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence                 001       011112334589999999999999999999999999988654

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=8.9e-42  Score=333.87  Aligned_cols=263  Identities=21%  Similarity=0.327  Sum_probs=184.8

Q ss_pred             CcccCCceecccCceEEEEEEeC-CCCEEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEee
Q 010309          225 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF  302 (513)
Q Consensus       225 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  302 (513)
                      +-+...+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++||||
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   94 (303)
T 2vwi_A           15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKL   94 (303)
T ss_dssp             CCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEEC
T ss_pred             hhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehh
Confidence            34455678899999999999864 68999999987543 23456788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhccC----CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccC
Q 010309          303 VVNGPLDRWLHHI----PRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV  378 (513)
Q Consensus       303 ~~~gsL~~~l~~~----~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~  378 (513)
                      +++++|.+++...    ......+++..+..++.||+.||.|||+.   +|+||||||+||+++.++.+||+|||++...
T Consensus        95 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  171 (303)
T 2vwi_A           95 LSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFL  171 (303)
T ss_dssp             CTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHHHC
T ss_pred             ccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchhee
Confidence            9999999998632    11235689999999999999999999999   9999999999999999999999999999765


Q ss_pred             Ccccc---ccceeecCccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccc
Q 010309          379 PWEVM---QERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRY  454 (513)
Q Consensus       379 ~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  454 (513)
                      .....   ........||+.|+|||++.+ ..++.++||||||+++|||++|..||.........  .    .... ...
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~----~~~~-~~~  244 (303)
T 2vwi_A          172 ATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL--M----LTLQ-NDP  244 (303)
T ss_dssp             C---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH--H----HHHT-SSC
T ss_pred             ccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH--H----HHhc-cCC
Confidence            43211   111122348999999999876 56899999999999999999999999875442111  0    0000 000


Q ss_pred             cccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          455 LELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       455 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      ........    ........+.++.+|+.+||+.||.+|||+.++++
T Consensus       245 ~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          245 PSLETGVQ----DKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             CCTTC---------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             Cccccccc----cchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            00000000    00011123457999999999999999999999986

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=2e-41  Score=346.74  Aligned_cols=261  Identities=22%  Similarity=0.301  Sum_probs=191.5

Q ss_pred             cCCceecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCC------ceEEEE
Q 010309          228 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG------DRYIVY  300 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------~~~lv~  300 (513)
                      ...++||+|+||.||+|... +|+.||||++....    ....+|+++|+.++||||+++++++....      ..++||
T Consensus        57 ~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~  132 (420)
T 1j1b_A           57 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL  132 (420)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEE
T ss_pred             EeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeeh
Confidence            34567899999999999985 59999999996542    22347999999999999999999986432      257999


Q ss_pred             eeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCC-CCeEEecccccccCC
Q 010309          301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE-FGAHLMGVGLSKFVP  379 (513)
Q Consensus       301 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~-~~~kl~Dfg~~~~~~  379 (513)
                      ||+++ +|.+++.........+++..++.++.||+.||+|||+.   +|+||||||+|||++.+ +.+||+|||+++...
T Consensus       133 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~  208 (420)
T 1j1b_A          133 DYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV  208 (420)
T ss_dssp             ECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             hcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhhhcc
Confidence            99965 67666654333456799999999999999999999999   99999999999999965 568999999998764


Q ss_pred             ccccccceeecCcccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHH-------hh-
Q 010309          380 WEVMQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPL-------VQ-  450 (513)
Q Consensus       380 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~-------~~-  450 (513)
                      ......   ...+|+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+...  .+......+       +. 
T Consensus       209 ~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~--~l~~i~~~lg~p~~~~~~~  283 (420)
T 1j1b_A          209 RGEPNV---SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIKVLGTPTREQIRE  283 (420)
T ss_dssp             TTCCCC---SCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCSCCHHHHHH
T ss_pred             cCCCce---eeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHHHHh
Confidence            332221   22389999999998765 78999999999999999999999998765321  111111100       00 


Q ss_pred             -cccccccccccccCCC-CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          451 -SHRYLELLDPLISSLS-SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       451 -~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                       ...+.+...+.+.... ........++++.+||.+||+.||.+|||+.|+++
T Consensus       284 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             HCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence             0001111001000000 00011123567999999999999999999999985

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=3.5e-41  Score=334.94  Aligned_cols=254  Identities=18%  Similarity=0.260  Sum_probs=175.0

Q ss_pred             HhhCcccCCceecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEee----CCce
Q 010309          222 ITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD----HGDR  296 (513)
Q Consensus       222 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~  296 (513)
                      +.++|....++||+|+||.||+|... +|+.||||++....    ....+....++.+.||||+++++++..    ....
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            45566666778899999999999976 69999999996532    122223334566799999999999876    4457


Q ss_pred             EEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecC---CCCeEEeccc
Q 010309          297 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE---EFGAHLMGVG  373 (513)
Q Consensus       297 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~---~~~~kl~Dfg  373 (513)
                      ++||||+++|+|.+++..  .....+++..++.++.||+.||.|||+.   +|+||||||+|||++.   ++.+||+|||
T Consensus       102 ~lv~e~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg  176 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQE--RGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFG  176 (336)
T ss_dssp             EEEEECCTTEEHHHHHHT--C-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             EEEEeccCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccc
Confidence            999999999999999975  2335699999999999999999999999   9999999999999976   4459999999


Q ss_pred             ccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccc
Q 010309          374 LSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHR  453 (513)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  453 (513)
                      ++........    ....+|+.|+|||++.+..++.++||||||+++|+|++|..||............   ..      
T Consensus       177 ~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~---~~------  243 (336)
T 3fhr_A          177 FAKETTQNAL----QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM---KR------  243 (336)
T ss_dssp             TCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------------
T ss_pred             cceecccccc----ccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhH---HH------
Confidence            9986543221    1233899999999998888999999999999999999999999765432110000   00      


Q ss_pred             ccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          454 YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       454 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                        ....... .. ........++++.+||.+||+.||++|||++|+++
T Consensus       244 --~~~~~~~-~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          244 --RIRLGQY-GF-PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             ----------CC-CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             --hhhcccc-cc-CchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence              0000000 00 01111234567999999999999999999999997

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=5.9e-41  Score=331.36  Aligned_cols=247  Identities=24%  Similarity=0.341  Sum_probs=191.2

Q ss_pred             cCCceecccCceEEEEEEeC-CCCEEEEEEecccch--------hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEE
Q 010309          228 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF--------QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYI  298 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l  298 (513)
                      ...+.||+|+||.||+|... +++.||||++.....        .....+.+|+.++++++||||+++++++...+ .++
T Consensus        13 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~l   91 (322)
T 2ycf_A           13 IMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYI   91 (322)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEE
T ss_pred             eEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEE
Confidence            34567899999999999975 588999999975421        12345889999999999999999999987654 899


Q ss_pred             EEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCC---eEEeccccc
Q 010309          299 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG---AHLMGVGLS  375 (513)
Q Consensus       299 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~---~kl~Dfg~~  375 (513)
                      ||||+++++|.+++..    ...+++..+..++.||+.||.|||++   +|+||||||+|||++.++.   +||+|||++
T Consensus        92 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~  164 (322)
T 2ycf_A           92 VLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHS  164 (322)
T ss_dssp             EEECCTTEETHHHHST----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred             EEecCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence            9999999999998853    35699999999999999999999999   9999999999999987654   999999999


Q ss_pred             ccCCccccccceeecCcccccccccccc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcc
Q 010309          376 KFVPWEVMQERTVMAGGTYGYLAPEFVY---RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSH  452 (513)
Q Consensus       376 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  452 (513)
                      ..........   ...||+.|+|||++.   ...++.++||||||+++|+|++|..||.......  .+....    ...
T Consensus       165 ~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~----~~~  235 (322)
T 2ycf_A          165 KILGETSLMR---TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQI----TSG  235 (322)
T ss_dssp             EECCCCHHHH---HHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHHHHH----HHT
T ss_pred             eecccccccc---cccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHHHHH----HhC
Confidence            8765432211   123899999999974   4678899999999999999999999997654321  111111    101


Q ss_pred             cccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          453 RYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       453 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      .. ... +..        ....++.+.+||.+||+.||++|||++++++
T Consensus       236 ~~-~~~-~~~--------~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          236 KY-NFI-PEV--------WAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             CC-CCC-HHH--------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cc-ccC-chh--------hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            00 000 000        0123567999999999999999999999985

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=5.6e-41  Score=327.56  Aligned_cols=247  Identities=21%  Similarity=0.305  Sum_probs=198.6

Q ss_pred             cCCceecccCceEEEEEEeC-CCCEEEEEEecccc---------hhcHHHHHHHHHHHhhcC-CCcEeeeeeEEeeCCce
Q 010309          228 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---------FQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDR  296 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~  296 (513)
                      ...+.||+|+||.||+|... +|+.||||++....         ....+.+.+|+.+++++. ||||+++++++...+..
T Consensus        20 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   99 (298)
T 1phk_A           20 EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFF   99 (298)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             ceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeE
Confidence            34567899999999999975 58899999997542         122456889999999995 99999999999999999


Q ss_pred             EEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccc
Q 010309          297 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK  376 (513)
Q Consensus       297 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~  376 (513)
                      ++||||+++++|.+++..    ...+++..+..++.||+.||.|||+.   +++|+||||+||+++.++.+||+|||++.
T Consensus       100 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~  172 (298)
T 1phk_A          100 FLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSC  172 (298)
T ss_dssp             EEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecccchh
Confidence            999999999999999964    24699999999999999999999999   99999999999999999999999999998


Q ss_pred             cCCccccccceeecCcccccccccccc------cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhh
Q 010309          377 FVPWEVMQERTVMAGGTYGYLAPEFVY------RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQ  450 (513)
Q Consensus       377 ~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  450 (513)
                      ........   ....+++.|+|||++.      ...++.++||||||+++|+|++|..||........      ......
T Consensus       173 ~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------~~~~~~  243 (298)
T 1phk_A          173 QLDPGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM------LRMIMS  243 (298)
T ss_dssp             ECCTTCCB---CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHH
T ss_pred             hcCCCccc---ccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHH------HHHHhc
Confidence            76543221   1233899999999985      45678999999999999999999999976543211      111111


Q ss_pred             cccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          451 SHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       451 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                       ... ..         ........+..+.+|+.+||+.||++|||+.++++
T Consensus       244 -~~~-~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          244 -GNY-QF---------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             -TCC-CC---------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             -CCc-cc---------CcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence             100 00         01111235667999999999999999999999986

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2.8e-41  Score=342.82  Aligned_cols=262  Identities=20%  Similarity=0.283  Sum_probs=191.8

Q ss_pred             ccCCceecccCceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCc------eEEEE
Q 010309          227 SEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD------RYIVY  300 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~------~~lv~  300 (513)
                      +...++||+|+||.||+|....+..||+|++.....    ...+|+.+++.++||||+++++++...+.      .++||
T Consensus        42 Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~  117 (394)
T 4e7w_A           42 YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVL  117 (394)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEE
T ss_pred             EEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEe
Confidence            344567899999999999987777799998865432    22369999999999999999999976543      78999


Q ss_pred             eeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEec-CCCCeEEecccccccCC
Q 010309          301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD-EEFGAHLMGVGLSKFVP  379 (513)
Q Consensus       301 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~-~~~~~kl~Dfg~~~~~~  379 (513)
                      ||++++ +...+.........+++..+..++.||+.||+|||+.   +|+||||||+|||++ .++.+||+|||+++...
T Consensus       118 e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~  193 (394)
T 4e7w_A          118 EYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI  193 (394)
T ss_dssp             ECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             eccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCccccc
Confidence            999765 4443332222346799999999999999999999999   999999999999999 78999999999998764


Q ss_pred             ccccccceeecCcccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhh--cc----
Q 010309          380 WEVMQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQ--SH----  452 (513)
Q Consensus       380 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~----  452 (513)
                      ......   ...+|+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+....  +.........  ..    
T Consensus       194 ~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--l~~i~~~~g~p~~~~~~~  268 (394)
T 4e7w_A          194 AGEPNV---SYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ--LVEIIKVLGTPSREQIKT  268 (394)
T ss_dssp             TTCCCC---SSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCHHHHHH
T ss_pred             CCCCCc---ccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHHHHHh
Confidence            433222   22389999999998765 589999999999999999999999987654311  1111110000  00    


Q ss_pred             cccccccccccCCCCC----CCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          453 RYLELLDPLISSLSSD----IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       453 ~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      ................    ......++++.+||.+||+.||++|||+.|+++
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (394)
T 4e7w_A          269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC  321 (394)
T ss_dssp             HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence            0000000001000000    011124568999999999999999999999987

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=6.8e-41  Score=331.29  Aligned_cols=265  Identities=20%  Similarity=0.278  Sum_probs=195.7

Q ss_pred             cCCceecccCceEEEEEEe--CCCCEEEEEEecccch--hcHHHHHHHHHHHhhc---CCCcEeeeeeEEe-----eCCc
Q 010309          228 EGNRLLGDSKTGGTYSGIL--PDGSRVAVKRLKRSSF--QRKKEFYSEIGRFARL---HHPNLVAVKGCCY-----DHGD  295 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~-----~~~~  295 (513)
                      ...+.||+|+||.||+|..  .+|+.||||++.....  .....+.+|+.+++.+   +||||+++++++.     ....
T Consensus        14 ~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   93 (326)
T 1blx_A           14 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETK   93 (326)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEE
T ss_pred             eeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCce
Confidence            3455779999999999997  3588999999975422  1233566777777666   8999999999987     4567


Q ss_pred             eEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEeccccc
Q 010309          296 RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLS  375 (513)
Q Consensus       296 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~  375 (513)
                      .++||||++ |+|.+++....  ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus        94 ~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~Dfg~~  167 (326)
T 1blx_A           94 LTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLA  167 (326)
T ss_dssp             EEEEEECCS-CBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred             EEEEEecCC-CCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEecCccc
Confidence            899999997 69999997632  34589999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccc
Q 010309          376 KFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL  455 (513)
Q Consensus       376 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  455 (513)
                      .........   ....+|+.|+|||++.+..++.++||||||+++|+|++|+.||.......................+.
T Consensus       168 ~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  244 (326)
T 1blx_A          168 RIYSFQMAL---TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP  244 (326)
T ss_dssp             CCCCGGGGG---CCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred             ccccCCCCc---cccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCc
Confidence            876543221   12338999999999999999999999999999999999999998765421111000000000000000


Q ss_pred             ccc---cccccC---CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          456 ELL---DPLISS---LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       456 ~~~---~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      ...   ......   ..........++.+.+||.+||+.||++|||+.++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          245 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            000   000000   0000011234567899999999999999999999995

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2e-40  Score=343.47  Aligned_cols=258  Identities=18%  Similarity=0.238  Sum_probs=202.7

Q ss_pred             ccCCceecccCceEEEEEEe-CCCCEEEEEEecccchhcHHHHHHHHHHHhhcCC-CcEeeeeeEEeeCCceEEEEeecc
Q 010309          227 SEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHH-PNLVAVKGCCYDHGDRYIVYEFVV  304 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~lv~e~~~  304 (513)
                      +...+.||+|+||.||+|.. .+++.||||++.....  ..++.+|++++..++| ++|..+..+....+..+|||||+ 
T Consensus         9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-   85 (483)
T 3sv0_A            9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-   85 (483)
T ss_dssp             EECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             EEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-
Confidence            34456779999999999996 4699999999875532  3457899999999976 56666777777888889999999 


Q ss_pred             CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEe---cCCCCeEEecccccccCCcc
Q 010309          305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL---DEEFGAHLMGVGLSKFVPWE  381 (513)
Q Consensus       305 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll---~~~~~~kl~Dfg~~~~~~~~  381 (513)
                      +++|.+++...   ...+++..++.|+.||+.||.|||++   +|+||||||+||||   +.++.+||+|||+++.....
T Consensus        86 g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (483)
T 3sv0_A           86 GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT  159 (483)
T ss_dssp             CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             CCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence            99999999742   35699999999999999999999999   99999999999999   68889999999999876543


Q ss_pred             cccc-----ceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccc
Q 010309          382 VMQE-----RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLE  456 (513)
Q Consensus       382 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  456 (513)
                      ....     ......||+.|+|||++.+..++.++|||||||+||||++|+.||.....................    .
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~----~  235 (483)
T 3sv0_A          160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA----T  235 (483)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHH----S
T ss_pred             ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccc----c
Confidence            2211     111334899999999999999999999999999999999999999876553322222221111110    1


Q ss_pred             cccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q 010309          457 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  506 (513)
Q Consensus       457 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  506 (513)
                      .+....         ..+++++.+||.+||+.||++||++++|++.|+.+
T Consensus       236 ~~~~l~---------~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l  276 (483)
T 3sv0_A          236 SIEALC---------RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL  276 (483)
T ss_dssp             CHHHHH---------TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             cHHHHh---------cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            111100         12345799999999999999999999999999876

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=9.8e-42  Score=342.64  Aligned_cols=258  Identities=20%  Similarity=0.322  Sum_probs=180.2

Q ss_pred             cCCceecccCceEEEEEEeC-CCCEEEEEEeccc--chhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeC------CceEE
Q 010309          228 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH------GDRYI  298 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~~~~l  298 (513)
                      ...+.||+|+||.||+|... +|+.||||++...  .....+.+.+|+.+++.++||||+++++++...      ...++
T Consensus        32 ~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~l  111 (367)
T 2fst_X           32 QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL  111 (367)
T ss_dssp             EEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEE
T ss_pred             EEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEE
Confidence            33457899999999999964 6889999999754  233456788999999999999999999998754      56799


Q ss_pred             EEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccC
Q 010309          299 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV  378 (513)
Q Consensus       299 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~  378 (513)
                      |+|++ +++|.+++..     ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus       112 v~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~~~  182 (367)
T 2fst_X          112 VTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHT  182 (367)
T ss_dssp             EEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC-------
T ss_pred             Eeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence            99999 7899988853     4699999999999999999999999   9999999999999999999999999999865


Q ss_pred             CccccccceeecCccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhH-----Hhh--
Q 010309          379 PWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATP-----LVQ--  450 (513)
Q Consensus       379 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~-----~~~--  450 (513)
                      ....     ....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.......+.....     ...  
T Consensus       183 ~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~  257 (367)
T 2fst_X          183 ADEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI  257 (367)
T ss_dssp             -------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTC
T ss_pred             cccC-----CCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence            4321     12238999999999887 6789999999999999999999999987654321111100000     000  


Q ss_pred             -cccccccccccccCCCCCCCc----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          451 -SHRYLELLDPLISSLSSDIPE----AGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       451 -~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                       .......+.. +... .....    ...++.+.+||.+||+.||++|||++++++
T Consensus       258 ~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          258 SSESARNYIQS-LTQM-PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             CCHHHHHHHHT-SCCC-CCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhHHHHHHHhc-cCCC-CCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence             0000000000 0000 00000    123467899999999999999999999986

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.2e-40  Score=331.07  Aligned_cols=260  Identities=21%  Similarity=0.256  Sum_probs=200.0

Q ss_pred             ccCCceecccCceEEEEEEe--CCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCC------cEeeeeeEEeeCCceEE
Q 010309          227 SEGNRLLGDSKTGGTYSGIL--PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHP------NLVAVKGCCYDHGDRYI  298 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~------nIv~l~~~~~~~~~~~l  298 (513)
                      +...+.||+|+||.||+|..  .+++.||||+++... ...+.+.+|+.+++.++|+      +|+++++++.+.+..++
T Consensus        16 y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~l   94 (339)
T 1z57_A           16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICI   94 (339)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEE
T ss_pred             eEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEE
Confidence            34456789999999999986  358899999997542 3456788999999988665      49999999999999999


Q ss_pred             EEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecC---------------
Q 010309          299 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE---------------  363 (513)
Q Consensus       299 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~---------------  363 (513)
                      ||||+ +++|.+++...  ....+++..+..++.||+.||+|||++   +|+||||||+|||++.               
T Consensus        95 v~e~~-~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~  168 (339)
T 1z57_A           95 VFELL-GLSTYDFIKEN--GFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDE  168 (339)
T ss_dssp             EEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CEE
T ss_pred             EEcCC-CCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCcccccc
Confidence            99999 88999999752  234689999999999999999999999   9999999999999987               


Q ss_pred             ----CCCeEEecccccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccc
Q 010309          364 ----EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ  439 (513)
Q Consensus       364 ----~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~  439 (513)
                          ++.+||+|||++.......     ....||+.|+|||++.+..++.++||||||+++|||++|..||...+.....
T Consensus       169 ~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~  243 (339)
T 1z57_A          169 RTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL  243 (339)
T ss_dssp             EEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHH
T ss_pred             ccccCCCceEeeCcccccCcccc-----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence                6689999999998654321     1233899999999999999999999999999999999999999876543221


Q ss_pred             hhHHhhhH-----Hhhcccccc---------------------cccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCC
Q 010309          440 SIFEWATP-----LVQSHRYLE---------------------LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMR  493 (513)
Q Consensus       440 ~~~~~~~~-----~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R  493 (513)
                      ........     .........                     ...+..   .........++++.+||.+||+.||++|
T Consensus       244 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~L~~dP~~R  320 (339)
T 1z57_A          244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLK---EFMLSQDVEHERLFDLIQKMLEYDPAKR  320 (339)
T ss_dssp             HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGG---GGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchh---hhcccchhhHHHHHHHHHHHhCcCcccc
Confidence            11111000     000000000                     000000   0011233567889999999999999999


Q ss_pred             CCHHHHHH
Q 010309          494 PRMSHVVH  501 (513)
Q Consensus       494 Ps~~evl~  501 (513)
                      ||++|+++
T Consensus       321 pt~~ell~  328 (339)
T 1z57_A          321 ITLREALK  328 (339)
T ss_dssp             CCHHHHTT
T ss_pred             cCHHHHhc
Confidence            99999985

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=4.5e-41  Score=337.40  Aligned_cols=274  Identities=24%  Similarity=0.287  Sum_probs=189.8

Q ss_pred             HHHHHhhCcccCCceecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCc-
Q 010309          218 ELRSITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD-  295 (513)
Q Consensus       218 ~l~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-  295 (513)
                      +.....++|.. .+.||+|+||.||+|... +|+.||||++.... .....+.+|+..+..++||||+++++++...+. 
T Consensus        17 ~~~~~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           17 RSRKEMDRFQV-ERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHTTEEE-C----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hchhhccceEE-EEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            44455556654 456799999999999974 68999999986543 333456788888999999999999999976544 


Q ss_pred             ------eEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHh--cCCCCCceEcCCCCCceEecC-CCC
Q 010309          296 ------RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLH--DKVKPHVVHRDIRASNVLLDE-EFG  366 (513)
Q Consensus       296 ------~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH--~~~~~~ivH~Dikp~NIll~~-~~~  366 (513)
                            .++||||+++ +|...+.........+++..+..++.|++.||.|||  +.   +|+||||||+|||++. ++.
T Consensus        95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~  170 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGT  170 (360)
T ss_dssp             CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTE
T ss_pred             cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCc
Confidence                  7899999976 555544432234567899999999999999999999  88   9999999999999996 889


Q ss_pred             eEEecccccccCCccccccceeecCcccccccccccccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhh
Q 010309          367 AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNE-LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWA  445 (513)
Q Consensus       367 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~  445 (513)
                      +||+|||++..........   ...||+.|+|||++.+.. ++.++||||||+++|||++|+.||...+...........
T Consensus       171 ~kl~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~  247 (360)
T 3e3p_A          171 LKLCDFGSAKKLSPSEPNV---AYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRV  247 (360)
T ss_dssp             EEECCCTTCBCCCTTSCCC---STTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred             EEEeeCCCceecCCCCCcc---cccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHH
Confidence            9999999998765433221   233899999999987654 899999999999999999999999876543211111000


Q ss_pred             ---------hHHhhccccccccccc---ccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          446 ---------TPLVQSHRYLELLDPL---ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       446 ---------~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                               ................   ...... ......++++.+||.+||+.||.+|||+.|+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          248 LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFS-DHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             HCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTT-TCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             cCCCCHHHHHhcccchhhccccccccCCcccccc-hhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence                     0000000000000000   000000 001124678999999999999999999999986

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=3.5e-41  Score=346.39  Aligned_cols=257  Identities=22%  Similarity=0.281  Sum_probs=191.4

Q ss_pred             HhhCcccCCceecccCceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCCceEEEE
Q 010309          222 ITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVY  300 (513)
Q Consensus       222 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~  300 (513)
                      ..+++....++||+|+||+||.+...+|+.||||++...   ..+.+.+|+.+|.++ +||||+++++++.+.+..++||
T Consensus        12 ~l~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~   88 (434)
T 2rio_A           12 SLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIAL   88 (434)
T ss_dssp             SCSSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEE
Confidence            345566667789999999998777778999999998654   245678999999887 8999999999999999999999


Q ss_pred             eeccCCCHHHHhccCCCCCCC---CCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCC-------------
Q 010309          301 EFVVNGPLDRWLHHIPRGGRS---LDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE-------------  364 (513)
Q Consensus       301 e~~~~gsL~~~l~~~~~~~~~---l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~-------------  364 (513)
                      ||+. |+|.+++.........   .++..++.++.||+.||+|||+.   +|+||||||+|||++.+             
T Consensus        89 E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~  164 (434)
T 2rio_A           89 ELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAEN  164 (434)
T ss_dssp             CCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCS
T ss_pred             ecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCc
Confidence            9995 6999999753221111   13335678999999999999999   99999999999999754             


Q ss_pred             CCeEEecccccccCCcccccc--ceeecCccccccccccccc-------CCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 010309          365 FGAHLMGVGLSKFVPWEVMQE--RTVMAGGTYGYLAPEFVYR-------NELTTKSDVYSFGVLLLEIVS-GRRPAQAVD  434 (513)
Q Consensus       365 ~~~kl~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlGvil~ellt-g~~p~~~~~  434 (513)
                      +.+||+|||++..........  ......||+.|+|||++.+       ..++.++|||||||++|||+| |..||....
T Consensus       165 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~  244 (434)
T 2rio_A          165 LRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY  244 (434)
T ss_dssp             CEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred             eEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence            479999999998775432211  1122349999999999975       568999999999999999999 999997543


Q ss_pred             ccccchhHHhhhHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          435 SVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       435 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      ...    .    ...... . .  .+..    ........++++.+||.+||+.||++|||+.+|++
T Consensus       245 ~~~----~----~i~~~~-~-~--~~~~----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          245 SRE----S----NIIRGI-F-S--LDEM----KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             THH----H----HHHHTC-C-C--CCCC----TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhH----H----HHhcCC-C-C--cccc----cccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            221    0    000000 0 0  0000    12234567889999999999999999999999985

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.4e-41  Score=335.13  Aligned_cols=270  Identities=20%  Similarity=0.287  Sum_probs=193.7

Q ss_pred             cCCceecccCceEEEEEEeCC-CCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEe--------------e
Q 010309          228 EGNRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY--------------D  292 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~--------------~  292 (513)
                      ...+.||+|+||.||+|.... ++.||||++........+.+.+|+.++++++||||+++++++.              +
T Consensus        14 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~   93 (320)
T 2i6l_A           14 MDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTE   93 (320)
T ss_dssp             EEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCS
T ss_pred             eEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccc
Confidence            345678999999999999864 8999999998776666788999999999999999999999874              3


Q ss_pred             CCceEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEec-CCCCeEEec
Q 010309          293 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD-EEFGAHLMG  371 (513)
Q Consensus       293 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~-~~~~~kl~D  371 (513)
                      .+..++||||++ |+|.+++..     ..+++..++.++.|++.||+|||+.   +|+||||||+|||++ .++.+||+|
T Consensus        94 ~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~D  164 (320)
T 2i6l_A           94 LNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGD  164 (320)
T ss_dssp             CSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEECC
T ss_pred             cCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEEcc
Confidence            467799999997 699999853     4689999999999999999999999   999999999999997 567899999


Q ss_pred             ccccccCCccccc-cceeecCccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHh
Q 010309          372 VGLSKFVPWEVMQ-ERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLV  449 (513)
Q Consensus       372 fg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  449 (513)
                      ||++......... .......+|..|+|||++.+ ..++.++||||||+++|||++|+.||...+............+..
T Consensus       165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  244 (320)
T 2i6l_A          165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVV  244 (320)
T ss_dssp             CTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCC
T ss_pred             CccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            9999876432211 11122237889999998865 678999999999999999999999998765422111100000000


Q ss_pred             hcccccc---c----ccccccCCCCCCC----cHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcCcC
Q 010309          450 QSHRYLE---L----LDPLISSLSSDIP----EAGVVQKVVDLVYACTQHVPSMRPRMSHVVH--QLQQLAQ  508 (513)
Q Consensus       450 ~~~~~~~---~----~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~~  508 (513)
                      ......+   .    +......  ...+    ....+.++.+||.+||+.||++|||++++++  .+.....
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  314 (320)
T 2i6l_A          245 HEEDRQELLSVIPVYIRNDMTE--PHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSF  314 (320)
T ss_dssp             CHHHHHHHHTTSCHHHHHHTTS--CCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC
T ss_pred             chhhhhhhhhcCcccccccccC--CCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccC
Confidence            0000000   0    0000000  0000    0124567999999999999999999999987  4554433

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=4.7e-41  Score=361.44  Aligned_cols=251  Identities=27%  Similarity=0.369  Sum_probs=200.1

Q ss_pred             CCceecccCceEEEEEEeCC----CCEEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeec
Q 010309          229 GNRLLGDSKTGGTYSGILPD----GSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  303 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  303 (513)
                      ..+.||+|+||.||+|.+..    +..||||+++... ....+.+.+|+.++++++||||+++++++. .+..++||||+
T Consensus       394 i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E~~  472 (656)
T 2j0j_A          394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELC  472 (656)
T ss_dssp             EEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred             EeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEEcC
Confidence            34678999999999999742    4579999987643 334577999999999999999999999985 56789999999


Q ss_pred             cCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccc
Q 010309          304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM  383 (513)
Q Consensus       304 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~  383 (513)
                      ++|+|.+++...   ...+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++........
T Consensus       473 ~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~  546 (656)
T 2j0j_A          473 TLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY  546 (656)
T ss_dssp             TTCBHHHHHHHT---TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC---
T ss_pred             CCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeecCCCcc
Confidence            999999999742   34689999999999999999999999   999999999999999999999999999987654332


Q ss_pred             ccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccccccc
Q 010309          384 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI  462 (513)
Q Consensus       384 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  462 (513)
                      ... ....+|+.|+|||++.+..++.++||||||+++|||++ |..||.+.....   ...   .... ...        
T Consensus       547 ~~~-~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~---~~~---~i~~-~~~--------  610 (656)
T 2j0j_A          547 YKA-SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIG---RIEN-GER--------  610 (656)
T ss_dssp             --------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHH---HHHH-TCC--------
T ss_pred             eec-cCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH---HHH---HHHc-CCC--------
Confidence            211 12236789999999998999999999999999999997 999998654321   111   1111 000        


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCc
Q 010309          463 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  507 (513)
Q Consensus       463 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  507 (513)
                           ...+..+++.+.+||.+||+.||++|||+.+|++.|+++.
T Consensus       611 -----~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il  650 (656)
T 2j0j_A          611 -----LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  650 (656)
T ss_dssp             -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -----CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence                 0011234567999999999999999999999999998764

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=9e-41  Score=324.47  Aligned_cols=251  Identities=22%  Similarity=0.318  Sum_probs=199.4

Q ss_pred             HhhCcccCCceecccCceEEEEEEeC-CCCEEEEEEecccc--hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEE
Q 010309          222 ITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYI  298 (513)
Q Consensus       222 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l  298 (513)
                      +.++|. ..+.||+|+||.||+|... +++.||||++....  ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        20 ~~~~y~-i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   98 (287)
T 2wei_A           20 FAERYN-IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (287)
T ss_dssp             HHHHEE-EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             Hhhcce-eeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence            334444 4567899999999999975 68999999997543  2346789999999999999999999999999999999


Q ss_pred             EEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCC---CCeEEeccccc
Q 010309          299 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE---FGAHLMGVGLS  375 (513)
Q Consensus       299 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~---~~~kl~Dfg~~  375 (513)
                      ||||+++++|.+++..    ...+++..++.++.||+.||.|||+.   +++|+||||+||+++.+   +.+||+|||++
T Consensus        99 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~  171 (287)
T 2wei_A           99 VGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS  171 (287)
T ss_dssp             EECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred             EEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence            9999999999998864    24689999999999999999999999   99999999999999764   46999999999


Q ss_pred             ccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccc
Q 010309          376 KFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL  455 (513)
Q Consensus       376 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  455 (513)
                      ..........   ...+|+.|+|||++.+ .++.++||||||+++|+|++|..||........      ... .......
T Consensus       172 ~~~~~~~~~~---~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------~~~-~~~~~~~  240 (287)
T 2wei_A          172 TCFQQNTKMK---DRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI------LKR-VETGKYA  240 (287)
T ss_dssp             GTBCCCSSCS---CHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHH-HHHCCCC
T ss_pred             eeecCCCccc---cccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHH------HHH-HHcCCCC
Confidence            8664332211   1227899999998865 489999999999999999999999987543211      111 1111100


Q ss_pred             ccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          456 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       456 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      .          ........++++.++|.+||+.||++|||+.++++
T Consensus       241 ~----------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          241 F----------DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             C----------CSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             C----------CchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence            0          00001234567999999999999999999999997

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=3e-40  Score=335.62  Aligned_cols=264  Identities=16%  Similarity=0.204  Sum_probs=198.4

Q ss_pred             ccCCceecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhcC--------CCcEeeeeeEEe----eC
Q 010309          227 SEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH--------HPNLVAVKGCCY----DH  293 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~nIv~l~~~~~----~~  293 (513)
                      +...+.||+|+||.||+|... +++.||||++... ....+.+.+|+.+++.++        ||||+++++++.    +.
T Consensus        39 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~  117 (397)
T 1wak_A           39 YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNG  117 (397)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTE
T ss_pred             EEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCC
Confidence            344567899999999999864 5889999999754 344567889999999985        788999999988    55


Q ss_pred             CceEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCC--------
Q 010309          294 GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF--------  365 (513)
Q Consensus       294 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~--------  365 (513)
                      ...++||||+ +++|.+++..  .....+++..++.++.||+.||+|||+++  +|+||||||+|||++.++        
T Consensus       118 ~~~~lv~e~~-~~~l~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~~~  192 (397)
T 1wak_A          118 THICMVFEVL-GHHLLKWIIK--SNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAA  192 (397)
T ss_dssp             EEEEEEECCC-CCBHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHHHH
T ss_pred             ceEEEEEecc-CccHHHHHHh--cccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhhhh
Confidence            6789999999 6667666654  22356999999999999999999999853  899999999999998775        


Q ss_pred             -----------------------------------------CeEEecccccccCCccccccceeecCccccccccccccc
Q 010309          366 -----------------------------------------GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR  404 (513)
Q Consensus       366 -----------------------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  404 (513)
                                                               .+||+|||++.......     ....||+.|+|||++.+
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~-----~~~~gt~~y~aPE~~~~  267 (397)
T 1wak_A          193 EATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF-----TEDIQTRQYRSLEVLIG  267 (397)
T ss_dssp             HHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS-----CSCCSCGGGCCHHHHHT
T ss_pred             hhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC-----ccCCCCCcccCChhhcC
Confidence                                                     79999999998764321     12238999999999999


Q ss_pred             CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHh-----------hccccc-ccccc--cccCCC----
Q 010309          405 NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLV-----------QSHRYL-ELLDP--LISSLS----  466 (513)
Q Consensus       405 ~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~-----------~~~~~~-~~~~~--~~~~~~----  466 (513)
                      ..++.++|||||||++|||+||+.||...+...............           ...... +....  .+....    
T Consensus       268 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (397)
T 1wak_A          268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKP  347 (397)
T ss_dssp             SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCC
T ss_pred             CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCC
Confidence            999999999999999999999999998765433221111111100           000000 00000  000000    


Q ss_pred             ---------CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          467 ---------SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       467 ---------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                               ........+..+.+||.+||+.||++|||++|+++
T Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          348 WGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             cchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence                     01124567788999999999999999999999985

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=6e-41  Score=329.89  Aligned_cols=248  Identities=19%  Similarity=0.278  Sum_probs=191.5

Q ss_pred             ccCCceecccCceEEEEEEeCCCCEEEEEEecccc--hhcHHHHHHHHHHHhhcC--CCcEeeeeeEEeeCCceEEEEee
Q 010309          227 SEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLH--HPNLVAVKGCCYDHGDRYIVYEF  302 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~~~~lv~e~  302 (513)
                      +...+.||+|+||.||++...+++.||||++....  ....+.+.+|+.++.+++  ||||+++++++.+.+..++||| 
T Consensus        30 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-  108 (313)
T 3cek_A           30 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-  108 (313)
T ss_dssp             EEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-
T ss_pred             EEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-
Confidence            34456789999999999999889999999997542  334577899999999996  5999999999999999999999 


Q ss_pred             ccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccc
Q 010309          303 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV  382 (513)
Q Consensus       303 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~  382 (513)
                      +.+++|.+++..    ...+++..++.++.|++.||.|||+.   +|+||||||+|||+++ +.+||+|||++.......
T Consensus       109 ~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~  180 (313)
T 3cek_A          109 CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDT  180 (313)
T ss_dssp             CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC-----
T ss_pred             cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccccccCcc
Confidence            558899999975    34689999999999999999999999   9999999999999965 789999999998765433


Q ss_pred             cccceeecCccccccccccccc-----------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhc
Q 010309          383 MQERTVMAGGTYGYLAPEFVYR-----------NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQS  451 (513)
Q Consensus       383 ~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  451 (513)
                      .........||+.|+|||++.+           ..++.++||||||+++|||++|..||......     ........  
T Consensus       181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-----~~~~~~~~--  253 (313)
T 3cek_A          181 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKLHAII--  253 (313)
T ss_dssp             ---------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHHHH--
T ss_pred             ccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH-----HHHHHHHH--
Confidence            2222223348999999999875           46888999999999999999999999754321     01111111  


Q ss_pred             ccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          452 HRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       452 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                             ++..    ....+...+.++.++|.+||+.||++|||+.++++
T Consensus       254 -------~~~~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          254 -------DPNH----EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             -------CTTS----CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -------hccc----ccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence                   1100    00001112456899999999999999999999986

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=6e-41  Score=337.86  Aligned_cols=259  Identities=19%  Similarity=0.274  Sum_probs=191.9

Q ss_pred             cCCceecccCceEEEEEEeC-CCCEEEEEEecccc--hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCce------EE
Q 010309          228 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR------YI  298 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~------~l  298 (513)
                      ...+.||+|+||.||+|... +|+.||||++....  ....+.+.+|+.+++.++||||+++++++...+..      ++
T Consensus        45 ~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~l  124 (371)
T 4exu_A           45 VSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYL  124 (371)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEE
T ss_pred             EEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEE
Confidence            33457899999999999965 58999999997642  23357788999999999999999999999887665      99


Q ss_pred             EEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccC
Q 010309          299 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV  378 (513)
Q Consensus       299 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~  378 (513)
                      ||||+. ++|.+++.      ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++...
T Consensus       125 v~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~  194 (371)
T 4exu_A          125 VMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHA  194 (371)
T ss_dssp             EEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC---
T ss_pred             EEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCccccc
Confidence            999996 68988874      3499999999999999999999999   9999999999999999999999999999865


Q ss_pred             CccccccceeecCccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhH-Hhhh----HHhhc-
Q 010309          379 PWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIF-EWAT----PLVQS-  451 (513)
Q Consensus       379 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~-~~~~----~~~~~-  451 (513)
                      ....     ....+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||...+........ ....    ..... 
T Consensus       195 ~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  269 (371)
T 4exu_A          195 DAEM-----TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKL  269 (371)
T ss_dssp             ----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred             ccCc-----CCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHh
Confidence            4321     12348999999999987 67899999999999999999999999875532111100 0000    00000 


Q ss_pred             --ccccccccccccCCCCCC--CcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          452 --HRYLELLDPLISSLSSDI--PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       452 --~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                        ..................  .....++.+.+||.+||+.||++|||++|+++
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          270 NDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             SCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence              000000000000000000  00123567999999999999999999999986

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.3e-40  Score=333.18  Aligned_cols=262  Identities=21%  Similarity=0.248  Sum_probs=195.1

Q ss_pred             cCCceecccCceEEEEEEeC-CCCEEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeC-----CceEEEE
Q 010309          228 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH-----GDRYIVY  300 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~~lv~  300 (513)
                      ...+.||+|+||.||+|... +|+.||||++.... ......+.+|+.++++++||||+++++++...     ...++||
T Consensus        14 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~   93 (353)
T 2b9h_A           14 QLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQ   93 (353)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEE
T ss_pred             EEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEE
Confidence            33567899999999999975 58899999997543 23356788999999999999999999988764     6789999


Q ss_pred             eeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCc
Q 010309          301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW  380 (513)
Q Consensus       301 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~  380 (513)
                      ||+. ++|.+++..     ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++.....
T Consensus        94 e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  164 (353)
T 2b9h_A           94 ELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE  164 (353)
T ss_dssp             CCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             eccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccccccc
Confidence            9996 699999865     4699999999999999999999999   999999999999999999999999999987653


Q ss_pred             ccccc--------ceeecCccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhc
Q 010309          381 EVMQE--------RTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQS  451 (513)
Q Consensus       381 ~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  451 (513)
                      .....        ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+.......   .......
T Consensus       165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---~~~~~~~  241 (353)
T 2b9h_A          165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLL---IFGIIGT  241 (353)
T ss_dssp             ---------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCC
T ss_pred             ccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH---HHHHhCC
Confidence            32111        1112248999999998765 6789999999999999999999999987653211110   0000000


Q ss_pred             cc----cccccc----ccccCCC--CCCC----cHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          452 HR----YLELLD----PLISSLS--SDIP----EAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       452 ~~----~~~~~~----~~~~~~~--~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      ..    ......    .......  ....    ....++++.+||.+||+.||++|||++|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            00    000000    0000000  0000    0134567899999999999999999999987

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=7.3e-40  Score=331.32  Aligned_cols=198  Identities=19%  Similarity=0.252  Sum_probs=165.9

Q ss_pred             cCCceecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhcC-CC-----cEeeeeeEEeeCCceEEEE
Q 010309          228 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-HP-----NLVAVKGCCYDHGDRYIVY  300 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----nIv~l~~~~~~~~~~~lv~  300 (513)
                      ...+.||+|+||.||+|... +++.||||+++... .....+..|+.++..++ |+     +|+++++++...+..++||
T Consensus        57 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~  135 (382)
T 2vx3_A           57 EIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVF  135 (382)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEE
T ss_pred             EEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEE
Confidence            33457899999999999975 58899999997542 33566788888888884 55     4999999999999999999


Q ss_pred             eeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEec--CCCCeEEecccccccC
Q 010309          301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD--EEFGAHLMGVGLSKFV  378 (513)
Q Consensus       301 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~--~~~~~kl~Dfg~~~~~  378 (513)
                      ||+. ++|.+++...  ....+++..+..++.|++.||.|||++ ..+|+||||||+|||++  .++.+||+|||++...
T Consensus       136 e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~  211 (382)
T 2vx3_A          136 EMLS-YNLYDLLRNT--NFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL  211 (382)
T ss_dssp             ECCC-CBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred             ecCC-CCHHHHHhhc--CcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCceec
Confidence            9995 5999999763  234599999999999999999999952 12899999999999995  4778999999999876


Q ss_pred             CccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCc
Q 010309          379 PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS  435 (513)
Q Consensus       379 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~  435 (513)
                      ....     ....||+.|+|||++.+..++.++|||||||++|||+||+.||...+.
T Consensus       212 ~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~  263 (382)
T 2vx3_A          212 GQRI-----YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE  263 (382)
T ss_dssp             TCCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             cccc-----ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            4321     123489999999999999999999999999999999999999987654

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=4.5e-40  Score=329.33  Aligned_cols=255  Identities=18%  Similarity=0.260  Sum_probs=191.6

Q ss_pred             CCceecccCceEEEEEEeC-CCCEEEEEEecccc--hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCc------eEEE
Q 010309          229 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD------RYIV  299 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~------~~lv  299 (513)
                      ..+.||+|+||.||+|... +|+.||||++....  ....+.+.+|+.+++.++||||+++++++...+.      .++|
T Consensus        28 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv  107 (353)
T 3coi_A           28 SPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLV  107 (353)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEE
T ss_pred             EeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEE
Confidence            3457899999999999974 58999999997642  2334678899999999999999999999987654      4999


Q ss_pred             EeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCC
Q 010309          300 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP  379 (513)
Q Consensus       300 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~  379 (513)
                      |||+. ++|.+++.      ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++....
T Consensus       108 ~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  177 (353)
T 3coi_A          108 MPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHAD  177 (353)
T ss_dssp             EECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred             ecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence            99996 68887763      3499999999999999999999999   99999999999999999999999999998654


Q ss_pred             ccccccceeecCccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcc------
Q 010309          380 WEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSH------  452 (513)
Q Consensus       380 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------  452 (513)
                      ...     ....+|+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+......   .........      
T Consensus       178 ~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~---~i~~~~~~~~~~~~~  249 (353)
T 3coi_A          178 AEM-----TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLT---QILKVTGVPGTEFVQ  249 (353)
T ss_dssp             -----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHH---HHHHHHCBCCHHHHT
T ss_pred             CCc-----cccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHhCCCCHHHHH
Confidence            321     12238999999999877 678999999999999999999999998755321111   000000000      


Q ss_pred             cc-----cccccccccCCCC--CCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          453 RY-----LELLDPLISSLSS--DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       453 ~~-----~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      ..     ...+.........  .......++++.+||.+||+.||++|||++++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          250 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             TCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            00     0000000000000  0011234668999999999999999999999986

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=6.6e-40  Score=320.37  Aligned_cols=251  Identities=20%  Similarity=0.313  Sum_probs=188.9

Q ss_pred             hCcccCCceecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEee----------
Q 010309          224 KNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD----------  292 (513)
Q Consensus       224 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----------  292 (513)
                      ++|.. .+.||+|+||.||+|... +|+.||||++... ....+.+.+|+.++++++||||+++++++.+          
T Consensus         6 ~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            6 SDFEE-IAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHEEE-EEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             ccchh-hheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            34433 457799999999999974 6999999999654 3445778999999999999999999998865          


Q ss_pred             ---CCceEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEE
Q 010309          293 ---HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHL  369 (513)
Q Consensus       293 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl  369 (513)
                         .+..++||||+++++|.+++..   ....+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl  157 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKI  157 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHH---SCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEE
T ss_pred             cccCCceEEEEecCCCCCHHHhhhc---cccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEE
Confidence               3467999999999999999974   235688899999999999999999999   9999999999999999999999


Q ss_pred             ecccccccCCcccc------------ccceeecCcccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCcc
Q 010309          370 MGVGLSKFVPWEVM------------QERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSV  436 (513)
Q Consensus       370 ~Dfg~~~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~  436 (513)
                      +|||++........            ........||+.|+|||++.+. .++.++||||||+++|||++   ||..... 
T Consensus       158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~-  233 (303)
T 1zy4_A          158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME-  233 (303)
T ss_dssp             CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH-
T ss_pred             eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh-
Confidence            99999987643210            1111223389999999999764 68999999999999999998   5432111 


Q ss_pred             ccchhHHhhhHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          437 CWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       437 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                          .......... .      ....    +.......++.+.+++.+||+.||++|||++++++
T Consensus       234 ----~~~~~~~~~~-~------~~~~----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          234 ----RVNILKKLRS-V------SIEF----PPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             ----HHHHHHHHHS-T------TCCC----CTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----HHHHHHhccc-c------cccc----CccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence                0011111000 0      0000    11112234556899999999999999999999986

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=2.4e-40  Score=327.69  Aligned_cols=253  Identities=22%  Similarity=0.380  Sum_probs=175.6

Q ss_pred             cCCceecccCceEEEEEEeC-CCCEEEEEEecccc-hhcHHHHHHHHH-HHhhcCCCcEeeeeeEEeeCCceEEEEeecc
Q 010309          228 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIG-RFARLHHPNLVAVKGCCYDHGDRYIVYEFVV  304 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  304 (513)
                      ...+.||+|+||.||+|... +|+.||||++.... ......+..|+. +++.++||||+++++++.+.+..++||||++
T Consensus        25 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~  104 (327)
T 3aln_A           25 KDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS  104 (327)
T ss_dssp             EC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCS
T ss_pred             hehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecC
Confidence            34557899999999999975 68999999997653 233445666665 6777899999999999999999999999997


Q ss_pred             CCCHHHHhccCC-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccc
Q 010309          305 NGPLDRWLHHIP-RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM  383 (513)
Q Consensus       305 ~gsL~~~l~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~  383 (513)
                      + +|.+++.... .....+++..+..++.|++.||.|||+..  +|+||||||+|||++.++.+||+|||++........
T Consensus       105 ~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  181 (327)
T 3aln_A          105 T-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA  181 (327)
T ss_dssp             E-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC------
T ss_pred             C-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceecccccc
Confidence            5 8887775311 12456899999999999999999999842  899999999999999999999999999987654322


Q ss_pred             ccceeecCccccccccccc----ccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccccccc
Q 010309          384 QERTVMAGGTYGYLAPEFV----YRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD  459 (513)
Q Consensus       384 ~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  459 (513)
                      ..   ...||+.|+|||++    .+..++.++||||||+++|+|++|..||.......     +         .......
T Consensus       182 ~~---~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~---------~~~~~~~  244 (327)
T 3aln_A          182 KT---RDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-----D---------QLTQVVK  244 (327)
T ss_dssp             ---------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------------------CCCCC
T ss_pred             cc---cCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-----H---------HHHHHhc
Confidence            21   22389999999998    45678999999999999999999999997643210     0         0001111


Q ss_pred             ccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          460 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       460 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      ...... ........++.+.+|+.+||+.||++|||+.+|++
T Consensus       245 ~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          245 GDPPQL-SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             SCCCCC-CCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCCC-CCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            000000 01111234567999999999999999999999975

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.5e-39  Score=325.36  Aligned_cols=263  Identities=18%  Similarity=0.223  Sum_probs=197.1

Q ss_pred             ccCCceecccCceEEEEEEeC-CC-CEEEEEEecccchhcHHHHHHHHHHHhhcCCCc------EeeeeeEEeeCCceEE
Q 010309          227 SEGNRLLGDSKTGGTYSGILP-DG-SRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPN------LVAVKGCCYDHGDRYI  298 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------Iv~l~~~~~~~~~~~l  298 (513)
                      +...+.||+|+||.||+|... ++ +.||||+++.. ....+.+.+|+.+++.++|++      ++.+++++...+..++
T Consensus        21 y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~l   99 (355)
T 2eu9_A           21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCI   99 (355)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEE
T ss_pred             EEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEE
Confidence            344567899999999999974 34 68999999754 244567888999999997665      9999999999999999


Q ss_pred             EEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEe-----------------
Q 010309          299 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL-----------------  361 (513)
Q Consensus       299 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll-----------------  361 (513)
                      ||||+ +++|.+++..  .....+++..++.++.||+.||+|||++   +|+||||||+|||+                 
T Consensus       100 v~e~~-~~~l~~~l~~--~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~  173 (355)
T 2eu9_A          100 AFELL-GKNTFEFLKE--NNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEE  173 (355)
T ss_dssp             EEECC-CCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CCCE
T ss_pred             EEecc-CCChHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccccccc
Confidence            99999 6677777764  2234699999999999999999999999   99999999999999                 


Q ss_pred             --cCCCCeEEecccccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccc
Q 010309          362 --DEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ  439 (513)
Q Consensus       362 --~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~  439 (513)
                        +.++.+||+|||++.......     ....||+.|+|||++.+..++.++||||||+++|||++|..||...+.....
T Consensus       174 ~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~  248 (355)
T 2eu9_A          174 KSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL  248 (355)
T ss_dssp             EEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             cccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence              567889999999998654322     1234899999999999999999999999999999999999999876543211


Q ss_pred             hhHHhhhH-----Hhhcccccccc-c----------------ccccC-CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCH
Q 010309          440 SIFEWATP-----LVQSHRYLELL-D----------------PLISS-LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRM  496 (513)
Q Consensus       440 ~~~~~~~~-----~~~~~~~~~~~-~----------------~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  496 (513)
                      ........     ........... .                ..... ..........+.++.+||.+||+.||++|||+
T Consensus       249 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~  328 (355)
T 2eu9_A          249 VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITL  328 (355)
T ss_dssp             HHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred             HHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCH
Confidence            11111000     00000000000 0                00000 00011223456789999999999999999999


Q ss_pred             HHHHH
Q 010309          497 SHVVH  501 (513)
Q Consensus       497 ~evl~  501 (513)
                      .|+++
T Consensus       329 ~e~l~  333 (355)
T 2eu9_A          329 AEALL  333 (355)
T ss_dssp             HHHTT
T ss_pred             HHHhc
Confidence            99985

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=9.8e-40  Score=329.18  Aligned_cols=264  Identities=16%  Similarity=0.222  Sum_probs=195.2

Q ss_pred             ccCCceecccCceEEEEEEe-CCCCEEEEEEecccchhcHHHHHHHHHHHhhcC-----------CCcEeeeeeEEeeCC
Q 010309          227 SEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-----------HPNLVAVKGCCYDHG  294 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~nIv~l~~~~~~~~  294 (513)
                      +...+.||+|+||.||+|.. .+++.||||++... ....+.+.+|+.++++++           ||||+++++++...+
T Consensus        21 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~   99 (373)
T 1q8y_A           21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG   99 (373)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred             EEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccC
Confidence            34456789999999999996 46889999999754 234567889999999886           899999999998654


Q ss_pred             ----ceEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEec------CC
Q 010309          295 ----DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD------EE  364 (513)
Q Consensus       295 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~------~~  364 (513)
                          ..++|||++ +++|.+++...  ....+++..+..++.||+.||+|||+++  +|+||||||+|||++      ..
T Consensus       100 ~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~~~  174 (373)
T 1q8y_A          100 PNGVHVVMVFEVL-GENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENL  174 (373)
T ss_dssp             TTEEEEEEEECCC-CEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTE
T ss_pred             CCCceEEEEEecC-CCCHHHHHHHh--hccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCcCc
Confidence                679999999 89999999763  2345999999999999999999999843  899999999999994      34


Q ss_pred             CCeEEecccccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHh
Q 010309          365 FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEW  444 (513)
Q Consensus       365 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~  444 (513)
                      +.+||+|||++.......     ....||+.|+|||++.+..++.++||||||+++|||+||..||..............
T Consensus       175 ~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~  249 (373)
T 1q8y_A          175 IQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH  249 (373)
T ss_dssp             EEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred             ceEEEcccccccccCCCC-----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHH
Confidence            479999999998764321     122389999999999999999999999999999999999999986543221111111


Q ss_pred             hhHHhh-----------ccccc-------ccccccccC---------CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 010309          445 ATPLVQ-----------SHRYL-------ELLDPLISS---------LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMS  497 (513)
Q Consensus       445 ~~~~~~-----------~~~~~-------~~~~~~~~~---------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  497 (513)
                      ......           .....       .........         ......+...++++.+||.+||+.||++|||++
T Consensus       250 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~  329 (373)
T 1q8y_A          250 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG  329 (373)
T ss_dssp             HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred             HHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHH
Confidence            100000           00000       000000000         001122356788999999999999999999999


Q ss_pred             HHHH
Q 010309          498 HVVH  501 (513)
Q Consensus       498 evl~  501 (513)
                      ||++
T Consensus       330 ell~  333 (373)
T 1q8y_A          330 GLVN  333 (373)
T ss_dssp             HHHT
T ss_pred             HHhh
Confidence            9997

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.5e-39  Score=333.54  Aligned_cols=246  Identities=24%  Similarity=0.303  Sum_probs=184.2

Q ss_pred             cCCceecccCceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          228 EGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      ...++||+|+||+|+.....+|+.||||++......   .+.+|+.+|+.+ +||||+++++++.+.+..++||||+. |
T Consensus        27 ~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g  102 (432)
T 3p23_A           27 CPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-A  102 (432)
T ss_dssp             EEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-E
T ss_pred             ecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-C
Confidence            345678999999976655668999999999764322   356899999999 89999999999999999999999995 6


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecC-----CCCeEEecccccccCCcc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE-----EFGAHLMGVGLSKFVPWE  381 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~-----~~~~kl~Dfg~~~~~~~~  381 (513)
                      +|.+++....   ..+.+..+..++.||+.||.|||+.   +|+||||||+|||++.     ...+||+|||++......
T Consensus       103 ~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~  176 (432)
T 3p23_A          103 TLQEYVEQKD---FAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG  176 (432)
T ss_dssp             EHHHHHHSSS---CCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred             CHHHHHHhcC---CCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence            9999997532   3344556678999999999999999   9999999999999953     335789999999876543


Q ss_pred             ccc-cceeecCcccccccccccc---cCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccc
Q 010309          382 VMQ-ERTVMAGGTYGYLAPEFVY---RNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLE  456 (513)
Q Consensus       382 ~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  456 (513)
                      ... .......||+.|+|||++.   ...++.++|||||||++|||++ |..||.......       .........   
T Consensus       177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~-------~~~~~~~~~---  246 (432)
T 3p23_A          177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-------ANILLGACS---  246 (432)
T ss_dssp             ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH-------HHHHTTCCC---
T ss_pred             CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH-------HHHHhccCC---
Confidence            211 1122334999999999997   4567889999999999999999 999986543210       000000000   


Q ss_pred             cccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          457 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       457 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                              .....+....+..+.+||.+||+.||++|||+++|++
T Consensus       247 --------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          247 --------LDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             --------CTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             --------ccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence                    0011123345677899999999999999999999984

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.7e-40  Score=325.03  Aligned_cols=242  Identities=22%  Similarity=0.333  Sum_probs=188.8

Q ss_pred             HHhhCcccCCceecccCceEEEEEEe-CCCCEEEEEEecccchh------cHHHHHHHHHHHhhc----CCCcEeeeeeE
Q 010309          221 SITKNFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQ------RKKEFYSEIGRFARL----HHPNLVAVKGC  289 (513)
Q Consensus       221 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~h~nIv~l~~~  289 (513)
                      .+.++|. ..+.||+|+||.||+|.. .+++.||||++......      ....+.+|+.++.++    +||||++++++
T Consensus        28 ~~~~~y~-~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           28 AFEAEYR-LGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             -----CE-EEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhceE-EeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            3444444 456789999999999986 46899999999765322      223456799999988    89999999999


Q ss_pred             EeeCCceEEEEee-ccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEec-CCCCe
Q 010309          290 CYDHGDRYIVYEF-VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD-EEFGA  367 (513)
Q Consensus       290 ~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~-~~~~~  367 (513)
                      +...+..++|||+ +.+++|.+++..    ...+++..++.++.||+.||.|||+.   +|+||||||+||+++ .++.+
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~  179 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCA  179 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEE
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeE
Confidence            9999999999999 789999999965    24599999999999999999999999   999999999999999 78899


Q ss_pred             EEecccccccCCccccccceeecCcccccccccccccCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhh
Q 010309          368 HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELT-TKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWAT  446 (513)
Q Consensus       368 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~  446 (513)
                      ||+|||++.........    ...|++.|+|||++.+..+. .++||||||+++|||++|+.||.....           
T Consensus       180 kl~dfg~~~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----------  244 (312)
T 2iwi_A          180 KLIDFGSGALLHDEPYT----DFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE-----------  244 (312)
T ss_dssp             EECCCSSCEECCSSCBC----CCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----------
T ss_pred             EEEEcchhhhcccCccc----ccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-----------
Confidence            99999999876543221    23389999999999877664 589999999999999999999964311           


Q ss_pred             HHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          447 PLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       447 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                       ... ..        .      ..+...+..+.+||.+||+.||++|||++|+++
T Consensus       245 -~~~-~~--------~------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          245 -ILE-AE--------L------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             -HHH-TC--------C------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -Hhh-hc--------c------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             000 00        0      011224457899999999999999999999997

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.6e-40  Score=328.04  Aligned_cols=237  Identities=20%  Similarity=0.319  Sum_probs=194.0

Q ss_pred             ccCCceecccCceEEEEEEe-CCCCEEEEEEecccchh------cHHHHHHHHHHHhhcC--CCcEeeeeeEEeeCCceE
Q 010309          227 SEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQ------RKKEFYSEIGRFARLH--HPNLVAVKGCCYDHGDRY  297 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~~~~  297 (513)
                      +...+.||+|+||.||+|.. .+++.||||++......      ....+.+|+.++++++  ||||+++++++...+..+
T Consensus        45 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~  124 (320)
T 3a99_A           45 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFV  124 (320)
T ss_dssp             EEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEE
T ss_pred             eEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEE
Confidence            44556789999999999986 46889999999765322      2245678999999996  599999999999999999


Q ss_pred             EEEeeccC-CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEec-CCCCeEEeccccc
Q 010309          298 IVYEFVVN-GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD-EEFGAHLMGVGLS  375 (513)
Q Consensus       298 lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~-~~~~~kl~Dfg~~  375 (513)
                      +|||++.+ ++|.+++..    ...+++..++.++.||+.||+|||+.   +|+||||||+|||++ .++.+||+|||++
T Consensus       125 lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~  197 (320)
T 3a99_A          125 LILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSG  197 (320)
T ss_dssp             EEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             EEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeCccc
Confidence            99999976 899999864    35689999999999999999999999   999999999999999 7789999999999


Q ss_pred             ccCCccccccceeecCcccccccccccccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccc
Q 010309          376 KFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRY  454 (513)
Q Consensus       376 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  454 (513)
                      .........    ...||+.|+|||++.+..+ +.++||||||+++|||++|+.||.....            .... . 
T Consensus       198 ~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------------~~~~-~-  259 (320)
T 3a99_A          198 ALLKDTVYT----DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRG-Q-  259 (320)
T ss_dssp             EECCSSCBC----CCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------------HHHC-C-
T ss_pred             ccccccccc----CCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------------hhcc-c-
Confidence            876543221    2338999999999987765 6889999999999999999999965321            0000 0 


Q ss_pred             cccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          455 LELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       455 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                             .      ......++++.+||.+||+.||++|||+++|++
T Consensus       260 -------~------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          260 -------V------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             -------C------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -------c------cccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                   0      001123457999999999999999999999987

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.6e-39  Score=320.16  Aligned_cols=245  Identities=22%  Similarity=0.368  Sum_probs=175.3

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccchh-c-HHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQ-R-KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~-~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      .+.||+|+||.||+|... +|+.||||++...... . .+.+.++..+++.++||||+++++++.+.+..++||||+ ++
T Consensus        30 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~  108 (318)
T 2dyl_A           30 LGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GT  108 (318)
T ss_dssp             EEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SE
T ss_pred             cceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CC
Confidence            456799999999999975 6899999999765322 2 233445556788889999999999999999999999999 55


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD-KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  385 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  385 (513)
                      .+..+...   ....+++..+..++.|++.||.|||+ .   +|+|+||||+|||++.++.+||+|||++..........
T Consensus       109 ~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  182 (318)
T 2dyl_A          109 CAEKLKKR---MQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKD  182 (318)
T ss_dssp             EHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred             cHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccCCcccc
Confidence            66655542   13568999999999999999999998 6   89999999999999999999999999997664432221


Q ss_pred             ceeecCcccccccccccc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccc
Q 010309          386 RTVMAGGTYGYLAPEFVY-----RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP  460 (513)
Q Consensus       386 ~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  460 (513)
                         ...+|+.|+|||++.     ...++.++||||||+++|||++|+.||......     .+.........      .+
T Consensus       183 ---~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~~------~~  248 (318)
T 2dyl_A          183 ---RSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-----FEVLTKVLQEE------PP  248 (318)
T ss_dssp             -------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHHHHHSC------CC
T ss_pred             ---ccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-----HHHHHHHhccC------CC
Confidence               223899999999984     456889999999999999999999999764321     01111111110      00


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          461 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       461 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      .+      ......++++.+||.+||+.||.+|||++++++
T Consensus       249 ~~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          249 LL------PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             CC------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CC------CccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            00      001124457999999999999999999999986

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.9e-38  Score=307.75  Aligned_cols=229  Identities=14%  Similarity=0.081  Sum_probs=180.8

Q ss_pred             ccCCceecccCceEEEEEEeCC-CCEEEEEEecccch---hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEee
Q 010309          227 SEGNRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF  302 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  302 (513)
                      +...+.||+|+||.||+|.... |+.||||++.....   ...+.+.+|+.++.+++||||+++++++.+.+..|+||||
T Consensus        33 y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  112 (286)
T 3uqc_A           33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEW  112 (286)
T ss_dssp             EEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             EEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEe
Confidence            4445678999999999999754 89999999986533   2347789999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccc
Q 010309          303 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV  382 (513)
Q Consensus       303 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~  382 (513)
                      +++++|.+++..      .....++..++.|++.||+|||++   +|+||||||+|||++.++.+||++++         
T Consensus       113 ~~g~~L~~~l~~------~~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~---------  174 (286)
T 3uqc_A          113 IRGGSLQEVADT------SPSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA---------  174 (286)
T ss_dssp             CCEEEHHHHHTT------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC---------
T ss_pred             cCCCCHHHHHhc------CCChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc---------
Confidence            999999999953      235567889999999999999999   99999999999999999999997443         


Q ss_pred             cccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccc
Q 010309          383 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI  462 (513)
Q Consensus       383 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  462 (513)
                                   |++|       ++.++||||||+++|||+||+.||...+.......            ....+....
T Consensus       175 -------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~------------~~~~~~~~~  222 (286)
T 3uqc_A          175 -------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP------------AERDTAGQP  222 (286)
T ss_dssp             -------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE------------CCBCTTSCB
T ss_pred             -------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH------------HHHHhccCC
Confidence                         3333       68899999999999999999999987554210000            000000000


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcC
Q 010309          463 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  508 (513)
Q Consensus       463 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  508 (513)
                      ..  ........++++.+||.+||+.||++| |+.|+++.|+++..
T Consensus       223 ~~--~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~  265 (286)
T 3uqc_A          223 IE--PADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA  265 (286)
T ss_dssp             CC--HHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred             CC--hhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence            00  000012345679999999999999999 99999999987654

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=2.4e-39  Score=342.81  Aligned_cols=261  Identities=21%  Similarity=0.308  Sum_probs=196.6

Q ss_pred             ccCCceecccCceEEEEEEeC-CCCEEEEEEeccc-chhcHHHHHHHHHHHhhcCCCcEeeeeeEEee------CCceEE
Q 010309          227 SEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD------HGDRYI  298 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~------~~~~~l  298 (513)
                      +...+.||+|+||.||+|... +|+.||||++... .....+.+.+|+.++++++||||+++++++..      .+..++
T Consensus        16 Y~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~L   95 (676)
T 3qa8_A           16 WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLL   95 (676)
T ss_dssp             -CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCC
T ss_pred             eEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEE
Confidence            344567799999999999974 5899999998764 33445778999999999999999999998765      667799


Q ss_pred             EEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCC---eEEeccccc
Q 010309          299 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG---AHLMGVGLS  375 (513)
Q Consensus       299 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~---~kl~Dfg~~  375 (513)
                      ||||+++|+|.+++.... ....+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.   +||+|||++
T Consensus        96 VmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a  171 (676)
T 3qa8_A           96 AMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYA  171 (676)
T ss_dssp             EEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred             EEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence            999999999999997532 234689999999999999999999999   9999999999999997765   899999999


Q ss_pred             ccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcc---
Q 010309          376 KFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSH---  452 (513)
Q Consensus       376 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---  452 (513)
                      .........   ....||+.|+|||++.+..++.++||||||+++|+|++|..||......     ..+........   
T Consensus       172 ~~~~~~~~~---~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-----~~~~~~i~~~~~~~  243 (676)
T 3qa8_A          172 KELDQGELC---TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-----VQWHGKVREKSNEH  243 (676)
T ss_dssp             CBTTSCCCC---CCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-----HHSSTTCC------
T ss_pred             ccccccccc---ccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-----hhhhhhhhcccchh
Confidence            876543322   1234899999999999999999999999999999999999999764221     11110000000   


Q ss_pred             -cccccccccc--cC--CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Q 010309          453 -RYLELLDPLI--SS--LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHV  499 (513)
Q Consensus       453 -~~~~~~~~~~--~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev  499 (513)
                       ...+......  ..  ..........++.+.+||.+||+.||++|||+.++
T Consensus       244 ~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el  295 (676)
T 3qa8_A          244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN  295 (676)
T ss_dssp             CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred             hhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence             0000000000  00  00112234577889999999999999999999873

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=3.8e-38  Score=307.90  Aligned_cols=230  Identities=18%  Similarity=0.293  Sum_probs=180.2

Q ss_pred             HhhCcccCCceecccCceEEEEEEe-CCCCEEEEEEecccchhcHHHHHHHHHHH-hhcCCCcEeeeeeEEee----CCc
Q 010309          222 ITKNFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRF-ARLHHPNLVAVKGCCYD----HGD  295 (513)
Q Consensus       222 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~nIv~l~~~~~~----~~~  295 (513)
                      +.++|....++||+|+||.||++.. .+++.||||+++..     ..+.+|+.++ +.++||||+++++++..    ...
T Consensus        15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~   89 (299)
T 3m2w_A           15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC   89 (299)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence            3455666667889999999999997 46899999999643     4567888888 55599999999999887    677


Q ss_pred             eEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecC---CCCeEEecc
Q 010309          296 RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE---EFGAHLMGV  372 (513)
Q Consensus       296 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~---~~~~kl~Df  372 (513)
                      .++||||+++++|.+++..  .....+++..++.++.|++.||+|||+.   +|+||||||+|||++.   ++.+||+||
T Consensus        90 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Df  164 (299)
T 3m2w_A           90 LLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF  164 (299)
T ss_dssp             EEEEECCCCSCBHHHHHHH--CTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred             EEEEEeecCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEecc
Confidence            8999999999999999976  2335699999999999999999999999   9999999999999998   788999999


Q ss_pred             cccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcc
Q 010309          373 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSH  452 (513)
Q Consensus       373 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  452 (513)
                      |++....                        +..++.++||||||+++|||++|..||..........            
T Consensus       165 g~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~------------  208 (299)
T 3m2w_A          165 GFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP------------  208 (299)
T ss_dssp             TTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C------------
T ss_pred             ccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH------------
Confidence            9986432                        2345789999999999999999999997654321000            


Q ss_pred             cccccccccccCCCCCCCc---HHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          453 RYLELLDPLISSLSSDIPE---AGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       453 ~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                         .... .........+.   ...++++.+|+.+||+.||++|||++|+++
T Consensus       209 ---~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          209 ---GMKT-RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             ---CSCC-SSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ---HHHH-HHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence               0000 00000011111   234678999999999999999999999997

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.6e-38  Score=344.71  Aligned_cols=235  Identities=22%  Similarity=0.252  Sum_probs=189.7

Q ss_pred             ccCCceecccCceEEEEEEeC--CCCEEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCc-----eEE
Q 010309          227 SEGNRLLGDSKTGGTYSGILP--DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD-----RYI  298 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-----~~l  298 (513)
                      +...+.||+|+||.||+|.+.  +|+.||||++.... ......+.+|+.++.+++||||+++++++...+.     .||
T Consensus        82 y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~l  161 (681)
T 2pzi_A           82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYI  161 (681)
T ss_dssp             EEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred             eEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEE
Confidence            344567899999999999975  58999999987542 3445678999999999999999999999988766     699


Q ss_pred             EEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccC
Q 010309          299 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV  378 (513)
Q Consensus       299 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~  378 (513)
                      ||||+++++|.+++.      ..+++..++.++.||+.||.|||++   +|+||||||+|||++.+ .+||+|||++...
T Consensus       162 v~E~~~g~~L~~~~~------~~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~~  231 (681)
T 2pzi_A          162 VMEYVGGQSLKRSKG------QKLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRI  231 (681)
T ss_dssp             EEECCCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred             EEEeCCCCcHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccchhc
Confidence            999999999988764      2699999999999999999999999   99999999999999986 8999999999876


Q ss_pred             CccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccc
Q 010309          379 PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELL  458 (513)
Q Consensus       379 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  458 (513)
                      ...      ....||+.|+|||++.+.. +.++||||||+++|+|++|.+||.......                     
T Consensus       232 ~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~---------------------  283 (681)
T 2pzi_A          232 NSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG---------------------  283 (681)
T ss_dssp             TCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS---------------------
T ss_pred             ccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc---------------------
Confidence            433      1233899999999987654 899999999999999999998876421110                     


Q ss_pred             cccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCC-HHHHHHHHhc
Q 010309          459 DPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPR-MSHVVHQLQQ  505 (513)
Q Consensus       459 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~L~~  505 (513)
                            .....+....++.+.+||.+||+.||++||+ ++++.+.|..
T Consensus       284 ------~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          284 ------LPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             ------CCTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             ------ccccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence                  0011122334567999999999999999994 6666666653

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=2.3e-38  Score=323.33  Aligned_cols=237  Identities=18%  Similarity=0.165  Sum_probs=177.3

Q ss_pred             CceecccCceEEEEEEe-CCCCEEEEEEecccch---hcHHHHHHHHHHHhhcCC-CcE---------------eee---
Q 010309          230 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHH-PNL---------------VAV---  286 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-~nI---------------v~l---  286 (513)
                      .++||+|+||.||+|.+ .+|+.||||++.....   ...+.+.+|+.+++.++| +|+               +.+   
T Consensus        83 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (413)
T 3dzo_A           83 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK  162 (413)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC-
T ss_pred             ecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCC
Confidence            45789999999999995 4699999999974322   235789999999999977 221               111   


Q ss_pred             ---eeEEee-----CCceEEEEeeccCCCHHHHhccC---CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCC
Q 010309          287 ---KGCCYD-----HGDRYIVYEFVVNGPLDRWLHHI---PRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIR  355 (513)
Q Consensus       287 ---~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dik  355 (513)
                         ..+...     ....+++|+++ +++|.+++...   ......+++..++.++.||+.||+|||++   +|+|||||
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiHrDiK  238 (413)
T 3dzo_A          163 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLR  238 (413)
T ss_dssp             --------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSCCC
T ss_pred             CccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcc
Confidence               111111     22457777766 78999988421   22345688889999999999999999999   99999999


Q ss_pred             CCceEecCCCCeEEecccccccCCccccccceeecCccccccccccc----------ccCCCCchhhHHHHHHHHHHHHc
Q 010309          356 ASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFV----------YRNELTTKSDVYSFGVLLLEIVS  425 (513)
Q Consensus       356 p~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~sDvwSlGvil~ellt  425 (513)
                      |+|||++.++.+||+|||+++.....     .....| +.|+|||++          .+..++.++|||||||++|||+|
T Consensus       239 p~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ellt  312 (413)
T 3dzo_A          239 PVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC  312 (413)
T ss_dssp             GGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHH
T ss_pred             cceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHH
Confidence            99999999999999999998865433     222337 999999999          55568889999999999999999


Q ss_pred             CCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          426 GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       426 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      |+.||........                   ....+... .     .+++++.+||.+||+.||++|||+.++++
T Consensus       313 g~~Pf~~~~~~~~-------------------~~~~~~~~-~-----~~~~~~~~li~~~l~~dP~~Rpt~~~~l~  363 (413)
T 3dzo_A          313 ADLPNTDDAALGG-------------------SEWIFRSC-K-----NIPQPVRALLEGFLRYPKEDRLLPLQAME  363 (413)
T ss_dssp             SSCCCCTTGGGSC-------------------SGGGGSSC-C-----CCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCCCCcchhhh-------------------HHHHHhhc-c-----cCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            9999976543211                   11111100 1     12467999999999999999999877753

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=4.7e-38  Score=312.45  Aligned_cols=238  Identities=14%  Similarity=0.135  Sum_probs=179.2

Q ss_pred             cCCceecccCceEEEEEEeCCCCEEEEEEecccch--------hcHHHHHHHHHHHhhcC---------CCcEeeeeeEE
Q 010309          228 EGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSF--------QRKKEFYSEIGRFARLH---------HPNLVAVKGCC  290 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---------h~nIv~l~~~~  290 (513)
                      ...+.||+|+||.||+|+. +|+.||||++.....        ...+.+.+|+.+++.++         ||||+++.+++
T Consensus        23 ~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~  101 (336)
T 2vuw_A           23 QRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVH  101 (336)
T ss_dssp             HTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEE
T ss_pred             hheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhccee
Confidence            4456789999999999998 789999999976532        22377889999988886         66666666653


Q ss_pred             -----------------ee-------------CCceEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 010309          291 -----------------YD-------------HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAF  340 (513)
Q Consensus       291 -----------------~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~  340 (513)
                                       .+             .+..+|||||+++|++.+.+..     ..+++..++.++.||+.||+|
T Consensus       102 ~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~~aL~~  176 (336)
T 2vuw_A          102 CVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLTASLAV  176 (336)
T ss_dssp             EEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHHHHHHH
T ss_pred             EecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHHHHHHH
Confidence                             32             6789999999999977666632     458999999999999999999


Q ss_pred             Hh-cCCCCCceEcCCCCCceEecCCC--------------------CeEEecccccccCCccccccceeecCcccccccc
Q 010309          341 LH-DKVKPHVVHRDIRASNVLLDEEF--------------------GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAP  399 (513)
Q Consensus       341 LH-~~~~~~ivH~Dikp~NIll~~~~--------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aP  399 (513)
                      || +.   +|+||||||+|||++.++                    .+||+|||+++.....       ...||+.|+||
T Consensus       177 lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y~aP  246 (336)
T 2vuw_A          177 AEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVSMDE  246 (336)
T ss_dssp             HHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCTTCS
T ss_pred             HHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecccCh
Confidence            99 88   999999999999999887                    8999999999865422       12399999999


Q ss_pred             cccccCCCCchhhHHHHHHH-HHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCCCCCcHHHHHHH
Q 010309          400 EFVYRNELTTKSDVYSFGVL-LLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKV  478 (513)
Q Consensus       400 E~~~~~~~~~~sDvwSlGvi-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  478 (513)
                      |++.+.. +.++||||||++ .+++++|..||.....   .  ..............        ...........++++
T Consensus       247 E~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~---~--~~~~~~~~~~~~~~--------~~~~~~~~~~~s~~~  312 (336)
T 2vuw_A          247 DLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLW---L--HYLTDKMLKQMTFK--------TKCNTPAMKQIKRKI  312 (336)
T ss_dssp             GGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHH---H--HHHHHHHHHTCCCS--------SCCCSHHHHHHHHHH
T ss_pred             hhhcCCC-ccceehhhhhCCCCcccccccCCCcchhh---h--hHHHHhhhhhhccC--------cccchhhhhhcCHHH
Confidence            9998766 899999998777 7788899999743100   0  00000111000000        000111234688899


Q ss_pred             HHHHHHhcCCCCCCCCCHHHHH
Q 010309          479 VDLVYACTQHVPSMRPRMSHVV  500 (513)
Q Consensus       479 ~~li~~cl~~dP~~RPs~~evl  500 (513)
                      .+||.+||+.|     |++|++
T Consensus       313 ~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          313 QEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHHHGGGSS-----SHHHHH
T ss_pred             HHHHHHHhccC-----CHHHHH
Confidence            99999999976     999988

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=2.1e-31  Score=281.39  Aligned_cols=183  Identities=17%  Similarity=0.084  Sum_probs=128.4

Q ss_pred             cccCceEEEEEEe-CCCCEEEEEEecccc----------hhcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCCceEEEEe
Q 010309          234 GDSKTGGTYSGIL-PDGSRVAVKRLKRSS----------FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYE  301 (513)
Q Consensus       234 g~G~~g~Vy~~~~-~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e  301 (513)
                      +.|+.|.+..++. -.|+.||+|++.+..          ....++|.+|+++|+++ .|+||+++++++++++..|||||
T Consensus       243 ~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVME  322 (569)
T 4azs_A          243 YAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVME  322 (569)
T ss_dssp             C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEE
T ss_pred             ccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEe
Confidence            4555555554442 248889999997542          12346799999999999 79999999999999999999999


Q ss_pred             eccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcc
Q 010309          302 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE  381 (513)
Q Consensus       302 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~  381 (513)
                      |++|++|.++|..    ..+++..   .|+.||+.||+|||++   |||||||||+||||+.++.+||+|||+++.....
T Consensus       323 yv~G~~L~d~i~~----~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~  392 (569)
T 4azs_A          323 KLPGRLLSDMLAA----GEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD  392 (569)
T ss_dssp             CCCSEEHHHHHHT----TCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred             cCCCCcHHHHHHh----CCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence            9999999999964    3456654   5889999999999999   9999999999999999999999999999876544


Q ss_pred             ccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCC
Q 010309          382 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP  429 (513)
Q Consensus       382 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p  429 (513)
                      .....  ...||+.|+|||++.+ .+..++|+||+|++++++.++..+
T Consensus       393 ~~~~~--t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          393 CSWPT--NLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             -CCSH--HHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             Ccccc--CceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            32222  2349999999999865 467789999999998877665443

>3vpp_A C-type lectin domain family 9 member A; dendritic cell, C-type lectin-like domain, membrane, immune; 1.64A {Homo sapiens}

Probab=99.96  E-value=2.8e-29  Score=213.85  Aligned_cols=127  Identities=26%  Similarity=0.485  Sum_probs=107.0

Q ss_pred             cCCCCCCCcccCCCCeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCC--CCCeEEeeeecCCCCCCc
Q 010309            6 KAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGLS   83 (513)
Q Consensus         6 ~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~~   83 (513)
                      |++||+||.  .|+++||+++.+.++|.+|+..|+.+||+||+|+|.+|++||.+++...  ...+||||+  +...++.
T Consensus         1 c~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~WIGl~--~~~~~~~   76 (132)
T 3vpp_A            1 SSPCPNNWI--QNRESCYYVSEIWSIWHTSQENCLKEGSTLLQIESKEEMDFITGSLRKIKGSYDYWVGLS--QDGHSGR   76 (132)
T ss_dssp             -CCSCTTCE--EETTEEEEECSSCBCHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHTTSSSCCEEEEEEE--ECTTTCC
T ss_pred             CCCCCccce--EeCCEEEEEECCccCHHHHHHHHHhcCCEEeEECCHHHHHHHHHHHhccCCCccEEEEec--ccCCCCc
Confidence            789999999  7999999999999999999999999999999999999999999988643  457999999  5555799


Q ss_pred             eEEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCccccccccC
Q 010309           84 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEHEN  150 (513)
Q Consensus        84 w~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~~~~~  150 (513)
                      |+|+||+++.|++|..++|            +.+.++|+.+..  +.|++..|....+|||+.++..
T Consensus        77 w~W~dg~~~~~~~w~~~~p------------~~~~~~C~~~~~--~~w~~~~C~~~~~fiCe~~~~~  129 (132)
T 3vpp_A           77 WLWQDGSSPSPGLLPAERS------------QSANQVCGYVKS--NSLLSSNCDTWKYFICEKYALR  129 (132)
T ss_dssp             EEETTSCCCCTTSCCCC------------------CEEEEEET--TEEEEEESSSCBEEEEEEECC-
T ss_pred             eEecCCCcCChhhcccCCC------------CCCCCceEEEEC--CeEeccCCCCCceEECCccccc
Confidence            9999999999988876554            224568999864  4799999999999999997654

>2py2_A Antifreeze protein type II; type II antifreeze protein; 1.70A {Clupea harengus}

Probab=99.96  E-value=3.7e-29  Score=214.16  Aligned_cols=129  Identities=23%  Similarity=0.494  Sum_probs=111.7

Q ss_pred             CCCCCCCcccCCCCeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEE
Q 010309            7 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKW   86 (513)
Q Consensus         7 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W   86 (513)
                      +.||+||.  .|+++||+++...++|.+|+..|+.+||+||+|+|.+|++||.+++......+||||+  +...++.|+|
T Consensus         2 ~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~WIGl~--~~~~~~~w~W   77 (136)
T 2py2_A            2 DECPTDWK--MFNGRCFLFNPLQLHWADAQESCMKEGANLASIHSLEESTFVKELTSADLIPSWIGGT--DCQVSTRWFW   77 (136)
T ss_dssp             --CCTTCE--EETTEEEEEEEEEECHHHHHHHHHTTTCEECCCCSHHHHHHHHTTSTTTTCCEEEEEE--CCSSTTCCEE
T ss_pred             CCCCcCce--ecCCEEEEEECCCcCHHHHHHHHhhCCCEEeeeCCHHHHHHHHHHHHcCCCCEeEeeE--cCCCCCceEe
Confidence            57999999  7999999999999999999999999999999999999999999988643368999999  6656799999


Q ss_pred             cCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecC-CCcccccccCCCCCccccccccC
Q 010309           87 SDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG-SRSLVTERCNTSHPFICMVEHEN  150 (513)
Q Consensus        87 ~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~-~~~w~d~~C~~~~~~iC~~~~~~  150 (513)
                      +||+++.|++|.+++|+           +.+.|+|+.+... .+.|+|..|....+|||+.+.+.
T Consensus        78 ~dG~~~~y~~W~~geP~-----------~~~~~~Cv~~~~~~~~~W~d~~C~~~~~fIC~~~~~~  131 (136)
T 2py2_A           78 MDSTSMDYADWCAAQPD-----------TTLTECCIQMNVGIGKCWNDTPCTHLHSSICAKPLKH  131 (136)
T ss_dssp             TTCCCCCCCCBCTTCCC-----------CCGGGCEEEEEETTTTEEEEECTTSCEEEEEEEECC-
T ss_pred             CCCCCcccCCCCCCCCC-----------CCCCCCCeEEccCCCCeEcCCCCCCCccEEeeECccc
Confidence            99999999999999983           2223789998654 46799999999999999987655

>1ypq_A Oxidised low density lipoprotein (lectin-like) receptor 1; oxidized low density lipoprotein receptor, LOX-1, CTLD, C- type lectin like domain; 1.40A {Homo sapiens} SCOP: d.169.1.1 PDB: 1ypu_A 1yxk_A 3vlg_A 1ypo_A 1yxj_A

Probab=99.96  E-value=1.2e-28  Score=210.76  Aligned_cols=129  Identities=19%  Similarity=0.382  Sum_probs=112.8

Q ss_pred             CCcCCCCCCCcccCCCCeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCc
Q 010309            4 DWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLS   83 (513)
Q Consensus         4 ~~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~   83 (513)
                      ..+.+||+||.  .|+++||+++.+.++|.+|+..|+.+||+||+|+|.+|++||.+++......+||||+  +...++.
T Consensus         4 ~~~~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~WIGl~--~~~~~~~   79 (135)
T 1ypq_A            4 NCSAPCPQDWI--WHGENCYLFSSGSFNWEKSQEKCLSLDAKLLKINSTADLDFIQQAISYSSFPFWMGLS--RRNPSYP   79 (135)
T ss_dssp             -CCCSSCTTSE--EETTEEEEECSSCBCHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHTTCCCCEEEEEE--ESSTTSC
T ss_pred             ccCCcCCcccE--EcCCEEEEEECCccCHHHHHHHHHhCCCEEeEeCCHHHHHHHHHHHhccCCCEEEecc--ccCCCCC
Confidence            45789999999  7999999999999999999999999999999999999999999998754567999999  5556799


Q ss_pred             eEEcCCCCC-ccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCccccccc
Q 010309           84 WKWSDNMSK-WNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEH  148 (513)
Q Consensus        84 w~W~dg~~~-~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~~~  148 (513)
                      |+|+||+++ .|.+|.+++|++          ..+.++|+.+..  +.|++..|....+|||+.+.
T Consensus        80 w~W~dg~~~~~~~~w~~g~P~~----------~~~~~~Cv~~~~--~~w~~~~C~~~~~fICe~~~  133 (135)
T 1ypq_A           80 WLWEDGSPLMPHLFRVRGAVSQ----------TYPSGTCAYIQR--GAVYAENCILAAFSICQKKA  133 (135)
T ss_dssp             CEETTSCBCCTTSCCEEESCSC----------CCTTCEEEEEET--TEEEEEETTSCBEEEEEEEC
T ss_pred             eEeCCcCccCcccccccCCCCC----------CCCCCCeeEEeC--CcEEccCCCCCeeeEeeecC
Confidence            999999998 588999888832          134678999864  47999999999999999864

>3rs1_A C-type lectin domain family 2 member I; C-type lectin-like, ligand of NK receptor, natural killer CE receptors, surface of activated T lymphocytes; 1.94A {Mus musculus}

Probab=99.95  E-value=4.6e-28  Score=203.27  Aligned_cols=119  Identities=23%  Similarity=0.444  Sum_probs=105.6

Q ss_pred             CCcCCCCCCCcccCCCCeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCc
Q 010309            4 DWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLS   83 (513)
Q Consensus         4 ~~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~   83 (513)
                      ..+++||+||.  .|+++||+++.+.++|.+|+..|+.+||+||+|+|++|++||.+++.  ...+||||+  +...++.
T Consensus         3 ~~~~~Cp~gw~--~~~~~Cy~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~--~~~~WIGl~--~~~~~~~   76 (122)
T 3rs1_A            3 KTYAACSKNWT--GVGNKCFYFSGYPRNWTFAQAFCMAQEAQLARFDNEEELIFLKRFKG--DFDSWIGLH--RESSEHP   76 (122)
T ss_dssp             BSSSSCCTTCE--EETTEEEEECSSCBCHHHHHHHHHHTTCEECCCSSHHHHHHHHHHTT--TSCEEEEEE--CSSTTSC
T ss_pred             cccCCCChhhe--ecCCEEEEEECCccCHHHHHHHHHhcCCEEeeeCCHHHHHHHHHhcC--CCCEEEEEE--ecCCCCc
Confidence            45899999999  89999999999999999999999999999999999999999999986  457999999  6556799


Q ss_pred             eEEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCcccccc
Q 010309           84 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE  147 (513)
Q Consensus        84 w~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~~  147 (513)
                      |+|+||+++.|.+|..                 +.++|+.+...  .|++..|....+|||+.+
T Consensus        77 w~W~dg~~~~~~~w~~-----------------~~~~C~~~~~~--~w~~~~C~~~~~fICekp  121 (122)
T 3rs1_A           77 WKWTNNTEYNNMNPIL-----------------GVGRYAYLSSD--RISSSRSYINRMWICSKL  121 (122)
T ss_dssp             CEETTCCBCCCCSCCC-----------------SSCSEEEEETT--EEEEECSCSCBCBEEEEE
T ss_pred             eECCCCCcCCccccCC-----------------CCCceEEEeCC--cEeccccCCCCCeeeecC
Confidence            9999999998888732                 23468888654  699999999999999986

>2c6u_A CLEC1B protein; lectin, rhodocytin, aggretin, C-type lectin-like, platelets, thrombosis; 1.6A {Homo sapiens}

Probab=99.95  E-value=1.3e-28  Score=206.72  Aligned_cols=121  Identities=18%  Similarity=0.429  Sum_probs=107.9

Q ss_pred             CCCCCCCcccCCCCeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEE
Q 010309            7 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKW   86 (513)
Q Consensus         7 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W   86 (513)
                      ++||+||.  .|+++||+++.++++|.+|+..|+.+||+||+|+|.+|++||.+++.   ..+||||+  +...++.|+|
T Consensus         1 ~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~L~~i~s~~e~~~l~~~~~---~~~WiGl~--~~~~~~~~~W   73 (122)
T 2c6u_A            1 SPCDTNWR--YYGDSCYGFFRHNLTWEESKQYCTDMNATLLKIDNRNIVEYIKARTH---LIRWVGLS--RQKSNEVWKW   73 (122)
T ss_dssp             CCSCTTEE--EETTEEEEEEEEEECHHHHHHHHHHTTCEECCCCSHHHHHHHHTTCC---SCEEEEEE--CSSTTSCCBC
T ss_pred             CCCCccce--EeCCEEEEEECCcCCHHHHHHHHHhCCCeEeeECCHHHHHHHHHhhc---CCEEEEee--ecCCCCCeEe
Confidence            47999999  79999999999999999999999999999999999999999999886   46899999  6556799999


Q ss_pred             cCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCccccccc
Q 010309           87 SDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEH  148 (513)
Q Consensus        87 ~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~~~  148 (513)
                      +||+++.| +|.+++|.           +.+.++|+.+.  .+.|++..|....+|||+.++
T Consensus        74 ~dg~~~~~-~W~~~~P~-----------~~~~~~C~~~~--~g~w~~~~C~~~~~~ICe~~~  121 (122)
T 2c6u_A           74 EDGSVISE-NMFEFLED-----------GKGNMNCAYFH--NGKMHPTFCENKHYLMCERKA  121 (122)
T ss_dssp             TTSCBCCG-GGGGGBCC-----------CCTTCCEEEEE--TTEEEEECTTSCEEEEEEEEC
T ss_pred             CCCCccCc-CcccCCCC-----------CCCCCCeeEEc--CCeEEeccCCCCceEeeeecC
Confidence            99999988 99999883           22457899984  358999999999999999864

>1gz2_A Ovocleidin-17, OC-17 ovocleidin; structural protein, CTLD, eggshell structural protein, phosphoprotein, sugar-binding protein, glycoprotein; HET: SEP; 1.5A {Gallus gallus} SCOP: d.169.1.1

Probab=99.95  E-value=3.4e-28  Score=209.88  Aligned_cols=127  Identities=24%  Similarity=0.547  Sum_probs=110.2

Q ss_pred             CcCCCCCCCcccCCCCeeEEEECCCCChHHHHHHHhh--cCCEEeeeCCHHHHHHHHHHhCCC----------CCCeEEe
Q 010309            5 WKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN----------VNGCWVG   72 (513)
Q Consensus         5 ~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~----------~~~~WiG   72 (513)
                      .|++||+||.  .|+++||+++...++|.+|+..|+.  +||+||+|+|.+|++||.+++...          ...+|||
T Consensus         1 ~~~~Cp~gw~--~~~~~Cy~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~~~~~~~~WIG   78 (142)
T 1gz2_A            1 DPDGCGPGWV--PTPGGCLGFFSRELSWSRAESFCRRWGPGSHLAAVRSAAELRLLAELLNASRGGDGSGEGADGRVWIG   78 (142)
T ss_dssp             ---CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHTTCTTEEECCCCSHHHHHHHHHHHHCSSCCSSSCCCCSSCEEEE
T ss_pred             CCCCCCcccE--EcCCEEEEEcCCCcCHHHHHHHHhccCCCceECccCCHHHHHHHHHHHHhcccccccccccCCCEEEE
Confidence            3689999999  7999999999999999999999999  999999999999999999988643          3579999


Q ss_pred             eeecCCCCCCceEEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCCC--cccccccCCCCCcccccc
Q 010309           73 GRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSR--SLVTERCNTSHPFICMVE  147 (513)
Q Consensus        73 l~~~~~~~~~~w~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~--~w~d~~C~~~~~~iC~~~  147 (513)
                      |+  +...++.|+|+||+++.|.+|.+++|.+           . .++|+.+....+  .|++..|....+|||+.+
T Consensus        79 l~--~~~~~~~w~W~dg~~~~~~~W~~~~P~~-----------~-~~~C~~~~~~~~~~~w~~~~C~~~~~fICe~~  141 (142)
T 1gz2_A           79 LH--RPAGSRSWRWSDGTAPRFASWHRTAKAR-----------R-GGRCAALRDEEAFTSWAARPCTERNAFVCKAA  141 (142)
T ss_dssp             EE--CCTTCSSCEETTSCCCCCCCBCSSSGGG-----------C-SCSEEEECTTTTSSCEEEECTTCCEEEEEEEE
T ss_pred             ee--cCCCCCCcEeCCCCccCccCcCCCCCCC-----------C-CCCCeEEecCCCCCeEecCCCCCCceeEEeec
Confidence            99  6666799999999999999999998832           1 567889876553  799999999999999975

>2afp_A Protein (SEA raven type II antifreeze protein); recombinant SEA raven protein, solution backbone fold, C- type lectin; NMR {Hemitripterus americanus} SCOP: d.169.1.1

Probab=99.95  E-value=3.4e-28  Score=206.24  Aligned_cols=126  Identities=25%  Similarity=0.499  Sum_probs=110.3

Q ss_pred             CCcCCCCCCCcccCCCCeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCc
Q 010309            4 DWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLS   83 (513)
Q Consensus         4 ~~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~   83 (513)
                      ..+..||+||.  .|+++||+++.+.++|.+|+..|+.+||+||+|+|.+|++||.++ .  ...+||||+  +...++.
T Consensus         2 ~~~~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~-~--~~~~WIGl~--~~~~~~~   74 (129)
T 2afp_A            2 RAGPNCPAGWQ--PLGDRCIYYETTAMTWALAETNCMKLGGHLASIHSQEEHSFIQTL-N--AGVVWIGGS--ACLQAGA   74 (129)
T ss_dssp             CCCCSSCSSSC--CCSSSEECCCCSCCCHHHHHHHHHHHSCEECCCSSSHHHHHHHHH-C--SSCBCCSCB--CSSSSSC
T ss_pred             CccCCCCcCcE--EcCCEEEEEECCcCCHHHHHHHHHHcCCEECCcCCHHHHHHHHhc-C--CCCEEEccc--ccCCCCc
Confidence            45789999999  899999999999999999999999999999999999999999998 3  567999999  6556799


Q ss_pred             eEEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCCC-cccccccCCCCCcccccc
Q 010309           84 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSR-SLVTERCNTSHPFICMVE  147 (513)
Q Consensus        84 w~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~-~w~d~~C~~~~~~iC~~~  147 (513)
                      |+|+||+++.|++|.+++|.+           .+.++|+.+....+ .|++..|....+|||+.+
T Consensus        75 ~~W~dg~~~~~~~W~~~~P~~-----------~~~~~C~~~~~~~~~~w~~~~C~~~~~~iCe~~  128 (129)
T 2afp_A           75 WTWSDGTPMNFRSWCSTKPDD-----------VLAACCMQMTAAADQCWDDLPCPASHKSVCAMT  128 (129)
T ss_dssp             CBSSSSCCCCCCCSSSCCSCC-----------STTCCBCCBCCSSSSCBCCBCSCCCCCCCEEEC
T ss_pred             eEeCCCCccccCCcCCCccCC-----------CCCCCCeEEccCCCCEEeCCCCCCCcceEEeee
Confidence            999999999999999998832           11267888865544 599999999999999974

>1sl6_A C-type lectin DC-signr; sugar binding protein; HET: GAL NDG FUC; 2.25A {Homo sapiens} SCOP: d.169.1.1 PDB: 1xar_A

Probab=99.95  E-value=6.7e-28  Score=217.07  Aligned_cols=130  Identities=21%  Similarity=0.457  Sum_probs=112.7

Q ss_pred             CcCCCCCCCcccCCCCeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCce
Q 010309            5 WKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSW   84 (513)
Q Consensus         5 ~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w   84 (513)
                      .|.+||.||.  .|+++||+|+...++|.+|+..|+.+||+||+|+|.+|++||..++......+||||+  +...++.|
T Consensus        49 ~~~~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~fl~~~~~~~~~~~WIGl~--~~~~~~~w  124 (184)
T 1sl6_A           49 LCRHCPKDWT--FFQGNCYFMSNSQRNWHDSVTACQEVRAQLVVIKTAEEQNFLQLQTSRSNRFSWMGLS--DLNQEGTW  124 (184)
T ss_dssp             TCCBCCTTCE--EETTEEEEECSSCBCHHHHHHHHHTTTCEECCCCSHHHHHHHHHHHHHTTCCEEEEEE--CCSSTTCC
T ss_pred             cCCCCCCCcE--EECCEEEEEECCCCCHHHHHHHHHhcCCEEEEeCCHHHHHHHHHHhccCCccEEEEEE--ccCCCCCe
Confidence            5789999999  7999999999999999999999999999999999999999999865433567999999  66667999


Q ss_pred             EEcCCCCCc---cCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCccccccccCccc
Q 010309           85 KWSDNMSKW---NESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEHENKCY  153 (513)
Q Consensus        85 ~W~dg~~~~---~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~~~~~~c~  153 (513)
                      .|+||+++.   |++|.+++|+           +.+.++|+.+...  +|++..|....+|||+.+..  |.
T Consensus       125 ~W~DGs~~~~~~~~~W~~geP~-----------~~~~~~Cv~~~~~--gW~d~~C~~~~~fICe~~~~--C~  181 (184)
T 1sl6_A          125 QWVDGSPLSPSFQRYWNSGEPN-----------NSGNEDCAEFSGS--GWNDNRCDVDNYWICKKPAA--CF  181 (184)
T ss_dssp             EETTSCBCCGGGGGGBCTTCCC-----------CTTSCCEEEEETT--EEEEECTTSCBEEEEEEECB--SC
T ss_pred             EecCCCccCCcccCCCCCCCCC-----------CCCCCCceEEeCC--cEEccCCCCCeeEEEeECCc--CC
Confidence            999999976   3689988883           2356789999764  49999999999999999765  64

>2b6b_D CD209 antigen; cryo EM dengue CRD DC-SIGN, icosahedral virus, virus-recepto; 25.00A {Homo sapiens} SCOP: d.169.1.1

Probab=99.95  E-value=1.8e-27  Score=212.15  Aligned_cols=132  Identities=23%  Similarity=0.465  Sum_probs=113.7

Q ss_pred             CCcCCCCCCCcccCCCCeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCc
Q 010309            4 DWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLS   83 (513)
Q Consensus         4 ~~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~   83 (513)
                      ..|..||.||.  .|+++||+|+.+.++|.+|+..|+.+||+||+|+|.+|++||..++......+||||+  +...++.
T Consensus        22 ~~~~~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~fl~~~~~~~~~~~WIGl~--~~~~~~~   97 (175)
T 2b6b_D           22 RLCHPCPWEWT--FFQGNCYFMSNSQRNWHDSITACKEVGAQLVVIKSAEEQNFLQLQSSRSNRFTWMGLS--DLNQEGT   97 (175)
T ss_pred             cccCCCCcCcE--EeCCEEEEEECCccCHHHHHHHHhhCCCEEeeeCCHHHHHHHHHHhccCCCcEEEeeE--ccCCCCc
Confidence            45789999999  7999999999999999999999999999999999999999999877544568999999  6556799


Q ss_pred             eEEcCCCCCc---cCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCccccccccCccc
Q 010309           84 WKWSDNMSKW---NESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEHENKCY  153 (513)
Q Consensus        84 w~W~dg~~~~---~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~~~~~~c~  153 (513)
                      |+|+||+++.   |.+|.+++|.           +.+.++|+.+...  +|++..|....+|||+.+.. .|.
T Consensus        98 w~W~dGs~~~~~~~~~W~~geP~-----------~~~~~~Cv~~~~~--gW~d~~C~~~~~fICe~~~~-~C~  156 (175)
T 2b6b_D           98 WQWVDGSPLLPSFKQYWNRGEPN-----------NVGEEDCAEFSGN--GWNDDKCNLAKFWICKKSAA-SCS  156 (175)
T ss_pred             EEeCCCCCcccccccCCCCCCCC-----------CCCCCCeeEEcCC--ceEccCCCCCeeEEEEECCC-CCC
Confidence            9999999976   4789988883           2245689998654  49999999999999999766 443

>1dv8_A Asialoglycoprotein receptor 1; C-type lectin CRD, signaling protein; 2.30A {Homo sapiens} SCOP: d.169.1.1

Probab=99.95  E-value=1.5e-27  Score=201.98  Aligned_cols=125  Identities=21%  Similarity=0.500  Sum_probs=109.1

Q ss_pred             CCCCCcccCCCCeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEcC
Q 010309            9 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSD   88 (513)
Q Consensus         9 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~d   88 (513)
                      ||+||.  .|+++||+++.+.++|.+|+..|+.+||+||+|+|.+|++||.+++.  ...+||||+  +.  ++.|+|+|
T Consensus         1 Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~--~~~~WIGl~--~~--~~~~~W~d   72 (128)
T 1dv8_A            1 CPVNWV--EHERSCYWFSRSGKAWADADNYCRLEDAHLVVVTSWEEQKFVQHHIG--PVNTWMGLH--DQ--NGPWKWVD   72 (128)
T ss_dssp             CCTTCE--EETTEEEEECSSCBCHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHC--SSCEEEEEE--CT--TSSCEETT
T ss_pred             CCCcce--ecCCEEEEEECCCcCHHHHHHHHhhCCCEEcccCCHHHHHHHHHhhC--CCCEEeeEE--cC--CCcEEeCC
Confidence            999999  79999999999999999999999999999999999999999999987  468999999  53  69999999


Q ss_pred             CCCC--ccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCcccccc
Q 010309           89 NMSK--WNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE  147 (513)
Q Consensus        89 g~~~--~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~~  147 (513)
                      |+++  .|.+|.+++|.+....     ...+.++|+.+.. .+.|++..|....+|||+.+
T Consensus        73 g~~~~~~~~~W~~g~P~~~~~~-----~~~~~~~C~~~~~-~g~W~~~~C~~~~~fICe~~  127 (128)
T 1dv8_A           73 GTDYETGFKNWRPEQPDDWYGH-----GLGGGEDCAHFTD-DGRWNDDVCQRPYRWVCETE  127 (128)
T ss_dssp             CCCSTTSCCCBCTTCCCCCCTT-----SSSSCCCEEEECT-TSCEEEECTTSCBEEEEEEE
T ss_pred             CCcCCcccccCCCCCCCCcccc-----cCCCCCcCceecC-CCcCCCccCCCCcceeeeeC
Confidence            9998  8999999998442111     1135678999864 46899999999999999975

>3bdw_A Natural killer cells antigen CD94; NK cells, receptor, glycoprotein, lectin, signal-A transmembrane, immune system receptor; 2.50A {Homo sapiens} SCOP: d.169.1.1 PDB: 3cdg_J 1b6e_A 3cii_G

Probab=99.95  E-value=2.1e-28  Score=205.73  Aligned_cols=122  Identities=16%  Similarity=0.378  Sum_probs=107.1

Q ss_pred             CcCCCCCCCcccCCCCeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCce
Q 010309            5 WKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSW   84 (513)
Q Consensus         5 ~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w   84 (513)
                      .|++||+||.  .|+++||+++.+.++|.+|+..|+.+||+||+|+|.+|++||.++    ...+||||+  +...++.|
T Consensus         1 ~c~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~----~~~~WIGl~--~~~~~~~w   72 (123)
T 3bdw_A            1 DCCSCQEKWV--GYRCNCYFISSEQKTWNESRHLCASQKSSLLQLQNTDELDFMSSS----QQFYWIGLS--YSEEHTAW   72 (123)
T ss_dssp             CCCCCTTTCE--EETTEEEEECSSCBCHHHHHHHHHHTTCEECCCSCGGGGGGGTTC----CCCEECSEE--EETTTTEE
T ss_pred             CCCCCCCCce--EECCEEEEEeCCCCCHHHHHHHHHHCCCeeEEECCHHHHHHHHhC----cCCEEeeee--cCCCCCcE
Confidence            4899999999  799999999999999999999999999999999999999999875    357999999  55567999


Q ss_pred             EEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCccccccc
Q 010309           85 KWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEH  148 (513)
Q Consensus        85 ~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~~~  148 (513)
                      +|+||+++.|.+|.+++|             .+.++|+.+... +.|++..|....+|||+.+.
T Consensus        73 ~W~dg~~~~~~~w~~~~~-------------~~~~~C~~~~~~-~~w~d~~C~~~~~fICe~~~  122 (123)
T 3bdw_A           73 LWENGSALSQYLFPSFET-------------FNTKNCIAYNPN-GNALDESCEDKNRYICKQQL  122 (123)
T ss_dssp             EETTSCBCCTTTSGGGGG-------------CCTTSEEEEETT-TEEEEECTTSCBEEEEEECC
T ss_pred             EeeCCCcCCcccccccCC-------------CCCCCCcEEcCC-CcEEccCCCCCCeeeEeEec
Confidence            999999999999876654             134679988654 58999999999999999753

>1tdq_B Aggrecan core protein; extracellular matrix, lecticans, tenascins, protein-protein interactions, C-type lectin domain; 2.60A {Rattus norvegicus} SCOP: d.169.1.1

Probab=99.95  E-value=8.6e-28  Score=204.05  Aligned_cols=126  Identities=23%  Similarity=0.432  Sum_probs=110.2

Q ss_pred             cCCCCCCCcccCCCCeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceE
Q 010309            6 KAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWK   85 (513)
Q Consensus         6 ~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~   85 (513)
                      ...||+||.  .|+++||+++.+.++|.+|+..|+.+||+||+|+|.+|++||.+++.   ..+||||+  +...++.|+
T Consensus         4 ~~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~---~~~WIGl~--~~~~~~~~~   76 (130)
T 1tdq_B            4 QEQCEEGWT--KFQGHCYRHFPDRETWVDAERRCREQQSHLSSIVTPEEQEFVNKNAQ---DYQWIGLN--DRTIEGDFR   76 (130)
T ss_dssp             -CCCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHC---SCEEEEEE--CSSSTTCCE
T ss_pred             ccCCCcccE--EeCCEEEEEECCCCCHHHHHHHHHhcCCEEeeeCCHHHHHHHHhccC---CCEEEeee--cCCCCCEEE
Confidence            568999999  79999999999999999999999999999999999999999999885   57999999  655679999


Q ss_pred             EcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeec-CCCcccccccCCCCCcccccc
Q 010309           86 WSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN-GSRSLVTERCNTSHPFICMVE  147 (513)
Q Consensus        86 W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~-~~~~w~d~~C~~~~~~iC~~~  147 (513)
                      |+||+++.|.+|.+++|.+.         ..+.++|+.+.. ..+.|++.+|....+|||+.+
T Consensus        77 W~dg~~~~~~~W~~~~P~~~---------~~~~~~C~~~~~~~~~~w~~~~C~~~~~fICe~~  130 (130)
T 1tdq_B           77 WSDGHSLQFEKWRPNQPDNF---------FATGEDCVVMIWHERGEWNDVPCNYQLPFTCKKG  130 (130)
T ss_dssp             ETTCCCCCCCCBCTTCCCCC---------STTTEEEEEEETTTTTEEEEEETTSCEEEEEEEC
T ss_pred             ecCCCcCCccccCCCCCCCc---------cCCCCCeEEEccCCCCcccCcCCCCCeeeeeecC
Confidence            99999999999999988321         124578999863 456799999999999999863

>2kv3_A Regenerating islet-derived protein 4; GISP, C-type lectin, REG IV, disulfide bond, glycoPro lectin, secreted, sugar binding protein; NMR {Homo sapiens}

Probab=99.95  E-value=7.7e-28  Score=204.64  Aligned_cols=125  Identities=24%  Similarity=0.604  Sum_probs=110.2

Q ss_pred             CCCCCCCcccCCCCeeEEEECCCCChHHHHHHHhhc--CCEEeeeCCHHHHHHHHHHhCCC--CCCeEEeeeecCCCCCC
Q 010309            7 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGL   82 (513)
Q Consensus         7 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~--~~~L~~i~~~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~   82 (513)
                      ++||+||.  .|+++||+++.+.++|.+|+..|+.+  ||+||+|+|.+|++||.+++...  ...+||||+  +...++
T Consensus         1 ~~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~WIGl~--~~~~~~   76 (131)
T 2kv3_A            1 QSCAPGWF--YHKSNCYGYFRKLRNWSDAELECQSYGNGAHLASILSLKEASTIAEYISGYQRSQSIWIGLH--DPQKRQ   76 (131)
T ss_dssp             CCSCTTCC--EETTEEEEEEEEEECHHHHHHHHHTTSSSCEECCCSSHHHHHHHHHHHTCTTSCCCCBCSEE--CSSSSS
T ss_pred             CcCCcccE--EcCCEeEEEECCCCCHHHHHHHHhccCCCceEeeeCCHHHHHHHHHHHHhcCCCCCEEEecc--CCCCCC
Confidence            47999999  79999999999999999999999999  99999999999999999998754  467999999  665679


Q ss_pred             ceEEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCCC--cccccccCCCCCccccccc
Q 010309           83 SWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSR--SLVTERCNTSHPFICMVEH  148 (513)
Q Consensus        83 ~w~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~--~w~d~~C~~~~~~iC~~~~  148 (513)
                      .|+|+||+++.|++|.+++|             .+.++|+.+....+  .|++..|....+|||+.++
T Consensus        77 ~~~W~dg~~~~~~~W~~~~P-------------~~~~~C~~~~~~~~~~~W~~~~C~~~~~~iCe~~p  131 (131)
T 2kv3_A           77 QWQWIDGAMYLYRSWSGKSM-------------GGNKHCAEMSSNNNFLTWSSNECNKRQHFLCKYRP  131 (131)
T ss_dssp             CCEETTCCCCSSCCCSSCCC-------------TTCTTEEEECTTCTTCCEEEECTTCCEEEEEEECC
T ss_pred             CeEeCCcCcccccccCCCCC-------------CCCCCceEEECCCCcCceecCCCCCCceEEEeeCC
Confidence            99999999999999998887             13457888876544  5999999999999999863

>2ox9_A Collectin placenta 1; C-type lectin, sugar binding protein; HET: GAL NAG FUC; 1.95A {Mus musculus} PDB: 2ox8_A

Probab=99.95  E-value=1.3e-27  Score=205.76  Aligned_cols=133  Identities=22%  Similarity=0.408  Sum_probs=113.0

Q ss_pred             cCCCCCCCcccCCCCeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceE
Q 010309            6 KAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWK   85 (513)
Q Consensus         6 ~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~   85 (513)
                      ...||.||.  .|+++||+|+...++|.+|+..|+.+||+||+|+|.+|++||.+++.. ...+||||+  +...++.|+
T Consensus         2 ~~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~-~~~~WIGl~--~~~~~~~~~   76 (140)
T 2ox9_A            2 VNGCPPHWK--NFTDKCYYFSLEKEIFEDAKLFCEDKSSHLVFINSREEQQWIKKHTVG-RESHWIGLT--DSEQESEWK   76 (140)
T ss_dssp             --CCCTTCE--EETTEEEEECSCCBCHHHHHHHHHHTTCEECCCCSHHHHHHHHHTCCS-SSCEEEEEE--CSSSTTCCE
T ss_pred             CCCCCcCce--EcCCEEEEEECCCcCHHHHHHHHHhcCCEEeeeCCHHHHHHHHHHhcC-CCCEEeeeE--eCCCCCceE
Confidence            357999999  799999999999999999999999999999999999999999998863 457999999  655679999


Q ss_pred             EcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCccccccccC
Q 010309           86 WSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEHEN  150 (513)
Q Consensus        86 W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~~~~~  150 (513)
                      |+||+++.|++|.+++|.+. .     ....+.++|+.+.. .+.|++..|....+|||+.+...
T Consensus        77 W~dg~~~~~~~W~~~~P~~~-~-----~~~~~~~~Cv~~~~-~g~W~d~~C~~~~~fICe~~~~~  134 (140)
T 2ox9_A           77 WLDGSPVDYKNWKAGQPDNW-G-----SGHGPGEDCAGLIY-AGQWNDFQCDEINNFICEKEREA  134 (140)
T ss_dssp             ETTSCBCCSCCBCTTCCCCT-T-----TTTSSCCCEEEECG-GGCEEEECTTSCBEEEEEEECC-
T ss_pred             eCCcCcCCccCcCCcCCCCc-c-----cCCCCCCCCceECC-CCeEeccCCCCCceeEEeecCCC
Confidence            99999999999999998432 1     01235678999864 36899999999999999987654

>3kqg_A Langerin, C-type lectin domain family 4 member K; trimer, NECK and CRD, coiled coil, immune system; 2.30A {Homo sapiens}

Probab=99.95  E-value=1.3e-27  Score=215.31  Aligned_cols=129  Identities=19%  Similarity=0.300  Sum_probs=112.8

Q ss_pred             cCCCCCCCcccCCCCeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceE
Q 010309            6 KAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWK   85 (513)
Q Consensus         6 ~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~   85 (513)
                      +..||.||.  .|+++||+|+...++|.+|+.+|+.+||+||+|+|.+|++||.+++.  ...|||||+  +...+|.|+
T Consensus        46 ~~~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~--~~~~WIGl~--~~~~~~~w~  119 (182)
T 3kqg_A           46 LQVVSQGWK--YFKGNFYYFSLIPKTWYSAEQFCVSRNSHLTSVTSESEQEFLYKTAG--GLIYWIGLT--KAGMEGDWS  119 (182)
T ss_dssp             HHHHTTTCE--EETTEEEEECSSCBCHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHT--TCCEEEEEE--ECSTTCCEE
T ss_pred             hccCCCCCE--EeCCEEEEEECCCCCHHHHHHHHHhCCCEEeeeCCHHHHHHHHHhcC--CCcEEEEeE--ccCCCCceE
Confidence            457999999  79999999999999999999999999999999999999999999986  457999999  555679999


Q ss_pred             EcCCCCCc----cCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCC-CcccccccCCCCCccccccccC
Q 010309           86 WSDNMSKW----NESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS-RSLVTERCNTSHPFICMVEHEN  150 (513)
Q Consensus        86 W~dg~~~~----~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~-~~w~d~~C~~~~~~iC~~~~~~  150 (513)
                      |+||+++.    |.+|.+++|.+          .++.++|+.+...+ +.|++..|....+|||+.+..+
T Consensus       120 W~dG~~~~~~~~~~~W~~geP~~----------~~~~~~Cv~~~~~~~~~W~d~~C~~~~~fICe~~~~~  179 (182)
T 3kqg_A          120 WVDDTPFNKVQSARFWIPGEPNN----------AGNNEHCGNIKAPSLQAWNDAPCDKTFLFICKRPYVP  179 (182)
T ss_dssp             ETTCCCCCHHHHTTTBCTTCCCC----------TTSCCCEEEECSSSSSCEEEECTTSCBEEEEEEECCC
T ss_pred             eCCCCccccccccCCCCCCCCCC----------CCCCCCeeEEecCCCCCEeCcCCCCCeeEEeccCCCC
Confidence            99999987    89999998832          23457899987544 5799999999999999997654

>1qdd_A Lithostathine; pancreatic stone inhibitor, metal binding protein; HET: SIA NDG GAL; 1.30A {Homo sapiens} SCOP: d.169.1.1 PDB: 1lit_A

Probab=99.95  E-value=7.9e-28  Score=208.14  Aligned_cols=127  Identities=17%  Similarity=0.429  Sum_probs=111.2

Q ss_pred             cCCCCCCCcccCCCCeeEEEECCCCChHHHHHHHhhc-CCEEeeeCCHHHHHHHHHHhCCC---CCCeEEeeeecCCCCC
Q 010309            6 KAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI-GGHLAALTSYEEEHSAQKLCGKN---VNGCWVGGRSINTTVG   81 (513)
Q Consensus         6 ~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~-~~~L~~i~~~~e~~f~~~~~~~~---~~~~WiGl~~~~~~~~   81 (513)
                      +..||+||.  .|+++||+++.+.++|.+|+..|+.+ ||+||+|+|.+|++||.+++...   ...+||||+  +...+
T Consensus        11 ~~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~gg~La~i~s~~e~~~l~~~~~~~~~~~~~~WIGl~--~~~~~   86 (144)
T 1qdd_A           11 RISCPEGTN--AYRSYCYYFNEDRETWVDADLYCQNMNSGNLVSVLTQAEGAFVASLIKESGTDDFNVWIGLH--DPKKN   86 (144)
T ss_dssp             GTSCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHTTSCEECCCCSHHHHHHHHHHHHHTTCCCSEEEEEEE--CTTSS
T ss_pred             CCCCCCCce--ecCCEeEEEeCCCcCHHHHHHHhhccCCceECccCCHHHHHHHHHHHHhcCCCCCCEEEeeE--cCCCC
Confidence            468999999  79999999999999999999999998 99999999999999999988532   457999999  66667


Q ss_pred             CceEEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCC--CcccccccCCCCCcccccc
Q 010309           82 LSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMVE  147 (513)
Q Consensus        82 ~~w~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~--~~w~d~~C~~~~~~iC~~~  147 (513)
                      +.|+|+||+++.|++|.+++|.           +.+.++|+.+....  +.|++..|....+|||+.+
T Consensus        87 ~~~~W~dg~~~~~~~W~~~~P~-----------~~~~~~Cv~~~~~~~~~~W~d~~C~~~~~fICe~~  143 (144)
T 1qdd_A           87 RAWHWSSGSLVSYKSWGIGAPS-----------SVNPGYCVSLTSSTGFQKWKDVPCEDKFSFVCKFK  143 (144)
T ss_dssp             SCCEETTCCCCCCCCBCTTCSC-----------SSSCCSEEEEEGGGTTCSEEEECTTSCEEEEEEEE
T ss_pred             CeEEeCCCCCcCcCccCCCCcC-----------CCCCCCcEEEEecCCCCeEeCCCCCCCceeeeeec
Confidence            9999999999999999999883           22457899987543  4799999999999999975

>1hq8_A NKG2-D; homodimer, CIS-proline, apoptosis; 1.95A {Mus musculus} SCOP: d.169.1.1 PDB: 1jsk_A 1kcg_A*

Probab=99.95  E-value=2e-28  Score=205.75  Aligned_cols=120  Identities=23%  Similarity=0.538  Sum_probs=106.8

Q ss_pred             CcCCCCCCCcccCCCCeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCce
Q 010309            5 WKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSW   84 (513)
Q Consensus         5 ~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w   84 (513)
                      .|++||+||.  .|+++||+++.+.++|.+|+..|+.+||+||+|+|.+|++||..+.    ..+||||+  +...++.|
T Consensus         2 ~c~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~fl~~~~----~~~WIGl~--~~~~~~~w   73 (123)
T 1hq8_A            2 YCGPCPNNWI--CHRNNCYQFFNEEKTWNQSQASCLSQNSSLLKIYSKEEQDFLKLVK----SYHWMGLV--QIPANGSW   73 (123)
T ss_dssp             CCCCCSTTCE--EETTEEEEEEEEEECHHHHHHHHHTTTCEECCCSCTTTTGGGGGCC----SCEEEEEE--ECTTTCCE
T ss_pred             cCCCCCcccE--EcCCEEEEEeCCccCHHHHHHHHHhcCCEecccCCHHHHHHHHhcc----CCEEEEee--ecCCCCCe
Confidence            5899999999  7999999999999999999999999999999999999999998653    47999999  55567999


Q ss_pred             EEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCcccccc
Q 010309           85 KWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE  147 (513)
Q Consensus        85 ~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~~  147 (513)
                      +|+||+++.|.+|.+++|.              +++|+.+... +.|++..|....+|||+.+
T Consensus        74 ~W~dg~~~~~~~w~~~~p~--------------~~~C~~~~~~-~~w~~~~C~~~~~fICe~~  121 (123)
T 1hq8_A           74 QWEDGSSLSYNQLTLVEIP--------------KGSCAVYGSS-FKAYTEDCANLNTYICMKR  121 (123)
T ss_dssp             EETTSCBCCTTTCEEECCT--------------TCCEEEECST-TEEEEECTTSCEEEEEEEC
T ss_pred             EeCCCCCccccccccCCCC--------------CCCcEEEecc-CCEeccCCCCCceeEeeee
Confidence            9999999999999988872              3468888654 5899999999999999975

>1egg_A Macrophage mannose receptor; C-type lectin, sugar binding protein; 2.30A {Homo sapiens} SCOP: d.169.1.1 PDB: 1egi_A

Probab=99.95  E-value=7.8e-28  Score=208.94  Aligned_cols=131  Identities=24%  Similarity=0.493  Sum_probs=108.3

Q ss_pred             cCCCCCCC--cccCCCCeeEEEEC----CCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCC---CCCeEEeeeec
Q 010309            6 KAPCPPDW--IINEEKSKCFGYIG----NFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN---VNGCWVGGRSI   76 (513)
Q Consensus         6 ~~~Cp~~w--~~~~~~~~Cy~~~~----~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~---~~~~WiGl~~~   76 (513)
                      +..||.||  .  .++++||+++.    ..++|.+|+..|+.+||+||+|+|.+|++||.+++...   ...+||||+  
T Consensus         2 ~~~Cp~gw~~~--~~~~~CY~~~~~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~WIGl~--   77 (147)
T 1egg_A            2 IPKCPEDWGAS--SRTSLCFKLYAKGKHEKKTWFESRDFCRALGGDLASINNKEEQQTIWRLITASGSYHKLFWLGLT--   77 (147)
T ss_dssp             ---CCTTCEEC--SSSSCEEEEECSCGGGCBCHHHHHHHHHTTTCEECCCCSHHHHHHHHHHHHHHTCTTCEEEEEEE--
T ss_pred             CCCCCCCCccc--cCCCEEEEEeccCCccccCHHHHHHHHHHcCCEECccCCHHHHHHHHHHHHhccCCCCcEEEeee--
Confidence            35899999  8  89999999999    99999999999999999999999999999999887532   357999999  


Q ss_pred             CCCCCCceEEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecC-CCcccccccCCCCCccccccccC
Q 010309           77 NTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG-SRSLVTERCNTSHPFICMVEHEN  150 (513)
Q Consensus        77 ~~~~~~~w~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~-~~~w~d~~C~~~~~~iC~~~~~~  150 (513)
                      +...++.|+|+||+++.|++|.+++|++          ..+.++|+.+... ++.|++..|....+|||+.+...
T Consensus        78 ~~~~~~~w~W~dg~~~~~~~W~~g~P~~----------~~~~~~Cv~~~~~~~~~W~d~~C~~~~~fICe~~~~~  142 (147)
T 1egg_A           78 YGSPSEGFTWSDGSPVSYENWAYGEPNN----------YQNVEYCGELKGDPTMSWNDINCEHLNNWICQIQKGQ  142 (147)
T ss_dssp             CC----CCCCTTSCCCCCCCCCTTCSCG----------GGSCCEEEEEECSTTCCEEEEETTSCBEEEEECCC--
T ss_pred             cCCCCCcEEecCCCCcccCccCCCCCCC----------CCCCCCCeEECCCCCCceeccCCCCCccEEeeCCCCC
Confidence            6556799999999999999999998832          1356789999765 46899999999999999987644

>1wmz_A Lectin CEL-I, N-acetyl-D-galactosamine-specific C-type; C-type lectin, N-acetylgalactosamine, invertebrate, sugar binding protein; HET: NGA A2G; 1.70A {Cucumaria echinata} SCOP: d.169.1.1 PDB: 1wmy_A*

Probab=99.95  E-value=6.1e-28  Score=207.77  Aligned_cols=128  Identities=13%  Similarity=0.325  Sum_probs=112.2

Q ss_pred             CCCCCCCcccCCCCeeEEEECCCCChHHHHHHHh-------hcCCEEeeeCCHHHHHHHHHHhCCC---CCCeEEeeeec
Q 010309            7 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCK-------EIGGHLAALTSYEEEHSAQKLCGKN---VNGCWVGGRSI   76 (513)
Q Consensus         7 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~-------~~~~~L~~i~~~~e~~f~~~~~~~~---~~~~WiGl~~~   76 (513)
                      ++||+||+  .|+++||+++.+.++|.+|+..|+       ..||+||+|+|.+|++||.+++...   ...+||||+  
T Consensus         1 ~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~WiGl~--   76 (140)
T 1wmz_A            1 NQCPTDWE--AEGDHCYRFFNTLTTWENAHHECVSYSCSTLNVRSDLVSVHSAAEQAYVFNYWRGIDSQAGQLWIGLY--   76 (140)
T ss_dssp             CCCCTTCE--EETTEEEEEEEEEECHHHHHHHHHTTCBGGGTEEEEECCCCSHHHHHHHHHHHHHHCCSSCCEEEEEE--
T ss_pred             CcCCCcce--ecCCEEEEEECCCcCHHHHHHhhhhhccCCCCCCcEEcccCCHHHHHHHHHHHhhccCCCCCEEEeee--
Confidence            47999999  799999999999999999999999       9999999999999999999988532   468999999  


Q ss_pred             CCCCCCceEEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCCC-cccccccCCCCCccccccc
Q 010309           77 NTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSR-SLVTERCNTSHPFICMVEH  148 (513)
Q Consensus        77 ~~~~~~~w~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~-~w~d~~C~~~~~~iC~~~~  148 (513)
                      +...++.|+|+||+++.|++|.+++|.+          ..+.++|+.+....+ .|++..|....+|||+.+.
T Consensus        77 ~~~~~~~~~W~dg~~~~~~~W~~~~P~~----------~~~~~~Cv~~~~~~~~~W~~~~C~~~~~fICe~~~  139 (140)
T 1wmz_A           77 DKYNEGDFIWTDGSKVGYTKWAGGQPDN----------WNNAEDYGQFRHTEGGAWNDNSAAAQAKYMCKLTF  139 (140)
T ss_dssp             CSSSTTCCEETTCCCCCCCCBCTTCCCC----------GGGCEEEEEECSSTTTCEEEEETTCCEEEEEEEEE
T ss_pred             ecCCCCeeEECCcCcccccCcCcccCCC----------CCCcCCcEEEccCCCCCEeCCCCCCCceEEEEEec
Confidence            6656799999999999999999998832          124678999976655 7999999999999999754

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.94  E-value=1.5e-27  Score=250.51  Aligned_cols=184  Identities=16%  Similarity=0.171  Sum_probs=146.7

Q ss_pred             CceecccCceEEEEEEeCCCCEEEEEEecccchh--------cHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEe
Q 010309          230 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQ--------RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE  301 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  301 (513)
                      .++||+|+||.||++.. .++.+++|+.......        ..+.+.+|++++++++||||+++..++...+..+||||
T Consensus       341 ~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE  419 (540)
T 3en9_A          341 EHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS  419 (540)
T ss_dssp             -------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred             CCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence            45789999999999955 6889999987543211        13458999999999999999976666668888899999


Q ss_pred             eccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcc
Q 010309          302 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE  381 (513)
Q Consensus       302 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~  381 (513)
                      |+++++|.+++..            +..++.|++.||.|||++   +|+||||||+|||++.  .+||+|||+++.....
T Consensus       420 ~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~  482 (540)
T 3en9_A          420 YINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD  482 (540)
T ss_dssp             CCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred             CCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence            9999999999853            568999999999999999   9999999999999999  9999999999987654


Q ss_pred             cccc-----ceeecCccccccccccccc--CCCCchhhHHHHHHHHHHHHcCCCCCC
Q 010309          382 VMQE-----RTVMAGGTYGYLAPEFVYR--NELTTKSDVYSFGVLLLEIVSGRRPAQ  431 (513)
Q Consensus       382 ~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvil~elltg~~p~~  431 (513)
                      ....     ......||+.|+|||++..  ..|+..+|+||..+-..+.+.++.+|.
T Consensus       483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            2211     1122348999999999986  567888999999999998888777663

>1uv0_A Pancreatitis-associated protein 1; lectin, C-type, secreted, inflammatory response, acute phase; 1.78A {Homo sapiens} SCOP: d.169.1.1 PDB: 2go0_A

Probab=99.94  E-value=2.7e-27  Score=205.99  Aligned_cols=127  Identities=20%  Similarity=0.406  Sum_probs=110.8

Q ss_pred             cCCCCCCCcccCCCCeeEEEECCCCChHHHHHHHhhc-CCEEeeeCCHHHHHHHHHHhCCC---CCCeEEeeeecCCCCC
Q 010309            6 KAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI-GGHLAALTSYEEEHSAQKLCGKN---VNGCWVGGRSINTTVG   81 (513)
Q Consensus         6 ~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~-~~~L~~i~~~~e~~f~~~~~~~~---~~~~WiGl~~~~~~~~   81 (513)
                      ...||+||.  .|+++||+++...++|.+|+..|+.+ ||+||+|+|.+|++||.+++...   ...+||||+  +...+
T Consensus        11 ~~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~WiGl~--~~~~~   86 (149)
T 1uv0_A           11 RIRCPKGSK--AYGSHCYALFLSPKSWTDADLACQKRPSGNLVSVLSGAEGSFVSSLVKSIGNSYSYVWIGLH--DPTQG   86 (149)
T ss_dssp             CCCCCTTCE--EETTEEEEEEEEEECHHHHHHHHTTSTTCEECCCCSHHHHHHHHHHHTTSCTTCCEEEEEEE--CTTTT
T ss_pred             CCCCCcccc--ccCCEEEEEECCCCCHHHHHHHhhcCCCccEeEeCCHHHHHHHHHHHHhhccCCCCEEEeeE--ccCCC
Confidence            457999999  79999999999999999999999998 89999999999999999999753   457999999  55555


Q ss_pred             Cc-----eEEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCC--CcccccccCCCCCcccccc
Q 010309           82 LS-----WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMVE  147 (513)
Q Consensus        82 ~~-----w~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~--~~w~d~~C~~~~~~iC~~~  147 (513)
                      +.     |+|+||+++.|++|.+++|.           +.+.++|+.+....  +.|++..|....+|||+.+
T Consensus        87 ~~~~~~~w~W~dg~~~~~~~W~~~~P~-----------~~~~~~Cv~~~~~~~~~~W~d~~C~~~~~fICe~~  148 (149)
T 1uv0_A           87 TEPNGEGWEWSSSDVMNYFAWERNPST-----------ISSPGHCASLSRSTAFLRWKDYNCNVRLPYVCKFT  148 (149)
T ss_dssp             CC--CCCCEETTCCCCCCCCBSSCGGG-----------SSSCCSEEEEEGGGTTCSEEEECTTSCEEEEEEEC
T ss_pred             CccCCCccEECCCCccCccCcCCCCcC-----------CCCCCCCEEEEcCCCCCeEeCcCCCCCCceEEeec
Confidence            55     99999999999999999883           23567899987653  4799999999999999975

>1jzn_A Galactose-specific lectin; C-type lectin, protein-disaccharide complex, sugar binding P; HET: BGC GAL; 2.20A {Crotalus atrox} SCOP: d.169.1.1 PDB: 1muq_A*

Probab=99.94  E-value=1.2e-27  Score=204.54  Aligned_cols=127  Identities=20%  Similarity=0.573  Sum_probs=110.3

Q ss_pred             CCCCCCCcccCCCCeeEEEECCCCChHHHHHHHhh--cCCEEeeeCCHHHHHHHHHHhCCC---CCCeEEeeeecCCCCC
Q 010309            7 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN---VNGCWVGGRSINTTVG   81 (513)
Q Consensus         7 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~---~~~~WiGl~~~~~~~~   81 (513)
                      ++||+||.  .|+++||+++.+.++|.+|+..|+.  .||+||+|+|.+|++||.+++...   ...+||||+  +...+
T Consensus         1 ~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~WIGl~--~~~~~   76 (135)
T 1jzn_A            1 NNCPLDWL--PMNGLCYKIFNQLKTWEDAEMFCRKYKPGCHLASFHRYGESLEIAEYISDYHKGQENVWIGLR--DKKKD   76 (135)
T ss_dssp             CCSCTTSE--EETTEEEEEEEEEECHHHHHHHHHHHSSSEEECCCCSHHHHHHHHHHHHHHCCSSCCEEEEEE--CTTSS
T ss_pred             CcCCCCce--eeCCEEEEEECCccCHHHHHHHHhccCCCCEECccCCHHHHHHHHHHHHhcccCCCCEEEeeE--cCCcC
Confidence            47999999  7999999999999999999999999  699999999999999999887532   357999999  66667


Q ss_pred             CceEEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCC--CcccccccCCCCCcccccc
Q 010309           82 LSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMVE  147 (513)
Q Consensus        82 ~~w~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~--~~w~d~~C~~~~~~iC~~~  147 (513)
                      +.|+|+||+++.|++|.+++|.+          ..+.++|+.+....  +.|++..|....+|||+.+
T Consensus        77 ~~~~W~dg~~~~~~~W~~~~P~~----------~~~~~~C~~~~~~~~~~~w~~~~C~~~~~~ICe~~  134 (135)
T 1jzn_A           77 FSWEWTDRSCTDYLTWDKNQPDH----------YQNKEFCVELVSLTGYRLWNDQVCESKDAFLCQCK  134 (135)
T ss_dssp             SCCEETTCCCCCCCCBCTTCCCC----------GGGCCCEEEECGGGTTCSEEEECTTSCEEEEEEEC
T ss_pred             CceEECCCCccCcCcCCcCCCCC----------CCCCCCceEEECCCCCCcCCCcCCCCCCceeeeec
Confidence            99999999999999999998832          12467899986543  4799999999999999974

>3bdw_B NKG2-A/NKG2-B type II integral membrane protein; NK cells, receptor, glycoprotein, lectin, signal-A transmembrane, immune system receptor; 2.50A {Homo sapiens} PDB: 3cdg_K 3cii_H

Probab=99.94  E-value=2.9e-27  Score=197.75  Aligned_cols=118  Identities=20%  Similarity=0.385  Sum_probs=101.9

Q ss_pred             CCcCCCCCCCcccCCCCeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCc
Q 010309            4 DWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLS   83 (513)
Q Consensus         4 ~~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~   83 (513)
                      ..|++||+||.  .|+++||+++.+.++|.+|+..|+.+||+||+|+|.+|++||.++.    ..+||||+  +...++.
T Consensus         2 ~~c~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~----~~~WIGl~--~~~~~~~   73 (120)
T 3bdw_B            2 RHCGHCPEEWI--TYSNSCYYIGKERRTWEESLLACTSKNSSLLSIDNEEEMKFLSIIS----PSSWIGVF--RNSSHHP   73 (120)
T ss_dssp             CCCTTSCTTCE--ESSSSEEEEEEEEECHHHHHHHHHHTTSEECCCCCHHHHHHHHHHC----SEEEEEEE--CSSTTSC
T ss_pred             CcCCCCCCCce--EECCEEEEEECCccCHHHHHHHHHhCCCEEceeCCHHHHHHHHHcC----CCEeEEEE--ecCCCCc
Confidence            46899999999  7999999999999999999999999999999999999999999975    37999999  6666799


Q ss_pred             eEEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCccccc
Q 010309           84 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMV  146 (513)
Q Consensus        84 w~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~  146 (513)
                      |+|+||+++.|.+|   +|++            +.++|+.+...  .|++..|....+|||+.
T Consensus        74 w~W~dg~~~~~~~~---~p~~------------~~~~C~~~~~~--~w~~~~C~~~~~fICe~  119 (120)
T 3bdw_B           74 WVTMNGLAFKHEIK---DSDN------------AELNCAVLQVN--RLKSAQCGSSIIYHCKH  119 (120)
T ss_dssp             CEETTSSBCCSCCC-------------------CCCCEEEEESS--SEEEECTTSCEEEEEEC
T ss_pred             eEeCCCCccCccCc---CCCC------------CCCCccEEeCC--ceECCCCCCCcceeeee
Confidence            99999999877653   4411            34679998765  59999999999999986

>2bpd_A Dectin-1; receptor, beta-glucan, fungal recognition, C-type lectin-like domain, CTLD, carbohydrate; 1.5A {Mus musculus} PDB: 2bph_A 2bpe_A 2cl8_A*

Probab=99.94  E-value=2.2e-27  Score=204.62  Aligned_cols=127  Identities=22%  Similarity=0.484  Sum_probs=109.0

Q ss_pred             cCCCCCCCcccCCCCeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCC-CCCeEEeeeecCCCCCCce
Q 010309            6 KAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN-VNGCWVGGRSINTTVGLSW   84 (513)
Q Consensus         6 ~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~-~~~~WiGl~~~~~~~~~~w   84 (513)
                      ...||.||.  .|+++||+++.+.++|.+|+..|+.+||+||+|+|.+|++||.+++... ...+||||+  +...++.|
T Consensus        14 ~~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~WIGl~--~~~~~~~w   89 (142)
T 2bpd_A           14 SQSCLPNWI--MHGKSCYLFSFSGNSWYGSKRHCSQLGAHLLKIDNSKEFEFIESQTSSHRINAFWIGLS--RNQSEGPW   89 (142)
T ss_dssp             -CCCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHGGGTTSEEEEEEE--CSSTTSCC
T ss_pred             CCCCCccce--ecCCEEEEEECCCCCHHHHHHHHHHcCCEEeeeCCHHHHHHHHHHHhccCCCCEEEEee--cCCCCCCe
Confidence            568999999  7999999999999999999999999999999999999999999998643 457999999  66667999


Q ss_pred             EEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCcccccc
Q 010309           85 KWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE  147 (513)
Q Consensus        85 ~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~~  147 (513)
                      +|+||+++.|++|..+.+++         +..+.++|+.+..  +.|++..|....+|||+.+
T Consensus        90 ~W~dg~~~~~~~w~~~~~~~---------~~~~~~~Cv~~~~--~~W~d~~C~~~~~fICe~~  141 (142)
T 2bpd_A           90 FWEDGSAFFPNSFQVRNAVP---------QESLLHNCVWIHG--SEVYNQICNTSSYSICEKE  141 (142)
T ss_dssp             EETTSCBCCSSSCCEECCCC---------SCCSCCCEEEEET--TEEEEECTTSCEEEEEEEC
T ss_pred             EeCCCCccccccccccCCCC---------CCCCCCCCcEEcC--CeEECcCCCCCceeeeeee
Confidence            99999999999988763211         1235678999864  4899999999999999975

>3c22_A C-type lectin domain family 4 member K; coiled coil, glycoprotein, membrane, signal-anchor, transmembrane, immune system, sugar binding protein; 1.50A {Homo sapiens} PDB: 3p5g_A* 3p5d_A* 3p5f_A* 3p5e_A* 3p5h_A* 3p5i_A* 3p7g_A* 3p7f_A* 3p7h_A* 3bc7_A* 3bbs_A* 3bc6_A*

Probab=99.94  E-value=3.2e-27  Score=207.15  Aligned_cols=131  Identities=19%  Similarity=0.306  Sum_probs=109.0

Q ss_pred             CCcCCCCCCCcccCCCCeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCc
Q 010309            4 DWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLS   83 (513)
Q Consensus         4 ~~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~   83 (513)
                      ..+..||.||.  .|+++||+++...++|.+|+..|+.+||+||+|+|.+|++||.+++.  ...+||||+  +...++.
T Consensus        18 ~~~~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~--~~~~WIGl~--~~~~~~~   91 (156)
T 3c22_A           18 DILQVVSQGWK--YFKGNFYYFSLIPKTWYSAEQFCVSRNSHLTSVTSESEQEFLYKTAG--GLIYWIGLT--KAGMEGD   91 (156)
T ss_dssp             ------CCCCE--EETTEEEEECSSCBCHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHT--TCCEEEEEE--EETTTTE
T ss_pred             hhhccCCCCCE--EcCCEEEEEECCCCCHHHHHHHHHhCCCEEeecCCHHHHHHHHHhhc--CCcEEEeee--ccCCCCc
Confidence            34678999999  79999999999999999999999999999999999999999999986  468999999  4445799


Q ss_pred             eEEcCCCCCcc----CCcccCCCCCCCCCCCCCCCCcCCCceeEeecCC-CcccccccCCCCCccccccccC
Q 010309           84 WKWSDNMSKWN----ESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS-RSLVTERCNTSHPFICMVEHEN  150 (513)
Q Consensus        84 w~W~dg~~~~~----~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~-~~w~d~~C~~~~~~iC~~~~~~  150 (513)
                      |+|+||+++.+    .+|.+++|.+          ..+.++|+.+.... +.|++..|....+|||+.+..+
T Consensus        92 w~W~dG~~~~~~~~~~~W~~geP~~----------~~~~~~Cv~~~~~~~~~W~d~~C~~~~~fICe~~~~~  153 (156)
T 3c22_A           92 WSWVDDTPFNKVQSARFWIPGEPNN----------AGNNEHCGNIKAPSLQAWNDAPCDKTFLFICKRPYVP  153 (156)
T ss_dssp             EEETTCCCCCHHHHGGGBCTTCCCC----------GGGCCCEEEECSSSSSCEEEECTTSCBEEEEEEECCC
T ss_pred             eEeCCCCccccccccCcCCCCCCCC----------CCCCCCceEECCCCCCcEECCCCCCCeeEEEeeCCcC
Confidence            99999999875    7899988832          12567899986543 6799999999999999987543

>1jwi_B Platelet aggregation inducer; domain swapping, C-type lectin, toxin; 2.00A {Bitis arietans} SCOP: d.169.1.1 PDB: 1uex_B

Probab=99.94  E-value=1.2e-27  Score=201.61  Aligned_cols=119  Identities=24%  Similarity=0.489  Sum_probs=105.5

Q ss_pred             CCCCCCCcccCCCCeeEEEECCCCChHHHHHHHh--hcCCEEeeeCCHHHHHHHHHHhCCC--CCCeEEeeeecCCCCCC
Q 010309            7 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCK--EIGGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGL   82 (513)
Q Consensus         7 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~--~~~~~L~~i~~~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~   82 (513)
                      +.||+||.  .|+++||+++.+.++|.+|+..|+  ..||+||+|+|.+|++||.+++...  ...+||||+  +...++
T Consensus         2 ~~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~WiGl~--~~~~~~   77 (125)
T 1jwi_B            2 EGCLPDWS--SYKGHCYKVFKVEKTWADAEKFCKELVNGGHLMSVNSREEGEFISKLALEKMRIVLVWIGLS--HFWRIC   77 (125)
T ss_dssp             -CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCSHHHHHHHHHHHHHTTCCCEEEEEEE--ECGGGS
T ss_pred             CCCCCCCE--ecCCEEEEEECCCcCHHHHHHHhhccCCCceECccCCHHHHHHHHHHHHhcCCCCCEEEeee--cCCCCC
Confidence            57999999  799999999999999999999999  8999999999999999999988542  467999999  555579


Q ss_pred             ceEEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCcccccc
Q 010309           83 SWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE  147 (513)
Q Consensus        83 ~w~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~~  147 (513)
                      .|+|+||+++.|++|.+++|                  |+.+...++.|++..|....+|||+.+
T Consensus        78 ~~~W~dg~~~~~~~W~~g~p------------------C~~~~~~~~~W~~~~C~~~~~~iCe~~  124 (125)
T 1jwi_B           78 PLRWTDGARLDYRALSDEPI------------------CFVAESFHNKWIQWTCNRKKSFVCKYR  124 (125)
T ss_dssp             CEEETTCCCCCSCCSCCSCE------------------EEEEETTTCCEEEEETTSCEEEEEEEE
T ss_pred             ceEeeCcCcCccCCcCCCCC------------------eEEEECCCCeEecCCCCCCCcEEEeEe
Confidence            99999999999999987765                  677766557899999999999999975

>1fvu_B Botrocetin beta chain; VON WILLBRAND factor modulator, C-type lectin, metal- binding, loop exchanged dimer, toxin; 1.80A {Bothrops jararaca} SCOP: d.169.1.1 PDB: 1ijk_C 1u0n_C 1u0o_B

Probab=99.94  E-value=2.3e-27  Score=199.96  Aligned_cols=120  Identities=23%  Similarity=0.576  Sum_probs=104.5

Q ss_pred             CCCCCCcccCCCCeeEEEECCCCChHHHHHHHhh--cCCEEeeeCCHHHHHHHHHHhCCC--CCCeEEeeeecCCCCCCc
Q 010309            8 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGLS   83 (513)
Q Consensus         8 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~~   83 (513)
                      +||+||.  .|+++||+++.+.++|.+|+..|+.  .||+||+|+|.+|++||.+++...  ...+||||+  +...++.
T Consensus         1 ~Cp~gw~--~~~~~Cy~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~WIGl~--~~~~~~~   76 (125)
T 1fvu_B            1 DCPPDWS--SYEGHCYRFFKEWMHWDDAEEFCTEQQTGAHLVSFQSKEEADFVRSLTSEMLKGDVVWIGLS--DVWNKCR   76 (125)
T ss_dssp             CCSTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCSSHHHHHHHHTTCTTSCTTCCEECSCC--CCSTTSC
T ss_pred             CcCCccE--EcCCEEEEEeCCCCCHHHHHHHHhccCCCcEECccCCHHHHHHHHHHHHhcCCCCCEEEeee--ecCCCCc
Confidence            5999999  7999999999999999999999999  899999999999999999988654  368999999  6656799


Q ss_pred             eEEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCcccccc
Q 010309           84 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE  147 (513)
Q Consensus        84 w~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~~  147 (513)
                      |+|+||+++.|++|.+++|.                +|+.+....+.|++..|....+|||+.+
T Consensus        77 ~~W~dg~~~~~~~w~~~~P~----------------~C~~~~~~~g~w~~~~C~~~~~~iCe~~  124 (125)
T 1fvu_B           77 FEWTDGMEFDYDDYYLIAEY----------------ECVASKPTNNKWWIIPCTRFKNFVCEFQ  124 (125)
T ss_dssp             EEETTSCCCCC----CCSCC----------------EEEEEETTTTEEEEEETTSCEEEEEEEC
T ss_pred             eEecCCCccCccccCCCCCC----------------CceEEECCCCcEeCCcCCCCCcEEEeec
Confidence            99999999999999988872                5888877666899999999999999975

>2h2t_B Low affinity immunoglobulin epsilon FC receptor ( IGE receptor) (FC-epsilon-RII)...; C-type lectin, calcium-bound, lectin domain; 1.30A {Homo sapiens} PDB: 2h2r_A 1t8c_A 1t8d_A

Probab=99.94  E-value=2.4e-27  Score=211.79  Aligned_cols=129  Identities=19%  Similarity=0.397  Sum_probs=109.7

Q ss_pred             CCcCCCCCCCcccCCCCeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCc
Q 010309            4 DWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLS   83 (513)
Q Consensus         4 ~~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~   83 (513)
                      ..+..||.||.  .|+++||+|+.+.++|.+|+..|+.+||+||+|+|.+|++||.+++.  ...+||||+  +...++.
T Consensus        12 ~~~~~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~fl~~~~~--~~~~WIGl~--~~~~~~~   85 (175)
T 2h2t_B           12 FVCNTCPEKWI--NFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKRAS--HTGSWIGLR--NLDLKGE   85 (175)
T ss_dssp             --CCBCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHTTCEECCCCSHHHHHHHHTTCC--TTCEEEEEE--EETTTTE
T ss_pred             ccCCCCCcccE--EeCCEEEEEeCCccCHHHHHHHHhhcCCEEeecCCHHHHHHHHHHhc--CCcEEecce--ecCCCCC
Confidence            45789999999  79999999999999999999999999999999999999999999886  467999999  4445799


Q ss_pred             eEEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCC-Ccccccccc
Q 010309           84 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSH-PFICMVEHE  149 (513)
Q Consensus        84 w~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~-~~iC~~~~~  149 (513)
                      |+|+||+++.|.+|..++|.+          ..+.++|+.+.. .+.|++..|.... .|||+.+..
T Consensus        86 w~W~dG~~~~y~~W~~geP~~----------~~~~~~Cv~~~~-~g~W~d~~C~~~~~~fICe~~~~  141 (175)
T 2h2t_B           86 FIWVDGSHVDYSNWAPGEPTS----------RSQSEDCVMMRG-SGRWNDAFCDRKLGAWVCDRLAT  141 (175)
T ss_dssp             EEETTSCCCSSCCBCTTCCCC---------------CEEEECT-TSCEEEECTTCCEEEEEEEEECB
T ss_pred             eEeCCCCcccCcCcCCCCCCC----------CCCCCCceEEcC-CCcEEECCCCCcCcceEEeECCc
Confidence            999999999999999998832          135678999864 4689999999999 999998654

>1tn3_A Tetranectin; plasminogen binding, kringle 4, C-type lectin, carbohydrate recognition domain; 2.00A {Homo sapiens} SCOP: d.169.1.1 PDB: 1rjh_A 3l9j_C

Probab=99.94  E-value=8.4e-28  Score=206.09  Aligned_cols=126  Identities=16%  Similarity=0.311  Sum_probs=109.2

Q ss_pred             cCCCCCCCcccCCCCeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCC---CCCeEEeeeecCCCCCC
Q 010309            6 KAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN---VNGCWVGGRSINTTVGL   82 (513)
Q Consensus         6 ~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~---~~~~WiGl~~~~~~~~~   82 (513)
                      ...||+||.   ++++||+++.+.++|.+|+..|+.+||+||+|+|.+|++||.+++...   ...+||||+  +...++
T Consensus         3 ~~~Cp~gw~---~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~WIGl~--~~~~~~   77 (137)
T 1tn3_A            3 QTVCLKGTK---VHMKCFLAFTQTKTFHEASEDCISRGGTLSTPQTGSENDALYEYLRQSVGNEAEIWLGLN--DMAAEG   77 (137)
T ss_dssp             CCEEEECSS---SSEEEEEEEEEEECHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHHHHTCTTCEEEEEEE--EEEETT
T ss_pred             CCCCCCCeE---ECCEEEEEeCCCCCHHHHHHHHHhcCCEEcccCCHHHHHHHHHHHHhhcCCCCCEEEeeE--ccCCCc
Confidence            468999997   789999999999999999999999999999999999999999887532   457999999  444579


Q ss_pred             ceEEcCCCCCccCCcc---cCCCCCCCCCCCCCCCCcCCCceeEeec-CCCcccccccCCCCCcccccc
Q 010309           83 SWKWSDNMSKWNESIH---AVGSFNSSCTSLPCHVHATVDLCTLVSN-GSRSLVTERCNTSHPFICMVE  147 (513)
Q Consensus        83 ~w~W~dg~~~~~~~~~---~~~~~~~~~~~~~c~~~~~~~~C~~~~~-~~~~w~d~~C~~~~~~iC~~~  147 (513)
                      .|+|+||+++.|++|.   +++|.           +.+.++|+.+.. ..+.|++..|....+|||+.+
T Consensus        78 ~w~W~dg~~~~~~~W~~~~~g~P~-----------~~~~~~Cv~~~~~~~~~W~d~~C~~~~~fiCe~~  135 (137)
T 1tn3_A           78 TWVDMTGARIAYKNWETEITAQPD-----------GGKTENCAVLSGAANGKWFDKRCRDQLPYICQFG  135 (137)
T ss_dssp             EEEETTSCBCSCCCBCCTTTCSSC-----------CGGGCCEEEEETTTTTEEEEECTTSCEEEEEEEE
T ss_pred             eEEeCCcCCCcccccCcCCCCcCC-----------CCCccCCcEEccCCCCeEeCcCCCCCccceEeEe
Confidence            9999999999999999   88872           234678999864 356799999999999999985

>2zib_A Type II antifreeze protein; thermal hysteresis, lectin; 1.34A {Brachyopsis rostratus}

Probab=99.94  E-value=6.7e-27  Score=199.16  Aligned_cols=124  Identities=25%  Similarity=0.515  Sum_probs=109.8

Q ss_pred             CCCCCCCcccCCCCeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEE
Q 010309            7 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKW   86 (513)
Q Consensus         7 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W   86 (513)
                      .++|.+|.  .|+++||+++...++|.+|+..|+.+||+||+|+|.+|++||.+++.   ..+||||+  +...++.|+|
T Consensus         8 ~~~~~~~~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~---~~~WIGl~--~~~~~~~w~W   80 (133)
T 2zib_A            8 LVCPAGWT--LHGQRCFYSEATAMTWDLAEANCVNKGGHLASIHSLEEQLYIKDIVA---GIVWIGGS--ACKVAGAWSW   80 (133)
T ss_dssp             CCCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHTTSEECCCCSHHHHHHHHHHCS---SCEEEEEE--CCSSTTCCEE
T ss_pred             eeCCCCEE--EeCCEEEEEECCccCHHHHHHHHHHCCCEECccCCHHHHHHHHHhhc---cCEEEccE--ecCCCCceEE
Confidence            46889999  89999999999999999999999999999999999999999999986   67999999  6656799999


Q ss_pred             cCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCCC-cccccccCCCCCccccccc
Q 010309           87 SDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSR-SLVTERCNTSHPFICMVEH  148 (513)
Q Consensus        87 ~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~-~w~d~~C~~~~~~iC~~~~  148 (513)
                      +||+++.|++|.+++|.+           .+.++|+.+...++ .|++..|....+|||+.++
T Consensus        81 ~dG~~~~y~~W~~g~P~~-----------~~~~~Cv~~~~~~~~~W~d~~C~~~~~fICe~~~  132 (133)
T 2zib_A           81 TDGTPVDYRTWCPTKPND-----------ILSDCCMQMTAAVDKCWDDLPCPASHASICAKAA  132 (133)
T ss_dssp             TTCCCCCCCCBCTTCCCC-----------CTTSCEEEECSSTTCCEEEECTTCCEEEEEEEEC
T ss_pred             CCCCCcccCCcCCCCCCC-----------CCCCCceEEecCCCCcEeCCCCCCCeeEEEeEcC
Confidence            999999999999998832           12268999876654 5999999999999999864

>1oz7_B Echicetin B-chain; platelet aggregation, dimer, toxin; 2.40A {Echis carinatus} SCOP: d.169.1.1

Probab=99.94  E-value=2.8e-27  Score=198.78  Aligned_cols=118  Identities=20%  Similarity=0.473  Sum_probs=105.9

Q ss_pred             CCCCCCcccCCCCeeEEEECCCCChHHHHHHHhh--cCCEEeeeCCHHHHHHHHHHhCCC--CCCeEEeeeecCCCCCCc
Q 010309            8 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGLS   83 (513)
Q Consensus         8 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~~   83 (513)
                      +||+||.  .|+++||+++.+.++|.+|+..|+.  .||+||+|+|.+|++||.+++...  ...+||||+  +...++.
T Consensus         1 ~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~WIGl~--~~~~~~~   76 (123)
T 1oz7_B            1 NCLPDWS--VYEGYCYKVFKERMNWADAEKFCTKQHKDGHLVSFRNSKEVDFVISLAFPMLKNDLVWIGLT--DYWRDCN   76 (123)
T ss_dssp             CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCCSSHHHHHHHTSSTTTTCSEEEEEEE--CCCCGGG
T ss_pred             CCCCCcE--EcCCEEEEEECCccCHHHHHHHHhccCCCcEECCcCCHHHHHHHHHHHHhcCCCCCEEEeee--eCCCCCC
Confidence            5999999  7999999999999999999999999  899999999999999999998754  367999999  6656799


Q ss_pred             eEEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCcccccc
Q 010309           84 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE  147 (513)
Q Consensus        84 w~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~~  147 (513)
                      |+|+||+++.|++|. ++|                 +|+.+....+.|++..|....+|||+.+
T Consensus        77 ~~W~dg~~~~~~~W~-g~P-----------------~C~~~~~~~g~w~~~~C~~~~~~ICe~~  122 (123)
T 1oz7_B           77 WEWSDGAQLDYKAWD-NER-----------------HCFIYKNTDNQWTRRDCTWTFSFVCKCP  122 (123)
T ss_dssp             EEETTCCCCCSCCBC-SST-----------------TEEEEEGGGTEEEEECTTSCEEEEEEEE
T ss_pred             EEEcCCCcccccCCC-CCC-----------------CeEEEECCCCcEeCCCCCCCeeEEEeEe
Confidence            999999999999998 776                 4778866556899999999999999975

>1umr_C Convulxin beta, CVX beta; lectin, C-type lectin, platelet, sugar-binding protein, activator, snake venom; 2.40A {Crotalus durissus terrificus} SCOP: d.169.1.1 PDB: 1uos_B

Probab=99.94  E-value=3.7e-27  Score=198.67  Aligned_cols=119  Identities=23%  Similarity=0.529  Sum_probs=106.6

Q ss_pred             CCCCCCCcccCCCCeeEEEECCCCChHHHHHHHhh--cCCEEeeeCCHHHHHHHHHHhCCC--CCCeEEeeeecCCCCCC
Q 010309            7 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGL   82 (513)
Q Consensus         7 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~   82 (513)
                      ..||+||.  .|+++||+++.+.++|.+|+..|+.  .||+||+|+|.+|++||.+++...  ...+||||+  +...++
T Consensus         2 ~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~WIGl~--~~~~~~   77 (125)
T 1umr_C            2 FCCPSHWS--SYDRYCYKVFKQEMTWADAEKFCTQQHTGSHLVSFHSTEEVDFVVKMTHQSLKSTFFWIGAN--NIWNKC   77 (125)
T ss_dssp             CCCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCSSHHHHHHHHHHHHTTCSSSEEECSCC--CTTTSS
T ss_pred             CCCCCCCE--EcCCEeEEEECCCcCHHHHHHHHhccCCcceECccCCHHHHHHHHHHHHhcCCCCCEEEeeE--eCCCCC
Confidence            47999999  7999999999999999999999999  899999999999999999988643  367999999  665679


Q ss_pred             ceEEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCcccccc
Q 010309           83 SWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE  147 (513)
Q Consensus        83 ~w~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~~  147 (513)
                      .|+|+||+++.|++|. ++|                 +|+.+....+.|++.+|....+|||+.+
T Consensus        78 ~~~W~dg~~~~~~~W~-g~P-----------------~C~~~~~~~g~w~~~~C~~~~~fICe~~  124 (125)
T 1umr_C           78 NWQWSDGTKPEYKEWH-EEF-----------------ECLISRTFDNQWLSAPCSDTYSFVCKFE  124 (125)
T ss_dssp             CEEETTSCCCSSCCBC-CCC-----------------EEEEEESSCSCEEEEETTSCEEEEEEEE
T ss_pred             eeEeCCcCccCcccCC-CCC-----------------CcEEEECCCCcEeCCCCCCCcceEEeec
Confidence            9999999999999998 766                 4778876556899999999999999975

>2yhf_A C-type lectin domain family 5 member A; immune system; 1.90A {Homo sapiens}

Probab=99.94  E-value=4.9e-27  Score=195.76  Aligned_cols=117  Identities=22%  Similarity=0.418  Sum_probs=101.1

Q ss_pred             CCCCCCcccCCCCeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEc
Q 010309            8 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWS   87 (513)
Q Consensus         8 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~   87 (513)
                      +||+||.  .|+++||+++.+.++|.+|+..|+.+||+||+|+|.+|++||.+++.  ...+||||+  +...++.|+|+
T Consensus         1 ~Cp~gw~--~~~~~Cy~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~--~~~~WIGl~--~~~~~~~w~W~   74 (118)
T 2yhf_A            1 MCPKDWE--FYQARCFFLSTSESSWNESRDFCKGKGSTLAIVNTPEKLKFLQDITD--AEKYFIGLI--YHREEKRWRWI   74 (118)
T ss_dssp             CCCTTCE--EETTEEEEECSSCBCHHHHHHHHHTTTCEECCCCSHHHHHHHHHHHC--SSCEEEEEE--EETTTTEEEET
T ss_pred             CCCCCcE--EeCCEEEEEeCCCCCHHHHHHHHhhcCCEEEEeCCHHHHHHHHHhhC--CCcEEEecc--ccCCCCcEEEe
Confidence            5999999  79999999999999999999999999999999999999999999986  468999999  54567999999


Q ss_pred             CCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCcccccc
Q 010309           88 DNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE  147 (513)
Q Consensus        88 dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~~  147 (513)
                      ||+++  .+|.+++|              +.++|+.+... +.|++..|....+|||+.+
T Consensus        75 dg~~~--~~~~~~~~--------------~~~~C~~~~~~-~~w~~~~C~~~~~fICe~~  117 (118)
T 2yhf_A           75 NNSVF--NGNVTNQN--------------QNFNCATIGLT-KTFDAASCDISYRRICEKN  117 (118)
T ss_dssp             TTEEC--CSCEESCC--------------TTCCEEEESSS-SSEEEECTTSCBEEEEEEE
T ss_pred             CCCcC--CCCccCCC--------------CCCCeeEEcCC-CcCccccCCCCceeeeccc
Confidence            99884  35554443              23578888653 5799999999999999975

>1mpu_A NKG2-D type II integral membrane protein; C-type lectin-like domain, immune system; 2.50A {Homo sapiens} SCOP: d.169.1.1 PDB: 1hyr_B

Probab=99.94  E-value=9.2e-28  Score=205.99  Aligned_cols=120  Identities=23%  Similarity=0.516  Sum_probs=106.3

Q ss_pred             CcCCCCCCCcccCCCCeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCce
Q 010309            5 WKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSW   84 (513)
Q Consensus         5 ~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w   84 (513)
                      .|+.||.||.  .|+++||+++.+.++|.+|+..|+.+||+||+|+|.+|++||..+.    ..+||||+  +...++.|
T Consensus        17 ~~~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~fl~~~~----~~~WIGl~--~~~~~~~w   88 (138)
T 1mpu_A           17 YCGPCPKNWI--CYKNNCYQFFDESKNWYESQASCMSQNASLLKVYSKEDQDLLKLVK----SYHWMGLV--HIPTNGSW   88 (138)
T ss_dssp             CCCCCCTTCE--ECSSCEEEEEEEEECHHHHHHHHHHTSCEECCCCCTTTCGGGGGCC----SEEEEEEE--ECTTTCCE
T ss_pred             ccCCCChhhe--EeCCEEEEEECCCCCHHHHHHHHHhcCCEEeeeCCHHHHHHHHhcc----CCEeEeee--ccCCCCce
Confidence            4678999999  7999999999999999999999999999999999999999998643    47999999  55567999


Q ss_pred             EEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCcccccc
Q 010309           85 KWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE  147 (513)
Q Consensus        85 ~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~~  147 (513)
                      +|+||+++.|.+|.+++|.              +++|+.+... +.|++..|....+|||+.+
T Consensus        89 ~W~dG~~~~~~~w~~~~p~--------------~~~C~~~~~~-~~w~~~~C~~~~~fICe~~  136 (138)
T 1mpu_A           89 QWEDGSILSPNLLTIIEMQ--------------KGDCALYASS-FKGYIENCSTPNTYICMQR  136 (138)
T ss_dssp             EETTSCBCCTTSCEEECSS--------------CCSEEEEETT-TEEEEECTTSCEEEEEEEC
T ss_pred             EeCCCCcCCccccccCCCC--------------CCCCeEEECC-CcEEccCCCCCCeEcccCc
Confidence            9999999999999988872              2468888654 5799999999999999975

>3gpr_C Rhodocetin subunit gamma; disulfide bond, lectin, secreted, toxin, cell adhesion; 3.20A {Calloselasma rhodostoma}

Probab=99.94  E-value=2e-27  Score=202.99  Aligned_cols=122  Identities=24%  Similarity=0.490  Sum_probs=106.5

Q ss_pred             CCCCCCCcccCCCCeeEEEECCCCChHHHHHHHhhc--CCEEeeeCCHHHHHHHHHHhCCC----CCCeEEeeeecCCCC
Q 010309            7 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKN----VNGCWVGGRSINTTV   80 (513)
Q Consensus         7 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~--~~~L~~i~~~~e~~f~~~~~~~~----~~~~WiGl~~~~~~~   80 (513)
                      ..||+||+  .|+++||+++.+.++|.+|+..|+.+  ||+||+|+|.+|++||.+++...    ...+||||+  +...
T Consensus         1 ~~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~~~G~~La~i~s~~e~~~l~~~~~~~~~~~~~~~WIGl~--~~~~   76 (134)
T 3gpr_C            1 FNCLPGWS--AYDQHCYQAFNEPKTWDEAERFCTEQAKRGHLVSIGSDGEADFVAQLVTNNIKRPELYVWIGLR--DRRK   76 (134)
T ss_dssp             CCCCTTCE--ESSSCEEEECSCCBCSHHHHHHHTTSSSCCEECCCCCHHHHHHHHHHHHHHHCSSCCBCCCSCB--CCSS
T ss_pred             CcCCCcce--eeCCEEEEEeCCCcCHHHHHHHHHhhCCCceEeeeCCHHHHHHHHHHHHhhccCCCCcEEEeeE--ecCC
Confidence            47999999  89999999999999999999999998  89999999999999999887532    167999999  6566


Q ss_pred             CCc-e-EEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCCC--cccccccCCCCCccccccc
Q 010309           81 GLS-W-KWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSR--SLVTERCNTSHPFICMVEH  148 (513)
Q Consensus        81 ~~~-w-~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~--~w~d~~C~~~~~~iC~~~~  148 (513)
                      ++. | +|+||+++.|++|.+++|                ++|+.+....+  .|++..|....+|||+.++
T Consensus        77 ~~~~w~~W~dG~~~~~~~W~~~~~----------------~~Cv~~~~~~~~~~W~~~~C~~~~~fICe~~~  132 (134)
T 3gpr_C           77 EQQCSSEWSMSASIIYVNWNTGES----------------QMCQGLARWTGFRKWDYSDCQAKNPFVCKFSS  132 (134)
T ss_dssp             TTSCSCEETTCCCSCCBCBSSCEE----------------CCEECCBCSSSSCBBCEECTTCCBCCEEEECC
T ss_pred             CCCcCCEeCCcCcccccccCCCCC----------------CcceEEeccCCCCcCcCCCCCCCCcEEeCcCC
Confidence            799 9 999999999999987664                35777765443  7999999999999999864

>3alu_A Lectin CEL-IV, C-type; C-type lectin, raffinose, sugar binding protein; HET: RAF; 1.65A {Cucumaria echinata} PDB: 3als_A* 3alt_A*

Probab=99.94  E-value=1.3e-27  Score=209.81  Aligned_cols=130  Identities=21%  Similarity=0.342  Sum_probs=112.4

Q ss_pred             cCCCCCCCcccCCCCeeEEEECCCCChHHHHHHHhh--c---------CCEEeeeCCHHHHHHHHHHhCCC-------C-
Q 010309            6 KAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--I---------GGHLAALTSYEEEHSAQKLCGKN-------V-   66 (513)
Q Consensus         6 ~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~---------~~~L~~i~~~~e~~f~~~~~~~~-------~-   66 (513)
                      .+.||+||.  .|+++||+++.+.++|.+|+..|+.  .         ||+||+|+|.+|++||.+++...       . 
T Consensus         2 ~~~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~~~~~~~~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~~~   79 (157)
T 3alu_A            2 LTSCPPLWT--GFNGKCFRLFHNHLNFDNAENACRQFGLASCSGDELATGHLASIHSAESQAFLTELVKTSLPDLITGGW   79 (157)
T ss_dssp             CCEECTTCE--EETTEEEEEEEEEECHHHHHHHHTTEEEEETTSCEEEECEECCCCSHHHHHHHHHHHHHHCGGGCCSSS
T ss_pred             CCCCCCCcE--eeCCEEEEEECCccCHHHHHHHhhccccccccCCCCCCeEEcccCCHHHHHHHHHHHHhcccccccccC
Confidence            468999999  7999999999999999999999999  8         99999999999999999887532       1 


Q ss_pred             -CCeEEeeeecCCCCCCceEEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCC-CcccccccCCCCCccc
Q 010309           67 -NGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS-RSLVTERCNTSHPFIC  144 (513)
Q Consensus        67 -~~~WiGl~~~~~~~~~~w~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~-~~w~d~~C~~~~~~iC  144 (513)
                       ..+||||+  +...++.|+|+||+++.|++|.+++|.+          ..+.++|+.+.... +.|++..|....+|||
T Consensus        80 ~~~~WIGl~--~~~~~~~w~W~dG~~~~y~~W~~g~P~~----------~~~~~~Cv~~~~~~~~~W~d~~C~~~~~fIC  147 (157)
T 3alu_A           80 APQVYIGMK--VGSTNSDQTWTDGSSVDYDGWVSGEPNN----------GPNSRGAIAAGDYSRGFWADVYSNNNFKYIC  147 (157)
T ss_dssp             CSEEEEEEE--ECSSTTCEEETTCCCCCCCCBCTTCCCS----------CSSEEEEEECSTTTTTCEEEECTTCCEEEEE
T ss_pred             CCCEEEeee--eCCCCCCeEeCCCCCCCccCcCCCCCCC----------CCCCCCeEEEecCCCCeEcCCCCCCccceEe
Confidence             57999999  5556799999999999999999999832          12467899986543 6899999999999999


Q ss_pred             ccccc
Q 010309          145 MVEHE  149 (513)
Q Consensus       145 ~~~~~  149 (513)
                      +.+..
T Consensus       148 e~~~~  152 (157)
T 3alu_A          148 QLPCV  152 (157)
T ss_dssp             ECCCE
T ss_pred             ccccc
Confidence            98653

>2xr6_A CD209 antigen; sugar binding protein, carbohydrate binding, mannose; HET: MAN 07B; 1.35A {Homo sapiens} PDB: 1sl4_A* 2it6_A* 1k9i_A* 2xr5_A* 1sl5_A* 2it5_A* 1xph_A 1k9j_A*

Probab=99.94  E-value=2.5e-27  Score=210.73  Aligned_cols=132  Identities=22%  Similarity=0.443  Sum_probs=109.4

Q ss_pred             CCcCCCCCCCcccCCCCeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCc
Q 010309            4 DWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLS   83 (513)
Q Consensus         4 ~~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~   83 (513)
                      ..|..||.||.  .|+++||+++...++|.+|+..|+.+||+||+|+|.+|++||..++......+||||+  +...++.
T Consensus        17 ~~~~~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~fl~~~~~~~~~~~WIGl~--~~~~~~~   92 (170)
T 2xr6_A           17 RLSHPCPWEWT--FFQGNCYFMSNSQRNWHDSITACKEVGAQLVVIKSAEEQNFLQLQSSRSNRFTWMGLS--DLNQEGT   92 (170)
T ss_dssp             ----CCCTTCE--EETTEEEEECSSCBCHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHHHHTCCEEEEEE--EEEETTE
T ss_pred             cccCCCCcCcE--EeCCEEEEEECCcCCHHHHHHHHHhCCCEEeeeCCHHHHHHHHHHhccCCCCEEeccc--cCCCCCe
Confidence            34789999999  7999999999999999999999999999999999999999999765323568999999  4445699


Q ss_pred             eEEcCCCCCc---cCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCccccccccCccc
Q 010309           84 WKWSDNMSKW---NESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEHENKCY  153 (513)
Q Consensus        84 w~W~dg~~~~---~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~~~~~~c~  153 (513)
                      |+|+||+++.   |.+|.+++|.           +.+.++|+.+...  +|++..|....+|||+.+.. .|.
T Consensus        93 w~W~dG~~~~~~~~~~W~~geP~-----------~~~~~~Cv~~~~~--gW~d~~C~~~~~fICe~~~~-~C~  151 (170)
T 2xr6_A           93 WQWVDGSPLLPSFKQYWNRGEPN-----------NVGEEDCAEFSGN--GWNDDKCNLAKFWICKKSAA-SSS  151 (170)
T ss_dssp             EEETTSCBCCGGGGGGBCTTCCC-----------CTTCCCEEEEETT--EEEEECTTSCBEEEEEEETT-TC-
T ss_pred             EEeCCCCCcccccccCCCCCCCC-----------CCCCCCCeEEeCC--cEEccccCCCccEEEEECCC-CCC
Confidence            9999999976   4789988883           2246789998764  49999999999999999766 443

>1j34_B Coagulation factor IX-binding protein B chain; magnesium ION, calcium ION, GLA domain, protein binding/blood clotting complex; HET: CGU; 1.55A {Trimeresurus flavoviridis} SCOP: d.169.1.1 PDB: 1bj3_B 1ixx_B* 1j35_B* 1x2t_B* 1x2w_B 1wt9_B 1iod_B 1y17_B

Probab=99.94  E-value=2.7e-27  Score=198.89  Aligned_cols=118  Identities=24%  Similarity=0.565  Sum_probs=105.6

Q ss_pred             CCCCCCcccCCCCeeEEEECCCCChHHHHHHHhh--cCCEEeeeCCHHHHHHHHHHhCCC--CCCeEEeeeecCCCCCCc
Q 010309            8 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGLS   83 (513)
Q Consensus         8 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~~   83 (513)
                      +||+||.  .|+++||+++.+.++|.+|+..|+.  .||+||+|+|.+|++||.+++...  ...+||||+  +...++.
T Consensus         1 ~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~WIGl~--~~~~~~~   76 (123)
T 1j34_B            1 DCPSDWS--SYEGHCYKPFSEPKNWADAENFCTQQHAGGHLVSFQSSEEADFVVKLAFQTFGHSIFWMGLS--NVWNQCN   76 (123)
T ss_dssp             CCCTTSE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCSSHHHHHHHHHHHHHHHCSCEEECSCC--SCSTTSC
T ss_pred             CcCCccc--ccCCEEEEEECCCcCHHHHHHHHhccCCCcEEcccCCHHHHHHHHHHHHhcCCCCCEEEeeE--cCCCCCe
Confidence            5999999  7999999999999999999999999  899999999999999999887532  357999999  6656799


Q ss_pred             eEEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCcccccc
Q 010309           84 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE  147 (513)
Q Consensus        84 w~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~~  147 (513)
                      |+|+||+++.|++|. ++|                 +|+.+....+.|++..|....+|||+.+
T Consensus        77 ~~W~dg~~~~~~~W~-g~P-----------------~C~~~~~~~g~w~~~~C~~~~~~iCe~~  122 (123)
T 1j34_B           77 WQWSNAAMLRYKAWA-EES-----------------YCVYFKSTNNKWRSRACRMMAQFVCEFQ  122 (123)
T ss_dssp             EEETTCCCCCCCCBS-CSC-----------------EEEEEETTSCCBEEEETTSCEEEEEEEE
T ss_pred             eEeCCCCCcCccCcC-CCC-----------------CcEEEECCCCCCcCCCCCCCCcEEEeec
Confidence            999999999999998 776                 4788876656899999999999999975

>2e3x_C Coagulation factor X-activating enzyme light CHAI; disintegrin, metalloproteinase, C-type lectin, hydrolase, BL clotting, toxin; HET: NAG MAN GM6; 2.91A {Daboia russellii siamensis}

Probab=99.94  E-value=5.6e-27  Score=196.69  Aligned_cols=117  Identities=26%  Similarity=0.587  Sum_probs=104.2

Q ss_pred             CCCCCCcccCCCCeeEEEECCCCChHHHHHHHhh--cCCEEeeeCCHHHHHHHHHHhCCC--CCCeEEeeeecCCCCCCc
Q 010309            8 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGLS   83 (513)
Q Consensus         8 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~~   83 (513)
                      +||+||.  .|+++||+++.+.++|.+|+..|+.  .||+||+|+|.+|++||.+++...  ...+||||+  +...++.
T Consensus         2 ~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~WIGl~--~~~~~~~   77 (122)
T 2e3x_C            2 DCPSGWL--SYEQHCYKGFNDLKNWTDAEKFCTEQKKGSHLVSLHSREEEKFVVNLISENLEYPATWIGLG--NMWKDCR   77 (122)
T ss_dssp             CCCSSCE--EETTEEEEECCCCBCHHHHHHHHHHHSTTCCBCCCSSHHHHHHHHHHHHHHCSSSEEEEEEE--STTSSSC
T ss_pred             CCCcchh--hhCCEeEEEECCCcCHHHHHHHHhccCCCCEECccCCHHHHHHHHHHHHhcCCCCCEEEeee--ecCCCCc
Confidence            6999999  7999999999999999999999999  899999999999999999887532  357999999  6666799


Q ss_pred             eEEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCccccc
Q 010309           84 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMV  146 (513)
Q Consensus        84 w~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~  146 (513)
                      |+|+||+++.|++|. ++|                 +|+.+....+.|++.+|....+|||+.
T Consensus        78 ~~W~dg~~~~~~~W~-~~P-----------------~C~~~~~~~g~w~~~~C~~~~~~ICe~  122 (122)
T 2e3x_C           78 MEWSDRGNVKYKALA-EES-----------------YCLIMITHEKVWKSMTCNFIAPVVCKF  122 (122)
T ss_dssp             EEETTSCCCCCCCBC-SCC-----------------EEEEEETTTCCEEEEETTSCBCCEEC-
T ss_pred             eEeCCCCcccccccC-CCC-----------------CCEEEECCCCcEeCCCCCCCCceeecC
Confidence            999999999999998 776                 477887665689999999999999974

>1c3a_A Flavocetin-A: alpha subunit; C-type lectin-like domains, membrane protein; 2.50A {Trimeresurus flavoviridis} SCOP: d.169.1.1 PDB: 1v4l_A

Probab=99.94  E-value=3.2e-27  Score=201.90  Aligned_cols=124  Identities=24%  Similarity=0.471  Sum_probs=108.5

Q ss_pred             CCCCCCCcccCCCCeeEEEECCCCChHHHHHHHhh--cCCEEeeeCCHHHHHHHHHHhCCC---CC-CeEEeeeecCCCC
Q 010309            7 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN---VN-GCWVGGRSINTTV   80 (513)
Q Consensus         7 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~---~~-~~WiGl~~~~~~~   80 (513)
                      .+||+||.  .|+++||+++.+.++|.+|+..|+.  .||+||+|+|.+|++||.+++...   .. .+||||++.+...
T Consensus         2 ~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~~WIGl~~~~~~~   79 (135)
T 1c3a_A            2 FDCIPGWS--AYDRYCYQAFSKPKNWEDAESFCEEGVKTSHLVSIESSGEGDFVAQLVAEKIKTSFQYVWIGLRIQNKEQ   79 (135)
T ss_dssp             CCCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCSHHHHHHHHHHHHHHCCSCCSEEEEEEEECCCSS
T ss_pred             cCCCCcCE--ecCCeeEEEeCCCcCHHHHHHHHhhcCCCCEECeeCCHHHHHHHHHHHhhccccCCCcEEecccccCCCC
Confidence            47999999  7999999999999999999999999  899999999999999999888532   24 7999998444445


Q ss_pred             CCceEEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCC--CcccccccCCCCCccccccc
Q 010309           81 GLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMVEH  148 (513)
Q Consensus        81 ~~~w~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~--~~w~d~~C~~~~~~iC~~~~  148 (513)
                      ++.|+|+||+++.|++|.+++|.                +|+.+....  +.|++..|....+|||+.++
T Consensus        80 ~~~~~W~dg~~~~~~~W~~~~P~----------------~C~~~~~~~~~~~W~d~~C~~~~~fICe~~~  133 (135)
T 1c3a_A           80 QCRSEWSDASSVNYENLVKQFSK----------------KCYALKKGTELRTWFNVYCGTENPEVCKYTP  133 (135)
T ss_dssp             SCCCBCTTSCBCCCCCBCGGGCC----------------CEEEEETTSCSCSBEEECTTSCEEEEEEECC
T ss_pred             CCceEECCCCcccccccCCCCCC----------------cceEEeccCCCCeEccCCCCCCccEEcccCC
Confidence            79999999999999999998872                477876554  57999999999999999875

>3ubu_A Agglucetin subunit alpha-1; platelet inhibiting, agkisacucetin, dimer, toxin, C-type LEC GPIB inhibitor, GPIB binding; 1.91A {Deinagkistrodon acutus}

Probab=99.94  E-value=2.6e-27  Score=201.35  Aligned_cols=124  Identities=23%  Similarity=0.557  Sum_probs=106.3

Q ss_pred             CCCCCCCcccCCCCeeEEEECCCCChHHHHHHHhhc--CCEEeeeCCHHHHHHHHHHhCCC--CCCeEEeeeecCCCCCC
Q 010309            7 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGL   82 (513)
Q Consensus         7 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~--~~~L~~i~~~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~   82 (513)
                      ..||+||+  .|+++||+++.+.++|.+|+..|+.+  ||+||+|+|++|++||.+++...  ...+||||++.....++
T Consensus         2 ~~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~~~G~~La~i~s~~e~~~l~~~~~~~~~~~~~WIGl~~~~~~~~~   79 (131)
T 3ubu_A            2 VDCLPGWS--AYDQSCYRVFKLLKTWDDAEKFCTERPKGGHLVSIESAGERDFVAQLVSENKQTDNVWLGLKIQSKGQQC   79 (131)
T ss_dssp             CCCCTTCE--EETTEEEEEEEEEECHHHHHHHHHTSTTCCEECCCCSHHHHHHHHHHHHHTTCCSCEEEEEEEECSSSSS
T ss_pred             cCCCccCE--ecCCEeeEEcCCCcCHHHHHHHHhccCCCceEceeCCHHHHHHHHHHHHhcCCCCCEEEeEecCCCCCCC
Confidence            47999999  89999999999999999999999998  89999999999999999988643  34799999954322279


Q ss_pred             ceEEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCCC--cccccccCCCCCccccccc
Q 010309           83 SWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSR--SLVTERCNTSHPFICMVEH  148 (513)
Q Consensus        83 ~w~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~--~w~d~~C~~~~~~iC~~~~  148 (513)
                      .|+|+||+++.|++|.+++|                ++|+.+....+  .|++..|....+|||+.++
T Consensus        80 ~~~W~dg~~~~~~~w~~~~~----------------~~Cv~~~~~~~~~~W~~~~C~~~~~fiCe~~p  131 (131)
T 3ubu_A           80 STEWTDGSSVSYENFSEYQS----------------KKCFVLEKNTGFRTWLNLNCGSEYSFVCKSPP  131 (131)
T ss_dssp             CCBCTTSCBCCCCCBCTTTC----------------CCEEEECGGGTSCSEEEECTTCCEEEEEEECC
T ss_pred             ceEeCCCCccceeccCCCCC----------------CCcEEEeCCCCCCeEcCCCCCCCceeEEecCC
Confidence            99999999999999987654                36888865433  7999999999999999864

>3m9z_A Killer cell lectin-like receptor subfamily B MEMB; C-type lectin-like domain, domain swapping, disulfide bond, transmembrane protein; 1.70A {Mus musculus} SCOP: d.169.1.0 PDB: 3t3a_A

Probab=99.94  E-value=3.9e-27  Score=202.43  Aligned_cols=127  Identities=26%  Similarity=0.557  Sum_probs=108.8

Q ss_pred             cCCCCCCCcccCCCCeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceE
Q 010309            6 KAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWK   85 (513)
Q Consensus         6 ~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~   85 (513)
                      ...||+||+  .|+++||+|+.+.++|.+|+..|+.+||+||+|+|.+|++||.+++......+||||+  +...++.|+
T Consensus         3 ~~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~WIGl~--~~~~~~~w~   78 (139)
T 3m9z_A            3 KLECPQDWL--SHRDKCFHVSQVSNTWEEGLVDCDGKGATLMLIQDQEELRFLLDSIKEKYNSFWIGLR--YTLPDMNWK   78 (139)
T ss_dssp             -CCCCTTCE--EETTEEEEECSSCBCHHHHHHHHHHTTCEECCCCCHHHHHHHHHHHTCSSSCEEEEEE--EECCCCCCB
T ss_pred             CCCCCccce--ecCCEEEEEECCcCCHHHHHHHHHhcCCeEeeeCCHHHHHHHHHHhcccCccEEEEEe--ccCCCCCeE
Confidence            468999999  7999999999999999999999999999999999999999999998754568999999  444568999


Q ss_pred             EcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCccccccccCc
Q 010309           86 WSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEHENK  151 (513)
Q Consensus        86 W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~~~~~~  151 (513)
                      |+||+++.+.+|+..+++             +.++|+.+..  +.|++..|....+|||+.+....
T Consensus        79 W~dg~~~~~~~~~~~~~~-------------~~~~Cv~~~~--~~w~~~~C~~~~~fICe~~~~~~  129 (139)
T 3m9z_A           79 WINGSTLNSDVLKITGDT-------------ENDSCAAISG--DKVTFESCNSDNRWICQKELYHE  129 (139)
T ss_dssp             CTTSCBCCHHHHTTSSCT-------------TCEEEEEEET--TEEEEEETTSCBEEEEEEECC--
T ss_pred             eCCCCcCCcCccccCCCC-------------CCCCeeEEeC--CcEEeCCCCCCCceEeeecCccc
Confidence            999999988888755441             1357988865  48999999999999999977654

>1c3a_B Flavocetin-A: beta subunit; C-type lectin-like domains, membrane protein; 2.50A {Trimeresurus flavoviridis} SCOP: d.169.1.1 PDB: 1v4l_B

Probab=99.94  E-value=4.5e-27  Score=198.17  Aligned_cols=119  Identities=20%  Similarity=0.414  Sum_probs=105.9

Q ss_pred             CCCCCCCcccCCCCeeEEEECCCCChHHHHHHHhh--cCCEEeeeCCHHHHHHHHHHhCCC--CCCeEEeeeecCCCCCC
Q 010309            7 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGL   82 (513)
Q Consensus         7 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~   82 (513)
                      ..||+||+  .|+++||+++.+.++|.+|+..|+.  .||+||+|+|.+|++||.+++...  ...+||||+  +...++
T Consensus         2 ~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~WIGl~--~~~~~~   77 (125)
T 1c3a_B            2 FCCPLGWS--SYDEHCYQVFQQKMNWEDAEKFCTQQHKGSHLVSFHSSEEVDFVTSKTFPILKYDFVWIGLS--NVWNEC   77 (125)
T ss_dssp             CCCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCSSHHHHHHHHHHHHHHHCSCEEECSCC--CTTTSS
T ss_pred             CCCCCcce--ecCCEEEEEECCCCCHHHHHHHhhccCCCcEECccCCHHHHHHHHHHHHhcCCCCCEEEeeE--cCCCCC
Confidence            47999999  7999999999999999999999999  899999999999999999887532  357999999  665679


Q ss_pred             ceEEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCcccccc
Q 010309           83 SWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE  147 (513)
Q Consensus        83 ~w~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~~  147 (513)
                      .|+|+||+++.|++|. ++|                 +|+.+....+.|++..|....+|||+.+
T Consensus        78 ~~~W~dg~~~~~~~w~-~~P-----------------~C~~~~~~~g~w~~~~C~~~~~fiCe~~  124 (125)
T 1c3a_B           78 TKEWSDGTKLDYKAWS-GGS-----------------DCIVSKTTDNQWLSMDCSSKYYVVCKFQ  124 (125)
T ss_dssp             CEEETTCCCCCSCCBC-CCC-----------------EEEEEESSSSCEEEEETTSCEEEEEEEE
T ss_pred             ceEeCCCCcccccccC-CCC-----------------CcEEEECCCCCEeCCCCCCCCeeEEeee
Confidence            9999999999999998 765                 4778876666899999999999999975

>3bx4_A Aggretin alpha chain; toxin; 1.70A {Agkistrodon rhodostoma} PDB: 2vrp_A

Probab=99.94  E-value=6.2e-27  Score=200.39  Aligned_cols=124  Identities=26%  Similarity=0.521  Sum_probs=107.5

Q ss_pred             CCCCCCCcccCCCCeeEEEECCCCChHHHHHHHhh--cCCEEeeeCCHHHHHHHHHHhCCC--C---CCeEEeeeecCCC
Q 010309            7 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN--V---NGCWVGGRSINTT   79 (513)
Q Consensus         7 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~--~---~~~WiGl~~~~~~   79 (513)
                      ..||+||.  .|+++||+++.+.++|.+|+..|+.  .||+||+|+|.+|++||.+++...  .   ..+||||++.+..
T Consensus         3 ~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~~~WIGl~~~~~~   80 (136)
T 3bx4_A            3 EDCDFGWS--PYDQHCYQAFNEQKTWDEAEKFCRAQENGAHLASIESNGEADFVSWLISQKDELADEDYVWIGLRAQNKE   80 (136)
T ss_dssp             -CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHTSTTTCEECCCCSHHHHHHHHHHHHTCGGGTTCCEEEEEEEECCCS
T ss_pred             CCCCCCCE--ecCCEEEEEECCCcCHHHHHHHHhccCCCcEEcccCCHHHHHHHHHHHHhhcccCccCCEEEeeeccCCC
Confidence            57999999  7999999999999999999999999  899999999999999999988643  2   5799999844444


Q ss_pred             CCCceEEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCC--CcccccccCCCCCccccccc
Q 010309           80 VGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMVEH  148 (513)
Q Consensus        80 ~~~~w~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~--~~w~d~~C~~~~~~iC~~~~  148 (513)
                      .++.|+|+||+++.|++|.+++|.                +|+.+....  +.|++..|....+|||+.+.
T Consensus        81 ~~~~~~W~dg~~~~~~~W~~~~P~----------------~C~~~~~~~~~~~W~~~~C~~~~~fICe~~~  135 (136)
T 3bx4_A           81 QQCSSEWSDGSSVSYENLIDLHTK----------------KCGALEKLTGFRKWVNYYCEQMHAFVCKLLP  135 (136)
T ss_dssp             SSSCCBCTTSCBCCCCCCTTCCCC----------------CEEEEEGGGTTTSEEEECTTSCEEEEEEECC
T ss_pred             CCCceEeCCCCccCcccccCCCCC----------------ccEEEEecCCCCeEeCCCCCCCcceEEeecC
Confidence            579999999999999999988872                477776543  57999999999999999753

>3hup_A Early activation antigen CD69; C-type lectin-like domain, disulfide bond, glycoprotein, LEC membrane, phosphoprotein, signal-anchor, transmembrane; 1.37A {Homo sapiens} SCOP: d.169.1.1 PDB: 1e87_A 1e8i_A 3cck_A

Probab=99.94  E-value=2.3e-26  Score=195.19  Aligned_cols=119  Identities=24%  Similarity=0.536  Sum_probs=102.8

Q ss_pred             CCcCCCCCCCcccCCCCeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCc
Q 010309            4 DWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLS   83 (513)
Q Consensus         4 ~~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~   83 (513)
                      ..+..||+||+  .|+++||+++.+.++|.+|+..|+.+||+||+|+|.+|++||.+++.  ...+||||++  . .++.
T Consensus        11 ~~~~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~--~~~~WIGl~~--~-~~~~   83 (130)
T 3hup_A           11 SHVSSCSEDWV--GYQRKCYFISTVKRSWTSAQNACSEHGATLAVIDSEKDMNFLKRYAG--REEHWVGLKK--E-PGHP   83 (130)
T ss_dssp             CCCBCCCTTCE--EETTEEEEECSSCBCHHHHHHHHHTTTCEECCCCSHHHHHHHHHHHT--TSCEEEEEEE--C-TTSC
T ss_pred             CCCCCCChhhe--ecCCEEEEEECCccCHHHHHHHHHhcCCEEeecCCHHHHHHHHHhhC--CCCEEEEEEe--C-CCCe
Confidence            34678999999  79999999999999999999999999999999999999999999986  4579999994  2 4689


Q ss_pred             eEEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCccccccc
Q 010309           84 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEH  148 (513)
Q Consensus        84 w~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~~~  148 (513)
                      |+|+||++  |++|..               ..+.++|+.+...  .|++..|....+|||+.+.
T Consensus        84 w~W~dg~~--~~~w~~---------------~~~~~~Cv~~~~~--~w~~~~C~~~~~fICe~~~  129 (130)
T 3hup_A           84 WKWSNGKE--FNNWFN---------------VTGSDKCVFLKNT--EVSSMECEKNLYWICNKPY  129 (130)
T ss_dssp             EEETTSCB--CCCCSC---------------CCSSCSEEEEETT--EEEEECTTSCBEEEEEEEC
T ss_pred             EEeCCCCc--ccCccC---------------CCCCCCceEEeCC--CcccCCCCCCccEEeccCc
Confidence            99999987  566651               1245679998754  6999999999999999864

>3ff7_C Killer cell lectin-like receptor subfamily G member 1; KLRG1-cadherin complex, calcium, cell adhesion, cell junction, cell membrane; 1.80A {Homo sapiens} SCOP: d.169.1.0

Probab=99.94  E-value=1.2e-26  Score=191.36  Aligned_cols=112  Identities=22%  Similarity=0.545  Sum_probs=99.6

Q ss_pred             CCCCCcccCCCCeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEcC
Q 010309            9 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSD   88 (513)
Q Consensus         9 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~d   88 (513)
                      ||+||.  .|+++||+++.+.++|.+|+..|+.+||+||+|+|.+|++||.+++.  ...+||||+  +   ++.|+|+|
T Consensus         1 Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~--~~~~WiGl~--~---~~~~~W~d   71 (112)
T 3ff7_C            1 CPDRWM--KYGNHCYYFSVEEKDWNSSLEFCLARDSHLLVITDNQEMSLLQVFLS--EAFSWIGLR--N---NSGWRWED   71 (112)
T ss_dssp             CCTTCE--EETTEEEEECSSCBCHHHHHHHHHTTTCEECCCCSHHHHHHHHTTCC--SSCEEEEEE--E---SSSEEETT
T ss_pred             CCccce--EeCCEEEEEeCCccCHHHHHHHHhhcCCeEeeECCHHHHHHHHHhcc--CCCEEEeee--c---CCceEeCC
Confidence            999999  79999999999999999999999999999999999999999999886  457999999  3   47899999


Q ss_pred             CCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCccccc
Q 010309           89 NMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMV  146 (513)
Q Consensus        89 g~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~  146 (513)
                      |+++.|++|.++.               +.++|+.+...  +|++..|....+|||++
T Consensus        72 g~~~~~~~w~~~~---------------~~~~C~~~~~~--~w~~~~C~~~~~fICek  112 (112)
T 3ff7_C           72 GSPLNFSRISSNS---------------FVQTCGAINKN--GLQASSCEVPLHWVCKK  112 (112)
T ss_dssp             SCBCCSSCEECSS---------------TTCCEEEEETT--EEEEECTTSCBEEEEEC
T ss_pred             CCccccceecCCC---------------CCCCCeEEeCC--CcccCCCCCCCceeecC
Confidence            9999999986321               24578888764  59999999999999974

>3bx4_B Aggretin beta chain; toxin; 1.70A {Agkistrodon rhodostoma} PDB: 2vrp_B

Probab=99.94  E-value=1.1e-26  Score=201.44  Aligned_cols=119  Identities=25%  Similarity=0.544  Sum_probs=105.7

Q ss_pred             CCCCCCCcccCCCCeeEEEECCCCChHHHHHHHhh--cCCEEeeeCCHHHHHHHHHHhCCC--CCCeEEeeeecCCCCCC
Q 010309            7 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGL   82 (513)
Q Consensus         7 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~   82 (513)
                      +.||+||.  .++++||+++.++++|.+|+..|+.  .||+||+|+|++|++||.+++...  ...+||||+  +...++
T Consensus        23 ~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~WIGl~--~~~~~~   98 (146)
T 3bx4_B           23 ADCPSGWS--SYEGHCYKPFNEPKNWADAERFCKLQPKHSHLVSFQSAEEADFVVKLTRPRLKANLVWMGLS--NIWHGC   98 (146)
T ss_dssp             --CCTTCE--EETTEEEEEEEEEECHHHHHHHHHHSSSCCEECCCSSHHHHHHHHHHHTTTTTTSEEECSCC--CTTSSS
T ss_pred             CCCCcCcE--eeCCEEEEEECCCcCHHHHHHHHhccCCCceEeccCCHHHHHHHHHHHhhcCCCCCEEEecc--cCCCCC
Confidence            48999999  7999999999999999999999999  599999999999999999998754  467999999  665679


Q ss_pred             ceEEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCcccccc
Q 010309           83 SWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE  147 (513)
Q Consensus        83 ~w~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~~  147 (513)
                      .|+|+||+++.|++|. ++|                 +|+.+....+.|++.+|....+|||+.+
T Consensus        99 ~~~W~dg~~~~~~~W~-g~P-----------------~C~~~~~~~g~w~~~~C~~~~~~ICe~~  145 (146)
T 3bx4_B           99 NWQWSDGARLNYKDWQ-EQS-----------------ECLAFRGVHTEWLNMDCSSTCSFVCKFK  145 (146)
T ss_dssp             CEEETTCCCCCSCCBC-SCC-----------------EEEEEETTCCCEEEEETTSCEEEEEEEE
T ss_pred             ceEeCCCCcccccCcC-CCC-----------------CceEEECCCCeEecCCCCCCcceEEeec
Confidence            9999999999999998 776                 4788876656899999999999999975

>1hup_A Mannose-binding protein; alpha-helical coiled-coil, C-type lectin; 2.50A {Homo sapiens} SCOP: d.169.1.1 h.1.1.1

Probab=99.93  E-value=6e-27  Score=201.64  Aligned_cols=122  Identities=14%  Similarity=0.126  Sum_probs=109.4

Q ss_pred             CCCCCCcccCCCCeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEc
Q 010309            8 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWS   87 (513)
Q Consensus         8 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~   87 (513)
                      .||+||.  .++++||+++...++|.+|+..|+.+||+||+|+|.+|++||.+++.   ..+||||+  +...++.|.|+
T Consensus        19 ~~~~~w~--~~~~~Cy~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~---~~~WIGl~--~~~~~~~w~W~   91 (141)
T 1hup_A           19 LTFSLGK--QVGNKFFLTNGEIMTFEKVKALCVKFQASVATPRNAAENGAIQNLIK---EEAFLGIT--DEKTEGQFVDL   91 (141)
T ss_dssp             HHHHTSE--EETTEEEEEEEEEEEHHHHHHHHHHTTCEECCCCSHHHHHHHHHHCS---SCEEEEEE--CSSSTTCCEET
T ss_pred             hhcCCeE--EECCEEEEEeCCCcCHHHHHHHHHhCCCEECccCCHHHHHHHHHHhc---CCEEEeee--ecCcCCcEEEC
Confidence            5889999  89999999999999999999999999999999999999999999885   67999999  66667999999


Q ss_pred             CCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCcccccc
Q 010309           88 DNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE  147 (513)
Q Consensus        88 dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~~  147 (513)
                      ||+++.|++|.+++|.+          ..+.++|+.+. ..+.|++.+|....+|||+.+
T Consensus        92 dG~~~~~~~W~~g~P~~----------~~~~~~Cv~~~-~~g~W~~~~C~~~~~fICe~~  140 (141)
T 1hup_A           92 TGNRLTYTNWNEGEPNN----------AGSDEDCVLLL-KNGQWNDVPCSTSHLAVCEFP  140 (141)
T ss_dssp             TSCBCSCCCBCTTCCCC----------GGGCCCEEEEC-TTSCEEEECTTSEEEEEEEEE
T ss_pred             CcCCCcCCCCCCCCCCC----------CCCCCCeEEEC-CCCcEeccCCCCCccEEEEEE
Confidence            99999999999999832          13567899986 346899999999999999975

>1ukm_A EMS16 A chain, EMS16 subunit A; domain swapping, C-type lectin, toxin; HET: NAG; 1.90A {Echis multisquamatus} SCOP: d.169.1.1 PDB: 1v7p_A*

Probab=99.93  E-value=6.4e-27  Score=199.78  Aligned_cols=124  Identities=24%  Similarity=0.483  Sum_probs=107.2

Q ss_pred             CCCCCCCcccCCCCeeEEEECCCCChHHHHHHHhh--cCCEEeeeCCHHHHHHHHHHhCCC---CC-CeEEeeeecCCCC
Q 010309            7 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN---VN-GCWVGGRSINTTV   80 (513)
Q Consensus         7 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~---~~-~~WiGl~~~~~~~   80 (513)
                      .+||+||+  .|+++||+++.+.++|.+|+..|+.  .||+||+|+|.+|++||.+++...   .. .+||||++.....
T Consensus         2 ~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~~WIGl~~~~~~~   79 (134)
T 1ukm_A            2 FDCPSDWT--AYDQHCYLAIGEPQNWYEAERFCTEQAKDGHLVSIQSREEGNFVAQLVSGFMHRSEIYVWIGLRDRREEQ   79 (134)
T ss_dssp             -CCSTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCSHHHHHHHHHHTGGGGGSSCCEEEEEEEECCSSS
T ss_pred             cCCCCccE--ecCCEEEEEECCCcCHHHHHHHHhhcCCCcEECccCCHHHHHHHHHHHhhhccCCCCCEEEeeecCCCCC
Confidence            47999999  7999999999999999999999999  899999999999999999988643   25 7999999431155


Q ss_pred             CCceEEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCC--CcccccccCCCCCccccccc
Q 010309           81 GLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMVEH  148 (513)
Q Consensus        81 ~~~w~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~--~~w~d~~C~~~~~~iC~~~~  148 (513)
                      ++.|+|+||+++.|++|.+++|.                +|+.+....  +.|++..|....+|||+.+.
T Consensus        80 ~~~~~W~dg~~~~~~~W~~g~P~----------------~C~~~~~~~~~~~W~~~~C~~~~~~ICe~~~  133 (134)
T 1ukm_A           80 QCNPEWNDGSKIIYVNWKEGESK----------------MCQGLTKWTNFHDWNNINCEDLYPFVCKFSA  133 (134)
T ss_dssp             CSCCBCTTSCBCCCCCBCTTCCC----------------CEEEEEGGGTSCSEEEECTTSCEEEEEEEEC
T ss_pred             CCceEEcCcCccccceECCCcCc----------------cceEEEecCCCCeeecCCCCCCceeEEeEcC
Confidence            79999999999999999998872                477776544  57999999999999999863

>1fvu_A Botrocetin alpha chain; VON WILLBRAND factor modulator, C-type lectin, metal- binding, loop exchanged dimer, toxin; 1.80A {Bothrops jararaca} SCOP: d.169.1.1 PDB: 1ijk_B 1u0n_B 1u0o_A

Probab=99.93  E-value=6.5e-27  Score=199.47  Aligned_cols=123  Identities=26%  Similarity=0.557  Sum_probs=106.8

Q ss_pred             CCCCCCcccCCCCeeEEEECCCCChHHHHHHHhh--cCCEEeeeCCHH-HHHHHHHHhCCC----CCCeEEeeeecCCCC
Q 010309            8 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYE-EEHSAQKLCGKN----VNGCWVGGRSINTTV   80 (513)
Q Consensus         8 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~-e~~f~~~~~~~~----~~~~WiGl~~~~~~~   80 (513)
                      +||+||+  .|+++||+++.+.++|.+|+..|+.  .||+||+|+|.+ |++||.+++...    ...+||||+..+...
T Consensus         1 ~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~~~g~~La~i~s~~~e~~~l~~~~~~~~~~~~~~~WIGl~~~~~~~   78 (133)
T 1fvu_A            1 DCPSGWS--SYEGNCYKFFQQKMNWADAERFCSEQAKGGHLVSIKIYSKEKDFVGDLVTKNIQSSDLYAWIGLRVENKEK   78 (133)
T ss_dssp             CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCTTSTHHHHHHHHHHHHCCSSCCEEEEEEEECCSSS
T ss_pred             CcCCCcE--EcCCeeEEEECCCcCHHHHHHHHhccCCCcEEeeecChHHHHHHHHHHHhhccccCCCCEEEeeecccCCC
Confidence            5999999  7999999999999999999999999  799999999999 999999987532    357999999333345


Q ss_pred             CCceEEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCC--CcccccccCCCCCccccccc
Q 010309           81 GLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMVEH  148 (513)
Q Consensus        81 ~~~w~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~--~~w~d~~C~~~~~~iC~~~~  148 (513)
                      ++.|+|+||+++.|++|.+ +|.               ++|+.+....  +.|++..|....+|||+.+.
T Consensus        79 ~~~w~W~dg~~~~~~~W~~-~P~---------------~~C~~~~~~~~~~~w~~~~C~~~~~fICe~~~  132 (133)
T 1fvu_A           79 QCSSEWSDGSSVSYENVVE-RTV---------------KKCFALEKDLGFVLWINLYCAQKNPFVCKSPP  132 (133)
T ss_dssp             SSCCBCTTSCBCCCCCBCG-GGC---------------CCEEEEETTTTSCSEEEECTTCCEEEEEEECC
T ss_pred             CCccEeCCCCcccccCccc-CCC---------------CCcEEEEecCCCCeEecCCCCCCCCEEeeecC
Confidence            6999999999999999998 772               4688887654  57999999999999999864

>1sb2_A Rhodocetin alpha subunit; C-type lectin, domain swapping, toxin; 1.90A {Calloselasma rhodostoma} SCOP: d.169.1.1 PDB: 3gpr_A

Probab=99.93  E-value=9.1e-27  Score=198.53  Aligned_cols=123  Identities=24%  Similarity=0.514  Sum_probs=106.1

Q ss_pred             CCCCCCcccCCCCeeEEEECCCCChHHHHHHHhh--cCCEEeeeCCHHHHHHHHHHhCCC----CCCeEEeeeecCCCCC
Q 010309            8 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN----VNGCWVGGRSINTTVG   81 (513)
Q Consensus         8 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~----~~~~WiGl~~~~~~~~   81 (513)
                      +||+||.  .|+++||+++.+.++|.+|+..|+.  .||+||+|+|.+|++||.+++...    ...+||||+..+...+
T Consensus         1 ~Cp~gw~--~~~~~Cy~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~~WIGl~~~~~~~~   78 (133)
T 1sb2_A            1 DCPDGWS--STKSYCYRPFKEKKTWEEAERFCTEQEKEAHLVSMENRLEAVFVDMVMENNFENKIYRSWIGLKIENKGQR   78 (133)
T ss_dssp             CCCTTCE--ECSSEEEEEEEEEECHHHHHHHHHTSSSCCEECCCSSHHHHHHHHHHHHHHTTTCCEEEEEEEEEECSSTT
T ss_pred             CcCCCcE--EcCCEeEEEECCcCCHHHHHHHHhhhCCCcEEeeECCHHHHHHHHHHHHhhccCccCCEEEeeeccCCCCC
Confidence            5999999  7999999999999999999999999  899999999999999999987532    3579999983333456


Q ss_pred             CceEEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCC--CcccccccCCCCCccccccc
Q 010309           82 LSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMVEH  148 (513)
Q Consensus        82 ~~w~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~--~~w~d~~C~~~~~~iC~~~~  148 (513)
                      +.|+|+||+++.|++|.+ +|               .++|+.+....  +.|++..|....+|||+.+.
T Consensus        79 ~~~~W~dg~~~~~~~W~~-~P---------------~~~C~~~~~~~~~~~w~~~~C~~~~~fICe~~~  131 (133)
T 1sb2_A           79 SNLEWSDGSSISYENLYE-PY---------------MEKCFLMDHQSGLPKWHTADCEEKNVFMCKFQL  131 (133)
T ss_dssp             SSEEETTCCCCCCCCBSS-CC---------------CEEEEEEEESSSSCEEEEECTTSCEEEEEEEEC
T ss_pred             CceEECCCCcccccccCc-CC---------------CCCcEEEEecCCCCeEccCCCCCCceeEecccC
Confidence            999999999999999988 76               23678876554  57999999999999999865

>1ukm_B EMS16 B chain, EMS16 subunit B; domain swapping, C-type lectin, toxin; HET: NAG; 1.90A {Echis multisquamatus} SCOP: d.169.1.1 PDB: 1v7p_B*

Probab=99.93  E-value=8.3e-27  Score=197.38  Aligned_cols=120  Identities=28%  Similarity=0.552  Sum_probs=104.5

Q ss_pred             CCCCCcccCCCCeeEEEECCCCChHHHHHHHhh--cCCEEeeeCCHHHHHHHHHHhCCC--CCCeEEeeeecCCCCCCce
Q 010309            9 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGLSW   84 (513)
Q Consensus         9 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~~w   84 (513)
                      ||+||.  .|+++||+++.+.++|.+|+..|+.  .||+||+|+|.+|++||.+++...  ...+||||+  +...++.|
T Consensus         1 Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~WiGl~--~~~~~~~~   76 (128)
T 1ukm_B            1 CPLGWS--SFDQHCYKVFEPVKNWTEAEEICMQQHKGSRLASIHSSEEEAFVSKLASKALKFTSMWIGLN--NPWKDCKW   76 (128)
T ss_dssp             CCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCSHHHHHHHHHHHHHHCSSCEEEEEEE--CTTTTCCE
T ss_pred             CCCcCE--ecCCEeEEEECCccCHHHHHHHHhccCCccEEcccCCHHHHHHHHHHHHhcCCcCcEEEecc--cCCCCCce
Confidence            999999  7999999999999999999999999  899999999999999999887532  357999999  66567999


Q ss_pred             EEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecC--CCcccccccCCCCCccccccccC
Q 010309           85 KWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG--SRSLVTERCNTSHPFICMVEHEN  150 (513)
Q Consensus        85 ~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~--~~~w~d~~C~~~~~~iC~~~~~~  150 (513)
                      +|+||+++.|++|. ++|                 +|+.+...  .+.|++..|....+|||+.+..+
T Consensus        77 ~W~dg~~~~~~~W~-g~P-----------------~C~~~~~~~~~~~w~~~~C~~~~~fICe~~~~~  126 (128)
T 1ukm_B           77 EWSDNARFDYKAWK-RRP-----------------YCTVMVVKPDRIFWFTRGCEKSVSFVCKFLTDP  126 (128)
T ss_dssp             EETTCCCCCCCCBC-CCC-----------------EEEEEEECSSCEEEEEEETTSCEEEEEEEEC--
T ss_pred             EeCCCCccccCCCC-CCC-----------------CcEEEeCCCCCCeEeCCCCCCCcCeEeeecCCC
Confidence            99999999999998 776                 47777543  25799999999999999987654

>1rtm_1 Mannose-binding protein-A; lectin; 1.80A {Rattus norvegicus} SCOP: d.169.1.1 h.1.1.1 PDB: 1kwu_A* 1kwv_A* 1kwt_A* 1kwx_A* 1kwy_A* 1kx1_A* 1kww_A 1kwz_A* 1kx0_A* 3kmb_1* 1kmb_1* 2kmb_1* 4kmb_1* 1afb_1* 1afa_1* 1afd_1 1bch_1* 1bcj_1* 1fif_A 1fih_A*

Probab=99.93  E-value=8.4e-27  Score=202.67  Aligned_cols=122  Identities=13%  Similarity=0.176  Sum_probs=109.2

Q ss_pred             CCCCCCcccCCCCeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEc
Q 010309            8 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWS   87 (513)
Q Consensus         8 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~   87 (513)
                      .||++|.  .++++||+++...++|.+|+..|+.+||+||+|+|.+|++||.+++.   ..+||||+  +...++.|.|+
T Consensus        27 ~~~~~w~--~~~~~Cy~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~---~~~WIGl~--~~~~~~~w~W~   99 (149)
T 1rtm_1           27 HAFSMGK--KSGKKFFVTNHERMPFSKVKALCSELRGTVAIPRNAEENKAIQEVAK---TSAFLGIT--DEVTEGQFMYV   99 (149)
T ss_dssp             HHHHTTC--CTTSCEEEEEEEEEEHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHS---SCEEEEEE--CSSSTTCCEET
T ss_pred             hcCCCeE--EeCCEEEEEeCCCCCHHHHHHHHHhCCCEEeeeCCHHHHHHHHHHhc---CCEEEEee--ccCcCCeEEEC
Confidence            5789999  89999999999999999999999999999999999999999999985   67999999  66678999999


Q ss_pred             CCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCcccccc
Q 010309           88 DNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE  147 (513)
Q Consensus        88 dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~~  147 (513)
                      ||+++.|++|.+++|.+          ..+.++|+.+.. .+.|++.+|....+|||+.+
T Consensus       100 dg~~~~~~~W~~g~P~~----------~~~~~~Cv~~~~-~g~W~d~~C~~~~~fICe~~  148 (149)
T 1rtm_1          100 TGGRLTYSNWKKDEPND----------HGSGEDCVTIVD-NGLWNDISCQASHTAVCEFP  148 (149)
T ss_dssp             TSSBCCSCCBCTTCCCC----------CTTCCCEEEECG-GGCEEEECTTSEEEEEEEEC
T ss_pred             CCCCccccCcCCCCCCC----------CCCCCCeEEECC-CCCEeCCCCCCCeeEEEEee
Confidence            99999999999999832          135678999863 45899999999999999975

>3gpr_D Rhodocetin subunit delta; disulfide bond, lectin, secreted, toxin, cell adhesion; 3.20A {Calloselasma rhodostoma}

Probab=99.93  E-value=2.6e-27  Score=199.37  Aligned_cols=118  Identities=23%  Similarity=0.566  Sum_probs=103.4

Q ss_pred             CCCCCcccCCCCeeEEEECCCCChHHHHHHHhhc--CCEEeeeCCHHHHHHHHHHhCCC--CCCeEEeeeecCCCCCCce
Q 010309            9 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGLSW   84 (513)
Q Consensus         9 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~--~~~L~~i~~~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~~w   84 (513)
                      ||+||+  .|+++||+++.+.++|.+|+..|+.+  ||+||+|+|.+|++||.+++...  ...+||||+  +...++.|
T Consensus         1 Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~WIGl~--~~~~~~~~   76 (124)
T 3gpr_D            1 CPLHWS--SYNGYCYRVFSELKTWEDAESFCYAQHKGSRLASIHSREEEAFVGKLASQTLKYTSMWLGLN--NAWAACKW   76 (124)
T ss_dssp             CCSSCC--CSSSEEEEEEEEEEESHHHHHHHHHHSTTCBSCCCCSHHHHHHHHHHHHHSCSSCCBCCSEE--CCSSCSSC
T ss_pred             CCCcce--ecCCEeEEEeCCCcCHHHHHHHHHhcCCCCEEcccCCHHHHHHHHHHHHhcCCCCCEEEEeE--cCCCCCce
Confidence            999999  89999999999999999999999999  99999999999999999988532  357999999  66667999


Q ss_pred             EEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCC--CcccccccCCCCCccccccc
Q 010309           85 KWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMVEH  148 (513)
Q Consensus        85 ~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~--~~w~d~~C~~~~~~iC~~~~  148 (513)
                      +|+||+++.|++|.+ +|                 +|+.+....  +.|++..|....+|||+.++
T Consensus        77 ~W~dg~~~~~~~W~~-~p-----------------~C~~~~~~~~~~~W~~~~C~~~~~fiCe~ps  124 (124)
T 3gpr_D           77 EWSDDAKLDYKVWLR-RA-----------------YCAVMVVKTDRIFWYNRGCEKTVSFLCKFYS  124 (124)
T ss_dssp             SSSSCCCSCCBCCCS-CC-----------------CEECCBCCSSSCBBCEECTTSEEEEEEEEEC
T ss_pred             EECCCCcccccccCC-CC-----------------CcEEEEcCCCCCcEeCCCCCCCccEEeeecC
Confidence            999999999999976 33                 466665544  47999999999999999863

>3ubu_B Agglucetin subunit beta-2; platelet inhibiting, agkisacucetin, dimer, toxin, C-type LEC GPIB inhibitor, GPIB binding; 1.91A {Deinagkistrodon acutus}

Probab=99.93  E-value=1.2e-26  Score=195.84  Aligned_cols=119  Identities=24%  Similarity=0.490  Sum_probs=104.8

Q ss_pred             CCCCCCCcccCCCCeeEEEECCCCChHHHHHHHhh--cCCEEeeeCCHHHHHHHHHHhCCC--CCCeEEeeeecCCCCCC
Q 010309            7 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGL   82 (513)
Q Consensus         7 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~   82 (513)
                      ..||+||+  .|+++||+++.+.++|.+|+..|+.  .||+||+|+|.+|++||.+++...  ...+||||+  +...++
T Consensus         2 ~~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~WIGl~--~~~~~~   77 (126)
T 3ubu_B            2 FCCPLRWS--AYEGHCYLVVKEKKTWDDAEKFCTEQRKGGHLVSVHSREEADFLVHLAYPILDLSLIWMGLS--NMWNDC   77 (126)
T ss_dssp             CSCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCSHHHHHHHHHHHHHHHCSCEEEEEEE--CTTTSS
T ss_pred             CCCCCCCe--EcCCEeEEEeCCCCCHHHHHHHHhccCCCcEECccCCHHHHHHHHHHHhhccCCCcEEEeEE--cCCCCC
Confidence            47999999  8999999999999999999999999  999999999999999999987532  347999999  655679


Q ss_pred             ceEEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCC-CcccccccCCCCCcccccc
Q 010309           83 SWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS-RSLVTERCNTSHPFICMVE  147 (513)
Q Consensus        83 ~w~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~-~~w~d~~C~~~~~~iC~~~  147 (513)
                      .|+|+||+++.|.+|.+                  .++|+.+.... +.|++.+|....+|||+.+
T Consensus        78 ~~~W~dg~~~~~~~W~~------------------~~~Cv~~~~~~~~~W~~~~C~~~~~fICe~~  125 (126)
T 3ubu_B           78 KREWSDGTKLDFKSWAK------------------TSDCLIGKTDGDNQWLNMDCSKKHYFVCKFK  125 (126)
T ss_dssp             EEEETTCCCCCCCCBCC------------------CCCEEEEESSTTCCEEEECTTSCEEEEEEEE
T ss_pred             ceEecCCCeeeeeccCC------------------CCCeEEEecCCCCcCcCCCCCCCceeEEeee
Confidence            99999999999999865                  24688887654 5799999999999999975

>1umr_A Convulxin alpha, CVX alpha; lectin, C-type lectin, platelet, sugar-binding protein, activator, snake venom; 2.40A {Crotalus durissus terrificus} SCOP: d.169.1.1 PDB: 1uos_A

Probab=99.93  E-value=6.4e-27  Score=200.04  Aligned_cols=124  Identities=24%  Similarity=0.472  Sum_probs=107.6

Q ss_pred             CCCCCCCcccCCCCeeEEEECCCCChHHHHHHHhh--cCCEEeeeCCHHHHHHHHHHhCCC---CC-CeEEeeeecCCCC
Q 010309            7 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN---VN-GCWVGGRSINTTV   80 (513)
Q Consensus         7 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~---~~-~~WiGl~~~~~~~   80 (513)
                      .+||+||+  .|+++||+++.+.++|.+|+..|+.  .||+||+|+|.+|++||.+++...   .. .+||||+..+...
T Consensus         2 ~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~~WIGl~~~~~~~   79 (135)
T 1umr_A            2 LHCPSDWY--YYDQHCYRIFNEEMNWEDAEWFCTKQAKGAHLVSIKSAKEADFVAWMVTQNIEESFSHVSIGLRVQNKEK   79 (135)
T ss_dssp             CSSCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCSHHHHHHHHHHHHHHSCTTCCEEECSEEECCSSS
T ss_pred             CCCCCCCE--EcCCEeEEEECCCCCHHHHHHHHHccCCCceECccCCHHHHHHHHHHHHhhcccCCCCEEEeccccCCCC
Confidence            47999999  7999999999999999999999999  899999999999999999887532   24 7999999333445


Q ss_pred             CCceEEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCC--CcccccccCCCCCccccccc
Q 010309           81 GLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMVEH  148 (513)
Q Consensus        81 ~~~w~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~--~~w~d~~C~~~~~~iC~~~~  148 (513)
                      ++.|+|+||+++.|++|.+++|.                +|+.+....  +.|++..|....+|||+.++
T Consensus        80 ~~~w~W~dg~~~~~~~W~~g~P~----------------~C~~~~~~~~~g~W~~~~C~~~~~~ICe~~~  133 (135)
T 1umr_A           80 QCSTKWSDGSSVSYDNLLDLYIT----------------KCSLLKKETGFRKWFVASCIGKIPFVCKFPP  133 (135)
T ss_dssp             SSCCBCTTSCBCCCCCBCGGGCC----------------CEEEEEGGGTTCSBEEECTTCCEEEEEEECC
T ss_pred             CCccCcCCCCeecccccCCCCCC----------------ccEEEecCCCCCeEecCCCCCCCcEEeCccC
Confidence            69999999999999999998872                477776544  57999999999999999865

>1htn_A Tetranectin; plasminogen binding, kringle 4, alpha-helical coiled coil, C-type lectin, carbohydrate recognition domain; 2.80A {Homo sapiens} SCOP: d.169.1.1 h.1.1.1

Probab=99.93  E-value=3.1e-27  Score=212.51  Aligned_cols=126  Identities=16%  Similarity=0.311  Sum_probs=110.1

Q ss_pred             cCCCCCCCcccCCCCeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCC---CCCeEEeeeecCCCCCC
Q 010309            6 KAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN---VNGCWVGGRSINTTVGL   82 (513)
Q Consensus         6 ~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~---~~~~WiGl~~~~~~~~~   82 (513)
                      +..||.||.   ++++||+++...++|.+|+..|+.+||+||+|+|.+|++||.+++...   ...+||||+  +...++
T Consensus        48 ~~~Cp~gw~---~~~~CY~~~~~~~tw~~A~~~C~~~gg~La~i~s~~e~~~l~~~~~~~~~~~~~~WIGl~--~~~~~g  122 (182)
T 1htn_A           48 QTVCLKGTK---VHMKCFLAFTQTKTFHEASEDCISRGGTLSTPQTGSENDALYEYLRQSVGNEAEIWLGLN--DMAAEG  122 (182)
T ss_dssp             HHHHHHSEE---ETTEEEEEEEEEECHHHHHHHHHTTTCEECCCCSHHHHHHHHHHHHHHTCSSCEEEEEEE--CSSSTT
T ss_pred             cCCCCCCcE---ECCEEEEEECCCcCHHHHHHHHhhCCCEEeeeCCHHHHHHHHHHHHhccCCCCcEEEeeE--CCCCCC
Confidence            458999998   789999999999999999999999999999999999999999887422   357999999  666689


Q ss_pred             ceEEcCCCCCccCCcc---cCCCCCCCCCCCCCCCCcCCCceeEeec-CCCcccccccCCCCCcccccc
Q 010309           83 SWKWSDNMSKWNESIH---AVGSFNSSCTSLPCHVHATVDLCTLVSN-GSRSLVTERCNTSHPFICMVE  147 (513)
Q Consensus        83 ~w~W~dg~~~~~~~~~---~~~~~~~~~~~~~c~~~~~~~~C~~~~~-~~~~w~d~~C~~~~~~iC~~~  147 (513)
                      .|.|+||+++.|++|.   +++|.           +.+.++|+.+.. ..+.|++.+|....+|||+.+
T Consensus       123 ~w~W~dG~~~~y~nW~~~~~geP~-----------~~~~~~Cv~l~~~~~g~W~d~~C~~~~~fICe~~  180 (182)
T 1htn_A          123 TWVDMTGARIAYKNWETEITAQPD-----------GGKTENCAVLSGAANGKWFDKRCRDQLPYICQFG  180 (182)
T ss_dssp             CCBCTTSCBCCCCCBCCSSSCSCC-----------CTTTCCEEEEETTTTTEEEEECTTSCEEEEEEEE
T ss_pred             eEEeCCCCCccCCCCCCCCCCcCC-----------CCCCCCCEEEccCCCCCEECCCCCCCeeEEEEEe
Confidence            9999999999999999   88872           235678999874 456799999999999999975

>1buu_A Protein (mannose-binding protein A); lectin, HOST defense, metalloprotein, sugar binding protein; 1.90A {Rattus norvegicus} SCOP: d.169.1.1 h.1.1.1

Probab=99.93  E-value=2.1e-26  Score=204.03  Aligned_cols=122  Identities=13%  Similarity=0.171  Sum_probs=109.8

Q ss_pred             CCCCCCcccCCCCeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEc
Q 010309            8 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWS   87 (513)
Q Consensus         8 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~   87 (513)
                      .||++|.  .++++||+++...++|.+|+..|+.+||+||+|+|.+|++||.+++.   ..+||||+  +...++.|+|+
T Consensus        46 ~~~~~~~--~~~~~Cy~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~---~~~WIGl~--d~~~~g~w~W~  118 (168)
T 1buu_A           46 HAFSMGK--KSGKKFFVTNHERMPFSKVKALCSELRGTVAIPRNAEENKAIQEVAK---TSAFLGIT--DEVTEGQFMYV  118 (168)
T ss_dssp             HHHHTTC--CTTSCEEEEEEEEECHHHHHHHHHHTTSEECCCCSHHHHHHHHHHHC---SCEECSEE--CSSSTTCCEET
T ss_pred             ccCCCeE--EECCEEEEEeCCccCHHHHHHHHHhCCCEEeeeCCHHHHHHHHHHhc---CCEEeeee--cCCcCCCEEeC
Confidence            5899999  89999999999999999999999999999999999999999999985   57999999  76678999999


Q ss_pred             CCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCcccccc
Q 010309           88 DNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE  147 (513)
Q Consensus        88 dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~~  147 (513)
                      ||+++.|++|.+++|.+          ..+.|+|+.+. ..+.|++..|....+|||+.+
T Consensus       119 dG~~~~y~~W~~geP~~----------~~~~e~Cv~~~-~~g~W~d~~C~~~~~~ICe~~  167 (168)
T 1buu_A          119 TGGRLTYSNWKKDEPND----------HGSGEDCVTIV-DNGLWNDISCQASHTAVCEFP  167 (168)
T ss_dssp             TSSBCSCCCBSSSSCCC----------TTSCCCEEEEC-TTSCEEEECTTSCEEEEEEEC
T ss_pred             CCCCcCCCCCCCCCCCC----------CCCCCCeEEEC-CCCCEEccCCCCCEEEEEEec
Confidence            99999999999999832          13567899997 445899999999999999975

>3ff9_A Killer cell lectin-like receptor subfamily G member 1; natural killer cell receptor KLTG1, glycoprotein, membrane, phosphoprotein, signal-anchor; 1.80A {Mus musculus} SCOP: d.169.1.0 PDB: 3ff8_C

Probab=99.93  E-value=1.9e-26  Score=191.18  Aligned_cols=114  Identities=21%  Similarity=0.502  Sum_probs=99.0

Q ss_pred             CCCCCCcccCCCCeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEc
Q 010309            8 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWS   87 (513)
Q Consensus         8 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~   87 (513)
                      .||+||.  .|+++||+++.+.++|.+|+..|+.+||+||+|+|.+|++||.+++.  ...+||||+  +   ++.|+|+
T Consensus         1 ~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~--~~~~WIGl~--~---~~~w~W~   71 (115)
T 3ff9_A            1 MCPILWT--RNGSHCYYFSMEKKDWNSSLKFCADKGSHLLTFPDNQGVKLFGEYLG--QDFYWIGLR--N---IDGWRWE   71 (115)
T ss_dssp             CCCTTCE--EETTEEEEECSSCBCHHHHHHHHHHTTCEECCCTTSCCHHHHHTTCC--SSCEEEEEE--E---SSSEEET
T ss_pred             CCCccce--ecCCEEEEEEcCCcCHHHHHHHHHhcCCeeeeeCCHHHHHHHHHhhC--CCcEEEeee--e---CCceEeC
Confidence            4999999  89999999999999999999999999999999999999999999886  457999999  4   4789999


Q ss_pred             CCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCccccccc
Q 010309           88 DNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEH  148 (513)
Q Consensus        88 dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~~~  148 (513)
                      ||+++.| +|   .|            +.+.++|+.+...  +|++..|....+|||+.++
T Consensus        72 dg~~~~~-~~---~p------------~~~~~~C~~~~~~--~w~~~~C~~~~~fICe~~~  114 (115)
T 3ff9_A           72 GGPALSL-RI---LT------------NSLIQRCGAIHRN--GLQASSCEVALQWICKKVL  114 (115)
T ss_dssp             TSCBCCS-CC---BC------------SSTTCCEEEEETT--EEEEECTTSCBEEEEEEEC
T ss_pred             CCCcccc-cc---cC------------CCCCCCCeEEcCC--CcccccCCCCCceEEEEec
Confidence            9999877 33   22            1145689998764  5999999999999999864

>1jwi_A Bitiscetin; domain swapping, C-type lectin, toxin; 2.00A {Bitis arietans} SCOP: d.169.1.1 PDB: 1uex_A

Probab=99.93  E-value=1.1e-26  Score=197.56  Aligned_cols=122  Identities=29%  Similarity=0.581  Sum_probs=102.7

Q ss_pred             CCCCCCCcccCCCCeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCC---CC-CeEEeeeecCCCCCC
Q 010309            7 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN---VN-GCWVGGRSINTTVGL   82 (513)
Q Consensus         7 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~---~~-~~WiGl~~~~~~~~~   82 (513)
                      ..||+||+  .|+++||+++.+.++|.+|+..|+.+||+||+|+|.+|++||.+++...   .. .+||||++.+...++
T Consensus         2 ~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~~WIGl~~~~~~~~~   79 (131)
T 1jwi_A            2 PGCLPDWS--SYKGHCYKVFKKVGTWEDAEKFCVENSGHLASIDSKEEADFVTKLASQTLTKFVYDAWIGLRDESKTQQC   79 (131)
T ss_dssp             --CCTTSE--EETTEEEEEEEEEECHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHHHHC--CCSCEEEEEEECCSSSSS
T ss_pred             cCCCCCCE--EeCCEeEEEECCCcCHHHHHHHHHHcCCeECccCCHHHHHHHHHHHhhcccccCccEEEeeeecCCCCCC
Confidence            47999999  7999999999999999999999999999999999999999999887532   24 899999943444579


Q ss_pred             ceEEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCC--CcccccccCCCCCccccccc
Q 010309           83 SWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMVEH  148 (513)
Q Consensus        83 ~w~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~--~~w~d~~C~~~~~~iC~~~~  148 (513)
                      .|+|+||+++.|++|.  +|.                +|+.+....  +.|++..|....+|||+.+.
T Consensus        80 ~~~W~dg~~~~~~~W~--~P~----------------~C~~~~~~~~~~~w~~~~C~~~~~fICe~~~  129 (131)
T 1jwi_A           80 SPQWTDGSSVVYENVD--EPT----------------KCFGLDVHTEYRTWTDLPCGEKNPFICKSRL  129 (131)
T ss_dssp             CSBCTTSCBCCSCCBS--SCC----------------CEEEECGGGTTSSEEEECTTSCEEEEEEC--
T ss_pred             ceEEeCcCcccCcCCC--CCC----------------CceEEecCCCCCeEcCcCCCCCcceeeCcCC
Confidence            9999999999999997  661                477776543  57999999999999999865

>1j34_A Coagulation factor IX-binding protein A chain; magnesium ION, calcium ION, GLA domain, protein binding/blood clotting complex; HET: CGU; 1.55A {Trimeresurus flavoviridis} SCOP: d.169.1.1 PDB: 1bj3_A* 1j35_A* 1x2t_A* 1x2w_A 1ixx_A 1y17_A 1wt9_A 1iod_A*

Probab=99.93  E-value=1.4e-26  Score=196.19  Aligned_cols=121  Identities=28%  Similarity=0.584  Sum_probs=104.6

Q ss_pred             CCCCCCcccCCCCeeEEEECCCCChHHHHHHHhh--cCCEEeeeCCHHHHHHHHHHhCCC---CC-CeEEeeeecCCCCC
Q 010309            8 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN---VN-GCWVGGRSINTTVG   81 (513)
Q Consensus         8 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~---~~-~~WiGl~~~~~~~~   81 (513)
                      +||+||+  .|+++||+++.+.++|.+|+..|+.  .||+||+|+|.+|++||.+++...   .. .+||||+..+...+
T Consensus         1 ~Cp~gw~--~~~~~Cy~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~~WIGl~~~~~~~~   78 (129)
T 1j34_A            1 DCPSGWS--SYEGHCYKPFKLYKTWDDAERFCTEQAKGGHLVSIESAGEADFVAQLVTENIQNTKSYVWIGLRVQGKEKQ   78 (129)
T ss_dssp             CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCSHHHHHHHHHHHHHHCCCTTCCEEEEEEECSSCSC
T ss_pred             CCCCCcE--EeCCEEEEEECCCCCHHHHHHHHhccCCCCEECccCCHHHHHHHHHHHhhcccCCCCCEEEeeecCCCCCC
Confidence            5999999  7999999999999999999999999  899999999999999999887532   24 89999983333356


Q ss_pred             CceEEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCC--CcccccccCCCCCccccc
Q 010309           82 LSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMV  146 (513)
Q Consensus        82 ~~w~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~--~~w~d~~C~~~~~~iC~~  146 (513)
                      +.|+|+||+++.|++|.+++|.                +|+.+....  +.|++.+|....+|||+.
T Consensus        79 ~~~~W~dg~~~~~~~W~~~~P~----------------~C~~~~~~~~~~~w~~~~C~~~~~fiCe~  129 (129)
T 1j34_A           79 CSSEWSDGSSVSYENWIEAESK----------------TCLGLEKETGFRKWVNIYCGQQNPFVCEA  129 (129)
T ss_dssp             SCCBCTTSCBCCCCCBCGGGSC----------------CEEEECGGGTTCSBEEECTTSCEEEEEEC
T ss_pred             CceEECCcCccceeccCCCCCC----------------cceEEEccCCCCeEccCCCCCCCceEeeC
Confidence            9999999999999999998872                477775543  579999999999999974

>2ls8_A C-type lectin domain family 4 member D; structural genomics, NEW YORK structural genomics research consortium, nysgrc, PSI-biology, immune system; NMR {Homo sapiens}

Probab=99.88  E-value=8e-28  Score=210.88  Aligned_cols=127  Identities=21%  Similarity=0.440  Sum_probs=110.4

Q ss_pred             CCCCCCcccCCCCeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEc
Q 010309            8 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWS   87 (513)
Q Consensus         8 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~   87 (513)
                      +||.||.  .|+++||+++.+.++|.+|+..|+.+||+||+|+|.+|++||.+++.. ...+||||+  +...++.|+|+
T Consensus         2 ~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~-~~~~WIGl~--~~~~~~~w~W~   76 (156)
T 2ls8_A            2 VCPIDWR--AFQSNCYFPLTDNKTWAESERNCSGMGAHLMTISTEAEQNFIIQFLDR-RLSYFLGLR--DENAKGQWRWV   76 (156)
Confidence            6999999  899999999999999999999999999999999999999999998863 357999999  66567999999


Q ss_pred             CCCCC--ccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCC--CcccccccCCCCCccccccccC
Q 010309           88 DNMSK--WNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMVEHEN  150 (513)
Q Consensus        88 dg~~~--~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~--~~w~d~~C~~~~~~iC~~~~~~  150 (513)
                      ||+++  .|++|.+++|.+           .+.++|+.+....  +.|++..|....+|||+.+...
T Consensus        77 dG~~~~~~~~~W~~g~P~~-----------~~~~~Cv~l~~~~~~~~W~d~~C~~~~~fICe~~~~~  132 (156)
T 2ls8_A           77 DQTPFNPRRVFWHKNEPDN-----------SQGENCVVLVYNQDKWAWNDVPCNFEASRICKIPGTT  132 (156)
Confidence            99987  688999998832           2456788886543  3799999999999999987654

>2vuv_A Codakine; sugar-binding protein, C-type, lectin, mannose, invertebrate; HET: CIT; 1.3A {Codakia orbicularis} PDB: 2vuz_A*

Probab=99.93  E-value=1.6e-26  Score=195.85  Aligned_cols=123  Identities=23%  Similarity=0.469  Sum_probs=106.8

Q ss_pred             CCCCCCcccCCCCeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCC--CCCe--EEeeeecCCCCCCc
Q 010309            8 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN--VNGC--WVGGRSINTTVGLS   83 (513)
Q Consensus         8 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~--~~~~--WiGl~~~~~~~~~~   83 (513)
                      +||+||.  .|+++||+++...++|.+|+..|+.+||+||+|+|.+|++||.+++...  ...+  ||| .+ .  .++.
T Consensus         1 ~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~~WiG-~~-~--~~~~   74 (129)
T 2vuv_A            1 GCPDGWT--QFLDLCYIYQSAKASWASAQSSCQALGGILAEPDTACENEVLIHMCKENGDAGSFGPWLG-GQ-K--VGGA   74 (129)
T ss_dssp             CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHTTSEECCCCSHHHHHHHHHHHHHTTCCSSSCCEEE-EE-E--ETTE
T ss_pred             CCCcchh--hhCCEEEEEECCCcCHHHHHHHHHhcCCEECccCCHHHHHHHHHHHHhccCCCCcccccC-CC-C--CCCe
Confidence            5999999  7999999999999999999999999999999999999999999988643  3467  999 31 2  4689


Q ss_pred             eEEcC-CCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCccccccc
Q 010309           84 WKWSD-NMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEH  148 (513)
Q Consensus        84 w~W~d-g~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~~~  148 (513)
                      |+|+| |+++.|++|.+++|.+          ..+.++|+.+...+  |++..|....+|||+.++
T Consensus        75 ~~W~d~g~~~~~~~W~~~~P~~----------~~~~~~C~~~~~~~--w~~~~C~~~~~~ICe~~~  128 (129)
T 2vuv_A           75 WQWSSSGAAFDYLRWGPNEPNN----------SGGNEDCLHYNWLS--WNDLRCHYQASYLCQRAA  128 (129)
T ss_dssp             EEETTTCCBCSSCCBCTTCSCC----------TTSCCCEEEEETTE--EEEECTTSCEEEEEEEEC
T ss_pred             EEEcCCCCccccCCcCCCCCCC----------CCCCCCccEEcCCc--ccCCCCCCCcceEeeecC
Confidence            99999 9999999999998832          13567899997663  999999999999999865

>2e3x_B Coagulation factor X-activating enzyme light CHAI; disintegrin, metalloproteinase, C-type lectin, hydrolase, BL clotting, toxin; HET: NAG MAN GM6; 2.91A {Daboia russellii siamensis}

Probab=99.93  E-value=1.2e-26  Score=198.16  Aligned_cols=123  Identities=25%  Similarity=0.475  Sum_probs=106.8

Q ss_pred             CCCCCCcccCCCCeeEEEECCCCChHHHHHHHhh--cCCEEeeeCCHHHHHHHHHHhCCCC---C-CeEEeeeecCCCCC
Q 010309            8 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV---N-GCWVGGRSINTTVG   81 (513)
Q Consensus         8 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~~---~-~~WiGl~~~~~~~~   81 (513)
                      +||+||+  .|+++||+++.+.++|.+|+..|+.  .||+||+|+|.+|++||.+++....   . .+||||+..+...+
T Consensus         2 ~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~~WIGl~~~~~~~~   79 (134)
T 2e3x_B            2 DCPPDSS--LYRYFCYRVFKEHKTWEAAERFCMEHPNNGHLVSIESMEEAEFVAKLLSNTTGKFITHFWIGLMIKDKEQE   79 (134)
T ss_dssp             CCTTTSE--EETTEEEEEEEEEEEHHHHHHHHTSTTTTCCBCCCCSHHHHHHHHHHHHTCC----CEEECCEEECSSCTT
T ss_pred             CCCCCCE--EeCCEeeEEeCCCcCHHHHHHHHhccCCCcEEcccCCHHHHHHHHHHHHhhccCCCCCEEEeeeecCCCCC
Confidence            6999999  7999999999999999999999999  8999999999999999999886542   4 89999983233356


Q ss_pred             CceEEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCC--CcccccccCCCCCccccccc
Q 010309           82 LSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMVEH  148 (513)
Q Consensus        82 ~~w~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~--~~w~d~~C~~~~~~iC~~~~  148 (513)
                      +.|.|+||+++.|++|.+++|.                +|+.+....  +.|++..|....+|||+.++
T Consensus        80 ~~~~W~dg~~~~~~~W~~~~P~----------------~C~~~~~~~~~~~w~~~~C~~~~~~ICe~~~  132 (134)
T 2e3x_B           80 CSSEWSDGSSVSYDKLGKQEFR----------------KCFVLEKESGYRMWFNRNCEERYLFVCKVPP  132 (134)
T ss_dssp             TTCCCTTSCCCCCCCBCGGGCC----------------CEEEEEGGGTTCCBEEECTTSEEEEEEEECC
T ss_pred             CccEeCCCCcccccccCCCCCC----------------CeEEEEecCCCCcCCCCCCCCCcceEeCccC
Confidence            9999999999999999998872                477776544  57999999999999999864

>3c8j_A Natural killer cell receptor LY49C; MHC, virus, immune system; 2.60A {Mus musculus} SCOP: d.169.1.1 PDB: 3c8k_D 1p4l_D 1ja3_A 1p1z_D

Probab=99.93  E-value=1.2e-26  Score=211.71  Aligned_cols=123  Identities=18%  Similarity=0.325  Sum_probs=108.0

Q ss_pred             cCCCCCCCcccCCCCeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceE
Q 010309            6 KAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWK   85 (513)
Q Consensus         6 ~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~   85 (513)
                      +++||+||.  .|+++||+|+.+.++|.+|+..|+.+||+||+|+|.+|++||.+++.  ...+||||+  +...++.|+
T Consensus        77 ~~~Cp~gW~--~~~~~CY~~~~~~~tw~~A~~~C~~~g~~LasI~s~~E~~fl~~~~~--~~~~WIGl~--~~~~~~~w~  150 (203)
T 3c8j_A           77 TGRGVKYWF--CYSTKCYYFIMNKTTWSGCKANCQHYGVPILKIEDEDELKFLQRHVI--PGNYWIGLS--YDKKKKEWA  150 (203)
T ss_dssp             CCCCCEEEE--EEETEEEEEEEEEECHHHHHHHHHHTTCCBCCCCSHHHHHHHHHHSC--SSCEEEEEE--EETTTTEEE
T ss_pred             CCCCCCCcE--EeCCEEEEEECCCCCHHHHHHHHHhCCCEeeeeCCHHHHHHHHHhcC--CCCEEEeee--ecCCCCceE
Confidence            578999999  79999999999999999999999999999999999999999999986  467999999  444579999


Q ss_pred             EcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCcccccccc
Q 010309           86 WSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEHE  149 (513)
Q Consensus        86 W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~~~~  149 (513)
                      |+||+++.+ +|..++|.            .+.++|+.+...  .|++..|....+|||+.+..
T Consensus       151 W~DGs~~~~-~w~~~~pn------------~~~~~Cv~l~~~--~W~d~~C~~~~~fICe~~~~  199 (203)
T 3c8j_A          151 WIDNGPSKL-DMKIKKMN------------FKSRGCVFLSKA--RIEDIDCNIPYYCICGKKLD  199 (203)
T ss_dssp             ETTSCCCTT-HHHHHTTC------------CCSSSEEEECSS--CEEEECTTSCEEEEEEEECS
T ss_pred             ECCCCCCCC-CCCCCCCC------------CCCCCcEEEECC--cEECcCCCCCEEEEEeECCc
Confidence            999999875 78877762            245689998653  79999999999999998764

>1sb2_B Rhodocetin beta subunit; C-type lectin, domain swapping, toxin; 1.90A {Calloselasma rhodostoma} SCOP: d.169.1.1 PDB: 3gpr_B

Probab=99.93  E-value=1.8e-26  Score=195.62  Aligned_cols=118  Identities=22%  Similarity=0.432  Sum_probs=104.7

Q ss_pred             CCCCCCCcccCCCCeeEEEECCCCChHHHHHHHhh--cCCEEeeeCCHHHHHHHHHHhCCC----CCCeEEeeeecCCCC
Q 010309            7 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN----VNGCWVGGRSINTTV   80 (513)
Q Consensus         7 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~----~~~~WiGl~~~~~~~   80 (513)
                      ..||+||.  .|+++||+++.+.++|.+|+..|+.  .||+||+|+|.+|++||.+++...    ...+||||+      
T Consensus         2 ~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~~WiGl~------   73 (129)
T 1sb2_B            2 FRCPTTWS--ASKLYCYKPFKEKKTWIEAERFCAKQAENGHLVSIGSAAEADFLDLVIVVNFDKQRYRAWTGLT------   73 (129)
T ss_dssp             CCCCTTCE--ECSSEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCSHHHHHHHHHHHHHHC---CCCEEEEEE------
T ss_pred             CCCCCCCE--EeCCEeEEEECCCcCHHHHHHHHhhcCCCceECccCCHHHHHHHHHHHHhhcccCCCCEeEeec------
Confidence            47999999  7999999999999999999999999  899999999999999999887532    357999998      


Q ss_pred             CCceEEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCCC--cccccccCCCCCccccccc
Q 010309           81 GLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSR--SLVTERCNTSHPFICMVEH  148 (513)
Q Consensus        81 ~~~w~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~--~w~d~~C~~~~~~iC~~~~  148 (513)
                      ++.|+|+||+++.|++|.+++|.                +|+.+....+  .|++..|....+|||+.+.
T Consensus        74 ~~~~~W~dg~~~~~~~W~~~~P~----------------~C~~~~~~~~~~~W~~~~C~~~~~fICe~~~  127 (129)
T 1sb2_B           74 ERNLKWTNGASVSYENLYEPYIR----------------KCFVVQPWEGKSKWYKADCEEKNAFLCKFPK  127 (129)
T ss_dssp             ECCCBCTTSCBCCSCCBSSCCCC----------------CEEEEEEETTEEEEEEECTTSCEEEEEEEEC
T ss_pred             CCccEECCCCcccccccCCCCCC----------------CeEEEEecCCCCeEeCcCCCCCcceEecccC
Confidence            48999999999999999988872                4777765544  7999999999999999865

>1oz7_A Echicetin A-chain; platelet aggregation, dimer, toxin; 2.40A {Echis carinatus} SCOP: d.169.1.1

Probab=99.93  E-value=1.4e-26  Score=196.87  Aligned_cols=120  Identities=27%  Similarity=0.560  Sum_probs=105.5

Q ss_pred             CCCCCCcccCCCCeeEEEECCCCChHHHHHHHhh--cCCEEeeeCCHHHHHHHHHHhCCC---CCCeEEeeeecCCC--C
Q 010309            8 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN---VNGCWVGGRSINTT--V   80 (513)
Q Consensus         8 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~---~~~~WiGl~~~~~~--~   80 (513)
                      +||+||.  .|+++||+++.+.++|.+|+..|+.  .||+||+|+|.+|++||.+++...   ...+||||+  +..  .
T Consensus         1 ~Cp~gw~--~~~~~Cy~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~WIGl~--~~~~~~   76 (131)
T 1oz7_A            1 MCPPGWS--SNGVYCYMLFKEPKTWDEAEKFCNKQGKDGHLLSIESKKEEILVDIVVSENIGKMYKIWTGLS--ERSKEQ   76 (131)
T ss_dssp             CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCSHHHHHHHHHHHHHHSCCCSEEEEEEE--ECCCGG
T ss_pred             CcCCCcE--EeCCEEEEEECCCCCHHHHHHHHHhcCCCCEECccCCHHHHHHHHHHHHhhcCCCCCEEEeee--CCCCCC
Confidence            5999999  7999999999999999999999999  899999999999999999987532   357999999  544  5


Q ss_pred             CCceEEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCC--CcccccccCCCCCccccccc
Q 010309           81 GLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMVEH  148 (513)
Q Consensus        81 ~~~w~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~--~~w~d~~C~~~~~~iC~~~~  148 (513)
                      ++.|+|+||+++.|++|.+ +|.                +|+.+....  +.|++..|....+|||+.+.
T Consensus        77 ~~~~~W~dg~~~~~~~W~~-~P~----------------~Cv~~~~~~~~~~w~~~~C~~~~~fICe~~~  129 (131)
T 1oz7_A           77 HCSSRWSDGSFFRSYEIAI-RYS----------------ECFVLEKQSVFRTWVATPCENTFPFMCKYPV  129 (131)
T ss_dssp             GSCCBCSSSBCCSCCCCCC-SCC----------------CEEEEEGGGTTCSEEEECTTSCEEEEEEECT
T ss_pred             CCceEECCCCeeccccccC-CCC----------------CeEEEEccCCCCeEeecCCCCCCcEEeeecC
Confidence            7999999999999999998 772                477776554  57999999999999999865

>2msb_A Mannose-binding protein-A; lectin; HET: BMA MAN; 1.70A {Rattus rattus} SCOP: d.169.1.1 PDB: 1msb_A 1ytt_A*

Probab=99.92  E-value=2.1e-25  Score=184.93  Aligned_cols=113  Identities=14%  Similarity=0.218  Sum_probs=99.4

Q ss_pred             CCeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEcCCCCCccCCcc
Q 010309           19 KSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIH   98 (513)
Q Consensus        19 ~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~dg~~~~~~~~~   98 (513)
                      +++||+++...++|.+|+..|+.+||+||+|+|.+|++||.+++.   ..+||||+  +...++.|+|+||+++.|++|.
T Consensus         2 g~~Cy~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~---~~~WiGl~--~~~~~~~w~W~dg~~~~~~~W~   76 (115)
T 2msb_A            2 GKKFFVTNHERMPFSKVKALCSELRGTVAIPRNAEENKAIQEVAK---TSAFLGIT--DEVTEGQFMYVTGGRLTYSNWK   76 (115)
T ss_dssp             --CEEEEEEEEECHHHHHHHHHHTTCEECCCSSHHHHHHHHHHHS---SCEEEEEE--CSSSTTCCEETTSSBCCSCCBC
T ss_pred             CCEEEEEeCCCcCHHHHHHHHHhCCCEEeccCCHHHHHHHHHhhc---CCEEEeeE--cCCCCCcEEECCCCEeeecCcC
Confidence            688999999999999999999999999999999999999999985   57999999  6667899999999999999999


Q ss_pred             cCCCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCcccccc
Q 010309           99 AVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE  147 (513)
Q Consensus        99 ~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~~  147 (513)
                      +++|.+          ..+.++|+.+. ..+.|++..|....+|||+.+
T Consensus        77 ~~~P~~----------~~~~~~C~~~~-~~g~W~~~~C~~~~~fiCe~~  114 (115)
T 2msb_A           77 KDEPND----------HGSGEDCVTIV-DNGLWNDISCQASHTAVCEFP  114 (115)
T ss_dssp             TTCCCC----------CTTCCCEEEEC-TTSCEEEECTTSCEEEEEEEC
T ss_pred             CCCCCC----------CCCCCCeEEEC-CCCCEECcCCCCCeEEEEeEc
Confidence            998832          13567899987 345899999999999999975

>1h8u_A MBP, eosinophil granule major basic protein 1; lectin, eosinophil granule protein, EMBP; 1.8A {Homo sapiens} SCOP: d.169.1.1 PDB: 2brs_A*

Probab=99.92  E-value=2.9e-25  Score=184.69  Aligned_cols=114  Identities=16%  Similarity=0.340  Sum_probs=98.9

Q ss_pred             ee-EEEECCCCChHHHHHHHhh-cCCEEeeeCCHHHHHHHHHHhCCC-CCCeEEeeeecCCCCCCceEEcCCCCCccCCc
Q 010309           21 KC-FGYIGNFRSWDESETYCKE-IGGHLAALTSYEEEHSAQKLCGKN-VNGCWVGGRSINTTVGLSWKWSDNMSKWNESI   97 (513)
Q Consensus        21 ~C-y~~~~~~~~w~~a~~~C~~-~~~~L~~i~~~~e~~f~~~~~~~~-~~~~WiGl~~~~~~~~~~w~W~dg~~~~~~~~   97 (513)
                      +| |+++...++|.+|+..|+. .||+||+|+|.+|++||.+++... ...+||||++.+...++.|+|+||+++.|.+|
T Consensus         1 ~C~Y~~~~~~~tw~~A~~~C~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~WIGl~~~~~~~~~~~~W~dg~~~~y~~W   80 (117)
T 1h8u_A            1 TCRYLLVRSLQTFSQAWFTCRRCYRGNLVSIHNFNINYRIQCSVSALNQGQVWIGGRITGSGRCRRFQWVDGSRWNFAYW   80 (117)
T ss_dssp             --CEEEEEEEECHHHHHHHHHHHHSSEECCCCSHHHHHHHHHHHTTCSSSEEEEEEEEECSSSCCEEEETTCCCCCCCCB
T ss_pred             CeEEEEeCCccCHHHHHHHhccCCCCeEEeecCHHHHHHHHHHHhccCCCCEEEcccccCCCCCCccEeCCCCcCCccCc
Confidence            59 9999999999999999999 999999999999999999998744 35799999965555679999999999999999


Q ss_pred             ccCCCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCccccc
Q 010309           98 HAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMV  146 (513)
Q Consensus        98 ~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~  146 (513)
                      .+++|.+            +.++|+.+....+.|++.+|....+|||+.
T Consensus        81 ~~~~P~~------------~~~~C~~~~~~~g~W~~~~C~~~~~fiCe~  117 (117)
T 1h8u_A           81 AAHQPWS------------RGGHCVALCTRGGYWRRAHCLRRLPFICSY  117 (117)
T ss_dssp             CSSSCCT------------TSCSEEEEETTTTCEEEECTTSCEEEEEEC
T ss_pred             CCCCCCC------------CCCCCeEEECCCCcCCCCCCCCCcceeEeC
Confidence            9999832            246899998766789999999999999974

>1wk1_A Hypothetical protein YK1067A12; lectin C-type domain, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Caenorhabditis elegans} SCOP: d.169.1.1

Probab=99.92  E-value=2.5e-25  Score=193.71  Aligned_cols=119  Identities=16%  Similarity=0.279  Sum_probs=104.1

Q ss_pred             cCCCCeeEEEECCC---CChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEcCCCCC
Q 010309           16 NEEKSKCFGYIGNF---RSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSK   92 (513)
Q Consensus        16 ~~~~~~Cy~~~~~~---~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~dg~~~   92 (513)
                      ++|+++||+|+...   ++|.+|+..|+.+||+||+|+|.+|++||.+++.  ...+||||+  + ..++.|+|+||+++
T Consensus         1 ~~~~~~CY~~~~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~--~~~~WIGl~--~-~~~~~w~W~dg~~~   75 (150)
T 1wk1_A            1 GSSGSSGVKFLTVNDDILSMPQARNFCASAGGYLADDLGDDKNNFYSSIAA--NTQFWIGLF--K-NSDGQFYWDRGQGI   75 (150)
T ss_dssp             CCCSSCCCCSSSCCSSCBCHHHHHHHHHHHTCEECCCCSHHHHHHHHHHTT--TCEEEEEEE--E-CSSSCEEECCSSSS
T ss_pred             CccCCEEEEEEecCCCccCHHHHHHHHHhCCCEEeeeCCHHHHHHHHHhhc--cCCEEEEEE--e-CCCCcEEeCCCCcc
Confidence            36899999999999   9999999999999999999999999999999987  347999999  5 56799999999998


Q ss_pred             -------ccCCcccCCCCCCCCCCCCCCCCcCCCceeEee----cCCCcccccccCCCCCccccccccC
Q 010309           93 -------WNESIHAVGSFNSSCTSLPCHVHATVDLCTLVS----NGSRSLVTERCNTSHPFICMVEHEN  150 (513)
Q Consensus        93 -------~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~----~~~~~w~d~~C~~~~~~iC~~~~~~  150 (513)
                             .|.+|.+++|.           +.+.++|+.+.    ...+.|++..|....+|||+.+...
T Consensus        76 ~~~~~~~~y~~W~~geP~-----------~~~~~~Cv~~~~~~~~~~~~W~d~~C~~~~~fICe~~~~~  133 (150)
T 1wk1_A           76 NPDLLNQPITYWANGEPS-----------NDPTRQCVYFDGRSGDKSKVWTTDTCATPRPFICQKHRYD  133 (150)
T ss_dssp             CCEECCCSCCCBCTTCSC-----------CCSSCCEEEEESSCSCGGGCEEEECTTSCBCCCEECCCCC
T ss_pred             ccccccCCcCCCCCCCCC-----------CCCCCCcEEEeCccCCCCCEEeCcCcCCCeeEEEeecCCC
Confidence                   89999999883           23467899987    3446799999999999999986544

>3g8l_A Lectin-related NK cell receptor LY49L1; natural killer cell receptor, immune system; 2.50A {Mus musculus}

Probab=99.92  E-value=9.3e-26  Score=203.93  Aligned_cols=124  Identities=17%  Similarity=0.303  Sum_probs=106.6

Q ss_pred             CcCCCCC-CCcccCCCCeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCc
Q 010309            5 WKAPCPP-DWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLS   83 (513)
Q Consensus         5 ~~~~Cp~-~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~   83 (513)
                      .++.||+ ||.  .|+++||+|+.+.++|.+|+..|+.+||+||+|+|.+|++||..++.  ...+||||+  +...++.
T Consensus        62 ~~~~Cp~~gW~--~~~~~CY~~~~~~~tw~~A~~~C~~~g~~LasI~s~~e~~fl~~~~~--~~~~WIGl~--~~~~~~~  135 (190)
T 3g8l_A           62 HTGRGFEKYWF--CYGIKCYYFVMDRKTWSGCKQTCQISSLSLLKIDNEDELKFLKLLVP--SDSYWIGLS--YDNKKKD  135 (190)
T ss_dssp             STTCEEEEEEE--EEETEEEEEEEEEECHHHHHHHHHHTTCEECCCCSHHHHHHHHHHSC--SSCEEEEEE--EETTTTE
T ss_pred             CCCCCCCCCcE--EECCEEEEEEcccCCHHHHHHHHHhCCCEEeeeCCHHHHHHHHHhhC--cCCEEEEEE--cCCCCCc
Confidence            3578999 999  79999999999999999999999999999999999999999999986  468999999  4445799


Q ss_pred             eEEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCcccccccc
Q 010309           84 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEHE  149 (513)
Q Consensus        84 w~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~~~~  149 (513)
                      |+|+||+++.+.+|..+ |            +.+.++|+.+..  +.|++..|....+|||+.+..
T Consensus       136 w~W~DGs~~~~~~~~~~-~------------~~~~~~Cv~l~~--~~W~d~~C~~~~~fICek~~~  186 (190)
T 3g8l_A          136 WAWINNGPSKLALNTMK-Y------------NIRDGGCMLLSK--TRLDNDNCDKSFICICGKRLD  186 (190)
T ss_dssp             EEETTTBCCCCCCCGGG-C------------CGGGCSEEEECS--SCEEEECTTSCEEEEEEEECC
T ss_pred             eEeCCCCcccccccCCC-C------------CCCCCCeEEEeC--CcEECCCCCCCeeEEEeeCCC
Confidence            99999998877776543 2            224567999854  479999999999999998754

>1rdl_1 SUB-MBP-C, mannose-binding protein-C; C-type lectin, calcium-binding protein; HET: MMA; 1.70A {Rattus rattus} SCOP: d.169.1.1 PDB: 1rdj_1* 1rdk_1* 1rdi_1* 1rdm_1* 1rdn_1* 1rdo_1 1bv4_A 1kza_1* 1kzb_1* 1kzc_1* 1kzd_1* 1kze_1*

Probab=99.92  E-value=8e-25  Score=180.74  Aligned_cols=112  Identities=13%  Similarity=0.178  Sum_probs=98.8

Q ss_pred             CeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEcCCCCCccCCccc
Q 010309           20 SKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHA   99 (513)
Q Consensus        20 ~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~dg~~~~~~~~~~   99 (513)
                      .+||+++.+.++|.+|+..|+.+||+||+|+|.+|++||.+++.   ..+||||+  +...++.|+|+||+++.|++|.+
T Consensus         1 ~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~---~~~WIGl~--~~~~~~~~~W~dg~~~~y~~W~~   75 (113)
T 1rdl_1            1 KKYFMSSVRRMPLNRAKALCSELQGTVATPRNAEENRAIQNVAK---DVAFLGIT--DQRTENVFEDLTGNRVRYTNWNE   75 (113)
T ss_dssp             -CEEEECSSCBCHHHHHHHHHHTTCEECCCCSHHHHHHHHHHCS---SCEEEEEE--CSSSTTCCEETTSCBCCCCCBCT
T ss_pred             CeEEEEeCCccCHHHHHHHHHhcCCEEcccCCHHHHHHHHHHhc---CCEEEEeE--CCCCCCcEEECCCCEeecCCCCC
Confidence            47999999999999999999999999999999999999999873   67999999  65667999999999999999999


Q ss_pred             CCCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCcccccc
Q 010309          100 VGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE  147 (513)
Q Consensus       100 ~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~~  147 (513)
                      ++|.+          ..+.++|+.+.. .+.|++..|....+|||+.+
T Consensus        76 ~~P~~----------~~~~~~Cv~~~~-~g~w~~~~C~~~~~~ICe~~  112 (113)
T 1rdl_1           76 GEPNN----------VGSGENCVVLLT-NGKWNDVPCSDSFLVVCEFS  112 (113)
T ss_dssp             TCCCC----------CTTCCCEEEECT-TSCEEEECTTSCBEEEEEEC
T ss_pred             CcCCC----------CCCCCCeeEECC-CCcEeccCCCCCceEEEeeC
Confidence            98832          135678999864 46899999999999999975

>1fm5_A Early activation antigen CD69; C-type lectin-like domain, natural killer cell receptor, lectin, C-type lectin, immune system; 2.27A {Homo sapiens} SCOP: d.169.1.1

Probab=99.91  E-value=9.1e-25  Score=198.82  Aligned_cols=118  Identities=25%  Similarity=0.552  Sum_probs=100.4

Q ss_pred             CcCCCCCCCcccCCCCeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCce
Q 010309            5 WKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSW   84 (513)
Q Consensus         5 ~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w   84 (513)
                      .+..||.||.  .|+++||+++.+.++|.+|+..|+.+||+||+|+|++|++||.+++.  ...|||||+  +.. ++.|
T Consensus        81 ~~~~Cp~gW~--~~~~~CY~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~fl~~~~~--~~~~WIGl~--~~~-~~~w  153 (199)
T 1fm5_A           81 HVSSCSEDWV--GYQRKCYFISTVKRSWTSAQNACSEHGATLAVIDSEKDMNFLKRYAG--REEHWVGLK--KEP-GHPW  153 (199)
T ss_dssp             ----CCTTSE--EETTEEEEECSSCBCHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHC--SSCEEEEEE--CCT-TSCC
T ss_pred             CCCCCCCCcE--EECCEEEEEeCCccCHHHHHHHHhhcCCEEEecCCHHHHHHHHHhhC--CCCEEeeeE--ECC-CCCe
Confidence            4578999999  89999999999999999999999999999999999999999999997  468999999  554 7999


Q ss_pred             EEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCccccccc
Q 010309           85 KWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEH  148 (513)
Q Consensus        85 ~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~~~  148 (513)
                      +|+||++  |++|.   +            +.+.++|+.+..  +.|++..|....+|||+.+.
T Consensus       154 ~W~DGs~--~~~W~---~------------~~~~~~Cv~l~~--~~W~d~~C~~~~~fICe~~~  198 (199)
T 1fm5_A          154 KWSNGKE--FNNWF---N------------VTGSDKCVFLKN--TEVSSMECEKNLYWICNKPY  198 (199)
T ss_dssp             EETTSCB--CCCSS---C------------CCSSSSEEEECS--SCEEEECTTSCBEEEEEEEC
T ss_pred             EECCCCc--ccccc---C------------CCCCCCceEEEC--CCEEEecCCCCEEEEccccC
Confidence            9999987  45775   1            224568998865  57999999999999999753

>1pwb_A SP-D, PSP-D, pulmonary surfactant-associated protein D; collectin, C-type lectin, alpha-helical coiled coil, carbohydrate recognition domain; HET: GLC; 1.40A {Homo sapiens} SCOP: d.169.1.1 h.1.1.1 PDB: 1pw9_A* 3ikn_A* 3ikp_A* 3ikq_A* 3ikr_A* 2rie_A* 2ggx_A* 2ggu_A* 2ork_A* 2orj_A* 2ria_A* 2rib_A* 2ric_A* 2rid_A* 2os9_A* 3dbz_A 3g81_A* 3g83_A* 1b08_A 3g84_A* ...

Probab=99.91  E-value=1.6e-25  Score=200.38  Aligned_cols=124  Identities=15%  Similarity=0.220  Sum_probs=108.7

Q ss_pred             CCCCCCcccCCCCeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEc
Q 010309            8 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWS   87 (513)
Q Consensus         8 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~   87 (513)
                      .|+++|.  .++++||+++...++|.+|+.+|+.+||+||+|+|.+|++||.+++......+||||+  +...++.|+|+
T Consensus        54 ~~~~~~~--~~~~~Cy~~~~~~~~w~~A~~~C~~~gg~La~i~s~~e~~~l~~~~~~~~~~~WIGl~--~~~~~~~w~W~  129 (177)
T 1pwb_A           54 ELFPNGQ--SVGEKIFKTAGFVKPFTEAQLLCTQAGGQLASPRSAAENAALQQLVVAKNEAAFLSMT--DSKTEGKFTYP  129 (177)
T ss_dssp             HHTTTEE--EETTEEEEEEEEEEEHHHHHHHHHHTTSEECCCCSHHHHHHHHHHHHHHTCCEECSCB--CSSSTTCCBCT
T ss_pred             hcCCCeE--EECCEEEEEcCCccCHHHHHHHHHhcCCEEcccCCHHHHHHHHHHHhcCCCcEEEEEe--ccCcCCceEeC
Confidence            4778999  7999999999999999999999999999999999999999999988433468999999  66668999999


Q ss_pred             CCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCccccc
Q 010309           88 DNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMV  146 (513)
Q Consensus        88 dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~  146 (513)
                      ||+++.|++|.+++|.+          ..+.|+|+.+.. .+.|+|..|....+|||+.
T Consensus       130 dG~~~~y~~W~~geP~~----------~~~~~~Cv~~~~-~g~W~d~~C~~~~~fICe~  177 (177)
T 1pwb_A          130 TGESLVYSNWAPGEPND----------DGGSEDCVEIFT-NGKWNDRACGEKRLVVCEF  177 (177)
T ss_dssp             TSCBCSCCCBCTTCCCC----------GGGCCCEEEECT-TSCEEEECTTSEEEEEEEC
T ss_pred             CcCCcccCCcCCCcCCC----------CCCCCCcEEECC-CCcEeCCCCCCCeeEEEeC
Confidence            99999999999999822          135678999864 4689999999999999973

>3pbf_A Pulmonary surfactant-associated protein A; collectin, carbohydrate binding, lectin, mannose, sugar BIND protein; 1.80A {Rattus norvegicus} PDB: 1r14_A* 1r13_A* 3paq_A* 3par_A 3pak_A

Probab=99.91  E-value=5.9e-25  Score=190.85  Aligned_cols=122  Identities=15%  Similarity=0.190  Sum_probs=104.8

Q ss_pred             CCCCCcccCCCCeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEcC
Q 010309            9 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSD   88 (513)
Q Consensus         9 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~d   88 (513)
                      +...+.  .++++||+++.+.++|.+|+..|+.+||+||+|+|.+|++||.+++......+||||+  +...++.|.|+|
T Consensus        27 ~~~~~~--~~~~~Cy~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~WIGl~--~~~~~~~w~W~d  102 (148)
T 3pbf_A           27 LQGSML--SVGDKVFSTNGQSVNFDTIKEMCTRAGGNIAVPRTPEENEAIASIAKKYNNYVYLGMI--EDQTPGDFHYLD  102 (148)
T ss_dssp             HTTSCE--EETTEEEEEEEEEECHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHHHHTSCEEEEEE--ECSSTTCEEETT
T ss_pred             HHhcce--eeCCEEEEEcCCccCHHHHHHHHhhcCCEEeeeCCHHHHHHHHHHHHhCCCCEEEEeE--ecCCCCceEeCC
Confidence            345556  7999999999999999999999999999999999999999999988633357999999  544579999999


Q ss_pred             CCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCccccc
Q 010309           89 NMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMV  146 (513)
Q Consensus        89 g~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~  146 (513)
                      |+++.|.+|.+++|.+           .+.++|+.+.. .+.|++.+|....+|||+.
T Consensus       103 g~~~~~~~W~~~~P~~-----------~~~~~Cv~~~~-~g~W~~~~C~~~~~fICe~  148 (148)
T 3pbf_A          103 GASVSYTNWYPGEPRG-----------QGKEKCVEMYT-DGTWNDRGCLQYRLAVCEF  148 (148)
T ss_dssp             SCBCCSCCBCTTCCCS-----------TTSCCEEEECT-TSCEEEECSCSCEEEEEEC
T ss_pred             CCCcccCCcCCCccCc-----------CCCCCceEECC-CCcEecCCCCCCeeEeeeC
Confidence            9999999999999832           24568998865 4589999999999999973

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.90  E-value=1.2e-24  Score=209.79  Aligned_cols=144  Identities=17%  Similarity=0.148  Sum_probs=116.6

Q ss_pred             cccCCceecccCceEEEEEEeCCCCEEEEEEecccch------------------hcHHHHHHHHHHHhhcCCCcEeeee
Q 010309          226 FSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSF------------------QRKKEFYSEIGRFARLHHPNLVAVK  287 (513)
Q Consensus       226 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~l~  287 (513)
                      ++...+.||+|+||.||+|...+|+.||||+++....                  .....+.+|+.++++++  | +++.
T Consensus        91 ~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~  167 (282)
T 1zar_A           91 VDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP  167 (282)
T ss_dssp             CSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred             EEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence            3334578899999999999997799999999965321                  13456899999999999  5 6666


Q ss_pred             eEEeeCCceEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCe
Q 010309          288 GCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA  367 (513)
Q Consensus       288 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~  367 (513)
                      +++.. +..++||||+++++|.+ +..          .....++.|++.||.|||+.   +|+||||||+|||++ ++.+
T Consensus       168 ~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~~v  231 (282)
T 1zar_A          168 KVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGI  231 (282)
T ss_dssp             CEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TTEE
T ss_pred             eEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CCcE
Confidence            65543 56799999999999988 421          12457999999999999999   999999999999999 9999


Q ss_pred             EEecccccccCCccccccceeecCcccccccccccc
Q 010309          368 HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY  403 (513)
Q Consensus       368 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  403 (513)
                      ||+|||++.               .+..++|||++.
T Consensus       232 kl~DFG~a~---------------~~~~~~a~e~l~  252 (282)
T 1zar_A          232 WIIDFPQSV---------------EVGEEGWREILE  252 (282)
T ss_dssp             EECCCTTCE---------------ETTSTTHHHHHH
T ss_pred             EEEECCCCe---------------ECCCCCHHHHHH
Confidence            999999986               334578899874

>1byf_A TC14, protein (polyandrocarpa lectin); C-type lectin, galactose-specific, sugar binding protein; 2.00A {Polyandrocarpa misakiensis} SCOP: d.169.1.1 PDB: 1tlg_A*

Probab=99.90  E-value=4.1e-24  Score=179.91  Aligned_cols=118  Identities=16%  Similarity=0.247  Sum_probs=99.3

Q ss_pred             CCeeEEEECCCCChHHHHHHHhhcCCEEee--eCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCc--eEEcCCCCC-c
Q 010309           19 KSKCFGYIGNFRSWDESETYCKEIGGHLAA--LTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLS--WKWSDNMSK-W   93 (513)
Q Consensus        19 ~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~--i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~--w~W~dg~~~-~   93 (513)
                      +++||+++.+.++|.+|+..|+.+||+||+  |+|.+|++||.++.......+|||| +..  .++.  |+|+||+++ .
T Consensus         1 g~~Cy~~~~~~~~w~~A~~~C~~~g~~La~~~i~s~~e~~~l~~~~~~~~~~~WIGl-~~~--~~~~~~w~W~dg~~~~~   77 (125)
T 1byf_A            1 MDYEILFSDETMNYADAGTYCQSRGMALVSSAMRDSTMVKAILAFTEVKGHDYWVGA-DNL--QDGAYNFLWNDGVSLPT   77 (125)
T ss_dssp             -CEEEEEEEEEECHHHHHHHHHTTTCEESCGGGGSHHHHHHHHHHHHHHTCCEEEEE-EST--TTCTTCCEETTSCBCCT
T ss_pred             CCeEEEEeCCCCCHHHHHHHHHHcCCEeeecCCCCHHHHHHHHHhcCCCCCCEEEec-ccC--CCCceeEEECCCCCCcc
Confidence            478999999999999999999999999999  9999999999988211146799999 433  4688  999999999 8


Q ss_pred             cC-CcccCCCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCcccccccc
Q 010309           94 NE-SIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEHE  149 (513)
Q Consensus        94 ~~-~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~~~~  149 (513)
                      |. +|.+++|.+          ..+.|+|+.+....+.|++..|....+|||+.++.
T Consensus        78 ~~~~W~~~~P~~----------~~~~~~Cv~~~~~~~~W~d~~C~~~~~fICe~~~~  124 (125)
T 1byf_A           78 DSDLWSPNEPSN----------PQSWQLCVQIWSKYNLLDDVGCGGARRVICEKELD  124 (125)
T ss_dssp             TCTTBCTTCSCS----------CTTSCCEEEEETTTTEEEEECSCSCEEEEEEEECC
T ss_pred             cccCcCCCcCCC----------CCCCCCceEEECCCCcEECcCCCCceeEEEeeeCC
Confidence            99 999998832          13567899998544689999999999999998754

>3cfw_A L-selectin; EGF, cell adhesion, EGF-like domain, glycoprotein, membrane, sushi, transmembrane; HET: NAG MAN BMA; 2.20A {Homo sapiens}

Probab=99.86  E-value=4.9e-22  Score=175.48  Aligned_cols=114  Identities=16%  Similarity=0.296  Sum_probs=97.6

Q ss_pred             eeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEcCCCC-C--ccCCc
Q 010309           21 KCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMS-K--WNESI   97 (513)
Q Consensus        21 ~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~dg~~-~--~~~~~   97 (513)
                      .||+|+..+++|.+|+..|+.+||+||+|+|.+|++||.+++......+||||+  +.  ++.|+|+||++ +  .|++|
T Consensus         1 wcY~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~fl~~~~~~~~~~~WIGl~--~~--~~~~~W~dg~~~~~~~y~~W   76 (164)
T 3cfw_A            1 WTYHYSEKPMNWQRARRFCRDNYTDLVAIQNKAEIEYLEKTLPFSRSYYWIGIR--KI--GGIWTWVGTNKSLTEEAENW   76 (164)
T ss_dssp             CEEEEEEEEECHHHHHHHHHHHSSEECCCCSHHHHHHHHHHSCCCTTCEEESEE--EE--TTEEEETTTCCBCCTTTCCB
T ss_pred             CeEEEecCCcCHHHHHHHHHHCCCEECccCCHHHHHHHHHHhccCCccEEEeEE--CC--CCEEEECCCCcccccccCCC
Confidence            499999999999999999999999999999999999999998754568999999  43  58999999985 3  48899


Q ss_pred             ccCCCCCCCCCCCCCCCCcCCCceeEeec----CCCcccccccCCCCCccccccc
Q 010309           98 HAVGSFNSSCTSLPCHVHATVDLCTLVSN----GSRSLVTERCNTSHPFICMVEH  148 (513)
Q Consensus        98 ~~~~~~~~~~~~~~c~~~~~~~~C~~~~~----~~~~w~d~~C~~~~~~iC~~~~  148 (513)
                      .+++|.+          ..+.|+|+.+..    ..+.|++..|....+|||+.++
T Consensus        77 ~~geP~~----------~~~~~~Cv~~~~~~~~~~~~W~d~~C~~~~~fICe~~~  121 (164)
T 3cfw_A           77 GDGEPNN----------KKNKEDCVEIYIKRNKDAGKWNDDACHKLKAALCYTAS  121 (164)
T ss_dssp             CTTCCCC----------GGGCCCEEEECTTCSSSTTCEEEECTTSCEEEEEEECC
T ss_pred             CCCCCCC----------CCCCccceeeeccCCCCCCceeCCCCCCCcEeEEccCC
Confidence            9999832          124678999864    3467999999999999999875

>1g1t_A E-selectin; EGF, adhesion molecule, SLEX, immune system, membrane protein; HET: SIA GAL MAG FUC; 1.50A {Homo sapiens} SCOP: d.169.1.1 g.3.11.1 PDB: 1esl_A

Probab=99.86  E-value=8.5e-22  Score=172.66  Aligned_cols=113  Identities=18%  Similarity=0.310  Sum_probs=96.8

Q ss_pred             eEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEcCCCC-C--ccCCcc
Q 010309           22 CFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMS-K--WNESIH   98 (513)
Q Consensus        22 Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~dg~~-~--~~~~~~   98 (513)
                      ||+|+.+.++|.+|+..|+.+||+||+|+|.+|++||.+++......+||||+  +.  ++.|+|+||++ +  .|++|.
T Consensus         2 ~Y~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~WIGl~--~~--~~~~~W~dg~~~~~~~y~~W~   77 (157)
T 1g1t_A            2 SYNTSTEAMTYDEASAYCQQRYTHLVAIQNKEEIEYLNSILSYSPSYYWIGIR--KV--NNVWVWVGTQKPLTEEAKNWA   77 (157)
T ss_dssp             EEEECSSCBCHHHHHHHHHHHSSEECCCCSHHHHHHHHHHSCCCTTCEEESEE--EE--TTEEEETTTCCBCCTTTCCBC
T ss_pred             ceEeCCCccCHHHHHHHHHHCCCEEcccCCHHHHHHHHHHhccCCCCEEEEEE--CC--CCeeEEeCCCccCCcccCCCC
Confidence            89999999999999999999999999999999999999998754567999999  43  58999999984 4  488999


Q ss_pred             cCCCCCCCCCCCCCCCCcCCCceeEeec----CCCcccccccCCCCCccccccc
Q 010309           99 AVGSFNSSCTSLPCHVHATVDLCTLVSN----GSRSLVTERCNTSHPFICMVEH  148 (513)
Q Consensus        99 ~~~~~~~~~~~~~c~~~~~~~~C~~~~~----~~~~w~d~~C~~~~~~iC~~~~  148 (513)
                      +++|.+          ..+.|+|+.+..    ..+.|++..|....+|||+.+.
T Consensus        78 ~geP~~----------~~~~~~Cv~~~~~~~~~~~~W~d~~C~~~~~fICe~~~  121 (157)
T 1g1t_A           78 PGEPNN----------RQKDEDCVEIYIKREKDVGMWNDERCSKKKLALCYTAA  121 (157)
T ss_dssp             TTCCCC----------CSTTCCEEEECTTCSSSTTCEEEECTTSCBEEEEEECC
T ss_pred             CCcCCC----------CCCCCCceEEeCcCCCCCCccccCCCCCCcceEeCcCC
Confidence            998832          124678999864    2467999999999999999864

>1g1s_A P-selectin; selectin, lectin, EGF, sulphated, SLEX, immune system, membr protein; HET: TYS SIA GAL NAG FUC NGA; 1.90A {Homo sapiens} SCOP: d.169.1.1 g.3.11.1 PDB: 1g1r_A* 1g1q_A* 1fsb_A

Probab=99.86  E-value=6.6e-22  Score=174.26  Aligned_cols=113  Identities=19%  Similarity=0.329  Sum_probs=97.0

Q ss_pred             eEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEcCCC-CCc--cCCcc
Q 010309           22 CFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNM-SKW--NESIH   98 (513)
Q Consensus        22 Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~dg~-~~~--~~~~~   98 (513)
                      ||+|+...++|.+|+..|+.+||+||+|+|.+|++||.+++......+||||++  .  ++.|+|+||+ ++.  |++|.
T Consensus         2 ~Y~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~WIGl~~--~--~~~~~W~dg~~~~~~~~~~W~   77 (162)
T 1g1s_A            2 TYHYSTKAYSWNISRKYCQNRYTDLVAIQNKNEIDYLNKVLPYYSSYYWIGIRK--N--NKTWTWVGTKKALTNEAENWA   77 (162)
T ss_dssp             EEEEEEEEECHHHHHHHHHHHSSEECCCCCHHHHHHHHHHSCCCTTCEEEEEEE--E--TTEEEETTTCCBCCTTTCCBC
T ss_pred             eEEEecCCcCHHHHHHHHHhcCCEEeeeCCHHHHHHHHHHhccCCCCEEEeEEC--C--CCCeEECCCCccCCcccCccC
Confidence            899999999999999999999999999999999999999987555689999994  3  5899999996 553  88999


Q ss_pred             cCCCCCCCCCCCCCCCCcCCCceeEeec----CCCcccccccCCCCCccccccc
Q 010309           99 AVGSFNSSCTSLPCHVHATVDLCTLVSN----GSRSLVTERCNTSHPFICMVEH  148 (513)
Q Consensus        99 ~~~~~~~~~~~~~c~~~~~~~~C~~~~~----~~~~w~d~~C~~~~~~iC~~~~  148 (513)
                      +++|.+          ..+.|+|+.+..    ..+.|++..|....+|||+.+.
T Consensus        78 ~geP~~----------~~~~~~Cv~~~~~~~~~~~~W~d~~C~~~~~fICe~~~  121 (162)
T 1g1s_A           78 DNEPNN----------KRNNEDCVEIYIKSPSAPGKWNDEHCLKKKHALCYTAS  121 (162)
T ss_dssp             TTCCCC----------TTSCCCEEEECTTCSSSTTCEEEECTTSCEEEEEEECC
T ss_pred             CCCCCC----------CCCCcceEEEeccCCCCCCeEECCCCCCCCCEEEEeCC
Confidence            999832          234678999864    3467999999999999999863

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.82  E-value=2e-20  Score=177.95  Aligned_cols=136  Identities=13%  Similarity=0.118  Sum_probs=106.0

Q ss_pred             ccCCceecccCceEEEEEEe-CCCCE--EEEEEecccchh------------------------cHHHHHHHHHHHhhcC
Q 010309          227 SEGNRLLGDSKTGGTYSGIL-PDGSR--VAVKRLKRSSFQ------------------------RKKEFYSEIGRFARLH  279 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~  279 (513)
                      +...+.||+|+||.||+|.. .+|+.  ||||+++.....                        ....+.+|+.+|.++.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            34556789999999999997 68989  999997543111                        1136789999999998


Q ss_pred             CCcE--eeeeeEEeeCCceEEEEeeccC-C----CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHh-cCCCCCceE
Q 010309          280 HPNL--VAVKGCCYDHGDRYIVYEFVVN-G----PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLH-DKVKPHVVH  351 (513)
Q Consensus       280 h~nI--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH-~~~~~~ivH  351 (513)
                      |++|  +.+++.    +..+|||||+.+ |    +|.++...       .++..+..++.|++.||.||| +.   +|+|
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~---givH  194 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA---ELVH  194 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS---CEEC
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC---CEEe
Confidence            8754  333332    367899999942 3    67766532       234567889999999999999 88   9999


Q ss_pred             cCCCCCceEecCCCCeEEecccccccC
Q 010309          352 RDIRASNVLLDEEFGAHLMGVGLSKFV  378 (513)
Q Consensus       352 ~Dikp~NIll~~~~~~kl~Dfg~~~~~  378 (513)
                      |||||+|||++.  .++|+|||++...
T Consensus       195 rDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          195 ADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCCCHHHEEEcC--cEEEEECcccccC
Confidence            999999999998  8999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.70  E-value=5.8e-18  Score=167.45  Aligned_cols=139  Identities=14%  Similarity=0.082  Sum_probs=99.7

Q ss_pred             cccCCceecccCceEEEEEEeCCCCEEEEEEecccch--------------hcHHH--------HHHHHHHHhhcCCCcE
Q 010309          226 FSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSF--------------QRKKE--------FYSEIGRFARLHHPNL  283 (513)
Q Consensus       226 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------------~~~~~--------~~~E~~~l~~l~h~nI  283 (513)
                      .+.....||.|++|.||+|...+|+.||||+++....              .....        ..+|...|.++.+.++
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            4556678899999999999998999999999764210              00111        2356667777754443


Q ss_pred             eeeeeEEeeCCceEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecC
Q 010309          284 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE  363 (513)
Q Consensus       284 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~  363 (513)
                      .-..-+..  ...+|||||++|++|..+..        .  .....++.|++.+|.+||+.   |||||||||.|||+++
T Consensus       176 ~vp~p~~~--~~~~LVME~i~G~~L~~l~~--------~--~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~  240 (397)
T 4gyi_A          176 PVPEPIAQ--SRHTIVMSLVDALPMRQVSS--------V--PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIRE  240 (397)
T ss_dssp             SCCCEEEE--ETTEEEEECCSCEEGGGCCC--------C--SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEE
T ss_pred             CCCeeeec--cCceEEEEecCCccHhhhcc--------c--HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeC
Confidence            22111111  23479999999988865432        1  13456889999999999999   9999999999999987


Q ss_pred             CC----------CeEEecccccccCC
Q 010309          364 EF----------GAHLMGVGLSKFVP  379 (513)
Q Consensus       364 ~~----------~~kl~Dfg~~~~~~  379 (513)
                      ++          .+.|+||+-+....
T Consensus       241 dgd~~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          241 EKDAEDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             EECSSCTTSEEEEEEECCCTTCEETT
T ss_pred             CCCcccccccccceEEEEeCCcccCC
Confidence            76          38899999876543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.37  E-value=1.4e-12  Score=123.91  Aligned_cols=147  Identities=12%  Similarity=0.052  Sum_probs=111.0

Q ss_pred             HHHHhhCcccCCceecccCceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhcC-CCcEeeeeeEEeeCCceE
Q 010309          219 LRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRY  297 (513)
Q Consensus       219 l~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~  297 (513)
                      +.....++.. ...++.|+.+.||+... +++.+++|+...........+.+|+.+++.+. +..+.+++++..+.+..|
T Consensus         9 l~~~l~~~~~-~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~   86 (263)
T 3tm0_A            9 LKKLIEKYRC-VKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             HHHHHTTSEE-EECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             HHHHhcccee-EeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceE
Confidence            3344444432 33457788899999986 47899999987532233446889999999984 677889999998888999


Q ss_pred             EEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--------------------------------
Q 010309          298 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV--------------------------------  345 (513)
Q Consensus       298 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--------------------------------  345 (513)
                      +|||+++|.+|.+.+..         ......++.+++.+|..||+..                                
T Consensus        87 lv~e~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (263)
T 3tm0_A           87 LLMSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN  157 (263)
T ss_dssp             EEEECCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGG
T ss_pred             EEEEecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccc
Confidence            99999999999876421         1223467889999999999810                                


Q ss_pred             ------------------------CCCceEcCCCCCceEecCCCCeEEecccccc
Q 010309          346 ------------------------KPHVVHRDIRASNVLLDEEFGAHLMGVGLSK  376 (513)
Q Consensus       346 ------------------------~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~  376 (513)
                                              .+.++|+|++|.|||++.+..+.|+||+.+.
T Consensus       158 ~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             GSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                    1358999999999999876556799998774

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.23  E-value=1.3e-11  Score=116.91  Aligned_cols=128  Identities=16%  Similarity=0.141  Sum_probs=97.4

Q ss_pred             cccCceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCc--EeeeeeEEeeCCceEEEEeeccCCCHHHH
Q 010309          234 GDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPN--LVAVKGCCYDHGDRYIVYEFVVNGPLDRW  311 (513)
Q Consensus       234 g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~  311 (513)
                      +.|..+.||++...+|..+++|+....   ....+.+|+.+++.+.+.+  +.+++++...++..++||||++|.+|.  
T Consensus        29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--  103 (264)
T 1nd4_A           29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--  103 (264)
T ss_dssp             CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred             cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence            355669999998777889999997654   2245788999999885434  566888888888899999999998884  


Q ss_pred             hccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC----------------------------------------------
Q 010309          312 LHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV----------------------------------------------  345 (513)
Q Consensus       312 l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~----------------------------------------------  345 (513)
                      ...       .+   ...++.+++..|..||+..                                              
T Consensus       104 ~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (264)
T 1nd4_A          104 SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR  173 (264)
T ss_dssp             TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred             cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHH
Confidence            211       11   2356788888888888751                                              


Q ss_pred             ---------CCCceEcCCCCCceEecCCCCeEEecccccc
Q 010309          346 ---------KPHVVHRDIRASNVLLDEEFGAHLMGVGLSK  376 (513)
Q Consensus       346 ---------~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~  376 (513)
                               ...++|+|++|.|||++.+..+.|+||+.+.
T Consensus       174 l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          174 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                     1129999999999999877656799999875

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.15  E-value=1.2e-10  Score=115.85  Aligned_cols=141  Identities=18%  Similarity=0.220  Sum_probs=106.3

Q ss_pred             ceecccCceEEEEEEeCCCCEEEEEEec--ccc-hhcHHHHHHHHHHHhhcC--CCcEeeeeeEEeeC---CceEEEEee
Q 010309          231 RLLGDSKTGGTYSGILPDGSRVAVKRLK--RSS-FQRKKEFYSEIGRFARLH--HPNLVAVKGCCYDH---GDRYIVYEF  302 (513)
Q Consensus       231 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~---~~~~lv~e~  302 (513)
                      +.|+.|.++.||+.... +..+++|+..  ... ......+.+|+.+++.|.  +..+++++.++.+.   +..++||||
T Consensus        44 ~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~  122 (359)
T 3dxp_A           44 EQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF  122 (359)
T ss_dssp             EECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred             EEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence            45799999999999874 5689999876  332 123457888999999996  45678888888776   457999999


Q ss_pred             ccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-------------------------------------
Q 010309          303 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV-------------------------------------  345 (513)
Q Consensus       303 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-------------------------------------  345 (513)
                      ++|.++.+..      -..++......++.+++..|+.||+..                                     
T Consensus       123 v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (359)
T 3dxp_A          123 VSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA  196 (359)
T ss_dssp             CCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred             cCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence            9998774321      134778888999999999999999731                                     


Q ss_pred             ------------------CCCceEcCCCCCceEecCCCC--eEEecccccccC
Q 010309          346 ------------------KPHVVHRDIRASNVLLDEEFG--AHLMGVGLSKFV  378 (513)
Q Consensus       346 ------------------~~~ivH~Dikp~NIll~~~~~--~kl~Dfg~~~~~  378 (513)
                                        .+.++|+|++|.|||++.++.  +.|+||+.+...
T Consensus       197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                              247999999999999997754  689999998754

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.02  E-value=1.5e-10  Score=112.34  Aligned_cols=186  Identities=16%  Similarity=0.168  Sum_probs=121.6

Q ss_pred             ceecccCceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhc-CCCc--EeeeeeEEeeCC---ceEEEEeecc
Q 010309          231 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPN--LVAVKGCCYDHG---DRYIVYEFVV  304 (513)
Q Consensus       231 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~n--Iv~l~~~~~~~~---~~~lv~e~~~  304 (513)
                      +.++.|....||+..    ..+++|+....  .....+.+|+.+|+.+ .+..  +.+++......+   ..|+|||+++
T Consensus        26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~   99 (304)
T 3sg8_A           26 EISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK   99 (304)
T ss_dssp             CEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred             EecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence            357999999999863    56899986533  3456788999999888 3332  344444433333   3489999999


Q ss_pred             CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC---------------------------------------
Q 010309          305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV---------------------------------------  345 (513)
Q Consensus       305 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---------------------------------------  345 (513)
                      |.+|.....      ..++..+...++.+++..|+.||+..                                       
T Consensus       100 G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  173 (304)
T 3sg8_A          100 GVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV  173 (304)
T ss_dssp             CEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred             CeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence            988865332      24677788888999999999998621                                       


Q ss_pred             ----------------CCCceEcCCCCCceEecC--CCCeEEecccccccCCccccccceeec---Ccc-------ccc-
Q 010309          346 ----------------KPHVVHRDIRASNVLLDE--EFGAHLMGVGLSKFVPWEVMQERTVMA---GGT-------YGY-  396 (513)
Q Consensus       346 ----------------~~~ivH~Dikp~NIll~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~---~gt-------~~y-  396 (513)
                                      .+.++|+|++|.||+++.  +..+.|+||+.+........-......   .+.       ..| 
T Consensus       174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~  253 (304)
T 3sg8_A          174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK  253 (304)
T ss_dssp             HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred             HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence                            135799999999999998  455789999998654321110000000   000       001 


Q ss_pred             -cc-ccccccCCCCchhhHHHHHHHHHHHHcCCCCC
Q 010309          397 -LA-PEFVYRNELTTKSDVYSFGVLLLEIVSGRRPA  430 (513)
Q Consensus       397 -~a-PE~~~~~~~~~~sDvwSlGvil~elltg~~p~  430 (513)
                       .. |+...  ......+.|+++.++|.+.+|..+|
T Consensus       254 ~~~~~~~~~--r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          254 HKDIPTVLE--KYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             CSCHHHHHH--HHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CCCcHHHHH--HHHHHHHHHHHHHHHHHHHcCCHHH
Confidence             11 22111  0112368999999999999998775

>3k7b_A Protein A33; C-type lectin-like domain, homodimer, poxvirus, EEV, EV, VIR protein; 2.10A {Vaccinia virus WR}

Probab=98.71  E-value=1.2e-09  Score=83.11  Aligned_cols=46  Identities=7%  Similarity=0.161  Sum_probs=42.9

Q ss_pred             CCCCeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhC
Q 010309           17 EEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCG   63 (513)
Q Consensus        17 ~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~   63 (513)
                      .|+++||+|+.++++|.+|+..|..+|++|++|++.++ .||..++.
T Consensus        15 ~f~~~CY~f~~~pkTW~eA~~~C~~~G~~Lpsi~s~~~-~wL~~YL~   60 (96)
T 3k7b_A           15 YYQGSCYILHSDYQMFSDAAANCTAESSTLPNKSDVMI-TWLIDYVE   60 (96)
T ss_dssp             EETTEEEEEEEEEECHHHHHHHHHHTTCBCCCHHHHTT-STTHHHHB
T ss_pred             eeCCeeEEEeCCCCCHHHHHHHHHHcCCccCCcccchh-HHHHHHHh
Confidence            48999999999999999999999999999999999887 88888875

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.57  E-value=4.1e-07  Score=88.06  Aligned_cols=136  Identities=17%  Similarity=0.109  Sum_probs=96.3

Q ss_pred             ceecccCceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCC---cEeeeeeEEe-eCCceEEEEeeccCC
Q 010309          231 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHP---NLVAVKGCCY-DHGDRYIVYEFVVNG  306 (513)
Q Consensus       231 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---nIv~l~~~~~-~~~~~~lv~e~~~~g  306 (513)
                      +.++.|....||+.    |..+++|+-..  ......+.+|+.+|+.|.+.   .+.+++.+.. ..+..++|||+++|.
T Consensus        25 ~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~   98 (306)
T 3tdw_A           25 ESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ   98 (306)
T ss_dssp             EEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred             eecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence            34688888899987    57788998532  23456789999999999642   3556666654 445678999999998


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC------------------------------------------
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK------------------------------------------  344 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~------------------------------------------  344 (513)
                      +|.....      ..++..+...++.+++..|+.||+.                                          
T Consensus        99 ~l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l  172 (306)
T 3tdw_A           99 ILGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL  172 (306)
T ss_dssp             ECHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred             ECchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence            8876321      1245555666666666666666643                                          


Q ss_pred             ---------------CCCCceEcCCCCCceEecC---CCC-eEEecccccccC
Q 010309          345 ---------------VKPHVVHRDIRASNVLLDE---EFG-AHLMGVGLSKFV  378 (513)
Q Consensus       345 ---------------~~~~ivH~Dikp~NIll~~---~~~-~kl~Dfg~~~~~  378 (513)
                                     ..+.++|+|++|.|||++.   ++. +.|+||+.+...
T Consensus       173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                           1224699999999999987   455 489999988653

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.47  E-value=8.2e-07  Score=84.13  Aligned_cols=133  Identities=18%  Similarity=0.128  Sum_probs=95.9

Q ss_pred             ecccCce-EEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhcC-CCcEeeeeeEEeeCCceEEEEeeccCCCHH
Q 010309          233 LGDSKTG-GTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVYEFVVNGPLD  309 (513)
Q Consensus       233 lg~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~  309 (513)
                      +..|..+ .||+.... ++..+++|+-...   ....+.+|+..|+.+. +--+.++++++.+.+..++|||+++|.++.
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~  108 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF  108 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence            3555554 68988754 4678999987543   3456888999998884 334777888888889999999999998887


Q ss_pred             HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--------------------------------------------
Q 010309          310 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV--------------------------------------------  345 (513)
Q Consensus       310 ~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--------------------------------------------  345 (513)
                      +....        .......+..+++..|.-||+..                                            
T Consensus       109 ~~~~~--------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (272)
T 4gkh_A          109 QVLEE--------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW  180 (272)
T ss_dssp             HHHHH--------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred             ccccC--------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence            65532        11223345666666677776421                                            


Q ss_pred             -----------CCCceEcCCCCCceEecCCCCeEEecccccc
Q 010309          346 -----------KPHVVHRDIRASNVLLDEEFGAHLMGVGLSK  376 (513)
Q Consensus       346 -----------~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~  376 (513)
                                 .+.++|+|+.+.|||++.++.+-|+||+.+.
T Consensus       181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                       1137999999999999987667799998875

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.36  E-value=8.7e-07  Score=87.67  Aligned_cols=79  Identities=5%  Similarity=-0.051  Sum_probs=55.4

Q ss_pred             cee-cccCceEEEEEEeC-------CCCEEEEEEecccc---hhcHHHHHHHHHHHhhcC-C--CcEeeeeeEEeeC---
Q 010309          231 RLL-GDSKTGGTYSGILP-------DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLH-H--PNLVAVKGCCYDH---  293 (513)
Q Consensus       231 ~~l-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~nIv~l~~~~~~~---  293 (513)
                      +.| +.|....+|+....       ++..+++|+.....   ......+.+|+.+++.|. +  -.+.+++.+..+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            356 78888999998764       26789999875432   111245778888888873 2  3567778776655   


Q ss_pred             CceEEEEeeccCCCHH
Q 010309          294 GDRYIVYEFVVNGPLD  309 (513)
Q Consensus       294 ~~~~lv~e~~~~gsL~  309 (513)
                      +..++|||+++|.++.
T Consensus       106 g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             SSCEEEEECCCCBCCC
T ss_pred             CCceEEEEecCCCChh
Confidence            3568999999887664

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.14  E-value=6.2e-06  Score=80.76  Aligned_cols=141  Identities=18%  Similarity=0.230  Sum_probs=79.0

Q ss_pred             eecccCceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhcC--CCcEeeeee------EEeeCCceEEEEeec
Q 010309          232 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH--HPNLVAVKG------CCYDHGDRYIVYEFV  303 (513)
Q Consensus       232 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~nIv~l~~------~~~~~~~~~lv~e~~  303 (513)
                      .|+.|..+.||+....+| .+++|+....    ...+..|+.++..|.  .-.+++++.      +....+..++||||+
T Consensus        39 ~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i  113 (346)
T 2q83_A           39 VIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI  113 (346)
T ss_dssp             ECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred             eccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence            355677899999987554 5999998753    233444555555542  112333332      123456679999999


Q ss_pred             cCCCHH-----------HH---hccCCC----C-C-----CCCCHHH-------------------------------HH
Q 010309          304 VNGPLD-----------RW---LHHIPR----G-G-----RSLDWAM-------------------------------RM  328 (513)
Q Consensus       304 ~~gsL~-----------~~---l~~~~~----~-~-----~~l~~~~-------------------------------~~  328 (513)
                      +|.++.           ..   ++....    . .     ....+..                               ..
T Consensus       114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  193 (346)
T 2q83_A          114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID  193 (346)
T ss_dssp             CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred             cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence            986542           11   111000    0 0     0011211                               01


Q ss_pred             HHHHHHHHHHHHHhc----------CCCCCceEcCCCCCceEecCCCCeEEeccccccc
Q 010309          329 KVATTLAQGIAFLHD----------KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF  377 (513)
Q Consensus       329 ~i~~qi~~~L~~LH~----------~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~  377 (513)
                      .+..++..++.+|+.          .....++|+|+++.|||++.++.+.|+||+.+..
T Consensus       194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            111234446666653          0234899999999999998888899999998753

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.13  E-value=1.5e-05  Score=79.87  Aligned_cols=74  Identities=14%  Similarity=0.001  Sum_probs=49.2

Q ss_pred             ceecccCceEEEEEEeC-CCCEEEEEEecccch-------hcHHHHHHHHHHHhhcCC--C-cEeeeeeEEeeCCceEEE
Q 010309          231 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF-------QRKKEFYSEIGRFARLHH--P-NLVAVKGCCYDHGDRYIV  299 (513)
Q Consensus       231 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~-nIv~l~~~~~~~~~~~lv  299 (513)
                      +.||.|..+.||++... +++.|+||.......       .....+..|.++|+.+..  | .+.+++.+  +.+..++|
T Consensus        36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv  113 (397)
T 2olc_A           36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  113 (397)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence            45799999999999754 478999998754211       123456778888887732  3 34455543  45567899


Q ss_pred             EeeccCC
Q 010309          300 YEFVVNG  306 (513)
Q Consensus       300 ~e~~~~g  306 (513)
                      ||++++.
T Consensus       114 mE~l~g~  120 (397)
T 2olc_A          114 MEDLSHL  120 (397)
T ss_dssp             ECCCTTS
T ss_pred             EEeCCCc
Confidence            9999764

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=98.07  E-value=2e-05  Score=75.22  Aligned_cols=74  Identities=26%  Similarity=0.240  Sum_probs=54.7

Q ss_pred             ceecccCceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhcC-C--CcEeeeeeEEeeCCceEEEEeeccCCC
Q 010309          231 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-H--PNLVAVKGCCYDHGDRYIVYEFVVNGP  307 (513)
Q Consensus       231 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h--~nIv~l~~~~~~~~~~~lv~e~~~~gs  307 (513)
                      ..+|.|..+.||+....+|+.|++|+-..........+..|+..|+.|. .  --+++++++    +..++|||+++++.
T Consensus        21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~l~~~~   96 (288)
T 3f7w_A           21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEWVDERP   96 (288)
T ss_dssp             EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEECCCCCC
T ss_pred             EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEeecccC
Confidence            4569999999999999999999999876554444556888999988884 2  124444443    23479999998765


Q ss_pred             H
Q 010309          308 L  308 (513)
Q Consensus       308 L  308 (513)
                      .
T Consensus        97 ~   97 (288)
T 3f7w_A           97 P   97 (288)
T ss_dssp             C
T ss_pred             C
Confidence            3

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.97  E-value=3.8e-05  Score=74.03  Aligned_cols=138  Identities=19%  Similarity=0.226  Sum_probs=91.1

Q ss_pred             ceecccCceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhcC---CCcEeeeeeEEeeCCceEEEEeeccCCC
Q 010309          231 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH---HPNLVAVKGCCYDHGDRYIVYEFVVNGP  307 (513)
Q Consensus       231 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~lv~e~~~~gs  307 (513)
                      +.|+.|....+|+... ++..+++|+....   ....+..|+..|+.|.   ...+++++.+....+..++|||++++..
T Consensus        42 ~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~  117 (312)
T 3jr1_A           42 EKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSK  117 (312)
T ss_dssp             EEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCC
T ss_pred             EEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCC
Confidence            3469999999999886 5778999987643   3567888998888883   3668888888887788999999999876


Q ss_pred             HH--------HH---hccCCC-CC-----------------CCCCHHHHH---HHH----------------HHHHHHH-
Q 010309          308 LD--------RW---LHHIPR-GG-----------------RSLDWAMRM---KVA----------------TTLAQGI-  338 (513)
Q Consensus       308 L~--------~~---l~~~~~-~~-----------------~~l~~~~~~---~i~----------------~qi~~~L-  338 (513)
                      +.        ..   |+.... ..                 ..-+|....   ++.                ..++..+ 
T Consensus       118 ~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~  197 (312)
T 3jr1_A          118 NKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVA  197 (312)
T ss_dssp             CCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHH
T ss_pred             CCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHH
Confidence            42        11   222111 00                 011343221   111                1122222 


Q ss_pred             HHHhc-CCCCCceEcCCCCCceEecCCCCeEEeccc
Q 010309          339 AFLHD-KVKPHVVHRDIRASNVLLDEEFGAHLMGVG  373 (513)
Q Consensus       339 ~~LH~-~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg  373 (513)
                      ..|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus       198 ~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          198 DTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            23431 2356899999999999999887 8888974

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.88  E-value=2.8e-05  Score=78.62  Aligned_cols=78  Identities=9%  Similarity=0.103  Sum_probs=49.4

Q ss_pred             CCceEcCCCCCceEecCCCCeEEecccccccCCccccccceeecCcccccccccccccC---CCCchhhHHHHHHHHHHH
Q 010309          347 PHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN---ELTTKSDVYSFGVLLLEI  423 (513)
Q Consensus       347 ~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlGvil~el  423 (513)
                      +.++|+|++|.|||++.++ ++|+||+.+........-... ...-...|.+|+.....   ......++.+....+|+.
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAY-LGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL  309 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHH-HHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHH-HHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence            3899999999999998876 999999998764422111000 00012346777655321   112345666888888888


Q ss_pred             HcC
Q 010309          424 VSG  426 (513)
Q Consensus       424 ltg  426 (513)
                      +++
T Consensus       310 y~~  312 (420)
T 2pyw_A          310 FNK  312 (420)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            765

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.70  E-value=0.00021  Score=63.81  Aligned_cols=101  Identities=12%  Similarity=0.106  Sum_probs=66.2

Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccc
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  385 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  385 (513)
                      -+|.++|...   +.++++++++.++.|.+.+|.-+-...  .-..+=+.|..|++..+|.|.+.+ ..+.         
T Consensus        33 vSL~eIL~~~---~~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------   97 (229)
T 2yle_A           33 LSLEEILRLY---NQPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD---------   97 (229)
T ss_dssp             EEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred             ccHHHHHHHc---CCCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc---------
Confidence            3788888753   478999999999999999988772210  111233457899999999987764 1111         


Q ss_pred             ceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCC
Q 010309          386 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGR  427 (513)
Q Consensus       386 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~  427 (513)
                           .....+.|||... ...+.+.=|||||++||..+-=.
T Consensus        98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDyg  133 (229)
T 2yle_A           98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYG  133 (229)
T ss_dssp             --------------CCSS-SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred             -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcC
Confidence                 0223467888763 34568889999999999988633

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.61  E-value=0.00092  Score=64.60  Aligned_cols=161  Identities=14%  Similarity=0.165  Sum_probs=88.9

Q ss_pred             ccCHHHHHHHhhCcccC----CceecccCceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCc--Eeee
Q 010309          213 VFTTEELRSITKNFSEG----NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPN--LVAV  286 (513)
Q Consensus       213 ~~~~~~l~~~~~~~~~~----~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~l  286 (513)
                      .++.+++..+...|...    -+.|+.|....+|+....+| .+++|+....  .....+..|+.++..|....  +.++
T Consensus         6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~   82 (322)
T 2ppq_A            6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLP   82 (322)
T ss_dssp             CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred             cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcc
Confidence            35677888877766541    12356788889999987555 6889988753  12234566777777663212  3333


Q ss_pred             eeE------EeeCCceEEEEeeccCCCHHH-----------H---hcc----CCCCC-CCCC---HHHHHH---------
Q 010309          287 KGC------CYDHGDRYIVYEFVVNGPLDR-----------W---LHH----IPRGG-RSLD---WAMRMK---------  329 (513)
Q Consensus       287 ~~~------~~~~~~~~lv~e~~~~gsL~~-----------~---l~~----~~~~~-~~l~---~~~~~~---------  329 (513)
                      +..      ....+..+++|++++|..+..           .   ++.    ..... ....   |.....         
T Consensus        83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~  162 (322)
T 2ppq_A           83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV  162 (322)
T ss_dssp             CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred             cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence            321      122356789999998865311           0   111    00000 0011   111000         


Q ss_pred             ---HHHHHHHHHHHHhcC----CCCCceEcCCCCCceEecCCCCeEEecccccc
Q 010309          330 ---VATTLAQGIAFLHDK----VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK  376 (513)
Q Consensus       330 ---i~~qi~~~L~~LH~~----~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~  376 (513)
                         +...+...++.++..    ....++|+|+.+.|||++.+..+.|+||+.+.
T Consensus       163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence               011234445555431    13479999999999999887556899998775

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.60  E-value=0.00067  Score=65.76  Aligned_cols=162  Identities=15%  Similarity=0.144  Sum_probs=91.7

Q ss_pred             cccCHHHHHHHhhCccc----CCceecccCceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCC--cEee
Q 010309          212 KVFTTEELRSITKNFSE----GNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHP--NLVA  285 (513)
Q Consensus       212 ~~~~~~~l~~~~~~~~~----~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--nIv~  285 (513)
                      ...+.+++..+...+..    ....|+ |....||+....+|+.+++|+..... .....+..|..++..|...  .+++
T Consensus         9 ~~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~   86 (328)
T 1zyl_A            9 QTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAA   86 (328)
T ss_dssp             CCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCC
T ss_pred             CCCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecc
Confidence            34556667666655432    123456 78889999887778889999986432 2345677788888777321  2444


Q ss_pred             eeeE-----EeeCCceEEEEeeccCCCHH-----H------Hh---cc----CCC-CCCCCCHHHH--------------
Q 010309          286 VKGC-----CYDHGDRYIVYEFVVNGPLD-----R------WL---HH----IPR-GGRSLDWAMR--------------  327 (513)
Q Consensus       286 l~~~-----~~~~~~~~lv~e~~~~gsL~-----~------~l---~~----~~~-~~~~l~~~~~--------------  327 (513)
                      ++..     ....+..++|||+++|.++.     .      .|   +.    ... ....++....              
T Consensus        87 ~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  166 (328)
T 1zyl_A           87 PVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLI  166 (328)
T ss_dssp             CCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSS
T ss_pred             eeecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcC
Confidence            4443     12244567899999875432     0      11   10    000 0111222111              


Q ss_pred             --------HHHHHHHHHHHHHHhc-CCCCCceEcCCCCCceEecCCCCeEEeccccccc
Q 010309          328 --------MKVATTLAQGIAFLHD-KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF  377 (513)
Q Consensus       328 --------~~i~~qi~~~L~~LH~-~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~  377 (513)
                              ...+..++..+.-+-. .....++|+|+++.|||++ + .+.|+||+.+..
T Consensus       167 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          167 PSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             CHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence                    1111222222222211 1233689999999999999 4 899999988764

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.45  E-value=0.00027  Score=67.79  Aligned_cols=71  Identities=7%  Similarity=-0.026  Sum_probs=43.3

Q ss_pred             CceecccCceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcE-eeeeeEEeeCCceEEEEeec-cCCC
Q 010309          230 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNL-VAVKGCCYDHGDRYIVYEFV-VNGP  307 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lv~e~~-~~gs  307 (513)
                      -+.|+.|....+|+.     ..+++|+....... .....+|+.+++.+....+ .++++.  +.+.-++++||+ ++.+
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~   94 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT   94 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence            345788999999998     56889988653211 1123467777776632222 455543  344457899999 6644


Q ss_pred             H
Q 010309          308 L  308 (513)
Q Consensus       308 L  308 (513)
                      |
T Consensus        95 l   95 (301)
T 3dxq_A           95 M   95 (301)
T ss_dssp             C
T ss_pred             C
Confidence            4

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.38  E-value=0.00099  Score=64.78  Aligned_cols=141  Identities=12%  Similarity=0.005  Sum_probs=72.1

Q ss_pred             ecccCceE-EEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhcC-C-CcEeeeeeEEeeCCceEEEEeeccCCCHH
Q 010309          233 LGDSKTGG-TYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-H-PNLVAVKGCCYDHGDRYIVYEFVVNGPLD  309 (513)
Q Consensus       233 lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-~nIv~l~~~~~~~~~~~lv~e~~~~gsL~  309 (513)
                      |+.|.... +|+....+|..+++|.......   ..+..|+.++..+. + -.+.+++.+..+  .-+++||++.+.++.
T Consensus        26 l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~--~g~ll~e~l~~~~l~  100 (333)
T 3csv_A           26 LAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHA--RGLLLIEDLGDALFT  100 (333)
T ss_dssp             --------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETT--TTEEEECCCCSCBHH
T ss_pred             CCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCC--CCEEEEeeCCCcchH
Confidence            44554444 6677654477888886544321   23445666666663 2 234556655332  237899999776665


Q ss_pred             HHhccC---------------------CCC-CCCCCHHHHH-------H-------------HHHHHHHHHHHHh---cC
Q 010309          310 RWLHHI---------------------PRG-GRSLDWAMRM-------K-------------VATTLAQGIAFLH---DK  344 (513)
Q Consensus       310 ~~l~~~---------------------~~~-~~~l~~~~~~-------~-------------i~~qi~~~L~~LH---~~  344 (513)
                      +.+...                     ... -..++.....       .             ....+...+..|.   ..
T Consensus       101 ~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~~  180 (333)
T 3csv_A          101 EVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQLE  180 (333)
T ss_dssp             HHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHCC
T ss_pred             HHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhccc
Confidence            443211                     000 0112221100       0             0011112222221   11


Q ss_pred             CCCCceEcCCCCCceEecCC----CCeEEecccccccC
Q 010309          345 VKPHVVHRDIRASNVLLDEE----FGAHLMGVGLSKFV  378 (513)
Q Consensus       345 ~~~~ivH~Dikp~NIll~~~----~~~kl~Dfg~~~~~  378 (513)
                      ....++|+|+.+.|||++.+    ..+.|+||+.+...
T Consensus       181 ~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          181 GDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             SCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            23479999999999999874    67899999988754

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.27  E-value=0.00051  Score=69.40  Aligned_cols=71  Identities=13%  Similarity=0.128  Sum_probs=48.3

Q ss_pred             eecccCceEEEEEEeCC--------CCEEEEEEecccchhcHHHHHHHHHHHhhcCCCc-EeeeeeEEeeCCceEEEEee
Q 010309          232 LLGDSKTGGTYSGILPD--------GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPN-LVAVKGCCYDHGDRYIVYEF  302 (513)
Q Consensus       232 ~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~~~~lv~e~  302 (513)
                      .|+.|....+|+....+        +..+++|+....  .....+.+|+.+++.|...+ .+++++.+.+    .+|+||
T Consensus        80 ~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~  153 (429)
T 1nw1_A           80 RIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY  153 (429)
T ss_dssp             EECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred             EeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEE
Confidence            46888889999998753        578999988442  11245668998888884323 3566665432    389999


Q ss_pred             ccCCCH
Q 010309          303 VVNGPL  308 (513)
Q Consensus       303 ~~~gsL  308 (513)
                      ++|.+|
T Consensus       154 l~G~~l  159 (429)
T 1nw1_A          154 IPSRPL  159 (429)
T ss_dssp             CCEEEC
T ss_pred             eCCccc
Confidence            986443

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.22  E-value=0.00058  Score=67.57  Aligned_cols=141  Identities=16%  Similarity=0.161  Sum_probs=82.4

Q ss_pred             eecccCceEEEEEEeC--------CCCEEEEEEecccchhcHHHHHHHHHHHhhcC-CCcEeeeeeEEeeCCceEEEEee
Q 010309          232 LLGDSKTGGTYSGILP--------DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVYEF  302 (513)
Q Consensus       232 ~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~  302 (513)
                      .|..|....+|+....        +++.+++|+.... ......+.+|..+++.|. +.-..++++.+.+    .+||||
T Consensus        57 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~  131 (379)
T 3feg_A           57 PVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQY  131 (379)
T ss_dssp             EC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEEC
T ss_pred             EcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEE
Confidence            4577888889998864        2578999986432 234566778999988883 3323566666543    299999


Q ss_pred             ccCCCHHH--------------Hh---ccCC-CCCCCCC--HHHHHHHHHHHHH-------------------HHHHHh-
Q 010309          303 VVNGPLDR--------------WL---HHIP-RGGRSLD--WAMRMKVATTLAQ-------------------GIAFLH-  342 (513)
Q Consensus       303 ~~~gsL~~--------------~l---~~~~-~~~~~l~--~~~~~~i~~qi~~-------------------~L~~LH-  342 (513)
                      ++|.+|..              .|   +... ...+...  +.++.++..++..                   .+..|. 
T Consensus       132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~  211 (379)
T 3feg_A          132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK  211 (379)
T ss_dssp             CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred             ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence            98865531              11   1110 0111222  3455555544322                   223332 


Q ss_pred             ---cC-CCCCceEcCCCCCceEecCC----CCeEEeccccccc
Q 010309          343 ---DK-VKPHVVHRDIRASNVLLDEE----FGAHLMGVGLSKF  377 (513)
Q Consensus       343 ---~~-~~~~ivH~Dikp~NIll~~~----~~~kl~Dfg~~~~  377 (513)
                         .. ....++|+|+.+.|||++.+    +.+.|+||..+..
T Consensus       212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence               21 12368999999999999876    6899999998764

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.14  E-value=0.0021  Score=65.36  Aligned_cols=72  Identities=10%  Similarity=-0.096  Sum_probs=46.4

Q ss_pred             eecccCceEEEEEEeCC-CCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcE-eeeeeEEeeCCceEEEEeeccCCCH
Q 010309          232 LLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNL-VAVKGCCYDHGDRYIVYEFVVNGPL  308 (513)
Q Consensus       232 ~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lv~e~~~~gsL  308 (513)
                      .|+.|-...+|+....+ +..+++|+...... ..-+..+|+.++..|...++ .++++.+.  +  .+||||++|.+|
T Consensus       115 ~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~-~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l  188 (458)
T 2qg7_A          115 IINGGITNILIKVKDMSKQAKYLIRLYGPKTD-EIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL  188 (458)
T ss_dssp             EECC--CEEEEEEEETTTTEEEEEEEECC-CC-SCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred             EcCCCeEeEEEEEEECCCCceEEEEECCCChh-hhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence            46888889999998765 47899998754321 11122578888888864444 56777653  2  369999987544

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.94  E-value=0.003  Score=61.63  Aligned_cols=32  Identities=25%  Similarity=0.282  Sum_probs=27.8

Q ss_pred             CCceEcCCCCCceEecCCCCeEEecccccccC
Q 010309          347 PHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV  378 (513)
Q Consensus       347 ~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~  378 (513)
                      ..++|+|+.+.||+++.++.+.|+||+.+...
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA  237 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence            37999999999999998888999999877643

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=96.77  E-value=0.00076  Score=43.21  Aligned_cols=33  Identities=33%  Similarity=0.352  Sum_probs=19.9

Q ss_pred             eeEEEeehHHHHHHHHHHHHHHHHHHHHhhccc
Q 010309          159 REYLITLGVVSGLILLTTFAIVIWLLAYRRSKR  191 (513)
Q Consensus       159 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (513)
                      .+..|+.++++|++++++++++++++.+||+.+
T Consensus         9 ~~~~IA~gVVgGv~~~~ii~~~~~~~~RRr~~~   41 (44)
T 2ks1_B            9 KIPSIATGMVGALLLLLVVALGIGLFMRRRHIV   41 (44)
T ss_dssp             CSSSSTHHHHHHHHHHHHHHHHHHHHHHTTTCC
T ss_pred             CcceEEeehhHHHHHHHHHHHHHHHHhhhhHhh
Confidence            334477777777777666665555555444443

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.74  E-value=0.0028  Score=62.50  Aligned_cols=72  Identities=13%  Similarity=0.080  Sum_probs=43.0

Q ss_pred             eecccCceEEEEEEeCC---------CCEEEEEEecccchhcHHHHHHHHHHHhhcCCCc-EeeeeeEEeeCCceEEEEe
Q 010309          232 LLGDSKTGGTYSGILPD---------GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPN-LVAVKGCCYDHGDRYIVYE  301 (513)
Q Consensus       232 ~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~~~~lv~e  301 (513)
                      .|+.|....+|+....+         +..+++|+...... ...+...|..+++.+...+ +.++++..  .  -++|||
T Consensus        40 ~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~e  114 (369)
T 3c5i_A           40 QILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIEE  114 (369)
T ss_dssp             EC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred             EeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEEE
Confidence            45778888999998754         27899998764321 1112457787777774223 34565543  2  368999


Q ss_pred             eccCCCH
Q 010309          302 FVVNGPL  308 (513)
Q Consensus       302 ~~~~gsL  308 (513)
                      |++|.++
T Consensus       115 ~i~G~~l  121 (369)
T 3c5i_A          115 WLYGDPL  121 (369)
T ss_dssp             CCCSEEC
T ss_pred             EecCCcC
Confidence            9987543

>3fd4_A Glycoprotein GP42; C type lectin, virus entry, membrane fusion, HOST-virus interaction, lectin, membrane, transmembrane, viral protein; 2.40A {Human herpesvirus 4} PDB: 1kg0_C

Probab=96.53  E-value=0.008  Score=49.70  Aligned_cols=117  Identities=19%  Similarity=0.315  Sum_probs=78.3

Q ss_pred             CCcCCCCCC-CcccCCCCeeEEEECCCCChHHHHHHHhhc--CCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCC
Q 010309            4 DWKAPCPPD-WIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTV   80 (513)
Q Consensus         4 ~~~~~Cp~~-w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~--~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~   80 (513)
                      .-|..|+.- -++ .+++.||+|....-+|+..-.+|++.  --.|.-. ....+-++.+.++. .+.+|||..+.   .
T Consensus        65 ~~C~~C~~r~~tF-s~~~~CyYftp~kytf~~CF~aCa~ls~C~yfY~P-q~~~~PiV~~NLk~-~eslWVGifK~---~  138 (191)
T 3fd4_A           65 ANCTYCNTREYTF-SYKGCCFYFTKKKHTWNGCFQACAELYPCTYFYGP-TPDILPVVTRNLNA-IESLWVGVYRV---G  138 (191)
T ss_dssp             CCSCCCCTTTCSE-EETTEEEEECSSCBCTTHHHHHHHHHSTTEEECCC-CTTTHHHHHTTSCT-TCEEEECCEEC---T
T ss_pred             CCCeecCcceeEE-EecceEEEeCcccccHHHHHHHHHhhcCeeEEecC-CccCChhhhcccCC-cCcEEEEEEEc---C
Confidence            447788865 222 58999999999999999999999985  3344433 33457788877762 46799999842   2


Q ss_pred             CCceEEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCCCc-ccccccCCCCCcccc
Q 010309           81 GLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRS-LVTERCNTSHPFICM  145 (513)
Q Consensus        81 ~~~w~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~-w~d~~C~~~~~~iC~  145 (513)
                      ++.|.=.||+  ++.-|..-+.                 +|+.+...+.. |.-..|+...+-.|-
T Consensus       139 ~~~W~sLDn~--n~~V~Di~gS-----------------yCaYvt~~S~~P~s~~eC~~~K~CLC~  185 (191)
T 3fd4_A          139 EGNWTSLDGG--TFKVYQIFGS-----------------HCTYVSKFSTVPVSHHECSFLKPCLCV  185 (191)
T ss_dssp             TCCEEETTEE--EECCBCSSSS-----------------SCEEEESSCSSCEECSCTTSCBCBEEE
T ss_pred             ccceEEccCC--ceEEEEeccC-----------------eeeEEecccccccceeeccccceeEEe
Confidence            4888888875  3333322211                 36666554433 777778877766553

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=96.16  E-value=0.0021  Score=41.07  Aligned_cols=31  Identities=29%  Similarity=0.503  Sum_probs=18.2

Q ss_pred             EEEeehHHHHHHHHHHHHHHHHHHHHhhccc
Q 010309          161 YLITLGVVSGLILLTTFAIVIWLLAYRRSKR  191 (513)
Q Consensus       161 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (513)
                      ..|+.++++|++++++++++++++.+||+++
T Consensus        10 ~aIA~gVVgGv~~v~ii~~~~~~~~RRRr~~   40 (44)
T 2l2t_A           10 PLIAAGVIGGLFILVIVGLTFAVYVRRKSIK   40 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHHTTCSS
T ss_pred             ceEEEeehHHHHHHHHHHHHHHHHhhhhhhh
Confidence            3466777777776666665555555444443

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=96.16  E-value=0.0024  Score=40.64  Aligned_cols=26  Identities=27%  Similarity=0.572  Sum_probs=11.7

Q ss_pred             hHHHHHHHHHHHHHHHHHHHHhhccc
Q 010309          166 GVVSGLILLTTFAIVIWLLAYRRSKR  191 (513)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (513)
                      +.++|++++++++++++++.+||+.+
T Consensus        16 ~~vVGvll~vi~~l~~~~~~RRR~~~   41 (44)
T 2jwa_A           16 SAVVGILLVVVLGVVFGILIKRRQQK   41 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHCSC
T ss_pred             HHHHHHHHHHHHHHHHHhheehhhhh
Confidence            34445544444444444444444443

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.44  E-value=0.047  Score=54.64  Aligned_cols=72  Identities=13%  Similarity=0.065  Sum_probs=46.7

Q ss_pred             eecccCceEEEEEEeCC--------CCEEEEEEecccchhcHHHHHHHHHHHhhcC-CCcEeeeeeEEeeCCceEEEEee
Q 010309          232 LLGDSKTGGTYSGILPD--------GSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVYEF  302 (513)
Q Consensus       232 ~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~  302 (513)
                      .|..|....+|+....+        +..+++|+..... ...-+..+|+.+++.+. +.-..++++.+  .  -++||||
T Consensus        77 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~ef  151 (424)
T 3mes_A           77 QIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIEEF  151 (424)
T ss_dssp             EECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEEC
T ss_pred             EcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEEE
Confidence            45778888999998753        6889999875432 11223457888887773 32234555533  2  3789999


Q ss_pred             ccCCCH
Q 010309          303 VVNGPL  308 (513)
Q Consensus       303 ~~~gsL  308 (513)
                      ++|.+|
T Consensus       152 I~G~~l  157 (424)
T 3mes_A          152 IDGEPL  157 (424)
T ss_dssp             CCSEEC
T ss_pred             eCCccC
Confidence            998654

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=93.55  E-value=0.16  Score=50.47  Aligned_cols=29  Identities=28%  Similarity=0.452  Sum_probs=24.5

Q ss_pred             ceEcCCCCCceEe------cCCCCeEEeccccccc
Q 010309          349 VVHRDIRASNVLL------DEEFGAHLMGVGLSKF  377 (513)
Q Consensus       349 ivH~Dikp~NIll------~~~~~~kl~Dfg~~~~  377 (513)
                      ++|+|+.+.|||+      +++..+.++||..|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            5799999999999      4456799999998864

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=88.48  E-value=0.81  Score=40.66  Aligned_cols=115  Identities=11%  Similarity=0.145  Sum_probs=78.0

Q ss_pred             CCCcEeeeeeEEeeCCceEEEEeeccC-CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCC
Q 010309          279 HHPNLVAVKGCCYDHGDRYIVYEFVVN-GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS  357 (513)
Q Consensus       279 ~h~nIv~l~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~  357 (513)
                      .||+.+.. .+-.+.+...+.++.-+. -++.. +       +.++...+++++.+|+....+++..     +|--|.|+
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i-------k~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~  108 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I-------KSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPD  108 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G-------GGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGG
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H-------HhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecc
Confidence            68888866 455566665555554432 23332 3       3478899999999999888666643     78899999


Q ss_pred             ceEecCCCCeEEecccccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 010309          358 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQ  431 (513)
Q Consensus       358 NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~  431 (513)
                      ||+++.++.+++.-.|+...+                   +|.-     .+...=.-.+=+++..+++++..|.
T Consensus       109 NL~f~~~~~p~i~~RGik~~l-------------------~P~~-----~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          109 ELFFTRDGLPIAKTRGLQNVV-------------------DPLP-----VSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             GEEECTTSCEEESCCEETTTB-------------------SCCC-----CCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             eEEEcCCCCEEEEEccCccCC-------------------CCCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            999999999999877764322                   2221     1222223356778888999988875

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=87.82  E-value=1.4  Score=39.19  Aligned_cols=114  Identities=12%  Similarity=0.162  Sum_probs=74.8

Q ss_pred             CCCcEeeeeeEEeeCCceEEEEeeccCC-CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHH-HHhcCCCCCceEcCCCC
Q 010309          279 HHPNLVAVKGCCYDHGDRYIVYEFVVNG-PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA-FLHDKVKPHVVHRDIRA  356 (513)
Q Consensus       279 ~h~nIv~l~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~-~LH~~~~~~ivH~Dikp  356 (513)
                      .||++  -..+-.+++...+.++.-+++ ++. .+       +.++...+++++.+|+.... +++     .-+|--|.|
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~-~i-------~~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P  112 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFA-AI-------RKTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCP  112 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHH-HH-------HTSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHH-HH-------HhcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeC
Confidence            67887  334445666666666655333 333 33       24788889999988887766 555     457889999


Q ss_pred             CceEecCCCCeEEecccccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 010309          357 SNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQ  431 (513)
Q Consensus       357 ~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~  431 (513)
                      +||++|.++.+++.-.|+-..                   ++|.-+     +..-=.-.+=+++..++.++..|.
T Consensus       113 ~NL~f~~~~~p~i~hRGi~~~-------------------lpP~e~-----~ee~fl~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          113 ENLMFNRALEPFFLHVGVKES-------------------LPPDEW-----DDERLLREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             GGEEECTTCCEEESCCEETTT-------------------BSSCSC-----CHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred             ceEEEeCCCcEEEEEcCCccc-------------------CCCCCC-----CHHHHHHHHHHHHHHHHcCCCCHH
Confidence            999999999999987766432                   333321     111112346677788888887764

>2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A

Probab=82.53  E-value=1  Score=27.78  Aligned_cols=8  Identities=50%  Similarity=0.899  Sum_probs=3.3

Q ss_pred             hHHHHHHH
Q 010309          166 GVVSGLIL  173 (513)
Q Consensus       166 ~~~~~~~~  173 (513)
                      +++++.++
T Consensus        15 GiVvG~v~   22 (38)
T 2k1k_A           15 AVIFGLLL   22 (38)
T ss_dssp             HHHHHHHH
T ss_pred             eeehHHHH
Confidence            44444433

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	513
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-57
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-51
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	5e-51
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-50
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-48
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-48
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-48
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	4e-48
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	6e-48
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-47
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	4e-46
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	9e-46
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-45
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-45
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-45
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-45
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	7e-45
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-44
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-44
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-44
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-44
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	9e-44
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-43
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-43
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-42
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-41
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-41
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	3e-41
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	5e-41
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	9e-41
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-40
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	3e-40
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	4e-39
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	9e-39
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-38
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-36
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	3e-35
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	7e-35
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-34
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-33
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-33
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	6e-33
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-32
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-32
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-32
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	3e-32
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-31
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-30
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	6e-30
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-29
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-29
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-29
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-28
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	6e-28
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-27
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	4e-27
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	6e-26
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-25
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	9e-23
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-21
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	8e-21
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	5e-20
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	9e-13
d1ypqa1	131	d.169.1.1 (A:140-270) Oxidised low density lipopro	7e-12
d1egga_	136	d.169.1.1 (A:) Macrophage mannose receptor, CRD4 {	1e-10
d1g1sa1	118	d.169.1.1 (A:1-118) P-selectin, C-lectin domain {H	4e-10
d1e87a_	117	d.169.1.1 (A:) CD69 {Human (Homo sapiens) [TaxId:	6e-10
d1wk1a_	150	d.169.1.1 (A:) Hypothetical protein F28B4.3 {Caeno	3e-09
d1xpha1	130	d.169.1.1 (A:265-394) DC-SIGNR (DC-SIGN related re	3e-09
d1hq8a_	123	d.169.1.1 (A:) NK cell-activating receptor nkg2d {	4e-09
d1qo3c_	133	d.169.1.1 (C:) NK cell receptor {Mouse (Mus muscul	5e-09
d3c8ja1	122	d.169.1.1 (A:138-259) NK cell receptor {Mouse (Mus	7e-09
d1g1ta1	118	d.169.1.1 (A:1-118) E-selectin, C-lectin domain {H	2e-08
d1tdqb_	126	d.169.1.1 (B:) Aggrecan core protein {Rat (Rattus	3e-08
d1dv8a_	128	d.169.1.1 (A:) H1 subunit of the asialoglycoprotei	6e-08
d1h8ua_	115	d.169.1.1 (A:) Eosinophil major basic protein {Hum	9e-08
d1kg0c_	136	d.169.1.1 (C:) EBV gp42 {Epstein-Barr virus [TaxId	3e-07
d1r13a1	119	d.169.1.1 (A:110-228) Surfactant protein, lectin d	9e-07
d2msba_	112	d.169.1.1 (A:) Mannose-binding protein A, C-lectin	1e-06
d1pwba1	121	d.169.1.1 (A:235-355) Surfactant protein, lectin d	2e-06
d1tn3a_	137	d.169.1.1 (A:) Tetranectin {Human (Homo sapiens) [	2e-06
d1oz7b_	123	d.169.1.1 (B:) Snake coagglutinin beta chain {Saw-	2e-06
d1t8da1	143	d.169.1.1 (A:1-143) Low affinity immunoglobulin ep	2e-06
d1v7pb_	127	d.169.1.1 (B:) Snake coagglutinin beta chain {Snak	3e-06
d1hupa1	117	d.169.1.1 (A:112-228) Mannose-binding protein A, C	4e-06
d1wmza_	140	d.169.1.1 (A:) Lectin CEL-I {Cucumaria echinata [T	4e-06
d1c3ab_	125	d.169.1.1 (B:) Snake coagglutinin beta chain {Habu	4e-06
d3bdwa1	121	d.169.1.1 (A:59-179) CD94 {Human (Homo sapiens) [T	6e-06
d1jwia_	124	d.169.1.1 (A:) Snake coagglutinin alpha chain {Puf	9e-06
d1gz2a_	139	d.169.1.1 (A:) Ovocleidin-17 {Chicken (Gallus gall	1e-05
d1uv0a_	140	d.169.1.1 (A:) Pancreatitis-associated protein 1 {	2e-05
d1rdl1_	111	d.169.1.1 (1:) Mannose-binding protein A, C-lectin	2e-05
d1oz7a_	131	d.169.1.1 (A:) Snake coagglutinin alpha chain {Saw	2e-05
d1jwib_	123	d.169.1.1 (B:) Snake coagglutinin beta chain {Puff	4e-05
d1jzna_	135	d.169.1.1 (A:) Galactose-specific C-type lectin {W	4e-05
d1qdda_	144	d.169.1.1 (A:) Lithostathine, inhibitor of stone f	7e-05
d2afpa_	129	d.169.1.1 (A:) Type II antifreeze protein {Sea rav	7e-05
d1v7pa_	134	d.169.1.1 (A:) Snake coagglutinin alpha chain {Sna	1e-04
d1umrc_	125	d.169.1.1 (C:) Snake coagglutinin beta chain {Sout	1e-04
d1byfa_	123	d.169.1.1 (A:) Lectin TC14 {Tunicate (Polyandrocar	1e-04
d1c3aa_	135	d.169.1.1 (A:) Snake coagglutinin alpha chain {Hab	2e-04
d1j34b_	123	d.169.1.1 (B:) Snake coagglutinin beta chain {Habu	3e-04
d1sb2a1	132	d.169.1.1 (A:1-132) Snake coagglutinin alpha chain	5e-04
d1umra_	135	d.169.1.1 (A:) Snake coagglutinin alpha chain {Sou	5e-04
d1fvua_	133	d.169.1.1 (A:) Snake coagglutinin alpha chain {Jar	5e-04
d1fvub_	125	d.169.1.1 (B:) Snake coagglutinin beta chain {Jara	5e-04
d1sb2b1	127	d.169.1.1 (B:2-128) Snake coagglutinin beta chain	0.001
d1j34a_	129	d.169.1.1 (A:) Snake coagglutinin alpha chain {Hab	0.002

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 2e-57
 Identities = 63/283 (22%), Positives = 122/283 (43%), Gaps = 29/283 (10%)

Query: 231 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKG 288
           + +G    G  Y G       VAVK L  ++   Q+ + F +E+G   +  H N++   G
Sbjct: 14  QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71

Query: 289 CCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH 348
                    IV ++     L   LH         +    + +A   AQG+ +LH K    
Sbjct: 72  YS-TAPQLAIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQGMDYLHAK---S 124

Query: 349 VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY---RN 405
           ++HRD++++N+ L E+    +   GL+          +     G+  ++APE +    +N
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184

Query: 406 ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL 465
             + +SDVY+FG++L E+++G+ P   +++             +        L P +S +
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ----------IIFMVGRGYLSPDLSKV 234

Query: 466 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 508
            S+ P+A     +  L+  C +     RP    ++  ++ LA+
Sbjct: 235 RSNCPKA-----MKRLMAECLKKKRDERPLFPQILASIELLAR 272

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (441), Expect = 2e-51
 Identities = 68/274 (24%), Positives = 116/274 (42%), Gaps = 27/274 (9%)

Query: 231 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 290
             LG  + G  + G     ++VAVK LK+ S      F +E     +L H  LV +    
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 77

Query: 291 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 350
                 YI+ E++ NG L  +L      G  L     + +A  +A+G+AF+ ++   + +
Sbjct: 78  TQ-EPIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEER---NYI 131

Query: 351 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 410
           HRD+RA+N+L+ +     +   GL++ +       R   A     + APE +     T K
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFPIKWTAPEAINYGTFTIK 190

Query: 411 SDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIP 470
           SDV+SFG+LL EIV+  R      +                    E++  L        P
Sbjct: 191 SDVWSFGILLTEIVTHGRIPYPGMT------------------NPEVIQNLERGYRMVRP 232

Query: 471 EAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ 504
           +    +++  L+  C +  P  RP   ++   L+
Sbjct: 233 D-NCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (438), Expect = 5e-51
 Identities = 59/278 (21%), Positives = 120/278 (43%), Gaps = 27/278 (9%)

Query: 231 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 290
           + +G  + G  + G   +  +VA+K ++  +   +++F  E     +L HP LV + G C
Sbjct: 11  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVC 69

Query: 291 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 350
            +     +V+EF+ +G L  +L               + +   + +G+A+L +     V+
Sbjct: 70  LEQAPICLVFEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEEA---CVI 123

Query: 351 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 410
           HRD+ A N L+ E     +   G+++FV  +     +        + +PE    +  ++K
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSK 182

Query: 411 SDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIP 470
           SDV+SFGVL+ E+ S  +                     ++    E+++ + +      P
Sbjct: 183 SDVWSFGVLMWEVFSEGKIPY------------------ENRSNSEVVEDISTGFRLYKP 224

Query: 471 EAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 508
                  V  ++  C +  P  RP  S ++ QL ++A+
Sbjct: 225 R-LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 2e-50
 Identities = 60/276 (21%), Positives = 113/276 (40%), Gaps = 27/276 (9%)

Query: 231 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 290
           + LG  + G    G       VA+K +K  S   + EF  E      L H  LV + G C
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 68

Query: 291 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 350
                 +I+ E++ NG L  +L               +++   + + + +L  K     +
Sbjct: 69  TKQRPIFIITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESK---QFL 122

Query: 351 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 410
           HRD+ A N L++++    +   GLS++V  +     +V +     +  PE +  ++ ++K
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 181

Query: 411 SDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIP 470
           SD+++FGVL+ EI S  +             +E  T    +    + L      L+S+  
Sbjct: 182 SDIWAFGVLMWEIYSLGKM-----------PYERFTNSETAEHIAQGLRLYRPHLASE-- 228

Query: 471 EAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 506
                 KV  ++Y+C       RP    ++  +  +
Sbjct: 229 ------KVYTIMYSCWHEKADERPTFKILLSNILDV 258

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  168 bits (425), Expect = 1e-48
 Identities = 67/314 (21%), Positives = 133/314 (42%), Gaps = 43/314 (13%)

Query: 214 FTTEELRSITKNFSEGN--------RLLGDSKTGGTYSGILPDGSR----VAVKRLKRS- 260
           FT E+     + F++          +++G  + G   SG L    +    VA+K LK   
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 261 SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGR 320
           + +++++F SE     +  HPN++ ++G         I+ EF+ NG LD +L        
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ---NDG 123

Query: 321 SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 380
                  + +   +A G+ +L D    + VHRD+ A N+L++      +   GLS+F+  
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180

Query: 381 EVMQE---RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSV 436
           +         +       + APE +   + T+ SDV+S+G+++ E++S G RP   + + 
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ 240

Query: 437 CWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRM 496
                              ++++ +        P       +  L+  C Q   + RP+ 
Sbjct: 241 -------------------DVINAIEQDYRLPPPM-DCPSALHQLMLDCWQKDRNHRPKF 280

Query: 497 SHVVHQLQQLAQPP 510
             +V+ L ++ + P
Sbjct: 281 GQIVNTLDKMIRNP 294

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (424), Expect = 2e-48
 Identities = 57/296 (19%), Positives = 113/296 (38%), Gaps = 25/296 (8%)

Query: 231 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 290
             +G  + G  + G    G  VAVK       +R     +EI +   L H N++      
Sbjct: 9   ESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAAD 66

Query: 291 YDHGDR----YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV- 345
                     ++V ++  +G L  +L+       ++     +K+A + A G+A LH ++ 
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIV 121

Query: 346 ----KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAP 399
               KP + HRD+++ N+L+ +     +  +GL+                  GT  Y+AP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181

Query: 400 EFVYRN------ELTTKSDVYSFGVLLLEIVSGRRP-AQAVDSVCWQSIFEWATPLVQSH 452
           E +  +      E   ++D+Y+ G++  EI           D          + P V+  
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241

Query: 453 RYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 508
           R +     L  ++ +       ++ +  ++  C     + R     +   L QL+Q
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (425), Expect = 2e-48
 Identities = 61/294 (20%), Positives = 112/294 (38%), Gaps = 35/294 (11%)

Query: 231 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQR-KKEFYSEIGRFARLHHPNLVAVKG 288
             LG    G  +     P G  +A K +        + +   E+      + P +V   G
Sbjct: 12  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71

Query: 289 CCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH 348
             Y  G+  I  E +  G LD+ L    R    +   +  KV+  + +G+ +L +K K  
Sbjct: 72  AFYSDGEISICMEHMDGGSLDQVLKKAGR----IPEQILGKVSIAVIKGLTYLREKHK-- 125

Query: 349 VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELT 408
           ++HRD++ SN+L++      L   G+S  +   +         GT  Y++PE +     +
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV----GTRSYMSPERLQGTHYS 181

Query: 409 TKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIF-----------------------EWA 445
            +SD++S G+ L+E+  GR P    D+   + +F                        + 
Sbjct: 182 VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYG 241

Query: 446 TPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHV 499
                     ELLD +++     +P      +  D V  C    P+ R  +  +
Sbjct: 242 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (420), Expect = 4e-48
 Identities = 67/280 (23%), Positives = 108/280 (38%), Gaps = 27/280 (9%)

Query: 231 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 290
             LG    G  + G     +RVA+K LK  +    + F  E     +L H  LV +    
Sbjct: 23  VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVV 81

Query: 291 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 350
                 YIV E++  G L  +L      G+ L     + +A  +A G+A++      + V
Sbjct: 82  S-EEPIYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERM---NYV 135

Query: 351 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 410
           HRD+RA+N+L+ E     +   GL++ +       R         + APE       T K
Sbjct: 136 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIK 194

Query: 411 SDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIP 470
           SDV+SFG+LL E+ +  R             +             E+LD +        P
Sbjct: 195 SDVWSFGILLTELTTKGRV-----------PYPGMVN-------REVLDQVERGYRMPCP 236

Query: 471 EAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 510
                + + DL+  C +  P  RP   ++   L+      
Sbjct: 237 P-ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  165 bits (419), Expect = 6e-48
 Identities = 74/279 (26%), Positives = 119/279 (42%), Gaps = 27/279 (9%)

Query: 231 RLLGDSKTGGTYSGILPDGSR-VAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGC 289
             LG  + G  Y G+    S  VAVK LK  + + + EF  E      + HPNLV + G 
Sbjct: 23  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 81

Query: 290 CYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHV 349
           C      YI+ EF+  G L  +L       + +   + + +AT ++  + +L    K + 
Sbjct: 82  CTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLE---KKNF 136

Query: 350 VHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTT 409
           +HRD+ A N L+ E     +   GLS+ +  +        A     + APE +  N+ + 
Sbjct: 137 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA-GAKFPIKWTAPESLAYNKFSI 195

Query: 410 KSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDI 469
           KSDV++FGVLL EI +                              ++ + L      + 
Sbjct: 196 KSDVWAFGVLLWEIATYGM------------------SPYPGIDLSQVYELLEKDYRMER 237

Query: 470 PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 508
           PE G  +KV +L+ AC Q  PS RP  + +    + + Q
Sbjct: 238 PE-GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (413), Expect = 2e-47
 Identities = 69/277 (24%), Positives = 115/277 (41%), Gaps = 33/277 (11%)

Query: 231 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 290
           + +G  + G    G    G++VAVK +K  +    + F +E     +L H NLV + G  
Sbjct: 13  QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 69

Query: 291 YDHGDR-YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHV 349
            +     YIV E++  G L  +L    RG   L     +K +  + + + +L      + 
Sbjct: 70  VEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLE---GNNF 124

Query: 350 VHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTT 409
           VHRD+ A NVL+ E+  A +   GL+K                   + APE +   + +T
Sbjct: 125 VHRDLAARNVLVSEDNVAKVSDFGLTKE-----ASSTQDTGKLPVKWTAPEALREKKFST 179

Query: 410 KSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDI 469
           KSDV+SFG+LL EI S  R       +                   +++  +      D 
Sbjct: 180 KSDVWSFGILLWEIYSFGRVPYPRIPL------------------KDVVPRVEKGYKMDA 221

Query: 470 PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 506
           P+ G    V +++  C     +MRP    +  QL+ +
Sbjct: 222 PD-GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (408), Expect = 4e-46
 Identities = 73/297 (24%), Positives = 126/297 (42%), Gaps = 36/297 (12%)

Query: 221 SITKNFSEGNRLLGDSKTGGTYSGILPDGSR----VAVKRLKRSSFQRK-KEFYSEIGRF 275
           S+  +F+E   ++G    G  Y G L D        AVK L R +   +  +F +E    
Sbjct: 26  SLIVHFNE---VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 82

Query: 276 ARLHHPNLVAVKGCCYDH-GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTL 334
               HPN++++ G C    G   +V  ++ +G L  ++ +      +      +     +
Sbjct: 83  KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQV 139

Query: 335 AQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--G 392
           A+G+ FL  K     VHRD+ A N +LDE+F   +   GL++ +  +         G   
Sbjct: 140 AKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 196

Query: 393 TYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSH 452
              ++A E +   + TTKSDV+SFGVLL E+++   P          + F+    L+Q  
Sbjct: 197 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP-----DVNTFDITVYLLQGR 251

Query: 453 RYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 509
           R   LL P         P+      + +++  C      MRP  S +V ++  +   
Sbjct: 252 R---LLQP------EYCPD-----PLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  160 bits (404), Expect = 9e-46
 Identities = 64/305 (20%), Positives = 117/305 (38%), Gaps = 49/305 (16%)

Query: 231 RLLGDSKTGGTYSGILP------DGSRVAVKRLKRSSFQR-KKEFYSEIGRFARLHHPNL 283
           R +G+   G  +    P        + VAVK LK  +    + +F  E    A   +PN+
Sbjct: 19  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 78

Query: 284 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLH--------------------HIPRGGRSLD 323
           V + G C       +++E++  G L+ +L                         G   L 
Sbjct: 79  VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 138

Query: 324 WAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 383
            A ++ +A  +A G+A+L    +   VHRD+   N L+ E     +   GLS+ +     
Sbjct: 139 CAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 195

Query: 384 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFE 443
            +          ++ PE ++ N  TT+SDV+++GV+L EI S                + 
Sbjct: 196 YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ-----------PYY 244

Query: 444 WATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQL 503
                       E++  +        PE     ++ +L+  C   +P+ RP    +   L
Sbjct: 245 GMAH-------EEVIYYVRDGNILACPE-NCPLELYNLMRLCWSKLPADRPSFCSIHRIL 296

Query: 504 QQLAQ 508
           Q++ +
Sbjct: 297 QRMCE 301

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (403), Expect = 1e-45
 Identities = 65/303 (21%), Positives = 122/303 (40%), Gaps = 36/303 (11%)

Query: 215 TTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSR-----VAVKRLKRSSFQR-KKEF 268
           TTE   S     +   +++G  + G  Y G+L   S      VA+K LK    ++ + +F
Sbjct: 1   TTEIHPS---CVTRQ-KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDF 56

Query: 269 YSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRM 328
             E G   +  H N++ ++G    +    I+ E++ NG LD     +            +
Sbjct: 57  LGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALD---KFLREKDGEFSVLQLV 113

Query: 329 KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 388
            +   +A G+ +L      + VHRD+ A N+L++      +   GLS+ +  +     T 
Sbjct: 114 GMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTT 170

Query: 389 MAG-GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATP 447
             G     + APE +   + T+ SDV+SFG+++ E+++                  W   
Sbjct: 171 SGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER------------PYWELS 218

Query: 448 LVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA 507
                   E++  +        P       +  L+  C Q   + RP+ + +V  L +L 
Sbjct: 219 NH------EVMKAINDGFRLPTPM-DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271

Query: 508 QPP 510
           + P
Sbjct: 272 RAP 274

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (402), Expect = 1e-45
 Identities = 61/277 (22%), Positives = 104/277 (37%), Gaps = 29/277 (10%)

Query: 231 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQR--KKEFYSEIGRFARLHHPNLVAVK 287
             +G    G         DG  +  K L   S     K+   SE+     L HPN+V   
Sbjct: 10  YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69

Query: 288 GCCYDHGDR--YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK- 344
               D  +   YIV E+   G L   +    +  + LD    ++V T L   +   H + 
Sbjct: 70  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 129

Query: 345 -VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 403
                V+HRD++ +NV LD +    L   GL++ +  +    +  +  GT  Y++PE + 
Sbjct: 130 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFV--GTPYYMSPEQMN 187

Query: 404 RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS 463
           R     KSD++S G LL E+ +   P            F   +    + +  E     I 
Sbjct: 188 RMSYNEKSDIWSLGCLLYELCALMPP------------FTAFSQKELAGKIREGKFRRIP 235

Query: 464 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVV 500
              SD        ++ +++          RP +  ++
Sbjct: 236 YRYSD--------ELNEIITRMLNLKDYHRPSVEEIL 264

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (402), Expect = 2e-45
 Identities = 63/301 (20%), Positives = 114/301 (37%), Gaps = 35/301 (11%)

Query: 217 EELRSITKNFSEGNR-----LLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYS 270
           E+LRSI        +      +G   +G  Y+ + +  G  VA++++      +K+   +
Sbjct: 7   EKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN 66

Query: 271 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 330
           EI       +PN+V          + ++V E++  G L   +         +D      V
Sbjct: 67  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAV 121

Query: 331 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 390
                Q + FLH      V+HRDI++ N+LL  +    L   G    +  E  Q +    
Sbjct: 122 CRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTM 176

Query: 391 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQ 450
            GT  ++APE V R     K D++S G++ +E++ G  P            +    PL  
Sbjct: 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP------------YLNENPLRA 224

Query: 451 SHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVV-HQLQQLAQP 509
            +       P + +    +          D +  C       R     ++ HQ  ++A+P
Sbjct: 225 LYLIATNGTPELQN-PEKLSAI-----FRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKP 278

Query: 510 P 510
            
Sbjct: 279 L 279

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (401), Expect = 2e-45
 Identities = 59/295 (20%), Positives = 114/295 (38%), Gaps = 31/295 (10%)

Query: 217 EELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSR---VAVKRLKRSSFQR-KKEFYSEI 272
           ++L     N    +  LG    G    G+     +   VA+K LK+ + +   +E   E 
Sbjct: 1   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60

Query: 273 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVAT 332
               +L +P +V + G C       +V E    GPL ++L         +  +   ++  
Sbjct: 61  QIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLV---GKREEIPVSNVAELLH 116

Query: 333 TLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV-PWEVMQERTVMAG 391
            ++ G+ +L +K   + VHRD+ A NVLL     A +   GLSK +   +          
Sbjct: 117 QVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173

Query: 392 GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQS 451
               + APE +   + +++SDV+S+GV + E +S  +             ++        
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP-----------YKKMKG---- 218

Query: 452 HRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 506
               E++  +      + P      ++  L+  C  +    RP    V  +++  
Sbjct: 219 ---PEVMAFIEQGKRMECPP-ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (399), Expect = 7e-45
 Identities = 62/300 (20%), Positives = 110/300 (36%), Gaps = 43/300 (14%)

Query: 231 RLLGDSKTGGTYSGIL------PDGSRVAVKRLKRSSFQR-KKEFYSEIGRFARL-HHPN 282
           + LG    G                  VAVK LK S+    ++   SE+   + L +H N
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88

Query: 283 LVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHH--------------IPRGGRSLDWAMRM 328
           +V + G C   G   ++ E+   G L  +L                +     +LD    +
Sbjct: 89  IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148

Query: 329 KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 388
             +  +A+G+AFL  K   + +HRD+ A N+LL       +   GL++ +  +       
Sbjct: 149 SFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205

Query: 389 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPL 448
            A     ++APE ++    T +SDV+S+G+ L E+ S          V  +         
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--------- 256

Query: 449 VQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 508
                       +        PE     ++ D++  C    P  RP    +V  +++   
Sbjct: 257 --------FYKMIKEGFRMLSPE-HAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (394), Expect = 1e-44
 Identities = 70/289 (24%), Positives = 120/289 (41%), Gaps = 35/289 (12%)

Query: 224 KNFSEGNRLLGDSKTGGTYSGILPD---GSRVAVKRLKRSSFQR--KKEFYSEIGRFARL 278
           K  +  ++ LG    G    G          VAVK LK  +     K E  +E     +L
Sbjct: 6   KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL 65

Query: 279 HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGI 338
            +P +V + G C +     +V E    GPL+++L       R +     +++   ++ G+
Sbjct: 66  DNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGM 120

Query: 339 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG-GTYGYL 397
            +L +    + VHRD+ A NVLL  +  A +   GLSK +  +    +    G     + 
Sbjct: 121 KYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY 177

Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLE 456
           APE +   + ++KSDV+SFGVL+ E  S G++P + +                      E
Sbjct: 178 APECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-------------------E 218

Query: 457 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ 505
           +   L        P  G  +++ DL+  C  +    RP  + V  +L+ 
Sbjct: 219 VTAMLEKGERMGCPA-GCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 2e-44
 Identities = 68/302 (22%), Positives = 121/302 (40%), Gaps = 43/302 (14%)

Query: 224 KNFSEGNRLLGDSKTGGTYSGILPDGSR---VAVKRLKR-SSFQRKKEFYSEIGRFARL- 278
            +    + ++G+   G      +         A+KR+K  +S    ++F  E+    +L 
Sbjct: 10  NDIKFQD-VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG 68

Query: 279 HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLH------------HIPRGGRSLDWAM 326
           HHPN++ + G C   G  Y+  E+  +G L  +L                    +L    
Sbjct: 69  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128

Query: 327 RMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 386
            +  A  +A+G+ +L    +   +HRD+ A N+L+ E + A +   GLS+     V   +
Sbjct: 129 LLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---K 182

Query: 387 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWAT 446
             M      ++A E +  +  TT SDV+S+GVLL EIVS         +           
Sbjct: 183 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---------- 232

Query: 447 PLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 506
                    EL + L      + P      +V DL+  C +  P  RP  + ++  L ++
Sbjct: 233 --------AELYEKLPQGYRLEKPL-NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283

Query: 507 AQ 508
            +
Sbjct: 284 LE 285

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  157 bits (397), Expect = 2e-44
 Identities = 65/311 (20%), Positives = 119/311 (38%), Gaps = 44/311 (14%)

Query: 208 PPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRK- 265
           P   ++F  ++     K FS+   + G    G  Y    + +   VA+K++  S  Q   
Sbjct: 2   PDVAELFFKDD---PEKLFSDLREI-GHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE 57

Query: 266 --KEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLD 323
             ++   E+    +L HPN +  +GC       ++V E+ +    D    H     + L 
Sbjct: 58  KWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH----KKPLQ 113

Query: 324 WAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 383
                 V     QG+A+LH     +++HRD++A N+LL E     L   G +  +     
Sbjct: 114 EVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA---- 166

Query: 384 QERTVMAGGTYGYLAPEFV---YRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS 440
              + +  GT  ++APE +      +   K DV+S G+  +E+   + P           
Sbjct: 167 PANSFV--GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP----------- 213

Query: 441 IFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVV 500
                  +   +   +   P +   S    E        + V +C Q +P  RP    ++
Sbjct: 214 -LFNMNAMSALYHIAQNESPALQ--SGHWSEY-----FRNFVDSCLQKIPQDRPTSEVLL 265

Query: 501 -HQLQQLAQPP 510
            H+     +PP
Sbjct: 266 KHRFVLRERPP 276

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 2e-44
 Identities = 65/338 (19%), Positives = 121/338 (35%), Gaps = 48/338 (14%)

Query: 194 KSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSR-- 251
           +  +++  + +      ++ +  +      +   E  ++LG    G   +      S+  
Sbjct: 6   QMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTG 65

Query: 252 ----VAVKRLKRSSFQR-KKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVN 305
               VAVK LK  +    ++   SE+    +L  H N+V + G C   G  Y+++E+   
Sbjct: 66  VSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCY 125

Query: 306 GPLDRWLH-------------------HIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVK 346
           G L  +L                            L +   +  A  +A+G+ FL  K  
Sbjct: 126 GDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK-- 183

Query: 347 PHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNE 406
              VHRD+ A NVL+       +   GL++ +  +        A     ++APE ++   
Sbjct: 184 -SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI 242

Query: 407 LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 466
            T KSDV+S+G+LL EI S                     P             + +   
Sbjct: 243 YTIKSDVWSYGILLWEIFSLGVN-----------------PYPGIPVDANFYKLIQNGFK 285

Query: 467 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ 504
            D P     +++  ++ +C       RP   ++   L 
Sbjct: 286 MDQPF-YATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (389), Expect = 9e-44
 Identities = 53/290 (18%), Positives = 105/290 (36%), Gaps = 36/290 (12%)

Query: 220 RSITKNFSEGNRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQR--KKEFYSEIGRFA 276
            S    F + +  +G       Y G+  +    VA   L+     +  ++ F  E     
Sbjct: 4   MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLK 63

Query: 277 RLHHPNLVAVKGCCYDHGDR----YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVAT 332
            L HPN+V                 +V E + +G L  +L       + +   +      
Sbjct: 64  GLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCR 119

Query: 333 TLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG-AHLMGVGLSKFVPWEVMQERTVMAG 391
            + +G+ FLH +  P ++HRD++  N+ +    G   +  +GL+        +       
Sbjct: 120 QILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI---- 174

Query: 392 GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQS 451
           GT  ++APE +Y  +     DVY+FG+ +LE+ +   P    +      I+      V S
Sbjct: 175 GTPEFMAPE-MYEEKYDESVDVYAFGMCMLEMATSEYPYS--ECQNAAQIYRR----VTS 227

Query: 452 HRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 501
                  D +               +V +++  C +     R  +  +++
Sbjct: 228 GVKPASFDKVAI------------PEVKEIIEGCIRQNKDERYSIKDLLN 265

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 1e-43
 Identities = 66/274 (24%), Positives = 104/274 (37%), Gaps = 36/274 (13%)

Query: 231 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAV 286
           R LG  K G  Y          +A+K L ++  ++     +   E+   + L HPN++ +
Sbjct: 12  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71

Query: 287 KGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVK 346
            G  +D    Y++ E+   G + R L  + +     D        T LA  +++ H K  
Sbjct: 72  YGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHSK-- 125

Query: 347 PHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNE 406
             V+HRDI+  N+LL       +   G S   P      R     GT  YL PE +    
Sbjct: 126 -RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPPEMIEGRM 180

Query: 407 LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 466
              K D++S GVL  E + G+ P            FE  T      R   +       ++
Sbjct: 181 HDEKVDLWSLGVLCYEFLVGKPP------------FEANTYQETYKRISRVEFTFPDFVT 228

Query: 467 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVV 500
                        DL+    +H PS RP +  V+
Sbjct: 229 EG---------ARDLISRLLKHNPSQRPMLREVL 253

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 3e-43
 Identities = 58/286 (20%), Positives = 117/286 (40%), Gaps = 32/286 (11%)

Query: 231 RLLGDSKTGGTYSGI-LPDGSR----VAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLV 284
           ++LG    G  Y G+ +P+G +    VA+K L+ + S +  KE   E    A + +P++ 
Sbjct: 15  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74

Query: 285 AVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 344
            + G C       ++ + +  G L   L ++     ++     +     +A+G+ +L D+
Sbjct: 75  RLLGICLT-STVQLITQLMPFGCL---LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 130

Query: 345 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR 404
               +VHRD+ A NVL+       +   GL+K +  E  +           ++A E +  
Sbjct: 131 ---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 187

Query: 405 NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS 464
              T +SDV+S+GV + E+++        D +    I      +++    L         
Sbjct: 188 RIYTHQSDVWSYGVTVWELMTFGSK--PYDGIPASEISS----ILEKGERLP-------- 233

Query: 465 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 510
                P       V  ++  C       RP+   ++ +  ++A+ P
Sbjct: 234 ----QPP-ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 274

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 1e-42
 Identities = 57/275 (20%), Positives = 99/275 (36%), Gaps = 32/275 (11%)

Query: 231 RLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGC 289
             LGD   G  Y     +     A K +   S +  +++  EI   A   HPN+V +   
Sbjct: 18  GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77

Query: 290 CYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHV 349
            Y   + +I+ EF   G +D     +    R L  +    V       + +LHD     +
Sbjct: 78  FYYENNLWILIEFCAGGAVD---AVMLELERPLTESQIQVVCKQTLDALNYLHDN---KI 131

Query: 350 VHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL-- 407
           +HRD++A N+L   +    L   G+S      + +  + +  GT  ++APE V       
Sbjct: 132 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI--GTPYWMAPEVVMCETSKD 189

Query: 408 ---TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS 464
                K+DV+S G+ L+E+     P                 P+    +  +   P ++ 
Sbjct: 190 RPYDYKADVWSLGITLIEMAEIEPP------------HHELNPMRVLLKIAKSEPPTLAQ 237

Query: 465 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHV 499
            S             D +  C +     R   S +
Sbjct: 238 PSRWSSNF------KDFLKKCLEKNVDARWTTSQL 266

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (373), Expect = 2e-41
 Identities = 66/283 (23%), Positives = 110/283 (38%), Gaps = 36/283 (12%)

Query: 240 GTYSGILPDGSRVAVKRLKRSSFQR-KKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRY 297
           G         ++VAVK LK  + ++   +  SE+     +  H N++ + G C   G  Y
Sbjct: 36  GLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLY 95

Query: 298 IVYEFVVNGPLDRWLHHIPRGG------------RSLDWAMRMKVATTLAQGIAFLHDKV 345
           ++ E+   G L  +L      G              L     +  A  +A+G+ +L  K 
Sbjct: 96  VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK- 154

Query: 346 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN 405
               +HRD+ A NVL+ E+    +   GL++ +      ++T        ++APE ++  
Sbjct: 155 --KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR 212

Query: 406 ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL 465
             T +SDV+SFGVLL EI +          V                   EL   L    
Sbjct: 213 IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV------------------EELFKLLKEGH 254

Query: 466 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 508
             D P      ++  ++  C   VPS RP    +V  L ++  
Sbjct: 255 RMDKPS-NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 3e-41
 Identities = 65/283 (22%), Positives = 111/283 (39%), Gaps = 32/283 (11%)

Query: 231 RLLGDSKTGGTYSGILPDGSR----VAVKRLKRSSFQRKKE-FYSEIGRFARLHHPNLVA 285
           R +G+ + G  + GI          VA+K  K  +    +E F  E     +  HP++V 
Sbjct: 13  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 72

Query: 286 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 345
           + G   ++   +I+ E    G L      +     SLD A  +  A  L+  +A+L  K 
Sbjct: 73  LIGVITEN-PVWIIMELCTLGEL---RSFLQVRKYSLDLASLILYAYQLSTALAYLESK- 127

Query: 346 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN 405
               VHRDI A NVL+       L   GLS+++       +         ++APE +   
Sbjct: 128 --RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFR 184

Query: 406 ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL 465
             T+ SDV+ FGV + EI+                         Q  +  +++  + +  
Sbjct: 185 RFTSASDVWMFGVCMWEILMHGVKPF------------------QGVKNNDVIGRIENGE 226

Query: 466 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 508
              +P       +  L+  C  + PS RPR + +  QL  + +
Sbjct: 227 RLPMPP-NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  149 bits (376), Expect = 3e-41
 Identities = 50/272 (18%), Positives = 91/272 (33%), Gaps = 29/272 (10%)

Query: 231 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGC 289
             LG    G  +  +    G     K +       K    +EI    +LHHP L+ +   
Sbjct: 35  EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 94

Query: 290 CYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHV 349
             D  +  ++ EF+  G L      I      +  A  +       +G+  +H+     +
Sbjct: 95  FEDKYEMVLILEFLSGGEL---FDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SI 148

Query: 350 VHRDIRASNVLLDEEFGAH--LMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL 407
           VH DI+  N++ + +  +   ++  GL+  +  +   E   +   T  + APE V R  +
Sbjct: 149 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPD---EIVKVTTATAEFAAPEIVDREPV 205

Query: 408 TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS 467
              +D+++ GVL   ++SG  P            F     L                  S
Sbjct: 206 GFYTDMWAIGVLGYVLLSGLSP------------FAGEDDLETLQNVKRCDWEFDEDAFS 253

Query: 468 DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHV 499
            +          D +    Q  P  R  +   
Sbjct: 254 SVSPE-----AKDFIKNLLQKEPRKRLTVHDA 280

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 5e-41
 Identities = 59/292 (20%), Positives = 120/292 (41%), Gaps = 35/292 (11%)

Query: 231 RLLGDSKTGGTYSGIL------PDGSRVAVKRLKRSSFQR-KKEFYSEIGRFARLHHPNL 283
           R LG    G  Y G+          +RVA+K +  ++  R + EF +E       +  ++
Sbjct: 26  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 85

Query: 284 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS------LDWAMRMKVATTLAQG 337
           V + G         ++ E +  G L  +L  +     +         +  +++A  +A G
Sbjct: 86  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 145

Query: 338 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 397
           +A+L+       VHRD+ A N ++ E+F   +   G+++ +       +         ++
Sbjct: 146 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 202

Query: 398 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLEL 457
           +PE +     TT SDV+SFGV+L EI +                ++  +         ++
Sbjct: 203 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP-----------YQGLSN-------EQV 244

Query: 458 LDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 509
           L  ++     D P+      + +L+  C Q+ P MRP    ++  +++  +P
Sbjct: 245 LRFVMEGGLLDKPD-NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  147 bits (373), Expect = 9e-41
 Identities = 50/272 (18%), Positives = 92/272 (33%), Gaps = 29/272 (10%)

Query: 231 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGC 289
             LG    G  +       G+  A K +       K+    EI   + L HP LV +   
Sbjct: 32  EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 91

Query: 290 CYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHV 349
             D  +  ++YEF+  G L      +      +     ++    + +G+  +H+    + 
Sbjct: 92  FEDDNEMVMIYEFMSGGEL---FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NY 145

Query: 350 VHRDIRASNVLLDEEFGAHLMGV--GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL 407
           VH D++  N++   +    L  +  GL+  +     ++   +  GT  + APE      +
Sbjct: 146 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP---KQSVKVTTGTAEFAAPEVAEGKPV 202

Query: 408 TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS 467
              +D++S GVL   ++SG  P            F                  +  S  S
Sbjct: 203 GYYTDMWSVGVLSYILLSGLSP------------FGGENDDETLRNVKSCDWNMDDSAFS 250

Query: 468 DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHV 499
            I E        D +       P+ R  +   
Sbjct: 251 GISED-----GKDFIRKLLLADPNTRMTIHQA 277

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 3e-40
 Identities = 54/272 (19%), Positives = 100/272 (36%), Gaps = 28/272 (10%)

Query: 231 RLLGDSKTGGTYSGI-LPDGSRVAVKRL-KRSSFQRKKEFYSEIGRFARLHHPNLVAVKG 288
           + LG+   G     +       VAVK +  + +    +    EI     L+H N+V   G
Sbjct: 11  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70

Query: 289 CCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH 348
              +   +Y+  E+   G L   +         +      +    L  G+ +LH      
Sbjct: 71  HRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI---G 123

Query: 349 VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL- 407
           + HRDI+  N+LLDE     +   GL+    +   +       GT  Y+APE + R E  
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 183

Query: 408 TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS 467
               DV+S G++L  +++G  P            ++  +   Q +   +     ++    
Sbjct: 184 AEPVDVWSCGIVLTAMLAGELP------------WDQPSDSCQEYSDWKEKKTYLN---- 227

Query: 468 DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHV 499
             P   +    + L++      PS R  +  +
Sbjct: 228 --PWKKIDSAPLALLHKILVENPSARITIPDI 257

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (365), Expect = 3e-40
 Identities = 52/283 (18%), Positives = 96/283 (33%), Gaps = 32/283 (11%)

Query: 231 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAV 286
           ++LG+           L      A+K L++    ++        E    +RL HP  V +
Sbjct: 14  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73

Query: 287 KGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVK 346
                D    Y    +  NG L +++  I       D          +   + +LH    
Sbjct: 74  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEYLH---G 126

Query: 347 PHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNE 406
             ++HRD++  N+LL+E+    +   G +K +  E  Q R     GT  Y++PE +    
Sbjct: 127 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS 186

Query: 407 LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 466
               SD+++ G ++ ++V+G  P            F      +   + ++L         
Sbjct: 187 ACKSSDLWALGCIIYQLVAGLPP------------FRAGNEYLIFQKIIKLEYDFPEKFF 234

Query: 467 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 509
                        DLV        + R     +       A P
Sbjct: 235 PK---------ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHP 268

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (356), Expect = 4e-39
 Identities = 53/271 (19%), Positives = 92/271 (33%), Gaps = 29/271 (10%)

Query: 240 GTYSGILPDGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR 296
           G +         VAVK LK       +   +F  E+     L H NL+ + G        
Sbjct: 27  GEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85

Query: 297 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRA 356
            +V E    G L   L  + +           + A  +A+G+ +L  K     +HRD+ A
Sbjct: 86  KMVTELAPLGSL---LDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAA 139

Query: 357 SNVLLDEEFGAHLMGVGLSKFVPWEV-MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYS 415
            N+LL       +   GL + +P               + + APE +     +  SD + 
Sbjct: 140 RNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWM 199

Query: 416 FGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVV 475
           FGV L E+ +  +             +         H+  +  +        D P+    
Sbjct: 200 FGVTLWEMFTYGQE-----------PWIGLNGSQILHKIDK--EGERLPRPEDCPQ---- 242

Query: 476 QKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 506
             + +++  C  H P  RP    +   L + 
Sbjct: 243 -DIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (355), Expect = 9e-39
 Identities = 69/299 (23%), Positives = 106/299 (35%), Gaps = 42/299 (14%)

Query: 231 RLLGDSKTGGTYSGI------LPDGSRVAVKRLKRSSFQ-RKKEFYSEIGRFAR-LHHPN 282
           + LG    G                  VAVK LK  +     +   SE+       HH N
Sbjct: 19  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78

Query: 283 LVAVKGCCYDHGDR-YIVYEFVVNGPLDRWLHH------------IPRGGRSLDWAMRMK 329
           +V + G C   G    ++ EF   G L  +L                     L     + 
Sbjct: 79  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138

Query: 330 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 389
            +  +A+G+ FL  +     +HRD+ A N+LL E+    +   GL++ +  +    R   
Sbjct: 139 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 195

Query: 390 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLV 449
           A     ++APE ++    T +SDV+SFGVLL EI S               I E     +
Sbjct: 196 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-----PGVKIDEEFCRRL 250

Query: 450 QSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 508
           +    +   D                 ++   +  C    PS RP  S +V  L  L Q
Sbjct: 251 KEGTRMRAPD-------------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  139 bits (352), Expect = 2e-38
 Identities = 58/286 (20%), Positives = 108/286 (37%), Gaps = 34/286 (11%)

Query: 231 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAV 286
            +LG       +    L     VAVK L+    +       F  E    A L+HP +VAV
Sbjct: 13  EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 72

Query: 287 KGCCYDHGDR----YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLH 342
                         YIV E+V    L   +H        +     ++V     Q + F H
Sbjct: 73  YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVIADACQALNFSH 128

Query: 343 DKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV-MQERTVMAGGTYGYLAPEF 401
                 ++HRD++ +N+++       +M  G+++ +        +T    GT  YL+PE 
Sbjct: 129 QN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 185

Query: 402 VYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL 461
              + +  +SDVYS G +L E+++G  P            F   +P+  +++++      
Sbjct: 186 ARGDSVDARSDVYSLGCVLYEVLTGEPP------------FTGDSPVSVAYQHVREDPIP 233

Query: 462 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPR-MSHVVHQLQQL 506
            S+    +        +  +V       P  R +  + +   L ++
Sbjct: 234 PSARHEGLSAD-----LDAVVLKALAKNPENRYQTAAEMRADLVRV 274

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (340), Expect = 3e-36
 Identities = 39/267 (14%), Positives = 84/267 (31%), Gaps = 30/267 (11%)

Query: 231 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGC 289
             LG  + G  +  +          K +K     +      EI       H N++ +   
Sbjct: 11  EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV-LVKKEISILNIARHRNILHLHES 69

Query: 290 CYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHV 349
                +  +++EF+    +   ++        L+    +     + + + FLH     ++
Sbjct: 70  FESMEELVMIFEFISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFLHSH---NI 123

Query: 350 VHRDIRASNVLLDEEFGAH--LMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL 407
            H DIR  N++      +   ++  G ++ +      +   +      Y APE    + +
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP---GDNFRLLFTAPEYYAPEVHQHDVV 180

Query: 408 TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS 467
           +T +D++S G L+  ++SG  P            F   T        +            
Sbjct: 181 STATDMWSLGTLVYVLLSGINP------------FLAETNQQIIENIMNAEYTFDEEAFK 228

Query: 468 DIPEAGVVQKVVDLVYACTQHVPSMRP 494
           +I         +D V          R 
Sbjct: 229 EISIE-----AMDFVDRLLVKERKSRM 250

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (333), Expect = 3e-35
 Identities = 52/301 (17%), Positives = 111/301 (36%), Gaps = 31/301 (10%)

Query: 220 RSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL 278
            +I  ++   +++LG    G            + A+K L+        +   E+    R 
Sbjct: 7   NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRA 61

Query: 279 -HHPNLVAVKGCCYD----HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATT 333
              P++V +     +         IV E +  G L   +    RG ++       ++  +
Sbjct: 62  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKS 119

Query: 334 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT 393
           + + I +LH     ++ HRD++  N+L   +    ++ +    F               T
Sbjct: 120 IGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 176

Query: 394 YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHR 453
             Y+APE +   +     D++S GV++  ++ G  P  +       +I       ++  +
Sbjct: 177 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG---LAISPGMKTRIRMGQ 233

Query: 454 YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVV-HQ-LQQLAQPPV 511
           Y E  +P  S +S +         V  L+    +  P+ R  ++  + H  + Q  + P 
Sbjct: 234 Y-EFPNPEWSEVSEE---------VKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQ 283

Query: 512 T 512
           T
Sbjct: 284 T 284

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  132 bits (332), Expect = 7e-35
 Identities = 53/282 (18%), Positives = 102/282 (36%), Gaps = 38/282 (13%)

Query: 225 NFSEGNRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRK------KEFYSEIGRFAR 277
           +FS   R++G    G  Y     D G   A+K L +   + K            +   + 
Sbjct: 5   DFSVH-RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 278 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 337
              P +V +    +       + + +  G L   L            A     A  +  G
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILG 119

Query: 338 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 397
           +  +H++    VV+RD++ +N+LLDE     +  +GL+        +++   + GT+GY+
Sbjct: 120 LEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPHASVGTHGYM 172

Query: 398 APEFVYRNE-LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLE 456
           APE + +     + +D +S G +L +++ G  P +   +     I             L 
Sbjct: 173 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID---------RMTLT 223

Query: 457 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSH 498
           +   L  S S +         +  L+    Q   + R     
Sbjct: 224 MAVELPDSFSPE---------LRSLLEGLLQRDVNRRLGCLG 256

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  130 bits (327), Expect = 1e-34
 Identities = 52/271 (19%), Positives = 90/271 (33%), Gaps = 26/271 (9%)

Query: 231 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKE-FYSEIGRFARLHHPNLVAVKG 288
            +LG                  VA+K + + + + K+    +EI    ++ HPN+VA+  
Sbjct: 15  DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDD 74

Query: 289 CCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH 348
                G  Y++ + V  G L   +                ++   +   + +LHD    H
Sbjct: 75  IYESGGHLYLIMQLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDLGIVH 130

Query: 349 VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELT 408
              +        LDE+    +   GLSK    E        A GT GY+APE + +   +
Sbjct: 131 RDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVLAQKPYS 187

Query: 409 TKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD 468
              D +S GV+   ++ G  P            F          + L+      S    D
Sbjct: 188 KAVDCWSIGVIAYILLCGYPP------------FYDENDAKLFEQILKAEYEFDSPYWDD 235

Query: 469 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHV 499
           I ++       D +    +  P  R      
Sbjct: 236 ISDS-----AKDFIRHLMEKDPEKRFTCEQA 261

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (321), Expect = 1e-33
 Identities = 55/269 (20%), Positives = 90/269 (33%), Gaps = 35/269 (13%)

Query: 231 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKE---FYSEIGRFAR-LHHPNLVA 285
           ++LG    G  +           A+K LK+       +      E    +    HP L  
Sbjct: 8   KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67

Query: 286 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 345
           +        + + V E++  G L   +          D +     A  +  G+ FLH K 
Sbjct: 68  MFCTFQTKENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSK- 122

Query: 346 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN 405
              +V+RD++  N+LLD++    +   G+ K       +  T    GT  Y+APE +   
Sbjct: 123 --GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC--GTPDYIAPEILLGQ 178

Query: 406 ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL 465
           +     D +SFGVLL E++ G+ P            F         H            L
Sbjct: 179 KYNHSVDWWSFGVLLYEMLIGQSP------------FHGQDEEELFHSIRMDNPFYPRWL 226

Query: 466 SSDIPEAGVVQKVVDLVYACTQHVPSMRP 494
             +           DL+       P  R 
Sbjct: 227 EKE---------AKDLLVKLFVREPEKRL 246

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  127 bits (320), Expect = 1e-33
 Identities = 54/268 (20%), Positives = 95/268 (35%), Gaps = 37/268 (13%)

Query: 231 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKE---FYSEIGRFARLHHPNLVAV 286
           R LG    G  +      +G   A+K LK+    R K+      E    + + HP ++ +
Sbjct: 10  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69

Query: 287 KGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVK 346
            G   D    +++ +++  G L   L                      A+    L     
Sbjct: 70  WGTFQDAQQIFMIMDYIEGGELFSLLRKSQ-------RFPNPVAKFYAAEVCLALEYLHS 122

Query: 347 PHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNE 406
             +++RD++  N+LLD+     +   G +K+VP     + T    GT  Y+APE V    
Sbjct: 123 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP-----DVTYTLCGTPDYIAPEVVSTKP 177

Query: 407 LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 466
                D +SFG+L+ E+++G  P            F  +  +    + L          +
Sbjct: 178 YNKSIDWWSFGILIYEMLAGYTP------------FYDSNTMKTYEKILNAELRFPPFFN 225

Query: 467 SDIPEAGVVQKVVDLVYACTQHVPSMRP 494
            D+          DL+        S R 
Sbjct: 226 EDVK---------DLLSRLITRDLSQRL 244

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  125 bits (314), Expect = 6e-33
 Identities = 45/287 (15%), Positives = 90/287 (31%), Gaps = 30/287 (10%)

Query: 231 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGC 289
           R +G    G  Y G  +  G  VA+K     +  +  + + E   +  +     +     
Sbjct: 13  RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRW 70

Query: 290 CYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHV 349
           C   GD  ++   ++   L+   +      R       + +A  +   I ++H K   + 
Sbjct: 71  CGAEGDYNVMVMELLGPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NF 124

Query: 350 VHRDIRASNVL---LDEEFGAHLMGVGLSKFVPWE-----VMQERTVMAGGTYGYLAPEF 401
           +HRD++  N L     +    +++  GL+K          +         GT  Y +   
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184

Query: 402 VYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL 461
               E + + D+ S G +L+    G           WQ +              + +   
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFNLGSL--------PWQGLKAATKRQKYERISEKKMSTP 236

Query: 462 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 508
           I  L    P           +  C       +P  S++    + L  
Sbjct: 237 IEVLCKGYPSE-----FATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  123 bits (310), Expect = 2e-32
 Identities = 42/290 (14%), Positives = 90/290 (31%), Gaps = 34/290 (11%)

Query: 231 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKG 288
           R +G+   G  + G  L +  +VA+K   R S     +   E   +  L     +  V  
Sbjct: 11  RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYY 68

Query: 289 CCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH 348
              +     +V + +           +   GR          A  +   +  +H+K    
Sbjct: 69  FGQEGLHNVLVIDLLGPS----LEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---S 121

Query: 349 VVHRDIRASNVLLDEEFGAHLMGVGLSKF----------VPWEVMQERTVMAGGTYGYLA 398
           +V+RDI+  N L+      +   + +  F              +         GT  Y++
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181

Query: 399 PEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELL 458
                  E + + D+ + G + +  + G  P Q + +   +  +E      QS       
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS------- 234

Query: 459 DPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 508
              +  L +  PE          ++          P   ++     ++ +
Sbjct: 235 -TPLRELCAGFPEE-----FYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (313), Expect = 2e-32
 Identities = 57/296 (19%), Positives = 108/296 (36%), Gaps = 20/296 (6%)

Query: 231 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQR-KKEFYSEIGRFARLHHPNLVAVKG 288
             +G+   G   S     +  RVA+K++     Q   +    EI    R  H N++ +  
Sbjct: 14  SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73

Query: 289 CCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH 348
                    +   ++V   +   L+ + +    L           + +G+ ++H     +
Sbjct: 74  IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-LSNDHICYFLYQILRGLKYIHSA---N 129

Query: 349 VVHRDIRASNVLLDEEFGAHLMGVGLSKFV-PWEVMQERTVMAGGTYGYLAPEFVYRNEL 407
           V+HRD++ SN+LL+      +   GL++   P             T  Y APE +  ++ 
Sbjct: 130 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 189

Query: 408 TTKS-DVYSFGVLLLEIVSGRRP----------AQAVDSVCWQSIFEWATPLVQSHRYLE 456
            TKS D++S G +L E++S R               +  +   S  +    +    R   
Sbjct: 190 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 249

Query: 457 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVV-HQ-LQQLAQPP 510
           L  P  + +  +        K +DL+       P  R  +   + H  L+Q   P 
Sbjct: 250 LSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 305

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (309), Expect = 2e-32
 Identities = 51/298 (17%), Positives = 98/298 (32%), Gaps = 42/298 (14%)

Query: 213 VFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQR------K 265
           VF  E   ++   +  G   LG  +            G + A K +K+   +       +
Sbjct: 2   VFRQE---NVDDYYDTG-EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSR 57

Query: 266 KEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWA 325
           ++   E+     + HPN++ +     +  D  ++ E V  G L  +L        SL   
Sbjct: 58  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE----KESLTEE 113

Query: 326 MRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA----HLMGVGLSKFVPWE 381
              +    +  G+ +LH      + H D++  N++L +         ++  GL+  +   
Sbjct: 114 EATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-- 168

Query: 382 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSI 441
                     GT  ++APE V    L  ++D++S GV+   ++SG  P            
Sbjct: 169 -FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP------------ 215

Query: 442 FEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHV 499
           F   T          +         S+           D +       P  R  +   
Sbjct: 216 FLGDTKQETLANVSAVNYEFEDEYFSNTSAL-----AKDFIRRLLVKDPKKRMTIQDS 268

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  122 bits (308), Expect = 3e-32
 Identities = 56/286 (19%), Positives = 102/286 (35%), Gaps = 44/286 (15%)

Query: 231 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSF---------QRKKEFYSEIGRFARLH- 279
            +LG   +      I  P     AVK +  +           + ++    E+    ++  
Sbjct: 9   EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68

Query: 280 HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA 339
           HPN++ +K     +   ++V++ +  G L  +L        +L      K+   L + I 
Sbjct: 69  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVIC 124

Query: 340 FLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAP 399
            LH     ++VHRD++  N+LLD++    L   G S  +      E+     GT  YLAP
Sbjct: 125 ALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLD---PGEKLREVCGTPSYLAP 178

Query: 400 EFVYRNEL------TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHR 453
           E +  +          + D++S GV++  +++G  P            F     ++    
Sbjct: 179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP------------FWHRKQMLMLRM 226

Query: 454 YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHV 499
            +       S    D  +      V DLV       P  R      
Sbjct: 227 IMSGNYQFGSPEWDDYSDT-----VKDLVSRFLVVQPQKRYTAEEA 267

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (307), Expect = 1e-31
 Identities = 53/292 (18%), Positives = 109/292 (37%), Gaps = 29/292 (9%)

Query: 220 RSITKNFSEGNRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARL 278
           R    ++++  +++G+   G  Y   L D G  VA+K++     Q K+    E+    +L
Sbjct: 16  RPQEVSYTDT-KVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKL 70

Query: 279 HHPNLVAVKGCCYDHGDR------YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVAT 332
            H N+V ++   Y  G++       +V ++V         H+  R  ++L          
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS-RAKQTLPVIYVKLYMY 129

Query: 333 TLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH-LMGVGLSKFVPWEVMQERTVMAG 391
            L + +A++H      + HRDI+  N+LLD +     L   G +K +         +   
Sbjct: 130 QLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC-- 184

Query: 392 GTYGYLAP-EFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSV--------CWQSIF 442
            +  Y AP       + T+  DV+S G +L E++ G+        V           +  
Sbjct: 185 -SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 243

Query: 443 EWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP 494
                 +  +        + +   + +       + + L     ++ P+ R 
Sbjct: 244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL 295

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (295), Expect = 3e-30
 Identities = 46/284 (16%), Positives = 93/284 (32%), Gaps = 21/284 (7%)

Query: 231 RLLGDSKTGGTYSG--ILPDGSRVAVKRLKRSSFQRKKEFY-----SEIGRFARLHHPNL 283
             +G+   G  +    +   G  VA+KR++  + +           + +       HPN+
Sbjct: 13  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72

Query: 284 VAVKGCCYDHGDRYIVYEFVVNGPLDRW--LHHIPRGGRSLDWAMRMKVATTLAQGIAFL 341
           V +   C            +V   +D+    +        +       +   L +G+ FL
Sbjct: 73  VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132

Query: 342 HDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEF 401
           H      VVHRD++  N+L+       L   GL++   +++     V    T  Y APE 
Sbjct: 133 HSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV---VTLWYRAPEV 186

Query: 402 VYRNELTTKSDVYSFGVLLLEIVSGRRP------AQAVDSVCWQSIFEWATPLVQSHRYL 455
           + ++   T  D++S G +  E+   +           +  +             +     
Sbjct: 187 LLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 246

Query: 456 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHV 499
                  S+   +     + +   DL+  C    P+ R      
Sbjct: 247 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (292), Expect = 6e-30
 Identities = 55/278 (19%), Positives = 94/278 (33%), Gaps = 23/278 (8%)

Query: 231 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKE-----FYSEIGRFARLHHPNLV 284
             LG+ +    Y          VA+K++K       K+        EI     L HPN++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 285 AVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 344
            +        +  +V++F+           I      L  +          QG+ +LH  
Sbjct: 64  GLLDAFGHKSNISLVFDFMET----DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH 119

Query: 345 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR 404
               ++HRD++ +N+LLDE     L   GL+K            +   T  Y APE ++ 
Sbjct: 120 ---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV--VTRWYRAPELLFG 174

Query: 405 NEL-TTKSDVYSFGVLLLEIVSGRRPAQAVDSV-CWQSIFE--WATPLVQSHRYLELLDP 460
             +     D+++ G +L E++           +     IFE        Q      L D 
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234

Query: 461 LISSLSSDIPEAGVVQKV----VDLVYACTQHVPSMRP 494
           +       IP   +        +DL+       P  R 
Sbjct: 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI 272

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (290), Expect = 1e-29
 Identities = 59/293 (20%), Positives = 105/293 (35%), Gaps = 22/293 (7%)

Query: 231 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRK--KEFYSEIGRFARLHHPNLVAVK 287
             +G+   G  Y       G  VA+K+++  +           EI     L+HPN+V + 
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67

Query: 288 GCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKP 347
              +     Y+V+EF+              G   +   +       L QG+AF H     
Sbjct: 68  DVIHTENKLYLVFEFLHQDLKKFMDASALTG---IPLPLIKSYLFQLLQGLAFCHSH--- 121

Query: 348 HVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNE- 406
            V+HRD++  N+L++ E    L   GL++     V      +   T  Y APE +   + 
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV--VTLWYRAPEILLGCKY 179

Query: 407 LTTKSDVYSFGVLLLEIVSGRRPAQAVDSV--------CWQSIFEWATPLVQSHRYLELL 458
            +T  D++S G +  E+V+ R        +           +  E   P V S    +  
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239

Query: 459 DPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVV-HQ-LQQLAQP 509
            P  +          + +    L+     + P+ R      + H   Q + +P
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (291), Expect = 2e-29
 Identities = 58/270 (21%), Positives = 88/270 (32%), Gaps = 34/270 (12%)

Query: 231 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKE---FYSEIGRFARLHHPNLVAV 286
           +LLG    G          G   A+K L++     K E     +E        HP L A+
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70

Query: 287 KGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVK 346
           K     H     V E+   G L   L       R             +   + +LH +  
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR-- 124

Query: 347 PHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNE 406
             VV+RDI+  N++LD++    +   GL K    +          GT  YLAPE +  N+
Sbjct: 125 -DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEVLEDND 181

Query: 407 LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 466
                D +  GV++ E++ GR P            F            L        +LS
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLP------------FYNQDHERLFELILMEEIRFPRTLS 229

Query: 467 SDIPEAGVVQKVVDLVYACTQHVPSMRPRM 496
            +            L+    +  P  R   
Sbjct: 230 PE---------AKSLLAGLLKKDPKQRLGG 250

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (286), Expect = 2e-29
 Identities = 54/280 (19%), Positives = 96/280 (34%), Gaps = 48/280 (17%)

Query: 231 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKE------FYSEIGRFARLH--HP 281
            LLG    G  YSGI + D   VA+K +++       E         E+    ++     
Sbjct: 10  PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69

Query: 282 NLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 341
            ++ +           ++ E          L        +L   +       + + +   
Sbjct: 70  GVIRLLDWFERPDSFVLILERPEPVQD---LFDFITERGALQEELARSFFWQVLEAVRHC 126

Query: 342 HDKVKPHVVHRDIRASNVLLDEEFG-AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 400
           H+     V+HRDI+  N+L+D   G   L+  G    +   V  +      GT  Y  PE
Sbjct: 127 HNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD----GTRVYSPPE 179

Query: 401 FVYRNELTTKS-DVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD 459
           ++  +    +S  V+S G+LL ++V G  P            FE    +++   +     
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIP------------FEHDEEIIRGQVFFR--- 224

Query: 460 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHV 499
                +SS+            L+  C    PS RP    +
Sbjct: 225 ---QRVSSE---------CQHLIRWCLALRPSDRPTFEEI 252

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  112 bits (281), Expect = 1e-28
 Identities = 51/280 (18%), Positives = 98/280 (35%), Gaps = 20/280 (7%)

Query: 231 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRK--KEFYSEIGRFARLHHPNLVAVKG 288
             +G+   G  Y      G   A+K+++              EI     L H N+V +  
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67

Query: 289 CCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH 348
             +      +V+E +           +      L+          L  GIA+ HD+    
Sbjct: 68  VIHTKKRLVLVFEHLDQ----DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---R 120

Query: 349 VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNE-L 407
           V+HRD++  N+L++ E    +   GL++     V +    +   T  Y AP+ +  ++  
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEI--VTLWYRAPDVLMGSKKY 178

Query: 408 TTKSDVYSFGVLLLEIVSGRRPAQAVDSV--------CWQSIFEWATPLVQSHRYLELLD 459
           +T  D++S G +  E+V+G      V              +      P V      +   
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238

Query: 460 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHV 499
            +   L  +    G+ +  +DL+    +  P+ R      
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  112 bits (280), Expect = 6e-28
 Identities = 56/268 (20%), Positives = 99/268 (36%), Gaps = 37/268 (13%)

Query: 231 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKE---FYSEIGRFARLHHPNLVAV 286
           + LG    G          G+  A+K L +    + K+     +E      ++ P LV +
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106

Query: 287 KGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVK 346
           +    D+ + Y+V E+V  G +   L  I R             A  +     +LH    
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHSL-- 160

Query: 347 PHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNE 406
             +++RD++  N+L+D++    +   G +K      ++ RT    GT   LAPE +    
Sbjct: 161 -DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEIILSKG 214

Query: 407 LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 466
                D ++ GVL+ E+ +G  P            F    P+    + +       S  S
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPP------------FFADQPIQIYEKIVSGKVRFPSHFS 262

Query: 467 SDIPEAGVVQKVVDLVYACTQHVPSMRP 494
           SD+          DL+    Q   + R 
Sbjct: 263 SDLK---------DLLRNLLQVDLTKRF 281

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (277), Expect = 2e-27
 Identities = 45/297 (15%), Positives = 95/297 (31%), Gaps = 23/297 (7%)

Query: 214 FTTEELRSITKNFSEGNRL---LGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRK--KE 267
           F  +E+           R    +G    G   S +    G++VA+K+L R        K 
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63

Query: 268 FYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMR 327
            Y E+     + H N++ +              +F +  P              L     
Sbjct: 64  AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123

Query: 328 MKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 387
             +   + +G+ ++H      ++HRD++  N+ ++E+    ++  GL++        E T
Sbjct: 124 QFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQAD----SEMT 176

Query: 388 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSV--------CWQ 439
                 +       +     T   D++S G ++ E+++G+   +  D +           
Sbjct: 177 GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 236

Query: 440 SIFEWATPLVQSHRYLELLDPLISSLSSDIPE--AGVVQKVVDLVYACTQHVPSMRP 494
           +        +QS      +  L      D            V+L+          R 
Sbjct: 237 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV 293

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (272), Expect = 4e-27
 Identities = 45/289 (15%), Positives = 95/289 (32%), Gaps = 32/289 (11%)

Query: 231 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRK--KEFYSEIGRFARLHHPNLVAVK 287
             +G    G  +       G +VA+K++   + +         EI     L H N+V + 
Sbjct: 16  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75

Query: 288 GCCYDH--------GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA 339
             C           G  Y+V++F  +       + + +   +L    R+     +   + 
Sbjct: 76  EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK--FTLSEIKRV-----MQMLLN 128

Query: 340 FLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYL 397
            L+   +  ++HRD++A+NVL+  +    L   GL++        +         T  Y 
Sbjct: 129 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR 188

Query: 398 APEFV-YRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSH---- 452
            PE +    +     D++  G ++ E+ +     Q        ++       +       
Sbjct: 189 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248

Query: 453 -------RYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP 494
                    LEL+      +   +         +DL+       P+ R 
Sbjct: 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 297

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (264), Expect = 6e-26
 Identities = 57/279 (20%), Positives = 96/279 (34%), Gaps = 36/279 (12%)

Query: 231 RLLGDSKTGGTYSGIL----PDGSRVAVKRLKRSSFQRK----KEFYSEIGRFARL-HHP 281
           ++LG    G  +          G   A+K LK+++  +K    +   +E      +   P
Sbjct: 30  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89

Query: 282 NLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 341
            LV +          +++ +++  G L   L    R                +   +  L
Sbjct: 90  FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIVLALEHL 145

Query: 342 HDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEF 401
           H      +++RDI+  N+LLD      L   GLSK        ER     GT  Y+AP+ 
Sbjct: 146 HKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF-VADETERAYDFCGTIEYMAPDI 201

Query: 402 VYRNE--LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD 459
           V   +       D +S GVL+ E+++G  P        +    E  +    S R L+   
Sbjct: 202 VRGGDSGHDKAVDWWSLGVLMYELLTGASP--------FTVDGEKNSQAEISRRILKSEP 253

Query: 460 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSH 498
           P    +S+            DL+       P  R     
Sbjct: 254 PYPQEMSAL---------AKDLIQRLLMKDPKKRLGCGP 283

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (259), Expect = 2e-25
 Identities = 48/283 (16%), Positives = 95/283 (33%), Gaps = 24/283 (8%)

Query: 231 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRK--KEFYSEIGRFARLHHPNLVAVK 287
             +G+   G  +          VA+KR++              EI     L H N+V + 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67

Query: 288 GCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKP 347
              +      +V+EF           +       LD  +       L +G+ F H +   
Sbjct: 68  DVLHSDKKLTLVFEFCDQ----DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR--- 120

Query: 348 HVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL 407
           +V+HRD++  N+L++      L   GL++      ++  +      +             
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VRCYSAEVVTLWYRPPDVLFGAKLY 179

Query: 408 TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ-----------SIFEWATPLVQSHRYLE 456
           +T  D++S G +  E+ +  RP    + V  Q           +  +W +          
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239

Query: 457 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHV 499
            + P  +SL + +P+  +     DL+    +  P  R      
Sbjct: 240 PMYPATTSLVNVVPK--LNATGRDLLQNLLKCNPVQRISAEEA 280

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 96.8 bits (240), Expect = 9e-23
 Identities = 51/286 (17%), Positives = 100/286 (34%), Gaps = 37/286 (12%)

Query: 231 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKG 288
           R LG  K    +  I + +  +V VK LK     +KK+   EI     L   PN++ +  
Sbjct: 41  RKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLAD 97

Query: 289 CCYDHGDR--YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVK 346
              D   R   +V+E V N    +         ++L           + + + + H    
Sbjct: 98  IVKDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM-- 148

Query: 347 PHVVHRDIRASNVLLDEEFG-AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN 405
             ++HRD++  NV++D E     L+  GL++F      QE  V     Y       V   
Sbjct: 149 -GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG--QEYNVRVASRYFKGPELLVDYQ 205

Query: 406 ELTTKSDVYSFGVLLLEIVSGRRP-----------AQAVDSVCWQSIFEWAT--PLVQSH 452
                 D++S G +L  ++  + P            +    +  + ++++     +    
Sbjct: 206 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 265

Query: 453 RYLELLDPLISSLSSDIPEAGVVQKV----VDLVYACTQHVPSMRP 494
           R+ ++L             +     V    +D +    ++    R 
Sbjct: 266 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRL 311

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.2 bits (233), Expect = 1e-21
 Identities = 44/277 (15%), Positives = 89/277 (32%), Gaps = 20/277 (7%)

Query: 231 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVK 287
             +G    G   +      G RVAVK+L R   S    K  Y E+     + H N++ + 
Sbjct: 24  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83

Query: 288 GCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKP 347
                        +  +   L     +     + L       +   + +G+ ++H     
Sbjct: 84  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA--- 140

Query: 348 HVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL 407
            ++HRD++ SN+ ++E+    ++  GL++        E T      +       +     
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMHY 196

Query: 408 TTKSDVYSFGVLLLEIVSGRRPAQAVDSV--------CWQSIFEWATPLVQSHRYLELLD 459
               D++S G ++ E+++GR      D +           +        + S      + 
Sbjct: 197 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 256

Query: 460 PLISSLSSDIPEA--GVVQKVVDLVYACTQHVPSMRP 494
            L      +      G     VDL+          R 
Sbjct: 257 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 293

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 91.5 bits (226), Expect = 8e-21
 Identities = 39/208 (18%), Positives = 77/208 (37%), Gaps = 22/208 (10%)

Query: 231 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRK--KEFYSEIGRFARLHHPNLVAVK 287
           + +G    G   +         VA+K+L R    +   K  Y E+     ++H N++++ 
Sbjct: 23  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82

Query: 288 GCC------YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 341
                     +  D Y+V E +           +              +   +  GI  L
Sbjct: 83  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-------HERMSYLLYQMLCGIKHL 135

Query: 342 HDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEF 401
           H      ++HRD++ SN+++  +    ++  GL++      M    V    T  Y APE 
Sbjct: 136 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV---VTRYYRAPEV 189

Query: 402 VYRNELTTKSDVYSFGVLLLEIVSGRRP 429
           +         D++S G ++ E+V  +  
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMVRHKIL 217

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 89.3 bits (220), Expect = 5e-20
 Identities = 31/228 (13%), Positives = 79/228 (34%), Gaps = 17/228 (7%)

Query: 231 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGC 289
           R LG       +    + + + VA+K ++      +     EI    R++  +       
Sbjct: 19  RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE-AAEDEIKLLQRVNDADNTKEDSM 77

Query: 290 CYDHGDRYIVYE------------FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 337
             +H  + + +                    +          R +      +++  L  G
Sbjct: 78  GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137

Query: 338 IAFLHDKVKPHVVHRDIRASNVLLDEE-FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGY 396
           + ++H +    ++H DI+  NVL++      +L+ + ++         E    +  T  Y
Sbjct: 138 LDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREY 195

Query: 397 LAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEW 444
            +PE +        +D++S   L+ E+++G    +  +   +    + 
Sbjct: 196 RSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 64.8 bits (157), Expect = 9e-13
 Identities = 40/209 (19%), Positives = 71/209 (33%), Gaps = 40/209 (19%)

Query: 231 RLLGDSKTGGTYSGILPDGSRVAVK--RLKRSSFQ--------RKKEFYSEIGRFARLHH 280
           +L+G+ K    ++          VK  ++  +SF+            F     R AR   
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 281 PNLVAVKGCC----YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ 336
             L  ++G      Y      ++ E +    L R     P            +V   + +
Sbjct: 66  RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPD-----------EVLDMILE 114

Query: 337 GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP---WEVMQERTVMAGGT 393
            +A  + +    +VH D+   NVL+  E G  ++    S  V    W  + ER V    T
Sbjct: 115 EVAKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIIT 170

Query: 394 YGYLAPEFVYRNELTTKSDVYSFGVLLLE 422
           Y        +     T+ D+ S    +L+
Sbjct: 171 Y--------FSRTYRTEKDINSAIDRILQ 191

>d1ypqa1 d.169.1.1 (A:140-270) Oxidised low density lipoprotein {Human (Homo sapiens) [TaxId: 9606]} Length = 131

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Oxidised low density lipoprotein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 60.7 bits (146), Expect = 7e-12
 Identities = 28/138 (20%), Positives = 48/138 (34%), Gaps = 15/138 (10%)

Query: 7   APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNV 66
           APCP DWI +     C+ +     +W++S+  C  +   L  + S  +    Q+    + 
Sbjct: 3   APCPQDWIWHG--ENCYLFSSGSFNWEKSQEKCLSLDAKLLKINSTADLDFIQQAISYSS 60

Query: 67  NGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN 126
              W+G    N      W W D            G+ + +  S           C  +  
Sbjct: 61  FPFWMGLSRRNP--SYPWLWEDGSPLMPHLFRVRGAVSQTYPS---------GTCAYIQR 109

Query: 127 GSRSLVTERCNTSHPFIC 144
           G  ++  E C  +   IC
Sbjct: 110 G--AVYAENCILAAFSIC 125

>d1egga_ d.169.1.1 (A:) Macrophage mannose receptor, CRD4 {Human (Homo sapiens) [TaxId: 9606]} Length = 136

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Macrophage mannose receptor, CRD4
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 57.6 bits (137), Expect = 1e-10
 Identities = 28/143 (19%), Positives = 53/143 (37%), Gaps = 12/143 (8%)

Query: 9   CPPDWIINEEKSKCFGYIGNF----RSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGK 64
           CP DW  +   S CF          ++W ES  +C+ +GG LA++ + EE+ +  +L   
Sbjct: 1   CPEDWGASSRTSLCFKLYAKGKHEKKTWFESRDFCRALGGDLASINNKEEQQTIWRLITA 60

Query: 65  NVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLV 124
           + +   +    +            + S  +    A G  N+      C          L 
Sbjct: 61  SGSYHKLFWLGLTYGSPSEGFTWSDGSPVSYENWAYGEPNNYQNVEYC--------GELK 112

Query: 125 SNGSRSLVTERCNTSHPFICMVE 147
            + + S     C   + +IC ++
Sbjct: 113 GDPTMSWNDINCEHLNNWICQIQ 135

>d1g1sa1 d.169.1.1 (A:1-118) P-selectin, C-lectin domain {Human (Homo sapiens) [TaxId: 9606]} Length = 118

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: P-selectin, C-lectin domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.1 bits (131), Expect = 4e-10
 Identities = 23/123 (18%), Positives = 39/123 (31%), Gaps = 7/123 (5%)

Query: 22  CFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVG 81
            + Y     SW+ S  YC+     L A+ +  E     K+     +  W+G R  N T  
Sbjct: 2   TYHYSTKAYSWNISRKYCQNRYTDLVAIQNKNEIDYLNKVLPYYSSYYWIGIRKNNKTW- 60

Query: 82  LSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHP 141
            +W  +           A    N+   +  C     V++     +       E C     
Sbjct: 61  -TWVGTKKALTNEAENWADNEPNNKRNNEDC-----VEIYIKSPSAPGKWNDEHCLKKKH 114

Query: 142 FIC 144
            +C
Sbjct: 115 ALC 117

>d1e87a_ d.169.1.1 (A:) CD69 {Human (Homo sapiens) [TaxId: 9606]} Length = 117

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: CD69
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.5 bits (130), Expect = 6e-10
 Identities = 28/138 (20%), Positives = 52/138 (37%), Gaps = 26/138 (18%)

Query: 7   APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNV 66
           + C  DW+    + KC+      RSW  ++  C E G  LA + S ++ +  ++  G+  
Sbjct: 1   SSCSEDWV--GYQRKCYFISTVKRSWTSAQNACSEHGATLAVIDSEKDMNFLKRYAGREE 58

Query: 67  NGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN 126
           +   +         G  WKWS+   ++N   +  GS                  C  + N
Sbjct: 59  HWVGL-----KKEPGHPWKWSNG-KEFNNWFNVTGSDK----------------CVFLKN 96

Query: 127 GSRSLVTERCNTSHPFIC 144
               + +  C  +  +IC
Sbjct: 97  T--EVSSMECEKNLYWIC 112

>d1wk1a_ d.169.1.1 (A:) Hypothetical protein F28B4.3 {Caenorhabditis elegans [TaxId: 6239]} Length = 150

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Hypothetical protein F28B4.3
species: Caenorhabditis elegans [TaxId: 6239]

 Score = 53.5 bits (127), Expect = 3e-09
 Identities = 19/126 (15%), Positives = 39/126 (30%), Gaps = 7/126 (5%)

Query: 20  SKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTT 79
            K      +  S  ++  +C   GG+LA     ++ +    +         +   S    
Sbjct: 8   VKFLTVNDDILSMPQARNFCASAGGYLADDLGDDKNNFYSSIAANTQFWIGLFKNSDGQF 67

Query: 80  VGLSW-KWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNT 138
                   + ++     +  A G  ++  T    +            + S+   T+ C T
Sbjct: 68  YWDRGQGINPDLLNQPITYWANGEPSNDPTRQCVYFDGR------SGDKSKVWTTDTCAT 121

Query: 139 SHPFIC 144
             PFIC
Sbjct: 122 PRPFIC 127

>d1xpha1 d.169.1.1 (A:265-394) DC-SIGNR (DC-SIGN related receptor) {Human (Homo sapiens) [TaxId: 9606]} Length = 130

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: DC-SIGNR (DC-SIGN related receptor)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.8 bits (125), Expect = 3e-09
 Identities = 29/137 (21%), Positives = 51/137 (37%), Gaps = 14/137 (10%)

Query: 8   PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 67
            CP DW   +    C+    + R+W +S T C+E+   L  + + EE++  Q    ++  
Sbjct: 3   HCPKDWTFFQ--GNCYFMSNSQRNWHDSVTACQEVRAQLVVIKTAEEQNFLQLQTSRSNR 60

Query: 68  GCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG 127
             W+G   +N      W     +S   +     G  N+S            + C   S  
Sbjct: 61  FSWMGLSDLNQEGTWQWVDGSPLSPSFQRYWNSGEPNNSGN----------EDCAEFSGS 110

Query: 128 SRSLVTERCNTSHPFIC 144
                  RC+  + +IC
Sbjct: 111 --GWNDNRCDVDNYWIC 125

>d1hq8a_ d.169.1.1 (A:) NK cell-activating receptor nkg2d {Mouse (Mus musculus) [TaxId: 10090]} Length = 123

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: NK cell-activating receptor nkg2d
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 52.6 bits (125), Expect = 4e-09
 Identities = 27/137 (19%), Positives = 48/137 (35%), Gaps = 23/137 (16%)

Query: 8   PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 67
           PCP +WI +   + C+ +    ++W++S+  C      L  + S EE+   + +      
Sbjct: 5   PCPNNWICHR--NNCYQFFNEEKTWNQSQASCLSQNSSLLKIYSKEEQDFLKLVK----- 57

Query: 68  GCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG 127
             +     +      SW+W D  S     +  V     SC                 S+ 
Sbjct: 58  -SYHWMGLVQIPANGSWQWEDGSSLSYNQLTLVEIPKGSC-------------AVYGSSF 103

Query: 128 SRSLVTERCNTSHPFIC 144
                TE C   + +IC
Sbjct: 104 --KAYTEDCANLNTYIC 118

>d1qo3c_ d.169.1.1 (C:) NK cell receptor {Mouse (Mus musculus), ly49-a [TaxId: 10090]} Length = 133

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: NK cell receptor
species: Mouse (Mus musculus), ly49-a [TaxId: 10090]

 Score = 52.6 bits (125), Expect = 5e-09
 Identities = 20/137 (14%), Positives = 37/137 (27%), Gaps = 21/137 (15%)

Query: 8   PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 67
                W       KC+ ++ + ++W   +  C+     L  +   +E    Q +   +  
Sbjct: 13  GDKVYWF--CYGMKCYYFVMDRKTWSGCKQTCQSSSLSLLKIDDEDELKFLQLVVPSDSC 70

Query: 68  GCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG 127
              +   +        W W DN               S         +     C L+S  
Sbjct: 71  WVGLSYDNKKK----DWAWIDNRP-------------SKLALNTRKYNIRDGGCMLLSKT 113

Query: 128 SRSLVTERCNTSHPFIC 144
              L    C+     IC
Sbjct: 114 --RLDNGNCDQVFICIC 128

>d3c8ja1 d.169.1.1 (A:138-259) NK cell receptor {Mouse (Mus musculus), ly49-c [TaxId: 10090]} Length = 122

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: NK cell receptor
species: Mouse (Mus musculus), ly49-c [TaxId: 10090]

 Score = 51.8 bits (123), Expect = 7e-09
 Identities = 22/136 (16%), Positives = 38/136 (27%), Gaps = 21/136 (15%)

Query: 9   CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 68
               W      +KC+ +I N  +W   +  C+  G  +  +   +E    Q+        
Sbjct: 2   GVKYWFCYS--TKCYYFIMNKTTWSGCKANCQHYGVPILKIEDEDELKFLQRHVIPGNYW 59

Query: 69  CWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS 128
             +            W W DN     +      +F S               C  +S   
Sbjct: 60  IGLSYDKKKKE----WAWIDNGPSKLDMKIKKMNFKSRG-------------CVFLSKA- 101

Query: 129 RSLVTERCNTSHPFIC 144
             +    CN  +  IC
Sbjct: 102 -RIEDIDCNIPYYCIC 116

>d1g1ta1 d.169.1.1 (A:1-118) E-selectin, C-lectin domain {Human (Homo sapiens) [TaxId: 9606]} Length = 118

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: E-selectin, C-lectin domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.1 bits (118), Expect = 2e-08
 Identities = 23/115 (20%), Positives = 41/115 (35%), Gaps = 7/115 (6%)

Query: 30  RSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDN 89
            ++DE+  YC++   HL A+ + EE      +   + +  W+G R +N      W  +  
Sbjct: 10  MTYDEASAYCQQRYTHLVAIQNKEEIEYLNSILSYSPSYYWIGIRKVNNVW--VWVGTQK 67

Query: 90  MSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFIC 144
                    A G  N+      C     V++             ERC+     +C
Sbjct: 68  PLTEEAKNWAPGEPNNRQKDEDC-----VEIYIKREKDVGMWNDERCSKKKLALC 117

>d1tdqb_ d.169.1.1 (B:) Aggrecan core protein {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 126

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Aggrecan core protein
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 50.1 bits (118), Expect = 3e-08
 Identities = 26/137 (18%), Positives = 48/137 (35%), Gaps = 15/137 (10%)

Query: 8   PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 67
            C   W   + +  C+ +  +  +W ++E  C+E   HL+++ + EE+        KN  
Sbjct: 2   QCEEGWT--KFQGHCYRHFPDRETWVDAERRCREQQSHLSSIVTPEEQE----FVNKNAQ 55

Query: 68  GCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG 127
                G +  T  G  ++WSD         H++                  D   ++ + 
Sbjct: 56  DYQWIGLNDRTIEG-DFRWSDG--------HSLQFEKWRPNQPDNFFATGEDCVVMIWHE 106

Query: 128 SRSLVTERCNTSHPFIC 144
                   CN   PF C
Sbjct: 107 RGEWNDVPCNYQLPFTC 123

>d1dv8a_ d.169.1.1 (A:) H1 subunit of the asialoglycoprotein receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 128

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: H1 subunit of the asialoglycoprotein receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.4 bits (116), Expect = 6e-08
 Identities = 23/142 (16%), Positives = 45/142 (31%), Gaps = 18/142 (12%)

Query: 9   CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 68
           CP +W+  E +  C+ +  + ++W +++ YC+    HL  +TS+EE+   Q   G     
Sbjct: 1   CPVNWV--EHERSCYWFSRSGKAWADADNYCRLEDAHLVVVTSWEEQKFVQHHIGPVNTW 58

Query: 69  CWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLP---CHVHATVDLCTLVS 125
                              +   KW +       F +     P                 
Sbjct: 59  MG-------------LHDQNGPWKWVDGTDYETGFKNWRPEQPDDWYGHGLGGGEDCAHF 105

Query: 126 NGSRSLVTERCNTSHPFICMVE 147
                   + C   + ++C  E
Sbjct: 106 TDDGRWNDDVCQRPYRWVCETE 127

>d1h8ua_ d.169.1.1 (A:) Eosinophil major basic protein {Human (Homo sapiens) [TaxId: 9606]} Length = 115

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Eosinophil major basic protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.4 bits (114), Expect = 9e-08
 Identities = 18/117 (15%), Positives = 37/117 (31%), Gaps = 14/117 (11%)

Query: 30  RSWDESETYCKEI-GGHLAALTSYEEEHSAQKLCGK-NVNGCWVGGRSINTTVGLSWKWS 87
           +++ ++   C+    G+L ++ ++   +  Q      N    W+GGR   +     ++W 
Sbjct: 9   QTFSQAWFTCRRCYRGNLVSIHNFNINYRIQCSVSALNQGQVWIGGRITGSGRCRRFQWV 68

Query: 88  DNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFIC 144
           D          A   ++                C  +           C    PFIC
Sbjct: 69  DGSRWNFAYWAAHQPWSRG------------GHCVALCTRGGYWRRAHCLRRLPFIC 113

>d1kg0c_ d.169.1.1 (C:) EBV gp42 {Epstein-Barr virus [TaxId: 10376]} Length = 136

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: EBV gp42
species: Epstein-Barr virus [TaxId: 10376]

 Score = 47.5 bits (112), Expect = 3e-07
 Identities = 14/138 (10%), Positives = 28/138 (20%), Gaps = 23/138 (16%)

Query: 8   PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 67
                      K  CF +     +W+     C E            +           + 
Sbjct: 18  NTREYTF--SYKGCCFYFTKKKHTWNGCFQACAEKYPCTYFYGPTPDILPVVTRNLNAIE 75

Query: 68  GCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG 127
             WVG   +      +W   D    +                             +    
Sbjct: 76  SLWVG---VYRVGEGNWTSLDG-GTFKVYQIFGSHC-----------------TYVSKFS 114

Query: 128 SRSLVTERCNTSHPFICM 145
           +  +    C+   P +C+
Sbjct: 115 TVPVSHHECSFLKPCLCV 132

>d1r13a1 d.169.1.1 (A:110-228) Surfactant protein, lectin domain {Rat (Rattus norvegicus), SP-A [TaxId: 10116]} Length = 119

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Surfactant protein, lectin domain
species: Rat (Rattus norvegicus), SP-A [TaxId: 10116]

 Score = 45.8 bits (107), Expect = 9e-07
 Identities = 18/125 (14%), Positives = 37/125 (29%), Gaps = 14/125 (11%)

Query: 20  SKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTT 79
            K F   G   ++D  +  C   GG++A   + EE  +   +  K  N  ++        
Sbjct: 7   DKVFSTNGQSVNFDTIKEMCTRAGGNIAVPRTPEENEAIASIAKKYNNYVYL-------- 58

Query: 80  VGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTS 139
                        ++    A  S+ +     P           + ++G  +     C   
Sbjct: 59  ---GMIEDQTPGDFHYLDGASVSYTNWYPGEPRG-QGKEKCVEMYTDG--TWNDRGCLQY 112

Query: 140 HPFIC 144
              +C
Sbjct: 113 RLAVC 117

>d2msba_ d.169.1.1 (A:) Mannose-binding protein A, C-lectin domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 112

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Mannose-binding protein A, C-lectin domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 45.0 bits (105), Expect = 1e-06
 Identities = 17/125 (13%), Positives = 36/125 (28%), Gaps = 18/125 (14%)

Query: 21  KCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN-GCWVGGRSINTT 79
           K F        + + +  C E+ G +A   + EE  + Q++   +   G           
Sbjct: 2   KFFVTNHERMPFSKVKALCSELRGTVAIPRNAEENKAIQEVAKTSAFLGITDEVTEGQFM 61

Query: 80  VGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTS 139
                + + +  K +E        +  C ++                 +       C  S
Sbjct: 62  YVTGGRLTYSNWKKDEPNDHGSGED--CVTI---------------VDNGLWNDISCQAS 104

Query: 140 HPFIC 144
           H  +C
Sbjct: 105 HTAVC 109

>d1pwba1 d.169.1.1 (A:235-355) Surfactant protein, lectin domain {Human (Homo sapiens), SP-D [TaxId: 9606]} Length = 121

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Surfactant protein, lectin domain
species: Human (Homo sapiens), SP-D [TaxId: 9606]

 Score = 45.1 bits (105), Expect = 2e-06
 Identities = 22/125 (17%), Positives = 40/125 (32%), Gaps = 13/125 (10%)

Query: 20  SKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTT 79
            K F   G  + + E++  C + GG LA+  S  E  + Q+L        ++        
Sbjct: 8   EKIFKTAGFVKPFTEAQLLCTQAGGQLASPRSAAENAALQQLVVAKNEAAFL-------- 59

Query: 80  VGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTS 139
              S   S    K+         +++     P     + D   + +NG        C   
Sbjct: 60  ---SMTDSKTEGKFTYPTGESLVYSNWAPGEPNDDGGSEDCVEIFTNG--KWNDRACGEK 114

Query: 140 HPFIC 144
              +C
Sbjct: 115 RLVVC 119

>d1tn3a_ d.169.1.1 (A:) Tetranectin {Human (Homo sapiens) [TaxId: 9606]} Length = 137

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Tetranectin
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.5 bits (106), Expect = 2e-06
 Identities = 18/137 (13%), Positives = 39/137 (28%), Gaps = 11/137 (8%)

Query: 9   CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN- 67
           C     ++    KCF      +++ E+   C   GG L+   +  E  +  +   ++V  
Sbjct: 6   CLKGTKVH---MKCFLAFTQTKTFHEASEDCISRGGTLSTPQTGSENDALYEYLRQSVGN 62

Query: 68  GCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG 127
              +     +     +W          ++     +                    L    
Sbjct: 63  EAEIWLGLNDMAAEGTWVDMTGARIAYKNWETEITAQPDGGKTENCAV-------LSGAA 115

Query: 128 SRSLVTERCNTSHPFIC 144
           +     +RC    P+IC
Sbjct: 116 NGKWFDKRCRDQLPYIC 132

>d1oz7b_ d.169.1.1 (B:) Snake coagglutinin beta chain {Saw-scaled viper (Echis carinatus), echicetin [TaxId: 40353]} Length = 123

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Snake coagglutinin beta chain
species: Saw-scaled viper (Echis carinatus), echicetin [TaxId: 40353]

 Score = 44.7 bits (104), Expect = 2e-06
 Identities = 25/142 (17%), Positives = 43/142 (30%), Gaps = 30/142 (21%)

Query: 9   CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKNV 66
           C PDW     +  C+       +W ++E +C +    GHL +  + +E      L    +
Sbjct: 2   CLPDWS--VYEGYCYKVFKERMNWADAEKFCTKQHKDGHLVSFRNSKEVDFVISLAFPML 59

Query: 67  NGCWVGGRSINTTVGLSWKWSDNM----SKWNESIHAVGSFNSSCTSLPCHVHATVDLCT 122
               V     +     +W+WSD        W+   H                      C 
Sbjct: 60  KNDLVWIGLTDYWRDCNWEWSDGAQLDYKAWDNERH----------------------CF 97

Query: 123 LVSNGSRSLVTERCNTSHPFIC 144
           +  N         C  +  F+C
Sbjct: 98  IYKNTDNQWTRRDCTWTFSFVC 119

>d1t8da1 d.169.1.1 (A:1-143) Low affinity immunoglobulin epsilon Fc receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 143

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Low affinity immunoglobulin epsilon Fc receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.0 bits (105), Expect = 2e-06
 Identities = 26/138 (18%), Positives = 46/138 (33%), Gaps = 18/138 (13%)

Query: 8   PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 67
            CP  WI    + KC+ +    + W  +   C ++ G L ++ S EE+    K      +
Sbjct: 7   TCPEKWI--NFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGS 64

Query: 68  GCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG 127
              +    +       + W D  S  + S  A G   S      C          ++  G
Sbjct: 65  WIGLRNLDLKGE----FIWVDG-SHVDYSNWAPGEPTSRSQGEDC----------VMMRG 109

Query: 128 SRSLVTERCNTS-HPFIC 144
           S       C+     ++C
Sbjct: 110 SGRWNDAFCDRKLGAWVC 127

>d1v7pb_ d.169.1.1 (B:) Snake coagglutinin beta chain {Snake (Echis multisquamatus), Ems16 [TaxId: 93050]} Length = 127

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Snake coagglutinin beta chain
species: Snake (Echis multisquamatus), Ems16 [TaxId: 93050]

 Score = 44.7 bits (104), Expect = 3e-06
 Identities = 33/142 (23%), Positives = 46/142 (32%), Gaps = 28/142 (19%)

Query: 9   CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 66
           CP  W        C+      ++W E+E  C +   G  LA++ S EEE    KL  K +
Sbjct: 1   CPLGWS--SFDQHCYKVFEPVKNWTEAEEICMQQHKGSRLASIHSSEEEAFVSKLASKAL 58

Query: 67  NGCWVGGRSINTTVGLSWKWSDNM----SKWNESIHAVGSFNSSCTSLPCHVHATVDLCT 122
               +     N      W+WSDN       W             CT +            
Sbjct: 59  KFTSMWIGLNNPWKDCKWEWSDNARFDYKAWKR--------RPYCTVM------------ 98

Query: 123 LVSNGSRSLVTERCNTSHPFIC 144
           +V        T  C  S  F+C
Sbjct: 99  VVKPDRIFWFTRGCEKSVSFVC 120

>d1hupa1 d.169.1.1 (A:112-228) Mannose-binding protein A, C-lectin domain {Human (Homo sapiens) [TaxId: 9606]} Length = 117

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Mannose-binding protein A, C-lectin domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.9 bits (102), Expect = 4e-06
 Identities = 18/125 (14%), Positives = 41/125 (32%), Gaps = 16/125 (12%)

Query: 20  SKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTT 79
           +K F   G   ++++ +  C +    +A   +  E  + Q L  +     ++G     T 
Sbjct: 5   NKFFLTNGEIMTFEKVKALCVKFQASVATPRNAAENGAIQNLIKEEA---FLGITDEKTE 61

Query: 80  VGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTS 139
                      ++   +    G  N++ +   C +             +       C+TS
Sbjct: 62  G---QFVDLTGNRLTYTNWNEGEPNNAGSDEDCVLL----------LKNGQWNDVPCSTS 108

Query: 140 HPFIC 144
           H  +C
Sbjct: 109 HLAVC 113

>d1wmza_ d.169.1.1 (A:) Lectin CEL-I {Cucumaria echinata [TaxId: 40245]} Length = 140

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Lectin CEL-I
species: Cucumaria echinata [TaxId: 40245]

 Score = 44.5 bits (103), Expect = 4e-06
 Identities = 17/148 (11%), Positives = 36/148 (24%), Gaps = 17/148 (11%)

Query: 9   CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGG-------HLAALTSYEEEHSAQKL 61
           CP DW    E   C+ +     +W+ +   C             L ++ S  E+      
Sbjct: 3   CPTDWE--AEGDHCYRFFNTLTTWENAHHECVSYSCSTLNVRSDLVSVHSAAEQAYVFNY 60

Query: 62  CGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLC 121
                +        +            + SK   +  A G  ++   +            
Sbjct: 61  WRGIDSQAGQLWIGLYDKYNEGDFIWTDGSKVGYTKWAGGQPDNWNNAEDY--------G 112

Query: 122 TLVSNGSRSLVTERCNTSHPFICMVEHE 149
                   +           ++C +  E
Sbjct: 113 QFRHTEGGAWNDNSAAAQAKYMCKLTFE 140

>d1c3ab_ d.169.1.1 (B:) Snake coagglutinin beta chain {Habu snake (Trimeresurus flavoviridis), flavocetin-A [TaxId: 88087]} Length = 125

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Snake coagglutinin beta chain
species: Habu snake (Trimeresurus flavoviridis), flavocetin-A [TaxId: 88087]

 Score = 43.9 bits (102), Expect = 4e-06
 Identities = 22/142 (15%), Positives = 42/142 (29%), Gaps = 30/142 (21%)

Query: 9   CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKNV 66
           CP  W        C+       +W+++E +C +   G HL +  S EE           +
Sbjct: 4   CPLGWS--SYDEHCYQVFQQKMNWEDAEKFCTQQHKGSHLVSFHSSEEVDFVTSKTFPIL 61

Query: 67  NGCWVGGRSINTTVGLSWKWSDNM----SKWNESIHAVGSFNSSCTSLPCHVHATVDLCT 122
              +V     N     + +WSD        W+                          C 
Sbjct: 62  KYDFVWIGLSNVWNECTKEWSDGTKLDYKAWSGGSD----------------------CI 99

Query: 123 LVSNGSRSLVTERCNTSHPFIC 144
           +        ++  C++ +  +C
Sbjct: 100 VSKTTDNQWLSMDCSSKYYVVC 121

>d3bdwa1 d.169.1.1 (A:59-179) CD94 {Human (Homo sapiens) [TaxId: 9606]} Length = 121

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: CD94
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.5 bits (101), Expect = 6e-06
 Identities = 20/137 (14%), Positives = 40/137 (29%), Gaps = 22/137 (16%)

Query: 8   PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 67
            C   W+       C+      ++W+ES   C      L  L + +E             
Sbjct: 2   SCQEKWVGYR--CNCYFISSEQKTWNESRHLCASQKSSLLQLQNTDELDFMSSSQQFYWI 59

Query: 68  GCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG 127
           G         +    +W W +  S  ++ +       ++            +      NG
Sbjct: 60  GLS------YSEEHTAWLWENG-SALSQYLFPSFETFNTK-----------NCIAYNPNG 101

Query: 128 SRSLVTERCNTSHPFIC 144
             + + E C   + +IC
Sbjct: 102 --NALDESCEDKNRYIC 116

>d1jwia_ d.169.1.1 (A:) Snake coagglutinin alpha chain {Puff adder (Bitis arietans), bitiscetin [TaxId: 8692]} Length = 124

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Snake coagglutinin alpha chain
species: Puff adder (Bitis arietans), bitiscetin [TaxId: 8692]

 Score = 42.8 bits (99), Expect = 9e-06
 Identities = 36/144 (25%), Positives = 54/144 (37%), Gaps = 30/144 (20%)

Query: 9   CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN- 67
           C PDW     K  C+       +W+++E +C E  GHLA++ S EE     KL  + +  
Sbjct: 1   CLPDWS--SYKGHCYKVFKKVGTWEDAEKFCVENSGHLASIDSKEEADFVTKLASQTLTK 58

Query: 68  ---GCWVGGRSINTTVGLSWKWSDNM----SKWNESIHAVGSFNSSCTSLPCHVHATVDL 120
                W+G R  + T   S +W+D         +E         + C  L  H       
Sbjct: 59  FVYDAWIGLRDESKTQQCSPQWTDGSSVVYENVDE--------PTKCFGLDVH------- 103

Query: 121 CTLVSNGSRSLVTERCNTSHPFIC 144
                   R+     C   +PFIC
Sbjct: 104 -----TEYRTWTDLPCGEKNPFIC 122

>d1gz2a_ d.169.1.1 (A:) Ovocleidin-17 {Chicken (Gallus gallus) [TaxId: 9031]} Length = 139

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Ovocleidin-17
species: Chicken (Gallus gallus) [TaxId: 9031]

 Score = 42.9 bits (99), Expect = 1e-05
 Identities = 24/137 (17%), Positives = 35/137 (25%), Gaps = 4/137 (2%)

Query: 9   CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIG-GHLAALTSYEEEHSAQKLCGKNVN 67
           C P W+       C G+     SW  +E++C+  G G   A      E            
Sbjct: 2   CGPGWV--PTPGGCLGFFSRELSWSRAESFCRRWGPGSHLAAVRSAAELRLLAELLNASR 59

Query: 68  GCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG 127
           G    G   +  V +          W  S      F S   +                  
Sbjct: 60  GGDGSGEGADGRVWIGLHRPAGSRSWRWSDGTAPRFASWHRTAKAR-RGGRCAALRDEEA 118

Query: 128 SRSLVTERCNTSHPFIC 144
             S     C   + F+C
Sbjct: 119 FTSWAARPCTERNAFVC 135

>d1uv0a_ d.169.1.1 (A:) Pancreatitis-associated protein 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 140

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Pancreatitis-associated protein 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.4 bits (98), Expect = 2e-05
 Identities = 18/136 (13%), Positives = 38/136 (27%), Gaps = 4/136 (2%)

Query: 9   CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 68
           CP         S C+    + +SW +++  C++             E S      K++  
Sbjct: 5   CPKGSK--AYGSHCYALFLSPKSWTDADLACQKRPSGNLVSVLSGAEGSFVSSLVKSIGN 62

Query: 69  CWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS 128
            +              + +    +W  S   V ++ +   +               S   
Sbjct: 63  SYSYVWIGLHDPTQGTEPNGEGWEW--SSSDVMNYFAWERNPSTISSPGHCASLSRSTAF 120

Query: 129 RSLVTERCNTSHPFIC 144
                  CN   P++C
Sbjct: 121 LRWKDYNCNVRLPYVC 136

>d1rdl1_ d.169.1.1 (1:) Mannose-binding protein A, C-lectin domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 111

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Mannose-binding protein A, C-lectin domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 41.6 bits (96), Expect = 2e-05
 Identities = 16/124 (12%), Positives = 34/124 (27%), Gaps = 16/124 (12%)

Query: 21  KCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTV 80
           K F         + ++  C E+ G +A         +A++          V    I    
Sbjct: 1   KYFMSSVRRMPLNRAKALCSELQGTVATP------RNAEENRAIQNVAKDVAFLGITDQR 54

Query: 81  GLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSH 140
             +       ++   +    G  N+  +   C          +V   +       C+ S 
Sbjct: 55  TENVFEDLTGNRVRYTNWNEGEPNNVGSGENC----------VVLLTNGKWNDVPCSDSF 104

Query: 141 PFIC 144
             +C
Sbjct: 105 LVVC 108

>d1oz7a_ d.169.1.1 (A:) Snake coagglutinin alpha chain {Saw-scaled viper (Echis carinatus), echicetin [TaxId: 40353]} Length = 131

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Snake coagglutinin alpha chain
species: Saw-scaled viper (Echis carinatus), echicetin [TaxId: 40353]

 Score = 42.0 bits (97), Expect = 2e-05
 Identities = 26/136 (19%), Positives = 44/136 (32%), Gaps = 12/136 (8%)

Query: 9   CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 68
           CPP W  N     C+      ++WDE+E +C + G     L+   ++             
Sbjct: 2   CPPGWSSNG--VYCYMLFKEPKTWDEAEKFCNKQGKDGHLLSIESKKEEILVDI----VV 55

Query: 69  CWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS 128
               G+      GLS +  +             S  S   S    +  +        +  
Sbjct: 56  SENIGKMYKIWTGLSERSKEQHCSSRW------SDGSFFRSYEIAIRYSECFVLEKQSVF 109

Query: 129 RSLVTERCNTSHPFIC 144
           R+ V   C  + PF+C
Sbjct: 110 RTWVATPCENTFPFMC 125

>d1jwib_ d.169.1.1 (B:) Snake coagglutinin beta chain {Puff adder (Bitis arietans), bitiscetin [TaxId: 8692]} Length = 123

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Snake coagglutinin beta chain
species: Puff adder (Bitis arietans), bitiscetin [TaxId: 8692]

 Score = 41.2 bits (95), Expect = 4e-05
 Identities = 29/138 (21%), Positives = 49/138 (35%), Gaps = 22/138 (15%)

Query: 9   CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKNV 66
           C PDW     K  C+      ++W ++E +CKE+  GGHL ++ S EE     KL  + +
Sbjct: 2   CLPDWS--SYKGHCYKVFKVEKTWADAEKFCKELVNGGHLMSVNSREEGEFISKLALEKM 59

Query: 67  NGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN 126
               V     +       +W+D                     L     +   +C +  +
Sbjct: 60  RIVLVWIGLSHFWRICPLRWTDG------------------ARLDYRALSDEPICFVAES 101

Query: 127 GSRSLVTERCNTSHPFIC 144
                +   CN    F+C
Sbjct: 102 FHNKWIQWTCNRKKSFVC 119

>d1jzna_ d.169.1.1 (A:) Galactose-specific C-type lectin {Western diamondback rattlesnake (Crotalus atrox) [TaxId: 8730]} Length = 135

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Galactose-specific C-type lectin
species: Western diamondback rattlesnake (Crotalus atrox) [TaxId: 8730]

 Score = 41.3 bits (95), Expect = 4e-05
 Identities = 21/137 (15%), Positives = 44/137 (32%), Gaps = 9/137 (6%)

Query: 9   CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 68
           CP DW+       C+      ++W+++E +C++        + +    S +         
Sbjct: 3   CPLDWL--PMNGLCYKIFNQLKTWEDAEMFCRKYKPGCHLASFHRYGESLEIAE------ 54

Query: 69  CWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVS-NG 127
                      V +  +       W  +  +   + +   + P H         LVS  G
Sbjct: 55  YISDYHKGQENVWIGLRDKKKDFSWEWTDRSCTDYLTWDKNQPDHYQNKEFCVELVSLTG 114

Query: 128 SRSLVTERCNTSHPFIC 144
            R    + C +   F+C
Sbjct: 115 YRLWNDQVCESKDAFLC 131

>d1qdda_ d.169.1.1 (A:) Lithostathine, inhibitor of stone formation {Human (Homo sapiens) [TaxId: 9606]} Length = 144

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Lithostathine, inhibitor of stone formation
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.9 bits (94), Expect = 7e-05
 Identities = 18/140 (12%), Positives = 41/140 (29%), Gaps = 11/140 (7%)

Query: 6   KAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN 65
           +  CP        +S C+ +  +  +W +++ YC+ +          + E +      K 
Sbjct: 11  RISCPEGTN--AYRSYCYYFNEDRETWVDADLYCQNMNSGNLVSVLTQAEGAFVASLIKE 68

Query: 66  VNGCWVGGRSINTTVGLSWKWSD-NMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLV 124
                            +  W   + S  +     +G+ +S        + +        
Sbjct: 69  SGTDDFNVWIGLHDPKKNRAWHWSSGSLVSYKSWGIGAPSSVNPGYCVSLTS-------- 120

Query: 125 SNGSRSLVTERCNTSHPFIC 144
           S G +      C     F+C
Sbjct: 121 STGFQKWKDVPCEDKFSFVC 140

>d2afpa_ d.169.1.1 (A:) Type II antifreeze protein {Sea raven (Hemitripterus americanus) [TaxId: 8094]} Length = 129

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Type II antifreeze protein
species: Sea raven (Hemitripterus americanus) [TaxId: 8094]

 Score = 40.5 bits (93), Expect = 7e-05
 Identities = 25/138 (18%), Positives = 40/138 (28%), Gaps = 17/138 (12%)

Query: 7   APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNV 66
             CP  W       +C  Y     +W  +ET C ++GGHLA++ S EE    Q L    V
Sbjct: 5   PNCPAGWQ--PLGDRCIYYETTAMTWALAETNCMKLGGHLASIHSQEEHSFIQTLNAGVV 62

Query: 67  NGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN 126
                                 + +  N         +    +             + + 
Sbjct: 63  WIGGSACLQAG------AWTWSDGTPMNFRSWCSTKPDDVLAA---------CCMQMTAA 107

Query: 127 GSRSLVTERCNTSHPFIC 144
             +      C  SH  +C
Sbjct: 108 ADQCWDDLPCPASHKSVC 125

>d1v7pa_ d.169.1.1 (A:) Snake coagglutinin alpha chain {Snake (Echis multisquamatus), Ems16 [TaxId: 93050]} Length = 134

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Snake coagglutinin alpha chain
species: Snake (Echis multisquamatus), Ems16 [TaxId: 93050]

 Score = 39.7 bits (91), Expect = 1e-04
 Identities = 29/142 (20%), Positives = 47/142 (33%), Gaps = 22/142 (15%)

Query: 9   CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGK-- 64
           CP DW        C+  IG  ++W E+E +C E    GHL ++ S EE +   +L     
Sbjct: 4   CPSDWT--AYDQHCYLAIGEPQNWYEAERFCTEQAKDGHLVSIQSREEGNFVAQLVSGFM 61

Query: 65  --NVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCT 122
             +    W+G R        + +W+D       +     S      +             
Sbjct: 62  HRSEIYVWIGLRDRREEQQCNPEWNDGSKIIYVNWKEGESKMCQGLT------------- 108

Query: 123 LVSNGSRSLVTERCNTSHPFIC 144
                        C   +PF+C
Sbjct: 109 -KWTNFHDWNNINCEDLYPFVC 129

>d1umrc_ d.169.1.1 (C:) Snake coagglutinin beta chain {South american rattlesnake (Crotalus durissus terrificus), convulxin [TaxId: 8732]} Length = 125

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Snake coagglutinin beta chain
species: South american rattlesnake (Crotalus durissus terrificus), convulxin [TaxId: 8732]

 Score = 39.7 bits (91), Expect = 1e-04
 Identities = 25/142 (17%), Positives = 49/142 (34%), Gaps = 30/142 (21%)

Query: 9   CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKNV 66
           CP  W        C+       +W ++E +C +   G HL +  S EE     K+  +++
Sbjct: 4   CPSHWS--SYDRYCYKVFKQEMTWADAEKFCTQQHTGSHLVSFHSTEEVDFVVKMTHQSL 61

Query: 67  NGCWVGGRSINTTVGLSWKWSDNM----SKWNESIHAVGSFNSSCTSLPCHVHATVDLCT 122
              +    + N     +W+WSD       +W+E                         C 
Sbjct: 62  KSTFFWIGANNIWNKCNWQWSDGTKPEYKEWHEEFE----------------------CL 99

Query: 123 LVSNGSRSLVTERCNTSHPFIC 144
           +        ++  C+ ++ F+C
Sbjct: 100 ISRTFDNQWLSAPCSDTYSFVC 121

>d1byfa_ d.169.1.1 (A:) Lectin TC14 {Tunicate (Polyandrocarpa misakiensis) [TaxId: 7723]} Length = 123

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Lectin TC14
species: Tunicate (Polyandrocarpa misakiensis) [TaxId: 7723]

 Score = 39.5 bits (90), Expect = 1e-04
 Identities = 19/124 (15%), Positives = 38/124 (30%), Gaps = 9/124 (7%)

Query: 22  CFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNV-NGCWVGGRSINTTV 80
              +     ++ ++ TYC+  G  L +    +       L    V    +  G       
Sbjct: 3   EILFSDETMNYADAGTYCQSRGMALVSSAMRDSTMVKAILAFTEVKGHDYWVGADNLQDG 62

Query: 81  GLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSH 140
             ++ W+D +S   +S     +  S+  S    V         + +    L    C  + 
Sbjct: 63  AYNFLWNDGVSLPTDSDLWSPNEPSNPQSWQLCVQ--------IWSKYNLLDDVGCGGAR 114

Query: 141 PFIC 144
             IC
Sbjct: 115 RVIC 118

>d1c3aa_ d.169.1.1 (A:) Snake coagglutinin alpha chain {Habu snake (Trimeresurus flavoviridis), flavocetin-A [TaxId: 88087]} Length = 135

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Snake coagglutinin alpha chain
species: Habu snake (Trimeresurus flavoviridis), flavocetin-A [TaxId: 88087]

 Score = 39.7 bits (91), Expect = 2e-04
 Identities = 15/136 (11%), Positives = 37/136 (27%), Gaps = 10/136 (7%)

Query: 9   CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 68
           C P W        C+      ++W+++E++C+E       ++                  
Sbjct: 4   CIPGWS--AYDRYCYQAFSKPKNWEDAESFCEEGVKTSHLVSIESSGEGDFVAQLVAEKI 61

Query: 69  CWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS 128
                           +  +   +   S  +  ++ +         +A            
Sbjct: 62  KTSFQYVWIGLR---IQNKEQQCRSEWSDASSVNYENLVKQFSKKCYALKK-----GTEL 113

Query: 129 RSLVTERCNTSHPFIC 144
           R+     C T +P +C
Sbjct: 114 RTWFNVYCGTENPEVC 129

>d1j34b_ d.169.1.1 (B:) Snake coagglutinin beta chain {Habu snake (Trimeresurus flavoviridis) [TaxId: 88087]} Length = 123

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Snake coagglutinin beta chain
species: Habu snake (Trimeresurus flavoviridis) [TaxId: 88087]

 Score = 38.5 bits (88), Expect = 3e-04
 Identities = 27/142 (19%), Positives = 45/142 (31%), Gaps = 30/142 (21%)

Query: 9   CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKNV 66
           CP DW     +  C+      ++W ++E +C +   GGHL +  S EE     KL  +  
Sbjct: 2   CPSDWS--SYEGHCYKPFSEPKNWADAENFCTQQHAGGHLVSFQSSEEADFVVKLAFQTF 59

Query: 67  NGCWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCT 122
                     N     +W+WS+        W E  +                      C 
Sbjct: 60  GHSIFWMGLSNVWNQCNWQWSNAAMLRYKAWAEESY----------------------CV 97

Query: 123 LVSNGSRSLVTERCNTSHPFIC 144
              + +    +  C     F+C
Sbjct: 98  YFKSTNNKWRSRACRMMAQFVC 119

>d1sb2a1 d.169.1.1 (A:1-132) Snake coagglutinin alpha chain {Malayan pit viper (Calloselasma rhodostoma), rhodocetin [TaxId: 8717]} Length = 132

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Snake coagglutinin alpha chain
species: Malayan pit viper (Calloselasma rhodostoma), rhodocetin [TaxId: 8717]

 Score = 38.2 bits (87), Expect = 5e-04
 Identities = 25/138 (18%), Positives = 41/138 (29%), Gaps = 14/138 (10%)

Query: 9   CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKNV 66
           CP  W     KS C+      ++W+E+E +C E     HL ++ +  E      +   N 
Sbjct: 2   CPDGWS--STKSYCYRPFKEKKTWEEAERFCTEQEKEAHLVSMENRLEAVFVDMVMENNF 59

Query: 67  NGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN 126
                           SW      +K   S       +S         +          +
Sbjct: 60  ENKIYR----------SWIGLKIENKGQRSNLEWSDGSSISYENLYEPYMEKCFLMDHQS 109

Query: 127 GSRSLVTERCNTSHPFIC 144
           G     T  C   + F+C
Sbjct: 110 GLPKWHTADCEEKNVFMC 127

>d1umra_ d.169.1.1 (A:) Snake coagglutinin alpha chain {South american rattlesnake (Crotalus durissus terrificus), convulxin [TaxId: 8732]} Length = 135

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Snake coagglutinin alpha chain
species: South american rattlesnake (Crotalus durissus terrificus), convulxin [TaxId: 8732]

 Score = 38.2 bits (87), Expect = 5e-04
 Identities = 26/140 (18%), Positives = 48/140 (34%), Gaps = 18/140 (12%)

Query: 9   CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKNV 66
           CP DW        C+       +W+++E +C +   G HL ++ S +E      +  +N+
Sbjct: 4   CPSDWY--YYDQHCYRIFNEEMNWEDAEWFCTKQAKGAHLVSIKSAKEADFVAWMVTQNI 61

Query: 67  NGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVS- 125
              +            S        +  E   +    + S  S    +   +  C+L+  
Sbjct: 62  EESF------------SHVSIGLRVQNKEKQCSTKWSDGSSVSYDNLLDLYITKCSLLKK 109

Query: 126 -NGSRSLVTERCNTSHPFIC 144
             G R      C    PF+C
Sbjct: 110 ETGFRKWFVASCIGKIPFVC 129

>d1fvua_ d.169.1.1 (A:) Snake coagglutinin alpha chain {Jararaca (Bothrops jararaca), botrocetin [TaxId: 8724]} Length = 133

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Snake coagglutinin alpha chain
species: Jararaca (Bothrops jararaca), botrocetin [TaxId: 8724]

 Score = 38.2 bits (87), Expect = 5e-04
 Identities = 24/138 (17%), Positives = 41/138 (29%), Gaps = 13/138 (9%)

Query: 9   CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIG--GHLAALTSYEEEHSAQKLCGKNV 66
           CP  W     +  C+ +     +W ++E +C E    GHL ++  Y +E           
Sbjct: 2   CPSGWS--SYEGNCYKFFQQKMNWADAERFCSEQAKGGHLVSIKIYSKEKDFVGDLVTKN 59

Query: 67  NGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN 126
                    I   V    K   +      S+    S+ +          A          
Sbjct: 60  IQSSDLYAWIGLRVENKEKQCSSEWSDGSSV----SYENVVERTVKKCFALEK-----DL 110

Query: 127 GSRSLVTERCNTSHPFIC 144
           G    +   C   +PF+C
Sbjct: 111 GFVLWINLYCAQKNPFVC 128

>d1fvub_ d.169.1.1 (B:) Snake coagglutinin beta chain {Jararaca (Bothrops jararaca), botrocetin [TaxId: 8724]} Length = 125

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Snake coagglutinin beta chain
species: Jararaca (Bothrops jararaca), botrocetin [TaxId: 8724]

 Score = 37.9 bits (86), Expect = 5e-04
 Identities = 26/138 (18%), Positives = 44/138 (31%), Gaps = 20/138 (14%)

Query: 9   CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 66
           CPPDW     +  C+ +   +  WD++E +C E   G HL +  S EE    + L  + +
Sbjct: 2   CPPDWS--SYEGHCYRFFKEWMHWDDAEEFCTEQQTGAHLVSFQSKEEADFVRSLTSEML 59

Query: 67  NGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN 126
            G  V     +      ++W+D              +             T         
Sbjct: 60  KGDVVWIGLSDVWNKCRFEWTDG------MEFDYDDYYLIAEYECVASKPT--------- 104

Query: 127 GSRSLVTERCNTSHPFIC 144
            +       C     F+C
Sbjct: 105 -NNKWWIIPCTRFKNFVC 121

>d1sb2b1 d.169.1.1 (B:2-128) Snake coagglutinin beta chain {Malayan pit viper (Calloselasma rhodostoma), rhodocetin [TaxId: 8717]} Length = 127

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Snake coagglutinin beta chain
species: Malayan pit viper (Calloselasma rhodostoma), rhodocetin [TaxId: 8717]

 Score = 37.0 bits (84), Expect = 0.001
 Identities = 22/138 (15%), Positives = 39/138 (28%), Gaps = 20/138 (14%)

Query: 9   CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKNV 66
           CP  W     K  C+      ++W E+E +C +    GHL ++ S  E      +   N 
Sbjct: 3   CPTTWS--ASKLYCYKPFKEKKTWIEAERFCAKQAENGHLVSIGSAAEADFLDLVIVVNF 60

Query: 67  NGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN 126
           +               +W      +    +  +V   N          +           
Sbjct: 61  DKQR----------YRAWTGLTERNLKWTNGASVSYENLY------EPYIRKCFVVQPWE 104

Query: 127 GSRSLVTERCNTSHPFIC 144
           G        C   + F+C
Sbjct: 105 GKSKWYKADCEEKNAFLC 122

>d1j34a_ d.169.1.1 (A:) Snake coagglutinin alpha chain {Habu snake (Trimeresurus flavoviridis) [TaxId: 88087]} Length = 129

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Snake coagglutinin alpha chain
species: Habu snake (Trimeresurus flavoviridis) [TaxId: 88087]

 Score = 36.7 bits (83), Expect = 0.002
 Identities = 29/140 (20%), Positives = 51/140 (36%), Gaps = 18/140 (12%)

Query: 9   CPPDWIINEEKSKCFGYIGNFRSWDESETYC--KEIGGHLAALTSYEEEHSAQKLCGKNV 66
           CP  W     +  C+     +++WD++E +C  +  GGHL ++ S  E     +L  +N+
Sbjct: 2   CPSGWS--SYEGHCYKPFKLYKTWDDAERFCTEQAKGGHLVSIESAGEADFVAQLVTENI 59

Query: 67  NGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN 126
                            + W     +  E   +    + S  S    + A    C  +  
Sbjct: 60  QNTKS------------YVWIGLRVQGKEKQCSSEWSDGSSVSYENWIEAESKTCLGLEK 107

Query: 127 --GSRSLVTERCNTSHPFIC 144
             G R  V   C   +PF+C
Sbjct: 108 ETGFRKWVNIYCGQQNPFVC 127

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	513
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1xpha1	130	DC-SIGNR (DC-SIGN related receptor) {Human (Homo s	99.95
d1hq8a_	123	NK cell-activating receptor nkg2d {Mouse (Mus musc	99.95
d1t8da1	143	Low affinity immunoglobulin epsilon Fc receptor {H	99.94
d1oz7b_	123	Snake coagglutinin beta chain {Saw-scaled viper (E	99.94
d2afpa_	129	Type II antifreeze protein {Sea raven (Hemitripter	99.94
d1tdqb_	126	Aggrecan core protein {Rat (Rattus norvegicus) [Ta	99.94
d1fvub_	125	Snake coagglutinin beta chain {Jararaca (Bothrops	99.94
d1ypqa1	131	Oxidised low density lipoprotein {Human (Homo sapi	99.94
d1j34b_	123	Snake coagglutinin beta chain {Habu snake (Trimere	99.94
d1c3ab_	125	Snake coagglutinin beta chain {Habu snake (Trimere	99.94
d1gz2a_	139	Ovocleidin-17 {Chicken (Gallus gallus) [TaxId: 903	99.93
d1qdda_	144	Lithostathine, inhibitor of stone formation {Human	99.93
d1umrc_	125	Snake coagglutinin beta chain {South american ratt	99.93
d1dv8a_	128	H1 subunit of the asialoglycoprotein receptor {Hum	99.93
d1wmza_	140	Lectin CEL-I {Cucumaria echinata [TaxId: 40245]}	99.93
d1jwib_	123	Snake coagglutinin beta chain {Puff adder (Bitis a	99.93
d1jzna_	135	Galactose-specific C-type lectin {Western diamondb	99.93
d1v7pb_	127	Snake coagglutinin beta chain {Snake (Echis multis	99.93
d1e87a_	117	CD69 {Human (Homo sapiens) [TaxId: 9606]}	99.93
d1c3aa_	135	Snake coagglutinin alpha chain {Habu snake (Trimer	99.93
d1tn3a_	137	Tetranectin {Human (Homo sapiens) [TaxId: 9606]}	99.93
d1umra_	135	Snake coagglutinin alpha chain {South american rat	99.93
d1sb2a1	132	Snake coagglutinin alpha chain {Malayan pit viper	99.93
d1egga_	136	Macrophage mannose receptor, CRD4 {Human (Homo sap	99.92
d3bdwa1	121	CD94 {Human (Homo sapiens) [TaxId: 9606]}	99.92
d1fvua_	133	Snake coagglutinin alpha chain {Jararaca (Bothrops	99.92
d1jwia_	124	Snake coagglutinin alpha chain {Puff adder (Bitis	99.92
d1uv0a_	140	Pancreatitis-associated protein 1 {Human (Homo sap	99.92
d1qo3c_	133	NK cell receptor {Mouse (Mus musculus), ly49-a [Ta	99.92
d1j34a_	129	Snake coagglutinin alpha chain {Habu snake (Trimer	99.92
d1pwba1	121	Surfactant protein, lectin domain {Human (Homo sap	99.92
d2msba_	112	Mannose-binding protein A, C-lectin domain {Rat (R	99.92
d1sb2b1	127	Snake coagglutinin beta chain {Malayan pit viper (	99.92
d3c8ja1	122	NK cell receptor {Mouse (Mus musculus), ly49-c [Ta	99.91
d1v7pa_	134	Snake coagglutinin alpha chain {Snake (Echis multi	99.91
d1r13a1	119	Surfactant protein, lectin domain {Rat (Rattus nor	99.91
d1hupa1	117	Mannose-binding protein A, C-lectin domain {Human	99.91
d1oz7a_	131	Snake coagglutinin alpha chain {Saw-scaled viper (	99.91
d1rdl1_	111	Mannose-binding protein A, C-lectin domain {Rat (R	99.9
d1h8ua_	115	Eosinophil major basic protein {Human (Homo sapien	99.9
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.9
d1kg0c_	136	EBV gp42 {Epstein-Barr virus [TaxId: 10376]}	99.85
d1g1ta1	118	E-selectin, C-lectin domain {Human (Homo sapiens)	99.84
d1wk1a_	150	Hypothetical protein F28B4.3 {Caenorhabditis elega	99.84
d1g1sa1	118	P-selectin, C-lectin domain {Human (Homo sapiens)	99.83
d1byfa_	123	Lectin TC14 {Tunicate (Polyandrocarpa misakiensis)	99.77
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.62
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.03
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.64
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.24
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.87
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.73
d2pf5a1	95	TSG-6, Link module {Human (Homo sapiens) [TaxId: 9	83.03

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-54  Score=411.39  Aligned_cols=252  Identities=24%  Similarity=0.393  Sum_probs=198.6

Q ss_pred             CCceecccCceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCCH
Q 010309          229 GNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  308 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL  308 (513)
                      ..+.||+|+||+||+|.+.+++.||||+++... ...+++.+|++++++++||||++++|++.+++..++||||+++|+|
T Consensus         9 ~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L   87 (263)
T d1sm2a_           9 FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCL   87 (263)
T ss_dssp             EEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred             EEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcH
Confidence            345689999999999999888999999997653 4567899999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccccee
Q 010309          309 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  388 (513)
Q Consensus       309 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  388 (513)
                      .+++..   ....+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++........... 
T Consensus        88 ~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~-  160 (263)
T d1sm2a_          88 SDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST-  160 (263)
T ss_dssp             HHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC---------------
T ss_pred             HHHhhc---cccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCceeec-
Confidence            999864   335689999999999999999999999   9999999999999999999999999999876544332222 


Q ss_pred             ecCcccccccccccccCCCCchhhHHHHHHHHHHHHcC-CCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCC
Q 010309          389 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSG-RRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS  467 (513)
Q Consensus       389 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  467 (513)
                      ...||+.|+|||++.+..++.++|||||||++|||+|+ .+||...+..   .+.....   . ..             .
T Consensus       161 ~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~---~~~~~i~---~-~~-------------~  220 (263)
T d1sm2a_         161 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EVVEDIS---T-GF-------------R  220 (263)
T ss_dssp             ----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH---HHHHHHH---H-TC-------------C
T ss_pred             ceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH---HHHHHHH---h-cC-------------C
Confidence            23389999999999999999999999999999999995 5555543321   1111111   1 00             0


Q ss_pred             CCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcC
Q 010309          468 DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  508 (513)
Q Consensus       468 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  508 (513)
                      ...+..+++++.+||.+||+.||++|||++||++.|+++.+
T Consensus       221 ~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         221 LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence            01112345679999999999999999999999999998754

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.4e-54  Score=418.87  Aligned_cols=270  Identities=25%  Similarity=0.446  Sum_probs=205.5

Q ss_pred             CHHHHHHHhhCccc--------CCceecccCceEEEEEEeCC-C---CEEEEEEeccc-chhcHHHHHHHHHHHhhcCCC
Q 010309          215 TTEELRSITKNFSE--------GNRLLGDSKTGGTYSGILPD-G---SRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHP  281 (513)
Q Consensus       215 ~~~~l~~~~~~~~~--------~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~  281 (513)
                      +++++..++.+|..        ..++||+|+||+||+|.+.. +   ..||||.+... .....+.|.+|+.+|++++||
T Consensus         8 t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~Hp   87 (299)
T d1jpaa_           8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHP   87 (299)
T ss_dssp             GSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCT
T ss_pred             CHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCC
Confidence            34455555555542        24678999999999999743 3   26899998764 334457899999999999999


Q ss_pred             cEeeeeeEEeeCCceEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEe
Q 010309          282 NLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL  361 (513)
Q Consensus       282 nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll  361 (513)
                      |||+++|++.+++..++||||+++|+|.+++..   ....+++.+++.++.||+.||+|||++   +|+||||||+||||
T Consensus        88 nIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl  161 (299)
T d1jpaa_          88 NVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILV  161 (299)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred             CCccEEEEEeeCCEEEEEEEecCCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEE
Confidence            999999999999999999999999999998864   235699999999999999999999999   99999999999999


Q ss_pred             cCCCCeEEecccccccCCccccccc---eeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccc
Q 010309          362 DEEFGAHLMGVGLSKFVPWEVMQER---TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVC  437 (513)
Q Consensus       362 ~~~~~~kl~Dfg~~~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~  437 (513)
                      +.++.+||+|||+++..........   .....||+.|+|||++.++.++.++|||||||++|||+| |+.||.+.....
T Consensus       162 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~  241 (299)
T d1jpaa_         162 NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD  241 (299)
T ss_dssp             CTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred             CCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999987654322211   112237899999999999999999999999999999998 899998755421


Q ss_pred             cchhHHhhhHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcCCC
Q 010309          438 WQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP  510 (513)
Q Consensus       438 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  510 (513)
                         +...    +....             ....+..+++++.+||.+||+.||++|||+.||++.|+++.+.|
T Consensus       242 ---~~~~----i~~~~-------------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p  294 (299)
T d1jpaa_         242 ---VINA----IEQDY-------------RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP  294 (299)
T ss_dssp             ---HHHH----HHTTC-------------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             ---HHHH----HHcCC-------------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcCh
Confidence               1111    11100             01112335667999999999999999999999999999876544

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-54  Score=410.91  Aligned_cols=259  Identities=24%  Similarity=0.405  Sum_probs=201.6

Q ss_pred             ccCCceecccCceEEEEEEeCCCCEEEEEEeccc--chhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeecc
Q 010309          227 SEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV  304 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  304 (513)
                      +...+.||+|+||+||+|+.+  ..||||+++..  .....+.|.+|+.+|++++|||||++++++. .+..++||||++
T Consensus        10 ~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~Ey~~   86 (276)
T d1uwha_          10 ITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCE   86 (276)
T ss_dssp             CCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCC
T ss_pred             EEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEecCC
Confidence            344567899999999999863  36999999754  3344578999999999999999999999875 457899999999


Q ss_pred             CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccc
Q 010309          305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  384 (513)
Q Consensus       305 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  384 (513)
                      +|+|.+++..   ....+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+........
T Consensus        87 ~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~  160 (276)
T d1uwha_          87 GSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS  160 (276)
T ss_dssp             EEEHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred             CCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence            9999999964   235699999999999999999999999   9999999999999999999999999999877544333


Q ss_pred             cceeecCccccccccccccc---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccccccccc
Q 010309          385 ERTVMAGGTYGYLAPEFVYR---NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL  461 (513)
Q Consensus       385 ~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  461 (513)
                      .......||+.|+|||++.+   ..++.++|||||||++|||+||+.||.+.+...  .+.    ......    ...+.
T Consensus       161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~--~~~----~~~~~~----~~~p~  230 (276)
T d1uwha_         161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QII----FMVGRG----YLSPD  230 (276)
T ss_dssp             -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--HHH----HHHHHT----SCCCC
T ss_pred             ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH--HHH----HHHhcC----CCCCc
Confidence            33334459999999999864   358999999999999999999999998755421  111    111111    11111


Q ss_pred             ccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcCC
Q 010309          462 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP  509 (513)
Q Consensus       462 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  509 (513)
                      +...     ...+++++.+||.+||+.||++|||++||++.|+.+.+.
T Consensus       231 ~~~~-----~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~  273 (276)
T d1uwha_         231 LSKV-----RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS  273 (276)
T ss_dssp             GGGS-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             chhc-----cccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence            1111     123456799999999999999999999999999987653

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-54  Score=410.61  Aligned_cols=248  Identities=22%  Similarity=0.295  Sum_probs=201.1

Q ss_pred             CCceecccCceEEEEEEeC-CCCEEEEEEecccch-hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          229 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      ..+.||+|+||+||+|+.. +|+.||||+++.... ...+.+.+|+.+|++++||||+++++++.+++..||||||+++|
T Consensus         9 ~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg   88 (271)
T d1nvra_           9 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGG   88 (271)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred             EEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCC
Confidence            3467899999999999974 699999999976532 33467899999999999999999999999999999999999999


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  386 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  386 (513)
                      +|.+++..    ...+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+..........
T Consensus        89 ~L~~~l~~----~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~  161 (271)
T d1nvra_          89 ELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL  161 (271)
T ss_dssp             EGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred             cHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCcccc
Confidence            99999853    35799999999999999999999999   999999999999999999999999999987754433333


Q ss_pred             eeecCcccccccccccccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCC
Q 010309          387 TVMAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  465 (513)
Q Consensus       387 ~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  465 (513)
                      .....||+.|+|||++.+..+ +.++|||||||++|||+||++||........ ....    .....             
T Consensus       162 ~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~-~~~~----~~~~~-------------  223 (271)
T d1nvra_         162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSD----WKEKK-------------  223 (271)
T ss_dssp             BCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH-HHHH----HHTTC-------------
T ss_pred             ccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH-HHHH----HhcCC-------------
Confidence            334459999999999988776 5789999999999999999999976543211 0000    00000             


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          466 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       466 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      ....+....++++.+|+.+||+.||++|||++|+++
T Consensus       224 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         224 TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            011122345677999999999999999999999976

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-53  Score=410.33  Aligned_cols=247  Identities=21%  Similarity=0.338  Sum_probs=206.9

Q ss_pred             ccCCceecccCceEEEEEEe-CCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccC
Q 010309          227 SEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  305 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  305 (513)
                      ++..+.||+|+||+||+|.. .+|+.||||+++.......+.+.+|+.+|++++|||||++++++.+++..|+||||+++
T Consensus        22 Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~g  101 (293)
T d1yhwa1          22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG  101 (293)
T ss_dssp             BCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             cEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCC
Confidence            34456789999999999996 46999999999877666678899999999999999999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccc
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  385 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  385 (513)
                      |+|.+++.+     ..+++.+++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++........ 
T Consensus       102 g~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~-  172 (293)
T d1yhwa1         102 GSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-  172 (293)
T ss_dssp             CBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC-
T ss_pred             CcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecccccc-
Confidence            999998864     4599999999999999999999999   9999999999999999999999999999876543322 


Q ss_pred             ceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCC
Q 010309          386 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL  465 (513)
Q Consensus       386 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  465 (513)
                       .....||+.|+|||++.+..++.++|||||||++|||+||..||.+.+...  .    .........      +     
T Consensus       173 -~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~--~----~~~~~~~~~------~-----  234 (293)
T d1yhwa1         173 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--A----LYLIATNGT------P-----  234 (293)
T ss_dssp             -BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--H----HHHHHHHCS------C-----
T ss_pred             -ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH--H----HHHHHhCCC------C-----
Confidence             223349999999999999999999999999999999999999997654321  1    111111100      0     


Q ss_pred             CCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          466 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       466 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                       ....+..+++++.+||.+||+.||++|||++|+++
T Consensus       235 -~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         235 -ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             -CCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             -CCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             11112345678999999999999999999999986

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-53  Score=404.30  Aligned_cols=241  Identities=26%  Similarity=0.352  Sum_probs=202.6

Q ss_pred             CCceecccCceEEEEEEeC-CCCEEEEEEecccc---hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeecc
Q 010309          229 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV  304 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  304 (513)
                      ..+.||+|+||.||+|+.. +|+.||||++.+..   ....+.+.+|+.++++++||||+++++++.+++..|+||||++
T Consensus        10 i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~   89 (263)
T d2j4za1          10 IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP   89 (263)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             EEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecC
Confidence            3567899999999999975 68999999997542   2345778999999999999999999999999999999999999


Q ss_pred             CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccc
Q 010309          305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  384 (513)
Q Consensus       305 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  384 (513)
                      +|+|.+++..    ...+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++........ 
T Consensus        90 ~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~-  161 (263)
T d2j4za1          90 LGTVYRELQK----LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR-  161 (263)
T ss_dssp             TCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCCC-
T ss_pred             CCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCCcc-
Confidence            9999999964    35699999999999999999999999   999999999999999999999999999987654322 


Q ss_pred             cceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccC
Q 010309          385 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS  464 (513)
Q Consensus       385 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  464 (513)
                         ....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+...   ....    .....           
T Consensus       162 ---~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~---~~~~----i~~~~-----------  220 (263)
T d2j4za1         162 ---TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE---TYKR----ISRVE-----------  220 (263)
T ss_dssp             ---EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHH----HHTTC-----------
T ss_pred             ---cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH---HHHH----HHcCC-----------
Confidence               23449999999999999999999999999999999999999997654321   1110    00000           


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          465 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       465 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                         ...+...++++.+||.+||+.||++|||++|+++
T Consensus       221 ---~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         221 ---FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence               0011234567999999999999999999999986

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=9.3e-54  Score=412.18  Aligned_cols=256  Identities=28%  Similarity=0.437  Sum_probs=209.2

Q ss_pred             cCCceecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          228 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      +..+.||+|+||+||+|.+. +|+.||||+++... ...+++.+|+.+|++++|||||++++++.+++..++||||+++|
T Consensus        20 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g   98 (287)
T d1opja_          20 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG   98 (287)
T ss_dssp             EEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred             EEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCc
Confidence            33457899999999999975 58899999997653 45678999999999999999999999999999999999999999


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  386 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  386 (513)
                      +|.+++..  .....+++..++.++.||+.||+|||++   +|+||||||+||||+.++.+||+|||+++..........
T Consensus        99 ~l~~~l~~--~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~  173 (287)
T d1opja_          99 NLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH  173 (287)
T ss_dssp             BHHHHHHH--SCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEE
T ss_pred             chHHHhhh--ccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCCceee
Confidence            99999975  3346799999999999999999999999   999999999999999999999999999997754432222


Q ss_pred             eeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCC
Q 010309          387 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  466 (513)
Q Consensus       387 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  466 (513)
                      . ...|++.|+|||++.+..++.++|||||||++|||++|..|+......  ..+..    ......             
T Consensus       174 ~-~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~--~~~~~----~i~~~~-------------  233 (287)
T d1opja_         174 A-GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQVYE----LLEKDY-------------  233 (287)
T ss_dssp             T-TEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHHH----HHHTTC-------------
T ss_pred             c-cccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH--HHHHH----HHhcCC-------------
Confidence            1 123789999999999999999999999999999999977665433221  11111    111110             


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcCC
Q 010309          467 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP  509 (513)
Q Consensus       467 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  509 (513)
                      ....+..+++++.+||.+||+.||++|||++||++.|+.+.+.
T Consensus       234 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~  276 (287)
T d1opja_         234 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  276 (287)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred             CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence            0111223456799999999999999999999999999887654

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-53  Score=408.79  Aligned_cols=252  Identities=26%  Similarity=0.417  Sum_probs=202.5

Q ss_pred             cCCceecccCceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCC
Q 010309          228 EGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  307 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs  307 (513)
                      +..+.||+|+||.||+|.+++++.||||+++... ...+.+.+|+.+|++++|||||++++++.+ +..++||||+++|+
T Consensus        16 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~   93 (272)
T d1qpca_          16 KLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGS   93 (272)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCB
T ss_pred             EEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCc
Confidence            3345689999999999999888899999997653 456789999999999999999999998754 56799999999999


Q ss_pred             HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccce
Q 010309          308 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  387 (513)
Q Consensus       308 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  387 (513)
                      |.+++..  .....+++..++.|+.||+.||.|||++   +|+||||||+||||+.++.+||+|||+|+.......... 
T Consensus        94 L~~~~~~--~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~-  167 (272)
T d1qpca_          94 LVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR-  167 (272)
T ss_dssp             HHHHTTS--HHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECC-
T ss_pred             HHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCccccc-
Confidence            9998854  2234599999999999999999999999   999999999999999999999999999987754432222 


Q ss_pred             eecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCC
Q 010309          388 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS  467 (513)
Q Consensus       388 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  467 (513)
                      ....||+.|+|||++.+..++.++|||||||++|||+||..|+......  ..+...   ... .     ..        
T Consensus       168 ~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~--~~~~~~---i~~-~-----~~--------  228 (272)
T d1qpca_         168 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--PEVIQN---LER-G-----YR--------  228 (272)
T ss_dssp             TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHH---HHT-T-----CC--------
T ss_pred             cccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH--HHHHHH---HHh-c-----CC--------
Confidence            1233899999999999999999999999999999999965554332221  111111   110 0     00        


Q ss_pred             CCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q 010309          468 DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  506 (513)
Q Consensus       468 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  506 (513)
                      ...+..+++++.+||.+||+.||++|||+++|++.|+.+
T Consensus       229 ~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~  267 (272)
T d1qpca_         229 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (272)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence            011223456799999999999999999999999999864

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-53  Score=409.56  Aligned_cols=250  Identities=23%  Similarity=0.341  Sum_probs=205.5

Q ss_pred             cccCCceecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeecc
Q 010309          226 FSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV  304 (513)
Q Consensus       226 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  304 (513)
                      +++..+.||+|+||.||+|+.. +|+.||||+++.......+.+.+|+++|++++|||||++++++.+++..++||||++
T Consensus        13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~   92 (288)
T d2jfla1          13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA   92 (288)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCC
Confidence            3454567899999999999974 689999999987766667889999999999999999999999999999999999999


Q ss_pred             CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccc
Q 010309          305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  384 (513)
Q Consensus       305 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  384 (513)
                      +|+|.+++.+.   ...+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+|.........
T Consensus        93 ~g~L~~~~~~~---~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~  166 (288)
T d2jfla1          93 GGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR  166 (288)
T ss_dssp             TEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHH
T ss_pred             CCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCccc
Confidence            99999987642   35699999999999999999999999   9999999999999999999999999999765433221


Q ss_pred             cceeecCcccccccccccc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccccccc
Q 010309          385 ERTVMAGGTYGYLAPEFVY-----RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD  459 (513)
Q Consensus       385 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  459 (513)
                        .....||+.|+|||++.     +..++.++|||||||++|||+||+.||.+.+....   ..   ..... ..     
T Consensus       167 --~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~---~~---~i~~~-~~-----  232 (288)
T d2jfla1         167 --RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV---LL---KIAKS-EP-----  232 (288)
T ss_dssp             --HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH---HH---HHHHS-CC-----
T ss_pred             --ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH---HH---HHHcC-CC-----
Confidence              11234999999999984     45688999999999999999999999987654311   11   11110 00     


Q ss_pred             ccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          460 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       460 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      +      ....+...++++.+||.+||+.||++|||++|+++
T Consensus       233 ~------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         233 P------TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             C------CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             C------CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0      11122345678999999999999999999999986

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-53  Score=398.73  Aligned_cols=250  Identities=23%  Similarity=0.363  Sum_probs=209.2

Q ss_pred             CCceecccCceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCCH
Q 010309          229 GNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  308 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL  308 (513)
                      ..+.||+|+||+||+|++++++.||||+++... ...+++.+|+.++++++||||++++|++.+++..++||||+++|+|
T Consensus         8 ~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l   86 (258)
T d1k2pa_           8 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL   86 (258)
T ss_dssp             CCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEH
T ss_pred             EeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcH
Confidence            345679999999999999888899999998764 3567899999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccccee
Q 010309          309 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  388 (513)
Q Consensus       309 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  388 (513)
                      .+++..   ....+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++.......... .
T Consensus        87 ~~~~~~---~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~-~  159 (258)
T d1k2pa_          87 LNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS-V  159 (258)
T ss_dssp             HHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCC-C
T ss_pred             HHhhhc---cccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCceee-c
Confidence            998753   235689999999999999999999999   999999999999999999999999999987654433222 2


Q ss_pred             ecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCC
Q 010309          389 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS  467 (513)
Q Consensus       389 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  467 (513)
                      ...+|+.|+|||++.+..++.++|||||||++|||+| |+.||...+..+...      . +....             .
T Consensus       160 ~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~------~-i~~~~-------------~  219 (258)
T d1k2pa_         160 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE------H-IAQGL-------------R  219 (258)
T ss_dssp             CSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHH------H-HHTTC-------------C
T ss_pred             ccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHH------H-HHhCC-------------C
Confidence            2348999999999999999999999999999999998 899998765432111      1 11110             0


Q ss_pred             CCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q 010309          468 DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  506 (513)
Q Consensus       468 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  506 (513)
                      ...+...++++.+||.+||+.||++|||+++|++.|.++
T Consensus       220 ~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         220 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             CCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence            111223456799999999999999999999999998764

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-53  Score=406.83  Aligned_cols=250  Identities=23%  Similarity=0.302  Sum_probs=192.0

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccc--hhcHHHHHHHHHHHhhcCCCcEeeeeeEEee--CCceEEEEeecc
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYD--HGDRYIVYEFVV  304 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lv~e~~~  304 (513)
                      .+.||+|+||.||+|+.. +|+.||||++....  ....+.+.+|+++|++++|||||++++++.+  .+..|+||||++
T Consensus         9 ~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~   88 (269)
T d2java1           9 LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCE   88 (269)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCT
T ss_pred             eEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCC
Confidence            457899999999999974 68999999997653  2335678999999999999999999999865  456899999999


Q ss_pred             CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCceEcCCCCCceEecCCCCeEEecccccccCCccc
Q 010309          305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV--KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV  382 (513)
Q Consensus       305 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~  382 (513)
                      +|+|.+++.........+++..++.++.||+.||+|||+..  ..+|+||||||+|||++.++.+||+|||+++......
T Consensus        89 ~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~  168 (269)
T d2java1          89 GGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT  168 (269)
T ss_dssp             TEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC----
T ss_pred             CCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCC
Confidence            99999998654344567999999999999999999999861  1139999999999999999999999999998765432


Q ss_pred             cccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccc
Q 010309          383 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI  462 (513)
Q Consensus       383 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  462 (513)
                      ...  ....||+.|+|||++.+..++.++|||||||++|||+||+.||...+...   +...    +.....        
T Consensus       169 ~~~--~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~---~~~~----i~~~~~--------  231 (269)
T d2java1         169 SFA--KAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---LAGK----IREGKF--------  231 (269)
T ss_dssp             ---------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHH----HHHTCC--------
T ss_pred             Ccc--ccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH---HHHH----HHcCCC--------
Confidence            221  22348999999999999999999999999999999999999998654321   1111    111111        


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          463 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       463 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                          . ..+..+++++.+||.+||+.||++|||++|+++
T Consensus       232 ----~-~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         232 ----R-RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             ----C-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----C-CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence                0 112234567999999999999999999999975

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-52  Score=400.70  Aligned_cols=247  Identities=19%  Similarity=0.341  Sum_probs=197.0

Q ss_pred             CcccCCceecccCceEEEEEEeC-CCCEEEEEEecccc--hhcHHHHHHHHHHHhhcCCCcEeeeeeEEee----CCceE
Q 010309          225 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYD----HGDRY  297 (513)
Q Consensus       225 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~~  297 (513)
                      +|....+.||+|+||+||+|... +++.||+|++....  ....+.+.+|+++|++++|||||++++++.+    ....+
T Consensus         9 ry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~   88 (270)
T d1t4ha_           9 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV   88 (270)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             CEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEE
Confidence            34455556899999999999975 58899999997643  3345678999999999999999999999875    34579


Q ss_pred             EEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--ceEcCCCCCceEec-CCCCeEEecccc
Q 010309          298 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH--VVHRDIRASNVLLD-EEFGAHLMGVGL  374 (513)
Q Consensus       298 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--ivH~Dikp~NIll~-~~~~~kl~Dfg~  374 (513)
                      +||||+++|+|.+++..    ...+++..++.++.||+.||+|||++   +  |+||||||+|||++ .++.+||+|||+
T Consensus        89 ivmE~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGl  161 (270)
T d1t4ha_          89 LVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGL  161 (270)
T ss_dssp             EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred             EEEeCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCc
Confidence            99999999999999964    35699999999999999999999998   7  99999999999996 578999999999


Q ss_pred             cccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccc
Q 010309          375 SKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRY  454 (513)
Q Consensus       375 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  454 (513)
                      ++.......    ....||+.|+|||++.+ .++.++|||||||++|||++|+.||.......  .+..   . ..... 
T Consensus       162 a~~~~~~~~----~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~--~~~~---~-i~~~~-  229 (270)
T d1t4ha_         162 ATLKRASFA----KAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIYR---R-VTSGV-  229 (270)
T ss_dssp             GGGCCTTSB----EESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HHHH---H-HTTTC-
T ss_pred             ceeccCCcc----CCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH--HHHH---H-HHcCC-
Confidence            986543322    23349999999998864 69999999999999999999999997644321  1111   1 11000 


Q ss_pred             cccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          455 LELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       455 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                                 .+...+...++++.+||.+||+.||++|||++|+++
T Consensus       230 -----------~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         230 -----------KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             -----------CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -----------CCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence                       011112223457999999999999999999999985

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-53  Score=405.36  Aligned_cols=245  Identities=21%  Similarity=0.302  Sum_probs=200.5

Q ss_pred             cCCceecccCceEEEEEEeC-CCCEEEEEEecccc---hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeec
Q 010309          228 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  303 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  303 (513)
                      +..++||+|+||.||+|... +|+.||||++.+..   ....+.+.+|+++|++++||||+++++++.+++..|+||||+
T Consensus        11 ~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~   90 (288)
T d1uu3a_          11 KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYA   90 (288)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEcc
Confidence            44568899999999999974 69999999997542   234577999999999999999999999999999999999999


Q ss_pred             cCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccc
Q 010309          304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM  383 (513)
Q Consensus       304 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~  383 (513)
                      ++|+|.+++..    ...+++..++.++.|++.||+|||+.   +|+||||||+|||+++++.+||+|||+++.......
T Consensus        91 ~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~  163 (288)
T d1uu3a_          91 KNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  163 (288)
T ss_dssp             TTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             CCCCHHHhhhc----cCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence            99999998864    35699999999999999999999999   999999999999999999999999999998765443


Q ss_pred             ccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccccccccccc
Q 010309          384 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS  463 (513)
Q Consensus       384 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  463 (513)
                      ........||+.|+|||++.+..++.++|||||||++|||+||+.||...+...   +..   ... ...          
T Consensus       164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~~---~i~-~~~----------  226 (288)
T d1uu3a_         164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL---IFQ---KII-KLE----------  226 (288)
T ss_dssp             ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---HHH-TTC----------
T ss_pred             ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH---HHH---HHH-cCC----------
Confidence            333334459999999999999999999999999999999999999998654321   111   100 000          


Q ss_pred             CCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 010309          464 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVV  500 (513)
Q Consensus       464 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  500 (513)
                         . ..+...++++.+||.+||+.||++|||++|++
T Consensus       227 ---~-~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~  259 (288)
T d1uu3a_         227 ---Y-DFPEKFFPKARDLVEKLLVLDATKRLGCEEME  259 (288)
T ss_dssp             ---C-CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred             ---C-CCCccCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence               0 01123456799999999999999999999863

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-52  Score=402.30  Aligned_cols=247  Identities=23%  Similarity=0.358  Sum_probs=202.3

Q ss_pred             ecccCceEEEEEEeC---CCCEEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCCH
Q 010309          233 LGDSKTGGTYSGILP---DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL  308 (513)
Q Consensus       233 lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL  308 (513)
                      ||+|+||.||+|.+.   ++..||||+++... ....+.|.+|+++|++++|||||+++|++.+ +..||||||+++|+|
T Consensus        17 iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~L   95 (285)
T d1u59a_          17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPL   95 (285)
T ss_dssp             EECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEH
T ss_pred             EecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCcH
Confidence            799999999999864   35579999997653 3345789999999999999999999999864 568999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccc-cce
Q 010309          309 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ-ERT  387 (513)
Q Consensus       309 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~-~~~  387 (513)
                      .+++..   .+..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++........ ...
T Consensus        96 ~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~  169 (285)
T d1u59a_          96 HKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR  169 (285)
T ss_dssp             HHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCC
T ss_pred             HHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcccccccccccc
Confidence            999853   235699999999999999999999999   9999999999999999999999999999877544322 222


Q ss_pred             eecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCC
Q 010309          388 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  466 (513)
Q Consensus       388 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  466 (513)
                      ....||+.|+|||++.++.++.++|||||||++|||+| |+.||......+   +...    +..+..            
T Consensus       170 ~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~---~~~~----i~~~~~------------  230 (285)
T d1u59a_         170 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMAF----IEQGKR------------  230 (285)
T ss_dssp             CSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---HHHH----HHTTCC------------
T ss_pred             cccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH---HHHH----HHcCCC------------
Confidence            23348999999999999999999999999999999998 999998765421   1111    111110            


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q 010309          467 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  506 (513)
Q Consensus       467 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  506 (513)
                      . ..+..+++++.+||.+||+.||++|||+.+|++.|+..
T Consensus       231 ~-~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~  269 (285)
T d1u59a_         231 M-ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  269 (285)
T ss_dssp             C-CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             C-CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            1 11223556899999999999999999999999988754

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-52  Score=401.05  Aligned_cols=248  Identities=27%  Similarity=0.395  Sum_probs=199.6

Q ss_pred             ceecccCceEEEEEEeCC---CCEEEEEEecccch--hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccC
Q 010309          231 RLLGDSKTGGTYSGILPD---GSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  305 (513)
Q Consensus       231 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  305 (513)
                      +.||+|+||+||+|.+.+   ++.||||+++....  ...+.+.+|+++|++++|||||++++++.+ +..+|||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            568999999999998643   46899999975432  335679999999999999999999999864 567999999999


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccc-
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ-  384 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~-  384 (513)
                      |+|.+++..    ...+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++........ 
T Consensus        92 g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~  164 (277)
T d1xbba_          92 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  164 (277)
T ss_dssp             EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred             CcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence            999999964    35699999999999999999999999   9999999999999999999999999999876544322 


Q ss_pred             cceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhccccccccccccc
Q 010309          385 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS  463 (513)
Q Consensus       385 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  463 (513)
                      .......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+...   +..    .+..+..         
T Consensus       165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~---~~~----~i~~~~~---------  228 (277)
T d1xbba_         165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VTA----MLEKGER---------  228 (277)
T ss_dssp             EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHH----HHHTTCC---------
T ss_pred             ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH---HHH----HHHcCCC---------
Confidence            22223348999999999999999999999999999999998 899998755321   111    1111110         


Q ss_pred             CCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q 010309          464 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  506 (513)
Q Consensus       464 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  506 (513)
                         . ..+..+++++.+||.+||+.||++|||+++|++.|+..
T Consensus       229 ---~-~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~  267 (277)
T d1xbba_         229 ---M-GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  267 (277)
T ss_dssp             ---C-CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             ---C-CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence               0 11223556799999999999999999999999988753

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-52  Score=411.11  Aligned_cols=256  Identities=25%  Similarity=0.359  Sum_probs=203.3

Q ss_pred             ccCCceecccCceEEEEEEeCC-C-----CEEEEEEeccc-chhcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCCceEE
Q 010309          227 SEGNRLLGDSKTGGTYSGILPD-G-----SRVAVKRLKRS-SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYI  298 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~l  298 (513)
                      .+..+.||+|+||+||+|+... +     ..||||.+... .......+.+|+.+|.++ +|||||++++++.+.+..++
T Consensus        39 ~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~l  118 (325)
T d1rjba_          39 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYL  118 (325)
T ss_dssp             EEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             eEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEE
Confidence            3445788999999999999643 2     36999998754 333456789999999998 89999999999999999999


Q ss_pred             EEeeccCCCHHHHhccCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCce
Q 010309          299 VYEFVVNGPLDRWLHHIPR-------------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNV  359 (513)
Q Consensus       299 v~e~~~~gsL~~~l~~~~~-------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NI  359 (513)
                      ||||+++|+|.++|.....                   ....+++..++.++.||+.||+|||++   +|+||||||+||
T Consensus       119 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~Ni  195 (325)
T d1rjba_         119 IFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNV  195 (325)
T ss_dssp             EEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGGE
T ss_pred             EEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchhcc
Confidence            9999999999999975321                   123589999999999999999999999   999999999999


Q ss_pred             EecCCCCeEEecccccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCcccc
Q 010309          360 LLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCW  438 (513)
Q Consensus       360 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~  438 (513)
                      |++.++.+||+|||+|+...............||+.|+|||++.++.++.++|||||||++|||+| |.+||.+.+... 
T Consensus       196 ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~-  274 (325)
T d1rjba_         196 LVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA-  274 (325)
T ss_dssp             EEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-
T ss_pred             ccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHH-
Confidence            999999999999999987654433322223347999999999999999999999999999999998 899998654421 


Q ss_pred             chhHHhhhHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 010309          439 QSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ  504 (513)
Q Consensus       439 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  504 (513)
                       .+..    ......             ....+..+++++.+||.+||+.||++|||++||++.|.
T Consensus       275 -~~~~----~~~~~~-------------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         275 -NFYK----LIQNGF-------------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             -HHHH----HHHTTC-------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             -HHHH----HHhcCC-------------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence             1111    111110             00112234567999999999999999999999999985

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-52  Score=400.69  Aligned_cols=257  Identities=23%  Similarity=0.386  Sum_probs=198.9

Q ss_pred             CCceecccCceEEEEEEeCCC-----CEEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEee
Q 010309          229 GNRLLGDSKTGGTYSGILPDG-----SRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF  302 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  302 (513)
                      ..++||+|+||.||+|.+.+.     ..||||+++... .....+|.+|+.+|++++|||||+++|++.+.+..++||||
T Consensus        11 ~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~   90 (283)
T d1mqba_          11 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEY   90 (283)
T ss_dssp             EEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             eeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEe
Confidence            456899999999999997542     379999997653 33456789999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccc
Q 010309          303 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV  382 (513)
Q Consensus       303 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~  382 (513)
                      +.+++|.+++..   ....+++.+++.++.||+.||+|||++   +|+||||||+||||+.++.+||+|||+++......
T Consensus        91 ~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~  164 (283)
T d1mqba_          91 MENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  164 (283)
T ss_dssp             CTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred             cccCcchhhhhc---ccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccCCC
Confidence            999999998864   235699999999999999999999999   99999999999999999999999999998765432


Q ss_pred             ccc-ceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccccccccc
Q 010309          383 MQE-RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL  461 (513)
Q Consensus       383 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  461 (513)
                      ... ......||+.|+|||++.+..++.++|||||||++|||++|..|+......  ..+...    +....        
T Consensus       165 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~--~~~~~~----i~~~~--------  230 (283)
T d1mqba_         165 EATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HEVMKA----INDGF--------  230 (283)
T ss_dssp             ---------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHH----HHTTC--------
T ss_pred             ccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH--HHHHHH----HhccC--------
Confidence            221 222234899999999999999999999999999999999966655432221  111111    11110        


Q ss_pred             ccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcCCC
Q 010309          462 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP  510 (513)
Q Consensus       462 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  510 (513)
                           ....+..++.++.+||.+||+.||++|||+.||++.|+++.+.|
T Consensus       231 -----~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p  274 (283)
T d1mqba_         231 -----RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP  274 (283)
T ss_dssp             -----CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             -----CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCc
Confidence                 01112234567999999999999999999999999998876554

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-53  Score=412.62  Aligned_cols=262  Identities=22%  Similarity=0.344  Sum_probs=202.8

Q ss_pred             CCceecccCceEEEEEEeC-CCCEEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          229 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      ..+.||+|+||+||+|+.. +|+.||+|+++... ....+.+.+|+.+|++++|||||++++++.+.+..++||||+++|
T Consensus        10 ~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg   89 (322)
T d1s9ja_          10 KISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG   89 (322)
T ss_dssp             EEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred             EEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCC
Confidence            3456799999999999974 68999999997653 333567899999999999999999999999999999999999999


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD-KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  385 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  385 (513)
                      +|.+++.+    ...+++..+..++.|++.||.|||+ +   +|+||||||+|||++.++.+||+|||+|+.......  
T Consensus        90 ~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~--  160 (322)
T d1s9ja_          90 SLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--  160 (322)
T ss_dssp             EHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHTC--
T ss_pred             cHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccCCCcc--
Confidence            99999964    2469999999999999999999996 5   899999999999999999999999999986543221  


Q ss_pred             ceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhh-hHHh---------------
Q 010309          386 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWA-TPLV---------------  449 (513)
Q Consensus       386 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~-~~~~---------------  449 (513)
                        ....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+........... ....               
T Consensus       161 --~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (322)
T d1s9ja_         161 --NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS  238 (322)
T ss_dssp             -----CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------------
T ss_pred             --ccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccc
Confidence              2234999999999999999999999999999999999999999775543211100000 0000               


Q ss_pred             -------hcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          450 -------QSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       450 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                             ......+..+..........+....+.++.+||.+||+.||++|||++|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         239 SYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             -------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence                   0000000011111111122222334568999999999999999999999986

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5e-52  Score=403.49  Aligned_cols=250  Identities=21%  Similarity=0.324  Sum_probs=189.4

Q ss_pred             CcccCCceecccCceEEEEEEeC-CCCEEEEEEecccch-hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEee
Q 010309          225 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF  302 (513)
Q Consensus       225 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  302 (513)
                      +.++..+.||+|+||+||+|... +|+.||||++..... ...+.+.+|+.+|++++||||+++++++.+++..||||||
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~   88 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL   88 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            33455678899999999999975 689999999976533 2345688999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEec---CCCCeEEecccccccCC
Q 010309          303 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD---EEFGAHLMGVGLSKFVP  379 (513)
Q Consensus       303 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~---~~~~~kl~Dfg~~~~~~  379 (513)
                      +++|+|.+++..    ...+++..+..++.||+.||+|||++   +|+||||||+|||++   .++.+||+|||+++...
T Consensus        89 ~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~  161 (307)
T d1a06a_          89 VSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED  161 (307)
T ss_dssp             CCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred             cCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence            999999999964    35699999999999999999999999   999999999999995   57889999999998765


Q ss_pred             ccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccccccc
Q 010309          380 WEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD  459 (513)
Q Consensus       380 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  459 (513)
                      .....   ....||+.|+|||++.+..++.++|||||||++|||++|.+||.+.....   +..   .... ... ..  
T Consensus       162 ~~~~~---~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~~---~i~~-~~~-~~--  228 (307)
T d1a06a_         162 PGSVL---STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK---LFE---QILK-AEY-EF--  228 (307)
T ss_dssp             --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHH---HHHT-TCC-CC--
T ss_pred             CCCee---eeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH---HHH---HHhc-cCC-CC--
Confidence            43222   22349999999999999999999999999999999999999998654321   111   1111 000 00  


Q ss_pred             ccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          460 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       460 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                             ........++++.+||.+||+.||++|||++|+++
T Consensus       229 -------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         229 -------DSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             -------CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             -------CCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence                   01111235667999999999999999999999987

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.3e-52  Score=402.41  Aligned_cols=240  Identities=23%  Similarity=0.384  Sum_probs=197.6

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccch---hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccC
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  305 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  305 (513)
                      -+.||+|+||.||+|+.. +|+.||||+++....   ...+.+.+|+.+|++++|||||++++++.+++..|+||||+++
T Consensus        20 l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~   99 (309)
T d1u5ra_          20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG   99 (309)
T ss_dssp             EEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred             eEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCC
Confidence            345799999999999964 688999999976532   2346789999999999999999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccc
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE  385 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  385 (513)
                      |+|..++..    ...+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++.......   
T Consensus       100 g~l~~~~~~----~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~~---  169 (309)
T d1u5ra_         100 SASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN---  169 (309)
T ss_dssp             EHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBC---
T ss_pred             CchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCCCC---
Confidence            999877643    35699999999999999999999999   99999999999999999999999999998764322   


Q ss_pred             ceeecCccccccccccccc---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccc
Q 010309          386 RTVMAGGTYGYLAPEFVYR---NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI  462 (513)
Q Consensus       386 ~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  462 (513)
                         ...||+.|+|||++.+   ..++.++|||||||++|||++|..||.+.....      ........ .         
T Consensus       170 ---~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~------~~~~i~~~-~---------  230 (309)
T d1u5ra_         170 ---SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQN-E---------  230 (309)
T ss_dssp             ---CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHS-C---------
T ss_pred             ---ccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH------HHHHHHhC-C---------
Confidence               2349999999999864   468999999999999999999999997654321      11111110 0         


Q ss_pred             cCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          463 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       463 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                         .........++++.+||.+||+.||++|||++|+++
T Consensus       231 ---~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         231 ---SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             ---CCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ---CCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence               011122234567999999999999999999999986

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2.2e-51  Score=405.80  Aligned_cols=251  Identities=19%  Similarity=0.295  Sum_probs=206.8

Q ss_pred             hCcccCCceecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEee
Q 010309          224 KNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF  302 (513)
Q Consensus       224 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  302 (513)
                      ++| +..+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..||||||
T Consensus        26 ~~Y-~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          26 DHY-DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GTE-EEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             cCe-EEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            344 34567899999999999974 6899999999877666678899999999999999999999999999999999999


Q ss_pred             ccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecC--CCCeEEecccccccCCc
Q 010309          303 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE--EFGAHLMGVGLSKFVPW  380 (513)
Q Consensus       303 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~--~~~~kl~Dfg~~~~~~~  380 (513)
                      +++|+|.+++..   ....+++..+..++.||+.||+|||++   +|+||||||+|||++.  ++.+||+|||+++....
T Consensus       105 ~~gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~  178 (350)
T d1koaa2         105 MSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP  178 (350)
T ss_dssp             CCSCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred             CCCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence            999999999853   235699999999999999999999999   9999999999999964  57899999999987754


Q ss_pred             cccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccc
Q 010309          381 EVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP  460 (513)
Q Consensus       381 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  460 (513)
                      ....   ....||+.|+|||++.+..++.++|||||||++|||+||+.||.+.+...   ...   ..... .. ..   
T Consensus       179 ~~~~---~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~---~~~---~i~~~-~~-~~---  244 (350)
T d1koaa2         179 KQSV---KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE---TLR---NVKSC-DW-NM---  244 (350)
T ss_dssp             TSCE---EEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---HHHHT-CC-CS---
T ss_pred             cccc---ceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH---HHH---HHHhC-CC-CC---
Confidence            4322   22349999999999999999999999999999999999999998654321   111   11110 00 00   


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          461 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       461 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                            .......+++++.+||.+||+.||++|||++|+++
T Consensus       245 ------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         245 ------DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             ------CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             ------CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                  11112235667999999999999999999999987

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2.9e-51  Score=405.24  Aligned_cols=249  Identities=19%  Similarity=0.283  Sum_probs=206.4

Q ss_pred             ccCCceecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccC
Q 010309          227 SEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN  305 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  305 (513)
                      ++..+.||+|+||.||+|... +|+.||||+++.......+.+.+|+.+|++++|||||++++++.+++..||||||+++
T Consensus        31 Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~g  110 (352)
T d1koba_          31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG  110 (352)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred             eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCC
Confidence            445567899999999999974 6999999999877666677889999999999999999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEec--CCCCeEEecccccccCCcccc
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD--EEFGAHLMGVGLSKFVPWEVM  383 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~--~~~~~kl~Dfg~~~~~~~~~~  383 (513)
                      |+|.+++..   ....+++.+++.|+.||+.||+|||++   +|+||||||+||||+  .++.+||+|||+|........
T Consensus       111 g~L~~~~~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~  184 (352)
T d1koba_         111 GELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI  184 (352)
T ss_dssp             CBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred             ChHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCCCc
Confidence            999988753   335699999999999999999999999   999999999999998  568899999999988764432


Q ss_pred             ccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccccccccccc
Q 010309          384 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS  463 (513)
Q Consensus       384 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  463 (513)
                      .   ....||+.|+|||++.+..++.++|||||||++|||+||+.||.+.+....   ..   .... ... .     . 
T Consensus       185 ~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~---~~---~i~~-~~~-~-----~-  247 (352)
T d1koba_         185 V---KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET---LQ---NVKR-CDW-E-----F-  247 (352)
T ss_dssp             E---EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---HH---HHHH-CCC-C-----C-
T ss_pred             e---eeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH---HH---HHHh-CCC-C-----C-
Confidence            2   223499999999999999999999999999999999999999987554211   11   0000 000 0     0 


Q ss_pred             CCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          464 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       464 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                         .......+++++.+||.+||+.||.+|||++|+++
T Consensus       248 ---~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         248 ---DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             ---CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             ---CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               11111235667999999999999999999999986

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-51  Score=395.37  Aligned_cols=255  Identities=25%  Similarity=0.359  Sum_probs=200.4

Q ss_pred             ccCCceecccCceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          227 SEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      .+..+.||+|+||.||+|++++++.||||+++... ...+.|.+|+.++++++|||||++++++. .+..++||||+++|
T Consensus        19 ~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~~g   96 (285)
T d1fmka3          19 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKG   96 (285)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCTTC
T ss_pred             EEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecCCC
Confidence            34455679999999999999888899999997653 45678999999999999999999999985 45689999999999


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  386 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  386 (513)
                      +|..++...  ....+++.+++.++.||+.||+|||++   +|+||||||+||||+.++.+||+|||+++..........
T Consensus        97 ~l~~~~~~~--~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  171 (285)
T d1fmka3          97 SLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR  171 (285)
T ss_dssp             BHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred             chhhhhhhc--ccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCceee
Confidence            999988652  234699999999999999999999999   999999999999999999999999999987654332222


Q ss_pred             eeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCC
Q 010309          387 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS  466 (513)
Q Consensus       387 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  466 (513)
                       ....||+.|+|||++.+..++.++|||||||++|||+||..|+......  ..+....    ....             
T Consensus       172 -~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~--~~~~~~i----~~~~-------------  231 (285)
T d1fmka3         172 -QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQV----ERGY-------------  231 (285)
T ss_dssp             -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHH----HTTC-------------
T ss_pred             -ccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH--HHHHHHH----HhcC-------------
Confidence             2234899999999999999999999999999999999976665443221  1111111    1000             


Q ss_pred             CCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcC
Q 010309          467 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  508 (513)
Q Consensus       467 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  508 (513)
                      ....+..+++++.+||.+||+.||++|||+++|++.|+....
T Consensus       232 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~  273 (285)
T d1fmka3         232 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  273 (285)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             CCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence            001122345679999999999999999999999999987653

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-51  Score=394.99  Aligned_cols=250  Identities=19%  Similarity=0.293  Sum_probs=203.6

Q ss_pred             CcccCCceecccCceEEEEEEeC-CCCEEEEEEecccch------hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceE
Q 010309          225 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF------QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRY  297 (513)
Q Consensus       225 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  297 (513)
                      +.++..+.||+|+||+||+|... +|+.||||++++...      ...+.+.+|+.+|++++|||||++++++.+.+..|
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            34555677899999999999974 699999999975422      23578999999999999999999999999999999


Q ss_pred             EEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCC----CeEEeccc
Q 010309          298 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF----GAHLMGVG  373 (513)
Q Consensus       298 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~----~~kl~Dfg  373 (513)
                      |||||+++|+|.+++..    ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++    .+||+|||
T Consensus        90 iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG  162 (293)
T d1jksa_          90 LILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG  162 (293)
T ss_dssp             EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchh
Confidence            99999999999999965    24699999999999999999999999   999999999999998776    49999999


Q ss_pred             ccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccc
Q 010309          374 LSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHR  453 (513)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  453 (513)
                      ++..........   ...||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+....   ..   .. ....
T Consensus       163 ~a~~~~~~~~~~---~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~---~~---~i-~~~~  232 (293)
T d1jksa_         163 LAHKIDFGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET---LA---NV-SAVN  232 (293)
T ss_dssp             TCEECTTSCBCS---CCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HH---HH-HTTC
T ss_pred             hhhhcCCCcccc---ccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHH---HH---HH-HhcC
Confidence            998765433222   23389999999999999999999999999999999999999987553211   11   00 0000


Q ss_pred             ccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          454 YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       454 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      . ..         ........++++.+||.+||+.||++|||++|+++
T Consensus       233 ~-~~---------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         233 Y-EF---------EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             C-CC---------CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             C-CC---------CchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0 00         00001234567999999999999999999999986

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8e-51  Score=395.10  Aligned_cols=259  Identities=25%  Similarity=0.399  Sum_probs=208.2

Q ss_pred             ccCCceecccCceEEEEEEeC------CCCEEEEEEecccch-hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEE
Q 010309          227 SEGNRLLGDSKTGGTYSGILP------DGSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIV  299 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv  299 (513)
                      ++..+.||+|+||+||+|+..      +++.||||+++.... ...+++.+|+.+|++++||||+++++++.+.+..++|
T Consensus        15 ~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v   94 (301)
T d1lufa_          15 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLL   94 (301)
T ss_dssp             CEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             cEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEE
Confidence            344567799999999999863      357899999976533 3356799999999999999999999999999999999


Q ss_pred             EeeccCCCHHHHhccCC--------------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCce
Q 010309          300 YEFVVNGPLDRWLHHIP--------------------RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNV  359 (513)
Q Consensus       300 ~e~~~~gsL~~~l~~~~--------------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NI  359 (513)
                      |||+++|+|.+++....                    .....+++..++.|+.|++.||+|||++   +|+||||||+||
T Consensus        95 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlKp~NI  171 (301)
T d1lufa_          95 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNC  171 (301)
T ss_dssp             EECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred             EEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEcccce
Confidence            99999999999996422                    1123589999999999999999999999   999999999999


Q ss_pred             EecCCCCeEEecccccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCC-CCCCCCCcccc
Q 010309          360 LLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGR-RPAQAVDSVCW  438 (513)
Q Consensus       360 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~-~p~~~~~~~~~  438 (513)
                      |++.++.+||+|||+|+...............+|+.|+|||++.+..++.++|||||||++|||++|. +||...+..+.
T Consensus       172 Lld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~  251 (301)
T d1lufa_         172 LVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV  251 (301)
T ss_dssp             EECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH
T ss_pred             EECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHHH
Confidence            99999999999999998765544433333445889999999999999999999999999999999985 57766544221


Q ss_pred             chhHHhhhHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcC
Q 010309          439 QSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  508 (513)
Q Consensus       439 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  508 (513)
                         ..   . +......            . .+..+++++.+||.+||+.||++||||.||++.|+++.+
T Consensus       252 ---~~---~-v~~~~~~------------~-~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~  301 (301)
T d1lufa_         252 ---IY---Y-VRDGNIL------------A-CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  301 (301)
T ss_dssp             ---HH---H-HHTTCCC------------C-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             ---HH---H-HHcCCCC------------C-CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence               11   1 1111110            0 112345679999999999999999999999999998854

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-51  Score=389.39  Aligned_cols=253  Identities=27%  Similarity=0.371  Sum_probs=195.6

Q ss_pred             ccCCceecccCceEEEEEEeCC----CCEEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEe
Q 010309          227 SEGNRLLGDSKTGGTYSGILPD----GSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE  301 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  301 (513)
                      ++..+.||+|+||.||+|++..    +..||||.++... ....+.+.+|+.+|++++||||+++++++. .+..++|||
T Consensus         9 ~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E   87 (273)
T d1mp8a_           9 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIME   87 (273)
T ss_dssp             EEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred             eEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEE
Confidence            4456788999999999998643    3469999987543 334567999999999999999999999985 567899999


Q ss_pred             eccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcc
Q 010309          302 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE  381 (513)
Q Consensus       302 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~  381 (513)
                      |+++|+|.+++..   ....+++..++.++.||+.||.|||++   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        88 ~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~  161 (273)
T d1mp8a_          88 LCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  161 (273)
T ss_dssp             CCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred             eccCCcHHhhhhc---cCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccCC
Confidence            9999999998764   235699999999999999999999999   9999999999999999999999999999876543


Q ss_pred             ccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccccc
Q 010309          382 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP  460 (513)
Q Consensus       382 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  460 (513)
                      ..... ....||+.|+|||++.+..++.++|||||||++|||+| |.+||...+...   +....    .....      
T Consensus       162 ~~~~~-~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~---~~~~i----~~~~~------  227 (273)
T d1mp8a_         162 TYYKA-SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRI----ENGER------  227 (273)
T ss_dssp             ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHH----HTTCC------
T ss_pred             cceec-cceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH---HHHHH----HcCCC------
Confidence            32222 22348999999999999999999999999999999998 899998765432   11111    11100      


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCc
Q 010309          461 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  507 (513)
Q Consensus       461 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  507 (513)
                             ...+..+++++.+||.+||+.||++|||++||++.|+++.
T Consensus       228 -------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~  267 (273)
T d1mp8a_         228 -------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  267 (273)
T ss_dssp             -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence                   0112235567999999999999999999999999998764

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-50  Score=394.54  Aligned_cols=244  Identities=23%  Similarity=0.265  Sum_probs=203.2

Q ss_pred             cCCceecccCceEEEEEEe-CCCCEEEEEEecccc---hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeec
Q 010309          228 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV  303 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  303 (513)
                      +..++||+|+||.||+|+. .+|+.||||++++..   ....+.+.+|+.+|++++||||+++++++.+.+..|+||||+
T Consensus         8 ~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~   87 (337)
T d1o6la_           8 DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYA   87 (337)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             EEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceecc
Confidence            3346789999999999997 469999999997642   234577899999999999999999999999999999999999


Q ss_pred             cCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccc
Q 010309          304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM  383 (513)
Q Consensus       304 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~  383 (513)
                      ++|+|.+++..    ...+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+.......
T Consensus        88 ~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~  160 (337)
T d1o6la_          88 NGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             TTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred             CCCchhhhhhc----ccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence            99999999865    35689999999999999999999999   999999999999999999999999999987644322


Q ss_pred             ccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccccccccccc
Q 010309          384 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS  463 (513)
Q Consensus       384 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  463 (513)
                      .  ....+||+.|+|||++.+..++.++|||||||++|||++|++||.+.+...   +...    .....          
T Consensus       161 ~--~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~---~~~~----i~~~~----------  221 (337)
T d1o6la_         161 T--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---LFEL----ILMEE----------  221 (337)
T ss_dssp             C--BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH----HHHCC----------
T ss_pred             c--cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH---HHHH----HhcCC----------
Confidence            2  222349999999999999999999999999999999999999998765421   1111    11110          


Q ss_pred             CCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 010309          464 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPR-----MSHVVH  501 (513)
Q Consensus       464 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  501 (513)
                          ...+..+++++.+||.+||+.||++||+     ++|+++
T Consensus       222 ----~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         222 ----IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ----CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence                0112235667999999999999999995     788875

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-51  Score=388.22  Aligned_cols=246  Identities=28%  Similarity=0.440  Sum_probs=195.4

Q ss_pred             CceecccCceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEee-CCceEEEEeeccCCCH
Q 010309          230 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD-HGDRYIVYEFVVNGPL  308 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~lv~e~~~~gsL  308 (513)
                      .+.||+|+||.||+|.+ .|++||||+++..  ...+.+.+|++++++++||||++++|++.+ .+..++||||+++|+|
T Consensus        12 ~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L   88 (262)
T d1byga_          12 LQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL   88 (262)
T ss_dssp             EEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEH
T ss_pred             eEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCH
Confidence            45689999999999998 6889999999765  345789999999999999999999999865 4668999999999999


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccccccee
Q 010309          309 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV  388 (513)
Q Consensus       309 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  388 (513)
                      .++|...  ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++......     .
T Consensus        89 ~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~-----~  158 (262)
T d1byga_          89 VDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----D  158 (262)
T ss_dssp             HHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC--------------
T ss_pred             HHHHHhc--CCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCCC-----c
Confidence            9999642  223589999999999999999999999   99999999999999999999999999998654322     1


Q ss_pred             ecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccccccccCCCC
Q 010309          389 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS  467 (513)
Q Consensus       389 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  467 (513)
                      ...+|+.|+|||++.+..++.++||||||+++|||+| |++||...+..   ++....    ....     .       .
T Consensus       159 ~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~---~~~~~i----~~~~-----~-------~  219 (262)
T d1byga_         159 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRV----EKGY-----K-------M  219 (262)
T ss_dssp             ---CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHHHH----TTTC-----C-------C
T ss_pred             cccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH---HHHHHH----HcCC-----C-------C
Confidence            2237889999999999999999999999999999998 78887765432   121111    1110     0       1


Q ss_pred             CCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcC
Q 010309          468 DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  508 (513)
Q Consensus       468 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  508 (513)
                      .. +...++++.+||.+||+.||++|||+.+|++.|+++..
T Consensus       220 ~~-~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         220 DA-PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             CC-CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CC-CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence            11 12345679999999999999999999999999998754

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-50  Score=395.52  Aligned_cols=253  Identities=22%  Similarity=0.365  Sum_probs=200.2

Q ss_pred             cCCceecccCceEEEEEEeC-CCC----EEEEEEeccc-chhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEe
Q 010309          228 EGNRLLGDSKTGGTYSGILP-DGS----RVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE  301 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  301 (513)
                      +..++||+|+||+||+|.+. +|+    +||||.++.. +....+.+.+|+.++++++|||||+++|++.++ ..++++|
T Consensus        12 ~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e   90 (317)
T d1xkka_          12 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQ   90 (317)
T ss_dssp             EEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEE
T ss_pred             EEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEEE
Confidence            33467899999999999864 344    6899998754 334567899999999999999999999999764 6778899


Q ss_pred             eccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcc
Q 010309          302 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE  381 (513)
Q Consensus       302 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~  381 (513)
                      ++.+|+|.+++..   ....+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        91 ~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~  164 (317)
T d1xkka_          91 LMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  164 (317)
T ss_dssp             CCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred             eccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence            9999999998864   246799999999999999999999999   9999999999999999999999999999987654


Q ss_pred             ccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccccc
Q 010309          382 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP  460 (513)
Q Consensus       382 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  460 (513)
                      ..........||+.|+|||++.++.++.++|||||||++|||+| |.+||...+........       ..+.       
T Consensus       165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i-------~~~~-------  230 (317)
T d1xkka_         165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-------EKGE-------  230 (317)
T ss_dssp             CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHH-------HHTC-------
T ss_pred             cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHH-------HcCC-------
Confidence            43333333448999999999999999999999999999999999 88998776543221111       1110       


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCc
Q 010309          461 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  507 (513)
Q Consensus       461 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  507 (513)
                            ....+..+++++.+|+.+||+.||++|||+.||++.|+.+.
T Consensus       231 ------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~  271 (317)
T d1xkka_         231 ------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  271 (317)
T ss_dssp             ------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ------CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence                  00111234567999999999999999999999999987654

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.2e-49  Score=388.22  Aligned_cols=240  Identities=22%  Similarity=0.294  Sum_probs=201.0

Q ss_pred             CCceecccCceEEEEEEeC-CCCEEEEEEecccc---hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeecc
Q 010309          229 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV  304 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  304 (513)
                      ..+.||+|+||+||+|+.. +|+.||||++++..   ....+.+.+|+.+|++++||||+++++++.+.+..|+||||++
T Consensus         8 i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~   87 (316)
T d1fota_           8 ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIE   87 (316)
T ss_dssp             EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             EEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecC
Confidence            3457799999999999974 69999999997542   2345788999999999999999999999999999999999999


Q ss_pred             CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccc
Q 010309          305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  384 (513)
Q Consensus       305 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  384 (513)
                      ||+|..++..    ...+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+......  
T Consensus        88 gg~l~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~--  158 (316)
T d1fota_          88 GGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT--  158 (316)
T ss_dssp             SCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB--
T ss_pred             Cccccccccc----cccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecccc--
Confidence            9999998864    45688999999999999999999999   99999999999999999999999999998765332  


Q ss_pred             cceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccC
Q 010309          385 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS  464 (513)
Q Consensus       385 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  464 (513)
                         ....||+.|+|||++.+..++.++|||||||++|||+||+.||.+.+....      ...... ..           
T Consensus       159 ---~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~------~~~i~~-~~-----------  217 (316)
T d1fota_         159 ---YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT------YEKILN-AE-----------  217 (316)
T ss_dssp             ---CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHH-CC-----------
T ss_pred             ---ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHH------HHHHHc-CC-----------
Confidence               224499999999999999999999999999999999999999987543211      111111 00           


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 010309          465 LSSDIPEAGVVQKVVDLVYACTQHVPSMRP-----RMSHVVH  501 (513)
Q Consensus       465 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  501 (513)
                         ...+...++++.+++.+||+.||.+||     |++++++
T Consensus       218 ---~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         218 ---LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             ---CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             ---CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence               011123456799999999999999996     8999975

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-49  Score=391.49  Aligned_cols=253  Identities=17%  Similarity=0.229  Sum_probs=200.2

Q ss_pred             hhCcccCCceecccCceEEEEEEe-CCCCEEEEEEecccchhcHHHHHHHHHHHhhc-CCCcEeeeeeEEee----CCce
Q 010309          223 TKNFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYD----HGDR  296 (513)
Q Consensus       223 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~----~~~~  296 (513)
                      .++|....++||+|+||.||+|.. .+++.||||+++..     ..+.+|+.++.++ +|||||++++++.+    ....
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            456666667789999999999997 46999999999643     4577899987665 89999999999876    4568


Q ss_pred             EEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecC---CCCeEEeccc
Q 010309          297 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE---EFGAHLMGVG  373 (513)
Q Consensus       297 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~---~~~~kl~Dfg  373 (513)
                      |+|||||+||+|.++|..  .....+++.+++.++.||+.||+|||+.   +|+||||||+|||++.   ++.+||+|||
T Consensus        85 ~ivmEy~~gg~L~~~i~~--~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG  159 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG  159 (335)
T ss_dssp             EEEEECCCSEEHHHHHHS--CSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             EEEEECCCCCcHHHHHHh--cCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccc
Confidence            999999999999999975  3345799999999999999999999999   9999999999999985   4569999999


Q ss_pred             ccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccc
Q 010309          374 LSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHR  453 (513)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  453 (513)
                      +++........   ....||+.|+|||++.+..++.++|||||||++|+|+||++||.+.+.......   .   ..   
T Consensus       160 ~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~---~---~~---  227 (335)
T d2ozaa1         160 FAKETTSHNSL---TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG---M---KT---  227 (335)
T ss_dssp             TCEECCCCCCC---CCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------------
T ss_pred             eeeeccCCCcc---ccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHH---H---HH---
Confidence            99876543322   223499999999999999999999999999999999999999976543211100   0   00   


Q ss_pred             ccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          454 YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       454 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                        .+.....  ..+......+++++.+||.+||+.||++|||++|+++
T Consensus       228 --~i~~~~~--~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         228 --RIRMGQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             --CCCSCSS--SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             --HHhcCCC--CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence              0000000  0011112356788999999999999999999999987

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-49  Score=386.14  Aligned_cols=264  Identities=18%  Similarity=0.223  Sum_probs=198.1

Q ss_pred             ceecccCceEEEEEEeC-CCCEEEEEEecccchhc-----HHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeecc
Q 010309          231 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQR-----KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV  304 (513)
Q Consensus       231 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  304 (513)
                      ++||+|+||+||+|+.. +|+.||||+++......     .+.+.+|+.+|++++|||||++++++.+++..||||||+.
T Consensus         4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~   83 (299)
T d1ua2a_           4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME   83 (299)
T ss_dssp             EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred             eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence            47899999999999974 59999999997543221     2468899999999999999999999999999999999998


Q ss_pred             CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccc
Q 010309          305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  384 (513)
Q Consensus       305 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  384 (513)
                      ++++..++.    ....+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++........
T Consensus        84 ~~~~~~~~~----~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~  156 (299)
T d1ua2a_          84 TDLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA  156 (299)
T ss_dssp             EEHHHHHTT----CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred             chHHhhhhh----cccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCccc
Confidence            887776653    346689999999999999999999999   9999999999999999999999999999876544322


Q ss_pred             cceeecCcccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhh---cccccccc--
Q 010309          385 ERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQ---SHRYLELL--  458 (513)
Q Consensus       385 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~--  458 (513)
                      .  ....||+.|+|||++... .++.++|||||||++|||+||.+||.+.+..+....   ......   ........  
T Consensus       157 ~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~---i~~~~~~~~~~~~~~~~~~  231 (299)
T d1ua2a_         157 Y--THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTR---IFETLGTPTEEQWPDMCSL  231 (299)
T ss_dssp             C--CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HHHHHCCCCTTTSSSTTSS
T ss_pred             c--cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHH---HHHhcCCCChhhccchhcc
Confidence            2  123489999999998754 579999999999999999999999987654321111   111100   00000000  


Q ss_pred             -cccccCCCCCCCc----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcC
Q 010309          459 -DPLISSLSSDIPE----AGVVQKVVDLVYACTQHVPSMRPRMSHVVH--QLQQL  506 (513)
Q Consensus       459 -~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~  506 (513)
                       ...........+.    ...++++.+||.+||+.||++|||++|+++  .|++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~  286 (299)
T d1ua2a_         232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR  286 (299)
T ss_dssp             TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred             chhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence             0000000011111    123567999999999999999999999997  46554

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-50  Score=390.05  Aligned_cols=260  Identities=26%  Similarity=0.340  Sum_probs=195.4

Q ss_pred             ccCCceecccCceEEEEEEeC------CCCEEEEEEecccc-hhcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeC-CceE
Q 010309          227 SEGNRLLGDSKTGGTYSGILP------DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDH-GDRY  297 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~-~~~~  297 (513)
                      ++..+.||+|+||.||+|...      +++.||||+++... ....+.+.+|..++.++ +|+||+.+++++.+. +..+
T Consensus        15 y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~   94 (299)
T d1ywna1          15 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM   94 (299)
T ss_dssp             EEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCE
T ss_pred             EEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEE
Confidence            445567899999999999853      24689999997643 33456788888888887 789999999998765 4689


Q ss_pred             EEEeeccCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCC
Q 010309          298 IVYEFVVNGPLDRWLHHIPR------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF  365 (513)
Q Consensus       298 lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~  365 (513)
                      +||||+++|+|.+++.....            ....+++..++.++.||+.||+|||++   +|+||||||+||||+.++
T Consensus        95 iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~~~~  171 (299)
T d1ywna1          95 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKN  171 (299)
T ss_dssp             EEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGG
T ss_pred             EEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeECCCC
Confidence            99999999999999965321            124589999999999999999999999   999999999999999999


Q ss_pred             CeEEecccccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcC-CCCCCCCCccccchhHHh
Q 010309          366 GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSG-RRPAQAVDSVCWQSIFEW  444 (513)
Q Consensus       366 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg-~~p~~~~~~~~~~~~~~~  444 (513)
                      .+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||+|| .+||.......  .+.  
T Consensus       172 ~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~--~~~--  247 (299)
T d1ywna1         172 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFC--  247 (299)
T ss_dssp             CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH--HHH--
T ss_pred             cEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH--HHH--
Confidence            9999999999876544333333334599999999999999999999999999999999996 55776544321  111  


Q ss_pred             hhHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcC
Q 010309          445 ATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  508 (513)
Q Consensus       445 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  508 (513)
                        ........            . ..+...++++.+||.+||+.||++|||++||++.|+++.+
T Consensus       248 --~~~~~~~~------------~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq  296 (299)
T d1ywna1         248 --RRLKEGTR------------M-RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  296 (299)
T ss_dssp             --HHHHHTCC------------C-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --HHHhcCCC------------C-CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence              11111110            0 0112345679999999999999999999999999987643

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-50  Score=388.58  Aligned_cols=258  Identities=26%  Similarity=0.409  Sum_probs=205.0

Q ss_pred             ccCCceecccCceEEEEEEeCC--------CCEEEEEEecccch-hcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCCce
Q 010309          227 SEGNRLLGDSKTGGTYSGILPD--------GSRVAVKRLKRSSF-QRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDR  296 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~  296 (513)
                      ++..+.||+|+||.||+|+...        +..||||+++.... ....++.+|...+.++ +|||||++++++.+++..
T Consensus        15 ~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~   94 (299)
T d1fgka_          15 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPL   94 (299)
T ss_dssp             EEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             eEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeE
Confidence            4455778999999999998532        34799999976543 3457788999999888 899999999999999999


Q ss_pred             EEEEeeccCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCC
Q 010309          297 YIVYEFVVNGPLDRWLHHIPR------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE  364 (513)
Q Consensus       297 ~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~  364 (513)
                      ++||||+++|+|.++|.....            ....+++.+++.++.||+.||+|||+.   +|+||||||+|||++.+
T Consensus        95 ~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~~~  171 (299)
T d1fgka_          95 YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTED  171 (299)
T ss_dssp             EEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTT
T ss_pred             EEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeecCC
Confidence            999999999999999965321            234689999999999999999999999   99999999999999999


Q ss_pred             CCeEEecccccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHH
Q 010309          365 FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFE  443 (513)
Q Consensus       365 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~  443 (513)
                      +.+||+|||+++...............+|+.|+|||.+.++.++.++||||||+++|||++ |.+||...+..   .+..
T Consensus       172 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~---~~~~  248 (299)
T d1fgka_         172 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---ELFK  248 (299)
T ss_dssp             CCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHH
T ss_pred             CCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH---HHHH
Confidence            9999999999997765544443344458999999999999999999999999999999998 78888765432   1111


Q ss_pred             hhhHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCc
Q 010309          444 WATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  507 (513)
Q Consensus       444 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  507 (513)
                          .+.....            . ..+..+++++.+||.+||+.||++|||+.||++.|+++.
T Consensus       249 ----~i~~~~~------------~-~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~  295 (299)
T d1fgka_         249 ----LLKEGHR------------M-DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  295 (299)
T ss_dssp             ----HHHTTCC------------C-CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----HHHcCCC------------C-CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence                1111110            0 111234567999999999999999999999999998874

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=2.6e-49  Score=379.95  Aligned_cols=257  Identities=23%  Similarity=0.304  Sum_probs=200.4

Q ss_pred             ccCCceecccCceEEEEEEe-CCCCEEEEEEecccch---hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCc----eEE
Q 010309          227 SEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD----RYI  298 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~----~~l  298 (513)
                      ++..+.||+|+||.||+|.. .+|+.||||+++....   ...+.+.+|+.+|+.++||||+++++++...+.    .||
T Consensus         9 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~l   88 (277)
T d1o6ya_           9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI   88 (277)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             eEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEE
Confidence            34566889999999999996 4699999999976533   234578999999999999999999999987654    789


Q ss_pred             EEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccC
Q 010309          299 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV  378 (513)
Q Consensus       299 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~  378 (513)
                      ||||+++++|.+++..    ...+++.+++.++.||+.||+|||++   +|+||||||+|||++.++..+|+|||.+...
T Consensus        89 vmE~~~g~~L~~~~~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~  161 (277)
T d1o6ya_          89 VMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAI  161 (277)
T ss_dssp             EEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred             EEECCCCCEehhhhcc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhhh
Confidence            9999999999998864    35699999999999999999999999   9999999999999999999999999998765


Q ss_pred             Ccccc-ccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccccc
Q 010309          379 PWEVM-QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLEL  457 (513)
Q Consensus       379 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  457 (513)
                      ..... ........||+.|+|||++.+..++.++|||||||++|||+||++||...+...      ...........   
T Consensus       162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~~~~~~~~~---  232 (277)
T d1o6ya_         162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS------VAYQHVREDPI---  232 (277)
T ss_dssp             C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHCCCC---
T ss_pred             ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH------HHHHHHhcCCC---
Confidence            43322 122223349999999999999999999999999999999999999998654321      11111111100   


Q ss_pred             ccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHhcCc
Q 010309          458 LDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP-RMSHVVHQLQQLA  507 (513)
Q Consensus       458 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~  507 (513)
                       .+       .......++++.+||.+||+.||++|| |++++++.|.++.
T Consensus       233 -~~-------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         233 -PP-------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             -CG-------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             -CC-------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence             00       011123456799999999999999999 8999999998764

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-50  Score=392.01  Aligned_cols=259  Identities=24%  Similarity=0.368  Sum_probs=207.8

Q ss_pred             ccCCceecccCceEEEEEEe------CCCCEEEEEEecccc-hhcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCCceEE
Q 010309          227 SEGNRLLGDSKTGGTYSGIL------PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYI  298 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~l  298 (513)
                      .+..+.||+|+||.||+|++      .+++.||||+++... ......+.+|+.+++++ +|||||++++++.+.+..++
T Consensus        25 ~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~l  104 (311)
T d1t46a_          25 LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLV  104 (311)
T ss_dssp             EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             eEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEE
Confidence            34466889999999999985      246789999997653 33456789999999999 79999999999999999999


Q ss_pred             EEeeccCCCHHHHhccCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCC
Q 010309          299 VYEFVVNGPLDRWLHHIPR--------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE  364 (513)
Q Consensus       299 v~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~  364 (513)
                      ||||+++|+|.+++.....              ....+++..++.++.||+.||+|||++   +++||||||+|||++.+
T Consensus       105 vmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~~~~  181 (311)
T d1t46a_         105 ITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHG  181 (311)
T ss_dssp             EEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEETT
T ss_pred             EEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccccccccc
Confidence            9999999999999975321              234689999999999999999999999   99999999999999999


Q ss_pred             CCeEEecccccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHH
Q 010309          365 FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFE  443 (513)
Q Consensus       365 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~  443 (513)
                      +.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+| |.+||.......  .+. 
T Consensus       182 ~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~--~~~-  258 (311)
T d1t46a_         182 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS--KFY-  258 (311)
T ss_dssp             TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH--HHH-
T ss_pred             CcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH--HHH-
Confidence            9999999999998765443333333458999999999999999999999999999999999 555565543321  111 


Q ss_pred             hhhHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCc
Q 010309          444 WATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA  507 (513)
Q Consensus       444 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  507 (513)
                         .......             ....+...++++.+||.+||+.||++|||+++|++.|+++.
T Consensus       259 ---~~i~~~~-------------~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i  306 (311)
T d1t46a_         259 ---KMIKEGF-------------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI  306 (311)
T ss_dssp             ---HHHHHTC-------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---HHHhcCC-------------CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence               1111110             00111234567999999999999999999999999998754

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-50  Score=384.47  Aligned_cols=251  Identities=24%  Similarity=0.315  Sum_probs=192.7

Q ss_pred             CceecccCceEEEEEEeCC--C--CEEEEEEecccc---hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEee
Q 010309          230 NRLLGDSKTGGTYSGILPD--G--SRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF  302 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  302 (513)
                      .+.||+|+||.||+|+...  +  ..||||++++..   ....++|.+|+.+|++++||||++++|++.+ +..++||||
T Consensus        13 ~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e~   91 (273)
T d1u46a_          13 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTEL   91 (273)
T ss_dssp             EEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             EEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheeeee
Confidence            3467999999999998632  3  379999997642   2334689999999999999999999999976 467899999


Q ss_pred             ccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccc
Q 010309          303 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV  382 (513)
Q Consensus       303 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~  382 (513)
                      +++|+|.+++...   ...+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++......
T Consensus        92 ~~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~  165 (273)
T d1u46a_          92 APLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND  165 (273)
T ss_dssp             CTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred             ecCcchhhhhhcc---cCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhcccCC
Confidence            9999999887642   35699999999999999999999999   99999999999999999999999999999875443


Q ss_pred             ccc-ceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCccccchhHHhhhHHhhcccccccccc
Q 010309          383 MQE-RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP  460 (513)
Q Consensus       383 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  460 (513)
                      ... ......++..|+|||++.+..++.++|||||||++|||+| |+.||.+.+...   ..   ........       
T Consensus       166 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~---~~---~~i~~~~~-------  232 (273)
T d1u46a_         166 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---IL---HKIDKEGE-------  232 (273)
T ss_dssp             CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HH---HHHHTSCC-------
T ss_pred             CcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH---HH---HHHHhCCC-------
Confidence            222 2223347889999999999999999999999999999998 899998655421   11   11111110       


Q ss_pred             cccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q 010309          461 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  506 (513)
Q Consensus       461 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  506 (513)
                            ....+..++.++.+||.+||+.||++|||+++|++.|++.
T Consensus       233 ------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         233 ------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                  0011123456799999999999999999999999999764

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-49  Score=384.30  Aligned_cols=255  Identities=26%  Similarity=0.413  Sum_probs=202.0

Q ss_pred             CceecccCceEEEEEEeCCC----CEEEEEEeccc-chhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeC-CceEEEEeec
Q 010309          230 NRLLGDSKTGGTYSGILPDG----SRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH-GDRYIVYEFV  303 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-~~~~lv~e~~  303 (513)
                      +++||+|+||+||+|.+.++    ..||||+++.. .....++|.+|+++|++++||||++++|++.+. +..++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            35789999999999997542    26999999754 444557899999999999999999999998764 5789999999


Q ss_pred             cCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccc
Q 010309          304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM  383 (513)
Q Consensus       304 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~  383 (513)
                      ++|+|.+++..   ....+++..++.++.|++.||.|||+.   +|+||||||+|||+++++.+||+|||+++.......
T Consensus       112 ~~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~  185 (311)
T d1r0pa_         112 KHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF  185 (311)
T ss_dssp             TTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred             ecCchhhhhcc---ccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence            99999999874   345688899999999999999999999   999999999999999999999999999987654322


Q ss_pred             cc--ceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccccccccc
Q 010309          384 QE--RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL  461 (513)
Q Consensus       384 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  461 (513)
                      ..  ......||+.|+|||.+.++.++.++||||||+++|||+||..||......  ..+   ........+        
T Consensus       186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~--~~~---~~~i~~g~~--------  252 (311)
T d1r0pa_         186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDI---TVYLLQGRR--------  252 (311)
T ss_dssp             CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------C---HHHHHTTCC--------
T ss_pred             ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH--HHH---HHHHHcCCC--------
Confidence            21  111234899999999999999999999999999999999988877643221  111   111111110        


Q ss_pred             ccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcCC
Q 010309          462 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP  509 (513)
Q Consensus       462 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  509 (513)
                           .. .+..+++++.+||.+||+.||++|||+.||++.|+++...
T Consensus       253 -----~~-~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         253 -----LL-QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  294 (311)
T ss_dssp             -----CC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             -----CC-CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence                 01 1122456799999999999999999999999999877543

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.5e-49  Score=378.61  Aligned_cols=247  Identities=22%  Similarity=0.306  Sum_probs=201.3

Q ss_pred             cCCceecccCceEEEEEEe-CCCCEEEEEEecccchh---------cHHHHHHHHHHHhhcC-CCcEeeeeeEEeeCCce
Q 010309          228 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQ---------RKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDR  296 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~  296 (513)
                      +..+.||+|+||+||+|+. .+|+.||||++++....         ..+.+.+|+.++++++ ||||+++++++.+++..
T Consensus         6 ~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~   85 (277)
T d1phka_           6 EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFF   85 (277)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             EEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcce
Confidence            4466789999999999997 46899999999764321         1346889999999996 99999999999999999


Q ss_pred             EEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccc
Q 010309          297 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK  376 (513)
Q Consensus       297 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~  376 (513)
                      ||||||+++|+|.++|..    ...+++.+++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++
T Consensus        86 ~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~  158 (277)
T d1phka_          86 FLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSC  158 (277)
T ss_dssp             EEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchhee
Confidence            999999999999999964    35699999999999999999999999   99999999999999999999999999998


Q ss_pred             cCCccccccceeecCccccccccccccc------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhh
Q 010309          377 FVPWEVMQERTVMAGGTYGYLAPEFVYR------NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQ  450 (513)
Q Consensus       377 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  450 (513)
                      .........   ...||+.|+|||++.+      ..++.++||||+||++|||+||+.||.+.+.....      .... 
T Consensus       159 ~~~~~~~~~---~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~------~~i~-  228 (277)
T d1phka_         159 QLDPGEKLR---EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML------RMIM-  228 (277)
T ss_dssp             ECCTTCCBC---CCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHH-
T ss_pred             EccCCCcee---eeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHH------HHHH-
Confidence            775433222   2349999999999863      35688999999999999999999999876532111      1111 


Q ss_pred             cccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          451 SHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       451 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      ..... .         ........++++.+|+.+||+.||++|||++||++
T Consensus       229 ~~~~~-~---------~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         229 SGNYQ-F---------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             HTCCC-C---------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             hCCCC-C---------CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            11100 0         11122346678999999999999999999999975

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-49  Score=385.90  Aligned_cols=260  Identities=22%  Similarity=0.375  Sum_probs=210.0

Q ss_pred             cCCceecccCceEEEEEEeC------CCCEEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEE
Q 010309          228 EGNRLLGDSKTGGTYSGILP------DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY  300 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  300 (513)
                      ...+.||+|+||+||+|.+.      +++.||||+++... ......+.+|+.++++++||||+++++++...+..++||
T Consensus        23 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~  102 (308)
T d1p4oa_          23 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIM  102 (308)
T ss_dssp             EEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             EEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEE
Confidence            44567899999999999863      35789999997643 334467899999999999999999999999999999999


Q ss_pred             eeccCCCHHHHhccCC------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccc
Q 010309          301 EFVVNGPLDRWLHHIP------RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGL  374 (513)
Q Consensus       301 e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~  374 (513)
                      ||+++|+|.+++....      .....+++..+..++.|++.||.|||++   +|+||||||+|||++.++++||+|||+
T Consensus       103 e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~DFGl  179 (308)
T d1p4oa_         103 ELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGM  179 (308)
T ss_dssp             ECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCTTC
T ss_pred             eecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEeeccc
Confidence            9999999999885321      2224578999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCC-CCCCCCCccccchhHHhhhHHhhccc
Q 010309          375 SKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGR-RPAQAVDSVCWQSIFEWATPLVQSHR  453 (513)
Q Consensus       375 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~  453 (513)
                      ++...............+|+.|+|||.+.+..++.++||||||+++|||+||. +||...+...   ...   ... ...
T Consensus       180 a~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~---~~~---~i~-~~~  252 (308)
T d1p4oa_         180 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ---VLR---FVM-EGG  252 (308)
T ss_dssp             CCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH---HHH---HHH-TTC
T ss_pred             ceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH---HHH---HHH-hCC
Confidence            98765543333333334899999999999999999999999999999999984 6776544321   111   111 111


Q ss_pred             ccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcCCC
Q 010309          454 YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP  510 (513)
Q Consensus       454 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  510 (513)
                      .            .. .+..+++.+.+||.+||+.||++|||+++|++.|++..+|.
T Consensus       253 ~------------~~-~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~  296 (308)
T d1p4oa_         253 L------------LD-KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG  296 (308)
T ss_dssp             C------------CC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred             C------------CC-CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence            0            01 11234567999999999999999999999999999887764

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-49  Score=385.11  Aligned_cols=247  Identities=17%  Similarity=0.207  Sum_probs=201.2

Q ss_pred             cCCceecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          228 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      +..+.||+|+||+||+|... +|+.||||+++... .....+.+|+++|++++||||+++++++.+++..||||||+++|
T Consensus         8 ~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg   86 (321)
T d1tkia_           8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGL   86 (321)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCC
T ss_pred             EEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCC
Confidence            34457899999999999975 58899999998764 34566889999999999999999999999999999999999999


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCC--CCeEEecccccccCCccccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE--FGAHLMGVGLSKFVPWEVMQ  384 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~--~~~kl~Dfg~~~~~~~~~~~  384 (513)
                      +|.+++..   ....+++.++..++.||+.||+|||++   +|+||||||+|||++.+  ..+||+|||++.........
T Consensus        87 ~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~  160 (321)
T d1tkia_          87 DIFERINT---SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF  160 (321)
T ss_dssp             BHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE
T ss_pred             cHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccCCcc
Confidence            99999964   234699999999999999999999999   99999999999999854  47999999999876543322


Q ss_pred             cceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccC
Q 010309          385 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS  464 (513)
Q Consensus       385 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  464 (513)
                      .   ...+|+.|+|||.+.+..++.++|||||||++|+|++|..||...+...   ...   .... ... ..       
T Consensus       161 ~---~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~---~~~---~i~~-~~~-~~-------  222 (321)
T d1tkia_         161 R---LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ---IIE---NIMN-AEY-TF-------  222 (321)
T ss_dssp             E---EEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHH---HHHH-TCC-CC-------
T ss_pred             c---ccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH---HHH---HHHh-CCC-CC-------
Confidence            2   2338999999999999999999999999999999999999998765321   111   1110 000 00       


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          465 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       465 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                        .......+++++.+||.+||+.||++|||++|+++
T Consensus       223 --~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         223 --DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             --CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             --ChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              00001124567999999999999999999999987

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-49  Score=387.00  Aligned_cols=253  Identities=27%  Similarity=0.442  Sum_probs=201.4

Q ss_pred             CceecccCceEEEEEEeCC-CC--EEEEEEeccc-chhcHHHHHHHHHHHhhc-CCCcEeeeeeEEeeCCceEEEEeecc
Q 010309          230 NRLLGDSKTGGTYSGILPD-GS--RVAVKRLKRS-SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVV  304 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~  304 (513)
                      .+.||+|+||.||+|++.+ |.  .||||+++.. .....+.+.+|+++|+++ +|||||++++++.+.+..++||||++
T Consensus        15 ~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~   94 (309)
T d1fvra_          15 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP   94 (309)
T ss_dssp             EEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred             EEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecC
Confidence            4678999999999999754 43  5788888654 333456799999999999 79999999999999999999999999


Q ss_pred             CCCHHHHhccCC------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecc
Q 010309          305 NGPLDRWLHHIP------------RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV  372 (513)
Q Consensus       305 ~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df  372 (513)
                      +|+|.++|....            .....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus        95 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~kl~Df  171 (309)
T d1fvra_          95 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADF  171 (309)
T ss_dssp             TCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCT
T ss_pred             CCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCceEEccc
Confidence            999999996531            2346799999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCC-CCCCCCCccccchhHHhhhHHhhc
Q 010309          373 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGR-RPAQAVDSVCWQSIFEWATPLVQS  451 (513)
Q Consensus       373 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~  451 (513)
                      |+++.........   ...||..|+|||.+.+..++.++|||||||++|||++|. +||...+...   +....   .. 
T Consensus       172 G~a~~~~~~~~~~---~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~---~~~~i---~~-  241 (309)
T d1fvra_         172 GLSRGQEVYVKKT---MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYEKL---PQ-  241 (309)
T ss_dssp             TCEESSCEECCC-------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHG---GG-
T ss_pred             ccccccccccccc---ceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH---HHHHH---Hh-
Confidence            9998665433222   233899999999999999999999999999999999976 5666544321   11111   11 


Q ss_pred             ccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcC
Q 010309          452 HRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  508 (513)
Q Consensus       452 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  508 (513)
                      ..     .       . ..+..+++++.+||.+||+.||++|||++||++.|+++.+
T Consensus       242 ~~-----~-------~-~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~  285 (309)
T d1fvra_         242 GY-----R-------L-EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  285 (309)
T ss_dssp             TC-----C-------C-CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cC-----C-------C-CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            00     0       1 1122355689999999999999999999999999987653

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7.3e-49  Score=387.92  Aligned_cols=240  Identities=21%  Similarity=0.272  Sum_probs=200.7

Q ss_pred             CCceecccCceEEEEEEeC-CCCEEEEEEecccc---hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeecc
Q 010309          229 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV  304 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  304 (513)
                      ..+.||+|+||.||+|+.. +|+.||||++.+..   ....+.+.+|+.+|+.++||||+++++++.+.+..++||||+.
T Consensus        45 i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~  124 (350)
T d1rdqe_          45 RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA  124 (350)
T ss_dssp             EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             EEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccccccc
Confidence            3457899999999999974 69999999997542   2345678999999999999999999999999999999999999


Q ss_pred             CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccc
Q 010309          305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ  384 (513)
Q Consensus       305 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  384 (513)
                      +|+|..++..    ...+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++....... 
T Consensus       125 ~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~~-  196 (350)
T d1rdqe_         125 GGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW-  196 (350)
T ss_dssp             TCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCBC-
T ss_pred             ccchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecccccc-
Confidence            9999999865    24699999999999999999999999   999999999999999999999999999987653321 


Q ss_pred             cceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccccccccccC
Q 010309          385 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS  464 (513)
Q Consensus       385 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  464 (513)
                          ...||+.|+|||++.+..++.++|||||||++|||+||+.||.+.+...   +..   .... ..           
T Consensus       197 ----~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~---~i~~-~~-----------  254 (350)
T d1rdqe_         197 ----TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ---IYE---KIVS-GK-----------  254 (350)
T ss_dssp             ----CCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---HHHH-CC-----------
T ss_pred             ----cccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH---HHH---HHhc-CC-----------
Confidence                2339999999999999999999999999999999999999998654321   111   1110 00           


Q ss_pred             CCCCCCcHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 010309          465 LSSDIPEAGVVQKVVDLVYACTQHVPSMRP-----RMSHVVH  501 (513)
Q Consensus       465 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  501 (513)
                         ...+..+++++.+||.+||+.||.+|+     |+++|++
T Consensus       255 ---~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         255 ---VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             ---CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             ---CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence               011223556799999999999999994     8999985

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=7.1e-49  Score=390.09  Aligned_cols=245  Identities=20%  Similarity=0.243  Sum_probs=196.2

Q ss_pred             cCCceecccCceEEEEEEeC-CCCEEEEEEecccch---hcHHHHHH---HHHHHhhcCCCcEeeeeeEEeeCCceEEEE
Q 010309          228 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYS---EIGRFARLHHPNLVAVKGCCYDHGDRYIVY  300 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~---E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  300 (513)
                      +..++||+|+||.||+|+.. +|+.||||++.+...   .....+.+   |+.+++.++|||||++++++.+.+..|+||
T Consensus         7 ~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivm   86 (364)
T d1omwa3           7 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFIL   86 (364)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEE
Confidence            34567899999999999975 699999999965422   22233444   467777888999999999999999999999


Q ss_pred             eeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCc
Q 010309          301 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW  380 (513)
Q Consensus       301 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~  380 (513)
                      ||+++|+|.++|..    ...+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+|+....
T Consensus        87 E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~  159 (364)
T d1omwa3          87 DLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSK  159 (364)
T ss_dssp             CCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred             EecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence            99999999999965    35689999999999999999999999   999999999999999999999999999987654


Q ss_pred             cccccceeecCccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccccccc
Q 010309          381 EVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD  459 (513)
Q Consensus       381 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  459 (513)
                      ...    ....||+.|+|||++.. ..++.++|||||||+||||+||+.||..........+....            ..
T Consensus       160 ~~~----~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~------------~~  223 (364)
T d1omwa3         160 KKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT------------LT  223 (364)
T ss_dssp             SCC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHS------------SS
T ss_pred             Ccc----cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc------------cc
Confidence            322    22349999999999975 56899999999999999999999999875443211111100            00


Q ss_pred             ccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 010309          460 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPR-----MSHVVH  501 (513)
Q Consensus       460 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  501 (513)
                      .      ....+..+++++.+||.+||+.||++|||     ++|+++
T Consensus       224 ~------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         224 M------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             C------CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             C------CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence            0      01112235667999999999999999999     688874

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-49  Score=383.96  Aligned_cols=265  Identities=21%  Similarity=0.284  Sum_probs=196.7

Q ss_pred             CceecccCceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCC----ceEEEEeeccC
Q 010309          230 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG----DRYIVYEFVVN  305 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----~~~lv~e~~~~  305 (513)
                      .+.||+|+||.||+|++ +|+.||||+++.... .......|+..+.+++||||+++++++.+.+    ..++||||+++
T Consensus         8 ~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~   85 (303)
T d1vjya_           8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEH   85 (303)
T ss_dssp             EEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred             EEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccC
Confidence            45689999999999997 789999999975432 2222344556667789999999999998754    47999999999


Q ss_pred             CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCCceEcCCCCCceEecCCCCeEEecccccccCCc
Q 010309          306 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV-----KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW  380 (513)
Q Consensus       306 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-----~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~  380 (513)
                      |+|.++|+.     ..+++..++.++.|++.||+|||+..     ..+|+||||||+||||+.++.+||+|||+++....
T Consensus        86 g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~  160 (303)
T d1vjya_          86 GSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS  160 (303)
T ss_dssp             CBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred             CCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccC
Confidence            999999975     35899999999999999999999631     23999999999999999999999999999987644


Q ss_pred             ccccc--ceeecCcccccccccccccCC------CCchhhHHHHHHHHHHHHcCCCCCCCCCccccch--------hHHh
Q 010309          381 EVMQE--RTVMAGGTYGYLAPEFVYRNE------LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS--------IFEW  444 (513)
Q Consensus       381 ~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~--------~~~~  444 (513)
                      .....  ......||+.|+|||++.+..      ++.++|||||||+||||+||..|+..........        ....
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (303)
T d1vjya_         161 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE  240 (303)
T ss_dssp             TTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHH
T ss_pred             CCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHH
Confidence            32211  222344999999999987642      5678999999999999999998876533221100        0011


Q ss_pred             hhHHhhcccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCcC
Q 010309          445 ATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ  508 (513)
Q Consensus       445 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  508 (513)
                      .......    +.+++.+   ............+.+|+.+||+.||++|||+.||++.|+++.+
T Consensus       241 ~~~~~~~----~~~~p~~---~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~  297 (303)
T d1vjya_         241 MRKVVCE----QKLRPNI---PNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             HHHHHTT----SCCCCCC---CGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHhc----cccCCCC---CcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence            1111111    1111111   1111233466779999999999999999999999999987753

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-49  Score=384.70  Aligned_cols=242  Identities=22%  Similarity=0.313  Sum_probs=198.4

Q ss_pred             CCceecccCceEEEEEEeC-CCCEEEEEEecccc---hhcHHHHHHHHHHHh-hcCCCcEeeeeeEEeeCCceEEEEeec
Q 010309          229 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFA-RLHHPNLVAVKGCCYDHGDRYIVYEFV  303 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~h~nIv~l~~~~~~~~~~~lv~e~~  303 (513)
                      ..+.||+|+||+||+|+.. +|+.||||++++..   ....+.+..|..++. .++||||+++++++.+++..||||||+
T Consensus         6 i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~   85 (320)
T d1xjda_           6 LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYL   85 (320)
T ss_dssp             EEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             EeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeec
Confidence            4467899999999999975 68999999997542   233456677777665 689999999999999999999999999


Q ss_pred             cCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCcccc
Q 010309          304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM  383 (513)
Q Consensus       304 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~  383 (513)
                      ++|+|.+++..    ...+++.+++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.......
T Consensus        86 ~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~  158 (320)
T d1xjda_          86 NGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA  158 (320)
T ss_dssp             TTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred             CCCcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcccccc
Confidence            99999999965    35689999999999999999999999   999999999999999999999999999987654332


Q ss_pred             ccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccccccccccc
Q 010309          384 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS  463 (513)
Q Consensus       384 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  463 (513)
                      ..  ....||+.|+|||++.+..++.++|||||||++|||+||+.||.+.+...   +....    ....      +   
T Consensus       159 ~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~---~~~~i----~~~~------~---  220 (320)
T d1xjda_         159 KT--NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE---LFHSI----RMDN------P---  220 (320)
T ss_dssp             CB--CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH----HHCC------C---
T ss_pred             cc--cccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH---HHHHH----HcCC------C---
Confidence            22  22349999999999999999999999999999999999999998765421   11111    0000      0   


Q ss_pred             CCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHH-HHH
Q 010309          464 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMS-HVV  500 (513)
Q Consensus       464 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl  500 (513)
                           ..+..+++++.+||.+||+.||++|||+. +++
T Consensus       221 -----~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~  253 (320)
T d1xjda_         221 -----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  253 (320)
T ss_dssp             -----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             -----CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence                 11123456799999999999999999995 675

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-48  Score=373.26  Aligned_cols=270  Identities=21%  Similarity=0.302  Sum_probs=200.0

Q ss_pred             CceecccCceEEEEEEe-CCCCEEEEEEecccch--hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          230 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      .+.||+|+||+||+|+. .+|+.||||+++....  ...+.+.+|+++|++++|||||++++++.+++..|+||||+.++
T Consensus         7 ~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~~   86 (298)
T d1gz8a_           7 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD   86 (298)
T ss_dssp             EEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred             ccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCCc
Confidence            35679999999999997 4699999999975532  23578899999999999999999999999999999999999654


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  386 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  386 (513)
                       +.+++..  .....+++..+..++.||+.||+|||++   +||||||||+|||++.++.+||+|||+|+..........
T Consensus        87 -~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~  160 (298)
T d1gz8a_          87 -LKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT  160 (298)
T ss_dssp             -HHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTT
T ss_pred             -hhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCcccce
Confidence             4444433  2345699999999999999999999999   999999999999999999999999999987644322221


Q ss_pred             eeecCcccccccccccccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhh--ccccccc--c---
Q 010309          387 TVMAGGTYGYLAPEFVYRNE-LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQ--SHRYLEL--L---  458 (513)
Q Consensus       387 ~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~--~---  458 (513)
                        ...||+.|+|||++.... ++.++|||||||++|+|++|+.||.+.+....  +.........  .......  .   
T Consensus       161 --~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~~~~  236 (298)
T d1gz8a_         161 --HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ--LFRIFRTLGTPDEVVWPGVTSMPDY  236 (298)
T ss_dssp             --CCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             --eecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHH--HHHHHHhcCCCchhhcccccccccc
Confidence              223899999999887665 57899999999999999999999986543211  1110000000  0000000  0   


Q ss_pred             cccccCCCCCCC---cHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--HhcCcCC
Q 010309          459 DPLISSLSSDIP---EAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ--LQQLAQP  509 (513)
Q Consensus       459 ~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~~~  509 (513)
                      ............   ....++++.+|+.+||+.||++|||++|+++-  |+++..|
T Consensus       237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p  292 (298)
T d1gz8a_         237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP  292 (298)
T ss_dssp             CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence            000000000000   01234678999999999999999999999984  7777655

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.1e-47  Score=370.66  Aligned_cols=263  Identities=21%  Similarity=0.246  Sum_probs=197.4

Q ss_pred             CceecccCceEEEEEEeCCCCEEEEEEecccch--hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCCC
Q 010309          230 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP  307 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs  307 (513)
                      -+.||+|+||+||+|+.++|+.||||+++....  ...+.+.+|+.+|++++||||+++++++.+.+..+++||++.++.
T Consensus         7 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~   86 (286)
T d1ob3a_           7 LEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDL   86 (286)
T ss_dssp             EEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEH
T ss_pred             ccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhh
Confidence            346799999999999999999999999976532  235789999999999999999999999999999999999998877


Q ss_pred             HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccce
Q 010309          308 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT  387 (513)
Q Consensus       308 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  387 (513)
                      +..+..    ....+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||.+..........  
T Consensus        87 ~~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~--  157 (286)
T d1ob3a_          87 KKLLDV----CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY--  157 (286)
T ss_dssp             HHHHHT----STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred             HHHHHh----hcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCcccc--
Confidence            766654    246799999999999999999999999   99999999999999999999999999998765432222  


Q ss_pred             eecCcccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccc---cc--cccc
Q 010309          388 VMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL---EL--LDPL  461 (513)
Q Consensus       388 ~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~--~~~~  461 (513)
                      ....+++.|+|||.+.+. .++.++|||||||++|||++|+.||.+.+.....................   ..  ....
T Consensus       158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T d1ob3a_         158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN  237 (286)
T ss_dssp             ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred             ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccc
Confidence            222388999999998764 56899999999999999999999998755322111100000000000000   00  0000


Q ss_pred             cc---CCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          462 IS---SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       462 ~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      ..   ...........++.+.+||.+||+.||++|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00   00000111234567999999999999999999999984

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-47  Score=372.23  Aligned_cols=265  Identities=20%  Similarity=0.235  Sum_probs=193.6

Q ss_pred             cCCceecccCceEEEEEEeC-C-CCEEEEEEecccch--hcHHHHHHHHHHHhhc---CCCcEeeeeeEEee-----CCc
Q 010309          228 EGNRLLGDSKTGGTYSGILP-D-GSRVAVKRLKRSSF--QRKKEFYSEIGRFARL---HHPNLVAVKGCCYD-----HGD  295 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~-----~~~  295 (513)
                      +..+.||+|+||+||+|+.. + ++.||||+++....  .....+.+|+.+|+.|   +||||+++++++..     ...
T Consensus        10 ~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~   89 (305)
T d1blxa_          10 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETK   89 (305)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEE
T ss_pred             EEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCce
Confidence            34456799999999999973 4 56799999975422  2234566777777666   79999999999863     346


Q ss_pred             eEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEeccccc
Q 010309          296 RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLS  375 (513)
Q Consensus       296 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~  375 (513)
                      .+++|||+.++++.....   .....+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++
T Consensus        90 ~~~~~e~~~~~~~~~~~~---~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg~~  163 (305)
T d1blxa_          90 LTLVFEHVDQDLTTYLDK---VPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLA  163 (305)
T ss_dssp             EEEEEECCSCBHHHHHHH---SCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred             EEEEEEeccCCchhhhhh---ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchhhh
Confidence            799999998877655443   2346689999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccc
Q 010309          376 KFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL  455 (513)
Q Consensus       376 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  455 (513)
                      .........   ....||+.|+|||++.+.+++.++|||||||++|||+||++||.+.+.......+...........+.
T Consensus       164 ~~~~~~~~~---~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  240 (305)
T d1blxa_         164 RIYSFQMAL---TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP  240 (305)
T ss_dssp             CCCCGGGGG---CCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred             hhhcccccC---CCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccc
Confidence            876544322   23349999999999999999999999999999999999999998765432111110000000000000


Q ss_pred             c---ccccc---ccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          456 E---LLDPL---ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       456 ~---~~~~~---~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      .   .....   .............++.+.+||.+||+.||++|||++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            0   00000   0000000111234567899999999999999999999986

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-48  Score=372.54  Aligned_cols=243  Identities=20%  Similarity=0.310  Sum_probs=195.9

Q ss_pred             ccCCceecccCceEEEEEEeC-CCCEEEEEEecccchh------cHHHHHHHHHHHhhcC--CCcEeeeeeEEeeCCceE
Q 010309          227 SEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQ------RKKEFYSEIGRFARLH--HPNLVAVKGCCYDHGDRY  297 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~~~~  297 (513)
                      ++..++||+|+||.||+|+.. +|+.||||++++....      ....+.+|+.+|++++  ||||+++++++.+++..+
T Consensus         6 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~   85 (273)
T d1xwsa_           6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFV   85 (273)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEE
T ss_pred             EEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEE
Confidence            355678899999999999974 6999999999754221      1234678999999996  899999999999999999


Q ss_pred             EEEeeccC-CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCC-CCeEEeccccc
Q 010309          298 IVYEFVVN-GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE-FGAHLMGVGLS  375 (513)
Q Consensus       298 lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~-~~~kl~Dfg~~  375 (513)
                      +||||+.+ +++.+++..    ...+++..++.++.||+.||+|||++   +|+||||||+|||++.+ +.+||+|||++
T Consensus        86 lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a  158 (273)
T d1xwsa_          86 LILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSG  158 (273)
T ss_dssp             EEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             EEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccccc
Confidence            99999976 678887754    35699999999999999999999999   99999999999999854 78999999999


Q ss_pred             ccCCccccccceeecCcccccccccccccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccc
Q 010309          376 KFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRY  454 (513)
Q Consensus       376 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  454 (513)
                      ........    ....||+.|+|||++.+..+ +.++|||||||++|||+||+.||...+.            .... . 
T Consensus       159 ~~~~~~~~----~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------------i~~~-~-  220 (273)
T d1xwsa_         159 ALLKDTVY----TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRG-Q-  220 (273)
T ss_dssp             EECCSSCB----CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------------HHHC-C-
T ss_pred             eecccccc----cccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH------------Hhhc-c-
Confidence            87544322    12349999999999987765 5678999999999999999999975321            0000 0 


Q ss_pred             cccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcCc
Q 010309          455 LELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH--QLQQLA  507 (513)
Q Consensus       455 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~  507 (513)
                             .      ..+..+++++.+||.+||+.||++|||++|+++  .|+++.
T Consensus       221 -------~------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~  262 (273)
T d1xwsa_         221 -------V------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  262 (273)
T ss_dssp             -------C------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             -------c------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence                   0      011124567999999999999999999999987  355443

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-46  Score=367.13  Aligned_cols=268  Identities=20%  Similarity=0.246  Sum_probs=193.3

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeC------CceEEEEee
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH------GDRYIVYEF  302 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~~~~lv~e~  302 (513)
                      .++||+|+||+||+|+.. +|+.||||++.....    ...+|+.+|++++||||+++++++...      ...+|||||
T Consensus        25 ~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey  100 (350)
T d1q5ka_          25 TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY  100 (350)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEEC
T ss_pred             eeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEec
Confidence            467899999999999975 699999999976532    234799999999999999999998643      246899999


Q ss_pred             ccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCC-CeEEecccccccCCcc
Q 010309          303 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF-GAHLMGVGLSKFVPWE  381 (513)
Q Consensus       303 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~-~~kl~Dfg~~~~~~~~  381 (513)
                      ++++.+. .+.........+++..++.++.||+.||+|||++   +|+||||||+|||++.++ .+||+|||++......
T Consensus       101 ~~~~~~~-~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~  176 (350)
T d1q5ka_         101 VPETVYR-VARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG  176 (350)
T ss_dssp             CSEEHHH-HHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEECCTT
T ss_pred             cCCccHH-HHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhccCC
Confidence            9765443 3332223346799999999999999999999999   999999999999999775 8999999999876544


Q ss_pred             ccccceeecCccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhH-Hhh----hHHhh--ccc
Q 010309          382 VMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIF-EWA----TPLVQ--SHR  453 (513)
Q Consensus       382 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~-~~~----~~~~~--~~~  453 (513)
                      ....   ...||+.|+|||.+.+ ..++.++|||||||++|||++|++||...+.......+ ...    .....  ...
T Consensus       177 ~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~  253 (350)
T d1q5ka_         177 EPNV---SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN  253 (350)
T ss_dssp             SCCC---SCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC-
T ss_pred             cccc---cccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccc
Confidence            3222   2338999999998875 46899999999999999999999999766543211100 000    00000  000


Q ss_pred             ccccccccccC-CCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcCcC
Q 010309          454 YLELLDPLISS-LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH--QLQQLAQ  508 (513)
Q Consensus       454 ~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~~  508 (513)
                      .....-+.... ..........++++.+|+.+||+.||++|||+.|+++  .|+++..
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  311 (350)
T d1q5ka_         254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD  311 (350)
T ss_dssp             --CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred             hhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence            00000000000 0000111234567999999999999999999999996  3555443

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-45  Score=360.28  Aligned_cols=265  Identities=17%  Similarity=0.210  Sum_probs=192.2

Q ss_pred             CceecccCceEEEEEEe-CCCCEEEEEEecccc--hhcHHHHHHHHHHHhhcCCCcEeeeeeEEee--------CCceEE
Q 010309          230 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYD--------HGDRYI  298 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--------~~~~~l  298 (513)
                      .+.||+|+||+||+|+. .+|+.||||++....  .....++.+|+.+|++++||||+++++++..        .+..++
T Consensus        15 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~i   94 (318)
T d3blha1          15 LAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYL   94 (318)
T ss_dssp             EEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEE
T ss_pred             EEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEE
Confidence            44679999999999997 479999999986542  2345778999999999999999999999865        346799


Q ss_pred             EEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccC
Q 010309          299 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV  378 (513)
Q Consensus       299 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~  378 (513)
                      ||||+.++++..+..    ....+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++...
T Consensus        95 v~e~~~~~~~~~~~~----~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~  167 (318)
T d3blha1          95 VFDFCEHDLAGLLSN----VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAF  167 (318)
T ss_dssp             EEECCCEEHHHHHTC----TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEeccCCCccchhhh----cccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecceeeec
Confidence            999998776665543    345689999999999999999999999   9999999999999999999999999999866


Q ss_pred             Cccccc--cceeecCcccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhccccc
Q 010309          379 PWEVMQ--ERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL  455 (513)
Q Consensus       379 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  455 (513)
                      ......  .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+.....................
T Consensus       168 ~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  247 (318)
T d3blha1         168 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP  247 (318)
T ss_dssp             CC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred             ccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhcc
Confidence            543221  112223489999999998765 68999999999999999999999998765432222211111000000000


Q ss_pred             cccc----ccccCCCC-CCCc------HHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          456 ELLD----PLISSLSS-DIPE------AGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       456 ~~~~----~~~~~~~~-~~~~------~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      ....    ........ ....      ...++.+.+||.+||+.||++|||++|+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             TCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence            0000    00000000 0011      122456789999999999999999999986

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-45  Score=364.37  Aligned_cols=260  Identities=20%  Similarity=0.290  Sum_probs=192.6

Q ss_pred             CCceecccCceEEEEEEeC-CCCEEEEEEecccc--hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCC------ceEEE
Q 010309          229 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG------DRYIV  299 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------~~~lv  299 (513)
                      ..+.||+|+||+||+|... +|+.||||+++...  ....+.+.+|+.+|++++|||||++++++...+      ..|+|
T Consensus        22 ~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv  101 (346)
T d1cm8a_          22 DLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLV  101 (346)
T ss_dssp             EEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEE
T ss_pred             EEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEE
Confidence            3456799999999999974 69999999997642  233567899999999999999999999998654      46999


Q ss_pred             EeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCC
Q 010309          300 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP  379 (513)
Q Consensus       300 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~  379 (513)
                      |||+ +.+|..++..     ..+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus       102 ~e~~-~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~  172 (346)
T d1cm8a_         102 MPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQAD  172 (346)
T ss_dssp             EECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             Eecc-cccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccceeccC
Confidence            9999 6788887754     4699999999999999999999999   99999999999999999999999999998765


Q ss_pred             ccccccceeecCcccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhH-----Hhhc--
Q 010309          380 WEVMQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATP-----LVQS--  451 (513)
Q Consensus       380 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~-----~~~~--  451 (513)
                      ...     ....||+.|+|||++.+. .++.++||||+||++|||++|++||.+.+.............     ....  
T Consensus       173 ~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (346)
T d1cm8a_         173 SEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ  247 (346)
T ss_dssp             SSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred             Ccc-----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhc
Confidence            432     223489999999998764 568999999999999999999999987654321111100000     0000  


Q ss_pred             --------ccccccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--HhcCc
Q 010309          452 --------HRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ--LQQLA  507 (513)
Q Consensus       452 --------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~  507 (513)
                              ....+.....+..     .....++.+.+||.+||+.||++|||++|+|+-  |+.+.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~-----~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         248 SDEAKNYMKGLPELEKKDFAS-----ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             CHHHHHHHHHSCCCCCCCGGG-----TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             chhhhhhhccCCcccccchHH-----hccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence                    0000000000000     012345678999999999999999999999973  55543

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-45  Score=364.88  Aligned_cols=263  Identities=18%  Similarity=0.212  Sum_probs=192.3

Q ss_pred             CCceecccCceEEEEEEe-CCCCEEEEEEecccc-hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCC----ceEEEEee
Q 010309          229 GNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG----DRYIVYEF  302 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----~~~lv~e~  302 (513)
                      ..+.||+|+||+||+|+. .+|+.||||++++.. ....+.+.+|+.+|++++||||+++++++....    ..++++++
T Consensus        12 ~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~   91 (345)
T d1pmea_          12 NLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTH   91 (345)
T ss_dssp             EEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEE
T ss_pred             EEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEe
Confidence            346789999999999996 479999999997643 334567899999999999999999999987653    23455566


Q ss_pred             ccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccc
Q 010309          303 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV  382 (513)
Q Consensus       303 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~  382 (513)
                      +.+|+|.+++..     ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++.......
T Consensus        92 ~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~  163 (345)
T d1pmea_          92 LMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH  163 (345)
T ss_dssp             CCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred             ecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeeccCCC
Confidence            779999999964     3599999999999999999999999   99999999999999999999999999998765543


Q ss_pred             ccc-ceeecCccccccccccccc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhh-----ccc--
Q 010309          383 MQE-RTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQ-----SHR--  453 (513)
Q Consensus       383 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-----~~~--  453 (513)
                      ... ......||+.|+|||++.. ..++.++||||+||++|||++|+.||...+................     ...  
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (345)
T d1pmea_         164 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL  243 (345)
T ss_dssp             CBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred             ccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhh
Confidence            221 1223448999999999854 5678999999999999999999999977553211111100000000     000  


Q ss_pred             -ccccccccccCCCCCCC----cHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          454 -YLELLDPLISSLSSDIP----EAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       454 -~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                       ....... .... ...+    ....+.++.+|+.+||+.||++|||++|+++
T Consensus       244 ~~~~~~~~-~~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~  294 (345)
T d1pmea_         244 KARNYLLS-LPHK-NKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  294 (345)
T ss_dssp             HHHHHHHT-SCCC-CCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhhccccc-CCcc-CCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             0000000 0000 0000    0123457899999999999999999999997

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=4.9e-45  Score=358.94  Aligned_cols=258  Identities=19%  Similarity=0.238  Sum_probs=195.3

Q ss_pred             cCCceecccCceEEEEEEe-CCCCEEEEEEecccchhcHHHHHHHHHHHhhcC-CCcEeeeeeEEeeC--CceEEEEeec
Q 010309          228 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDH--GDRYIVYEFV  303 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~--~~~~lv~e~~  303 (513)
                      +..+.||+|+||+||+|+. .+|+.||||+++..   ..+.+.+|+.+|++++ ||||+++++++...  ...++||||+
T Consensus        38 ~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~  114 (328)
T d3bqca1          38 QLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV  114 (328)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECC
T ss_pred             EEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeec
Confidence            3346789999999999997 46899999999754   3567889999999995 99999999998754  5689999999


Q ss_pred             cCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCC-CeEEecccccccCCccc
Q 010309          304 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF-GAHLMGVGLSKFVPWEV  382 (513)
Q Consensus       304 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~-~~kl~Dfg~~~~~~~~~  382 (513)
                      .+++|..+.       +.+++..++.++.||+.||+|||++   +|+||||||+|||++.++ .+||+|||+|.......
T Consensus       115 ~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~  184 (328)
T d3bqca1         115 NNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ  184 (328)
T ss_dssp             CSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred             CCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence            999997654       3599999999999999999999999   999999999999998765 58999999998765443


Q ss_pred             cccceeecCcccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCccccc--hhHHhh-----hHHhhcc--
Q 010309          383 MQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ--SIFEWA-----TPLVQSH--  452 (513)
Q Consensus       383 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~--~~~~~~-----~~~~~~~--  452 (513)
                      ..   ....+|+.|+|||.+.+. .++.++||||+||++|||++|+.||.........  .+....     .......  
T Consensus       185 ~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~  261 (328)
T d3bqca1         185 EY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI  261 (328)
T ss_dssp             CC---CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred             cc---cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence            22   223489999999998765 4799999999999999999999999765442111  000000     0000000  


Q ss_pred             ----ccccccc----ccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          453 ----RYLELLD----PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       453 ----~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                          .......    ...............++++.+||.+||+.||++|||++|+|+
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                0000000    001111122223345678999999999999999999999986

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-45  Score=351.72  Aligned_cols=268  Identities=19%  Similarity=0.235  Sum_probs=202.9

Q ss_pred             CceecccCceEEEEEEeC-CCCEEEEEEecccch--hcHHHHHHHHHHHhhcCCCcEeeeeeEEeeCCceEEEEeeccCC
Q 010309          230 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG  306 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  306 (513)
                      .+.||+|+||+||+|++. +|+.||||+++....  .....+.+|+.+|+.++||||+++++++.+.+..++|+|++.++
T Consensus         7 i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~   86 (292)
T d1unla_           7 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQD   86 (292)
T ss_dssp             EEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEE
T ss_pred             eeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeecccc
Confidence            356799999999999974 689999999975432  33578899999999999999999999999999999999999999


Q ss_pred             CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCCccccccc
Q 010309          307 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER  386 (513)
Q Consensus       307 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  386 (513)
                      +|..++..    ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||.+...........
T Consensus        87 ~l~~~~~~----~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~  159 (292)
T d1unla_          87 LKKYFDSC----NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS  159 (292)
T ss_dssp             HHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCC
T ss_pred             cccccccc----ccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCCccce
Confidence            98887753    45789999999999999999999999   999999999999999999999999999987654332221


Q ss_pred             eeecCcccccccccccccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhc---ccc---ccccc
Q 010309          387 TVMAGGTYGYLAPEFVYRNE-LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQS---HRY---LELLD  459 (513)
Q Consensus       387 ~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~---~~~~~  459 (513)
                        ...+++.|+|||++.... ++.++|||||||++|||++|+.||.......  ............   ...   ....+
T Consensus       160 --~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (292)
T d1unla_         160 --AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEEQWPSMTKLPD  235 (292)
T ss_dssp             --SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred             --eeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHH--HHHHHHHhhcCCCChhhhhhhhhccc
Confidence              223788999999987665 6899999999999999999999975443321  111111111000   000   00000


Q ss_pred             -----ccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcCcC
Q 010309          460 -----PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH--QLQQLAQ  508 (513)
Q Consensus       460 -----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~~  508 (513)
                           ...............++.+.+|+.+||+.||.+|||++||++  .|+++..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~~  291 (292)
T d1unla_         236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP  291 (292)
T ss_dssp             CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCSC
T ss_pred             ccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCCC
Confidence                 000000111112334567999999999999999999999987  4555443

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.7e-44  Score=350.30  Aligned_cols=258  Identities=17%  Similarity=0.238  Sum_probs=193.6

Q ss_pred             ccCCceecccCceEEEEEEe-CCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCc-EeeeeeEEeeCCceEEEEeecc
Q 010309          227 SEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPN-LVAVKGCCYDHGDRYIVYEFVV  304 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~~~~lv~e~~~  304 (513)
                      ++..+.||+|+||.||+|++ .+|+.||||++....  ...++..|+++++.++|+| |+.+.++..+.+..++||||+ 
T Consensus         9 Y~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-   85 (299)
T d1ckia_           9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-   85 (299)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             EEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-
Confidence            34456789999999999997 468999999987653  2345788999999997666 555566667778889999999 


Q ss_pred             CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEec---CCCCeEEecccccccCCcc
Q 010309          305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD---EEFGAHLMGVGLSKFVPWE  381 (513)
Q Consensus       305 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~---~~~~~kl~Dfg~~~~~~~~  381 (513)
                      +++|...+..   ....+++..+..++.|++.||+|||++   +|+||||||+|||++   .+..+||+|||+|+.....
T Consensus        86 ~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~  159 (299)
T d1ckia_          86 GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  159 (299)
T ss_dssp             CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred             CCchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence            5677666653   235699999999999999999999999   999999999999985   3557999999999876543


Q ss_pred             ccc-----cceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccc
Q 010309          382 VMQ-----ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLE  456 (513)
Q Consensus       382 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  456 (513)
                      ...     .......||+.|+|||++.+..++.++|||||||++|||+||+.||.......................   
T Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~---  236 (299)
T d1ckia_         160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP---  236 (299)
T ss_dssp             TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC---
T ss_pred             ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC---
Confidence            221     112233499999999999999999999999999999999999999987554322211111110000000   


Q ss_pred             cccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q 010309          457 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  506 (513)
Q Consensus       457 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  506 (513)
                        .+.+        ...+++++.+|+.+||+.||++||+++++.+.|+.+
T Consensus       237 --~~~~--------~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~  276 (299)
T d1ckia_         237 --IEVL--------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  276 (299)
T ss_dssp             --HHHH--------TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred             --hhHh--------ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence              0000        112446799999999999999999999998888754

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.7e-44  Score=348.71  Aligned_cols=258  Identities=17%  Similarity=0.227  Sum_probs=202.0

Q ss_pred             ccCCceecccCceEEEEEEeC-CCCEEEEEEecccchhcHHHHHHHHHHHhhcCC-CcEeeeeeEEeeCCceEEEEeecc
Q 010309          227 SEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHH-PNLVAVKGCCYDHGDRYIVYEFVV  304 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~lv~e~~~  304 (513)
                      ++..+.||+|+||.||+|+.. +|+.||||++....  ....+.+|+++++.|+| +||+.+++++.+....++||||+ 
T Consensus         7 Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-   83 (293)
T d1csna_           7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-   83 (293)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             eEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-
Confidence            345567899999999999965 68899999986543  23457789999999965 89999999999999999999999 


Q ss_pred             CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecC-----CCCeEEecccccccCC
Q 010309          305 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE-----EFGAHLMGVGLSKFVP  379 (513)
Q Consensus       305 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~-----~~~~kl~Dfg~~~~~~  379 (513)
                      +++|.+++...   ...++...+..++.|++.||+|||++   +|+||||||+|||++.     ++.+||+|||+|+...
T Consensus        84 ~~~l~~~~~~~---~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~  157 (293)
T d1csna_          84 GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  157 (293)
T ss_dssp             CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             CCCHHHHHHhh---ccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence            78999988642   35699999999999999999999999   9999999999999974     5679999999998764


Q ss_pred             ccccc-----cceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccc
Q 010309          380 WEVMQ-----ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRY  454 (513)
Q Consensus       380 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  454 (513)
                      .....     .......||+.|+|||++.+..++.++||||||+++|||+||+.||.+......................
T Consensus       158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (293)
T d1csna_         158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL  237 (293)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred             cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCCh
Confidence            33211     1122334999999999999999999999999999999999999999876543222222111111110000


Q ss_pred             cccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q 010309          455 LELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL  506 (513)
Q Consensus       455 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  506 (513)
                      .+     +   ..     .+++++.+++..|++.+|++||+++.+.+.|+++
T Consensus       238 ~~-----l---~~-----~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~  276 (293)
T d1csna_         238 RE-----L---CA-----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV  276 (293)
T ss_dssp             HH-----H---TT-----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             HH-----h---cC-----CCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence            00     0   01     2345799999999999999999999998887765

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-45  Score=356.17  Aligned_cols=249  Identities=20%  Similarity=0.234  Sum_probs=198.0

Q ss_pred             cCCceecccCceEEEEEEeC----CCCEEEEEEecccc----hhcHHHHHHHHHHHhhcCC-CcEeeeeeEEeeCCceEE
Q 010309          228 EGNRLLGDSKTGGTYSGILP----DGSRVAVKRLKRSS----FQRKKEFYSEIGRFARLHH-PNLVAVKGCCYDHGDRYI  298 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~l  298 (513)
                      +..+.||+|+||+||+|...    +|+.||||++++..    ....+.+.+|+++|++++| |||+++++++.+....++
T Consensus        27 ~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~  106 (322)
T d1vzoa_          27 ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHL  106 (322)
T ss_dssp             EEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEE
T ss_pred             EEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceee
Confidence            33457799999999999852    48899999997542    2234678899999999966 899999999999999999


Q ss_pred             EEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccC
Q 010309          299 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV  378 (513)
Q Consensus       299 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~  378 (513)
                      ||||+.+|+|.+++..    ...+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus       107 v~e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~  179 (322)
T d1vzoa_         107 ILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF  179 (322)
T ss_dssp             EECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred             eeecccccHHHHHHHh----cccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhhh
Confidence            9999999999999865    34578899999999999999999999   9999999999999999999999999999877


Q ss_pred             CccccccceeecCcccccccccccccC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHHhhcccccc
Q 010309          379 PWEVMQERTVMAGGTYGYLAPEFVYRN--ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLE  456 (513)
Q Consensus       379 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  456 (513)
                      ......... ...|++.|+|||.+.+.  .++.++|||||||+||||+||+.||.............  ......     
T Consensus       180 ~~~~~~~~~-~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~--~~~~~~-----  251 (322)
T d1vzoa_         180 VADETERAY-DFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS--RRILKS-----  251 (322)
T ss_dssp             CGGGGGGGC-GGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH--HHHHHC-----
T ss_pred             ccccccccc-ccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--HhcccC-----
Confidence            544333222 23489999999999764  46889999999999999999999998765432211111  100000     


Q ss_pred             cccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 010309          457 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP-----RMSHVVH  501 (513)
Q Consensus       457 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  501 (513)
                                ....+...++++.+|+.+||+.||++||     |++|+++
T Consensus       252 ----------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         252 ----------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             ----------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             ----------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence                      0011123567899999999999999999     4788886

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-44  Score=356.20  Aligned_cols=259  Identities=19%  Similarity=0.240  Sum_probs=187.3

Q ss_pred             CCceecccCceEEEEEEeC-CCCEEEEEEecccc--hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeC------CceEEE
Q 010309          229 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH------GDRYIV  299 (513)
Q Consensus       229 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~~~~lv  299 (513)
                      ..+.||+|+||+||+|.+. +|+.||||++....  ......+.+|+.+|++++||||+++++++...      ...|+|
T Consensus        21 i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv  100 (355)
T d2b1pa1          21 NLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLV  100 (355)
T ss_dssp             EEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEE
T ss_pred             EEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEE
Confidence            3457799999999999975 59999999997653  23346789999999999999999999999643      577999


Q ss_pred             EeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCC
Q 010309          300 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP  379 (513)
Q Consensus       300 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~  379 (513)
                      |||+.++.+. .+.      ..+++..++.++.||+.||.|||++   ||+||||||+|||++.++.+|++|||+++...
T Consensus       101 ~Ey~~~~l~~-~~~------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~  170 (355)
T d2b1pa1         101 MELMDANLCQ-VIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  170 (355)
T ss_dssp             EECCSEEHHH-HHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EeccchHHHH-hhh------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhccc
Confidence            9999765544 442      3589999999999999999999999   99999999999999999999999999988765


Q ss_pred             ccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhH-H---------------
Q 010309          380 WEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIF-E---------------  443 (513)
Q Consensus       380 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~-~---------------  443 (513)
                      ......   ...+|+.|+|||++.+..+++++||||+||++|||++|++||.+.+........ .               
T Consensus       171 ~~~~~~---~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  247 (355)
T d2b1pa1         171 TSFMMT---PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP  247 (355)
T ss_dssp             -------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred             cccccc---cccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh
Confidence            433222   233899999999999999999999999999999999999999765432111100 0               


Q ss_pred             hhhHHhhcc-cc-----cccccccccCCCCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 010309          444 WATPLVQSH-RY-----LELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH  501 (513)
Q Consensus       444 ~~~~~~~~~-~~-----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  501 (513)
                      ......... ..     ......... ..........++++.+||.+||+.||++|||++|||+
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         248 TVRNYVENRPKYAGLTFPKLFPDSLF-PADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHSCGGGS-CCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hHHHHhhcCccccccccccccccccc-cccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            000000000 00     000000000 0011123456788999999999999999999999985

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-44  Score=355.98  Aligned_cols=265  Identities=17%  Similarity=0.265  Sum_probs=193.8

Q ss_pred             cCCceecccCceEEEEEEe-CCCCEEEEEEecccc--hhcHHHHHHHHHHHhhcCCCcEeeeeeEEeeC-----CceEEE
Q 010309          228 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH-----GDRYIV  299 (513)
Q Consensus       228 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~~lv  299 (513)
                      +..+.||+|+||+||+|+. .+|+.||||++++..  ....+.+.+|+.+|++++||||+++++++...     ...+++
T Consensus        21 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i  100 (348)
T d2gfsa1          21 QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL  100 (348)
T ss_dssp             EEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEE
T ss_pred             EEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEE
Confidence            3445679999999999996 469999999997653  23446788999999999999999999998643     334666


Q ss_pred             EeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEecccccccCC
Q 010309          300 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP  379 (513)
Q Consensus       300 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~~~  379 (513)
                      ++++.+|+|.+++..     ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+|++|||++....
T Consensus       101 ~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~  172 (348)
T d2gfsa1         101 VTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTD  172 (348)
T ss_dssp             EEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred             EEeecCCchhhhccc-----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcccC
Confidence            777889999999853     4599999999999999999999999   99999999999999999999999999998664


Q ss_pred             ccccccceeecCcccccccccccccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhhhHH----hhcccc
Q 010309          380 WEVMQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPL----VQSHRY  454 (513)
Q Consensus       380 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~----~~~~~~  454 (513)
                      ....     ...||+.|+|||.+.+. .++.++|||||||++|+|++|++||.+.+.......+......    ......
T Consensus       173 ~~~~-----~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~  247 (348)
T d2gfsa1         173 DEMT-----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS  247 (348)
T ss_dssp             GGGS-----SSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCC
T ss_pred             cccc-----cccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhcc
Confidence            3321     23389999999987765 4688999999999999999999999876543211111000000    000000


Q ss_pred             ----cccccccccCCCCCCC----cHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcCc
Q 010309          455 ----LELLDPLISSLSSDIP----EAGVVQKVVDLVYACTQHVPSMRPRMSHVVH--QLQQLA  507 (513)
Q Consensus       455 ----~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~  507 (513)
                          ...... +... ....    ....++++.+||.+||+.||++|||++|+++  .+++..
T Consensus       248 ~~~~~~~~~~-~~~~-~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~  308 (348)
T d2gfsa1         248 SESARNYIQS-LTQM-PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH  308 (348)
T ss_dssp             CHHHHHHHTT-SCCC-CCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             chhhhhhhhh-cccC-CCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence                000000 0000 0000    0124567899999999999999999999997  455443

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.3e-38  Score=317.42  Aligned_cols=265  Identities=17%  Similarity=0.193  Sum_probs=186.9

Q ss_pred             ccCCceecccCceEEEEEEe-CCCCEEEEEEecccchhcHHHHHHHHHHHhhcC-----------CCcEeeeeeEEeeC-
Q 010309          227 SEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-----------HPNLVAVKGCCYDH-  293 (513)
Q Consensus       227 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~nIv~l~~~~~~~-  293 (513)
                      ++..+.||+|+||+||+|+. .+|+.||||+++... ...+.+.+|+.+++.++           |+||+++++++... 
T Consensus        15 Y~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~   93 (362)
T d1q8ya_          15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG   93 (362)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred             EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecc
Confidence            45567789999999999997 469999999998653 23467788998888875           57899999988654 


Q ss_pred             -CceEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCceEcCCCCCceEecCCCC-----
Q 010309          294 -GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD-KVKPHVVHRDIRASNVLLDEEFG-----  366 (513)
Q Consensus       294 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dikp~NIll~~~~~-----  366 (513)
                       ...+++++++..+........ ......+++..+..++.||+.||+|||+ .   +|+||||||+|||++.++.     
T Consensus        94 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~~~  169 (362)
T d1q8ya_          94 PNGVHVVMVFEVLGENLLALIK-KYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENLI  169 (362)
T ss_dssp             TTEEEEEEEECCCCEEHHHHHH-HTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTTEE
T ss_pred             ccceeeeeeecccccccccccc-cccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCcccccc
Confidence             455667776655443222221 1334678999999999999999999998 6   9999999999999986654     


Q ss_pred             -eEEecccccccCCccccccceeecCcccccccccccccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCccccchhHHhh
Q 010309          367 -AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWA  445 (513)
Q Consensus       367 -~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~  445 (513)
                       ++++|||.+.......     ....||+.|+|||++....++.++||||+||++++|++|+.||............+..
T Consensus       170 ~~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~  244 (362)
T d1q8ya_         170 QIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI  244 (362)
T ss_dssp             EEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred             eeeEeeccccccccccc-----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence             8999999998654322     2234999999999999999999999999999999999999999765432111111000


Q ss_pred             hH---H--------hhcccc-ccccc-----ccccCC----------CCCCCcHHHHHHHHHHHHHhcCCCCCCCCCHHH
Q 010309          446 TP---L--------VQSHRY-LELLD-----PLISSL----------SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSH  498 (513)
Q Consensus       446 ~~---~--------~~~~~~-~~~~~-----~~~~~~----------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  498 (513)
                      ..   .        ...... ....+     ..+...          .........++++.+|+.+||+.||.+|||++|
T Consensus       245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e  324 (362)
T d1q8ya_         245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG  324 (362)
T ss_dssp             HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred             HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence            00   0        000000 00000     000000          011223567889999999999999999999999


Q ss_pred             HHH
Q 010309          499 VVH  501 (513)
Q Consensus       499 vl~  501 (513)
                      +|+
T Consensus       325 ~L~  327 (362)
T d1q8ya_         325 LVN  327 (362)
T ss_dssp             HHT
T ss_pred             Hhc
Confidence            987

>d1xpha1 d.169.1.1 (A:265-394) DC-SIGNR (DC-SIGN related receptor) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: DC-SIGNR (DC-SIGN related receptor)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=3.4e-28  Score=204.53  Aligned_cols=126  Identities=21%  Similarity=0.428  Sum_probs=110.0

Q ss_pred             cCCCCCCCcccCCCCeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceE
Q 010309            6 KAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWK   85 (513)
Q Consensus         6 ~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~   85 (513)
                      |.+||+||+  .|+++||+|+.++++|.+|+..|+.+||+||+|+|++|++|+..++......+||||+  +...++.|+
T Consensus         1 c~~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~gg~La~i~s~~~~~~~~~~~~~~~~~~wig~~--~~~~~~~~~   76 (130)
T d1xpha1           1 CRHCPKDWT--FFQGNCYFMSNSQRNWHDSVTACQEVRAQLVVIKTAEEQNFLQLQTSRSNRFSWMGLS--DLNQEGTWQ   76 (130)
T ss_dssp             SCBCCTTCE--EETTEEEEECSSCBCHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHHHHTCCEEEEEE--CCSTTCCCE
T ss_pred             CCCCCCCCE--EECCEEEEEECcccCHHHHHHHHhhcCCeEeeeCCHHHhhhhhhhhccccceeeeeee--ccCcccceE
Confidence            789999999  7999999999999999999999999999999999999999999887654667999999  666679999


Q ss_pred             EcCCCCCc---cCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCccccccc
Q 010309           86 WSDNMSKW---NESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEH  148 (513)
Q Consensus        86 W~dg~~~~---~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~~~  148 (513)
                      |+||+++.   |.+|.+++|.           +.++++|+.+..  ++|++.+|....+|||+.|.
T Consensus        77 W~dg~~~~~~~~~~W~~~~P~-----------~~~~~~Cv~~~~--~~w~~~~C~~~~~fICe~pA  129 (130)
T d1xpha1          77 WVDGSPLSPSFQRYWNSGEPN-----------NSGNEDCAEFSG--SGWNDNRCDVDNYWICKKPA  129 (130)
T ss_dssp             ETTSCBCCGGGGGGBCTTCCC-----------CCTTCCEEEEET--TEEEEECTTSCBEEEEEEEC
T ss_pred             eccccccccccccccCCcCCC-----------CCCCCcEEEEEC--CEEEECCCCCCEEEEEEEeC
Confidence            99998754   6688888872           334567999864  47999999999999999864

>d1hq8a_ d.169.1.1 (A:) NK cell-activating receptor nkg2d {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: NK cell-activating receptor nkg2d
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.95  E-value=7.3e-29  Score=206.34  Aligned_cols=121  Identities=24%  Similarity=0.546  Sum_probs=105.7

Q ss_pred             CcCCCCCCCcccCCCCeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCce
Q 010309            5 WKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSW   84 (513)
Q Consensus         5 ~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w   84 (513)
                      .|++||+||.  .|+++||+++.++++|.+|+..|+.+||+||+|+|++|++||...    ...+||||+  +...++.|
T Consensus         2 ~c~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~gg~La~i~s~~e~~fl~~~----~~~~WiGl~--~~~~~~~w   73 (123)
T d1hq8a_           2 YCGPCPNNWI--CHRNNCYQFFNEEKTWNQSQASCLSQNSSLLKIYSKEEQDFLKLV----KSYHWMGLV--QIPANGSW   73 (123)
T ss_dssp             CCCCCSTTCE--EETTEEEEEEEEEECHHHHHHHHHTTTCEECCCSCTTTTGGGGGC----CSCEEEEEE--ECTTTCCE
T ss_pred             cCCCCCccCE--EECCEEEEEECcccCHHHHHHHHhhccCccceEehHHHHHHHhhh----hhceeeeee--ecCCCCce
Confidence            4899999999  799999999999999999999999999999999999999999654    347999999  55567999


Q ss_pred             EEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCccccccc
Q 010309           85 KWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEH  148 (513)
Q Consensus        85 ~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~~~  148 (513)
                      +|+||+++.|++|..++|+++              +|+.+. ..+.|.+..|....+|||+++.
T Consensus        74 ~W~dgs~~~~~~w~~~~~~~~--------------~c~~~~-~~~~w~~~~C~~~~~~ICek~a  122 (123)
T d1hq8a_          74 QWEDGSSLSYNQLTLVEIPKG--------------SCAVYG-SSFKAYTEDCANLNTYICMKRA  122 (123)
T ss_dssp             EETTSCBCCTTTCEEECCTTC--------------CEEEEC-STTEEEEECTTSCEEEEEEECC
T ss_pred             EECCCCcccccccCCCCCCCC--------------CEEEEE-CCCeEEEeCCCCCEeEEEEEcc
Confidence            999999999999998887432              355654 3468999999999999999753

>d1t8da1 d.169.1.1 (A:1-143) Low affinity immunoglobulin epsilon Fc receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Low affinity immunoglobulin epsilon Fc receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=2e-27  Score=203.21  Aligned_cols=133  Identities=19%  Similarity=0.367  Sum_probs=114.6

Q ss_pred             CCCcCCCCCCCcccCCCCeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCC
Q 010309            3 KDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGL   82 (513)
Q Consensus         3 ~~~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~   82 (513)
                      ...|.+||+||.  .|+++||+|+...++|.+|+..|+.+||+||+|+|.+|++||.++..  ...+||||+  +...++
T Consensus         2 g~~c~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~gg~La~i~s~~e~~~l~~~~~--~~~~wiGl~--~~~~~~   75 (143)
T d1t8da1           2 GFVCNTCPEKWI--NFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHAS--HTGSWIGLR--NLDLKG   75 (143)
T ss_dssp             CCSSCCCCSSSE--ECSSEEEEEEECCSSHHHHHHHHHHHTSBCCCCCSHHHHHHHHHHCS--SSCEEEEEE--ESSSSS
T ss_pred             CCcCCCCCcccE--EECCEEEEEECcccCHHHHHHHhhhcCCEEeeecCHHHhhhcccccc--cccccccce--ecCCCC
Confidence            357899999999  79999999999999999999999999999999999999999999876  457999999  555679


Q ss_pred             ceEEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCC-CCccccccccCcc
Q 010309           83 SWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTS-HPFICMVEHENKC  152 (513)
Q Consensus        83 ~w~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~-~~~iC~~~~~~~c  152 (513)
                      .|.|+||++..|++|.+++|.+          ..+.++|+.+.. .+.|++.+|... .+|||++.....+
T Consensus        76 ~~~w~dg~~~~~~~w~~~~P~~----------~~~~~~Cv~~~~-~g~W~~~~C~~~~~~fICek~~~~~~  135 (143)
T d1t8da1          76 EFIWVDGSHVDYSNWAPGEPTS----------RSQGEDCVMMRG-SGRWNDAFCDRKLGAWVCDRLATCTP  135 (143)
T ss_dssp             CEEETTSCBCSSCCBSSSCCCS----------CCSCCSEEEEET-TTEEEEECSCSCCCEEEEEEECSCCC
T ss_pred             ccEeCCCCccccccccccCCCC----------CCCCCCEEEEcC-CCEEEeeCCCCCccCeEEEECCCCCC
Confidence            9999999999999999998832          234567998865 468999999876 5799998765443

>d1oz7b_ d.169.1.1 (B:) Snake coagglutinin beta chain {Saw-scaled viper (Echis carinatus), echicetin [TaxId: 40353]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Snake coagglutinin beta chain
species: Saw-scaled viper (Echis carinatus), echicetin [TaxId: 40353]

Probab=99.94  E-value=1.1e-27  Score=199.18  Aligned_cols=118  Identities=20%  Similarity=0.473  Sum_probs=103.5

Q ss_pred             CCCCCCcccCCCCeeEEEECCCCChHHHHHHHhh--cCCEEeeeCCHHHHHHHHHHhCCC--CCCeEEeeeecCCCCCCc
Q 010309            8 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGLS   83 (513)
Q Consensus         8 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~~   83 (513)
                      -||+||.  .|+++||+|+..+++|.+|+..|+.  .||+||+|+|.+|++||.+++...  ...+||||+  +...+|.
T Consensus         1 ~Cp~gw~--~~~~~CY~~~~~~~~~~~A~~~C~~~~~gg~L~~i~s~~e~~~l~~~~~~~~~~~~~WIGl~--~~~~~~~   76 (123)
T d1oz7b_           1 NCLPDWS--VYEGYCYKVFKERMNWADAEKFCTKQHKDGHLVSFRNSKEVDFVISLAFPMLKNDLVWIGLT--DYWRDCN   76 (123)
T ss_dssp             CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCCSSHHHHHHHTSSTTTTCSEEEEEEE--CCCCGGG
T ss_pred             CCCccCE--eECCEEEEEeCcccCHHHHHHHHhhccCCCcccccCCHHHhhhceeeeeecccceeEEEEee--ccCcccc
Confidence            3999999  7999999999999999999999975  499999999999999999987654  346899999  6667899


Q ss_pred             eEEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCcccccc
Q 010309           84 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE  147 (513)
Q Consensus        84 w~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~~  147 (513)
                      |+|+||+++.|++|..++                  +|+.+...++.|++..|....+|||+.|
T Consensus        77 ~~W~dg~~~~y~nW~~~~------------------~C~~~~~~~~~W~~~~C~~~~~fICe~P  122 (123)
T d1oz7b_          77 WEWSDGAQLDYKAWDNER------------------HCFIYKNTDNQWTRRDCTWTFSFVCKCP  122 (123)
T ss_dssp             EEETTCCCCCSCCBCSST------------------TEEEEEGGGTEEEEECTTSCEEEEEEEE
T ss_pred             eeccCCCEeeccccCCCC------------------CEEEEECCCCEEEeeCCCCcEEEEEEEc
Confidence            999999999999985433                  4778876667899999999999999986

>d2afpa_ d.169.1.1 (A:) Type II antifreeze protein {Sea raven (Hemitripterus americanus) [TaxId: 8094]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Type II antifreeze protein
species: Sea raven (Hemitripterus americanus) [TaxId: 8094]

Probab=99.94  E-value=1.6e-27  Score=199.99  Aligned_cols=124  Identities=26%  Similarity=0.501  Sum_probs=107.7

Q ss_pred             CcCCCCCCCcccCCCCeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCce
Q 010309            5 WKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSW   84 (513)
Q Consensus         5 ~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w   84 (513)
                      ..+.||+||.  .++++||+|+..+++|.+|+..|+.+||+||+|+|.+|++||.++..   ..+||||+  +...++.|
T Consensus         3 ag~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~gg~La~i~s~~e~~fl~~~~~---~~~Wig~~--~~~~~~~w   75 (129)
T d2afpa_           3 AGPNCPAGWQ--PLGDRCIYYETTAMTWALAETNCMKLGGHLASIHSQEEHSFIQTLNA---GVVWIGGS--ACLQAGAW   75 (129)
T ss_dssp             CCCSSCSSSC--CCSSSEECCCCSCCCHHHHHHHHHHHSCEECCCSSSHHHHHHHHHCS---SCBCCSCB--CSSSSSCC
T ss_pred             CCCCCCCCCE--EECCEEEEEECcccCHHHHHHHHHhcCCeEeeeeehhcchhhccccc---Cceeeeee--ccccccee
Confidence            3456999999  89999999999999999999999999999999999999999999865   56999999  66677999


Q ss_pred             EEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecC-CCcccccccCCCCCccccc
Q 010309           85 KWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG-SRSLVTERCNTSHPFICMV  146 (513)
Q Consensus        85 ~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~-~~~w~d~~C~~~~~~iC~~  146 (513)
                      +|+||+++.|++|.+++|.           +...++|+.+... .+.|++..|....+|||+.
T Consensus        76 ~W~dgs~~~y~~W~~~~P~-----------~~~~~~c~~~~~~~~~~W~~~~C~~~~~~ICe~  127 (129)
T d2afpa_          76 TWSDGTPMNFRSWCSTKPD-----------DVLAACCMQMTAAADQCWDDLPCPASHKSVCAM  127 (129)
T ss_dssp             BSSSSCCCCCCCSSSCCSC-----------CSTTCCBCCBCCSSSSCBCCBCSCCCCCCCEEE
T ss_pred             eccCCCeeecccccCCCCC-----------CCCCCcEEEEECCCCCcEEeeCCCCCEeEEEEE
Confidence            9999999999999998883           2233467777544 3469999999999999986

>d1tdqb_ d.169.1.1 (B:) Aggrecan core protein {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Aggrecan core protein
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.94  E-value=4.1e-27  Score=196.68  Aligned_cols=123  Identities=24%  Similarity=0.431  Sum_probs=108.3

Q ss_pred             CCCCCCcccCCCCeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEc
Q 010309            8 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWS   87 (513)
Q Consensus         8 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~   87 (513)
                      +||+||+  .++++||+|+.++++|.+|+..|+.+||+||+|+|.+|++||.++..   ..+||||+  +...++.|+|+
T Consensus         2 ~Cp~gw~--~~~~~CY~~~~~~~sw~~A~~~C~~~g~~La~i~~~~e~~~l~~~~~---~~~wigl~--~~~~~~~~~W~   74 (126)
T d1tdqb_           2 QCEEGWT--KFQGHCYRHFPDRETWVDAERRCREQQSHLSSIVTPEEQEFVNKNAQ---DYQWIGLN--DRTIEGDFRWS   74 (126)
T ss_dssp             CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHC---SCEEEEEE--CSSSTTCCEET
T ss_pred             CCCCCCe--eeCCEEEEEECcccCHHHHHHHHHhhCcEEeEECChhHhhhhhcccc---ceeeeecc--cccCCCccCcC
Confidence            6999999  79999999999999999999999999999999999999999999875   57999999  66678999999


Q ss_pred             CCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecC-CCcccccccCCCCCccccc
Q 010309           88 DNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG-SRSLVTERCNTSHPFICMV  146 (513)
Q Consensus        88 dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~-~~~w~d~~C~~~~~~iC~~  146 (513)
                      ||+++.|++|.+++|.+..         ...++|+.+... .+.|++..|....+|||++
T Consensus        75 dg~~~~~~~w~~~~p~~~~---------~~~~~C~~~~~~~~~~W~~~~C~~~~~fICek  125 (126)
T d1tdqb_          75 DGHSLQFEKWRPNQPDNFF---------ATGEDCVVMIWHERGEWNDVPCNYQLPFTCKK  125 (126)
T ss_dssp             TCCCCCCCCBCTTCCCCCS---------TTTEEEEEEETTTTTEEEEEETTSCEEEEEEE
T ss_pred             CCCCcccccccccCCCccc---------cCCcceEEEEeCCCCeEEecCCCCCEEEEeee
Confidence            9999999999999984321         234578888643 4579999999999999986

>d1fvub_ d.169.1.1 (B:) Snake coagglutinin beta chain {Jararaca (Bothrops jararaca), botrocetin [TaxId: 8724]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Snake coagglutinin beta chain
species: Jararaca (Bothrops jararaca), botrocetin [TaxId: 8724]

Probab=99.94  E-value=1.9e-27  Score=198.40  Aligned_cols=120  Identities=23%  Similarity=0.554  Sum_probs=102.2

Q ss_pred             CCCCCCcccCCCCeeEEEECCCCChHHHHHHHhh--cCCEEeeeCCHHHHHHHHHHhCCC--CCCeEEeeeecCCCCCCc
Q 010309            8 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGLS   83 (513)
Q Consensus         8 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~~   83 (513)
                      -||+||.  .|+++||+++...++|.+|+..|+.  .||+||+|+|++|++||.+++...  ...+||||+  +...++.
T Consensus         1 ~Cp~gw~--~~~~~CY~~~~~~~t~~~A~~~C~~~~~gg~L~~i~s~~e~~~l~~~~~~~~~~~~~WiGl~--~~~~~~~   76 (125)
T d1fvub_           1 DCPPDWS--SYEGHCYRFFKEWMHWDDAEEFCTEQQTGAHLVSFQSKEEADFVRSLTSEMLKGDVVWIGLS--DVWNKCR   76 (125)
T ss_dssp             CCSTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCSSHHHHHHHHTTCTTSCTTCCEECSCC--CCSTTSC
T ss_pred             CCCCCCE--eeCCEEEEEeCccCCHHHHHHhhhhccCCceecccCCHHHcccccccccccccceeEEeeee--ccCcccc
Confidence            3999999  7999999999999999999999964  589999999999999999988654  346999999  6667899


Q ss_pred             eEEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCcccccc
Q 010309           84 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE  147 (513)
Q Consensus        84 w~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~~  147 (513)
                      |+|+||+++.|++|..++|                ++|+.+...++.|++.+|....+|||+.+
T Consensus        77 ~~W~dg~~~~~~~w~~~~~----------------~~Cv~~~~~~~~W~~~~C~~~~~fICe~~  124 (125)
T d1fvub_          77 FEWTDGMEFDYDDYYLIAE----------------YECVASKPTNNKWWIIPCTRFKNFVCEFQ  124 (125)
T ss_dssp             EEETTSCCCCC----CCSC----------------CEEEEEETTTTEEEEEETTSCEEEEEEEC
T ss_pred             cEecCCCccccCCCCCCCC----------------cceEEEEcCCCEEEeeCCCCCEEEEEEEc
Confidence            9999999999999976553                25888877777899999999999999975

>d1ypqa1 d.169.1.1 (A:140-270) Oxidised low density lipoprotein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Oxidised low density lipoprotein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=6.5e-27  Score=196.88  Aligned_cols=128  Identities=20%  Similarity=0.443  Sum_probs=108.1

Q ss_pred             cCCCCCCCcccCCCCeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceE
Q 010309            6 KAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWK   85 (513)
Q Consensus         6 ~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~   85 (513)
                      .++||+||.  .|+++||+|+.++++|.+|+..|+.+||+||+|+|++|++||.+++......+||||+  +...++.|+
T Consensus         2 ~~~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~WiGl~--~~~~~~~w~   77 (131)
T d1ypqa1           2 SAPCPQDWI--WHGENCYLFSSGSFNWEKSQEKCLSLDAKLLKINSTADLDFIQQAISYSSFPFWMGLS--RRNPSYPWL   77 (131)
T ss_dssp             CCSSCTTSE--EETTEEEEECSSCBCHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHTTCCCCEEEEEE--ESSTTSCCE
T ss_pred             cCCCCCCCE--EECCEEEEEECCccCHHHHHHHHHHcCCeeccchhhhhhhhhhhhhhccCCceEEEEE--ecCCCCceE
Confidence            479999999  7999999999999999999999999999999999999999999998755567999999  555679999


Q ss_pred             EcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCccccccc
Q 010309           86 WSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEH  148 (513)
Q Consensus        86 W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~~~  148 (513)
                      |+||+++.+.+|+..++++         .....++|+.+..  +.|.+.+|....+|||+.+.
T Consensus        78 w~dg~~~~~~~~~~~~~~~---------~~~~~~~C~~~~~--~~w~~~~C~~~~~~ICek~a  129 (131)
T d1ypqa1          78 WEDGSPLMPHLFRVRGAVS---------QTYPSGTCAYIQR--GAVYAENCILAAFSICQKKA  129 (131)
T ss_dssp             ETTSCBCCTTSCCEEESCS---------CCCTTCEEEEEET--TEEEEEETTSCBEEEEEEEC
T ss_pred             eCCCCCccccccccCCCCC---------CCCCCCCEEEEEC--CeEEEeCCCCCEeEEEeEEC
Confidence            9999998777665433322         1234567988864  47999999999999999864

>d1j34b_ d.169.1.1 (B:) Snake coagglutinin beta chain {Habu snake (Trimeresurus flavoviridis) [TaxId: 88087]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Snake coagglutinin beta chain
species: Habu snake (Trimeresurus flavoviridis) [TaxId: 88087]

Probab=99.94  E-value=1.5e-27  Score=198.31  Aligned_cols=118  Identities=23%  Similarity=0.562  Sum_probs=103.7

Q ss_pred             CCCCCCcccCCCCeeEEEECCCCChHHHHHHHhh--cCCEEeeeCCHHHHHHHHHHhCCC--CCCeEEeeeecCCCCCCc
Q 010309            8 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGLS   83 (513)
Q Consensus         8 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~~   83 (513)
                      -||+||.  .++++||+++..+++|.+|+..|+.  .||+||+|+|.+|++||.+++...  ...|||||+  +...++.
T Consensus         1 ~Cp~gw~--~~~~~CY~~~~~~~~~~~A~~~C~~~~~gg~L~~i~s~~e~~~l~~~~~~~~~~~~~WiGl~--~~~~~~~   76 (123)
T d1j34b_           1 DCPSDWS--SYEGHCYKPFSEPKNWADAENFCTQQHAGGHLVSFQSSEEADFVVKLAFQTFGHSIFWMGLS--NVWNQCN   76 (123)
T ss_dssp             CCCTTSE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCSSHHHHHHHHHHHHHHHCSCEEECSCC--SCSTTSC
T ss_pred             CCCCCCE--eECCEEEEEEccccCHHHHHHHHHhccCCCcccccCCHhHhhhhhhhhccccceeEEeecee--cccccce
Confidence            3999999  8999999999999999999999975  499999999999999999877533  456999999  6667899


Q ss_pred             eEEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCcccccc
Q 010309           84 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE  147 (513)
Q Consensus        84 w~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~~  147 (513)
                      |+|+||+++.|++|.+++                  +|+.+...++.|++..|....+|||+.+
T Consensus        77 w~W~dg~~~~y~~W~~~~------------------~Cv~~~~~~~~W~~~~C~~~~~fiCe~~  122 (123)
T d1j34b_          77 WQWSNAAMLRYKAWAEES------------------YCVYFKSTNNKWRSRACRMMAQFVCEFQ  122 (123)
T ss_dssp             EEETTCCCCCCCCBSCSC------------------EEEEEETTSCCBEEEETTSCEEEEEEEE
T ss_pred             eecCCCCcccccCCCCCC------------------CeEEEECCCCEEEeeCCCCCEeEEEEEc
Confidence            999999999999986443                  4888877777899999999999999975

>d1c3ab_ d.169.1.1 (B:) Snake coagglutinin beta chain {Habu snake (Trimeresurus flavoviridis), flavocetin-A [TaxId: 88087]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Snake coagglutinin beta chain
species: Habu snake (Trimeresurus flavoviridis), flavocetin-A [TaxId: 88087]

Probab=99.94  E-value=1.9e-27  Score=198.24  Aligned_cols=118  Identities=19%  Similarity=0.401  Sum_probs=103.4

Q ss_pred             CCCCCCcccCCCCeeEEEECCCCChHHHHHHHhh--cCCEEeeeCCHHHHHHHHHHhCCC--CCCeEEeeeecCCCCCCc
Q 010309            8 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGLS   83 (513)
Q Consensus         8 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~~   83 (513)
                      .||+||.  .++++||+++.++++|.+|+..|+.  .||+||+|+|.+|++||.+++...  ...+||||+  +...++.
T Consensus         3 ~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~L~~i~s~~e~~~l~~~~~~~~~~~~~WiGl~--~~~~~~~   78 (125)
T d1c3ab_           3 CCPLGWS--SYDEHCYQVFQQKMNWEDAEKFCTQQHKGSHLVSFHSSEEVDFVTSKTFPILKYDFVWIGLS--NVWNECT   78 (125)
T ss_dssp             CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCSSHHHHHHHHHHHHHHHCSCEEECSCC--CTTTSSC
T ss_pred             CCCCCCE--EECCEEEEEECcccCHHHHHHhhccccCCCeecccCCHHHhhhhhhhhhccCCceeEEEEec--ccCccee
Confidence            5999999  7999999999999999999999964  589999999999999999877532  456999999  6667899


Q ss_pred             eEEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCcccccc
Q 010309           84 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE  147 (513)
Q Consensus        84 w~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~~  147 (513)
                      |+|+||+++.|++|.+++                  +|+.+....+.|++.+|....+|||+.+
T Consensus        79 ~~W~dGs~~~y~~W~~~e------------------~Cv~~~~~~~~W~~~~C~~~~~fICe~~  124 (125)
T d1c3ab_          79 KEWSDGTKLDYKAWSGGS------------------DCIVSKTTDNQWLSMDCSSKYYVVCKFQ  124 (125)
T ss_dssp             EEETTCCCCCSCCBCCCC------------------EEEEEESSSSCEEEEETTSCEEEEEEEE
T ss_pred             eEeCCCCeeeccccCCCC------------------ceEEEECCCCeEEeeCCCCCEEEEEEEe
Confidence            999999999999996554                  3777776667899999999999999975

>d1gz2a_ d.169.1.1 (A:) Ovocleidin-17 {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Ovocleidin-17
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=99.93  E-value=9.6e-27  Score=197.96  Aligned_cols=124  Identities=25%  Similarity=0.580  Sum_probs=105.7

Q ss_pred             CCCCCCcccCCCCeeEEEECCCCChHHHHHHHhhc--CCEEeeeCCHHHHHHHHHHhCCC----------CCCeEEeeee
Q 010309            8 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKN----------VNGCWVGGRS   75 (513)
Q Consensus         8 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~--~~~L~~i~~~~e~~f~~~~~~~~----------~~~~WiGl~~   75 (513)
                      -||+||.  .|+++||+|+..+++|.+|+..|+.+  ||+||+|+|.+|++||.+++...          ...+||||+ 
T Consensus         1 gCp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~L~~i~s~~e~~~i~~~l~~~~~~~~~~~~~~~~~WiGl~-   77 (139)
T d1gz2a_           1 GCGPGWV--PTPGGCLGFFSRELSWSRAESFCRRWGPGSHLAAVRSAAELRLLAELLNASRGGDGSGEGADGRVWIGLH-   77 (139)
T ss_dssp             CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHTTCTTEEECCCCSHHHHHHHHHHHHCSSCCSSSCCCCSSCEEEEEE-
T ss_pred             CCCCCCE--eECCEEEEEeCeecCHHHHHhhhhcccCCceecchhhHHHHHHHHHHHHhhccccccccccccceeeeee-
Confidence            3999999  89999999999999999999999865  99999999999999999987432          346999999 


Q ss_pred             cCCCCCCceEEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCC--CcccccccCCCCCcccccc
Q 010309           76 INTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMVE  147 (513)
Q Consensus        76 ~~~~~~~~w~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~--~~w~d~~C~~~~~~iC~~~  147 (513)
                       +...++.|+|+||+++.|++|.+++|++            ..++|+.+....  ..|++..|....+|||+.+
T Consensus        78 -~~~~~~~w~W~dgs~~~y~~W~~~~p~~------------~~~~C~~l~~~~~~~~W~~~~C~~~~~fiCe~~  138 (139)
T d1gz2a_          78 -RPAGSRSWRWSDGTAPRFASWHRTAKAR------------RGGRCAALRDEEAFTSWAARPCTERNAFVCKAA  138 (139)
T ss_dssp             -CCTTCSSCEETTSCCCCCCCBCSSSGGG------------CSCSEEEECTTTTSSCEEEECTTCCEEEEEEEE
T ss_pred             -ecccCCceEeccCCcceeecccCCCCCC------------CCCcEEEEEecCCCCcEEecCCCCCEeEEEEEc
Confidence             6667799999999999999999888732            223577775433  4599999999999999986

>d1qdda_ d.169.1.1 (A:) Lithostathine, inhibitor of stone formation {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Lithostathine, inhibitor of stone formation
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=6.5e-27  Score=200.24  Aligned_cols=126  Identities=17%  Similarity=0.425  Sum_probs=107.3

Q ss_pred             CCCCCCCcccCCCCeeEEEECCCCChHHHHHHHhhc-CCEEeeeCCHHHHHHHHHHhCCC---CCCeEEeeeecCCCCCC
Q 010309            7 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI-GGHLAALTSYEEEHSAQKLCGKN---VNGCWVGGRSINTTVGL   82 (513)
Q Consensus         7 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~-~~~L~~i~~~~e~~f~~~~~~~~---~~~~WiGl~~~~~~~~~   82 (513)
                      ..||+||.  .|+++||+|+..+++|.+|+..|+.+ ||+||+|+|.+|++||.+++...   ...+||||+  +...++
T Consensus        12 ~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~gg~L~~i~s~~e~~~l~~~l~~~~~~~~~~WiGl~--~~~~~~   87 (144)
T d1qdda_          12 ISCPEGTN--AYRSYCYYFNEDRETWVDADLYCQNMNSGNLVSVLTQAEGAFVASLIKESGTDDFNVWIGLH--DPKKNR   87 (144)
T ss_dssp             TSCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHTTSCEECCCCSHHHHHHHHHHHHHTTCCCSEEEEEEE--CTTSSS
T ss_pred             CcCCCCCE--EECCEEEEEECCccCHHHHHHHHHhccccccceEEeeecchhhhhccccccccccceeeeee--cccccc
Confidence            47999999  79999999999999999999999986 78999999999999999887533   336999999  666779


Q ss_pred             ceEEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCC--CcccccccCCCCCcccccc
Q 010309           83 SWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMVE  147 (513)
Q Consensus        83 ~w~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~--~~w~d~~C~~~~~~iC~~~  147 (513)
                      .|+|+||+++.|++|.+++|.           +.+.++|+.+....  +.|++..|....+|||+++
T Consensus        88 ~w~W~dGs~~~y~~W~~~~P~-----------~~~~~~C~~~~~~~~~~~W~~~~C~~~~~fICe~k  143 (144)
T d1qdda_          88 AWHWSSGSLVSYKSWGIGAPS-----------SVNPGYCVSLTSSTGFQKWKDVPCEDKFSFVCKFK  143 (144)
T ss_dssp             CCEETTCCCCCCCCBCTTCSC-----------SSSCCSEEEEEGGGTTCSEEEECTTSCEEEEEEEE
T ss_pred             eeEecCCCeeecccccCCCCC-----------CCCCccEEEEEccCCCCcEEecCCCCCeEEEEEEC
Confidence            999999999999999998873           22334688875433  4699999999999999975

>d1umrc_ d.169.1.1 (C:) Snake coagglutinin beta chain {South american rattlesnake (Crotalus durissus terrificus), convulxin [TaxId: 8732]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Snake coagglutinin beta chain
species: South american rattlesnake (Crotalus durissus terrificus), convulxin [TaxId: 8732]

Probab=99.93  E-value=4.9e-27  Score=195.77  Aligned_cols=118  Identities=23%  Similarity=0.535  Sum_probs=103.7

Q ss_pred             CCCCCCcccCCCCeeEEEECCCCChHHHHHHHhh--cCCEEeeeCCHHHHHHHHHHhCCC--CCCeEEeeeecCCCCCCc
Q 010309            8 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGLS   83 (513)
Q Consensus         8 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~~   83 (513)
                      .||+||+  .++++||+++.+.++|.+|+..|+.  .||+||+|+|++|++||.+++...  ...+||||+  +...++.
T Consensus         3 ~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~gg~La~i~~~~e~~~l~~~~~~~~~~~~~WIGl~--~~~~~~~   78 (125)
T d1umrc_           3 CCPSHWS--SYDRYCYKVFKQEMTWADAEKFCTQQHTGSHLVSFHSTEEVDFVVKMTHQSLKSTFFWIGAN--NIWNKCN   78 (125)
T ss_dssp             CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCSSHHHHHHHHHHHHTTCSSSEEECSCC--CTTTSSC
T ss_pred             CCCccCE--EECCEEEEEECCccCHHHHHHhhcccCCCCcccccCCHHHhhhhhhhhcccccceeEEEeee--ccccccc
Confidence            5999999  7999999999999999999999976  489999999999999999988643  456999999  7777899


Q ss_pred             eEEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCcccccc
Q 010309           84 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE  147 (513)
Q Consensus        84 w~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~~  147 (513)
                      |+|+||+++.|++|.+++                  +|+.+....+.|++.+|....+|||+.+
T Consensus        79 w~W~dgs~~~y~~w~~~~------------------~c~~~~~~~~~W~~~~C~~~~~fICe~~  124 (125)
T d1umrc_          79 WQWSDGTKPEYKEWHEEF------------------ECLISRTFDNQWLSAPCSDTYSFVCKFE  124 (125)
T ss_dssp             EEETTSCCCSSCCBCCCC------------------EEEEEESSCSCEEEEETTSCEEEEEEEE
T ss_pred             eEecCCCcccccCcCCcC------------------CeeEEECCCCeEEeeCCCCCEEEEEEEe
Confidence            999999999999986443                  4777777777899999999999999975

>d1dv8a_ d.169.1.1 (A:) H1 subunit of the asialoglycoprotein receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: H1 subunit of the asialoglycoprotein receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=2.7e-26  Score=192.17  Aligned_cols=125  Identities=21%  Similarity=0.500  Sum_probs=107.4

Q ss_pred             CCCCCcccCCCCeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEcC
Q 010309            9 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSD   88 (513)
Q Consensus         9 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~d   88 (513)
                      ||+||.  .|+++||+++.++++|.+|+.+|+.+||+||+|+|.+|++||.+++.  ...+||||+  +.  ++.|+|+|
T Consensus         1 Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~~~~e~~~i~~~~~--~~~~WiG~~--~~--~~~~~W~d   72 (128)
T d1dv8a_           1 CPVNWV--EHERSCYWFSRSGKAWADADNYCRLEDAHLVVVTSWEEQKFVQHHIG--PVNTWMGLH--DQ--NGPWKWVD   72 (128)
T ss_dssp             CCTTCE--EETTEEEEECSSCBCHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHC--SSCEEEEEE--CT--TSSCEETT
T ss_pred             CCCCCE--EECCEEEEEECCccCHHHHHHHHhhcCCEEeeecccchhhhhhcccc--ceeeeeecc--cc--CCceEEee
Confidence            999999  89999999999999999999999999999999999999999999997  557999999  53  48999999


Q ss_pred             CCCC--ccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCcccccc
Q 010309           89 NMSK--WNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE  147 (513)
Q Consensus        89 g~~~--~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~~  147 (513)
                      |++.  .|++|.+++|.+....     ...+.++|+.+.. ++.|++.+|....+|||+.+
T Consensus        73 gs~~~~~~~~W~~~~P~~~~~~-----~~~~~~~C~~~~~-~~~w~~~~C~~~~~fICe~~  127 (128)
T d1dv8a_          73 GTDYETGFKNWRPEQPDDWYGH-----GLGGGEDCAHFTD-DGRWNDDVCQRPYRWVCETE  127 (128)
T ss_dssp             CCCSTTSCCCBCTTCCCCCCTT-----SSSSCCCEEEECT-TSCEEEECTTSCBEEEEEEE
T ss_pred             ccccCCcceeeccCCCCccccc-----cCCCCcceEEECC-CCEEEeEcCCCCEEEEEEEE
Confidence            9864  5889999998432211     1345678998854 46899999999999999975

>d1wmza_ d.169.1.1 (A:) Lectin CEL-I {Cucumaria echinata [TaxId: 40245]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Lectin CEL-I
species: Cucumaria echinata [TaxId: 40245]

Probab=99.93  E-value=5.7e-27  Score=199.58  Aligned_cols=128  Identities=13%  Similarity=0.328  Sum_probs=109.2

Q ss_pred             CCCCCCCcccCCCCeeEEEECCCCChHHHHHHHhhcC-------CEEeeeCCHHHHHHHHHHhCC---CCCCeEEeeeec
Q 010309            7 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIG-------GHLAALTSYEEEHSAQKLCGK---NVNGCWVGGRSI   76 (513)
Q Consensus         7 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~-------~~L~~i~~~~e~~f~~~~~~~---~~~~~WiGl~~~   76 (513)
                      ..||+||.  .|+++||+|+.++++|.+|+..|+++|       |+||+|++.+|++||.+++..   ....|||||+  
T Consensus         1 n~Cp~gw~--~~~~~CY~~~~~~~~~~~A~~~C~~~g~~l~~~~~~L~~i~~~~e~~~~~~~~~~~~~~~~~~WiGl~--   76 (140)
T d1wmza_           1 NQCPTDWE--AEGDHCYRFFNTLTTWENAHHECVSYSCSTLNVRSDLVSVHSAAEQAYVFNYWRGIDSQAGQLWIGLY--   76 (140)
T ss_dssp             CCCCTTCE--EETTEEEEEEEEEECHHHHHHHHHTTCBGGGTEEEEECCCCSHHHHHHHHHHHHHHCCSSCCEEEEEE--
T ss_pred             CCCCCCCE--eeCCEEEEEECccCCHHHHHHHHHHhhcccccccceeeeeCCHHHHHhhhhhhccccccccceeeeee--
Confidence            36999999  799999999999999999999999877       669999999999999987742   2456999999  


Q ss_pred             CCCCCCceEEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeec-CCCcccccccCCCCCccccccc
Q 010309           77 NTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN-GSRSLVTERCNTSHPFICMVEH  148 (513)
Q Consensus        77 ~~~~~~~w~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~-~~~~w~d~~C~~~~~~iC~~~~  148 (513)
                      +...++.|+|+||+++.|++|.+++|.+          ..+.++|+.+.. ..+.|++..|....+|||+.+.
T Consensus        77 ~~~~~~~w~W~dG~~~~y~~W~~g~P~~----------~~~~~~c~~~~~~~~~~W~~~~C~~~~~fICe~~~  139 (140)
T d1wmza_          77 DKYNEGDFIWTDGSKVGYTKWAGGQPDN----------WNNAEDYGQFRHTEGGAWNDNSAAAQAKYMCKLTF  139 (140)
T ss_dssp             CSSSTTCCEETTCCCCCCCCBCTTCCCC----------GGGCEEEEEECSSTTTCEEEEETTCCEEEEEEEEE
T ss_pred             eccccceeeecCCccccccccccccccc----------CCCCccEEEEEeCCCCEEEeeCCCCCEeEEEEEee
Confidence            6667899999999999999999998822          234567888864 3457999999999999999863

>d1jwib_ d.169.1.1 (B:) Snake coagglutinin beta chain {Puff adder (Bitis arietans), bitiscetin [TaxId: 8692]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Snake coagglutinin beta chain
species: Puff adder (Bitis arietans), bitiscetin [TaxId: 8692]

Probab=99.93  E-value=6.6e-27  Score=194.35  Aligned_cols=118  Identities=25%  Similarity=0.542  Sum_probs=101.4

Q ss_pred             CCCCCCcccCCCCeeEEEECCCCChHHHHHHHhhc--CCEEeeeCCHHHHHHHHHHhCCC--CCCeEEeeeecCCCCCCc
Q 010309            8 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGLS   83 (513)
Q Consensus         8 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~--~~~L~~i~~~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~~   83 (513)
                      -||+||.  .++++||+++..+++|.+|+..|+++  ||+||+|+|.+|++||.+++...  ...+||||+  +...++.
T Consensus         1 gCp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~gg~L~~i~s~~e~~~l~~~~~~~~~~~~~WiGl~--~~~~~~~   76 (123)
T d1jwib_           1 GCLPDWS--SYKGHCYKVFKVEKTWADAEKFCKELVNGGHLMSVNSREEGEFISKLALEKMRIVLVWIGLS--HFWRICP   76 (123)
T ss_dssp             CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCSHHHHHHHHHHHHHTTCCCEEEEEEE--ECGGGSC
T ss_pred             CCCCCcE--eeCCEEEEEeCcccCHHHHHHHhhhccCCccccccCCHHHhhhhhhheeccccccceEeeee--ccCccce
Confidence            3999999  79999999999999999999999874  89999999999999999876433  346899999  5566799


Q ss_pred             eEEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCcccccc
Q 010309           84 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE  147 (513)
Q Consensus        84 w~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~~  147 (513)
                      |+|+||+++.|++| +++|                 +|+.+....+.|++.+|....+|||+.+
T Consensus        77 ~~W~dgs~~~y~~w-~~~~-----------------~c~~~~~~~~~W~~~~C~~~~~fiCe~k  122 (123)
T d1jwib_          77 LRWTDGARLDYRAL-SDEP-----------------ICFVAESFHNKWIQWTCNRKKSFVCKYR  122 (123)
T ss_dssp             EEETTCCCCCSCCS-CCSC-----------------EEEEEETTTCCEEEEETTSCEEEEEEEE
T ss_pred             eEccCCCCcccccC-CCCC-----------------CEEEEECCCCeEEecCCCCCEeEEEeEE
Confidence            99999999988887 2332                 4667766667899999999999999975

>d1jzna_ d.169.1.1 (A:) Galactose-specific C-type lectin {Western diamondback rattlesnake (Crotalus atrox) [TaxId: 8730]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Galactose-specific C-type lectin
species: Western diamondback rattlesnake (Crotalus atrox) [TaxId: 8730]

Probab=99.93  E-value=9.7e-27  Score=196.81  Aligned_cols=126  Identities=21%  Similarity=0.579  Sum_probs=107.7

Q ss_pred             CCCCCCcccCCCCeeEEEECCCCChHHHHHHHhhc--CCEEeeeCCHHHHHHHHHHhCC---CCCCeEEeeeecCCCCCC
Q 010309            8 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGK---NVNGCWVGGRSINTTVGL   82 (513)
Q Consensus         8 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~--~~~L~~i~~~~e~~f~~~~~~~---~~~~~WiGl~~~~~~~~~   82 (513)
                      .||+||.  .++++||+|+..+++|.+|+..|+.+  |++||+|++.+|++||...+..   ....|||||+  +...++
T Consensus         2 ~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~~~g~~L~~i~s~~e~~~i~~~l~~~~~~~~~~WiGl~--~~~~~~   77 (135)
T d1jzna_           2 NCPLDWL--PMNGLCYKIFNQLKTWEDAEMFCRKYKPGCHLASFHRYGESLEIAEYISDYHKGQENVWIGLR--DKKKDF   77 (135)
T ss_dssp             CSCTTSE--EETTEEEEEEEEEECHHHHHHHHHHHSSSEEECCCCSHHHHHHHHHHHHHHCCSSCCEEEEEE--CTTSSS
T ss_pred             CCCCCCE--eECCEEEEEECcccCHHHHHHHhhhccccccccccCCHHHHHHHHHhhhhccCCCccEEEEEe--ecCccc
Confidence            6999999  89999999999999999999999875  7999999999999999887642   2457999999  666779


Q ss_pred             ceEEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecC--CCcccccccCCCCCcccccc
Q 010309           83 SWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG--SRSLVTERCNTSHPFICMVE  147 (513)
Q Consensus        83 ~w~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~--~~~w~d~~C~~~~~~iC~~~  147 (513)
                      .|+|+||+++.|++|.+++|.+          ..+.++|+.+...  .+.|++..|....+|||+++
T Consensus        78 ~~~W~dg~~~~~~~W~~~~P~~----------~~~~~~Cv~~~~~~~~~~W~~~~C~~~~~fiCe~k  134 (135)
T d1jzna_          78 SWEWTDRSCTDYLTWDKNQPDH----------YQNKEFCVELVSLTGYRLWNDQVCESKDAFLCQCK  134 (135)
T ss_dssp             CCEETTCCCCCCCCBCTTCCCC----------GGGCCCEEEECGGGTTCSEEEECTTSCEEEEEEEC
T ss_pred             ceeecCCceeeccccCCCCCCC----------CCCCCCEEEEEecCCCCcEEeeCCCCCEEEEeeec
Confidence            9999999999999999998822          2345679888543  34699999999999999974

>d1v7pb_ d.169.1.1 (B:) Snake coagglutinin beta chain {Snake (Echis multisquamatus), Ems16 [TaxId: 93050]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Snake coagglutinin beta chain
species: Snake (Echis multisquamatus), Ems16 [TaxId: 93050]

Probab=99.93  E-value=1.5e-26  Score=193.41  Aligned_cols=119  Identities=28%  Similarity=0.549  Sum_probs=100.7

Q ss_pred             CCCCCcccCCCCeeEEEECCCCChHHHHHHHhh--cCCEEeeeCCHHHHHHHHHHhCCC--CCCeEEeeeecCCCCCCce
Q 010309            9 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGLSW   84 (513)
Q Consensus         9 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~~w   84 (513)
                      ||+||.  .|+++||+|+.++++|.+|+..|+.  .||+||+|+|++|++||.+++...  ...|||||+  +...++.|
T Consensus         1 Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~WiGl~--~~~~~~~w   76 (127)
T d1v7pb_           1 CPLGWS--SFDQHCYKVFEPVKNWTEAEEICMQQHKGSRLASIHSSEEEAFVSKLASKALKFTSMWIGLN--NPWKDCKW   76 (127)
T ss_dssp             CCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCSHHHHHHHHHHHHHHCSSCEEEEEEE--CTTTTCCC
T ss_pred             CCCCCE--eeCCEEEEEECcccCHHHHHHhhcccCCCCcccchhhhhhhhhhceeecccccceeEEeeee--ccCcccee
Confidence            999999  7999999999999999999999965  589999999999999999876432  457999999  66778999


Q ss_pred             EEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecC--CCcccccccCCCCCcccccccc
Q 010309           85 KWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG--SRSLVTERCNTSHPFICMVEHE  149 (513)
Q Consensus        85 ~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~--~~~w~d~~C~~~~~~iC~~~~~  149 (513)
                      +|+||+++.|++|..+++                  |+.+...  .+.|++..|....+|||+.+..
T Consensus        77 ~W~dg~~~~y~~W~~~~~------------------c~~~~~~~~~~~W~~~~C~~~~~fiCe~~~~  125 (127)
T d1v7pb_          77 EWSDNARFDYKAWKRRPY------------------CTVMVVKPDRIFWFTRGCEKSVSFVCKFLTD  125 (127)
T ss_dssp             EETTCCCCCCCCBCCCCE------------------EEEEEECSSCEEEEEEETTSCEEEEEEEECC
T ss_pred             EecCCCcccccccCCCCC------------------cEEEEEECCCCeEEecCCCCCEEEEEEEcCC
Confidence            999999999999965442                  4454332  3459999999999999998654

>d1e87a_ d.169.1.1 (A:) CD69 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: CD69
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=5.5e-26  Score=186.95  Aligned_cols=116  Identities=26%  Similarity=0.574  Sum_probs=99.4

Q ss_pred             CCCCCCCcccCCCCeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEE
Q 010309            7 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKW   86 (513)
Q Consensus         7 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W   86 (513)
                      ++||+||+  .|+++||+|+.++++|.+|+..|+.+||+||+|+|++|++||..++.  ...+||||+  +. .++.|+|
T Consensus         1 ssCp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~L~~i~s~~e~~~l~~~~~--~~~~WiGl~--~~-~~~~w~w   73 (117)
T d1e87a_           1 SSCSEDWV--GYQRKCYFISTVKRSWTSAQNACSEHGATLAVIDSEKDMNFLKRYAG--REEHWVGLK--KE-PGHPWKW   73 (117)
T ss_dssp             CCSCTTSE--EETTEEEEECSSCBCHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHC--SSCEEEEEE--CC-TTSCCEE
T ss_pred             CCCCCCCE--EECCEEEEEECcccCHHHHHHHHhhcCCEEeeecCHHHHHHHhhhhc--cceeecccc--cc-ccCccEe
Confidence            47999999  79999999999999999999999999999999999999999999987  457999998  43 3578999


Q ss_pred             cCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCccccccc
Q 010309           87 SDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEH  148 (513)
Q Consensus        87 ~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~~~  148 (513)
                      +||++  |++|.+..+               .++|+.+..  +.|++..|....+|||++|.
T Consensus        74 ~dg~~--~~~w~~~~~---------------~~~C~~l~~--~~w~~~~C~~~~~~ICekp~  116 (117)
T d1e87a_          74 SNGKE--FNNWFNVTG---------------SDKCVFLKN--TEVSSMECEKNLYWICNKPY  116 (117)
T ss_dssp             TTSCB--CCCSSCCBS---------------SCSEEEEET--TEEEEECTTSCBEEEEEEEC
T ss_pred             CCCCc--ccCccCCCC---------------CCcEEEEEC--CEEEEecCCCCEEEEEEEee
Confidence            99986  456653332               346888864  47999999999999999864

>d1c3aa_ d.169.1.1 (A:) Snake coagglutinin alpha chain {Habu snake (Trimeresurus flavoviridis), flavocetin-A [TaxId: 88087]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Snake coagglutinin alpha chain
species: Habu snake (Trimeresurus flavoviridis), flavocetin-A [TaxId: 88087]

Probab=99.93  E-value=1.4e-26  Score=195.79  Aligned_cols=123  Identities=24%  Similarity=0.484  Sum_probs=103.7

Q ss_pred             CCCCCCcccCCCCeeEEEECCCCChHHHHHHHhh--cCCEEeeeCCHHHHHHHHHHhCCC----CCCeEEeeeecCCCCC
Q 010309            8 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN----VNGCWVGGRSINTTVG   81 (513)
Q Consensus         8 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~----~~~~WiGl~~~~~~~~   81 (513)
                      .||+||.  .|+++||+|+..+++|.+|+..|++  .||+||+|+|++|++||.+++...    ...+||||++.+....
T Consensus         3 ~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~~WiGl~~~~~~~~   80 (135)
T d1c3aa_           3 DCIPGWS--AYDRYCYQAFSKPKNWEDAESFCEEGVKTSHLVSIESSGEGDFVAQLVAEKIKTSFQYVWIGLRIQNKEQQ   80 (135)
T ss_dssp             CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCSHHHHHHHHHHHHHHCCSCCSEEEEEEEECCCSSS
T ss_pred             CCCCCCE--eECCEEEEEECcccCHHHHHHHHhhccccccccccCCHHHHHHHHHhhhccccccccccceeeeecCCccc
Confidence            6999999  7999999999999999999999986  499999999999999998877421    3468999996655556


Q ss_pred             CceEEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecC--CCcccccccCCCCCccccccc
Q 010309           82 LSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG--SRSLVTERCNTSHPFICMVEH  148 (513)
Q Consensus        82 ~~w~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~--~~~w~d~~C~~~~~~iC~~~~  148 (513)
                      +.|.|+||+++.|++|.++.|.                +|+.+...  .+.|++..|....+|||+.+|
T Consensus        81 ~~~~W~dgs~~~y~nw~~~~p~----------------~C~~~~~~~~~~~W~~~~C~~~~~fICe~~P  133 (135)
T d1c3aa_          81 CRSEWSDASSVNYENLVKQFSK----------------KCYALKKGTELRTWFNVYCGTENPEVCKYTP  133 (135)
T ss_dssp             CCCBCTTSCBCCCCCBCGGGCC----------------CEEEEETTSCSCSBEEECTTSCEEEEEEECC
T ss_pred             ccccccccCcccccccCCCCCC----------------CeEEEEecCCCCCEEccCCCCCEeEEEEECC
Confidence            7899999999999999877651                36676543  246999999999999999875

>d1tn3a_ d.169.1.1 (A:) Tetranectin {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Tetranectin
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=9.8e-27  Score=197.24  Aligned_cols=129  Identities=16%  Similarity=0.290  Sum_probs=108.0

Q ss_pred             cCCCCCCCcccCCCCeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCC---CCCeEEeeeecCCCCCC
Q 010309            6 KAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN---VNGCWVGGRSINTTVGL   82 (513)
Q Consensus         6 ~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~---~~~~WiGl~~~~~~~~~   82 (513)
                      ...||+||.   ++++||+++.++++|.+|+..|+.+||+||+|+|.+|++||.+++.+.   ...+||||+  +...++
T Consensus         3 qt~C~~G~~---~~~~CY~~~~~~~tw~~A~~~C~~~gg~La~i~s~~e~~~l~~~l~~~~~~~~~~WiGl~--~~~~~~   77 (137)
T d1tn3a_           3 QTVCLKGTK---VHMKCFLAFTQTKTFHEASEDCISRGGTLSTPQTGSENDALYEYLRQSVGNEAEIWLGLN--DMAAEG   77 (137)
T ss_dssp             CCEEEECSS---SSEEEEEEEEEEECHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHHHHTCTTCEEEEEEE--EEEETT
T ss_pred             CCcCCCCeE---ECCEEEEEeCccCCHHHHHHHHHHcCCccccccchHhcccccccccccccccccEeeeec--cCCccc
Confidence            357999996   889999999999999999999999999999999999999999887432   457999999  555679


Q ss_pred             ceEEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecC-CCcccccccCCCCCcccccc
Q 010309           83 SWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG-SRSLVTERCNTSHPFICMVE  147 (513)
Q Consensus        83 ~w~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~-~~~w~d~~C~~~~~~iC~~~  147 (513)
                      .|+|+||+++.|++|....|..        +++++.++|+.+... .+.|++.+|....+|||+.+
T Consensus        78 ~w~w~dg~~~~y~~w~~~~p~~--------p~~~~~~~C~~~~~~~~~~W~~~~C~~~~~fICe~~  135 (137)
T d1tn3a_          78 TWVDMTGARIAYKNWETEITAQ--------PDGGKTENCAVLSGAANGKWFDKRCRDQLPYICQFG  135 (137)
T ss_dssp             EEEETTSCBCSCCCBCCTTTCS--------SCCGGGCCEEEEETTTTTEEEEECTTSCEEEEEEEE
T ss_pred             ccEeCCCCeeeeeeeccccccC--------CCCCCcceeEEEEeCCCCEEEeeCCCCCEEEEEEEe
Confidence            9999999999999887655411        134456789998643 45799999999999999985

>d1umra_ d.169.1.1 (A:) Snake coagglutinin alpha chain {South american rattlesnake (Crotalus durissus terrificus), convulxin [TaxId: 8732]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Snake coagglutinin alpha chain
species: South american rattlesnake (Crotalus durissus terrificus), convulxin [TaxId: 8732]

Probab=99.93  E-value=1.3e-26  Score=196.07  Aligned_cols=124  Identities=25%  Similarity=0.494  Sum_probs=105.1

Q ss_pred             CCCCCCCcccCCCCeeEEEECCCCChHHHHHHHhh--cCCEEeeeCCHHHHHHHHHHhCCC----CCCeEEeeeecCCCC
Q 010309            7 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN----VNGCWVGGRSINTTV   80 (513)
Q Consensus         7 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~----~~~~WiGl~~~~~~~   80 (513)
                      -.||+||.  .|+++||+++.+.++|.+|+..|+.  .||+||+|+|.+|++||.+++.+.    ...+||||.+.+...
T Consensus         2 ~~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~~~g~~La~i~s~~e~~fl~~~~~~~~~~~~~~~WiGl~~~~~~~   79 (135)
T d1umra_           2 LHCPSDWY--YYDQHCYRIFNEEMNWEDAEWFCTKQAKGAHLVSIKSAKEADFVAWMVTQNIEESFSHVSIGLRVQNKEK   79 (135)
T ss_dssp             CSSCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCSHHHHHHHHHHHHHHSCTTCCEEECSEEECCSSS
T ss_pred             CCCCCCCE--EECCEEEEEECcccCHHHHHHHhhccCCCcceeeehhhhhhHHHHHHhhcccCCCCcceeeeeeeecccc
Confidence            36999999  7999999999999999999999975  489999999999999998876432    346899999777777


Q ss_pred             CCceEEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeec--CCCcccccccCCCCCccccccc
Q 010309           81 GLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN--GSRSLVTERCNTSHPFICMVEH  148 (513)
Q Consensus        81 ~~~w~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~--~~~~w~d~~C~~~~~~iC~~~~  148 (513)
                      ++.|+|+||+++.|++|.+++|.                +|+.+..  ..+.|++..|....+|||+.+|
T Consensus        80 ~~~~~W~dGs~~~y~nw~~~~~~----------------~C~~~~~~~~~~~W~~~~C~~~~~fICe~pP  133 (135)
T d1umra_          80 QCSTKWSDGSSVSYDNLLDLYIT----------------KCSLLKKETGFRKWFVASCIGKIPFVCKFPP  133 (135)
T ss_dssp             SSCCBCTTSCBCCCCCBCGGGCC----------------CEEEEEGGGTTCSBEEECTTCCEEEEEEECC
T ss_pred             cCccccccCCcccccccCCCCCC----------------CEEEEEeeCCCCcEEecCCCCCEeEEEeECC
Confidence            78999999999999999877751                3556543  2346999999999999999875

>d1sb2a1 d.169.1.1 (A:1-132) Snake coagglutinin alpha chain {Malayan pit viper (Calloselasma rhodostoma), rhodocetin [TaxId: 8717]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Snake coagglutinin alpha chain
species: Malayan pit viper (Calloselasma rhodostoma), rhodocetin [TaxId: 8717]

Probab=99.93  E-value=2.3e-26  Score=193.68  Aligned_cols=123  Identities=24%  Similarity=0.499  Sum_probs=103.9

Q ss_pred             CCCCCCcccCCCCeeEEEECCCCChHHHHHHHhh--cCCEEeeeCCHHHHHHHHHHhCCC----CCCeEEeeeecCCCCC
Q 010309            8 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN----VNGCWVGGRSINTTVG   81 (513)
Q Consensus         8 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~----~~~~WiGl~~~~~~~~   81 (513)
                      -||+||.  .++++||+|+.++++|.+|+.+|+.  .||+||+|+|.+|++||.+++...    ...+||||++.+...+
T Consensus         1 ~Cp~gw~--~~~~~CY~~~~~~~~~~~A~~~C~~~~~g~~L~~i~s~~e~~~i~~~~~~~~~~~~~~~WiGl~~~~~~~~   78 (132)
T d1sb2a1           1 DCPDGWS--STKSYCYRPFKEKKTWEEAERFCTEQEKEAHLVSMENRLEAVFVDMVMENNFENKIYRSWIGLKIENKGQR   78 (132)
T ss_dssp             CCCTTCE--ECSSEEEEEEEEEECHHHHHHHHHTSSSCCEECCCSSHHHHHHHHHHHHHHTTTCCEEEEEEEEEECSSTT
T ss_pred             CCCCcCE--EECCEEEEEECcccCHHHHHHHHhhccCCccccccCCHHHHHHHHHHHhcccccccchhhhhhhccccccc
Confidence            3999999  8999999999999999999999975  599999999999999999887421    3468999997777778


Q ss_pred             CceEEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCC--CcccccccCCCCCccccccc
Q 010309           82 LSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMVEH  148 (513)
Q Consensus        82 ~~w~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~--~~w~d~~C~~~~~~iC~~~~  148 (513)
                      +.|+|+||+++.|.+|+.+.+                ++|+.+....  ..|++..|....+|||+.+.
T Consensus        79 ~~~~W~dG~~~~y~n~~~~~~----------------~~C~~~~~~~~~~~W~~~~C~~~~~fICe~~~  131 (132)
T d1sb2a1          79 SNLEWSDGSSISYENLYEPYM----------------EKCFLMDHQSGLPKWHTADCEEKNVFMCKFQL  131 (132)
T ss_dssp             SSEEETTCCCCCCCCBSSCCC----------------EEEEEEEESSSSCEEEEECTTSCEEEEEEEEC
T ss_pred             cceecccCCcccceecCCCCC----------------ccEEEEEcCCCCCcEEecCCCCCEeEEEEEeC
Confidence            999999999999999864321                3577775433  46999999999999999764

>d1egga_ d.169.1.1 (A:) Macrophage mannose receptor, CRD4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Macrophage mannose receptor, CRD4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=3.3e-26  Score=193.83  Aligned_cols=127  Identities=24%  Similarity=0.501  Sum_probs=103.9

Q ss_pred             CCCCCcccCCCCeeEEEE----CCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCC---CCCeEEeeeecCCCCC
Q 010309            9 CPPDWIINEEKSKCFGYI----GNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN---VNGCWVGGRSINTTVG   81 (513)
Q Consensus         9 Cp~~w~~~~~~~~Cy~~~----~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~---~~~~WiGl~~~~~~~~   81 (513)
                      ||+||...+++++||+++    .++++|.+|+..|+++||+||+|+|.+|++||.+++...   ...+||||+  +...+
T Consensus         1 Cp~gW~~~~~~~~CY~~~~~~~~~~~~w~~A~~~C~~~gg~L~~i~s~~e~~~i~~~l~~~~~~~~~~wiG~~--~~~~~   78 (136)
T d1egga_           1 CPEDWGASSRTSLCFKLYAKGKHEKKTWFESRDFCRALGGDLASINNKEEQQTIWRLITASGSYHKLFWLGLT--YGSPS   78 (136)
T ss_dssp             CCTTCEECSSSSCEEEEECSCGGGCBCHHHHHHHHHTTTCEECCCCSHHHHHHHHHHHHHHTCTTCEEEEEEE--CC---
T ss_pred             CCCCCeeCCCCCEEEEEEecCCCcccCHHHHHHHHHHCCCEEeEEecchhhhhhhhhcccccccccccccccc--ccccc
Confidence            999997446779999884    567899999999999999999999999999999987532   346899999  66677


Q ss_pred             CceEEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecC-CCcccccccCCCCCcccccc
Q 010309           82 LSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG-SRSLVTERCNTSHPFICMVE  147 (513)
Q Consensus        82 ~~w~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~-~~~w~d~~C~~~~~~iC~~~  147 (513)
                      +.|.|+||+++.|++|.+++|.+          ..+.++|+.+... ...|++.+|....+|||+.+
T Consensus        79 ~~~~W~dg~~~~y~~W~~g~P~~----------~~~~~~C~~~~~~~~~~W~~~~C~~~~~fICe~~  135 (136)
T d1egga_          79 EGFTWSDGSPVSYENWAYGEPNN----------YQNVEYCGELKGDPTMSWNDINCEHLNNWICQIQ  135 (136)
T ss_dssp             -CCCCTTSCCCCCCCCCTTCSCG----------GGSCCEEEEEECSTTCCEEEEETTSCBEEEEECC
T ss_pred             eeeeeecCCcceeecccCCCCCC----------CCCCcceEEEEcCCCCeEEecCCCCcEeEEEEEe
Confidence            99999999999999999998822          2355689988654 45699999999999999975

>d3bdwa1 d.169.1.1 (A:59-179) CD94 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: CD94
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=2.1e-26  Score=190.73  Aligned_cols=119  Identities=18%  Similarity=0.442  Sum_probs=102.7

Q ss_pred             CCCCCCcccCCCCeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEc
Q 010309            8 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWS   87 (513)
Q Consensus         8 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~   87 (513)
                      +||.||.  .|+++||+|+.+.++|.+|+.+|+++||+||+|++++|++||...    ...+||||++  ...++.|+|+
T Consensus         2 ~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~~~~fl~~~----~~~~WiGl~~--~~~~~~w~w~   73 (121)
T d3bdwa1           2 SCQEKWV--GYRCNCYFISSEQKTWNESRHLCASQKSSLLQLQNTDELDFMSSS----QQFYWIGLSY--SEEHTAWLWE   73 (121)
T ss_dssp             CCTTTCE--EETTEEEEECSSCBCHHHHHHHHHHTTCEECCCSCGGGGGGGTTC----CCCEECSEEE--ETTTTEEEET
T ss_pred             cCCCCcE--EECCEEEEEEccccCHHHHHHHHhhcCCcccceeeeeeeeEeeec----ccceEEEEee--cCccceeEeC
Confidence            6999999  899999999999999999999999999999999999999998542    4579999994  4456999999


Q ss_pred             CCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCccccccc
Q 010309           88 DNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEH  148 (513)
Q Consensus        88 dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~~~  148 (513)
                      ||+++.+.+|..++|.+             .++|+.+... +.|.+..|....+|||+.+.
T Consensus        74 dg~~~~~~~w~~~~~~~-------------~~~C~~~~~~-g~w~~~~C~~~~~fICek~l  120 (121)
T d3bdwa1          74 NGSALSQYLFPSFETFN-------------TKNCIAYNPN-GNALDESCEDKNRYICKQQL  120 (121)
T ss_dssp             TSCBCCTTTSGGGGGCC-------------TTSEEEEETT-TEEEEECTTSCBEEEEEECC
T ss_pred             CCCcccccccCCCCCCC-------------CCCEEEEECC-CEEEeeCCCCCEEEEEeEEc
Confidence            99999999988777621             2368787543 57999999999999999753

>d1fvua_ d.169.1.1 (A:) Snake coagglutinin alpha chain {Jararaca (Bothrops jararaca), botrocetin [TaxId: 8724]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Snake coagglutinin alpha chain
species: Jararaca (Bothrops jararaca), botrocetin [TaxId: 8724]

Probab=99.92  E-value=2.9e-26  Score=193.32  Aligned_cols=124  Identities=24%  Similarity=0.497  Sum_probs=102.5

Q ss_pred             CCCCCCcccCCCCeeEEEECCCCChHHHHHHHhh--cCCEEeeeCC-HHHHHHHHHHhCC----CCCCeEEeeeecCCCC
Q 010309            8 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTS-YEEEHSAQKLCGK----NVNGCWVGGRSINTTV   80 (513)
Q Consensus         8 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~-~~e~~f~~~~~~~----~~~~~WiGl~~~~~~~   80 (513)
                      -||+||.  .|+++||+|+.++++|.+|+..|+.  .||+||+|++ ++|+.||..++..    ....+||||++.+...
T Consensus         1 ~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~La~i~~~~e~~~~~~~~~~~~~~~~~~~~WIGl~~~~~~~   78 (133)
T d1fvua_           1 DCPSGWS--SYEGNCYKFFQQKMNWADAERFCSEQAKGGHLVSIKIYSKEKDFVGDLVTKNIQSSDLYAWIGLRVENKEK   78 (133)
T ss_dssp             CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCTTSTHHHHHHHHHHHHCCSSCCEEEEEEEECCSSS
T ss_pred             CCCCCCE--EECCEEEEEECcccCHHHHHHHHhhccccccccccCCHHHHHHHHHhhhhccccCccccceEEEeeccccc
Confidence            3999999  7999999999999999999999975  6999999975 5678888876532    2446999999766666


Q ss_pred             CCceEEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCC--CcccccccCCCCCcccccccc
Q 010309           81 GLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMVEHE  149 (513)
Q Consensus        81 ~~~w~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~--~~w~d~~C~~~~~~iC~~~~~  149 (513)
                      .+.|+|+||+++.|++|..++|.                +|+.+....  +.|++..|....+|||+.+++
T Consensus        79 ~~~w~W~dGs~~~y~~w~~~~p~----------------~C~~~~~~~~~~~W~~~~C~~~~~fICe~~Pp  133 (133)
T d1fvua_          79 QCSSEWSDGSSVSYENVVERTVK----------------KCFALEKDLGFVLWINLYCAQKNPFVCKSPPP  133 (133)
T ss_dssp             SSCCBCTTSCBCCCCCBCGGGCC----------------CEEEEETTTTSCSEEEECTTCCEEEEEEECCC
T ss_pred             ccccccccCCcccccccCCCCCC----------------CeEEEEecCCCCeEEccCCCCCEEEEEEECcC
Confidence            67899999999999999888762                366665433  469999999999999999764

>d1jwia_ d.169.1.1 (A:) Snake coagglutinin alpha chain {Puff adder (Bitis arietans), bitiscetin [TaxId: 8692]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Snake coagglutinin alpha chain
species: Puff adder (Bitis arietans), bitiscetin [TaxId: 8692]

Probab=99.92  E-value=4.3e-26  Score=189.82  Aligned_cols=118  Identities=31%  Similarity=0.628  Sum_probs=98.3

Q ss_pred             CCCCCcccCCCCeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCC----CCCeEEeeeecCCCCCCce
Q 010309            9 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN----VNGCWVGGRSINTTVGLSW   84 (513)
Q Consensus         9 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~----~~~~WiGl~~~~~~~~~~w   84 (513)
                      ||+||+  .|+++||+++.++++|.+|+..|+++||+||+|+|.+|++||.+++...    ...+||||++.....++.|
T Consensus         1 Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~i~~~~~~~~~~~~~~~WiGl~~~~~~~~~~~   78 (124)
T d1jwia_           1 CLPDWS--SYKGHCYKVFKKVGTWEDAEKFCVENSGHLASIDSKEEADFVTKLASQTLTKFVYDAWIGLRDESKTQQCSP   78 (124)
T ss_dssp             CCTTSE--EETTEEEEEEEEEECHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHHHHC--CCSCEEEEEEECCSSSSSCS
T ss_pred             CCCCCE--eeCCEEEEEECcccCHHHHHHHHHhcCCeeeeeehHHHHHHHHHHHhccccccccceeeEeeeccCCCccce
Confidence            999999  7999999999999999999999999999999999999999999876421    4469999996655566789


Q ss_pred             EEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEee--cCCCcccccccCCCCCccccc
Q 010309           85 KWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVS--NGSRSLVTERCNTSHPFICMV  146 (513)
Q Consensus        85 ~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~--~~~~~w~d~~C~~~~~~iC~~  146 (513)
                      +|+||+++.|.+|  ++|  ++              |+.+.  ...+.|++.+|....+|||+.
T Consensus        79 ~W~dgs~~~y~n~--~~p--~~--------------c~~~~~~~~~~~W~~~~C~~~~~fICet  124 (124)
T d1jwia_          79 QWTDGSSVVYENV--DEP--TK--------------CFGLDVHTEYRTWTDLPCGEKNPFICKS  124 (124)
T ss_dssp             BCTTSCBCCSCCB--SSC--CC--------------EEEECGGGTTSSEEEECTTSCEEEEEEC
T ss_pred             ecCCCCcccccCC--CCC--Cc--------------cEEEEEecCCCCEEccCCCCCEeeEeCC
Confidence            9999999988877  344  22              33332  334579999999999999984

>d1uv0a_ d.169.1.1 (A:) Pancreatitis-associated protein 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Pancreatitis-associated protein 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=1.8e-25  Score=190.22  Aligned_cols=129  Identities=19%  Similarity=0.380  Sum_probs=105.8

Q ss_pred             cCCCCCCCcccCCCCeeEEEECCCCChHHHHHHHhh-cCCEEeeeCCHHHHHHHHHHhCCC---CCCeEEeeeecCCC--
Q 010309            6 KAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE-IGGHLAALTSYEEEHSAQKLCGKN---VNGCWVGGRSINTT--   79 (513)
Q Consensus         6 ~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~-~~~~L~~i~~~~e~~f~~~~~~~~---~~~~WiGl~~~~~~--   79 (513)
                      +..||+||.  .++++||+|+...++|.+|+..|++ .||+||+|+|.+|++||.+++...   ...+||||++....  
T Consensus         2 ~~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~gg~La~i~s~~e~~~l~~~l~~~~~~~~~~WiGl~~~~~~~~   79 (140)
T d1uv0a_           2 RIRCPKGSK--AYGSHCYALFLSPKSWTDADLACQKRPSGNLVSVLSGAEGSFVSSLVKSIGNSYSYVWIGLHDPTQGTE   79 (140)
T ss_dssp             CCCCCTTCE--EETTEEEEEEEEEECHHHHHHHHTTSTTCEECCCCSHHHHHHHHHHHTTSCTTCCEEEEEEECTTTTCC
T ss_pred             CCccCcCcE--eeCCEEEEEECCccCHHHHHHhhhccccceecccCCHHHHHHHHHhhhccccccceeEEeeeccccccc
Confidence            468999999  8999999999999999999999987 599999999999999999998653   34699999843221  


Q ss_pred             -CCCceEEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCC--CcccccccCCCCCcccccc
Q 010309           80 -VGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMVE  147 (513)
Q Consensus        80 -~~~~w~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~--~~w~d~~C~~~~~~iC~~~  147 (513)
                       ....|.|+||+++.|++|..++|           ++.+.++|+.+....  +.|++.+|....+|||+..
T Consensus        80 ~~~~~w~w~dg~~~~~~~w~~~~~-----------~~~~~~~C~~~~~~~~~~~W~~~~C~~~~~fICe~t  139 (140)
T d1uv0a_          80 PNGEGWEWSSSDVMNYFAWERNPS-----------TISSPGHCASLSRSTAFLRWKDYNCNVRLPYVCKFT  139 (140)
T ss_dssp             --CCCCEETTCCCCCCCCBSSCGG-----------GSSSCCSEEEEEGGGTTCSEEEECTTSCEEEEEEEC
T ss_pred             CCCCceEccCCCcccccccCCCCC-----------CCCCCCCEEEEEccCCCCeEEecCCCCCEeEEEEEC
Confidence             12469999999999999977655           223456788886443  4599999999999999974

>d1qo3c_ d.169.1.1 (C:) NK cell receptor {Mouse (Mus musculus), ly49-a [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: NK cell receptor
species: Mouse (Mus musculus), ly49-a [TaxId: 10090]

Probab=99.92  E-value=5.5e-26  Score=191.38  Aligned_cols=123  Identities=19%  Similarity=0.310  Sum_probs=99.5

Q ss_pred             CcCCCCCCCcccCCCCeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCce
Q 010309            5 WKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSW   84 (513)
Q Consensus         5 ~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w   84 (513)
                      .+..||.+|.  .|+++||+|+.++++|.+|+..|+.+||+||+|+|++|++||..++.  ...|||||++  ...++.|
T Consensus        10 ~~~~c~~~W~--~~~~~CY~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~--~~~~WIGl~~--~~~~~~w   83 (133)
T d1qo3c_          10 TGRGDKVYWF--CYGMKCYYFVMDRKTWSGCKQTCQSSSLSLLKIDDEDELKFLQLVVP--SDSCWVGLSY--DNKKKDW   83 (133)
T ss_dssp             -----CEEEE--EETTEEEEEEEEEECHHHHHHHHHHTTCEECCCCSHHHHHHHHHHSC--SSCEEEEEEE--EGGGTEE
T ss_pred             CCCCCCCceE--EECCEEEEEECccCCHHHHHHHHHhcCCEEeEEeecceeeehhcccc--cceeEEEEEE--cCCCCCE
Confidence            4568999999  89999999999999999999999999999999999999999999987  4579999994  4456999


Q ss_pred             EEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCccccccc
Q 010309           85 KWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEH  148 (513)
Q Consensus        85 ~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~~~  148 (513)
                      +|+||+++.+.+|....             +.+.++|+.+..  +.|++.+|....+|||+++.
T Consensus        84 ~W~dg~~~~~~~~~~~~-------------~~~~~~C~~l~~--~~w~~~~C~~~~~~ICek~l  132 (133)
T d1qo3c_          84 AWIDNRPSKLALNTRKY-------------NIRDGGCMLLSK--TRLDNGNCDQVFICICGKRL  132 (133)
T ss_dssp             EETTSCCCSSCCCTTSS-------------CGGGCSEEEECS--SCEEEECTTSCEEEEEEEEC
T ss_pred             EECCCCccccccccCCC-------------CCCCCCEEEEEC--CEEEEcCCCCCEEEEEeEEC
Confidence            99999987665543222             123346888753  47999999999999999764

>d1j34a_ d.169.1.1 (A:) Snake coagglutinin alpha chain {Habu snake (Trimeresurus flavoviridis) [TaxId: 88087]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Snake coagglutinin alpha chain
species: Habu snake (Trimeresurus flavoviridis) [TaxId: 88087]

Probab=99.92  E-value=5.4e-26  Score=190.54  Aligned_cols=120  Identities=28%  Similarity=0.585  Sum_probs=100.4

Q ss_pred             CCCCCcccCCCCeeEEEECCCCChHHHHHHHhh--cCCEEeeeCCHHHHHHHHHHhCC----CCCCeEEeeeecCCCCCC
Q 010309            9 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGK----NVNGCWVGGRSINTTVGL   82 (513)
Q Consensus         9 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~----~~~~~WiGl~~~~~~~~~   82 (513)
                      ||+||.  .++++||+|+..+++|.+|+..|+.  .||+||+|+|++|++||.+++..    ....+||||++.+....+
T Consensus         2 Cp~gw~--~~~~~CY~~~~~~~~~~~A~~~C~~~~~g~~L~~i~s~~e~~~l~~~~~~~~~~~~~~~WIGl~~~~~~~~~   79 (129)
T d1j34a_           2 CPSGWS--SYEGHCYKPFKLYKTWDDAERFCTEQAKGGHLVSIESAGEADFVAQLVTENIQNTKSYVWIGLRVQGKEKQC   79 (129)
T ss_dssp             CCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCSHHHHHHHHHHHHHHCCCTTCCEEEEEEECSSCSCS
T ss_pred             CCCcCE--eeCCEEEEEECcccCHHHHHHhhhhccCCccccccCCHHHHHHHHhhhccccccccceEEeeeecccccccc
Confidence            999999  7999999999999999999999965  69999999999999999887642    245699999965555456


Q ss_pred             ceEEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEee--cCCCcccccccCCCCCccccc
Q 010309           83 SWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVS--NGSRSLVTERCNTSHPFICMV  146 (513)
Q Consensus        83 ~w~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~--~~~~~w~d~~C~~~~~~iC~~  146 (513)
                      .|+|+||+++.|++|.+++|.                +|+.+.  ...+.|++..|....+|||+.
T Consensus        80 ~~~W~dgs~~~y~~W~~~ep~----------------~c~~~~~~~~~~~W~~~~C~~~~~fICea  129 (129)
T d1j34a_          80 SSEWSDGSSVSYENWIEAESK----------------TCLGLEKETGFRKWVNIYCGQQNPFVCEA  129 (129)
T ss_dssp             CCBCTTSCBCCCCCBCGGGSC----------------CEEEECGGGTTCSBEEECTTSCEEEEEEC
T ss_pred             ceecCCCCcccccccCCCCCC----------------cEEEEEccCCCCCEEecCCCCCcceEecC
Confidence            799999999999999998872                244443  223469999999999999984

>d1pwba1 d.169.1.1 (A:235-355) Surfactant protein, lectin domain {Human (Homo sapiens), SP-D [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Surfactant protein, lectin domain
species: Human (Homo sapiens), SP-D [TaxId: 9606]

Probab=99.92  E-value=3.3e-26  Score=189.40  Aligned_cols=121  Identities=15%  Similarity=0.237  Sum_probs=105.1

Q ss_pred             CCCCcccCCCCeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEcCC
Q 010309           10 PPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDN   89 (513)
Q Consensus        10 p~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~dg   89 (513)
                      |+|+.   ++++||+++.+.++|.+|+..|+.+||+||+|+|++|++||.+++......+||||+  +...++.|+|+||
T Consensus         1 P~g~~---~g~~cy~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~WiGl~--~~~~~~~~~w~dg   75 (121)
T d1pwba1           1 PNGQS---VGEKIFKTAGFVKPFTEAQLLCTQAGGQLASPRSAAENAALQQLVVAKNEAAFLSMT--DSKTEGKFTYPTG   75 (121)
T ss_dssp             TTEEE---ETTEEEEEEEEEEEHHHHHHHHHHTTSEECCCCSHHHHHHHHHHHHHHTCCEECSCB--CSSSTTCCBCTTS
T ss_pred             CCcEE---ECCEEEEEeCeeECHHHHHHHHHHcCCEecceeechhhhhhhhccccceeeeeeeee--ccCccceeeeccc
Confidence            55654   899999999999999999999999999999999999999999987644567999999  6667799999999


Q ss_pred             CCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCccccc
Q 010309           90 MSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMV  146 (513)
Q Consensus        90 ~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~  146 (513)
                      +++.|++|.+++|.+          ..+.++|+.+.. ++.|++.+|....+|||+.
T Consensus        76 ~~~~~~~W~~~eP~~----------~~~~~~C~~~~~-~~~W~~~~C~~~~~fICey  121 (121)
T d1pwba1          76 ESLVYSNWAPGEPND----------DGGSEDCVEIFT-NGKWNDRACGEKRLVVCEF  121 (121)
T ss_dssp             CBCSCCCBCTTCCCC----------GGGCCCEEEECT-TSCEEEECTTSEEEEEEEC
T ss_pred             cccccceecCCCCCC----------CCCceeEEEECC-CCEEEeeCCCCCEEEEEeC
Confidence            999999999998832          235678999854 4689999999999999984

>d2msba_ d.169.1.1 (A:) Mannose-binding protein A, C-lectin domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Mannose-binding protein A, C-lectin domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.92  E-value=2.6e-25  Score=180.90  Aligned_cols=111  Identities=14%  Similarity=0.232  Sum_probs=98.5

Q ss_pred             eeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEcCCCCCccCCcccC
Q 010309           21 KCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAV  100 (513)
Q Consensus        21 ~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~dg~~~~~~~~~~~  100 (513)
                      +||+++.++++|.+|+..|+.+||+||+|+|.+|++||.+++.   ..+||||+  +...+|.|+|+||+++.|++|.++
T Consensus         2 k~y~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~---~~~WiGl~--~~~~~g~~~w~dg~~~~y~~W~~~   76 (112)
T d2msba_           2 KFFVTNHERMPFSKVKALCSELRGTVAIPRNAEENKAIQEVAK---TSAFLGIT--DEVTEGQFMYVTGGRLTYSNWKKD   76 (112)
T ss_dssp             CEEEEEEEEECHHHHHHHHHHTTCEECCCSSHHHHHHHHHHHS---SCEEEEEE--CSSSTTCCEETTSSBCCSCCBCTT
T ss_pred             cEEEECCcEeCHHHHHHHHHhCCCEEeeEcCHHHhhhhhhccc---ceEEEEEe--ecCccccccccccccccccccccC
Confidence            6999999999999999999999999999999999999999986   47999999  666779999999999999999999


Q ss_pred             CCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCcccccc
Q 010309          101 GSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE  147 (513)
Q Consensus       101 ~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~~  147 (513)
                      +|.+          ..+.|+|+.+.. .+.|++..|....+|||+.|
T Consensus        77 eP~~----------~~~~~~Cv~~~~-~~~W~~~~C~~~~~fICe~P  112 (112)
T d2msba_          77 EPND----------HGSGEDCVTIVD-NGLWNDISCQASHTAVCEFP  112 (112)
T ss_dssp             CCCC----------CTTCCCEEEECT-TSCEEEECTTSCEEEEEEEC
T ss_pred             CCCC----------CCCCCCEEEEeC-CCEEEEeCCCCcEEEEEecC
Confidence            8832          234568998854 46899999999999999875

>d1sb2b1 d.169.1.1 (B:2-128) Snake coagglutinin beta chain {Malayan pit viper (Calloselasma rhodostoma), rhodocetin [TaxId: 8717]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Snake coagglutinin beta chain
species: Malayan pit viper (Calloselasma rhodostoma), rhodocetin [TaxId: 8717]

Probab=99.92  E-value=5.1e-26  Score=190.10  Aligned_cols=117  Identities=22%  Similarity=0.474  Sum_probs=97.1

Q ss_pred             CCCCCCcccCCCCeeEEEECCCCChHHHHHHHhh--cCCEEeeeCCHHHHHHHHHHhCC----CCCCeEEeeeecCCCCC
Q 010309            8 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGK----NVNGCWVGGRSINTTVG   81 (513)
Q Consensus         8 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~----~~~~~WiGl~~~~~~~~   81 (513)
                      .||+||.  .|+++||+++.++++|.+|+..|+.  .||+||+|+|.+|++||..++..    ....+||||+  +    
T Consensus         2 ~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~~~gg~La~i~s~~e~~fl~~~~~~~~~~~~~~~WiGl~--~----   73 (127)
T d1sb2b1           2 RCPTTWS--ASKLYCYKPFKEKKTWIEAERFCAKQAENGHLVSIGSAAEADFLDLVIVVNFDKQRYRAWTGLT--E----   73 (127)
T ss_dssp             CCCTTCE--ECSSEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCSHHHHHHHHHHHHHHC---CCCEEEEEE--E----
T ss_pred             cCCCCCe--ecCCEEEEEECeecCHHHHHHHHHhhcCCcccccccCHHHHHHHHHHHhhhccccccceeeeec--c----
Confidence            5999999  7999999999999999999999975  59999999999999999987642    1446999998  4    


Q ss_pred             CceEEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEe--ecCCCcccccccCCCCCccccccc
Q 010309           82 LSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLV--SNGSRSLVTERCNTSHPFICMVEH  148 (513)
Q Consensus        82 ~~w~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~--~~~~~~w~d~~C~~~~~~iC~~~~  148 (513)
                      +.|+|+||+++.|++|..+++  +              +|+.+  ....+.|++..|.....|||+.|.
T Consensus        74 ~~~~W~dGs~~~y~nw~~~~~--~--------------~c~~~~~~~~~~~W~~~~C~~~~~fICe~Pk  126 (127)
T d1sb2b1          74 RNLKWTNGASVSYENLYEPYI--R--------------KCFVVQPWEGKSKWYKADCEEKNAFLCKFPK  126 (127)
T ss_dssp             CCCBCTTSCBCCSCCBSSCCC--C--------------CEEEEEEETTEEEEEEECTTSCEEEEEEEEC
T ss_pred             cceeecccCCccccccCCCCC--c--------------ceeEEEEeCCCCCEEecCCCCCEEEEEEEcC
Confidence            569999999999999975543  2              24444  333346999999999999999864

>d3c8ja1 d.169.1.1 (A:138-259) NK cell receptor {Mouse (Mus musculus), ly49-c [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: NK cell receptor
species: Mouse (Mus musculus), ly49-c [TaxId: 10090]

Probab=99.91  E-value=6.5e-26  Score=187.92  Aligned_cols=120  Identities=18%  Similarity=0.322  Sum_probs=102.2

Q ss_pred             CCCCCcccCCCCeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEcC
Q 010309            9 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSD   88 (513)
Q Consensus         9 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~d   88 (513)
                      |+.+|.  .|+++||+|+.+.+||.+|+..|+.+||+||+|+|.+|++||.+++.  ...|||||+  +...++.|+|+|
T Consensus         2 ~~k~W~--~~~~~CY~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~fi~~~~~--~~~~WIGl~--~~~~~~~w~W~d   75 (122)
T d3c8ja1           2 GVKYWF--CYSTKCYYFIMNKTTWSGCKANCQHYGVPILKIEDEDELKFLQRHVI--PGNYWIGLS--YDKKKKEWAWID   75 (122)
T ss_dssp             CCEEEE--EEETEEEEEEEEEECHHHHHHHHHHTTCCBCCCCSHHHHHHHHHHSC--SSCEEEEEE--EETTTTEEEETT
T ss_pred             CCcccE--EECCEEEEEeCCcCCHHHHHHHHHhCCCcccceehHHHhhhhhhhhe--eeeeEEEEE--EcCCCCcEEECC
Confidence            889999  79999999999999999999999999999999999999999999886  457999999  444569999999


Q ss_pred             CCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCcccccccc
Q 010309           89 NMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEHE  149 (513)
Q Consensus        89 g~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~~~~  149 (513)
                      |+++.+.+|..+++             .+.++|+.+..  +.|++.+|....+|||+.+.+
T Consensus        76 g~~~~~~~~~~~~~-------------~~~~~Cv~~~~--~~w~~~~C~~~~~~ICek~l~  121 (122)
T d3c8ja1          76 NGPSKLDMKIKKMN-------------FKSRGCVFLSK--ARIEDIDCNIPYYCICGKKLD  121 (122)
T ss_dssp             SCCCTTHHHHHTTC-------------CCSSSEEEECS--SCEEEECTTSCEEEEEEEECS
T ss_pred             CCcccccccCCCCC-------------CCCCCEEEEEC--CEEEEcCCCCCEeEEEeEECC
Confidence            99887766654433             12346888753  479999999999999998653

>d1v7pa_ d.169.1.1 (A:) Snake coagglutinin alpha chain {Snake (Echis multisquamatus), Ems16 [TaxId: 93050]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Snake coagglutinin alpha chain
species: Snake (Echis multisquamatus), Ems16 [TaxId: 93050]

Probab=99.91  E-value=9.5e-26  Score=190.38  Aligned_cols=126  Identities=24%  Similarity=0.437  Sum_probs=101.2

Q ss_pred             CCCCCCCcccCCCCeeEEEECCCCChHHHHHHHhhc--CCEEeeeCCHHHHHHHHHHhCCC----CCCeEEeeeecCCCC
Q 010309            7 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKN----VNGCWVGGRSINTTV   80 (513)
Q Consensus         7 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~--~~~L~~i~~~~e~~f~~~~~~~~----~~~~WiGl~~~~~~~   80 (513)
                      ..||+||.  .|+++||+++.++++|.+|+..|+.+  ||+||+|+|.+|++||.+++...    ...+||||++.....
T Consensus         2 ~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~~g~La~i~s~~e~~fi~~~~~~~~~~~~~~~WIGl~~~~~~~   79 (134)
T d1v7pa_           2 FDCPSDWT--AYDQHCYLAIGEPQNWYEAERFCTEQAKDGHLVSIQSREEGNFVAQLVSGFMHRSEIYVWIGLRDRREEQ   79 (134)
T ss_dssp             TTSCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCSHHHHHHHHHHTGGGGGSSCSEEEEEEECCCSSS
T ss_pred             CCCCCCCE--EECCEEEEEECcccCHHHHHHhhcccCCCccccccCCHHHhHHHHhhcccccccccchhhhhccccCCcc
Confidence            36999999  79999999999999999999999764  89999999999999999988543    335999999433332


Q ss_pred             CCceEEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCccccccc
Q 010309           81 GLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEH  148 (513)
Q Consensus        81 ~~~w~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~~~  148 (513)
                      ...|+|+||+++.|++|.+++|.  +|..            +......+.|++..|....+|||+.+.
T Consensus        80 ~~~~~W~dgs~~~y~~W~~~~p~--~~~~------------~~~~~~~~~W~~~~C~~~~~fICe~~A  133 (134)
T d1v7pa_          80 QCNPEWNDGSKIIYVNWKEGESK--MCQG------------LTKWTNFHDWNNINCEDLYPFVCKFSA  133 (134)
T ss_dssp             CSCCBCTTSCBCCCCCBCTTCCC--CEEE------------EEGGGTTCSEEEECTTSCEEEEEEEEC
T ss_pred             eeeeeecCCCcccccccCCCCCC--ceeE------------EEEecCCCcEEeeCCCCCEEEEEEEee
Confidence            33678899999999999998873  2321            122234457999999999999999853

>d1r13a1 d.169.1.1 (A:110-228) Surfactant protein, lectin domain {Rat (Rattus norvegicus), SP-A [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Surfactant protein, lectin domain
species: Rat (Rattus norvegicus), SP-A [TaxId: 10116]

Probab=99.91  E-value=5.1e-25  Score=181.29  Aligned_cols=116  Identities=16%  Similarity=0.197  Sum_probs=102.3

Q ss_pred             CCCCeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEcCCCCCccCC
Q 010309           17 EEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNES   96 (513)
Q Consensus        17 ~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~dg~~~~~~~   96 (513)
                      ..+++||+++.++++|.+|+..|+.+||+||+|+|.+|++||.+++......+||||+  +...++.|+|+||+++.|++
T Consensus         4 ~vG~~cy~~~~~~~~w~~A~~~C~~~gg~La~i~s~~e~~~l~~~~~~~~~~~WiGl~--~~~~~~~w~w~dg~~~~y~~   81 (119)
T d1r13a1           4 SVGDKVFSTNGQSVNFDTIKEMCTRAGGNIAVPRTPEENEAIASIAKKYNNYVYLGMI--EDQTPGDFHYLDGASVSYTN   81 (119)
T ss_dssp             EETTEEEEEEEEEECHHHHHHHHHHTTSEECCCCSHHHHHHHHHHHHHTTSCEEEEEE--ECSSTTCEEETTSCBCCSCC
T ss_pred             cCccEEEEECCEEECHHHHHHHhhhCCCEEeEEeehHHhhhhhhcccccceEEEEEee--cCCcceeeeeecccccccce
Confidence            5789999999999999999999999999999999999999999988655667999999  55567999999999999999


Q ss_pred             cccCCCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCccccc
Q 010309           97 IHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMV  146 (513)
Q Consensus        97 ~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~  146 (513)
                      |.+++|.           +.+.++|+.+.. ++.|++.+|....+|||+.
T Consensus        82 W~~~~P~-----------~~~~~~Cv~~~~-~~~W~~~~C~~~~~~ICey  119 (119)
T d1r13a1          82 WYPGEPR-----------GQGKEKCVEMYT-DGTWNDRGCLQYRLAVCEF  119 (119)
T ss_dssp             BCTTCCC-----------CSSCCCEEEECT-TSCEEEECSCSCEEEEEEC
T ss_pred             EEeeccC-----------CCCCCCEEEEcC-CCEEEecCCCCCEeEEEeC
Confidence            9999882           234567998864 4689999999999999984

>d1hupa1 d.169.1.1 (A:112-228) Mannose-binding protein A, C-lectin domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Mannose-binding protein A, C-lectin domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=6.5e-25  Score=180.26  Aligned_cols=115  Identities=15%  Similarity=0.186  Sum_probs=101.6

Q ss_pred             CCCCeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEcCCCCCccCC
Q 010309           17 EEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNES   96 (513)
Q Consensus        17 ~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~dg~~~~~~~   96 (513)
                      .++++||+++.++++|.+|+..|+.+||+||+|+|++|++||.+++.   ..+||||+  +...+|.|.|+||+++.|++
T Consensus         2 ~vG~~~y~~~~~~~tw~~A~~~C~~~gg~La~i~s~~e~~~l~~~~~---~~~WiGl~--~~~~~~~w~w~dg~~~~~~~   76 (117)
T d1hupa1           2 QVGNKFFLTNGEIMTFEKVKALCVKFQASVATPRNAAENGAIQNLIK---EEAFLGIT--DEKTEGQFVDLTGNRLTYTN   76 (117)
T ss_dssp             EETTEEEEEEEEEEEHHHHHHHHHHTTCEECCCCSHHHHHHHHHHCS---SCEEEEEE--CSSSTTCCEETTSCBCSCCC
T ss_pred             cccCEEEEEcCEEECHHHHHHHHHHCCCEEcccCCHHHHHHHhhccc---ceEEEEee--ccCcccceeecccccccccc
Confidence            46899999999999999999999999999999999999999999985   57999999  66667999999999999999


Q ss_pred             cccCCCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCcccccc
Q 010309           97 IHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE  147 (513)
Q Consensus        97 ~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~~  147 (513)
                      |.+++|.+          ..++++|+.+.. ++.|++.+|....+|||+.|
T Consensus        77 w~~~~p~~----------~~~~~~Cv~~~~-~~~W~~~~C~~~~~fICe~P  116 (117)
T d1hupa1          77 WNEGEPNN----------AGSDEDCVLLLK-NGQWNDVPCSTSHLAVCEFP  116 (117)
T ss_dssp             BCTTCCCC----------GGGCCCEEEECT-TSCEEEECTTSEEEEEEEEE
T ss_pred             cCCCCCCC----------CCCcCCeEEECC-CCeEEeeCCCCCEEEEEEEe
Confidence            99888722          235678998854 46899999999999999985

>d1oz7a_ d.169.1.1 (A:) Snake coagglutinin alpha chain {Saw-scaled viper (Echis carinatus), echicetin [TaxId: 40353]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Snake coagglutinin alpha chain
species: Saw-scaled viper (Echis carinatus), echicetin [TaxId: 40353]

Probab=99.91  E-value=2.1e-25  Score=187.39  Aligned_cols=122  Identities=26%  Similarity=0.559  Sum_probs=97.0

Q ss_pred             CCCCCcccCCCCeeEEEECCCCChHHHHHHHhhcC--CEEeeeCCHHHHHHHHHHhCCC---CCCeEEeeeecCCCCCCc
Q 010309            9 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIG--GHLAALTSYEEEHSAQKLCGKN---VNGCWVGGRSINTTVGLS   83 (513)
Q Consensus         9 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~--~~L~~i~~~~e~~f~~~~~~~~---~~~~WiGl~~~~~~~~~~   83 (513)
                      ||+||.  .++++||+++.++++|.+|+.+|+.+|  |+||+|+|.+|++||.+++...   ...+||||++........
T Consensus         2 Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~g~L~~i~s~~e~~fi~~~~~~~~~~~~~~WIGl~~~~~~~~~~   79 (131)
T d1oz7a_           2 CPPGWS--SNGVYCYMLFKEPKTWDEAEKFCNKQGKDGHLLSIESKKEEILVDIVVSENIGKMYKIWTGLSERSKEQHCS   79 (131)
T ss_dssp             CCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCSHHHHHHHHHHHHHHSCCCSEEEEEEEECCCGGGSC
T ss_pred             CCCCCE--EECCEEEEEECcccCHHHHHhhhhccCCCccccccCCHHHhhhhhhheecccCCCccEEEEEEecCcccccc
Confidence            999999  799999999999999999999999876  9999999999999998877422   457999999544333346


Q ss_pred             eEEcCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeecC--CCcccccccCCCCCcccccccc
Q 010309           84 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG--SRSLVTERCNTSHPFICMVEHE  149 (513)
Q Consensus        84 w~W~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~--~~~w~d~~C~~~~~~iC~~~~~  149 (513)
                      |+|+||+++.+.+++.+                 .++|+.+...  ...|++..|....+|||+++.+
T Consensus        80 ~~W~dgs~~~~~~~~~~-----------------~~~C~~~~~~~~~~~W~~~~C~~~~~fICe~~~p  130 (131)
T d1oz7a_          80 SRWSDGSFFRSYEIAIR-----------------YSECFVLEKQSVFRTWVATPCENTFPFMCKYPVP  130 (131)
T ss_dssp             CBCSSSBCCSCCCCCCS-----------------CCCEEEEEGGGTTCSEEEECTTSCEEEEEEECTT
T ss_pred             cccCCCCcccCCccCCC-----------------CCCEEEEEecCCCCcEEecCCCCCEeEEEeEeCC
Confidence            99999987554443322                 2357777533  3469999999999999999753

>d1rdl1_ d.169.1.1 (1:) Mannose-binding protein A, C-lectin domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Mannose-binding protein A, C-lectin domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.90  E-value=3e-24  Score=174.26  Aligned_cols=110  Identities=14%  Similarity=0.181  Sum_probs=97.2

Q ss_pred             eeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEcCCCCCccCCcccC
Q 010309           21 KCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAV  100 (513)
Q Consensus        21 ~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~dg~~~~~~~~~~~  100 (513)
                      +||+++.++++|.+|+..|+++||+||+|+|++|++||.+++.   ..+||||+  +...+|.|.|+||+++.|++|.++
T Consensus         1 kyy~~~~~~~~~~~A~~~C~~~gg~La~i~s~~e~~~l~~~~~---~~~WiGl~--~~~~~~~~~w~dG~~~~y~~W~~g   75 (111)
T d1rdl1_           1 KYFMSSVRRMPLNRAKALCSELQGTVATPRNAEENRAIQNVAK---DVAFLGIT--DQRTENVFEDLTGNRVRYTNWNEG   75 (111)
T ss_dssp             CEEEECSSCBCHHHHHHHHHHTTCEECCCCSHHHHHHHHHHCS---SCEEEEEE--CSSSTTCCEETTSCBCCCCCBCTT
T ss_pred             CEEEECCcEeCHHHHHHHHHHcCCEEEEECCHHHhHHHhhccc---ceeeEEee--ecCccceeeecccccceeeecccc
Confidence            5899999999999999999999999999999999999999875   56999999  666779999999999999999999


Q ss_pred             CCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCccccc
Q 010309          101 GSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMV  146 (513)
Q Consensus       101 ~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~  146 (513)
                      +|.+          .++.++|+.+.. ++.|++..|....+|||+.
T Consensus        76 eP~~----------~~~~~~Cv~~~~-~g~W~d~~C~~~~~fICe~  110 (111)
T d1rdl1_          76 EPNN----------VGSGENCVVLLT-NGKWNDVPCSDSFLVVCEF  110 (111)
T ss_dssp             CCCC----------CTTCCCEEEECT-TSCEEEECTTSCBEEEEEE
T ss_pred             CCCC----------CCCcceEEEECC-CCEEEeeCCCCCEEEEEEE
Confidence            8822          235678998854 4689999999999999985

>d1h8ua_ d.169.1.1 (A:) Eosinophil major basic protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Eosinophil major basic protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.90  E-value=2.5e-24  Score=175.94  Aligned_cols=112  Identities=15%  Similarity=0.312  Sum_probs=98.1

Q ss_pred             EEEECCCCChHHHHHHHhh-cCCEEeeeCCHHHHHHHHHHhCCC-CCCeEEeeeecCCCCCCceEEcCCCCCccCCcccC
Q 010309           23 FGYIGNFRSWDESETYCKE-IGGHLAALTSYEEEHSAQKLCGKN-VNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAV  100 (513)
Q Consensus        23 y~~~~~~~~w~~a~~~C~~-~~~~L~~i~~~~e~~f~~~~~~~~-~~~~WiGl~~~~~~~~~~w~W~dg~~~~~~~~~~~  100 (513)
                      |+++.+.+||.+|+..|++ +||+||+|+|.+|++||.+++... ...+||||+..+...++.|+|+||+++.|.+|.++
T Consensus         2 Y~~~~~~~tw~~A~~~C~~~~gg~L~sI~s~~e~~~i~~~~~~~~~~~~WIGl~~~~~~~~~~~~W~dGs~~~y~~W~~~   81 (115)
T d1h8ua_           2 YLLVRSLQTFSQAWFTCRRCYRGNLVSIHNFNINYRIQCSVSALNQGQVWIGGRITGSGRCRRFQWVDGSRWNFAYWAAH   81 (115)
T ss_dssp             EEEEEEEECHHHHHHHHHHHHSSEECCCCSHHHHHHHHHHHTTCSSSEEEEEEEEECSSSCCEEEETTCCCCCCCCBCSS
T ss_pred             eEEECCccCHHHHHHHhhcccCCcCcccCHHHHHHHHHHHHhhcCCCcEEEEEEecCCCCcceEEEecCceeecccccCC
Confidence            8899999999999999987 799999999999999999998765 45799999866777778999999999999999999


Q ss_pred             CCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCccccc
Q 010309          101 GSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMV  146 (513)
Q Consensus       101 ~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~  146 (513)
                      +|.+            ..++|+.+...++.|++..|....+|||+.
T Consensus        82 ~P~~------------~~~~Cv~~~~~~g~W~~~~C~~~~~fICe~  115 (115)
T d1h8ua_          82 QPWS------------RGGHCVALCTRGGYWRRAHCLRRLPFICSY  115 (115)
T ss_dssp             SCCT------------TSCSEEEEETTTTCEEEECTTSCEEEEEEC
T ss_pred             CCCC------------CCCCEEEEECCCCEEEeeCCCCCEeeEEeC
Confidence            8832            124699987777789999999999999984

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.90  E-value=9.6e-25  Score=195.93  Aligned_cols=161  Identities=19%  Similarity=0.188  Sum_probs=119.4

Q ss_pred             CceecccCceEEEEEEeCCCCEEEEEEecccch------------------hcHHHHHHHHHHHhhcCCCcEeeeeeEEe
Q 010309          230 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSF------------------QRKKEFYSEIGRFARLHHPNLVAVKGCCY  291 (513)
Q Consensus       230 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  291 (513)
                      ++.||+|+||.||+|...+|+.||||+++....                  .......+|...+.++.|++++..+++. 
T Consensus         5 g~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~-   83 (191)
T d1zara2           5 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE-   83 (191)
T ss_dssp             EEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE-
T ss_pred             CCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec-
Confidence            467899999999999998999999998753211                  0113346788899999999999887653 


Q ss_pred             eCCceEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceEcCCCCCceEecCCCCeEEec
Q 010309          292 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMG  371 (513)
Q Consensus       292 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~D  371 (513)
                         ..+++|||+++..+..           ++...+..++.|++.+|+|||++   +|+||||||+|||++++ .++|+|
T Consensus        84 ---~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~liD  145 (191)
T d1zara2          84 ---GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWIID  145 (191)
T ss_dssp             ---TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEECC
T ss_pred             ---CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEEE
Confidence               2479999998765533           33344568999999999999999   99999999999999976 589999


Q ss_pred             ccccccCCccccccceeecCccccccc------ccccccCCCCchhhHHHHHHHH
Q 010309          372 VGLSKFVPWEVMQERTVMAGGTYGYLA------PEFVYRNELTTKSDVYSFGVLL  420 (513)
Q Consensus       372 fg~~~~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~sDvwSlGvil  420 (513)
                      ||.|.........          .|..      .+. ....|+.++|+||..--+
T Consensus       146 FG~a~~~~~~~~~----------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         146 FPQSVEVGEEGWR----------EILERDVRNIITY-FSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CTTCEETTSTTHH----------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred             CCCcccCCCCCcH----------HHHHHHHHHHHHH-HcCCCCCcccHHHHHHHH
Confidence            9999765432211          1111      111 135677889999976443

>d1kg0c_ d.169.1.1 (C:) EBV gp42 {Epstein-Barr virus [TaxId: 10376]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: EBV gp42
species: Epstein-Barr virus [TaxId: 10376]

Probab=99.85  E-value=7.4e-22  Score=165.25  Aligned_cols=115  Identities=16%  Similarity=0.224  Sum_probs=92.8

Q ss_pred             CCCCCCcccCCCCeeEEEECCCCChHHHHHHHhhc-CCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEE
Q 010309            8 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI-GGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKW   86 (513)
Q Consensus         8 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~-~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W   86 (513)
                      .||.+|.  .|+++||+|+.++++|.+|+..|+++ +++|++|++++|+.||..++.. ...|||||++  . .+|.|+|
T Consensus        18 ~~~~~~~--~~~~~CY~~~~~~~tw~~A~~~C~~~~~~~L~~i~~~~e~~fl~~~~~~-~~~~WIGL~~--~-~~~~W~W   91 (136)
T d1kg0c_          18 NTREYTF--SYKGCCFYFTKKKHTWNGCFQACAEKYPCTYFYGPTPDILPVVTRNLNA-IESLWVGVYR--V-GEGNWTS   91 (136)
T ss_dssp             CTTTCSE--EETTEEEEECSSCBCTTHHHHHHHHHSTTCEECCCCTTTHHHHHHTSCS-SCCEECSEEE--S-SSSSEEE
T ss_pred             CCCCCeE--eECCEEEEEEcccCcHHHHHHHHhcCCCCcEeccCCHHHHHHHHHhcCC-CCcEEEEEEe--c-CCCceEE
Confidence            4689999  89999999999999999999999886 5699999999999999998753 4579999984  2 3689999


Q ss_pred             cCCCCCccCCcccCCCCCCCCCCCCCCCCcCCCceeEeec-CCCcccccccCCCCCcccccc
Q 010309           87 SDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN-GSRSLVTERCNTSHPFICMVE  147 (513)
Q Consensus        87 ~dg~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~-~~~~w~d~~C~~~~~~iC~~~  147 (513)
                      +||+++.  .|...                 .++|+.+.. ..+.|++..|....+|||+..
T Consensus        92 ~Dgs~~~--~~~~~-----------------~~~C~~l~~~~~~~w~~~~C~~~~~~IC~~~  134 (136)
T d1kg0c_          92 LDGGTFK--VYQIF-----------------GSHCTYVSKFSTVPVSHHECSFLKPCLCVSQ  134 (136)
T ss_dssp             TTCSCCC--CBCSS-----------------CTTCEEECTTCSSCEECSCTTSCBCBEEEEE
T ss_pred             CCCCccc--ccccc-----------------ccceEEEEecCCCcEeecCCCCCcceEEEEe
Confidence            9998743  33111                 125766643 335699999999999999864

>d1g1ta1 d.169.1.1 (A:1-118) E-selectin, C-lectin domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: E-selectin, C-lectin domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.84  E-value=2.1e-21  Score=159.48  Aligned_cols=109  Identities=18%  Similarity=0.345  Sum_probs=92.2

Q ss_pred             eEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEcCCCC---CccCCcc
Q 010309           22 CFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMS---KWNESIH   98 (513)
Q Consensus        22 Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~dg~~---~~~~~~~   98 (513)
                      ||+|+.++++|.+|+..|+..||+||+|+|.+|++||.+++......+||||+  +.  ++.|.|+||+.   ..|.+|.
T Consensus         2 ~Y~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~WiGl~--~~--~~~~~w~~~~~~~~~~~~~W~   77 (118)
T d1g1ta1           2 SYNTSTEAMTYDEASAYCQQRYTHLVAIQNKEEIEYLNSILSYSPSYYWIGIR--KV--NNVWVWVGTQKPLTEEAKNWA   77 (118)
T ss_dssp             EEEECSSCBCHHHHHHHHHHHSSEECCCCSHHHHHHHHHHSCCCTTCEEESEE--EE--TTEEEETTTCCBCCTTTCCBC
T ss_pred             EEEEeCCccCHHHHHHHHHHCCCEEeEEccHHHhHHHHhccccccceeeeccc--cc--ceeeeeecCCCCccccccccC
Confidence            79999999999999999999999999999999999999998766678999999  43  47899998864   3688999


Q ss_pred             cCCCCCCCCCCCCCCCCcCCCceeEee----cCCCcccccccCCCCCccc
Q 010309           99 AVGSFNSSCTSLPCHVHATVDLCTLVS----NGSRSLVTERCNTSHPFIC  144 (513)
Q Consensus        99 ~~~~~~~~~~~~~c~~~~~~~~C~~~~----~~~~~w~d~~C~~~~~~iC  144 (513)
                      +++|.+          ..+.++|+.+.    ...+.|++..|....+|||
T Consensus        78 ~~eP~~----------~~~~~~Cv~l~~~~~~~~~~W~d~~C~~~~~fIC  117 (118)
T d1g1ta1          78 PGEPNN----------RQKDEDCVEIYIKREKDVGMWNDERCSKKKLALC  117 (118)
T ss_dssp             TTCCCC----------CSTTCCEEEECTTCSSSTTCEEEECTTSCBEEEE
T ss_pred             CCCccC----------CCCCCCeEEEEecCCCCCCeEeccCCCCCeeEEc
Confidence            998832          23456798874    2335699999999999999

>d1wk1a_ d.169.1.1 (A:) Hypothetical protein F28B4.3 {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Hypothetical protein F28B4.3
species: Caenorhabditis elegans [TaxId: 6239]

Probab=99.84  E-value=2.9e-21  Score=165.46  Aligned_cols=118  Identities=16%  Similarity=0.280  Sum_probs=96.2

Q ss_pred             CCCCeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEcCCCCCc---
Q 010309           17 EEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKW---   93 (513)
Q Consensus        17 ~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~dg~~~~---   93 (513)
                      ..+.+||.++.+.++|.+|+.+|+.+||+||+|++++|++||.+++.  ...|||||++  . .+|.|+|+||+++.   
T Consensus         5 ~~g~~~~~~~~~~~s~~~A~~~C~~~gg~La~i~~~~e~~fi~~~~~--~~~~WiGl~~--~-~~g~w~W~dg~~~~~~~   79 (150)
T d1wk1a_           5 SSGVKFLTVNDDILSMPQARNFCASAGGYLADDLGDDKNNFYSSIAA--NTQFWIGLFK--N-SDGQFYWDRGQGINPDL   79 (150)
T ss_dssp             SCCCCSSSCCSSCBCHHHHHHHHHHHTCEECCCCSHHHHHHHHHHTT--TCEEEEEEEE--C-SSSCEEECCSSSSCCEE
T ss_pred             CCCcEEEEEeCCccCHHHHHHHHHhCCCEEeeeCCHHHHHHhhhccc--ccceeEeeee--c-ccccccccccccccccc
Confidence            34566777889999999999999999999999999999999999987  5689999984  2 46899999998854   


Q ss_pred             ----cCCcccCCCCCCCCCCCCCCCCcCCCceeEeecCC----CcccccccCCCCCccccccccC
Q 010309           94 ----NESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS----RSLVTERCNTSHPFICMVEHEN  150 (513)
Q Consensus        94 ----~~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~----~~w~d~~C~~~~~~iC~~~~~~  150 (513)
                          |.+|.+++|.           +.+.++|+.+....    ..|++..|....+|||+.....
T Consensus        80 ~~~~~~~W~~~eP~-----------~~~~~~C~~~~~~~~~~~~~W~~~~C~~~~~fICe~~~~~  133 (150)
T d1wk1a_          80 LNQPITYWANGEPS-----------NDPTRQCVYFDGRSGDKSKVWTTDTCATPRPFICQKHRYD  133 (150)
T ss_dssp             CCCSCCCBCTTCSC-----------CCSSCCEEEEESSCSCGGGCEEEECTTSCBCCCEECCCCC
T ss_pred             cccccccccCCCCC-----------CCCCcceEEEeccCCCCCCceEccCCCCCEeEEEEECCCC
Confidence                7788888872           23445688875432    3599999999999999975433

>d1g1sa1 d.169.1.1 (A:1-118) P-selectin, C-lectin domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: P-selectin, C-lectin domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.83  E-value=6.5e-21  Score=156.44  Aligned_cols=108  Identities=19%  Similarity=0.352  Sum_probs=90.2

Q ss_pred             EEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEcCCCC---CccCCccc
Q 010309           23 FGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMS---KWNESIHA   99 (513)
Q Consensus        23 y~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~dg~~---~~~~~~~~   99 (513)
                      |+|+.++++|.+|+..|+.+||+||+|+|++|++||.+++......+||||+  +.  ++.|+|+||++   ..|.+|.+
T Consensus         3 Y~~~~~~~~w~~A~~~C~~~gg~La~i~s~~e~~fl~~~~~~~~~~~WiGl~--~~--~~~~~W~~~~~~~~~~~~~W~~   78 (118)
T d1g1sa1           3 YHYSTKAYSWNISRKYCQNRYTDLVAIQNKNEIDYLNKVLPYYSSYYWIGIR--KN--NKTWTWVGTKKALTNEAENWAD   78 (118)
T ss_dssp             EEEEEEEECHHHHHHHHHHHSSEECCCCCHHHHHHHHHHSCCCTTCEEEEEE--EE--TTEEEETTTCCBCCTTTCCBCT
T ss_pred             EEEECCccCHHHHHHHHHHcCCEEeEEeCHHHHHHHHhhhccccccchhhcc--cc--ccccceecCCCCccceecccCC
Confidence            8999999999999999999999999999999999999998766667999999  43  37799988764   35788998


Q ss_pred             CCCCCCCCCCCCCCCCcCCCceeEeec----CCCcccccccCCCCCccc
Q 010309          100 VGSFNSSCTSLPCHVHATVDLCTLVSN----GSRSLVTERCNTSHPFIC  144 (513)
Q Consensus       100 ~~~~~~~~~~~~c~~~~~~~~C~~~~~----~~~~w~d~~C~~~~~~iC  144 (513)
                      ++|.+          ..+.++|+.+..    ..+.|++.+|....+|||
T Consensus        79 ~eP~~----------~~~~~~Cv~~~~~~~~~~~~W~d~~C~~~~~fIC  117 (118)
T d1g1sa1          79 NEPNN----------KRNNEDCVEIYIKSPSAPGKWNDEHCLKKKHALC  117 (118)
T ss_dssp             TCCCC----------TTSCCCEEEECTTCSSSTTCEEEECTTSCEEEEE
T ss_pred             CCCCC----------CCCCCCeEEEEccCCCCCCeEEeeCCCCCEeEEc
Confidence            88822          235668988742    234699999999999999

>d1byfa_ d.169.1.1 (A:) Lectin TC14 {Tunicate (Polyandrocarpa misakiensis) [TaxId: 7723]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: C-type lectin domain
domain: Lectin TC14
species: Tunicate (Polyandrocarpa misakiensis) [TaxId: 7723]

Probab=99.77  E-value=3e-19  Score=147.51  Aligned_cols=117  Identities=19%  Similarity=0.284  Sum_probs=94.1

Q ss_pred             CeeEEEECCCCChHHHHHHHhhcCCEEeeeCCHHHHHHHHHHhCCC--CCCeEEeeeecCCCCC-CceEEcCCCCC--cc
Q 010309           20 SKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVG-LSWKWSDNMSK--WN   94 (513)
Q Consensus        20 ~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~-~~w~W~dg~~~--~~   94 (513)
                      ++.|+|+.++++|.+|+..|+.+||+||+|.+++|+.|+..+....  ...+||||+  +...+ ..|.|.||+++  .+
T Consensus         1 ~y~~~f~~~~~tw~~A~~~C~~~g~~La~i~~~~~~~~~~~~~~~~~~~~~~WiG~~--~~~~~~~~w~~~~~~~~~~~~   78 (123)
T d1byfa_           1 DYEILFSDETMNYADAGTYCQSRGMALVSSAMRDSTMVKAILAFTEVKGHDYWVGAD--NLQDGAYNFLWNDGVSLPTDS   78 (123)
T ss_dssp             CEEEEEEEEEECHHHHHHHHHTTTCEESCGGGGSHHHHHHHHHHHHHHTCCEEEEEE--STTTCTTCCEETTSCBCCTTC
T ss_pred             CeEEEEECcEeCHHHHHHHHHHCCCCCCccCCHHHHHHHHHHHhccCCCccEEEeec--cccccccccccccCCcccccc
Confidence            3678999999999999999999999999999999999987655322  457999998  43333 46999999875  45


Q ss_pred             CCcccCCCCCCCCCCCCCCCCcCCCceeEeecCCCcccccccCCCCCccccccc
Q 010309           95 ESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEH  148 (513)
Q Consensus        95 ~~~~~~~~~~~~~~~~~c~~~~~~~~C~~~~~~~~~w~d~~C~~~~~~iC~~~~  148 (513)
                      .+|..++|.+          ..+.++|+.+....+.|++.+|....+|||+.+.
T Consensus        79 ~~~~~~~p~~----------~~~~~~Cv~l~~~~~~W~~~~C~~~~~fICe~~~  122 (123)
T d1byfa_          79 DLWSPNEPSN----------PQSWQLCVQIWSKYNLLDDVGCGGARRVICEKEL  122 (123)
T ss_dssp             TTBCTTCSCS----------CTTSCCEEEEETTTTEEEEECSCSCEEEEEEEEC
T ss_pred             cccccccccc----------ccCcceeEEEecCCCeEeeeCCCCCEeEEEEEcc
Confidence            6777777621          2345689999877778999999999999999853

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.62  E-value=8.6e-08  Score=88.21  Aligned_cols=149  Identities=12%  Similarity=0.056  Sum_probs=99.9

Q ss_pred             HHHHHHhhCcccCCceecccCceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhcC-CCcEeeeeeEEeeCCc
Q 010309          217 EELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGD  295 (513)
Q Consensus       217 ~~l~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~  295 (513)
                      .|+.+....+... +..+.++.+.||+... +++.++||+...........+.+|...+..+. +--+.+++.+..+++.
T Consensus         7 ~~l~~~~~~~~~~-~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~   84 (263)
T d1j7la_           7 PELKKLIEKYRCV-KDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW   84 (263)
T ss_dssp             HHHHHHHTTSEEE-ECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred             HHHHHhhhceEEE-EcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCc
Confidence            3556655555332 1212334468998865 67778899887665445556778888887773 4346777888888888


Q ss_pred             eEEEEeeccCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC------------------------------
Q 010309          296 RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV------------------------------  345 (513)
Q Consensus       296 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~------------------------------  345 (513)
                      .++||++++|.++.+....         ......++.+++..|+.||+..                              
T Consensus        85 ~~lv~~~l~G~~~~~~~~~---------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (263)
T d1j7la_          85 SNLLMSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC  155 (263)
T ss_dssp             EEEEEECCSSEEHHHHTTT---------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCG
T ss_pred             eEEEEEecccccccccccc---------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhh
Confidence            9999999999888665421         0112234555566666666421                              


Q ss_pred             --------------------------CCCceEcCCCCCceEecCCCCeEEecccccc
Q 010309          346 --------------------------KPHVVHRDIRASNVLLDEEFGAHLMGVGLSK  376 (513)
Q Consensus       346 --------------------------~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~  376 (513)
                                                .+.++|+|+.|.|||++++..+-|+||+.+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             GGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             hcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                      1137899999999999987666799998875

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.03  E-value=1.1e-05  Score=73.08  Aligned_cols=72  Identities=15%  Similarity=0.105  Sum_probs=53.0

Q ss_pred             cccC-ceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhcC--CCcEeeeeeEEeeCCceEEEEeeccCCCH
Q 010309          234 GDSK-TGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH--HPNLVAVKGCCYDHGDRYIVYEFVVNGPL  308 (513)
Q Consensus       234 g~G~-~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~~~~lv~e~~~~gsL  308 (513)
                      ..|. .+.||+....++..+++|.......   ..+..|+..|+.+.  .-.+.+++.+..+++..++||++++|.++
T Consensus        19 ~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          19 TIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             SCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             CCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            4444 3689999987888899998765532   34667777777763  33466778888888889999999988665

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.64  E-value=0.00011  Score=71.00  Aligned_cols=74  Identities=15%  Similarity=-0.002  Sum_probs=48.2

Q ss_pred             eecccCceEEEEEEeCC-CCEEEEEEeccc------c-hhcHHHHHHHHHHHhhc-CC--CcEeeeeeEEeeCCceEEEE
Q 010309          232 LLGDSKTGGTYSGILPD-GSRVAVKRLKRS------S-FQRKKEFYSEIGRFARL-HH--PNLVAVKGCCYDHGDRYIVY  300 (513)
Q Consensus       232 ~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~------~-~~~~~~~~~E~~~l~~l-~h--~nIv~l~~~~~~~~~~~lv~  300 (513)
                      -||.|....||+....+ ++.|+||.-...      + .....+...|+..|..+ .+  ..+++++.+  +.+..++||
T Consensus        33 eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lvm  110 (392)
T d2pula1          33 EIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTVM  110 (392)
T ss_dssp             ECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEEE
T ss_pred             EeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEEE
Confidence            46999999999998654 678999975431      0 11233456688777766 22  345556543  556678999


Q ss_pred             eeccCCC
Q 010309          301 EFVVNGP  307 (513)
Q Consensus       301 e~~~~gs  307 (513)
                      |++.+..
T Consensus       111 E~L~~~~  117 (392)
T d2pula1         111 EDLSHLK  117 (392)
T ss_dssp             CCCTTSE
T ss_pred             eccCCcc
Confidence            9997654

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.24  E-value=0.001  Score=62.23  Aligned_cols=164  Identities=12%  Similarity=0.116  Sum_probs=89.6

Q ss_pred             ccccCHHHHHHHhhCc--ccCCceecccC-ceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCcE--ee
Q 010309          211 WKVFTTEELRSITKNF--SEGNRLLGDSK-TGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNL--VA  285 (513)
Q Consensus       211 ~~~~~~~~l~~~~~~~--~~~~~~lg~G~-~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI--v~  285 (513)
                      ...++.+.+..+....  ....+++--++ --.||++..++|+.|++|+.+.. ....+++..|...+..|....|  +.
T Consensus         5 f~~L~pd~i~~al~~~g~~~~~~~~~L~s~EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~   83 (325)
T d1zyla1           5 FQTLHPDTIMDALFEHGIRVDSGLTPLNSYENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAA   83 (325)
T ss_dssp             CCCCCHHHHHHHHHHTTCCCCSCCEEECCSSSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCC
T ss_pred             ccccCHHHHHHHHHHcCCCCCcCccccccccceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCC
Confidence            3445556555554333  22223322233 35899999999999999998764 2345678888888887742222  11


Q ss_pred             eee-----EEeeCCceEEEEeeccCCCHH-----H------Hh-------ccCC-CCCCCCCH-----------------
Q 010309          286 VKG-----CCYDHGDRYIVYEFVVNGPLD-----R------WL-------HHIP-RGGRSLDW-----------------  324 (513)
Q Consensus       286 l~~-----~~~~~~~~~lv~e~~~~gsL~-----~------~l-------~~~~-~~~~~l~~-----------------  324 (513)
                      .+.     .+...+..+.++++++|..+.     .      .+       .... .....++.                 
T Consensus        84 p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~  163 (325)
T d1zyla1          84 PVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLI  163 (325)
T ss_dssp             CCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSS
T ss_pred             ceecCCCeeeeeeeEEEEEEeecCCcCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcC
Confidence            111     123345668899998764321     0      01       1000 00111111                 


Q ss_pred             --H---HHHHHHHHHHHHHHHH-hcCCCCCceEcCCCCCceEecCCCCeEEeccccccc
Q 010309          325 --A---MRMKVATTLAQGIAFL-HDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF  377 (513)
Q Consensus       325 --~---~~~~i~~qi~~~L~~L-H~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~~  377 (513)
                        .   .....+.++...+.-+ .+....+++|+|+.|.|||++++  ..++||+.+..
T Consensus       164 ~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         164 PSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             CHHHHHHHHHHHHHHHHHHHHhccccCCceeecCCCCcccEEEeCC--ceEEechhccc
Confidence              1   1122233333333222 12224478999999999999754  56899998864

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.87  E-value=0.0012  Score=61.22  Aligned_cols=159  Identities=13%  Similarity=0.079  Sum_probs=83.4

Q ss_pred             cCHHHHHHHhhCcccCCce-----ecccCceEEEEEEeCCCCEEEEEEecccchhcHHHHHHHHHHHhhcCCCc--Eeee
Q 010309          214 FTTEELRSITKNFSEGNRL-----LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPN--LVAV  286 (513)
Q Consensus       214 ~~~~~l~~~~~~~~~~~~~-----lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~l  286 (513)
                      .+.+|+..+...|..+ ++     |..|---+.|+....+| .+++|+.....  ..+++..|+.++..|...+  ++..
T Consensus         3 ls~~el~~~l~~Y~lg-~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~p   78 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVG-SLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLP   78 (316)
T ss_dssp             CCHHHHHHHHTTBCCC-CEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred             CCHHHHHHHHHhCCCC-CceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhcccccccc
Confidence            5678899999887543 23     34566678899988655 48999986542  2344555666777663222  1111


Q ss_pred             eeE------EeeCCceEEEEeeccCCCHHH-----------H---hc----cCC--CCCCCC-----------------C
Q 010309          287 KGC------CYDHGDRYIVYEFVVNGPLDR-----------W---LH----HIP--RGGRSL-----------------D  323 (513)
Q Consensus       287 ~~~------~~~~~~~~lv~e~~~~gsL~~-----------~---l~----~~~--~~~~~l-----------------~  323 (513)
                      +..      .........++.+..+.....           .   ++    ...  ......                 .
T Consensus        79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (316)
T d2ppqa1          79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV  158 (316)
T ss_dssp             CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred             ceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhc
Confidence            111      112334566666665533210           0   00    000  000000                 0


Q ss_pred             HHHHHHHHHHHHHHHHHHhc-CCCCCceEcCCCCCceEecCCCCeEEecccccc
Q 010309          324 WAMRMKVATTLAQGIAFLHD-KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK  376 (513)
Q Consensus       324 ~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~~~  376 (513)
                      .......+..+...+.-.+. ....++||+|+.++||+++.+...-|.||+.+.
T Consensus       159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             chhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            00111222223333333332 123479999999999999988777899999875

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.73  E-value=0.0019  Score=62.02  Aligned_cols=71  Identities=13%  Similarity=0.109  Sum_probs=48.6

Q ss_pred             eecccCceEEEEEEeCC--------CCEEEEEEecccchhcHHHHHHHHHHHhhcC-CCcEeeeeeEEeeCCceEEEEee
Q 010309          232 LLGDSKTGGTYSGILPD--------GSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVYEF  302 (513)
Q Consensus       232 ~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~  302 (513)
                      .|+.|-.-.+|+...++        ...|++++....  .......+|..+++.+. +.-..++++++.+    .+|+||
T Consensus        49 ~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ef  122 (395)
T d1nw1a_          49 RIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY  122 (395)
T ss_dssp             EECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred             EcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEE
Confidence            46888889999998654        356777776532  23445668888888884 4334567777643    589999


Q ss_pred             ccCCCH
Q 010309          303 VVNGPL  308 (513)
Q Consensus       303 ~~~gsL  308 (513)
                      ++|.+|
T Consensus       123 i~g~~l  128 (395)
T d1nw1a_         123 IPSRPL  128 (395)
T ss_dssp             CCEEEC
T ss_pred             eccccC
Confidence            987544

>d2pf5a1 d.169.1.4 (A:1-95) TSG-6, Link module {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: C-type lectin-like
superfamily: C-type lectin-like
family: Link domain
domain: TSG-6, Link module
species: Human (Homo sapiens) [TaxId: 9606]

Probab=83.03  E-value=0.31  Score=35.33  Aligned_cols=21  Identities=33%  Similarity=0.596  Sum_probs=19.6

Q ss_pred             CCChHHHHHHHhhcCCEEeee
Q 010309           29 FRSWDESETYCKEIGGHLAAL   49 (513)
Q Consensus        29 ~~~w~~a~~~C~~~~~~L~~i   49 (513)
                      ..|+.||+..|+..|+.||+.
T Consensus        13 ~l~f~eA~~~C~~~ga~LAt~   33 (95)
T d2pf5a1          13 KLTYAEAKAVCEFEGGHLATY   33 (95)
T ss_dssp             CBCHHHHHHHHHHTTCEECCH
T ss_pred             cCCHHHHHHHHHHcCCccCCH
Confidence            479999999999999999986